PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Voipio, J; Boron, WF; Jones, SW; Hopfer, U; Payne, JA; Kaila, K				Voipio, Juha; Boron, Walter F.; Jones, Stephen W.; Hopfer, Ulrich; Payne, John A.; Kaila, Kai			Comment on "Local impermeant anions establish the neuronal chloride concentration"	SCIENCE			English	Editorial Material							DIVALENT IONS; TRANSPORTERS		[Voipio, Juha; Kaila, Kai] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Boron, Walter F.; Jones, Stephen W.; Hopfer, Ulrich] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Payne, John A.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Kaila, Kai] Univ Helsinki, Ctr Neurosci, Helsinki, Finland	University of Helsinki; Case Western Reserve University; University of California System; University of California Davis; University of Helsinki	Voipio, J (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	juha.voipio@helsinki.fi	Luhmann, Heiko J./N-8797-2019; Boron, Walter/ABI-1564-2020; Kaila, Kai K/R-8528-2016; Jones, Stephen/AAJ-4465-2020	Luhmann, Heiko J./0000-0002-7934-8661; Kaila, Kai K/0000-0003-0668-5955; Boron, Walter/0000-0003-4741-7287; Voipio, Juha/0000-0001-7096-1286				Aronson PS, 2012, MED PHYSL CELLULAR M, P106; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; Hille B., 2001, ION CHANNELS EXCITAB, p[340, 545, 649]; MCLAUGHLIN SG, 1971, J GEN PHYSIOL, V58, P667, DOI 10.1085/jgp.58.6.667; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008	8	23	23	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201								10.1126/science.1252978	http://dx.doi.org/10.1126/science.1252978			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190788				2022-12-28	WOS:000341179800032
J	Luhmann, HJ; Kirischuk, S; Kilb, W				Luhmann, Heiko J.; Kirischuk, Sergei; Kilb, Werner			Comment on "Local impermeant anions establish the neuronal chloride concentration"	SCIENCE			English	Editorial Material							RAT NEOCORTICAL NEURONS; HIPPOCAMPAL-NEURONS; DEVELOPING BRAIN; COTRANSPORT; KCC2; MATURATION; SEIZURES; NKCC1		[Luhmann, Heiko J.; Kirischuk, Sergei; Kilb, Werner] Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Luhmann, HJ (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, Duesbergweg 6, D-55128 Mainz, Germany.	luhmann@uni-mainz.de	Luhmann, Heiko J./N-8797-2019; Boron, Walter/ABI-1564-2020; Kaila, Kai K/R-8528-2016; Jones, Stephen/AAJ-4465-2020	Luhmann, Heiko J./0000-0002-7934-8661; Kaila, Kai K/0000-0003-0668-5955; Boron, Walter/0000-0003-4741-7287; Voipio, Juha/0000-0001-7096-1286				Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Brumback AC, 2008, J NEUROSCI, V28, P1301, DOI 10.1523/JNEUROSCI.3378-07.2008; Chudotvorova I, 2005, J PHYSIOL-LONDON, V566, P671, DOI 10.1113/jphysiol.2005.089821; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Minlebaev M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00083; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SZATKOWSKI MS, 1989, J PHYSIOL-LONDON, V409, P89, DOI 10.1113/jphysiol.1989.sp017486; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471	15	23	23	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201								10.1126/science.1255337	http://dx.doi.org/10.1126/science.1255337			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190788				2022-12-28	WOS:000341179800033
J	Thwaites, CL; Beeching, NJ; Newton, CR				Thwaites, C. Louise; Beeching, Nicholas J.; Newton, Charles R.			Maternal and neonatal tetanus	LANCET			English	Article							RISK-FACTORS; CLOSTRIDIUM-TETANI; ANTIBODY TRANSFER; NERVOUS-SYSTEM; HIV-INFECTION; MORTALITY; CARE; MAGNESIUM; IMMUNOGLOBULIN; ELIMINATION	Maternal and neonatal tetanus is still a substantial but preventable cause of mortality in many developing countries. Case fatality from these diseases remains high and treatment is limited by scarcity of resources and effective drug treatments. The Maternal and Neonatal Tetanus Elimination Initiative, launched by WHO and its partners, has made substantial progress in eliminating maternal and neonatal tetanus. Sustained emphasis on improvement of vaccination coverage, birth hygiene, and surveillance, with specific approaches in high-risk areas, has meant that the incidence of the disease continues to fall. Despite this progress, an estimated 58 000 neonates and an unknown number of mothers die every year from tetanus. As of June, 2014, 24 countries are still to eliminate the disease. Maintenance of elimination needs ongoing vaccination programmes and improved public health infrastructure.	[Thwaites, C. Louise] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Beeching, Nicholas J.] Royal Liverpool Univ Hosp, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Beeching, Nicholas J.] Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool, Merseyside, England; [Beeching, Nicholas J.] Natl Inst Hlth, Res Hlth Protect Res Unit Emerging & Zoonot Infec, Liverpool, Merseyside, England; [Newton, Charles R.] Univ Oxford, Kenya Med Res Inst, Wellcome Trust Collaborat Programme, Kilifi, Kenya; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England	Liverpool School of Tropical Medicine; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Kenya Medical Research Institute; University of Oxford	Thwaites, CL (corresponding author), Hosp Trop Dis, Oxford Univ Clin Res Unit, 764 Vo Van Kiet,Dist 5, Ho Chi Minh City, Vietnam.	lthwaites@oucru.org	Newton, Charles/V-7872-2019; Beeching, Nicholas J/L-5363-2017; Ibrahim, Essam Hassan/G-1960-2018; Newton, Charles RJC/B-7578-2014	Newton, Charles/0000-0002-6999-5507; Ibrahim, Essam Hassan/0000-0003-0130-2257; Newton, Charles RJC/0000-0002-6999-5507; Beeching, Nicholas/0000-0002-7019-8791	Li Ka Shing Foundation; Wellcome Trust	Li Ka Shing Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	CRN is funded by the Wellcome Trust and CLT is funded by the Li Ka Shing Foundation.	Adekanle O, 2009, LIBYAN J MED, V4, P78, DOI 10.4176/081125; Ahmad A, 2011, JCPSP-J COLL PHYSICI, V21, P539, DOI 09.2011/JCPSP.539541; Ali G., 2011, J POSTGRADUATE MED I, V25, P106; Amar-Singh H S S, 2009, Med J Malaysia, V64, P1; Amare A, 2011, AFR HEALTH SCI, V11, P36; [Anonymous], 2006, WKLY EPIDEMIOL REC, V20, P197; Atkinson W, 1997, EPIDEMIOLOGY PREVENT, P291; Attygalle D, 2002, ANAESTHESIA, V57, P811; Barlow JL, 2001, TROP MED INT HEALTH, V6, P305, DOI 10.1046/j.1365-3156.2001.00705.x; Basu S, 2006, ANN TROP PAEDIATR, V26, P233, DOI 10.1179/146532806X120336; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BLAKE PA, 1976, JAMA-J AM MED ASSOC, V235, P42, DOI 10.1001/jama.235.1.42; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Bonetti TCS, 2004, VACCINE, V22, P3707, DOI 10.1016/j.vaccine.2004.03.023; Borrow R., 2006, IMMUNOLOGICAL BASIS; Brabin L, 2000, T ROY SOC TROP MED H, V94, P455, DOI 10.1016/S0035-9203(00)90139-1; Brauner JS, 2002, INTENS CARE MED, V28, P930, DOI 10.1007/s00134-002-1332-4; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Campbell JI, 2009, AM J TROP MED HYG, V80, P827, DOI 10.4269/ajtmh.2009.80.827; Chalya PL, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-20; Chavada VK, 2010, J CLIN DIAGN RES, V4, P2649; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; Cutts FT, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001404; Datta SS, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.1.008, 10.5365/WPSAR.2013.4.1.008]; DAVIS P R, 1965, J Bone Joint Surg Br, V47, P61; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Demicheli V, 2013, COCHRANE DB SYST REV, V5; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Dey A C, 2011, Mymensingh Med J, V20, P54; Dieye TN, 2001, VACCINE, V20, P905, DOI 10.1016/S0264-410X(01)00383-8; Ertem M, 2004, J TROP PEDIATRICS, V50, P297, DOI 10.1093/tropej/50.5.297; FAUVEAU V, 1993, INT J GYNECOL OBSTET, V40, P3, DOI 10.1016/0020-7292(93)90765-O; Feroz A.H.M., 2007, J BANGLADESH COLL PH, V25, P62, DOI DOI 10.3329/BCPS.V25I2.371; Fetuga BM, 2010, WORLD J PEDIATR, V6, P71, DOI 10.1007/s12519-010-0010-9; FINN CW, 1984, SCIENCE, V224, P881, DOI 10.1126/science.6326263; FISHMAN PS, 1988, ARCH NEUROL-CHICAGO, V45, P558, DOI 10.1001/archneur.1988.00520290094020; Gibson K, 2009, CAN J ANAESTH, V56, P307, DOI 10.1007/s12630-009-9058-1; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Huang SW, 2013, J VET MED SCI, V75, P489, DOI 10.1292/jvms.12-0271; Jeena PM, 1997, S AFR MED J, V87, P46; Kabura L, 2006, TROP MED INT HEALTH, V11, P1075, DOI 10.1111/j.1365-3156.2006.01659.x; Karanikolas Menelaos, 2010, J Med Case Rep, V4, P100, DOI 10.1186/1752-1947-4-100; Lambo JA, 2013, INT J INFECT DIS, V17, pE1100, DOI 10.1016/j.ijid.2013.05.016; Lambo JA, 2012, INT J INFECT DIS, V16, pE833, DOI 10.1016/j.ijid.2012.07.015; Liu XN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-566; Manga N M, 2010, Med Trop (Mars), V70, P97; Marulappa VG, 2012, J CLIN DIAGN RES, V6, P1377, DOI 10.7860/JCDR/2012/4137.2363; Mathew PJ, 2010, ANAESTH INTENS CARE, V38, P185, DOI 10.1177/0310057X1003800128; Mchil Ugwu GI, 2010, CONT J MED RES, V4, P3; Meegan ME, 2001, LANCET, V358, P640, DOI 10.1016/S0140-6736(01)05787-7; Miranda DD, 2004, BMJ-BRIT MED J, V328, P615, DOI 10.1136/bmj.38027.560347.7C; Miranda DB, 2013, TROP MED INT HEALTH, V18, P555, DOI 10.1111/tmi.12091; Mishra K, 2012, TROP DOCT, V42, P157, DOI 10.1258/td.2012.110445; Muteya MM, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.93.2180; Mwaniki Michael K, 2010, BMC Public Health, V10, P591, DOI 10.1186/1471-2458-10-591; Nagao K, 2007, JPN J INFECT DIS, V60, P149; Namasivayam A, 2012, INT J WOMENS HEALTH, V4, P351, DOI 10.2147/IJWH.S32569; NATION NS, 1963, CALIF MED, V98, P305; Newton C, 2013, PRINCIPLES MED AFRIC, P345; Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59; Okusanya BO, 2013, J MATERN-FETAL NEO M, V26, P885, DOI 10.3109/14767058.2013.765851; Osalusi BS, 2008, SCI RES ESSAYS, V3, P571; Patel J C, 1999, Indian J Med Sci, V53, P393; Peterside O, 2012, INT J PEDIATR NEONAT, V14; Pirazzini M, 2013, BIOCHEM BIOPH RES CO, V430, P38, DOI 10.1016/j.bbrc.2012.11.048; Pomara C, 2009, INT J CARDIOL, V136, pE54, DOI 10.1016/j.ijcard.2008.05.007; Public Health England, TET INF HLTH PROF; Rai R, 2012, INDIAN J PEDIATR, V79, P1648, DOI 10.1007/s12098-011-0666-8; Raza SA, 2013, INT J GYNECOL OBSTET, V120, P148, DOI 10.1016/j.ijgo.2012.07.030; ROBERT R, 1984, PRESSE MED, V13, P1947; Rochat R, 1999, LANCET, V354, P565, DOI 10.1016/S0140-6736(98)05193-9; Rodrigo C, 2012, ANAESTHESIA, V67, P1370, DOI 10.1111/anae.12020; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; Sathirapanya Pornchai, 2009, Journal of the Medical Association of Thailand, V92, P315; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048891; Soumare M, 2005, MED MALADIES INFECT, V35, P450, DOI 10.1016/j.medmal.2005.09.005; Swaminathan S, 2011, FEBS J, V278, P4467, DOI 10.1111/j.1742-4658.2011.08183.x; Sykora M, 2008, J NEUROL SCI, V270, P201, DOI 10.1016/j.jns.2008.02.008; Thwaites CL, 2006, LANCET, V368, P1436, DOI 10.1016/S0140-6736(06)69444-0; Thwaites CL, 2006, ANAESTHESIA, V61, P355, DOI 10.1111/j.1365-2044.2006.04580.x; Thwaites CL, 2006, TROP MED INT HEALTH, V11, P279, DOI 10.1111/j.1365-3156.2006.01562.x; Thwaites CL, 2004, T ROY SOC TROP MED H, V98, P671, DOI 10.1016/j.trstmh.2004.01.008; UNICEF, EL MAT NEON TET; UNICEF, 2013, STATE WORLDS CHILDRE; Vandelaer J, 2009, J PUBLIC HEALTH-UK, V31, P561, DOI 10.1093/pubmed/fdp039; Wateba Mi, 2008, Sante, V18, P125, DOI 10.1684/san.2008.0115; WHO, MAT NEON TET MNT EL; WHO, 2012, WORLD HLTH STAT 2013; WHO, EXP PROGR IMM; Wilson TJ, 2012, J NEUROSURG-SPINE, V16, P82, DOI 10.3171/2011.7.SPINE11335; World Health Organisation, 2019, WHO REC SURV STAND N; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2013, UNS AB GLOB REG EST; World Health Organization, 1994, ESS NEWB CAR REP TEC; World Health Organization, 2012, ACH SUST MAT NEON TE; World Health Organization, 2000, MAT NEON TET EL 2005; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Organization (WHO), WHO REC SURV STAND	103	87	94	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					362	370		10.1016/S0140-6736(14)60236-1	http://dx.doi.org/10.1016/S0140-6736(14)60236-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25149223	Green Accepted			2022-12-28	WOS:000348509000029
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							NULLIPAROUS WOMEN; RISK; PREGNANCY; PREDICTION; GUIDELINES; COHORT	Description: Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation on aspirin prophylaxis in pregnancy. Methods: The USPSTF reviewed the evidence on the effectiveness of low-dose aspirin in preventing preeclampsia in women at increased risk and in decreasing adverse maternal and perinatal health outcomes, and assessed the maternal and fetal harms of low-dose aspirin during pregnancy. Population: This recommendation applies to asymptomatic pregnant women who are at increased risk for preeclampsia and who have no prior adverse effects with or contraindications to low-dose aspirin. Recommendation: The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia. (B recommendation)	[LeFevre, Michael L.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		LeFevre, ML (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2014, REC CLIN PREV SERV; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; [Anonymous], 2013, HYPERTENSION PREGNAN; [Anonymous], 1995, BR J OBSTET GYNAECOL, V102, P861; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Henderson JT, 2014, ANN INTERN MED, V160, P695, DOI 10.7326/M13-2844; Henderson JT, 2014, AHRQ PUBLICATION, V14-05207-EF-1; Jensen MS, 2010, EPIDEMIOLOGY, V21, P779, DOI 10.1097/EDE.0b013e3181f20bed; Keim SA, 2006, EPIDEMIOLOGY, V17, P435, DOI 10.1097/01.ede.0000221693.72971.b3; Myatt L, 2012, OBSTET GYNECOL, V119, P1234, DOI 10.1097/AOG.0b013e3182571669; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Redman CWG, 2011, HEART, V97, P1967, DOI 10.1136/heartjnl-2011-300949; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; World Health Organization, 2011, WHO REC PREV TREATM	18	260	279	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					819	U114		10.7326/M14-1884	http://dx.doi.org/10.7326/M14-1884			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25200125				2022-12-28	WOS:000347247200011
J	Crandall, CJ; Newberry, SJ; Diamant, A; Lim, YW; Gellad, WF; Booth, MJ; Motala, A; Shekelle, PG				Crandall, Carolyn J.; Newberry, Sydne J.; Diamant, Allison; Lim, Yee-Wei; Gellad, Walid F.; Booth, Marika J.; Motala, Aneesa; Shekelle, Paul G.			Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures An Updated Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							BISPHOSPHONATE-RELATED OSTEONECROSIS; ATYPICAL FEMORAL FRACTURES; BONE-MINERAL DENSITY; YEARLY ZOLEDRONIC ACID; POSTMENOPAUSAL WOMEN; ATRIAL-FIBRILLATION; ORAL BISPHOSPHONATES; VERTEBRAL FRACTURE; SUBTROCHANTERIC FRACTURES; PRIMARY OSTEOPOROSIS	Background: Osteoporosis is a major contributor to the propensity to fracture among older adults, and various pharmaceuticals are available to treat it. Purpose: To update a review about the benefits and harms of pharmacologic treatments used to prevent fractures in adults at risk. Data Sources: Multiple computerized databases were searched between 2 January 2005 and 4 March 2014 for English-language studies. Study Selection: Trials, observational studies, and systematic reviews. Data Extraction: Duplicate extraction and assessment of data about study characteristics, outcomes, and quality. Data Synthesis: From more than 52 000 titles screened, 315 articles were included in this update. There is high-strength evidence that bisphosphonates, denosumab, and teriparatide reduce fractures compared with placebo, with relative risk reductions from 0.40 to 0.60 for vertebral fractures and 0.60 to 0.80 for nonvertebral fractures. Raloxifene has been shown in placebo-controlled trials to reduce only vertebral fractures. Since 2007, there is a newly recognized adverse event of bisphosphonate use: atypical subtrochanteric femur fracture. Gastrointestinal side effects, hot flashes, thromboembolic events, and infections vary among drugs. Limitations: Few studies have directly compared drugs used to treat osteoporosis. Data in men are very sparse. Costs were not assessed. Conclusion: Good-quality evidence supports that several medications for bone density in osteoporotic range and/or preexisting hip or vertebral fracture reduce fracture risk. Side effects vary among drugs, and the comparative effectiveness of the drugs is unclear.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; RAND Corp, Santa Monica, CA USA; Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; RAND Corp, Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA USA; Ctr Hlth Equity Res & Promot, Pittsburgh, PA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; National University of Singapore; RAND Corporation	Crandall, CJ (corresponding author), Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, David Geffen Sch Med, 911 Broxton Ave,1st Floor, Los Angeles, CA 90024 USA.	ccrandall@mednet.ucla.edu			Agency for Healthcare Research and Quality (AHRQ) [HHSA290200710062I]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (AHRQ) (HHSA290200710062I). No statement in this article should be construed as an official position of AHRQ or the U.S. Department of Health and Human Services.	Abrahamsen B, 2010, J CLIN ENDOCR METAB, V95, P5258, DOI 10.1210/jc.2010-1571; Abrahamsen B, 2010, CURR OPIN RHEUMATOL, V22, P404, DOI 10.1097/BOR.0b013e32833ad677; Adachi JD, 2011, CALCIFIED TISSUE INT, V89, P427, DOI 10.1007/s00223-011-9543-8; Agency for Healthcare Research and Quality, 2010, COMP EFF TREATM PREV; Almasan HA, 2011, ROM J MORPHOL EMBRYO, V52, P1233; Andrews EB, 2012, J BONE MINER RES, V27, P2429, DOI 10.1002/jbmr.1768; Andrici J, 2012, ALIMENT PHARM THER, V36, P708, DOI 10.1111/apt.12041; Andrici J, 2013, GASTROENTEROLOGY, V144, pS385; [Anonymous], 2013, Bonekey Rep, V2, P269, DOI 10.1038/bonekey.2013.3; [Anonymous], 2012, COMPARISON OF THE EF; [Anonymous], 2012, VERTEBRAL FRACT TREA; [Anonymous], 2013, STATXACT PROCS SAS U; [Anonymous], 2012, COMB RIS PAR HORM TR; Arslan C, 2011, SUPPORT CARE CANCER, V19, P425, DOI 10.1007/s00520-010-0868-z; Bai H, 2013, J INT MED RES, V41, P697, DOI 10.1177/0300060513480917; Baillargeon J, 2011, ANN PHARMACOTHER, V45, P1199, DOI 10.1345/aph.1Q239; Barrett-Connor E, 2012, OSTEOPOROSIS INT, V23, P233, DOI 10.1007/s00198-011-1546-9; Berry SD, 2013, JAMA-J AM MED ASSOC, V310, P1256, DOI 10.1001/jama.2013.277817; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Bocanegra-Perez MS, 2012, MED ORAL PATOL ORAL, V17, pE948, DOI 10.4317/medoral.17946; Bone HG, 2008, J CLIN ENDOCR METAB, V93, P2149, DOI 10.1210/jc.2007-2814; Bone HG, 2013, J CLIN ENDOCR METAB, V98, P4483, DOI 10.1210/jc.2013-1597; Boonen S, 2012, NEW ENGL J MED, V367, P1714, DOI 10.1056/NEJMoa1204061; Brown JP, 2013, J BONE MINER RES, V28, P746, DOI 10.1002/jbmr.1808; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cardwell CR, 2012, INT J CANCER, V131, pE717, DOI 10.1002/ijc.27389; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Carmona EC, 2013, REUMATOL CLIN, V9, P172, DOI 10.1016/j.reuma.2012.05.005; Chao Ma, 2013, Pak J Med Sci, V29, P1381; Chapman I, 2009, CLIN ENDOCRINOL, V70, P838, DOI 10.1111/j.1365-2265.2008.03434.x; Chapurlat RD, 2005, OSTEOPOROSIS INT, V16, P842, DOI 10.1007/s00198-004-1770-7; Chen PQ, 2006, J BONE MINER RES, V21, P1785, DOI 10.1359/JBMR.060802; Chen YM, 2011, J AM GERIATR SOC, V59, P2379, DOI 10.1111/j.1532-5415.2011.03693.x; Chiang CH, 2012, J BONE MINER RES, V27, P1951, DOI 10.1002/jbmr.1645; Christensen S, 2011, OSTEOPOROSIS INT, V22, P1773, DOI 10.1007/s00198-010-1395-y; Combs BP, 2013, JAMA INTERN MED, V173, DOI 10.1001/jamainternmed.2013.8998; Crandall CJ, 2012, TREATMENT PREVENT FR; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dalal SR, 2013, MED DECIS MAKING, V33, P343, DOI 10.1177/0272989X12457243; Dell RM, 2012, J BONE MINER RES, V27, P2544, DOI 10.1002/jbmr.1719; Diniz-Freitas M, 2012, MED ORAL PATOL ORAL, V17, pE751, DOI 10.4317/medoral.18041; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Etminan M, 2012, CAN MED ASSOC J, V184, pE431, DOI 10.1503/cmaj.111752; Filleul O, 2010, J CANCER RES CLIN, V136, P1117, DOI 10.1007/s00432-010-0907-7; Fitzpatrick SG, 2012, J ORAL MAXIL SURG, V70, P325, DOI 10.1016/j.joms.2011.02.049; Fowler JR, 2012, ORTHOPEDICS, V35, pE38, DOI 10.3928/01477447-20111122-06; Freemantle N, 2013, OSTEOPOROSIS INT, V24, P209, DOI 10.1007/s00198-012-2068-9; Fujita T, 2014, CALCIFIED TISSUE INT, V94, P170, DOI 10.1007/s00223-013-9777-8; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Ghirardi A, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-5; Girgis CM, 2010, NEW ENGL J MED, V362, P1848, DOI 10.1056/NEJMc0910389; Giusti A, 2010, BONE, V47, P169, DOI 10.1016/j.bone.2010.05.019; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Grbic JT, 2008, J AM DENT ASSOC, V139, P32, DOI 10.14219/jada.archive.2008.0017; Grbic JT, 2010, J AM DENT ASSOC, V141, P1365, DOI 10.14219/jada.archive.2010.0082; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Grove EL, 2013, J INTERN MED, V274, P342, DOI 10.1111/joim.12087; Hagino H, 2013, OSTEOPOROSIS INT, V24, pS592; Hansen PJ, 2013, CLIN ORAL INVEST, V17, P1829, DOI 10.1007/s00784-012-0873-3; Hartle JE, 2012, AM J KIDNEY DIS, V59, P636, DOI 10.1053/j.ajkd.2011.11.037; Hopkins RB, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-209; Hosoi T, 2013, OSTEOPOROSIS INT, V24, pS177; Hsiao FY, 2011, CLIN THER, V33, P1659, DOI 10.1016/j.clinthera.2011.09.006; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jansen JP, 2011, SEMIN ARTHRITIS RHEU, V40, P275, DOI 10.1016/j.semarthrit.2010.06.001; Kajino Y, 2012, J ORTHOP SCI, V17, P313, DOI 10.1007/s00776-011-0085-8; Kang JH, 2012, OSTEOPOROSIS INT, V23, P2551, DOI 10.1007/s00198-012-1894-0; Kendler D, 2013, OSTEOPOROSIS INT, V24, pS653; Khalili H, 2012, J CLIN ONCOL, V30, P3229, DOI 10.1200/JCO.2011.39.2670; Khan AA, 2009, J RHEUMATOL, V36, P478, DOI 10.3899/jrheum.080759; Kim SY, 2011, J BONE MINER RES, V26, P993, DOI 10.1002/jbmr.288; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2938; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kumagai Y, 2011, BONE, V49, P1101, DOI 10.1016/j.bone.2011.08.007; Lapi F, 2013, OSTEOPOROSIS INT, V24, P697, DOI 10.1007/s00198-012-2013-y; Lee SH, 2014, OSTEOPOROSIS INT, V25, P1131, DOI 10.1007/s00198-013-2575-3; Lee WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053032; Lee YK, 2013, OSTEOPOROSIS INT, V24, P707, DOI 10.1007/s00198-012-2016-8; Lippuner K, 2013, OSTEOPOROSIS INT, V24, pS39; Lo JC, 2012, BONE, V51, P181, DOI 10.1016/j.bone.2012.02.632; Lo JC, 2010, J ORAL MAXIL SURG, V68, P243, DOI 10.1016/j.joms.2009.03.050; Loke YK, 2009, DRUG SAFETY, V32, P219, DOI 10.2165/00002018-200932030-00004; Lopez-Lopez L, 2011, P R HEALTH SCI J, V30, P211; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MacLean C, 2007, COMP EFFECTIVENESS T; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; Meier RPH, 2012, ARCH INTERN MED, V172, P930, DOI 10.1001/archinternmed.2012.1796; Mellstrom DD, 2004, CALCIFIED TISSUE INT, V75, P462, DOI 10.1007/s00223-004-0286-7; Migliore A, 2013, EUR REV MED PHARMACO, V17, P658; Miller PD, 2010, CALCIFIED TISSUE INT, V87, P305, DOI 10.1007/s00223-010-9403-y; Mulgund M, 2011, J RHEUMATOL, V38, P2686, DOI 10.3899/jrheum.110725; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Murphy CG, 2011, ACTA ORTHOP BELG, V77, P632; Nakamura T, 2014, OSTEOPOROSIS INT, V25, P367, DOI 10.1007/s00198-013-2398-2; Nakamura T, 2013, CALCIFIED TISSUE INT, V93, P137, DOI 10.1007/s00223-013-9734-6; Nakamura T, 2012, J CLIN ENDOCR METAB, V97, P3097, DOI 10.1210/jc.2011-3479; Ng YH, 2011, INJURY, V42, P702, DOI 10.1016/j.injury.2010.12.019; Nguyen DM, 2010, DIGEST DIS SCI, V55, P3404, DOI 10.1007/s10620-010-1198-1; O'Ryan FS, 2012, J ORAL MAXIL SURG, V70, P1844, DOI 10.1016/j.joms.2011.08.033; Otto S, 2012, J CRANIO MAXILL SURG, V40, P303, DOI 10.1016/j.jcms.2011.05.003; Otto S, 2011, J CRANIO MAXILL SURG, V39, P272, DOI 10.1016/j.jcms.2010.05.009; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Palacios S, 2013, OSTEOPOROSIS INT, V24, pS299; Papapoulos S, 2013, OSTEOPOROSIS INT, V24, pS151; Papapoulos S, 2013, OSTEOPOROSIS INT, V24, pS45; Park W, 2012, J CRANIOFAC SURG, V23, pE510, DOI 10.1097/SCS.0b013e31825b33f6; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Pazianas M, 2012, OSTEOPOROSIS INT, V23, P2873, DOI 10.1007/s00198-012-1952-7; Pazianas M, 2012, OSTEOPOROSIS INT, V23, P2693, DOI 10.1007/s00198-012-1902-4; Pazianas M, 2013, J BONE MINER RES, V28, P455, DOI 10.1002/jbmr.1783; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Rhee CW, 2012, OSTEOPOROSIS INT, V23, P247, DOI 10.1007/s00198-011-1608-z; Sarkar S, 2002, J BONE MINER RES, V17, P1, DOI 10.1359/jbmr.2002.17.1.1; Sasaki S, 2012, J BONE MINER METAB, V30, P561, DOI 10.1007/s00774-012-0358-0; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Schneider JP, 2012, J CLIN ENDOCR METAB, V97, P4324, DOI 10.1210/jc.2012-2590; Schwartz AV, 2013, J BONE MINER RES, V28, P1348, DOI 10.1002/jbmr.1865; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Sharma A, 2013, CHEST, V144, P1311, DOI 10.1378/chest.13-0675; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shih AWY, 2012, KIDNEY INT, V82, P903, DOI 10.1038/ki.2012.227; Shkolnikova J, 2013, ANZ J SURG, V83, P175, DOI 10.1111/ans.12018; Solomon DH, 2013, OSTEOPOROSIS INT, V24, P237, DOI 10.1007/s00198-012-2042-6; Solomon DH, 2009, OSTEOPOROSIS INT, V20, P895, DOI 10.1007/s00198-008-0759-z; Sun K, 2013, OSTEOPOROSIS INT, V24, P279, DOI 10.1007/s00198-012-2158-8; Tadrous M, 2014, OSTEOPOROSIS INT, V25, P1225, DOI 10.1007/s00198-013-2576-2; Tennis P, 2012, PHARMACOEPIDEM DR S, V21, P810, DOI 10.1002/pds.3292; Thompson RN, 2012, J BONE JOINT SURG BR, V94B, P385, DOI 10.1302/0301-620X.94B3.27999; Toulis KA, 2010, OSTEOPOROSIS INT, V21, P1963, DOI 10.1007/s00198-009-1145-1; Tsai JN, 2013, LANCET, V382, P50, DOI 10.1016/S0140-6736(13)60856-9; U.S. Food and Drug Administration, 2010, FDA DRUG SAF COMM SA; Urade M, 2011, J ORAL MAXIL SURG, V69, pE364, DOI 10.1016/j.joms.2011.03.051; Vescovi P, 2011, ORAL ONCOL, V47, P191, DOI 10.1016/j.oraloncology.2010.11.007; Vestergaard P, 2011, OSTEOPOROSIS INT, V22, P993, DOI 10.1007/s00198-010-1512-y; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P434, DOI 10.1007/s00223-011-9539-4; Vieira RL, 2012, AM J ROENTGENOL, V198, P1144, DOI 10.2214/AJR.11.7442; Villa Alessandro, 2011, ISRN Rheumatol, V2011, P654027, DOI 10.5402/2011/654027; Vinogradova Y, 2013, BRIT J CANCER, V109, P795, DOI 10.1038/bjc.2013.383; Vinogradova Y, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f114; Wang Z, 2011, J BONE MINER RES, V26, P553, DOI 10.1002/jbmr.233; Ward WG, 2012, CLIN ORTHOP RELAT R, V470, P759, DOI 10.1007/s11999-011-2194-2; Warren C, 2012, ANZ J SURG, V82, P908, DOI 10.1111/j.1445-2197.2012.06199.x; Watts NB, 2005, J BONE MINER RES, V20, P2097, DOI 10.1359/JBMR.050814; Wells G., NEWCASTLE OTTAWA SCA; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Wright E, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5315; Yavropoulou MP, 2012, J BONE MINER RES, V27, P1425, DOI 10.1002/jbmr.1593; Zafeiris CP, 2012, J MUSCULOSKEL NEURON, V12, P262	157	180	189	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					711	U163		10.7326/M14-0317	http://dx.doi.org/10.7326/M14-0317			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25199883				2022-12-28	WOS:000347245600028
J	Yuan, F; Yang, HM; Xue, Y; Kong, DD; Ye, R; Li, CJ; Zhang, JY; Theprungsirikul, L; Shrift, T; Krichilsky, B; Johnson, DM; Swift, GB; He, YK; Siedow, JN; Pei, ZM				Yuan, Fang; Yang, Huimin; Xue, Yan; Kong, Dongdong; Ye, Rui; Li, Chijun; Zhang, Jingyuan; Theprungsirikul, Lynn; Shrift, Tayler; Krichilsky, Bryan; Johnson, Douglas M.; Swift, Gary B.; He, Yikun; Siedow, James N.; Pei, Zhen-Ming			OSCA1 mediates osmotic-stress-evoked Ca2+ increases vital for osmosensing in Arabidopsis	NATURE			English	Article							ABSCISIC-ACID; ION-CHANNEL; SIGNAL-TRANSDUCTION; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; CATION CHANNELS; ANION CHANNELS; THALIANA L; RECEPTOR; IDENTIFICATION	Water is crucial to plant growth and development. Environmental water deficiency triggers an osmotic stress signalling cascade, which induces short-term cellular responses to reduce water loss and long-term responses to remodel the transcriptional network and physiological and developmental processes(1-4). Several signalling components that have been identified by extensive genetic screens for altered sensitivities to osmotic stress seem to function downstream of the perception of osmotic stress. It is known that hyperosmolality and various other stimuli trigger increases in cytosolic free calcium concentration ([Ca2+](i))(5,6). Considering that in bacteria and animals osmosensing Ca2+ channels serve as osmosensors(7,8), hyperosmolality-induced [Ca2+] i increases have been widely speculated to be involved in osmosensing in plants(1,9). However, the molecular nature of corresponding Ca2+ channels remain unclear(6,10,11). Here we describe a hyperosmolalitygated calcium-permeable channel and its function in osmosensing in plants. Using calcium-imaging-based unbiased forward genetic screens we isolated Arabidopsis mutants that exhibit low hyperosmolality-induced [Ca2+](i) increases. These mutants were rescreened for their cellular, physiological and developmental responses to osmotic stress, and those with clear combined phenotypes were selected for further physical mapping. One of the mutants, reduced hyperosmolality-induced [Ca2+](i) increase 1 (osca1), displays impaired osmotic Ca2+ signalling in guard cells and root cells, and attenuated water transpiration regulation and root growth in response to osmotic stress. OSCA1 is identified as a previously unknown plasma membrane protein and forms hyperosmolality-gated calcium-permeable channels, revealing that OSCA1 may be an osmosensor. OSCA1 represents a channel responsible for [Ca2+](i) increases induced by a stimulus in plants, opening up new avenues for studying Ca2+ machineries for other stimuli and providing potential molecular genetic targets for engineering drought-resistant crops.	[Yuan, Fang; Yang, Huimin; Xue, Yan; Kong, Dongdong; Ye, Rui; Li, Chijun; Zhang, Jingyuan; Theprungsirikul, Lynn; Shrift, Tayler; Krichilsky, Bryan; He, Yikun; Siedow, James N.; Pei, Zhen-Ming] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Yuan, Fang; Zhang, Jingyuan] Hangzhou Normal Univ, Coll Life & Environm Sci, Ctr Plant Environm Sensing, Hangzhou 310036, Zhejiang, Peoples R China; [Johnson, Douglas M.; Swift, Gary B.] Duke Univ, Dept Phys, Durham, NC 27708 USA	Duke University; Hangzhou Normal University; Duke University	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	fangyuan@hznu.edu.cn; zpei@duke.edu	Yuan, Fang/GRE-6482-2022	Yuan, Fang/0000-0001-6498-8079; Pei, Zhen-Ming/0000-0003-1473-696X; Theprungsirikul, Jomkuan/0000-0002-2139-9079	Hangzhou Normal University [PanDeng11001008001]; Zhejiang NSF [Z3110433]; USDA [CSREES-2005-35304-16196, CSREES-2006-35100-17304]; NSF [MCB-0451072, IOS-0848263]	Hangzhou Normal University; Zhejiang NSF; USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	We thank M. R. Knight for providing an aequorin vector and aequorin expressing Arabidopsis seeds, S. Gilroy for a YC3.6 vector and YC3.6 expressing Arabidopsis seeds, M. R. Knight and S. Gilroy for sharing unpublished data ongenetic screening and physical mapping, X. Dong and M. Chen for advice on physical mapping, J. Grandl, G. Chen and Q. Liu for advice concerning electrophysiology, W. G. Zhang and M. H. Zhu for providing HEK293 cells and advice on transfection, Y. Gao and S. Johnson for confocal imaging, and D. R. McClay, T.-p. Sun, J. Grandl and P. N. Benfey for discussions and critical reading of the manuscript. F. Y. and J.Z. were supported in part by grants from Hangzhou Normal University (PanDeng11001008001) and Zhejiang NSF (Z3110433). This work was supported by grants from USDA (CSREES-2005-35304-16196, CSREES-2006-35100-17304) and NSF (MCB-0451072, IOS-0848263) to Z.-M.P.	Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Berbey C, 2009, BIOPHYS J, V96, P2648, DOI 10.1016/j.bpj.2009.01.008; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COSGROVE DJ, 1991, PLANTA, V186, P143, DOI 10.1007/BF00201510; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Demidchik V, 2002, ANNU REV PLANT BIOL, V53, P67, DOI 10.1146/annurev.arplant.53.091901.161540; DING JP, 1993, PLANT J, V3, P713, DOI 10.1111/j.1365-313X.1993.00713.x; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Han SC, 2003, NATURE, V425, P196, DOI 10.1038/nature01932; Hashii M, 1996, BIOCHEM J, V319, P649, DOI 10.1042/bj3190649; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; KOORNNEEF M, 1982, MUTAT RES, V93, P109, DOI 10.1016/0027-5107(82)90129-4; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Nakano M, 2011, PLANT CELL PHYSIOL, V52, P1915, DOI 10.1093/pcp/pcr131; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Osakabe Y, 2013, PLANT CELL, V25, P609, DOI 10.1105/tpc.112.105700; Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Ranf S, 2012, MOL PLANT, V5, P115, DOI 10.1093/mp/ssr064; Roelfsema MRG, 2010, PLANT CELL ENVIRON, V33, P305, DOI 10.1111/j.1365-3040.2009.02075.x; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wadskog I, 2006, MOL BIOL CELL, V17, P4988, DOI 10.1091/mbc.E05-08-0798; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1992, PLANT CELL PHYSIOL, V33, P217, DOI 10.1093/oxfordjournals.pcp.a078243; Zhang ZJ, 2011, PROTEOMICS, V11, P1780, DOI 10.1002/pmic.201000648; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	62	364	390	38	358	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					367	+		10.1038/nature13593	http://dx.doi.org/10.1038/nature13593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25162526				2022-12-28	WOS:000342988600052
J	Lau, OS; Davies, KA; Chang, J; Adrian, J; Rowe, MH; Ballenger, CE; Bergmann, DC				Lau, On Sun; Davies, Kelli A.; Chang, Jessica; Adrian, Jessika; Rowe, Matthew H.; Ballenger, Catherine E.; Bergmann, Dominique C.			Direct roles of SPEECHLESS in the specification of stomatal self-renewing cells	SCIENCE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; DIVISION; DIFFERENTIATION; GROWTH; BRASSINOSTEROIDS; ELONGATION; POLARITY; LINEAGE; PLANT	Lineage-specific stem cells are critical for the production and maintenance of specific cell types and tissues in multicellular organisms. In Arabidopsis, the initiation and proliferation of stomatal lineage cells is controlled by the basic helix-loop-helix transcription factor SPEECHLESS (SPCH). SPCH-driven asymmetric and self-renewing divisions allow flexibility in stomatal production and overall organ growth. How SPCH directs stomatal lineage cell behaviors, however, is unclear. Here, we improved the chromatin immunoprecipitation (ChIP) assay and profiled the genome-wide targets of Arabidopsis SPCH in vivo. We found that SPCH controls key regulators of cell fate and asymmetric cell divisions and modulates responsiveness to peptide and phytohormone-mediated intercellular communication. Our results delineate the molecular pathways that regulate an essential adult stem cell lineage in plants.	[Lau, On Sun; Davies, Kelli A.; Chang, Jessica; Adrian, Jessika; Rowe, Matthew H.; Bergmann, Dominique C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Ballenger, Catherine E.; Bergmann, Dominique C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Bergmann, Dominique C.] Carnegie Inst Sci, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Carnegie Institution for Science	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dbergmann@stanford.edu	Lau, On Sun/D-2521-2016	Lau, On Sun/0000-0002-8121-235X; Bergmann, Dominique/0000-0003-0873-3543	National Institutes of Health (NIH) [1R01GM086632]; Cellular and Molecular Biology Training Program [NIH5T32GM007276]; National Science Foundation; DAAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086632, T32GM007276] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biology Training Program; National Science Foundation(National Science Foundation (NSF)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z.-Y. Wang (Carnegie) for the antibody to YFP and the bin2-1 allele; Y. Yin (Iowa State University) for the BES1pro: bes1-D-GFP construct; J. Chory (SALK) for the bes1 RNAi line; and members of our laboratory for critical comments. Funding for this work was provided by National Institutes of Health (NIH) 1R01GM086632. O.S.L. was a Croucher Fellow, K. A. D. was supported by Cellular and Molecular Biology Training Program NIH5T32GM007276 and by a National Science Foundation graduate research fellowship, and J. A. was supported by the DAAD. D. C. B. is a Gordon and Betty Moore Foundation Investigator of the Howard Hughes Medical Institute. The ChIP-seq and RNA-seq data in this study can be found in National Center for Biotechnology Information's Gene Expression Omnibus repository (www.ncbi.nlm.nih.gov/geo) as GSE57954. The supplementary materials contain additional data.	Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Dong J, 2009, CELL, V137, P1320, DOI 10.1016/j.cell.2009.04.018; Fong AP, 2013, CURR OPIN GENET DEV, V23, P568, DOI 10.1016/j.gde.2013.05.002; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kim TW, 2012, NATURE, V482, P419, DOI 10.1038/nature10794; Lau OS, 2012, DEVELOPMENT, V139, P3683, DOI 10.1242/dev.080523; Le J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4090; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Malcos JL, 2011, CYTOSKELETON, V68, P247, DOI 10.1002/cm.20508; Muino JM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-11; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri Lynn Jo, 2013, Arabidopsis Book, V11, pe0162, DOI 10.1199/tab.0162; Pillitteri LJ, 2011, PLANT CELL, V23, P3260, DOI 10.1105/tpc.111.088583; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; Robinson S, 2011, SCIENCE, V333, P1436, DOI 10.1126/science.1202185; Schiessl K, 2014, P NATL ACAD SCI USA, V111, P2830, DOI 10.1073/pnas.1320457111; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tanaka Y, 2013, PLANT J, V74, P448, DOI 10.1111/tpj.12136; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	29	124	131	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1605	1609		10.1126/science.1256888	http://dx.doi.org/10.1126/science.1256888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25190717	Green Accepted			2022-12-28	WOS:000342164500044
J	Olivier, NB				Olivier, Nelson B.			Ribosome revelations	NATURE			English	Editorial Material									AstraZeneca, Innovat Med & Early Dev Unit, Cambridge CB4 0FZ, England	AstraZeneca	Olivier, NB (corresponding author), AstraZeneca, Innovat Med & Early Dev Unit, Cambridge Sci Pk, Cambridge CB4 0FZ, England.	nelson.olivier@astrazeneca.com						Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Perez-Fernandez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4112; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Taguchi A., 2014, CHEMMEDCHEM; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Wimberly BT, 2009, CURR OPIN INVEST DR, V10, P750; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080	9	1	2	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					491	492		10.1038/nature13747	http://dx.doi.org/10.1038/nature13747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25209662				2022-12-28	WOS:000342075800024
J	Correia-Pinto, J; Ribeiro, A				Correia-Pinto, Jorge; Ribeiro, Andreia			Congenital Duodenal Obstruction and Double-Bubble Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Correia-Pinto, Jorge; Ribeiro, Andreia] Univ Minho, Braga, Portugal	Universidade do Minho	Correia-Pinto, J (corresponding author), Univ Minho, Braga, Portugal.	jcp@ecsaude.uminho.pt	Correia-Pinto, Jorge/B-3344-2012	Correia-Pinto, Jorge/0000-0002-9265-6896					0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					E16	E16		10.1056/NEJMicm1313374	http://dx.doi.org/10.1056/NEJMicm1313374			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25207787	Green Published			2022-12-28	WOS:000341382800011
J	Jomelli, V; Favier, V; Vuille, M; Braucher, R; Martin, L; Blard, PH; Colose, C; Brunstein, D; He, F; Khodri, M; Bourles, DL; Leanni, L; Rinterknecht, V; Grancher, D; Francou, B; Ceballos, JL; Fonseca, H; Liu, Z; Otto-Bliesner, BL				Jomelli, V.; Favier, V.; Vuille, M.; Braucher, R.; Martin, L.; Blard, P. -H.; Colose, C.; Brunstein, D.; He, F.; Khodri, M.; Bourles, D. L.; Leanni, L.; Rinterknecht, V.; Grancher, D.; Francou, B.; Ceballos, J. L.; Fonseca, H.; Liu, Z.; Otto-Bliesner, B. L.			A major advance of tropical Andean glaciers during the Antarctic cold reversal	NATURE			English	Article							PERUVIAN ANDES; BE-10; CLIMATE; SURFACE; RATES; AGE; FLUCTUATIONS; GLACIATION; INTENSITY; ATLANTIC	The Younger Dryas stadial, a cold event spanning 12,800 to 11,500 years ago, during the last deglaciation, is thought to coincide with the last major glacial re-advance in the tropical Andes(1). This interpretation relies mainly on cosmic-ray exposure dating of glacial deposits. Recent studies, however, have established new production rates' for cosmogenic Be-10 and He-3, which make it necessary to update all chronologies in this region(1,5-15) and revise our understanding of cryospheric responses to climate variability. Here we present a new Be-10 moraine chronology in Colombia showing that glaciers in the northern tropical Andes expanded to a larger extent during the Antarctic cold reversal (14,500 to 12,900 years ago) than during the Younger Dryas. On the basis of a homogenized chronology of all Be-10 and He-3 moraine ages across the tropical Andes, we show that this behaviour was common to the northern and southern tropical Andes. Transient simulations with a coupled global climate model suggest that the common glacier behaviour was the result of Atlantic meridional overturning circulation variability superimposed on a deglacial increase in the atmospheric carbon dioxide concentration. During the Antarctic cold reversal, glaciers advanced primarily in response to cold sea surface temperatures over much of the Southern Hemisphere. During the Younger Dryas, however, northern tropical Andes glaciers retreated owing to abrupt regional warming in response to reduced precipitation and land-surface feedbacks triggered by a weakened Atlantic meridional overturning circulation. Conversely, glacier retreat during the Younger Dryas in the southern tropical Andes occurred as a result of progressive warming, probably influenced by an increase in atmospheric carbon dioxide. Considered with evidence from mid-latitude Andean glaciers(16), our results argue for a common glacier response to cold conditions in the Antarctic cold reversal exceeding that of the Younger Dryas.	[Jomelli, V.; Brunstein, D.; Grancher, D.] Univ Paris 01, CNRS, Lab Geog Phys, F-92195 Meudon, France; [Favier, V.] Univ Grenoble Alpes, LGGE, UMR 5183, F-38041 Grenoble, France; [Vuille, M.; Colose, C.] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA; [Braucher, R.; Bourles, D. L.; Leanni, L.] Aix Marseille Univ, CNRS, Coll France, IRD,CEREGE,UM34, F-13545 Aix En Provence, France; [Martin, L.; Blard, P. -H.] Univ Lorraine, UMR 7358, CNRS, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; [He, F.] Univ Wisconsin, Nelson Inst Environm Studies, Ctr Climat Res, Madison, WI 53706 USA; [Khodri, M.] Univ Paris 06, IRD, Lab Oceanog & Climat Experimentat & Approche Nume, F-75252 Paris 05, France; [Rinterknecht, V.] Univ St Andrews, Sch Geog & Geosci Irvine Bldg, St Andrews KY16 9AL, Fife, Scotland; [Francou, B.] Inst Rech Dev, La Paz 9214, Bolivia; [Ceballos, J. L.] Inst Hydrol Meteorol & Environm Studies, Bogota 07603, Colombia; [Fonseca, H.] UPTC Sede Secc Sogamoso, Escuela Ingn Geol, Sogamoso, Colombia; [Liu, Z.] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Liu, Z.] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Otto-Bliesner, B. L.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA	Centre National de la Recherche Scientifique (CNRS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of Wisconsin System; University of Wisconsin Madison; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; University of St Andrews; Institut de Recherche pour le Developpement (IRD); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Center Atmospheric Research (NCAR) - USA	Jomelli, V (corresponding author), Univ Paris 01, CNRS, Lab Geog Phys, F-92195 Meudon, France.	vincent.jomelli@lgp.cnrs.fr	Otto-Bliesner, Bette/AAY-7691-2020; Vuille, Mathias/O-8128-2019; BLARD, Pierre-Henri/ABB-9401-2021; , Braucher/Q-5971-2017; Favier, Vincent/T-1936-2017; Vuille, Mathias/S-3906-2019; He, Feng/B-3583-2008; Khodri, Myriam/K-1399-2016; jomelli, vincent/AAO-9488-2020; Martin, Leo/V-5865-2019	Vuille, Mathias/0000-0002-9736-4518; , Braucher/0000-0002-4637-4302; Favier, Vincent/0000-0001-6024-9498; He, Feng/0000-0002-3355-6406; Khodri, Myriam/0000-0003-1941-1646; jomelli, vincent/0000-0002-4512-5216; Bourles, Didier/0000-0001-5991-6126; Blard, Pierre-Henri/0000-0002-8455-8014; Martin, Leo/0000-0001-5405-0175; brunstein, daniel/0000-0001-5496-8349; Rinterknecht, Vincent/0000-0002-5410-2075	French ANR El Paso programme [10-blan-68-01]	French ANR El Paso programme(French National Research Agency (ANR))	Financial support was provided by the French ANR El Paso programme no. 10-blan-68-01. The <SUP>10</SUP>Be measurements were performed at the ASTER AMS national facility (CEREGE, Aix en Provence), which is supported by the INSU/CNRS,the French Ministry of Research and Higher Education, IRD and CEA. TRACE21 is supported by the P2C2 programme (NSF), the Abrupt Change Program (DOE), the EaSM programme (DOE) and the INCITE computing programme (DOE and NCAR). We thank M. Arnold, G. Aumaitre and K. Keddadouche for their assistance during <SUP>10</SUP>Be measurements.	Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Blard PH, 2013, EARTH PLANET SC LETT, V382, P140, DOI 10.1016/j.epsl.2013.09.010; Blard PH, 2013, EARTH PLANET SC LETT, V377, P260, DOI 10.1016/j.epsl.2013.07.006; Blard P. H., QUAT RES IN PRESS; Broecker W, 2013, WHAT DRIVES GLACIER; Bromley GRM, 2011, J QUATERNARY SCI, V26, P37, DOI 10.1002/jqs.1424; Carcaillet J, 2013, QUATERNARY RES, V80, P482, DOI 10.1016/j.yqres.2013.08.001; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Dunne J, 1999, GEOMORPHOLOGY, V27, P3, DOI 10.1016/S0169-555X(98)00086-5; Farber DL, 2005, J QUATERNARY SCI, V20, P759, DOI 10.1002/jqs.994; Favier V, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020654; Favier V, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004359; Francou B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004484; Glasser NF, 2009, QUATERNARY SCI REV, V28, P3448, DOI 10.1016/j.quascirev.2009.10.006; Guyodo Y, 1999, NATURE, V399, P249, DOI 10.1038/20420; Hall SR, 2009, QUATERNARY SCI REV, V28, P2991, DOI 10.1016/j.quascirev.2009.08.004; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; He F., 2011, SIMULATING TRANSIENT; He F, 2014, GEOPHYS RES LETT, V41, P623, DOI 10.1002/2013GL058085; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Jomelli V, 2011, NATURE, V474, P196, DOI 10.1038/nature10150; Jomelli V, 2009, PALAEOGEOGR PALAEOCL, V281, P269, DOI 10.1016/j.palaeo.2008.10.033; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kelly M., 2010, QUAT GEOCHR IN PRESS; Leduc G, 2007, NATURE, V445, P908, DOI 10.1038/nature05578; Licciardi JM, 2009, SCIENCE, V325, P1677, DOI 10.1126/science.1175010; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Mahaney WC, 2008, GEOMORPHOLOGY, V96, P199, DOI 10.1016/j.geomorph.2007.08.002; Menabreaz L, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009256; Merchel S, 2008, NUCL INSTRUM METH B, V266, P4921, DOI 10.1016/j.nimb.2008.07.031; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; NISHIIZUMI K, 1989, J GEOPHYS RES-SOLID, V94, P17907, DOI 10.1029/JB094iB12p17907; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Pierrehumbert RT, 2000, P NATL ACAD SCI USA, V97, P1355, DOI 10.1073/pnas.97.4.1355; Putnam AE, 2010, NAT GEOSCI, V3, P700, DOI 10.1038/NGEO962; Rodbell DT, 2009, QUATERNARY SCI REV, V28, P2165, DOI 10.1016/j.quascirev.2009.03.012; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Smith CA, 2011, QUATERNARY RES, V75, P1, DOI 10.1016/j.yqres.2010.07.001; Smith JA, 2005, SCIENCE, V308, P678, DOI 10.1126/science.1107075; Smith JA, 2010, J QUATERNARY SCI, V25, P243, DOI 10.1002/jqs.1393; Stansell ND, 2010, EARTH PLANET SC LETT, V293, P154, DOI 10.1016/j.epsl.2010.02.040; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1; Zech J, 2009, PALAEOGEOGR PALAEOCL, V284, P180, DOI 10.1016/j.palaeo.2009.09.023; Zech R, 2007, CLIM PAST, V3, P623, DOI 10.5194/cp-3-623-2007	50	66	66	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					224	228		10.1038/nature13546	http://dx.doi.org/10.1038/nature13546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25156258				2022-12-28	WOS:000341362800048
J	Cole, TB				Cole, Thomas B.			Ponds and Streams	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					984	985		10.1001/jama.2013.279713	http://dx.doi.org/10.1001/jama.2013.279713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203065				2022-12-28	WOS:000341385600001
J	O'Keeffe, AG; Geneletti, S; Baio, G; Sharples, LD; Nazareth, I; Petersen, I				O'Keeffe, Aidan G.; Geneletti, Sara; Baio, Gianluca; Sharples, Linda D.; Nazareth, Irwin; Petersen, Irene			Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; HEALTH-CARE; DISEASE; METAANALYSIS; BENEFITS; STATINS		[O'Keeffe, Aidan G.; Baio, Gianluca] UCL, Dept Stat Sci, London WC1E 6BT, England; [Geneletti, Sara] London Sch Econ, Dept Stat, London WC2A 2AE, England; [Sharples, Linda D.] Univ Leeds, Leeds Clin Trials Res Unit, Leeds LS2 9JT, W Yorkshire, England; [Nazareth, Irwin; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of London; University College London; University of London; London School Economics & Political Science; University of Leeds; University of London; University College London	O'Keeffe, AG (corresponding author), UCL, Dept Stat Sci, Mortimer St, London WC1E 6BT, England.	a.o'keeffe@ucl.ac.uk	; Petersen, Irene/C-5702-2009	Sharples, Linda/0000-0003-0894-966X; Baio, Gianluca/0000-0003-4314-2570; Petersen, Irene/0000-0002-0037-7524	Medical Research Council [MR/K014838/1]; MRC [MC_U105232027, MR/K014838/1] Funding Source: UKRI; Medical Research Council [MC_U105232027] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: all authors receive support through grant MR/K014838/1 from the Medical Research Council; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work	Almond D, 2011, AM ECON J-ECON POLIC, V3, P1, DOI 10.1257/pol.3.3.1; Almond D, 2010, Q J ECON, V125, P591, DOI 10.1162/qjec.2010.125.2.591; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Berk RA, 1999, J AM STAT ASSOC, V94, P1045, DOI 10.2307/2669918; Black N, 1996, BRIT MED J, V312, P1215; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Card D, 2008, AM ECON REV, V98, P2242, DOI 10.1257/aer.98.5.2242; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Koch TG, 2013, J HEALTH ECON, V32, P599, DOI 10.1016/j.jhealeco.2013.03.002; Lalive R, 2008, J ECONOMETRICS, V142, P785, DOI 10.1016/j.jeconom.2007.05.013; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lee DS, 2008, J ECONOMETRICS, V142, P675, DOI 10.1016/j.jeconom.2007.05.004; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Linden A, 2006, J EVAL CLIN PRACT, V12, P124, DOI 10.1111/j.1365-2753.2005.00573.x; Linden A, 2012, J EVAL CLIN PRACT, V18, P317, DOI 10.1111/j.1365-2753.2011.01768.x; *NIH CLIN EXC, 2008, LIP MOD CARD RISK AS; PRINGLE M, 1995, BRIT MED J, V311, P1382, DOI 10.1136/bmj.311.7017.1382; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2340; THISTLETHWAITE DL, 1960, J EDUC PSYCHOL, V51, P309, DOI 10.1037/h0044319; Trusler D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4350	20	45	45	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2014	349								g5293	10.1136/bmj.g5293	http://dx.doi.org/10.1136/bmj.g5293			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9QJ	25199521	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000341690700001
J	McCarthy, EA; Walker, SP				McCarthy, Elizabeth A.; Walker, Susan P.			International fetal growth standards: one size fits all	LANCET			English	Editorial Material							CHARTS; METHODOLOGY; BIOMETRY; PROJECT		[McCarthy, Elizabeth A.; Walker, Susan P.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Heidelberg, Vic 3084, Australia	University of Melbourne	McCarthy, EA (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Heidelberg, Vic 3084, Australia.	eamcca@unimelb.edu.au	McCarthy, Elizabeth Anne/J-5186-2019	McCarthy, Elizabeth Anne/0000-0001-7321-9319; Walker, Susan Phillipa/0000-0001-9075-4655				ALTMAN DG, 1994, BRIT J OBSTET GYNAEC, V101, P29, DOI 10.1111/j.1471-0528.1994.tb13006.x; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Ioannou C, 2012, BJOG-INT J OBSTET GY, V119, P1425, DOI 10.1111/j.1471-0528.2012.03451.x; Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P42, DOI 10.1111/1471-0528.12125; Li Z, 2012, PERINATAL STAT; McCarthy EA, 2013, AUST NZ J OBSTET GYN, V53, P203, DOI 10.1111/ajo.12049; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Salomon LJ, 2005, ULTRASOUND OBST GYN, V25, P559, DOI 10.1002/uog.1901; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; Villar J, 2014, LANCET DIABETES ENDO	13	13	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					835	836		10.1016/S0140-6736(14)61416-1	http://dx.doi.org/10.1016/S0140-6736(14)61416-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	25209473				2022-12-28	WOS:000341362200006
J	Sidebotham, P; Fraser, J; Covington, T; Freemantle, J; Petrou, S; Pulikottil-Jacob, R; Cutler, T; Ellis, C				Sidebotham, Peter; Fraser, James; Covington, Teresa; Freemantle, Jane; Petrou, Stavros; Pulikottil-Jacob, Ruth; Cutler, Tessa; Ellis, Catherine			Child death in high-income countries 3 Understanding why children die in high-income countries	LANCET			English	Article							LOW-BIRTH-WEIGHT; POSTNEONATAL INFANT-MORTALITY; MOTOR-VEHICLE OCCUPANT; QUALITY-OF-LIFE; SOCIOECONOMIC INEQUALITIES; YOUNG-PEOPLE; RISK-FACTORS; HOUSEHOLD COMPOSITION; PERINATAL-MORTALITY; HEALTH-SERVICES	Many factors affect child and adolescent mortality in high-income countries. These factors can be conceptualised within four domains-intrinsic (biological and psychological) factors, the physical environment, the social environment, and service delivery. The most prominent factors are socioeconomic gradients, although the mechanisms through which they exert their effects are complex, affect all four domains, and are often poorly understood. Although some contributing factors are relatively fixed-including a child's sex, age, ethnic origin, and genetics, some parental characteristics, and environmental conditions-others might be amenable to interventions that could lessen risks and help to prevent future child deaths. We give several examples of health service features that could affect child survival, along with interventions, such as changes to the physical or social environment, which could affect upstream (distal) factors.	[Sidebotham, Peter] Univ Warwick, Div Mental Hlth & Well Being, Coventry CV4 7AL, W Midlands, England; [Petrou, Stavros] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Pulikottil-Jacob, Ruth] Univ Warwick, Warwick Evidence, Coventry CV4 7AL, W Midlands, England; [Fraser, James] Bristol Royal Hosp Children, Bristol, Avon, England; [Covington, Teresa] Michigan Publ Hlth Inst, Natl Ctr Review & Prevent Child Deaths, Okemos, MI USA; [Freemantle, Jane] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth & Soc, Melbourne, Vic, Australia; [Cutler, Tessa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Ellis, Catherine] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; Bristol Royal Hospital For Children; University of Melbourne; University of Melbourne; Coventry University	Sidebotham, P (corresponding author), Univ Warwick, Div Mental Hlth & Well Being, Coventry CV4 7AL, W Midlands, England.	p.sidebotham@warwick.ac.uk	Sidebotham, Peter D/E-3011-2010; Petrou, Stavros/ABD-8323-2021; Johnson, Samantha/D-4736-2014	Sidebotham, Peter D/0000-0003-4891-6926; Petrou, Stavros/0000-0003-3121-6050; Johnson, Samantha/0000-0002-4716-1229; Ellis, Catherine/0000-0001-6739-8314; Pulikottil-Jacob, Ruth/0000-0003-0630-960X	UK Department for Education	UK Department for Education	PS runs the Warwick advanced course in the management of unexpected child death. He has received grant money from the UK Department for Education for research into child death review and for the development of training materials on child death review. JF is on the faculty of the Warwick advanced course in the management of unexpected child death. TC is the Director of the US National Center for the Review and Prevention of Child Deaths. The other authors declare no competing interests.	Agarwal S, 2010, PEDIATR CRIT CARE ME, V11, P568, DOI 10.1097/PCC.0b013e3181d8e405; Agerbo E, 2002, UGESKRIFT LAEGER, V164, P5786; Alio AP, 2010, MATERN CHILD HLTH J, V14, P557, DOI 10.1007/s10995-009-0495-9; Anachebe Ngozi F, 2006, Ethn Dis, V16, pS3; Anthikkat AP, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/841360; Arntzen A, 2004, SCAND J PUBLIC HEALT, V32, P381, DOI 10.1080/14034940410029450; Arntzen A, 2006, INT J EPIDEMIOL, V35, P1083, DOI 10.1093/ije/dyl047; Australian Bureau of Statistics, 2012, BIRTHS IN AUSTRALIA; Baker SP, 1998, ARCH PEDIAT ADOL MED, V152, P1209; Bauman LJ, 2006, PEDIATRICS, V117, P1321, DOI 10.1542/peds.2005-1647; Beautrais AL, 2006, AUST NZ J PSYCHIAT, V40, P253, DOI 10.1111/j.1440-1614.2006.01782.x; Becares Laia, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2012.300832; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Berkowitz C D, 2001, Adv Pediatr, V48, P331; Bernhard M, 2007, RESUSCITATION, V73, P362, DOI 10.1016/j.resuscitation.2006.09.014; Biglan A, 2004, HELPING ADOLESCENTS; Birken CS, 2009, PEDIATRICS, V123, pE815, DOI 10.1542/peds.2008-0132; Blair PS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3666; Blair PS, 2006, LANCET, V367, P314, DOI 10.1016/S0140-6736(06)67968-3; Blakely T, 2003, INT J EPIDEMIOL, V32, P410, DOI 10.1093/ije/dyg154; Bollini P, 2009, SOC SCI MED, V68, P452, DOI 10.1016/j.socscimed.2008.10.018; Bourget D, 2005, J AM ACAD PSYCHIATRY, V33, P354; Bourget D, 2002, J AM ACAD PSYCHIATRY, V30, P345; Brandon M., 2009, UNDERSTANDING SERIOU; Bronfenbrenner U, 2000, SOC DEV, V9, P115, DOI 10.1111/1467-9507.00114; BRONFENBRENNER U, 1974, CHILD DEV, V45, P1; Bunyavanich S, 2003, AMBUL PEDIATR, V3, P44, DOI 10.1367/1539-4409(2003)003<0044:TIOCCO>2.0.CO;2; Calling S, 2011, PAEDIATR PERINAT EP, V25, P357, DOI 10.1111/j.1365-3016.2011.01200.x; Cammu H, 2010, EUR J OBSTET GYN R B, V148, P13, DOI 10.1016/j.ejogrb.2009.08.016; Carcillo JA, 2009, PEDIATRICS, V124, P500, DOI 10.1542/peds.2008-1967; Carrington PJ, 1999, ARCH SUICIDE RES, V5, P71, DOI 10.1023/A:1009697214333; Cavanagh K, 2005, BRIT J SOC WORK, V35, P667, DOI 10.1093/bjsw/bch202; Collison D, 2007, J PUBLIC HEALTH-UK, V29, P114, DOI 10.1093/pubmed/fdm009; Costeloe Kate L, 2012, BMJ, V345, pe7976, DOI 10.1136/bmj.e7976; Culbertson FM, 1997, AM PSYCHOL, V52, P25, DOI 10.1037/0003-066X.52.1.25; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Department for Education, 2011, CHILD DEATH REVIEWS; Diaz J, 2004, J OCCUP ENVIRON MED, V46, P768, DOI 10.1097/01.jom.0000135542.12974.49; Dominguez-Berjon MF, 1999, EUR J EPIDEMIOL, V15, P723, DOI 10.1023/A:1007653831765; Draper G, 2004, HEALTH INEQUALITIES, V1; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; Elliott MR, 2006, ARCH PEDIAT ADOL MED, V160, P617, DOI 10.1001/archpedi.160.6.617; Ewing R, 2003, AM J PUBLIC HEALTH, V93, P1541, DOI 10.2105/AJPH.93.9.1541; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Finch BK, 2003, DEMOGRAPHY, V40, P675, DOI 10.2307/1515203; Fleming P., 2000, SUDDEN UNEXPECTED DE; Formby E, 2011, PERSONAL SOCIAL HEAL; Forrest CB, 2003, ARCH PEDIAT ADOL MED, V157, P279, DOI 10.1001/archpedi.157.3.279; Fraser J, 2014, LANCET, V384, P894, DOI 10.1016/S0140-6736(13)61089-2; Freemantle N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2892; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldney RD, 2006, MED J AUSTRALIA, V185, P304, DOI 10.5694/j.1326-5377.2006.tb00582.x; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Green BN, 2001, J SPORT CHIROPR REH, V15, P5, DOI 10.1016/S0899-3467(07)60142-6; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Grundstein A, 2011, GEOGR REV, V101, P353, DOI 10.1111/j.1931-0846.2011.00101.x; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; Hamilton B.E., 2013, BIRTHS PRELIMINARY D; Hardelid P, 2013, CHILD HEALTH REVIEWS; Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520; Heslop P., 2013, CONFIDENTIAL INQUIRY; Hessol NA, 2005, PEDIATRICS, V115, pE44, DOI 10.1542/peds.2004-0478; Hjern A, 2002, J EPIDEMIOL COMMUN H, V56, P688, DOI 10.1136/jech.56.9.688; Holden J, 1998, BRIT J GEN PRACT, V48, P1409; Hoshi A, 2005, INT J BIOMETEOROL, V49, P224, DOI 10.1007/s00484-004-0238-y; Jonson-Reid M, 2007, CHILD MALTREATMENT, V12, P86, DOI 10.1177/1077559506296722; Kaiser Reinhard, 2004, Environ Health, V3, P4, DOI 10.1186/1476-069X-3-4; Kalben BB, 2000, N AM ACTUAR J, V4, P83; Kanter RK, 2010, DISASTER MED PUBLIC, V4, P62, DOI 10.1017/S1935789300002433; Kennedy HG, 1999, BRIT J PSYCHIAT, V175, P462, DOI 10.1192/bjp.175.5.462; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; King CA, 2008, ARCH SUICIDE RES, V12, P181, DOI 10.1080/13811110802101203; Knowlton K, 2011, HEALTH AFFAIR, V30, P2167, DOI 10.1377/hlthaff.2011.0229; KOHN LT, 1999, TO ERR IS HUMAN; Kong KA, 2010, CANCER CAUSE CONTROL, V21, P1559, DOI 10.1007/s10552-010-9584-8; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Lightfoot TJ, 2012, EUR J CANCER, V48, P263, DOI 10.1016/j.ejca.2011.10.007; Ligi I, 2008, LANCET, V371, P404, DOI 10.1016/S0140-6736(08)60204-4; LOFTIN C, 1991, NEW ENGL J MED, V325, P1615, DOI 10.1056/NEJM199112053252305; Loggins S, 2014, J COMMUN HEALTH, V39, P118, DOI 10.1007/s10900-013-9747-0; MacArthur GJ, 2012, J PUBLIC HEALTH-UK, V34, pI20, DOI 10.1093/pubmed/fds006; Macdorman Marian F, 2008, NCHS Data Brief, P1; Mangano JJ, 2002, ARCH ENVIRON HEALTH, V57, P23, DOI 10.1080/00039890209602913; Marriott C, 2014, CHILD ABUSE REV, V23, P17, DOI 10.1002/car.2258; Mason WA, 2010, J CHILD PSYCHOL PSYC, V51, P1377, DOI 10.1111/j.1469-7610.2010.02292.x; Miller M, 2008, NEW ENGL J MED, V359, P989, DOI 10.1056/NEJMp0805923; Miller MR, 2004, PEDIATRICS, V113, P1741, DOI 10.1542/peds.113.6.1741; Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6; Morse SB, 2009, PEDIATRICS, V123, pE622, DOI 10.1542/peds.2008-1405; Nielssen OB, 2009, MED J AUSTRALIA, V190, P7, DOI 10.5694/j.1326-5377.2009.tb02252.x; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Office for National Statistics, 2012, MORTALITY STATISTICS; Onwuachi-Saunders C, 1999, Inj Prev, V5, P276; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Payne NR, 2010, PEDIATRICS, V125, P437, DOI 10.1542/peds.2009-1272; Pearson G., 2008, WHY CHILDREN DIE A P; Petrou S, 2006, PAEDIATR PERINAT EP, V20, P14, DOI 10.1111/j.1365-3016.2006.00688.x; Pickett KE, 2007, BMJ-BRIT MED J, V335, P1080, DOI 10.1136/bmj.39377.580162.55; Pickett KE, 2005, AM J PUBLIC HEALTH, V95, P1976, DOI 10.2105/AJPH.2004.059063; Pitkanen T, 2005, ADDICTION, V100, P652, DOI 10.1111/j.1360-0443.2005.01053.x; Pomerantz WJ, 2001, J URBAN HEALTH, V78, P141, DOI 10.1093/jurban/78.1.141; Pritchard Colin, 2011, Int J Adolesc Med Health, V23, P251; Pritchard Colin, 2011, JRSM Short Rep, V2, P60, DOI 10.1258/shorts.2011.011076; Raatikainen K, 2006, EUR J PUBLIC HEALTH, V16, P157, DOI 10.1093/eurpub/cki158; Raine JE, 2011, ARCH DIS CHILD, V96, P838, DOI 10.1136/adc.2011.212555; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Regidor E, 2011, INT J EPIDEMIOL, V40, P1187, DOI 10.1093/ije/dyr092; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; RIVARA FP, 1985, PEDIATRICS, V76, P375; ROBERTS I, 1995, BRIT MED J, V310, P91, DOI 10.1136/bmj.310.6972.91; Roberts I, 2013, LANCET, V381, P2219, DOI 10.1016/S0140-6736(13)60602-9; Rodwin VG, 2005, AM J PUBLIC HEALTH, V95, P86, DOI 10.2105/AJPH.2004.040287; Rogowski JA, 2004, HEALTH AFFAIR, V23, P88, DOI 10.1377/hlthaff.23.5.88; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schnitzer PG, 2008, J NURS SCHOLARSHIP, V40, P91, DOI 10.1111/j.1547-5069.2007.00211.x; Sethi D, 2008, EUROPEAN REPORT ON C; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; SIBERT JR, 1977, LANCET, V2, P289; Sidebotham P., 2008, PREVENTING CHILDHOOD; Sidebotham P, 2014, LANCET, V384, P904, DOI 10.1016/S0140-6736(13)61090-9; Sidebotham P, 2011, CHILD ABUSE NEGLECT, V35, P299, DOI 10.1016/j.chiabu.2011.01.005; Singh GK, 2007, AM J PUBLIC HEALTH, V97, P1658, DOI 10.2105/AJPH.2006.087320; Smith D., 1995, PSYCHOSOCIAL DISORDE, P389; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; Smith LK, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6654; Smith LK, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4702; Social Exclusion Unit, 1999, TEENAGE PREGNANCY; Son JY, 2011, INT J PUBLIC HEALTH, V56, P7, DOI 10.1007/s00038-010-0178-8; Sparks PJ, 2009, J RURAL HEALTH, V25, P332, DOI 10.1111/j.1748-0361.2009.00241.x; Spencer N, 2004, CHILD CARE HLTH DEV, V30, P699, DOI 10.1111/j.1365-2214.2004.00485.x; Spencer N, 2004, J EPIDEMIOL COMMUN H, V58, P366, DOI 10.1136/jech.2003.011551; Spencer N, 2003, PEDIATRICS, V112, P704; Stein REK, 2006, PEDIATRICS, V118, P217, DOI 10.1542/peds.2005-2836; Stevens-Simon Catherine, 2002, J Perinatol, V22, P315, DOI 10.1038/sj.jp.7210694; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Stiffman MN, 2002, PEDIATRICS, V109, P615, DOI 10.1542/peds.109.4.615; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; Strine TW, 2008, SOC PSYCH PSYCH EPID, V43, P151, DOI 10.1007/s00127-007-0277-x; Tenenbein M, 2005, ARCH PEDIAT ADOL MED, V159, P557, DOI 10.1001/archpedi.159.6.557; Tickle L, 1997, THE SEX DIFF ERENTIA; Urban Child Institute, 2012, PREMATURITY AND LOW; van der Klis KAM, 2002, AUST NZ J PUBL HEAL, V26, P125, DOI 10.1111/j.1467-842X.2002.tb00904.x; Vennemann MMT, 2005, ACTA PAEDIATR, V94, P655, DOI 10.1080/08035250410024231; Vincent C., 2010, PATIENT SAFETY, V2nd Ed.; Vincent CA, 2004, QUAL SAF HEALTH CARE, V13, P242, DOI 10.1136/qshc.2004.010454; WALTON WW, 1982, PEDIATRICS, V69, P363; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOSING THE GAP IN A; Wild CP, 2003, CANCER EPIDEM BIOMAR, V12, P1389; WILLIAMS CL, 1980, J CLIN PSYCHOL, V36, P90, DOI 10.1002/1097-4679(198001)36:1<90::AID-JCLP2270360104>3.0.CO;2-F; Winter P, 2010, NEUROSCIENCE AND EAR; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6; Wolfe I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1277; Wood AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1552; Woodruff TJ, 2006, ENVIRON HEALTH PERSP, V114, P786, DOI 10.1289/ehp.8484; World Health Organisation (WHO), 2002, THE WORLD HEALTH REP; Zwicker JG, 2008, PEDIATRICS, V121, pE366, DOI 10.1542/peds.2007-0169	160	63	63	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					915	927		10.1016/S0140-6736(14)60581-X	http://dx.doi.org/10.1016/S0140-6736(14)60581-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	25209491	Green Submitted			2022-12-28	WOS:000341362200034
J	Denoeud, F; Carretero-Paulet, L; Dereeper, A; Droc, G; Guyot, R; Pietrella, M; Zheng, CF; Alberti, A; Anthony, F; Aprea, G; Aury, JM; Bento, P; Bernard, M; Bocs, S; Campa, C; Cenci, A; Combes, MC; Crouzillat, D; Da Silva, C; Daddiego, L; De Bellis, F; Dussert, S; Garsmeur, O; Gayraud, T; Guignon, V; Jahn, K; Jamilloux, V; Joet, T; Labadie, K; Lan, TY; Leclercq, J; Lepelley, M; Leroy, T; Li, LT; Librado, P; Lopez, L; Munoz, A; Noel, B; Pallavicini, A; Perrotta, G; Poncet, V; Pot, D; Priyono; Rigoreau, M; Rouard, M; Rozas, J; Tranchant-Dubreuil, C; VanBuren, R; Zhang, Q; Andrade, AC; Argout, X; Bertrand, B; de Kochko, A; Graziosi, G; Henry, RJ; Jayarama; Ming, R; Nagai, C; Rounsley, S; Sankoff, D; Giuliano, G; Albert, VA; Wincker, P; Lashermes, P				Denoeud, France; Carretero-Paulet, Lorenzo; Dereeper, Alexis; Droc, Gaetan; Guyot, Romain; Pietrella, Marco; Zheng, Chunfang; Alberti, Adriana; Anthony, Francois; Aprea, Giuseppe; Aury, Jean-Marc; Bento, Pascal; Bernard, Maria; Bocs, Stephanie; Campa, Claudine; Cenci, Alberto; Combes, Marie-Christine; Crouzillat, Dominique; Da Silva, Corinne; Daddiego, Loretta; De Bellis, Fabien; Dussert, Stephane; Garsmeur, Olivier; Gayraud, Thomas; Guignon, Valentin; Jahn, Katharina; Jamilloux, Veronique; Joet, Thierry; Labadie, Karine; Lan, Tianying; Leclercq, Julie; Lepelley, Maud; Leroy, Thierry; Li, Lei-Ting; Librado, Pablo; Lopez, Loredana; Munoz, Adriana; Noel, Benjamin; Pallavicini, Alberto; Perrotta, Gaetano; Poncet, Valerie; Pot, David; Priyono; Rigoreau, Michel; Rouard, Mathieu; Rozas, Julio; Tranchant-Dubreuil, Christine; VanBuren, Robert; Zhang, Qiong; Andrade, Alan C.; Argout, Xavier; Bertrand, Benoit; de Kochko, Alexandre; Graziosi, Giorgio; Henry, Robert J.; Jayarama; Ming, Ray; Nagai, Chifumi; Rounsley, Steve; Sankoff, David; Giuliano, Giovanni; Albert, Victor A.; Wincker, Patrick; Lashermes, Philippe			The coffee genome provides insight into the convergent evolution of caffeine biosynthesis	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; HORIZONTAL TRANSFERS; GENE CLUSTERS; FAMILY; PLANTS; PATHWAY; ARABICA; SEEDS	Coffee is a valuable beverage crop due to its characteristic flavor, aroma, and the stimulating effects of caffeine. We generated a high-quality draft genome of the species Coffea canephora, which displays a conserved chromosomal gene order among asterid angiosperms. Although it shows no sign of the whole-genome triplication identified in Solanaceae species such as tomato, the genome includes several species-specific gene family expansions, among them N-methyltransferases (NMTs) involved in caffeine production, defense-related genes, and alkaloid and flavonoid enzymes involved in secondary compound synthesis. Comparative analyses of caffeine NMTs demonstrate that these genes expanded through sequential tandem duplications independently of genes from cacao and tea, suggesting that caffeine in eudicots is of polyphyletic origin.	[Denoeud, France; Alberti, Adriana; Aury, Jean-Marc; Bento, Pascal; Bernard, Maria; Da Silva, Corinne; Labadie, Karine; Noel, Benjamin; Wincker, Patrick] Commissariat Energie Atom, Genoscope, Inst Genom, F-91057 Evry, France; [Denoeud, France; Wincker, Patrick] CNRS, UMR 8030, Evry, France; [Denoeud, France; Wincker, Patrick] Univ Evry, UMR 8030, CP5706, Evry, France; [Carretero-Paulet, Lorenzo; Lan, Tianying; Albert, Victor A.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Dereeper, Alexis; Anthony, Francois; Cenci, Alberto; Combes, Marie-Christine; Lashermes, Philippe] Ctr Cooperat Int Rech Agron Dev CIRAD, IRD, UMR Resistance Plantes Bioagresseurs RPB, UM2, F-34394 Montpellier 5, France; [Droc, Gaetan; Bocs, Stephanie; De Bellis, Fabien; Garsmeur, Olivier; Leclercq, Julie; Leroy, Thierry; Pot, David; Argout, Xavier] CIRAD, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, F-34398 Montpellier, France; [Guyot, Romain; Campa, Claudine; Dussert, Stephane; Gayraud, Thomas; Joet, Thierry; Poncet, Valerie; Tranchant-Dubreuil, Christine; de Kochko, Alexandre] CIRAD, IRD, UMR Diversite Adaptat & Dev Plantes, UM2, F-34394 Montpellier 5, France; [Pietrella, Marco; Aprea, Giuseppe; Giuliano, Giovanni] Italian Natl Agcy New Technol Energy & Sustainabl, Casaccia Res Ctr, I-00123 Rome, Italy; [Zheng, Chunfang; Jahn, Katharina; Sankoff, David] Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada; [Cenci, Alberto; Guignon, Valentin; Rouard, Mathieu] Biovers Int, F-34397 Montpellier 5, France; [Crouzillat, Dominique; Lepelley, Maud; Rigoreau, Michel] Nestle Res & Dev Ctr, F-37097 Tours 2, France; [Daddiego, Loretta; Lopez, Loredana; Perrotta, Gaetano] ENEA Trisaia Res Ctr, I-75026 Rotondella, Italy; [Jahn, Katharina] Univ t Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Jahn, Katharina] Univ Bielefeld, AG Genominformat, Tech Fak, D-33594 Bielefeld, Germany; [Jamilloux, Veronique] INRA, Ctr Rech Versailles, Unit Rech Genom Info, UR 1164, F-78026 Versailles, France; [Lan, Tianying] Chongqing Univ Sci & Technol, Dept Biol, Chongqing 4000042, Peoples R China; [Li, Lei-Ting; VanBuren, Robert; Zhang, Qiong; Ming, Ray] Univ Illinois, Dept Plant Biol, Edward R Madigan Lab 148, Urbana, IL 61801 USA; [Librado, Pablo; Rozas, Julio] Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; [Librado, Pablo; Rozas, Julio] Univ Barcelona, Inst Recerca Biodiversitat IRBio, E-08028 Barcelona, Spain; [Munoz, Adriana] Univ Maryland, Dept Math, College Pk, MD 20742 USA; [Munoz, Adriana] Univ Ottawa, Sch Elect Engn & Comp Sci, Ottawa, ON K1N 6N5, Canada; [Pallavicini, Alberto; Graziosi, Giorgio] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Priyono] Indonesian Coffee & Cocoa Inst, Jember, East Java, Indonesia; [Andrade, Alan C.] Embrapa Recursos Genet & Biotecnol, Lab Genet Mol, Nucleo Biotecnol NTBio, BR-70770917 Brasilia, DF, Brazil; [Bertrand, Benoit] CIRAD, UMR RPB, UM2, IRD, F-34394 Montpellier 5, France; [Graziosi, Giorgio] DNA Analyt Srl, I-34127 Trieste, Italy; [Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia; [Jayarama] Cent Coffee Res Inst, Chikamagaluru 577117, Karnataka, India; [Nagai, Chifumi] Hawaii Agr Res Ctr, Kunia, HI 96759 USA; [Rounsley, Steve] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Ottawa; Alliance; Bioversity International; University of Bielefeld; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Chongqing University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Barcelona; University of Barcelona; University System of Maryland; University of Maryland College Park; University of Ottawa; University of Trieste; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Queensland; University of Arizona	Albert, VA (corresponding author), SUNY Buffalo, Dept Biol Sci, 109 Cooke Hall, Buffalo, NY 14260 USA.	vaalbert@buffalo.edu; pwincker@genoscope.cns.fr; philippe.lashermes@ird.fr	Rouard, Mathieu/H-5035-2017; Alberti, Adriana/AAZ-2013-2021; Li, Leiting/F-6334-2013; LEPELLEY, Maud/GQY-8143-2022; Alberti, Adriana/E-7142-2017; de Kochko, Alexandre/C-7512-2009; Anthony, Francois F/A-9341-2008; Pallavicini, Alberto/H-9281-2019; Gaetan, DROC/AAH-2616-2021; JOËT, Thierry/A-9070-2011; Aury, Jean-Marc/N-1621-2019; guyot, romain/M-1118-2015; Rozas, Julio/A-1733-2009; Carretero-Paulet, Lorenzo/Z-2744-2019; Giuliano, Giovanni/A-2701-2012; Pallavicini, Alberto/J-4158-2012; guyot, romain/AAE-2262-2021; Andrade, Alan Carvalho/C-7722-2012; Poncet, Valérie/AGG-5592-2022; Leclercq, Julie/B-2147-2012; CAMPA, Claudine/C-9241-2015; Labadie, Karine/AFL-7408-2022; Labadie, Karine/AAG-7355-2022; Pietrella, Marco/ABE-3613-2020; Cenci, Alberto/H-2823-2019; Henry, Robert J/B-5824-2008; Lashermes, Philippe/J-5295-2016; Pot, David/AAA-3983-2021; Albert, Victor A/A-1690-2010	Rouard, Mathieu/0000-0003-0284-1885; Alberti, Adriana/0000-0003-3372-9423; Li, Leiting/0000-0002-9606-2497; Alberti, Adriana/0000-0003-3372-9423; de Kochko, Alexandre/0000-0001-9212-3195; Pallavicini, Alberto/0000-0001-7174-4603; Gaetan, DROC/0000-0003-1849-1269; JOËT, Thierry/0000-0002-0531-5146; Aury, Jean-Marc/0000-0003-1718-3010; guyot, romain/0000-0002-7016-7485; Rozas, Julio/0000-0002-6839-9148; Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Giuliano, Giovanni/0000-0002-2486-0510; Pallavicini, Alberto/0000-0001-7174-4603; guyot, romain/0000-0002-7016-7485; Andrade, Alan Carvalho/0000-0001-7128-3472; Poncet, Valérie/0000-0002-1099-2846; Labadie, Karine/0000-0001-7467-8509; Labadie, Karine/0000-0001-7467-8509; Cenci, Alberto/0000-0002-4390-5948; Henry, Robert J/0000-0002-4060-0292; Christine, Tranchant-Dubreuil/0000-0001-6934-1215; Bernard, Maria/0000-0001-9005-5563; Pietrella, Marco/0000-0002-8789-6860; Denoeud, France/0000-0001-8819-7634; Lashermes, Philippe/0000-0001-7692-9076; Leclercq, Julie/0000-0001-8110-3762; Noel, Benjamin/0000-0002-5830-3253; Argout, Xavier/0000-0002-0100-5511; Librado, Pablo/0000-0001-5974-2189; Aprea, Giuseppe/0000-0003-4969-2696; Guignon, Valentin/0000-0003-0903-6811; Dussert, Stephane/0000-0001-5222-4282; DA SILVA, Corinne/0000-0002-7618-7831; Perrotta, Gaetano/0000-0003-2037-1063; Jamilloux, Veronique/0000-0002-6898-4910	Australian Research Council; Natural Sciences and Engineering Research Council of Canada; CNR-ENEA Agrifood Project [A2 C44 L191]; FINEP-Qualicafe; NSF [0922742, 0922545]; College of Arts and Sciences, University at Buffalo; SouthGreen Bioinformatics platform (UMR AGAP) CIRAD; INCT-CAFE;  [ANR-08-GENM-022-001];  [ANR-09-GENM-014-002]	Australian Research Council(Australian Research Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CNR-ENEA Agrifood Project; FINEP-Qualicafe; NSF(National Science Foundation (NSF)); College of Arts and Sciences, University at Buffalo; SouthGreen Bioinformatics platform (UMR AGAP) CIRAD; INCT-CAFE; ; 	We acknowledge the following sources for funding: ANR-08-GENM-022-001 (to P. L.); ANR-09-GENM-014-002 (to P. W.); Australian Research Council (to R.J.H.); Natural Sciences and Engineering Research Council of Canada (to D. S.); CNR-ENEA Agrifood Project A2 C44 L191 (to G.Gi.); FINEP-Qualicafe, INCT-CAFE (to A. C. A.); NSF grants 0922742 (to V. A. A.) and 0922545 (to R. M.); and the College of Arts and Sciences, University at Buffalo (to V. A. A.). We thank P. Facella (ENEA) for Roche 454 sequencing and Instituto Agronomico do Parana (Parana, Brazil) for fruit RNA. This work was supported by the high-performance cluster of the SouthGreen Bioinformatics platform (UMR AGAP) CIRAD (www.southgreen.fr). The C. canephora genome assembly and gene models are available on the Coffee Genome Hub (http://coffee-genome.org) and the CoGe platform (www.genomevolution.org). Sequencing data are deposited in the European Nucleotide Archive under the accession numbers CBUE020000001 to CBUE020025216 (contigs), HG739085 to HG752429 (scaffolds), and HG974428 to HG974439 (chromosomes). Gene family alignments and phylogenetic trees for BAHD acyltransferases and NMTs are available in the GreenPhylDB (www.greenphyl.org/cgi-bin/index.cgi) under the gene family IDs CF158535 and CF158539 to CF158545, respectively. We declare no competing financial interests.	Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Dussert S, 2008, PHYTOCHEMISTRY, V69, P2950, DOI 10.1016/j.phytochem.2008.09.021; El Baidouri M, 2014, GENOME RES, V24, P831, DOI 10.1101/gr.164400.113; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Gleason F., 2011, PLANT BIOCHEMISTRY; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Joet T, 2009, NEW PHYTOL, V182, P146, DOI 10.1111/j.1469-8137.2008.02742.x; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Librado P, 2012, BIOINFORMATICS, V28, P279, DOI 10.1093/bioinformatics/btr623; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; McCarthy AA, 2007, PLANT PHYSIOL, V144, P879, DOI 10.1104/pp.106.094854; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Moisy C, 2014, THEOR APPL GENET, V127, P1223, DOI 10.1007/s00122-014-2293-z; NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592; Noirot M, 2003, ANN BOT-LONDON, V92, P709, DOI 10.1093/aob/mcg183; Ogawa M, 2001, J BIOL CHEM, V276, P8213, DOI 10.1074/jbc.M009480200; Pacheco A, 2008, ALLELOPATHY J, V21, P39; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Robbrecht Elmar, 2006, Systematics and Geography of Plants, V76, P85; Roulin A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-58; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Villarreal D, 2009, J AGR FOOD CHEM, V57, P11321, DOI 10.1021/jf902441n; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	26	369	381	16	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1181	1184		10.1126/science.1255274	http://dx.doi.org/10.1126/science.1255274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190796	Green Published			2022-12-28	WOS:000341179800047
J	Gibney, E				Gibney, Elizabeth			HOW TO TAME THE FLOOD OF LITERATURE	NATURE			English	Editorial Material																			0	9	9	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					129	130		10.1038/513129a	http://dx.doi.org/10.1038/513129a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2SD	25186906	Bronze			2022-12-28	WOS:000341174800045
J	Liu, PL; Guo, Y; Qian, X; Tang, SL; Li, ZH; Chen, L				Liu, Peilong; Guo, Yan; Qian, Xu; Tang, Shenglan; Li, Zhihui; Chen, Lincoln			China's distinctive engagement in global health	LANCET			English	Review							ASIA	China has made rapid progress in four key domains of global health. China's health aid deploys medical teams, constructs facilities, donates drugs and equipment, trains personnel, and supports malaria control mainly in Africa and Asia. Prompted by the severe acute respiratory syndrome (SARS) outbreak in 2003, China has prioritised the control of cross-border transmission of infectious diseases and other health-related risks. In governance, China has joined UN and related international bodies and has begun to contribute to pooled multilateral funds. China is both a knowledge producer and sharer, offering lessons based on its health accomplishments, traditional Chinese medicine, and research and development investment in drug discovery. Global health capacity is being developed in medical universities in China, which also train foreign medical students. China's approach to global health is distinctive; different from other countries; and based on its unique history, comparative strength, and policies driven by several governmental ministries. The scope and depth of China's global engagement are likely to grow and reshape the contours of global health.	[Liu, Peilong] Peking Univ, Dept Global Hlth, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Guo, Yan] Peking Univ, Dept Hlth Policy & Adm, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Qian, Xu] Fudan Univ, Global Hlth Inst, Shanghai 200433, Peoples R China; [Qian, Xu] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Tang, Shenglan] Duke Global Hlth Inst, Durham, NC USA; [Tang, Shenglan] Duke Kunshan Univ, Global Hlth Res Ctr, Kunshan, Peoples R China; [Li, Zhihui; Chen, Lincoln] China Med Board, Cambridge, MA USA	Peking University; Peking University; Fudan University; Fudan University; Duke University; Duke Kunshan University	Liu, PL (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100191, Peoples R China.	liupeilong@bjmu.edu.cn	Tang, Shenglan/AAO-7403-2020					[Anonymous], 2004, BBC NEWS; [Anonymous], 2012, CHINA DAILY; [Anonymous], 2013, GLOB HLTH SUPP PROGR; [Anonymous], 1998, CHINESE MAT MED CHEM; [Anonymous], 2012, SHIFT PAR BRICS RESH; Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; Bliss K. E, 2010, KEY PLAYERS GLOBAL H; Br?utigam D., 2011, CHINESE DEV AID AFRI; BUTLER AR, 1992, CHEM SOC REV, V21, P85, DOI 10.1039/cs9922100085; Chakma J, 2014, NEW ENGL J MED, V370, P3, DOI 10.1056/NEJMp1311068; Chan LH, 2009, GLOB PUBLIC HEALTH, V4, P1, DOI 10.1080/17441690701524471; Chan LH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000266; Chen L., 2011, HLTH PROFESSIONALS N; Chen Zhu, 2012, CHINAS HLTH DIPLOMAC; Clapp J., 2001, TOXIC EXPORTS TRANSF; de Haan A, 2011, J INT DEV, V23, P881, DOI 10.1002/jid.1732; Deaton A., 2013, GREAT ESCAPE HLTH WE; Deng L, 2001, CHINESE ACUPUNCTURE; DFID, 2013, CHIN UK GLOB HLTH SU; Duke Kunshan University, 2014, LIB ED MEETS CHIN TR; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; Emory Global Health Institute, 2013, CAS STUD CAN GLOB SA; Forum on China-Africa Cooperation, 2012, 5 MIN C FOR CHIN AFR; Halle M, 2010, ELEMENTS SUSTAINABLE; Haller CA, 2008, J MED TOXICOL, V4, P141, DOI 10.1007/BF03160969; Hanson S., 2008, CHINA AFRICA OIL; Ho S, 2012, CHINA FOREIGN POLICY; Huang Y., 2012, CHINA GLOBAL HLTH GO; Information Office of the State Council of the PRC, 2011, WHIT PAP CHIN FOR AI; Information Office of the State Council of the PRC, 2014, WHIT PAP CHIN FOR AI; [蒋晓晓 Jiang Xiaoxiao], 2014, [中国卫生政策研究, Chinese Journal of Health Policy], V7, P64; Kickbusch I, 2009, MOVING GLOBAL HLTH G; King K, 2006, AIDS WIDER CHINA AFR; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Li Anshan, 2011, CHINESE MED COOPERAT; Lum T., 2009, CHINAS FOREIGN AID A; McKee M, 2006, LANCET, V367, P1224, DOI 10.1016/S0140-6736(06)68520-6; Ministry of Education of People's Republic of China, 2012, BRIEF STAT INT STUD; Ministry of Education of People's Republic of China, 2012, CHIN ED YB; Ministry of Education of People's Republic of China, 2013, NEW LIST CHIN MED I; Ministry of Education of People's Republic of China, 2007, INT PROV CONTR QUAL; Mitka M, 2008, JAMA-J AM MED ASSOC, V300, P2597, DOI 10.1001/jama.2008.786; Moon S, 2013, DEV ASSISTANCE HLTH; Ng N, 2011, GLOBAL HLTH GOVERNAN; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Okudera A, 2013, AIR POLLUTION CHINA; Party Literature Research Center of the CPC Central Committee, 1982, COLL IMP DOC 3 PLEN; Rogers S, 2011, WORLD CARBON DIOXIDE; SCC [State Council of China], 2013, STAT COUNC ISS ACT P; Sen A, 2004, NEW YORK REV BOOKS, V51, P61; SIDEL VW, 1972, NEW ENGL J MED, V286, P1292, DOI 10.1056/NEJM197206152862404; Sky J, 2014, EMERGING EC LAUNCH D; Strange A, 2013, CHINA DEV FINANCE AF; Stuckler D, 2008, LANCET, V372, P95, DOI 10.1016/S0140-6736(08)61013-2; Summers William C., 2012, GREAT MANCHURIAN PLA; Terada H, 2002, ATMOS ENVIRON, V36, P503, DOI 10.1016/S1352-2310(01)00509-X; Tremblay J., 2013, CHINA UPGRADES DRUG; Wang K, 2012, GLOB PUBLIC HEALTH, V7, P196, DOI 10.1080/17441692.2011.594450; Wang L, 2013, J CONTROL DECIS, DOI DOI 10.13195/J.KZYJC.2013.0850; WHO, 2000, HUM RES ANN REP 2000; WHO, 2012, CONTR POL OUTBR CHIN; WHO, FIN AUD REP WORLD HL; WHO, 2006, INT PLEDG C AV HUM P; Wikipedia, 2013, INFL VIR SUBT H7N9; World Bank, DAT NET OFF DEV ASS; World Health Organization, 2013, CHIN WHO JOINT MISS; Xinhua News Agency, 2006, CHIN REG AL MAL DENG; Xiu CB, 2010, FOOD POLICY, V35, P463, DOI 10.1016/j.foodpol.2010.05.001; Xu J, 2013, FIGHTING MALARIA; Zhong J, 2014, CHINAS PRIORITIES AF; Zhu N, 2013, CHINA STRENGTHEN COO; Zweig D., 2005, CHINAS GLOBAL HUNT E	72	61	78	2	126	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					793	804		10.1016/S0140-6736(14)60725-X	http://dx.doi.org/10.1016/S0140-6736(14)60725-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	25176550	Green Published, Bronze			2022-12-28	WOS:000341361500040
J	Chandler, JA; Turelli, M				Chandler, James Angus; Turelli, Michael			Comment on "The hologenomic basis of speciation: Gut bacteria cause hybrid lethality in the genus Nasonia"	SCIENCE			English	Editorial Material															NIGMS NIH HHS [R01-GM-104325-01, R01 GM104325] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104325] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	16	16	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1011	1011		10.1126/science.1251997	http://dx.doi.org/10.1126/science.1251997			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170144	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000340870900025
J	McCartney, M				McCartney, Margaret			Talking about death is not outrageous-reducing it to a tickbox exercise is	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADMISSIONS					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; Huntley AL, 2013, FAM PRACT, V30, P266, DOI 10.1093/fampra/cms081; NHS Employers, 2014, 01778 NHS EMPL; Prynne M., 2014, DAILY TELEGRAPH; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2014	349								g5369	10.1136/bmj.g5369	http://dx.doi.org/10.1136/bmj.g5369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO2SA	25171925	Green Published, Bronze			2022-12-28	WOS:000341174500007
J	Park, RW				Park, Robert W.			Stories of Arctic colonization	SCIENCE			English	Editorial Material									Univ Waterloo, Dept Anthropol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Park, RW (corresponding author), Univ Waterloo, Dept Anthropol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	robert.park@uwaterloo.ca	Park, Robert/C-5049-2011	Park, Robert/0000-0002-4520-6382				COLLINS HB, 1956, NATL GEOGR, V110, P669; Friesen TM, 2000, IDENTITIES CULTURAL, P206; Hayes MG., 2005, CONTRIBUTIONS STUDY, P11, DOI [DOI 10.2307/J.CTV16P21.9, 10.2307/j.ctv16p21.9]; Mathiassen T., 1927, ARCHAEOLOGY CENTRAL, Vfirst; MCGHEE R, 1976, E ARCTIC PREHISTORY, P6; McGhee R., 1997, 50 YEARS ARCTIC RES, P209; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rowley S., 1994, THREADS ARCTIC PREHI, P361; Savene JM, 2014, AM ANTIQUITY, V79, P249, DOI 10.7183/0002-7316.79.2.249; Sutherland P. D., 2009, NO WORLD AD 900 1400, P279; Sutherland P.D., 2000, IDENTITIES CULTURAL, P159; Tauber H, 1979, RADIOCARBON DATING, P447	12	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1004	1005		10.1126/science.1258607	http://dx.doi.org/10.1126/science.1258607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8RE	25170138				2022-12-28	WOS:000340870900018
J	Bertet, C; Li, X; Erclik, T; Cavey, M; Wells, B; Desplan, C				Bertet, Claire; Li, Xin; Erclik, Ted; Cavey, Matthieu; Wells, Brent; Desplan, Claude			Temporal Patterning of Neuroblasts Controls Notch-Mediated Cell Survival through Regulation of Hid or Reaper	CELL			English	Article							DROSOPHILA OPTIC LOBE; CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; PROGENITOR CELLS; LINEAGE; FATE; IDENTITY; BRAIN; PROLIFERATION; SPECIFICATION	Temporal patterning of neural progenitors is one of the core mechanisms generating neuronal diversity in the central nervous system. Here, we show that, in the tips of the outer proliferation center (tOPC) of the developing Drosophila optic lobes, a unique temporal series of transcription factors not only governs the sequential production of distinct neuronal subtypes but also controls the mode of progenitor division, as well as the selective apoptosis of Notch(OFF) or Notch(ON) neurons during binary cell fate decisions. Within a single lineage, intermediate precursors initially do not divide and generate only one neuron; subsequently, precursors divide, but their Notch(ON) progeny systematically die through Reaper activity, whereas later, their Notch(OFF) progeny die through Hid activity. These mechanisms dictate how the tOPC produces neurons for three different optic ganglia. We conclude that temporal patterning generates neuronal diversity by specifying both the identity and survival/death of each unique neuronal subtype.	[Bertet, Claire; Li, Xin; Erclik, Ted; Cavey, Matthieu; Wells, Brent; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Desplan, Claude] New York Univ Abu Dhabi, CGSB, Abu Dhabi, U Arab Emirates	New York University	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.	cd38@nyu.edu	Li, Xin/D-3421-2013	Li, Xin/0000-0002-3428-3569; Desplan, Claude/0000-0002-6914-1413	NIH [R01 EY017916, T32EY022843-02]; NYU Abu Dhabi [G-1205C]; EMBO [ALTF 680-2009, ALTF 249-2009]; HFSPO [LT000077/2010-L]; Philippe Foundation; Robert Leet and Clara Guthrie Patterson Trust; Canadian Institutes of Health and Research (CIHR); Revson Foundation; NATIONAL EYE INSTITUTE [F32EY022843, R01EY017916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Abu Dhabi; EMBO(European Molecular Biology Organization (EMBO)); HFSPO(Human Frontier Science Program); Philippe Foundation; Robert Leet and Clara Guthrie Patterson Trust; Canadian Institutes of Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Revson Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the fly community and the modENCODE team for gifts of antibodies and fly stocks. We especially thank Don Ryoo for his valuable help and advice regarding cell death experiments. We thank the Desplan laboratory members for discussions and support, as well as M. Slaidina, L. Christiaen, C. Maurange, N. Vogt, J. Bos, C. Doe, T. Lee, and R. Jonhston for critically reading the manuscript. This work was supported by a grant from NIH to C.D. (R01 EY017916). Support was also provided by NYU Abu Dhabi grant G-1205C to C.D.; fellowships from EMBO (ALTF 680-2009), HFSPO (LT000077/2010-L), and Philippe Foundation to C.B.; The Robert Leet and Clara Guthrie Patterson Trust to X.L.; The Canadian Institutes of Health and Research (CIHR) to T.E.; EMBO (ALTF 249-2009) and The Revson Foundation to M.C; and NIH (T32EY022843-02) to B.W.	Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; He J, 2012, NEURON, V75, P786, DOI 10.1016/j.neuron.2012.06.033; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7; Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371; Lee T, 1999, DEVELOPMENT, V126, P4065; Li X, 2013, NATURE, V498, P456, DOI 10.1038/nature12319; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593; Meinertzhagen Ian A., 1993, P1363; Monastirioti M, 2010, DEVELOPMENT, V137, P191, DOI 10.1242/dev.043604; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036; Rogulja-Ortmann A, 2008, FLY, V2, P316, DOI 10.4161/fly.7464; Suzuki T, 2013, DEV BIOL, V380, P12, DOI 10.1016/j.ydbio.2013.05.002; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; Ulvklo C, 2012, DEVELOPMENT, V139, P678, DOI 10.1242/dev.074500; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	31	87	88	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1173	1186		10.1016/j.cell.2014.07.045	http://dx.doi.org/10.1016/j.cell.2014.07.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171415	Bronze, Green Accepted			2022-12-28	WOS:000340945000021
J	Boyle, AP; Araya, CL; Brdlik, C; Cayting, P; Cheng, C; Cheng, Y; Gardner, K; Hillier, LW; Janette, J; Jiang, LX; Kasper, D; Kawli, T; Kheradpour, P; Kundaje, A; Li, JJ; Ma, LJ; Niu, W; Rehm, EJ; Rozowsky, J; Slattery, M; Spokony, R; Terrell, R; Vafeados, D; Wang, DF; Weisdepp, P; Wu, YC; Xie, D; Yan, KK; Feingold, EA; Good, PJ; Pazin, MJ; Huang, HY; Bickel, PJ; Brenner, SE; Reinke, V; Waterston, RH; Gerstein, M; White, KP; Kellis, M; Snyder, M				Boyle, Alan P.; Araya, Carlos L.; Brdlik, Cathleen; Cayting, Philip; Cheng, Chao; Cheng, Yong; Gardner, Kathryn; Hillier, LaDeana W.; Janette, Judith; Jiang, Lixia; Kasper, Dionna; Kawli, Trupti; Kheradpour, Pouya; Kundaje, Anshul; Li, Jingyi Jessica; Ma, Lijia; Niu, Wei; Rehm, E. Jay; Rozowsky, Joel; Slattery, Matthew; Spokony, Rebecca; Terrell, Robert; Vafeados, Dionne; Wang, Daifeng; Weisdepp, Peter; Wu, Yi-Chieh; Xie, Dan; Yan, Koon-Kiu; Feingold, Elise A.; Good, Peter J.; Pazin, Michael J.; Huang, Haiyan; Bickel, Peter J.; Brenner, Steven E.; Reinke, Valerie; Waterston, Robert H.; Gerstein, Mark; White, Kevin P.; Kellis, Manolis; Snyder, Michael			Comparative analysis of regulatory information and circuits across distant species	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHIP-SEQ; HISTONE DEACETYLASE; CHROMATIN-IMMUNOPRECIPITATION; DROSOPHILA-MELANOGASTER; FACTOR COLOCALIZATION; MOTIF DISCOVERY; HIGH-THROUGHPUT; HUMAN-CELLS; RNA-SEQ	Despite the large evolutionary distances between metazoan species, they can show remarkable commonalities in their biology, and this has helped to establish fly and worm as model organisms for human biology(1,2). Although studies of individual elements and factors have explored similarities in gene regulation, a large-scale comparative analysis of basic principles of transcriptional regulatory features is lacking. Here we map the genome-wide binding locations of 165 human, 93 worm and 52 fly transcription regulatory factors, generating a total of 1,019 data sets from diverse cell types, developmental stages, or conditions in the three species, of which 498 (48.9%) are presented here for the first time. We find that structural properties of regulatory networks are remarkably conserved and that orthologous regulatory factor families recognize similar binding motifs in vivo and show some similar co-associations. Our results suggest that gene-regulatory properties previously observed for individual factors are general principles of metazoan regulation that are remarkably well-preserved despite extensive functional divergence of individual network connections. The comparative maps of regulatory circuitry provided here will drive an improved understanding of the regulatory underpinnings of model organism biology and how these relate to human biology, development and disease.	[Boyle, Alan P.; Araya, Carlos L.; Brdlik, Cathleen; Cayting, Philip; Cheng, Yong; Jiang, Lixia; Kawli, Trupti; Xie, Dan; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Cheng, Chao; Rozowsky, Joel; Wang, Daifeng; Yan, Koon-Kiu; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gardner, Kathryn; Janette, Judith; Kasper, Dionna; Niu, Wei; Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Hillier, LaDeana W.; Ma, Lijia; Terrell, Robert; Vafeados, Dionne; Waterston, Robert H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Kheradpour, Pouya; Kundaje, Anshul; Wu, Yi-Chieh; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Li, Jingyi Jessica; Huang, Haiyan; Bickel, Peter J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Li, Jingyi Jessica] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Rehm, E. Jay; Slattery, Matthew; Spokony, Rebecca; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Feingold, Elise A.; Good, Peter J.; Pazin, Michael J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Brenner, Steven E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Stanford University; Yale University; Yale University; University of Washington; University of Washington Seattle; Stanford University; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	kpwhite@uchicago.edu; manoli@mit.edu; mpsnyder@stanford.edu	Spokony, Rebecca/AAD-3014-2020; Kellis, Manolis/ABE-7385-2020; Brenner, Steven E/A-8729-2008; Kundaje, Anshul/Y-2739-2019; Wang, Daifeng/K-2412-2019; cheng, yong/I-4270-2012; Li, Jingyi Jessica/I-2779-2019; Kundaje, Anshul/Y-2598-2019; Boyle, Alan/I-1848-2014	Kellis, Manolis/0000-0001-7113-9630; Brenner, Steven E/0000-0001-7559-6185; Kundaje, Anshul/0000-0003-3084-2287; Li, Jingyi Jessica/0000-0002-9288-5648; Kundaje, Anshul/0000-0003-3084-2287; Boyle, Alan/0000-0002-2081-1105; Snyder, Michael/0000-0003-0784-7987; Araya, Carlos/0000-0002-5512-3062; Kasper, Dionna/0000-0002-3964-6680; Rozowsky, Joel/0000-0002-3565-0762; Pazin, Michael/0000-0002-7561-3640; Gerstein, Mark/0000-0002-9746-3719	NHGRI as part of the modENCODE; NHGRI as part of the ENCODE;  [U01HG004264];  [RC2HG005679];  [P50GM081892];  [U54HG006996];  [U54HG004558];  [U01HG004267];  [F32GM101778]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005679, U01HG004264, U54HG006996, U01HG004267, K99HG007356, R01HG004037, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892, F32GM101778] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	NHGRI as part of the modENCODE; NHGRI as part of the ENCODE; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by the NHGRI as part of the modENCODE and ENCODE projects. This work was funded by U01HG004264, RC2HG005679 and P50GM081892 to K.P.W., U54HG006996, U54HG004558 and U01HG004267 to M.S., and F32GM101778 to K.E.G.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carroll S. B., 2004, DNA DIVERSITY MOL GE; Cheng C, 2011, BIOINFORMATICS, V27, P3221, DOI 10.1093/bioinformatics/btr552; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Li JJ, 2014, GENOME RES, V24, P1086, DOI 10.1101/gr.170100.113; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Rasmussen MD, 2012, GENOME RES, V22, P755, DOI 10.1101/gr.123901.111; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wehrens R, 2007, J STAT SOFTW, V21, P1; Wu YC, 2013, SYST BIOL, V62, P110, DOI 10.1093/sysbio/sys076; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	54	124	125	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					453	+		10.1038/nature13668	http://dx.doi.org/10.1038/nature13668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164757	hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000340840600039
J	Weeks, WB; Auerbach, D				Weeks, William B.; Auerbach, David			A VA Exit Strategy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VETERANS; CARE		[Weeks, William B.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Auerbach, David] RAND, Boston, MA USA	Dartmouth College; RAND Corporation	Weeks, WB (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA.		Weeks, WB/G-7436-2014					Auerbach D.I., 2013, HLTH CARE SPENDING E; Trivedi AN, 2012, JAMA-J AM MED ASSOC, V308, P67, DOI 10.1001/jama.2012.7115; Weeks WB, 2007, AM J PUBLIC HEALTH, V97, P2186, DOI 10.2105/AJPH.2007.115337; Weeks WB, 2007, MIL MED, V172, P1154, DOI 10.7205/MILMED.172.11.1154	4	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					789	791		10.1056/NEJMp1407535	http://dx.doi.org/10.1056/NEJMp1407535			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25162884				2022-12-28	WOS:000340819800002
J	Saha, K; Shetty, D				Saha, Kunal; Shetty, Devi			Are large compensation payouts for negligence good for medicine in India?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REFORM		[Saha, Kunal] People Better Treatment, Hilliard, OH 43026 USA; [Shetty, Devi] Narayana Hrudayalaya Private Ltd, Bangalore 560099, Karnataka, India		Saha, K (corresponding author), People Better Treatment, 2704 Bridgewatch Lane, Hilliard, OH 43026 USA.	anku1@earthlink.net; devishetty@nhhospitals.org						[Anonymous], 2014, ZEENEWS         0211; [Anonymous], 2006, NO ILLINOIS U LAW RE, V26, P413; Avraham R, 2009, 15371 NBER; Chatterjee P, 2010, LANCET, V375, P1679, DOI 10.1016/S0140-6736(10)60720-9; Chaudhuri M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g183; Currie J, 2008, Q J ECON, V123, P795, DOI 10.1162/qjec.2008.123.2.795; Ganz K., 2013, LEGALLY INDIA   0218; Hermer LD, 2010, J GEN INTERN MED, V25, P470, DOI 10.1007/s11606-010-1259-3; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Lakdawalla D., 2009, 15383 NBER; McLaughlin MG, 2012, EXAMINER        0415; Nagarajan R, 2013, TIMES INDIA; Organisation for Economic Cooperation and Development, 2006, MED MALPR PREV INS C; Rayamane AP, PRIFILE MED NEGLIGEN; Sachan D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2163; Saha K, 2003, BRIT MED J, V326, P713, DOI 10.1136/bmj.326.7391.713; *US GEN ACC OFF, 2003, GAO03836; Winston C, 2011, 1 THINGS WE DO LETS	19	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2014	349								g5229	10.1136/bmj.g5229	http://dx.doi.org/10.1136/bmj.g5229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO2RY	25164243				2022-12-28	WOS:000341174300006
J	Udell, JA; Wang, TY; Li, S; Kohli, P; Roe, MT; de Lemos, JA; Wiviott, SD				Udell, Jacob A.; Wang, Tracy Y.; Li, Shuang; Kohli, Payal; Roe, Matthew T.; de Lemos, James A.; Wiviott, Stephen D.			Clinical Trial Participation After Myocardial Infarction in a National Cardiovascular Data Registry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ACUTE CORONARY SYNDROMES; CLOPIDOGREL		[Udell, Jacob A.] Univ Toronto, Womens Coll Hosp, Toronto, ON M5S 1B1, Canada; [Wang, Tracy Y.; Li, Shuang; Roe, Matthew T.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Kohli, Payal] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Wiviott, Stephen D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Womens College Hospital; Duke University; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital	Udell, JA (corresponding author), Univ Toronto, Womens Coll Hosp, 76 Grenville St, Toronto, ON M5S 1B1, Canada.	jay.udell@utoronto.ca	de Lemos, James/ABD-6669-2021; Wiviott, Stephen/HIK-2534-2022	Udell, Jacob/0000-0001-7402-9584; Kohli, Payal/0000-0002-1049-5233	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Chin CT, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.004; Humphreys K, 2013, JAMA INTERN MED, V173, P1029, DOI 10.1001/jamainternmed.2013.496; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	6	38	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					841	843		10.1001/jama.2014.6217	http://dx.doi.org/10.1001/jama.2014.6217			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157729				2022-12-28	WOS:000340788500028
J	Mellin, JR; Koutero, M; Dar, D; Nahori, MA; Sorek, R; Cossart, P				Mellin, J. R.; Koutero, Mikael; Dar, Daniel; Nahori, Marie-Anne; Sorek, Rotem; Cossart, Pascale			Sequestration of a two-component response regulator by a riboswitch-regulated noncoding RNA	SCIENCE			English	Article							ETHANOLAMINE UTILIZATION; ANTISENSE RNA	Riboswitches are ligand-binding elements contained within the 5' untranslated regions of bacterial transcripts, which generally regulate expression of downstream open reading frames. Here, we show that in Listeria monocytogenes, a riboswitch that binds vitamin B-12 controls expression of a noncoding regulatory RNA, Rli55. Rli55, in turn, controls expression of the eut genes, whose products enable ethanolamine utilization and require B12 as a cofactor. Defects in ethanolamine utilization, or in its regulation by Rli55, significantly attenuate Listeria virulence in mice. Rli55 functions by sequestering the two-component response regulator EutV by means of a EutV-binding site contained within the RNA. Thus, Rli55 is a riboswitch-regulated member of the small group of regulatory RNAs that function by sequestering a protein and reveals a distinctive mechanism of signal integration in bacterial gene regulation.	[Mellin, J. R.; Koutero, Mikael; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Mellin, J. R.; Koutero, Mikael; Nahori, Marie-Anne; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Mellin, J. R.; Koutero, Mikael; Nahori, Marie-Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Dar, Daniel; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Weizmann Institute of Science	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr		Dar, Daniel/0000-0002-6650-5488; Marie-Anne, Nahori/0000-0002-4066-4528	European Research Council [233348]; ANR [BACNET 09-BLAN-0024-02]; ANR Investissement d'Avenir Programme [10-LABX-62]; Fondation Le Roch; Fondation Jeantet	European Research Council(European Research Council (ERC)European Commission); ANR(French National Research Agency (ANR)); ANR Investissement d'Avenir Programme(French National Research Agency (ANR)); Fondation Le Roch; Fondation Jeantet	We are grateful to D. Garsin and W. Winkler for their exchange of ideas and discussion of unpublished data. We also thank, N. King and J. Pederson for helpful and insightful discussions and Y. Chao and J. Vogel for assistance with the CLIP-seq protocol. This work was supported by grants to P. C., European Research Council advanced grant (233348), ANR (BACNET 09-BLAN-0024-02), ANR Investissement d'Avenir Programme (10-LABX-62), Fondation Le Roch, and Fondation Jeantet. P. C. is an International Senior Research Scholar of the Howard Hughes Medical Institute.	Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Archambaud C, 2012, P NATL ACAD SCI USA, V109, P16684, DOI 10.1073/pnas.1212809109; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Del Papa MF, 2008, J BACTERIOL, V190, P7147, DOI 10.1128/JB.00952-08; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; KAWAI K, 1974, BIOCHIM BIOPHYS ACTA, V369, P222; Mellin JR, 2013, P NATL ACAD SCI USA, V110, P13132, DOI 10.1073/pnas.1304795110; Ramesh A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002666; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsoy O, 2009, J BACTERIOL, V191, P7157, DOI 10.1128/JB.00838-09; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11	17	111	115	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					940	943		10.1126/science.1255083	http://dx.doi.org/10.1126/science.1255083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146292	Green Submitted			2022-12-28	WOS:000340524700049
J	Hennig, J; Militti, C; Popowicz, GM; Wang, I; Sonntag, M; Geerlof, A; Gabel, F; Gebauer, F; Sattler, M				Hennig, Janosch; Militti, Cristina; Popowicz, Grzegorz M.; Wang, Iren; Sonntag, Miriam; Geerlof, Arie; Gabel, Frank; Gebauer, Fatima; Sattler, Michael			Structural basis for the assembly of the Sxl-Unr translation regulatory complex	NATURE			English	Article							MSL-2 MESSENGER-RNA; ANGLE SCATTERING DATA; SEX-LETHAL; DOSAGE COMPENSATION; CRYSTAL-STRUCTURE; X-RAY; BIOLOGICAL MACROMOLECULES; NEUTRON-SCATTERING; NMR EXPERIMENTS; DROSOPHILA UNR	Genetic equality between males and females is established by chromosome-wide dosage-compensation mechanisms. In the fruit-fly Drosophila melanogaster, the dosage-compensation complex promotes two fold hypertranscription of the singlemale X-chromosome and is silenced in females by inhibition of the translation of msl2, which codes for the limiting component of the dosage-compensation complex(1,2). The female-specific protein Sex-lethal (Sxl) recruits Upstream of-N-ras(Unr) to the 39 untranslated region of msl2 messenger RNA, preventing the engagement of the small ribosomal subunit(3). Here we report the 2.8 angstrom crystal structure, NMR and small-angle X-ray and neutron scattering data of the ternary Sxl-Unr-msl2 ribonucleoprotein complex featuring unprecedented intertwined interactions of two Sxl RNA recognition motifs, a Unr cold-shock domain and RNA. Cooperative complex formation is associated with a 1,000-fold increase of RNA binding affinity for the Unr cold-shock domain and involves novel ternary interactions, as well as non-canonical RNA contacts by the alpha 1 helix of Sxl RNA recognition motif 1. Our results suggest that repression of dosage compensation, necessary for female viability, is triggered by specific, cooperative molecular interactions that lock a ribonucleoprotein switch to regulate translation. The structure serves as a paradigm for how a combination of general and widespread RNA binding domains expands the code for specific single-stranded RNA recognition in the regulation of gene expression.	[Hennig, Janosch; Popowicz, Grzegorz M.; Wang, Iren; Sonntag, Miriam; Geerlof, Arie; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Struct Biol, DE-85764 Munich, Germany; [Hennig, Janosch; Popowicz, Grzegorz M.; Wang, Iren; Sonntag, Miriam; Sattler, Michael] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich Biomol NMR Spect, DE-85747 Garching, Germany; [Militti, Cristina; Gebauer, Fatima] Ctr Genom Regulat, Gene Regulat Stem Cells & Canc Programme, Barcelona 08003, Spain; [Militti, Cristina; Gebauer, Fatima] Univ Pompeu Fabra, Barcelona 08003, Spain; [Gabel, Frank] Univ Grenoble Alpes, Inst Biol Struct, F-38044 Grenoble, France; [Gabel, Frank] CNRS, Inst Biol Struct, F-38044 Grenoble, France; [Gabel, Frank] Commissariat Energie Atom & Energies Alternat, Inst Biol Struct, F-38044 Grenoble, France; [Gabel, Frank] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Laue-Langevin (ILL)	Sattler, M (corresponding author), Helmholtz Zentrum Munchen, Inst Struct Biol, Ingolstadter Landstr 1, DE-85764 Munich, Germany.	fatima.gebauer@crg.eu; sattler@helmholtz-muenchen.de	Popowicz, Grzegorz/G-4769-2017; Gebauer, Fatima/E-7725-2015; Sattler, Michael/A-2407-2012	Popowicz, Grzegorz/0000-0003-2818-7498; Gebauer, Fatima/0000-0001-7563-0013; Sattler, Michael/0000-0002-1594-0527; Hennig, Janosch/0000-0001-5214-7002; Gabel, Frank/0000-0003-3446-2601	Swedish Research Council (Vetenskapsradet); European Molecular Biology Organization (EMBO) [ALTF276-2010]; Spanish Ministry of Economy and Competitiveness [BFU2009-08243, Consolider CSD2009-00080]; Deutsche Forschungsgemeinschaft [SFB1035, GRK1721]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank H.-S. Kang, M. Pabis and L. Warner for discussions and reading the manuscript. We acknowledge the ILL, Grenoble for BAG SANS beamtime on D22 (local contact A. Martel), the ESRF for beamtime on BM29 (local contact L. Zerrad), the Swiss Light Source for beamtime, the crystallization facility at the Max-Planck-Institute for Biochemistry, Martinsried, and the Bavarian NMR Center for NMR measurement time. We thank T. Madl and C. Gobl for assisting in SAXS measurements of the 34-mer complex. J.H. acknowledges postdoctoral fellowships from the Swedish Research Council (Vetenskapsradet) and the European Molecular Biology Organization (EMBO, ALTF276-2010), C.M. acknowledges a La Caixa Foundation fellowship. Funding support is acknowledged by grants BFU2009-08243 and Consolider CSD2009-00080 from the Spanish Ministry of Economy and Competitiveness (to. F.Ge.) and the Deutsche Forschungsgemeinschaft, grants SFB1035 and GRK1721 (to M. Sa.).	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; Abaza I, 2008, RNA, V14, P482, DOI 10.1261/rna.802908; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; BERNSTEIN M, 1995, GENETICS, V139, P631; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; CLINE TW, 1984, GENETICS, V107, P231; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Goddard T. D., SPARKY 3; Gosh R. E., 2006, ILL06GH05T; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graindorge A, 2011, WIRES RNA, V2, P534, DOI 10.1002/wrna.75; Grskovic M, 2003, EMBO J, V22, P5571, DOI 10.1093/emboj/cdg539; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hennig J, 2013, J BIOMOL NMR, V56, P17, DOI 10.1007/s10858-013-9719-9; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Mackereth CD, 2012, CURR OPIN STRUC BIOL, V22, P287, DOI 10.1016/j.sbi.2012.03.013; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; MAINE EM, 1985, CELL, V43, P521, DOI 10.1016/0092-8674(85)90181-3; Mayr F, 2012, NUCLEIC ACIDS RES, V40, P7492, DOI 10.1093/nar/gks355; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin KJ, 2011, BIOCHEMISTRY-US, V50, P1429, DOI 10.1021/bi102057m; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Otting G, 2000, J BIOMOL NMR, V16, P343, DOI 10.1023/A:1008372630606; Park SW, 2007, GENETICS, V177, P1429, DOI 10.1534/genetics.107.071001; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Salzmann M, 1999, J BIOMOL NMR, V14, P85, DOI 10.1023/A:1008346931993; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHINDELIN H, 1993, NATURE, V364, P164, DOI 10.1038/364164a0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Triqueneaux G, 1999, NUCLEIC ACIDS RES, V27, P1926, DOI 10.1093/nar/27.8.1926; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975	60	80	80	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					287	U343		10.1038/nature13693	http://dx.doi.org/10.1038/nature13693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25209665				2022-12-28	WOS:000344631400055
J	Huang, JH; Kang, BH; Pancera, M; Lee, JH; Tong, T; Feng, Y; Imamichi, H; Georgiev, IS; Chuang, GY; Druz, A; Doria-Rose, NA; Laub, L; Sliepen, K; van Gils, MJ; de la Pena, AT; Derking, R; Klasse, PJ; Migueles, SA; Bailer, RT; Alam, M; Pugach, P; Haynes, BF; Wyatt, RT; Sanders, RW; Binley, JM; Ward, AB; Mascola, JR; Kwong, PD; Connors, M				Huang, Jinghe; Kang, Byong H.; Pancera, Marie; Lee, Jeong Hyun; Tong, Tommy; Feng, Yu; Imamichi, Hiromi; Georgiev, Ivelin S.; Chuang, Gwo-Yu; Druz, Aliaksandr; Doria-Rose, Nicole A.; Laub, Leo; Sliepen, Kwinten; van Gils, Marit J.; de la Pena, Alba Torrents; Derking, Ronald; Klasse, Per-Johan; Migueles, Stephen A.; Bailer, Robert T.; Alam, Munir; Pugach, Pavel; Haynes, Barton F.; Wyatt, Richard T.; Sanders, Rogier W.; Binley, James M.; Ward, Andrew B.; Mascola, John R.; Kwong, Peter D.; Connors, Mark			Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; B-CELLS; DEPENDENT EPITOPE; ENV TRIMERS; CLEAVAGE; GP120; SERA; SPECIFICITIES; VULNERABILITY	The isolation of human monoclonal antibodies is providing important insights into the specificities that underlie broad neutralization of HIV-1 (reviewed in ref. 1). Here we report a broad and extremely potent HIV-specific monoclonal antibody, termed 35O22, which binds a novel HIV-1 envelope glycoprotein (Env) epitope. 35O22 neutralized 62% of 181 pseudoviruses with a half-maximum inhibitory concentration (IC50)<50 mu gml(-1). The median IC50 of neutralized viruses was 0.033 mu gml(-1), among themost potent thus far described. 35O22 did not bind monomeric forms of Env tested, but did bind the trimeric BG505 SOSIP. 664. Mutagenesis and a reconstruction by negative-stain electron microscopy of the Fab in complex with trimer revealed that it bound to a conserved epitope, which stretched across gp120 and gp41. The specificity of 35O22 represents a novel site of vulnerability on HIV Env, which serum analysis indicates to be commonly elicited by natural infection. Binding to this new site of vulnerability may thus be an important complement to current monoclonal-antibody-based approaches to immunotherapies, prophylaxis and vaccine design.	[Huang, Jinghe; Kang, Byong H.; Imamichi, Hiromi; Laub, Leo; Migueles, Stephen A.; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Pancera, Marie; Georgiev, Ivelin S.; Chuang, Gwo-Yu; Druz, Aliaksandr; Doria-Rose, Nicole A.; Bailer, Robert T.; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Lee, Jeong Hyun; Wyatt, Richard T.; Ward, Andrew B.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA; [Lee, Jeong Hyun; Feng, Yu; Wyatt, Richard T.; Ward, Andrew B.] Scripps Res Inst, Int AIDS Vaccine Initiat IAVI Neutralizing Antibo, La Jolla, CA 92037 USA; [Tong, Tommy; Binley, James M.] San Diego Biomed Res Inst, San Diego, CA 92121 USA; [Sliepen, Kwinten; van Gils, Marit J.; de la Pena, Alba Torrents; Derking, Ronald; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1100 DD Amsterdam, Netherlands; [Klasse, Per-Johan; Pugach, Pavel; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Alam, Munir; Haynes, Barton F.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; Duke University	Connors, M (corresponding author), NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.	mconnors@nih.gov	van Gils, Marit J./H-4791-2019; Klasse, P.J./AEX-0142-2022; Mascola, John/AAI-7193-2021; Alam, S. Munir/AAC-6711-2019; Koyuncu, ayfer/M-3872-2015; Ward, Andrew B/F-9203-2014; Huang, Jinghe/P-8068-2019; Ward, Andrew/ABD-7728-2021; Huang, Jinghe/O-1986-2015	van Gils, Marit J./0000-0003-3422-8161; Klasse, P.J./0000-0001-8222-278X; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Lee, Jeong Hyun/0000-0001-7371-845X; Huang, Jinghe/0000-0002-1968-871X	Intramural Research Programs of NIAID, National Institutes of Health; NIH HIVRAD grant [P01 AI082362]; Aids Fonds Netherlands [2011032, 2012041]; Netherlands Organization for Scientific Research (NWO); European Research Council [ERC-StG-2011-280829-SHEV]; International AIDS Vaccine Initiative; NIH [AI93278, AI84714]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100790, ZICAI005111, UM1AI100645, R21AI084714, ZIAAI005022, R01AI093278, ZIAAI005089, UM1AI100663, ZIAAI005023, P01AI082362, ZIAAI001090, R33AI084714] Funding Source: NIH RePORTER	Intramural Research Programs of NIAID, National Institutes of Health; NIH HIVRAD grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aids Fonds Netherlands; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); International AIDS Vaccine Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. P. Moore for experiments using the BG505 SOSIP trimer, discussions of experimental data, and review of this manuscript. We thank K. Lloyd. R. Parks, J. Eudailey and J. Blinn for performing autoantibody assays. We also thank S. Moir for providing patient samples. This project has been funded in part with federal funds from the Intramural Research Programs of NIAID, National Institutes of Health. This work was also supported by the NIH HIVRAD grant P01 AI082362, and by the Aids Fonds Netherlands, grants 2011032 and 2012041. R. W. S. is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). J. H. L., Y.F., R. T. W. and A. W. are supported through the International AIDS Vaccine Initiative. J. M. B. is supported by NIH grants AI93278 and AI84714. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Chuang GY, 2013, J VIROL, V87, P10047, DOI 10.1128/JVI.00984-13; Crooks Emma T., 2005, Human Antibodies, V14, P101; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Thornburg NJ, 2013, J CLIN INVEST, V123, P4405, DOI 10.1172/JCI69377; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yasmeen A., 2014, RETROVIROLO IN PRESS; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241	47	318	336	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					138	+		10.1038/nature13601	http://dx.doi.org/10.1038/nature13601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25186731	Green Accepted			2022-12-28	WOS:000344187500045
J	Perz, SG				Perz, Stephen G.			SUSTAINABLE DEVELOPMENT The promise and perils of roads	NATURE			English	Editorial Material									Univ Florida, Dept Sociol & Criminol & Law, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Perz, SG (corresponding author), Univ Florida, Dept Sociol & Criminol & Law, Gainesville, FL 32611 USA.	sperz@ufl.edu						Forman Richard T.T., 2002, ROAD ECOLOGY SCI SOL; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Perz SG, 2012, REG ENVIRON CHANGE, V12, P35, DOI 10.1007/s10113-011-0233-x; Straub S, 2008, 4460 WORLD BANK	4	15	16	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					178	179		10.1038/nature13744	http://dx.doi.org/10.1038/nature13744			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5DP	25162532				2022-12-28	WOS:000341362800037
J	Chan, FKM				Chan, Francis Ka-Ming			CELL BIOLOGY A guardian angel of cell integrity	NATURE			English	Editorial Material							NF-KAPPA-B; DEATH DOMAIN; NECROSIS; RIP; INFLAMMATION; ACTIVATION; APOPTOSIS; CASPASE-8; PROTEIN		Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; 				Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	13	0	0	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					38	40		10.1038/513038a	http://dx.doi.org/10.1038/513038a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186894				2022-12-28	WOS:000341174800022
J	Chitty, LS; Finning, K; Wade, A; Soothill, P; Martin, B; Oxenford, K; Daniels, G; Massey, E				Chitty, Lyn S.; Finning, Kirstin; Wade, Angela; Soothill, Peter; Martin, Bill; Oxenford, Kerry; Daniels, Geoff; Massey, Edwin			Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL PLASMA; PREGNANT-WOMEN; DNA; IMMUNOGLOBULIN; PROPHYLAXIS	Objectives To assess the accuracy of fetal RHD genotyping using cell-free fetal DNA in maternal plasma at different gestational ages. Design A prospective multicentre cohort study. Setting Seven maternity units in England. Participants RhD negative pregnant women who booked for antenatal care before 24 weeks' gestation. Interventions Women who gave consent for fetal RHD genotyping had blood taken at the time of booking for antenatal care and, when possible, at other routine visits such as for Down's syndrome screening between 11 and 21 weeks' gestation, at the anomaly scan at 18-21 weeks, and in the third trimester when blood was taken for the routine antibody check. The results of cord blood analysis, done routinely in RhD negative pregnancies, were also obtained to confirm the fetal RHD genotyping. Main outcome measures The accuracy of fetal RHD genotyping compared with RhD status predicted by cord blood serology. Results Up to four analyses per woman were performed in 2288 women, generating 4913 assessable fetal results. Sensitivity for detection of fetal RHD positivity was 96.85% (94.95% to 98.05%), 99.83% (99.06% to 99.97%), 99.67% (98.17% to 99.94%), 99.82% (98.96% to 99.97%), and 100% (99.59% to 100%) at <11, 11-13, 14-17, 18-23, and >23 completed weeks' gestation, respectively. Before 11 weeks' gestation 16/865 (1.85%) babies tested were falsely predicted as RHD negative. Conclusions Mass throughput fetal RHD genotyping is sufficiently accurate for the prediction of RhD type if it is performed from 11 weeks' gestation. Testing before this time could result in a small but significant number of babies being incorrectly classified as RHD negative. These mothers would not receive anti-RhD immunoglobulin, and there would be a risk of haemolytic disease of the newborn in subsequent pregnancies.	[Chitty, Lyn S.] Great Ormond St Hosp Children NHS Fdn Trust, UCL Inst Child Hlth, London WC1N 3BH, England; [Chitty, Lyn S.] Univ Coll London Hosp NHS Fdn Trust, London WC1N 3BH, England; [Finning, Kirstin; Daniels, Geoff; Massey, Edwin] NHS Blood & Transplant, Int Blood Grp Reference Lab, Bristol BS34 7QH, Avon, England; [Wade, Angela] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; [Soothill, Peter] St Michaels Hosp, Fetal Med Unit, Bristol BS2 8EG, Avon, England; [Martin, Bill] Birmingham Womens NHS Fdn Trust, Fetal Med Unit, Birmingham B15 2TG, W Midlands, England; [Oxenford, Kerry] Univ Coll London Hosp NHS Fdn Trust, Fetal Med Unit, London NW1 2BU, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Chitty, LS (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, UCL Inst Child Hlth, London WC1N 3BH, England.	l.chitty@ucl.ac.uk		chitty, lyn/0000-0002-4857-7138	National Institute for Health Research; Research for Patient Benefit Programme [PB-PG-0107-12005]; Howard Ostin Trust [011]; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research [NF-SI-0513-10141, PB-PG-0107-12005] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Research for Patient Benefit Programme; Howard Ostin Trust; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research, Research for Patient Benefit Programme (PB-PG-0107-12005), and Howard Ostin Trust (Project No 011). LSC is partially funded by the Great Ormond Street Hospital Children's Charity and the NIHR Biomedical Research Centre at Great Ormond Street Hospital. The funded research is independent and the views expressed in the paper are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	AUSTIN E, 2009, GUIDELINES ESTIMATIO; Clausen FB, 2012, TRANSFUSION, V52, P752, DOI 10.1111/j.1537-2995.2011.03362.x; Daniels G., 2013, HUMAN BLOOD GROUPS; Daniels G, 2009, PRENATAL DIAG, V29, P101, DOI 10.1002/pd.2172; de, 2012, ISBT SCI SERIES, V7, P164; Finning K, 2004, ANN NY ACAD SCI, V1022, P119, DOI 10.1196/annals.1318.019; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Kumar S, 2005, BRIT MED J, V330, P1255, DOI 10.1136/bmj.330.7502.1255; Lo YM, 1997, LANCET, V350, P485, DOI DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Muller SP, 2008, TRANSFUSION, V48, P2292, DOI 10.1111/j.1537-2995.2008.01843.x; National Institute for Health and Care Excellence, 2002, TECHN APPR GUID 41 G; Qureshi H, 2014, TRANSFUSION MED, V24, P8, DOI 10.1111/tme.12091; Rouillac-Le Sciellour Christelle, 2004, Mol Diagn, V8, P23, DOI 10.2165/00066982-200408010-00004; Van der Schoot CE, 2006, TRANSFUS CLIN BIOL, V13, P53, DOI 10.1016/j.tracli.2006.02.021; Wang E, 2013, PRENATAL DIAG, V33, P662, DOI 10.1002/pd.4119	16	62	64	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2014	349								g5243	10.1136/bmj.g5243	http://dx.doi.org/10.1136/bmj.g5243			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MK	25190055	Green Published, hybrid			2022-12-28	WOS:000341388800002
J	Staples, JE; Fischer, M				Staples, J. Erin; Fischer, Marc			Chikungunya Virus in the Americas - What a Vectorborne Pathogen Can Do	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Staples, J. Erin; Fischer, Marc] Ctr Dis Control & Prevent, Arboviral Dis Branch, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Staples, JE (corresponding author), Ctr Dis Control & Prevent, Arboviral Dis Branch, Ft Collins, CO 80521 USA.				Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Pan American Health Organization, CHIK; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Staples E, 2011, PREPAREDNESS RESPONS; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496	5	97	101	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					887	889		10.1056/NEJMp1407698	http://dx.doi.org/10.1056/NEJMp1407698			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5NB	25184860	Green Accepted, Bronze			2022-12-28	WOS:000341390600004
J	Menke, A; Rust, KF; Fradkin, J; Cheng, YLJ; Cowie, CC				Menke, Andy; Rust, Keith F.; Fradkin, Judith; Cheng, Yiling J.; Cowie, Catherine C.			Associations Between Trends in Race/Ethnicity, Aging, and Body Mass Index With Diabetes Prevalence in the United States A Series of Cross-sectional Studies	ANNALS OF INTERNAL MEDICINE			English	Article							US ADULTS; NATIONAL-HEALTH; PHYSICAL-ACTIVITY; SECULAR CHANGES; AIR-POLLUTION; LIFE-STYLE; TYPE-2; OBESITY; MELLITUS; ADJUSTMENT	Background: The increase in the prevalence of diabetes over the past few decades has coincided with an increase in certain risk factors for diabetes, such as a changing race/ethnicity distribution, an aging population, and a rising obesity prevalence. Objective: To determine the extent to which the increase in diabetes prevalence is explained by changing distributions of race/ethnicity, age, and obesity prevalence in U. S. adults. Design: Cross-sectional, using data from 5 NHANES (National Health and Nutrition Examination Surveys): NHANES II (1976-1980), NHANES III (1988-1994), and the continuous NHANES 1999-2002, 2003-2006, and 2007-2010. Setting: Nationally representative samples of the U. S. non-institutionalized civilian population. Patients: 23 932 participants aged 20 to 74 years. Measurements: Diabetes was defined as a self-reported diagnosis or fasting plasma glucose level of 7.0 mmol/L (126 mg/dL) or more. Results: Between 1976 to 1980 and 2007 to 2010, diabetes prevalence increased from 4.7% to 11.2% in men and from 5.7% to 8.7% in women (P for trends for both groups < 0.001). After adjustment for age, race/ethnicity, and body mass index, diabetes prevalence increased in men (6.2% to 9.6%; P for trend < 0.001) but not women (7.6% to 7.5%; P for trend = 0.69). Body mass index was the greatest contributor among the 3 covariates to the change in prevalence estimates after adjustment. Limitation: Some possible risk factors, such as physical activity, waist circumference, and mortality, could not be studied because data on these variables were not collected in all surveys. Conclusion: The increase in the prevalence of diabetes was greater in men than in women in the U. S. population between 1976 to 1980 and 2007 to 2010. After changes in age, race/ethnicity, and body mass index were controlled for, the increase in diabetes prevalence over time was approximately halved in men and diabetes prevalence was no longer increased in women.	[Menke, Andy] Social & Sci Syst, Silver Spring, MD 20910 USA; Westat Corp, Rockville, MD 20850 USA; NIDDK, NIH, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Social & Scientific Systems; Westat; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Centers for Disease Control & Prevention - USA	Menke, A (corresponding author), Social & Sci Syst, 8757 Georgia Ave,12th Floor, Silver Spring, MD 20910 USA.	amenke@s-3.com	Cheng, Yiling J/A-6547-2009	Cheng, Yiling J/0000-0002-5053-0814	Centers for Disease Control and Prevention; National Institutes of Diabetes and Digestive and Kidney Diseases; National Institute of Diabetes and Digestive and Kidney Diseases [GS10F0381L]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Centers for Disease Control and Prevention and National Institutes of Diabetes and Digestive and Kidney Diseases.; By a contract from the National Institute of Diabetes and Digestive and Kidney Diseases (GS10F0381L; Dr. Menke).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], VITAL HLTH STAT; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Bureau of the Census, 1983, 1980 CENS POP GEN PO; Caspersen CJ, 2012, AM J PUBLIC HEALTH, V102, P1482, DOI 10.2105/AJPH.2011.300616; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention. National Center for Health Statistics, 2010, NAT HLTH NUTR EX SUR; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Howden LM, 2010, AGE SEX COMPOSITION; Humes KR, 2011, OVERVIEW RACE HISPAN; Jiang Y, 2008, PUBLIC HEALTH, V122, P271, DOI 10.1016/j.puhe.2007.06.002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Maull EA, 2012, ENVIRON HEALTH PERSP, V120, P1658, DOI 10.1289/ehp.1104579; McDowell A, 1981, Vital Health Stat 1, P1; Mezza T, 2012, ANN NUTR METAB, V61, P337, DOI 10.1159/000342771; Michalek JE, 2008, J OCCUP ENVIRON MED, V50, P330, DOI 10.1097/JOM.0b013e31815f889b; Morris CJ, 2012, PROG BRAIN RES, V199, P337, DOI 10.1016/B978-0-444-59427-3.00019-8; O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Pearson JF, 2010, DIABETES CARE, V33, P2196, DOI 10.2337/dc10-0698; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Pouwer F, 2010, DISCOV MED, V9, P112; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Steinbrecher A, 2011, ANN EPIDEMIOL, V21, P526, DOI 10.1016/j.annepidem.2011.03.009; Taylor KW, 2013, ENVIRON HEALTH PERSP, V121, P774, DOI 10.1289/ehp.1205502; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Zhang Q, 2009, ETHNIC HEALTH, V14, P439, DOI 10.1080/13557850802699155; Zipf George, 2013, Vital Health Stat 1, P1	42	80	86	1	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					328	+		10.7326/M14-0286	http://dx.doi.org/10.7326/M14-0286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO7VT	25178569				2022-12-28	WOS:000341561400003
J	Youngman, RE				Youngman, Randall E.			Glimpsing glass structure under pressure	SCIENCE			English	Editorial Material							SOLID-STATE NMR; MELTS; TRANSITION		Corning Inc, Div Sci & Technol, Corning, NY 14831 USA	Corning Inc; State University of New York (SUNY) System	Youngman, RE (corresponding author), Corning Inc, Div Sci & Technol, Corning, NY 14831 USA.	youngmanre@corning.com	Youngman, Randall E/D-4659-2013	Youngman, Randall E/0000-0002-6647-9865				Angeli F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054110; Calas G, 2006, ELEMENTS, V2, P265, DOI 10.2113/gselements.2.5.265; Cummings K., 2002, HIST GLASSFORMING; ECKERT H, 1992, PROG NUCL MAG RES SP, V24, P159, DOI 10.1016/0079-6565(92)80001-V; Edwards T, 2014, SCIENCE, V345, P1027, DOI 10.1126/science.1256224; Lee SK, 2012, J PHYS CHEM C, V116, P2183, DOI 10.1021/jp206765s; ONORATO PIK, 1976, J NON-CRYST SOLIDS, V22, P367, DOI 10.1016/0022-3093(76)90066-1; Pollard AM, 2008, ARCHAEOLOGICAL CHEMISTRY, SECOND EDITION, P1, DOI 10.1039/9781847558299; Smedskjaer MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03770; Stebbins JF, 1996, J AM CERAM SOC, V79, P2247, DOI 10.1111/j.1151-2916.1996.tb08969.x; Svenson MN, 2014, ACS APPL MATER INTER, V6, P10436, DOI 10.1021/am5019868; Webb S, 1997, REV GEOPHYS, V35, P191, DOI 10.1029/96RG03263	12	7	7	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					998	999		10.1126/science.1258785	http://dx.doi.org/10.1126/science.1258785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170134				2022-12-28	WOS:000340870900014
J	Haxton, W				Haxton, Wick			NEUTRINO PHYSICS what makes the Sun shine	NATURE			English	Editorial Material									[Haxton, Wick] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Haxton, Wick] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Nucl Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Haxton, W (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	haxton@berkeley.edu						Abdurashitov JN, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.015807; Abe K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.052010; Ahmad QR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.011302; BAHCALL JN, 2000, J R ASTRON SOC CAN, V94, P219; Bellini G, 2014, NATURE, V512, P383, DOI 10.1038/nature13702; Bellini G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.051302; Bellini G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.141302; Bethe HA, 1939, PHYS REV, V55, P0434, DOI 10.1103/PhysRev.55.434; DAVIS R, 1968, PHYS REV LETT, V20, P1205, DOI 10.1103/PhysRevLett.20.1205; Fukuda Y, 1996, PHYS REV LETT, V77, P1683, DOI 10.1103/PhysRevLett.77.1687; Hampel W, 1999, PHYS LETT B, V447, P127, DOI 10.1016/S0370-2693(98)01579-2; Haxton WC, 2013, ANNU REV ASTRON ASTR, V51, P21, DOI 10.1146/annurev-astro-081811-125539	12	2	3	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					378	380		10.1038/512378a	http://dx.doi.org/10.1038/512378a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164744				2022-12-28	WOS:000340840600020
J	Kirshner, RP				Kirshner, Robert P.			ASTROPHYSICS Supernova seen through gamma-ray eyes	NATURE			English	Editorial Material									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Kirshner, RP (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	rkirshner@cfa.harvard.edu						ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Churazov E, 2014, NATURE, V512, P406, DOI 10.1038/nature13672; Fossey S.J., 2014, CENT BUREAU ELECT TE, V3792, P1; Kirshner Robert P., 2004, EXTRAVAGANT UNIVERSE; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; The LS, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/141; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.aa.24.090186.001225	7	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					375	376		10.1038/512375a	http://dx.doi.org/10.1038/512375a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164743				2022-12-28	WOS:000340840600018
J	Spechler, SJ; Souza, RF				Spechler, Stuart J.; Souza, Rhonda F.			Barrett's Esophagus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX DISEASE; RADIOFREQUENCY ABLATION; ENDOSCOPIC SURVEILLANCE; NEOPLASTIC PROGRESSION; INTESTINAL METAPLASIA; COLUMNAR EPITHELIUM; ACID EXPOSURE; GOBLET CELLS; HIGH-RISK		Vet Affairs VA North Texas Hlth Care Syst, Esophageal Dis Ctr, Dept Med, Dallas, TX USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Spechler, SJ (corresponding author), Dallas VA Med Ctr, Div Gastroenterol & Hepatol 111B1, 4500 S Lancaster Rd, Dallas, TX 75216 USA.				Takeda Pharmaceuticals USA; Ironwood Pharmaceuticals; Torax Medical; Otsuka America	Takeda Pharmaceuticals USA; Ironwood Pharmaceuticals; Torax Medical; Otsuka America(Otsuka Pharmaceutical)	Dr. Spechler reports receiving consulting fees from Takeda Pharmaceuticals USA, Ironwood Pharmaceuticals, and Torax Medical. Dr. Souza reports receiving consulting fees from Ironwood Pharmaceuticals and Otsuka America. No other potential conflict of interest relevant to this article was reported.	Alvi MA, 2013, CLIN CANCER RES, V19, P878, DOI 10.1158/1078-0432.CCR-12-2880; Anaparthy R, 2013, CLIN GASTROENTEROL H, V11, P1430, DOI 10.1016/j.cgh.2013.05.007; Anders M, 2014, CLIN GASTROENTEROL H, V12, P405, DOI 10.1016/j.cgh.2013.07.013; Bhat S, 2013, JNCI-J NATL CANCER I, V105, P581, DOI 10.1093/jnci/djt070; Bhat SK, 2014, GUT; Bird-Lieberman EL, 2012, GASTROENTEROLOGY, V143, P927, DOI 10.1053/j.gastro.2012.06.041; Boerwinkel DF, 2014, GASTROENTEROLOGY, V146, P622, DOI 10.1053/j.gastro.2014.01.007; Burke ZD, 2012, CURR OPIN GENET DEV, V22, P494, DOI 10.1016/j.gde.2012.08.001; Chak A, 2006, CANCER-AM CANCER SOC, V107, P2160, DOI 10.1002/cncr.22245; Chandrasoma PT, 2013, CURR OPIN GASTROEN, V29, P460, DOI 10.1097/MOG.0b013e32836228fa; Coleman HG, 2011, EUR J EPIDEMIOL, V26, P739, DOI 10.1007/s10654-011-9596-z; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2013, GASTROENTEROLOGY, V145, P312, DOI 10.1053/j.gastro.2013.05.004; Curvers WL, 2010, AM J GASTROENTEROL, V105, P1523, DOI 10.1038/ajg.2010.171; Desai TK, 2012, GUT, V61, P970, DOI 10.1136/gutjnl-2011-300730; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; Dunbar KB, 2013, CURR OPIN GASTROEN, V29, P446, DOI 10.1097/MOG.0b013e3283622848; Dunbar KB, 2012, AM J GASTROENTEROL, V107, P850, DOI 10.1038/ajg.2012.78; El-Serag H, 2008, DIGEST DIS SCI, V53, P2307, DOI 10.1007/s10620-008-0413-9; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; El-Serag HB, 2006, GASTROINTEST ENDOSC, V64, P671, DOI 10.1016/j.gie.2006.03.010; Evans JA, 2012, GASTROINTEST ENDOSC, V76, P1087, DOI 10.1016/j.gie.2012.08.004; Fass R, 2001, GUT, V48, P310, DOI 10.1136/gut.48.3.310; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Fleischer DE, 2010, DIGEST DIS SCI, V55, P1918, DOI 10.1007/s10620-010-1218-1; Fletcher J, 2004, GUT, V53, P168, DOI 10.1136/gut.2003.022160; Fountoulakis A, 2004, BRIT J SURG, V91, P997, DOI 10.1002/bjs.4591; Fritcher EGB, 2008, HUM PATHOL, V39, P1128, DOI 10.1016/j.humpath.2008.02.003; Gaddam S, 2013, GASTROENTEROLOGY, V145, P548, DOI 10.1053/j.gastro.2013.05.040; Gray NA, 2011, AM J GASTROENTEROL, V106, P1899, DOI 10.1038/ajg.2011.255; Greer KB, 2012, GUT, V61, P665, DOI 10.1136/gutjnl-2011-300641; Gupta M, 2013, GASTROENTEROLOGY, V145, P79, DOI 10.1053/j.gastro.2013.03.008; Hahn HP, 2009, AM J SURG PATHOL, V33, P1006, DOI 10.1097/PAS.0b013e31819f57e9; Hayeck TJ, 2010, DIS ESOPHAGUS, V23, P451, DOI 10.1111/j.1442-2050.2010.01054.x; Huo XF, 2011, AM J PHYSIOL-GASTR L, V301, pG278, DOI 10.1152/ajpgi.00092.2011; Hur C, 2012, GASTROENTEROLOGY, V143, P567, DOI 10.1053/j.gastro.2012.05.010; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Iijima K, 2002, GASTROENTEROLOGY, V122, P1248, DOI 10.1053/gast.2002.32963; Inadomi JM, 2003, ANN INTERN MED, V138, P176, DOI 10.7326/0003-4819-138-3-200302040-00009; Jin Z, 2009, CANCER RES, V69, P4112, DOI 10.1158/0008-5472.CAN-09-0028; Kastelein F, 2013, GUT, V62, P1676, DOI 10.1136/gutjnl-2012-303594; Kastelein F, 2013, CLIN GASTROENTEROL H, V11, P382, DOI 10.1016/j.cgh.2012.11.014; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Larghi A, 2005, GASTROINTEST ENDOSC, V62, P16, DOI 10.1016/S0016-5107(05)00319-6; Liu W, 2009, AM J GASTROENTEROL, V104, P816, DOI 10.1038/ajg.2009.85; Munitiz V, 2008, J CLIN GASTROENTEROL, V42, P806, DOI 10.1097/MCG.0b013e3180329015; Orloff M, 2011, JAMA-J AM MED ASSOC, V306, P410, DOI 10.1001/jama.2011.1029; Orman ES, 2013, CLIN GASTROENTEROL H, V11, P1245, DOI 10.1016/j.cgh.2013.03.039; Overholt BF, 2006, GASTROINTEST ENDOSC, V63, P359; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; Pechz O, 2008, GUT, V57, P1200, DOI 10.1136/gut.2007.142539; Phoa KN, 2014, JAMA-J AM MED ASSOC, V311, P1209, DOI 10.1001/jama.2014.2511; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Rubenstein JH, 2013, AM J GASTROENTEROL, V108, P353, DOI 10.1038/ajg.2012.446; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; Shaheen NJ, 2012, ANN INTERN MED, V157, P808, DOI 10.7326/0003-4819-157-11-201212040-00008; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 1998, AM J GASTROENTEROL, V93, P1033; Sonnenberg A, 2002, ALIMENT PHARM THERAP, V16, P41, DOI 10.1046/j.1365-2036.2002.01146.x; Spechler SJ, 2005, AM J GASTROENTEROL, V100, P927, DOI 10.1111/j.1572-0241.2005.41201.x; SPECHLER SJ, 1994, LANCET, V344, P1533, DOI 10.1016/S0140-6736(94)90349-2; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; Spechler SJ, 2014, DIGEST DIS, V32, P156, DOI 10.1159/000357184; Spechler SJ, 2013, JAMA-J AM MED ASSOC, V310, P627, DOI 10.1001/jama.2013.226450; Taylor JB, 2010, AM J GASTROENTEROL, V105, P1730, DOI 10.1038/ajg.2010.194; Thrift AP, 2012, ANN ONCOL, V23, P3155, DOI 10.1093/annonc/mds181; Titi M, 2012, GASTROENTEROLOGY, V143, P564, DOI 10.1053/j.gastro.2012.04.051; Wang A, 2009, DIGEST DIS SCI, V54, P964, DOI 10.1007/s10620-009-0742-3; Wang DH, 2010, GASTROENTEROLOGY, V138, P1810, DOI 10.1053/j.gastro.2010.01.048; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Wani S, 2011, GASTROENTEROLOGY, V141, P1179, DOI 10.1053/j.gastro.2011.06.055; Wani S, 2011, CLIN GASTROENTEROL H, V9, P220, DOI 10.1016/j.cgh.2010.11.008; Westerhoff M, 2012, CLIN GASTROENTEROL H, V10, P1232, DOI 10.1016/j.cgh.2012.05.013	77	307	322	5	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					836	845		10.1056/NEJMra1314704	http://dx.doi.org/10.1056/NEJMra1314704			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162890				2022-12-28	WOS:000340819800010
J	Weniger, BG				Weniger, Bruce G.			Influenza vaccination in the off-label grey zone	LANCET			English	Editorial Material									Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50200, Thailand	Chiang Mai University	Weniger, BG (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50200, Thailand.	bgweniger@siamlotus.com		Weniger, Bruce/0000-0002-5450-5464				[Anonymous], 1982, FDA Drug Bull, V12, P4; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; International Organization for Standardization, 216492006 ISODIS; McAllister L, 2014, LANCET, V384, P674, DOI 10.1016/S0140-6736(14)60524-9; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; Parrish TN, 2011, PITTSBURGH TRIB 1021; PATH, SHOTS NEEDL SAF EFF; PATH WHO (Project Optimize), LANDSC AN TRENDS VAC; Potters H., 2011, SUMMARY REPORT ADVIS, P183; US Food and Drug Administration, LAB INV US MARK DRUG; US Food and Drug Administration, 2011, FDA COMM US JET INJ; US Food and Drug Administration, 2011, FDA UPD COMM US JET; Weniger B.G., 2013, VACCINES, P1200, DOI [DOI 10.1016/B978-1-4557-0090-5.00063, 10.1016/B978-1-4557-0090-5.00063-X]; Weniger BG, 2011, JET INJECTION IMMUNI; Weniger BG, 2011, RES NEW VACCINE DELI	15	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					642	644		10.1016/S0140-6736(14)61367-2	http://dx.doi.org/10.1016/S0140-6736(14)61367-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25152263				2022-12-28	WOS:000341359100008
J	Chen, XY; Tung, KK				Chen, Xianyao; Tung, Ka-Kit			Varying planetary heat sink led to global-warming slowdown and acceleration	SCIENCE			English	Article							MERIDIONAL OVERTURNING CIRCULATION; ATLANTIC MULTIDECADAL OSCILLATION; SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; DECADAL CHANGES; EARTHS ENERGY; UPPER-OCEAN; VARIABILITY; 20TH-CENTURY; HIATUS	A vacillating global heat sink at intermediate ocean depths is associated with different climate regimes of surface warming under anthropogenic forcing: The latter part of the 20th century saw rapid global warming as more heat stayed near the surface. In the 21st century, surface warming slowed as more heat moved into deeper oceans. In situ and reanalyzed data are used to trace the pathways of ocean heat uptake. In addition to the shallow La Nina-like patterns in the Pacific that were the previous focus, we found that the slowdown is mainly caused by heat transported to deeper layers in the Atlantic and the Southern oceans, initiated by a recurrent salinity anomaly in the subpolar North Atlantic. Cooling periods associated with the latter deeper heat-sequestration mechanism historically lasted 20 to 35 years.	[Chen, Xianyao] Ocean Univ China, Key Lab Phys Oceanog, Qingdao, Peoples R China; [Chen, Xianyao; Tung, Ka-Kit] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Ocean University of China; University of Washington; University of Washington Seattle	Tung, KK (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	ktung@uw.edu		Tung, Ka-Kit/0000-0001-8667-7167	NSF [AGS-1262231]; Natural Science Foundation of China [41330960, 41176029]; Div Atmospheric & Geospace Sciences [1262231] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research of K.-K. T. is supported by NSF under AGS-1262231. X. C. is supported by Natural Science Foundation of China under 41330960 and 41176029. He thanks First Institute of Oceanography of China for its support during his visit to University of Washington. The authors are grateful to many colleagues and the anonymous reviewers who commented on the manuscript and helped improve it. The data sets used in this study are publicly available in http://rda.ucar.edu/datasets/ds285.3/ and https://climatedataguide.ucar.edu/climate-data/oras4-ecmwf-ocean-reanalysis-and-derived-ocean-heat-content.	Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Danabasoglu G, 2012, J CLIMATE, V25, P5153, DOI 10.1175/JCLI-D-11-00463.1; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Dima M, 2007, J CLIMATE, V20, P2706, DOI 10.1175/JCLI4174.1; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Intergovernmental Panel on Climate Change, 2007, SUMM POL CLIM CHANG; Ishii M, 2005, INT J CLIMATOL, V25, P865, DOI 10.1002/joc.1169; Ishii M, 2006, J OCEANOGR, V62, P155, DOI 10.1007/s10872-006-0041-y; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Jungclaus JH, 2005, J CLIMATE, V18, P4013, DOI 10.1175/JCLI3462.1; Katsman CA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048417; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Lyman JM, 2008, J CLIMATE, V21, P5629, DOI 10.1175/2008JCLI2259.1; Lyman JM, 2014, J CLIMATE, V27, P1945, DOI 10.1175/JCLI-D-12-00752.1; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Polyakov IV, 2010, CLIM DYNAM, V34, P439, DOI 10.1007/s00382-008-0522-3; Roemmich D, 2009, OCEANOGRAPHY, V22, P46, DOI 10.5670/oceanog.2009.65; Santer BD, 2014, NAT GEOSCI, V7, P185, DOI [10.1038/ngeo2098, 10.1038/NGEO2098]; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Trenberth KE, 2014, J CLIMATE, V27, P3129, DOI 10.1175/JCLI-D-13-00294.1; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Trenberth KE, 2010, SCIENCE, V328, P316, DOI 10.1126/science.1187272; Tung KK, 2013, P NATL ACAD SCI USA, V110, P2058, DOI 10.1073/pnas.1212471110; Wang CZ, 2013, J CLIMATE, V26, P6137, DOI 10.1175/JCLI-D-12-00721.1; Welch WT, 1998, J ATMOS SCI, V55, P1285, DOI 10.1175/1520-0469(1998)055<1285:NBAAWS>2.0.CO;2; Wu ZH, 2011, CLIM DYNAM, V37, P759, DOI 10.1007/s00382-011-1128-8; Wyatt MG, 2014, CLIM DYNAM, V42, P2763, DOI 10.1007/s00382-013-1950-2; Wyatt MG, 2012, CLIM DYNAM, V38, P929, DOI 10.1007/s00382-011-1071-8; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030225; Zhang R, 2013, J ATMOS SCI, V70, P1135, DOI 10.1175/JAS-D-12-0331.1; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028683; Zhang R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035463; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031601; Zhou JS, 2010, J CLIMATE, V23, P3234, DOI 10.1175/2010JCLI3232.1	47	326	379	22	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					897	903		10.1126/science.1254937	http://dx.doi.org/10.1126/science.1254937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146282				2022-12-28	WOS:000340524700037
J	Davies, W				Davies, William			PALAEOANTHROPOLOGY The time of the last Neanderthals	NATURE			English	Editorial Material							EARLY-MODERN HUMANS		Univ Southampton, Ctr Archaeol Human Origins, Fac Humanities, Southampton SO17 1BF, Hants, England	University of Southampton	Davies, W (corresponding author), Univ Southampton, Ctr Archaeol Human Origins, Fac Humanities, Southampton SO17 1BF, Hants, England.	s.w.g.davies@soton.ac.uk						Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; Bird MI, 1999, RADIOCARBON, V41, P127, DOI 10.1017/S0033822200019482; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Lowe J, 2012, P NATL ACAD SCI USA, V109, P13532, DOI 10.1073/pnas.1204579109; Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Zilhao J., 1993, ORIGEN HOMBRE MODERN, P127	13	4	4	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					260	261		10.1038/512260a	http://dx.doi.org/10.1038/512260a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3SF	25143108				2022-12-28	WOS:000340508200022
J	Appleby, J				Appleby, John			DATA BRIEFING Population projections: why they are often wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Office for Budgetary Responsibility, 2014, FISCAL SUSTAINABILIT; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2014, WORLD POPULATION PRO	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2014	349								g5184	10.1136/bmj.g5184	http://dx.doi.org/10.1136/bmj.g5184			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FL	25142125				2022-12-28	WOS:000340838700002
J	Nguyen, PV				Nguyen, Paul V.			PERSONAL VIEW Electronic health records may threaten blinding in trials of statins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; ROSUVASTATIN-JUPITER; PRIMARY PREVENTION; LOW-RISK; CHOLESTEROL; METAANALYSIS; PEOPLE		Ctr Hosp Univ Montreal, Montreal, PQ H2W 1T8, Canada	Universite de Montreal	Nguyen, PV (corresponding author), Ctr Hosp Univ Montreal, 3840 St Urbain, Montreal, PQ H2W 1T8, Canada.	pnguyen920@aol.com						Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; de Lorgeril M, 2010, ARCH INTERN MED, V170, P1032, DOI 10.1001/archinternmed.2010.184; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Hassouneh B, 2013, FUTURE SCI, P62; Kazi DS, 2012, CIRC-CARDIOVASC QUAL, V5, P249, DOI 10.1161/CIRCOUTCOMES.112.965764; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Vos E, 2010, CIRCULATION, V122, pE576, DOI 10.1161/CIRCULATIONAHA.110.954016; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2014	349								g5239	10.1136/bmj.g5239	http://dx.doi.org/10.1136/bmj.g5239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FL	25143525				2022-12-28	WOS:000340838700005
J	Carroll, SP; Jorgensen, PS; Kinnison, MT; Bergstrom, CT; Denison, RF; Gluckman, P; Smith, TB; Strauss, SY; Tabashnik, BE				Carroll, Scott P.; Jorgensen, Peter Sogaard; Kinnison, Michael T.; Bergstrom, Carl T.; Denison, R. Ford; Gluckman, Peter; Smith, Thomas B.; Strauss, Sharon Y.; Tabashnik, Bruce E.			Applying evolutionary biology to address global challenges	SCIENCE			English	Review							ANTIMICROBIAL RESISTANCE; CLIMATE-CHANGE; GENE-THERAPY; HUMAN HEALTH; BT CROPS; AGRICULTURAL BIOTECHNOLOGY; BACILLUS-THURINGIENSIS; CONTEMPORARY EVOLUTION; CONSERVATION BIOLOGY; ASSISTED MIGRATION	Two categories of evolutionary challenges result from escalating human impacts on the planet. The first arises from cancers, pathogens, and pests that evolve too quickly and the second, from the inability of many valued species to adapt quickly enough. Applied evolutionary biology provides a suite of strategies to address these global challenges that threaten human health, food security, and biodiversity. This Review highlights both progress and gaps in genetic, developmental, and environmental manipulations across the life sciences that either target the rate and direction of evolution or reduce the mismatch between organisms and human-altered environments. Increased development and application of these underused tools will be vital in meeting current and future targets for sustainable development.	[Carroll, Scott P.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Carroll, Scott P.] Inst Contemporary Evolut, Davis, CA 95616 USA; [Jorgensen, Peter Sogaard] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Jorgensen, Peter Sogaard] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Kinnison, Michael T.] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Denison, R. Ford] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Gluckman, Peter] Univ Auckland, Liggins Inst, Ctr Human Evolut Adaptat & Dis, Auckland 1, New Zealand; [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Smith, Thomas B.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA; [Strauss, Sharon Y.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Strauss, Sharon Y.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of California System; University of California Davis; University of Copenhagen; University of Copenhagen; University of Maine System; University of Maine Orono; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Auckland; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona	Carroll, SP (corresponding author), Univ Calif Davis, Dept Entomol, One Shields Ave, Davis, CA 95616 USA.	spcarroll@ucdavis.edu; psjorgensen@bio.ku.dk	Strauss, Sharon/J-1827-2012; Bergstrom, Carl T./H-2299-2011; Jørgensen, Peter Søgaard/AAF-8570-2020	Strauss, Sharon/0000-0002-6117-4085; Bergstrom, Carl T./0000-0002-2070-385X; Jørgensen, Peter Søgaard/0000-0002-2621-378X; Kinnison, Michael/0000-0003-4211-2118; Carroll, Scott/0000-0003-2094-9398	NSF; National Institute of General Medical Sciences, NIH [U54GM088558]; Maine Agricultural and Forest Experiment Station; National Research Centre for Growth and Development; Commonwealth Scientific and Industrial Research Organization (Australia); Australian-American Fulbright Commission; College of Biological Sciences, University of California Davis; NIH; U.S. Department of Agriculture Biotechnology Risk Assessment grant [2011-33522-30729]; Danish National Research Foundation; Office Of The Director [1243524] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Maine Agricultural and Forest Experiment Station; National Research Centre for Growth and Development; Commonwealth Scientific and Industrial Research Organization (Australia); Australian-American Fulbright Commission; College of Biological Sciences, University of California Davis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture Biotechnology Risk Assessment grant; Danish National Research Foundation(Danmarks Grundforskningsfond); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.T.K., R.F.D., S.P.C., S.Y.S., and T.B.S. were supported by grants from NSF. C.T.B. is supported by National Institute of General Medical Sciences, NIH, grant number U54GM088558. M.T.K., is supported by Maine Agricultural and Forest Experiment Station; P.D.G. by the National Research Centre for Growth and Development; S.P.C. by Commonwealth Scientific and Industrial Research Organization (Australia) and the Australian-American Fulbright Commission; S.Y.S. by grants from the College of Biological Sciences, University of California Davis; T.B.S. by grants from NIH and B.E.T. by U.S. Department of Agriculture Biotechnology Risk Assessment grant 2011-33522-30729. P.S.J. acknowledges the Danish National Research Foundation for support to the Center for Macroecology, Evolution, and Climate and the American-Scandinavian Foundation. S. Singhal, J. Boomsma, C. Rahbek, N. Strange, and T. Fuller provided useful comments on previous versions of the manuscript. G. Reygondeau provided advice for the summary figure.	Abrams PA, 2001, ECOL LETT, V4, P166, DOI 10.1046/j.1461-0248.2001.00199.x; Aerni P, 2013, BIOTECHNOL J, V8, P1129, DOI 10.1002/biot.201300188; Aktipis CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026100; Alliance for the Prudent Use of Antibiotics, 2010, COST ANT RES US FAM; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Althouse BM, 2010, P NATL ACAD SCI USA, V107, P1696, DOI 10.1073/pnas.0906078107; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2013, NAG PROT ACC BEN SHA; [Anonymous], 2012, CONV BIOL DIV C PART; Antonovics J, 2007, PLOS BIOL, V5, P137, DOI 10.1371/journal.pbio.0050030; Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Ashraf M, 2010, Biotechnol Adv, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Bal AM, 2011, CURR OPIN INFECT DIS, V24, P357, DOI 10.1097/QCO.0b013e3283483262; Baquero F, 2003, Rev Esp Quimioter, V16, P11; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Baskett ML, 2013, CONSERV BIOL, V27, P83, DOI 10.1111/j.1523-1739.2012.01949.x; Benkman C.W., 2008, CONSERVATION BIOL EV; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bloom D. E., 2012, 87 HARV SCH PUBL HLT; Bourguet D, 2013, TRENDS ECOL EVOL, V28, P110, DOI 10.1016/j.tree.2012.09.001; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Brownson RC, 2006, ANNU REV PUBL HEALTH, V27, P341, DOI 10.1146/annurev.publhealth.27.021405.102137; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; Bull JJ, 2001, ANNU REV ECOL SYST, V32, P183, DOI 10.1146/annurev.ecolsys.32.081501.114020; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Byrne M, 2011, J APPL ECOL, V48, P1365, DOI 10.1111/j.1365-2664.2011.02045.x; Carroll S, 2011, EVOL APPL, V4, P155, DOI 10.1111/j.1752-4571.2011.00182.x; Chevin LM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0089; Choi IK, 2013, CANCER GENE THER, V20, P70, DOI 10.1038/cgt.2012.95; Chokshi DA, 2012, NEW ENGL J MED, V367, P295, DOI 10.1056/NEJMp1206268; Convention on Biological Diversity, 2010, AICH BIOD TARG STRAT; Cook CN, 2013, CONSERV BIOL, V27, P669, DOI 10.1111/cobi.12050; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cunningham JJ, 2011, MOL PHARMACEUT, V8, P2094, DOI 10.1021/mp2002279; Dana GV, 2012, NATURE, V483, P29, DOI 10.1038/483029a; Denison R.F., 2012, DARWINIAN AGR; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Department of Human and Health Services, 2012, FED REGISTER, V77, P735; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; DUNCAN WG, 1967, CROP SCI, V7, P37, DOI 10.2135/cropsci1967.0011183X000700010013x; Dunlop ES, 2009, EVOL APPL, V2, P371, DOI 10.1111/j.1752-4571.2009.00089.x; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Edelstein M., 2014, J GENE MED DATABASE; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; *EPA, 1998, ENV PROT AG WHIT PAP; European Center for Disease Prevention and Control and European Medicines Agency, 2009, EMEA5761762009 ECDC; European Commission, 2011, 748 COM EUR COMM, P748; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Gatenby RA, 2009, CANCER RES, V69, P7499, DOI 10.1158/0008-5472.CAN-09-1354; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Gaudin ACM, 2013, J EXP BOT, V64, P109, DOI 10.1093/jxb/ers313; Gaziano TA, 2013, ANNU REV PUBL HEALTH, V34, P317, DOI 10.1146/annurev-publhealth-031912-114402; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Gluckman PD, 2006, MISMATCH WHY OUR WOR; Gluckman PD, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7671; Gluckman PD, 2011, EVOL APPL, V4, P249, DOI 10.1111/j.1752-4571.2010.00164.x; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Godefroid S, 2011, BIODIVERS CONSERV, V20, P3683, DOI 10.1007/s10531-011-0120-2; Godefroid S, 2011, BIOL CONSERV, V144, P672, DOI 10.1016/j.biocon.2010.10.003; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 2008, EVOLUTION, V62, P500, DOI 10.1111/j.1558-5646.2007.00298.x; Gray LK, 2011, ECOL APPL, V21, P1591, DOI 10.1890/10-1054.1; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Greene S, 2013, MOVING TARGETS FIGHT; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Gulick RM, 2010, JAIDS-J ACQ IMM DEF, V55, pS43, DOI 10.1097/QAI.0b013e3181f9c09e; Gupta RK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-82; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hartl DL., 1988, PRIMER POPULATION GE; Heap I., 2013, INT SURVEY HERBICIDE; Hendry AP, 2011, EVOL APPL, V4, P159, DOI 10.1111/j.1752-4571.2010.00165.x; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; Herrmann M, 2010, ANNU REV RESOUR ECON, V2, P125, DOI 10.1146/annurev.resource.050708.144125; Hicke JA, 2008, FOREST ECOL MANAG, V255, P1536, DOI 10.1016/j.foreco.2007.11.027; Hollomon DW, 2012, PEST MANAG SCI, V68, P149, DOI 10.1002/ps.2291; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; International Service for the Acquisition of Agri-Biotech Applications, 2013, APPR DAT 2013; Jackson JA, 2012, CONSERV GENET RESOUR, V4, P527, DOI 10.1007/s12686-011-9545-x; Jacobsen SE, 2013, AGRON SUSTAIN DEV, V33, P651, DOI 10.1007/s13593-013-0138-9; Jacquemin B, 2009, PEST MANAG SCI, V65, P113, DOI 10.1002/ps.1647; Jaffe G., 2009, COMPLACENCY FARM SIG; JENNINGS PETER R., 1964, CROP SCI, V4, P13, DOI 10.2135/cropsci1964.0011183X000400010005x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kaier K, 2012, NAT RESOUR MODEL, V25, P388, DOI 10.1111/j.1939-7445.2011.00114.x; Kaier K, 2010, PHARMACOECONOMICS, V28, P1123, DOI 10.2165/11535640-000000000-00000; Kilpivaara O, 2013, SCIENCE, V339, P1559, DOI 10.1126/science.1233899; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Kordower JH, 2012, NEUROBIOL DIS, V48, P151, DOI 10.1016/j.nbd.2012.07.014; Kumar A, 1999, PHOTOSYNTHETICA, V37, P601, DOI 10.1023/A:1007127726207; Latta RG, 2008, EVOL APPL, V1, P84, DOI 10.1111/j.1752-4571.2007.00008.x; Laugen A. T., 2012, FISH FISH, V15, P1; Leus K., 2011, International Zoo Yearbook, V45, P213, DOI 10.1111/j.1748-1090.2011.00138.x; Lipinski DM, 2013, PROG RETIN EYE RES, V32, P22, DOI 10.1016/j.preteyeres.2012.09.001; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lowenstein PR, 2009, CURR GENE THER, V9, P368, DOI 10.2174/156652309789753392; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; MacDougall C, 2005, CLIN MICROBIOL REV, V18, P638, DOI 10.1128/CMR.18.4.638-656.2005; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502; Marshall A., 2014, Nature Biotechnology, V32, P308, DOI 10.1038/nbt.2875; Martinez J. L., 2011, ANTIMICROBIAL RESIST, P157; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mercer KL, 2012, GLOBAL ENVIRON CHANG, V22, P495, DOI 10.1016/j.gloenvcha.2012.01.003; Merritt DJ, 2011, SCIENCE, V332, P424, DOI 10.1126/science.1203083; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; NOKES DJ, 1991, LANCET, V338, P1309, DOI 10.1016/0140-6736(91)92601-W; Oberthur S, 2006, GLOBAL ENVIRON POLIT, V6, P1, DOI 10.1162/glep.2006.6.2.1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Omenn GS, 2010, P NATL ACAD SCI USA, V107, P1702, DOI 10.1073/pnas.0906198106; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pauwels E, 2013, BIOSCIENCE, V63, P79, DOI 10.1525/bio.2013.63.2.4; Pedlar JH, 2012, BIOSCIENCE, V62, P835, DOI 10.1525/bio.2012.62.9.10; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Potter KM, 2012, NEW FOREST, V43, P581, DOI 10.1007/s11056-012-9322-z; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Rabinowitz P, 2013, ANNU REV PUBL HEALTH, V34, P189, DOI 10.1146/annurev-publhealth-031912-114426; Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Read AF, 2009, EVOL APPL, V2, P40, DOI 10.1111/j.1752-4571.2008.00066.x; Redford KH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001530; Rios-Soto KR, 2011, MATH BIOSCI ENG, V8, P199, DOI 10.3934/mbe.2011.8.199; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Santamaria L, 2012, EVOL APPL, V5, P202, DOI 10.1111/j.1752-4571.2011.00229.x; Shelton AM, 2007, FIELD MANUAL TECHNIQ, P793; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Silva AS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-25; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Snow AA, 2012, BIOSCIENCE, V62, P765, DOI 10.1525/bio.2012.62.8.9; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; TABASHNIK BE, 1989, J ECON ENTOMOL, V82, P1263, DOI 10.1093/jee/82.5.1263; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Thomas MA, 2013, NATURE, V501, P485, DOI 10.1038/501485a; Thrall PH, 2011, EVOL APPL, V4, P200, DOI 10.1111/j.1752-4571.2010.00179.x; Torella JP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000796; Transatlantic Taskforce on Antimicrobial Resistance, 2011, REC FUT COLL US EU; Travisano M, 2013, EVOLUTION, V67, P305, DOI 10.1111/j.1558-5646.2012.01802.x; US Food and Drug Administration, 2010, 2009 SUMM REP ANT SO; Vander Mijnsbrugge K, 2010, BASIC APPL ECOL, V11, P300, DOI 10.1016/j.baae.2009.09.002; Varshney RK, 2012, NAT BIOTECHNOL, V30, P1172, DOI 10.1038/nbt.2440; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Vigueira CC, 2013, HEREDITY, V110, P303, DOI 10.1038/hdy.2012.104; Wade MJ, 2010, EVOL APPL, V3, P453, DOI 10.1111/j.1752-4571.2010.00147.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Weiner J, 2010, EVOL APPL, V3, P473, DOI 10.1111/j.1752-4571.2010.00144.x; Welch EW, 2012, J ANIM BREED GENET, V129, P423, DOI 10.1111/jbg.12013; Wert KJ, 2013, HUM MOL GENET, V22, P558, DOI 10.1093/hmg/dds466; WHO, ENV OCC CANC; Williams SE, 2009, BIOL CONSERV, V142, P2388, DOI 10.1016/j.biocon.2009.05.034; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Woolhouse MEJ, 2013, SCIENCE, V341, P1460, DOI 10.1126/science.1243444; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organization, 2016, ANTIMICROBIAL RESIST; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Yassine HM, 2013, CURR TOP MICROBIOL, V370, P227, DOI 10.1007/82_2011_180; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	178	160	165	16	560	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					313	+	1245993	10.1126/science.1245993	http://dx.doi.org/10.1126/science.1245993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25213376	Green Accepted			2022-12-28	WOS:000343041100027
J	Fox, K; Ford, I; Steg, PG; Tardif, JC; Tendera, M; Ferrari, R				Fox, Kim; Ford, Ian; Steg, Philippe Gabriel; Tardif, Jean-Claude; Tendera, Michal; Ferrari, Roberto		SIGNIFY Investigators	Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; VENTRICULAR SYSTOLIC DYSFUNCTION; I-F INHIBITOR; SUBGROUP ANALYSIS; RATE REDUCTION; DOUBLE-BLIND; RISK-FACTOR; OUTCOMES; ANGINA; BEAUTIFUL	BACKGROUND An elevated heart rate is an established marker of cardiovascular risk. Previous analyses have suggested that ivabradine, a heart-rate-reducing agent, may improve outcomes in patients with stable coronary artery disease, left ventricular dysfunction, and a heart rate of 70 beats per minute or more. METHODS We conducted a randomized, double-blind, placebo-controlled trial of ivabradine, added to standard background therapy, in 19,102 patients who had both stable coronary artery disease without clinical heart failure and a heart rate of 70 beats per minute or more (including 12,049 patients with activity-limiting angina [class >= II on the Canadian Cardiovascular Society scale, which ranges from I to IV, with higher classes indicating greater limitations on physical activity owing to angina]). We randomly assigned patients to placebo or ivabradine, at a dose of up to 10 mg twice daily, with the dose adjusted to achieve a target heart rate of 55 to 60 beats per minute. The primary end point was a composite of death from cardiovascular causes or nonfatal myocardial infarction. RESULTS At 3 months, the mean (+/- SD) heart rate of the patients was 60.7 +/- 9.0 beats per minute in the ivabradine group versus 70.6 +/- 10.1 beats per minute in the placebo group. After a median follow-up of 27.8 months, there was no significant difference between the ivabradine group and the placebo group in the incidence of the primary end point (6.8% and 6.4%, respectively; hazard ratio, 1.08; 95% confidence interval, 0.96 to 1.20; P = 0.20), nor were there significant differences in the incidences of death from cardiovascular causes and nonfatal myocardial infarction. Ivabradine was associated with an increase in the incidence of the primary end point among patients with activity-limiting angina but not among those without activity-limiting angina (P = 0.02 for interaction). The incidence of bradycardia was higher with ivabradine than with placebo (18.0% vs. 2.3%, P<0.001). CONCLUSIONS Among patients who had stable coronary artery disease without clinical heart failure, the addition of ivabradine to standard background therapy to reduce the heart rate did not improve outcomes.	[Fox, Kim; Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inst Cardiovasc Med & Sci, Royal Brompton Hosp, London, England; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ Fibrosis Inflammat Remodeling, INSERM,U1148, F-75877 Paris, France; [Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst Coordinating Ctr, Montreal, PQ, Canada; [Tendera, Michal] Med Univ Silesia, Div Cardiol 3, Katowice, Poland; [Ferrari, Roberto] Univ Hosp Ferrara, Dept Cardiol, Cotignola, Italy; [Ferrari, Roberto] Univ Hosp Ferrara, Lab Technol Adv Therapies Ctr, Cotignola, Italy; [Ferrari, Roberto] Maria Cecilia Hosp, GVM Care & Res, Ettore Sansavini Hlth Sci Fdn, Cotignola, Italy	Imperial College London; Royal Brompton Hospital; University of Glasgow; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Medical University Silesia; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; Maria Cecilia Hospital	Fox, K (corresponding author), Natl Heart & Lung Inst, Guy Scadding Bldg,Dovehouse St, London SW3 6LY, England.	kim.fox@imperial.ac.uk	Hradec, Jaromir/S-2388-2016; Poposka, Lidija/N-6851-2019; Vasilieva, Elena/B-2137-2016; Georgescu, Catalina Arsenescu/R-5709-2017; Shpektor, Alexander V/B-1083-2016; Shaposhnik, Igor I./P-2221-2015; Zelveian, Parounak/P-8603-2017; Colquhoun, David M/F-9078-2013; SOLOVEV, OLEG/Y-6307-2018; Barillà, Francesco/Q-2665-2016; Korzh, Oleksii/E-4291-2016; FERRARI, ROBERTO/ABD-5169-2020; Kolomiets, Sergiy M/P-8059-2017; STEG, Philippe Gabriel/Z-1567-2019; Ford, Ian/ABE-6145-2020; Freedman, Ben/AAD-9917-2022; Saifutdinov, Rustam/ABC-3695-2020; Gapon, Lyudmila I./S-6520-2016; Zadionchenko, Vladimir/A-7445-2016; Maggioni, Aldo Pietro/AAL-5334-2020; Linhart, Ales/O-2375-2017; Khasanov, Niiaz/W-7678-2019; Munzel, Thomas/A-2912-2014; Malynovsky, Yaroslav/T-1898-2017; Panina, Svitlana/W-2900-2019; Castro, Fabio FM/C-1082-2017; Freedman, Saul B/C-1625-2013; Nedogoda, Sergey V/O-4656-2014; Bazylevych, Andriy/G-2834-2019; Tendera, Michal/AAA-1875-2022; Ushakov, Alexei V/P-4465-2015; Nifontov, Evgeniy M/A-5954-2017; Moiseeva, Olga/A-4580-2014; Neskovic, Aleksandar/P-5204-2015; Mareev, Vyacheslav Yurievich/Q-1375-2017	Hradec, Jaromir/0000-0001-7597-8239; Poposka, Lidija/0000-0002-2539-6828; Vasilieva, Elena/0000-0003-4111-0874; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Zelveian, Parounak/0000-0002-6513-6772; SOLOVEV, OLEG/0000-0002-2590-9283; Barillà, Francesco/0000-0003-0594-7212; Korzh, Oleksii/0000-0001-6838-4360; Freedman, Ben/0000-0002-3809-2911; Saifutdinov, Rustam/0000-0001-6504-8900; Gapon, Lyudmila I./0000-0002-3620-0659; Zadionchenko, Vladimir/0000-0003-2377-5266; Maggioni, Aldo Pietro/0000-0003-2764-6779; Linhart, Ales/0000-0002-3372-7850; Khasanov, Niiaz/0000-0002-7760-0763; Munzel, Thomas/0000-0001-5503-4150; Malynovsky, Yaroslav/0000-0002-9118-1104; Panina, Svitlana/0000-0003-1080-7185; Castro, Fabio FM/0000-0002-6211-5773; Freedman, Saul B/0000-0002-3809-2911; Nedogoda, Sergey V/0000-0001-5981-1754; Bazylevych, Andriy/0000-0001-5053-2548; Ushakov, Alexei V/0000-0002-7020-4442; Tendera, Michal/0000-0002-0812-6113; Maher, Vincent/0000-0002-3592-4508; Ferrari, Roberto/0000-0003-2046-9175; Moiseeva, Olga/0000-0002-7817-3847; Rha, Seung-Woon/0000-0001-9456-9852; gosse, philippe/0000-0002-5840-7749; Neskovic, Aleksandar/0000-0001-8617-966X; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; HEDDLE, WILLIAM/0000-0001-8167-2826; Phrommintikul, Arintaya/0000-0003-3986-1951; Nikonov, Vadim/0000-0002-0078-9991; BOBESCU, ELENA/0000-0002-0945-9067; Kolomiets, Sergiy/0000-0002-3095-7386; Sanmartin-Fernandez, Marcelo/0000-0001-5469-4579; Varela-Roman, Alfonso/0000-0002-0879-8980; Costa Duarte Barbosa, Eduardo/0000-0002-4361-936X; STEG, Philippe Gabriel/0000-0001-6896-2941	Servier; National Institute for Health Research [NF-SI-0611-10149] Funding Source: researchfish	Servier(Servier); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by Servier.	Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; DiFrancesco D, 2006, PHARMACOL RES, V53, P399, DOI 10.1016/j.phrs.2006.03.006; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Fox K, 2013, AM HEART J, V166, P654, DOI 10.1016/j.ahj.2013.06.024; Fox K, 2009, EUR HEART J, V30, P2337, DOI 10.1093/eurheartj/ehp358; Fox KM, 2011, NAT REV CARDIOL, V8, P369, DOI 10.1038/nrcardio.2011.58; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Swedberg K, 2012, J AM COLL CARDIOL, V59, P1938, DOI 10.1016/j.jacc.2012.01.020; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586; Tardif JC, 2009, EUR HEART J, V30, P540, DOI 10.1093/eurheartj/ehn571	19	321	338	0	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1091	1099		10.1056/NEJMoa1406430	http://dx.doi.org/10.1056/NEJMoa1406430			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25176136	Green Published, Green Accepted			2022-12-28	WOS:000341687300004
J	Graham, J				Graham, Jesse			Morality beyond the lab	SCIENCE			English	Editorial Material							VALIDITY		Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	University of Southern California	Graham, J (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	jesse.graham@usc.edu		Graham, Jesse/0000-0001-8863-7978				Epley N, 2000, J PERS SOC PSYCHOL, V79, P861, DOI 10.1037//0022-3514.79.6.861; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Graham J, 2012, CURR DIR PSYCHOL SCI, V21, P373, DOI 10.1177/0963721412456842; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hofmann W, 2014, SCIENCE, V345, P1340, DOI 10.1126/science.1251560; Mehl MR, 2001, BEHAV RES METH INS C, V33, P517, DOI 10.3758/BF03195410; Sagi E, 2014, SOC SCI COMPUT REV, V32, P132, DOI 10.1177/0894439313506837; Vazire S, 2008, J PERS SOC PSYCHOL, V95, P1202, DOI 10.1037/a0013314	8	17	17	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1242	1242		10.1126/science.1259500	http://dx.doi.org/10.1126/science.1259500			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214589				2022-12-28	WOS:000341483800017
J	Bourzac, K				Bourzac, Katherine			Early warning system	NATURE			English	Editorial Material							LUNG-CANCER											Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556	6	21	22	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S4	S6		10.1038/513S4a	http://dx.doi.org/10.1038/513S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208071				2022-12-28	WOS:000341362800003
J	Laurance, WF; Clements, GR; Sloan, S; O'Connell, CS; Mueller, ND; Goosem, M; Venter, O; Edwards, DP; Phalan, B; Balmford, A; Van Der Ree, R; Arrea, IB				Laurance, William F.; Clements, Gopalasamy Reuben; Sloan, Sean; O'Connell, Christine S.; Mueller, Nathan D.; Goosem, Miriam; Venter, Oscar; Edwards, David P.; Phalan, Ben; Balmford, Andrew; Van Der Ree, Rodney; Arrea, Irene Burgues			A global strategy for road building	NATURE			English	Article							BRAZILIAN AMAZON; PROTECTED AREAS; DEFORESTATION; CONSERVATION; ENVIRONMENT; YIELD	The number and extent of roads will expand dramatically this century(1). Globally, at least 25 million kilometres of new roads are anticipated by 2050; a 60% increase in the total length of roads over that in 2010. Nine-tenths of all road construction is expected to occur in developing nations(1), including many regions that sustain exceptional biodiversity and vital ecosystem services. Roads penetrating into wilderness or frontier areas are a major proximate driver of habitat loss and fragmentation, wildfires, overhunting and other environmental degradation, often with irreversible impacts on ecosystems'. Unfortunately, much road proliferation is chaotic or poorly planned(3,4,6), and the rate of expansion is so great that it often overwhelms the capacity of environmental planners and managers(2-7). Here we present a global scheme for prioritizing road building. This large-scale zoning plan seeks to limit the environmental costs of road expansion while maximizing its benefits for human development, by helping to increase agricultural production, which is an urgent priority given that global food demand could double by mid-century(8,9). Our analysis identifies areas with high environmental values where future road building should be avoided if possible, areas where strategic road improvements could promote agricultural development with relatively modest environmental costs, and 'conflict areas' where road building could have sizeable benefits for agriculture but with serious environmental damage. Our plan provides a template for proactively zoning and prioritizing roads during the most explosive era of road expansion in human history.	[Laurance, William F.; Clements, Gopalasamy Reuben; Sloan, Sean; Goosem, Miriam; Venter, Oscar] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld 4878, Australia; [Laurance, William F.; Clements, Gopalasamy Reuben; Sloan, Sean; Goosem, Miriam; Venter, Oscar] James Cook Univ, Coll Marine & Environm Sci, Cairns, Qld 4878, Australia; [Clements, Gopalasamy Reuben] Univ Malaysia Terengganu, Kenyir Res Inst, Kuala Terengganu 21030, Malaysia; [O'Connell, Christine S.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [O'Connell, Christine S.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Mueller, Nathan D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Edwards, David P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Phalan, Ben; Balmford, Andrew] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Van Der Ree, Rodney] Australian Res Ctr Urban Ecol, Melbourne, Vic 3010, Australia; [Van Der Ree, Rodney] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Arrea, Irene Burgues] Conservat Strategy Fund, San Jose, Costa Rica	James Cook University; James Cook University; Universiti Malaysia Terengganu; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Sheffield; University of Cambridge; University of Melbourne	Laurance, WF (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld 4878, Australia.	bill.laurance@jcu.edu.au	Venter, Oscar/ABE-1477-2021; Phalan, Ben/A-5783-2009; Laurance, William F/B-2709-2012; Sloan, Sean/A-8630-2012; Mueller, Nathan D/E-5864-2010; Goosem, Miriam/D-8677-2012; Edwards, David/AAC-5091-2019	Phalan, Ben/0000-0001-7876-7226; Laurance, William F/0000-0003-4430-9408; Sloan, Sean/0000-0002-7834-0203; Mueller, Nathan D/0000-0003-1857-5104; Goosem, Miriam/0000-0001-9332-022X; Edwards, David/0000-0001-8562-3853; Balmford, Andrew/0000-0002-0144-3589; Clements, Gopalasamy Reuben/0000-0002-9715-4385	Australian Research Council	Australian Research Council(Australian Research Council)	We thank T. Brooks, S. Butchart, J. Geldmann, S. Goosem, C. Mendenhall, N. Pares,S. Pimm, U. Srinivasan, N. Velho, and two anonymous referees for comments and feedback. The Australian Research Council provided support	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Balmford A, 2012, P ROY SOC B-BIOL SCI, V279, P2714, DOI 10.1098/rspb.2012.0515; Barber CP, 2014, BIOL CONSERV, V177, P203, DOI 10.1016/j.biocon.2014.07.004; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Boakes EH, 2010, P ROY SOC B-BIOL SCI, V277, P1081, DOI 10.1098/rspb.2009.1771; Bradshaw CJA, 2009, TRENDS ECOL EVOL, V24, P541, DOI 10.1016/j.tree.2009.03.019; Campbell W. B., 2011, INTEGRATING AGR ECOT; Caro T, 2014, CURR BIOL, V24, pR722, DOI 10.1016/j.cub.2014.07.007; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Dulac J., 2013, GLOBAL LAND TRANSPOR; Edwards DP, 2014, CONSERV LETT, V7, P302, DOI 10.1111/conl.12076; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Gullett W., 1998, AUST J ENV MANAG, V5, P146, DOI [DOI 10.1080/14486563.1998.10648411, 10.1080/14486563.1998.10648411]; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance W, 2007, NEW SCI, V194, P25, DOI 10.1016/S0262-4079(07)61423-7; Laurance WF, 2013, NATURE, V495, P308, DOI 10.1038/495308a; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lawrence DP, 2003, ENV IMPACT ASSESSMEN; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Perz SG, 2012, REG ENVIRON CHANGE, V12, P35, DOI 10.1007/s10113-011-0233-x; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Warner E, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015003; Weinhold D, 2008, GLOBAL ENVIRON CHANG, V18, P54, DOI 10.1016/j.gloenvcha.2007.06.004; Weng LF, 2013, GLOB FOOD SECUR-AGR, V2, P195, DOI 10.1016/j.gfs.2013.07.003	30	454	473	10	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					229	+		10.1038/nature13717	http://dx.doi.org/10.1038/nature13717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25162528	Green Accepted			2022-12-28	WOS:000341362800049
J	Xi, YN; Chen, D				Xi, Yannan; Chen, Danica			Partitioning the circadian clock	SCIENCE			English	Editorial Material							DEACETYLASE; CHROMATIN		[Xi, Yannan; Chen, Danica] Univ Calif Berkeley, Program Metab Biol Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Xi, YN (corresponding author), Univ Calif Berkeley, Program Metab Biol Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	danicac@berkeley.edu			NIA NIH HHS [AG040990, R01 AG040990] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG040990] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007	12	5	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1122	1123		10.1126/science.1259601	http://dx.doi.org/10.1126/science.1259601			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190781	Green Accepted			2022-12-28	WOS:000341179800023
J	Dimick, JB; Birkmeyer, NJ				Dimick, Justin B.; Birkmeyer, Nancy J.			Rethinking Eligibility Criteria for Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTRIC BYPASS	IMPORTANCE Current eligibility criteria for bariatric surgery use arbitrarily chosen body mass index (BMI) (calculated asweight in kilograms divided by height in meters squared) thresholds, an approach that has been criticized as arbitrary and lacking evidence. OBJECTIVES To verify the importance of BMI as a mortality predictor, to identify other important mortality predictors, and to construct a mortality prediction rule in a population eligible for bariatric surgery. DESIGN We studied individuals from a population-representative register who met contemporary eligibility criteria for bariatric surgery (BMI, >= 35.0 alone or 30.0-34.9 with an obesity-related comorbidity) from January 1, 1988, through December 31, 1998. We used binary logistic regression to construct a parsimonious model and a clinical prediction rule for 10-year all-cause mortality. SETTING The United Kingdom General Practice Research Database, a population-representative primary care registry. PARTICIPANTS Fifteen thousand three hundred ninety-four patients aged 18 to 65 years. EXPOSURE Bariatric surgery. MAIN OUTCOME AND MEASURE Ten-year all-cause mortality. RESULTS Mean (SD) agewas 46.9 (11.9) years, BMIwas 36.2 (5.5), and 63.2% of the patients were women. All-cause mortality was 2.1%, and mean follow-up duration was 9.9 years. The final model, which included age (odds ratio, 1.09 per year [95% CI, 1.07-1.10]), type 2 diabetes mellitus (2.25 [1.76-2.87]), current smoking (1.62 [1.28-2.06]), and male sex (1.50 [1.20-1.87]), had a C statistic of 0.768. Although BMI significantly predicted mortality (odds ratio, 1.03 per unit [95% CI, 1.01-1.05]), it did not improve model discrimination or calibration. We divided clinical prediction rule scoring into 4 tiers. All-cause mortality was 0.2% in tier 1,0.9% in tier 2, 2.0% in tier 3, and 5.2% in tier 4. CONCLUSIONS AND RELEVANCE All-cause 10-year mortality in obese individuals eligible for bariatric surgery can be estimated using a simple 4-variable prediction rule based on age, sex, smoking, and diabetes mellitus. Body mass index was not an important mortality predictor. Further work is needed to define low, moderate, and high absolute risk thresholds and to provide external validation.	[Dimick, Justin B.; Birkmeyer, Nancy J.] Univ Michigan, Dept Surg, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 16,Room 137E, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Dimick, JB (corresponding author), Univ Michigan, Dept Surg, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 16,Room 137E, Ann Arbor, MI 48109 USA.	jdimick@umich.edu						Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; GRUNDY SM, 1991, ANN INTERN MED, V115, P956; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Nguyen NT, 2011, J AM COLL SURGEONS, V213, P261, DOI 10.1016/j.jamcollsurg.2011.04.030; Padwal RS, 2013, JAMA SURG, V148, P1109, DOI 10.1001/jamasurg.2013.3953; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914	7	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					953	+		10.1001/jama.2014.3836	http://dx.doi.org/10.1001/jama.2014.3836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182104				2022-12-28	WOS:000341668600024
J	Dworzynski, K; Ardern-Jones, M; Nasser, S				Dworzynski, Katharina; Ardern-Jones, Michael; Nasser, Shuaib		Guideline Dev Grp GDG	Diagnosis and management of drug allergy in adults, children and young people: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dworzynski, Katharina] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Ardern-Jones, Michael] Univ Southampton, Southampton Gen Hosp, Dept Dermatopharmacol, Southampton, Hants, England; [Nasser, Shuaib] Cambridge Univ Hosp NHS Fdn Trust, Dept Allergy, Cambridge, England	Royal College of Physicians; University of Southampton; University of Cambridge	Dworzynski, K (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	Katharina.Dworzynski@rcplondon.ac.uk		Larcombe, James/0000-0002-3111-7346; Harker, Martin/0000-0001-6154-3517; Ardern-Jones, Michael/0000-0003-1466-2016				[Anonymous], 2014, DRUG ALL DIAGN MAN D; Department of Health, REV SERV ALL EP DEM; KERR JR, 1994, BRIT J CLIN PRACT, V48, P5; National Institute for Health and Care Excellence, 2011, AN ASS CONF AN EP DE; The Health and Social Care Information Centre, HESONLINE HOSP EP ST	5	18	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2014	349								g4852	10.1136/bmj.g4852	http://dx.doi.org/10.1136/bmj.g4852			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LX	25186447				2022-12-28	WOS:000341387400001
J	Lawler, A				Lawler, Andrew			In search of Green Arabia	SCIENCE			English	Editorial Material																			0	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					994	997		10.1126/science.345.6200.994	http://dx.doi.org/10.1126/science.345.6200.994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170133				2022-12-28	WOS:000340870900013
J	Chen, X; Bracht, JR; Goldman, AD; Dolzhenko, E; Clay, DM; Swart, EC; Perlman, DH; Doak, TG; Stuart, A; Amemiya, CT; Sebra, RP; Landweber, LF				Chen, Xiao; Bracht, John R.; Goldman, Aaron David; Dolzhenko, Egor; Clay, Derek M.; Swart, Estienne C.; Perlman, David H.; Doak, Thomas G.; Stuart, Andrew; Amemiya, Chris T.; Sebra, Robert P.; Landweber, Laura F.			The Architecture of a Scrambled Genome Reveals Massive Levels of Genomic Rearrangement during Development	CELL			English	Article							CILIATED PROTOZOA; OXYTRICHA-NOVA; TETRAHYMENA-THERMOPHILA; EUPLOTES-CRASSUS; DNA ELIMINATION; NESTED GENES; ORGANIZATION; ANNOTATION; SEQUENCES; ELEMENTS	Programmed DNA rearrangements in the single-celled eukaryote Oxytricha trifallax completely rewire its germline into a somatic nucleus during development. This elaborate, RNA-mediated pathway eliminates noncoding DNA sequences that interrupt gene loci and reorganizes the remaining fragments by inversions and permutations to produce functional genes. Here, we report the Oxytricha germline genome and compare it to the somatic genome to present a global view of its massive scale of genome rearrangements. The remarkably encrypted genome architecture contains >3,500 scrambled genes, as well as >800 predicted germline-limited genes expressed, and some posttranslationally modified, during genome rearrangements. Gene segments for different somatic loci often interweave with each other. Single gene segments can contribute to multiple, distinct somatic loci. Terminal precursor segments from neighboring somatic loci map extremely close to each other, often overlapping. This genome assembly provides a draft of a scrambled genome and a powerful model for studies of genome rearrangement.	[Chen, Xiao; Clay, Derek M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bracht, John R.; Goldman, Aaron David; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dolzhenko, Egor] Univ S Florida, Dept Math & Stat, Tampa, FL 33620 USA; [Swart, Estienne C.] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Perlman, David H.] Princeton Univ, Dept Mol Biol, Collaborat Prote & Mass Spectrometry Ctr, Princeton, NJ 08544 USA; [Perlman, David H.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Doak, Thomas G.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Stuart, Andrew; Amemiya, Chris T.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Sebra, Robert P.] Icahn Sch Med Mt Sinai, Icahn Inst, New York, NY 10029 USA; [Sebra, Robert P.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Princeton University; Princeton University; State University System of Florida; University of South Florida; University of Bern; Princeton University; Princeton University; Indiana University System; Indiana University Bloomington; Benaroya Research Institute; Virginia Mason Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Chen, Xiao/R-2157-2016	Doak, Thomas/0000-0001-5487-553X	National Science Foundation [NSF] [ABI-1062432, 0900544, 0923810]; NIH [GM59708, GM109459, 1F32GM099462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, F32GM099462, R01GM109459, R01GM059708] Funding Source: NIH RePORTER; Direct For Biological Sciences [1062432] Funding Source: National Science Foundation	National Science Foundation [NSF](National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the late David Prescott for suggesting sucrose purification of the Oxytricha micronuclei, Jingmei Wang for laboratory assistance, Jessica Wiggins, Wei Wang, and Donna Storton of the Princeton Sequencing Core Facility for assistance with Illumina library preparation and sequencing, Gintaras Deikus for assistance with PacBio sequencing, Klaas Schotanus, Mariusz Nowacki, Wenwen Fang, and all current laboratory members for discussion. We thank Jue Ruan at Beijing Institute of Genomics for advice on the assembly strategy. We are grateful to National Center for Genome Analysis Support (NCGAS) computing resources (supported by National Science Foundation [NSF] grant ABI-1062432 to Indiana University). This study was supported by NIH grant GM59708 and GM109459 and NSF grants 0900544 and 0923810 to L.F.L.. J.R.B. was supported by NIH fellowship 1F32GM099462 and A.D.G. was a National Aeronautics and Space Administration (NASA) postdoctoral fellow.	Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BOSWELL RE, 1983, NUCLEIC ACIDS RES, V11, P3651, DOI 10.1093/nar/11.11.3651; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; DAWSON D, 1984, CHROMOSOMA, V90, P289, DOI 10.1007/BF00287037; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Fass JN, 2011, G3-GENES GENOM GENET, V1, P515, DOI 10.1534/g3.111.000927; Fillingham JS, 2004, EUKARYOT CELL, V3, P157, DOI 10.1128/EC.3.1.157-169.2004; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Ghosh S, 2000, GENESIS, V26, P179, DOI 10.1002/(SICI)1526-968X(200003)26:3<179::AID-GENE3>3.0.CO;2-B; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; HERRICK G, 1985, CELL, V43, P759, DOI 10.1016/0092-8674(85)90249-1; Jacobs ME, 1996, J EUKARYOT MICROBIOL, V43, P442, DOI 10.1111/j.1550-7408.1996.tb04503.x; Karamysheva Z, 2003, CELL, V113, P565, DOI 10.1016/S0092-8674(03)00363-5; Katz LA, 2010, J EXP ZOOL PART B, V314B, P480, DOI 10.1002/jez.b.21354; KLOBUTCHER LA, 1987, J PROTOZOOL, V34, P424, DOI 10.1111/j.1550-7408.1987.tb03206.x; Klobutcher LA, 1997, PROG NUCLEIC ACID RE, V56, P1, DOI 10.1016/S0079-6603(08)61001-6; KLOBUTCHER LA, 1995, NUCLEIC ACIDS RES, V23, P2006, DOI 10.1093/nar/23.11.2006; KLOBUTCHER LA, 1988, NUCLEIC ACIDS RES, V16, P251, DOI 10.1093/nar/16.1.251; Kumar A, 2009, EUKARYOT CELL, V8, P1321, DOI 10.1128/EC.00143-09; Kuo SY, 2006, MOL BIOL EVOL, V23, P4, DOI 10.1093/molbev/msj017; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAUTH MR, 1976, CELL, V7, P67, DOI 10.1016/0092-8674(76)90256-7; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Prescott DM, 1999, NUCLEIC ACIDS RES, V27, P1243, DOI 10.1093/nar/27.5.1243; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Smith JK, 2012, PSYCHOL AESTHET CREA, V6, P1, DOI 10.1037/a0027241; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; Wang JB, 2012, DEV CELL, V23, P1072, DOI 10.1016/j.devcel.2012.09.020; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	45	112	116	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1187	1198		10.1016/j.cell.2014.07.034	http://dx.doi.org/10.1016/j.cell.2014.07.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171416	Green Accepted, Bronze			2022-12-28	WOS:000340945000022
J	Tan, KW				Tan, Ki-Wei			Discharging Dental Sinus Tract	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Changi Gen Hosp, Singapore, Singapore	Changi General Hospital	Tan, KW (corresponding author), Changi Gen Hosp, Singapore, Singapore.	ki_wei_tan@cgh.com.sg	Tan, Ki-Wei/GPK-1644-2022						0	0	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					846	846		10.1056/NEJMicm1315204	http://dx.doi.org/10.1056/NEJMicm1315204			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162891				2022-12-28	WOS:000340819800011
J	Azubel, M; Koivisto, J; Malola, S; Bushnell, D; Hura, GL; Koh, AL; Tsunoyama, H; Tsukuda, T; Pettersson, M; Hakkinen, H; Kornberg, RD				Azubel, Maia; Koivisto, Jaakko; Malola, Sami; Bushnell, David; Hura, Greg L.; Koh, Ai Leen; Tsunoyama, Hironori; Tsukuda, Tatsuya; Pettersson, Mika; Hakkinen, Hannu; Kornberg, Roger D.			Electron microscopy of gold nanoparticles at atomic resolution	SCIENCE			English	Article							CRYSTAL-STRUCTURE	Structure determination of gold nanoparticles (AuNPs) is necessary for understanding their physical and chemical properties, but only one AuNP larger than 1 nanometer in diameter [a 102-gold atom NP (Au102NP)] has been solved to atomic resolution. Whereas the Au102NP structure was determined by x-ray crystallography, other large AuNPs have proved refractory to this approach. Here, we report the structure determination of a Au68NP at atomic resolution by aberration-corrected transmission electron microscopy, performed with the use of a minimal electron dose, an approach that should prove applicable to metal NPs in general. The structure of the Au68NP was supported by small-angle x-ray scattering and by comparison of observed infrared absorption spectra with calculations by density functional theory.	[Azubel, Maia; Bushnell, David; Kornberg, Roger D.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Koivisto, Jaakko; Pettersson, Mika; Hakkinen, Hannu] Univ Jyvaskyla, Nanosci Ctr, Dept Chem, FI-40014 Jyvaskyla, Finland; [Malola, Sami; Hakkinen, Hannu] Univ Jyvaskyla, Nanosci Ctr, Dept Phys, FI-40014 Jyvaskyla, Finland; [Hura, Greg L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Koh, Ai Leen] Stanford Univ, Stanford Nanocharacterizat Lab, Stanford, CA 94305 USA; [Tsunoyama, Hironori; Tsukuda, Tatsuya] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 060, Japan	Stanford University; University of Jyvaskyla; University of Jyvaskyla; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; Hokkaido University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.	kornberg@stanford.edu	Tsukuda, Tatsuya/G-4979-2014; Tsunoyama, Hironori/D-7124-2014	Tsukuda, Tatsuya/0000-0002-0190-6379; Tsunoyama, Hironori/0000-0002-0332-5324; Hakkinen, Hannu/0000-0002-8558-5436; Pettersson, Mika/0000-0002-6880-2283; Hura, Greg/0000-0003-0501-8464	Human Frontier Science Program Organization; NIH [AI-21144]; Academy of Finland; National Graduate School in Computational Chemistry and Spectroscopy LASKEMO; U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049985, R01GM036659, R01GM105404] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26248003] Funding Source: KAKEN	Human Frontier Science Program Organization(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); National Graduate School in Computational Chemistry and Spectroscopy LASKEMO; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work at Stanford University was supported by the Human Frontier Science Program Organization (M. A.) and NIH grant AI-21144 (R. D. K). The work at the University of Jyvaskyla was supported by the Academy of Finland (H. H. and M. P.) and the National Graduate School in Computational Chemistry and Spectroscopy LASKEMO (J. K.). G. L. H was supported by U.S. Department of Energy Biological and Environmental Research grant DE-AC02-05CH11231 under Integrated Diffraction Analysis Technologies. We thank P. Robinson for assistance with EM processing and helpful discussions and E. Hulkko and P. A. Clayborne for help with spectroscopic experiments and preliminary computations, respectively.	Akola J, 2008, J AM CHEM SOC, V130, P3756, DOI 10.1021/ja800594p; Bahena D, 2013, J PHYS CHEM LETT, V4, P975, DOI 10.1021/jz400111d; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; Goris B, 2012, NAT MATER, V11, P930, DOI [10.1038/NMAT3462, 10.1038/nmat3462]; Hakkinen H, 2006, J PHYS CHEM B, V110, P9927, DOI 10.1021/jp0619787; Hakkinen H, 2012, NAT CHEM, V4, P443, DOI [10.1038/NCHEM.1352, 10.1038/nchem.1352]; Heaven MW, 2008, J AM CHEM SOC, V130, P3754, DOI 10.1021/ja800561b; Hulkko E, 2011, J AM CHEM SOC, V133, P3752, DOI 10.1021/ja111077e; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Koivisto J, 2014, J PHYS CHEM LETT, V5, P387, DOI 10.1021/jz4026003; Levi-Kalisman Y, 2011, J AM CHEM SOC, V133, P2976, DOI 10.1021/ja109131w; Li ZY, 2008, NATURE, V451, P46, DOI 10.1038/nature06470; Lopez-Acevedo O, 2010, J AM CHEM SOC, V132, P8210, DOI 10.1021/ja102934q; Nimmala PR, 2013, J PHYS CHEM A, V117, P504, DOI 10.1021/jp311491v; Qian HF, 2010, J AM CHEM SOC, V132, P8280, DOI 10.1021/ja103592z; Scholl JA, 2012, NATURE, V483, P421, DOI 10.1038/nature10904; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Walter M, 2008, P NATL ACAD SCI USA, V105, P9157, DOI 10.1073/pnas.0801001105; Whetten RL, 1996, ADV MATER, V8, P428, DOI 10.1002/adma.19960080513; Zeng CJ, 2012, ANGEW CHEM INT EDIT, V51, P13114, DOI 10.1002/anie.201207098; Zhu M, 2008, J AM CHEM SOC, V130, P5883, DOI 10.1021/ja801173r	23	213	216	6	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					909	912		10.1126/science.1251959	http://dx.doi.org/10.1126/science.1251959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146285	Green Accepted			2022-12-28	WOS:000340524700040
J	Chen, JD; Gottesman, S				Chen, Jiandong; Gottesman, Susan			RNA Riboswitch regulates RNA	SCIENCE			English	Editorial Material							ETHANOLAMINE UTILIZATION; RESPONSE REGULATOR; SEQUESTRATION; EXPRESSION		[Chen, Jiandong; Gottesman, Susan] NCI, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, JD (corresponding author), NCI, Mol Biol Lab, Bldg 37, Bethesda, MD 20892 USA.	gottesms@helix.nih.gov	Chen, Jiandong/H-4016-2019	Chen, Jiandong/0000-0002-5144-7537	NATIONAL CANCER INSTITUTE [ZIABC008714] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker KA, 2011, J BACTERIOL, V193, P2575, DOI 10.1128/JB.00217-11; DebRoy S, 2014, SCIENCE, V345, P937, DOI 10.1126/science.1255091; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Jorgensen MG, 2013, GENE DEV, V27, P1132, DOI 10.1101/gad.214734.113; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Mellin JR, 2013, P NATL ACAD SCI USA, V110, P13132, DOI 10.1073/pnas.1304795110; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Ramesh A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002666; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024	11	12	15	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					876	877		10.1126/science.1258494	http://dx.doi.org/10.1126/science.1258494			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146272				2022-12-28	WOS:000340524700023
J	Cory, RM; Ward, CP; Crump, BC; Kling, GW				Cory, Rose M.; Ward, Collin P.; Crump, Byron C.; Kling, George W.			Sunlight controls water column processing of carbon in arctic fresh waters	SCIENCE			English	Article							DISSOLVED ORGANIC-CARBON; PERMAFROST-CARBON; SURFACE WATERS; CLIMATE-CHANGE; HUMIC LAKE; MATTER; TUNDRA; CYCLE; CONSUMPTION; ATMOSPHERE	Carbon in thawing permafrost soils may have global impacts on climate change; however, the factors that control its processing and fate are poorly understood. The dominant fate of dissolved organic carbon (DOC) released from soils to inland waters is either complete oxidation to CO2 or partial oxidation and river export to oceans. Although both processes are most often attributed to bacterial respiration, we found that photochemical oxidation exceeds rates of respiration and accounts for 70 to 95% of total DOC processed in the water column of arctic lakes and rivers. At the basin scale, photochemical processing of DOC is about one-third of the total CO2 released from surface waters and is thus an important component of the arctic carbon budget.	[Cory, Rose M.; Ward, Collin P.] Univ Michigan, Ann Arbor, MI 48109 USA; [Crump, Byron C.] Oregon State Univ, Corvallis, OR 97331 USA; [Kling, George W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Oregon State University; University of Michigan System; University of Michigan	Cory, RM (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	rmcory@umich.edu	Crump, Byron/ABF-3711-2020; Cory, Rose M/C-4198-2016; Kling, George W/C-7867-2015	Kling, George W/0000-0002-6349-8227; Ward, Collin/0000-0003-2979-0280; Crump, Byron/0000-0001-7062-1273	NSF [OPP 1023270/1022876, PLR 1107593, DEB-1147378/1347042, DEB-1026843, 455541, 1048361.]; Direct For Biological Sciences [1147336, 1026843] Funding Source: National Science Foundation; Directorate For Geosciences [1107593, 1421603] Funding Source: National Science Foundation; Division Of Environmental Biology [1347042] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1022876] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank K. Harrold, J. Dobkowski, S. Fortin, S. Michael, J. Olsen, B. Papworth, A. Clinger, A. Rocha, W. Eugster, and researchers and technicians of the Toolik Lake Arctic LTER and Toolik Lake Field Station (GIS, R. Fulweber, J. Stuckey) for assistance. Supported by NSF grants OPP 1023270/1022876, PLR 1107593, and DEB-1147378/1347042. The data set provided by the Arctic Long Term Ecological Research Program (table S1) was supported by NSF grant DEB-1026843. The data set provided by the Toolik Field Station Environmental Data Center (table S1) was supported by NSF grants 455541 and 1048361. Other experimental data are presented in the supplementary materials.	Amon RMW, 1996, GEOCHIM COSMOCHIM AC, V60, P1783, DOI 10.1016/0016-7037(96)00055-5; Amon RMW, 2004, MAR CHEM, V92, P311, DOI 10.1016/j.marchem.2004.06.034; Andrews SS, 2000, LIMNOL OCEANOGR, V45, P267, DOI 10.4319/lo.2000.45.2.0267; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Belanger S, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002708; Berggren M, 2012, ISME J, V6, P984, DOI 10.1038/ismej.2011.157; Carignan R, 2000, LIMNOL OCEANOGR, V45, P189, DOI 10.4319/lo.2000.45.1.0189; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Cory RM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000343; Cory RM, 2013, P NATL ACAD SCI USA, V110, P3429, DOI 10.1073/pnas.1214104110; Graneli W, 1996, LIMNOL OCEANOGR, V41, P698, DOI 10.4319/lo.1996.41.4.0698; Hobbie J. E., 2014, CHANGING ARCTIC ECOL; Hobbie J. E., 1980, LIMNOLOGY TUNDRA PON; Judd KE, 2007, AQUAT SCI, V69, P96, DOI 10.1007/s00027-006-0908-4; KLING GW, 1991, SCIENCE, V251, P298, DOI 10.1126/science.251.4991.298; Koehler B., 2014, GLOBAL BIOGEOCHEM CY; MacDougall AH, 2012, NAT GEOSCI, V5, P719, DOI [10.1038/NGEO1573, 10.1038/ngeo1573]; Mann PJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001798; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Molot LA, 1997, GLOBAL BIOGEOCHEM CY, V11, P357, DOI 10.1029/97GB01198; Pace Michael L., 2005, P103, DOI 10.1093/acprof:oso/9780198527084.003.0007; RAMLAL PS, 1994, BIOGEOCHEMISTRY, V24, P145; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Reader HE, 2014, LIMNOL OCEANOGR, V59, P182, DOI 10.4319/lo.2014.59.1.0182; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tranvik LJ, 2001, ECOL LETT, V4, P458, DOI 10.1046/j.1461-0248.2001.00245.x; Vahatalo AV, 2000, LIMNOL OCEANOGR, V45, P664; Vahatalo AV, 2003, ARCH HYDROBIOL, V156, P287, DOI 10.1127/0003-9136/2003/0156-0287; Vallieres C, 2008, J MARINE SYST, V74, P756, DOI 10.1016/j.jmarsys.2007.12.002; Vonk JE, 2013, NAT GEOSCI, V6, P675, DOI 10.1038/ngeo1937; White EM, 2010, MAR CHEM, V118, P11, DOI 10.1016/j.marchem.2009.10.001; Zhang Y, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007284	36	315	326	28	421	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					925	928		10.1126/science.1253119	http://dx.doi.org/10.1126/science.1253119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146289				2022-12-28	WOS:000340524700045
J	Muller, NZ				Muller, Nicholas Z.			ECONOMICS Boosting GDP growth by accounting for the environment	SCIENCE			English	Editorial Material									[Muller, Nicholas Z.] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Muller, Nicholas Z.] Middlebury Coll, Environm Studies Program, Middlebury, VT 05753 USA; [Muller, Nicholas Z.] Natl Bur Econ Res, Cambridge, MA 02138 USA	National Bureau of Economic Research	Muller, NZ (corresponding author), Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA.	nmuller@middlebury.edu						Abraham KG, 2006, STUD INCOME, V66, P161; Banzhaf HS, 2004, RESOUR ENERGY ECON, V26, P317, DOI 10.1016/j.reseneeco.2003.10.002; Bartelmus P, 2009, ECOL ECON, V68, P1850, DOI 10.1016/j.ecolecon.2008.12.011; Muller N. Z., 2014, NBER BOOK S IN PRESS; Muller NZ, 2011, AM ECON REV, V101, P1649, DOI 10.1257/aer.101.5.1649; Muller NZ, 2011, BE J ECON ANAL POLI, V11, DOI 10.2202/1935-1682.2925; National Academy of Sciences National Research Council, 2010, HIDD COSTS EN UNPR C; Nordhaus W.D., 1999, NAT NUMB EXP US NAT; Nordhaus W. D., 2006, NEW ARCHITECTURE US, V66; United States Department of Energy Energy Information Administration, 2013, 2013 MONTHL EN REV T; United States Environmental Protection Agency, 1999, 410R99001 EPA; United States Office of Management and Budget, 2013, 12866 US OFF MAN BUD	12	39	39	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					873	874		10.1126/science.1253506	http://dx.doi.org/10.1126/science.1253506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3YL	25146270				2022-12-28	WOS:000340524700021
J	Mahonen, AP; ten Tusscher, K; Siligato, R; Smetana, O; Diaz-Trivino, S; Salojarvi, J; Wachsman, G; Prasad, K; Heidstra, R; Scheres, B				Maehoenen, Ari Pekka; ten Tusscher, Kirsten; Siligato, Riccardo; Smetana, Ondrej; Diaz-Trivino, Sara; Salojaervi, Jarkko; Wachsman, Guy; Prasad, Kalika; Heidstra, Renze; Scheres, Ben			PLETHORA gradient formation mechanism separates auxin responses	NATURE			English	Article							INFLAMMATORY BREAST-CANCER; CHEMOATTRACTANT PROTEIN-1; TRANSCRIPTION FACTORS; CARCINOMA CELLS; ARABIDOPSIS; ROOT; ANGIOGENESIS; EXPRESSION; TRANSPORT; GROWTH	During plant growth, dividing cells in meristems must coordinate transitions from division to expansion and differentiation, thus generating three distinct developmental zones: the meristem, elongation zone and differentiation zone(1). Simultaneously, plants display tropisms, rapid adjustments of their direction of growth to adapt to environmental conditions. It is unclear how stable zonation is maintained during transient adjustments in growth direction. In Arabi-dopsis roots, many aspects of zonation are controlled by the phytohormone auxin and auxin-induced PLETHORA(PLT) transcription factors, both of which display a graded distribution with a maximum near the root tip(2-12). In addition, auxin is also pivotal for tropic responses(13,14). Here, using an iterative experimental and computational approach, we show how an interplay between auxin and PLTs controls zonation and gravitropism. We find that the PLT gradient is not a direct, proportionate readout of the auxin gradient. Rather, prolonged high auxin levels generate a narrow PLT transcription domain from which a gradient of PLT protein is subsequently generated through slow growth dilution and cell-to-cell movement. The resulting PLT levels define the location of developmental zones. In addition to slowly promoting PLT transcription, auxin also rapidly influences division, expansion and differentiation rates. We demonstrate how this specific regulatory design in which auxin cooperates with PLTs through different mechanisms and on different time scales enables both the fast tropic environmental responses and stable zonation dynamics necessary for coordinated cell differentiation.	[Maehoenen, Ari Pekka; Siligato, Riccardo; Smetana, Ondrej] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Maehoenen, Ari Pekka; Diaz-Trivino, Sara; Wachsman, Guy; Prasad, Kalika; Heidstra, Renze; Scheres, Ben] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Maehoenen, Ari Pekka; Siligato, Riccardo; Smetana, Ondrej; Salojaervi, Jarkko] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [ten Tusscher, Kirsten] Univ Utrecht, NL-3584 CH Utrecht, Netherlands; [Diaz-Trivino, Sara; Heidstra, Renze; Scheres, Ben] Wageningen Univ Res, NL-6708 PB Wageningen, Netherlands	University of Helsinki; Utrecht University; University of Helsinki; Utrecht University; Wageningen University & Research	Mahonen, AP (corresponding author), Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland.	AriPekka.Mahonen@helsinki.fi; ben.scheres@wur.nl	Tusscher, Kirsten HWJ ten/B-9427-2011; Mähönen, Ari Pekka/B-9764-2015; Salojärvi, Jarkko/E-9103-2016; Prasad, Kalika/AAS-6293-2020	Mähönen, Ari Pekka/0000-0001-6051-866X; Salojärvi, Jarkko/0000-0002-4096-6278; Prasad, Kalika/0000-0001-8666-856X; Scheres, Ben/0000-0001-5400-9578; Siligato, Riccardo/0000-0002-1310-2757	Human Frontier Science Program fellowship; European Research Council Advanced Investigator Fellowship SysArc; SPINOZA award; ALW-NWO European Research Area Network Plant Genomics (ERAPG) grant [855.50.017]; Academy of Finland; Biocentrum Helsinki; University of Helsinki; Integrative Life Science Doctoral Program; Marie Curie Intra-European Fellowship [IEF-2008-237643]; Netherlands Organisation for Scientific Research (NWO)-Horizon grant; NWO-ALW grant; EMBO Long-term fellowship	Human Frontier Science Program fellowship(Human Frontier Science Program); European Research Council Advanced Investigator Fellowship SysArc; SPINOZA award; ALW-NWO European Research Area Network Plant Genomics (ERAPG) grant; Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki; Integrative Life Science Doctoral Program; Marie Curie Intra-European Fellowship(European Commission); Netherlands Organisation for Scientific Research (NWO)-Horizon grant(Netherlands Organization for Scientific Research (NWO)); NWO-ALW grant; EMBO Long-term fellowship(European Molecular Biology Organization (EMBO))	We thank M. Grebe, P. Benfey and K.-i. Hayashi for materials; the Light Microscopy Unit (Institute of Biotechnology), S. El-Showk, A.-M. Bagman, J. van Amerongen and F. Kindt for technical advice or assistance. This work is supported by a Human Frontier Science Program fellowship (A. P. M.), European Research Council Advanced Investigator Fellowship SysArc (B. S.), SPINOZA award (B. S., K.t.T., K. P.), ALW-NWO European Research Area Network Plant Genomics (ERAPG) grant 855.50.017 (S.D.-T.), the Academy of Finland (A. P. M., R. S., O.S., J. S.), Biocentrum Helsinki and University of Helsinki (A. P. M., R. S., O.S.), Integrative Life Science Doctoral Program (R. S.), Marie Curie Intra-European Fellowship (IEF-2008-237643) (S.D.-T.), the Netherlands Organisation for Scientific Research (NWO)-Horizon grant (R. H.), NWO-ALW grant (G. W.), and EMBO Long-term fellowship (A. P. M., K.P.).	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Band LR, 2014, PLANT CELL, V26, P862, DOI 10.1105/tpc.113.119495; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bonapace L, 2012, J MAMMARY GLAND BIOL, V17, P125, DOI 10.1007/s10911-012-9250-8; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; DOLAN L, 1993, DEVELOPMENT, V119, P71; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Goldman M, 2013, NUCLEIC ACIDS RES, V41, pD949, DOI 10.1093/nar/gks1008; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Hofhuis H, 2013, CURR BIOL, V23, P956, DOI 10.1016/j.cub.2013.04.048; Ibanes M, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100098; Ishida T, 2010, DEVELOPMENT, V137, P63, DOI 10.1242/dev.035840; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; PALANGIE T, 1994, EUR J CANCER, V30A, P921, DOI 10.1016/0959-8049(94)90115-5; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pinon V, 2013, P NATL ACAD SCI USA, V110, P1107, DOI 10.1073/pnas.1213497110; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wani AA, 2011, ONCOGENE, V30, P2778, DOI 10.1038/onc.2010.644; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Wu S, 2012, CURR OPIN PLANT BIOL, V15, P645, DOI 10.1016/j.pbi.2012.09.010; Wyckoff Jeffrey, 2011, Cold Spring Harb Protoc, V2011, P1167, DOI 10.1101/pdb.top065904; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	62	232	240	3	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					125	+		10.1038/nature13663	http://dx.doi.org/10.1038/nature13663			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25156253	Green Accepted			2022-12-28	WOS:000344187500043
J	Saavedra, J; Doan, HA; Pursell, CJ; Grabow, LC; Chandler, BD				Saavedra, Johnny; Doan, Hieu A.; Pursell, Christopher J.; Grabow, Lars C.; Chandler, Bert D.			The critical role of water at the gold-titania interface in catalytic CO oxidation	SCIENCE			English	Article							GAS SHIFT REACTION; ACTIVE GOLD; OXYGEN; ADSORPTION; MECHANISM; HYDROXYL; CLUSTERS; SIZE; SITES	We provide direct evidence of a water-mediated reaction mechanism for room-temperature CO oxidation over Au/TiO2 catalysts. A hydrogen/deuterium kinetic isotope effect of nearly 2 implicates O-H(D) bond breaking in the rate-determining step. Kinetics and in situ infrared spectroscopy experiments showed that the coverage of weakly adsorbed water on TiO2 largely determines catalyst activity by changing the number of active sites. Density functional theory calculations indicated that proton transfer at the metal-support interface facilitates O-2 binding and activation; the resulting Au-OOH species readily reacts with adsorbed Au-CO, yielding Au-COOH. Au-COOH decomposition involves proton transfer to water and was suggested to be rate determining. These results provide a unified explanation to disparate literature results, clearly defining the mechanistic roles of water, support OH groups, and the metal-support interface.	[Saavedra, Johnny; Pursell, Christopher J.; Chandler, Bert D.] Trinity Univ, Dept Chem, San Antonio, TX 78212 USA; [Doan, Hieu A.; Grabow, Lars C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA	Trinity University; University of Houston System; University of Houston	Grabow, LC (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.	grabow@uh.edu; bert.chandler@trinity.edu	Doan, Hieu/N-4074-2014; Grabow, Lars/F-7095-2011; Saavedra, Johnny/V-1950-2018	Doan, Hieu/0000-0003-1460-9004; Grabow, Lars/0000-0002-7766-8856; Saavedra, Johnny/0000-0002-7542-5826; Chandler, Bert/0000-0002-8621-0361	U.S. National Science Foundation [CBET-1160217, CHE-1012395, CHE-1300619]; U.S. Department of Energy [NSF/DOE CBET-1258688]; University of Houston New Faculty Grant; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NSF [OCI-1053575, 0711134, 0933959, 1041709, 1041710]; University of Tennessee; Directorate For Engineering [1160217] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); University of Houston New Faculty Grant; U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); University of Tennessee; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We gratefully acknowledge the U.S. National Science Foundation (grants CBET-1160217, CHE-1012395, and CHE-1300619) and the U.S. Department of Energy (NSF/DOE CBET-1258688) for financial support of this work. We also thank R. Rioux (Pennsylvania State University) and Z. Tonzetich (University of Texas at San Antonio) for assistance with transmission electron microscopy and thermogravimetric analysis measurements, respectively. Additional financial support was provided to L. C. G. and H. A. D. through a University of Houston New Faculty Grant. Use of the computational resources at the Center for Nanoscale Materials was supported by the U.S. DOE, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. This work also used the Extreme Science and Engineering Discovery Environment (XSEDE, supported by NSF grant OCI-1053575) and the Kraken computing resource at the National Institute for Computational Sciences (supported by NSF grants 0711134, 0933959, 1041709, and 1041710 and the University of Tennessee). We acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high-performance computing resources that have contributed to the research results reported in this paper. Additional computational resources were provided by the Center for Advanced Computing and Data Systems (CACDS, formerly Texas Learning and Computation Center, TLC<SUP>2</SUP>) and the Research Computing Center (RCC) at the University of Houston.	Calla JT, 2006, J CATAL, V241, P407, DOI 10.1016/j.jcat.2006.05.017; Cargnello M, 2013, SCIENCE, V341, P771, DOI 10.1126/science.1240148; Carrasco J, 2012, NAT MATER, V11, P667, DOI [10.1038/NMAT3354, 10.1038/nmat3354]; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Costello CK, 2003, APPL CATAL A-GEN, V243, P15, DOI 10.1016/S0926-860X(02)00533-1; Date M, 2004, ANGEW CHEM INT EDIT, V43, P2129, DOI 10.1002/anie.200453796; Della Pina C, 2012, CHEM SOC REV, V41, P350, DOI 10.1039/c1cs15089h; Falsig H, 2008, ANGEW CHEM INT EDIT, V47, P4835, DOI 10.1002/anie.200801479; Fujitani T, 2011, ANGEW CHEM INT EDIT, V50, P10144, DOI 10.1002/anie.201104694; Gokhale AA, 2008, J AM CHEM SOC, V130, P1402, DOI 10.1021/ja0768237; Grabow LC, 2008, J PHYS CHEM C, V112, P4608, DOI 10.1021/jp7099702; Green IX, 2011, SCIENCE, V333, P736, DOI 10.1126/science.1207272; Haruta M, 2011, FARADAY DISCUSS, V152, P11, DOI 10.1039/c1fd00107h; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; Ide MS, 2014, ACCOUNTS CHEM RES, V47, P825, DOI 10.1021/ar4001907; Ketchie WC, 2007, TOP CATAL, V44, P307, DOI 10.1007/s11244-007-0304-x; Kung HH, 2003, J CATAL, V216, P425, DOI 10.1016/S0021-9517(02)00111-2; Kung MC, 2007, J PHYS CHEM C, V111, P11767, DOI 10.1021/jp072102i; Laursen S, 2009, PHYS CHEM CHEM PHYS, V11, P11006, DOI 10.1039/b912641d; Lemire C, 2004, ANGEW CHEM INT EDIT, V43, P118, DOI 10.1002/anie.200352538; Liu ZP, 2002, J AM CHEM SOC, V124, P14770, DOI 10.1021/ja0205885; Long CG, 2008, J AM CHEM SOC, V130, P10103, DOI 10.1021/ja801279a; Merte LR, 2012, SCIENCE, V336, P889, DOI 10.1126/science.1219468; Mills G, 2003, J CHEM PHYS, V118, P4198, DOI 10.1063/1.1542879; Molina LM, 2004, J CHEM PHYS, V120, P7673, DOI 10.1063/1.1687337; Ojeda M, 2012, J CATAL, V285, P92, DOI 10.1016/j.jcat.2011.09.015; Ojifinni RA, 2008, J AM CHEM SOC, V130, P6801, DOI 10.1021/ja800351j; Remediakis IN, 2005, ANGEW CHEM INT EDIT, V44, P1824, DOI 10.1002/anie.200461699; Shekhar M, 2012, J AM CHEM SOC, V134, P4700, DOI 10.1021/ja210083d; Singh JA, 2012, ACS CATAL, V2, P1138, DOI 10.1021/cs3001094; Takei T, 2012, ADV CATAL, V55, P1, DOI 10.1016/B978-0-12-385516-9.00001-6; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Veith GM, 2009, J PHYS CHEM C, V113, P269, DOI 10.1021/jp808249f; Widmann D, 2014, ACCOUNTS CHEM RES, V47, P740, DOI 10.1021/ar400203e; Zope BN, 2010, SCIENCE, V330, P74, DOI 10.1126/science.1195055	36	410	410	36	848	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1599	1602		10.1126/science.1256018	http://dx.doi.org/10.1126/science.1256018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25190716	Green Submitted, Bronze			2022-12-28	WOS:000342164500042
J	Barrangou, R; Klaenhammer, TR				Barrangou, Rodolphe; Klaenhammer, Todd R.			MICROBIOLOGY Bacteria get vaccinated	NATURE			English	Editorial Material									[Barrangou, Rodolphe; Klaenhammer, Todd R.] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Barrangou, R (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu	Barrangou, Rodolphe/I-2878-2014	Barrangou, Rodolphe/0000-0002-0648-3504				Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279	8	2	2	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					175	176		10.1038/513175a	http://dx.doi.org/10.1038/513175a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209793				2022-12-28	WOS:000341362800035
J	Haffajee, R; Parmet, WE; Mello, MM				Haffajee, Rebecca; Parmet, Wendy E.; Mello, Michelle M.			What Is a Public Health "Emergency"?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Haffajee, Rebecca] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02138 USA; [Haffajee, Rebecca] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Parmet, Wendy E.] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Northeastern University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Haffajee, R (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02138 USA.			Mello, Michelle/0000-0003-2877-4270				Annas GJ, 2002, NEW ENGL J MED, V346, P1337, DOI 10.1056/NEJM200204253461722; Smith S, 2009, BOSTON GLOBE    0917, V17, pA1; State of Florida Department of Health, 2011, DECL PUBL HLTH EM	3	31	33	3	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					986	988		10.1056/NEJMp1406167	http://dx.doi.org/10.1056/NEJMp1406167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25207765				2022-12-28	WOS:000341382800003
J	Ye, ZL; Cao, T; O'Brien, K; Zhu, HY; Yin, XB; Wang, Y; Louie, SG; Zhang, X				Ye, Ziliang; Cao, Ting; O'Brien, Kevin; Zhu, Hanyu; Yin, Xiaobo; Wang, Yuan; Louie, Steven G.; Zhang, Xiang			Probing excitonic dark states in single-layer tungsten disulphide	NATURE			English	Article							VALLEY POLARIZATION; OPTICAL-PROPERTIES; CARBON NANOTUBES; QUASI-PARTICLE; MOS2; SEMICONDUCTORS; SPECTRA	Transition metal dichalcogenide (TMDC) monolayers have recently emerged as an important class of two-dimensional semiconductors with potential for electronic and optoelectronic devices(1,2). Unlike semi-metallic graphene, layered TMDCs have a sizeable bandgap(3). More interestingly, when thinned down to a monolayer, TMDCs transform from indirect-bandgap to direct-bandgap semiconductors(4,5), exhibiting a number of intriguing optical phenomena such as valley-selective circular dichroism(6-8), doping-dependent charged excitons(9,10) and strong photocurrent responses(11). However, the fundamental mechanism underlying such a strong light-matter interaction is still under intensive investigation. First-principles calculations have predicted a quasi-particle bandgap much larger than the measured optical gap, and an optical response dominated by excitonic effects(12-14). In particular, a recent study based on a GW plus Bethe-Salpeter equation (GW-BSE) approach, which employed many-body Green's-function methodology to address electron-electron and electron-hole interactions, theoretically predicted a diversity of strongly bound exdtons(14). Here we report experimental evidence of a series of excitonic dark states in single-layer WS2 using two-photon excitation spectroscopy. In combination with GW-BSE theory, we prove that the excitons are of Wannier type, meaning that each exciton wavefunction extends over multiple unit cells, but with extraordinarily large binding energy (similar to 0.7 electron-volts), leading to a quasiparticle bandgap of 2.7 electronvolts. These strongly bound exciton states are observed to be stable even at room temperature. We reveal an exciton series that deviates substantially from hydrogen models, with a novel energy dependence on the orbital angular momentum. These excitonic energy levels are experimentally found to be robust against environmental perturbations. The discovery of excitonic dark states and exceptionally large binding energy not only sheds light on the importance of many-electron effects in this two-dimensional gapped system, but also holds potential for the device application of TMDC monolayers and their heterostructures(15) in computing, communication and bio-sensing.	[Ye, Ziliang; O'Brien, Kevin; Zhu, Hanyu; Yin, Xiaobo; Wang, Yuan; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr NSEC, Berkeley, CA 94720 USA; [Cao, Ting; Louie, Steven G.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Cao, Ting; Louie, Steven G.; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Zhang, Xiang] King Abdulaziz Univ, Dept Phys, Jeddah 21589, Saudi Arabia; [Zhang, Xiang] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94704 USA; [Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94704 USA	National Science Foundation (NSF); University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; King Abdulaziz University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr NSEC, 3112 Etcheverry Hall, Berkeley, CA 94720 USA.	sglouie@berkeley.edu; xzhang@me.berkeley.edu	Ye, Ziliang/AGU-2783-2022; Zhang, Xiang/F-6905-2011; Ye, Ziliang/A-2104-2011; Wang, Yuan/F-7211-2011; Cao, Ting/GPC-5837-2022; Yin, Xiaobo/A-4142-2011	Ye, Ziliang/0000-0001-8314-6977; Wang, Yuan/0000-0001-7892-2812; Cao, Ting/0000-0003-1300-6084; Zhu, Hanyu/0000-0003-3376-5352; Zhang, Xiang/0000-0002-3272-894X	Lawrence Berkeley National Laboratory through the Office of Basic Energy Sciences, US Department of Energy [DE-AC02-05CH11231]	Lawrence Berkeley National Laboratory through the Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE))	This research was supported by the Lawrence Berkeley National Laboratory through the Office of Basic Energy Sciences, US Department of Energy under contract no. DE-AC02-05CH11231: the experimental work was supported by Sub-wavelength Metamaterial Design, Physics and Applications Program, and the theory part was supported by the Theory Program (GW-BSE calculations and simulations) and by the SciDAC Program on Excited State Phenomena (computer codes and algorithm developments), with computer time provided by the DOE National Energy Research Scientific Computing Center (NERSC). Z.Y. acknowledges discussions with T. Ishihara and F. Wang.	BEAL AR, 1972, J PHYS PART C SOLID, V5, P3540, DOI 10.1088/0022-3719/5/24/016; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Cheiwchanchamnangij T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205302; Deslippe J, 2012, COMPUT PHYS COMMUN, V183, P1269, DOI 10.1016/j.cpc.2011.12.006; Deslippe J, 2009, NANO LETT, V9, P1330, DOI 10.1021/nl802957t; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; HYBERTSEN MS, 1986, PHYS REV B, V34, P5390, DOI 10.1103/PhysRevB.34.5390; ISHIHARA T, 1990, PHYS REV B, V42, P11099, DOI 10.1103/PhysRevB.42.11099; KELDYSH LV, 1979, JETP LETT+, V29, P658; Knox R S, 1963, THEORY EXCITONS; Kumar N, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.125427; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/NMAT3505, 10.1038/nmat3505]; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Malard LM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.201401; Maultzsch J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.241402; Qiu DY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.216805; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Ramasubramaniam A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115409; Rohlfing M, 2000, PHYS REV B, V62, P4927, DOI 10.1103/PhysRevB.62.4927; Ross JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2498; Scholes GD, 2006, NAT MATER, V5, P683, DOI 10.1038/nmat1714; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Ye Y, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4875959; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]	29	707	714	38	887	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					214	218		10.1038/nature13734	http://dx.doi.org/10.1038/nature13734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25162523	Green Published, Green Submitted			2022-12-28	WOS:000341362800046
J	Petrou, S; Fraser, J; Sidebotham, P				Petrou, Stavros; Fraser, James; Sidebotham, Peter			Child death in high-income countries	LANCET			English	Editorial Material							HEALTH-SERVICES; PREGNANT-WOMEN; INTERVENTIONS; VALIDATION; ENGLAND		[Petrou, Stavros] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Sidebotham, Peter] Univ Warwick, Div Mental Hlth & Well Being, Coventry CV4 7AL, W Midlands, England; [Fraser, James] Bristol Royal Hosp Children, Bristol, Avon, England	University of Warwick; University of Warwick; Bristol Royal Hospital For Children	Petrou, S (corresponding author), Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	s.petrou@warwick.ac.uk	Petrou, Stavros/ABD-8323-2021; Sidebotham, Peter D/E-3011-2010	Petrou, Stavros/0000-0003-3121-6050; Sidebotham, Peter D/0000-0003-4891-6926				Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Davies S., 2013, OUR CHILDREN DESERVE; Department of Health, 2011, SPOTT SICK CHILD; Fraser J, 2014, LANCET, V384, P894, DOI 10.1016/S0140-6736(13)61089-2; Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520; Harvey A, 2009, B WORLD HEALTH ORGAN, V87, P390, DOI 10.2471/BLT.08.059808; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Parshuram CS, 2011, CRIT CARE, V15, DOI 10.1186/cc10337; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Royal College of Paediatrics and Child Health, 2011, FAC FUT; Sidebotham P, 2014, LANCET, V384, P904, DOI 10.1016/S0140-6736(13)61090-9; Sidebotham P, 2014, LANCET, V384, P915, DOI 10.1016/S0140-6736(14)60581-X; Soll R, 2010, COCHRANE DB SYST REV, V1; Thangaratinam S, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16310; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6; Wolfe I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1277	20	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					831	833		10.1016/S0140-6736(14)61372-6	http://dx.doi.org/10.1016/S0140-6736(14)61372-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	25209471	Green Submitted			2022-12-28	WOS:000341362200004
J	Saito, MA; McIlvin, MR; Moran, DM; Goepfert, TJ; DiTullio, GR; Post, AF; Lamborg, CH				Saito, Mak A.; McIlvin, Matthew R.; Moran, Dawn M.; Goepfert, Tyler J.; DiTullio, Giacomo R.; Post, Anton F.; Lamborg, Carl H.			Multiple nutrient stresses at intersecting Pacific Ocean biomes detected by protein biomarkers	SCIENCE			English	Article							MARINE CYANOBACTERIA PROCHLOROCOCCUS; EQUATORIAL PACIFIC; GENE-EXPRESSION; IRON STRESS; SYNECHOCOCCUS; ECOTYPES; PHYTOPLANKTON; DISTRIBUTIONS; AVAILABILITY; TRANSDUCTION	Marine primary productivity is strongly influenced by the scarcity of required nutrients, yet our understanding of these nutrient limitations is informed by experimental observations with sparse geographical coverage and methodological limitations. We developed a quantitative proteomic method to directly assess nutrient stress in high-light ecotypes of the abundant cyanobacterium Prochlorococcus across a meridional transect in the central Pacific Ocean. Multiple peptide biomarkers detected widespread and overlapping regions of nutritional stress for nitrogen and phosphorus in the North Pacific Subtropical Gyre and iron in the equatorial Pacific. Quantitative protein analyses demonstrated simultaneous stress for these nutrients at biome interfaces. This application of proteomic biomarkers to diagnose ocean metabolism demonstrated Prochlorococcus actively and simultaneously deploying multiple biochemical strategies for low-nutrient conditions in the oceans.	[Saito, Mak A.; McIlvin, Matthew R.; Moran, Dawn M.; Goepfert, Tyler J.; Lamborg, Carl H.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [DiTullio, Giacomo R.] Coll Charleston, Charleston, SC 29401 USA; [Post, Anton F.] Marine Biol Lab, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; College of Charleston; Marine Biological Laboratory - Woods Hole	Saito, MA (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	msaito@whoi.edu	McIlvin, Matthew/ABB-4762-2020; Saito, Mak/ADT-4986-2022	Lamborg, Carl/0000-0003-4379-3904; Goepfert, Tyler/0000-0001-9328-8901	NSF [OCE-1031271, 1155566, 1233261]; Gordon Betty Moore Foundation [2724, 3782]; Center for Microbial Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Directorate For Geosciences [1233261, 1260233] Funding Source: National Science Foundation; Division Of Ocean Sciences [1220484] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Gordon Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Microbial Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was made possible by NSF grants OCE-1031271, 1155566, and 1233261 Gordon Betty Moore Foundation grants 2724 and 3782, the Center for Microbial Research and Education, and the Woods Hole Oceanographic Institution Ocean Life Institute. We are grateful to the captain and crew of the R/V Kilo Moana, particularly V. Polidoro for his resourcefulness. We thank N. Hawco, D. Wang, and P. Balcom for sampling assistance and J. Dusenberry for programming assistance. We thank A. Santoro, J. Waterbury, and P. Chivers for helpful discussions and J. Blethrow and V. Zabrouskov (Thermo Scientific) for analyses on the prototype Fusion. Data for the Metyme Expedition are available at www.bco-dmo.org.	Birkey SM, 1998, MOL MICROBIOL, V30, P943, DOI 10.1046/j.1365-2958.1998.01122.x; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Casey JR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028725; DITULLIO GR, 1993, LIMNOL OCEANOGR, V38, P495, DOI 10.4319/lo.1993.38.3.0495; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Gordon RM, 1997, LIMNOL OCEANOGR, V42, P419, DOI 10.4319/lo.1997.42.3.0419; Kamennaya NA, 2013, LIMNOL OCEANOGR, V58, P1959, DOI 10.4319/lo.2013.58.6.1959; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; LaRoche J, 1996, NATURE, V382, P802; Lindell D, 1998, J BACTERIOL, V180, P1878, DOI 10.1128/JB.180.7.1878-1886.1998; Lindell D, 2001, APPL ENVIRON MICROB, V67, P3340, DOI 10.1128/AEM.67.8.3340-3349.2001; Mann EL, 2000, LIMNOL OCEANOGR, V45, P1067, DOI 10.4319/lo.2000.45.5.1067; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Mary I, 2003, FEMS MICROBIOL LETT, V226, P135, DOI 10.1016/S0378-1097(03)00587-1; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Noble AE, 2008, DEEP-SEA RES PT II, V55, P1473, DOI 10.1016/j.dsr2.2008.02.010; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; Reygondeau G, 2013, GLOBAL BIOGEOCHEM CY, V27, P1046, DOI 10.1002/gbc.20089; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; Saito MA, 2002, LIMNOL OCEANOGR, V47, P1629, DOI 10.4319/lo.2002.47.6.1629; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Slemons LO, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003693; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Thompson AW, 2011, ISME J, V5, P1580, DOI 10.1038/ismej.2011.49; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Wawrik B, 2009, APPL ENVIRON MICROB, V75, P6662, DOI 10.1128/AEM.01002-09; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001	35	119	121	0	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1173	1177		10.1126/science.1256450	http://dx.doi.org/10.1126/science.1256450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190794				2022-12-28	WOS:000341179800045
J	Zhao, YH; Smith, JP; Strauss, J				Zhao, Yaohui; Smith, James P.; Strauss, John			Can China age healthily?	LANCET			English	Editorial Material									[Zhao, Yaohui] Peking Univ, Natl Sch Dev, Beijing 100871, Peoples R China; [Smith, James P.] RAND Corp, Labor & Populat, Santa Monica, CA USA; [Strauss, John] Univ So Calif, Dept Econ, Los Angeles, CA 90089 USA	Peking University; RAND Corporation; University of Southern California	Zhao, YH (corresponding author), Peking Univ, Natl Sch Dev, Beijing 100871, Peoples R China.	yaohuizhao@gmail.com		Zhao, Yaohui/0000-0002-9252-9715	NATIONAL INSTITUTE ON AGING [R01AG037031] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW008358] Funding Source: Medline; NIA NIH HHS [R21 AG031372, R01 AG037031] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CHARLS Research Team, 2013, CHALL POP AG CHIN EV; Kinsella K, 2009, INT POPULATION REPOR; Lei X, 2013, POP ASS AM ANN M NEW; Lei XY, 2014, J ECON AGEING, V3, P29, DOI 10.1016/j.jeoa.2014.05.001; National Bureau of Statistics, 2011, COMM PEOPL REP CHIN; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Smith JP, J EC AGEING IN PRESS; United Nations, 2013, WORLD POP AG 2013; Yang G, 2013, LANCET; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203	11	45	46	4	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					723	724		10.1016/S0140-6736(14)61292-7	http://dx.doi.org/10.1016/S0140-6736(14)61292-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25176535	Green Accepted			2022-12-28	WOS:000341361500009
J	Banks-Leite, C; Pardini, R; Tambosi, LR; Pearse, WD; Bueno, AA; Bruscagin, RT; Condez, TH; Dixo, M; Igari, AT; Martensen, AC; Metzger, JP				Banks-Leite, Cristina; Pardini, Renata; Tambosi, Leandro R.; Pearse, William D.; Bueno, Adriana A.; Bruscagin, Roberta T.; Condez, Thais H.; Dixo, Marianna; Igari, Alexandre T.; Martensen, Alexandre C.; Metzger, Jean Paul			Using ecological thresholds to evaluate the costs and benefits of set-asides in a biodiversity hotspot	SCIENCE			English	Article							HABITAT LOSS; EXTINCTION; BIRDS; SERVICES	Ecological set-asides are a promising strategy for conserving biodiversity in human-modified landscapes; however, landowner participation is often precluded by financial constraints. We assessed the ecological benefits and economic costs of paying landowners to set aside private land for restoration. Benefits were calculated from data on nearly 25,000 captures of Brazilian Atlantic Forest vertebrates, and economic costs were estimated for several restoration scenarios and values of payment for ecosystem services. We show that an annual investment equivalent to 6.5% of what Brazil spends on agricultural subsidies would revert species composition and ecological functions across farmlands to levels found inside protected areas, thereby benefiting local people. Hence, efforts to secure the future of this and other biodiversity hotspots may be cost-effective.	[Banks-Leite, Cristina] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Banks-Leite, Cristina; Tambosi, Leandro R.; Bruscagin, Roberta T.; Dixo, Marianna; Metzger, Jean Paul] Univ Sao Paulo, Inst Biociencias, Dept Ecol, BR-05508090 Sao Paulo, Brazil; [Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Dept Zool, BR-05508090 Sao Paulo, Brazil; [Pearse, William D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Bueno, Adriana A.] Fundacao Florestal, BR-02377000 Sao Paulo, Brazil; [Condez, Thais H.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, BR-13506900 Rio Claro, SP, Brazil; [Igari, Alexandre T.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Curso Gestao Ambiental, BR-03828000 Sao Paulo, Brazil; [Martensen, Alexandre C.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	Imperial College London; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Minnesota System; University of Minnesota Twin Cities; Universidade Estadual Paulista; Universidade de Sao Paulo; University of Toronto	Banks-Leite, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	c.banks@imperial.ac.uk	Banks-Leite, Cristina/D-3075-2011; Martensen, Alexandre Camargo/H-3180-2012; Tambosi, Leandro Reverberi/ABH-7869-2020; Pardini, Renata/C-4095-2012; IGARI, ALEXANDRE/P-1998-2014; Tambosi, Leandro R/B-2359-2013; Metzger, Jean Paul/C-2514-2012	Banks-Leite, Cristina/0000-0002-0091-2857; Martensen, Alexandre Camargo/0000-0001-9017-7480; Tambosi, Leandro Reverberi/0000-0001-5486-7310; Pardini, Renata/0000-0002-3769-8401; IGARI, ALEXANDRE/0000-0002-1382-5031; Tambosi, Leandro R/0000-0001-5486-7310; Metzger, Jean Paul/0000-0002-0087-5240; Pearse, William D/0000-0002-6241-3164	NERC [NE/H016228/1]; CNPq [306715/2011-2]; FAPESP [05/56555-4]; CNPq/BMBF [690144/01-6]; Marie Curie International Incoming Fellowship within 7th European Community Framework Programme; Natural Environment Research Council [NE/H016228/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/BMBF; Marie Curie International Incoming Fellowship within 7th European Community Framework Programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Didham, T. Gardner, R. Gill, and R. Ewers for comments on the manuscript. Supported by NERC grant NE/H016228/1 (C. B. L.), CNPq research fellowship 306715/2011-2 (R. P.), FAPESP grant 05/56555-4, CNPq/BMBF grant 690144/01-6, and a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme. This article is a contribution to Imperial College's Grand Challenges in Ecosystems and the Environment initiative. The data reported in this paper can be obtained by contacting the corresponding author, and the R code used in analyses is provided in the supplementary materials. C. B.-L., R. P., L. R. T., A. A. B., R. T. B., T. H. C., M. D., A. T. I., and A. C. M. carried out the data collection; C. B.-L., L. R. T., and W. D. P. analyzed the data; C. B.-L., R. P., L. R. T., W. D. P., and J.P.M. wrote the paper.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Banks-Leite C, 2011, J APPL ECOL, V48, P706, DOI 10.1111/j.1365-2664.2011.01966.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Edwards DP, 2013, CONSERV BIOL, V27, P1079, DOI 10.1111/cobi.12059; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Guedes FB, 2011, PAGAMENTOS SERVICOS; Lima MM, 2014, FOREST ECOL MANAG, V312, P260, DOI 10.1016/j.foreco.2013.09.003; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Melo FPL, 2013, ENVIRON SCI POLICY, V33, P395, DOI 10.1016/j.envsci.2013.07.013; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Milder JC, 2010, ECOL SOC, V15; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; Van Buskirk J, 2004, CONSERV BIOL, V18, P987, DOI 10.1111/j.1523-1739.2004.00359.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x	25	251	255	11	359	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1041	1045		10.1126/science.1255768	http://dx.doi.org/10.1126/science.1255768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170150				2022-12-28	WOS:000340870900037
J	Sedgwick, P				Sedgwick, Philip			Pitfalls of statistical hypothesis testing: multiple testing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4550; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4287; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4285; Wen LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3732	6	12	12	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2014	349								g5310	10.1136/bmj.g5310	http://dx.doi.org/10.1136/bmj.g5310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO2SA	25172184	Green Published			2022-12-28	WOS:000341174500004
J	Hu, SW; Shima, T; Hou, ZM				Hu, Shaowei; Shima, Takanori; Hou, Zhaomin			Carbon-carbon bond cleavage and rearrangement of benzene by a trinuclear titanium hydride	NATURE			English	Article							RARE-EARTH; HYDROGENATION; HYDROISOMERIZATION; CYCLOPENTADIENE; CONTRACTION; CATALYSTS; INSERTION; CLUSTERS; MONOXIDE; ARENE	The cleavage of carbon-carbon ( C-C) bonds by transition metals is of great interest, especially as this transformation can be used to produce fuels and other industrially important chemicals from natural resources such as petroleum and biomass. Carbon-carbon bonds are quite stable and are consequently unreactive under many reaction conditions. In the industrial naphtha hydrocracking process, the aromatic carbon skeleton of benzene can be transformed to methylcyclopentane and acyclic saturated hydrocarbons through C-C bond cleavage and rearrangement on the surfaces of solid catalysts(1-6). However, these chemical transformations usually require high temperatures and are fairly non-selective. Microorganisms can degrade aromatic compounds under ambient conditions, but the mechanistic details are not known and are difficult to mimic(7). Several transition metal complexes have been reported to cleave C-C bonds in a selective fashion in special circumstances, such as relief of ring strain, formation of an aromatic system, chelation-assisted cyclometallation and beta-carbon elimination(8-15). However, the cleavage of benzene by a transition metal complex has not been reported(16-19). Here we report the C-C bond cleavage and rearrangement of benzene by a trinuclear titanium poly-hydride complex. The benzene ring is transformed sequentially to a methylcyclopentenyl and a 2-methylpentenyl species through the cleavage of the aromatic carbon skeleton at the multi-titanium sites. Our results suggest that multinuclear titanium hydrides could serve as a unique platform for the activation of aromatic molecules, and may facilitate the design of new catalysts for the transformation of inactive aromatics.	[Hu, Shaowei; Shima, Takanori; Hou, Zhaomin] RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, Wako, Saitama 3510198, Japan; [Shima, Takanori; Hou, Zhaomin] RIKEN, Organometall Chem Lab, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Hou, ZM (corresponding author), RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	houz@riken.jp	Hou, Zhaomin/I-5981-2014; Hu, Shaowei/C-7982-2017; Shima, Takanori/C-8166-2017	Hou, Zhaomin/0000-0003-2841-5120; Shima, Takanori/0000-0003-1813-0439; Hu, Shaowei/0000-0002-7209-438X	JSPS [26810041, 26410082, 26220802]; RIKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN	This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 26810041), a Grant-in-Aid for Scientific Research (C) (no. 26410082) and a Grant-in-Aid for Scientific Research (S) (no. 26220802) from JSPS, and an Incentive Research Grant from RIKEN. We thank J. Cheng for help with X-ray structure analyses, and A. Karube for conducting elemental analyses.	Benitez VM, 2006, ENERG FUEL, V20, P1791, DOI 10.1021/ef060165e; BISHOP KC, 1976, CHEM REV, V76, P461, DOI 10.1021/cr60302a003; BROOKHART M, 1983, J ORGANOMET CHEM, V250, P395, DOI 10.1016/0022-328X(83)85065-7; Brown DB, 1997, J CHEM SOC DALTON, P1909, DOI 10.1039/a700990i; Bugg TDH, 1998, NAT PROD REP, V15, P513; CRABTREE RH, 1985, CHEM REV, V85, P245, DOI 10.1021/cr00068a002; Dyson PJ, 2003, DALTON T, P2964, DOI 10.1039/b303250g; Ellis D, 2010, ANGEW CHEM INT EDIT, V49, P4943, DOI 10.1002/anie.201001555; Jones D. S. J. S., 2006, HDB PETROLEUM PROCES; JONES WD, 1993, NATURE, V364, P676, DOI 10.1038/364676a0; Jun CH, 2004, CHEM SOC REV, V33, P610, DOI 10.1039/b308864m; Kazakov MO, 2010, KINET CATAL+, V51, P438, DOI 10.1134/S0023158410030171; Kira M, 2002, J AM CHEM SOC, V124, P3830, DOI 10.1021/ja025522o; McVicker GB, 2002, J CATAL, V210, P137, DOI 10.1006/jcat.2002.3685; Murakami M, 2011, CHEM COMMUN, V47, P1100, DOI 10.1039/c0cc02566f; Nishiura M, 2010, NAT CHEM, V2, P257, DOI 10.1038/nchem.595; Ruhland K, 2012, EUR J ORG CHEM, V2012, P2683, DOI 10.1002/ejoc.201101616; Rybtchinski B, 1999, ANGEW CHEM INT EDIT, V38, P870, DOI 10.1002/(SICI)1521-3773(19990401)38:7<870::AID-ANIE870>3.0.CO;2-3; Sattler A, 2010, NATURE, V463, P523, DOI 10.1038/nature08730; Shima T, 2006, J AM CHEM SOC, V128, P8124, DOI 10.1021/ja062348l; Shima T, 2013, SCIENCE, V340, P1549, DOI 10.1126/science.1238663; Shima T, 2011, NAT CHEM, V3, P814, DOI [10.1038/NCHEM.1147, 10.1038/nchem.1147]; SUZUKI H, 1994, J AM CHEM SOC, V116, P10779, DOI 10.1021/ja00102a051; Szyszko B, 2011, ANGEW CHEM INT EDIT, V50, P6587, DOI 10.1002/anie.201102218; Takao T, 2012, COORDIN CHEM REV, V256, P695, DOI 10.1016/j.ccr.2011.10.024; Takao T, 2011, ORGANOMETALLICS, V30, P5057, DOI 10.1021/om200728e; Tardif O, 2004, J AM CHEM SOC, V126, P8080, DOI 10.1021/ja047889u; VANHOVE MA, 1986, J AM CHEM SOC, V108, P2532, DOI 10.1021/ja00270a007; Watanabe R, 2001, CATAL TODAY, V66, P123, DOI 10.1016/S0920-5861(00)00612-X; Weitkamp J., 2008, HDB HETEROGENEOUS CA, V1	30	90	91	8	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					413	415		10.1038/nature13624	http://dx.doi.org/10.1038/nature13624			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164752				2022-12-28	WOS:000340840600029
J	Muerdter, F; Stark, A				Muerdter, Felix; Stark, Alexander			GENOMICS Hiding in plain sight	NATURE			English	Editorial Material							DNA ELEMENTS; ENCYCLOPEDIA; MODENCODE; ENHANCERS; PROJECT; REGIONS		[Muerdter, Felix; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Muerdter, F (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	stark@starklab.org	Dodson, Thomas Benton/L-6406-2019; Stark, Alexander/D-1473-2012	Dodson, Thomas Benton/0000-0002-4659-8322; Muerdter, Felix/0000-0002-0840-2544; Stark, Alexander/0000-0003-2611-0841				Araya CL, 2014, NATURE, V512, P400, DOI 10.1038/nature13497; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Furlong EEM, 2011, NATURE, V471, P458, DOI 10.1038/471458a; Gerstein MB, 2014, NATURE, V512, P445, DOI 10.1038/nature13424; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Kwasnieski J. C., 2014, GENOME RES; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	20	2	2	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					374	375		10.1038/512374a	http://dx.doi.org/10.1038/512374a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164742				2022-12-28	WOS:000340840600017
J	King, G; Pan, J; Roberts, ME				King, Gary; Pan, Jennifer; Roberts, Margaret E.			Reverse-engineering censorship in China: Randomized experimentation and participant observation	SCIENCE			English	Article							FEDERALISM	Existing research on the extensive Chinese censorship organization uses observational methods with well-known limitations. We conducted the first large-scale experimental study of censorship by creating accounts on numerous social media sites, randomly submitting different texts, and observing from a worldwide network of computers which texts were censored and which were not. We also supplemented interviews with confidential sources by creating our own social media site, contracting with Chinese firms to install the same censoring technologies as existing sites, and-with their software, documentation, and even customer support-reverse-engineering how it all works. Our results offer rigorous support for the recent hypothesis that criticisms of the state, its leaders, and their policies are published, whereas posts about real-world events with collective action potential are censored.	[King, Gary] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Pan, Jennifer; Roberts, Margaret E.] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA	University of California System; University of California San Diego; Harvard University	King, G (corresponding author), Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA.	king@harvard.edu						Al-Jazeera, 2013, DEMOCRACY PUSH HONG; Bamman David, 2012, First Monday, V17, DOI 10.5210/fm.v17i3.3943; Barefoot P., 2013, CHINA SMACK     0531; Blanchard O., 2000, FEDERALISM POLITICAL; Chen X, 2012, SOCIAL PROTEST CONTE; Crandall Jedidiah R., 2013, First Monday, V18, P121, DOI 10.5210/fm.v18i7.4628; Dimitrov M, 2008, CURR HIST, V107, P24; Distelhorst G, 2014, Q J POLIT SCI, V9, P203, DOI 10.1561/100.00013110; Egorov G, 2011, J EUR ECON ASSOC, V9, P903, DOI 10.1111/j.1542-4774.2011.01033.x; Esarey A, 2008, ASIAN SURV, V48, P752, DOI 10.1525/AS.2008.48.5.752; Fallows James, 2008, ATLANTIC; Freedom House, FREED PRESS 2012; Fu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058356; Hong K., 2013, THE NEXT WEB    0813; Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414; Kelleher D, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1608; King G., 2014, REPLICATION DATA REV, DOI [10.7910/DVN/26212, DOI 10.7910/DVN/26212]; King G, 2013, AM POLIT SCI REV, V107, P326, DOI 10.1017/S0003055413000014; Lee S., 2013, BLOOMBERG BUSINESSWE; Lorentzen P, 2014, AM J POLIT SCI, V58, P402, DOI 10.1111/ajps.12065; Lorentzen PL, 2013, Q J POLIT SCI, V8, P127, DOI 10.1561/100.00012051; MacKinnon, 2012, CONSENT NETWORKED WO; MacKinnon Rebecca, 2009, 1 MONDAY, V2, DOI [10.5210/fm.v14i2.2378, DOI 10.5210/FM.V14I2.2378]; Malesky E, 2010, AM POLIT SCI REV, V104, P482, DOI 10.1017/S0003055410000250; Marolt P, 2011, MEDIA CULT SOC CHANG, V25, P53; Millward S., 2013, TECH IN ASIA    0122; Ng J. Q., 2013, TEA LEAF NATION 0621; Ngo J, 2013, S CHINA MORNING POST; Pearl J., 2001, P 17 C UNC ART INT, P411, DOI DOI 10.5555/2074022.2074073; Perry E., 2011, MAOS INVISIBLE HAND, P30; Qian YY, 1997, J ECON PERSPECT, V11, P83, DOI 10.1257/jep.11.4.83; Qian YY, 1998, AM ECON REV, V88, P1143; Salton G, 1988, AUTOMATIC TEXT PROCE; Shirk SusanL., 2008, CHINA FRAGILE SUPERP; Shirk SusanL., 2011, CHANGING MEDIA CHANG; Whyte M., 2010, MYTH SOCIAL VOLCANO; Yung C., 2013, WALL STREET J; Zhang L., 2002, THE TIANANMEN PAPERS; Zhu T., 2013, 22 USENIX SEC S	41	136	139	10	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					891	+	1251722	10.1126/science.1251722	http://dx.doi.org/10.1126/science.1251722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB6ZO	25146296	Green Submitted			2022-12-28	WOS:000349775800002
J	Fatkenheuer, G; Hirschel, B; Harbarth, S				Faetkenheuer, Gerd; Hirschel, Bernard; Harbarth, Stephan			Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence	LANCET			English	Editorial Material							INTERRUPTED TIME-SERIES; INTENSIVE-CARE UNITS; OF-THE-LITERATURE; SURGICAL-PATIENTS; CONTACT ISOLATION; INFECTION-CONTROL; RANDOMIZED-TRIAL; IMPACT; ACQUISITION; HOSPITALS		[Faetkenheuer, Gerd] Univ Hosp Cologne, Dept Internal Med 1, D-50937 Cologne, Germany; [Faetkenheuer, Gerd] German Ctr Infect Res DZIF, Bonn, Germany; [Hirschel, Bernard] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Hirschel, Bernard; Harbarth, Stephan] Fac Med, Geneva, Switzerland; [Harbarth, Stephan] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland	University of Cologne; German Center for Infection Research; University of Geneva; University of Geneva; University of Geneva	Fatkenheuer, G (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany.	g.faetkenheuer@uni-koeln.de						Bessesen MT, 2013, AM J INFECT CONTROL, V41, P1048, DOI 10.1016/j.ajic.2013.01.032; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Derde LPG, 2014, LANCET INFECT DIS, V14, P31, DOI 10.1016/S1473-3099(13)70295-0; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Glick SB, 2014, AM J INFECT CONTROL, V42, P148, DOI 10.1016/j.ajic.2013.07.020; Gurieva T, 2012, CLIN INFECT DIS, V54, P1618, DOI 10.1093/cid/cis272; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Kirkland KB, 2012, BMJ QUAL SAF, V21, P1019, DOI 10.1136/bmjqs-2012-000800; Lee AS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003126; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; Lee AS, 2011, INFECT DIS CLIN N AM, V25, P155, DOI 10.1016/j.idc.2010.11.002; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; McGinigle KL, 2008, CLIN INFECT DIS, V46, P1717, DOI 10.1086/587901; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1016/S0196-6553(02)48250-8; Sroka S, 2010, J HOSP INFECT, V74, P204, DOI 10.1016/j.jhin.2009.08.023; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Zingg W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093898	29	47	48	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1146	1149		10.1016/S0140-6736(14)60660-7	http://dx.doi.org/10.1016/S0140-6736(14)60660-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25150745				2022-12-28	WOS:000351270400033
J	Rid, A; Emanuel, EJ				Rid, Annette; Emanuel, Ezekiel J.			Ethical considerations of experimental interventions in the Ebola outbreak	LANCET			English	Editorial Material									[Rid, Annette] Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine	Rid, A (corresponding author), Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England.	annette.rid@kcl.ac.uk						Arie S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4997; Bernstein L, 2014, WASHINGTON POST; Calain P, 2009, PUBLIC HEALTH ETH-UK, V2, P7, DOI 10.1093/phe/phn037; Edwards SJL, 2013, AM J BIOETHICS, V13, P3, DOI 10.1080/15265161.2013.813597; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Fink S., 2014, NY TIMES; Ford Nathan, 2009, Confl Health, V3, P7, DOI 10.1186/1752-1505-3-7; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Institute for Health Metrics and Evaluation, GLOB BURD DIS DAT; IPBES (Intergovernmental Panel on Biodiversity and Ecosystems), 2021, POLICY DISCUSSION PA; Lenzer Jeanne, 2006, BMJ, V332, P1233, DOI 10.1136/bmj.332.7552.1233-a; London Alex John, 2009, Seton Hall Law Rev, V39, P1173; Medecins Sans Frontieres, 2013, RES ETH FRAM GUID DO; Millum J, 2012, GLOBAL JUSTICE BIOET; National Health Research Ethics Committee Nigeria, 2014, STAT US INN NONV MED; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Pollack A., 2014, NY TIMES; Rid A, 2011, KENNEDY INST ETHIC J, V21, P141; Schopper D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000115; UNDP, HUM DEV REP 2014 SUS; VIENS AM, 2013, EMERGENCY RES ETHICS; WHO, 2014, ETH CONS US UNR INT; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, EB VIR DIS; World Health Organization, 2014, WHO STAT M INT HLTH; World Health Organization, 2010, RES ETH INT EP RESP	28	82	87	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1896	1899		10.1016/S0140-6736(14)61315-5	http://dx.doi.org/10.1016/S0140-6736(14)61315-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	25155413				2022-12-28	WOS:000345116800030
J	Gillespie, SH; Crook, AM; McHugh, TD; Mendel, CM; Meredith, SK; Murray, SR; Pappas, F; Phillips, PPJ; Nunn, AJ				Gillespie, Stephen H.; Crook, Angela M.; McHugh, Timothy D.; Mendel, Carl M.; Meredith, Sarah K.; Murray, Stephen R.; Pappas, Frances; Phillips, Patrick P. J.; Nunn, Andrew J.		REMoxTB Consortium	Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY TUBERCULOSIS; BACTERICIDAL ACTIVITY; RESISTANT TUBERCULOSIS; MURINE TUBERCULOSIS; RANDOMIZED-TRIAL; PHASE-II; GATIFLOXACIN; PHARMACOKINETICS; ETHAMBUTOL; RELAPSE	BACKGROUND Early-phase and preclinical studies suggest that moxifloxacin-containing regimens could allow for effective 4-month treatment of uncomplicated, smear-positive pulmonary tuberculosis. METHODS We conducted a randomized, double-blind, placebo-controlled, phase 3 trial to test the noninferiority of two moxifloxacin-containing regimens as compared with a control regimen. One group of patients received isoniazid, rifampin, pyrazinamide, and ethambutol for 8 weeks, followed by 18 weeks of isoniazid and rifampin (control group). In the second group, we replaced ethambutol with moxifloxacin for 17 weeks, followed by 9 weeks of placebo (isoniazid group), and in the third group, we replaced isoniazid with moxifloxacin for 17 weeks, followed by 9 weeks of placebo (ethambutol group). The primary end point was treatment failure or relapse within 18 months after randomization. RESULTS Of the 1931 patients who underwent randomization, in the per-protocol analysis, a favorable outcome was reported in fewer patients in the isoniazid group (85%) and the ethambutol group (80%) than in the control group (92%), for a difference favoring the control group of 6.1 percentage points (97.5% confidence interval [CI], 1.7 to 10.5) versus the isoniazid group and 11.4 percentage points (97.5% CI, 6.7 to 16.1) versus the ethambutol group. Results were consistent in the modified intention-to-treat analysis and all sensitivity analyses. The hazard ratios for the time to culture negativity in both solid and liquid mediums for the isoniazid and ethambutol groups, as compared with the control group, ranged from 1.17 to 1.25, indicating a shorter duration, with the lower bounds of the 95% confidence intervals exceeding 1.00 in all cases. There was no significant difference in the incidence of grade 3 or 4 adverse events, with events reported in 127 patients (19%) in the isoniazid group, 111 (17%) in the ethambutol group, and 123 (19%) in the control group. CONCLUSIONS The two moxifloxacin-containing regimens produced a more rapid initial decline in bacterial load, as compared with the control group. However, noninferiority for these regimens was not shown, which indicates that shortening treatment to 4 months was not effective in this setting. (Funded by the Global Alliance for TB Drug Development and others; REMoxTB ClinicalTrials.gov number, NCT00864383.)	[Gillespie, Stephen H.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Crook, Angela M.; Meredith, Sarah K.; Phillips, Patrick P. J.; Nunn, Andrew J.] UCL, Med Res Council Clin Trials Unit, London, England; [McHugh, Timothy D.] UCL, Div Infect & Immun, London, England; [Mendel, Carl M.; Murray, Stephen R.; Pappas, Frances] TB Alliance, New York, NY USA	University of St Andrews; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London	Gillespie, SH (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland.	shg3@st-andrews.ac.uk	Yorke-Edwards, Victoria/AAA-2942-2019; McHugh, Timothy D/AAF-7231-2020; McHugh, Timothy/O-3683-2019; Trajman, Anete/C-7679-2016; Phillips, Patrick/B-6347-2008	Yorke-Edwards, Victoria/0000-0002-6465-7330; McHugh, Timothy D/0000-0003-4658-8594; Trajman, Anete/0000-0002-4000-4984; Murphy, Michael E/0000-0002-3161-6612; Gillespie, Stephen/0000-0001-6537-7712; Miheso, Barbara/0000-0001-6056-4199; Pym, Alexander/0000-0002-6260-8180; Charalambous, Salome/0000-0001-7143-1009; Nunn, Andrew/0000-0002-9158-4595; Phillips, Patrick/0000-0002-6336-7024; Zumla, Professor Sir Alimuddin/0000-0002-5111-5735	Global Alliance for TB Drug Development; Bill and Melinda Gates Foundation; European and Developing Countries Clinical Trials Partnership; U.S. Agency for International Development; U.K. Department for International Development; Directorate General for International Cooperation of the Netherlands; Irish Aid; Australia Department of Foreign Affairs and Trade; National Institutes of Health, AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID) [UM1AI068634, UM1 AI068636, UM1AI106701]; NIAID [1U01AI069469, 1U01AI069453, 1U01AI069426]; Medical Research Council [MC_U122888469] Funding Source: researchfish; MRC [MC_U122888469] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069469, UM1AI068636, UM1AI068634, UM1AI106701, U01AI069453, U01AI069426] Funding Source: NIH RePORTER	Global Alliance for TB Drug Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European and Developing Countries Clinical Trials Partnership; U.S. Agency for International Development(United States Agency for International Development (USAID)); U.K. Department for International Development; Directorate General for International Cooperation of the Netherlands; Irish Aid(CGIAR); Australia Department of Foreign Affairs and Trade; National Institutes of Health, AIDS Clinical Trials Group(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Global Alliance for TB Drug Development with support from the Bill and Melinda Gates Foundation, the European and Developing Countries Clinical Trials Partnership, U.S. Agency for International Development, U.K. Department for International Development, Directorate General for International Cooperation of the Netherlands, Irish Aid, Australia Department of Foreign Affairs and Trade, and National Institutes of Health, AIDS Clinical Trials Group and by grants from the National Institute of Allergy and Infectious Diseases (NIAID) (UM1AI068634, UM1 AI068636, and UM1AI106701) and by NIAID grants to the University of KwaZulu Natal, South Africa, AIDS Clinical Trials Group (ACTG) site 31422 (1U01AI069469); to the Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, South Africa, ACTG site 12301 (1U01AI069453); and to the Durban International Clinical Trials Unit, South Africa, ACTG site 11201 (1U01AI069426); Bayer Healthcare for the donation of moxifloxacin; and Sanofi for the donation of rifampin.	Aber V R, 1978, Bull Int Union Tuberc, V53, P276; [Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P733; Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; EAST AFRICAN/BRITISH MEDICAL RESEARCH COUNCILS STUDY, 1981, American Review of Respiratory Disease, V123, P165; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gillespie SH, 1999, J ANTIMICROB CHEMOTH, V44, P393, DOI 10.1093/jac/44.3.393; Ginsberg AM, 2010, TUBERCULOSIS, V90, P162, DOI 10.1016/j.tube.2010.03.003; Gosling RD, 2003, AM J RESP CRIT CARE, V168, P1342, DOI 10.1164/rccm.200305-682OC; Grossman RF, 2014, INT J INFECT DIS, V18, P14, DOI 10.1016/j.ijid.2013.09.013; Jindani A., 2013, 41 WORLD C LUNG HLTH; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Lubasch A, 2000, ANTIMICROB AGENTS CH, V44, P2600, DOI 10.1128/AAC.44.10.2600-2603.2000; Merle CS, 2013, 41 WORLD C LUNG HLTH; Miyazaki E, 1999, ANTIMICROB AGENTS CH, V43, P85, DOI 10.1128/AAC.43.1.85; Muller M, 1999, ANTIMICROB AGENTS CH, V43, P2345, DOI 10.1128/AAC.43.10.2345; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Nunn AJ, 2011, INT J TUBERC LUNG D, V15, P741, DOI 10.5588/ijtld.10.0392; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Phillips PPJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063840; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P780, DOI 10.1128/AAC.48.3.780-782.2004; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; *SING TUB SERV BRI, 1981, TUBERCLE, V62, P95; Sullivan JT, 1999, ANTIMICROB AGENTS CH, V43, P2793, DOI 10.1128/AAC.43.11.2793	30	408	417	2	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1577	1587		10.1056/NEJMoa1407426	http://dx.doi.org/10.1056/NEJMoa1407426			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25196020	Green Accepted, Green Published			2022-12-28	WOS:000343648500006
J	Graetz, I; Kaplan, CM; Kaplan, EK; Bailey, JE; Waters, TM				Graetz, Ilana; Kaplan, Cameron M.; Kaplan, Erin K.; Bailey, James E.; Waters, Teresa M.			The US Health Insurance Marketplace: Are Premiums Truly Affordable?	ANNALS OF INTERNAL MEDICINE			English	Article								The Patient Protection and Affordable Care Act requires that individuals have health insurance or pay a penalty. Individuals are exempt from paying this penalty if the after-subsidy cost of the least-expensive plan available to them is greater than 8% of their income. For this study, premium data for all health plans offered on the state and federal health insurance marketplaces were collected; the after-subsidy cost of premiums for the least-expensive bronze plan for every county in the United States was calculated; and variations in premium affordability by age, income, and geographic area were assessed. Results indicated that-although marketplace subsidies ensure affordable health insurance for most persons in the United States-many individuals with incomes just above the subsidy threshold will lack affordable coverage and will be exempt from the mandate. Furthermore, young individuals with low incomes often pay as much as or more than older individuals for bronze plans. If substantial numbers of younger, healthier adults choose to remain uninsured because of cost, health insurance premiums across all ages may increase over time.	Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Rhodes Coll, Memphis, TN 38112 USA	University of Tennessee System; University of Tennessee Health Science Center	Graetz, I (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, 66 North Pauline St,Suite 633, Memphis, TN 38163 USA.	igraetz@uthsc.edu	Graetz, Ilana/N-1189-2016; Kaplan, Cameron/AAJ-2895-2020; Kaplan, Cameron M./I-6014-2019	Graetz, Ilana/0000-0003-3664-5815; Kaplan, Cameron M./0000-0001-6430-6816; Waters, Teresa/0000-0002-3823-5177				Centers for Medicare & Medicaid Services, 2013, STAT SPEC AG CURV VA; Centers for Medicare & Medicaid Services, 2013, HEALTHCARE GOV HLTH; Crowley RA, 2013, ANN INTERN MED, V159, P784, DOI 10.7326/0003-4819-159-10-201311190-00724; Gresenz CR, 2011, J HEALTH POLIT POLIC, V36, P859, DOI 10.1215/03616878-1407658; Kaplan CM, 2014, HEALTH AFFAIR, V33, P1466, DOI 10.1377/hlthaff.2013.1338; Saloner B, 2011, J HEALTH POLIT POLIC, V36, P815, DOI 10.1215/03616878-1407631	6	8	8	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					599	U104		10.7326/M14-0757	http://dx.doi.org/10.7326/M14-0757			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25199512				2022-12-28	WOS:000343906800023
J	Johnston, DT; Gill, BC; Masterson, A; Beirne, E; Casciotti, KL; Knapp, AN; Berelson, W				Johnston, D. T.; Gill, B. C.; Masterson, A.; Beirne, E.; Casciotti, K. L.; Knapp, A. N.; Berelson, W.			Placing an upper limit on cryptic marine sulphur cycling	NATURE			English	Article							BACTERIAL SULFATE REDUCTION; OXYGEN ISOTOPIC COMPOSITION; PORE-WATER SULFATE; ORGANIC-MATTER; DEEP BIOSPHERE; STABLE SULFUR; FRACTIONATION; NITRATE; DENITRIFICATION; RATES	A quantitative understanding of sources and sinks of fixed nitrogen in low-oxygen waters is required to explain the role of oxygen-minimum zones (OMZs) in controlling the fixed nitrogen inventory of the global ocean. Apparent imbalances in geochemical nitrogen budgets(1) have spurred numerous studies to measure the contributions of heterotrophic and autotrophic N-2-producing metabolisms(denitrification and anaerobic ammonia oxidation, respectively)(2,3). Recently, 'cryptic' sulphur cycling was proposed as a partial solution to the fundamental biogeochemical problem of closing marine fixed-nitrogen budgets in intensely oxygen-deficient regions(4). The degree to which the cryptic sulphur cycle can fuel a loss of fixed nitrogen in the modern ocean requires the quantification of sulphur recycling in OMZ settings. Here we provide a new constraint for OMZ sulphate reduction based on isotopic profiles of oxygen (O-18/O-16) and sulphur (S-33/S-32, S-34/S-32) in seawater sulphate through oxygenated open-ocean and OMZ-bearing water columns. When coupled with observations and models of sulphate isotope dynamics and data-constrained model estimates of OMZ water-mass residence time, we find that previous estimates for sulphur-driven remineralization and loss of fixed nitrogen from the oceans are near the upper limit for what is possible given in situ sulphate isotope data.	[Johnston, D. T.; Masterson, A.; Beirne, E.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Gill, B. C.] Virginia Tech Univ, Dept Geosci, Blacksburg, VA 24061 USA; [Casciotti, K. L.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Knapp, A. N.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Berelson, W.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Harvard University; Virginia Polytechnic Institute & State University; Stanford University; State University System of Florida; Florida State University; University of Southern California	Johnston, DT (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.	johnston@eps.harvard.edu	Gill, Benjamin C/B-8047-2012; Knapp, Angela N/A-2194-2009	Gill, Benjamin C/0000-0001-7402-0811; Knapp, Angela N/0000-0001-5575-3382; Casciotti, Karen/0000-0002-5286-7795; Masterson, Andrew/0000-0002-3422-2985	National Science Foundation (NSF) Division of Ocean Sciences; Harvard University; Agouron Institute; NSF EAR-I/F; NSF/OCE [1140404, 0850905]	National Science Foundation (NSF) Division of Ocean Sciences(National Science Foundation (NSF)); Harvard University; Agouron Institute(Pfizer); NSF EAR-I/F(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF/OCE(National Science Foundation (NSF))	We thank the Johnston laboratory, B. Chang, S. Wankel, D. Canfield and J. Granger for discussions and comments; D. Capone and M. Prokopenko for sample collection (all supported by National Science Foundation (NSF) Division of Ocean Sciences); and G. Henderson, W. Homoky and GEOTRACES. Funding was provided by Harvard University (D. T. J., A. M.), the Agouron Institute (D. T. J., B. C. G.) and the NSF EAR-I/F (D. T. J., E. B.) and NSF/OCE grant nos 1140404 (K. L. C.) and 0850905 (A.N.K.).	Aharon P, 2000, GEOCHIM COSMOCHIM AC, V64, P233, DOI 10.1016/S0016-7037(99)00292-6; Aharon P, 2003, CHEM GEOL, V195, P201, DOI 10.1016/S0009-2541(02)00395-9; Aller RC, 2010, GEOCHIM COSMOCHIM AC, V74, P4671, DOI 10.1016/j.gca.2010.05.008; Antler G, 2013, GEOCHIM COSMOCHIM AC, V118, P98, DOI 10.1016/j.gca.2013.05.005; Bottcher ME, 1998, ORG GEOCHEM, V29, P1517, DOI 10.1016/S0146-6380(98)00124-7; Bottcher ME, 1999, ISOT ENVIRON HEALT S, V35, P39, DOI 10.1080/10256019908234078; Brand WA, 2009, RAPID COMMUN MASS SP, V23, P999, DOI 10.1002/rcm.3958; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4773, DOI 10.1016/j.gca.2005.04.017; Canfield D. E., 2005, AQUATIC GEOMICROBIOL, DOI [10.1515/9781501509551, DOI 10.1515/9781501509551]; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Casciotti KL, 2013, DEEP-SEA RES PT I, V80, P78, DOI 10.1016/j.dsr.2013.05.017; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CORTECCI G, 1974, NATURE, V250, P134, DOI 10.1038/250134a0; DeVries T, 2013, BIOGEOSCIENCES, V10, P2481, DOI 10.5194/bg-10-2481-2013; DeVries T, 2012, NAT GEOSCI, V5, P547, DOI [10.1038/ngeo1515, 10.1038/NGEO1515]; Farquhar J, 2008, GEOCHIM COSMOCHIM AC, V72, P2805, DOI 10.1016/j.gca.2008.03.013; FORREST J, 1977, ANAL CHEM, V49, P1579, DOI 10.1021/ac50019a030; FRITZ P, 1989, CHEM GEOL, V79, P99, DOI 10.1016/0168-9622(89)90012-2; GARSIDE C, 1982, MAR CHEM, V11, P159, DOI 10.1016/0304-4203(82)90039-1; Granger J, 2009, RAPID COMMUN MASS SP, V23, P3753, DOI 10.1002/rcm.4307; Johnston DT, 2011, EARTH-SCI REV, V106, P161, DOI 10.1016/j.earscirev.2011.02.003; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Knoller K, 2008, ENVIRON SCI TECHNOL, V42, P7807, DOI 10.1021/es800331p; Ku TCW, 1999, GEOCHIM COSMOCHIM AC, V63, P2529, DOI 10.1016/S0016-7037(99)00115-5; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Leavitt WD, 2013, P NATL ACAD SCI USA, V110, P11244, DOI 10.1073/pnas.1218874110; LLOYD RM, 1967, SCIENCE, V156, P1228, DOI 10.1126/science.156.3779.1228; LONGINELLI A, 1967, SCIENCE, V156, P56, DOI 10.1126/science.156.3771.56; LONGINELLI A, 1989, HDB ENV ISOTOPE GEOC, V3, P219; Mandernack KW, 2003, CHEM GEOL, V195, P181, DOI 10.1016/S0009-2541(02)00394-7; Mangalo M, 2007, GEOCHIM COSMOCHIM AC, V71, P4161, DOI 10.1016/j.gca.2007.06.058; McIlvin MR, 2011, ANAL CHEM, V83, P1850, DOI 10.1021/ac1028984; Mikucki JA, 2009, SCIENCE, V324, P397, DOI 10.1126/science.1167350; MIZUTANI Y, 1969, NEW ZEAL J SCI, V12, P60; Muller IA, 2013, GEOCHIM COSMOCHIM AC, V120, P562, DOI 10.1016/j.gca.2013.06.037; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Saito MA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002216; Schunck H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068661; Sigman D. M., 2005, GLOB BIOGEOCHEM CYCL, V19; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Strickland JDH., 1972, J FISH RES BOARD CAN; Turchyn AV, 2006, GEOBIOLOGY, V4, P191, DOI 10.1111/j.1472-4669.2006.00079.x; Turchyn AV, 2004, SCIENCE, V303, P2004, DOI 10.1126/science.1092296; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Wankel SD, 2014, GEOCHIM COSMOCHIM AC, V125, P694, DOI 10.1016/j.gca.2013.08.039; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Wortmann UG, 2001, GEOLOGY, V29, P647, DOI 10.1130/0091-7613(2001)029<0647:HDBIES>2.0.CO;2; Wortmann UG, 2007, GEOCHIM COSMOCHIM AC, V71, P4221, DOI 10.1016/j.gca.2007.06.033; Zak I., 1980, ISOTOPE MARINE CHEM, P339; Zamora LM, 2012, BIOGEOSCIENCES, V9, P5007, DOI 10.5194/bg-9-5007-2012	55	67	68	1	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					530	+		10.1038/nature13698	http://dx.doi.org/10.1038/nature13698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25209667				2022-12-28	WOS:000342075800036
J	Mugele, J; Priest, C				Mugele, Josh; Priest, Chad			A Good Death - Ebola and Sacrifice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mugele, Josh; Priest, Chad] Indiana Univ, Sch Med, Napolis, India; [Priest, Chad] Indiana Univ, Sch Nursing, Napolis, India		Mugele, J (corresponding author), Indiana Univ, Sch Med, Napolis, India.			Priest, Chad/0000-0002-4701-3402				Sokol DK, 2006, EMERG INFECT DIS, V12, P1238, DOI 10.3201/eid1708.060360	1	10	10	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1185	1187		10.1056/NEJMp1410301	http://dx.doi.org/10.1056/NEJMp1410301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25184515				2022-12-28	WOS:000342079700005
J	DeLong, MR; Benabid, AL				DeLong, Mahlon R.; Benabid, Alim-Louis			Discovery of High-Frequency Deep Brain Stimulation for Treatment of Parkinson Disease 2014 Lasker Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUBTHALAMIC NUCLEUS; THALAMIC NUCLEUS		[DeLong, Mahlon R.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Benabid, Alim-Louis] Grenoble Univ Hosp, Dept Neurol & Neurosurg, Grenoble, France; [Benabid, Alim-Louis] Univ Grenoble 1, INSERM, U318, Grenoble, France	Emory University; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	DeLong, MR (corresponding author), Emory Univ, Sch Med, Dept Neurol, 101 Woodruff Circle,WMRB 6313, Atlanta, GA 30322 USA.	medmrd@emory.edu	Benabid, Alim L/Q-3506-2017					BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Wichmann T, 2011, MOVEMENT DISORD, V26, P1032, DOI 10.1002/mds.23695	6	29	30	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1093	1094		10.1001/jama.2014.11132	http://dx.doi.org/10.1001/jama.2014.11132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25198255				2022-12-28	WOS:000341624700014
J	Giovannoni, S; Nemergut, D				Giovannoni, Stephen; Nemergut, Diana			Microbes ride the current	SCIENCE			English	Editorial Material							BIOGEOGRAPHY; EVERYWHERE; PATTERNS		[Giovannoni, Stephen] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Nemergut, Diana] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Nemergut, Diana] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, Boulder, CO 80309 USA	Oregon State University; Duke University; University of Colorado System; University of Colorado Boulder	Giovannoni, S (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu						Aguilar M, 2014, ISME J, V8, P737, DOI 10.1038/ismej.2013.183; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Hellweger FL, 2014, SCIENCE, V345, P1346, DOI 10.1126/science.1254421; Hu XS, 2006, OIKOS, V113, P548, DOI 10.1111/j.2006.0030-1299.14837.x; Hubbell S.P., 2001, MG POP BIOL, V32; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111	15	9	9	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1246	1247		10.1126/science.1259467	http://dx.doi.org/10.1126/science.1259467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214592				2022-12-28	WOS:000341483800020
J	Ferrari, R				Ferrari, Raffaele			OCEANOGRAPHY What goes down must come up	NATURE			English	Editorial Material							CIRCULATION; OCEAN		Massachusetts Inst Oceanog, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA		Ferrari, R (corresponding author), Massachusetts Inst Oceanog, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	rferrari@mit.edu	Ferrari, Raffaele/C-9337-2013	Ferrari, Raffaele/0000-0002-3736-1956	Division Of Ocean Sciences [1233832] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Ferrari R, 2014, P NATL ACAD SCI USA, V111, P8753, DOI 10.1073/pnas.1323922111; Garrett C, 2007, ANNU REV FLUID MECH, V39, P57, DOI 10.1146/annurev.fluid.39.050905.110227; Lumpkin R, 2007, J PHYS OCEANOGR, V37, P2550, DOI 10.1175/JPO3130.1; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Nikurashin M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046576; Toggweiler JR, 1998, J PHYS OCEANOGR, V28, P1832, DOI 10.1175/1520-0485(1998)028<1832:OTOSLS>2.0.CO;2; Waterhouse AF, 2014, J PHYS OCEANOGR, V44, P1854, DOI 10.1175/JPO-D-13-0104.1; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121	9	26	27	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					179	180		10.1038/513179a	http://dx.doi.org/10.1038/513179a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209795				2022-12-28	WOS:000341362800038
J	Ebrahim, S; Sohani, ZN; Montoya, L; Agarwal, A; Thorlund, K; Mills, EJ; Ioannidis, JPA				Ebrahim, Shanil; Sohani, Zahra N.; Montoya, Luis; Agarwal, Arnav; Thorlund, Kristian; Mills, Edward J.; Ioannidis, John P. A.			Reanalyses of Randomized Clinical Trial Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIPHERAL NEUROPATHY; EFFICACY CRITERIA; NATIONAL-SURVEY; ACUPUNCTURE; GENETICS; SCIENCE; DISEASE; MODEL	IMPORTANCE Reanalyses of randomized clinical trial (RCT) data may help the scientific community assess the validity of reported trial results. OBJECTIVES To identify published reanalyses of RCT data, to characterize methodological and other differences between the original trial and reanalysis, to evaluate the independence of authors performing the reanalyses, and to assess whether the reanalysis changed interpretations from the original article about the types or numbers of patients who should be treated. DESIGN We completed an electronic search of MEDLINE from inception to March 9, 2014, to identify all published studies that completed a reanalysis of individual patient data from previously published RCTs addressing the same hypothesis as the original RCT. Four data extractors independently screened articles and extracted data. MAIN OUTCOMES AND MEASURES Changes in direction and magnitude of treatment effect, statistical significance, and interpretation about the types or numbers of patients who should be treated. RESULTS We identified 37 eligible reanalyses in 36 published articles, 5 of which were performed by entirely independent authors (2 based on publicly available data and 2 on data that were provided on request; data availability was unclear for 1). Reanalyses differed most commonly in statistical or analytical approaches (n = 18) and in definitions or measurements of the outcome of interest (n = 12). Four reanalyses changed the direction and 2 changed the magnitude of treatment effect, whereas 4 led to changes in statistical significance of findings. Thirteen reanalyses (35%) led to interpretations different from that of the original article, 3 (8%) showing that different patients should be treated; 1 (3%), that fewer patients should be treated; and 9 (24%), that more patients should be treated. CONCLUSIONS AND RELEVANCE A small number of reanalyses of RCTs have been published to date. Only a few were conducted by entirely independent authors. Thirty-five percent of published reanalyses led to changes in findings that implied conclusions different from those of the original article about the types and number of patients who should be treated.	[Ebrahim, Shanil; Thorlund, Kristian; Mills, Edward J.; Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ebrahim, Shanil; Sohani, Zahra N.; Thorlund, Kristian; Mills, Edward J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ebrahim, Shanil] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4L8, Canada; [Ebrahim, Shanil] Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON M5G 1X8, Canada; [Sohani, Zahra N.] McMaster Univ, Populat Genom Program, Hamilton, ON L8S 4L8, Canada; [Montoya, Luis] Univ Hlth Network, Toronto, ON, Canada; [Agarwal, Arnav] McMaster Univ, Fac Hlth Sci, Hamilton, ON L8S 4L8, Canada; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	Stanford University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; University of Ottawa; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Agarwal, Arnav/J-1553-2014; Ioannidis, John P. A./G-9836-2011	Agarwal, Arnav/0000-0002-0931-7851; 	MITACS Elevate Award; MITACS SickKids Restracomp Postdoctoral Award; Canadian Institutes of Health Research Canada Research Chair	MITACS Elevate Award; MITACS SickKids Restracomp Postdoctoral Award; Canadian Institutes of Health Research Canada Research Chair(Canada Research ChairsCanadian Institutes of Health Research (CIHR))	Dr Ebrahim reports receiving support from MITACS Elevate and SickKids Restracomp Postdoctoral Awards. Dr Mills reports receiving support via a Canadian Institutes of Health Research Canada Research Chair.	Amer-Wahlin I, 2011, ACTA OBSTET GYN SCAN, V90, P990, DOI 10.1111/j.1600-0412.2011.01203.x; [Anonymous], 2010, LANCET, V375, P1940, DOI 10.1016/S0140-6736(10)60906-3; [Anonymous], 2012, PAROXETINE AND PEDIA; Berman F, 2013, SCIENCE, V341, P616, DOI 10.1126/science.1241625; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Brooks J O 3rd, 1998, Int Psychogeriatr, V10, P193, DOI 10.1017/S1041610298005304; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Chmielewski L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.027; Christakis DA, 2013, JAMA-J AM MED ASSOC, V310, P2499, DOI 10.1001/jama.2013.281337; COLQUHOUN D, 1990, LANCET, V336, P441, DOI 10.1016/0140-6736(90)91989-N; Diener HC, 2004, EUR NEUROL, V51, P89, DOI 10.1159/000076535; Doshi P, 2013, BMJ-BRIT MED J, V347, pf4251; Doshi P, 2013, TRENDS PHARMACOL SCI, V34, P645, DOI 10.1016/j.tips.2013.10.006; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Gallo C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-196; Holdren JP, PUBLIC ACCESS MEMORA; HOLLY JMP, 1981, LANCET, V2, P1384; HUFF JC, 1993, J MED VIROL, P93; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Johnson SR, 2009, J RHEUMATOL, V36, P323, DOI 10.3899/jrheum.071169; JOHNSTON D L, 1985, Canadian Journal of Cardiology, V1, P174; Kobashigawa JA, 2006, AM J TRANSPLANT, V6, P993, DOI 10.1111/j.1600-6143.2006.01297.x; Koch HJ, 2002, INT J CLIN PHARM TH, V40, P30; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; McCann DJ, 2012, CNS NEUROSCI THER, V18, P414, DOI 10.1111/j.1755-5949.2011.00263.x; Monforton C, 2006, AM J PUBLIC HEALTH, V96, P271, DOI 10.2105/AJPH.2005.064410; Nagakane Y, 2011, STROKE, V42, P59, DOI 10.1161/STROKEAHA.110.580464; Paradis NA, 2010, AM J EMERG MED, V28, P391, DOI 10.1016/j.ajem.2010.02.002; Pisani E, 2010, B WORLD HEALTH ORGAN, V88, P462, DOI 10.2471/BLT.09.074393; Reiffel JA, 1996, PROG CARDIOVASC DIS, V38, P359, DOI 10.1016/S0033-0620(96)80029-6; Ross JS, 2012, CIRC-CARDIOVASC QUAL, V5, P238, DOI 10.1161/CIRCOUTCOMES.112.965798; Rothwell PM, 2003, STROKE, V34, P514, DOI 10.1161/01.STR.0000054671.71777.C7; Samet JM, 2009, EPIDEMIOLOGY, V20, P172, DOI 10.1097/EDE.0b013e3181930df3; Shiflett SC, 2011, EXPLORE-NY, V7, P148, DOI 10.1016/j.explore.2011.02.004; Shlay JC, 1998, JAMA-J AM MED ASSOC, V280, P1590, DOI 10.1001/jama.280.18.1590; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; Teschan PE, 1998, CLIN NEPHROL, V50, P273; Thomsen BL, 1998, J HEPATOL, V28, P107, DOI 10.1016/S0168-8278(98)80209-2; van der Linden YM, 2004, INT J RADIAT ONCOL, V59, P528, DOI 10.1016/j.ijrobp.2003.10.006; Vansteenkiste J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-311; Welling DB, 2000, OTOLARYNG HEAD NECK, V122, P340, DOI 10.1016/S0194-5998(00)70044-1; Witkiewitz K, 2007, J ABNORM PSYCHOL, V116, P378, DOI 10.1037/0021-843X.116.2.378	44	116	119	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1024	1032		10.1001/jama.2014.9646	http://dx.doi.org/10.1001/jama.2014.9646			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203082	Bronze			2022-12-28	WOS:000341385600020
J	O'Brien, A; Sokol, DK				O'Brien, Aidan; Sokol, Daniel K.			ETHICS MAN Lessons from the Ashya King case	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												daniel.sokol@talk21.com						Boseley S, 2014, GUARDIAN; Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5570; Fins J, 2006, PALLIATIVE ETHIC CAR	3	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2014	349								g5563	10.1136/bmj.g5563	http://dx.doi.org/10.1136/bmj.g5563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QO	25209621				2022-12-28	WOS:000341691200023
J	Prystowsky, EN; Fry, ET				Prystowsky, Eric N.; Fry, Edward T.			Atrial Fibrillation and Incident Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WARFARIN; DYSFUNCTION; ASPIRIN	IMPORTANCE Myocardial infarction (MI) is an established risk factor for atrial fibrillation (AF). However, the extent to which AF is a risk factor for MI has not been investigated. OBJECTIVE To examine the risk of incident MI associated with AF. DESIGN, SETTING, AND PARTICIPANTS A prospective cohort of 23 928 participants residing in the continental United States and without coronary heart disease at baseline were enrolled from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort between 2003 and 2007, with follow-up through December 2009. MAIN OUTCOMES AND MEASURES Expert-adjudicated total MI events (fatal and nonfatal). RESULTS Over 6.9 years of follow-up (median 4.5 years), 648 incident MI events occurred. In a sociodemographic-adjusted model, AF was associated with about 2-fold increased risk of MI (hazard ratio [HR], 1.96 [95% CI, 1.52-2.52]). This association remained significant (HR, 1.70 [95% CI, 1.26-2.30]) after further adjustment for total cholesterol, high-density lipoprotein cholesterol, smoking status, systolic blood pressure, blood pressure-lowering drugs, body mass index, diabetes, warfarin use, aspirin use, statin use, history of stroke and vascular disease, estimated glomerular filtration rate, albumin to creatinine ratio, and C-reactive protein level. In subgroup analysis, the risk of MI associated with AF was significantly higher in women (HR, 2.16 [95% CI, 1.41-3.31]) than in men (HR, 1.39 [95% CI, 0.91-2.10]) and in blacks (HR, 2.53 [95% CI, 1.67-3.86]) than in whites (HR, 1.26 [95% CI, 0.83-1.93]); for interactions, P = .03 and P = .02, respectively. On the other hand, there were no significant differences in the risk of MI associated with AF in older (>= 75 years) vs younger (<75 years) participants (HR, 2.00 [95% CI, 1.16-3.35] and HR, 1.60 [95% CI, 1.11-2.30], respectively); for interaction, P = .44. CONCLUSIONS AND RELEVANCE AF is independently associated with an increased risk of incident MI, especially in women and blacks. These findings add to the growing concerns of the seriousness of AF as a public health burden: in addition to being a well-known risk factor for stroke, AF is also associated with increased risk of MI.	[Prystowsky, Eric N.; Fry, Edward T.] St Vincent Hosp, St Vincent Med Grp, Indianapolis, IN USA		Prystowsky, EN (corresponding author), St Vincent Med Grp, 8333 Naab Rd, Indianapolis, IN 46260 USA.	eprymd@aol.com	Fry, Edward/AAP-7004-2021					Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; Blackshear JL, 1999, STROKE, V30, P834, DOI 10.1161/01.STR.30.4.834; Carrero JJ, 2014, JAMA-J AM MED ASSOC, V311, P919, DOI 10.1001/jama.2014.1334; Dukes JW, 2014, JAMA INTERN MED, V174, P5, DOI 10.1001/jamainternmed.2013.11392; HELGASON CM, 1993, STROKE, V24, P1458, DOI 10.1161/01.STR.24.10.1458; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; PRIZEL KR, 1978, ANN INTERN MED, V88, P155, DOI 10.7326/0003-4819-88-2-155; Saaby L, 2013, AM J MED, V126, P789, DOI 10.1016/j.amjmed.2013.02.029; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912	10	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1049	1050		10.1001/jama.2014.5742	http://dx.doi.org/10.1001/jama.2014.5742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203084				2022-12-28	WOS:000341385600022
J	Moore, CM				Moore, C. Mark			Microbial proteins and oceanic nutrient cycles	SCIENCE			English	Editorial Material									Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton	Moore, CM (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England.	c.moore@noc.soton.ac.uk		Moore, Mark/0000-0002-9541-6046				Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; LAROCHE J, 1993, J PHYCOL, V29, P767; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Saito MA, 2014, SCIENCE, V345, P1173, DOI 10.1126/science.1256450; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Yong SC, 2014, SCIENCE, V345, P1170, DOI 10.1126/science.1254237	12	5	5	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1120	1121		10.1126/science.1258133	http://dx.doi.org/10.1126/science.1258133			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190779				2022-12-28	WOS:000341179800021
J	Nielsen, MH; Aloni, S; De Yoreo, JJ				Nielsen, Michael H.; Aloni, Shaul; De Yoreo, James J.			In situ TEM imaging of CaCO3 nucleation reveals coexistence of direct and indirect pathways	SCIENCE			English	Article							AMORPHOUS CALCIUM-CARBONATE; PRECURSOR PHASE; CRYSTALLIZATION; GROWTH; PRECIPITATION; MICROSCOPY; INTERFACES; VATERITE; CLUSTERS; SURFACE	Mechanisms of nucleation from electrolyte solutions have been debated for more than a century. Recent discoveries of amorphous precursors and evidence for cluster aggregation and liquid-liquid separation contradict common assumptions of classical nucleation theory. Using in situ transmission electron microscopy (TEM) to explore calcium carbonate (CaCO3) nucleation in a cell that enables reagent mixing, we demonstrate that multiple nucleation pathways are simultaneously operative, including formation both directly from solution and indirectly through transformation of amorphous and crystalline precursors. However, an amorphous-to-calcite transformation is not observed. The behavior of amorphous calcium carbonate upon dissolution suggests that it encompasses a spectrum of structures, including liquids and solids. These observations of competing direct and indirect pathways are consistent with classical predictions, whereas the behavior of amorphous particles hints at an underlying commonality among recently proposed precursor-based mechanisms.	[Nielsen, Michael H.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Nielsen, Michael H.; Aloni, Shaul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [De Yoreo, James J.] Pacific NW Natl Lab, Phys Sci Div, Richland, WA 99352 USA; [De Yoreo, James J.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle	De Yoreo, JJ (corresponding author), Pacific NW Natl Lab, Phys Sci Div, Richland, WA 99352 USA.	james.deyoreo@pnnl.gov	Nielsen, Michael/D-1881-2015		U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences at Pacific Northwest National Laboratory and Lawrence Berkeley National Laboratory; Office of Basic Energy Sciences, Scientific User Facilities Division; U.S. Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship [32 CFR 168a]; NSF [DMR-1312697]; DOE [DE-AC05-76RL01830]; Direct For Mathematical & Physical Scien [1312697] Funding Source: National Science Foundation	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences at Pacific Northwest National Laboratory and Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences, Scientific User Facilities Division(United States Department of Energy (DOE)); U.S. Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank V. Altoe for the use of and assistance with the JEOL-2100F transmission electron microscope. This research was supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences at Pacific Northwest National Laboratory and Lawrence Berkeley National Laboratory. TEM was performed at the Molecular Foundry, Lawrence Berkeley National Laboratory, which is supported by the Office of Basic Energy Sciences, Scientific User Facilities Division. M.H.N. acknowledges support awarded by the U.S. Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship 32 CFR 168a, and the NSF under grant DMR-1312697. Pacific Northwest National Laboratory is operated by Battelle Memorial Institute for the DOE under contract DE-AC05-76RL01830.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Bewernitz MA, 2012, FARADAY DISCUSS, V159, P291, DOI 10.1039/c2fd20080e; Bots P, 2012, CRYST GROWTH DES, V12, P3806, DOI 10.1021/cg300676b; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Cheng L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.156103; Chernov A.A., 2012, MODERN CRYSTALLOGRAP, V36; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Demichelis R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1604; Gebauer D, 2010, ANGEW CHEM INT EDIT, V49, P8889, DOI 10.1002/anie.201003220; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Hedges LO, 2012, SOFT MATTER, V8, P8624, DOI 10.1039/c2sm26038g; Hu Q, 2012, FARADAY DISCUSS, V159, P509, DOI 10.1039/c2fd20124k; Kilpatrick JI, 2013, J AM CHEM SOC, V135, P2628, DOI 10.1021/ja310255s; Koga N, 2008, J THERM ANAL CALORIM, V94, P379, DOI 10.1007/s10973-008-9110-3; Lee JRI, 2007, J AM CHEM SOC, V129, P10370, DOI 10.1021/ja071535w; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; Pouget EM, 2010, J AM CHEM SOC, V132, P11560, DOI 10.1021/ja102439r; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Rieger J, 2000, LANGMUIR, V16, P8300, DOI 10.1021/la0004193; Sutter PW, 2007, NAT MATER, V6, P363, DOI 10.1038/nmat1894; Van Driessche AES, 2012, SCIENCE, V336, P69, DOI 10.1126/science.1215648; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915; Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Wolf SE, 2008, J AM CHEM SOC, V130, P12342, DOI 10.1021/ja800984y; Wolf SE, 2011, NANOSCALE, V3, P1158, DOI 10.1039/c0nr00761g	29	460	470	59	869	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1158	1162		10.1126/science.1254051	http://dx.doi.org/10.1126/science.1254051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190792				2022-12-28	WOS:000341179800041
J	Zamir, D				Zamir, Dani			A wake-up call with coffee	SCIENCE			English	Editorial Material									Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci & Genet, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Zamir, D (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci & Genet, IL-76100 Rehovot, Israel.	dani.zamir@mail.huji.ac.il						[Anonymous], 2014, GIGASCIENCE, V3, P7; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Gross M, 2014, CURR BIOL, V24, pR503, DOI 10.1016/j.cub.2014.05.035; Labouisse JP, 2008, GENET RESOUR CROP EV, V55, P1079, DOI 10.1007/s10722-008-9361-7; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Silvarolla MB, 2004, NATURE, V429, P826, DOI 10.1038/429826a; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Zamir D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001595	8	6	6	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1124	1124		10.1126/science.1258941	http://dx.doi.org/10.1126/science.1258941			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190782				2022-12-28	WOS:000341179800024
J	Ren, MH; Lu, GP				Ren Minghui; Lu Guoping			China's global health strategy	LANCET			English	Editorial Material									[Ren Minghui; Lu Guoping] Natl Hlth & Family Planning Commiss, Int Cooperat Dept, Beijing 100044, Peoples R China		Ren, MH (corresponding author), Natl Hlth & Family Planning Commiss, Int Cooperat Dept, Beijing 100044, Peoples R China.	renmh@nhfpc.gov.cn						Bosman A, 2013, CHINA AFRICA COLLABO, P206; Chen L, 2012, CHINAS CAPACITY PROD; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Han QD, 2008, LANCET, V372, P1439, DOI 10.1016/S0140-6736(08)61350-1; Hoekman A, 2013, STRENGTHENING REPROD, P92; Hui L, 2013, DEPTH CHANGES PHARM; Liu EW, 2013, J INFECT DIS, V208, P442, DOI 10.1093/infdis/jit163; Liu PL, 2014, LANCET, V384, P793, DOI 10.1016/S0140-6736(14)60725-X; Mengjie H, 2013, CHINA AFRICA COOPERA, P36; Qian W, 2013, MED SOC, V26, P5; Ren M, 2013, CHINA GLOBAL HLTH; Xiaofeng L, 2013, ANAL POTENTIAL AREAS, P238; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; Zhu C, 2012, GLOBAL HLTH 2012	15	12	15	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					719	721		10.1016/S0140-6736(14)61317-9	http://dx.doi.org/10.1016/S0140-6736(14)61317-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25176533				2022-12-28	WOS:000341361500007
J	Chuong, CM; Bhat, R; Widelitz, RB; Bissell, MJ				Chuong, Cheng-Ming; Bhat, Ramray; Widelitz, Randall B.; Bissell, Mina J.			SnapShot: Branching Morphogenesis	CELL			English	Editorial Material							MAMMARY-GLAND		[Chuong, Cheng-Ming; Widelitz, Randall B.] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Bhat, Ramray; Bissell, Mina J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Chuong, Cheng-Ming] Cheng Kung Univ, Ctr Wound Repair & Regenerat, Tainan, Taiwan	University of Southern California; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Cheng Kung University	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA.				NIAMS NIH HHS [R01 AR060306, R01 AR042177, R01 AR047364] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060306, R01AR042177, R01AR047364] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bhat R, 2014, WIRES DEV BIOL, V3, P147, DOI 10.1002/wdev.130; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Mori H, 2013, DEVELOPMENT, V140, P343, DOI 10.1242/dev.084236; Widelitz RB, 2007, SEMIN CELL DEV BIOL, V18, P255, DOI 10.1016/j.semcdb.2007.02.005	5	15	15	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1212	U265	1212.e1	10.1016/j.cell.2014.08.019	http://dx.doi.org/10.1016/j.cell.2014.08.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171418	Green Accepted, Bronze			2022-12-28	WOS:000340945000026
J	Sadtler, PT; Quick, KM; Golub, MD; Chase, SM; Ryu, SI; Tyler-Kabara, EC; Yu, BM; Batista, AP				Sadtler, Patrick T.; Quick, Kristin M.; Golub, Matthew D.; Chase, Steven M.; Ryu, Stephen I.; Tyler-Kabara, Elizabeth C.; Yu, Byron M.; Batista, Aaron P.			Neural constraints on learning	NATURE			English	Article							BRAIN-COMPUTER-INTERFACE; MOTOR; ADAPTATION; PERFORMANCE; DYNAMICS; CORTEX; ALGORITHM; RESPONSES; PATTERNS; TASKS	Learning, whether motor, sensory or cognitive, requires networks of neurons to generate new activity patterns. As some behaviours are easier to learn than others(1,2), we asked if some neural activity patterns are easier to generate than others. Here we investigate whether an existing network constrains the patterns that a subset of its neurons is capable of exhibiting, and if so, what principles define this constraint. We employed a closed-loop intracortical brain-computer interface learning paradigm in which Rhesus macaques (Macaca mulatta) controlled a computer cursor by modulating neural activity patterns in the primary motor cortex. Using the brain-computer interface paradigm, we could specify and alter how neural activity mapped to cursor velocity. At the start of each session, we observed the characteristic activity patterns of the recorded neural population. The activity of a neural population can be represented in a high-dimensional space (termed the neural space), wherein each dimension corresponds to the activity of one neuron. These characteristic activity patterns comprise a low-dimensional subspace (termed the intrinsic manifold) within the neural space. The intrinsic manifold presumably reflects constraints imposed by the underlying neural circuitry. Here we show that the animals could readily learn to proficiently control the cursor using neural activity patterns that were within the intrinsic manifold. However, animals were less able to learn to proficiently control the cursor using activity patterns that were outside of the intrinsic manifold. These results suggest that the existing structure of a network can shape learning. On a timescale of hours, it seems to be difficult to learn to generate neural activity patterns that are not consistent with the existing network structure. These findings offer a network-level explanation for the observation that we are more readily able to learn new skills when they are related to the skills that we already possess(3,4).	[Sadtler, Patrick T.; Quick, Kristin M.; Tyler-Kabara, Elizabeth C.; Batista, Aaron P.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Sadtler, Patrick T.; Quick, Kristin M.; Golub, Matthew D.; Chase, Steven M.; Yu, Byron M.; Batista, Aaron P.] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Sadtler, Patrick T.; Quick, Kristin M.; Batista, Aaron P.] Univ Pittsburgh, Syst Neurosci Inst, Pittsburgh, PA 15261 USA; [Golub, Matthew D.; Yu, Byron M.] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Chase, Steven M.; Yu, Byron M.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Ryu, Stephen I.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA 94301 USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University; Stanford University; Palo Alto Medical Foundation Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, BM (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.	byronyu@cmu.edu; apb10@pitt.edu	Tyler-Kabara, Elizabeth/H-4930-2013	Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Quick, Kristin/0000-0003-4028-2463; Batista, Aaron/0000-0002-1719-0061; Golub, Matthew/0000-0003-4508-0537; Chase, Steven/0000-0003-4450-6313	NIH NICHD CRCNS [R01-HD071686]; NIH NINDS [R01-NS065065]; Burroughs Wellcome Fund; NSF [DGE-0549352]; NIH [P30-NS076405]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065065, P30NS076405] Funding Source: NIH RePORTER	NIH NICHD CRCNS; NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Barth, C. Olson, D. Sussillo, R. J. Tibshirani and N. Urban for discussions; S. Flesher for help with data collection and R. Du m for advice on array placement. This work was funded by NIH NICHD CRCNS R01-HD071686 (A.P.B. and B.M.Y.), NIH NINDS R01-NS065065 (A.P.B.), Burroughs Wellcome Fund (A.P.B.), NSF DGE-0549352 (P.T.S.) and NIH P30-NS076405 (Systems Neuroscience Institute).	Ajemian R, 2013, P NATL ACAD SCI USA, V110, pE5078, DOI 10.1073/pnas.1320116110; BJORCK A, 1973, MATH COMPUT, V27, P579, DOI 10.2307/2005662; Boden MA, 1998, ARTIF INTELL, V103, P347, DOI 10.1016/S0004-3702(98)00055-1; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Cunningham J. P., NAT NEUROSCI, DOI DOI 10.1038/NN.3776; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Engelhard B, 2013, NEURON, V77, P361, DOI 10.1016/j.neuron.2012.11.015; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Hwang EJ, 2013, CURR BIOL, V23, P353, DOI 10.1016/j.cub.2013.01.027; Ingvalson EM, 2012, BILING-LANG COGN, V15, P255, DOI 10.1017/S1366728911000447; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Jeanne JM, 2013, NEURON, V78, P352, DOI 10.1016/j.neuron.2013.02.023; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Park DC, 2014, PSYCHOL SCI, V25, P103, DOI 10.1177/0956797613499592; Paz R, 2005, J NEUROSCI, V25, P10941, DOI 10.1523/JNEUROSCI.0164-05.2005; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Picard N, 2013, NAT NEUROSCI, V16, P1340, DOI 10.1038/nn.3477; Ranganathan R, 2014, J NEUROSCI, V34, P8289, DOI 10.1523/JNEUROSCI.4455-13.2014; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rouse AG, 2013, J NEUROSCI, V33, P1326, DOI 10.1523/JNEUROSCI.0271-12.2013; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; Santhanam G, 2009, J NEUROPHYSIOL, V102, P1315, DOI 10.1152/jn.00097.2009; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Tkach D, 2008, CURR OPIN NEUROBIOL, V18, P589, DOI 10.1016/j.conb.2008.09.016; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	39	303	305	6	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					423	U428		10.1038/nature13665	http://dx.doi.org/10.1038/nature13665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164754	Green Accepted			2022-12-28	WOS:000340840600032
J	Bruno, JF				Bruno, John F.			ECOLOGY How do coral reefs recover?	SCIENCE			English	Editorial Material							MACROALGAE; FISHES; SHIFTS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27517 USA	University of North Carolina; University of North Carolina Chapel Hill	Bruno, JF (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27517 USA.	jbruno@unc.edu						Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Bruno JF, 2014, MAR POLLUT BULL, V80, P24, DOI 10.1016/j.marpolbul.2014.01.010; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Kramer KL, 2007, MAR ECOL PROG SER, V349, P111, DOI 10.3354/meps07083; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Nagelkerken I, 2007, ESTUAR COAST SHELF S, V75, P417, DOI 10.1016/j.ecss.2007.05.030; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Zhang SY, 2014, PEERJ, V2, DOI 10.7717/peerj.308	14	6	7	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					879	880		10.1126/science.1258556	http://dx.doi.org/10.1126/science.1258556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146274				2022-12-28	WOS:000340524700025
J	Skinner, SR; Szarewski, A; Romanowski, B; Garland, SM; Lazcano-Ponce, E; Salmeron, J; Del Rosario-Raymundo, MR; Verheijen, RHM; Quek, SC; da Silva, DP; Kitchener, H; Fong, KL; Bouchard, C; Money, DM; Ilancheran, A; Cruickshank, ME; Levin, MJ; Chatterjee, A; Stapleton, JT; Martens, M; Quint, W; David, MP; Meric, D; Hardt, K; Descamps, D; Geeraerts, B; Struyf, F; Dubin, G				Skinner, S. Rachel; Szarewski, Anne; Romanowski, Barbara; Garland, Suzanne M.; Lazcano-Ponce, Eduardo; Salmeron, Jorge; Rowena Del Rosario-Raymundo, M.; Verheijen, Rene H. M.; Quek, Swee Chong; da Silva, Daniel P.; Kitchener, Henry; Fong, Kah Leng; Bouchard, Celine; Money, Deborah M.; Ilancheran, Arunachalam; Cruickshank, Margaret E.; Levin, Myron J.; Chatterjee, Archana; Stapleton, Jack T.; Martens, Mark; Quint, Wim; David, Marie-Pierre; Meric, Dorothee; Hardt, Karin; Descamps, Dominique; Geeraerts, Brecht; Struyf, Frank; Dubin, Gary		VIVIANE Study Grp	Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study	LANCET			English	Article							OF-STUDY ANALYSIS; PARTICLE VACCINE; CERVICAL-CANCER; YOUNG-WOMEN; HPV TYPES; BROAD-SPECTRUM; ADULT WOMEN; INFECTION; TYPE-16; RISK	Background Although adolescent girls are the main population for prophylactic human papillomavirus (HPV) vaccines, adult women who remain at risk of cervical cancer can also be vaccinated. We report data from the interim analysis of the ongoing VIVIANE study, the aim of which is to assess the efficacy, safety, and immunogenicity of the HPV 16/18 AS04-adjuvanted vaccine in adult women. Methods In this phase 3, multinational, double-blind, randomised controlled trial, we randomly assigned healthy women older than 25 years to the HPV 16/18 vaccine or control (1: 1), via an internet-based system with an algorithm process that accounted for region, age stratum, baseline HPV DNA status, HPV 16/18 serostatus, and cytology. Enrolment was age-stratified, with about 45% of participants in each of the 26-35 and 36-45 years age strata and 10% in the 46 years and older stratum. Up to 15% of women in each age stratum could have a history of HPV infection or disease. The primary endpoint was vaccine efficacy against 6-month persistent infection or cervical intraepithelial neoplasia grade 1 or higher (CIN1+) associated with HPV 16/18. The primary analysis was done in the according-to-protocol cohort for efficacy, which consists of women who received all three vaccine or control doses, had negative or low-grade cytology at baseline, and had no history of HPV disease. Secondary analyses included vaccine efficacy against non-vaccine oncogenic HPV types. Mean follow-up time was 40.3 months. This study is registered with ClinicalTrials.gov, number NCT00294047. Findings The first participant was enrolled on Feb 16, 2006, and the last study visit for the present analysis took place on Dec 10, 2010; 5752 women were included in the total vaccinated cohort (n=2881 vaccine, n=2871 control), and 4505 in the according-to-protocol cohort for efficacy (n=2264 vaccine, n=2241 control). Vaccine efficacy against HPV 16/18-related 6-month persistent infection or CIN1+ was significant in all age groups combined (81.1%, 97.7% CI 52.1-94.0), in the 26-35 years age group (83.5%, 45.0-96.8), and in the 36-45 years age group (77.2%, 2.8-96.9); no cases were seen in women aged 46 years and older. Vaccine efficacy against atypical squamous cells of undetermined significance or greater associated with HPV 16/18 was also significant. We also noted significant cross-protective vaccine efficacy against 6-month persistent infection with HPV 31 (79.1%, 97.7% CI 27.6-95.9) and HPV 45 (76.9%, 18.5-95.6]) Serious adverse events occurred in 285 (10%) of 2881 women in the vaccine group and 267 (9%) of 2871 in the control group; five (<1%) and eight (<1%) of these events, respectively, were believed to be related to vaccination. Interpretation In women older than 25 years, the HPV 16/18 vaccine is efficacious against infections and cervical abnormalities associated with the vaccine types, as well as infections with the non-vaccine HPV types 31 and 45.	[Skinner, S. Rachel] Telethon Inst Child Hlth Res, Vaccines Trials Grp, Perth, WA, Australia; [Skinner, S. Rachel] Childrens Hosp Westmead, Univ Discipline Paediat & Child Hlth, Sydney, NSW, Australia; [Szarewski, Anne] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England; [Romanowski, Barbara] Univ Alberta, Fac Med & Dent, Dept Med, Div Infect Dis, Edmonton, AB, Canada; [Garland, Suzanne M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia; [Garland, Suzanne M.] Royal Childrens Hosp, Dept Microbiol, Parkville, Vic 3052, Australia; [Garland, Suzanne M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Salmeron, Jorge] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv, Cuernavaca, Morelos, Mexico; [Rowena Del Rosario-Raymundo, M.] San Pablo Colleges Med Ctr, Dept Obstet & Gynecol, San Pablo City, Laguna, Philippines; [Verheijen, Rene H. M.] Univ Med Ctr Utrecht, Gynaecol Oncol & HumVac Res Grp, Utrecht, Netherlands; [Quek, Swee Chong] Gleneagles Hosp, Pkwy Gynaecol Screening & Treatment Ctr, Singapore, Singapore; [da Silva, Daniel P.] Inst Portugues Oncol Coimbra, Dept Ginecol, Coimbra, Portugal; [Kitchener, Henry] Univ Manchester, St Marys Hosp, Inst Canc Sci, Womens Canc Ctr, Manchester M13 0JH, Lancs, England; [Fong, Kah Leng] Singapore Gen Hosp, Dept Obstet & Gynaecol, Singapore, Singapore; [Bouchard, Celine] Clin RSF, Quebec City, PQ, Canada; [Money, Deborah M.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Money, Deborah M.] Womens Hlth Res Inst, Vancouver, BC, Canada; [Ilancheran, Arunachalam] Natl Univ Singapore Hosp, Div Gynecol Oncol, Singapore 117548, Singapore; [Cruickshank, Margaret E.] Univ Aberdeen, Div Med Educ, Aberdeen, Scotland; [Levin, Myron J.] Univ Colorado Denver, Aurora, CO USA; [Chatterjee, Archana] Univ South Dakota Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA; [Chatterjee, Archana] Sanford Childrens Specialty Clin, Sioux Falls, SD USA; [Stapleton, Jack T.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Martens, Mark] Jersey Shore Univ, Med Ctr, Neptune, NJ USA; [Quint, Wim] DDL Diagnost Lab, Rijswijk, Netherlands; [David, Marie-Pierre; Meric, Dorothee; Hardt, Karin; Descamps, Dominique; Geeraerts, Brecht; Struyf, Frank] GSK Vaccines, Wavre, Belgium; [Dubin, Gary] GSK Vaccines, King Of Prussia, PA USA	Telethon Kids Institute; University of Sydney; University of London; Queen Mary University London; University of Alberta; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Instituto Mexicano del Seguro Social; Utrecht University; Utrecht University Medical Center; Universidade de Coimbra; University of Manchester; Singapore General Hospital; University of British Columbia; National University of Singapore; University of Aberdeen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of South Dakota; Sanford Health; University of Iowa; Jersey Shore University Medical Center; DDL Diagnostic Laboratory; GlaxoSmithKline; GlaxoSmithKline	Skinner, SR (corresponding author), Univ Sydney, Childrens Hosp Westmead, Sch Clin, Discipline Paediat & Child Hlth, Sydney, NSW 2145, Australia.	rachel.skinner@health.nsw.gov.au	Skinner, Rachel S/J-8455-2017; Harper, Diane M./I-2180-2014; Raymundo, Maria Rowena D.R./C-9144-2017; Bouchard, Celine/ABE-5810-2021; Wang, Jing/M-5607-2016	Skinner, Rachel S/0000-0003-1970-9792; Harper, Diane M./0000-0001-7648-883X; Raymundo, Maria Rowena D.R./0000-0003-1857-2042; Bouchard, Celine/0000-0003-2258-058X; Salmeron, Jorge/0000-0002-5113-299X; Struyf, Frank/0000-0001-9988-0260; Stapleton, Jack/0000-0002-2302-9055; Cruickshank, Margaret/0000-0002-8893-8620; McNeil, Shelly/0000-0001-5444-4166	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	GlaxoSmithKline Biologicals SA.	Black LL, 2009, VACCINE, V27, P1668, DOI 10.1016/j.vaccine.2009.01.035; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Castle PE, 2002, CANCER-AM CANCER SOC, V95, P2145, DOI 10.1002/cncr.10927; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Grant LA, 2011, VACCINE, V29, P2365, DOI 10.1016/j.vaccine.2011.01.032; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Insinga RP, 2010, CANCER EPIDEM BIOMAR, V19, P1585, DOI 10.1158/1055-9965.EPI-09-1235; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Olsson SE, 2009, HUM VACCINES, V5, P696, DOI 10.4161/hv.5.10.9515; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; Skinner SR, 2008, MED J AUSTRALIA, V188, P238, DOI 10.5694/j.1326-5377.2008.tb01593.x; Syrjanen K, 2011, EUR J GYNAECOL ONCOL, V32, P17; Szarewski A, 2012, INT J CANCER, V131, P106, DOI 10.1002/ijc.26362; Trottier H, 2010, CANCER RES, V70, P8569, DOI 10.1158/0008-5472.CAN-10-0621; van Alewijk D, 2013, J CLIN MICROBIOL, V51, P1171, DOI 10.1128/JCM.02831-12; van Doorn LJ, 2006, J CLIN MICROBIOL, V44, P3292, DOI 10.1128/JCM.00539-06; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Viscidi RP, 2004, CANCER EPIDEM BIOMAR, V13, P324, DOI 10.1158/1055-9965.EPI-03-0166; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; WHO, 2001, CAUS ASS ADV EV FOLL; Xi LF, 2002, CANCER EPIDEM BIOMAR, V11, P343; Xi LF, 2010, J INFECT DIS, V202, P1667, DOI 10.1086/657083	41	124	139	0	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2213	2227		10.1016/S0140-6736(14)60920-X	http://dx.doi.org/10.1016/S0140-6736(14)60920-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25189358				2022-12-28	WOS:000346655700024
J	Smith, BT; McCormack, JE; Cuervo, AM; Hickerson, MJ; Aleixo, A; Cadena, CD; Perez-Eman, J; Burney, CW; Xie, XO; Harvey, MG; Faircloth, BC; Glenn, TC; Derryberry, EP; Prejean, J; Fields, S; Brumfield, RT				Smith, Brian Tilston; McCormack, John E.; Cuervo, Andres M.; Hickerson, Michael. J.; Aleixo, Alexandre; Cadena, Carlos Daniel; Perez-Eman, Jorge; Burney, Curtis W.; Xie, Xiaoou; Harvey, Michael G.; Faircloth, Brant C.; Glenn, Travis C.; Derryberry, Elizabeth P.; Prejean, Jesse; Fields, Samantha; Brumfield, Robb T.			The drivers of tropical speciation	NATURE			English	Article							EXTINCTION RATES; CLIMATE-CHANGE; AMAZONIA; PATTERNS; BIRDS; DIVERSIFICATION; SEASONALITY; ABUNDANCE; EVOLUTION; ISLAND	Since the recognition that allopatric speciation can be induced by large-scale reconfigurations of the landscape that isolate formerly continuous populations, such as the separation of continents by plate tectonics, the uplift of mountains or the formation of large rivers, landscape change has been viewed as a primary driver of biological diversification. This process is referred to in biogeography as vicariance(1). In the most species-rich region of the world, the Neotropics, the sundering of populations associated with the Andean uplift is ascribed this principal role in speciation(2-5). An alternative model posits that rather than being directly linked to landscape change, allopatric speciation is initiated to a greater extent by dispersal events, with the principal drivers of speciation being organism-specific abilities to persist and disperse in the landscape(6,7). Landscape change is not a necessity for speciation in this model(8). Here we show that spatial and temporal patterns of genetic differentiation in Neotropical birds are highly discordant across lineages and are not reconcilable with a model linking speciation solely to landscape change. Instead, the strongest predictors of speciation are the amount of time a lineage has persisted in the landscape and the ability of birds to move through the landscape matrix. These results, augmented by the observation that most species-level diversity originated after episodes of major Andean uplift in the Neogene period, suggest that dispersal and differentiation on a matrix previously shaped by large-scale landscape events was a major driver of avian speciation in lowland Neotropical rainforests.	[Smith, Brian Tilston; McCormack, John E.; Cuervo, Andres M.; Burney, Curtis W.; Harvey, Michael G.; Derryberry, Elizabeth P.; Prejean, Jesse; Fields, Samantha; Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Smith, Brian Tilston] Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA; [Cuervo, Andres M.; Burney, Curtis W.; Harvey, Michael G.; Prejean, Jesse; Fields, Samantha; Brumfield, Robb T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Hickerson, Michael. J.; Xie, Xiaoou] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Hickerson, Michael. J.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Aleixo, Alexandre] Museu Paraense Emilio Goeldi, BR-66040170 Belem, Para, Brazil; [Cadena, Carlos Daniel] Univ Los Andes, Dept Ciencias Biol, Lab Biol Evolut Vertebrados, Bogota, Colombia; [Perez-Eman, Jorge] Cent Univ Venezuela, Inst Zool & Ecol Trop, Caracas 1041A, Venezuela; [Perez-Eman, Jorge] Colecc Ornitol Phelps, Caracas 1010A, Venezuela; [Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	Louisiana State University System; Louisiana State University; American Museum of Natural History (AMNH); Louisiana State University System; Louisiana State University; City University of New York (CUNY) System; City College of New York (CUNY); American Museum of Natural History (AMNH); Museu Paraense Emilio Goeldi; Universidad de los Andes (Colombia); University of Central Venezuela; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia	Brumfield, RT (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	robb@lsu.edu	Glenn, Travis C/A-2390-2008; Faircloth, Brant C/Y-3978-2019; Aleixo, Alexandre/L-3135-2013; Brumfield, Robb T/K-6108-2015	Glenn, Travis C/0000-0001-7725-3637; Aleixo, Alexandre/0000-0002-7816-9725; Brumfield, Robb T/0000-0003-2307-0688; Faircloth, Brant/0000-0002-1943-0217; Derryberry, Elizabeth/0000-0002-8248-9748	NSF [DEB-0841729, DEB 1253710, DEB 1343578]; CUNY HPCC [CNS-0855217]; Coypu Foundation; Brazilian Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [574008-2008-0, 490131/2009-3, 310593/2009-3, 574008/2008-0, 563236/2010-8, 471342/ 2011-4]; FAPESPA [ICAAF 023/2011]; CDCH; INPMA	NSF(National Science Foundation (NSF)); CUNY HPCC; Coypu Foundation; Brazilian Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CDCH; INPMA	We thank the collectors, preparators, collection managers and curators of vouchered tissue samples who made this study possible. We thank the following people and institutions for providing samples: D. Dittman n, F. Sheldon (LSUMZ), N. Rice (ANSP), M. Robbins (KU), D. Willard, S. Hackett (FMNH), G. Graves, J. Dean (USNM),J. Cracraft, P. Sweet, T. Trombone (AMNH), S. Birks, J. Klicka (UWBM), K. Bostwick, I. Lovette (CUMV), B. Hernandez-Banos, A. Navarro (MZFC), D. Lopez (lAvH-BT), F. G. Stiles (ICN), M. Lentino (COP), F. Raposo, C. Miyaki (LGEMA, USP) and Museo de Historia Natural de la Universidad de los Andes. This study was supported by NSF awards to R.T.B. (DEB-0841729), M.J.H. (DEB 1253710; DEB 1343578) and CUNY HPCC (CNS-0855217), the Coypu Foundation, Brazilian Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (grant numbers: 574008-2008-0; 490131/2009-3; 310593/2009-3; 574008/2008-0; 563236/2010-8 and 471342/ 2011-4) and FAPESPA awards (ICAAF 023/2011) to A.A., and support from CDCH and INPMA to J.P.-E We thank G. Thomas, N. Gutierrez-Pinto, N. Reid, G. Bravo, J. Miranda, G. Seeholzer, C. Salisbury, C. Cooney, R. Bryson Jr, B. Riddle, N. Takebayashi, B. Winger, V. Chua and J. Weckstein for their assistance, comments and feedback. We thank Lynx Edicions and E. Badia for granting us permission to reuse bird plates from the Handbook of Birds of the World in Fig. 2.	Antonelli A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P386; bNelson G. J., 1981, SYSTEMATICS BIOGEOGR, V214; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Bush MB, 2011, S-P B ENVIRON SCI, P61; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Chapman F. M., 1917, DISTRIBUTION BIRD LI, V36; Cheng H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2415; Derryberry EP, 2011, EVOLUTION, V65, P2973, DOI 10.1111/j.1558-5646.2011.01374.x; Elliott A., 1992, HDB BIRDS WORLD ALIV; GREENBERG R, 1981, BIOTROPICA, V13, P241, DOI 10.2307/2387802; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hickerson MJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-268; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; LOISELLE BA, 1988, CONDOR, V90, P761, DOI 10.2307/1368833; Mayr E, 1942, SYSTEMATICS ORIGIN S, V13; Montes C, 2012, GEOL SOC AM BULL, V124, P780, DOI 10.1130/B30528.1; Naka LN, 2012, AM NAT, V179, pE115, DOI 10.1086/664627; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Udvardy MDF, 1969, DYNAMIC ZOOGEOGRAPHY; Wakeley J, 2001, GENETICS, V159, P893; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883	30	371	376	17	310	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					406	+		10.1038/nature13687	http://dx.doi.org/10.1038/nature13687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25209666	Green Published			2022-12-28	WOS:000345770600044
J	Xu, Y; Tao, YY; Cheung, LS; Fan, C; Chen, LQ; Xu, S; Perry, K; Frommer, WB; Feng, L				Xu, Yan; Tao, Yuyong; Cheung, Lily S.; Fan, Chao; Chen, Li-Qing; Xu, Sophia; Perry, Kay; Frommer, Wolf B.; Feng, Liang			Structures of bacterial homologues of SWEET transporters in two distinct conformations	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN; OLIGOMERIZATION; DROSOPHILA; YEAST	SWEETs and their prokaryotic homologues are monosaccharide and disaccharide transporters that are present from Archaea to plants and humans(1-3). SWEETs play crucial roles in cellular sugar efflux processes: that is, in phloem loading(4), pollen nutrition(5) and nectar secretion(6). Their bacterial homologues, which are called SemiSWEETs, are among the smallest known transporters(1,3). Here we show that SemiSWEET molecules, which consist of a triple-helix bundle, form symmetrical, parallel dimers, thereby generating the translocation pathway. Two SemiSWEET isoforms were crystallized, one in an apparently open state and one in an occluded state, indicating that SemiSWEETs and SWEETs are transporters that undergo rocking-type movements during the transport cycle. The topology of the triple-helix bundle is similar yet distinct to that of the basic building block of animal and plant major facilitator superfamily (MFS) transporters (for example, GLUTs and SUTs). This finding indicates two possibilities: that SWEETs and MFS transporters evolved from an ancestral triple-helix bundle or that the triple-helix bundle represents convergent evolution. In SemiSWEETs and SWEETs, two triple-helix bundles are arranged in a parallel configuration to produce the 6-and 6+1-transmembranehelix pores, respectively. In the 12-transmembrane-helix MFS transporters, four triple-helix bundles are arranged into an alternating antiparallel configuration, resulting in a much larger 2 X 2 triplehelix bundle forming the pore. Given the similarity of SemiSWEETs and SWEETs to PQ-loop amino acid transporters and to mitochondrial pyruvate carriers (MPCs), the structures characterized here may also be relevant to other transporters in the MtN3 clan(7-9). The insight gained from the structures of these transporters and from the analysis of mutations of conserved residues will improve the understanding of the transport mechanism, as well as allow comparative studies of the different superfamilies involved in sugar transport and the evolution of transporters in general.	[Xu, Yan; Tao, Yuyong; Fan, Chao; Feng, Liang] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Cheung, Lily S.; Chen, Li-Qing; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Xu, Sophia; Frommer, Wolf B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Perry, Kay] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Perry, Kay] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Stanford University; Carnegie Institution for Science; Stanford University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Feng, L (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	liangf@stanford.edu	Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017; Cheung, Lily S/AAA-8344-2022	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Cheung, Lily S/0000-0001-8089-7783	Stanford University; Harold and Leila Y. Mathers Charitable Foundation; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE) [DE-FG02-04ER15542]; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; DOE [DE-AC02-06CH11357]; Direct For Biological Sciences [1401855] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1258018] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	Stanford University(Stanford University); Harold and Leila Y. Mathers Charitable Foundation; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE)(United States Department of Energy (DOE)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); DOE(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at beamlines 23ID-B and 23ID-D (APS, Argonne National Laboratory) and S. Russi and the staff at beamlines 11-1 and 12-2 (SSRL, SLAC National Laboratory) for assistance at the synchrotrons. We thank the Kobilka laboratory for help and advice on the LCP. This work was made possible by support from Stanford University and the Harold and Leila Y. Mathers Charitable Foundation to L.F. and from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE) under grant number DE-FG02-04ER15542 to W.B.F. Part of this work is based upon research conducted at the APS on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health. Use of the APS, an Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory, was supported by the DOE under contract number DE-AC02-06CH11357.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Hamada M, 2005, DIFFERENTIATION, V73, P364, DOI 10.1111/j.1432-0436.2005.00037.x; HENDERSON PJF, 1977, BIOCHEM J, V162, P309, DOI 10.1042/bj1620309; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sosso D, 2013, ENCY BIOPHYSICS, V5, P2556; Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Sun MX, 2013, PLANT REPROD, V26, P83, DOI 10.1007/s00497-012-0208-1; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wright EM, 2013, MOL ASPECTS MED, V34, P183, DOI 10.1016/j.mam.2012.11.002; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8	43	99	106	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					448	+		10.1038/nature13670	http://dx.doi.org/10.1038/nature13670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25186729	Green Accepted			2022-12-28	WOS:000345770600054
J	Joffe, S				Joffe, Steven			Evaluating Novel Therapies During the Ebola Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Joffe, Steven] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Joffe, S (corresponding author), Dept Med Eth & Hlth Policy, 3401 Market St,Ste 320, Philadelphia, PA 19104 USA.	joffes@upenn.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Advisory Panel to the World Health Organization, 2014, ETH CONS US UNR INT; CHALMERS TC, 1975, MED CLIN N AM, V59, P1035, DOI 10.1016/S0025-7125(16)32001-6; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Hampton T, 2014, JAMA-J AM MED ASSOC, V312, P987, DOI 10.1001/jama.2014.11170; No authors listed, 1948, BMJ-BRIT MED J, V2, P769; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777	7	59	62	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1299	1300		10.1001/jama.2014.12867	http://dx.doi.org/10.1001/jama.2014.12867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25211645	Bronze, Green Published			2022-12-28	WOS:000342345400013
J	Chokshi, DA; Farley, TA				Chokshi, Dave A.; Farley, Thomas A.			Changing behaviors to prevent noncommunicable diseases	SCIENCE			English	Editorial Material							TOBACCO		[Chokshi, Dave A.] NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY 10016 USA; [Chokshi, Dave A.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Farley, Thomas A.] CUNY Hunter Coll, New York, NY 10065 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; City University of New York (CUNY) System; Hunter College (CUNY)	Chokshi, DA (corresponding author), NYU, Dept Populat Hlth, Langone Med Ctr, 550 1st Ave, New York, NY 10016 USA.	dave.chokshi@nyumc.org		Chokshi, Dave/0000-0001-7467-4591				Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Chokshi DA, 2012, NEW ENGL J MED, V367, P295, DOI 10.1056/NEJMp1206268; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P133, DOI 10.1001/jama.2013.284534; Guthrie A, 2014, WALL STREET J; Lin JS, 2014, ANN INTERN MED, V161, P568, DOI 10.7326/M14-0130; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Puska P, 2010, ANNU REV PUBL HEALTH, V31, P315, DOI 10.1146/annurev.publhealth.012809.103658	13	23	23	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1243	1244		10.1126/science.1259809	http://dx.doi.org/10.1126/science.1259809			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214590				2022-12-28	WOS:000341483800018
J	Brotherton, MS				Brotherton, Michael S.			ASTROPHYSICS Quasar complexity simplified	NATURE			English	Editorial Material									Univ Wyoming, Dept Phys & Astron, Laramie, WY 82071 USA	University of Wyoming	Brotherton, MS (corresponding author), Univ Wyoming, Dept Phys & Astron, Laramie, WY 82071 USA.	mbrother@uwyo.edu		Brotherton, Michael/0000-0002-1207-0909				BOROSON TA, 1992, ASTROPHYS J SUPPL S, V80, P109, DOI 10.1086/191661; SCHMIDT M, 1963, NATURE, V197, P1040, DOI 10.1038/1971040a0; Shen Y, 2014, NATURE, V513, P210, DOI 10.1038/nature13712; WILLS BJ, 1986, ASTROPHYS J, V302, P56, DOI 10.1086/163973	5	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					181	182		10.1038/513181a	http://dx.doi.org/10.1038/513181a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209796				2022-12-28	WOS:000341362800040
J	Mathews, JA; Tan, H				Mathews, John A.; Tan, Hao			Manufacture renewables to build energy security	NATURE			English	Editorial Material									[Mathews, John A.] Macquarie Univ, Macquarie Grad Sch Management, Sydney, NSW 2109, Australia; [Tan, Hao] Univ Newcastle, Newcastle Business Sch, Callaghan, NSW 2308, Australia	Macquarie University; University of Newcastle	Mathews, JA (corresponding author), Macquarie Univ, Macquarie Grad Sch Management, Sydney, NSW 2109, Australia.	john.mathews@mgsm.edu.au		Tan, Hao/0000-0002-8347-7837; Mathews, John/0000-0002-4380-7563				BP, 2014, STAT REV WORLD ENERG; Helm D, 2012, NATURE, V491, P663, DOI 10.1038/491663a; Mathews J. A., 2014, J SUSTAIN ENERGY ENG; Mathews J. A., 2014, ASIA PAC J, V12; Mathews JA, 2014, FUTURES, V61, P13, DOI 10.1016/j.futures.2014.04.011; Trancik JE, 2014, NATURE, V507, P300, DOI 10.1038/507300a; World Energy Council, 2013, WORLD EN PERSP COST	7	63	63	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					166	168		10.1038/513166a	http://dx.doi.org/10.1038/513166a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5DP	25209783	Bronze			2022-12-28	WOS:000341362800026
J	Zhang, WZ; Cao, L; Hu, SJ; Huang, XJ; Yang, YF				Zhang, Weizhi; Cao, Liang; Hu, Shijun; Huang, Xiaojie; Yang, Yifeng			Nail gun penetrating cardiac injury in a young child	LANCET			English	Editorial Material									[Zhang, Weizhi; Cao, Liang; Hu, Shijun; Huang, Xiaojie; Yang, Yifeng] Cent South Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha 410011, Hunan, Peoples R China	Central South University	Yang, YF (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China.	yyf627@163.com	hu, shijun/ABH-2693-2020					BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Eren E, 2004, J THORAC CARDIOV SUR, V127, P598, DOI 10.1016/j.jtcvs.2003.09.041; Hsia RY, 2012, J EMERG MED, V43, P116, DOI 10.1016/j.jemermed.2010.06.027; Temple AD, 2013, J EMERG MED, V44, pE161, DOI 10.1016/j.jemermed.2012.01.054; Wang MJ, 1999, CIRCULATION, V100, pE18	5	4	4	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					828	828		10.1016/S0140-6736(14)61370-2	http://dx.doi.org/10.1016/S0140-6736(14)61370-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	25176553				2022-12-28	WOS:000341361500043
J	Bellini, G; Benziger, J; Bick, D; Bonfini, G; Bravo, D; Caccianiga, B; Cadonati, L; Calaprice, F; Caminata, A; Cavalcante, P; Chavarria, A; Chepurnov, A; D'Angelo, D; Davini, S; Derbin, A; Empl, A; Etenko, A; Fomenke, K; Franco, D; Gabriele, F; Galbiati, C; Gazzana, S; Ghiano, C; Giammarchi, M; Goger-Neff, M; Goretti, A; Gromov, M; Hagner, C; Hungerford, E; Ianni, A; Ianni, A; Kobychev, V; Korablev, D; Korga, G; Kryn, D; Laubenstein, M; Lehnert, B; Lewke, T; Litvinovich, E; Lombardi, F; Lombardi, P; Ludhova, L; Lukyanchenko, G; Machulin, I; Manecki, S; Maneschg, W; Marcocci, S; Meindl, Q; Meroni, E; Meyer, M; Miramonti, L; Misiaszek, M; Montuschi, M; Mosteiro, P; Muratova, V; Oberauer, L; Obolensky, M; Ortica, F; Otis, K; Pallavicini, M; Papp, L; Perasso, L; Pocar, A; Ranucci, G; Razeto, A; Re, A; Romani, A; Rossi, N; Saldanha, R; Salvo, C; Schonert, S; Simgen, H; Skorokhvatov, M; Smirnov, O; Sotnikov, A; Sukhotin, S; Suvorov, Y; Tartaglia, R; Testera, G; Vignaud, D; Vogelaar, RB; von Feilitzsch, F; Wang, H; Winter, J; Wojcik, M; Wright, A; Wurm, M; Zaimidoroga, O; Zavatarelli, S; Zuber, K; Zuzel, G				Bellini, G.; Benziger, J.; Bick, D.; Bonfini, G.; Bravo, D.; Caccianiga, B.; Cadonati, L.; Calaprice, F.; Caminata, A.; Cavalcante, P.; Chavarria, A.; Chepurnov, A.; D'Angelo, D.; Davini, S.; Derbin, A.; Empl, A.; Etenko, A.; Fomenke, K.; Franco, D.; Gabriele, F.; Galbiati, C.; Gazzana, S.; Ghiano, C.; Giammarchi, M.; Goeger-Neff, M.; Goretti, A.; Gromov, M.; Hagner, C.; Hungerford, E.; Ianni, Aldo; Ianni, Andrea; Kobychev, V.; Korablev, D.; Korga, G.; Kryn, D.; Laubenstein, M.; Lehnert, B.; Lewke, T.; Litvinovich, E.; Lombardi, F.; Lombardi, P.; Ludhova, L.; Lukyanchenko, G.; Machulin, I.; Manecki, S.; Maneschg, W.; Marcocci, S.; Meindl, Q.; Meroni, E.; Meyer, M.; Miramonti, L.; Misiaszek, M.; Montuschi, M.; Mosteiro, P.; Muratova, V.; Oberauer, L.; Obolensky, M.; Ortica, F.; Otis, K.; Pallavicini, M.; Papp, L.; Perasso, L.; Pocar, A.; Ranucci, G.; Razeto, A.; Re, A.; Romani, A.; Rossi, N.; Saldanha, R.; Salvo, C.; Schoenert, S.; Simgen, H.; Skorokhvatov, M.; Smirnov, O.; Sotnikov, A.; Sukhotin, S.; Suvorov, Y.; Tartaglia, R.; Testera, G.; Vignaud, D.; Vogelaar, R. B.; von Feilitzsch, F.; Wang, H.; Winter, J.; Wojcik, M.; Wright, A.; Wurm, M.; Zaimidoroga, O.; Zavatarelli, S.; Zuber, K.; Zuzel, G.		Borexino Collaboration	Neutrinos from the primary proton-proton fusion process in the Sun	NATURE			English	Article							SOLAR NEUTRINOS; MODELS; OSCILLATIONS; ABUNDANCE; CHAIN; PP	In the core of the Sun, energy is released through sequences of nuclear reactions that convert hydrogen into helium. The primary reaction is thought to be the fusion of two protons with the emission of a low-energy neutrino. These These so-called pp neutrinos constitute nearly the entirety of the solar neutrino flux, vastly outnumbering those emitted in the reactions that follow. Although solar neutrinos from secondary processes have been observed, proving the nuclear origin of the Sun's energy and contributing to the discovery of neutrino oscillations, those from proton-proton fusion have hitherto eluded direct detection. Here we report spectral observations of pp neutrinos, demonstrating that about 99 per cent of the Power of the Sun, 3.84 x 10(33) ergs per second, is generated by the proton-proton fusion process.	[Bellini, G.; Caccianiga, B.; D'Angelo, D.; Giammarchi, M.; Lombardi, P.; Ludhova, L.; Meroni, E.; Miramonti, L.; Ranucci, G.; Re, A.] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy; [Bellini, G.; Caccianiga, B.; D'Angelo, D.; Giammarchi, M.; Lombardi, P.; Ludhova, L.; Meroni, E.; Miramonti, L.; Ranucci, G.; Re, A.] Ist Nazl Fis Nucl, I-20133 Milan, Italy; [Benziger, J.] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA; [Bick, D.; Hagner, C.; Meyer, M.] Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; [Bonfini, G.; Cavalcante, P.; Chavarria, A.; Fomenke, K.; Gabriele, F.; Gazzana, S.; Ianni, Aldo; Laubenstein, M.; Lombardi, F.; Montuschi, M.; Razeto, A.; Rossi, N.; Suvorov, Y.; Tartaglia, R.] Ist Nazl Fis Nucl, Lab Nazl Gran Sasso, I-67100 Assergi, Italy; [Bravo, D.; Manecki, S.; Papp, L.; Vogelaar, R. B.] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Cadonati, L.; Otis, K.; Pocar, A.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Calaprice, F.; Chavarria, A.; Galbiati, C.; Goretti, A.; Ianni, Andrea; Mosteiro, P.; Saldanha, R.; Wright, A.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Calaprice, F.; Marcocci, S.] Ist Nazl Fis Nucl, Gran Sasso Sci Inst, I-67100 Laquila, Italy; [Caminata, A.; Ghiano, C.; Marcocci, S.; Pallavicini, M.; Perasso, L.; Salvo, C.; Testera, G.; Zavatarelli, S.] Univ Genoa, Dipartimento Fis, I-16146 Genoa, Italy; [Caminata, A.; Ghiano, C.; Marcocci, S.; Pallavicini, M.; Perasso, L.; Salvo, C.; Testera, G.; Zavatarelli, S.] Ist Nazl Fis Nucl, I-16146 Genoa, Italy; [Chepurnov, A.; Gromov, M.] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow 119234, Russia; [Davini, S.; Empl, A.; Hungerford, E.; Korga, G.] Univ Houston, Dept Phys, Houston, TX 77204 USA; [Derbin, A.; Muratova, V.] St Petersburg Nucl Phys Inst, Gatchina 188350, Russia; [Etenko, A.; Litvinovich, E.; Lukyanchenko, G.; Machulin, I.; Skorokhvatov, M.; Sukhotin, S.; Suvorov, Y.] NRC Kurchatov Inst, Moscow 123182, Russia; [Etenko, A.; Litvinovich, E.; Machulin, I.] Natl Res Nucl Univ MEPhl, Moscow Engn Phys Inst, Moscow 115409, Russia; [Fomenke, K.; Korablev, D.; Smirnov, O.; Sotnikov, A.; Zaimidoroga, O.] Joint Inst Nucl Res, Dubna 141980, Russia; [Franco, D.; Kryn, D.; Obolensky, M.; Vignaud, D.] Univ Paris Diderot, APC, CNRS CEA Irfu IN2P3, Observ Paris,Sorbonne Paris Cite, F-75205 Paris 13, France; [Goeger-Neff, M.; Lewke, T.; Meindl, Q.; Oberauer, L.; Papp, L.; Schoenert, S.; von Feilitzsch, F.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Goeger-Neff, M.; Lewke, T.; Meindl, Q.; Oberauer, L.; Papp, L.; Schoenert, S.; von Feilitzsch, F.] Tech Univ Munich, Excellence Cluster Universe, D-85748 Garching, Germany; [Kobychev, V.] Kiev Inst Nucl Res, UA-03680 Kiev, Ukraine; [Lehnert, B.; Zuber, K.] Tech Univ Dresden, Dept Phys, D-01062 Dresden, Germany; [Maneschg, W.; Simgen, H.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Misiaszek, M.; Wojcik, M.; Zuzel, G.] Jagiellonian Univ, M Smoluchowski Inst Phys, PL-30059 Krakow, Poland; [Ortica, F.; Romani, A.] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06123 Perugia, Italy; [Suvorov, Y.; Wang, H.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Winter, J.; Wurm, M.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55122 Mainz, Germany	University of Milan; Istituto Nazionale di Fisica Nucleare (INFN); Princeton University; University of Hamburg; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN); Virginia Polytechnic Institute & State University; University of Massachusetts System; University of Massachusetts Amherst; Princeton University; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN); University of Genoa; Istituto Nazionale di Fisica Nucleare (INFN); Lomonosov Moscow State University; University of Houston System; University of Houston; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; National Research Centre - Kurchatov Institute; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Joint Institute for Nuclear Research - Russia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Technical University of Munich; Technical University of Munich; University of Munich; National Academy of Sciences Ukraine; Institute for Nuclear Research of NASU; Technische Universitat Dresden; Max Planck Society; Jagiellonian University; University of Perugia; University of California System; University of California Los Angeles; Johannes Gutenberg University of Mainz	Smirnov, O (corresponding author), Joint Inst Nucl Res, Dubna 141980, Russia.	borex-spokeperson@lngs.infn.it	Ortica, Fausto/C-1001-2013; Romani, Aldo/G-8103-2012; Gromov, Maxim/T-3342-2018; Montuschi, Michele/AAO-8592-2020; Davini, Stefano/HDN-4273-2022; Miramonti, Lino/J-3217-2012; Pallavicini, Marco/G-5500-2012; Derbin, Alexander V/L-5493-2017; Lombardi, Francesco/AAH-7657-2021; D'Angelo, Davide/K-9164-2013; Kobychev, Vladislav V/B-3322-2008; Lehnert, Bjoern/D-3450-2017; Miramonti, Lino/AAF-7880-2019; Testera, Gemma/AAG-2260-2020; Smirnov, Oleg/HHS-6187-2022; Ranucci, Gioacchino/O-2200-2015; Muratova, Valentina/AAP-4130-2021; Rossi, Nicola/A-7697-2013; Marcocci, Simone/O-6537-2018; Machulin, Igor Nikolaevich/R-9711-2016; Sotnikov, Alexandr/I-6836-2017; Fomenko, Kirill/P-2857-2018; Lombardi, Paolo/AAF-6960-2020; Ludhova, Livia/AAE-4487-2020; Galbiati, Cristiano/I-7487-2012; Re, Alessandra Carlotta/H-2411-2017; Caminata, Alessio/HHC-1509-2022; Litvinovich, Evgeny/R-9704-2016; Laubenstein, Matthias/C-4851-2013; Razeto, Alessandro/J-3320-2015; Skorokhvatov, Mikhail Dmytrievich/R-9735-2016; Smirnov, Oleg Yu/S-2971-2016; Schonert, Stefan/B-3230-2018; Ianni, Aldo/T-1747-2017	Ortica, Fausto/0000-0001-8276-452X; Romani, Aldo/0000-0002-7338-0097; Gromov, Maxim/0000-0003-2869-2363; Miramonti, Lino/0000-0002-2808-5363; Pallavicini, Marco/0000-0001-7309-3023; Derbin, Alexander V/0000-0002-4351-2255; Lombardi, Francesco/0000-0003-0229-4391; D'Angelo, Davide/0000-0001-9857-8107; Kobychev, Vladislav V/0000-0003-0030-7451; Lehnert, Bjoern/0000-0002-6705-7138; Miramonti, Lino/0000-0002-2808-5363; Ranucci, Gioacchino/0000-0002-3591-8191; Muratova, Valentina/0000-0001-5532-7711; Rossi, Nicola/0000-0002-7046-528X; Marcocci, Simone/0000-0002-4516-3191; Galbiati, Cristiano/0000-0002-2409-502X; Re, Alessandra Carlotta/0000-0002-2340-7802; Caminata, Alessio/0000-0002-5800-5504; Laubenstein, Matthias/0000-0001-5390-4343; Razeto, Alessandro/0000-0002-0578-097X; Smirnov, Oleg Yu/0000-0002-5238-0442; Montuschi, Michele/0000-0002-2930-5030; Saldanha, Richard/0000-0003-2771-3281; Sotnikov, Albert/0000-0001-8371-5949; Gabriele, Federico/0000-0001-9888-9175; Bravo Berguno, David/0000-0001-9876-2684; Lukyanchenko, Georgy/0000-0001-7449-2923; Schonert, Stefan/0000-0001-5276-2881; Franco, Davide/0000-0001-5604-2531; Ludhova, Livia/0000-0002-3875-0590; Wurm, Michael/0000-0003-2711-0915; Ianni, Aldo/0000-0002-6962-3682	INFN (Italy); NSF (USA); BMBF (Germany); DFG (Germany); MPG (Germany); JINR; RFBR (Russia); RSC (Russia); NRC Kurchatov Institute (Russia); NCN (Poland); Laboratori Nazionali del Gran Sasso (Italy); Division Of Physics [1102798, 1103987, 1413031] Funding Source: National Science Foundation	INFN (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); NSF (USA)(National Science Foundation (NSF)); BMBF (Germany)(Federal Ministry of Education & Research (BMBF)); DFG (Germany)(German Research Foundation (DFG)); MPG (Germany)(Max Planck Society); JINR; RFBR (Russia)(Russian Foundation for Basic Research (RFBR)); RSC (Russia); NRC Kurchatov Institute (Russia); NCN (Poland); Laboratori Nazionali del Gran Sasso (Italy); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The Borexino program is made possible by funding from the INFN (Italy); the NSF (USA); the BMBF, DFG and MPG (Germany); the JINR; the RFBR, RSC and NRC Kurchatov Institute (Russia); and the NCN (Poland). We acknowledge the support of the Laboratori Nazionali del Gran Sasso (Italy).	ABDURASHITOV JN, 1994, PHYS LETT B, V328, P234, DOI 10.1016/0370-2693(94)90454-5; Abe K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.052010; Adelberger EG, 2011, REV MOD PHYS, V83, P195, DOI 10.1103/RevModPhys.83.195; Ahmad QR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.071301; Alimonti G, 2009, NUCL INSTRUM METH A, V609, P58, DOI 10.1016/j.nima.2009.07.028; Alimonti G, 2009, NUCL INSTRUM METH A, V600, P568, DOI 10.1016/j.nima.2008.11.076; Alimonti G, 1998, ASTROPART PHYS, V8, P141, DOI 10.1016/S0927-6505(97)00050-9; Alimonti G, 1998, PHYS LETT B, V422, P349, DOI 10.1016/S0370-2693(97)01565-7; ANSELMANN P, 1992, PHYS LETT B, V285, P376, DOI 10.1016/0370-2693(92)91521-A; Arpesella C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.091302; Back H, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/10/P10018; Bahcall JN, 1997, PHYS REV C, V56, P3391, DOI 10.1103/PhysRevC.56.3391; BAHCALL JN, 1988, REV MOD PHYS, V60, P297, DOI 10.1103/RevModPhys.60.297; Bahcall JN, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.131301; Bahcall JN, 1995, REV MOD PHYS, V67, P781, DOI 10.1103/RevModPhys.67.781; BAHCALL JN, 1995, PHYS REV D, V51, P6146, DOI 10.1103/PhysRevD.51.6146; Bellini G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.051302; Bellini G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.141302; Bellini G, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.033006; Benziger J, 2008, NUCL INSTRUM METH A, V587, P277, DOI 10.1016/j.nima.2007.12.043; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Bethe HA, 1938, PHYS REV, V54, P248, DOI 10.1103/PhysRev.54.248; Bethe HA, 1939, PHYS REV, V55, P0434, DOI 10.1103/PhysRev.55.434; CAMERON AGW, 1958, ANN REV NUCL SCI, V8, P299, DOI 10.1146/annurev.ns.08.120158.001503; Cleveland BT, 1998, ASTROPHYS J, V496, P505, DOI 10.1086/305343; FOWLER WA, 1958, ASTROPHYS J, V127, P551, DOI 10.1086/146487; Fukuda Y, 1996, PHYS REV LETT, V77, P1683, DOI 10.1103/PhysRevLett.77.1687; Haxton WC, 2008, ASTROPHYS J, V687, P678, DOI 10.1086/591787; Haxton WC, 2013, ANNU REV ASTRON ASTR, V51, P21, DOI 10.1146/annurev-astro-081811-125539; Ianni A, 2014, PHYS DARK UNIVERSE, V4, P44, DOI 10.1016/j.dark.2014.06.002; Knoll G. F., 2010, RAD DETECTORS MEASUR, P290; KRAUSS LM, 1992, NATURE, V357, P437, DOI 10.1038/357437a0; Kuzminov VV, 2000, PHYS ATOM NUCL+, V63, P1292, DOI 10.1134/1.855786; McDonald AB, 2013, NUCL PHYS B-PROC SUP, V235, P61, DOI 10.1016/j.nuclphysbps.2013.03.012; MIKHEEV SP, 1985, SOV J NUCL PHYS+, V42, P913; MITALAS R, 1992, ASTROPHYS J, V401, P759, DOI 10.1086/172103; Serenelli AM, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/24; Turck-Chieze S, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/8/086901; von Weizsacker CF, 1937, PHYS Z, V38, P176; WOLFENSTEIN L, 1978, PHYS REV D, V17, P2369, DOI 10.1103/PhysRevD.17.2369	41	202	203	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					383	U313		10.1038/nature13702	http://dx.doi.org/10.1038/nature13702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164748				2022-12-28	WOS:000340840600023
J	Koch, G; Yepes, A; Forstner, KU; Wermser, C; Stengel, ST; Modamio, J; Ohlsen, K; Foster, KR; Lopez, D				Koch, Gudrun; Yepes, Ana; Foerstner, Konrad U.; Wermser, Charlotte; Stengel, Stephanie T.; Modamio, Jennifer; Ohlsen, Knut; Foster, Kevin R.; Lopez, Daniel			Evolution of Resistance to a Last-Resort Antibiotic in Staphylococcus aureus via Bacterial Competition	CELL			English	Article							QUORUM-SENSING SYSTEM; VANCOMYCIN-INTERMEDIATE; CLINICAL STRAIN; GENE REGULATOR; VIRULENCE; AGR; IDENTIFICATION; SIGMA(B); SUSCEPTIBILITY; EPIDERMIDIS	Antibiotic resistance is a key medical concern, with antibiotic use likely being an important cause. However, here we describe an alternative route to clinically relevant antibiotic resistance that occurs solely due to competitive interactions among bacterial cells. We consistently observe that isolates of Methicillin-resistant Staphylococcus aureus diversify spontaneously into two distinct, sequentially arising strains. The first evolved strain outgrows the parent strain via secretion of surfactants and a toxic bacteriocin. The second is resistant to the bacteriocin. Importantly, this second strain is also resistant to intermediate levels of vancomycin. This so-called VISA (vancomycin-intermediate S. aureus) phenotype is seen in many hard-to-treat clinical isolates. This strain diversification also occurs during in vivo infection in a mouse model, which is consistent with the fact that both coevolved phenotypes resemble strains commonly found in clinic. Our study shows how competition between coevolving bacterial strains can generate antibiotic resistance and recapitulate key clinical phenotypes.	[Koch, Gudrun; Yepes, Ana; Wermser, Charlotte; Stengel, Stephanie T.; Modamio, Jennifer; Lopez, Daniel] Univ Wurzburg, Res Ctr Infect Dis ZINF, D-97080 Wurzburg, Germany; [Foerstner, Konrad U.; Foster, Kevin R.; Lopez, Daniel] Univ Wurzburg, Inst Mol Infect Biol IMIB, D-97080 Wurzburg, Germany; [Foster, Kevin R.] Dept Zool, Oxford, England; [Foster, Kevin R.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Wurzburg; University of Wurzburg; University of Oxford	Lopez, D (corresponding author), Univ Wurzburg, Res Ctr Infect Dis ZINF, D-97080 Wurzburg, Germany.	daniel.lopez@uni-wuerzburg.de	Förstner, Konrad U./B-1531-2010; López, Daniel/HGB-9382-2022	Förstner, Konrad U./0000-0002-1481-2996; López, Daniel/0000-0002-8627-3813; Foster, Kevin/0000-0003-4687-6633	ZINF; DFG [LO 1804/2-1, SFB-TR34 Z3]; ERC grants [242670, 335568]; FWF fellowship	ZINF; DFG(German Research Foundation (DFG)); ERC grants; FWF fellowship(Austrian Science Fund (FWF))	We thank IMIB, especially Stan Gorski for his help in editing the manuscript, Dr. S. Engelmann (Univ. Greifswald, Germany) for providing antibodies, and AG Ohlsen for guidance with animal experiments. This work was funded by ZINF (D. L.); the DFG grants LO 1804/2-1 (D. L.) and SFB-TR34 Z3 (K. O.); and ERC grants 242670 (K. R. F.) and 335568 (D. L.). G. K. is a recipient of FWF fellowship.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BROWN DR, 1980, INFECT IMMUN, V30, P36, DOI 10.1128/IAI.30.1.36-42.1980; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P428, DOI 10.1128/AAC.50.2.428-438.2006; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Graham JW, 2013, J BACTERIOL, V195, P4506, DOI 10.1128/JB.00758-13; Gunther T, 2011, MAGNESIUM RES, V24, P223, DOI 10.1684/mrh.2011.0297; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Karlsson-Kanth A, 2006, INT J MED MICROBIOL, V296, P229, DOI 10.1016/j.ijmm.2006.01.067; Kies S, 2003, PEPTIDES, V24, P329, DOI 10.1016/S0196-9781(03)00046-9; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Lennette E.H., MANUAL OF CLINICAL M; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; Marles-Wright J, 2010, BIOCHEM SOC T, V38, P928, DOI 10.1042/BST0380928; MARSHALL JH, 1981, J BACTERIOL, V147, P914, DOI 10.1128/JB.147.3.914-919.1981; Matsuo M, 2013, ANTIMICROB AGENTS CH, V57, P5843, DOI 10.1128/AAC.00425-13; McDowell P, 2001, MOL MICROBIOL, V41, P503, DOI 10.1046/j.1365-2958.2001.02539.x; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Morfeldt E, 1996, MOL MICROBIOL, V21, P1227, DOI 10.1046/j.1365-2958.1996.751447.x; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Pereira PM, 2007, ANTIMICROB AGENTS CH, V51, P3627, DOI 10.1128/AAC.00431-07; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; SCHLIEVERT PM, 1985, J INFECT DIS, V152, P618, DOI 10.1093/infdis/152.3.618; Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13; SERVINM.M, 1961, J BACTERIOL, V82, P316, DOI 10.1128/JB.82.2.316-317.1961; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; TENOVER FC, 1994, J CLIN MICROBIOL, V32, P407, DOI 10.1128/JCM.32.2.407-415.1994; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; Votintseva AA, 2014, J CLIN MICROBIOL, V52, P1192, DOI 10.1128/JCM.03254-13; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	57	122	126	3	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1060	1071		10.1016/j.cell.2014.06.046	http://dx.doi.org/10.1016/j.cell.2014.06.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171407	Green Accepted, Bronze			2022-12-28	WOS:000340945000012
J	Sheldon, BC; Mangel, M				Sheldon, Ben C.; Mangel, Marc			BEHAVIOURAL ECOLOGY Love thy neighbour	NATURE			English	Editorial Material							PAIR; PATERNITY; SELECTION		[Sheldon, Ben C.] Univ Oxford, Edward Grey Inst, Dept Zool, Oxford OX1 3PS, England; [Mangel, Marc] Univ Calif Santa Cruz, Ctr Stock Assessment Res, Santa Cruz, CA 95064 USA	University of Oxford; University of California System; University of California Santa Cruz	Sheldon, BC (corresponding author), Univ Oxford, Edward Grey Inst, Dept Zool, Oxford OX1 3PS, England.	ben.sheldon@zoo.ox.ac.uk; msmangel@ucsc.edu	Sheldon, Ben C/A-8056-2010	Sheldon, Ben C/0000-0002-5240-7828				Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; Dercole F, 2008, PRINC SER THEOR COMP, P1; Eliassen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099878; Forstmeier W, 2014, TRENDS ECOL EVOL, V29, P456, DOI 10.1016/j.tree.2014.05.005; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Levin S., 2014, P NATL ACAD SCI U S3, V111, P10781; Sardell RJ, 2012, AM NAT, V179, P779, DOI 10.1086/665665; Sheldon BC, 2002, PHILOS T R SOC B, V357, P341, DOI 10.1098/rstb.2001.0931	10	2	2	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					381	382		10.1038/512381a	http://dx.doi.org/10.1038/512381a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164746				2022-12-28	WOS:000340840600022
J	Wrachtrup, J; Finkler, A				Wrachtrup, Joerg; Finkler, Amit			APPLIED PHYSICS Hybrid sensors ring the changes	NATURE			English	Editorial Material							DIAMOND; MAGNETOMETER; TRANSDUCER; RESOLUTION		[Wrachtrup, Joerg; Finkler, Amit] Univ Stuttgart, Inst Phys 3, D-70569 Stuttgart, Germany	University of Stuttgart	Wrachtrup, J (corresponding author), Univ Stuttgart, Inst Phys 3, D-70569 Stuttgart, Germany.	wrachtrup@physik.uni-stuttgart.de						Bagci T, 2014, NATURE, V507, P81, DOI 10.1038/nature13029; Budker D, 2007, NAT PHYS, V3, P227, DOI 10.1038/nphys566; Cai J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5065; Doherty MW, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047601; Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Forstner S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120801; Forstner S., 2014, ADV MAT; Gavartin E, 2012, NAT NANOTECHNOL, V7, P509, DOI [10.1038/nnano.2012.97, 10.1038/NNANO.2012.97]; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Kotler S, 2014, NATURE, V510, P376, DOI 10.1038/nature13403; Krause AG, 2012, NAT PHOTONICS, V6, P768, DOI [10.1038/nphoton.2012.245, 10.1038/NPHOTON.2012.245]; Lee SK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2390643; Neumann P, 2013, NANO LETT, V13, P2738, DOI 10.1021/nl401216y; Ovartchaiyapong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5429; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075	15	2	2	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					380	381		10.1038/512380a	http://dx.doi.org/10.1038/512380a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164745				2022-12-28	WOS:000340840600021
J	Tranvik, L				Tranvik, Lars			BIOGEOCHEMISTRY Carbon cycling in the Arctic	SCIENCE			English	Editorial Material							DISSOLVED ORGANIC-MATTER; EMISSIONS		Uppsala Univ, Dept Ecol & Genet, S-75236 Uppsala, Sweden	Uppsala University	Tranvik, L (corresponding author), Uppsala Univ, Dept Ecol & Genet, Norbyvagen 18D, S-75236 Uppsala, Sweden.	lars.tranvik@ebc.uu.se		Tranvik, Lars J./0000-0003-3509-8266				Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cory RM, 2014, SCIENCE, V345, P925, DOI 10.1126/science.1253119; Koehler B, 2014, GLOBAL BIOGEOCHEM CY, V28, P696, DOI 10.1002/2014GB004850; Miller WL, 1997, LIMNOL OCEANOGR, V42, P1317, DOI 10.4319/lo.1997.42.6.1317; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stocker P. F., 2013, CLIM CHANG 2013 PHYS; Wetzel RG, 1995, LIMNOL OCEANOGR, V40, P1369, DOI 10.4319/lo.1995.40.8.1369	9	11	13	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					870	870		10.1126/science.1258235	http://dx.doi.org/10.1126/science.1258235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146267				2022-12-28	WOS:000340524700018
J	King, MC; Levy-Lahad, E; Lahad, A				King, Mary-Claire; Levy-Lahad, Ephrat; Lahad, Amnon			Population-Based Screening for BRCA1 and BRCA2 2014 Lasker Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER-RISK		[King, Mary-Claire] Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA; [Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel; [Levy-Lahad, Ephrat; Lahad, Amnon] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Lahad, Amnon] Clalit Hlth Serv, Dept Family Med, Jerusalem, Israel	University of Washington; University of Washington Seattle; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Clalit Health Services	King, MC (corresponding author), Univ Washington, Dept Med & Genome Sci, Room K-160, Seattle, WA 98195 USA.	mcking@uw.edu	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [R01 CA157744, R35 CA197458] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA197458, R01CA157744] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Bellcross CA, 2011, AM J PREV MED, V40, P61, DOI 10.1016/j.amepre.2010.09.027; Domchek SM, 2014, GENET MED, V16, P827, DOI 10.1038/gim.2014.56; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Gabai-Kapara E, 2014, P NATL ACAD SCI US; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; King MC, 2014, SCIENCE, V343, P1462, DOI 10.1126/science.1251900; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Weitzel JN, 2007, JAMA-J AM MED ASSOC, V297, P2587, DOI 10.1001/jama.297.23.2587	10	192	194	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1091	1092		10.1001/jama.2014.12483	http://dx.doi.org/10.1001/jama.2014.12483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25198398	Bronze			2022-12-28	WOS:000341624700013
J	Eisenstein, M				Eisenstein, Michael			Special treatment	NATURE			English	Editorial Material							LUNG CANCERS; MUTATIONS											Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894	8	13	13	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S8	S9		10.1038/513S8a	http://dx.doi.org/10.1038/513S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208073	Bronze			2022-12-28	WOS:000341362800005
J	D'Silva, J				D'Silva, Jeetha			BMJ AWARDS INDIA Judging the best of Indian healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						[Anonymous], 2014, BIOSPECTRUM     0630; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4540; Singh S, 2005, EXPERT OPINION THERA, V15, P1439	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2014	349								g5454	10.1136/bmj.g5454	http://dx.doi.org/10.1136/bmj.g5454			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MK	25189833	Green Published, Bronze			2022-12-28	WOS:000341388800007
J	Poletti, ED; Munoz-Sandoval, R				David Poletti, Eduardo; Munoz-Sandoval, Rocio			Aquagenic Keratoderma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[David Poletti, Eduardo; Munoz-Sandoval, Rocio] Univ Autonoma Aguascalientes, Aguascalientes, Mexico	Universidad Autonoma de Aguascalientes	Poletti, ED (corresponding author), Univ Autonoma Aguascalientes, Aguascalientes, Mexico.	drpoletti@dermanorte.com.mx							0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					952	952		10.1056/NEJMicm1314806	http://dx.doi.org/10.1056/NEJMicm1314806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184867				2022-12-28	WOS:000341390600012
J	Hawkes, N				Hawkes, Nigel			Commission sets out funding options for widening eligibility for free social care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Commission on the Future of Health and Social Care in England, 2014, NEW SETTL HLTH SOC C; Hawkes N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2534; Hawkes N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3973	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2014	349								g5396	10.1136/bmj.g5396	http://dx.doi.org/10.1136/bmj.g5396			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MK	25190766				2022-12-28	WOS:000341388800004
J	Kurian, AW; Lichtensztajn, DY; Keegan, THM; Nelson, DO; Clarke, CA; Gomez, SL				Kurian, Allison W.; Lichtensztajn, Daphne Y.; Keegan, Theresa H. M.; Nelson, David O.; Clarke, Christina A.; Gomez, Scarlett L.			Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTRALATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; 20-YEAR FOLLOW-UP; RISK REDUCTION; SURVIVAL; SATISFACTION; OUTCOMES; WOMEN; RATES; PERCEPTIONS	IMPORTANCE Bilateral mastectomy is increasingly used to treat unilateral breast cancer. Because it may have medical and psychosocial complications, a better understanding of its use and outcomes is essential to optimizing cancer care. OBJECTIVE To compare use of and mortality after bilateral mastectomy, breast-conserving therapy with radiation, and unilateral mastectomy. DESIGN, SETTING, AND PARTICIPANTS Observational cohort study within the population-based California Cancer Registry; participants were women diagnosed with stages O-III unilateral breast cancer in California from 1998 through 2011, with median follow-up of 89.1 months. MAIN OUTCOMES AND MEASURES Factors associated with surgery use (from polytomous logistic regression); overall and breast cancer-specific mortality (from propensity score weighting and Cox proportional hazards analysis). RESULTS Among 189 734 patients, the rate of bilateral mastectomy increased from 2.0% (95% CI, 1.7%-2.2%) in 1998 to 12.3%(95% CI, 11.8%-12.9%) in 2011, an annual increase of 14.3%(95% CI, 13.1%-15.5%); among women younger than 40 years, the rate increased from 3.6%(95% CI, 2.3%-5.0%) in 1998 to 33%(95% CI, 29.8%-36.5%) in 2011. Bilateral mastectomy was more often used by non-Hispanic white women, those with private insurance, and those who received care at a National Cancer Institute (NCI)-designated cancer center (8.6%[95% CI, 8.1%-9.2%] among NCI cancer center patients vs 6.0% [95% CI, 5.9%-6.1%] among non-NCI cancer center patients; odds ratio [OR], 1.13 [95% CI, 1.04-1.22]); in contrast, unilateral mastectomy was more often used by racial/ethnic minorities (Filipina, 52.8%[95% CI, 51.6%-54.0%]; OR, 2.00 [95% CI, 1.90-2.11] and Hispanic, 45.6%[95% CI, 45.0%-46.2%]; OR, 1.16 [95% CI, 1.13-1.20] vs non-Hispanic white, 35.2% [95% CI, 34.9%-35.5%]) and those with public/Medicaid insurance (48.4%[95% CI, 47.8%-48.9%]; OR, 1.08 [95% CI, 1.05-1.11] vs private insurance, 36.6%[95% CI, 36.3%-36.8%]). Compared with breast-conserving surgery with radiation (10-year mortality, 16.8%[95% CI, 16.6%-17.1%]), unilateral mastectomy was associated with higher all-cause mortality (hazard ratio [HR], 1.35 [95% CI, 1.32-1.39]; 10-year mortality, 20.1%[95% CI, 19.9%-20.4%]). There was no significant mortality difference compared with bilateral mastectomy (HR, 1.02 [95% CI, 0.94-1.11]; 10-year mortality, 18.8% [95% CI, 18.6%-19.0%]). Propensity analysis showed similar results. CONCLUSIONS AND RELEVANCE Use of bilateral mastectomy increased significantly throughout California from 1998 through 2011 and was not associated with lower mortality than that achieved with breast-conserving surgery plus radiation. Unilateral mastectomy was associated with higher mortality than were the other 2 surgical options.	[Kurian, Allison W.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Kurian, Allison W.; Keegan, Theresa H. M.; Nelson, David O.; Clarke, Christina A.; Gomez, Scarlett L.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Lichtensztajn, Daphne Y.; Keegan, Theresa H. M.; Nelson, David O.; Clarke, Christina A.; Gomez, Scarlett L.] Canc Prevent Inst Calif, Fremont, CA 94538 USA	Stanford University; Stanford University; Cancer Prevention Institute of California	Gomez, SL (corresponding author), Canc Prevent Inst Calif, 2201 Walnut Ave,Ste 300, Fremont, CA 94538 USA.	scarlett.gomez@cpic.org	Kurian, Allison/A-4560-2019	Kurian, Allison/0000-0002-6175-9470	Jan Weimer Junior Faculty Chair in Breast Oncology; Suzanne Pride Bryan Fund for Breast Cancer Research at Stanford Cancer Institute; NCI SEER program [HHSN261201000140C, HHSN261201000035C, HHSN261201000034C]; CDC National Program of Cancer Registries [1U58 DP000807-01]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER	Jan Weimer Junior Faculty Chair in Breast Oncology; Suzanne Pride Bryan Fund for Breast Cancer Research at Stanford Cancer Institute; NCI SEER program; CDC National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the Jan Weimer Junior Faculty Chair in Breast Oncology, the Suzanne Pride Bryan Fund for Breast Cancer Research at Stanford Cancer Institute, and the NCI SEER program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California (CPIC). The collection of cancer incidence data was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the NCI SEER program under contracts HHSN261201000140C awarded to CPIC, HHSN261201000035C to the University of Southern California, and HHSN261201000034C to the Public Health Institute; and the CDC National Program of Cancer Registries, under agreement 1U58 DP000807-01 awarded to the Public Health Institute.	Abbott A, 2011, ANN SURG ONCOL, V18, P3129, DOI 10.1245/s10434-011-1914-x; Agarwal S, 2014, JAMA SURG, V149, P267, DOI 10.1001/jamasurg.2013.3049; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Barton M. B., 2005, J NATL CANC I MONOGR, V2005, P61; Bedrosian I, 2010, JNCI-J NATL CANCER I, V102, P401, DOI 10.1093/jnci/djq018; Bresser PJC, 2006, PLAST RECONSTR SURG, V117, P1675, DOI 10.1097/01.prs.0000217383.99038.f5; Carlson RW, 2011, J NATL COMPR CANC NE, V9, P136, DOI 10.6004/jnccn.2011.0016; Daly M.B., NCCN CLIN PRACTICE G; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Frost MH, 2005, J CLIN ONCOL, V23, P7849, DOI 10.1200/JCO.2005.09.233; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; Gomez SL, 2010, J CLIN ONCOL, V28, pE155, DOI 10.1200/JCO.2009.26.1032; Griggs JJ, 2007, J CLIN ONCOL, V25, P2522, DOI 10.1200/JCO.2006.10.2749; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hawley ST, 2014, JAMA SURG, V149, P582, DOI 10.1001/jamasurg.2013.5689; Heemskerk-Gerritsen BAM, 2013, ANN ONCOL, V24, P2029, DOI 10.1093/annonc/mdt134; Herrinton LJ, 2005, J CLIN ONCOL, V23, P4275, DOI 10.1200/JCO.2005.10.080; Howard-McNatt M, 2011, AM J SURG, V202, P298, DOI 10.1016/j.amjsurg.2011.04.001; Hwang ES, 2013, CANCER-AM CANCER SOC, V119, P1402, DOI 10.1002/cncr.27795; Katipamula R, 2009, J CLIN ONCOL, V27, P4082, DOI 10.1200/JCO.2008.19.4225; Kauffmann R, 2014, SOC SURG ONC CANC S; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; King TA, 2011, J CLIN ONCOL, V29, P2158, DOI 10.1200/JCO.2010.29.4041; Kurian AW, 2014, CANCER-AM CANCER SOC, V120, P103, DOI 10.1002/cncr.28395; Kurian AW, 2013, BREAST CANCER RES TR, V137, P247, DOI 10.1007/s10549-012-2329-5; Kurian AW, 2010, J CLIN ONCOL, V28, P222, DOI 10.1200/JCO.2009.22.7991; Lostumbo L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002748.pub3; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Miller ME, 2013, ANN SURG ONCOL, V20, P4113, DOI 10.1245/s10434-013-3108-1; Rosenberg SM, 2013, ANN INTERN MED, V159, P373, DOI 10.7326/0003-4819-159-6-201309170-00003; Schnipper LE, 2012, J CLIN ONCOL, V30, P1715, DOI 10.1200/JCO.2012.42.8375; Tuttle TM, 2007, J CLIN ONCOL, V25, P5203, DOI 10.1200/JCO.2007.12.3141; Tuttle TM, 2009, ANN SURG ONCOL, V16, P1461, DOI 10.1245/s10434-009-0427-3; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Wu AH, 2013, CANCER CAUSE CONTROL, V24, P1821, DOI 10.1007/s10552-013-0260-7; Yao K, 2013, BREAST CANCER RES TR, V142, P465, DOI 10.1007/s10549-013-2745-1; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516	39	180	181	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					902	914		10.1001/jama.2014.10707	http://dx.doi.org/10.1001/jama.2014.10707			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182099	Green Accepted, Bronze			2022-12-28	WOS:000341668600019
J	Thu, CA; Chen, WV; Rubinstein, R; Chevee, M; Wolcott, HN; Felsovalyi, KO; Tapia, JC; Shapiro, L; Honig, B; Maniatis, T				Thu, Chan Aye; Chen, Weisheng V.; Rubinstein, Rotem; Chevee, Maxime; Wolcott, Holly N.; Felsovalyi, Klara O.; Tapia, Juan Carlos; Shapiro, Lawrence; Honig, Barry; Maniatis, Tom			Single-Cell Identity Generated by Combinatorial Homophilic Interactions between alpha, beta, and gamma Protocadherins	CELL			English	Article							DROSOPHILA-DSCAM; AXON GUIDANCE; NEURONAL INDIVIDUALITY; CRYSTAL-STRUCTURES; EXPRESSION; SELF; DIVERSITY; ADHESION; SELECTION; PROMOTER	Individual mammalian neurons stochastically express distinct repertoires of alpha, beta, and gamma protocadherin (Pcdh) proteins, which function in neural circuit assembly. We report that all three subfamilies of clustered Pcdhs can engage in specific homophilic interactions, that cell surface delivery of Pcdh alpha isoforms requires cis interactions with other Pcdhs, and that the extracellular cadherin domain EC6 plays a critical role in this process. Examination of homophilic interactions between specific combinations of multiple Pcdh isoforms revealed that Pcdh combinatorial recognition specificities depend on the identity of all of the expressed isoforms. A single mismatched Pcdh isoform can interfere with these combinatorial homophilic interactions. A theoretical analysis reveals that assembly of Pcdh isoforms into multimeric recognition units and the observed tolerance for mismatched isoforms can generate cell surface diversity sufficient for single-cell identity. However, the competing demands of nonself discrimination and self-recognition place limitations on the mechanisms by which homophilic recognition units can function.	[Thu, Chan Aye; Chen, Weisheng V.; Chevee, Maxime; Wolcott, Holly N.; Shapiro, Lawrence; Honig, Barry; Maniatis, Tom] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Rubinstein, Rotem; Felsovalyi, Klara O.; Honig, Barry] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Rubinstein, Rotem; Felsovalyi, Klara O.; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Rubinstein, Rotem; Felsovalyi, Klara O.; Honig, Barry] Howard Hughes Med Inst, Chevy Chase, MD USA; [Tapia, Juan Carlos] Howard Hughes Med Inst, Chevy Chase, MD USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Honig, B (corresponding author), Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, 701W168th St, New York, NY 10032 USA.	bh6@columbia.edu; tm2472@cumc.columbia.edu	Shapiro, Lawrence/AAE-7172-2019; Wolcott, Holly N/K-6148-2014; , Holly/O-8244-2015	Wolcott, Holly N/0000-0002-4470-1162; , Holly/0000-0002-7450-7512; Rubinstein, Rotem/0000-0003-3657-5984	NIH [2R56NS043915-33A1, 1R01GM107571-01]; National Science Foundation [MCB-0918535]; NIH Training Programs [T32GM008281, T32GM082797]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, T32GM082797, R01GM107571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH Training Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Richard Axel, Dr. Charles Zuker, Dr. Wesley Grueber, and Dr. Hemali Phatnani for critical reading of the manuscript and valuable comments. We also thank Lin Jin and Angelica Struve for technical assistance and members of the T. M., L. S., and B. H. labs for discussion and comments. We thank Dr. Joshua Sanes, Dr. Julie Lefebvre, Dr. Stefanie S. Schalm, and Dr. Steven Vogel for providing reagents and plasmids. This work was supported by a grant from NIH (2R56NS043915-33A1 to T. M.), a joint grant from NIH (1R01GM107571-01 to T. M. and L. S.), a grant from the National Science Foundation (MCB-0918535 to B. H.), and NIH Training Programs (T32GM008281 to H.N.W. and T32GM082797 to K.O.F.).	Bonn S, 2007, MOL CELL BIOL, V27, P4121, DOI 10.1128/MCB.01708-06; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Forbes EM, 2011, NEURAL COMPUT, V23, P2746, DOI 10.1162/NECO_a_00186; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Han MH, 2010, MOL CELL PROTEOMICS, V9, P71, DOI 10.1074/mcp.M900343-MCP200; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hirano K, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00090; Jin XS, 2012, P NATL ACAD SCI USA, V109, pE127, DOI 10.1073/pnas.1117538108; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Miura SK, 2013, CELL, V155, P1166, DOI 10.1016/j.cell.2013.10.018; Murata Y, 2004, J BIOL CHEM, V279, P49508, DOI 10.1074/jbc.M408771200; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Sun W, 2013, EMBO J, V32, P2029, DOI 10.1038/emboj.2013.144; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Yagi T, 2013, J NEUROGENET, V27, P97, DOI 10.3109/01677063.2013.801969; Yagi T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00045; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	39	128	129	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1045	1059		10.1016/j.cell.2014.07.012	http://dx.doi.org/10.1016/j.cell.2014.07.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171406	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000340945000011
J	Tschowri, N; Schumacher, MA; Schlimpert, S; Chinnam, NB; Findlay, KC; Brennan, RG; Buttner, MJ				Tschowri, Natalia; Schumacher, Maria A.; Schlimpert, Susan; Chinnam, Naga Babu; Findlay, Kim C.; Brennan, Richard G.; Buttner, Mark J.			Tetrameric c-di-GMP Mediates Effective Transcription Factor Dimerization to Control Streptomyces Development	CELL			English	Article							ALLOSTERIC CONTROL; RESPONSE REGULATOR; CRYSTAL-STRUCTURE; BIOFILM FORMATION; BINDING PROTEIN; DOMAIN; COELICOLOR; BLDD; IDENTIFICATION; RECEPTOR	The cyclic dinucleotide c-di-GMP is a signaling molecule with diverse functions in cellular physiology. Here, we report that c-di-GMP can assemble into a tetramer that mediates the effective dimerization of a transcription factor, BldD, which controls the progression of multicellular differentiation in sporulating actinomycete bacteria. BldD represses expression of sporulation genes during vegetative growth in a manner that depends on c-di-GMP-mediated dimerization. Structural and biochemical analyses show that tetrameric c-di-GMP links two subunits of BldD through their C-terminal domains, which are otherwise separated by similar to 10 angstrom and thus cannot effect dimerization directly. Binding of the c-di-GMP tetramer by BldD is selective and requires a bipartite RXD-X-8-RXXD signature. The findings indicate a unique mechanism of protein dimerization and the ability of nucleotide signaling molecules to assume alternative oligomeric states to effect different functions.	[Tschowri, Natalia; Schlimpert, Susan; Findlay, Kim C.; Buttner, Mark J.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; [Schumacher, Maria A.; Chinnam, Naga Babu; Brennan, Richard G.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Duke University	Buttner, MJ (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	mark.buttner@jic.ac.uk	chinnam, Nagababu/AFS-2420-2022; Tschowri, Natalia/AFO-6489-2022; Chinnam, Nagababu/ABF-5512-2021	chinnam, Nagababu/0000-0001-8925-5365; Chinnam, Nagababu/0000-0001-8925-5365; Buttner, Mark/0000-0002-3505-2981; Schlimpert, Susan/0000-0001-6364-8056; Tschowri, Natalia/0000-0002-4304-1860; Brennan, Richard/0000-0001-7647-485X; Findlay, Kim/0000-0002-1556-0532	DOE Office of Biological and Environmental Research; Long Term EMBO Fellowship ALTF [693-2012]; Leopoldina Postdoctoral Fellowship; BBSRC [BB/H006125/1]; MET Institute Strategic Programme Grant to the John Innes Centre from the BBSRC; Duke University School of Medicine; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000015, BB/H006125/1] Funding Source: researchfish	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); Long Term EMBO Fellowship ALTF; Leopoldina Postdoctoral Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MET Institute Strategic Programme Grant to the John Innes Centre from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Duke University School of Medicine; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Govind Chandra for bioinformatics analysis, Gerhard Saalbach for tryptic mass spectrometry fingerprinting, and Ray Dixon and Regine Hengge for helpful discussion and critical reading of the manuscript. X-ray crystallographic data were collected at the Advanced Light Source (ALS), beamline 8.3.1. ALS is a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. This work was funded by Long Term EMBO Fellowship ALTF 693-2012 to N.T., by a Leopoldina Postdoctoral Fellowship to S. S., by BBSRC grant BB/H006125/1 to M.J.B., by the MET Institute Strategic Programme Grant to the John Innes Centre from the BBSRC, and by the Duke University School of Medicine.	Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Bush MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00684-13; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Chng C, 2008, P NATL ACAD SCI USA, V105, P11346, DOI 10.1073/pnas.0803622105; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; DeLano W.L, PYMOL MOL GRAPHICS S; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Elliot MA, 1999, J BACTERIOL, V181, P6832, DOI 10.1128/JB.181.21.6832-6835.1999; Elliot MA, 2001, MOL MICROBIOL, V40, P257, DOI 10.1046/j.1365-2958.2001.02387.x; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hull TD, 2012, J BACTERIOL, V194, P4642, DOI 10.1128/JB.00157-12; Kim IK, 2006, MOL MICROBIOL, V60, P1179, DOI 10.1111/j.1365-2958.2006.05176.x; Kim JM, 2014, PROTEINS, V82, P1093, DOI 10.1002/prot.24481; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Lee CJ, 2007, PROTEINS, V68, P344, DOI 10.1002/prot.21338; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lewis RJ, 1998, J MOL BIOL, V283, P907, DOI 10.1006/jmbi.1998.2163; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; McCormick JR, 2012, FEMS MICROBIOL REV, V36, P206, DOI 10.1111/j.1574-6976.2011.00317.x; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Nesper J, 2012, J PROTEOMICS, V75, P4874, DOI 10.1016/j.jprot.2012.05.033; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x; Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; Tran NT, 2011, J BACTERIOL, V193, P3100, DOI 10.1128/JB.01460-10; Wang SR, 2009, PROTEIN SCI, V18, P2410, DOI 10.1002/pro.251; Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714	45	147	150	4	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1136	1147		10.1016/j.cell.2014.07.022	http://dx.doi.org/10.1016/j.cell.2014.07.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171413	hybrid, Green Published			2022-12-28	WOS:000340945000018
J	Soma, P; Ellemdin, S; Roche, NJ				Soma, Prashilla; Ellemdin, Shiraz; Roche, Natalie J.			A crazy cause of dyspnoea: pulmonary alveolar proteinosis	LANCET			English	Editorial Material									[Soma, Prashilla] Univ Pretoria, Deparment Physiol, ZA-0007 Arcadia, South Africa; [Ellemdin, Shiraz; Roche, Natalie J.] Univ Pretoria, Deparment Internal Med, ZA-0007 Arcadia, South Africa	University of Pretoria; University of Pretoria	Soma, P (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Physiol, Private Bag X323, ZA-0007 Arcadia, South Africa.	prashilla.soma@up.ac.za						Borie R, 2011, EUR RESPIR REV, V20, P98, DOI 10.1183/09059180.00001311; Campo I, 2013, EMJ RESP, V1, P122; Campo I, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-4; Mazzone P, 2001, CLEV CLIN J MED, V68, P977, DOI 10.3949/ccjm.68.12.977; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					714	714		10.1016/S0140-6736(14)61369-6	http://dx.doi.org/10.1016/S0140-6736(14)61369-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25152273	Green Submitted			2022-12-28	WOS:000341359100029
J	Tranter, M				Tranter, Martyn			BIOGEOCHEMISTRY Microbes eat rock under ice	NATURE			English	Editorial Material							ANTARCTICA		Univ Bristol, Bristol Glaciol Ctr, Sch Geog Sci, Bristol BS8 1SS, Avon, England	University of Bristol	Tranter, M (corresponding author), Univ Bristol, Bristol Glaciol Ctr, Sch Geog Sci, Bristol BS8 1SS, Avon, England.	m.tranter@bristol.ac.uk	Tranter, Martyn/E-3722-2010	Tranter, Martyn/0000-0003-2071-3094	Natural Environment Research Council [NE/G005028/1] Funding Source: researchfish; NERC [NE/G005028/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anesio AM, 2012, TRENDS ECOL EVOL, V27, P219, DOI 10.1016/j.tree.2011.09.012; Christner BC, 2006, LIMNOL OCEANOGR, V51, P2485, DOI 10.4319/lo.2006.51.6.2485; Christner BC, 2014, NATURE, V512, P310, DOI 10.1038/nature13667; Cockell C. S., 2013, ANTARCTIC SUBGLACIAL, V192, P129; Hodson A, 2004, HYDROL PROCESS, V18, P2409, DOI 10.1002/hyp.1471; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Pattyn F, 2010, EARTH PLANET SC LETT, V295, P451, DOI 10.1016/j.epsl.2010.04.025; Sharp M, 1999, GEOLOGY, V27, P107, DOI 10.1130/0091-7613(1999)027<0107:WBPAGB>2.3.CO;2; Tranter M., 2014, SURFACE GROUND WATER, V7, P157; Wadham JL, 2012, NATURE, V488, P633, DOI 10.1038/nature11374	10	4	4	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					256	257		10.1038/512256a	http://dx.doi.org/10.1038/512256a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143107	Green Submitted			2022-12-28	WOS:000340508200019
J	Gostin, LO				Gostin, Lawrence O.			Ebola: towards an International Health Systems Fund	LANCET			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Gostin, Lawrence O.] WHO, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2008, INT HLTH REG; Center for Disease Control, 2014, 2014 EB OUTBR W AFR; Global Health Workforce Alliance, 2014, UN TRUTH NO HLTH WOR; Gostin L.O., 2014, GLOBAL HLTH LAW; Harris R., 2014, NATL PUBLIC RAD 0821; Institute for Health Metrics and Evaluation University of Washington, 2014, FIN GLOB HLTH 2014 T; Nossiter Adam, 2014, NEW YORK TIMES; NPR, 2014, EB OUTBR TAK TOLL AF; OCarroll Lisa, 2014, GUARDIAN SEP, V24; Siedner MJ, 2014, PLOS MED BLOG   0822; Sridhar D, 2011, JAMA-J AM MED ASSOC, V305, P1585, DOI 10.1001/jama.2011.418; WHO, 2019, GLOB HLTH OBS DAT RE; WHO, 2014, EB RESP ROADM; WHO Implementation of the International Health Regulations, 2011, IMPL INT HLTH REG 20	14	59	61	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					E49	E51		10.1016/S0140-6736(14)61345-3	http://dx.doi.org/10.1016/S0140-6736(14)61345-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7NH	25201591	Green Submitted, Bronze			2022-12-28	WOS:000343004000001
J	de Loubresse, NG; Prokhorova, I; Holtkamp, W; Rodnina, MV; Yusupova, G; Yusupov, M				de Loubresse, Nicolas Garreau; Prokhorova, Irina; Holtkamp, Wolf; Rodnina, Marina V.; Yusupova, Gulnara; Yusupov, Marat			Structural basis for the inhibition of the eukaryotic ribosome	NATURE			English	Article							PROTEIN-SYNTHESIS; AMINOGLYCOSIDE ANTIBIOTICS; SACCHAROMYCES-CEREVISIAE; TRANSFER-RNA; CRYPTOPLEURINE RESISTANCE; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; BLASTICIDIN S; YEAST; CELLS	The ribosome is a molecular machine responsible for protein synthesis and a major target for small-molecule inhibitors. Compared to the wealth of structural information available on ribosome-targeting antibiotics in bacteria, our understanding of the binding mode of ribosome inhibitors in eukaryotes is currently limited. Here we used X-ray crystallography to determine 16 high-resolution structures of 80S ribosomes from Saccharomyces cerevisiae in complexes with 12 eukaryote-specific and 4 broad-spectrum inhibitors. All inhibitors were found associated with messenger RNA and transfer RNA binding sites. In combination with kinetic experiments, the structures suggest a model for the action of cycloheximide and lactimidomycin, which explains why lactimidomycin, the larger compound, specifically targets the first elongation cycle. The study defines common principles of targeting and resistance, provides insights into translation inhibitor mode of action and reveals the structural determinants responsible for species selectivity which could guide future drug development.	[de Loubresse, Nicolas Garreau; Prokhorova, Irina; Yusupova, Gulnara; Yusupov, Marat] Univ Strasbourg, CNRS, IGBMC, INSERM,U964,UMR7104, F-67404 Illkirch Graffenstaden, France; [Holtkamp, Wolf; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society	Yusupov, M (corresponding author), Univ Strasbourg, CNRS, IGBMC, INSERM,U964,UMR7104, F-67404 Illkirch Graffenstaden, France.	marat@igbmc.fr	Yusupova, Gulnara/E-1877-2014; Rodnina, Marina V./AAD-4667-2019; Yusupov, Marat/I-6126-2013	Rodnina, Marina V./0000-0003-0105-3879; Yusupov, Marat/0000-0001-5544-0597	AFM-Telethon; SATT Conectus Technology Maturation [I12-042]; ERC [294312]; Human Frontier Science Program [RGP0062/2012]; Russian Government Program of Competitive Growth of Kazan Federal University; French National Research Agency [ANR-11-BSV8-006 01]; Deutsche Forschungsgemeinschaft	AFM-Telethon(Association Francaise contre les Myopathies); SATT Conectus Technology Maturation; ERC(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Russian Government Program of Competitive Growth of Kazan Federal University; French National Research Agency(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Liu (Johns Hopkins Medical Institute), D. Wilson (Gene Center Munich), P. Hazendonk (Agriculture and Agri-Food Canada) and the NIH/NCI Developmental Therapeutics Program for providing materials. We acknowledge SOLEIL synchrotron (France), all staff members of PROXIMA1 beamline, especially A. Thompson and P. Legrand for their assistance during data collection. We thank A. Perez Lara, MPI Gottingen, for the help with the ITC experiments and S. Melnikov, IGBMC, for reading the manuscript. I. P. acknowledges support from AFM-Telethon post-doctoral fellowship. This work was supported by the SATT Conectus Technology Maturation grant I12-042 (to N.G.D.L.), the ERC Advanced grant 294312, the Human Frontier Science Program grant RGP0062/2012 and the Russian Government Program of Competitive Growth of Kazan Federal University (to M.Y.), the French National Research Agency grant ANR-11-BSV8-006 01 (to G.Y.) and the Deutsche Forschungsgemeinschaft grant (to M. V. R.).	Adam G, 2001, Mycotoxin Res, V17 Suppl 1, P19, DOI 10.1007/BF03036704; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAEZ A, 1978, BIOCHIM BIOPHYS ACTA, V518, P95, DOI 10.1016/0005-2787(78)90119-3; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Blaha GM, 2012, CURR OPIN STRUC BIOL, V22, P750, DOI 10.1016/j.sbi.2012.07.016; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; BUCHER K, 1976, BIOCHEMISTRY-US, V15, P4755, DOI 10.1021/bi00667a001; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CARRASCO L, 1975, FEBS LETT, V52, P236, DOI 10.1016/0014-5793(75)80813-1; Chan J, 2004, RNA, V10, P528, DOI 10.1261/rna.5200204; Chen YY, 2014, ONCOTARGETS THER, V7, P177, DOI 10.2147/OTT.S41786; CONTRERAS A, 1978, J ANTIBIOT, V31, P598, DOI 10.7164/antibiotics.31.598; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DEHOUX P, 1993, EUR J BIOCHEM, V213, P841, DOI 10.1111/j.1432-1033.1993.tb17827.x; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; DOLZ H, 1982, BIOCHEMISTRY-US, V21, P3181; EHRLICH KC, 1987, BIOCHIM BIOPHYS ACTA, V923, P206, DOI 10.1016/0304-4165(87)90005-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EUSTICE DC, 1984, ANTIMICROB AGENTS CH, V26, P53, DOI 10.1128/AAC.26.1.53; Evidente A, 2009, PLANTA MED, V75, P501, DOI 10.1055/s-0029-1185340; Fan-Minogue H, 2008, RNA, V14, P148, DOI 10.1261/rna.805208; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Gurel G, 2009, J MOL BIOL, V389, P146, DOI 10.1016/j.jmb.2009.04.005; Gurel G, 2009, ANTIMICROB AGENTS CH, V53, P5010, DOI 10.1128/AAC.00817-09; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hobbie SN, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001161; HOBDEN AN, 1980, BIOCHEM J, V190, P765, DOI 10.1042/bj1900765; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; JIMENEZ A, 1976, BIOCHIM BIOPHYS ACTA, V425, P342, DOI 10.1016/0005-2787(76)90261-6; JIMENEZ A, 1975, FEBS LETT, V55, P53, DOI 10.1016/0014-5793(75)80955-0; JIMENEZ A, 1975, BIOCHIM BIOPHYS ACTA, V383, P427, DOI 10.1016/0005-2787(75)90312-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; KOSHINSKY HA, 1988, CURR GENET, V13, P363, DOI 10.1007/BF00365656; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KUKHANOVA M, 1983, FEBS LETT, V160, P129, DOI 10.1016/0014-5793(83)80951-X; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; Lu WL, 2011, CHEM BIOL, V18, P425, DOI 10.1016/j.chembiol.2011.01.016; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; MIDDLEBROOK JL, 1989, BIOCHEM PHARMACOL, V38, P3103, DOI 10.1016/0006-2952(89)90021-X; Mueller M, 2012, ACTA CRYSTALLOGR D, V68, P42, DOI 10.1107/S0907444911049833; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; PAULOVICH AG, 1993, GENETICS, V135, P719; Perez-Fernandez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4112; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Recht MI, 1999, EMBO J, V18, P3133, DOI 10.1093/emboj/18.11.3133; SANCHEZ L, 1977, MOL GEN GENET, V156, P319, DOI 10.1007/BF00267188; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; SCHULTZ LD, 1983, J BACTERIOL, V155, P8, DOI 10.1128/JB.155.1.8-14.1983; Shirai A, 2010, J BIOL CHEM, V285, P22448, DOI 10.1074/jbc.M110.132274; Shulman E, 2014, J BIOL CHEM, V289, P2318, DOI 10.1074/jbc.M113.533588; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Svidritskiy E, 2013, P NATL ACAD SCI USA, V110, P12283, DOI 10.1073/pnas.1304922110; TUJEBAJEVA RM, 1989, FEBS LETT, V257, P254, DOI 10.1016/0014-5793(89)81546-7; WINTERMEYER W, 1979, EUR J BIOCHEM, V98, P465; YAMAGUCHI H, 1965, J BIOCHEM, V57, P667; Zhou JC, 2008, BIOORG MED CHEM LETT, V18, P6179, DOI 10.1016/j.bmcl.2008.10.014	76	301	306	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					517	+		10.1038/nature13737	http://dx.doi.org/10.1038/nature13737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25209664	Green Published			2022-12-28	WOS:000342075800033
J	Deweerdt, S				Deweerdt, Sarah			Crucial clues	NATURE			English	Editorial Material							LUNG-CANCER; NEVER SMOKERS; T790M MUTATIONS; GEFITINIB											Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; Gazdar A, 2014, J THORAC ONCOL, V9, P456, DOI 10.1097/JTO.0000000000000130; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Oxnard GR, 2012, J THORAC ONCOL, V7, P1049, DOI 10.1097/JTO.0b013e318250ed9d; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190	7	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S12	S13		10.1038/513S12a	http://dx.doi.org/10.1038/513S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208067	Bronze			2022-12-28	WOS:000341362800007
J	McMurray, JJV; Packer, M; Desai, AS; Gong, JJ; Lefkowitz, MP; Rizkala, AR; Rouleau, JL; Shi, VC; Solomon, SD; Swedberg, K; Zile, MR				McMurray, John J. V.; Packer, Milton; Desai, Akshay S.; Gong, Jianjian; Lefkowitz, Martin P.; Rizkala, Adel R.; Rouleau, Jean L.; Shi, Victor C.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael R.		PARADIGM-HF Investigators Comm	Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUTRAL ENDOPEPTIDASE INHIBITION; CONVERTING ENZYME-INHIBITION; NATRIURETIC-PEPTIDE; RANDOMIZED-TRIAL; EJECTION FRACTION; DOUBLE-BLIND; MORTALITY; SURVIVAL; RECEPTOR; MORBIDITY	BACKGROUND We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with a reduced ejection fraction. In previous studies, enalapril improved survival in such patients. METHODS In this double-blind trial, we randomly assigned 8442 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive either LCZ696 (at a dose of 200 mg twice daily) or enalapril (at a dose of 10 mg twice daily), in addition to recommended therapy. The primary outcome was a composite of death from cardiovascular causes or hospitalization for heart failure, but the trial was designed to detect a difference in the rates of death from cardiovascular causes. RESULTS The trial was stopped early, according to prespecified rules, after a median follow-up of 27 months, because the boundary for an overwhelming benefit with LCZ696 had been crossed. At the time of study closure, the primary outcome had occurred in 914 patients (21.8%) in the LCZ696 group and 1117 patients (26.5%) in the enalapril group (hazard ratio in the LCZ696 group, 0.80; 95% confidence interval [CI], 0.73 to 0.87; P<0.001). A total of 711 patients (17.0%) receiving LCZ696 and 835 patients (19.8%) receiving enalapril died (hazard ratio for death from any cause, 0.84; 95% CI, 0.76 to 0.93; P<0.001); of these patients, 558 (13.3%) and 693 (16.5%), respectively, died from cardiovascular causes (hazard ratio, 0.80; 95% CI, 0.71 to 0.89; P<0.001). As compared with enalapril, LCZ696 also reduced the risk of hospitalization for heart failure by 21% (P<0.001) and decreased the symptoms and physical limitations of heart failure (P = 0.001). The LCZ696 group had higher proportions of patients with hypotension and nonserious angioedema but lower proportions with renal impairment, hyperkalemia, and cough than the enalapril group. CONCLUSIONS LCZ696 was superior to enalapril in reducing the risks of death and of hospitalization for heart failure.	[McMurray, John J. V.] Univ Glasgow, British Heart Fdn BHF Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Packer, Milton] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Desai, Akshay S.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Gong, Jianjian; Lefkowitz, Martin P.; Rizkala, Adel R.; Shi, Victor C.] Novartis Pharmaceut, E Hanover, NJ USA; [Rouleau, Jean L.] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada; [Swedberg, Karl] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Swedberg, Karl] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Zile, Michael R.] Med Univ S Carolina, Charleston, SC USA; [Zile, Michael R.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	University of Glasgow; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Novartis; Universite de Montreal; Institut de Cardiologie de Montreal; University of Gothenburg; Imperial College London; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Packer, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Clin Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	john.mcmurray@glasgow.ac.uk; milton.packer@utsouthwestern.edu	Libis, Roman/O-9193-2015; Zhilyaev, Evgeny/E-3774-2016; Marchev, Sotir/AAH-6529-2020; Urina-Triana, Miguel A/H-2605-2016; Munzel, Thomas/A-2912-2014; Ramires, Felix JA/D-5996-2012; Danzi, Gian Battista/P-2244-2016; Jhund, Pardeep/GLS-9508-2022; Nightingale, Angus/O-5205-2019; Mamas, Mamas Andreas/A-2549-2019; Torres, Filipa/G-9742-2016; Svistov, Aleksandr S/G-8291-2018; Kardos, Attila/S-7802-2019; mcmurray, John/B-2467-2013; Silva-Cardoso, Jose Carlos/L-8033-2013; Ramshev, Konstantin/GYU-1641-2022; Böhm, Michael/C-3638-2011; Rafalskiy, Vladimir V/G-3172-2013; Desai, Akshay/ABE-7250-2020; Swedberg, Karl/B-2475-2008; Khromtsova, Oksana M./F-4530-2018; sharma, kamal/AAG-7271-2019; YILMAZ, Mehmet Birhan/Y-1372-2019; Drapkina, Oksana/AAE-5376-2021; Kudat, Hasan/AAE-3298-2020; Krupicka, Jan/F-6916-2017; Senni, Michele/J-9380-2018; Bello, Natalie/J-1001-2019; Saifutdinov, Rustam/ABC-3695-2020	Libis, Roman/0000-0003-0130-990X; Zhilyaev, Evgeny/0000-0002-9443-1164; Marchev, Sotir/0000-0001-9250-510X; Urina-Triana, Miguel A/0000-0001-6003-4622; Munzel, Thomas/0000-0001-5503-4150; Ramires, Felix JA/0000-0003-2437-2485; Danzi, Gian Battista/0000-0003-0897-8006; Jhund, Pardeep/0000-0003-4306-5317; Nightingale, Angus/0000-0001-9435-726X; Mamas, Mamas Andreas/0000-0001-9241-8890; Svistov, Aleksandr S/0000-0003-0246-5680; mcmurray, John/0000-0002-6317-3975; Silva-Cardoso, Jose Carlos/0000-0002-9774-9864; Ramshev, Konstantin/0000-0002-6978-6641; Rafalskiy, Vladimir V/0000-0002-2503-9580; Khromtsova, Oksana M./0000-0003-0763-0542; sharma, kamal/0000-0001-5866-2566; YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Drapkina, Oksana/0000-0002-4453-8430; Kudat, Hasan/0000-0003-1936-5221; Krupicka, Jan/0000-0002-0849-7395; Senni, Michele/0000-0001-5502-7882; Bello, Natalie/0000-0003-3257-3623; Saifutdinov, Rustam/0000-0001-6504-8900; Kober, Lars/0000-0002-6635-1466; Strain, William/0000-0002-6826-418X; Sanmartin-Fernandez, Marcelo/0000-0001-5469-4579; HAGEGE, Albert/0000-0003-4685-6077; Bozkurt, Biykem/0000-0002-6362-0253; Pijanowski, Zbigniew/0000-0002-6624-7642; Nunez, Julio/0000-0003-1672-7119; GALINIER, Michel/0000-0003-1735-3390; URAL, DILEK/0000-0003-0224-1433; DUARTE VERA, YAN CARLOS/0000-0003-4685-6907; gosse, philippe/0000-0002-5840-7749; Martinez-Selles, Manuel/0000-0003-0289-6229; FREIXA-PAMIAS, ROMAN/0000-0001-5301-4236; de Figueiredo Neto, Jose Albuquerque/0000-0003-3739-7702; Zile, Michael/0000-0001-7076-221X; Bogle, Richard/0000-0002-8300-3367; Lanas, Fernando/0000-0003-3595-9759; Mohindra, Raj/0000-0002-8437-5066; Olexa, Peter/0000-0002-1846-4554; Manzur, Fernando/0000-0001-6679-5609	Novartis	Novartis(Novartis)	Supported by Novartis.	Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Cruden NLM, 2004, HYPERTENSION, V44, P913, DOI 10.1161/01.HYP.0000146483.78994.56; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Fryer RM, 2008, BRIT J PHARMACOL, V153, P947, DOI 10.1038/sj.bjp.0707641; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Hegde LG, 2011, J CARDIOVASC PHARM, V57, P495, DOI 10.1097/FJC.0b013e318210fc7e; Hjalmarson A, 1999, LANCET, V353, P2001; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Kuhn M, 2004, BASIC RES CARDIOL, V99, P76, DOI 10.1007/s00395-004-0460-0; Lechat P, 1999, LANCET, V353, P9; Maggioni AP, 2013, EUR J HEART FAIL, V15, P1173, DOI 10.1093/eurjhf/hft134; Maric C, 2006, NEPHRON PHYSIOL, V103, P149, DOI 10.1159/000092457; McMurray JJV, 2014, EUR J HEART FAIL, V16, P817, DOI 10.1002/ejhf.115; McMurray JJV, 2013, EUR J HEART FAIL, V15, P1062, DOI 10.1093/eurjhf/hft052; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rademaker MT, 1998, J CARDIOVASC PHARM, V31, P116, DOI 10.1097/00005344-199801000-00017; Rademaker MT, 1996, CLIN SCI, V91, P283, DOI 10.1042/cs0910283; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Trippodo NC, 1999, J CARDIOVASC PHARM, V34, P782, DOI 10.1097/00005344-199912000-00003; Wilkinson IB, 2001, BRIT J CLIN PHARMACO, V52, P159, DOI 10.1046/j.0306-5251.2001.1420.x; Young JB, 2004, CIRCULATION, V110, P2618, DOI 10.1161/01.CIR.0000146819.43235.A9; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	28	3511	3676	13	247	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					993	1004		10.1056/NEJMoa1409077	http://dx.doi.org/10.1056/NEJMoa1409077			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25176015	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000341382800005
J	Markova, A; Kam, SA; Miller, DD; Lichtman, MK				Markova, Alina; Kam, Sarah A.; Miller, Daniel D.; Lichtman, Michael K.			Common Cutaneous Parasites	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FLEA CTENOCEPHALIDES-FELIS; HEAD LICE ANOPLURA; BARTONELLA-QUINTANA; PEDICULOSIS CAPITIS; PHTHIRUS-PUBIS; PERMETHRIN; SCABIES; DISEASES; INFECTIONS; IVERMECTIN							Markova, Alina/0000-0002-2427-3199				Abramowicz KF, VECTOR-BORNE ZOONOT, DOI [10.1089/VDZ.20100117, DOI 10.1089/VDZ.20100117]; Amarre G, 2009, AM J TROP MED HYG, V81, P718, DOI [10.4269/ajtmh.2009.09-0104, DOI 10.4269/AJTMH.2009.09-0104]; Ameen M, 2010, PEDIATR INFECT DIS J, V29, P991, DOI 10.1097/INF.0b013e3181e63f5f; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Badiaga S, 2008, EMERG INFECT DIS, V14, P1353, DOI 10.3201/eid1409.080204; Boutellis A, 2013, EMERG INFECT DIS, V19, P796, DOI 10.3201/eid1905.121480; Bouvresse S, 2010, CURR OPIN INFECT DIS, V23, P111, DOI 10.1097/QCO.0b013e328336821b; Brouqui P, 2006, ANN NY ACAD SCI, V1078, P223, DOI 10.1196/annals.1374.041; BURGESS IF, 1995, BRIT MED J, V311, P752, DOI 10.1136/bmj.311.7007.752; Burke S, 2011, ARCH DIS CHILD, V96, P989, DOI 10.1136/archdischild-2011-300791; Bush SE, 2011, J MED ENTOMOL, V48, P67, DOI 10.1603/ME10122; Centers for Disease Control and Prevention, 2014, PAR SCAB CONTR; Centers for Disease Control and Prevention, PAR SCAB PREV CONTR; Chi CC, 2013, JAMA DERMATOL, V149, P1274, DOI 10.1001/jamadermatol.2013.5768; Chosidow O, 2006, NEW ENGL J MED, V354, P1718, DOI 10.1056/NEJMcp052784; Counahan M, 2004, J PAEDIATR CHILD H, V40, P616, DOI 10.1111/j.1440-1754.2004.00486.x; Cueto GM, 2006, J MED ENTOMOL, V43, P634, DOI 10.1603/0022-2585(2006)43[634:PHLAPI]2.0.CO;2; Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329; Currier RW, 2011, ANN NY ACAD SCI, V1230, pE50, DOI 10.1111/j.1749-6632.2011.06364.x; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Douri Thaer, 2009, Dermatol Online J, V15, P17; Elston CA, 2013, DERMATOL THER, V26, P312, DOI 10.1111/dth.12075; Elston DM, 2010, CUTIS, V85, P283; Elston DM, 2010, CUTIS, V85, P231; Faccini-Martinez AA, 2013, BIOMEDICA S19, V33; Fernandez S, 2006, ALLERGY, V61, P1372, DOI 10.1111/j.1398-9995.2006.01179.x; FitzGerald D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009943.pub2; Foucault C, 2006, J INFECT DIS, V193, P474, DOI 10.1086/499279; Foucault C, 2002, CLIN INFECT DIS, V35, P684, DOI 10.1086/342065; Frankowski BL, 2010, PEDIATRICS, V126, P392, DOI 10.1542/peds.2010-1308; Fuller LC, 2013, CURR OPIN INFECT DIS, V26, P123, DOI 10.1097/QCO.0b013e32835eb851; Gillis David, 1990, Public Health Reviews, V18, P345; Goates BM, 2006, PEDIATRICS, V118, P1962, DOI 10.1542/peds.2005-1847; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Golomb MR, 2010, CUTIS, V85, P10; Guss DA, 2011, J EMERG MED, V41, P362, DOI 10.1016/j.jemermed.2010.05.030; Haag-Wackernagel D, 2004, ANN AGR ENV MED, V11, P343; Hall RR, 2012, PEDIATR DERMATOL, V29, P513, DOI 10.1111/j.1525-1470.2011.01596.x; Halos L, 2014, TRENDS PARASITOL, V30, P228, DOI 10.1016/j.pt.2014.02.007; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Jordaan HF, 1997, AM J DERMATOPATH, V19, P119, DOI 10.1097/00000372-199704000-00004; Karthikeyan K, 2009, INDIAN J DERMATOL VE, V75, P340, DOI 10.4103/0378-6323.53128; Kennedy D, 2005, AM J PERINAT, V22, P87, DOI 10.1055/s-2005-837736; Kiran B, 2012, INDIAN J MED MICROBI, V30, P354, DOI 10.4103/0255-0857.99504; Ko CJ, 2004, J AM ACAD DERMATOL, V50, P1, DOI 10.1016/S0190-9622(03)02729-4; Krug LE, 2010, CUTIS, V86, P282; Madke B, 2012, INDIAN J DERMATOL VE, V78, P429, DOI 10.4103/0378-6323.98072; Mounsey KE, 2013, CURR OPIN INFECT DIS, V26, P133, DOI 10.1097/QCO.0b013e32835e1d57; Naumann DN, 2011, J ROY ARMY MED CORPS, V157, P226, DOI 10.1136/jramc-157-03-07; Obasanjo OO, 2001, INFECT CONT HOSP EP, V22, P13, DOI 10.1086/501818; Paes Barreto Rodrigo de Pinho, 2012, International Ophthalmology, V32, P467, DOI 10.1007/s10792-012-9528-2; Pearlman DL, 2004, PEDIATRICS, V114, pE275, DOI 10.1542/peds.2003-0666-F; Pierzchalski JL, 2002, SEX TRANSM DIS, V29, P331, DOI 10.1097/00007435-200206000-00004; Rolain JM, 2002, LANCET, V360, P226, DOI 10.1016/S0140-6736(02)09462-X; Scheinfeld N, 2004, AM J CLIN DERMATOL, V5, P31, DOI 10.2165/00128071-200405010-00005; Stough D, 2009, PEDIATRICS, V124, pE389, DOI 10.1542/peds.2008-3762; Studdiford JS, 2012, AM FAM PHYSICIAN, V86, P653; Tebruegge M, 2007, ARCH DIS CHILD, V92, P818, DOI 10.1136/adc.2007.121368; Vaidyanathan R, 2013, AM J TROP MED HYG, V88, P619, DOI 10.4269/ajtmh.12-0493; Valdyanathan R, 2013, AM TROP MED HYG, V88, P619, DOI [10.4269/ajtmh.12-0493, DOI 10.4269/AJTMH.12-0493]; Varela JA, 2003, SEX TRANSM DIS, V30, P292, DOI 10.1097/00007435-200304000-00004; Wang CL, 2013, J ECON ENTOMOL, V106, P347, DOI 10.1603/EC12259	62	5	5	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5								10.7326/0003-4819-161-5-201409020-01003	http://dx.doi.org/10.7326/0003-4819-161-5-201409020-01003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3RL	25178582				2022-12-28	WOS:000364909300001
J	Raghavan, M; DeGiorgio, M; Albrechtsen, A; Moltke, I; Skoglund, P; Korneliussen, TS; Gronnow, B; Appelt, M; Gullov, HC; Friesen, TM; Fitzhugh, W; Malmstrom, H; Rasmussen, S; Olsen, J; Melchior, L; Fuller, BT; Fahrni, SM; Stafford, T; Grimes, V; Renouf, MAP; Cybulski, J; Lynnerup, N; Lahr, MM; Britton, K; Knecht, R; Arneborg, J; Metspalu, M; Cornejo, OE; Malaspinas, AS; Wang, Y; Rasmussen, M; Raghavan, V; Hansen, TVO; Khusnutdinova, E; Pierre, T; Dneprovsky, K; Andreasen, C; Lange, H; Hayes, MG; Coltrain, J; Spitsyn, VA; GotherstrOm, A; Orlando, L; Kivisild, T; Villems, R; Crawford, MH; Nielsen, FC; Dissing, J; Heinemeier, J; Meldgaard, M; Bustamante, C; O'Rourke, DH; Jakobsson, M; Gilbert, MTP; Nielsen, R; Willerslev, E				Raghavan, Maanasa; DeGiorgio, Michael; Albrechtsen, Anders; Moltke, Ida; Skoglund, Pontus; Korneliussen, Thorfinn S.; Gronnow, Bjarne; Appelt, Martin; Gullov, Hans Christian; Friesen, T. Max; Fitzhugh, William; Malmstrom, Helena; Rasmussen, Simon; Olsen, Jesper; Melchior, Linea; Fuller, Benjamin T.; Fahrni, Simon M.; Stafford, Thomas, Jr.; Grimes, Vaughan; Renouf, M. A. Priscilla; Cybulski, Jerome; Lynnerup, Niels; Lahr, Marta Mirazon; Britton, Kate; Knecht, Rick; Arneborg, Jette; Metspalu, Mait; Cornejo, Omar E.; Malaspinas, Anna-Sapfo; Wang, Yong; Rasmussen, Morten; Raghavan, Vibha; Hansen, Thomas V. O.; Khusnutdinova, Elza; Pierre, Tracey; Dneprovsky, Kirill; Andreasen, Claus; Lange, Hans; Hayes, M. Geoffrey; Coltrain, Joan; Spitsyn, Victor A.; Gotherstrom, Anders; Orlando, Ludovic; Kivisild, Toomas; Villems, Richard; Crawford, Michael H.; Nielsen, Finn C.; Dissing, Jorgen; Heinemeier, Jan; Meldgaard, Morten; Bustamante, Carlos; O'Rourke, Dennis H.; Jakobsson, Mattias; Gilbert, M. Thomas P.; Nielsen, Rasmus; Willerslev, Eske			The genetic prehistory of the New World Arctic	SCIENCE			English	Article							GENOME SEQUENCE; MTDNA VARIATION; HISTORY; ADMIXTURE; DORSET; DIVERSITY; GREENLAND; CANADA; MODEL; SITE	The New World Arctic, the last region of the Americas to be populated by humans, has a relatively well-researched archaeology, but an understanding of its genetic history is lacking. We present genome-wide sequence data from ancient and present-day humans from Greenland, Arctic Canada, Alaska, Aleutian Islands, and Siberia. We show that Paleo-Eskimos (similar to 3000 BCE to 1300 CE) represent a migration pulse into the Americas independent of both Native American and Inuit expansions. Furthermore, the genetic continuity characterizing the Paleo-Eskimo period was interrupted by the arrival of a new population, representing the ancestors of present-day Inuit, with evidence of past gene flow between these lineages. Despite periodic abandonment of major Arctic regions, a single Paleo-Eskimo metapopulation likely survived in near-isolation for more than 4000 years, only to vanish around 700 years ago.	[Raghavan, Maanasa; Korneliussen, Thorfinn S.; Malmstrom, Helena; Stafford, Thomas, Jr.; Malaspinas, Anna-Sapfo; Rasmussen, Morten; Pierre, Tracey; Orlando, Ludovic; Meldgaard, Morten; Gilbert, M. Thomas P.; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [DeGiorgio, Michael] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Albrechtsen, Anders; Moltke, Ida] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Skoglund, Pontus; Malmstrom, Helena; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Skoglund, Pontus] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gronnow, Bjarne; Appelt, Martin; Gullov, Hans Christian] Natl Museum Denmark, Arctic Ctr, Ethnog Collect SILA, DK-1220 Copenhagen, Denmark; [Friesen, T. Max] Univ Toronto, Dept Anthropol, Toronto, ON M5S 2S2, Canada; [Fitzhugh, William] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Arctic Studies Ctr, Washington, DC 20013 USA; [Rasmussen, Simon] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Olsen, Jesper; Stafford, Thomas, Jr.; Heinemeier, Jan] Aarhus Univ, Dept Phys & Astron, AMS Dating Ctr 14C, DK-8000 Aarhus C, Denmark; [Melchior, Linea; Lynnerup, Niels; Dissing, Jorgen] Univ Copenhagen, Fac Hlth Sci, Inst Forens Med, Anthropol Lab, DK-2100 Copenhagen, Denmark; [Fuller, Benjamin T.; Fahrni, Simon M.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Grimes, Vaughan; Renouf, M. A. Priscilla] Mem Univ Newfoundland, Dept Archaeol, Queens Coll, St John, NF A1C 5S7, Canada; [Grimes, Vaughan; Britton, Kate] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Cybulski, Jerome] Canadian Museum Hist, Gatineau, PQ K1A 0M8, Canada; [Cybulski, Jerome] Univ Western Ontario, Dept Anthropol, London, ON N6A 5C2, Canada; [Lahr, Marta Mirazon] Univ Cambridge, Dept Archaeol & Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Britton, Kate; Knecht, Rick] Univ Aberdeen, Dept Archaeol, Aberdeen AB24 3UF, Scotland; [Arneborg, Jette] Natl Museum Denmark, DK-1220 Copenhagen, Denmark; [Arneborg, Jette] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Metspalu, Mait; Kivisild, Toomas; Villems, Richard] Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia; [Metspalu, Mait; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Cornejo, Omar E.; Bustamante, Carlos] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Cornejo, Omar E.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Wang, Yong; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wang, Yong] Ancestry Com DNA LLC, San Francisco, CA 94107 USA; [Raghavan, Vibha] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Hansen, Thomas V. O.; Nielsen, Finn C.] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Bashkortostan, Russia; [Dneprovsky, Kirill] State Museum Oriental Art, Moscow 119019, Russia; [Andreasen, Claus; Lange, Hans] Greenland Natl Museum & Arch, Nuuk 3900, Greenland; [Hayes, M. Geoffrey] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Hayes, M. Geoffrey] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Anthropol, Evanston, IL 60208 USA; [Hayes, M. Geoffrey] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Coltrain, Joan; O'Rourke, Dennis H.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Spitsyn, Victor A.] Russian Acad Med Sci, Res Ctr Med Genet, Moscow 115478, Russia; [Gotherstrom, Anders] Stockholm Univ, Dept Archaeol & Class Studies, S-10691 Stockholm, Sweden; [Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge CB2 1QH, England; [Crawford, Michael H.] Univ Kansas, Lab Biol Anthropol, Lawrence, KS 66045 USA	University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Copenhagen; University of Chicago; Uppsala University; Harvard University; Harvard Medical School; University of Toronto; Smithsonian Institution; Smithsonian National Museum of Natural History; Technical University of Denmark; Aarhus University; University of Copenhagen; University of California System; University of California Irvine; Memorial University Newfoundland; Max Planck Society; Western University (University of Western Ontario); University of Cambridge; University of Aberdeen; University of Edinburgh; Estonian Biocentre; University of Tartu; Stanford University; Washington State University; University of California System; University of California Berkeley; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Rigshospitalet; University of Copenhagen; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Feinberg School of Medicine; Utah System of Higher Education; University of Utah; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Stockholm University; University of Cambridge; University of Kansas	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Orlando, Ludovic/A-8932-2013; Gilbert, Marcus TP/A-8936-2013; Jakobsson, Mattias/A-6116-2011; Malmström, Helena/C-2476-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Korneliussen, Thorfinn Sand/F-6421-2014; Hansen, Thomas v. O./J-9361-2014; Kivisild, Toomas/P-5889-2017; Korneliussen, Thorfinn Sand/ABB-7656-2021; Hansen, Thomas/GWZ-2858-2022; Albrechtsen, Anders/K-4281-2013; Britton, Kate/A-3654-2010; Olsen, Jesper/F-1656-2013; Moltke, Ida/C-6158-2011; Willerslev, Eske/AAA-5686-2019; Grimes, Vaughan/AAG-5174-2021; Rasmussen, Simon/G-6258-2016; Nielsen, Finn Cilius/AAA-4926-2020; Metspalu, Mait/G-8671-2015; Willerslev, Eske/A-9619-2011; Rasmussen, Simon/AAA-2308-2020; wang, yong/J-6713-2013; Spitsyn, Viktor/O-8137-2015	Orlando, Ludovic/0000-0003-3936-1850; Gilbert, Marcus TP/0000-0002-5805-7195; Jakobsson, Mattias/0000-0001-7840-7853; Malmström, Helena/0000-0002-6456-8055; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Hansen, Thomas v. O./0000-0003-4635-2653; Kivisild, Toomas/0000-0002-6297-7808; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Albrechtsen, Anders/0000-0001-7306-031X; Olsen, Jesper/0000-0002-4445-5520; Moltke, Ida/0000-0001-7052-8554; Grimes, Vaughan/0000-0002-2177-3147; Rasmussen, Simon/0000-0001-6323-9041; Metspalu, Mait/0000-0003-3099-9161; Willerslev, Eske/0000-0002-7081-6748; Rasmussen, Simon/0000-0001-6323-9041; wang, yong/0000-0001-8772-7349; Britton, Kate/0000-0002-9478-5966; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Hayes, M Geoffrey/0000-0002-4617-3981; Gronnow, Bjarne/0000-0003-1979-1482; Spitsyn, Viktor/0000-0002-4354-2905; Mirazon Lahr, Marta/0000-0001-5752-5770; Bustamante, Carlos D./0000-0002-4187-7920; Skoglund, Pontus/0000-0002-3021-5913; Raghavan, Maanasa/0000-0003-1997-0739	Danish National Research Foundation; Lundbeck Foundation; Villum Foundation; Swiss National Science Foundation [PBSKP3_143259]; The Rock Foundation; Social Sciences and Humanities Research Council of Canada; National Science Foundation Office of Polar Programs [OPP-9974623, OPP-0327641, OPP-9726126, OPP-9977931, OPP-9813044]; Northern Worlds Initiative; Augustinus Foundation; Danish Council for Independent Research; National Science Foundation [0732327, OPP-9905090, OPP-0327676]; Wenner-Gren Foundation for Anthropological Research [6364]; Natural Sciences and Engineering Research Council of Canada; University of Utah; EU Marie Curie FP7 Initial Training Network Grant [FP7-ITN-215362-2]; Arts and Humanities Research Council [AH/K006029/1]; Memorial University Faculty of Arts Research Initiative; Memorial University Office of Research Grant; EU European Regional Development Fund through Centre of Excellence in Genomics to Estonian Biocentre; Estonian Institutional Research [IUT24-1]; Estonian Science Foundation [8973]; AHRC [AH/K006029/1] Funding Source: UKRI; Villum Fonden [00007171] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Villum Foundation(Villum Fonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The Rock Foundation; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Northern Worlds Initiative; Augustinus Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation for Anthropological Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Utah; EU Marie Curie FP7 Initial Training Network Grant; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Memorial University Faculty of Arts Research Initiative(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Memorial University Office of Research Grant; EU European Regional Development Fund through Centre of Excellence in Genomics to Estonian Biocentre; Estonian Institutional Research; Estonian Science Foundation; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Villum Fonden(Villum Fonden)	We thank the Danish National Sequencing Centre, T. B. Brand, and P. S. Olsen for technical assistance; anonymous donors for providing DNA samples; A. Helgason and S. Sunna Ebenesersdottir from deCODE for their input on mtDNA phylogenies; A, Di Rienzo for access to genotyping data from Siberian populations; J. R. Southon (B. T. F.), Kitikmeot Heritage Society (T. M. F.), Polar Continental Shelf Project (T. M. F.), Inuit Heritage Trust (D. H. O'R., Je.C., Jo.C., M. G. H.), Kivalliq Inuit Association (D. H. O'R., Jo.C., M. G. H.), communities of Coral Harbor and Chesterfield Inlet (D. H. O'R., Jo.C., M. G. H.), Canadian Museum of History (D. H. O'R., Je. C., Jo.C., M. G. H.), D. Morrison (D. H. O'R., Je. C., Jo.C., M. G. H.), L. Wood (D. H. O'R., Jo.C., M. G. H.), J. Young (D. H. O'R., Je. C., Jo.C., M. G. H.), D. Stenton (D. H. O'R., Je. C., Jo.C., M. G. H.), S. Girling-Christie (Je. C.), Commission for Scientific Research in Greenland (J. A.), Greenland National Museum and Archives (J. A.), Parks Canada (M. A. P. R., V. G.), Memorial University (V. G., M. A. P. R.), Government of Newfoundland and Labrador (V. G.), The Rooms Inc. (V. G.), Innu Nation (V. G.), Nunatsiavut Government (V. G.), Miawpukek First Nation (V. G.), D. Lavers (V. G.), R. Anstey (V. G.), W. Jones and Qanirtuuq Inc., Quinhagak, Alaska (K. B. and R. K.), the residents of Quinhagak, Alaska (K. B. and R. K.), Nunivak Island Mekoryuk Alaska Corporation, Mekoryuk, Alaska (K. B. and R. K.), and the Carnegie Trust for the Universities of Scotland (K. B. and R. K.). Supported by the Danish National Research Foundation (E. W.) Lundbeck Foundation (E. W., N.L.), Villum Foundation (A. A.), Swiss National Science Foundation Fellowship (A.S.-M, PBSKP3_143259), The Rock Foundation (B. G., M. A.), Social Sciences and Humanities Research Council of Canada (T. M. F.), National Science Foundation Office of Polar Programs (D, H, O'R.: OPP-9974623 and OPP-0327641; Jo.C.: OPP-9726126 and OPP-9977931; M. G. H.: OPP-9813044), Northern Worlds Initiative (H. C. G.), Augustinus Foundation (H. C. G.), the Danish Council for Independent Research (I. M.), National Science Foundation (J. A.: International Polar Year grant 0732327; M. H. C., OPP-9905090 and OPP-0327676), Wenner-Gren Foundation for Anthropological Research (M. G. H.: no. 6364), Natural Sciences and Engineering Research Council of Canada Postgraduate Fellowship (M. G. H.), University of Utah Graduate Research Fellowship (M. G. H.), EU Marie Curie FP7 Initial Training Network Grant (Ma.R.: FP7-ITN-215362-2), Arts and Humanities Research Council (K. B. and R. K.: AH/K006029/1), Memorial University Faculty of Arts Research Initiative (V. G.), Memorial University Office of Research Grant (V. G.), Social Sciences and Humanities Research Council of Canada (M. A. P. R.), EU European Regional Development Fund through the Centre of Excellence in Genomics to Estonian Biocentre (M. M. and R. V.), Estonian Institutional Research (M. M. and R. V.: grant IUT24-1), and Estonian Science Foundation (M. M. and R. V.: grant 8973). Informed consent was obtained for the genome sequencing of the modern individuals, with ethical approval from The National Committee on Health Research Ethics, Denmark (H-3-2012-FSP21). Sequence data for the ancient samples are available for download through European Nucleotide Archive (ENA) accession no. PRJEB6516, and for the Illumina genotype data through Gene Expression Omnibus (GEO) series accession no. GSE59546 and at www.ebc.ee/free_data.; Alignment files (BAMs) for the ancient genomes sequenced in this study are available at www.cbs.dtu.dk/suppl/arctic. The data for the modern populations are available for demographic research under data access agreement with E. W. The Thule samples from Silumiut, Kamarvik, and Sadlermiut were made available by D. H. O'R. under agreement with the Canadian Museum of Civilization and local communities who provided research access to the samples. C. B. is on the advisory board of a project at 23andMe and on the scientific advisory boards of Personalis Inc.; InVitae; Etalon Inc.; and Ancestry.com. The authors declare no competing financial interests.	Anderson SL, 2013, ARCTIC ANTHROPOL, V50, P49, DOI 10.3368/aa.50.1.49; Collins H.B., 1962, PREHISTORIC CULTURAL, V11, P126; Collins H.B., 1958, NATL MUSEUM CANADA B, V147, P22; Collins H. B., 1951, NWT B, V123, P49; deLaguna F., 1946, MAN NE N AM, P106; Desrosiers Pierre M., 2009, THESIS; Dyke AS, 2011, ARCTIC, V64, P151; Fitzhugh W. W., 1994, THREADS ARCTIC PREHI, P239; Fitzhugh W. W., 2008, ENCYCLOPEDIA OF ARCH, P247; Fitzhugh WW, 1997, HUM ECOL, V25, P385, DOI 10.1023/A:1021819509181; Friesen TM, 2008, AM ANTIQUITY, V73, P527, DOI 10.2307/25470503; Friesen TM, 2004, CURR ANTHROPOL, V45, P685, DOI 10.1086/425635; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTR, 2007, AM J PHYS ANTHROPOL, V133, P847, DOI 10.1002/ajpa.20602; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronnow Bjarne., 2006, DYNAMICS NO SOC, P59; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Harritt R. K., 1998, ETUD INUIT, V22, P61; Hayes MG., 2005, CONTRIBUTIONS STUDY, P11, DOI [DOI 10.2307/J.CTV16P21.9, 10.2307/j.ctv16p21.9]; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; IRVING WN, 1969, P 8 INT C ANTHR ETHN, V3, P340; Jensen Jens Fog, 2006, STUDIES ARCHAEOLOGY, V10, P75; Jordan R.H., 1984, HDB N AM INDIANS, V5, P540; LAUGHLIN WS, 1975, SCIENCE, V189, P507, DOI 10.1126/science.189.4202.507; Lynnerup Niels, 1998, THE GREENLAND NORSE; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Mathiassen T, 1935, GEOGR REV, V25, P408, DOI 10.2307/209309; Maxwell M.S., 1984, HDB N AM INDIANS, V5, P359; Maxwell M.S., 1985, PREHISTORY OF THE EA; McCARTNEY Allen P, 1977, THULE ESKIMO PREHIST; McGhee R., 1984, HDB N AM INDIANS, V5, P369; McGhee R., 1996, ANCIENT PEOPLE OF TH; McGhee R, 2000, IDENTITIES CULTURAL, P181; McGhee R, 1970, FOLK, p[173, 11]; Meldgaard J., 1962, PREHISTORIC CULTURAL, P92; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Morris Desmond, 2009, THE STUDY OF THE MAL, P164; Morrison D., 1999, CANADIAN J ARCHAEOLO, V22, P139; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Park Robert, 2000, IDENTITIES CULTURE C, P192; PARK RW, 1993, AM ANTIQUITY, V58, P203, DOI 10.2307/281966; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; POWERS WR, 1990, PHILOS T R SOC A, V330, P665, DOI 10.1098/rsta.1990.0047; Raff JA, 2011, AM J PHYS ANTHROPOL, V146, P503, DOI 10.1002/ajpa.21594; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Ritchie W. A., 1962, PREHISTORIC CULTURAL, P96; Rowley S., 1994, THREADS ARCTIC PREHI, P361; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Savene JM, 2014, AM ANTIQUITY, V79, P249, DOI 10.7183/0002-7316.79.2.249; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Taylor W.E., 1963, AM ANTIQUITY, V28, P456; Tuck J. A., 1986, PALAEO ESKIMO CULTUR, P161; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019	84	206	211	0	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1020	+	1255832	10.1126/science.1255832	http://dx.doi.org/10.1126/science.1255832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170159	Green Accepted, Green Submitted			2022-12-28	WOS:000340870900030
J	Sun, YT; Cao, C				Sun, Yutao; Cao, Cong			Demystifying central government R&D spending in China	SCIENCE			English	Editorial Material									[Sun, Yutao] Dalian Univ Technol, Dalian 116024, Peoples R China; [Sun, Yutao; Cao, Cong] Univ Nottingham, Nottingham NG8 1BB, England	Dalian University of Technology; University of Nottingham	Cao, C (corresponding author), Univ Nottingham, Nottingham NG8 1BB, England.	cong.cao@nottingham.ac.uk	Cao, Cong/U-1847-2019	Cao, Cong/0000-0002-3407-7837				Bound K., 2014, CHINAS ABSORPTIVE ST; Breznitz D., 2010, RUN RED QUEEN GOVT I; Cao C, 2006, PHYS TODAY, V59, P38, DOI 10.1063/1.2435680; Cao C, 2013, SCIENCE, V341, P460, DOI 10.1126/science.1234206; Liu FC, 2011, RES POLICY, V40, P917, DOI 10.1016/j.respol.2011.05.005; MOST, 2011, CHIN SCI TECHN IND 2; OECD, 2014, MAIN SCI TECHN IND I; OECD, 2002, FRASC MAN; Stephan P., 2012, EC SHAPES SCI; Van Noorden R, 2014, NATURE, V505, P144, DOI 10.1038/505144a	10	42	44	11	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1006	1008		10.1126/science.1253479	http://dx.doi.org/10.1126/science.1253479			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8RE	25170140				2022-12-28	WOS:000340870900020
J	Bech, BH; Kjaersgaard, MIS; Pedersen, HS; Howards, PP; Sorensen, MJ; Olsen, J; Thorlund, E; Pedersen, LH; Vestergaard, M; Christensen, J				Bech, Bodil Hammer; Kjaersgaard, Maiken Ina Siegismund; Pedersen, Henrik Sondergaard; Howards, Penelope P.; Sorensen, Merete Juul; Olsen, Jorn; Thorlund, Erik; Pedersen, Lars Henning; Vestergaard, Mogens; Christensen, Jakob			Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EURAP EPILEPSY; EXPOSURE; WOMEN; MALFORMATIONS; VALPROATE; REGISTRY; COMPLICATIONS	Objective To determine whether use of antiepileptic drugs during pregnancy may increase the risk of spontaneous abortion or stillbirth. Design Population based cohort study. Setting Register based study in Denmark, 1997-2008. Participants 983 305 pregnancies identified in the Danish medical birth register and the Danish national hospital discharge register from 1 February 1997 to 31 December 2008 were linked to the Danish Register of Medicinal Product Statistics to obtain information on use of antiepileptic drugs. Main outcome measures Risk ratio of spontaneous abortion and stillbirth after use of antiepileptic drugs during pregnancy, estimated by using binomial regression adjusting for potential confounders of maternal age, cohabitation, income, education, history of severe mental disorder, and history of drug misuse. Results Antiepileptic drugs were used in a total of 4700 (0.5%) pregnancies. 16 out of 100 pregnant women using antiepileptics and 13 out of 100 pregnant women not using antiepileptics experienced a spontaneous abortion. After adjusting for potential confounders pregnant women using antiepileptics had a 13% higher risk of spontaneous abortions than pregnant women not using antiepileptics (adjusted risk ratio 1.13, 95% confidence interval 1.04 to 1.24). However, the risk of spontaneous abortion was not increased in women with an epilepsy diagnosis (0.98, 0.87 to 1.09), only in women without a diagnosis of epilepsy (1.30, 1.14 to 1.49). In an analysis including women with at least two pregnancies with discordant antiepileptic drug use (for example, use in the first pregnancy but not in the second), the adjusted hazard ratio for spontaneous abortion was 0.83 (0.69 to 1.00) for exposed pregnancies compared with unexposed pregnancies. Stillbirth was identified in 18 women who used antiepileptic drugs (unadjusted risk ratio 1.29, 0.80 to 2.10). Conclusion Among women with epilepsy and when analysing the risk in antiepileptic drug discordant pregnancies in the same woman, we found no overall association between the use of antiepileptic drugs during pregnancy and spontaneous abortions. Therefore unmeasured confounding may explain the slight increased risk for spontaneous abortion with any antiepileptic drug use (among women both with and without epilepsy). We found no association between antiepileptic drug use during pregnancy and stillbirth, but the statistical precision was low.	[Bech, Bodil Hammer; Olsen, Jorn; Pedersen, Lars Henning] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, DK-8000 Aarhus C, Denmark; [Kjaersgaard, Maiken Ina Siegismund; Thorlund, Erik] Aarhus Univ, Dept Publ Hlth, Sect Biostat, DK-8000 Aarhus C, Denmark; [Pedersen, Henrik Sondergaard; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark; [Pedersen, Henrik Sondergaard; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, DK-8000 Aarhus C, Denmark; [Howards, Penelope P.] Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Risskov, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Dept Clin Med Obstet & Gynaecol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Emory University; Rollins School Public Health; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Bech, BH (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, DK-8000 Aarhus C, Denmark.	bhb@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Parner, Erik Thorlund/F-5532-2010; Olsen, Jørn/F-8801-2015; Vestergaard, Mogens/M-9333-2014	Bech, Bodil Hammer/0000-0002-0287-3687; Parner, Erik Thorlund/0000-0003-3661-1922; Olsen, Jørn/0000-0001-7462-5140; Vestergaard, Mogens/0000-0001-8830-2174; Christensen, Jakob/0000-0002-9385-6435	Danish Epilepsy Association; Danish Council for Independent Research	Danish Epilepsy Association; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	JC receives research support from the Danish Epilepsy Association. LHP is supported by a Sapere Aude-Postdoc grant from the Danish Council for Independent Research. The funding sources had no role in the design and conduct of the study; the collection, analysis and interpretation of data; or the preparation, review, or approval of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; ANNEGERS JF, 1988, EPILEPSIA, V29, P451, DOI 10.1111/j.1528-1157.1988.tb03745.x; Bobo WV, 2012, PAEDIATR PERINAT EP, V26, P578, DOI 10.1111/ppe.12004; Borthen I, 2009, BJOG-INT J OBSTET GY, V116, P1736, DOI 10.1111/j.1471-0528.2009.02354.x; Borthen I, 2012, CURR OPIN OBSTET GYN, V24, P78, DOI 10.1097/GCO.0b013e32834feb6a; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Diav-Citrin O, 2008, CNS DRUGS, V22, P325, DOI 10.2165/00023210-200822040-00004; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kulaga S, 2011, SEIZURE-EUR J EPILEP, V20, P667, DOI 10.1016/j.seizure.2011.06.012; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Mawhinney E, 2012, SEIZURE-EUR J EPILEP, V21, P215, DOI 10.1016/j.seizure.2012.01.005; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; NAKANE Y, 1980, EPILEPSIA, V21, P663, DOI 10.1111/j.1528-1157.1980.tb04320.x; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Ornoy A, 2008, REPROD TOXICOL, V25, P388, DOI 10.1016/j.reprotox.2008.03.001; Padmanabhan R, 2003, BIRTH DEFECTS RES B, V68, P428, DOI 10.1002/bdrb.10042; Padmanabhan R, 2010, REPROD TOXICOL, V29, P366, DOI 10.1016/j.reprotox.2010.02.005; Pedersen CB, 2006, DAN MED BULL, V53, P441; Richmond JR, 2004, AM J OBSTET GYNECOL, V190, P371, DOI 10.1016/j.ajog.2003.09.020; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; SPEIDEL BD, 1972, LANCET, V2, P839; Thomas SV, 2009, SEIZURE-EUR J EPILEP, V18, P163, DOI 10.1016/j.seizure.2008.08.010; Tomson T, 2006, NEUROLOGY, V66, P354; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; WHO Collaborating Centre for Drug Statistics Methodology (WHOCC), 2013, DEF DAIL DOS DEF GEN	27	40	40	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2014	349								g5159	10.1136/bmj.g5159	http://dx.doi.org/10.1136/bmj.g5159			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FP	25150301	Green Published, hybrid			2022-12-28	WOS:000340839100001
J	Brady, O				Brady, Oliver			Scale up the supply of experimental Ebola drugs	NATURE			English	Editorial Material									Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Brady, O (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	oliver.brady@zoo.ox.ac.uk	Hay, Simon Iain/F-8967-2015; Brady, Oliver/P-9421-2019	Hay, Simon Iain/0000-0002-0611-7272; Brady, Oliver/0000-0002-3235-2129					0	8	8	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					233	233		10.1038/512233a	http://dx.doi.org/10.1038/512233a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3SF	25143079	Green Submitted, Bronze			2022-12-28	WOS:000340508200003
J	Gambino, F; Pages, S; Kehayas, V; Baptista, D; Tatti, R; Carleton, A; Holtmaat, A				Gambino, Frederic; Pages, Stephane; Kehayas, Vassilis; Baptista, Daniela; Tatti, Roberta; Carleton, Alan; Holtmaat, Anthony			Sensory-evoked LTP driven by dendritic plateau potentials in vivo	NATURE			English	Article							LONG-TERM POTENTIATION; RAT BARREL CORTEX; DEPENDENT PLASTICITY; NEURAL ACTIVITY; NMDA; SPIKE; RESPONSES; NEURONS; DEPOLARIZATION; ORGANIZATION	Long-term synaptic potentiation (LTP) is thought to be a key process in cortical synaptic network plasticity and memory formation(1). Hebbian forms of LTPdependon strong postsynaptic depolarization, which in many models is generated by action potentials that propagate back from the soma into dendrites(2,3). However, local dendritic depolarization has been shown to mediate these forms of LTP as well(1,4,5). As pyramidal cells in supragranular layers of the somatosensory cortex spike infrequently(6-8), it is unclear which of the two mechanisms prevails for those cellsin vivo. Using whole-cell recordings in the mouse somatosensory cortexin vivo, we demonstrate that rhythmic sensory whisker stimulation efficiently induces synaptic LTP in layer 2/3 (L2/3) pyramidal cells in the absence of somatic spikes. The induction of LTP depended on the occurrence of NMDAR(N-methyl-D-aspartate receptor)-mediated long-lasting depolarizations, which bear similarities to dendritic plateau potentials(9-13). In addition, we show that whisker stimuli recruit synaptic networks that originate from the posteromedial complex of the thalamus (POm). Photostimulation of channelrhodopsin-2 expressing POm neurons generated NMDAR mediated plateau potentials, whereas the inhibition of POm activity during rhythmic whisker stimulation suppressed the generation of those potentials and prevented whisker-evoked LTP. Taken together, our data provide evidence for sensory-driven synaptic LTP in vivo, in the absence of somatic spiking. Instead, LTP is mediated by plateau potentials that are generated through the cooperative activity of lemniscal and paralemniscal synaptic circuitry(14-16).	[Gambino, Frederic; Pages, Stephane; Kehayas, Vassilis; Baptista, Daniela; Tatti, Roberta; Carleton, Alan; Holtmaat, Anthony] Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Gambino, Frederic; Pages, Stephane; Kehayas, Vassilis; Baptista, Daniela; Tatti, Roberta; Carleton, Alan; Holtmaat, Anthony] Univ Geneva, CMU, Ctr Neurosci, CH-1211 Geneva, Switzerland; [Kehayas, Vassilis; Tatti, Roberta] Leman Neurosci Doctoral Sch, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Holtmaat, A (corresponding author), Univ Geneva, Dept Basic Neurosci, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	anthony.holtmaat@unige.ch	Carleton, Alan/C-9721-2010; Core, Vector/CAF-4832-2022; Kehayas, Vassilis/I-1154-2019	Carleton, Alan/0000-0001-5633-9159; Kehayas, Vassilis/0000-0002-8759-2808; Holtmaat, Anthony/0000-0002-7577-0769; gambino, frederic/0000-0002-2981-5030	Swiss National Science Foundation [31003A_120685, 31003A_135631, CRSI33_127289, 31003A_153410]; National Centre of Competence in Research (NCCR) SYNAPSY - Swiss National Science Foundation [51AU40_125759]; International Foundation for Research on Paraplegia; Hans Wilsdorf Foundation; SyMBaD (EU FP7-PEOPLE-ITN Marie Curie) [238608]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research (NCCR) SYNAPSY - Swiss National Science Foundation; International Foundation for Research on Paraplegia; Hans Wilsdorf Foundation; SyMBaD (EU FP7-PEOPLE-ITN Marie Curie)	We thank E. Ahissar and T. Oram for advice on the muscimol experiments. We appreciate C. Luscher's comments on our manuscript. We thank L. L. Looger and D. Kim of the GENIE project, and K. Svoboda at the Janelia Farm Research Campus (HHMI) for distributing the GCaMP5G, GCaMP6S and ChR2 vectors, respectively. This work was supported by the Swiss National Science Foundation (grants 31003A_120685, 31003A_135631 and CRSI33_127289 to A. H.; 31003A_153410 to A. C.), the National Centre of Competence in Research (NCCR) SYNAPSY financed by the Swiss National Science Foundation (51AU40_125759), the International Foundation for Research on Paraplegia, and the Hans Wilsdorf Foundation. V. K. was supported by SyMBaD (EU FP7-PEOPLE-ITN Marie Curie, grant 238608).	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Favero M, 2013, J NEUROSCI, V33, P3151, DOI 10.1523/JNEUROSCI.4424-12.2013; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Gambino F, 2012, NEURON, V75, P490, DOI 10.1016/j.neuron.2012.05.020; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Hardie J, 2009, J NEUROSCI, V29, P3233, DOI 10.1523/JNEUROSCI.6000-08.2009; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Megevand P, 2009, J NEUROSCI, V29, P5326, DOI 10.1523/JNEUROSCI.5965-08.2009; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Palmer LM, 2014, NAT NEUROSCI, V17, P383, DOI 10.1038/nn.3646; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Rema V, 1998, J NEUROSCI, V18, P10196; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	41	142	142	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					116	+		10.1038/nature13664	http://dx.doi.org/10.1038/nature13664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25174710				2022-12-28	WOS:000344187500041
J	Rodin, G				Rodin, Gary			Effective treatment for depression in patients with cancer	LANCET			English	Editorial Material							LUNG-CANCER; TRIAL; CARE; INTERVENTIONS; MANAGEMENT; IMPROVE; HEALTH		Univ Hlth Network, Princess Margaret Canc Ctr, Dept Psychosocial Oncol & Palliat Care, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Rodin, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Dept Psychosocial Oncol & Palliat Care, Toronto, ON M5G 2M9, Canada.	gary.rodin@uhn.ca		Rodin, Gary/0000-0002-6626-6974				Brown LF, 2010, PSYCHO-ONCOLOGY, V19, P734, DOI 10.1002/pon.1627; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Holland JC, 2013, J NATL COMPR CANC NE, V11, P687, DOI 10.6004/jnccn.2013.0202; Lo C, 2014, PALLIATIVE MED, V28, P234, DOI 10.1177/0269216313507757; Lo C, 2010, J CLIN ONCOL, V28, P3084, DOI 10.1200/JCO.2009.26.9712; Miller M, 2008, J CLIN ONCOL, V26, P4720, DOI 10.1200/JCO.2007.14.3990; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Sharpe M, 2014, LANCET; Strong V, 2008, LANCET, V372, P40, DOI 10.1016/S0140-6736(08)60991-5; Walker J, 2014, PSYCHOL MED, V44, P897, DOI 10.1017/S0033291713001372; Walker J, 2014, LANCET PSYCHIAT; Walker J, 2014, LANCET ONCOL, V15, P1168, DOI 10.1016/S1470-2045(14)70343-2	13	9	9	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1076	1078		10.1016/S0140-6736(14)61342-8	http://dx.doi.org/10.1016/S0140-6736(14)61342-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	25175951	hybrid			2022-12-28	WOS:000342630600010
J	Mayosi, BM; Ntsekhe, M; Bosch, J; Pandie, S; Jung, H; Gumedze, F; Pogue, J; Thabane, L; Smieja, M; Francis, V; Joldersma, L; Thomas, KM; Thomas, B; Awotedu, AA; Magula, NP; Naidoo, DP; Damasceno, A; Banda, AC; Brown, B; Manga, P; Kirenga, B; Mondo, C; Mntla, P; Tsitsi, JM; Peters, F; Essop, MR; Russell, JBW; Hakim, J; Matenga, J; Barasa, AF; Sani, MU; Olunuga, T; Ogah, O; Ansa, V; Aje, A; Danbauchi, S; Ojji, D; Yusuf, S				Mayosi, B. M.; Ntsekhe, M.; Bosch, J.; Pandie, S.; Jung, H.; Gumedze, F.; Pogue, J.; Thabane, L.; Smieja, M.; Francis, V.; Joldersma, L.; Thomas, K. M.; Thomas, B.; Awotedu, A. A.; Magula, N. P.; Naidoo, D. P.; Damasceno, A.; Banda, A. C.; Brown, B.; Manga, P.; Kirenga, B.; Mondo, C.; Mntla, P.; Tsitsi, J. M.; Peters, F.; Essop, M. R.; Russell, J. B. W.; Hakim, J.; Matenga, J.; Barasa, A. F.; Sani, M. U.; Olunuga, T.; Ogah, O.; Ansa, V.; Aje, A.; Danbauchi, S.; Ojji, D.; Yusuf, S.		IMPI Trial Investigators	Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; ADJUNCTIVE PREDNISOLONE; CORTICOSTEROIDS; MANAGEMENT; VACCINE; IMMUNOTHERAPY; EFFUSIONS; MORTALITY; DIAGNOSIS	BACKGROUND Tuberculous pericarditis is associated with high morbidity and mortality even if antituberculosis therapy is administered. We evaluated the effects of adjunctive glucocorticoid therapy and Mycobacterium indicus pranii immunotherapy in patients with tuberculous pericarditis. METHODS Using a 2-by-2 factorial design, we randomly assigned 1400 adults with definite or probable tuberculous pericarditis to either prednisolone or placebo for 6 weeks and to either M. indicus pranii or placebo, administered in five injections over the course of 3 months. Two thirds of the participants had concomitant human immunodeficiency virus (HIV) infection. The primary efficacy outcome was a composite of death, cardiac tamponade requiring pericardiocentesis, or constrictive pericarditis. RESULTS There was no significant difference in the primary outcome between patients who received prednisolone and those who received placebo (23.8% and 24.5%, respectively; hazard ratio, 0.95; 95% confidence interval [CI], 0.77 to 1.18; P = 0.66) or between those who received M. indicus pranii immunotherapy and those who received placebo (25.0% and 24.3%, respectively; hazard ratio, 1.03; 95% CI, 0.82 to 1.29; P = 0.81). Prednisolone therapy, as compared with placebo, was associated with significant reductions in the incidence of constrictive pericarditis (4.4% vs. 7.8%; hazard ratio, 0.56; 95% CI, 0.36 to 0.87; P = 0.009) and hospitalization (20.7% vs. 25.2%; hazard ratio, 0.79; 95% CI, 0.63 to 0.99; P = 0.04). Both prednisolone and M. indicus pranii, each as compared with placebo, were associated with a significant increase in the incidence of cancer (1.8% vs. 0.6%; hazard ratio, 3.27; 95% CI, 1.07 to 10.03; P = 0.03, and 1.8% vs. 0.5%; hazard ratio, 3.69; 95% CI, 1.03 to 13.24; P = 0.03, respectively), owing mainly to an increase in HIV-associated cancer. CONCLUSIONS In patients with tuberculous pericarditis, neither prednisolone nor M. indicus pranii had a significant effect on the composite of death, cardiac tamponade requiring pericardiocentesis, or constrictive pericarditis.	[Mayosi, B. M.; Ntsekhe, M.; Pandie, S.; Francis, V.] Univ Cape Town, Dept Med, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Mayosi, B. M.; Ntsekhe, M.; Pandie, S.; Francis, V.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Gumedze, F.] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Thomas, K. M.; Thomas, B.; Awotedu, A. A.] Nelson Mandela Acad Hosp, Dept Internal Med, Mthatha, South Africa; [Thomas, K. M.; Thomas, B.; Awotedu, A. A.] Walter Sisulu Univ, Mthanta, South Africa; [Magula, N. P.] King Edward VIII Hosp, Dept Med, Durban, South Africa; [Magula, N. P.] Univ KwaZulu Natal, Durban, South Africa; [Naidoo, D. P.] Inkosi Albert Luthuli Cent Hosp, Dept Cardiol, Durham, South Africa; [Naidoo, D. P.] Univ KwaZulu Natal, Durham, South Africa; [Brown, B.] Prov & Livingstone Hosp, Dept Cardiol, Port Elizabeth, South Africa; [Brown, B.] Walter Sisulu Univ, Port Elizabeth, South Africa; [Manga, P.] Charlotte Maxeke Johannesburg Acad Hosp, Div Cardiol, Johannesburg, South Africa; [Manga, P.] Univ Witwatersrand, Johannesburg, South Africa; [Mntla, P.] Dr George Mukhari Hosp, Div Cardiol, Pretoria, South Africa; [Mntla, P.] Univ Limpopo, Pretoria, South Africa; [Tsitsi, J. M.; Peters, F.; Essop, M. R.] Chris Hani Baragwanath Hosp, Div Cardiol, Soweto, South Africa; [Tsitsi, J. M.; Peters, F.; Essop, M. R.] Univ Witwatersrand, Soweto, South Africa; [Bosch, J.; Jung, H.; Pogue, J.; Thabane, L.; Smieja, M.; Joldersma, L.; Yusuf, S.] McMaster Univ, Hamilton, ON, Canada; [Bosch, J.; Jung, H.; Pogue, J.; Thabane, L.; Smieja, M.; Yusuf, S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Damasceno, A.] Hosp Cent Maputo, Maputo, Mozambique; [Banda, A. C.] Malawi Mil Hlth Serv, Lilongwe, Malawi; [Kirenga, B.; Mondo, C.] New Mulago Hosp, Kampala, Uganda; [Russell, J. B. W.] Connaught Hosp, Freetown, Sierra Leone; [Hakim, J.; Matenga, J.] Parirenyatwa Hosp, Harare, Zimbabwe; [Barasa, A. F.] Moi Hosp, Eldoret, Kenya; [Sani, M. U.] Aminu Kano Teaching Hosp, Kano, Nigeria; [Olunuga, T.; Ogah, O.] Fed Med Ctr, Abeokuta, Ogun State, Niger; [Ansa, V.] Univ Calabar, Teaching Hosp, Calabar, Nigeria; [Aje, A.] Univ Coll Hosp, Ibadan, Oyo State, Nigeria; [Danbauchi, S.] Ahmadu Bello Teaching Hosp, Zaria, Kaduna State, Nigeria; [Ojji, D.] Abuja Teaching Hosp, Abuja, Nigeria	University of Cape Town; University of Cape Town; University of Cape Town; University of Kwazulu Natal; Walter Sisulu University; University of Kwazulu Natal; University of Kwazulu Natal; Walter Sisulu University; University of Witwatersrand; University of Witwatersrand; University of Limpopo; University of Witwatersrand; McMaster University; McMaster University; Population Health Research Institute; Mulago National Referral Hospital; Connaught Hospital; University of Calabar; University of Ibadan; University College Hospital, Ibadan	Mayosi, BM (corresponding author), Old Groote Schuur Hosp, Dept Med, J Fl,Rm J46-53,Groote Schuur Dr, ZA-7925 Cape Town, South Africa.	bongani.mayosi@uct.ac.za	Bosch, Jacqueline/AAP-6910-2021; ntsekhe, mpiko/AAI-8001-2021; Maseeh, Arun/AAO-7868-2021; Tsabedze, Nqoba/U-5941-2017	Bosch, Jacqueline/0000-0001-6292-4207; ntsekhe, mpiko/0000-0002-0851-7675; Maseeh, Arun/0000-0002-5435-941X; Russell, James/0000-0003-4732-6588; Meintjes, Graeme/0000-0003-1196-4414; Gumedze, Freedom N/0000-0003-4387-8844; Yusuf, Salim/0000-0003-4776-5601; Mayosi, Bongani/0000-0001-6641-8950; Kirenga, Bruce/0000-0002-2023-2840; Esmail, Hanif/0000-0002-4278-9316; Tsabedze, Nqoba/0000-0002-7210-1447	Canadian Institutes of Health Research; Canadian Network and Centre for Trials Internationally; Population Health Research Institute; South African Medical Research Council; Lily and Ernst Hausmann Research Trust; Cadila Pharma, India	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally; Population Health Research Institute; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily and Ernst Hausmann Research Trust; Cadila Pharma, India	Supported by grants from the Canadian Institutes of Health Research, the Canadian Network and Centre for Trials Internationally, the Population Health Research Institute, the South African Medical Research Council, the Lily and Ernst Hausmann Research Trust, and Cadila Pharma, India.	[Anonymous], 2019, IDF DIABETES ATLAS, V9th; Cherian G, 2004, POSTGRAD MED J, V80, P262, DOI 10.1136/pgmj.2003.013664; Critchley JA, 2013, LANCET INFECT DIS, V13, P223, DOI 10.1016/S1473-3099(12)70321-3; Elliott AM, 2004, J INFECT DIS, V190, P869, DOI 10.1086/422257; ELLIOTT AM, 1992, Q J MED, V85, P855; Evans DJ, 2008, RESP MED, V102, P793, DOI 10.1016/j.rmed.2008.01.018; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039215; Gupta S, 2008, J EUR ACAD DERMATOL, V22, P1089, DOI 10.1111/j.1468-3083.2008.02719.x; Hakim JG, 2000, HEART, V84, P183, DOI 10.1136/heart.84.2.183; Kharkar Rajendra, 2002, J Indian Med Assoc, V100, P578; LEPPER MH, 1963, ANN NY ACAD SCI, V106, P106, DOI 10.1111/j.1749-6632.1963.tb16629.x; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Mathur ML, 2006, CURR RESPIR MED REV, V2, P183, DOI 10.2174/157339806776843120; Mayosi B.M., 2002, COCHRANE DB SYST REV, V4), DOI [10.1002/14651858.CD000526, DOI 10.1002/14651858.CD000526]; Mayosi BM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-2; Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Mayosi BM, 2013, AM HEART J, V165, P109, DOI 10.1016/j.ahj.2012.08.006; Mutyaba A, 1990, J THORAC CA IN PRESS; Nath I, 1998, NAT MED, V4, P548, DOI 10.1038/nm0598-548; Ntsekhe M, 2003, QJM-INT J MED, V96, P593, DOI 10.1093/qjmed/hcg100; Pandie S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-101; Reuter H, 2006, QJM-INT J MED, V99, P827, DOI 10.1093/qjmed/hcl123; Reuter Helmuth, 2006, Cardiovasc J S Afr, V17, P233; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; SCHRIRE V., 1959, S AFRICAN MED JOUR, V33, P810; Sharma P, 2005, LEPROSY REV, V76, P127; STRANG JIG, 1994, J INFECTION, V28, P251, DOI 10.1016/S0163-4453(94)91593-8; STRANG JIG, 1988, LANCET, V2, P759; STRANG JIG, 1987, LANCET, V2, P1418; Talwar G P, 1999, Int Rev Immunol, V18, P229, DOI 10.3109/08830189909043027; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Treatment of tuberculosis, 2003, MMWR RECOMM REP, V52, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2006, ANT THER HIV INF AD; Zuhlke L, 2013, HEART, V99, P1554, DOI 10.1136/heartjnl-2013-303896	37	150	155	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1121	1130		10.1056/NEJMoa1407380	http://dx.doi.org/10.1056/NEJMoa1407380			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25178809	Green Accepted			2022-12-28	WOS:000341687300007
J	Pukkila-Worley, R; Nardi, V; Branda, JA				Pukkila-Worley, Read; Nardi, Valentina; Branda, John A.			Case 28-2014: A 39-Year-Old Man with a Rash, Headache, Fever, Nausea, and Photophobia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STRONGYLOIDES HYPERINFECTION SYNDROME; ENTEROCOCCAL MENINGITIS; STREPTOCOCCAL MENINGITIS; DIFFERENTIAL-DIAGNOSIS; BACTERIAL-MENINGITIS; UNITED-STATES; STERCORALIS; ADULTS; DISEASE		[Pukkila-Worley, Read] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Nardi, Valentina; Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Pukkila-Worley, Read] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Nardi, Valentina; Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pukkila-Worley, R (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020	Pukkila-Worley, Read/0000-0001-5340-8294				[Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P844; Ash LR, 2007, ASH ORIHELS HUMAN PA, P226; Bamias G, 2010, VIRULENCE, V1, P468, DOI 10.4161/viru.1.5.12703; Boatright MD, 2005, ARTHRITIS RHEUM, V52, P1336, DOI 10.1002/art.20882; Carvalho EM, 2004, PARASITE IMMUNOL, V26, P487, DOI 10.1111/j.0141-9838.2004.00726.x; CHAPEL TA, 1981, JAMA-J AM MED ASSOC, V246, P1440; CRUZ T, 1966, NEW ENGL J MED, V275, P1093, DOI 10.1056/NEJM196611172752003; Domingo P, 1997, CLIN INFECT DIS, V25, P1180, DOI 10.1086/516094; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; GENTA RM, 1987, JAMA-J AM MED ASSOC, V258, P49, DOI 10.1001/jama.258.1.49; Ghosh K, 2007, T ROY SOC TROP MED H, V101, P1163, DOI 10.1016/j.trstmh.2007.05.021; Grove DI, 1996, ADV PARASIT, V38, P251, DOI 10.1016/S0065-308X(08)60036-6; HARLEY WB, 1992, CLIN INFECT DIS, V14, P979, DOI 10.1093/clinids/14.4.979; Hsu J, 2007, INFECT CONT HOSP EP, V28, P614, DOI 10.1086/513496; JACKSON LA, 1995, ANN INTERN MED, V123, P415, DOI 10.7326/0003-4819-123-6-199509150-00003; JENSEN AG, 1993, ARCH INTERN MED, V153, P1902, DOI 10.1001/archinte.153.16.1902; Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004; Krishnamurthy R, 2007, JCR-J CLIN RHEUMATOL, V13, P150, DOI 10.1097/RHU.0b013e3180690933; LAGRENADE L, 1990, LANCET, V336, P1345; Link K, 1999, SOUTHERN MED J, V92, P728, DOI 10.1097/00007611-199907000-00016; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Lu CH, 2001, INFECTION, V29, P305, DOI 10.1007/s15010-001-1005-1; Mahe A, 1999, LANCET, V354, P1386, DOI 10.1016/S0140-6736(05)76239-5; Marcos LA, 2008, T ROY SOC TROP MED H, V102, P314, DOI 10.1016/j.trstmh.2008.01.020; Marty FM, 2009, TRANSPL INFECT DIS, V11, P97, DOI 10.1111/j.1399-3062.2009.00383.x; MCKINNEY WP, 1994, J GEN INTERN MED, V9, P8, DOI 10.1007/BF02599135; Nair D, 2001, J Am Board Fam Pract, V14, P51; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Pintado V, 2003, MEDICINE, V82, P346, DOI 10.1097/01.md.0000090402.56130.82; Rubin L, 2007, INFECT CONT HOSP EP, V28, P1187, DOI 10.1086/520748; Satoh M, 2003, CLIN EXP IMMUNOL, V133, P391, DOI 10.1046/j.1365-2249.2003.02224.x; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; STEVENSON KB, 1994, CLIN INFECT DIS, V18, P233, DOI 10.1093/clinids/18.2.233; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Tunkel AR, 2010, MANDELL DOUGLAS BENN, P1189; van de Beek D, 2002, CLIN INFECT DIS, V34, pE32, DOI 10.1086/339941; VONKUSTER LC, 1988, ARCH DERMATOL, V124, P1826, DOI 10.1001/archderm.124.12.1826	40	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					1051	1060		10.1056/NEJMcpc1405886	http://dx.doi.org/10.1056/NEJMcpc1405886			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25207769				2022-12-28	WOS:000341382800012
J	Schneider, DM; Nelson, A; Mooney, R				Schneider, David M.; Nelson, Anders; Mooney, Richard			A synaptic and circuit basis for corollary discharge in the auditory cortex	NATURE			English	Article							CORTICAL ACTIVITY; BEHAVIORAL STATE; VISUAL RESPONSES; MODULATION; BRAIN; SCHIZOPHRENIA; GAIN; HALLUCINATIONS; CONNECTIONS; DYSFUNCTION	Sensory regions of the brain integrate environmental cues with copies of motor-related signals important for imminent and ongoing movements. In mammals, signals propagating from the motor cortex to the auditory cortex are thought to have a critical role in normal hearing and behaviour, yet the synaptic and circuit mechanisms by which these motor-related signals influence auditory cortical activity remain poorly understood. Using in vivo intracellular recordings in behaving mice, we find that excitatory neurons in the auditory cortex are suppressed before and during movement, owing in part to increased activity of local parvalbumin-positive interneurons. Electrophysiology and optogenetic gain- and loss-of-function experiments reveal that motor-related changes in auditory cortical dynamics are driven by a subset of neurons in the secondary motor cortex that innervate the auditory cortex and are active during movement. These findings provide a synaptic and circuit basis for the motor-related corollary discharge hypothesized to facilitate hearing and auditory-guided behaviours.	[Schneider, David M.; Nelson, Anders; Mooney, Richard] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Mooney, R (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu		Mooney, Richard/0000-0002-3308-1367; Nelson, Anders/0000-0003-1460-9848	Holland-Trice Graduate Fellowship in Brain Sciences; NIH [NS079929]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013826] Funding Source: NIH RePORTER	Holland-Trice Graduate Fellowship in Brain Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the members of the Mooney laboratory for discussions regarding experimental design and data analysis; S. Lisberger, F. Wang and S. Shea for their valuable comments on the manuscript; and M. Booze for technical support and animal husbandry. D.M.S. is a fellow of the Helen Hay Whitney Foundation; A.N. was supported by the Holland-Trice Graduate Fellowship in Brain Sciences; R.M. was supported by NIH grant NS079929.	ALEXANDER GE, 1976, BRAIN RES, V116, P334, DOI 10.1016/0006-8993(76)90913-6; Bennett C, 2013, NEURON, V80, P350, DOI 10.1016/j.neuron.2013.08.007; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Buran BN, 2014, J NEUROSCI, V34, P4076, DOI 10.1523/JNEUROSCI.4825-13.2014; CARMEL PW, 1963, J NEUROPHYSIOL, V26, P598, DOI 10.1152/jn.1963.26.4.598; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Flinker A, 2010, J NEUROSCI, V30, P16643, DOI 10.1523/JNEUROSCI.1809-10.2010; Ford JM, 2005, INT J PSYCHOPHYSIOL, V58, P179, DOI 10.1016/j.ijpsycho.2005.01.014; Ford JM, 2004, J PSYCHIATR RES, V38, P37, DOI 10.1016/S0022-3956(03)00095-5; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hamaguchi K, 2014, ELIFE, V3, DOI 10.7554/eLife.01833; Heinks-Maldonado TH, 2007, ARCH GEN PSYCHIAT, V64, P286, DOI 10.1001/archpsyc.64.3.286; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Horvath J, 2013, PSYCHOPHYSIOLOGY, V50, P563, DOI 10.1111/psyp.12041; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Jaramillo S, 2014, J NEUROSCI, V34, P5291, DOI 10.1523/JNEUROSCI.4888-13.2014; KORN H, 1984, J NEUROSCI, V4, P125; Langguth B, 2005, NEUROSCI LETT, V380, P326, DOI 10.1016/j.neulet.2005.01.069; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mukerji S, 2010, TRENDS AMPLIF, V14, P170, DOI 10.1177/1084713810381771; Nelson A, 2013, J NEUROSCI, V33, P14342, DOI 10.1523/JNEUROSCI.2275-13.2013; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Reznik D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5059; Sanders JI, 2012, J NEUROPHYSIOL, V108, P3416, DOI 10.1152/jn.00669.2012; SCHULLER G, 1979, J COMP PHYSIOL, V132, P39, DOI 10.1007/BF00617730; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Wienisch M., 2012, NEUROMETHODS, V67, P45; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zhou M, 2014, NAT NEUROSCI, V17, P841, DOI 10.1038/nn.3701	49	283	284	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					189	+		10.1038/nature13724	http://dx.doi.org/10.1038/nature13724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25162524	Green Accepted			2022-12-28	WOS:000341362800042
J	Guglani, S				Guglani, Samir			Medicine Unboxed: voices and frontiers	LANCET			English	Editorial Material									Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					838	839		10.1016/S0140-6736(14)61414-8	http://dx.doi.org/10.1016/S0140-6736(14)61414-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	25209474				2022-12-28	WOS:000341362200008
J	Papageorghiou, AT; Ohuma, EO; Altman, DG; Todros, T; Ismail, LC; Lambert, A; Jaffer, YA; Bertino, E; Gravett, MG; Purwar, M; Noble, JA; Pang, RY; Victora, CG; Barros, FC; Carvalho, M; Salomon, LJ; Bhutta, ZA; Kennedy, SH; Villar, J				Papageorghiou, Aris T.; Ohuma, Eric O.; Altman, Douglas G.; Todros, Tullia; Ismail, Leila Cheikh; Lambert, Ann; Jaffer, Yasmin A.; Bertino, Enrico; Gravett, Michael G.; Purwar, Manorama; Noble, J. Alison; Pang, Ruyan; Victora, Cesar G.; Barros, Fernando C.; Carvalho, Maria; Salomon, Laurent J.; Bhutta, Zulfiqar A.; Kennedy, Stephen H.; Villar, Jose		Int Fetal Newborn Growth	International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project	LANCET			English	Article							CROWN-RUMP LENGTH; CENTILE CURVES; QUALITY-CONTROL; LMS METHOD; DESIGN; CHARTS; AGE; SKEWNESS	Background In 2006, WHO produced international growth standards for infants and children up to age 5 years on the basis of recommendations from a WHO expert committee. Using the same methods and conceptual approach, the Fetal Growth Longitudinal Study (FGLS), part of the INTERGROWTH-21st Project, aimed to develop international growth and size standards for fetuses. Methods The multicentre, population-based FGLS assessed fetal growth in geographically defined urban populations in eight countries, in which most of the health and nutritional needs of mothers were met and adequate antenatal care was provided. We used ultrasound to take fetal anthropometric measurements prospectively from 14 weeks and 0 days of gestation until birth in a cohort of women with adequate health and nutritional status who were at low risk of intrauterine growth restriction. All women had a reliable estimate of gestational age confirmed by ultrasound measurement of fetal crown-rump length in the first trimester. The five primary ultrasound measures of fetal growth-head circumference, biparietal diameter, occipitofrontal diameter, abdominal circumference, and femur length-were obtained every 5 weeks (within 1 week either side) from 14 weeks to 42 weeks of gestation. The best fitting curves for the five measures were selected using second-degree fractional polynomials and further modelled in a multilevel framework to account for the longitudinal design of the study. Findings We screened 13.108 women commencing antenatal care at less than 14 weeks and 0 days of gestation, of whom 4607 (35%) were eligible. 4321 (94%) eligible women had pregnancies without major complications and delivered live singletons without congenital malformations (the analysis population). We documented very low maternal and perinatal mortality and morbidity, confirming that the participants were at low risk of adverse outcomes. For each of the five fetal growth measures, the mean differences between the observed and smoothed centiles for the 3rd, 50th, and 97th centiles, respectively, were small: 2.25 mm (SD 3.0), 0.02 mm (3.0), and -2.69 mm (3.2) for head circumference; 0.83 mm (0.9), -0.05 mm (0.8), and -0.84 mm (1.0) for biparietal diameter; 0.63 mm (1.2), 0.04 mm (1.1), and -1.05 mm (1.3) for occipitofrontal diameter; 2.99 mm (3.1), 0.25 mm (3.2), and -4.22 mm (3.7) for abdominal circumference; and 0.62 mm (0.8), 0.03 mm (0.8), and -0.65 mm (0.8) for femur length. We calculated the 3rd, 5th 10th, 50th, 90th, 95th and 97th centile curves according to gestational age for these ultrasound measures, representing the international standards for fetal growth. Interpretation We recommend these international fetal growth standards for the clinical interpretation of routinely taken ultrasound measurements and for comparisons across populations.	[Papageorghiou, Aris T.; Ohuma, Eric O.; Ismail, Leila Cheikh; Lambert, Ann; Kennedy, Stephen H.; Villar, Jose] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Green Templeton Coll, Oxford OX3 9DU, England; [Papageorghiou, Aris T.; Ohuma, Eric O.; Ismail, Leila Cheikh; Lambert, Ann; Kennedy, Stephen H.; Villar, Jose] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Green Templeton Coll, Oxford OX3 9DU, England; [Ohuma, Eric O.; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Botnar Res Ctr, Oxford OX3 9DU, England; [Noble, J. Alison] Univ Oxford, Dept Engn Sci, Oxford OX3 9DU, England; [Todros, Tullia; Bertino, Enrico] Univ Turin, Turin, Italy; [Jaffer, Yasmin A.] Minist Hlth, Dept Family & Community Hlth, Muscat, Oman; [Gravett, Michael G.] Univ Washington, Sch Med, Seattle, WA USA; [Purwar, Manorama] Ketkar Hosp, Nagpur INTERGROWTH 21st Res Ctr, Nagpur, Maharashtra, India; [Pang, Ruyan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Victora, Cesar G.; Barros, Fernando C.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil; [Barros, Fernando C.] Univ Catolica Pelotas, Programa Posgrad Saude Comportamento, Pelotas, RS, Brazil; [Carvalho, Maria] Aga Khan Univ, Fac Hlth Sci, Nairobi, Kenya; [Salomon, Laurent J.] Univ Paris 05, Dept Obstet & Fetal Med, Hop Necker Enfants Malad, Paris, France; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Turin; University of Washington; University of Washington Seattle; Peking University; Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; Aga Khan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Villar, J (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Womens Ctr, John Radcliffe Hosp, Oxford OX3 9DU, England.	jose.villar@obs-gyn.ox.ac.uk	Sanchez Luna, Manuel/H-2165-2014; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Matijasevich, Alicia/C-5576-2009	Sanchez Luna, Manuel/0000-0001-9543-7392; Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Matijasevich, Alicia/0000-0003-0060-1589; Noble, Alison/0000-0002-3060-3772; Cheikh Ismail, Leila/0000-0003-3048-7481; Barros, Fernando/0000-0001-5973-1746; Papageorghiou, Aris T./0000-0001-8143-2232; Todros, Tullia/0000-0003-3016-1510; BERTINO, Enrico/0000-0002-6369-9352	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	Altman DG, 2013, BJOG-INT J OBSTET GY, V120, P71, DOI 10.1111/1471-0528.12031; ALTMAN DG, 1993, ULTRASOUND OBST GYN, V3, P378, DOI 10.1046/j.1469-0705.1993.03060378.x; Bellera CA, 2007, J CLIN EPIDEMIOL, V60, P610, DOI 10.1016/j.jclinepi.2006.09.004; Bricker L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001451.pub3; Chatfield A, 2013, BJOG-INT J OBSTET GY, V120, P139, DOI 10.1111/1471-0528.12416; COLE TJ, 1988, J R STAT SOC A STAT, V151, P385, DOI 10.2307/2982992; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; COLE TJ, 1989, ANN HUM BIOL, V16, P407, DOI 10.1080/03014468900000532; Conde-Agudelo A, 2013, BJOG-INT J OBSTET GY, V120, P681, DOI 10.1111/1471-0528.12172; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Eskenazi B, 2013, BJOG-INT J OBSTET GY, V120, P129, DOI 10.1111/1471-0528.12430; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Garza C, 2006, NUTR REV, V64, pS55, DOI 10.1301/nr.2006.may.S000-S000; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Green P.J., 1993, NONPARAMETRIC REGRES, DOI [10.1201/b15710, DOI 10.1201/B15710]; Hynek M, 2010, EUR J BIOMED INFORM, V6, P51; Ioannou C, 2013, BJOG-INT J OBSTET GY, V120, P38, DOI 10.1111/1471-0528.12056; Ioannou C, 2012, BJOG-INT J OBSTET GY, V119, P1425, DOI 10.1111/j.1471-0528.2012.03451.x; Kato N, 2012, HYPERTENS RES, V35, P574, DOI 10.1038/hr.2012.44; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Leckie G, 2013, J STAT SOFTW, V52, P1; Napolitano R, 2014, BJOG-INT J OBSTET GY, V121, P556, DOI 10.1111/1471-0528.12478; Ohuma EO, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/1471-0528.12080; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Papageorghiou AT, 2013, BJOG-INT J OBSTET GY, V120, P27, DOI 10.1111/1471-0528.12313; Rasbash J, 2009, MLWIN VERSION 21; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; ROYSTON P, 1995, ULTRASOUND OBST GYN, V6, P307, DOI 10.1046/j.1469-0705.1995.06050307.x; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Salomon LJ, 2006, ULTRASOUND OBST GYN, V27, P34, DOI 10.1002/uog.2665; Salomon LJ, 2005, ULTRASOUND OBST GYN, V25, P559, DOI 10.1002/uog.1901; Sarris I, 2013, BJOG-INT J OBSTET GY, V120, P33, DOI 10.1111/1471-0528.12315; Sarris I, 2011, ULTRASOUND OBST GYN, V38, P681, DOI 10.1002/uog.8997; Stasinopoulos D. M., 2007, J STAT SOFTW, V23, P1, DOI [DOI 10.18637/JSS.V023.I07, 10.18637/jss.v023.i07.]; Sylvan K, 2005, ACTA OBSTET GYN SCAN, V84, P1154, DOI 10.1111/j.0001-6349.2005.00649.x; Team RC., 2022, LANG ENV STAT COMP; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; Villar J, 2014, LANCET DIABETES ENDO; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Wade AM, 1998, STAT MED, V17, P1989, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1989::AID-SIM891>3.0.CO;2-Q; Wade A, 2009, BIOSTATISTICS, V10, P147, DOI 10.1093/biostatistics/kxn022; World Health Organization, 2009, DEV MED CHILD NEUROL, V51, P1002; Wright EM, 1997, J R STAT SOC A STAT, V160, P47, DOI 10.1111/1467-985X.00045	49	485	500	1	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					869	879		10.1016/S0140-6736(14)61490-2	http://dx.doi.org/10.1016/S0140-6736(14)61490-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	25209488	Green Submitted			2022-12-28	WOS:000341362200029
J	Palumbo, A; Cavallo, F; Gay, F; Di Raimondo, F; Yehuda, DB; Petrucci, MT; Pezzatti, S; Caravita, T; Cerrato, C; Ribakovsky, E; Genuardi, M; Cafro, A; Marcatti, M; Catalano, L; Offidani, M; Carella, AM; Zamagni, E; Patriarca, F; Musto, P; Evangelista, A; Ciccone, G; Omede, P; Crippa, C; Corradini, P; Nagler, A; Boccadoro, M; Cavo, M				Palumbo, A.; Cavallo, F.; Gay, F.; Di Raimondo, F.; Yehuda, D. B.; Petrucci, M. T.; Pezzatti, S.; Caravita, T.; Cerrato, C.; Ribakovsky, E.; Genuardi, M.; Cafro, A.; Marcatti, M.; Catalano, L.; Offidani, M.; Carella, A. M.; Zamagni, E.; Patriarca, F.; Musto, P.; Evangelista, A.; Ciccone, G.; Omede, P.; Crippa, C.; Corradini, P.; Nagler, A.; Boccadoro, M.; Cavo, M.			Autologous Transplantation and Maintenance Therapy in Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; RANDOMIZED CONTROLLED-TRIAL; PLUS DEXAMETHASONE; INDUCTION THERAPY; INITIAL TREATMENT; ELDERLY-PATIENTS; LENALIDOMIDE; BORTEZOMIB; PREDNISONE; MELPHALAN	BACKGROUND This open-label, randomized, phase 3 study compared melphalan at a dose of 200 mg per square meter of body-surface area plus autologous stem-cell transplantation with melphalan-prednisone-lenalidomide (MPR) and compared lenalidomide maintenance therapy with no maintenance therapy in patients with newly diagnosed multiple myeloma. METHODS We randomly assigned 273 patients 65 years of age or younger to high-dose melphalan plus stem-cell transplantation or MPR consolidation therapy after induction, and 251 patients to lenalidomide maintenance therapy or no maintenance therapy. The primary end point was progression-free survival. RESULTS The median follow-up period was 51.2 months. Both progression-free and overall survival were significantly longer with high-dose melphalan plus stem-cell transplantation than with MPR (median progression-free survival, 43.0 months vs. 22.4 months; hazard ratio for progression or death, 0.44; 95% confidence interval [CI], 0.32 to 0.61; P<0.001; and 4-year overall survival, 81.6% vs. 65.3%; hazard ratio for death, 0.55; 95% CI, 0.32 to 0.93; P=0.02). Median progression-free survival was significantly longer with lenalidomide maintenance than with no maintenance (41.9 months vs. 21.6 months; hazard ratio for progression or death, 0.47; 95% CI, 0.33 to 0.65; P<0.001), but 3-year overall survival was not significantly prolonged (88.0% vs. 79.2%; hazard ratio for death, 0.64; 95% CI, 0.36 to 1.15; P=0.14). Grade 3 or 4 neutropenia was significantly more frequent with high-dose melphalan than with MPR (94.3% vs. 51.5%), as were gastrointestinal adverse events (18.4% vs. 0%) and infections (16.3% vs. 0.8%); neutropenia and dermatologic toxic effects were more frequent with lenalidomide maintenance than with no maintenance (23.3% vs. 0% and 4.3% vs. 0%, respectively). CONCLUSIONS Consolidation therapy with high-dose melphalan plus stem-cell transplantation, as compared with MPR, significantly prolonged progression-free and overall survival among patients with multiple myeloma who were 65 years of age or younger. Lenalidomide maintenance, as compared with no maintenance, significantly prolonged progression-free survival.	[Palumbo, A.; Cavallo, F.; Gay, F.; Cerrato, C.; Genuardi, M.; Omede, P.; Boccadoro, M.] Univ Turin, Myeloma Unit, Div Hematol, I-10126 Turin, Italy; [Evangelista, A.; Ciccone, G.] Azienda Osped Univ Citta Salute & Sci Torino, Clin Epidemiol Unit, Turin, Italy; [Evangelista, A.; Ciccone, G.] Azienda Osped Univ Citta Salute & Sci Torino, Ctr Referimento Epidemiol Piemonte, Turin, Italy; [Di Raimondo, F.] Univ Catania, Div Hematol, Osped Ferrarotto, Azienda Policlin Osped Vittorio Emanuele, Catania, Italy; [Petrucci, M. T.] Univ Roma La Sapienza, I-00185 Rome, Italy; [Caravita, T.] Osped S Eugenio Univ Tor Vergata, Cattedra Ematol, Rome, Italy; [Pezzatti, S.] Osped San Gerardo, Div Ematol, Monza, Italy; [Cafro, A.] Azienda Osped Niguarda Ca Granda, Dipartimento Ematol & Oncol, Milan, Italy; [Marcatti, M.] Ist Sci San Raffaele, Hematol & Bone Marrow Transplantat Unit, I-20132 Milan, Italy; [Corradini, P.] IRCCS Ist Nazl Tumori Univ Milan, Div Hematol & Bone Marrow Transplantat, Milan, Italy; [Catalano, L.] Policlin Federico II, Naples, Italy; [Offidani, M.] Azienda Ospedal Univ Osped Riuniti Ancona, Clin Ematol, Ancona, Italy; [Carella, A. M.] Univ Bologna, Sch Med, Seragnoli Inst Hematol, Unita Operat Complessa Ematol 1,IRCCS Azienda Osp, Bologna, Italy; [Patriarca, F.] Azienda Osped Univ Udine, Clin Ematol, Dipartimento Sci Med Sperimentali & Clin, Udine, Italy; [Musto, P.] Ctr Riferimento Oncol Basilicata, Sci Direct, IRCCS, Rionero In Vulture, Italy; [Crippa, C.] Spedali Civili Brescia, Brescia, Italy; [Crippa, C.] Spedali Civili Brescia, Dipartimento Oncol Med, Brescia, Italy; [Yehuda, D. B.] Hadassah Univ Hosp, Div Hematol, IL-91120 Jerusalem, Israel; [Ribakovsky, E.; Nagler, A.] Chaim Sheba Med Ctr, Inst Hematol, IL-52621 Tel Hashomer, Israel	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; Sapienza University Rome; Sant'Eugenio Hospital; San Gerardo Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Bologna; Hospital Santa Maria della Misericordia; University of Udine; University Hospital of Udine; IRCCS CROB; Hospital Spedali Civili Brescia; Hebrew University of Jerusalem; Chaim Sheba Medical Center	Palumbo, A (corresponding author), Univ Turin, Dept Hematol, Via Genova 3, I-10126 Turin, Italy.	appalumbo@yahoo.com	Di Raimondo, Francesco/K-7965-2016; CAVO, MICHELE/AAK-8274-2020; evangelista, andrea/A-7802-2013; Cavallo, Federica/AAB-3867-2019; Corradini, Paolo/N-7584-2017; Ciccone, Giovannino/K-3136-2016; Patriarca, Francesca/ABH-9856-2020; Caravita, Tommaso/O-8929-2019	Di Raimondo, Francesco/0000-0002-7749-0293; CAVO, MICHELE/0000-0003-4514-3227; Cavallo, Federica/0000-0003-2047-1099; Corradini, Paolo/0000-0002-9186-1353; Ciccone, Giovannino/0000-0001-7644-9574; Offidani, Massimo/0000-0003-2749-7347; Gay, Francesca/0000-0002-8619-412X; Zamagni, Elena/0000-0003-1422-7305; Boccadoro, Mario/0000-0001-8130-5209; Musto, Pellegrino/0000-0003-3277-6594; evangelista, andrea/0000-0003-1901-2805	Celgene; Amgen; Array BioPharma; Bristol-Myers Squibb; Genmab, Janssen-Cilag; Millennium; Onyx; Sanofi-Aventis; Genmab; Janssen-Cilag; Novartis; Merck Sharp Dohme; BioLineRx; CureTech; Medison; Neopharm Israel; Sigma Tau; Johnson Johnson; Merck; Mil-lennium	Celgene(Bristol-Myers SquibbCelgene Corporation); Amgen(Amgen); Array BioPharma(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Genmab, Janssen-Cilag(Genmab); Millennium(Takeda Pharmaceutical Company Ltd); Onyx; Sanofi-Aventis(Sanofi-Aventis); Genmab(Genmab); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Merck Sharp Dohme(Merck & Company); BioLineRx; CureTech; Medison; Neopharm Israel; Sigma Tau; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck(Merck & Company); Mil-lennium	Supported by Celgene.; Dr. Palumbo reports receiving fees for serving on advisory boards from Amgen, Array BioPharma, Bristol-Myers Squibb, Celgene, Genmab, Janssen-Cilag, Millennium, Onyx, and Sanofi-Aventis; consulting fees from Amgen, Bristol-Myers Squibb, Celgene, Genmab, Janssen-Cilag, Millennium, and Onyx; lecture fees from Amgen, Bristol-Myers Squibb, Celgene, Janssen-Cilag, Millennium, and Onyx; and grant support from Janssen-Cilag, Millennium, and Onyx. Dr. Cavallo reports receiving fees for serving on an advisory committee from Celgene and honoraria from Janssen-Cilag, Onyx, and Celgene. Dr. Gay reports receiving honoraria from Janssen-Cilag and Celgene, and fees for serving on advisory committees from Sanofi-Aventis and Celgene. Dr. Di Raimondo reports receiving lecture fees from Celgene, Janssen-Cilag, and Novartis. Dr. Petrucci reports receiving honoraria from Janssen-Cilag, Celgene, Sanofi-Aventis, and Bristol-Myers Squibb. Dr. Caravita reports receiving grant support from Celgene. Dr. Offidani reports receiving honoraria from Celgene and Janssen-Cilag. Dr. Patriarca reports receiving honoraria from Celgene, Janssen, and Merck Sharp & Dohme. Dr. Musto reports receiving fees for serving on advisory boards from Janssen-Cilag and lecture fees from Celgene and Janssen-Cilag. Dr. Nagler reports serving on a scientific advisory board for Novartis, receiving honoraria, consulting fees, and grant support from BioLineRx, CureTech, Medison, Neopharm Israel, Novartis, and Sigma Tau, and being a principal investigator for clinical studies funded by Celgene, CureTech, Johnson & Johnson, Merck, Mil-lennium, Novartis, Onyx, and Sigma Tau. Dr. Boccadoro reports receiving fees for serving on scientific advisory boards, consulting fees, and grant support from Janssen-Cilag and Celgene. Dr. Cavo reports receiving fees for serving on advisory boards from Celgene, Janssen-Cilag, Millennium, Bristol-Myers Squibb, and Novartis, and consulting and lecture fees from Celgene, Janssen-Cilag, and Novartis. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Benson DM, 2010, LEUKEMIA LYMPHOMA, V51, P243, DOI 10.3109/10428190903480728; Cavallo F, 2011, LEUKEMIA, V25, P1627, DOI 10.1038/leu.2011.131; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Falco P, 2013, LEUKEMIA, V27, P695, DOI 10.1038/leu.2012.271; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Larocca A, 2012, BLOOD, V119, P933, DOI 10.1182/blood-2011-03-344333; Ludwig H, 2012, BLOOD, V119, P3003, DOI 10.1182/blood-2011-11-374249; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2012, BLOOD, V120, P4692, DOI 10.1182/blood-2012-05-423202; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Reece D, 2013, AM SOC CLIN ONCOL ED, V2013, P307; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Rocci A, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3126.3126; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sonneveld P, 2012, J CLIN ONCOL, V30, P3564; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820	26	523	544	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					895	905		10.1056/NEJMoa1402888	http://dx.doi.org/10.1056/NEJMoa1402888			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184862	Bronze, Green Published			2022-12-28	WOS:000341390600007
J	Aceto, N; Bardia, A; Miyamoto, DT; Donaldson, MC; Wittner, BS; Spencer, JA; Yu, M; Pely, A; Engstrom, A; Zhu, HL; Brannigan, BW; Kapur, R; Stott, SL; Shioda, T; Ramaswamy, S; Ting, DT; Lin, CP; Toner, M; Haber, DA; Maheswaran, S				Aceto, Nicola; Bardia, Aditya; Miyamoto, David T.; Donaldson, Maria C.; Wittner, Ben S.; Spencer, Joel A.; Yu, Min; Pely, Adam; Engstrom, Amanda; Zhu, Huili; Brannigan, Brian W.; Kapur, Ravi; Stott, Shannon L.; Shioda, Toshi; Ramaswamy, Sridhar; Ting, David T.; Lin, Charles P.; Toner, Mehmet; Haber, Daniel A.; Maheswaran, Shyamala			Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BONE METASTASIS; GAMMA-CATENIN; ADHESION; MOLECULES; GENES; BLOOD	Circulating tumor cell clusters (CTC clusters) are present in the blood of patients with cancer but their contribution to metastasis is not well defined. Using mouse models with tagged mammary tumors, we demonstrate that CTC clusters arise from oligoclonal tumor cell groupings and not from intravascular aggregation events. Although rare in the circulation compared with single CTCs, CTC clusters have 23- to 50-fold increased metastatic potential. In patients with breast cancer, single-cell resolution RNA sequencing of CTC clusters and single CTCs, matched within individual blood samples, identifies the cell junction component plakoglobin as highly differentially expressed. In mouse models, knockdown of plakoglobin abrogates CTC cluster formation and suppresses lung metastases. In breast cancer patients, both abundance of CTC clusters and high tumor plakoglobin levels denote adverse outcomes. Thus, CTC clusters are derived from multicellular groupings of primary tumor cells held together through plakoglobin-dependent intercellular adhesion, and though rare, they greatly contribute to the metastatic spread of cancer.	[Aceto, Nicola; Bardia, Aditya; Miyamoto, David T.; Donaldson, Maria C.; Wittner, Ben S.; Yu, Min; Engstrom, Amanda; Zhu, Huili; Brannigan, Brian W.; Stott, Shannon L.; Shioda, Toshi; Ramaswamy, Sridhar; Ting, David T.; Haber, Daniel A.; Maheswaran, Shyamala] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02129 USA; [Aceto, Nicola; Bardia, Aditya; Donaldson, Maria C.; Wittner, Ben S.; Yu, Min; Engstrom, Amanda; Zhu, Huili; Brannigan, Brian W.; Stott, Shannon L.; Shioda, Toshi; Ramaswamy, Sridhar; Ting, David T.; Haber, Daniel A.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02129 USA; [Spencer, Joel A.; Pely, Adam; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Adv Microscopy Program, Boston, MA 02114 USA; [Spencer, Joel A.; Pely, Adam; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Spencer, Joel A.; Pely, Adam; Lin, Charles P.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Miyamoto, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02129 USA; [Kapur, Ravi; Stott, Shannon L.; Toner, Mehmet] Harvard Univ, Ctr Bioengn Med, Sch Med, Boston, MA 02129 USA; [Toner, Mehmet; Maheswaran, Shyamala] Harvard Univ, Dept Surg, Sch Med, Boston, MA 02129 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Haber, DA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02129 USA.	dhaber@mgh.harvard.edu; maheswaran@helix.mgh.harvard.edu	Spencer, Joel/GLT-9687-2022; Stott, Shannon L./AAC-5311-2019; ravegnini, gloria/K-1330-2016; Ting, David/F-4389-2017; Aceto, Nicola/O-2484-2014	Spencer, Joel/0000-0002-4013-8763; ravegnini, gloria/0000-0002-7774-402X; Ting, David/0000-0002-3261-2322; Yu, Min/0000-0002-3969-8720; Donaldson Collier, Maria/0000-0001-6403-6713; Engstrom, Amanda/0000-0002-6796-2752; Aceto, Nicola/0000-0001-9579-6918	Breast Cancer Research Foundation; Stand Up to Cancer; National Foundation for Cancer Research; Howard Hughes Medical Institute; NIH [CA129933, P41 E8015903-02S1, P50 CA086355-12]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [EB008047]; Susan G. Komen for the Cure [KG09042]; ESSCO Breast Cancer Fund; NCI Federal Share Program and Income; MGH-Johnson & Johnson Center for Excellence in CTCs; NATIONAL CANCER INSTITUTE [K12CA087723, P50CA086355, R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012493, R01EB008047] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Stand Up to Cancer; National Foundation for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); ESSCO Breast Cancer Fund; NCI Federal Share Program and Income; MGH-Johnson & Johnson Center for Excellence in CTCs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We express our gratitude to all the patients who participated in this study. We thank C. Hart, A. McGovern, K. Harrington, L. C. Davis, and the Massachusetts General Hospital (MGH) clinical research coordinators for help with the clinical studies; Drs. P. S. Spuhler and T. A. Barber for support with the CTC-iChip technology; L. Libby and J. Brockmann for excellent technical support. This work was supported by grants from the Breast Cancer Research Foundation (D. A. H.), Stand Up to Cancer (D. A. H., M. T., S. M.), National Foundation for Cancer Research (D. A. H.), Howard Hughes Medical Institute (D. A. H.), NIH CA129933 (D. A. H.), National Institute of Biomedical Imaging and Bioengineering (NIBIB) EB008047 (M. T., D. A. H.), Susan G. Komen for the Cure KG09042 (S. M.), ESSCO Breast Cancer Fund (S. M.), NCI Federal Share Program and Income (S. M.), NIH P41 E8015903-02S1 (C. P. L.), NIH P50 CA086355-12 (C. P. L.), and the MGH-Johnson & Johnson Center for Excellence in CTCs (M. T., S. M.). N.A. is a fellow of the Human Frontiers Science Program, the Swiss National Science Foundation, and the Swiss Foundation for Grants in Biology and Medicine.	Aktary Zackie, 2012, Int J Cell Biol, V2012, P189521, DOI 10.1155/2012/189521; Alford D, 1996, J MAMMARY GLAND BIOL, V1, P207, DOI 10.1007/BF02013644; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; ElKhoury J, 1996, NATURE, V382, P716; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Hakimelahi S, 2000, J BIOL CHEM, V275, P10905, DOI 10.1074/jbc.275.15.10905; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kolligs FT, 2000, GENE DEV, V14, P1319; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; LIOTTA LA, 1976, CANCER RES, V36, P889; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	38	1406	1469	21	389	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1110	1122		10.1016/j.cell.2014.07.013	http://dx.doi.org/10.1016/j.cell.2014.07.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171411	Green Accepted, Bronze			2022-12-28	WOS:000340945000016
J	Nottebohm, F				Nottebohm, Fernando			Peterr Marler, (1928-2014) Pioneering interpreter of animal language OBITUARY	NATURE			English	Biographical-Item									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Nottebohm, F (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	nottebo@mail.rockefeller.edu						MARLER PR, PUBLICATION LIST	1	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					372	372		10.1038/512372a	http://dx.doi.org/10.1038/512372a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164741	Bronze			2022-12-28	WOS:000340840600016
J	O'Gorman, PA				O'Gorman, Paul A.			Contrasting responses of mean and extreme snowfall to climate change	NATURE			English	Article							PRECIPITATION EXTREMES; HEAVY PRECIPITATION; TRENDS; PROBABILITY; SIMULATIONS; TEMPERATURE; SNOWSTORMS; EVENTS	Snowfall is an important element of the climate system, and one that is expected to change in a warming climate(1-4). Both mean snowfall and the intensity distribution of snowfall are important, with heavy snowfall events having particularly large economic and human impacts(5-7). Simulations with climate models indicate that annual mean snowfall declines with warming in most regions but increases in regions with very low surface temperatures(3,4). The response of heavy snowfall events to a changing climate, however, is unclear. Here I show that in simulations with climate models under a scenario of high emissions of greenhouse gases, by the late twenty-first century there are smaller fractional changes in the intensities of daily snowfall extremes than in mean snowfall overmany Northern Hemisphere land regions. For example, for monthly climatological temperatures just below freezing and surface elevations below 1,000 metres, the 99.99th percentile of daily snowfall decreases by 8% in the multimodel median, compared to a 65% reduction in mean snowfall. Both mean and extreme snowfall must decrease for a sufficiently large warming, but the climatological temperature above which snowfall extremes decrease with warming in the simulations is as high as -9 degrees C, compared to -14 degrees C for mean snowfall. These results are supported by a physically based theory that is consistent with the observed rain-snow transition. According to the theory, snowfall extremes occur near an optimal temperature that is insensitive to climate warming, and this results in smaller fractional changes for higher percentiles of daily snowfall. The simulated changes in snowfall that I find would influence surface snow and its hazards; these changes also suggest that it may be difficult to detect a regional climate-change signal in snowfall extremes.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	O'Gorman, PA (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	pog@mit.edu		O'Gorman, Paul/0000-0003-1748-0816	NSF [AGS-1148594]; NASA ROSES [09-IDS09-0049]	NSF(National Science Foundation (NSF)); NASA ROSES(National Aeronautics & Space Administration (NASA))	I thank M. Singh, S. Pfah I, J. Feiccabrino and I. Held for discussions. I am grateful to N. Wood, G. Stephens and the NASA CloudSat project for providing CloudSat snowfall data. I acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and I thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. GPCP 1-degree daily precipitation data were downloaded from http://www1.ncdc.noaa.gov/pub/data/gpcp/ldd-v1.2/. NCEP-DOE Reanalysis 2 data were provided by the NOAA/OAR/ESRL PSD at http://www.esrl.noaa.gov/psd. I acknowledge support from NSF grant number AGS-1148594 and NASA ROSES grant number 09-IDS09-0049.	Abramowitz M, 1964, HDB MATH FUNCTIONS F, V55; [Anonymous], 2013, LEVEL 2C SNOW PROFIL; Bender C. M., 1999, ADV MATH METHODS SCI, V1; Bourgouin P, 2000, WEATHER FORECAST, V15, P583, DOI 10.1175/1520-0434(2000)015<0583:AMTDPT>2.0.CO;2; Brown RD, 2003, ATMOS OCEAN, V41, P1, DOI 10.3137/ao.410101; Brown RD, 2009, J CLIMATE, V22, P2124, DOI 10.1175/2008JCLI2665.1; Changnon SA, 2006, NAT HAZARDS, V37, P373, DOI 10.1007/s11069-005-6581-4; Changnon SA, 2006, J APPL METEOROL CLIM, V45, P1141, DOI 10.1175/JAM2395.1; Chen CT, 2008, J CLIMATE, V21, P1605, DOI 10.1175/2007JCLI1494.1; Dai A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033295; de Vries H, 2013, CLIM DYNAM, V41, P2319, DOI 10.1007/s00382-012-1583-x; Diffenbaugh NS, 2013, NAT CLIM CHANGE, V3, P379, DOI [10.1038/nclimate1732, 10.1038/NCLIMATE1732]; Feiccabrino J, 2013, HYDROL RES, V44, P44, DOI 10.2166/nh.2012.158; Furrer EM, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR007316; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; HOSKING JRM, 1985, TECHNOMETRICS, V27, P251, DOI 10.2307/1269706; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/BAMS-83-11-1631(2002)083<1631:NAR>2.3.CO;2, 10.1175/Bams-83-11-1631]; Kapnick SB, 2013, J CLIMATE, V26, P5537, DOI 10.1175/JCLI-D-12-00528.1; Kharin VV, 2013, CLIMATIC CHANGE, V119, P345, DOI 10.1007/s10584-013-0705-8; Kharin VV, 2000, J CLIMATE, V13, P3760, DOI 10.1175/1520-0442(2000)013<3760:CITEIA>2.0.CO;2; Kocin P. J., 2004, NE SNOWSTORMS; Kodra E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047103; Krasting JP, 2013, J CLIMATE, V26, P7813, DOI 10.1175/JCLI-D-12-00832.1; Kunkel KE, 2013, B AM METEOROL SOC, V94, P499, DOI 10.1175/BAMS-D-11-00262.1; Kunkel KE, 2009, J CLIMATE, V22, P6204, DOI 10.1175/2009JCLI2631.1; Lenderink G, 2008, NAT GEOSCI, V1, P511, DOI 10.1038/ngeo262; MASSONNET F, 2012, CRYOSPHERE, V6, P1383, DOI [10.5194/tc-6-1383-2012, DOI 10.5194/tc-6-1383-2012]; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; O'Gorman PA, 2012, NAT GEOSCI, V5, P697, DOI [10.1038/ngeo1568, 10.1038/NGEO1568]; O'Gorman PA, 2009, J CLIMATE, V22, P5676, DOI 10.1175/2009JCLI2701.1; O'Gorman PA, 2009, P NATL ACAD SCI USA, V106, P14773, DOI 10.1073/pnas.0907610106; Paulhus J. L. H., 1953, MONTHLY WEATHER REV, V81, P38; Pierce DW, 2013, J CLIMATE, V26, P4148, DOI 10.1175/JCLI-D-12-00534.1; Raisanen J, 2008, CLIM DYNAM, V30, P307, DOI 10.1007/s00382-007-0289-y; ROONEY JF, 1967, GEOGR REV, V57, P538, DOI 10.2307/212932; Siler N, 2014, GEOPHYS RES LETT, V41, P2606, DOI 10.1002/2013GL059095; Stephens GL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009982; Trenberth KE, 1999, CLIMATIC CHANGE, V42, P327, DOI 10.1023/A:1005488920935; Westra S, 2013, J CLIMATE, V26, P3904, DOI 10.1175/JCLI-D-12-00502.1; Wilcox EM, 2007, J CLIMATE, V20, P53, DOI 10.1175/JCLI3987.1; Zhang XB, 2001, J CLIMATE, V14, P1923, DOI 10.1175/1520-0442(2001)014<1923:SATCOH>2.0.CO;2	42	123	129	8	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					416	U401		10.1038/nature13625	http://dx.doi.org/10.1038/nature13625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164753	Green Submitted			2022-12-28	WOS:000340840600030
J	Diamond, J				Diamond, Jared			POPULATION HISTORY Human melting pots in southeast Asia	NATURE			English	Editorial Material							EXPANSION		Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Diamond, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	jdiamond@geog.ucla.edu						Bellwood P., 2004, FIRST FARMERS THE OR; Bellwood PS, 2013, 1 MIGRANTS ANCIENT M, V1st ed; Blust Robert, 2009, THE AUSTRONESIAN LAN; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Jinam TA, 2012, MOL BIOL EVOL, V29, P3513, DOI 10.1093/molbev/mss169; Kumar A., 2009, GLOBALIZING THE PREH; Lipson M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5689; Morwood M., 2007, THE DISCOVERY OF THE; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; PAWLEY A, 2002, EXAMINING FARMING LA, P251; Xu SH, 2012, P NATL ACAD SCI USA, V109, P4574, DOI 10.1073/pnas.1118892109	12	4	4	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					262	263		10.1038/512262a	http://dx.doi.org/10.1038/512262a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3SF	25143110				2022-12-28	WOS:000340508200024
J	Vaidya, B; Pearce, SHS				Vaidya, Bijay; Pearce, Simon H. S.			Diagnosis and management of thyrotoxicosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							STRESSFUL LIFE EVENTS; GRAVES-DISEASE; RADIOIODINE THERAPY; ANTITHYROID DRUGS; THYROID-DISEASE; INDUCED AGRANULOCYTOSIS; ATRIAL-FIBRILLATION; HYPERTHYROIDISM; PREGNANCY; RISK		[Vaidya, Bijay] Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England; [Vaidya, Bijay] Univ Exeter, Sch Med, Exeter EX2 5DW, Devon, England; [Pearce, Simon H. S.] Royal Victoria Infirm, Endocrine Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Pearce, Simon H. S.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Exeter; University of Exeter; Newcastle University - UK; Newcastle University - UK	Vaidya, B (corresponding author), Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England.	b.vaidya@exeter.ac.uk	Pearce, Simon/AAB-3692-2019; Vaidya, Bijay/AAF-1947-2020	Pearce, Simon/0000-0001-8384-8063; Vaidya, Bijay/0000-0002-2223-0494	Medical Research Council [G0500783] Funding Source: Medline; MRC [G0500783] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003420.pub4; Acharya SH, 2008, CLIN ENDOCRINOL, V69, P943, DOI 10.1111/j.1365-2265.2008.03279.x; Akamizu T, 2012, THYROID, V22, P661, DOI 10.1089/thy.2011.0334; Allahabadia A, 2000, J CLIN ENDOCR METAB, V85, P1038, DOI 10.1210/jc.85.3.1038; Andersen SL, 2013, J CLIN ENDOCR METAB, V98, P4373, DOI 10.1210/jc.2013-2831; [Anonymous], 2014, RADIOIODINE MANAGEME; Bahn RS, 2011, ENDOCR PRACT, V17, P456, DOI 10.4158/EP.17.3.456; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; BARTALENA L, 1989, NEW ENGL J MED, V321, P1349, DOI 10.1056/NEJM198911163212001; Bartalena L, 2008, THYROID, V18, P333, DOI 10.1089/thy.2007.0315; Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Chang CC, 2013, EUR J ENDOCRINOL, V169, P529, DOI 10.1530/EJE-13-0381; Cooper DS, 2009, J CLIN ENDOCR METAB, V94, P1881, DOI 10.1210/jc.2009-0850; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; de Rooij A, 2009, EUR J ENDOCRINOL, V161, P771, DOI 10.1530/EJE-09-0286; Effraimidis G, 2012, PSYCHONEUROENDOCRINO, V37, P1191, DOI 10.1016/j.psyneuen.2011.12.009; Elbers L, 2011, THYROID, V21, P279, DOI 10.1089/thy.2010.0181; Eskes SA, 2012, J CLIN ENDOCR METAB, V97, P499, DOI 10.1210/jc.2011-2390; Franklyn JA, 1999, LANCET, V353, P2111, DOI 10.1016/S0140-6736(98)12295-X; Garmendia Madariaga A, 2014, J CLIN ENDOCR METAB; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Laurberg P, 2011, THYROID, V21, P951, DOI 10.1089/thy.2011.0039; Matos-Santos A, 2001, CLIN ENDOCRINOL, V55, P15, DOI 10.1046/j.1365-2265.2001.01332.x; Mitchell AL, 2010, CLIN ENDOCRINOL, V72, P292, DOI 10.1111/j.1365-2265.2009.03694.x; Nakamura H, 2013, J CLIN ENDOCR METAB, V98, P4776, DOI 10.1210/jc.2013-2569; Nishihara E, 2008, INTERNAL MED, V47, P725, DOI 10.2169/internalmedicine.47.0740; Panzer C, 2004, J CLIN ENDOCR METAB, V89, P2142, DOI 10.1210/jc.2003-031981; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; Patel NN, 2006, THYROID, V16, P593, DOI 10.1089/thy.2006.16.593; Pearce SHS, 2004, CLIN ENDOCRINOL, V61, P589, DOI 10.1111/j.1365-2265.2004.02135.x; Pearce SHS, 2009, ENDOCRIN METAB CLIN, V38, P289, DOI 10.1016/j.ecl.2009.01.012; Perros P, 2005, J CLIN ENDOCR METAB, V90, P5321, DOI 10.1210/jc.2005-0507; Rochester DB, 2005, THYROID, V15, P1287, DOI 10.1089/thy.2005.15.1287; Ron E, 1998, JAMA-J AM MED ASSOC, V280, P347, DOI 10.1001/jama.280.4.347; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Selmer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7895; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Sundaresh V, 2013, J CLIN ENDOCR METAB, V98, P3671, DOI 10.1210/jc.2013-1954; Takata K, 2009, THYROID, V19, P559, DOI 10.1089/thy.2008.0364; Taylor PN, 2012, EUR THYROID J, V1, P176, DOI 10.1159/000342920; Topcu CB, 2012, INT J PSYCHIAT CLIN, V16, P307, DOI 10.3109/13651501.2011.631016; Torring O, 1996, J CLIN ENDOCR METAB, V81, P2986, DOI 10.1210/jc.81.8.2986; Tozzoli R, 2012, AUTOIMMUN REV, V12, P107, DOI 10.1016/j.autrev.2012.07.003; Vadiveloo T, 2011, J CLIN ENDOCR METAB, V96, P1344, DOI 10.1210/jc.2010-2693; Vaidya B, 2008, CLIN ENDOCRINOL, V68, P814, DOI 10.1111/j.1365-2265.2007.03097.x; Vestergaard P, 2002, EUR J ENDOCRINOL, V146, P153, DOI 10.1530/eje.0.1460153; Walter MA, 2007, BRIT MED J, V334, P514, DOI 10.1136/bmj.39114.670150.BE; Wartofsky L, 1997, THYROID, V7, P213, DOI 10.1089/thy.1997.7.213; Watanabe N, 2012, J CLIN ENDOCR METAB, V97, pE49, DOI 10.1210/jc.2011-2221; Weetman AP, 2014, CLIN ENDOCRINOL, V80, P629, DOI 10.1111/cen.12427	50	31	33	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2014	349								g5128	10.1136/bmj.g5128	http://dx.doi.org/10.1136/bmj.g5128			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FN	25146390	Green Published			2022-12-28	WOS:000340838900003
J	Largent, E				Largent, Emily			PERSONAL VIEW Is it ethical to hire sherpas when climbing Mount Everest?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Program Hlth Policy, Cambridge, MA 02138 USA	Harvard University	Largent, E (corresponding author), Harvard Univ, Program Hlth Policy, 14 Story St,4th Floor, Cambridge, MA 02138 USA.	elargent@fas.harvard.edu		Largent, Emily/0000-0002-7536-5077				[Anonymous], 2014, REUTERS; [Anonymous], 2014, GUARDIAN; Doward J., 2014, GUARDIAN; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Eyal N, 2011, STANFORD ENCY PHILOS; Firth PG, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2654; Gold T, 2014, GUARDIAN; Nestler S, 2014, DW ADVENTURE SPORTS; Salisbury R., 2004, HIMALAYAN DATABASE E; Schaffer G, 2013, OUTSIDE MAGAZINE AUG; The World Bank, NEP WORLD DEV IND; Wertheimer Alan, 1987, COERCION	12	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2014	349								g5113	10.1136/bmj.g5113	http://dx.doi.org/10.1136/bmj.g5113			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FL	25141851				2022-12-28	WOS:000340838700001
J	Bowen, AC; Tong, SYC; Andrews, RM; O'Meara, IM; McDonald, MI; Chatfield, MD; Currie, BJ; Carapetis, JR				Bowen, Asha C.; Tong, Steven Y. C.; Andrews, Ross M.; O'Meara, Irene M.; McDonald, Malcolm I.; Chatfield, Mark D.; Currie, Bart J.; Carapetis, Jonathan R.			Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial	LANCET			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NORTHERN-TERRITORY; ABORIGINAL CHILDREN; SKIN INFECTIONS; RHEUMATIC-FEVER; GLOBAL BURDEN; PENICILLIN-G; COMMUNITY; PYODERMA; DISEASES	Background Impetigo affects more than 110 million children worldwide at any one time. The major burden of disease is in developing and tropical settings where topical antibiotics are impractical and lead to rapid emergence of antimicrobial resistance. Few trials of systemic antibiotics are available to guide management of extensive impetigo. As such, we aimed to compare short-course oral co-trimoxazole with standard treatment with intramuscular benzathine benzylpenicillin in children with impetigo in a highly endemic setting. Methods In this randomised, controlled, non-inferiority trial, Indigenous Australian children aged 3 months to 13 years with purulent or crusted non-bullous impetigo were randomly assigned (1:1:1) to receive benzathine benzylpenicillin (weight-banded injection), twice-daily co-trimoxazole for 3 days (4 mg/kg plus 20 mg/kg per dose), or once-daily co-trimoxazole for 5 days (8 mg/kg plus 40 mg/kg per dose). At every visit, participants were randomised in blocks of six and 12, stratified by disease severity. Randomisation was done by research nurses and codes were in sealed, sequentially numbered, opaque envelopes. Independent reviewers masked to treatment allocation compared digital images of sores from days 0 and 7. The primary outcome was treatment success at day 7 in a modified intention-to-treat analysis. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12609000858291. Findings Between Nov 26, 2009, and Nov 20, 2012, 508 patients were randomly assigned to receive benzathine benzylpenicillin (n=165 [156 analysed]), twice-daily co-trimoxazole for 3 days (n=175 [173 analysed]), or once-daily co-trimoxazole for 5 days (n=168 [161 analysed]). Treatment was successful in 133 (85%) children who received benzathine benzylpenicillin and 283 (85%) who received pooled co-trimoxazole (absolute difference 0.5%; 95% CI -6.2 to 7.3), showing non-inferiority of co-trimoxazole (10% margin). Results for twice-daily co-trimoxazole for 3 days and once-daily co-trimoxazole for 5 days were similar. Adverse events occurred in 54 participants, 49 (90%) of whom received benzathine benzylpenicillin. Interpretation Short-course co-trimoxazole is a non-inferior, alternative treatment to benzathine benzylpenicillin for impetigo; it is palatable, pain-free, practical, and easily administered.	[Bowen, Asha C.; Tong, Steven Y. C.; Andrews, Ross M.; O'Meara, Irene M.; Chatfield, Mark D.; Currie, Bart J.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [McDonald, Malcolm I.] James Cook Univ, Townsville, Qld 4811, Australia; [Carapetis, Jonathan R.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Charles Darwin University; Menzies School of Health Research; James Cook University; Telethon Kids Institute; University of Western Australia	Bowen, AC (corresponding author), Menzies Sch Hlth Res, Casuarina, NT 0811, Australia.	asha.bowen@menzies.edu.au	Chatfield, Mark D/N-2278-2013; Tong, Steven/N-2353-2013; Bowen, Asha Clare/X-5221-2018; Carapetis, Jonathan R/H-8933-2014	Chatfield, Mark D/0000-0002-0004-6274; Tong, Steven/0000-0002-1368-8356; Bowen, Asha Clare/0000-0002-3242-1155; Carapetis, Jonathan R/0000-0002-1182-9792	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council.	Andrews RM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000554; Antibiotic Expert Group, 2010, THER GUID ANT; Bowen AC, 2013, T ROY SOC TROP MED H, V107, P384, DOI 10.1093/trstmh/trt032; Bowen AC, 2012, J CLIN MICROBIOL, V50, P4067, DOI 10.1128/JCM.02195-12; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1999, EPIDEMIOL INFECT, V122, P59, DOI 10.1017/S0950268898001952; CARPA, 2009, CARPA STAND TREATM M; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Currie BJ, 1996, PEDIATRICS, V97, P989; DERRICK CW, 1970, J PEDIATR-US, V77, P696, DOI 10.1016/S0022-3476(70)80218-9; DILLON HC, 1970, J PEDIATR, V76, P676, DOI 10.1016/S0022-3476(70)80284-0; ESTERLY NB, 1970, J AMER MED ASSOC, V212, P1667, DOI 10.1001/jama.212.10.1667; Faye O, 2007, INT J DERMATOL, V46, P19, DOI 10.1111/j.1365-4632.2007.03364.x; Kearns T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058231; Kemp K NT, 1994, AUST J RURAL HEALTH, V2, P25; Koning S, 2004, BMJ-BRIT MED J, V329, P695, DOI 10.1136/bmj.329.7468.695; Koning S, 2004, COCHRANE DB SYST REV, V2; Koning S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003261.pub3; Krolicki A, 2004, POL J PHARMACOL, V56, P257; Kumar R, 2012, INDIAN J MED RES, V135, P133, DOI 10.4103/0971-5916.93437; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Mahe AH, 2005, EPIDEMIOLOGY MANAGEM; Marshall CS, 2011, AM J TROP MED HYG, V85, P703, DOI 10.4269/ajtmh.2011.11-0185; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; Menzies School of Health Research Cooperative Research Centre for Aborginal Health, REC TREAT SKIN COND; Parks T, 2012, CURR OPIN INFECT DIS, V25, P145, DOI 10.1097/QCO.0b013e3283511d27; Parnaby MG, 2010, J PAEDIATR CHILD H, V46, P527, DOI 10.1111/j.1440-1754.2010.01841.x; Skull SA, 1999, AUST NZ J MED, V29, P66, DOI 10.1111/j.1445-5994.1999.tb01590.x; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Tong SYC, 2011, DERMATOL CLIN, V29, P21, DOI 10.1016/j.det.2010.09.005; Tong SYC, 2010, J PAEDIATR CHILD H, V46, P131, DOI 10.1111/j.1440-1754.2010.01697.x; Turnidge J., 2010, KUCERS USE ANTIBIOTI; UDO EE, 1994, J HOSP INFECT, V26, P157, DOI 10.1016/0195-6701(94)90038-8; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wyber R, 2013, GLOB HEART, V8, P227, DOI 10.1016/j.gheart.2013.08.011	35	68	69	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2132	2140		10.1016/S0140-6736(14)60841-2	http://dx.doi.org/10.1016/S0140-6736(14)60841-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25172376	Green Submitted			2022-12-28	WOS:000346354300029
J	Kiviet, DJ; Nghe, P; Walker, N; Boulineau, S; Sunderlikova, V; Tans, SJ				Kiviet, Daniel J.; Nghe, Philippe; Walker, Noreen; Boulineau, Sarah; Sunderlikova, Vanda; Tans, Sander J.			Stochasticity of metabolism and growth at the single-cell level	NATURE			English	Article							GENE-EXPRESSION NOISE; ESCHERICHIA-COLI; BACTERIA; NETWORKS	Elucidating the role of molecular stochasticity(1) in cellular growth is central to understanding phenotypic heterogeneity(2) and the stability of cellular proliferation(3). The inherent stochasticity of metabolic reaction events(4) should have negligible effect, because of averaging over the many reaction events contributing to growth. Indeed, metabolism and growth are often considered to be constant for fixed conditions(5,6). Stochastic fluctuations in the expression level(1,7-9) of metabolic enzymes could produce variations in the reactions they catalyse. However, whether such molecular fluctuations can affect growth is unclear, given the various stabilizing regulatory mechanisms(10-12), the slow adjustment of key cellular components such as ribosomes(13,14), and the secretion(15) and buffering(16,17) of excess metabolites. Here we use time-lapse microscopy to measure fluctuations in the instantaneous growth rate of single cells of Escherichia coli, and quantify time-resolved cross-correlations with the expression of lac genes and enzymes in central metabolism. We show that expression fluctuations of catabolically active enzymes can propagate and cause growth fluctuations, with transmission depending on the limitation of the enzyme to growth. Conversely, growth fluctuations propagate back to perturb expression. Accordingly, enzymes were found to transmit noise to other unrelated genes via growth. Homeostasis is promoted by a noise-cancelling mechanism that exploits fluctuations in the dilution of proteins by cell-volume expansion. The results indicate that molecular noise is propagated not only by regulatory proteins(18,19) but also by metabolic reactions. They also suggest that cellular metabolism is inherently stochastic, and a generic source of phenotypic heterogeneity.	[Kiviet, Daniel J.; Nghe, Philippe; Walker, Noreen; Boulineau, Sarah; Sunderlikova, Vanda; Tans, Sander J.] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Kiviet, Daniel J.] Swiss Fed Inst Technol, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland; [Kiviet, Daniel J.] Eawag, Dept Environm Microbiol, CH-8600 Dubendorf, Switzerland	AMOLF; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Tans, SJ (corresponding author), FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	kiviet@env.ethz.ch; tans@amolf.nl	Tans, Sander/AAS-2901-2020; Nghe, Philippe/AAB-3575-2019; Nghe, Philippe/M-3065-2015	Nghe, Philippe/0000-0003-3690-4610; Nghe, Philippe/0000-0003-3690-4610	ETH Zurich Postdoctoral Fellowship	ETH Zurich Postdoctoral Fellowship	Work in the laboratory of S.J.T. is part of the research programme of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisationfor Scientific Research(NWO). D.J.K. was partly supported by an ETH Zurich Postdoctoral Fellowship. We thank T. Shimizu, J. van Zon, H. Bakker, K. Kuipers, M. Ackermann, P.-R. ten Wolde, M. Heinemann and members of the Tans group for reading the manuscript.	Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; DEAN AM, 1995, GENETICS, V139, P19; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; ELMANSI EMT, 1989, J GEN MICROBIOL, V135, P2875; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fell D., 1997, UNDERSTANDING CONTRO; Ferguson ML, 2012, P NATL ACAD SCI USA, V109, P155, DOI 10.1073/pnas.1110541108; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hart Y, 2011, MOL CELL, V41, P117, DOI 10.1016/j.molcel.2010.12.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrgard MJ, 2004, CURR OPIN BIOTECH, V15, P70, DOI 10.1016/j.copbio.2003.11.002; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rodriguez M, 2005, J THEOR BIOL, V234, P299, DOI 10.1016/j.jtbi.2004.11.023; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Wagner A, 2013, P NATL ACAD SCI USA, V110, P19166, DOI 10.1073/pnas.1312361110; WALSH K, 1985, P NATL ACAD SCI USA, V82, P3577, DOI 10.1073/pnas.82.11.3577; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Yun HS, 1996, BIOTECHNOL BIOENG, V52, P615, DOI 10.1002/(SICI)1097-0290(19961205)52:5<615::AID-BIT9>3.0.CO;2-M	30	236	237	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					376	+		10.1038/nature13582	http://dx.doi.org/10.1038/nature13582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25186725				2022-12-28	WOS:000342988600054
J	Magnussen, H; Disse, B; Rodriguez-Roisin, R; Kirsten, A; Watz, H; Tetzlaff, K; Towse, L; Finnigan, H; Dahl, R; Decramer, M; Chanez, P; Wouters, EFM; Calverley, PMA; Chia, M; Peters, M; Polasek, J; Sajkov, D; Seale, P; Wheatley, J; Bedert, L; Driesen, P; Fievez, P; Flemale, A; Martinot, JB; Mentens, Y; Ninane, V; Peche, R; Plas, B; van Zandweghe, L; Adalberto, R; Moreira, MAC; Fritscher, C; Gondim, H; Jardim, JRB; Dancheva, A; Kostov, K; Lllieva-Fartunova, V; Metev, H; Osmanliev, D; Palaveev, KR; Taseva, M; Troshanova, E; Bai, C; Baiqiang, C; Li, H; Lin, Y; Tang, Y; Wu, Y; Xin, J; Yao, W; Backer, V; Titlestad, I; Arvin-Berod, C; Boyer, GR; Brouquieres, D; Brousse, C; Caillaud, D; Castelnau, O; Cavailles, A; Paulignan, MC; Dupouy, J; Gutgobert, C; Jasnot, JY; Le Merre, C; Meziane, L; Paganin, F; Pegliasco, H; Proust, A; Raspaud, C; de la Fuente, PT; Verdier, S; Andreas, S; Bewig, B; Buttner, C; Eich, A; Gebhardt, R; Herth, F; Kardos, P; Keller, C; Koch, A; Korn, S; Kronsbein, J; Kassner, F; Mikloweit, P; Pfeifer, M; Schroder-Babo, W; Schultebraucks, R; Vogelmeier, C; Knorr, R; Neurohr, C; Gaga, M; Gourgoulianis, K; Kakoura, M; Kosmas, E; Koulouris, N; Papiris, S; Siafakas, N; Sichletides, L; Tatsis, G; Toubis, M; Vassilakopoulos, T; Panagiotis, D; Balint, B; Jedlinszki, M; Meszaros, I; Papp, M; Radeczky, E; Rajakay, K; Schlezak, J; Di Maria, GU; Fabbri, LM; Foresi, A; Fracchia, C; Paggiaro, PL; Foschino, MP; Potena, A; Spanevello, A; Papi, A; de Munck, DRAJ; Pasma, HR; Rudolphus, A; van Noord, JA; Brockway, B; Epton, M; Jones, S; McWilliams, T; Mills, G; Quinn, D; Walford, E; Kelly, E; Custodio, V; Fernandez, L; de Guia, T; Jorge, M; Mortera, L; Roa, C; Santiaguel, J; Wang, A; Asankowicz-Bargiel, B; Batura-Gabryel, H; Chwist-Nowak, A; Filipczyk, GM; Madra-Rogacka, D; Pawlukiewicz, M; Silber, M; Wesolowski, S; Astafyeva, N; Ilkovich, M; Ivleva, A; Khokhlov, A; Leshchenko, I; Nikishenkova, L; Shilkina, N; Zhestkov, A; Mishina, I; Alekseeva, E; Abdool-Gaffar, M; Abdullah, I; Bateman, E; Irusen, E; Jansen, J; Joubert, JR; Ras, G; Alonso, A; Arismendi, E; Cejudo, P; Sustaeta, JME; Farrero, E; Ferrer, A; Iturri, JBG; Lara, JAG; Roldan, J; Perng, WC; Hang, LW; Huang, MS; Kuo, PH; Tsao, CY; Wu, RG; Abdelkader, A; Benzarti, M; Bouacha, H; Chabbou, A; Megdiche, ML; Aktogu, S; Altin, S; Atis, S; Caglayan, B; Cetinkaya, E; Cikrikcioglu, S; Damar, D; Ergun, P; Erkan, L; Evyapan, F; Guclu, SZ; Gulmez, I; Ilgazli, A; Karakurt, S; Sayiner, A; Uzaslan, EK; Yildiz, O; Dzyublyk, O; Krasnokutskiy, S; Mostoviy, Y; Ostrovskiy, M; Sevchuk, S; Voeykova, L; Iashyna, L; Barnes, NC; Calverley, P; Chilvers, ER; Elborn, S; Hadfield, JW; Langan, J; Lawson, R; Mahdi, H; Mansur, A; McKeith, D; Morice, A; Nordstrum, M; Russell, R; Sridharan, K; Wilson, AM; Winning, A				Magnussen, Helgo; Disse, Bernd; Rodriguez-Roisin, Roberto; Kirsten, Anne; Watz, Henrik; Tetzlaff, Kay; Towse, Lesley; Finnigan, Helen; Dahl, Ronald; Decramer, Marc; Chanez, Pascal; Wouters, Emiel F. M.; Calverley, Peter M. A.; Chia, M.; Peters, M.; Polasek, J.; Sajkov, D.; Seale, P.; Wheatley, J.; Bedert, L.; Driesen, P.; Fievez, P.; Flemale, A.; Martinot, J-B; Mentens, Y.; Ninane, V; Peche, R.; Plas, B.; van Zandweghe, L.; Adalberto, R.; Carmo Moreira, M. A.; Fritscher, C.; Gondim, H.; Jardim, J. R. B.; Dancheva, A.; Kostov, K.; Lllieva-Fartunova, V; Metev, H.; Osmanliev, D.; Palaveev, Rashkov K.; Taseva, M.; Troshanova, E.; Bai, C.; Baiqiang, C.; Li, H.; Lin, Y.; Tang, Y.; Wu, Y.; Xin, J.; Yao, W.; Backer, V; Titlestad, I; Arvin-Berod, C.; Boyer, G. R.; Brouquieres, D.; Brousse, C.; Caillaud, D.; Castelnau, O.; Cavailles, A.; Paulignan, Claussner M.; Dupouy, J.; Gutgobert, C.; Jasnot, J-Y; Le Merre, C.; Meziane, L.; Paganin, F.; Pegliasco, H.; Proust, A.; Raspaud, C.; de la Fuente, Tarodo P.; Verdier, S.; Andreas, S.; Bewig, B.; Buettner, C.; Eich, A.; Gebhardt, R.; Herth, F.; Kardos, P.; Keller, C.; Koch, A.; Korn, S.; Kronsbein, J.; Kaessner, F.; Mikloweit, P.; Pfeifer, M.; Schroeder-Babo, W.; Schultebraucks, R.; Vogelmeier, C.; Knorr, R.; Neurohr, C.; Gaga, M.; Gourgoulianis, K.; Kakoura, M.; Kosmas, E.; Koulouris, N.; Papiris, S.; Siafakas, N.; Sichletides, L.; Tatsis, G.; Toubis, M.; Vassilakopoulos, T.; Panagiotis, D.; Balint, B.; Jedlinszki, M.; Meszaros, I; Papp, M.; Radeczky, E.; Rajakay, K.; Schlezak, J.; Di Maria, G. U.; Fabbri, L. M.; Foresi, A.; Fracchia, C.; Paggiaro, P. L.; Foschino, M. P.; Potena, A.; Spanevello, A.; Papi, A.; de Munck, D. R. A. J.; Pasma, H. R.; Rudolphus, A.; van Noord, J. A.; Brockway, B.; Epton, M.; Jones, S.; McWilliams, T.; Mills, G.; Quinn, D.; Walford, E.; Kelly, E.; Custodio, V; Fernandez, L.; de Guia, T.; Jorge, M.; Mortera, L.; Roa, C.; Santiaguel, J.; Wang, A.; Asankowicz-Bargiel, B.; Batura-Gabryel, H.; Chwist-Nowak, A.; Filipczyk, Mieszko G.; Madra-Rogacka, D.; Pawlukiewicz, M.; Silber, M.; Wesolowski, S.; Astafyeva, N.; Ilkovich, M.; Ivleva, A.; Khokhlov, A.; Leshchenko, I; Nikishenkova, L.; Shilkina, N.; Zhestkov, A.; Mishina, I; Alekseeva, E.; Abdool-Gaffar, M.; Abdullah, I; Bateman, E.; Irusen, E.; Jansen, J.; Joubert, J. R.; Ras, G.; Alonso, A.; Arismendi, E.; Cejudo, P.; Echave Sustaeta, J. M.; Farrero, E.; Ferrer, A.; Galdiz Iturri, J. B.; Gutierrez Lara, J. A.; Roldan, J.; Perng, W-C; Hang, L-W; Huang, M-S; Kuo, P-H; Tsao, C-Y; Wu, R-G; Abdelkader, A.; Benzarti, M.; Bouacha, H.; Chabbou, A.; Megdiche, M. L.; Aktogu, S.; Altin, S.; Atis, S.; Caglayan, B.; Cetinkaya, E.; Cikrikcioglu, S.; Damar, D.; Ergun, P.; Erkan, L.; Evyapan, F.; Guclu, S. Z.; Gulmez, I; Ilgazli, A.; Karakurt, S.; Sayiner, A.; Uzaslan, E. K.; Yildiz, O.; Dzyublyk, O.; Krasnokutskiy, S.; Mostoviy, Y.; Ostrovskiy, M.; Sevchuk, S.; Voeykova, L.; Iashyna, L.; Barnes, N. C.; Calverley, P.; Chilvers, E. R.; Elborn, S.; Hadfield, J. W.; Langan, J.; Lawson, R.; Mahdi, H.; Mansur, A.; McKeith, D.; Morice, A.; Nordstrum, M.; Russell, R.; Sridharan, K.; Wilson, A. M.; Winning, A.		WISDOM Investigators	Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; FLUTICASONE PROPIONATE; CORTICOSTEROIDS; PREVENTION; TIOTROPIUM; SALMETEROL; ISOLDE	BACKGROUND Treatment with inhaled glucocorticoids in combination with long-acting bronchodilators is recommended in patients with frequent exacerbations of severe chronic obstructive pulmonary disease (COPD). However, the benefit of inhaled glucocorticoids in addition to two long-acting bronchodilators has not been fully explored. METHODS In this 12-month, double-blind, parallel-group study, 2485 patients with a history of exacerbation of COPD received triple therapy consisting of tiotropium (at a dose of 18 mu g once daily), salmeterol (50 mu g twice daily), and the inhaled glucocorticoid fluticasone propionate (500 mu g twice daily) during a 6-week run-in period. Patients were then randomly assigned to continued triple therapy or withdrawal of fluticasone in three steps over a 12-week period. The primary end point was the time to the first moderate or severe COPD exacerbation. Spirometric findings, health status, and dyspnea were also monitored. RESULTS As compared with continued glucocorticoid use, glucocorticoid withdrawal met the prespecified noninferiority criterion of 1.20 for the upper limit of the 95% confidence interval (CI) with respect to the first moderate or severe COPD exacerbation (hazard ratio, 1.06; 95% CI, 0.94 to 1.19). At week 18, when glucocorticoid withdrawal was complete, the adjusted mean reduction from baseline in the trough forced expiratory volume in 1 second was 38 ml greater in the glucocorticoid-withdrawal group than in the glucocorticoid-continuation group (P<0.001); a similar between-group difference (43 ml) was seen at week 52 (P = 0.001). No change in dyspnea and minor changes in health status occurred in the glucocorticoid-withdrawal group. CONCLUSIONS In patients with severe COPD receiving tiotropium plus salmeterol, the risk of moderate or severe exacerbations was similar among those who discontinued inhaled glucocorticoids and those who continued glucocorticoid therapy. However, there was a greater decrease in lung function during the final step of glucocorticoid withdrawal. (Funded by Boehringer Ingelheim Pharma; WISDOM ClinicalTrials.gov number, NCT00975195.)	[Magnussen, Helgo; Kirsten, Anne; Watz, Henrik] German Ctr Lung Res, Airway Res Ctr North, Lung Clin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany; [Disse, Bernd; Tetzlaff, Kay] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Tetzlaff, Kay] Univ Tubingen, Dept Sports Med, Tubingen, Germany; [Rodriguez-Roisin, Roberto] Univ Barcelona, Hosp Clin Inst Invest Biomed August Pi i Sunyer C, Serv Pneumol, Barcelona, Spain; [Towse, Lesley] Boehringer Ingelheim GmbH & Co KG, Dept Clin Res UK, Bracknell, Berks, England; [Finnigan, Helen] Boehringer Ingelheim GmbH & Co KG, Dept Biometry & Data Management, Bracknell, Berks, England; [Calverley, Peter M. A.] Aintree Univ Hosp NHS Fdn Trust, Inst Ageing & Chron Dis, Liverpool L9 7AL, Merseyside, England; [Dahl, Ronald] Odense Univ Hosp, DK-5000 Odense, Denmark; [Decramer, Marc] Univ Leuven, Dept Resp Dis, Leuven, Belgium; [Chanez, Pascal] Aix Marseille Univ, Dept Resp Dis, UMR INSERM U1067 CNRS 7733, Marseille, France; [Chanez, Pascal] Hop Nord Marseille, AP HP, CIC Nord, Marseille, France; [Wouters, Emiel F. M.] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands	Boehringer Ingelheim; Eberhard Karls University of Tubingen; University of Barcelona; Boehringer Ingelheim; Boehringer Ingelheim; Aintree University Hospitals NHS Foundation Trust; University of Southern Denmark; Odense University Hospital; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Maastricht University	Magnussen, H (corresponding author), Lung Clin Grosshansdorf, Pulm Res Inst, Woehrendamm 80, D-22927 Grosshansdorf, Germany.	magnussen@pulmoresearch.de	SPANEVELLO, ANTONIO/AAB-9503-2020; Lawson, Rod/GWV-0732-2022; Wouters, Emiel/ABD-6200-2021; Yıldız, Öznur/AAM-7271-2020; Khokhlov, Alexander L./E-2765-2017; Irusen, Elvis/AAU-4571-2020; Sayiner, Abdullah/A-7283-2018; Atış Naycı, Sibel/A-6015-2016; Siafakas, Nikolas/AAI-3324-2020; Papi, alberto/AAC-1888-2019; Gaga, Mina/AAP-8348-2020; PAPIRIS, SPYROS/AAD-1825-2020; Uzaslan, Esra/AAI-1004-2021	SPANEVELLO, ANTONIO/0000-0002-3595-9903; Yıldız, Öznur/0000-0002-5379-6829; Khokhlov, Alexander L./0000-0002-0032-0341; Atış Naycı, Sibel/0000-0002-8415-5717; Epton, Michael/0000-0003-4644-366X; PAPI, ALBERTO/0000-0002-6924-4500; Chilvers, Edwin/0000-0002-4230-9677; chanez, pascal/0000-0003-4059-0917; Gaga, Mina/0000-0002-9949-6012; Herth, Felix/0000-0002-7638-2506	Boehringer Ingelheim Pharma	Boehringer Ingelheim Pharma(Boehringer Ingelheim)	Funded by Boehringer Ingelheim Pharma; WISDOM ClinicalTrials.gov number, NCT00975195.	Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2010, LANCET, V376, P1146; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2003, CHEST, V124, P1350, DOI 10.1378/chest.124.4.1350; Choudhury AB, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-93; de Torres JP, 2002, CHEST, V121, P1092, DOI 10.1378/chest.121.4.1092; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Jarad NA, 1999, RESP MED, V93, P161, DOI 10.1016/S0954-6111(99)90001-X; Jones PW, 2014, LANCET RESP MED, V2, P167, DOI 10.1016/S2213-2600(14)70038-4; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Magnussen H, 2014, RESP MED, V108, P593, DOI 10.1016/j.rmed.2014.01.002; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2011, CLIN RESPIR J, V5, P44, DOI 10.1111/j.1752-699X.2010.00198.x; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280	22	424	458	1	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2014	371	14					1285	1294		10.1056/NEJMoa1407154	http://dx.doi.org/10.1056/NEJMoa1407154			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP9VS	25196117	Green Submitted, Green Published			2022-12-28	WOS:000342429800005
J	Rinn, J; Guttman, M				Rinn, John; Guttman, Mitchell			RNA and dynamic nuclear organization	SCIENCE			English	Editorial Material							X-CHROMOSOME INACTIVATION; XIST RNA; GENOME		[Rinn, John] Harvard Univ, Cambridge, MA 02138 USA; [Rinn, John] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rinn, John] Broad Inst MIT & Harvard, Cambridge, MA 02138 USA; [Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; California Institute of Technology	Rinn, J (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	johnrinn@fas.harvard.edu; mguttman@caltech.edu		Rinn, John/0000-0002-7231-7539	NIGMS NIH HHS [P01 GM099117] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Quinodoz S, 2014, TRENDS CELL BIOL, V24, P651, DOI 10.1016/j.tcb.2014.08.009; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646	14	91	92	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1240	1241		10.1126/science.1252966	http://dx.doi.org/10.1126/science.1252966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214588	Green Accepted			2022-12-28	WOS:000341483800016
J	Jack, A; Clark, P				Jack, Andrew; Clark, Peter			CANCER DRUGS FUND Peter Clark: public attitudes support a more favourable assessment for cancer treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									[Jack, Andrew] Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com							0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2014	349								g5545	10.1136/bmj.g5545	http://dx.doi.org/10.1136/bmj.g5545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QP	25214503				2022-12-28	WOS:000341691300004
J	O'Neill, MJ; O'Neill, RJ				O'Neill, Michael J.; O'Neill, Rachel J.			GENOMICS Something to swing about	NATURE			English	Editorial Material							EVOLUTION		[O'Neill, Michael J.; O'Neill, Rachel J.] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA; [O'Neill, Michael J.; O'Neill, Rachel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	O'Neill, MJ (corresponding author), Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA.	michael.oneill@uconn.edu; rachel.oneill@uconn.edu						Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Carbone L, 2012, GENOME BIOL EVOL, V4, P760, DOI 10.1093/gbe/evs048; King M., 1993, CHROMOSOMAL SPECIATI; Koda H, 2012, AM J PHYS ANTHROPOL, V149, P347, DOI 10.1002/ajpa.22124; MCCLINTOCK B, 1953, GENETICS, V38, P579; Michilsens F, 2009, J ANAT, V215, P335, DOI 10.1111/j.1469-7580.2009.01109.x; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046	8	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					174	175		10.1038/513174a	http://dx.doi.org/10.1038/513174a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209792				2022-12-28	WOS:000341362800034
J	Osborne, MS; Saunders, T; Fuerstenberg, F; Costello, D; Dhesi, B				Osborne, Max S.; Saunders, Tom; Fuerstenberg, Fiona; Costello, Declan; Dhesi, Balraj			PICTURE QUIZ A man with absolute dysphagia after eating a steak	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Osborne, Max S.] Princess Royal Hosp, Telford TF1 6TF, Shrops, England; [Saunders, Tom] Univ Hosp North Staffordshire, Dept Cardiothorac, Stoke On Trent, Staffs, England; [Fuerstenberg, Fiona] Royal Shrewsbury Hosp, Dept Anaesthet, Shrewsbury, Salop, England; [Costello, Declan] Univ Hosp Birmingham, Ear Nose & Throat Dept, Birmingham, W Midlands, England; [Dhesi, Balraj] Univ Hosp Coventry, Dept Radiol, Coventry, W Midlands, England	University of Birmingham; University of Warwick	Osborne, MS (corresponding author), Princess Royal Hosp, Telford TF1 6TF, Shrops, England.	maxosborne@doctors.org.uk						Lee J, 2005, EMERG MED J, V22, P123, DOI 10.1136/emj.2004.022053; Morales-Angulo C, 1999, Acta Otorrinolaringol Esp, V50, P142	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2014	349								g5462	10.1136/bmj.g5462	http://dx.doi.org/10.1136/bmj.g5462			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QO	25209933				2022-12-28	WOS:000341691200008
J	Glykys, J; Dzhala, V; Egawa, K; Balena, T; Saponjian, Y; Kuchibhotla, KV; Bacskai, BJ; Kahle, KT; Zeuthen, T; Staley, KJ				Glykys, J.; Dzhala, V.; Egawa, K.; Balena, T.; Saponjian, Y.; Kuchibhotla, K. V.; Bacskai, B. J.; Kahle, K. T.; Zeuthen, T.; Staley, K. J.			Response to Comments on "Local impermeant anions establish the neuronal chloride concentration"	SCIENCE			English	Editorial Material							CULTURED HIPPOCAMPAL-NEURONS; NEONATAL SEIZURES; BIPOLAR CELLS; MEMBRANE; DEPOLARIZATION; CLOMELEON; INDICATOR; BRAIN		[Glykys, J.; Dzhala, V.; Egawa, K.; Balena, T.; Saponjian, Y.; Bacskai, B. J.; Staley, K. J.] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Kuchibhotla, K. V.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA; [Kahle, K. T.] Harvard Univ, Sch Med, Dept Neurosurg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Zeuthen, T.] Univ Copenhagen, Dept Cellular & Mol Med, DK-1168 Copenhagen, Denmark	Harvard University; Harvard Medical School; Massachusetts General Hospital; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Copenhagen	Staley, KJ (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	staley.kevin@mgh.harvard.edu	Bacskai, Brian/AAE-9583-2021	Glykys, Joseph/0000-0002-1499-9172	NIMH NIH HHS [U01 MH106013] Funding Source: Medline; NINDS NIH HHS [R25 NS065743, R01 NS040109] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040109, R25NS065743] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Brumback AC, 2008, J NEUROSCI, V28, P1301, DOI 10.1523/JNEUROSCI.3378-07.2008; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P326, DOI 10.1113/jphysiol.1955.sp005412; DONNAN FG, 1995, J MEMBRANE SCI, V100, P45, DOI 10.1016/0376-7388(94)00297-C; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Enz R, 1999, J NEUROSCI, V19, P9841; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gilbertson TA, 2002, CHEM SENSES, V27, P383, DOI 10.1093/chemse/27.4.383; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kolbaev SN, 2011, J NEUROPHYSIOL, V106, P2034, DOI 10.1152/jn.00699.2010; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Luhmann HJ, 2014, SCIENCE, V345, DOI [10.1126/science.1255337, 10.1126/science.1252978]; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tyzio R, 2008, EUR J NEUROSCI, V27, P2515, DOI 10.1111/j.1460-9568.2008.06234.x; Wang DD, 2011, CEREB CORTEX, V21, P574, DOI 10.1093/cercor/bhq124	23	4	4	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201								10.1126/science.1253146	http://dx.doi.org/10.1126/science.1253146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190789	Green Accepted			2022-12-28	WOS:000341179800034
J	Schneider, T; Bischoff, T; Haug, GH				Schneider, Tapio; Bischoff, Tobias; Haug, Gerald H.			Migrations and dynamics of the intertropical convergence zone	NATURE			English	Review							MEDIATED REGIME TRANSITIONS; POLEWARD ENERGY-TRANSPORT; GENERAL-CIRCULATION MODEL; NINO-SOUTHERN-OSCILLATION; TROPICAL RAINFALL; INDIAN MONSOON; MILLENNIAL-SCALE; HEAT-TRANSPORT; HADLEY CIRCULATIONS; WARMING CONTRAST	Rainfall on Earth is most intense in the intertropical convergence zone (ITCZ), a narrow belt of clouds centred on average around six degrees north of the Equator. The mean position of the ITCZ north of the Equator arises primarily because the Atlantic Ocean transports energy northward across the Equator, rendering the Northern Hemisphere warmer than the Southern Hemisphere. On seasonal and longer timescales, the ITCZ migrates, typically towards a warming hemisphere but with exceptions, such as during El Nino events. An emerging framework links the ITCZ to the atmospheric energy balance and may account for ITCZ variations on timescales from years to geological epochs.	[Schneider, Tapio; Bischoff, Tobias] CALTECH, Pasadena, CA 91125 USA; [Schneider, Tapio; Bischoff, Tobias; Haug, Gerald H.] ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland	California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schneider, T (corresponding author), CALTECH, Pasadena, CA 91125 USA.	tapio@ethz.ch	Schneider, Tapio/A-7038-2014; Keyes, Dennis/AAZ-9285-2021	Schneider, Tapio/0000-0001-5687-2287; 	US National Science Foundation [AGS-1019211, AGS-1049201, AGS-1003614]; Div Atmospheric & Geospace Sciences [1049201, 1003614] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	J. Fasullo and K. Trenberth from the National Center for Atmospheric Research provided the energy flux data we used in Figs 1b and 5 and in some of the estimates in the text. The top-of-atmosphere radiative flux estimates in the text are based on NASA Clouds and the Earth's Radiant Energy System (CERES) data, version CERES EBAF-TOA Ed2.7. S. Marcott provided the temperature reconstructions in Fig. 3, and M. Hell drew Figs 4 and 5. We are grateful for discussions with D. Sigman and N. Meckler and for commentson drafts by F. Ait-Chaalal, A. Donohoe, R. Ferrari, and J.-E. Lee. The research underlying this paper was supported by grants from the US National Science Foundation (numbers AGS-1019211, AGS-1049201 and AGS-1003614).	An ZS, 2000, QUATERNARY SCI REV, V19, P171, DOI 10.1016/S0277-3791(99)00060-8; Arbuszewski JA, 2013, NAT GEOSCI, V6, P959, DOI [10.1038/NGEO1961, 10.1038/ngeo1961]; Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Bischoff T, 2014, J CLIMATE, V27, P4937, DOI 10.1175/JCLI-D-13-00650.1; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Bordoni S, 2008, NAT GEOSCI, V1, P515, DOI 10.1038/ngeo248; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Broecker WS, 2013, P NATL ACAD SCI USA, V110, P16710, DOI 10.1073/pnas.1301855110; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Byrne MP, 2013, GEOPHYS RES LETT, V40, P5223, DOI 10.1002/grl.50971; Caballero R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021581; Carolin SA, 2013, SCIENCE, V340, P1564, DOI 10.1126/science.1233797; CHARNEY JG, 1963, J ATMOS SCI, V20, P607, DOI 10.1175/1520-0469(1963)020<0607:ANOLSM>2.0.CO;2; Cheng H, 2012, CLIM DYNAM, V39, P1045, DOI 10.1007/s00382-012-1363-7; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Chiang JCH, 2012, ANNU REV EARTH PL SC, V40, P383, DOI [10.1146/annurev-earth-042711-185545, 10.1146/annurev-earth-042711-105545]; Chou C, 2003, J CLIMATE, V16, P406, DOI 10.1175/1520-0442(2003)016<0406:MLTNEO>2.0.CO;2; Clement AC, 2004, CLIM DYNAM, V22, P327, DOI 10.1007/s00382-003-0375-8; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Deplazes G, 2013, NAT GEOSCI, V6, P213, DOI 10.1038/ngeo1712; Donohoe A, 2013, J CLIMATE, V26, P4962, DOI 10.1175/JCLI-D-12-00713.1; Donohoe A, 2013, J CLIMATE, V26, P3597, DOI 10.1175/JCLI-D-12-00467.1; Fasullo JT, 2008, J CLIMATE, V21, P2313, DOI 10.1175/2007JCLI1936.1; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Feulner G, 2013, J CLIMATE, V26, P7136, DOI 10.1175/JCLI-D-12-00636.1; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; FOLLAND CK, 1986, NATURE, V320, P602, DOI 10.1038/320602a0; Friedman AR, 2013, J CLIMATE, V26, P5419, DOI 10.1175/JCLI-D-12-00525.1; Frierson DMW, 2013, NAT GEOSCI, V6, P940, DOI [10.1038/ngeo1987, 10.1038/NGEO1987]; Frierson DMW, 2012, J CLIMATE, V25, P720, DOI 10.1175/JCLI-D-11-00116.1; Fuckar NS, 2013, J CLIMATE, V26, P4612, DOI 10.1175/JCLI-D-12-00294.1; Gadgil S, 2003, ANNU REV EARTH PL SC, V31, P429, DOI 10.1146/annurev.earth.31.100901.141251; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; HARRISON EF, 1990, J GEOPHYS RES-ATMOS, V95, P18687, DOI 10.1029/JD095iD11p18687; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; HELD IM, 1980, J ATMOS SCI, V37, P515, DOI 10.1175/1520-0469(1980)037<0515:NASCIA>2.0.CO;2; Held IM, 2001, J ATMOS SCI, V58, P943, DOI 10.1175/1520-0469(2001)058<0943:TPOTPE>2.0.CO;2; Hwang YT, 2013, GEOPHYS RES LETT, V40, P2845, DOI 10.1002/grl.50502; Hwang YT, 2013, P NATL ACAD SCI USA, V110, P4935, DOI 10.1073/pnas.1213302110; Jayne SR, 2001, REV GEOPHYS, V39, P385, DOI 10.1029/2000RG000084; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Joshi MM, 2008, CLIM DYNAM, V30, P455, DOI 10.1007/s00382-007-0306-1; Kang SM, 2008, J CLIMATE, V21, P3521, DOI 10.1175/2007JCLI2146.1; Kang SM, 2014, CLIM DYNAM, V42, P2033, DOI 10.1007/s00382-013-1863-0; Kang SM, 2012, CLIM DYNAM, V38, P1917, DOI 10.1007/s00382-011-1048-7; Kang SM, 2009, J ATMOS SCI, V66, P2812, DOI 10.1175/2009JAS2924.1; Klinger BA, 2000, J PHYS OCEANOGR, V30, P696, DOI 10.1175/1520-0485(2000)030<0696:MHTBTS>2.0.CO;2; Koutavas A, 2004, ADV GLOB CHANGE RES, V21, P347, DOI 10.1007/978-1-4020-2944-8_12; Koutavas A, 2006, GEOLOGY, V34, P993, DOI 10.1130/G22810A.1; Levine XJ, 2011, J ATMOS SCI, V68, P769, DOI 10.1175/2010JAS3553.1; Lin JL, 2007, J CLIMATE, V20, P4497, DOI 10.1175/JCLI4272.1; LINDZEN RS, 1988, J ATMOS SCI, V45, P2416, DOI 10.1175/1520-0469(1988)045<2416:HCFZAH>2.0.CO;2; LINSLEY BK, 1994, J GEOPHYS RES-OCEANS, V99, P9977, DOI 10.1029/94JC00360; Liu Z, 2012, B AM METEOROL SOC, V93, P1317, DOI 10.1175/BAMS-D-11-00152.1; Loeb NG, 2009, J CLIMATE, V22, P748, DOI 10.1175/2008JCLI2637.1; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Marshall J, 2014, CLIM DYNAM, V42, P1967, DOI 10.1007/s00382-013-1767-z; Merlis TM, 2013, J CLIMATE, V26, P2010, DOI 10.1175/JCLI-D-12-00186.1; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; NEELIN JD, 1987, MON WEATHER REV, V115, P3, DOI 10.1175/1520-0493(1987)115<0003:MTCBOT>2.0.CO;2; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Pauluis O, 2004, J ATMOS SCI, V61, P1161, DOI 10.1175/1520-0469(2004)061<1161:BLDACH>2.0.CO;2; Peixoto J.P., 1992, PHYS CLIMATE, P520; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Philander SGH, 1996, J CLIMATE, V9, P2958, DOI 10.1175/1520-0442(1996)009<2958:WTIIMN>2.0.CO;2; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; Renssen H, 2009, NAT GEOSCI, V2, P410, DOI 10.1038/NGEO513; Rotstayn LD, 2002, J CLIMATE, V15, P2103, DOI 10.1175/1520-0442(2002)015&lt;2103:TRTATI&gt;2.0.CO;2; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Schneider T, 2001, J CLIMATE, V14, P249, DOI 10.1175/1520-0442(2001)014<0249:LDOTCC>2.0.CO;2; Schneider T, 2008, J ATMOS SCI, V65, P915, DOI 10.1175/2007JAS2415.1; Schneider T, 2006, ANNU REV EARTH PL SC, V34, P655, DOI 10.1146/annurev.earth.34.031405.125144; Schneider T, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000302; Schott FA, 2004, GEOPHYS MONOGR SER, V147, P261; Tett SFB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000028; Thompson DWJ, 2010, NATURE, V467, P444, DOI 10.1038/nature09394; Tokinaga H, 2011, NAT GEOSCI, V4, P222, DOI [10.1038/ngeo1078, 10.1038/NGEO1078]; Trenberth K.E., 2005, S-P BKS ENVIRONM SCI, P67, DOI 10.1007/3-540-37722-0_2; Trenberth KE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000298; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Voigt A, 2014, J CLIMATE, V27, P1029, DOI 10.1175/JCLI-D-13-00205.1; WALISER DE, 1993, J CLIMATE, V6, P2162, DOI 10.1175/1520-0442(1993)006<2162:ASDCOT>2.0.CO;2; Walker CC, 2006, J ATMOS SCI, V63, P3333, DOI 10.1175/JAS3821.1; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Xian P, 2008, J ATMOS SCI, V65, P1878, DOI 10.1175/2007JAS2367.1; Xie SP, 2004, ADV GLOB CHANGE RES, V21, P121; Zhang YG, 2014, SCIENCE, V344, P84, DOI 10.1126/science.1246172	100	681	700	40	392	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					45	53		10.1038/nature13636	http://dx.doi.org/10.1038/nature13636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186899				2022-12-28	WOS:000341174800027
J	Kushner, RF; Ryan, DH				Kushner, Robert F.; Ryan, Donna H.			Assessment and Lifestyle Management of Patients With Obesity Clinical Recommendations From Systematic Reviews	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; OBSTRUCTIVE SLEEP-APNEA; LONG-TERM EFFECTIVENESS; WEIGHT-LOSS PROGRAMS; ALL-CAUSE MORTALITY; PRACTICE GUIDELINES; DIABETES-MELLITUS; STAGING SYSTEM; TASK-FORCE	IMPORTANCE Even though one-third of US adults are obese, identification and treatment rates for obesity remain low. Clinician engagement is vital to provide guidance and assistance to patients who are overweight or obese to address the underlying cause of many chronic diseases. OBJECTIVES To describe current best practices for assessment and lifestyle management of obesity and to demonstrate how the updated Guidelines (2013) for Managing Overweight and Obesity in Adults based on a systematic evidence review sponsored by the National Heart, Lung, and Blood Institute (NHLBI) can be applied to an individual patient. EVIDENCE REVIEW Systematic evidence review conducted for the Guidelines (2013) for Managing Overweight and Obesity in Adults supports treatment recommendations in 5 areas (risk assessment, weight loss benefits, diets for weight loss, comprehensive lifestyle intervention approaches, and bariatric surgery); for areas outside this scope, recommendations are supported by other guidelines (for obesity, 1998 NHLBI-sponsored obesity guidelines and those from the National Center for Health and Clinical Excellence and Canadian and US professional societies such as the American Association of Clinical Endocrinologists and American Society of Bariatric Physicians; for physical activity recommendations, the 2008 Physical Activity Guidelines for Americans); a PubMed search identified recent systematic reviews covering depression and obesity, motivational interviewing for weight management, metabolic adaptation to weight loss, and obesity pharmacotherapy. FINDINGS The first step in obesity management is to screen all adults for overweight and obesity. A medical history should be obtained assessing for the multiple determinants of obesity, including dietary and physical activity patterns, psychosocial factors, weight-gaining medications, and familial traits. Emphasis on the complications of obesity to identify patients who will benefit the most from treatment is more useful than using body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) alone for treatment decisions. The Guidelines (2013) recommend that clinicians offer patients who would benefit from weight loss (either BMI of >= 30 with or without comorbidities or >= 25 along with 1 comorbidity or risk factor) intensive, multicomponent behavioral intervention. Some clinicians do this within their primary care practices; others refer patients for these services. Weight loss is achieved by creating a negative energy balance through modification of food and physical activity behaviors. The Guidelines (2013) endorse comprehensive lifestyle treatment by intensive intervention. Treatment can be implemented either in a clinician's office or by referral to a registered dietitian or commercial weight loss program. Weight loss of 5% to 10% is the usual goal. It is not necessary for patients to attain a BMI of less than 25 to achieve a health benefit. CONCLUSIONS AND RELEVANCE Screening and assessment of patients for obesity followed by initiation or referral of treatment should be incorporated into primary care practice settings. If clinicians can identify appropriate patients for weight loss efforts and provide informed advice and assistance on how to achieve and sustain modest weight loss, they will be addressing the underlying driver of many comorbidities and can have a major influence on patients' health status.	[Kushner, Robert F.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Ryan, Donna H.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Northwestern University; Feinberg School of Medicine; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kushner, RF (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, 750 N Lake Shore Dr,Rubloff 9-976, Chicago, IL 60611 USA.	rkushner@northwestern.edu		Ryan, Donna/0000-0001-8374-2277	Vivus Inc; Takeda Pharmaceutical; Novo Nordisk; Weight Watchers; Retrofit; Zafgen; Takeda; Vivus; Eisai; Janssen	Vivus Inc; Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Novo Nordisk(Novo Nordisk); Weight Watchers; Retrofit; Zafgen; Takeda(Takeda Pharmaceutical Company Ltd); Vivus; Eisai(Eisai Co Ltd); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kushner reports personal fees for medical advisory board membership from Vivus Inc, Takeda Pharmaceutical, Novo Nordisk, Weight Watchers, Retrofit, and Zafgen and research grants from Novo Nordisk and Weight Watchers. Dr Ryan reports personal fees from Novo Nordisk, Takeda, Vivus, Eisai, and Janssen and equity in Scientific Intake.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], EL PROF MEAN US TABL; Armstrong MJ, 2011, OBES REV, V12, P709, DOI 10.1111/j.1467-789X.2011.00892.x; Association, 2003, ASSESSMENT MANAGEMEN; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Breyer BN, 2014, J UROLOGY, V192, P144, DOI 10.1016/j.juro.2014.02.036; Daniel S, 2013, CURR OPIN ENDOCRINOL, V20, P377, DOI 10.1097/01.med.0000433067.01671.f5; Espeland M, 2007, DIABETES CARE, V30, P1374; Farrell SW, 2002, OBES RES, V10, P417, DOI 10.1038/oby.2002.58; Faulconbridge LF, 2012, OBESITY, V20, P783, DOI 10.1038/oby.2011.315; Fava M, 2000, J CLIN PSYCHIAT, V61, P863, DOI 10.4088/JCP.v61n1109; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Foster GD, 2009, POSTGRAD MED, V121, P113, DOI 10.3810/pgm.2009.09.2046; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Jastreboff AM, 2013, DIABETES CARE, V36, P394, DOI 10.2337/dc12-1112; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Jensen MD, 2014, JAMA-J AM MED ASSOC, V311, P23, DOI 10.1001/jama.2013.282546; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Jones S, 2009, ACSMS EXERCISE IS ME; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kuk JL, 2011, APPL PHYSIOL NUTR ME, V36, P570, DOI [10.1139/h11-058, 10.1139/H11-058]; Kuna ST, 2013, SLEEP, V36, P641, DOI 10.5665/sleep.2618; Kushner RF, 2014, HDB OBESITY, V2, P53; Kushner RF, 2010, ARCH INTERN MED, V170, P121, DOI 10.1001/archinternmed.2009.479; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maldonato A, 2010, PATIENT EDUC COUNS, V79, P287, DOI 10.1016/j.pec.2010.02.010; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; National Committee for Quality Assurance, 2009 HEALTHC EFF DAT; National Heart Lung and Blood Institute, 2013, MAN OV OB AD SYST EV; National Institute for Health and Clinical Excellence, 2006, OB GUID PREV ID ASS; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden J, 2009, PSYCHOL HEALTH MED, V14, P239, DOI 10.1080/13548500802512302; Padwal RS, 2011, CAN MED ASSOC J, V183, pE1059, DOI 10.1503/cmaj.110387; Phelan S, 2012, J UROLOGY, V187, P939, DOI 10.1016/j.juro.2011.10.139; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Rollnick S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1900; Ryan D, 2014, OBESITY, V22, pS1, DOI 10.1002/oby.20819; Schwartz A, 2010, OBES REV, V11, P531, DOI 10.1111/j.1467-789X.2009.00654.x; Seger JC, OBESITY ALGORITHM CH; Sharma AM, 2009, INT J OBESITY, V33, P289, DOI 10.1038/ijo.2009.2; Silk AW, 2011, JAMA-J AM MED ASSOC, V305, P193, DOI 10.1001/jama.2010.1950; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; Unick JL, 2013, AM J MED, V126, P236, DOI 10.1016/j.amjmed.2012.10.010; United States Department of Health and Human Services, 2008 PHYS ACT GUID A; Wadden TA, 2013, INT J OBESITY, V37, pS3, DOI 10.1038/ijo.2013.90; Wadden TA, 2006, OBESITY, V14, P737; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2013, DIABETES CARE, V36, P2937, DOI 10.2337/dc13-0315; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Wing RR, 2010, J SEX MED, V7, P156, DOI 10.1111/j.1743-6109.2009.01458.x; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2011, WAIST CIRC WAIST HIP; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65	73	128	130	0	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					943	952		10.1001/jama.2014.10432	http://dx.doi.org/10.1001/jama.2014.10432			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182103				2022-12-28	WOS:000341668600023
J	Cole, GD; Francis, DP				Cole, Graham D.; Francis, Darrel P.			Perioperative beta blockade: guidelines do not reflect the problems with the evidence from the DECREASE trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIGH-RISK PATIENTS; RANDOMIZED-CONTROLLED-TRIAL; NONCARDIAC SURGERY; MYOCARDIAL-INFARCTION; CARDIOVASCULAR MORBIDITY; CARDIAC MORTALITY; VASCULAR-SURGERY; CR ZOK; BISOPROLOL; METAANALYSIS		[Cole, Graham D.; Francis, Darrel P.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England	Imperial College London	Cole, GD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England.	g.cole@imperial.ac.uk		Cole, Graham/0000-0002-3157-0335	National Institute for Health Research [ACF-2009-21-008] Funding Source: researchfish; British Heart Foundation [FS/10/38/28268, FS/12/12/29294] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)		Angeli F, 2010, AM J CARDIOVASC DRUG, V10, P247, DOI 10.2165/11539510-000000000-00000; Biccard BM, 2008, BRIT J ANAESTH, V100, P23, DOI 10.1093/bja/aem331; Bolsin S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5640; Bouri S, 2014, HEART, V100, P456, DOI 10.1136/heartjnl-2013-304262; Cole GD, 2014, EUR HE IN PRESS 0616; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Erasmus Medical Centre, 2011, INV POSS VIOL SCI IN; Erasmus Medical Centre Follow-up Investigation Committee, 2012, REP 2012 FOLL UP INV; European Society of Cardiologists, REC GUID PROD GEN CO; European Society of Cardiology, REG SIT D POLD PREV; European Society of Cardiology, REC GUID PROD; European Society of Cardiology, 2014, CARDIO NEWSWIRE 0501; Joint Task Force on Non-Cardiac Surgery Cardiovascular Assessment and Management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA), 2014, EUR HEART J; London MJ, 2013, JAMA-J AM MED ASSOC, V309, P1704, DOI 10.1001/jama.2013.4135; Luscher TF, 2013, EUR HEART J, V34, P1018, DOI 10.1093/eurheartj/eht063; Luscher TF, 2014, EUR HEART J; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; McGory ML, 2005, SURGERY, V138, P171, DOI 10.1016/j.surg.2005.03.022; Neuman MD, 2014, BMJ QUAL SAF; Pinto FJ, CURRICULUM VITAE; Pogue JM, 2013, CLIN TRIALS, V10, P225, DOI 10.1177/1740774512469312; Poldermans D, 2001, EUR HEART J, V22, P1353, DOI 10.1053/euhj.2000.2555; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; SANDBERG A, 1993, PHARMACEUT RES, V10, P28, DOI 10.1023/A:1018960626925; SANDBERG A, 1990, J CLIN PHARMACOL, V30, pS2, DOI 10.1002/j.1552-4604.1990.tb03490.x; Schouten O, 2004, AM HEART J, V148, P1047, DOI 10.1016/j.ahj.2004.05.046; Swedberg K, 1998, Evid Based Cardiovasc Med, V2, P33, DOI 10.1016/S1361-2611(98)80029-8; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005	30	19	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2014	349								g5210	10.1136/bmj.g5210	http://dx.doi.org/10.1136/bmj.g5210			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO2SA	25172044				2022-12-28	WOS:000341174500002
J	Mazumder, S; Taneja, S; Bahl, R; Mohan, P; Strand, TA; Sommerfelt, H; Kirkwood, BR; Goyal, N; Van Den Hombergh, H; Martines, J; Bhandari, N				Mazumder, Sarmila; Taneja, Sunita; Bahl, Rajiv; Mohan, Pavitra; Strand, Tor A.; Sommerfelt, Halvor; Kirkwood, Betty R.; Goyal, Nidhi; Van Den Hombergh, Henri; Martines, Jose; Bhandari, Nita		Integrated Management Neonatal	Effect of implementation of Integrated Management of Neonatal and Childhood Illness programme on treatment seeking practices for morbidities in infants: cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE PRACTICES; IMNCI PROGRAM; HEALTH-CARE; MORTALITY; BEHAVIOR; WORKERS; INTERVENTION; BANGLADESH; NUTRITION; DISTRICT	Objective To determine the effect of implementation of the Integrated Management of Neonatal and Childhood Illness strategy on treatment seeking practices and on neonatal and infant morbidity. Design Cluster randomised trial. Setting Haryana, India. Participants 29 667 births in nine intervention clusters and 30 813 births in nine control clusters. Main outcome measures The pre-specified outcome was the effect on treatment seeking practices. Post hoc exploratory analyses assessed morbidity, hospital admission, post-neonatal infant care, and nutritional status outcomes. Interventions The Integrated Management of Neonatal and Childhood Illness intervention included home visits by community health workers, improved case management of sick children, and strengthening of health systems. Outcomes were ascertained through interviews with randomly selected caregivers: 6204, 3073, and 2045 in intervention clusters and 6163, 3048, and 2017 in control clusters at ages 29 days, 6 months, and 12 months, respectively. Results In the intervention cluster, treatment was sought more often from an appropriate provider for severe neonatal illness (risk ratio 1.76, 95% confidence interval 1.38 to 2.24), for local neonatal infection (4.86, 3.80 to 6.21), and for diarrhoea at 6 months (1.96, 1.38 to 2.79) and 12 months (1.22, 1.06 to 1.42) and pneumonia at 6 months (2.09, 1.31 to 3.33) and 12 months (1.44, 1.00 to 2.08). Intervention mothers reported fewer episodes of severe neonatal illness (risk ratio 0.82, 0.67 to 0.99) and lower prevalence of diarrhoea (0.71, 0.60 to 0.83) and pneumonia (0.73, 0.52 to 1.04) in the two weeks preceding the 6 month interview and of diarrhoea (0.63, 0.49 to 0.80) and pneumonia (0.60, 0.46 to 0.78) in the two weeks preceding the 12 month interview. Infants in the intervention clusters were more likely to still be exclusively breast fed in the sixth month of life (risk ratio 3.19, 2.67 to 3.81). Conclusion Implementation of the Integrated Management of Neonatal and Childhood Illness programme was associated with timely treatment seeking from appropriate providers and reduced morbidity, a likely explanation for the reduction in mortality observed following implementation of the programme in this study.	[Mazumder, Sarmila; Taneja, Sunita; Goyal, Nidhi; Bhandari, Nita] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi 110016, India; [Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Mohan, Pavitra] UNICEF India Country Off, New Delhi, India; [Van Den Hombergh, Henri] UNICEF India Country Off, Hlth Sect, New Delhi, India; [Strand, Tor A.] Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway; [Sommerfelt, Halvor] Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth, N-5020 Bergen, Norway; [Kirkwood, Betty R.] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of Bergen; University of Bergen; University of London; London School of Hygiene & Tropical Medicine	Bhandari, N (corresponding author), Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi 110016, India.	CHRD@sas.org.in	Sommerfelt, Halvor/ABD-3552-2020; Strand, Tor/D-9836-2016; Mazumder, Sarmila/AAD-8952-2020	Sommerfelt, Halvor/0000-0002-5670-9786; Strand, Tor/0000-0002-4038-151X; Mazumder, Sarmila/0000-0003-4200-6112; Kirkwood, Betty/0000-0001-5274-6072	World Health Organization, Geneva; United States Agency for International Development; United Nations Children's Fund, New Delhi; Programme for Global Health and Vaccination Research of the Research Council of Norway [183722]	World Health Organization, Geneva(World Health Organization); United States Agency for International Development(United States Agency for International Development (USAID)); United Nations Children's Fund, New Delhi; Programme for Global Health and Vaccination Research of the Research Council of Norway	The study was funded by the World Health Organization, Geneva (through umbrella grant from United States Agency for International Development); the United Nations Children's Fund, New Delhi; and the Programme for Global Health and Vaccination Research of the Research Council of Norway through grant No 183722. Individual scientists at WHO and UNICEF contributed importantly to the planning, analysis, and reporting of this study. However, the central bodies of these agencies and the Research Council of Norway had no influence on how the data were collected, analysed, or presented.	Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS108, DOI 10.1038/sj.jp.7211278; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Bhattacharyya Agnihotri, 2012, Indian J Community Med, V37, P174, DOI 10.4103/0970-0218.99923; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Biswas AB, 2011, J TROP PEDIATRICS, V57, P352, DOI 10.1093/tropej/fmq106; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; D'Souza RM, 2003, J BIOSOC SCI, V35, P131, DOI 10.1017/S0021932003001317; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; de Silva MWA, 2001, SOC SCI MED, V53, P1363, DOI 10.1016/S0277-9536(00)00425-1; de Souza ACT, 2000, SOC SCI MED, V51, P1675, DOI 10.1016/S0277-9536(00)00100-3; De Zoysa I, 1998, SOC SCI MED, V47, P2101, DOI 10.1016/S0277-9536(98)00275-5; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Goldman N, 2000, TROP MED INT HEALTH, V5, P145, DOI 10.1046/j.1365-3156.2000.00527.x; Hill Z, 2004, FAMILY AND COMMUNITY; International Institute for Population Sciences (IIPS), 2007, NATIONAL FAMILY HEAL; Kesterton AJ, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-20; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lahariya Chandrakant, 2009, Indian J Community Med, V34, P15, DOI 10.4103/0970-0218.45370; Lassi Z, 2010, COCHRANE DB SYST REV, V11; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Ministry of Health and Family Welfare, NATIONAL RURAL HEALT; Ministry of Health and Family Welfare, 2003, IMNCI TRAINING MODUL; Ministry of Health and Family Welfare, IMNCI WALL CHART ASS; Ministry of Health and Family Welfare, 2003, INTEGRATED MANAGEMEN; Mittal K, 2014, INDIAN J PEDIATR, V81, P797, DOI 10.1007/s12098-013-1225-2; Mohan P, 2011, J HEALTH POPUL NUTR, V29, P629; National Rural Health Mission, MEETING PEOPLES HEAL; Prinja S, 2013, J TROP PEDIATRICS, V59, P489, DOI 10.1093/tropej/fmt057; Shewade HD, 2013, INDIAN J PEDIATR, V80, P448, DOI 10.1007/s12098-012-0835-4; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; Tsion A, 2008, ETHIOP J HEALTH SCI, V18, P87; UNICEF World Health Organization World Bank United Nations, 2013, LEVEL AND TRENDS IN; Upadhyay RP, 2012, J TROP PEDIATRICS, V58, P406, DOI 10.1093/tropej/fmr113; World Health Organization, 2003, INTEGRATED MANAGEMEN; World Health Organization, 1998, IMCI ADAPTATION GUID; World Health Organization, 2013, CHILDREN REDUCING MO; World Health Organization, 2008, INDICATORS FOR ASSES	45	22	23	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2014	349								g4988	10.1136/bmj.g4988	http://dx.doi.org/10.1136/bmj.g4988			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO2SA	25172514	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000341174500001
J	Palmer, PI; Smith, MJ				Palmer, Paul I.; Smith, Matthew J.			Model human adaptation to climate change	NATURE			English	Editorial Material									[Palmer, Paul I.] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Smith, Matthew J.] Microsoft Res, Sci Computat Lab, Cambridge, England	University of Edinburgh; Microsoft	Palmer, PI (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	pip@ed.ac.uk	Palmer, Paul I/F-7008-2010	Palmer, Paul I/0000-0002-1487-0969; Smith, Matthew/0000-0002-5401-1763				Fehren-Schmitz L, 2014, P NATL ACAD SCI USA, V111, P9443, DOI 10.1073/pnas.1403466111; Foresight, 2011, MIGR GLOB ENV CHANG; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; KAHNEMAN D, 1972, COGNITIVE PSYCHOL, V3, P430, DOI 10.1016/0010-0285(72)90016-3; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mueller V, 2014, NAT CLIM CHANGE, V4, P182, DOI [10.1038/NCLIMATE2103, 10.1038/nclimate2103]	8	66	67	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					365	366		10.1038/512365a	http://dx.doi.org/10.1038/512365a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8GC	25164733	Bronze			2022-12-28	WOS:000340840600009
J	Varadhachary, GR; Raber, MN				Varadhachary, Gauri R.; Raber, Martin N.			Cancer of Unknown Primary Site	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							POORLY DIFFERENTIATED CARCINOMA; METASTATIC CARCINOMA; PRIMARY TUMOR; COLON-CANCER; ORIGIN; EXPRESSION; TISSUE; DIAGNOSIS; IMMUNOHISTOCHEMISTRY; IDENTIFICATION		[Varadhachary, Gauri R.; Raber, Martin N.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Varadhachary, GR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol, Med Oncol Unit, Unit 426, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gvaradha@mdanderson.org						Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Briasoulis E, 2000, J CLIN ONCOL, V18, P3101, DOI 10.1200/JCO.2000.18.17.3101; Briasoulis E, 1998, ANTICANCER RES, V18, P1907; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Culine S, 2003, J CLIN ONCOL, V21, P3479, DOI 10.1200/JCO.2003.12.104; Culine S, 2002, J CLIN ONCOL, V20, P4679, DOI 10.1200/JCO.2002.04.019; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; DeYoung BR, 2000, SEMIN DIAGN PATHOL, V17, P184; ESMO Guidelines Task Force, 2005, ANN ONCOL, V16, P75, DOI 10.1093/annonc/mdi804; Ferracin M, 2011, J PATHOL, V225, P43, DOI 10.1002/path.2915; Greco FA, 2013, JNCI-J NATL CANCER I, V105, P782, DOI 10.1093/jnci/djt099; Greco FA, 2010, ONCOLOGIST, V15, P500, DOI 10.1634/theoncologist.2009-0328; Greco FA, 2000, ANN ONCOL, V11, P211, DOI 10.1023/A:1008369812295; GRECO FA, 1986, ANN INTERN MED, V104, P547, DOI 10.7326/0003-4819-104-4-547; Hainsworth JD, 2000, J CLIN ONCOL, V18, P632, DOI 10.1200/JCO.2000.18.3.632; HAINSWORTH JD, 1993, NEW ENGL J MED, V329, P257; Hainsworth JD, 2008, CANC PRINCIPLES PRAC, P2363; Hainsworth JD, 2013, J CLIN ONCOL, V31, P217, DOI 10.1200/JCO.2012.43.3755; Hale KS, 2012, J CLIN ONCOL, V30; Handorf CR, 2013, AM J SURG PATHOL, V37, P1067, DOI 10.1097/PAS.0b013e31828309c4; Hillen HFP, 1997, INT J CANCER, V74, P81; Horlings HM, 2008, J CLIN ONCOL, V26, P4435, DOI 10.1200/JCO.2007.14.6969; Jagirdar J, 2008, ARCH PATHOL LAB MED, V132, P384, DOI 10.1043/1543-2165(2008)132[384:AOITTD]2.0.CO;2; Joshi U, 2004, BRIT J RADIOL, V77, P1000, DOI 10.1259/bjr/69059431; Karavasilis V, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-25; Kerr SE, 2012, CLIN CANCER RES, V18, P3952, DOI 10.1158/1078-0432.CCR-12-0920; Lu H, 2011, CHINESE MED J-PEKING, V124, P1790, DOI 10.3760/cma.j.issn.0366-6999.2011.12.006; Mao ML, 2013, CLIN CANCER RES, V19, P657, DOI 10.1158/1078-0432.CCR-11-1446; Meiri E, 2012, ONCOLOGIST, V17, P801, DOI 10.1634/theoncologist.2011-0466; Moller AKH, 2011, ONCOLOGIST, V16, P445, DOI 10.1634/theoncologist.2010-0189; National Comprehensive Cancer Network, 2013, OCC PRIM CANC UNKN P; Oien KA, 2012, ANN ONCOL, V23, P271, DOI 10.1093/annonc/mds357; Olsen JA, 2000, ANN SURG ONCOL, V7, P411, DOI 10.1007/s10434-000-0411-4; Pavlidis N, 1995, ANTICANCER RES, V15, P2563; Pentheroudakis G, 2007, EUR J CANCER, V43, P2026, DOI 10.1016/j.ejca.2007.06.023; Pillai R, 2011, J MOL DIAGN, V13, P48, DOI 10.1016/j.jmoldx.2010.11.001; Randall DA, 2000, OTOLARYNG HEAD NECK, V122, P52, DOI 10.1016/S0194-5998(00)70143-4; Rubin BP, 2001, EUR J CANCER PREV, V10, P77, DOI 10.1097/00008469-200102000-00009; Rudmik L, 2011, HEAD NECK-J SCI SPEC, V33, P935, DOI 10.1002/hed.21566; Rusthoven KE, 2004, CANCER-AM CANCER SOC, V101, P2641, DOI 10.1002/cncr.20687; Schelfout K, 2003, EUR RADIOL, V13, P2128, DOI 10.1007/s00330-002-1674-x; Taylor MB, 2012, BRIT J RADIOL, V85, P661, DOI 10.1259/bjr/75018360; Tothill RW, 2005, CANCER RES, V65, P4031, DOI 10.1158/0008-5472.CAN-04-3617; Varadhachary G, 2013, CLIN CANCER RES, V19, P4027, DOI 10.1158/1078-0432.CCR-12-3030; Varadhachary GR, 2011, J NATL COMPR CANC NE, V9, P1406, DOI 10.6004/jnccn.2011.0119; Varadhachary GR, 2011, CLIN CANCER RES, V17, P4063, DOI 10.1158/1078-0432.CCR-10-2599; Varadhachary GR, 2008, LANCET ONCOL, V9, P596, DOI 10.1016/S1470-2045(08)70151-7; Varadhachary GR, 2013, INT J CLIN ONCOL; Weiss LM, 2013, J MOL DIAGN, V15, P263, DOI 10.1016/j.jmoldx.2012.10.001	49	140	147	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					757	765		10.1056/NEJMra1303917	http://dx.doi.org/10.1056/NEJMra1303917			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140961				2022-12-28	WOS:000340509900010
J	Wolkewitz, M; Cooper, BS; Bonten, MJM; Barnett, AG; Schumacher, M				Wolkewitz, Martin; Cooper, Ben S.; Bonten, Marc J. M.; Barnett, Adrian G.; Schumacher, Martin			Interpreting and comparing risks in the presence of competing events	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE-UNIT; MODELS; MORTALITY; INFECTION; HAZARDS; TIME		[Wolkewitz, Martin; Schumacher, Martin] Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, Ctr Med Biometry & Med Informat, Freiburg, Germany; [Cooper, Ben S.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3508 GA Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Barnett, Adrian G.] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4059, Australia	University of Freiburg; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Wolkewitz, M (corresponding author), Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, Ctr Med Biometry & Med Informat, Freiburg, Germany.	wolke@imbi.uni-freiburg.de	Cooper, Ben/HGC-7082-2022; Barnett, Adrian/I-9850-2012	Barnett, Adrian/0000-0001-6339-0374; Wolkewitz, Martin/0000-0002-1268-5057; Cooper, Ben/0000-0002-9445-7217	German Research Foundation (Deutsche Forschungsgemeinschaft) [WO 1746/1-1]; Deutsche Forschungsgemeinschaft; Medical Research Council; Department for International Development [MR/K006924/1]; Wellcome Trust of Great Britain [089275/Z/09/Z]; MRC [MR/K006924/1] Funding Source: UKRI; Medical Research Council [MR/K006924/1] Funding Source: researchfish	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development; Wellcome Trust of Great Britain(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft) (grant No WO 1746/1-1). MW received funding from Deutsche Forschungsgemeinschaft. BSC was supported by the Medical Research Council and Department for International Development (grant No MR/K006924/1). The Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme is supported by the Wellcome Trust of Great Britain (089275/Z/09/Z).	Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Alvarez JA, 2011, CIRCULATION, V124, P814, DOI 10.1161/CIRCULATIONAHA.110.973826; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Beyersmann J, 2011, COMPETING RISKS MULT; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Grambauer N, 2010, AM J EPIDEMIOL, V172, P1077, DOI 10.1093/aje/kwq246; Haller B, 2013, LIFETIME DATA ANAL, V19, P33, DOI 10.1007/s10985-012-9230-8; Horton NJ, 2005, NEW ENGL J MED, V353, P1977, DOI 10.1056/NEJM200511033531823; Ju MJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13053; Koller MT, 2012, STAT MED, V31, P1089, DOI 10.1002/sim.4384; Latouche A, 2013, J CLIN EPIDEMIOL, V66, P648, DOI 10.1016/j.jclinepi.2012.09.017; Schmoor C, 2013, CLIN CANCER RES, V19, P12, DOI 10.1158/1078-0432.CCR-12-1619; Schumacher M, 2013, INT J EPIDEMIOL, V42, P1502, DOI 10.1093/ije/dyt111; Wolkewitz M, 2008, CRIT CARE, V12, DOI 10.1186/cc6852; Wolkewitz M, 2014, CRIT CARE, V18, DOI 10.1186/cc13757; Wolkewitz M, 2014, CRIT CARE, V18, DOI 10.1186/cc13821; Wolkewitz M, 2013, NEW ENGL J MED, V368, P2330, DOI 10.1056/NEJMc1304820; Wolkewitz M, 2009, INTENS CARE MED, V35, P826, DOI 10.1007/s00134-009-1423-6	20	122	125	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2014	349								g5060	10.1136/bmj.g5060	http://dx.doi.org/10.1136/bmj.g5060			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FN	25146097	Green Published, Bronze			2022-12-28	WOS:000340838900002
J	[Anonymous]				[Anonymous]			Cervical Spine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLUNT TRAUMA; INJURY; RULE											CASSARPULLICINO VN, 2006, SPINAL TRAUMA IMAGIN; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Hogan GJ, 2005, RADIOLOGY, V237, P106, DOI 10.1148/radiol.2371040697; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841	4	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2014	349								g2177	10.1136/bmj.g2177	http://dx.doi.org/10.1136/bmj.g2177			32	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FN	25145468				2022-12-28	WOS:000340838900001
J	Bi, SD; Wang, YQ; Guan, J; Sheng, X; Meng, J				Bi, Shundong; Wang, Yuanqing; Guan, Jian; Sheng, Xia; Meng, Jin			Three new Jurassic euharamiyidan species reinforce early divergence of mammals	NATURE			English	Article							FUNCTIONAL-ADAPTIVE ANATOMY; MARSUPIALS MAYULESTES-FEROX; EVOLUTION; DIVERSIFICATION; MAMMALIAFORM; PALEOBIOLOGY; SKELETON; BEARING; TEETH	The phylogeny of Allotheria, including Multituberculata and Haramiyida, remains unsolved and has generated contentious views on the origin and earliest evolution of mammals. Here we report three new species of a new clade, Euharamiyida, based on six well-preserved fossils from the Jurassic period of China. These fossils reveal many craniodental and post-cranial features of euharamiyidans and clarify several ambiguous structures that are currently the topic of debate. Our phylogenetic analyses recognize Euharamiyida as the sister group of Multituberculata, and place Allotheria within the Mammalia. The phylogeny suggests that allotherian mammals evolved from a Late Triassic (approximately 208 million years ago) Haramiyavia-like ancestor and diversified into euharamiyidans and multituberculates with a cosmopolitan distribution, implying homologous acquisition of many craniodental and postcranial features in the two groups. Our findings also favour a Late Triassic origin of mammals in Laurasia and two independent detachment events of the middle ear bones during mammalian evolution.	[Bi, Shundong; Wang, Yuanqing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Bi, Shundong] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Guan, Jian] Beijing Nat Hist Museum, Beijing 100050, Peoples R China; [Sheng, Xia] Shenyang Normal Univ, Paleontol Museum Liaoning, Shenyang 110034, Liaoning, Peoples R China; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Shenyang Normal University; American Museum of Natural History (AMNH)	Meng, J (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk West & 79th St, New York, NY 10024 USA.	wangyuanqing@ivpp.ac.cn; jmeng@amnh.org			National Basic Research Program of China (973 program) [2012CB821906]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB03020501]; National Science Foundation of China [41128002]; Hundred Talents Programs of the Chinese Academy of Sciences	National Basic Research Program of China (973 program)(National Basic Research Program of China); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Programs of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank H.-J. Li and Z.-J. Gao for using the specimens housed at the Jizantang Paleontological Museum; Z.-Y. Sun and D.-Y. Sun for using the specimen housed at the Museum of Wuyishan Mountain; J.-C. Lu for assistance in specimen collecting; S.-H. Xie for specimen preparation; M. A. Klingler and F.-X. Wu for specimen drawing and photography; W.-D. Zhang for SEMimaging; Z.-H. Zhou, X. Xu, F.-C. Zhang and X.-L. Wang for discussion on stratigraphy and faunal compositions; and A. Weil and G. W. Rougier for instructive comments. The study was supported by the National Basic Research Program of China (973 program, 2012CB821906), the Strategic Priority Research Program of Chinese Academy of Sciences (XDB03020501), the National Science Foundation of China (41128002) and the Hundred Talents Programs of the Chinese Academy of Sciences.	ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Asher RJ, 2011, J EVOLUTION BIOL, V24, P1080, DOI 10.1111/j.1420-9101.2011.02240.x; Averianov A O, 2011, Dokl Biol Sci, V437, P103, DOI 10.1134/S0012496611020074; Buchholtz EA, 2012, EVOL DEV, V14, P399, DOI 10.1111/j.1525-142X.2012.00560.x; BUTLER PM, 1994, PHILOS T ROY SOC B, V345, P433, DOI 10.1098/rstb.1994.0119; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Clemens W.A., 1980, Zitteliana, V5, P51; Filler AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001019; Griffiths M., 1978, BIOL MONOTREMES; Hahn G., 1989, Geologica et Palaeontologica, V23, P205; Hahn G., 1977, Geologica Palaeont., V113, P161; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hurum JH, 2006, ACTA PALAEONTOL POL, V51, P1; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji S.-A., 1999, NATURE, V398, P573; KERMACK DORIS M., 1968, J LINN SOC LONDON ZOOL, V47, P407; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z., 1994, POSTCRANIAL ANATOMY; Kielan-Jaworowska Z., 2013, PURSUIT EARLY MAMMAL, V272; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Krause DW, 2013, CAN J EARTH SCI, V50, P324, DOI 10.1139/e2012-074; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Schmitt D, 2005, AM J PHYS ANTHROPOL, V126, P435, DOI 10.1002/ajpa.20075; SERENO PC, 1995, NATURE, V377, P144, DOI 10.1038/377144a0; SIGOGNEAU-RUSSELL D, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P137; Sigogneau-Russell Denise, 1995, Acta Palaeontologica Polonica, V40, P245; Szalay F. S., 1994, EVOLUTIONARY HIST MA; Yuan CX, 2013, SCIENCE, V341, P779, DOI 10.1126/science.1237970; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	50	99	109	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					579	+		10.1038/nature13718	http://dx.doi.org/10.1038/nature13718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25209669				2022-12-28	WOS:000343801500038
J	Breman, JG; Johnson, KM				Breman, Joel G.; Johnson, Karl M.			Ebola Then and Now	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEMORRHAGIC-FEVER; ZAIRE		[Breman, Joel G.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Johnson, Karl M.] NIH, Fogarty Int Ctr, Portland, OR USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA	Breman, JG (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.							Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Breman JG, 1978, EBOLA VIRUS HAEMORRH, V85-97; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Isaacson M., 1978, EBOLA VIRUS HAEMORRH, P122; JOHNSON KM, 1977, LANCET, V1, P569	5	32	35	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1663	1666		10.1056/NEJMp1410540	http://dx.doi.org/10.1056/NEJMp1410540			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25207624				2022-12-28	WOS:000343768500002
J	Frieden, TR; Brudney, KF; Harries, AD				Frieden, Thomas R.; Brudney, Karen F.; Harries, Anthony D.			Global Tuberculosis Perspectives, Prospects, and Priorities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE		[Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Brudney, Karen F.] Columbia Univ, New York, NY USA; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	Centers for Disease Control & Prevention - USA; Columbia University; University of London; London School of Hygiene & Tropical Medicine	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P603, DOI 10.5588/ijtld.12.0505; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Liu Y, 2012, INT J TUBERC LUNG D, V16, P486, DOI 10.5588/ijtld.11.0255; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Smith GD, 2001, BRIT MED J, V322, P184, DOI 10.1136/bmj.322.7280.184; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; World Health Organization, GLOB TUB REP 2013	8	23	24	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1393	1394		10.1001/jama.2014.11450	http://dx.doi.org/10.1001/jama.2014.11450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25188638	Green Accepted			2022-12-28	WOS:000342630200009
J	Baruch, K; Deczkowska, A; David, E; Castellano, JM; Miller, O; Kertser, A; Berkutzki, T; Barnett-Itzhaki, Z; Bezalel, D; Wyss-Coray, T; Amit, I; Schwartz, M				Baruch, Kuti; Deczkowska, Aleksandra; David, Eyal; Castellano, Joseph M.; Miller, Omer; Kertser, Alexander; Berkutzki, Tamara; Barnett-Itzhaki, Zohar; Bezalel, Dana; Wyss-Coray, Tony; Amit, Ido; Schwartz, Michal			Aging-induced type I interferon response at the choroid plexus negatively affects brain function	SCIENCE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; PERSISTENT LCMV INFECTION; CENTRAL-NERVOUS-SYSTEM; IMMUNE SURVEILLANCE; COGNITIVE FUNCTION; T-CELLS; BLOCKADE; REJUVENATION; INFLAMMATION; RECRUITMENT	Aging-associated cognitive decline is affected by factors produced inside and outside the brain. By using multiorgan genome-wide analysis of aged mice, we found that the choroid plexus, an interface between the brain and the circulation, shows a type I interferon (IFN-I)-dependent gene expression profile that was also found in aged human brains. In aged mice, this response was induced by brain-derived signals, present in the cerebrospinal fluid. Blocking IFN-I signaling within the aged brain partially restored cognitive function and hippocampal neurogenesis and reestablished IFN-II-dependent choroid plexus activity, which is lost in aging. Our data identify a chronic aging-induced IFN-I signature, often associated with antiviral response, at the brain's choroid plexus and demonstrate its negative influence on brain function, thereby suggesting a target for ameliorating cognitive decline in aging.	[Baruch, Kuti; Deczkowska, Aleksandra; Miller, Omer; Kertser, Alexander; Berkutzki, Tamara; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [David, Eyal; Barnett-Itzhaki, Zohar; Bezalel, Dana; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Castellano, Joseph M.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Weizmann Institute of Science; Weizmann Institute of Science; Stanford University	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ido.amit@weizmann.ac.il; michal.schwartz@weizmann.ac.il	Barnett-Itzhaki, Zohar/AAA-4029-2021; Baruch, Kuti/I-3535-2016; Castellano, Joseph M/ABD-7639-2021; Wyss-Coray, Tony/AAF-3380-2019	Barnett-Itzhaki, Zohar/0000-0001-9891-9397; Baruch, Kuti/0000-0002-1466-8795; Wyss-Coray, Tony/0000-0001-5893-0831; Castellano, Joseph/0000-0002-8026-6292	European Research Council (E.R.C.) [232835]; European Union [279017, 309788]; Israeli Science Foundation [1782/11]; National Institute on Aging [AG045034]; Jane Coffin Childs Postdoctoral fellowship; MRC [MR/L022656/1] Funding Source: UKRI; Medical Research Council [MR/L022656/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG045034] Funding Source: NIH RePORTER	European Research Council (E.R.C.)(European Research Council (ERC)European Commission); European Union(European Commission); Israeli Science Foundation(Israel Science Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Jane Coffin Childs Postdoctoral fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Esiri and A. Troen for their help in obtaining human brain sections, K. I. Mosher for technical assistance in parabiosis experiments, and A. Tsitsou-Kampeli and A. Hutzler for assistance in immunohistochemistry experiments. Supported by a European Research Council (E.R.C.) grant (232835), a European Union Seventh Framework Program (FP7) grant (279017) given to M. S., an E. R. C. grant (309788), and an Israeli Science Foundation grant given to I. A. (1782/11), a National Institute on Aging grant given to T. W.-C. (AG045034), and a Jane Coffin Childs Postdoctoral fellowship given to J.M.C.	Axtell RC, 2008, IMMUNITY, V28, P600, DOI 10.1016/j.immuni.2008.04.006; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Falcao AM, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00034; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hofer MJ, 2013, CYTOKINE GROWTH F R, V24, P257, DOI 10.1016/j.cytogfr.2013.03.006; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wichers M, 2002, INT J NEUROPSYCHOPH, V5, P375, DOI 10.1017/S1461145702003103; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yeoman M, 2012, NAT REV NEUROSCI, V13, P435, DOI 10.1038/nrn3230; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	30	326	337	7	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					89	93		10.1126/science.1252945	http://dx.doi.org/10.1126/science.1252945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25147279	Green Accepted			2022-12-28	WOS:000342446900057
J	Rid, A; Emanuel, EJ				Rid, Annette; Emanuel, Ezekiel J.			Why Should High-Income Countries Help Combat Ebola?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rid, Annette] Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine	Rid, A (corresponding author), Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England.	annette.rid@kcl.ac.uk						Bennett S., 2014, EBOLA FIGHT GETS 250; Caney Simon, 2005, JUSTICE BEYOND BORDE; Deaton A., 2013, THE GREAT ESCAPE HEA; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Rawls J., 1999, LAW PEOPLES; SINGER P, 1972, PHILOS PUBLIC AFF, V1, P229; WHO, GLOBAL HEALTH OBSERV; World Health Organization, 2009, RAPID ADVICE ANTIRET; World Health Organization (WHO), 2014, EBOLA RESPONSE ROADM	10	23	25	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2014	312	13					1297	1298		10.1001/jama.2014.12869	http://dx.doi.org/10.1001/jama.2014.12869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RB	25210838	Green Published, Bronze			2022-12-28	WOS:000342345400012
J	Brody, H				Brody, Herb			Lung Cancer	NATURE			English	Editorial Material																			0	65	67	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S1	S1		10.1038/513S1a	http://dx.doi.org/10.1038/513S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208065	Bronze			2022-12-28	WOS:000341362800001
J	Rethlefsen, ML; Murad, H; Livingston, EH				Rethlefsen, Melissa L.; Murad, Hassan; Livingston, Edward H.			Engaging Medical Librarians to Improve the Quality of Review Articles	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rethlefsen, Melissa L.] Spencer S Eccles Hlth Sci Lib, Salt Lake City, UT USA; [Murad, Hassan] Mayo Clin, Ctr Sci Healthcare Delivery, Knowledge Synth Program, Rochester, MN USA; [Livingston, Edward H.] JAMA, Clin Reviews & Educ, Chicago, IL 60611 USA	Mayo Clinic	Livingston, EH (corresponding author), JAMA, Clin Reviews & Educ, 330 N Wabash Ave,Room41410, Chicago, IL 60611 USA.	edward.livingston@jamanetwork.org	Melissa L. Rethlefsen, MSLS/B-6840-2009; Murad, M. Hassan/AAW-4367-2020	Melissa L. Rethlefsen, MSLS/0000-0001-5322-9368; Murad, Mohammad Hassan/0000-0001-5502-5975				Egger M, 2003, Health Technol Assess, V7, P1; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Sollenberger JF, 2013, JAMA-J AM MED ASSOC, V310, P1231, DOI 10.1001/jama.2013.277050	4	41	43	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					999	1000		10.1001/jama.2014.9263	http://dx.doi.org/10.1001/jama.2014.9263			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203078				2022-12-28	WOS:000341385600014
J	Keber, FC; Loiseau, E; Sanchez, T; DeCamp, SJ; Giomi, L; Bowick, MJ; Marchetti, MC; Dogic, Z; Bausch, AR				Keber, Felix C.; Loiseau, Etienne; Sanchez, Tim; DeCamp, Stephen J.; Giomi, Luca; Bowick, Mark J.; Marchetti, M. Cristina; Dogic, Zvonimir; Bausch, Andreas R.			Topology and dynamics of active nematic vesicles	SCIENCE			English	Article							GRAIN-BOUNDARY SCARS; MICROTUBULE ORGANIZATION; COLLOIDAL INTERACTIONS; LIQUID-CRYSTALS; DROPLETS; ORDER; MOTORS; SHAPE	Engineering synthetic materials that mimic the remarkable complexity of living organisms is a fundamental challenge in science and technology. We studied the spatiotemporal patterns that emerge when an active nematic film of microtubules and molecular motors is encapsulated within a shape-changing lipid vesicle. Unlike in equilibrium systems, where defects are largely static structures, in active nematics defects move spontaneously and can be described as self-propelled particles. The combination of activity, topological constraints, and vesicle deformability produces a myriad of dynamical states. We highlight two dynamical modes: a tunable periodic state that oscillates between two defect configurations, and shape-changing vesicles with streaming filopodia-like protrusions. These results demonstrate how biomimetic materials can be obtained when topological constraints are used to control the non-equilibrium dynamics of active matter.	[Keber, Felix C.; Loiseau, Etienne; Bausch, Andreas R.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Keber, Felix C.; Dogic, Zvonimir] Tech Univ Munich, Inst Adv Study, D-85748 Garching, Germany; [Sanchez, Tim; DeCamp, Stephen J.; Dogic, Zvonimir] Brandeis Univ, Dept Phys, Waltham, MA 02474 USA; [Giomi, Luca] SISSA Int Sch Adv Studies, I-34136 Trieste, Italy; [Giomi, Luca] Leiden Univ, Inst Lorentz Theoret Phys, NL-2333 CA Leiden, Netherlands; [Bowick, Mark J.; Marchetti, M. Cristina] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; [Bowick, Mark J.; Marchetti, M. Cristina] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA	Technical University of Munich; Technical University of Munich; Brandeis University; International School for Advanced Studies (SISSA); Leiden University; Leiden University - Excl LUMC; Syracuse University; Syracuse University	Bausch, AR (corresponding author), Tech Univ Munich, Dept Phys, D-85748 Garching, Germany.	abausch@mytum.de	Loiseau, Etienne/AAE-1538-2022	Loiseau, Etienne/0000-0002-4688-8645; DeCamp, Stephen/0000-0001-7002-7370; Giomi, Luca/0000-0001-7740-5960	ERC-SelfOrg; Nanosystems Initiative Munich; Institute of Advanced Study-Technical University Munich; NSF [DMR-1305184, DGE-1068780]; Soft Matter Program at Syracuse University; W. M. Keck Foundation; U.S. Department of Energy, Office of Basic Energy Sciences [DE-SC0010432TDD];  [SFB863];  [NSF-MRSEC-0820492]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; Division Of Materials Research [1305184] Funding Source: National Science Foundation	ERC-SelfOrg; Nanosystems Initiative Munich; Institute of Advanced Study-Technical University Munich; NSF(National Science Foundation (NSF)); Soft Matter Program at Syracuse University; W. M. Keck Foundation(W.M. Keck Foundation); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Research was supported by ERC-SelfOrg (F. C. K., E. L., A. R. B.), partly by the SFB863 and the Nanosystems Initiative Munich (F. C. K., E. L., A. R. B.), the Institute of Advanced Study-Technical University Munich (Z.D., F. C. K.), NSF grants DMR-1305184 and DGE-1068780 (M. C. M.), and the Soft Matter Program at Syracuse University (M.J.B., M. C. M.). The primary support for work at Brandeis was provided by the W. M. Keck Foundation and NSF-MRSEC-0820492 (T. S., Z.D.). Acquisition of ATP dependence data was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, grant DE-SC0010432TDD (S.J.D., Z.D.). We also acknowledge use of the Brandeis MRSEC optical microscopy facility.	Abkarian M, 2011, SOFT MATTER, V7, P4610, DOI 10.1039/c1sm05239j; Abu Shah E, 2014, ELIFE, V3, DOI 10.7554/eLife.01433; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Baumann H, 2014, J BIOL CHEM, V289, P22524, DOI 10.1074/jbc.M114.582015; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; Duclos G, 2014, SOFT MATTER, V10, P2346, DOI 10.1039/c3sm52323c; Elbaum M, 1996, PHYS REV LETT, V76, P4078, DOI 10.1103/PhysRevLett.76.4078; Giomi L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.228101; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Irvine WTM, 2010, NATURE, V468, P947, DOI 10.1038/nature09620; Lapointe CP, 2009, SCIENCE, V326, P1083, DOI 10.1126/science.1176587; Lin IH, 2011, SCIENCE, V332, P1297, DOI 10.1126/science.1195639; Lipowsky P, 2005, NAT MATER, V4, P407, DOI 10.1038/nmat1376; Lopez-Leon T, 2011, NAT PHYS, V7, P391, DOI 10.1038/NPHYS1920; LUBENSKY TC, 1992, J PHYS II, V2, P371, DOI 10.1051/jp2:1992133; Marenduzzo D, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031921; Meng GN, 2014, SCIENCE, V343, P634, DOI 10.1126/science.1244827; Moreno-Razo JA, 2012, NATURE, V485, P86, DOI 10.1038/nature11084; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Nelson DR, 2002, NANO LETT, V2, P1125, DOI [10.1021/nl0202096, 10.1021/n10202096]; Palacci J, 2013, SCIENCE, V339, P936, DOI 10.1126/science.1230020; PENROSE LS, 1965, NATURE, V205, P544, DOI 10.1038/205544a0; Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Prinsen P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021701; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Senyuk B, 2013, NATURE, V493, P200, DOI 10.1038/nature11710; Shin H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037802; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Thampi SP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.118101; Nguyen TS, 2013, SOFT MATTER, V9, P8314, DOI 10.1039/c3sm50489a; Tjhung E, 2012, P NATL ACAD SCI USA, V109, P12381, DOI 10.1073/pnas.1200843109; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705; Vitelli V, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021711; Voituriez R, 2005, EUROPHYS LETT, V70, P404, DOI 10.1209/epl/i2004-10501-2; Zhou S, 2014, P NATL ACAD SCI USA, V111, P1265, DOI 10.1073/pnas.1321926111	38	353	354	10	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1135	1139		10.1126/science.1254784	http://dx.doi.org/10.1126/science.1254784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190790	Green Accepted, Green Submitted			2022-12-28	WOS:000341179800036
J	Krishnan, V				Krishnan, Vidya			CORRUPTION IN HEALTHCARE India turns spotlight on kickbacks for referrals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												vidyakrishnan13@gmail.com						[Anonymous], 2014, INDIAN EXPRESS; Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Chatterjee P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e453; Jain A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4184; Jesani Amar, 2014, Indian J Med Ethics, V11, P134; Nagarajan R., 2014, TIMES INDIA; Paediatric Formulary Committee, 2014, BMJ; PWC, 2012, TAK ADV MEDT MARK PO; Sayyed N, 2014, PUNE MIRROR     0707	9	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2014	349								g5265	10.1136/bmj.g5265	http://dx.doi.org/10.1136/bmj.g5265			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO2RY	25164130				2022-12-28	WOS:000341174300007
J	DeBaun, MR; Gordon, M; McKinstry, RC; Noetzel, MJ; White, DA; Sarnaik, SA; Meier, ER; Howard, TH; Majumdar, S; Inusa, BPD; Telfer, PT; Kirby-Allen, M; McCavit, TL; Kamdem, A; Airewele, G; Woods, GM; Berman, B; Panepinto, JA; Fuh, BR; Kwiatkowski, JL; King, AA; Fixler, JM; Rhodes, MM; Thompson, AA; Heiny, ME; Redding-Lallinger, RC; Kirkham, FJ; Dixon, N; Gonzalez, CE; Kalinyak, KA; Quinn, CT; Strouse, JJ; Miller, JP; Lehmann, H; Kraut, MA; Ball, WS; Hirtz, D; Casella, JF				DeBaun, M. R.; Gordon, M.; McKinstry, R. C.; Noetzel, M. J.; White, D. A.; Sarnaik, S. A.; Meier, E. R.; Howard, T. H.; Majumdar, S.; Inusa, B. P. D.; Telfer, P. T.; Kirby-Allen, M.; McCavit, T. L.; Kamdem, A.; Airewele, G.; Woods, G. M.; Berman, B.; Panepinto, J. A.; Fuh, B. R.; Kwiatkowski, J. L.; King, A. A.; Fixler, J. M.; Rhodes, M. M.; Thompson, A. A.; Heiny, M. E.; Redding-Lallinger, R. C.; Kirkham, F. J.; Dixon, N.; Gonzalez, C. E.; Kalinyak, K. A.; Quinn, C. T.; Strouse, J. J.; Miller, J. P.; Lehmann, H.; Kraut, M. A.; Ball, W. S., Jr.; Hirtz, D.; Casella, J. F.			Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN; DISEASE; STROKE; BRAIN; HEMOGLOBINOPATHY; PREVENTION; STATE; BLOOD; RISK	BACKGROUND Silent cerebral infarcts are the most common neurologic injury in children with sickle cell anemia and are associated with the recurrence of an infarct (stroke or silent cerebral infarct). We tested the hypothesis that the incidence of the recurrence of an infarct would be lower among children who underwent regular blood transfusion therapy than among those who received standard care. METHODS In this randomized, single-blind clinical trial, we randomly assigned children with sickle cell anemia to receive regular blood transfusions (transfusion group) or standard care (observation group). Participants were between 5 and 15 years of age, with no history of stroke and with one or more silent cerebral infarcts on magnetic resonance imaging and a neurologic examination showing no abnormalities corresponding to these lesions. The primary end point was the recurrence of an infarct, defined as a stroke or a new or enlarged silent cerebral infarct. RESULTS A total of 196 children (mean age, 10 years) were randomly assigned to the observation or transfusion group and were followed for a median of 3 years. In the transfusion group, 6 of 99 children (6%) had an end-point event (1 had a stroke, and 5 had new or enlarged silent cerebral infarcts). In the observation group, 14 of 97 children (14%) had an end-point event (7 had strokes, and 7 had new or enlarged silent cerebral infarcts). The incidence of the primary end point in the transfusion and observation groups was 2.0 and 4.8 events, respectively, per 100 years at risk, corresponding to an incidence rate ratio of 0.41 (95% confidence interval, 0.12 to 0.99; P = 0.04). CONCLUSIONS Regular blood-transfusion therapy significantly reduced the incidence of the recurrence of cerebral infarct in children with sickle cell anemia. (Funded by the National Institute of Neurological Disorders and Stroke and others; Silent Cerebral Infarct Multi-Center Clinical Trial ClinicalTrials.gov number, NCT00072761, and Current Controlled Trials number, ISRCTN52713285.)	[DeBaun, M. R.] Vanderbilt Univ, Sch Med, Vanderbilt Meharry Ctr Excellence Sickle Cell Dis, Dept Pediat,Div Hematol Oncol, Nashville, TN 37212 USA; [Gordon, M.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Div Biostat, St Louis, MO 63130 USA; [McKinstry, R. C.] Washington Univ, Sch Med, Dept Radiol & Pediat, St Louis, MO 63130 USA; [Noetzel, M. J.] Washington Univ, Sch Med, Dept Neurol & Pediat, St Louis, MO 63130 USA; [White, D. A.] Washington Univ, Sch Med, Dept Psychol, St Louis, MO 63130 USA; [King, A. A.] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO 63130 USA; [King, A. A.] Washington Univ, Sch Med, Dept Pediat Hematol Oncol, St Louis, MO 63130 USA; [Miller, J. P.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63130 USA; [Miller, J. P.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63130 USA; [Sarnaik, S. A.] Wayne State Univ, Dept Pediat, Div Hematol Oncol, Detroit, MI 48202 USA; [Meier, E. R.] George Washington Univ, Dept Pediat, Med Ctr, Ctr Canc & Blood Disorders,Childrens Natl Med Ctr, Washington, DC 20052 USA; [Gonzalez, C. E.] Georgetown Univ Hosp, Dept Pediat, Div Hematol Oncol, Washington, DC 20007 USA; [Howard, T. H.] Univ Alabama Birmingham, Dept Pediat, Div Hematol Oncol, Birmingham, W Midlands, England; [Majumdar, S.] Univ Mississippi, Med Ctr, Dept Pediat, Div Hematol Oncol, Jackson, MS USA; [Inusa, B. P. D.] St Thomas Hosp NHS Trust, Evelina Childrens Hosp, Dept Paediat, London, England; [Telfer, P. T.] Barts Hlth NHS Trust, Royal London Hosp, Dept Pediat Hematol, London, England; [Kirkham, F. J.] UCL, Inst Child Hlth, Neurosci Unit, London WC1E 6BT, England; [Kirby-Allen, M.] Univ Toronto, Dept Paediat, Hosp Sick Children, Toronto, ON M5S 1A1, Canada; [McCavit, T. L.] UT Southwestern Med Ctr, Dept Pediat, Div Hematol Oncol, Dallas, TX USA; [Kamdem, A.] Hop Intercommunal Creteil, Dept Pediat, Creteil, France; [Airewele, G.] Baylor Coll Med, Dept Pediat, Div Hematol Oncol, Houston, TX 77030 USA; [Woods, G. M.] Univ Missouri Kansas City, Dept Pediat, Kansas City, MO USA; [Berman, B.] Case Western Reserve Univ, Dept Pediat, Div Hematol Oncol, Cleveland, OH 44106 USA; [Rhodes, M. M.] Ohio State Univ, Dept Pediat, Div Hematol Oncol, Columbus, OH 43210 USA; [Kalinyak, K. A.; Quinn, C. T.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Hematol, Cincinnati, OH 45229 USA; [Ball, W. S., Jr.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; [Panepinto, J. A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Fuh, B. R.] Brody Sch Med, Dept Pediat, Greenville, NC USA; [Redding-Lallinger, R. C.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Dixon, N.] Wake Forest Univ Hlth Sci, Dept Pediat, Winston Salem, NC USA; [Kwiatkowski, J. L.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Kwiatkowski, J. L.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fixler, J. M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Sinai Hosp, Baltimore, MD 21205 USA; [Strouse, J. J.] Johns Hopkins Univ, Sch Med, Dept Pediat & Med, Div Pediat Hematol, Baltimore, MD USA; [Casella, J. F.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Hematol, Baltimore, MD 21205 USA; [Kraut, M. A.] Johns Hopkins Univ, Sch Med, Dept Radiol, Div Neuroradiol, Baltimore, MD 21205 USA; [Lehmann, H.] Johns Hopkins Bloomberg Sch Publ Hlth, Div Hlth Sci Informat, Baltimore, MD USA; [Hirtz, D.] NINDS, NIH, Bethesda, MD 20892 USA; [Thompson, A. A.] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol, Chicago, IL 60611 USA; [Heiny, M. E.] Indiana Univ Purdue Univ, Dept Pediat, Indianapolis, IN 46202 USA	Meharry Medical College; Vanderbilt University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Wayne State University; Children's National Health System; George Washington University; Georgetown University; University of Mississippi; University of Mississippi Medical Center; Guy's & St Thomas' NHS Foundation Trust; Barts Health NHS Trust; Royal London Hospital; University of London; University College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Southwestern Medical Center Dallas; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Baylor College of Medicine; University of Missouri System; University of Missouri Kansas City; Case Western Reserve University; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Medical College of Wisconsin; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest University School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Sinai Hospital of Baltimore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Indiana University System; Indiana University-Purdue University Indianapolis	DeBaun, MR (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Meharry Ctr Excellence Sickle Cell Dis, Dept Pediat,Div Hematol Oncol, Nashville, TN 37212 USA.	m.debaun@vanderbilt.edu	Quinn, Charles T./J-6842-2012; Kirkham, Fenella/C-2442-2009; Miller, John J/GZG-5663-2022; Strouse, J/A-2690-2008; Inusa, Baba/R-7447-2017	Quinn, Charles T./0000-0002-2372-2175; Kirkham, Fenella/0000-0002-2443-7958; Strouse, J/0000-0003-0341-1457; Inusa, Baba/0000-0003-2643-765X; Lehmann, Harold/0000-0002-7698-219X; White, Desiree/0000-0001-9439-9574; King, Allison/0000-0002-1951-6176	National Institute of Neurological Disorders and Stroke; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003, UL1TR000448, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS042804] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke and others; Silent Cerebral Infarct Multi-Center Clinical Trial ClinicalTrials.gov number, NCT00072761, and Current Controlled Trials number, ISRCTN52713285.	Adams RJ, 2004, BLOOD, V103, P3689, DOI 10.1182/blood-2003-08-2733; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Armstrong FD, 1996, PEDIATRICS, V97, P864; Bernaudin F, 2000, J CHILD NEUROL, V15, P333, DOI 10.1177/088307380001500510; Bernaudin F, 2011, BLOOD, V117, P1130, DOI 10.1182/blood-2010-06-293514; Brousseau DC, 2010, AM J HEMATOL, V85, P77, DOI 10.1002/ajh.21570; Casella JF, 2010, PEDIATR HEMAT ONCOL, V27, P69, DOI 10.3109/08880010903360367; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; Dowling MM, 2012, BLOOD, V120, P3891, DOI 10.1182/blood-2012-01-406314; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; GLAUSER TA, 1995, J CHILD NEUROL, V10, P88, DOI 10.1177/088307389501000203; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; King AA, 2008, PEDIATR BLOOD CANCER, V50, P599, DOI 10.1002/pbc.21338; King AA, 2014, AM J HEMATOL, V89, P162, DOI 10.1002/ajh.23604; Kwiatkowski JL, 2009, BRIT J HAEMATOL, V146, P300, DOI 10.1111/j.1365-2141.2009.07753.x; Lorey FW, 1996, GENET EPIDEMIOL, V13, P501, DOI 10.1002/(SICI)1098-2272(1996)13:5<501::AID-GEPI6>3.0.CO;2-4; Miller ST, 2001, J PEDIATR-US, V139, P385, DOI 10.1067/mpd.2001.117580; Pegelow CH, 2002, BLOOD, V99, P3014, DOI 10.1182/blood.V99.8.3014; PROHOVNIK I, 1989, NEUROLOGY, V39, P344, DOI 10.1212/WNL.39.3.344; Quinn CT, 2013, JAMA NEUROL, V70, P58, DOI 10.1001/jamaneurol.2013.576; Schatz J, 2001, NEUROLOGY, V56, P1109, DOI 10.1212/WNL.56.8.1109; VICHINSKY EP, 1990, NEW ENGL J MED, V322, P1617, DOI 10.1056/NEJM199006073222301; Vichinsky EP, 2001, TRANSFUSION, V41, P1086, DOI 10.1046/j.1537-2995.2001.41091086.x; Wang WC, 2008, PEDIATR BLOOD CANCER, V51, P643, DOI 10.1002/pbc.21612; Wechsler D., 1967, WPPSI MANUAL WECHSLE; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Zagorsky JL, 2007, INTELLIGENCE, V35, P489, DOI 10.1016/j.intell.2007.02.003	27	322	326	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					699	710		10.1056/NEJMoa1401731	http://dx.doi.org/10.1056/NEJMoa1401731			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140956	Green Accepted, Green Published			2022-12-28	WOS:000340509900005
J	Lederer, SE				Lederer, Susan E.			The Challenges of Challenge Experiments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Dept Med Hist & Bioeth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lederer, SE (corresponding author), Univ Wisconsin, Dept Med Hist & Bioeth, Madison, WI 53706 USA.							BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; Lantos John D, 2010, Perspect Biol Med, V53, P613, DOI 10.1353/pbm.2010.0011; Lederer Susan, 1995, SUBJECTED SCI HUMAN; Miller FG, 2001, CLIN INFECT DIS, V33, P1028, DOI 10.1086/322664; Rusnock Andrea, 2007, Centaurus, V49, P337	5	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					695	697		10.1056/NEJMp1408554	http://dx.doi.org/10.1056/NEJMp1408554			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN3SV	25140955				2022-12-28	WOS:000340509900004
J	Nishtar, S				Nishtar, Sania			Reflections from my tenure as minister	LANCET			English	Editorial Material							PAKISTAN; HEALTH		Heartfile, Islamabad, Pakistan		Nishtar, S (corresponding author), Heartfile, Islamabad, Pakistan.	sania@heartfile.org						Cabinet Division, 2013, COD COND MIN; Horton R, 2013, LANCET, V381, P2137, DOI 10.1016/S0140-6736(13)60946-0; Intel, 2011, BEN APPL UN SERV FUN; Kassim-Lakha S, 2013, LANCET, V381, P2236, DOI 10.1016/S0140-6736(13)60678-9; Nishtar S., HANDOVER PAPERS IMPR; Nishtar S, 2013, LANCET, V381, P2291, DOI 10.1016/S0140-6736(13)60813-2; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Prime Minister's Secretariat, 2013, REALL BUS MIN DIV; Transparency International, 2014, FIGHT CORR S AS BUIL; Transparency International, CORR PERC IND 2013	10	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					910	913		10.1016/S0140-6736(14)61284-8	http://dx.doi.org/10.1016/S0140-6736(14)61284-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC6CB	25194447				2022-12-28	WOS:000350451100039
J	Castle, PE; Schmeler, KM				Castle, Philip E.; Schmeler, Kathleen M.			HPV vaccination: for women of all ages?	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; GRADE 3; EFFICACY; PERSISTENCE; RISK		[Castle, Philip E.] Global Coalit Cerv Canc, Arlington, VA 22203 USA; [Schmeler, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Castle, PE (corresponding author), Global Coalit Cerv Canc, Arlington, VA 22203 USA.	castle.philip@gmail.com	Castle, Philip/AAP-6395-2020	Castle, Philip/0000-0003-1082-6554				Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Castellsague X, 2013, EUROGIN C 2013 FLOR; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2569; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Franceschi S, 2011, INT J CANCER, V128, P2765, DOI 10.1002/ijc.25915; Guided Therapeutics and GE Healthcare, KMS DECL NO COMP INT; Herrero R, 2011, CANCER DISCOV, V1, P408, DOI 10.1158/2159-8290.CD-11-0131; Joura E, 2013, EUROGIN C 2013 FLOR; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS56, DOI 10.1097/LGT.0b013e318285437b; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Rositch AF, 2012, CANCER RES, V72, P6183, DOI 10.1158/0008-5472.CAN-12-2635; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Skinner SR, 2014, LANCET; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510	17	7	7	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2178	2180		10.1016/S0140-6736(14)61230-7	http://dx.doi.org/10.1016/S0140-6736(14)61230-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX0QC	25189357				2022-12-28	WOS:000346655700008
J	Vinothkumar, KR; Zhu, JP; Hirst, J				Vinothkumar, Kutti R.; Zhu, Jiapeng; Hirst, Judy			Architecture of mammalian respiratory complex I	NATURE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ACYL CARRIER PROTEIN; 3-DIMENSIONAL STRUCTURE; STRUCTURAL BASIS; SUBUNIT; MUTATIONS; ENVIRONMENT; RESOLUTION; PREDICTION; TOPOLOGY	Complex I (NADH: ubiquinone oxidoreductase) is essential for oxidative phosphorylation in mammalian mitochondria. It couples electron transfer from NADH to ubiquinone with proton translocation across the energy-transducing inner membrane, providing electrons for respiration and driving ATP synthesis. Mammalian complex I contains 44 different nuclear-and mitochondrial-encoded subunits, with a combined mass of 1MDa. The 14 conserved 'core' subunits have been structurally defined in the minimal, bacterial complex, but the structures and arrangement of the 30 'supernumerary' subunits are unknown. Here we describe a 5 angstrom resolution structure of complex I from Bos taurus heart mitochondria, a close relative of the human enzyme, determined by single-particle electron cryo-microscopy. Wepresent the structures of themammalian core subunits that contain eight iron-sulphur clusters and 60 transmembrane helices, identify 18 supernumerary transmembrane helices, and assign and model 14 supernumerary subunits. Thus, we considerably advance knowledge of the structure of mammalian complex I and the architecture of its supernumerary ensemble around the core domains. Our structure provides insights into the roles of the supernumerary subunits in regulation, assembly and homeostasis, and a basis for understanding the effects of mutations that cause a diverse range of human diseases.	[Vinothkumar, Kutti R.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Zhu, Jiapeng; Hirst, Judy] Wellcome Trust Res Labs, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute	Vinothkumar, KR (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	vkumar@mrc-lmb.cam.ac.uk; jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797	Medical Research Council [U105184322, U105663141]; Medical Research Council [MC_U105663141, MC_U105184322] Funding Source: researchfish; MRC [MC_U105184322, MC_U105663141] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Henderson, S. H. W. Scheres, G. McMullan, G. Murshudov, P. Emsley and J.E. Walker for helpful advice, the FEI fellows for educating us on use of the Titan Krios, J. Grimmett and T. Darling for computational help, and S. Chen and C. Savva for EM help. This work was supported by the Medical Research Council, grant numbers U105184322 (K. R. V., in R. Henderson's group) and U105663141 (J.H.).	Abdrakhmanova A, 2006, BBA-BIOENERGETICS, V1757, P1676, DOI 10.1016/j.bbabio.2006.09.003; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Banci L, 2012, J STRUCT BIOL, V180, P190, DOI 10.1016/j.jsb.2012.07.007; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Brockmann C, 2004, STRUCTURE, V12, P1645, DOI 10.1016/j.str.2004.06.021; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Dieteren CEJ, 2012, J BIOL CHEM, V287, P41851, DOI 10.1074/jbc.M112.391151; Dobrynin K, 2010, BBA-BIOENERGETICS, V1797, P152, DOI 10.1016/j.bbabio.2009.09.007; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; King JD, 2007, J MOL BIOL, V374, P749, DOI 10.1016/j.jmb.2007.09.055; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LEONARD K, 1987, J MOL BIOL, V194, P277, DOI 10.1016/0022-2836(87)90375-5; Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharpley M. S., 2005, THESIS CAMBRIDGE U; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Szklarczyk R, 2011, FEBS LETT, V585, P737, DOI 10.1016/j.febslet.2011.01.046; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	63	292	297	9	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					80	+		10.1038/nature13686	http://dx.doi.org/10.1038/nature13686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25209663	Green Accepted			2022-12-28	WOS:000344187500032
J	Del Toro-De Leon, G; Garcia-Aguilar, M; Gillmor, CS				Del Toro-De Leon, Gerardo; Garcia-Aguilar, Marcelina; Stewart Gillmor, C.			Non-equivalent contributions of maternal and paternal genomes to early plant embryogenesis	NATURE			English	Article							TO-ZYGOTIC TRANSITION; SEED DEVELOPMENT; ARABIDOPSIS HYBRIDS; EMBRYO DEVELOPMENT; GENE-EXPRESSION; METHYLATION; ACTIVATION; ENDOSPERM; MAIZE	Zygotic genome activation in metazoans typically occurs several hours to a day after fertilization, and thus maternal RNAs and proteins drive early animal embryo development(1). In plants, despite several molecular studies of post-fertilization transcriptional activation, the timing of zygotic genome activation remains a matter of debate. For example, two recent reports that used different hybrid ecotype combinations for RNA sequence profiling of early Arabidopsis embryo transcriptomes came to divergent conclusions. One identified paternal contributions that varied by gene, but with overall maternal dominance(2), while the other found that the maternal and paternal genomes are transcriptionally equivalent(3). Here we assess paternal gene activation functionally in an isogenic background, by performing a large-scale genetic analysis of 49 EMBRYO DEFECTIVE genes and testing the ability of wild-type paternal alleles to complement phenotypes conditioned by mutant maternal alleles. Our results demonstrate that wild-type paternal alleles for nine of these genes are completely functional 2 days after pollination, with the remaining 40 genes showing partial activity beginning at 2, 3 or 5 days after pollination. Using our functional assay, we also demonstrate that different hybrid combinations exhibit significant variation in paternal allele activation, reconciling the apparently contradictory results of previous transcriptional studies(2,3). The variation in timing of gene function that we observe confirms that paternal genome activation does not occur in one early discrete step, provides large-scale functional evidence that maternal and paternal genomes make non-equivalent contributions to early plant embryogenesis, and uncovers an unexpectedly profound effect of hybrid genetic backgrounds on paternal gene activity.	[Del Toro-De Leon, Gerardo; Garcia-Aguilar, Marcelina; Stewart Gillmor, C.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada, Lab Nacl Genom Biodiversidad Langebio, Irapuato 36821, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Gillmor, CS (corresponding author), Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada, Lab Nacl Genom Biodiversidad Langebio, Irapuato 36821, Guanajuato, Mexico.	sgillmor@langebio.cinvestav.mx	Gillmor, Stewart/C-1965-2014; Del Toro, Gerardo/F-6908-2019	Gillmor, Stewart/0000-0003-1009-2167; Del Toro, Gerardo/0000-0003-2079-1746	CONACyT [300802, 152333]; CINVESTAV	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CINVESTAV	This study was facilitated by the efforts of D. Meinke and collaborators in creating and maintaining the SeedGenes Project (www.seedgenes.org). Seeds were obtained from the Arabidopsis Biological Resource Center (http://abrc.osu.edu). We thank S. Poethig, in whose laboratory C. S. G. generated GCT and CCT GUS reporter constructs, K. Gallagher for reagents, C. Silva-Ortega for preliminary experiments, A. de Luna, D. Lepe-Soltero and C. Abreu-Goodger for suggestions on data analysis and presentation, R. Datla for suggesting Col/Tsu hybrid, D. Bergmann for advice, and L. Herrera-Estrella, D. Autran, C. Baroux, J.-P. Vielle-Calzada and D. Grimanelli for reading the manuscript. Research was supported by a CONACyT graduate fellowship to G.D.T.-D.L. (No. 300802), a CONACyT postdoctoral fellowship to M. G.-A., a CONACyT research grant (Ciencia Basica No. 152333) to C. S. G., and by CINVESTAV institutional funds.	Autran D, 2011, CELL, V145, P707, DOI 10.1016/j.cell.2011.04.014; Barber WT, 2012, P NATL ACAD SCI USA, V109, P10444, DOI 10.1073/pnas.1202073109; Baroux C, 2001, FEBS LETT, V509, P11, DOI 10.1016/S0014-5793(01)03097-6; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Costa LM, 2014, SCIENCE, V344, P168, DOI 10.1126/science.1243005; Gillmor CS, 2010, DEVELOPMENT, V137, P113, DOI 10.1242/dev.043174; Greaves IK, 2012, P NATL ACAD SCI USA, V109, P3570, DOI 10.1073/pnas.1201043109; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Muralla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028398; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Ueda M, 2011, DEV CELL, V20, P264, DOI 10.1016/j.devcel.2011.01.009; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Zhao J, 2011, PLANT J, V65, P131, DOI 10.1111/j.1365-313X.2010.04403.x	26	62	62	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					624	+		10.1038/nature13620	http://dx.doi.org/10.1038/nature13620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25209660				2022-12-28	WOS:000343801500048
J	Hooper, LV				Hooper, Lora V.			Innate lymphoid cells sweeten the pot	SCIENCE			English	Editorial Material							HOST; COMMENSAL; ECOSYSTEM; INTESTINE; GUT		[Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Marcobal A, 2013, GLYCOBIOLOGY, V23, P1038, DOI 10.1093/glycob/cwt040; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	10	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1248	1249		10.1126/science.1259808	http://dx.doi.org/10.1126/science.1259808			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214594				2022-12-28	WOS:000341483800022
J	Sakaida, H; Kobayashi, M; Ito, A; Takeuchi, K				Sakaida, Hiroshi; Kobayashi, Masayoshi; Ito, Ai; Takeuchi, Kazuhiko			Cavernous sinus thrombosis: linking a swollen red eye and headache	LANCET			English	Editorial Material									[Sakaida, Hiroshi; Kobayashi, Masayoshi; Takeuchi, Kazuhiko] Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tsu, Mie 5148507, Japan; [Ito, Ai] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 5148507, Japan	Mie University; Mie University	Sakaida, H (corresponding author), Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	hsakaida@clin.medic.mie-u.ac.jp		Sakaida, Hiroshi/0000-0002-9431-3301				Ebright JR, 2001, ARCH INTERN MED, V161, P2671, DOI 10.1001/archinte.161.22.2671; Guvenc MG, 2009, EUR ARCH OTO-RHINO-L, V266, P987, DOI 10.1007/s00405-008-0873-8; Osborn MK, 2007, LANCET INFECT DIS, V7, P62, DOI 10.1016/S1473-3099(06)70688-0; Parmar H, 2009, J NEURO-OPHTHALMOL, V29, P16, DOI 10.1097/WNO.0b013e31818e3f40; Siegman-Igra Y, 2012, EUR J CLIN MICROBIOL, V31, P2453, DOI 10.1007/s10096-012-1589-7	5	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					928	928		10.1016/S0140-6736(14)61404-5	http://dx.doi.org/10.1016/S0140-6736(14)61404-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	25209492				2022-12-28	WOS:000341362200035
J	Jacobs, D				Jacobs, Danny			Hemorrhoids	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RUBBER BAND LIGATION; PRACTICE PARAMETERS; DOUBLE-BLIND; PREVALENCE; TRIAL; COMPLICATIONS; MANAGEMENT		[Jacobs, Danny] UTMB Galveston, Off Provost, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Jacobs, D (corresponding author), UTMB Galveston, 301 Univ Blvd, Galveston, TX 77555 USA.	djacobs@utmb.edu						Alonso-Coello P, 2006, BRIT J SURG, V93, P909, DOI 10.1002/bjs.5378; Alonso-Coello P, 2006, AM J GASTROENTEROL, V101, P181, DOI 10.1111/j.1572-0241.2005.00359.x; Altomare D F, 2006, Tech Coloproctol, V10, P181, DOI 10.1007/s10151-006-0277-y; Altomare DF, 2006, DIS COLON RECTUM, V49, P1018, DOI 10.1007/s10350-006-0532-3; Altomare DF, 2013, NAT REV GASTRO HEPAT, V10, P513, DOI 10.1038/nrgastro.2013.91; Baker H, 2006, GALE ENCY MED, V3rd, P1766; Bleday R, 2012, TREATMENT HEMORRHOID; Cataldo P, 2005, DIS COLON RECTUM, V48, P189, DOI 10.1007/s10350-004-0921-4; Chung CC, 2002, DIS COLON RECTUM, V45, P789, DOI 10.1007/s10350-004-6299-5; Cleator IGM, 2005, US GASTROENTEROLOGY, V5, P69; Clinical Practice Committee American Gastroenterological Association, 2004, Gastroenterology, V126, P1461; De la Garza M, 2013, SEMIN COLON RECTAL S, V24, P96, DOI 10.1053/j.scrs.2013.02.008; El Nakeeb AM, 2008, WORLD J GASTROENTERO, V14, P6525, DOI 10.3748/wjg.14.6525; Everhart J, 2008, BURDEN DIGESTIVE DIS; Ganz RA, 2013, CLIN GASTROENTEROL H, V11, P593, DOI 10.1016/j.cgh.2012.12.020; Greenspon J, 2004, DIS COLON RECTUM, V47, P1493, DOI 10.1007/s10350-004-0607-y; HAAS PA, 1984, DIS COLON RECTUM, V27, P442, DOI 10.1007/BF02555533; HAAS PA, 1983, DIS COLON RECTUM, V26, P435, DOI 10.1007/BF02556521; Hackford AW, 2013, SEMIN COLON RECTAL S, V24, P81, DOI 10.1053/j.scrs.2013.02.005; HANCOCK BD, 1977, GUT, V18, P651, DOI 10.1136/gut.18.8.651; Iyer VS, 2004, DIS COLON RECTUM, V47, P1364, DOI 10.1007/s10350-004-0591-2; Jayaraman S, 2007, DIS COLON RECTUM, V50, P1297, DOI 10.1007/s10350-007-0308-4; JOHANSON JF, 1990, GASTROENTEROLOGY, V98, P380, DOI 10.1016/0016-5085(90)90828-O; Kann BR., 2004, TECH GASTROINTEST EN, V6.1, P6, DOI [10.1053/j.tgie.2004.01.004, DOI 10.1053/J.TGIE.2004.01.004]; KELLY SM, 1986, J CLIN GASTROENTEROL, V8, P658, DOI 10.1097/00004836-198612000-00014; Ko CY, 2012, MANAGEMENT HEMORRHOI; Kwok SY, 2005, DIS COLON RECTUM, V48, P344, DOI 10.1007/s10350-004-0845-z; MacRae HM, 1997, CAN J SURG, V40, P14; Madoff RD, 2004, GASTROENTEROLOGY, V126, P1463, DOI 10.1053/j.gastro.2004.03.008; Marques CFS, 2009, TECH COLOPROCTOL, V13, P103; Milone M, 2012, UPDATES SURG, V64, P191, DOI 10.1007/s13304-012-0155-2; MILSOM JW, 1992, FUNDAMENTALS ANORECT, P192; Ohning GV, 2009, REV GASTROENTEROL DI, V9, P16; Poen AC, 2000, EUR J GASTROEN HEPAT, V12, P535, DOI 10.1097/00042737-200012050-00010; Riss S, 2012, INT J COLORECTAL DIS, V27, P215, DOI 10.1007/s00384-011-1316-3; Rivadeneira DE, 2011, DIS COLON RECTUM, V54, P1059, DOI 10.1097/DCR.0b013e318225513d; Schubert MC, 2009, WORLD J GASTROENTERO, V15, P3201, DOI 10.3748/wjg.15.3201; Singer M, 2011, ASCRS TEXTBOOK OF COLON AND RECTAL SURGERY, SECOND EDITION, P175, DOI 10.1007/978-1-4419-1584-9_11; Tjandra JJ, 2007, DIS COLON RECTUM, V50, P878, DOI 10.1007/s10350-006-0852-3	39	62	66	2	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					944	951		10.1056/NEJMcp1204188	http://dx.doi.org/10.1056/NEJMcp1204188			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184866				2022-12-28	WOS:000341390600011
J	Scott, WG				Scott, William G.			STRUCTURAL BIOLOGY How fluorescent RNA gets its glow	NATURE			English	Editorial Material							PROTEIN; MIMICS		[Scott, William G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Scott, William G.] Univ Calif Santa Cruz, RNA, Ctr Mol Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Scott, WG (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	wgscott@ucsc.edu		Scott, William/0000-0002-9273-3564				Huang H., 2014, NATURE CHEM BIOL; Koldobskaya Y, 2011, NAT STRUCT MOL BIOL, V18, P100, DOI 10.1038/nsmb.1945; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865	4	1	1	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					42	43		10.1038/513042a	http://dx.doi.org/10.1038/513042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186897				2022-12-28	WOS:000341174800025
J	Siliciano, JD; Siliciano, RF				Siliciano, Janet D.; Siliciano, Robert F.			Rekindled HIV infection	SCIENCE			English	Editorial Material							LATENT RESERVOIR; REPLICATION		[Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, JD (corresponding author), Johns Hopkins Univ Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu						Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	15	13	15	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1005	1006		10.1126/science.1259452	http://dx.doi.org/10.1126/science.1259452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170139				2022-12-28	WOS:000340870900019
J	Aoki, W; Tominaga, N; Beers, TC; Honda, S; Lee, YS				Aoki, W.; Tominaga, N.; Beers, T. C.; Honda, S.; Lee, Y. S.			A chemical signature of first-generation very massive stars	SCIENCE			English	Article							METAL-POOR STARS; 1ST STARS; ABUNDANCES; NUCLEOSYNTHESIS; POPULATION; SUPERNOVAE; EVOLUTION; PARAMETERS; FEEDBACK; HALO	Numerical simulations of structure formation in the early universe predict the formation of some fraction of stars with several hundred solar masses. No clear evidence of supernovae from such very massive stars has, however, yet been found in the chemical compositions of Milky Way stars. We report on an analysis of a very metal-poor star SDSS J001820.5-093939.2, which possesses elemental-abundance ratios that differ significantly from any previously known star. This star exhibits low [alpha-element Fe] ratios and large contrasts between the abundances of odd and even element pairs, such as scandium/titanium and cobalt/nickel. Such features have been predicted by nucleosynthesis models for supernovae of stars more than 140 times as massive as the Sun, suggesting that the mass distribution of first-generation stars might extend to 100 solar masses or larger.	[Aoki, W.] Natl Astron Observ Japan NAOJ, Mitaka, Tokyo 1818588, Japan; [Aoki, W.] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Tominaga, N.] Konan Univ, Fac Sci & Engn, Dept Phys, Kobe, Hyogo 6588501, Japan; [Tominaga, N.] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778569, Japan; [Beers, T. C.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46656 USA; [Beers, T. C.] Univ Notre Dame, Joint Inst Nucl Astrophys, Notre Dame, IN 46556 USA; [Honda, S.] Univ Hyogo, Ctr Astron, Sayo, Hyogo 6795313, Japan; [Lee, Y. S.] New Mexico State Univ, Dept Astron, Las Cruces, NM 88003 USA	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; Konan University; University of Tokyo; University of Notre Dame; University of Notre Dame; University of Hyogo; New Mexico State University	Aoki, W (corresponding author), Natl Astron Observ Japan NAOJ, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	aoki.wako@nao.ac.jp	Beers, Timothy/D-1193-2019	Tominaga, Nozomu/0000-0001-8537-3153; Lee, Young Sun/0000-0001-5297-4518	Japan Society for the Promotion of Science [23224004]; Physics Frontiers Center/Joint Institute for Nuclear Astrophysics (JINA) - U.S. National Science Foundation [PHY 08-22648]; Direct For Mathematical & Physical Scien [1430152] Funding Source: National Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Physics Frontiers Center/Joint Institute for Nuclear Astrophysics (JINA) - U.S. National Science Foundation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is based on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. The data obtained with the Subaru/HDS are available on the Subaru Mitaka Okayama Kiso Archive system (SMOKA) (http://smoka.nao.ac.jp). We thank H. Susa for useful discussions about the formation and mass distribution of the first stars. We also appreciate T. Ohkubo for providing us progenitor models of core-collapse very massive stars. W. A. and N. T. were supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (23224004). T. C. B. acknowledges partial support from grant PHY 08-22648: Physics Frontiers Center/Joint Institute for Nuclear Astrophysics (JINA), awarded by the U.S. National Science Foundation. Y. S. L. is a Tombaugh Fellow.	Aoki W, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/13; Bergemann M, 2010, MON NOT R ASTRON SOC, V401, P1334, DOI 10.1111/j.1365-2966.2009.15736.x; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; Castelli F, 1997, ASTRON ASTROPHYS, V318, P841; Cayrel R, 2004, ASTRON ASTROPHYS, V416, P1117, DOI 10.1051/0004-6361:20034074; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Hirano S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/60; Hosokawa T, 2011, SCIENCE, V334, P1250, DOI 10.1126/science.1207433; Iwamoto K, 1999, ASTROPHYS J SUPPL S, V125, P439, DOI 10.1086/313278; Karlsson T, 2008, ASTROPHYS J, V679, P6, DOI 10.1086/533520; Kim YC, 2002, ASTROPHYS J SUPPL S, V143, P499, DOI 10.1086/343041; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855, DOI 10.1093/pasj/54.6.855; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Ohkubo T, 2006, ASTROPHYS J, V645, P1352, DOI 10.1086/504578; Ohkubo T, 2009, ASTROPHYS J, V706, P1184, DOI 10.1088/0004-637X/706/2/1184; Spite M, 2005, ASTRON ASTROPHYS, V430, P655, DOI 10.1051/0004-6361:20041274; Suda T, 2008, PUBL ASTRON SOC JPN, V60, P1159, DOI 10.1093/pasj/60.5.1159; Tolstoy E, 2009, ANNU REV ASTRON ASTR, V47, P371, DOI 10.1146/annurev-astro-082708-101650; Umeda H, 2002, ASTROPHYS J, V565, P385, DOI 10.1086/323946; Wada K, 2003, ASTROPHYS J, V591, P38, DOI 10.1086/375335; Yanny B, 2009, ASTRON J, V137, P4377, DOI 10.1088/0004-6256/137/5/4377; Yong D, 2003, PUBL ASTRON SOC PAC, V115, P22, DOI 10.1086/345104; Yong D, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/26	26	80	80	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					912	915		10.1126/science.1252633	http://dx.doi.org/10.1126/science.1252633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146286				2022-12-28	WOS:000340524700041
J	Gomez, LF; Ferguson, KR; Cryan, JP; Bacellar, C; Tanyag, RMP; Jones, C; Schorb, S; Anielski, D; Belkacem, A; Bernando, C; Boll, R; Bozek, J; Carron, S; Chen, G; Delmas, T; Englert, L; Epp, SW; Erk, B; Foucar, L; Hartmann, R; Hexemer, A; Huth, M; Kwok, J; Leone, SR; Ma, JHS; Maia, FRNC; Malmerberg, E; Marchesini, S; Neumark, DM; Poon, B; Prell, J; Rolles, D; Rudek, B; Rudenko, A; Seifrid, M; Siefermann, KR; Sturm, FP; Swiggers, M; Ullrich, J; Weise, F; Zwart, P; Bostedt, C; Gessner, O; Vilesov, AF				Gomez, Luis F.; Ferguson, Ken R.; Cryan, James P.; Bacellar, Camila; Tanyag, Rico Mayro P.; Jones, Curtis; Schorb, Sebastian; Anielski, Denis; Belkacem, Ali; Bernando, Charles; Boll, Rebecca; Bozek, John; Carron, Sebastian; Chen, Gang; Delmas, Tjark; Englert, Lars; Epp, Sascha W.; Erk, Benjamin; Foucar, Lutz; Hartmann, Robert; Hexemer, Alexander; Huth, Martin; Kwok, Justin; Leone, Stephen R.; Ma, Jonathan H. S.; Maia, Filipe R. N. C.; Malmerberg, Erik; Marchesini, Stefano; Neumark, Daniel M.; Poon, Billy; Prell, James; Rolles, Daniel; Rudek, Benedikt; Rudenko, Artem; Seifrid, Martin; Siefermann, Katrin R.; Sturm, Felix P.; Swiggers, Michele; Ullrich, Joachim; Weise, Fabian; Zwart, Petrus; Bostedt, Christoph; Gessner, Oliver; Vilesov, Andrey F.			Shapes and vorticities of superfluid helium nanodroplets	SCIENCE			English	Article							LIQUID-HELIUM; STABILITY; DROP	Helium nanodroplets are considered ideal model systems to explore quantum hydrodynamics in self-contained, isolated superfluids. However, exploring the dynamic properties of individual droplets is experimentally challenging. In this work, we used single-shot femtosecond x-ray coherent diffractive imaging to investigate the rotation of single, isolated superfluid helium-4 droplets containing similar to 10(8) to 10(11) atoms. The formation of quantum vortex lattices inside the droplets is confirmed by observing characteristic Bragg patterns from xenon clusters trapped in the vortex cores. The vortex densities are up to five orders of magnitude larger than those observed in bulk liquid helium. The droplets exhibit large centrifugal deformations but retain axially symmetric shapes at angular velocities well beyond the stability range of viscous classical droplets.	[Gomez, Luis F.; Tanyag, Rico Mayro P.; Jones, Curtis; Seifrid, Martin; Vilesov, Andrey F.] Univ Southern Calif USC, Dept Chem, Los Angeles, CA 90089 USA; [Ferguson, Ken R.; Schorb, Sebastian; Bozek, John; Carron, Sebastian; Swiggers, Michele; Bostedt, Christoph] SLAC Natl Accelerator Lab, Linac Coherent Light Source LCLS, Menlo Pk, CA 94025 USA; [Cryan, James P.; Bacellar, Camila; Belkacem, Ali; Leone, Stephen R.; Ma, Jonathan H. S.; Neumark, Daniel M.; Siefermann, Katrin R.; Sturm, Felix P.; Weise, Fabian; Gessner, Oliver] Lawrence Berkeley Natl Lab LBNL, Ultrafast X Ray Sci Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Bacellar, Camila; Leone, Stephen R.; Neumark, Daniel M.; Prell, James] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Anielski, Denis; Boll, Rebecca; Epp, Sascha W.; Erk, Benjamin; Rudek, Benedikt; Rudenko, Artem; Ullrich, Joachim] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Anielski, Denis; Boll, Rebecca; Epp, Sascha W.; Erk, Benjamin; Foucar, Lutz; Rolles, Daniel; Rudek, Benedikt; Rudenko, Artem; Ullrich, Joachim] Ctr Free Electron Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Bernando, Charles; Vilesov, Andrey F.] USC, Dept Phys & Astron, Los Angeles, CA 90089 USA; [Boll, Rebecca; Erk, Benjamin; Rolles, Daniel] Deutsch Elektronen Synchrotron DESY, D-22607 Hamburg, Germany; [Chen, Gang; Hexemer, Alexander; Marchesini, Stefano] LBNL, Adv Light Source, Berkeley, CA 94720 USA; [Delmas, Tjark] DESY, CFEL, D-22607 Hamburg, Germany; [Englert, Lars] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Foucar, Lutz; Rolles, Daniel] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Hartmann, Robert; Huth, Martin] PNSensor GmbH, D-81739 Munich, Germany; [Kwok, Justin] USC, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Leone, Stephen R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Ma, Jonathan H. S.] Chinese Univ Hong Kong, Dept Phys, Hong Kong, Peoples R China; [Maia, Filipe R. N. C.] LBNL, Natl Energy Res Sci Comp Ctr, Berkeley, CA 94720 USA; [Malmerberg, Erik; Poon, Billy; Zwart, Petrus] LBNL, Phys Biosci Div, Berkeley, CA 94720 USA; [Malmerberg, Erik] Univ Calfornia Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Marchesini, Stefano] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Rudenko, Artem] Kansas State Univ, Dept Phys, James R Macdonald Lab, Manhattan, KS 66506 USA; [Bostedt, Christoph] Stanford Univ, PULSE Inst, Menlo Pk, CA 94025 USA; [Bostedt, Christoph] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Max Planck Society; Max Planck Society; University of Southern California; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Max Planck Society; PNSensor GmbH; University of Southern California; University of California System; University of California Berkeley; Chinese University of Hong Kong; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Davis; Kansas State University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Bostedt, C (corresponding author), SLAC Natl Accelerator Lab, Linac Coherent Light Source LCLS, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	bostedt@slac.stanford.edu; ogessner@lbl.gov; vilesov@usc.edu	Tanyag, Rico Mayro P/F-9374-2012; Rudek, Benedikt/AAX-1278-2021; Bozek, John D/E-9260-2010; Neumark, Daniel M/B-9551-2009; Rudek, Benedikt/A-5100-2017; Poon, Billy/AAT-5234-2020; Seifrid, Martin/ABA-6540-2020; Marchesini, Stefano/GYR-1409-2022; Rudenko, Artem/C-7412-2009; Young, Michelle A/N-7228-2017; Englert, Lars/GWF-0049-2022; Poon, Billy/AAH-7065-2020; Marchesini, Stefano/A-6795-2009; Boll, Rebecca/AAL-8222-2020; Rocha Neves Couto Maia, Filipe/C-3146-2014	Tanyag, Rico Mayro P/0000-0002-2874-199X; Rudek, Benedikt/0000-0002-6404-4294; Bozek, John D/0000-0001-7486-7238; Neumark, Daniel M/0000-0002-3762-9473; Poon, Billy/0000-0001-9633-6067; Seifrid, Martin/0000-0001-5238-0058; Rudenko, Artem/0000-0002-9154-8463; Marchesini, Stefano/0000-0002-6798-2913; Boll, Rebecca/0000-0001-6286-4064; Cryan, James/0000-0002-7776-0919; Chen, Gang/0000-0001-8112-3579; Rocha Neves Couto Maia, Filipe/0000-0002-2141-438X; Erk, Benjamin/0000-0001-8413-3588; Hexemer, Alexander/0000-0002-5269-0125; Epp, Sascha/0000-0001-6366-9113; Jones, Curtis/0000-0002-6008-4408	NSF [CHE-1112391]; U.S. Department of Energy (DOE), Office of Basic Energy Sciences (OBES), Chemical Sciences, Geosciences and Biosciences Division [DE-AC02-05CH11231]; Max Planck Society; U.S. DOE OBES [L549]; Office of the Secretary of Defense, National Security Science and Engineering Faculty Fellowship; PULSE Institute at SLAC National Accelerator Laboratory - U.S. DOE OBES [DE-AC02-76SF00515]; USC; Center for Applied Mathematics for Energy Research Applications (CAMERA); NSF; USC Dornsife College of Letters, Arts and Sciences; Alexander von Humboldt Foundation; Division Of Chemistry [1112391] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE), Office of Basic Energy Sciences (OBES), Chemical Sciences, Geosciences and Biosciences Division(United States Department of Energy (DOE)); Max Planck Society(Max Planck SocietyFoundation CELLEX); U.S. DOE OBES(United States Department of Energy (DOE)); Office of the Secretary of Defense, National Security Science and Engineering Faculty Fellowship; PULSE Institute at SLAC National Accelerator Laboratory - U.S. DOE OBES; USC; Center for Applied Mathematics for Energy Research Applications (CAMERA); NSF(National Science Foundation (NSF)); USC Dornsife College of Letters, Arts and Sciences; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by NSF grant CHE-1112391 (A. F. V.) at USC; the U.S. Department of Energy (DOE), Office of Basic Energy Sciences (OBES), Chemical Sciences, Geosciences and Biosciences Division through contract no. DE-AC02-05CH11231; and the Max Planck Society by funding the development and operation of the CFEL Advanced Study Group (ASG) Multi-Purpose (CAMP) instrument. Portions of this research were carried out at the LCLS, a national user facility operated by Stanford University on behalf of the U.S. DOE OBES under beam-time grant L549: Imaging of quantum vortices in superfluid helium droplets. S. R. L. and J. P. acknowledge support from the Office of the Secretary of Defense, National Security Science and Engineering Faculty Fellowship. C. B. was partially supported through the PULSE Institute at SLAC National Accelerator Laboratory funded by the U.S. DOE OBES under contract no. DE-AC02-76SF00515. J. K. was supported by the USC Undergraduate Research Associates Program. S. M. was supported by the Center for Applied Mathematics for Energy Research Applications (CAMERA). A. R. was supported by the NSF. M. Seifrid was supported by the USC Dornsife College of Letters, Arts and Sciences Student Opportunities for Academic Research and Summer Undergraduate Research Fund fellowships. K. R. S. was supported by the Alexander von Humboldt Foundation.	Abo-Shaeer JR, 2001, SCIENCE, V292, P476, DOI 10.1126/science.1060182; Allen JF, 1938, NATURE, V141, P75, DOI 10.1038/141075a0; [Anonymous], 1990, SUPERFLUIDITY SUPERC; Barranco M, 2006, J LOW TEMP PHYS, V142, P1, DOI 10.1007/s10702-005-0267-x; BAUER GH, 1995, J LOW TEMP PHYS, V98, P47, DOI 10.1007/BF00754067; Bewley GP, 2006, NATURE, V441, P588, DOI 10.1038/441588a; Bostedt C, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/16/164003; BROWN RA, 1980, P ROY SOC LOND A MAT, V371, P331, DOI 10.1098/rspa.1980.0084; CHANDRAS.S, 1965, PROC R SOC LON SER-A, V286, P1, DOI 10.1098/rspa.1965.0127; Donnelly R. J., 1991, CAMBRIDGE STUDIES LO; Fetter AL, 2009, REV MOD PHYS, V81, P647, DOI 10.1103/RevModPhys.81.647; Feynman R. P., 1955, PROGR LOW TEMPERATUR, V1, P1; Finne AP, 2003, NATURE, V424, P1022, DOI 10.1038/nature01880; Gomez LF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155302; Gomez LF, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3650235; Gorkhover T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.245005; Grebenev S, 1998, SCIENCE, V279, P2083, DOI 10.1126/science.279.5359.2083; Hill RJA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.234501; Kapitza P, 1938, NATURE, V141, P74, DOI 10.1038/141074a0; Landau L. D., 1941, J PHYS, V5, P185; Lehmann KK, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.224520; Pitaevskii L P, 2003, INT SERIES MONOGRAPH, V116; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; Toennies JP, 2004, ANGEW CHEM INT EDIT, V43, P2622, DOI 10.1002/anie.200300611; Walmsley PM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.265302; Weilert MA, 1997, J LOW TEMP PHYS, V106, P101, DOI 10.1007/BF02403919; YARMCHUK EJ, 1979, PHYS REV LETT, V43, P214, DOI 10.1103/PhysRevLett.43.214	27	163	163	2	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					906	909		10.1126/science.1252395	http://dx.doi.org/10.1126/science.1252395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146284	Green Published, Green Submitted			2022-12-28	WOS:000340524700039
J	Fischer, WA; Hynes, NA; Perl, TM				Fischer, William A., II; Hynes, Noreen A.; Perl, Trish M.			Protecting Health Care Workers From Ebola: Personal Protective Equipment Is Critical but Is Not Enough	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27599 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Hlth Syst, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Fischer, WA (corresponding author), Univ N Carolina, Chapel Hill Sch Med, Div Pulm & Crit Care Med, Dept Med,Ctr Environm Med Asthma & Lung Biol, 104 Mason Farm Rd, Chapel Hill, NC 27599 USA.	William_Fischer@med.unc.edu	Hynes, Noreen/AAA-2550-2020					[Anonymous], 2014, EB VIR DIS UPD W AFR; Hinshaw D., 2014, WALL STREET J; Khan AS, 1999, J INFECT DIS S1, V179, pS76, DOI DOI 10.1086/514306; The World Bank, 2013, GNI PER CAP RANK ATL; World Bank, 2010, PHYS PER 1000 PEOPL; World Health Organization (WHO), 2014, BARR RAP CONT EB OUT	6	68	70	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					753	U209		10.7326/M14-1953	http://dx.doi.org/10.7326/M14-1953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25155746				2022-12-28	WOS:000347245600037
J	Sofikitis, D; Bougas, L; Katsoprinakis, GE; Spiliotis, AK; Loppinet, B; Rakitzis, TP				Sofikitis, Dimitris; Bougas, Lykourgos; Katsoprinakis, Georgios E.; Spiliotis, Alexandros K.; Loppinet, Benoit; Rakitzis, T. Peter			Evanescent-wave and ambient chiral sensing by signal-reversing cavity ringdown polarimetry	NATURE			English	Article							OPTICAL-ACTIVITY; MOLECULES	Detecting and quantifying chirality is important in fields ranging from analytical and biological chemistry to pharmacology(1) and fundamental physics(2): it can aid drug design and synthesis, contribute to protein structure determination, and help detect parity violation of the weak force. Recent developments employ microwaves(3), femto-second pulses(4), superchiral light(5) or photoionization(6) to determine chirality, yet the most widely used methods remain the traditional methods of measuring circular dichroism and optical rotation. However, these signals are typically very weak against larger time-dependent backgrounds(7). Cavity-enhanced optical methods can be used to amplify weak signals by passing them repeatedly through anoptical cavity, and two-mirror cavities achieving up to 10(5) cavity passes have enabled absorption and birefringence measurements with record sensitivities(8-10). But chiral signals cancel when passing back and forth through a cavity, while the ubiquitous spurious linear birefringence background is enhanced. Even when intracavity optics overcome these problems(11-15), absolute chirality measurements remain difficult and sometimes impossible. Here we use a pulsed-laser bowtie cavity ringdown polarimeter with counter-propagating beams(16,17) to enhance chiral signals by a factor equal to the number of cavity passes (typically > 10(3)); to suppress the effects of linear birefringence by means of a large induced intracavity Faraday rotation; and to effect rapid signal reversals by reversing the Faraday rotation and subtracting signals from the counter-propagating beams. These features allow absolute chiral signal measurements in environments where background subtraction is not feasible: we determine optical rotation from a-pinene vapour in open air, and from maltodextrin and fructose solutions in the evanescent wave produced by total internal reflection at a prism surface. The limits of the present polarimeter, when using a continuous-wave laser locked to a stable, high-finesse cavity, should match the sensitivity of linear birefringence measurements(8) (3 x 10(-13) radians), which is several orders of magnitude more sensitive than current chiral detection limits(7,14,15) and is expected to transform chiral sensing in many fields.	[Sofikitis, Dimitris; Bougas, Lykourgos; Katsoprinakis, Georgios E.; Spiliotis, Alexandros K.; Loppinet, Benoit; Rakitzis, T. Peter] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion 71110, Greece; [Sofikitis, Dimitris; Bougas, Lykourgos; Katsoprinakis, Georgios E.; Spiliotis, Alexandros K.; Rakitzis, T. Peter] Univ Crete, Dept Phys, Iraklion 71003, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Rakitzis, TP (corresponding author), Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion 71110, Greece.	ptr@iesl.forth.gr	Spiliotis, Alexandros K./G-7896-2016; Loppinet, Benoit/A-1749-2018; Rakitzis, T. Peter/C-5564-2011; Rakitzis, Peter/ABA-1640-2021; Sofikitis, Dimitrios/F-9620-2010	Loppinet, Benoit/0000-0003-1855-7619; Rakitzis, T. Peter/0000-0002-0385-3936; Sofikitis, Dimitrios/0000-0002-3451-9260; K. Spiliotis, Alexandros/0000-0003-4051-4439	ERC grant TRICEPS [207542]; FP7 IAPP Programme SOFORT [PIAPGA-2009-251598]; FP7 Infrastructure programme ESMI [CPCSA-2010-262348]	ERC grant TRICEPS; FP7 IAPP Programme SOFORT; FP7 Infrastructure programme ESMI	This research was supported by the ERC grant TRICEPS (grant no. 207542), and the FP7 IAPP Programme SOFORT (PIAPGA-2009-251598). B. L. acknowledges the FP7 Infrastructure programme ESMI (CP&CSA-2010-262348) for partial support. We thank P. Tzallas for access to the Attosecond labs at IESL-FORTH.	Berden G, 2000, INT REV PHYS CHEM, V19, P565, DOI 10.1080/014423500750040627; Berova N., 2012, COMPREHENSIVE CHIROP, V1; Bouchiat MA, 1997, REP PROG PHYS, V60, P1351, DOI 10.1088/0034-4885/60/11/004; Bougas B., 2014, PHYS REV A, V89; Bougas L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210801; Busch K. W., 2006, CHIRAL ANALYSIS; Condon EU, 1937, REV MOD PHYS, V9, P0432, DOI 10.1103/RevModPhys.9.432; Durand M, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031803; Emile J, 2013, J COLLOID INTERF SCI, V408, P113, DOI 10.1016/j.jcis.2013.07.030; Engeln R, 1998, REV SCI INSTRUM, V69, P3763, DOI 10.1063/1.1149176; EVTUHOV V, 1965, APPL OPTICS, V4, P142, DOI 10.1364/AO.4.000142; GOOS F, 1947, ANN PHYS-BERLIN, V1, P333, DOI 10.1002/andp.19474360704; Janssen MHM, 2014, PHYS CHEM CHEM PHYS, V16, P856, DOI 10.1039/c3cp53741b; KASTLER A, 1970, CR ACAD SCI B PHYS, V271, P999; Lekner J., 1996, Pure and Applied Optics, V5, P417, DOI 10.1088/0963-9659/5/4/008; Muller T, 2000, J PHYS CHEM A, V104, P5959, DOI 10.1021/jp000705n; Patterson D, 2013, NATURE, V497, P475, DOI 10.1038/nature12150; Poirson J, 1998, ANAL CHEM, V70, P4636, DOI 10.1021/ac980286e; Rhee HJ, 2009, NATURE, V458, P310, DOI 10.1038/nature07846; SILVERMAN MP, 1986, J OPT SOC AM A, V3, P830, DOI 10.1364/JOSAA.3.000830; Tang YQ, 2011, SCIENCE, V332, P333, DOI 10.1126/science.1202817; Wilson SM, 2005, J PHYS CHEM A, V109, P11752, DOI 10.1021/jp054283z; Woody R.W., 2012, COMPREHENSIVE CHIROP, V2	23	87	89	3	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					76	+		10.1038/nature13680	http://dx.doi.org/10.1038/nature13680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25209661	Green Submitted			2022-12-28	WOS:000342420800038
J	Linos, E; Schroeder, SA; Chren, MM				Linos, Eleni; Schroeder, Steven A.; Chren, Mary-Margaret			Potential Overdiagnosis of Basal Cell Carcinoma in Older Patients With Limited Life Expectancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONMELANOMA-SKIN-CANCER		[Linos, Eleni; Chren, Mary-Margaret] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chren, Mary-Margaret] San Francisco VA Med Ctr, Dermatol Serv, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Linos, E (corresponding author), Univ Calif San Francisco, Dept Dermatol, 2340 Sutter St,Room N421, San Francisco, CA 94143 USA.	linose@derm.ucsf.edu		, Eleni/0000-0003-2538-0700; Linos, Eleni/0000-0002-5856-6301	NCATS NIH HHS [KL2 TR000143] Funding Source: Medline; NIAMS NIH HHS [K24 AR052667] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR052667] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		American Cancer Society, SKIN CANC BAS SQUAM; American Cancer Society, 2014, CANC FACTS FIG 2014; Institute of Medicine, 2013, DEL HIGH QUAL CANC C; Linos E, 2013, JAMA INTERN MED, V173, P1249, DOI 10.1001/jamainternmed.2013.1040; Linos E, 2013, JAMA INTERN MED, V173, P1006, DOI 10.1001/jamainternmed.2013.639; Rieger KE, 2010, J CUTAN PATHOL, V37, P59, DOI 10.1111/j.1600-0560.2009.01340.x; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Viola KV, 2012, ARCH DERMATOL, V148, P473, DOI 10.1001/archdermatol.2011.2456	8	30	31	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					997	998		10.1001/jama.2014.9655	http://dx.doi.org/10.1001/jama.2014.9655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203077				2022-12-28	WOS:000341385600013
J	Gludovatz, B; Hohenwarter, A; Catoor, D; Chang, EH; George, EP; Ritchie, RO				Gludovatz, Bernd; Hohenwarter, Anton; Catoor, Dhiraj; Chang, Edwin H.; George, Easo P.; Ritchie, Robert O.			A fracture-resistant high-entropy alloy for cryogenic applications	SCIENCE			English	Article							AUSTENITIC STAINLESS-STEELS; TRIP/TWIP STEELS; TOUGHNESS; STRENGTH; CRACK; DUCTILE; STRESS; INITIATION; GROWTH	High-entropy alloys are equiatomic, multi-element systems that can crystallize as a single phase, despite containing multiple elements with different crystal structures. A rationale for this is that the configurational entropy contribution to the total free energy in alloys with five or more major elements may stabilize the solid-solution state relative to multiphase microstructures. We examined a five-element high-entropy alloy, CrMnFeCoNi, which forms a single-phase face-centered cubic solid solution, and found it to have exceptional damage tolerance with tensile strengths above 1 GPa and fracture toughness values exceeding 200 MPa.m(1/2). Furthermore, its mechanical properties actually improve at cryogenic temperatures; we attribute this to a transition from planar-slip dislocation activity at room temperature to deformation by mechanical nanotwinning with decreasing temperature, which results in continuous steady strain hardening.	[Gludovatz, Bernd; Chang, Edwin H.; Ritchie, Robert O.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Hohenwarter, Anton] Univ Leoben, Dept Mat Phys, A-8700 Leoben, Austria; [Hohenwarter, Anton] Austrian Acad Sci, Erich Schmid Inst Mat Sci, A-8700 Leoben, Austria; [Catoor, Dhiraj; George, Easo P.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [George, Easo P.] Univ Tennessee, Mat Sci & Engn Dept, Knoxville, TN 37996 USA; [Ritchie, Robert O.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Leoben; Austrian Academy of Sciences; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Berkeley	George, EP (corresponding author), Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA.	georgeep@ornl.gov; roritchie@lbl.gov	Gludovatz, Bernd/O-2121-2014; Ritchie, Robert O/A-8066-2008; George, Easo P/L-5434-2014; Hohenwarter, Anton/G-7059-2016	Gludovatz, Bernd/0000-0002-2420-3879; Ritchie, Robert O/0000-0002-0501-6998; George, Easo P/0000-0001-9898-9694; Hohenwarter, Anton/0000-0001-9827-9828	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	Sponsored by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division. All data presented in this article can additionally be found in the supplementary materials. Author contributions: E. P. G. and R.O.R. had full access to the experimental results in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The alloys were processed by D. C. and mechanically characterized by B. G., A. H., and D. C. Study design, interpretation and analysis of data, and preparation of the manuscript were performed jointly by B. G., A. H., D. C., E. H. C., E. P. G., and R.O.R. The authors declare no conflict of interest.	Ashby M.F., 2011, MAT SELECTION MECH D, P31; Cantor B, 2004, MAT SCI ENG A-STRUCT, V375, P213, DOI 10.1016/j.msea.2003.10.257; Chen LQ, 2013, ACTA METALL SIN-ENGL, V26, P1, DOI 10.1007/s40195-012-0501-x; COTTERELL B, 1980, INT J FRACTURE, V16, P155, DOI 10.1007/BF00012619; Dao M, 2006, ACTA MATER, V54, P5421, DOI 10.1016/j.actamat.2006.06.062; Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]; Demetriou MD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3184792; E08 Committee, 2013, E182013 E08 COMM AST; Frommeyer G, 2003, ISIJ INT, V43, P438, DOI 10.2355/isijinternational.43.438; Gali A, 2013, INTERMETALLICS, V39, P74, DOI 10.1016/j.intermet.2013.03.018; GEROLD V, 1989, ACTA METALL MATER, V37, P2177, DOI 10.1016/0001-6160(89)90143-0; Gilbert CJ, 1997, APPL PHYS LETT, V71, P476, DOI 10.1063/1.119610; Grassel O, 2000, INT J PLASTICITY, V16, P1391, DOI 10.1016/S0749-6419(00)00015-2; Hadfield R. A., 1888, SCIENCE, V12, P284; Hsu CY, 2004, METALL MATER TRANS A, V35A, P1465, DOI 10.1007/s11661-004-0254-x; HUTCHINSON JW, 1968, J MECH PHYS SOLIDS, V16, P13, DOI 10.1016/0022-5096(68)90014-8; Kawashima A, 2005, MATER TRANS, V46, P1725, DOI 10.2320/matertrans.46.1725; KIM TW, 1993, MAT SCI ENG A-STRUCT, V160, pL13, DOI 10.1016/0921-5093(93)90463-O; Liu WH, 2013, SCRIPTA MATER, V68, P526, DOI 10.1016/j.scriptamat.2012.12.002; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; MACKENZIE AC, 1977, ENG FRACT MECH, V9, P167, DOI 10.1016/0013-7944(77)90062-5; Maynard J, 1996, PHYS TODAY, V49, P26, DOI 10.1063/1.881483; Mills WJ, 1997, INT MATER REV, V42, P45, DOI 10.1179/095066097790326010; NEUHAUSER H, 1975, ACTA METALL MATER, V23, P455, DOI 10.1016/0001-6160(75)90084-X; Nouri AS, 2008, PHIL MAG LETT, V88, P853, DOI 10.1080/09500830802438131; Otto F, 2013, ACTA MATER, V61, P5743, DOI 10.1016/j.actamat.2013.06.018; Otto F, 2013, ACTA MATER, V61, P2628, DOI 10.1016/j.actamat.2013.01.042; PENSE AW, 1975, WELD RES COUNC BULL, P1; READ DT, 1981, CRYOGENICS, V21, P415, DOI 10.1016/0011-2275(81)90175-2; REMY L, 1977, MATER SCI ENG, V28, P99, DOI 10.1016/0025-5416(77)90093-3; RICE JR, 1968, J MECH PHYS SOLIDS, V16, P1, DOI 10.1016/0022-5096(68)90013-6; RICE JR, 1969, J MECH PHYS SOLIDS, V17, P201, DOI 10.1016/0022-5096(69)90033-7; RITCHIE RO, 1979, METALL TRANS A, V10, P1557, DOI 10.1007/BF02812022; RITCHIE RO, 1985, METALL TRANS A, V16, P233, DOI 10.1007/BF02816050; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Sa J.W., 2005, 21 IEEE NPS S FUS EN, P1; Schumann V. H., 1972, NEUE HUTTE, V17, P605; Senkov ON, 2011, INTERMETALLICS, V19, P698, DOI 10.1016/j.intermet.2011.01.004; SHIH CF, 1981, J MECH PHYS SOLIDS, V29, P305, DOI 10.1016/0022-5096(81)90003-X; Shindo Y, 2003, SCI TECHNOL ADV MAT, V4, DOI 10.1016/S1468-6996(03)00063-9; Singh A, 2011, ACTA MATER, V59, P2437, DOI 10.1016/j.actamat.2010.12.043; Sokolov MA, 2001, AM SOC TEST MATER, V1045, P125, DOI 10.1520/STP10530S; Stampfl J, 1996, APPL PHYS A-MATER, V63, P341, DOI 10.1007/BF01567324; Stampfl J, 1996, INT J FRACTURE, V78, P35, DOI 10.1007/BF00018499; Stout R.D., 1986, ADV CRYOGEN ENG, P389, DOI [10.1007/978-1-4613-9871-4_47f, DOI 10.1007/978-1-4613-9871-4_47F]; STRIFE JR, 1980, METALL TRANS A, V11, P1341, DOI 10.1007/BF02653488; SYN CK, 1976, METALL TRANS A, V7, P1827, DOI 10.1007/BF02654977; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567	50	2978	3107	205	2742	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1153	1158		10.1126/science.1254581	http://dx.doi.org/10.1126/science.1254581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190791	Green Published			2022-12-28	WOS:000341179800040
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Renewing the call for clinical ethicists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												daniel.sokol@talk21.com						Francis R., 2013, REPORT MIDSTAFFORDSH, V3, P1593; McLean SAM, 2009, DIAMETROS, V22, P76; Murgatroyd G., 2013, LEGAL WEEK      0531; Sokol DK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4179; Sokol DK, 2005, BRIT MED J, V330, P741, DOI 10.1136/bmj.330.7494.741; The Press Association, 2014, HLTH SERVICE J; Whitehead JM, 2009, POSTGRAD MED J, V85, P451, DOI 10.1136/pgmj.2008.075879	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2014	349								g5342	10.1136/bmj.g5342	http://dx.doi.org/10.1136/bmj.g5342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MS	25193940				2022-12-28	WOS:000341389600002
J	Kandel, ER; Kandel, DB				Kandel, Eric R.; Kandel, Denise B.			A Molecular Basis for Nicotine as a Gateway Drug	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG ADULTHOOD; E-CIGARETTES; COCAINE; ADOLESCENCE; FOSB; ADDICTION; ALCOHOL; RISK; INVOLVEMENT; MECHANISMS		[Kandel, Eric R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Kandel, Eric R.; Kandel, Denise B.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Kandel, Denise B.] Columbia Univ, Coll Phys & Surg, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Kandel, Denise B.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Kandel, ER (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	erk5@columbia.edu			Howard Hughes Medical Institute; National Institutes of Health [R01 DA024001]; National Institute on Drug Abuse [K5 DA00081]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024001, K05DA000081] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from the Howard Hughes Medical Institute (to Dr. E. Kandel) and the National Institutes of Health (R01 DA024001, to Drs. E. Kandel and D. Kandel) and the National Institute on Drug Abuse (K5 DA00081, to Dr. E. Kandel).	Alibhai IN, 2007, BRAIN RES, V1143, P22, DOI 10.1016/j.brainres.2007.01.069; Caponnetto P, 2012, EXPERT REV RESP MED, V6, P63, DOI [10.1586/ers.11.92, 10.1586/ERS.11.92]; Colby CR, 2003, J NEUROSCI, V23, P2488; Degenhardt L, 2010, DRUG ALCOHOL DEPEN, V108, P84, DOI 10.1016/j.drugalcdep.2009.12.001; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; Huang YY, 2014, LEARN MEMORY, V21, P153, DOI 10.1101/lm.032292.113; Huang YY, 2013, NEUROPHARMACOLOGY, V74, P126, DOI 10.1016/j.neuropharm.2013.03.031; Huizink AC, 2010, J STUD ALCOHOL DRUGS, V71, P5, DOI 10.15288/jsad.2010.71.5; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; KANDEL D, 1975, SCIENCE, V190, P912, DOI 10.1126/science.1188374; KANDEL DB, 1992, J STUD ALCOHOL, V53, P447, DOI 10.15288/jsa.1992.53.447; KANDEL DB, 1984, AM J PUBLIC HEALTH, V74, P660, DOI 10.2105/AJPH.74.7.660; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kendler KS, 2007, ARCH GEN PSYCHIAT, V64, P1313, DOI 10.1001/archpsyc.64.11.1313; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; McQuown SC, 2007, NEUROTOXICOL TERATOL, V29, P66, DOI 10.1016/j.ntt.2006.10.012; McQuown SC, 2009, PSYCHOPHARMACOLOGY, V207, P143, DOI 10.1007/s00213-009-1642-0; Nestler EJ, 2004, SCI AM, V290, P78, DOI 10.1038/scientificamerican0304-78; Palmer RHC, 2009, DRUG ALCOHOL DEPEN, V102, P78, DOI 10.1016/j.drugalcdep.2009.01.012; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Rhee SH, 2003, ARCH GEN PSYCHIAT, V60, P1256, DOI 10.1001/archpsyc.60.12.1256; Stanbrook MB, 2013, CAN MED ASSOC J, V185, P1379, DOI 10.1503/cmaj.131469; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Vanyukov MM, 2012, DRUG ALCOHOL DEPEN, V123, pS3, DOI 10.1016/j.drugalcdep.2011.12.018; Wagner FA, 2002, AM J EPIDEMIOL, V155, P918, DOI 10.1093/aje/155.10.918; Wikler A, 1961, BRIT J ADDICT, V57, P73	30	174	178	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					932	943		10.1056/NEJMsa1405092	http://dx.doi.org/10.1056/NEJMsa1405092			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184865	Green Accepted			2022-12-28	WOS:000341390600010
J	Ikramuddin, S; Blackstone, RP; Brancatisano, A; Toouli, J; Shah, SN; Wolfe, BM; Fujioka, K; Maher, JW; Swain, J; Que, FG; Morton, JM; Leslie, DB; Brancatisano, R; Kow, L; O'Rourke, RW; Deveney, C; Takata, M; Miller, CJ; Knudson, MB; Tweden, KS; Shikora, SA; Sarr, MG; Billington, CJ				Ikramuddin, Sayeed; Blackstone, Robin P.; Brancatisano, Anthony; Toouli, James; Shah, Sajani N.; Wolfe, Bruce M.; Fujioka, Ken; Maher, James W.; Swain, James; Que, Florencia G.; Morton, John M.; Leslie, Daniel B.; Brancatisano, Roy; Kow, Lilian; O'Rourke, Robert W.; Deveney, Clifford; Takata, Mark; Miller, Christopher J.; Knudson, Mark B.; Tweden, Katherine S.; Shikora, Scott A.; Sarr, Michael G.; Billington, Charles J.			Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity The ReCharge Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; SURGERY; SHAM; VERTEBROPLASTY	IMPORTANCE Although conventional bariatric surgery results in weight loss, it does so with potential short-term and long-term morbidity. OBJECTIVE To evaluate the effectiveness and safety of intermittent, reversible vagal nerve blockade therapy for obesity treatment. DESIGN, SETTING, AND PARTICIPANTS A randomized, double-blind, sham-controlled clinical trial involving 239 participants who had a body mass index of 40 to 45 or 35 to 40 and 1 or more obesity-related condition was conducted at 10 sites in the United States and Australia between May and December 2011. The 12-month blinded portion of the 5-year study was completed in January 2013. INTERVENTIONS One hundred sixty-two patients received an active vagal nerve block device and 77 received a sham device. All participants received weight management education. MAIN OUTCOMES AND MEASURES The coprimary efficacy objectives were to determine whether the vagal nerve block was superior in mean percentage excess weight loss to sham by a 10-point margin with at least 55% of patients in the vagal block group achieving a 20% loss and 45% achieving a 25% loss. The primary safety objective was to determine whether the rate of serious adverse events related to device, procedure, or therapy in the vagal block group was less than 15%. RESULTS In the intent-to-treat analysis, the vagal nerve block group had a mean 24.4% excess weight loss (9.2% of their initial body weight loss) vs 15.9% excess weight loss (6.0% initial body weight loss) in the sham group. The mean difference in the percentage of the excess weight loss between groups was 8.5 percentage points (95% CI, 3.1-13.9), which did not meet the 10-point target (P = .71), although weight loss was statistically greater in the vagal nerve block group (P = .002 for treatment difference in a post hoc analysis). At 12 months, 52% of patients in the vagal nerve block group achieved 20% or more excess weight loss and 38% achieved 25% or more excess weight loss vs 32% in the sham group who achieved 20% or more loss and 23% who achieved 25% or more loss. The device, procedure, or therapy-related serious adverse event rate in the vagal nerve block group was 3.7%(95% CI, 1.4%-7.9%), significantly lower than the 15% goal. The adverse events more frequent in the vagal nerve block group were heartburn or dyspepsia and abdominal pain attributed to therapy; all were reported as mild or moderate in severity. CONCLUSION AND RELEVANCE Among patients with morbid obesity, the use of vagal nerve block therapy compared with a sham control device did not meet either of the prespecified coprimary efficacy objectives, although weight loss in the vagal block group was statistically greater than in the sham device group. The treatment was well tolerated, having met the primary safety objective.	[Ikramuddin, Sayeed; Leslie, Daniel B.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Blackstone, Robin P.; Swain, James; Billington, Charles J.] Univ Minnesota, Minneapolis, MN USA; [Blackstone, Robin P.; Swain, James] Scottsdale Healthcare Bariatr Ctr, Scottsdale, AZ USA; [Brancatisano, Anthony; Brancatisano, Roy] Inst Weight Control, Sydney, NSW, Australia; [Toouli, James; Kow, Lilian] Adelaide Bariatr Ctr, Adelaide, SA, Australia; [Shah, Sajani N.] Tufts Med Ctr, Dept Surg, Boston, MA USA; [Wolfe, Bruce M.; Deveney, Clifford] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Fujioka, Ken; Takata, Mark] Scripps Clin, San Diego, CA USA; [Maher, James W.] Virginia Commonwealth Univ, Div Gen Surg, Richmond, VA 23284 USA; [Que, Florencia G.; Sarr, Michael G.] Mayo Clin Rochester, Dept Gastroenterol & Gen Surg, Rochester, MN USA; [Morton, John M.] Stanford Univ, Sch Med, Div Gen Surg, Stanford, CA 94305 USA; [O'Rourke, Robert W.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [O'Rourke, Robert W.] Ann Arbor VA Hosp, Ann Arbor, MI USA; [Miller, Christopher J.] North Amer Sci Associates, Minneapolis, MN USA; [Knudson, Mark B.; Tweden, Katherine S.; Shikora, Scott A.] EnteroMedics Inc, St Paul, MN USA; [Shikora, Scott A.] Brigham & Womens Hosp, Div Gen & Gastrointestinal Surg, Boston, MA 02115 USA; [Billington, Charles J.] Minneapolis VA Med Ctr, Div Endocrinol & Diabet, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Tufts Medical Center; Oregon Health & Science University; Scripps Research Institute; Virginia Commonwealth University; Mayo Clinic; Stanford University; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Billington, CJ (corresponding author), Minneapolis VA Med Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	billi005@umn.edu		O'Rourke, Robert/0000-0002-4038-4198	EnteroMedics Inc, St Paul, Minnesota; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097449] Funding Source: NIH RePORTER	EnteroMedics Inc, St Paul, Minnesota; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The ReCharge Study was supported by EnteroMedics Inc, St Paul, Minnesota.	Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Apovian CM, 2013, OBESITY, V21, P935, DOI 10.1002/oby.20309; Berthoud HR, 2008, NEUROGASTROENT MOTIL, V20, P64, DOI 10.1111/j.1365-2982.2008.01104.x; Birch S, 2006, J ALTERN COMPLEM MED, V12, P303, DOI 10.1089/acm.2006.12.303; Bray GA, 2011, MED CLIN N AM, V95, P989, DOI 10.1016/j.mcna.2011.06.009; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Camilleri M, 2008, SURGERY, V143, P723, DOI 10.1016/j.surg.2008.03.015; Cobourn C, 2013, J AM COLL SURGEONS, V217, P907, DOI 10.1016/j.jamcollsurg.2013.06.010; Cunneen SA, 2012, SURG OBES RELAT DIS, V8, P288, DOI 10.1016/j.soard.2011.05.004; Hamdan K, 2011, BRIT J SURG, V98, P1345, DOI 10.1002/bjs.7568; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Miller FG, 2012, PROG CARDIOVASC DIS, V55, P246, DOI 10.1016/j.pcad.2012.09.002; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Phillips E, 2009, SURG OBES RELAT DIS, V5, P588, DOI 10.1016/j.soard.2008.12.007; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Shikora S, 2013, J OBES, V2013, DOI 10.1155/2013/245683; Shikora SA, 2009, SURG OBES RELAT DIS, V5, P31, DOI 10.1016/j.soard.2008.09.012; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	22	136	141	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					915	922		10.1001/jama.2014.10540	http://dx.doi.org/10.1001/jama.2014.10540			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182100	Bronze			2022-12-28	WOS:000341668600020
J	Mozaffarian, D; Rogoff, KS; Ludwig, DS				Mozaffarian, Dariush; Rogoff, Kenneth S.; Ludwig, David S.			The Real Cost of Food Can Taxes and Subsidies Improve Public Health?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BURDEN; DIET		[Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Rogoff, Kenneth S.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA USA	Tufts University; Harvard University; Harvard University; Boston Children's Hospital	Mozaffarian, D (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	dariush.mozaffarian@tufts.edu	Mozaffarian, Dariush/ABC-2822-2020; Rogoff, Kenneth/G-1894-2018	Ludwig, David/0000-0003-3307-8544	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730, P30DK040561] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL115189] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561, K24 DK082730, K24DK082730] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ludwig DS, 2014, JAMA-J AM MED ASSOC, V311, P2167, DOI 10.1001/jama.2014.4133; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; Mozaffarian D, 2012, BRAUNWALDS HEART DIS; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Pomeranz Jennifer L., 2013, U MICH J LAW REFORM, V46, P1007; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277	10	28	28	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					889	890		10.1001/jama.2014.8232	http://dx.doi.org/10.1001/jama.2014.8232			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182094	Green Accepted			2022-12-28	WOS:000341668600013
J	Holmes, D				Holmes, David			Profile Yan Guo: shaping China's public health policy	LANCET			English	Biographical-Item																			0	0	0	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					737	737		10.1016/S0140-6736(14)61426-4	http://dx.doi.org/10.1016/S0140-6736(14)61426-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	25176537				2022-12-28	WOS:000341361500018
J	DeSimone, DW; Horwitz, AR				DeSimone, Douglas W.; Horwitz, A. Rick			Many modes of motility	SCIENCE			English	Editorial Material							CELL-MIGRATION; PLASTICITY		[DeSimone, Douglas W.; Horwitz, A. Rick] Univ Virginia Sch Med, Dept Cell Biol, Charlottesville, VA 22903 USA	University of Virginia	DeSimone, DW (corresponding author), Univ Virginia Sch Med, Dept Cell Biol, Charlottesville, VA 22903 USA.	desimone@virginia.edu; horwitz@virginia.edu	DeSimone, Douglas/A-3351-2012	DeSimone, Douglas/0000-0003-1926-1588	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071136] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094793] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD026402, R21 HD071136] Funding Source: Medline; NIGMS NIH HHS [R01 GM094793] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Kubow KE, 2013, CURR BIOL, V23, P1607, DOI 10.1016/j.cub.2013.06.053; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083	11	11	11	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1002	U226		10.1126/science.1259176	http://dx.doi.org/10.1126/science.1259176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170137				2022-12-28	WOS:000340870900017
J	Mishra, J				Mishra, Jyoti			Having it all	SCIENCE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mishra, J (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.		Mishra, Jyoti/AAM-3589-2021	Mishra, Jyoti/0000-0001-6612-4557					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1090	1090		10.1126/science.345.6200.1090	http://dx.doi.org/10.1126/science.345.6200.1090			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170158				2022-12-28	WOS:000340870900047
J	Neumann, PJ; Cohen, JT; Weinstein, MC				Neumann, Peter J.; Cohen, Joshua T.; Weinstein, Milton C.			Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADJUSTED LIFE-YEAR; PAY		[Neumann, Peter J.; Cohen, Joshua T.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Tufts Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Neumann, PJ (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA.			Cohen, Joshua/0000-0003-1737-0991				Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Weinstein MC, 2008, MED CARE, V46, P343, DOI 10.1097/MLR.0b013e31816a7144; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104	5	1357	1361	4	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					796	797		10.1056/NEJMp1405158	http://dx.doi.org/10.1056/NEJMp1405158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25162885				2022-12-28	WOS:000340819800005
J	Sahai, I; Mochida, GH; Grabowski, EF; Caruso, PA				Sahai, Inderneel; Mochida, Ganeshwaran H.; Grabowski, Eric F.; Caruso, Paul A.			Case 27-2014: A 10-Month-Old Boy with Microcephaly and Episodic Cyanosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THROMBOSIS; BRAIN; MR		[Sahai, Inderneel; Grabowski, Eric F.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Mochida, Ganeshwaran H.] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Sahai, Inderneel; Mochida, Ganeshwaran H.; Grabowski, Eric F.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Caruso, Paul A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sahai, I (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.			Mochida, Ganeshwaran/0000-0001-7912-4097	UCB Japan; Otsuka; Roche	UCB Japan; Otsuka(Otsuka Pharmaceutical); Roche(Roche Holding)	Dr. Mochida reports receiving lecture fees from UCB Japan and Otsuka and grant support from Roche. No other potential conflict of interest relevant to this article was reported.	Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bauman ME, 2009, THROMB HAEMOSTASIS, V101, P86, DOI 10.1160/TH08-03-0148; Beck C, 1998, J PEDIATR-US, V133, P237, DOI 10.1016/S0022-3476(98)70226-4; de Baulny HO, 1998, EUR J PEDIATR, V157, pS77, DOI 10.1007/PL00014307; de Koning TJ, 2000, NEUROPEDIATRICS, V31, P287, DOI 10.1055/s-2000-12944; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Engelbrecht V, 1997, AM J NEURORADIOL, V18, P536; Grabowski EF, 2008, P 21 INT C THROMB HA; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Prasad Asuri N., 2007, Congenital Anomalies, V47, P125, DOI 10.1111/j.1741-4520.2007.00160.x; PRESS GA, 1989, AM J NEURORADIOL, V10, P315; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003	15	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					847	858		10.1056/NEJMcpc1400833	http://dx.doi.org/10.1056/NEJMcpc1400833			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162892				2022-12-28	WOS:000340819800012
J	Shaul, YD; Freinkman, E; Comb, WC; Cantor, JR; Tam, WL; Thiru, P; Kim, D; Kanarek, N; Pacold, ME; Chen, WW; Bierie, B; Possemato, R; Reinhardt, F; Weinberg, RA; Yaffe, MB; Sabatini, DM				Shaul, Yoav D.; Freinkman, Elizaveta; Comb, William C.; Cantor, Jason R.; Tam, Wai Leong; Thiru, Prathapan; Kim, Dohoon; Kanarek, Naama; Pacold, Michael E.; Chen, Walter W.; Bierie, Brian; Possemato, Richard; Reinhardt, Ferenc; Weinberg, Robert A.; Yaffe, Michael B.; Sabatini, David M.			Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition	CELL			English	Article							CANCER-CELL METABOLISM; THYMIDINE GLYCOL; GENE; 5-FLUOROURACIL; DEHYDROGENASE; PLASTICITY; DIHYDROTHYMIDINE; DEFICIENCY; HALLMARK; RELEVANT	It is increasingly appreciated that oncogenic transformation alters cellular metabolism to facilitate cell proliferation, but less is known about the metabolic changes that promote cancer cell aggressiveness. Here, we analyzed metabolic gene expression in cancer cell lines and found that a set of high-grade carcinoma lines expressing mesenchymal markers share a unique 44 gene signature, designated the "mesenchymal metabolic signature'' (MMS). A FACS-based shRNA screen identified several MMS genes as essential for the epithelial-mesenchymal transition (EMT), but not for cell proliferation. Dihydropyrimidine dehydrogenase (DPYD), a pyrimidine-degrading enzyme, was highly expressed upon EMT induction and was necessary for cells to acquire mesenchymal characteristics in vitro and for tumorigenic cells to extravasate into the mouse lung. This role of DPYD was mediated through its catalytic activity and enzymatic products, the dihydropyrimidines. Thus, we identify metabolic processes essential for the EMT, a program associated with the acquisition of metastatic and aggressive cancer cell traits.	[Shaul, Yoav D.; Freinkman, Elizaveta; Comb, William C.; Cantor, Jason R.; Tam, Wai Leong; Thiru, Prathapan; Kim, Dohoon; Kanarek, Naama; Pacold, Michael E.; Chen, Walter W.; Bierie, Brian; Possemato, Richard; Reinhardt, Ferenc; Weinberg, Robert A.; Sabatini, David M.] Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA; [Shaul, Yoav D.; Yaffe, Michael B.; Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Weinberg, Robert A.; Yaffe, Michael B.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Pacold, Michael E.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Tam, Wai Leong] Genome Inst Singapore, Singapore 138672, Singapore	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Nine Cambridge Ctr, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Shaul, Yoav/AAY-7011-2020; Kanarek, Naama/GQB-4951-2022; Tam, Wai Leong/P-1497-2019	Tam, Wai Leong/0000-0003-2365-5264; /0000-0002-1446-7256; Kanarek, Naama/0000-0002-2068-3908; Chen, Walter/0000-0002-7752-9581	NIH [RO1 CA103866, AI047389, K99 CA168940]; Life Science Research Foundation and Ludwig Postdoctoral Fellowship; American Cancer Society fellowship [PF-12-099-01-TGB]; Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation [DRG112-12]; American Cancer Society-Ellison Foundation Postdoctoral Fellowship [PF-13-356-01-TBE]; Ruth L. Kirchstein NRSA F30 fellowship; Hope Funds for Cancer Research Fellowship [HFCR-13-03-03]; Department of Defense Breast Cancer Research Program [BC123066]; NIH grants [CA112967, ES015339]; NATIONAL CANCER INSTITUTE [P30CA014051, K99CA168940, U54CA112967, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Science Research Foundation and Ludwig Postdoctoral Fellowship; American Cancer Society fellowship(American Cancer Society); Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation; American Cancer Society-Ellison Foundation Postdoctoral Fellowship; Ruth L. Kirchstein NRSA F30 fellowship; Hope Funds for Cancer Research Fellowship; Department of Defense Breast Cancer Research Program(United States Department of Defense); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Sabatini Lab for helpful suggestions and Tom DiCesare for graphical assistance. This work was supported by grants from the NIH (RO1 CA103866 and AI047389 to D. M. S.; K99 CA168940 to R. P.), the Life Science Research Foundation and Ludwig Postdoctoral Fellowship (to Y.D.S.), the American Cancer Society fellowship (PF-12-099-01-TGB) (to J.R.C.), the Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation (DRG112-12) (to M. E. P.), American Cancer Society-Ellison Foundation Postdoctoral Fellowship (PF-13-356-01-TBE) (to W. C. C.), the Ruth L. Kirchstein NRSA F30 fellowship (to W. W. C.), and the Hope Funds for Cancer Research Fellowship (HFCR-13-03-03) and Department of Defense Breast Cancer Research Program (BC123066) (to E. F.). M.B.Y. is supported by NIH grants (CA112967 and ES015339). D. M. S. is an investigator of the Howard Hughes Medical Institute.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amstutz U, 2011, PHARMACOGENOMICS, V12, P1321, DOI [10.2217/pgs.11.72, 10.2217/PGS.11.72]; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Buchel B, 2013, BIOMED CHROMATOGR, V27, P7, DOI 10.1002/bmc.2741; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dolinnaya NG, 2013, BIOCHIMIE, V95, P134, DOI 10.1016/j.biochi.2012.09.008; Elbein SC, 2004, MOL GENET METAB, V82, P321, DOI 10.1016/j.ymgme.2004.05.004; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; IDE H, 1987, BIOCHEMISTRY-US, V26, P964, DOI 10.1021/bi00377a042; IDE H, 1988, NUCLEIC ACIDS RES, V16, P11339, DOI 10.1093/nar/16.23.11339; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Li SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070282, 10.1371/journal.pone.0070461]; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lohkamp B, 2010, BBA-PROTEINS PROTEOM, V1804, P2198, DOI 10.1016/j.bbapap.2010.08.014; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Offer SM, 2013, CANCER RES, V73, P1958, DOI 10.1158/0008-5472.CAN-12-3858; Onganer PU, 2005, BRIT J CANCER, V93, P1197, DOI 10.1038/sj.bjc.6602857; Parham D M, 2001, Am J Clin Pathol, V115 Suppl, pS113; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; van Kuilenburg ABP, 2004, HUM MOL GENET, V13, P2793, DOI 10.1093/hmg/ddh303; van Kuilenburg ABP, 2010, BBA-MOL BASIS DIS, V1802, P639, DOI 10.1016/j.bbadis.2010.03.013; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Zhang HL, 2004, J CLIN ENDOCR METAB, V89, P748, DOI 10.1210/jc.2003-031286	47	147	150	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1094	1109		10.1016/j.cell.2014.07.032	http://dx.doi.org/10.1016/j.cell.2014.07.032			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171410	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000340945000015
J	Butler, J; Braunwald, E; Gheorghiade, M				Butler, Javed; Braunwald, Eugene; Gheorghiade, Mihai			Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; HOSPITALIZATION; THERAPY; RATES		[Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Braunwald, Eugene] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA; [Gheorghiade, Mihai] Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, Chicago, IL 60611 USA	Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, 201 E Huron St,Galter 3-150, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Ambrosy AP, 2013, EUR HEART J, V34, P835, DOI 10.1093/eurheartj/ehs444; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Goldenberg I, 2014, NEW ENGL J MED, V370, P1694, DOI 10.1056/NEJMoa1401426; Schrager J, 2013, ACAD EMERG MED, V20, P554, DOI 10.1111/acem.12147; Skali H, 2014, EUR J HEART FAIL, V16, P560, DOI 10.1002/ejhf.71; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	9	50	63	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					789	790		10.1001/jama.2014.6643	http://dx.doi.org/10.1001/jama.2014.6643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157719				2022-12-28	WOS:000340788500017
J	Leuchter, RHV; Gui, L; Poncet, A; Hagmann, C; Lodygensky, GA; Martin, E; Koller, B; Darque, A; Bucher, HU; Huppi, PS				Leuchter, Russia Ha-Vinh; Gui, Laura; Poncet, Antoine; Hagmann, Cornelia; Lodygensky, Gregory Anton; Martin, Ernst; Koller, Brigitte; Darque, Alexandra; Bucher, Hans Ulrich; Hueppi, Petra Susan			Association Between Early Administration of High-Dose Erythropoietin in Preterm Infants and Brain MRI Abnormality at Term-Equivalent Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; WHITE-MATTER; NEURODEVELOPMENTAL OUTCOMES; COGNITIVE OUTCOMES; CHILDREN BORN; INJURY; ENCEPHALOPATHY; SUBPLATE; CELLS	IMPORTANCE Premature infants are at risk of developing encephalopathy of prematurity, which is associated with long-term neurodevelopmental delay. Erythropoietin was shown to be neuroprotective in experimental and retrospective clinical studies. OBJECTIVE To determine if there is an association between early high-dose recombinant human erythropoietin treatment in preterm infants and biomarkers of encephalopathy of prematurity on magnetic resonance imaging (MRI) at term-equivalent age. DESIGN, SETTING, AND PARTICIPANTS A total of 495 infants were included in a randomized, double-blind, placebo-controlled study conducted in Switzerland between 2005 and 2012. In a nonrandomized subset of 165 infants (n = 77 erythropoietin; n = 88 placebo), brain abnormalities were evaluated on MRI acquired at term-equivalent age. INTERVENTIONS Participants were randomly assigned to receive recombinant human erythropoietin (3000 IU/kg; n = 256) or placebo (n = 239) intravenously before 3 hours, at 12 to 18 hours, and at 36 to 42 hours after birth. MAIN OUTCOMES AND MEASURES The primary outcome of the trial, neurodevelopment at 24 months, has not yet been assessed. The secondary outcome, white matter disease of the preterm infant, was semiquantitatively assessed from MRI at term-equivalent age based on an established scoring method. The resulting white matter injury and gray matter injury scores were categorized as normal or abnormal according to thresholds established in the literature by correlation with neurodevelopmental outcome. RESULTS At term-equivalent age, compared with untreated controls, fewer infants treated with recombinant human erythropoietin had abnormal scores for white matter injury, white matter signal intensity, periventricular white matter loss, and gray matter injury. [GRAPHICS] CONCLUSIONS AND RELEVANCE In an analysis of secondary outcomes of a randomized clinical trial of preterm infants, high-dose erythropoietin treatment within 42 hours after birth was associated with a reduced risk of brain injury on MRI. These findings require assessment in a randomized trial designed primarily to assess this outcome as well as investigation of the association with neurodevelopmental outcomes. Copyright 2014 American Medical Association. All rights reserved.	[Leuchter, Russia Ha-Vinh; Gui, Laura; Lodygensky, Gregory Anton; Darque, Alexandra; Hueppi, Petra Susan] Univ Hosp Geneva, Div Dev & Growth, Dept Pediat, CH-1211 Geneva 14, Switzerland; [Poncet, Antoine] Univ Geneva, Clin Res Ctr, Geneva, Switzerland; [Poncet, Antoine] Univ Geneva, Div Clin Epidemiol, Dept Hlth & Community Med, Geneva, Switzerland; [Poncet, Antoine] Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland; [Hagmann, Cornelia; Koller, Brigitte; Bucher, Hans Ulrich] Univ Zurich Hosp, Zurich, Switzerland; [Martin, Ernst] Univ Childrens Hosp Zurich, MR Ctr, Zurich, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich	Huppi, PS (corresponding author), Univ Hosp Geneva, Div Dev & Growth, Dept Pediat, Rue Willy Donze 6, CH-1211 Geneva 14, Switzerland.	petra.huppi@hcuge.ch	Bucher, Hans/AAL-1100-2020; Bucher, Hans Ulrich/AAF-2995-2020; Gui, Laura/AAB-6072-2020; Bucher, Hans/AAL-1739-2020; Pfister, Riccardo E/N-7082-2014; Ha-Vinh Leuchter, Russia/AAA-5924-2022; poncet, antoine/AAB-9984-2019; Lodygensky, Gregory/N-6576-2016; Huppi, Petra S/A-4079-2009; Huppi, Petra/A-4079-2009	Bucher, Hans/0000-0003-4458-1161; Bucher, Hans Ulrich/0000-0003-4458-1161; Bucher, Hans/0000-0003-4458-1161; Pfister, Riccardo E/0000-0002-7395-0512; Huppi, Petra S/0000-0002-7383-6648; Huppi, Petra/0000-0002-7063-4215; Ha-Vinh Leuchter, Russia/0000-0001-9068-9670; Hagmann, Cornelia/0000-0003-2647-9809	Swiss National Science Foundation [SNF 3200B0-108176]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This trial was sponsored by the Swiss National Science Foundation (grant SNF 3200B0-108176).	Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; Dean JM, 2011, ANN NEUROL, V70, P846, DOI 10.1002/ana.22480; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Fauchere JC, 2008, PEDIATRICS, V122, P375, DOI 10.1542/peds.2007-2591; Gonzalez FF, 2013, STROKE, V44, P753, DOI 10.1161/STROKEAHA.111.000104; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Jantzie LL, 2015, CEREB CORTEX, V25, P2683, DOI 10.1093/cercor/bhu066; Jantzie LL, 2013, PEDIATR RES, V74, P658, DOI 10.1038/pr.2013.155; Jeon TY, 2012, RADIOLOGY, V263, P518, DOI 10.1148/radiol.12111615; Juul S, 2012, J MATERN-FETAL NEO M, V25, P105, DOI 10.3109/14767058.2012.715025; Juul SE, 2008, PEDIATRICS, V122, P383, DOI 10.1542/peds.2007-2711; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Kato S, 2011, J NEUROSCI RES, V89, P1566, DOI 10.1002/jnr.22702; Keswani SC, 2011, P NATL ACAD SCI USA, V108, P4986, DOI 10.1073/pnas.1019591108; Kim YJ, 2010, ANAT CELL BIOL, V43, P140, DOI 10.5115/acb.2010.43.2.140; Kinney HC, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/295389; Kinney HC, 2012, ANN NEUROL, V71, P397, DOI 10.1002/ana.22612; Kinney HC, 2009, SEMIN PEDIATR NEUROL, V16, P179, DOI 10.1016/j.spen.2009.09.003; Kostovic I, 2014, BRAIN STRUCT FUNCT, V219, P231, DOI 10.1007/s00429-012-0496-0; McAdams RM, 2013, J PERINATOL, V33, P226, DOI 10.1038/jp.2012.78; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Nagasunder AC, 2011, AM J NEURORADIOL, V32, P185, DOI 10.3174/ajnr.A2243; Neubauer AP, 2010, ANN NEUROL, V67, P657, DOI 10.1002/ana.21977; Nguyen TMN, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009395.pub2; Ohls RK, 2014, PEDIATRICS, V133, P1023, DOI 10.1542/peds.2013-4307; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; van de Looij Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095643; van de Looij Y, 2014, CURR OPIN NEUROL, V27, P157, DOI 10.1097/WCO.0000000000000066; Voigt M, 2006, GEBURTSH FRAUENHEILK, V66, P956, DOI 10.1055/s-2006-924458; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Woodward LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051879; Xiong T, 2011, INT J DEV NEUROSCI, V29, P583, DOI 10.1016/j.ijdevneu.2010.12.007	40	95	102	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					817	824		10.1001/jama.2014.9645	http://dx.doi.org/10.1001/jama.2014.9645			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157725	Bronze			2022-12-28	WOS:000340788500024
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Adrenaline in cardiac arrest: it's unethical for patients not to know	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPINEPHRINE; SURVIVAL; OUTCOMES					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, BBC; Edwards P, 2005, LANCET, V365, P1957; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; Patanwala AE, 2014, MINERVA ANESTESIOL, V80, P831; Ristagno G, 2009, CRIT CARE MED, V37, P1408, DOI 10.1097/CCM.0b013e31819cedc9; Stirton R, 2014, J MED ETHICS	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2014	349								g5258	10.1136/bmj.g5258	http://dx.doi.org/10.1136/bmj.g5258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FP	25148860	Bronze, Green Published			2022-12-28	WOS:000340839100004
J	Ferlaino, F				Ferlaino, Francesca			MOLECULAR PHYSICS Complexity trapped by simplicity	NATURE			English	Editorial Material							RADIATION		Univ Innsbruck, Inst Expt Phys, Austrian Acad Sci, A-6020 Innsbruck, Austria	Austrian Academy of Sciences; University of Innsbruck	Ferlaino, F (corresponding author), Univ Innsbruck, Inst Expt Phys, Austrian Acad Sci, A-6020 Innsbruck, Austria.		Ferlaino, Francesca/E-6726-2012	Ferlaino, Francesca/0000-0002-3020-6291	Austrian Science Fund (FWF) [Y 479] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Cohen-Tannoudji C., 2011, ADV ATOMIC PHYS OVER, DOI 10.11426631; HANSCH TW, 1975, OPT COMMUN, V13, P68, DOI 10.1016/0030-4018(75)90159-5; Hummon MT, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.143001; McClelland JJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.143005; RAAB EL, 1987, PHYS REV LETT, V59, P2631, DOI 10.1103/PhysRevLett.59.2631; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Stuhl BK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.243002; Zhelyazkova V, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.053416	12	1	1	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					261	262		10.1038/512261a	http://dx.doi.org/10.1038/512261a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143109				2022-12-28	WOS:000340508200023
J	Higham, T; Douka, K; Wood, R; Ramsey, CB; Brock, F; Basell, L; Camps, M; Arrizabalaga, A; Baena, J; Barroso-Ruiz, C; Bergman, C; Boitard, C; Boscato, P; Caparros, M; Conard, NJ; Draily, C; Froment, A; Galvan, B; Gambassini, P; Garcia-Moreno, A; Grimaldi, S; Haesaerts, P; Holt, B; Iriarte-Chiapusso, MJ; Jelinek, A; Pardo, JFJ; Maillo-Fernandez, JM; Marom, A; Maroto, J; Menendez, M; Metz, L; Morin, E; Moroni, A; Negrino, F; Panagopoulou, E; Peresani, M; Pirson, S; de la Rasilla, M; Riel-Salvatore, J; Ronchitelli, A; Santamaria, D; Semal, P; Slimak, L; Soler, J; Soler, N; Villaluenga, A; Pinhasi, R; Jacobi, R				Higham, Tom; Douka, Katerina; Wood, Rachel; Ramsey, Christopher Bronk; Brock, Fiona; Basell, Laura; Camps, Marta; Arrizabalaga, Alvaro; Baena, Javier; Barroso-Ruiz, Cecillio; Bergman, Christopher; Boitard, Coralie; Boscato, Paolo; Caparros, Miguel; Conard, Nicholas J.; Draily, Christelle; Froment, Alain; Galvan, Bertila; Gambassini, Paolo; Garcia-Moreno, Alejandro; Grimaldi, Stefano; Haesaerts, Paul; Holt, Brigitte; Iriarte-Chiapusso, Maria-Jose; Jelinek, Arthur; Jorda Pardo, Jesus F.; Maillo-Fernandez, Jose-Manuel; Marom, Anat; Maroto, Julia; Menendez, Mario; Metz, Laure; Morin, Eugene; Moroni, Adriana; Negrino, Fabio; Panagopoulou, Eleni; Peresani, Marco; Pirson, Stephane; de la Rasilla, Marco; Riel-Salvatore, Julien; Ronchitelli, Annamaria; Santamaria, David; Semal, Patrick; Slimak, Ludovic; Soler, Joaquim; Soler, Narcis; Villaluenga, Aritza; Pinhasi, Ron; Jacobi, Roger			The timing and spatiotemporal patterning of Neanderthal disappearance	NATURE			English	Article							RADIOCARBON-DATES; CHRONOLOGY; MIDDLE; BONE; PRETREATMENT; SEQUENCE; EUROPE; GROTTE; RENNE; AGE	The timing of Neanderthal disappearance and the extent to which they overlapped with the earliest incoming anatomically modern humans (AMHs) in Eurasia are key questions in palaeoanthropology(1,2). Determining the spatiotemporal relationship between the two populations is crucial if we are to understand the processes, timing and reasons leading to the disappearance of Neanderthals and the likelihood of cultural and genetic exchange. Serious technical challenges, however, have hindered reliable dating of the period, as the radiocarbon method reaches its limit at 50,000 years ago(3). Here we apply improved accelerator mass spectrometry C-14 techniques to construct robust chronologies from 40 key Mousterian and Neanderthal archaeological sites, ranging from Russia to Spain. Bayesian age modelling was used to generate probability distribution functions to determine the latest appearance date. We show that the Mousterian ended by 41,030-39,260 calibrated years BP (at 95.4% probability) across Europe. Wealso demonstrate that succeeding 'transitional' archaeological industries, one of which has been linked with Neanderthals (Chatelperronian)(4), end at a similar time. Our data indicate that the disappearance of Neanderthals occurred at different times in different regions. Comparing the data with results obtained from the earliest dated AMH sites in Europe, associated with the Uluzzian technocomplex(5), allows us to quantify the temporal overlap between the two human groups. The results reveal a significant overlap of 2,600-5,400 years (at 95.4% probability). This has important implications for models seeking to explain the cultural, technological and biological elements involved in the replacement of Neanderthals by AMHs. A mosaic of populations in Europe during the Middle to Upper Palaeolithic transition suggests that there was ample time for the transmission of cultural and symbolic behaviours, as well as possible genetic exchanges, between the two groups.	[Higham, Tom; Douka, Katerina; Wood, Rachel; Ramsey, Christopher Bronk; Brock, Fiona; Marom, Anat] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; [Wood, Rachel] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Basell, Laura] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol GAP, Belfast BT7 1NN, Antrim, North Ireland; [Camps, Marta] Univ Maryland, Sch Languages Literatures & Cultures, College Pk, MD 20742 USA; [Arrizabalaga, Alvaro; Iriarte-Chiapusso, Maria-Jose] Univ Basque Country UPV EHU, IKERBASQUE, Res Team Prehist IT 622 13, Vitoria 01006, Spain; [Baena, Javier] Univ Autonoma Madrid, Departimento Prehist & Arqueol, E-28049 Madrid, Spain; [Barroso-Ruiz, Cecillio] Fdn Inst Invest Prehist & Evoluc Humana, Cordoba 14900, Spain; [Bergman, Christopher] URS, Cincinnati, OH 45202 USA; [Boscato, Paolo; Gambassini, Paolo; Moroni, Adriana; Ronchitelli, Annamaria] Univ Siena, UR Preistoria & Antropol, Dipartimento Sci Fis Terra & Ambiente, I-53100 Siena, Italy; [Caparros, Miguel] Museum Natl Hist Nat, Dept Prehist, F-75013 Paris, France; [Conard, Nicholas J.] Univ Tubingen, Abt Altere Urgeschichte & Quartarokol, D-72070 Tubingen, Germany; [Conard, Nicholas J.] Tubingen Senckenberg Ctr Human Evolut & Paleoecol, D-72070 Tubingen, Germany; [Draily, Christelle] Serv Archeol, Serv Publ Wallonie, DGO4, B-6700 Arlon, Belgium; [Froment, Alain] Musee Homme Paris, Lab Ecoantropol & Ethnobiol, F-75116 Paris, France; [Galvan, Bertila] Univ La Laguna, Dept Prehist Arqueol Antropol & Hist Antigua, Tenerife 38071, Spain; [Garcia-Moreno, Alejandro; Villaluenga, Aritza] Monrepos Archaeol Res Ctr, D-56567 Neuwied, Germany; [Garcia-Moreno, Alejandro; Villaluenga, Aritza] Museum Human Behav Evolut, D-56567 Neuwied, Germany; [Grimaldi, Stefano] Univ Trento, Dipartimento Lettere & Filosofia, Lab Preistoria B Bagolini, I-38122 Trento, Italy; [Haesaerts, Paul] Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; [Holt, Brigitte] Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA; [Jelinek, Arthur] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Jorda Pardo, Jesus F.; Maillo-Fernandez, Jose-Manuel; Menendez, Mario] UNED, Dept Prehist & Arqueol, Madrid 20840, Spain; [Marom, Anat] Weizmann Inst Sci, Kimmel Ctr Archaeol Sci, IL-76100 Rehovot, Israel; [Maroto, Julia; Soler, Joaquim; Soler, Narcis] Univ Girona, Area Prehist, Girona 17071, Spain; [Metz, Laure; Slimak, Ludovic] Toulouse Jean Jaures Univ, CNRS, TRACES, UMR 5608, F-31058 Toulouse 9, France; [Morin, Eugene] Trent Univ, Dept Anthropol, Peterborough, ON K9J 7B8, Canada; [Negrino, Fabio] Univ Genoa, Dipartimento Antichita Filosofia & Storia, I-16126 Genoa, Italy; [Panagopoulou, Eleni] Ephoreia Paleoanthropol Southern Greece, Athens 11636, Greece; [Peresani, Marco] Univ Ferrara, Dipartimento Studi Umanist, Sez Sci Preistor & Antropol, I-44100 Ferrara, Italy; [Pirson, Stephane] Serv Publ Wallonie, DGO4, Direct Archeol, B-5100 Jambes, Belgium; [de la Rasilla, Marco; Santamaria, David] Univ Oviedo, Dept Hist, Oviedo 33011, Spain; [Riel-Salvatore, Julien] Univ Montreal, Dept Anthropol, Montreal, PQ H3T 1N8, Canada; [Semal, Patrick] Royal Belgian Inst Nat Sci, Serv Sci Heritage, B-1000 Brussels, Belgium; [Pinhasi, Ron] Natl Univ Ireland Univ Coll Dublin, UCD Earth Inst, Dublin 4, Ireland; [Pinhasi, Ron] Natl Univ Ireland Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland; [Jacobi, Roger] British Museum, Dept Prehist & Europe, London N1 5QJ, England; [Jacobi, Roger] Nat Hist Museum, London SW7 5BD, England; [Garcia-Moreno, Alejandro] Univ Cantabria, Cantabria Int Inst Prehist Res IIIPC, E-39005 Santander, Spain	University of Oxford; Australian National University; Queens University Belfast; University System of Maryland; University of Maryland College Park; Basque Foundation for Science; University of Basque Country; Autonomous University of Madrid; University of Siena; Museum National d'Histoire Naturelle (MNHN); Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Museum National d'Histoire Naturelle (MNHN); Universidad de la Laguna; University of Trento; University of Massachusetts System; University of Massachusetts Amherst; University of Arizona; Universidad Nacional de Educacion a Distancia (UNED); Weizmann Institute of Science; Universitat de Girona; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Trent University; University of Genoa; University of Ferrara; University of Oviedo; Universite de Montreal; Royal Belgian Institute of Natural Sciences; University College Dublin; University College Dublin; Natural History Museum London; Natural History Museum London; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC)	Higham, T (corresponding author), Univ Oxford, Oxford Radiocarbon Accelerator Unit, Res Lab Archaeol & Hist Art, S Parks Rd, Oxford OX1 3QY, England.	thomas.higham@rlaha.ox.ac.uk	Ramsey, Christopher Bronk/AAQ-2227-2021; Maíllo-Fernández, José-Manuel/AAU-3715-2020; Iriarte-Chiapusso, Maria-Jose/B-5705-2011; Peresani, Marco/X-1343-2019; Maroto, Julià/AAB-2533-2019; Higham, Tom/Y-2707-2019; Wood, Rachel/K-5577-2016; Brock, Fiona/I-4970-2016; Slimak, Ludovic/AAG-7890-2020; Jordá, Jesús F. F./M-9193-2014; Arrizabalaga, Alvaro/D-1102-2010; Ramsey, Christopher Bronk/A-3277-2012; baena, javier/L-2383-2013; Douka, Katerina/L-3287-2014; Pinhasi, Ron/AAT-1531-2020; Garcia, Alejandro/I-7829-2012	Ramsey, Christopher Bronk/0000-0002-8641-9309; Maíllo-Fernández, José-Manuel/0000-0002-7555-4943; Iriarte-Chiapusso, Maria-Jose/0000-0002-4409-2408; Maroto, Julià/0000-0001-7051-9623; Higham, Tom/0000-0002-5949-598X; Wood, Rachel/0000-0002-1694-3295; Brock, Fiona/0000-0003-0728-6091; Jordá, Jesús F. F./0000-0002-3937-9199; Arrizabalaga, Alvaro/0000-0001-6127-2972; Ramsey, Christopher Bronk/0000-0002-8641-9309; baena, javier/0000-0002-6373-8286; Douka, Katerina/0000-0002-0558-0011; Pinhasi, Ron/0000-0003-1629-8131; Garcia, Alejandro/0000-0003-4861-7774; Riel-Salvatore, Julien/0000-0001-8418-0958; de la RASILLA, Marco/0000-0002-5505-0625; Grimaldi, Stefano/0000-0002-9145-8011; Peresani, Marco/0000-0001-6562-6336; Barroso Ruiz, Cecilio/0000-0002-1372-3908; Metz, Laure/0000-0003-0304-5645; Conard, Nicholas/0000-0002-4633-0385; Negrino, Fabio/0000-0001-7539-2959; Semal, Patrick/0000-0002-4048-7728	Natural Environment Research Council (NERC) [NE/D014077/1]; Leverhulme Trust through the Ancient Human Occupation of Britain (AHOB) project; NRCF (NERC Radiocarbon Facility) programme, Keble College (Oxford); European Research Council; NERC [NRCF010002, NE/D014077/1] Funding Source: UKRI; Natural Environment Research Council [NE/D014077/1, NRCF010002] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust through the Ancient Human Occupation of Britain (AHOB) project; NRCF (NERC Radiocarbon Facility) programme, Keble College (Oxford); European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Natural Environment Research Council (NERC) funded this work (NE/D014077/1). Additional funding was received from the Leverhulme Trust, through the Ancient Human Occupation of Britain (AHOB) project, the NRCF (NERC Radiocarbon Facility) programme, Keble College (Oxford) and the European Research Council. We thank our many collaborators and their excavation teams, and all staff at the Oxford Radiocarbon Accelerator Unit for their contribution to this work. Maps at -80 m below current sea level were produced by M. Deves and A. Scheder Black.	Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bird MI, 1999, RADIOCARBON, V41, P127, DOI 10.1017/S0033822200019482; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; Douka K, 2014, J HUM EVOL, V68, P1, DOI 10.1016/j.jhevol.2013.12.007; Douka K, 2010, RADIOCARBON, V52, P735, DOI 10.1017/S0033822200045756; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Higham T, 2006, P NATL ACAD SCI USA, V103, P553, DOI 10.1073/pnas.0510005103; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; Higham T, 2011, ANTIQUITY, V85, P235, DOI 10.1017/S0003598X00067570; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; LEVEQUE F, 1980, CR ACAD SCI D NAT, V291, P187; Lohse K, 2014, GENETICS, V196, P1241, DOI 10.1534/genetics.114.162396; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Slimak L, 2011, SCIENCE, V332, P841, DOI 10.1126/science.1203866; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wood RE, 2010, RADIOCARBON, V52, P600, DOI 10.1017/S003382220004563X; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845	29	457	464	11	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					306	309		10.1038/nature13621	http://dx.doi.org/10.1038/nature13621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AN3SF	25143113				2022-12-28	WOS:000340508200034
J	McKee, M				McKee, Martin			FUTURE OF THE NHS Mutual ownership: privatisation under a different name?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									London Sch Hyg & Trop Med, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				Hutton W., 1996, WHY BRITAIN IN CRISI; Mason R., 2014, GUARDIAN; McKee M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e399; Mckee M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7897; Rimmer A, 2014, BMJ CAREERS; The King's Fund, 2014, IMPR NHS CAR ENG STA; Wachman R., 2007, SORRY SAGA AA	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2014	349								g5150	10.1136/bmj.g5150	http://dx.doi.org/10.1136/bmj.g5150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FN	25145815	Green Published			2022-12-28	WOS:000340838900004
J	Di Mitri, D; Toso, A; Chen, JJ; Sarti, M; Pinton, S; Jost, TR; D'Antuono, R; Montani, E; Garcia-Escudero, R; Guccini, I; Da Silva-Alvarez, S; Collado, M; Eisenberger, M; Zhang, Z; Catapano, C; Grassi, F; Alimonti, A				Di Mitri, Diletta; Toso, Alberto; Chen, Jing Jing; Sarti, Manuela; Pinton, Sandra; Jost, Tanja Rezzonico; D'Antuono, Rocco; Montani, Erica; Garcia-Escudero, Ramon; Guccini, Ilaria; Da Silva-Alvarez, Sabela; Collado, Manuel; Eisenberger, Mario; Zhang, Zhe; Catapano, Carlo; Grassi, Fabio; Alimonti, Andrea			Tumour-infiltrating Gr-1(+) myeloid cells antagonize senescence in cancer	NATURE			English	Article							CELLULAR SENESCENCE; PTEN; DEFICIENT; SECRETION; SCREEN; GENES; MICE	Aberrant activation of oncogenes or loss of tumour suppressor genes opposes malignant transformation by triggering a stable arrest in cell growth, which is termed cellular senescence(1-3). This process is finely tuned by both cell-autonomous and non-cell-autonomous mechanisms that regulate the entry of tumour cells to senescence(4-6). Whether tumour-infiltrating immune cells can oppose senescence is unknown. Here we show that at the onset of senescence, PTEN null prostate tumours inmice(2,7) are massively infiltrated by a population of CD11b(+)Gr-1(+) myeloid cells that protect a fraction of proliferating tumour cells from senescence, thus sustaining tumour growth. Mechanistically, we found that Gr-1(+) cells antagonize senescence in a paracrine manner by interfering with the senescence-associated secretory phenotype of the tumour through the secretion of interleukin-1 receptor antagonist (IL-1RA). Strikingly, Pten-loss-induced cellular senescence was enhanced in vivo when Il1ra knockout myeloid cells were adoptively transferred to PTEN null mice. Therapeutically, docetaxel-induced senescence and efficacy were higher in PTEN null tumours when the percentage of tumour-infiltrating CD11b(+)Gr-1(+)myeloid cells was reduced using an antagonist of CXC chemokine receptor 2 (CXCR2)(8). Taken together, our findings identify a novel non-cell-autonomous network, established by innate immunity, that controls senescence evasion and chemoresistance. Targeting this network provides novel opportunities for cancer therapy.	[Di Mitri, Diletta; Toso, Alberto; Chen, Jing Jing; Sarti, Manuela; Pinton, Sandra; Garcia-Escudero, Ramon; Guccini, Ilaria; Catapano, Carlo; Alimonti, Andrea] Oncol Inst Southern Switzerland, Inst Oncol Res IOR, CH-6500 Bellinzona, Switzerland; [Chen, Jing Jing; Alimonti, Andrea] Univ Lausanne UNIL, Fac Biol & Med, CH-1011 Lausanne, Switzerland; [Jost, Tanja Rezzonico; D'Antuono, Rocco; Montani, Erica; Grassi, Fabio] Inst Res Biomed IRB, CH-6500 Bellinzona, Switzerland; [Garcia-Escudero, Ramon] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Da Silva-Alvarez, Sabela; Collado, Manuel] Clin Univ Hosp CHUS, StemCHUS Hlth Res Inst Santiago de Compostela IDI, Lab Stem Cells Canc & Aging, E-15706 Santiago De Compostela, Spain; [Eisenberger, Mario] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Zhang, Zhe] Johns Hopkins Univ, Div Biostat, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Grassi, Fabio] Univ Milan, Dept Med Biotechnol & Translat Med, I-20100 Milan, Italy	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; University of Lausanne; Universita della Svizzera Italiana; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Milan	Alimonti, A (corresponding author), Oncol Inst Southern Switzerland, Inst Oncol Res IOR, CH-6500 Bellinzona, Switzerland.	andrea.alimonti@ior.iosi.ch	D'Antuono, Rocco/HDM-4063-2022; Collado, Manuel/K-8140-2014; Garcia-Escudero, Ramon/A-2735-2012; Di Mitri, Diletta/AAA-4273-2019; GUCCINI, Ilaria/E-8262-2018	D'Antuono, Rocco/0000-0003-0180-6500; Collado, Manuel/0000-0002-0330-0880; Garcia-Escudero, Ramon/0000-0001-5640-6542; Catapano, Carlo V./0000-0002-7079-557X; DI MITRI, DILETTA/0000-0002-9626-4259; GRASSI, FABIO/0000-0003-3348-1712; Alimonti, Andrea/0000-0002-9362-2313; Chen, Jingjing/0000-0001-6994-0074; Da Silva Alvarez, Sabela/0000-0003-2702-8524; GUCCINI, Ilaria/0000-0002-3644-0679	Department of Defense Prostate Cancer Research Program [W81XWH-10-2-0056, W81XWH-10-2-0046]; Swiss national science foundation (SNF) grant Ambizione [PZ00P3_136612/1]; European Society for Medical Oncology (ESMO) translational research award; Swiss Bridge Award; PEOPLE-IRG [22484]; European Research Council [ERCsg 261342]; ABREOC; Train COFUND Marie Curie; Fondazione IBSA	Department of Defense Prostate Cancer Research Program(United States Department of Defense); Swiss national science foundation (SNF) grant Ambizione(Swiss National Science Foundation (SNSF)); European Society for Medical Oncology (ESMO) translational research award; Swiss Bridge Award; PEOPLE-IRG; European Research Council(European Research Council (ERC)European Commission); ABREOC; Train COFUND Marie Curie; Fondazione IBSA(Fondazione CarifeFondazione Caritro)	We thank L. Buhler for providing the Il1ra knockout mice, the F. Grassi laboratory and all members of the IRB animal core facility for technical assistance and the animal work, F. Stoffel for providing human samples, D. Jarrossay for helping with the flow cytometry analysis and cell sorting experiments, and all members of the Alimonti laboratory for scientific discussions. We thank C. Pissot-Soldermann, who developed NVP-BSK805. We thank T. Radimersky for providing NVP-BSK805. The human tissue microarray (as described in ref. 26) was obtained from the Department of Defense Prostate Cancer Research Program, Awards W81XWH-10-2-0056 and W81XWH-10-2-0046, Prostate Cancer Biorepository Network (PCBN). We thank G. Chiorino, I. Gregnanin, P. Ostano and L. Sacchetto for the gene expression analysis performed on myeloid and tumour cells. This work was supported by Swiss national science foundation (SNF) grant Ambizione (PZ00P3_136612/1), the European Society for Medical Oncology (ESMO) translational research award to A. A., the Swiss Bridge Award to A. A., PEOPLE-IRG (22484), a European Research Council starting grant (ERCsg 261342), ABREOC, the Train COFUND Marie Curie to D. D. M. and Fondazione IBSA.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Antonarakis ES, 2012, CANCER-AM CANCER SOC, V118, P6063, DOI 10.1002/cncr.27689; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Ruiz EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4175; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Sgroi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025442; Tamassia N, 2010, FASEB J, V24, P1365, DOI 10.1096/fj.09-145573; Tasdemir N, 2013, EMBO J, V32, P1975, DOI 10.1038/emboj.2013.139; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	31	205	208	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					134	+		10.1038/nature13638	http://dx.doi.org/10.1038/nature13638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25156255				2022-12-28	WOS:000344187500044
J	Frank, L; Basch, E; Selby, JV				Frank, Lori; Basch, Ethan; Selby, Joe V.			The PCORI Perspective on Patient-Centered Outcomes Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frank, Lori; Selby, Joe V.] Patient Ctr Outcomes Res Inst, Washington, DC 20036 USA; [Basch, Ethan] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Frank, L (corresponding author), Patient Ctr Outcomes Res Inst, 1828 L St NW, Washington, DC 20036 USA.	lfrank@pcori.org						[Anonymous], 2012, JAMA, V307, P1636; Brett J, 2014, PATIENT, V7, P387, DOI 10.1007/s40271-014-0065-0; Cashman SB, 2008, AM J PUBLIC HEALTH, V98, P1407, DOI 10.2105/AJPH.2007.113571; Drolet BC, 2011, TRANSL RES, V157, P1, DOI 10.1016/j.trsl.2010.10.002; Edwards V, 2011, HEALTH EXPECT, V14, P429, DOI 10.1111/j.1369-7625.2010.00652.x; Hoffman A, 2010, HEALTH AFFAIR, V29, P1834, DOI 10.1377/hlthaff.2010.0675; Willis J.W., 2007, FDN QUALITATIVE RES	7	322	323	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1513	1514		10.1001/jama.2014.11100	http://dx.doi.org/10.1001/jama.2014.11100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25167382	Bronze			2022-12-28	WOS:000342983200012
J	Brawand, D; Wagner, CE; Li, YI; Malinsky, M; Keller, I; Fan, SH; Simakov, O; Ng, AY; Lim, ZW; Bezault, E; Turner-Maier, J; Johnson, J; Alcazar, R; Noh, HJ; Russell, P; Aken, B; Alfoldi, J; Amemiya, C; Azzouzi, N; Baroiller, JF; Barloy-Hubler, F; Berlin, A; Bloomquist, R; Carleton, KL; Conte, MA; D'Cotta, H; Eshel, O; Gaffney, L; Galibert, F; Gante, HF; Gnerre, S; Greuter, L; Guyon, R; Haddad, NS; Haerty, W; Harris, RM; Hofmann, HA; Hourlier, T; Hulata, G; Jaffe, DB; Lara, M; Lee, AP; MacCallum, I; Mwaiko, S; Nikaido, M; Nishihara, H; Ozouf-Costaz, C; Penman, DJ; Przybylski, D; Rakotomanga, M; Renn, SCP; Ribeiro, FJ; Ron, M; Salzburger, W; Sanchez-Pulido, L; Santos, ME; Searle, S; Sharpe, T; Swofford, R; Tan, FJ; Williams, L; Young, S; Yin, SY; Okada, N; Kocher, TD; Miska, EA; Lander, ES; Venkatesh, B; Fernald, RD; Meyer, A; Ponting, CP; Streelman, JT; Lindblad-Toh, K; Seehausen, O; Di Palma, F				Brawand, David; Wagner, Catherine E.; Li, Yang I.; Malinsky, Milan; Keller, Irene; Fan, Shaohua; Simakov, Oleg; Ng, Alvin Y.; Lim, Zhi Wei; Bezault, Etienne; Turner-Maier, Jason; Johnson, Jeremy; Alcazar, Rosa; Noh, Hyun Ji; Russell, Pamela; Aken, Bronwen; Alfoeldi, Jessica; Amemiya, Chris; Azzouzi, Naoual; Baroiller, Jean-Francois; Barloy-Hubler, Frederique; Berlin, Aaron; Bloomquist, Ryan; Carleton, Karen L.; Conte, Matthew A.; D'Cotta, Helena; Eshel, Orly; Gaffney, Leslie; Galibert, Francis; Gante, Hugo F.; Gnerre, Sante; Greuter, Lucie; Guyon, Richard; Haddad, Natalie S.; Haerty, Wilfried; Harris, Rayna M.; Hofmann, Hans A.; Hourlier, Thibaut; Hulata, Gideon; Jaffe, David B.; Lara, Marcia; Lee, Alison P.; MacCallum, Iain; Mwaiko, Salome; Nikaido, Masato; Nishihara, Hidenori; Ozouf-Costaz, Catherine; Penman, David J.; Przybylski, Dariusz; Rakotomanga, Michaelle; Renn, Suzy C. P.; Ribeiro, Filipe J.; Ron, Micha; Salzburger, Walter; Sanchez-Pulido, Luis; Santos, M. Emilia; Searle, Steve; Sharpe, Ted; Swofford, Ross; Tan, Frederick J.; Williams, Louise; Young, Sarah; Yin, Shuangye; Okada, Norihiro; Kocher, Thomas D.; Miska, Eric A.; Lander, Eric S.; Venkatesh, Byrappa; Fernald, Russell D.; Meyer, Axel; Ponting, Chris P.; Streelman, J. Todd; Lindblad-Toh, Kerstin; Seehausen, Ole; Di Palma, Federica			The genomic substrate for adaptive radiation in African cichlid fish	NATURE			English	Article							LAKE-VICTORIA; SEXUAL SELECTION; EVOLUTION; AGE; DUPLICATION; TANGANYIKA; SPECIATION; CONFLICT; TRAIT	Cichlid fishes are famous for large, diverse and replicated adaptive radiations in the Great Lakes of East Africa. To understand themolecular mechanisms underlying cichlid phenotypic diversity, we sequenced the genomes and transcriptomes of five lineages of African cichlids: the Nile tilapia (Oreochromis niloticus), an ancestral lineage with low diversity; and four members of the East African lineage: Neolamprologus brichardi/pulcher (older radiation, Lake Tanganyika), Metriaclima zebra (recent radiation, Lake Malawi), Pundamilia nyererei (very recent radiation, Lake Victoria), and Astatotilapia burtoni (riverine species around Lake Tanganyika). We found an excess of gene duplications in the East African lineage compared to tilapia and other teleosts, an abundance of non-coding element divergence, accelerated coding sequence evolution, expression divergence associated with transposable element insertions, and regulation by novel microRNAs. In addition, we analysed sequence data from sixty individuals representing six closely related species from Lake Victoria, and show genome-wide diversifying selection on coding and regulatory variants, some of which were recruited from ancient polymorphisms. We conclude that a number of molecular mechanisms shaped East African cichlid genomes, and that amassing of standing variation during periods of relaxed purifying selection may have been important in facilitating subsequent evolutionary diversification.	[Brawand, David; Turner-Maier, Jason; Johnson, Jeremy; Noh, Hyun Ji; Alfoeldi, Jessica; Berlin, Aaron; Gaffney, Leslie; Gnerre, Sante; Jaffe, David B.; Lara, Marcia; MacCallum, Iain; Przybylski, Dariusz; Ribeiro, Filipe J.; Sharpe, Ted; Swofford, Ross; Williams, Louise; Young, Sarah; Yin, Shuangye; Lander, Eric S.; Lindblad-Toh, Kerstin; Di Palma, Federica] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Brawand, David; Li, Yang I.; Haerty, Wilfried; Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Wagner, Catherine E.; Greuter, Lucie; Mwaiko, Salome; Seehausen, Ole] Eawag Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochemis, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland; [Wagner, Catherine E.; Keller, Irene; Greuter, Lucie; Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, Div Aquat Ecol, CH-3012 Bern, Switzerland; [Malinsky, Milan; Miska, Eric A.] Gurdon Inst, Cambridge CB2 1QN, England; [Malinsky, Milan; Aken, Bronwen; Hourlier, Thibaut; Searle, Steve] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Fan, Shaohua; Simakov, Oleg; Meyer, Axel] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Simakov, Oleg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Ng, Alvin Y.; Lim, Zhi Wei; Lee, Alison P.; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Bezault, Etienne; Renn, Suzy C. P.] Reed Coll, Dept Biol, Portland, OR 97202 USA; [Alcazar, Rosa; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Russell, Pamela] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Amemiya, Chris] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Azzouzi, Naoual; Barloy-Hubler, Frederique; Galibert, Francis; Guyon, Richard; Rakotomanga, Michaelle] Univ Rennes, Inst Genet & Dev, F-35043 Rennes, France; [Baroiller, Jean-Francois; D'Cotta, Helena] CIRAD, F-34398 Montpellier 5, France; [Bloomquist, Ryan; Haddad, Natalie S.; Streelman, J. Todd] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Carleton, Karen L.; Conte, Matthew A.; Kocher, Thomas D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Eshel, Orly; Hulata, Gideon; Ron, Micha] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel; [Gante, Hugo F.; Salzburger, Walter; Santos, M. Emilia] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Harris, Rayna M.; Hofmann, Hans A.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Dept Integrat Biol, Austin, TX 78712 USA; [Nikaido, Masato; Nishihara, Hidenori; Okada, Norihiro] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; [Ozouf-Costaz, Catherine] Natl Museum Nat Hist, F-75005 Paris, France; [Penman, David J.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Tan, Frederick J.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Okada, Norihiro] Natl Cheng Kung Univ, Tainan 704, Taiwan; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75123 Uppsala, Sweden; [Di Palma, Federica] Genome Anal Ctr, Norwich NR18 7UH, Norfolk, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern; Wellcome Trust Sanger Institute; University of Konstanz; European Molecular Biology Laboratory (EMBL); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Reed College - Oregon; Stanford University; California Institute of Technology; Benaroya Research Institute; Virginia Mason Medical Center; Universite de Rennes; CIRAD; University System of Georgia; Georgia Institute of Technology; University System of Maryland; University of Maryland College Park; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; University of Basel; University of Texas System; University of Texas Austin; Tokyo Institute of Technology; Museum National d'Histoire Naturelle (MNHN); University of Stirling; Carnegie Institution for Science; National Cheng Kung University; Uppsala University; The Genome Analysis Centre (TGAC)	Di Palma, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	todd.streelman@biology.gatech.edu; Kersli@broadinstitute.org; ole.seehausen@eawag.ch; Federica.di-palma@tgac.ac.uk	Wagner, Catherine/F-4692-2012; Ponting, Chris/AAV-2621-2021; Harris, Rayna M/B-7091-2015; Simakov, Oleg/G-4572-2015; Seehausen, Ole/C-8272-2011; Lim, Zhiwei/Q-7858-2016; Hofmann, Hans A/E-4538-2016; Simakov, Oleg/AAV-2494-2020; Nishihara, Hidenori/B-9324-2015; Nikaido, Masato/B-1698-2015; Malinsky, Milan/J-4087-2019; Hulata, Gideon/B-4238-2008; Russell, Pamela/O-8504-2019; Meyer, Axel/C-9826-2009; Lee, Alison/HCH-1286-2022; Berlin, Aaron M/AFY-6549-2022; Baroiller, Jean-Francois/I-3455-2013; Salzburger, Walter/G-1598-2011	Wagner, Catherine/0000-0001-8585-6120; Harris, Rayna M/0000-0002-7943-5650; Simakov, Oleg/0000-0002-3585-4511; Seehausen, Ole/0000-0001-6598-1434; Lim, Zhiwei/0000-0003-4620-1986; Hofmann, Hans A/0000-0002-3335-330X; Simakov, Oleg/0000-0002-3585-4511; Nishihara, Hidenori/0000-0002-5843-9994; Nikaido, Masato/0000-0002-2430-6974; Malinsky, Milan/0000-0002-1462-6317; Hulata, Gideon/0000-0001-7318-7505; Meyer, Axel/0000-0002-0888-8193; Lee, Alison/0000-0002-3773-1021; Berlin, Aaron M/0000-0002-0714-2808; Swofford, Ross/0000-0003-3676-8479; Russell, Pamela/0000-0003-2997-6392; Ponting, Chris/0000-0003-0202-7816; Gante, Hugo/0000-0002-0321-3023; Miska, Eric/0000-0002-4450-576X; Carleton, Karen/0000-0001-6306-5643; Venkatesh, Byrappa/0000-0003-3620-0277; Hourlier, Thibaut/0000-0003-4894-7773; Salzburger, Walter/0000-0002-9988-1674; Haerty, Wilfried/0000-0003-0111-191X; Alcazar, Rosa/0000-0003-3623-4151; Sanchez Pulido, Luis/0000-0002-2300-8502; Conte, Matthew/0000-0003-2712-7960; Li, Yang/0000-0002-0736-251X; Aken, Bronwen/0000-0002-3032-4095; Santos, M. Emilia/0000-0003-3158-7935; Ng, Alvin/0000-0002-1744-6063; Di-Palma, Federica/0000-0002-4394-0102; Kocher, Thomas/0000-0002-7547-0133; Bloomquist, Ryan/0000-0003-3514-8593; Okada, Norihiro/0000-0002-3655-8060; Barloy-Hubler, Frederique/0000-0002-8277-6034; baroiller, jean-francois/0000-0002-0992-1725	National Human Genome Research Institute (NHGRI); Swiss National Science Foundation [PBLAP3-142774, 31003A-118293, 31003A-144046]; University of Oxford Nuffield Department of Medicine Prize Studentship; German Science Foundation (DFG); European Research Council (ERC) [29700]; Biomedical Research Council of A*STAR, Singapore; ERC; Wellcome Trust;  [2R01DE019637-04]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; Cancer Research UK [11832] Funding Source: researchfish; Medical Research Council [MC_UU_12021/1, MC_U137761446] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; MRC [MC_UU_12021/1, MC_U137761446] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002045, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023013, R01DE019637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034950] Funding Source: NIH RePORTER; Division Of Environmental Biology [1021582] Funding Source: National Science Foundation	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Oxford Nuffield Department of Medicine Prize Studentship; German Science Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank the Broad Institute Genomics Platform for sequencing of the 5 cichlid genomes and transcriptomes. Sequencing, assembly, annotation and analysis by Broad Institute were supported by grants from the National Human Genome Research Institute (NHGRI). Genome evolution, duplication and TE analysis, ILS and ancient variant analyses were also supported by Swiss National Science Foundation grant PBLAP3-142774 awarded to D. B. and by University of Oxford Nuffield Department of Medicine Prize Studentship to Y.I.L. TE and copy number variation analyses were supported by the German Science Foundation (DFG), and advanced grant 29700 ("GenAdap") by the European Research Council (ERC). CNE analysis and zebrafish functional assays were supported by the Biomedical Research Council of A*STAR, Singapore. MicroRNA sequencing and annotation was supported by ERC Starting Grant to E. A. M.; M. M. was supported by a fellowship from the Wellcome Trust. MicroRNA and target in situ hybridization was supported by grant 2R01DE019637-04 to J.T.S. Population genomics analyses were supported by Swiss National Science Foundation grants 31003A-118293 and 31003A-144046 to O.S.	Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; COHEN AS, 1993, GEOLOGY, V21, P511, DOI 10.1130/0091-7613(1993)021<0511:ETAOFO>2.3.CO;2; Darwin C., 1959, WHATS NEW, V67, P2; Fan SH, 2011, J MOL EVOL, V73, P1, DOI 10.1007/s00239-011-9452-5; FERNALD RD, 1984, AM SCI, V72, P58; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Hofmann CM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000266; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P167, DOI 10.1159/000113330; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; Magalhaes IS, 2012, EVOL ECOL RES, V14, P381; McCune A., 1997, FAST FISHES SPECIATE, P585; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; MEYER A, 1990, J ZOOL, V221, P237, DOI 10.1111/j.1469-7998.1990.tb03994.x; Muschick M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-116; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Parnell NF, 2013, HEREDITY, V110, P239, DOI 10.1038/hdy.2012.73; Plenderleith M, 2005, BIOL LETT-UK, V1, P411, DOI 10.1098/rsbl.2005.0355; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simpson G. G., 1944, P1; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Sylvester JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2753; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2001, TRENDS GENET, V17, P299, DOI 10.1016/S0168-9525(01)02318-6; Terai Y, 2002, MOL BIOL EVOL, V19, P1628, DOI 10.1093/oxfordjournals.molbev.a004225; THIGPEN AE, 1992, J CLIN INVEST, V90, P799, DOI 10.1172/JCI115954; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144	39	618	630	14	376	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					375	+		10.1038/nature13726	http://dx.doi.org/10.1038/nature13726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25186727	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000341814900051
J	McMenamin, SK; Bain, EJ; McCann, AE; Patterson, LB; Eom, DS; Waller, ZP; Hamill, JC; Kuhlman, JA; Eisen, JS; Parichy, DM				McMenamin, Sarah K.; Bain, Emily J.; McCann, Anna E.; Patterson, Larissa B.; Eom, Dae Seok; Waller, Zachary P.; Hamill, James C.; Kuhlman, Julie A.; Eisen, Judith S.; Parichy, David M.			Thyroid hormone-dependent adult pigment cell lineage and pattern in zebrafish	SCIENCE			English	Article							STEM-CELLS; METAMORPHOSIS; STRIPE; FISH; FMS; REQUIREMENTS; REGENERATION; IRIDOPHORES; SUGGESTS; BEHAVIOR	Pigment patterns are useful for elucidating fundamental mechanisms of pattern formation and how these mechanisms evolve. In zebrafish, several pigment cell classes interact to generate stripes, yet the developmental requirements and origins of these cells remain poorly understood. Using zebrafish and a related species, we identified roles for thyroid hormone (TH) in pigment cell development and patterning, and in postembryonic development more generally. We show that adult pigment cells arise from distinct lineages having distinct requirements for TH and that differential TH dependence can evolve within lineages. Our findings demonstrate critical functions for TH in determining pigment pattern phenotype and highlight the potential for evolutionary diversification at the intersection of developmental and endocrine mechanisms.	[McMenamin, Sarah K.; Bain, Emily J.; McCann, Anna E.; Patterson, Larissa B.; Eom, Dae Seok; Waller, Zachary P.; Hamill, James C.; Parichy, David M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kuhlman, Julie A.] Iowa State Univ, Ames, IA 50011 USA; [Eisen, Judith S.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Parichy, David M.] UW Med Res, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Iowa State University; University of Oregon	Parichy, DM (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	dparichy@u.washington.edu	McMenamin, Sarah/ABD-0228-2022; McMenamin, Sarah/A-3480-2011	Eom, Dae Seok/0000-0002-0617-8788; McMenamin, Sarah/0000-0002-1154-5810	NIH grants [R01 GM096906, R03 HD074787]; NIH grant [P01 HD22486]; NIH [F32 GM090362, K99 GM105874]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486, R03HD074787, T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111233, R01GM096906, K99GM105874, F32GM090362, R01GM062182] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants R01 GM096906, R01 GM096906, and R03 HD074787 (D.M.P.), NIH grant P01 HD22486 (J.S.E.), and NIH grants F32 GM090362 and K99 GM105874 (S.K.M.). For assistance we thank O. Blackstone, T. Larson, J. Lewis, H. Majeski, E. Melancon, S. Palekha, T. Pham, A. Pruett, S. Redmond, J. Spiewak, and A. Wagner.	[Anonymous], [No title captured]; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Ellerhorst JA, 2003, ONCOL REP, V10, P1317; Engeszer RE, 2008, P NATL ACAD SCI USA, V105, P929, DOI 10.1073/pnas.0708778105; Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Hebrant A, 2011, EUR J ENDOCRINOL, V164, P1, DOI 10.1530/EJE-10-0775; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; McMenamin SK, 2013, CURR TOP DEV BIOL, V103, P127, DOI 10.1016/B978-0-12-385979-2.00005-8; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parichy DM, 2003, DEV BIOL, V256, P242, DOI 10.1016/S0012-1606(03)00015-0; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Price AC, 2008, ZEBRAFISH, V5, P297, DOI 10.1089/zeb.2008.0551; Quigley AK, 2004, DEVELOPMENT, V131, P6053, DOI 10.1242/dev.01526; Quigley IK, 2005, DEVELOPMENT, V132, P89, DOI 10.1242/dev.01547; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shah Monica, 2006, Dermatol Online J, V12, P1; Shi Y.B., 2000, AMPHIBIAN METAMORPHO; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; Tu S, 2010, DEVELOPMENT, V137, P3931, DOI 10.1242/dev.057075; van der Ven LTM, 2006, ENVIRON SCI TECHNOL, V40, P74, DOI 10.1021/es050972c; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Yamanaka H, 2014, P NATL ACAD SCI USA, V111, P1867, DOI 10.1073/pnas.1315416111	31	121	125	5	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1358	1361		10.1126/science.1256251	http://dx.doi.org/10.1126/science.1256251			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25170046	Green Accepted			2022-12-28	WOS:000341483800068
J	Kupferman, JV; Basu, J; Russo, MJ; Guevarra, J; Cheung, SK; Siegelbaum, SA				Kupferman, Justine V.; Basu, Jayeeta; Russo, Marco J.; Guevarra, Jenieve; Cheung, Stephanie K.; Siegelbaum, Steven A.			Reelin Signaling Specifies the Molecular Identity of the Pyramidal Neuron Distal Dendritic Compartment	CELL			English	Article							NUCLEOTIDE-GATED CHANNELS; ACTIVATED PACEMAKER CHANNELS; MESSENGER-RNA EXPRESSION; SYNAPTIC PLASTICITY; ION CHANNELS; HIPPOCAMPAL-NEURONS; SURFACE EXPRESSION; BRAIN-DEVELOPMENT; TYROSINE KINASES; HCN1 CHANNELS	The apical dendrites of many neurons contain proximal and distal compartments that receive synaptic inputs from different brain regions. These compartments also contain distinct complements of ion channels that enable the differential processing of their respective synaptic inputs, making them functionally distinct. At present, the molecular mechanisms that specify dendritic compartments are not well understood. Here, we report that the extracellular matrix protein Reelin, acting through its downstream, intracellular Dab1 and Src family tyrosine kinase signaling cascade, is essential for establishing and maintaining the molecular identity of the distal dendritic compartment of cortical pyramidal neurons. We find that Reelin signaling is required for the striking enrichment of HCN1 and GIRK1 channels in the distal tuft dendrites of both hippocampal CA1 and neocortical layer 5 pyramidal neurons, where the channels actively filter inputs targeted to these dendritic domains.	[Kupferman, Justine V.; Guevarra, Jenieve] Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Biol, New York, NY 10032 USA; [Kupferman, Justine V.; Basu, Jayeeta; Russo, Marco J.; Cheung, Stephanie K.; Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu		Kupferman, Justine/0000-0001-5689-4734; Russo, Marco/0000-0001-8064-6685	NIH [T32 GM008798, R01 NS036658]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Rebecca Piskorowski, Vivien Chevaleyre, Fred Hitti, and Christine Denny for helpful discussions and invaluable advice. We thank Haiying Liu for expert technical assistance. We are indebted to Beth Crowell, Gabriella D'Arcangelo, Ulrich Muller, Shigeyoshi Itohara, Justin Trotter, and Ed Weeber for sharing information, animals and reagents. We also thank Bina Santoro and Arjun Masurkar for very helpful comments on the manuscript. Funding was provided by NIH grants T32 GM008798 and R01 NS036658 and from the Howard Hughes Medical Institute.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Alvarez-Dolado M, 1999, J NEUROSCI, V19, P6979, DOI 10.1523/JNEUROSCI.19-16-06979.1999; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arnold DB, 2007, PFLUG ARCH EUR J PHY, V453, P763, DOI 10.1007/s00424-006-0155-5; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Borrell V, 2007, MOL CELL NEUROSCI, V36, P158, DOI 10.1016/j.mcn.2007.06.006; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chameau P, 2009, P NATL ACAD SCI USA, V106, P7227, DOI 10.1073/pnas.0810764106; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DelRio JA, 1996, J NEUROSCI, V16, P6896; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; Horton AC, 2006, BRAIN CELL BIOL, V35, P29, DOI 10.1007/s11068-006-9003-y; Huang JY, 2008, J BIOL CHEM, V283, P29912, DOI 10.1074/jbc.M804205200; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Li CH, 2008, AM J PHYSIOL-CELL PH, V294, pC355, DOI 10.1152/ajpcell.00236.2007; Lin YC, 2009, J BIOL CHEM, V284, P30433, DOI 10.1074/jbc.M109.039180; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Nusser Z, 2012, CURR OPIN NEUROBIOL, V22, P366, DOI 10.1016/j.conb.2011.10.006; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Powell KL, 2008, EPILEPSIA, V49, P1686, DOI 10.1111/j.1528-1167.2008.01593.x; Ramos-Moreno T, 2006, EUR J NEUROSCI, V23, P401, DOI 10.1111/j.1460-9568.2005.04567.x; Ramos-Moreno T., 2013, BRAIN STRUCT FUNCT; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Shipman SL, 2013, J NEUROSCI, V33, P13312, DOI 10.1523/JNEUROSCI.0678-13.2013; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	62	45	45	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1335	1347		10.1016/j.cell.2014.07.035	http://dx.doi.org/10.1016/j.cell.2014.07.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25201528	Green Accepted, Bronze			2022-12-28	WOS:000343094200015
J	Patra, PK; Krol, MC; Montzka, SA; Arnold, T; Atlas, EL; Lintner, BR; Stephens, BB; Xiang, B; Elkins, JW; Fraser, PJ; Ghosh, A; Hintsa, EJ; Hurst, DF; Ishijima, K; Krummel, PB; Miller, BR; Miyazaki, K; Moore, FL; Muhle, J; O'Doherty, S; Prinn, RG; Steele, LP; Takigawa, M; Wang, HJ; Weiss, RF; Wofsy, SC; Young, D				Patra, P. K.; Krol, M. C.; Montzka, S. A.; Arnold, T.; Atlas, E. L.; Lintner, B. R.; Stephens, B. B.; Xiang, B.; Elkins, J. W.; Fraser, P. J.; Ghosh, A.; Hintsa, E. J.; Hurst, D. F.; Ishijima, K.; Krummel, P. B.; Miller, B. R.; Miyazaki, K.; Moore, F. L.; Muehle, J.; O'Doherty, S.; Prinn, R. G.; Steele, L. P.; Takigawa, M.; Wang, H. J.; Weiss, R. F.; Wofsy, S. C.; Young, D.			Observational evidence for interhemispheric hydroxyl-radical parity	NATURE			English	Article							ATMOSPHERIC HYDROXYL; SULFUR-HEXAFLUORIDE; METHYL CHLOROFORM; TROPOSPHERIC OH; MODEL; VARIABILITY; CLIMATE; METHANE; ASSIMILATION; CIRCULATION	The hydroxyl radical (OH) is a key oxidant involved in the removal of air pollutants and greenhouse gases from the atmosphere(1-3). The ratio of Northern Hemispheric to Southern Hemispheric (NH/SH) OH concentration is important for our understanding of emission estimates of atmospheric species such as nitrogen oxides and methane(4-6). It remains poorly constrained, however, with a range of estimates from 0.85 to 1.4 (refs 4,7-10). Here we determine the NH/SH ratio of OH with the help of methyl chloroform data (a proxy for OH concentrations) and an atmospheric transport model that accurately describes interhemispheric transport and modelled emissions. We find that for the years 2004-2011 the model predicts an annual mean NH-SH gradient of methyl chloroform that is a tight linear function of the modelled NH/SH ratio in annual mean OH. We estimate a NH/SH OH ratio of 0.97 +/- 0.12 during this time period by optimizing global total emissions and mean OH abundance to fit methyl chloroform data from two surface-measurement networks and aircraft campaigns(11-13). Our findings suggest that top-down emission estimates of reactive species such as nitrogen oxides in key emitting countries in the NH that are based on a NH/SH OH ratio larger than 1 may be overestimated.	[Patra, P. K.; Ghosh, A.; Ishijima, K.; Miyazaki, K.; Takigawa, M.] JAMSTEC, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa 2360001, Japan; [Patra, P. K.] Tohoku Univ, Grad Sch Studies, CAOS, Sendai, Miyagi 9808578, Japan; [Krol, M. C.] Wageningen Univ, NL-6708 PB Wageningen, Netherlands; [Montzka, S. A.; Elkins, J. W.; Hintsa, E. J.; Hurst, D. F.; Miller, B. R.; Moore, F. L.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Arnold, T.; Muehle, J.; Weiss, R. F.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Atlas, E. L.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Lintner, B. R.] Rutgers State Univ, New Brunswick, NJ 08901 USA; [Stephens, B. B.] Natl Ctr Atmospher Res, Boulder, CO 80301 USA; [Xiang, B.; Wofsy, S. C.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Fraser, P. J.; Krummel, P. B.; Steele, L. P.] Commonwealth Sci & Ind Res Org CSIRO Oceans & Atm, Ctr Australian Weather & Climate Res, Aspendale, Vic 3195, Australia; [Ghosh, A.] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Hintsa, E. J.; Hurst, D. F.; Miller, B. R.; Moore, F. L.] Univ Colorado, CIRES, Boulder, CO 80309 USA; [O'Doherty, S.; Young, D.] Univ Bristol, Sch Chem, Cantocks Close BS8 1TS, Avon, England; [Prinn, R. G.] MIT, Cambridge, MA 02139 USA; [Wang, H. J.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tohoku University; Wageningen University & Research; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Miami; Rutgers State University New Brunswick; National Center Atmospheric Research (NCAR) - USA; Harvard University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; University of Colorado System; University of Colorado Boulder; University of Bristol; Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology	Patra, PK (corresponding author), JAMSTEC, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa 2360001, Japan.	prabir@jamstec.go.jp	Young, Dickon/AFO-7065-2022; Steele, Paul/B-3185-2009; Krol, Maarten C./E-3414-2013; Stephens, Britton B/B-7962-2008; Miyazaki, Kazuyuki/H-9744-2017; montzka, stephen/V-6162-2019; Atlas, Elliot/J-8171-2015; Takigawa, Masayuki/M-2095-2014; Muhle, Jens/AAN-1139-2020; Muhle, Jens/GPX-3244-2022; Miyazaki, Kazuyuki/AAL-1785-2021; Krummel, Paul B/A-4293-2013; Atlas, Elliot/AAE-4605-2021; Patra, Prabir/B-5206-2009; Fraser, Paul J. B./D-1755-2012; Xiang, Bin/E-8034-2012; Moore, Fred L/V-9985-2019; HURST, DALE/AAC-9948-2022	Young, Dickon/0000-0002-6723-3138; Steele, Paul/0000-0002-8234-3730; Krol, Maarten C./0000-0002-3506-2477; Stephens, Britton B/0000-0002-1966-6182; Miyazaki, Kazuyuki/0000-0002-1466-4655; montzka, stephen/0000-0002-9396-0400; Takigawa, Masayuki/0000-0002-5666-6026; Muhle, Jens/0000-0001-9776-3642; Miyazaki, Kazuyuki/0000-0002-1466-4655; Krummel, Paul B/0000-0002-4884-3678; Patra, Prabir/0000-0001-5700-9389; Moore, Fred L/0000-0002-8461-2535; HURST, DALE/0000-0002-6315-2322; Atlas, Elliot/0000-0003-3847-5346; Arnold, Tim/0000-0001-9097-8907; HINTSA, ERIC/0000-0002-5289-630X; Miller, Benjamin/0000-0003-1647-0122	Japan Society for the Promotion of Science [22241008]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); National Science Foundation (NSF); NSF grants [ATM-0628575, ATM-0628519, ATM-0628388 ATM-0628452, ATM-1036399]; NASA [NNX11AF36G, NNX11AF17G]; NCAR; EU FP7 project PEGASOS; Scripps Institution of Oceanography [NNX11AF16G]; NOAA; CSIRO; Department of Energy and Climate Change [GA0201]; CSIRO Oceans and Atmosphere Flagship; Bureau of Meteorology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF grants(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NCAR(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); EU FP7 project PEGASOS; Scripps Institution of Oceanography(University of California System); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Department of Energy and Climate Change; CSIRO Oceans and Atmosphere Flagship; Bureau of Meteorology(Bureau of Meteorology - Australia)	We thank the HIPPO science team and the crew and support staff at the NCAR Research Aviation Facility, and all the laboratory staff working for AGAGE and NOM measurement networks. This work is partly supported by the Japan Society for the Promotion of Science/Grants-in-Aid for Scientific Research (KAKENHI) Kiban-A (grant no. 22241008) and Ministry of Education, Culture, Sports, Science and Technology (MEXT)Arctic GRENE projects. NCAR is sponsored by the National Science Foundation (NSF). HIPPO was supported by NSF grants ATM-0628575, ATM-0628519, ATM-0628388 ATM-0628452 and ATM-1036399, by NASA award NNX11AF36G, and by NCAR. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of NSF, NOM or NASA. M.C.K. is supported by EU FP7 project PEGASOS. AGAGE is supported principally by NASA grants to Massachusetts Institute of Technology (NNX11AF17G) and Scripps Institution of Oceanography (NNX11AF16G) and also by NOAA and the CSIRO. Mace Head is supported by the Department of Energy and Climate Change, award GA0201. We thank the CSIRO Oceans and Atmosphere Flagship and the Bureau of Meteorology for Cape Grim project funding. NOAA flask measurements are supported in part by NOAA's Climate Program Office and its Atmospheric, Chemistry, Carbon Cycle and Climate Program.	[Anonymous], 2011, EDGAR4 2 EM DAT GLOB; BRENNINKMEIJER CAM, 1992, NATURE, V356, P50, DOI 10.1038/356050a0; Crutzen P. J., 1988, TROPOSPHERIC OZONE, P3, DOI [10.1007/978-94-009-2913-5_1, DOI 10.1007/978-94-009-2913-5_1]; Elshorbany YF, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017008; FRASER PJ, 1984, J ATMOS CHEM, V1, P125, DOI 10.1007/BF00053835; Hofzumahaus A, 2009, SCIENCE, V324, P1702, DOI 10.1126/science.1164566; Holmes CD, 2013, ATMOS CHEM PHYS, V13, P285, DOI 10.5194/acp-13-285-2013; HYSON P, 1980, J GEOPHYS RES-OCEANS, V85, P4443, DOI 10.1029/JC085iC08p04443; JACOB DJ, 1987, J GEOPHYS RES-ATMOS, V92, P6614, DOI 10.1029/JD092iD06p06614; Kanaya YG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007987; Krol M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002423; Krol M, 1998, J GEOPHYS RES-ATMOS, V103, P10697, DOI 10.1029/98JD00459; Krol MC, 2008, ATMOS CHEM PHYS, V8, P5033, DOI 10.5194/acp-8-5033-2008; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Levin I, 2010, ATMOS CHEM PHYS, V10, P2655, DOI 10.5194/acp-10-2655-2010; Levin I, 1996, J GEOPHYS RES-ATMOS, V101, P16745, DOI 10.1029/96JD01058; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; Lintner BR, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006535; Maione M., 2014, ATMOS CHEM PHYS DISC, V14, P8209; Maiss M, 1996, ATMOS ENVIRON, V30, P1621, DOI 10.1016/1352-2310(95)00425-4; Mao J, 2013, ATMOS CHEM PHYS, V13, P509, DOI 10.5194/acp-13-509-2013; McCulloch A, 2001, ATMOS ENVIRON, V35, P5311, DOI 10.1016/S1352-2310(01)00306-5; Miller BR, 2008, ANAL CHEM, V80, P1536, DOI 10.1021/ac702084k; Miyazaki K, 2014, ATMOS CHEM PHYS, V14, P3277, DOI 10.5194/acp-14-3277-2014; Miyazaki K, 2012, ATMOS CHEM PHYS, V12, P2263, DOI 10.5194/acp-12-2263-2012; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; Murray LT, 2013, J GEOPHYS RES-ATMOS, V118, P11468, DOI 10.1002/jgrd.50857; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; NAKAZAWA T, 1991, TELLUS B, V43, P106, DOI 10.1034/j.1600-0889.1991.t01-1-00005.x; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Patra PK, 2011, ATMOS CHEM PHYS, V11, P4163, DOI [10.5194/acp-11-4163-2011, 10.5194/acp-11-12813-2011]; Patra PK, 2009, ATMOS CHEM PHYS, V9, P1209, DOI 10.5194/acp-9-1209-2009; Prather MJ, 2007, PHILOS T R SOC A, V365, P1705, DOI 10.1098/rsta.2007.2040; Prinn RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022228; Prinn RG, 2001, SCIENCE, V292, P1882, DOI 10.1126/science.1058673; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Rigby M, 2013, ATMOS CHEM PHYS, V13, P2691, DOI 10.5194/acp-13-2691-2013; Sander S. P., 2011, JPL PUBL, V10-6, P17; Sawa Y, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016933; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; Sudo K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001113; Takigawa M, 1999, J GEOPHYS RES-ATMOS, V104, P14003, DOI 10.1029/1998JD100105; Taraborrelli D, 2012, NAT GEOSCI, V5, P190, DOI [10.1038/ngeo1405, 10.1038/NGEO1405]; Waugh DW, 2013, J GEOPHYS RES-ATMOS, V118, P11429, DOI 10.1002/jgrd.50848; Wofsy SC, 2011, PHILOS T R SOC A, V369, P2073, DOI 10.1098/rsta.2010.0313; World Meteorological Organization, 2011, 52 WORLD MET ORG GLO; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2	48	86	86	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					219	223		10.1038/nature13721	http://dx.doi.org/10.1038/nature13721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209800				2022-12-28	WOS:000341362800047
J	Van Leuven, JT; Meister, RC; Simon, C; McCutcheon, JP				Van Leuven, James T.; Meister, Russell C.; Simon, Chris; McCutcheon, John P.			Sympatric Speciation in a Bacterial Endosymbiont Results in Two Genomes with the Functionality of One	CELL			English	Article							HORIZONTAL GENE-TRANSFER; SAP-FEEDING INSECTS; ESCHERICHIA-COLI; METABOLIC INTERDEPENDENCE; EVOLUTIONARY TRANSITIONS; DELETERIOUS MUTATIONS; BUCHNERA-APHIDICOLA; MAXIMUM-LIKELIHOOD; PROTEIN EVOLUTION; MULLERS RATCHET	Mutualisms that become evolutionarily stable give rise to organismal interdependencies. Some insects have developed intracellular associations with communities of bacteria, where the interdependencies are manifest in patterns of complementary gene loss and retention among members of the symbiosis. Here, using comparative genomics and microscopy, we show that a three-member symbiotic community has become a four-way assemblage through a novel bacterial lineage-splitting event. In some but not all cicada species of the genus Tettigades, the endosymbiont Candidatus Hodgkinia cicadicola has split into two new cytologically distinct but metabolically interdependent species. Although these new bacterial genomes are partitioned into discrete cell types, the intergenome patterns of gene loss and retention are almost perfectly complementary. These results defy easy classification: they show genomic patterns consistent with those observed after both speciation and whole-genome duplication. We suggest that our results highlight the potential power of nonadaptive forces in shaping organismal complexity.	[Van Leuven, James T.; McCutcheon, John P.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Meister, Russell C.; Simon, Chris] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [McCutcheon, John P.] Canadian Inst Adv Res, CIFAR Program Integrated Microbial Biodivers, Toronto, ON M5G 1Z8, Canada	University of Montana System; University of Montana; University of Connecticut; Canadian Institute for Advanced Research (CIFAR)	McCutcheon, JP (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	john.mccutcheon@umontana.edu		Van Leuven, James/0000-0002-2730-0287; McCutcheon, John/0000-0002-5489-6039	NSF MRI program; Murdock Charitable Trust; NIH NIGMS [P20RR017670]; NSF [DEB-0955849, DEB-0529679, IOS-1256680]; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017670] Funding Source: NIH RePORTER; Direct For Biological Sciences [0955849] Funding Source: National Science Foundation	NSF MRI program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Murdock Charitable Trust; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Mike Gray, Doug Emlen, Lila Fishman, Matt Herron, Jeff Good, Scott Miller, Frank Rosenzweig, Dan Vanderpool, and Art Woods and for helpful discussions and comments on the manuscript; Amanda Brown, Kelly Nelson, Mariah Meyer, and Kaitlin Carey for technical assistance; Benjamin Price and Geert Goemans for photographs of cicada types from the Museum of Natural History, London; Jason Cryan, Carlos Zamora-Manzur, and Stephen Chiswell for field assistance in Chile; Betsey Pitts and Phil Stewart at the Montana State University Center for Biofilm Engineering (supported by the NSF MRI program and the Murdock Charitable Trust); and the University of Montana Molecular Histology Fluorescence Imaging Core (supported by NIH NIGMS Grant P20RR017670). Cicada systematic work was supported by NSF DEB-0955849 and DEB-0529679 to C.S. Genomics at the University of Montana was supported by a grant from the M.J. Murdock Charitable Trust. J.P.M. was supported by NSF grant IOS-1256680.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Baumann P, 1996, CURR MICROBIOL, V32, P279, DOI 10.1007/s002849900050; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Friesen ML, 2004, EVOLUTION, V58, P245, DOI 10.1111/j.0014-3820.2004.tb01642.x; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; GRAY MW, 1982, MICROBIOL REV, V46, P1; Gruwell ME, 2010, APPL ENVIRON MICROB, V76, P7521, DOI 10.1128/AEM.01354-10; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Karban R., 1986, P222; Koga R, 2013, ENVIRON MICROBIOL, V15, P2073, DOI 10.1111/1462-2920.12121; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Lopez-Madrigal S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-74; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Macdonald SJ, 2012, P ROY SOC B-BIOL SCI, V279, P2965, DOI 10.1098/rspb.2012.0414; Margulis L., 1993, SYMBIOSIS CELL EVOLU; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2003, P NATL ACAD SCI USA, V100, P14543, DOI 10.1073/pnas.2135345100; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Ohno S., 1970, EVOLUTION GENE DUPLI; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pettersson ME, 2007, GENETICA, V130, P199, DOI 10.1007/s10709-006-9007-7; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Rispe C, 2000, AM NAT, V156, P425, DOI 10.1086/303396; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; Sloan DB, 2013, GENOME BIOL EVOL, V5, P783, DOI 10.1093/gbe/evt044; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Smith DR, 2013, MOL BIOL EVOL, V30, P793, DOI 10.1093/molbev/mst002; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; Torres Belindo A., 1958, SECCION ZOOLOGIA, VVII, P51; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	73	85	86	1	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1270	1280		10.1016/j.cell.2014.07.047	http://dx.doi.org/10.1016/j.cell.2014.07.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25175626	Bronze			2022-12-28	WOS:000343094200010
J	Sime, LC				Sime, Louise Claire			Greenland deglaciation puzzles	SCIENCE			English	Editorial Material							CLIMATE		British Antarctic Survey, Cambridge CB23 7PP, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Sime, LC (corresponding author), British Antarctic Survey, Cambridge CB23 7PP, England.	lsim@bas.ac.uk	Sime, Louise/F-8058-2012; Sime, Louise/AAX-7730-2021	Sime, Louise/0000-0002-9093-7926; Sime, Louise/0000-0002-9093-7926	Natural Environment Research Council [NE/J004804/1, bas0100024] Funding Source: researchfish; NERC [NE/J004804/1, bas0100024] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Broecker WS, 2010, QUATERNARY SCI REV, V29, P1078, DOI 10.1016/j.quascirev.2010.02.019; Buizert C, 2014, SCIENCE, V345, P1177, DOI 10.1126/science.1254961; Carlson AE, 2012, NAT GEOSCI, V5, P607, DOI [10.1038/ngeo1528, 10.1038/NGEO1528]; CUFFEY KM, 1995, SCIENCE, V270, P455, DOI 10.1126/science.270.5235.455; DANSGAARD W, 1964, TELLUS, V16, P436; Denton G.H., 2006, PAGES NEWS, V14, P14, DOI DOI 10.22498/PAGES.14.2.14; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Kindler P., 2013, CLIM PAST DISCUSS, V9, P4099, DOI [10.5194/cpd-9-4099-2013, DOI 10.5194/CPD-9-4099-2013]; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Liu ZY, 2012, P NATL ACAD SCI USA, V109, P11101, DOI 10.1073/pnas.1202183109; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Shakun JD, 2010, QUATERNARY SCI REV, V29, P1801, DOI 10.1016/j.quascirev.2010.03.016	12	0	0	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1116	1117		10.1126/science.1257842	http://dx.doi.org/10.1126/science.1257842			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190777	Green Accepted			2022-12-28	WOS:000341179800019
J	Buiter, S				Buiter, Susanne			GEODYNAMICS How plumes help to break plates	NATURE			English	Editorial Material							CONVECTION		[Buiter, Susanne] Geol Survey Norway, N-7040 Trondheim, Norway; [Buiter, Susanne] Univ Oslo, Ctr Earth Evolut & Dynam, N-0316 Oslo, Norway	Geological Survey of Norway; University of Oslo	Buiter, S (corresponding author), Geol Survey Norway, N-7040 Trondheim, Norway.	susanne.buiter@ngu.no	Buiter, Susanne/F-9767-2012					Ballmer MD, 2011, NAT GEOSCI, V4, P457, DOI [10.1038/NGEO1187, 10.1038/ngeo1187]; Burov E, 2005, GEOPHYS J INT, V161, P469, DOI 10.1111/j.1365-246X.2005.02588.x; Burov E, 2014, NATURE, V513, P85, DOI 10.1038/nature13703; COFFIN MF, 1994, REV GEOPHYS, V32, P1, DOI 10.1029/93RG02508; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Courtillot V., 1996, Geological Society of America Special Paper, V307, P513; Foulger G. R., 2002, ASTRON GEOPHYS, V43; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Nocquet JM, 2006, J GEODESY, V80, P591, DOI 10.1007/s00190-006-0078-0; Rychert CA, 2013, NAT GEOSCI, V6, P657, DOI [10.1038/ngeo1878, 10.1038/NGEO1878]; Sleep NH, 1997, J GEOPHYS RES-SOL EA, V102, P10001, DOI 10.1029/97JB00551; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094	12	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					36	37		10.1038/513036a	http://dx.doi.org/10.1038/513036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186893				2022-12-28	WOS:000341174800020
J	Bazzano, LA; Hu, T; Reynolds, K; Yao, L; Bunol, C; Liu, YX; Chen, CS; Klag, MJ; Whelton, PK; He, J				Bazzano, Lydia A.; Hu, Tian; Reynolds, Kristi; Yao, Lu; Bunol, Calynn; Liu, Yanxi; Chen, Chung-Shiuan; Klag, Michael J.; Whelton, Paul K.; He, Jiang			Effects of Low-Carbohydrate and Low-Fat Diets A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; WEIGHT-LOSS DIETS; RISK-FACTORS; PROTEIN; PLASMA; ATKINS; ORNISH; ZONE	Background: Low-carbohydrate diets are popular for weight loss, but their cardiovascular effects have not been well-studied, particularly in diverse populations. Objective: To examine the effects of a low-carbohydrate diet compared with a low-fat diet on body weight and cardiovascular risk factors. Design: A randomized, parallel-group trial. (ClinicalTrials.gov:NCT00609271) Setting: A large academic medical center. Participants: 148 men and women without clinical cardiovascular disease and diabetes. Intervention: A low-carbohydrate (<40 g/d) or low-fat (<30% of daily energy intake from total fat [<7% saturated fat]) diet. Both groups received dietary counseling at regular intervals throughout the trial. Measurements: Data on weight, cardiovascular risk factors, and dietary composition were collected at 0, 3, 6, and 12 months. Results: Sixty participants (82%) in the low-fat group and 59 (79%) in the low-carbohydrate group completed the intervention. At 12 months, participants on the low-carbohydrate diet had greater decreases in weight (mean difference in change, -3.5 kg [95% CI, -5.6 to -1.4 kg]; P = 0.002), fat mass (mean difference in change, -1.5% [CI, -2.6% to -0.4%]; P = 0.011), ratio of total-high-density lipoprotein (HDL) cholesterol (mean difference in change, -0.44 [CI, -0.71 to -0.16]; P = 0.002), and triglyceride level (mean difference in change, -0.16 mmol/L [-14.1 mg/dL] [CI, -0.31 to -0.01 mmol/L {-27.4 to -0.8 mg/dL}]; P = 0.038) and greater increases in HDL cholesterol level (mean difference in change, 0.18 mmol/L [7.0 mg/dL] [CI, 0.08 to 0.28 mmol/L {3.0 to 11.0 mg/dL}]; P = 0.001) than those on the low-fat diet. Limitation: Lack of clinical cardiovascular disease end points. Conclusion: The low-carbohydrate diet was more effective for weight loss and cardiovascular risk factor reduction than the low-fat diet. Restricting carbohydrate may be an option for persons seeking to lose weight and reduce cardiovascular risk factors.	[Bazzano, Lydia A.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; Kaiser Permanente So Calif, Pasadena, CA 91101 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Tulane University; Kaiser Permanente; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bazzano, LA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, 1440 Canal St,SL-18,Suite 2000, New Orleans, LA 70112 USA.	lbazzano@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652	National Institutes of Health; National Center for Research Resources of the National Institutes of Health [NIH/NCRR P20-RR017659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health.; From the National Center for Research Resources of the National Institutes of Health (NIH/NCRR P20-RR017659) to the Tulane University Hypertension and Renal Center of Excellence.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Brinkworth GD, 2009, AM J CLIN NUTR, V90, P23, DOI 10.3945/ajcn.2008.27326; Calonge N, 2009, ANN INTERN MED, V150, P396; Cardillo S, 2006, Eur Rev Med Pharmacol Sci, V10, P99; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Davis NJ, 2009, DIABETES CARE, V32, P1147, DOI 10.2337/dc08-2108; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Krauss RM, 2000, CIRCULATION, V102, P2284; Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026; LAROSA JC, 1980, J AM DIET ASSOC, V77, P264; Liuzzo G, 2001, Rays, V26, P221; Molenberghs G., 2007, MISSING DATA CLIN ST; Nutrition Data System for Research, 2005, MINN NUTR DAT SYST; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Seshadri P, 2004, AM J MED, V117, P398, DOI 10.1016/j.amjmed.2004.04.009; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Stone Neil J, 2002, Curr Atheroscler Rep, V4, P433, DOI 10.1007/s11883-002-0047-x; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	31	191	195	3	145	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					309	+		10.7326/M14-0180	http://dx.doi.org/10.7326/M14-0180			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO7VT	25178568	Green Accepted			2022-12-28	WOS:000341561400001
J	Loxterkamp, D				Loxterkamp, David			"We have met the enemy"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2014	349								g5324	10.1136/bmj.g5324	http://dx.doi.org/10.1136/bmj.g5324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LH	25179682				2022-12-28	WOS:000341385800003
J	Green, A				Green, Andrew			Sheik Humarr Khan Obituary	LANCET			English	Biographical-Item																		KHAN S, PUBLICATION LIST	1	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					740	740		10.1016/S0140-6736(14)61428-8	http://dx.doi.org/10.1016/S0140-6736(14)61428-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	25184171				2022-12-28	WOS:000341361500019
J	Gao, X; Wang, KL				Gao, Xiang; Wang, Kelin			Strength of stick-slip and creeping subduction megathrusts from heat flow observations	SCIENCE			English	Article							TOHOKU-OKI EARTHQUAKE; NORTH-ISLAND; NEW-ZEALAND; JAPAN; FRICTION; ZONES; PLATE	Subduction faults, called megathrusts, can generate large and hazardous earthquakes. The mode of slip and seismicity of a megathrust is controlled by the structural complexity of the fault zone. However, the relative strength of a megathrust based on the mode of slip is far from clear. The fault strength affects surface heat flow by frictional heating during slip. We model heat-flow data for a number of subduction zones to determine the fault strength. We find that smooth megathrusts that produce great earthquakes tend to be weaker and therefore dissipate less heat than geometrically rough megathrusts that slip mainly by creeping.	[Gao, Xiang] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Geol & Environm, Qingdao 266071, Peoples R China; [Wang, Kelin] Nat Resources Canada, Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada; [Wang, Kelin] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8P 5C2, Canada	Chinese Academy of Sciences; Institute of Oceanology, CAS; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Victoria	Wang, KL (corresponding author), Nat Resources Canada, Geol Survey Canada, Pacific Geosci Ctr, 9860 West Saanich Rd, Sidney, BC V8L 4B2, Canada.	kwang@nrcan.gc.ca			Chinese Academy of Sciences' Strategic Priority Research Program [XDA11030102]; Open Foundation of Key Laboratory of Marine Geology and Environment Grant [MGE2012KG04]; Geological Survey of Canada; Natural Sciences and Engineering Research Council of Canada through University of Victoria	Chinese Academy of Sciences' Strategic Priority Research Program; Open Foundation of Key Laboratory of Marine Geology and Environment Grant; Geological Survey of Canada(Natural Resources Canada); Natural Sciences and Engineering Research Council of Canada through University of Victoria	We thank J. He for writing finite element code PGCTherm and implementing the line-element method for fault modeling, W. -C. Chi for making available digital heat-flow data for Manila Trench, and S. Wu and J. Zhang for discussions. X. G. was supported by Chinese Academy of Sciences' Strategic Priority Research Program Grant XDA11030102 and Open Foundation of Key Laboratory of Marine Geology and Environment Grant MGE2012KG04, and K. W. was supported by Geological Survey of Canada core funding and a Natural Sciences and Engineering Research Council of Canada Discovery Grant through the University of Victoria. This is Geological Survey of Canada contribution 2014105. All heat-flow data used are from published sources as listed in the reference list. Modeling parameters and tabulated results are available in the supplementary materials.	Abercrombie RE, 2005, GEOPHYS J INT, V162, P406, DOI 10.1111/j.1365-246X.2005.02579.x; Allmann BP, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005821; Barker DHN, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002153; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Doser DI, 2003, GEOPHYS J INT, V152, P795, DOI 10.1046/j.1365-246X.2003.01895.x; Hasegawa A, 2012, EARTH PLANET SC LETT, V355, P231, DOI 10.1016/j.epsl.2012.08.042; Heuret A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050712; Kanamori H, 2006, GEOPHYS MONOGR SER, V170, P3, DOI 10.1029/170GM03; Kawada Y, 2014, GEOCHEM GEOPHY GEOSY, V15, P1580, DOI 10.1002/2014GC005285; Koketsu K, 2011, EARTH PLANET SC LETT, V310, P480, DOI 10.1016/j.epsl.2011.09.009; Kumagai H, 2012, EARTH PLANETS SPACE, V64, P649, DOI 10.5047/eps.2012.01.004; Lamb S, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003916; Lee SJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049580; Lockner DA, 2011, NATURE, V472, P82, DOI 10.1038/nature09927; Noda H, 2012, J STRUCT GEOL, V38, P234, DOI 10.1016/j.jsg.2011.08.012; Power W, 2012, PURE APPL GEOPHYS, V169, P1, DOI 10.1007/s00024-011-0299-x; Pritchard ME, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004258; Scholl D.W., 2011, AM GEOPH UN FALL M; SCHOLZ CH, 1995, J GEOPHYS RES-SOL EA, V100, P22103, DOI 10.1029/95JB01869; Uchida N, 2011, EARTH PLANETS SPACE, V63, P675, DOI 10.5047/eps.2011.07.006; Wallace LM, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002610; Wang KL, 2014, TECTONOPHYSICS, V610, P1, DOI 10.1016/j.tecto.2013.11.024; Wang KL, 2011, GEOLOGY, V39, P819, DOI 10.1130/G31856.1; Wang KL, 1999, GEOPHYS RES LETT, V26, P2307, DOI 10.1029/1999GL900528; Webb TH, 1998, GEOPHYS J INT, V134, P40, DOI 10.1046/j.1365-246x.1998.00531.x; Wibberley CAJ, 2008, GEOL SOC SPEC PUBL, V299, P5, DOI 10.1144/SP299.2; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683	28	147	151	9	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1038	1041		10.1126/science.1255487	http://dx.doi.org/10.1126/science.1255487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170149				2022-12-28	WOS:000340870900036
J	Lohmueller, KE				Lohmueller, Kirk E.			On the origin of Peter Rabbit	SCIENCE			English	Editorial Material							SELECTION; REVEALS; ADAPTATION; SWEEPS; SNP		Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Interdept Program Bioinformat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Lohmueller, KE (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Interdept Program Bioinformat, Los Angeles, CA 90095 USA.	klohmueller@ucla.edu						Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109	12	2	2	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1000	1001		10.1126/science.1258775	http://dx.doi.org/10.1126/science.1258775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170135				2022-12-28	WOS:000340870900015
J	Yusuf, S; Rangarajan, S; Teo, K; Islam, S; Li, W; Liu, L; Bo, J; Lou, Q; Lu, F; Liu, T; Yu, L; Zhang, S; Mony, P; Swaminathan, S; Mohan, V; Gupta, R; Kumar, R; Vijayakumar, K; Lear, S; Anand, S; Wielgosz, A; Diaz, R; Avezum, A; Lopez-Jaramillo, P; Lanas, F; Yusoff, K; Ismail, N; Iqbal, R; Rahman, O; Rosengren, A; Yusufali, A; Kelishadi, R; Kruger, A; Puoane, T; Szuba, A; Chifamba, J; Oguz, A; McQueen, M; McKee, M; Dagenais, G				Yusuf, S.; Rangarajan, S.; Teo, K.; Islam, S.; Li, W.; Liu, L.; Bo, J.; Lou, Q.; Lu, F.; Liu, T.; Yu, L.; Zhang, S.; Mony, P.; Swaminathan, S.; Mohan, V.; Gupta, R.; Kumar, R.; Vijayakumar, K.; Lear, S.; Anand, S.; Wielgosz, A.; Diaz, R.; Avezum, A.; Lopez-Jaramillo, P.; Lanas, F.; Yusoff, K.; Ismail, N.; Iqbal, R.; Rahman, O.; Rosengren, A.; Yusufali, A.; Kelishadi, R.; Kruger, A.; Puoane, T.; Szuba, A.; Chifamba, J.; Oguz, A.; McQueen, M.; McKee, M.; Dagenais, G.		PURE Investigators	Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; HEMORRHAGIC STROKE; MONICA PROJECT; GLOBAL BURDEN; RATES; POPULATIONS; INTERHEART; MORTALITY; REGIONS; DEATHS	BACKGROUND More than 80% of deaths from cardiovascular disease are estimated to occur in low-income and middle-income countries, but the reasons are unknown. METHODS We enrolled 156,424 persons from 628 urban and rural communities in 17 countries (3 high-income, 10 middle-income, and 4 low-income countries) and assessed their cardiovascular risk using the INTERHEART Risk Score, a validated score for quantifying risk-factor burden without the use of laboratory testing (with higher scores indicating greater risk-factor burden). Participants were followed for incident cardiovascular disease and death for a mean of 4.1 years. RESULTS The mean INTERHEART Risk Score was highest in high-income countries, intermediate in middle-income countries, and lowest in low-income countries (P<0.001). However, the rates of major cardiovascular events (death from cardiovascular causes, myocardial infarction, stroke, or heart failure) were lower in high-income countries than in middle- and low-income countries (3.99 events per 1000 person-years vs. 5.38 and 6.43 events per 1000 person-years, respectively; P<0.001). Case fatality rates were also lowest in high-income countries (6.5%, 15.9%, and 17.3% in high-, middle-, and low-income countries, respectively; P=0.01). Urban communities had a higher risk-factor burden than rural communities but lower rates of cardiovascular events (4.83 vs. 6.25 events per 1000 person-years, P<0.001) and case fatality rates (13.52% vs. 17.25%, P<0.001). The use of preventive medications and revascularization procedures was significantly more common in high-income countries than in middle- or low-income countries (P<0.001). CONCLUSIONS Although the risk-factor burden was lowest in low-income countries, the rates of major cardiovascular disease and death were substantially higher in low-income countries than in high-income countries. The high burden of risk factors in high-income countries may have been mitigated by better control of risk factors and more frequent use of proven pharmacologic therapies and revascularization. (Funded by the Population Health Research Institute and others.)	[Yusuf, S.; Rangarajan, S.; Teo, K.; Islam, S.; Anand, S.; McQueen, M.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Yusuf, S.; Rangarajan, S.; Teo, K.; Islam, S.; Anand, S.; McQueen, M.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Lear, S.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Wielgosz, A.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Dagenais, G.] Univ Laval, Heart & Lungs Inst, Quebec City, PQ, Canada; [Li, W.; Liu, L.; Bo, J.] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100730, Peoples R China; [Li, W.; Liu, L.; Bo, J.] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Lou, Q.] Jiangsu Prov Inst Geriatr, Nanjing, Jiangsu, Peoples R China; [Lu, F.] Shandong Prov Acad Med Sci, Jinan, Shandong, Peoples R China; [Liu, T.] Xian Elect Technol Univ Hosp, Xian, Shanxi Province, Peoples R China; [Yu, L.] Shenyang City 242 Hosp, Shenyang, Liaoning Provin, Peoples R China; [Zhang, S.] Bayannaoer Ctr Dis Control & Prevent, Linhe Dist, Jiefangxi, Peoples R China; [Mony, P.; Swaminathan, S.] St Johns Res Inst, Div Epidemiol & Populat Hlth, Bangalore, Karnataka, India; [Mohan, V.] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Gupta, R.] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Kumar, R.] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; [Vijayakumar, K.] Hlth Act People, Trivandrum, Kerala, India; [Diaz, R.] Estudios Clin Latinoamer ECLA, Rosario, Santa Fe, Argentina; [Avezum, A.] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Lopez-Jaramillo, P.] Univ Santander, Sch Med, Fdn Oftalmol Santander FOSCAL, Floridahlanca Santander, Colombia; [Lanas, F.] Univ La Frontera, Temuco, Chile; [Yusoff, K.] Univ Teknol MARA, Fac Med, Sungai Buloh, Selangor, Malaysia; [Yusoff, K.] UCSI Univ Kuala Lumpur, Kuala Lumpur, Malaysia; [Ismail, N.] Univ Kebangsaan Malaysia, Med Ctr, Dept Community Hlth, Kuala Lumpur, Malaysia; [Iqbal, R.] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Iqbal, R.] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Rahman, O.] Independent Univ, Dhaka, Bangladesh; [Rosengren, A.] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Yusufali, A.] Dubai Hlth Author, Hatta Hosp, Dubai, U Arab Emirates; [Kelishadi, R.] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Kruger, A.] North West Univ, Fac Hlth Sci, Potchefstroom, South Africa; [Puoane, T.] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Szuba, A.] Wroclaw Med Univ, Dept Internal Med, Wroclaw, Poland; [Chifamba, J.] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Oguz, A.] Medeniyet Univ, Fac Med, Dept Internal Med Istanbul, Istanbul, Turkey; [McKee, M.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	McMaster University; Population Health Research Institute; McMaster University; Simon Fraser University; University of Ottawa; Laval University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Shandong First Medical University & Shandong Academy of Medical Sciences; St. John's National Academy of Health Sciences; St. John's Research Institute; Madras Diabetes Research Foundation; Fortis Escorts Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Instituto Dante Pazzanese de Cardiologia; Universidad Industrial de Santander; Universidad de La Frontera; Universiti Teknologi MARA; UCSI University; Universiti Kebangsaan Malaysia; Aga Khan University; Aga Khan University; Independent University Bangladesh (IUB); University of Gothenburg; Isfahan University Medical Science; North West University - South Africa; University of the Western Cape; Wroclaw Medical University; University of Zimbabwe; Istanbul Medeniyet University; Istanbul University; University of London; London School of Hygiene & Tropical Medicine	Yusuf, S (corresponding author), Hamilton Gen Hosp, DBCVSRI, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Chifamba, Jephat/AHE-4535-2022; Szuba, Andrzej/AAY-1162-2020; Lanas, Fernando/AAE-8842-2022; Mony, Prem K./GRF-4752-2022; Avezum, Alvaro AA/K-6137-2016; Mckee, Martin/E-6673-2018; Husseini, Abdullatif/E-8377-2015; Oguz, Aytekin/AAJ-2732-2021; Avezum, Alvaro/AAP-7687-2020; McKee, Marc D/E-2187-2011; Yusoff, Khalid/I-7029-2019; Igumbor, Ehimario U/B-2652-2012; Kelishadi, Roya/E-6154-2012; Swaminathan, Sumathi/AGI-7678-2022; Rahman, Omar/E-1329-2019; Qorbani, Mostafa/M-8171-2017; Gomez-Arbelaez, Diego/K-1883-2013	Chifamba, Jephat/0000-0001-8166-1182; Mony, Prem K./0000-0002-1399-0520; Avezum, Alvaro AA/0000-0002-3073-6890; Mckee, Martin/0000-0002-0121-9683; Husseini, Abdullatif/0000-0001-8767-5956; Oguz, Aytekin/0000-0002-2595-5167; McKee, Marc D/0000-0001-8349-965X; Yusoff, Khalid/0000-0001-5669-5188; Igumbor, Ehimario U/0000-0002-6313-6031; Kelishadi, Roya/0000-0001-7455-1495; Rahman, Omar/0000-0002-0606-2507; Teo, Koon/0000-0002-3731-0956; Yusufali, Afzalhussein/0000-0003-3378-2646; Jerling, Johann/0000-0003-2600-3536; Ismail, Noor Hassim/0000-0003-1547-7904; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Yusuf, Salim/0000-0003-4776-5601; Iqbal, Romaina/0000-0002-5364-4366; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Gulec, Sadi/0000-0002-2685-2522; Szuba, Andrzej/0000-0002-7555-6201; Camacho, Paul Anthony/0000-0002-6233-9582; Rosengren, Annika/0000-0002-5409-6605; Lanas, Fernando/0000-0003-3595-9759	Population Health Research Institute	Population Health Research Institute	Funded by the Population Health Research Institute and others.	Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; MARMOT M, 1992, CORONARY HEART DIS E, P3; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Stringhini S, 2013, INT J CARDIOL, V168, P1201, DOI 10.1016/j.ijcard.2012.11.064; Teo K, 2009, AM HEART J, V158, p1e1; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Walker ARP, 2004, J R SOC PROMO HEALTH, V124, P40, DOI 10.1177/146642400312400112; Wu ZS, 2004, EUR J CARDIOV PREV R, V11, P275, DOI 10.1097/01.hjr.0000136566.89429.63; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	17	505	531	2	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					818	827		10.1056/NEJMoa1311890	http://dx.doi.org/10.1056/NEJMoa1311890			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162888	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000340819800008
J	Dickson, RP; Martinez, FJ; Huffnagle, GB				Dickson, Robert P.; Martinez, Fernando J.; Huffnagle, Gary B.			The role of the microbiome in exacerbations of chronic lung diseases	LANCET			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ACUTE RESPIRATORY EXACERBATIONS; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; AIRWAY MICROBIOME; SURFACE-AREA; DOUBLE-BLIND; GASTROESOPHAGEAL-REFLUX; COPD EXACERBATIONS; CONTROLLED-TRIAL	Culture-independent microbiological techniques have shown a previously unappreciated complexity to the bacterial microbiome of the respiratory tract that forces reconsideration of the interactions between host, bacteria, and the pathogenesis of exacerbations of chronic lung disease. The composition of the lung microbiome is determined by microbial immigration, elimination, and relative growth rates of its members. All these factors change dramatically in chronic lung disease and further during exacerbations. Exacerbations lack the features of bacterial infections, including increased bacterial burden and decreased diversity of microbial communities. We propose that exacerbations are occasions of respiratory tract dysbiosis-a disorder of the respiratory tract microbial ecosystem with negative effects on host biology. Respiratory tract dysbiosis provokes a dysregulated host immune response, which in turn alters growth conditions for microbes in airways, promoting further dysbiosis and perpetuating a cycle of inflammation and disordered microbiota. Differences in the composition of baseline respiratory tract microbiota might help to explain the so-called frequent-exacerbator phenotype observed in several disease states, and might provide novel targets for therapeutic intervention.	[Dickson, Robert P.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Martinez, Fernando J.] Weill Cornell Med Coll, Dept Internal Med, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University	Huffnagle, GB (corresponding author), Univ Michigan, Sch Med, Div Pulm & Crit Care Med, 6301 MSRB 3,SPC 5642,1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	ghuff@umich.edu	Huffnagle, Gary B./ABF-1323-2020; Dickson, Robert/AAU-2949-2020	Dickson, Robert/0000-0002-6875-4277	NIH grants [T32HL00774921, U01HL098961, R01HL114447]; Nesbitt Family Charitable Foundation; Nesbitt Program For Cystic Fibrosis Research; University of Michigan; Host Microbiome Initiative of the University of Michigan, MA, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749, U01HL098961, R01HL114447] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nesbitt Family Charitable Foundation; Nesbitt Program For Cystic Fibrosis Research; University of Michigan(University of Michigan System); Host Microbiome Initiative of the University of Michigan, MA, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH grants T32HL00774921 (RPD), U01HL098961 (GBH), R01HL114447 (GBH, FJM), the Nesbitt Family Charitable Foundation (GBH), the Nesbitt Program For Cystic Fibrosis Research (GBH), and the University of Michigan. Support was provided by the Host Microbiome Initiative of the University of Michigan, MA, USA.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; AlvarezLerma F, 1996, INTENS CARE MED, V22, P387, DOI 10.1007/BF01712153; Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; [Anonymous], 2010, DIVERSITY COMPLEXITY; Baas Becking LGM, 1934, GEOBIOLOGY INTRO SCI; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Bruzzese E, 2007, CLIN NUTR, V26, P322, DOI 10.1016/j.clnu.2007.01.004; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; ChanYeung M, 1996, AM J RESP CRIT CARE, V154, P889, DOI 10.1164/ajrccm.154.4.8887581; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Coxson HO, 1997, AM J RESP CRIT CARE, V155, P1649, DOI 10.1164/ajrccm.155.5.9154871; Cystic Fibrosis Foundation, 2012, PAT REG REP; D'Ovidio F, 2005, ANN THORAC SURG, V80, P1254, DOI 10.1016/j.athoracsur.2005.03.106; Dickson RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097214; Dickson RP, 2014, LANCET RESP MED, V2, P238, DOI 10.1016/S2213-2600(14)70028-1; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; DOCK DS, 1961, J CLIN INVEST, V40, P317, DOI 10.1172/JCI104259; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Evans SA, 1996, EUR RESPIR J, V9, P1601, DOI 10.1183/09031936.96.09081601; Fellermann K, 1998, AM J GASTROENTEROL, V93, P1860; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Freestone PP, 2012, CHEST, V142, P1200, DOI 10.1378/chest.11-2614; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; GOLD R, 1985, PEDIATR INFECT DIS J, V4, P172, DOI 10.1097/00006454-198503000-00012; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Gollwitzer ES, 2014, PHARMACOL THERAPEUT, V141, P32, DOI 10.1016/j.pharmthera.2013.08.002; GRAHAM V, 2001, COCHRANE DB SYST REV, V3; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; HASLETON PS, 1972, J ANAT, V112, P391; HATCH TF, 1961, BACTERIOL REV, V25, P237, DOI 10.1128/MMBR.25.3.237-240.1961; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hirschmann JV, 2000, CHEST, V118, P193, DOI 10.1378/chest.118.1.193; Holland J. H., 2006, Journal of Systems Science and Complexity, V19, P1, DOI 10.1007/s11424-006-0001-z; HOLLAND JH, 1992, DAEDALUS, V121, P17; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Hurley MN, 2012, J CYST FIBROS, V11, P288, DOI 10.1016/j.jcf.2012.02.006; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; HYATT AC, 1981, J PEDIATR-US, V99, P307, DOI 10.1016/S0022-3476(81)80486-6; Hyzy R, 2007, CHEST, V132, P1652, DOI 10.1378/chest.07-0299; INGENITO EP, 1987, J APPL PHYSIOL, V63, P2075, DOI 10.1152/jappl.1987.63.5.2075; Iwai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095726; Kanangat S, 1999, INFECT IMMUN, V67, P2834, DOI 10.1128/IAI.67.6.2834-2840.1999; Kaza SK, 2011, INT J MED MICROBIOL, V301, P26, DOI 10.1016/j.ijmm.2010.06.005; KELLY C, 1988, THORAX, V43, P684, DOI 10.1136/thx.43.9.684; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Krishnan V, 2006, AM J RESP CRIT CARE, V174, P633, DOI 10.1164/rccm.200601-007OC; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Lieu TA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e72; Lighthart B., 2000, AEROBIOLOGIA, V16, P7, DOI [DOI 10.1023/A:1007694618888, 10.1023/A:1007694618888]; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Lozupone C, 2013, AM J RESP CRIT CARE, V187, P1110, DOI 10.1164/rccm.201211-2145OC; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Magadle R, 2002, CHEST, V121, P329, DOI 10.1378/chest.121.2.329; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Maughan H, 2012, PULM MED, V2012, DOI 10.1155/2012/746358; MCFADDEN ER, 1985, J CLIN INVEST, V76, P1007, DOI 10.1172/JCI112052; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Millares L, 2014, EUR J CLIN MICROBIOL, V33, P1101, DOI 10.1007/s10096-013-2044-0; Molyneaux PL, 2013, AM J RESP CRIT CARE, V188, P1224, DOI 10.1164/rccm.201302-0341OC; Molyneaux PL, 2012, C103 PATHOGENESIS BI, V185, pA5174; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Munyard P, 1996, ARCH DIS CHILD, V74, P531, DOI 10.1136/adc.74.6.531; O'Donnell DE, 2006, THORAX, V61, P354, DOI 10.1136/thx.2005.041830; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Perera WR, 2007, EUR RESPIR J, V29, P527, DOI 10.1183/09031936.00092506; PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Raghu G, 2006, EUR RESPIR J, V27, P136, DOI 10.1183/09031936.06.00037005; Richter AG, 2009, THORAX, V64, P692, DOI 10.1136/thx.2008.110445; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Sanders DB, 2010, PEDIATR PULM, V45, P127, DOI 10.1002/ppul.21117; Sass AM, 2013, ISME J, V7, P1568, DOI 10.1038/ismej.2013.36; Schmidt A, 2014, J CYST FIBROS, V13, P623, DOI 10.1016/j.jcf.2014.03.004; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Short FL, 2014, TRENDS MICROBIOL, DOI [10.1016/S0966-842X(14)00116-4, DOI 10.1016/S0966-842X(14)00116-4]; Shulgina L, 2013, THORAX, V68, P155, DOI 10.1136/thoraxjnl-2012-202403; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Simon RH, 2014, CYSTIC FIBROSIS ANTI; Slater M, 2014, THORAX, V69, P673, DOI 10.1136/thoraxjnl-2013-204517; Smith AL, 2003, CHEST, V123, P1495, DOI 10.1378/chest.123.5.1495; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Twomey KB, 2012, ISME J, V6, P939, DOI 10.1038/ismej.2011.167; VANDEGRAAF EA, 1991, AM REV RESPIR DIS, V143, P362, DOI 10.1164/ajrccm/143.2.362; Vollenweider Daniela J, 2012, Cochrane Database Syst Rev, V12, pCD010257, DOI 10.1002/14651858.CD010257; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Weiss B, 2010, PEDIATR PULM, V45, P536, DOI 10.1002/ppul.21138; WEST JB, 1978, CHEST, V74, P426, DOI 10.1378/chest.74.4.426; WIENTZEN R, 1980, AM J DIS CHILD, V134, P1134, DOI 10.1001/archpedi.1980.02130240018007; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Zalacain R, 1999, EUR RESPIR J, V13, P343, DOI 10.1034/j.1399-3003.1999.13b21.x; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	138	261	279	9	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					691	702		10.1016/S0140-6736(14)61136-3	http://dx.doi.org/10.1016/S0140-6736(14)61136-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25152271	Green Accepted			2022-12-28	WOS:000341359100027
J	Fox, IJ; Daley, GQ; Goldman, SA; Huard, J; Kamp, TJ; Trucco, M				Fox, Ira J.; Daley, George Q.; Goldman, Steven A.; Huard, Johnny; Kamp, Timothy J.; Trucco, Massimo			Use of differentiated pluripotent stem cells in replacement therapy for treating disease	SCIENCE			English	Review							DUCHENNE MUSCULAR-DYSTROPHY; RED-BLOOD-CELLS; HEPATOCYTE TRANSPLANTATION; PROGENITOR CELLS; SKELETAL-MUSCLE; HUMAN ES; MYOBLAST TRANSPLANTATION; ANIMAL-MODELS; MOUSE MODEL; HEPATOCELLULAR TRANSPLANTATION	Pluripotent stem cells (PSCs) directed to various cell fates holds promise as source material for treating numerous disorders. The availability of precisely differentiated PSC-derived cells will dramatically affect blood component and hematopoietic stem cell therapies and should facilitate treatment of diabetes, some forms of liver disease and neurologic disorders, retinal diseases, and possibly heart disease. Although an unlimited supply of specific cell types is needed, other barriers must be overcome. This review of the state of cell therapies highlights important challenges. Successful cell transplantation will require optimizing the best cell type and site for engraftment, overcoming limitations to cell migration and tissue integration, and occasionally needing to control immunologic reactivity, as well as a number of other challenges. Collaboration among scientists, clinicians, and industry is critical for generating new stem cell-based therapies.	[Fox, Ira J.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; [Fox, Ira J.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Daley, George Q.] Boston Childrens Hosp, Boston, MA USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Broad Inst, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Goldman, Steven A.] Univ Copenhagen, Ctr Basic & Translat Neurosci, DK-1168 Copenhagen, Denmark; [Huard, Johnny] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Stem Cell Res Ctr, Pittsburgh, PA 15261 USA; [Kamp, Timothy J.] Univ Wisconsin, Dept Med, Stem Cell & Regenerat Med Ctr, Cellular & Mol Arrhythmia Res Program,Sch Med & P, Madison, WI USA; [Trucco, Massimo] Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Immunogenet, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; University of Rochester; University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fox, IJ (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.	foxi@upmc.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876	NIH [R01DK48794, P01DK096990, R01DK099320, 1P01AG043376, U01HL099773]; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; Mathers Charitable Foundation; National Multiple Sclerosis Society; Adelson Medical Research Foundation; Child Health and Development Institute; New York Stem Cell Research Program; DOD [W81XWH-10-1-1055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099320, R01DK048794, P01DK096990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104701, R01MH099578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG043376] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0004260] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mathers Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Adelson Medical Research Foundation; Child Health and Development Institute; New York Stem Cell Research Program; DOD(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank E. Tafaleng, N. Giannoukakis, and J. H. Cummins for providing figures and for text editing. This work was supported in part by NIH R01DK48794, P01DK096990, and R01DK099320 (I.J.F.); National Institute of Neurological Disorders and Stroke, National Institute of Mental Health, the Mathers Charitable Foundation, the National Multiple Sclerosis Society, the Adelson Medical Research Foundation, Child Health and Development Institute, and the New York Stem Cell Research Program (S.A.G.); NIH 1P01AG043376 (J. H.); U01HL099773 (T.J.K.); and DOD W81XWH-10-1-1055 (M.T.). I.J.F. is a member of the Scientific Advisory Board of Regenerative Medicine Solutions, Inc.; G.Q.D. is a member of the Senior Advisory Board of MPM Capital, Inc.; S.A.G. is a consultant for Biogen Idec; T.J.K. is a founding shareholder in Cellular Dynamics International; and J. H. is a consultant for Cook Myosite. S.A.G. is an inventor on patents owned by the University of Rochester and Cornell University concerning the use of tissue-and iPSC-derived glial progenitor cells.	ALEJANDRO R, 1986, J CLIN INVEST, V78, P1339, DOI 10.1172/JCI112720; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Benraiss A, 2013, CELL STEM CELL, V12, P787, DOI 10.1016/j.stem.2013.04.014; Benraiss A, 2011, NEUROTHERAPEUTICS, V8, P577, DOI 10.1007/s13311-011-0075-8; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bottino R, 2002, BEST PRACT RES CL GA, V16, P457, DOI 10.1053/bega.2002.0318; Buchholz DE, 2013, STEM CELL TRANSL MED, V2, P384, DOI 10.5966/sctm.2012-0163; Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z; Carri AD, 2013, DEVELOPMENT, V140, P301, DOI 10.1242/dev.084608; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Creusot RJ, 2014, DIABETES, V63, P20, DOI 10.2337/db13-0886; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DEMETRIOU AA, 1988, HEPATOLOGY, V8, P1006, DOI 10.1002/hep.1840080505; DEPAEPE ME, 1995, HEPATOLOGY, V21, P1144, DOI 10.1016/0270-9139(95)90267-8; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Echeverria GJ, 2009, AM J TRANSPLANT, V9, P2485, DOI 10.1111/j.1600-6143.2009.02815.x; Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550; Fisher SA, 2014, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD007888.PUB2; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Gagandeep S, 2000, J PATHOL, V191, P78, DOI 10.1002/(SICI)1096-9896(200005)191:1<78::AID-PATH587>3.0.CO;2-P; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Goldman SA, 2011, ARCH NEUROL-CHICAGO, V68, P848, DOI 10.1001/archneurol.2011.46; Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188; GROTH CG, 1977, TRANSPLANT P, V9, P313; Guha C, 2002, HEPATOLOGY, V36, P354, DOI 10.1053/jhep.2002.34516; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoppo T, 2011, GASTROENTEROLOGY, V140, P656, DOI 10.1053/j.gastro.2010.11.006; Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262; HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504; JASMIN G, 1984, LAB INVEST, V50, P197; Kallestad KM, 2011, EXP CELL RES, V317, P873, DOI 10.1016/j.yexcr.2011.01.018; KARPATI G, 1989, AM J PATHOL, V135, P27; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; KEMP CB, 1973, NATURE, V244, P447, DOI 10.1038/244447a0; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lacotte S, 2011, EXPERT OPIN BIOL TH, V11, P55, DOI 10.1517/14712598.2011.536530; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Lepore AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025968; Li M, 2014, J BIOL CHEM, V289, P4594, DOI 10.1074/jbc.R113.488247; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liao SW, 2013, BIOMATERIALS, V34, P3984, DOI 10.1016/j.biomaterials.2013.02.007; LIECHTIGALLATI S, 1981, PEDIATR RES, V15, P1411, DOI 10.1203/00006450-198111000-00004; Lindvall O, 2012, NAT BIOTECHNOL, V30, P56, DOI 10.1038/nbt.2077; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; MATAS AJ, 1976, SCIENCE, V192, P892, DOI 10.1126/science.818706; Mazurier C, 2011, CURR OPIN HEMATOL, V18, P249, DOI 10.1097/MOH.0b013e3283476129; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; MITO M, 1979, TRANSPLANTATION, V28, P499, DOI 10.1097/00007890-197912000-00013; MITO M, 1992, TRANSPLANT P, V24, P3052; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Muraca M, 2002, LANCET, V359, P317, DOI 10.1016/S0140-6736(02)07529-3; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakamura S, 2014, CELL STEM CELL, V14, P535, DOI 10.1016/j.stem.2014.01.011; Newsome PN, 2000, LIVER TRANSPLANT, V6, P21, DOI 10.1016/S1527-6465(00)80029-5; Nguyen PK, 2011, CIRC RES, V109, P962, DOI 10.1161/CIRCRESAHA.111.242909; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; PIPELEERS DG, 1991, DIABETES, V40, P908, DOI 10.2337/diabetes.40.7.908; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; RIBEIRO J, 1992, HEPATOLOGY, V15, P12, DOI 10.1002/hep.1840150104; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rinaldi F, 2014, TRANSL RES, V163, P409, DOI 10.1016/j.trsl.2013.11.006; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Rousseau GF, 2014, BIOTECHNOL J, V9, P28, DOI 10.1002/biot.201200368; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; RUGSTAD JE, 1970, SCIENCE, V170, P553; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Schumacher IK, 1996, HEPATOLOGY, V24, P337; Sharma V, 2006, NEW ENGL J MED, V355, P1397; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Sokal EM, 2003, TRANSPLANTATION, V76, P735, DOI 10.1097/01.TP.0000077420.81365.53; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Stern JH, 2011, NEUROTHERAPEUTICS, V8, P736, DOI 10.1007/s13311-011-0077-6; Sutherland DER, 2012, J AM COLL SURGEONS, V214, P409, DOI 10.1016/j.jamcollsurg.2011.12.040; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541; TERBLANCHE J, 1991, DIGEST DIS SCI, V36, P770, DOI 10.1007/BF01311235; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2006, STEM CELLS, V24, P1370, DOI 10.1634/stemcells.2005-0340; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Torrente Y, 2000, CELL TRANSPLANT, V9, P539, DOI 10.1177/096368970000900410; Tuszynski MH, 2014, CELL, V156, P388, DOI 10.1016/j.cell.2014.01.016; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; van der Windt DJ, 2009, AM J TRANSPLANT, V9, P2716, DOI 10.1111/j.1600-6143.2009.02850.x; VILQUIN JT, 1995, J CELL BIOL, V131, P975, DOI 10.1083/jcb.131.4.975; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang L, 2005, EXP HEMATOL, V33, P987, DOI 10.1016/j.exphem.2005.06.002; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WIEDERKEHR JC, 1990, TRANSPLANTATION, V50, P466, DOI 10.1097/00007890-199009000-00021; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yoshida Y, 1996, GASTROENTEROLOGY, V111, P1654, DOI 10.1016/S0016-5085(96)70029-X; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zhou HC, 2009, HEPATOLOGY, V50, p303A; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	150	202	210	10	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					889	+	1247391	10.1126/science.1247391	http://dx.doi.org/10.1126/science.1247391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6ZO	25146295	Green Accepted			2022-12-28	WOS:000349775800001
J	Qureshi, B; Albany, C				Qureshi, Beenish; Albany, Costantine			Posterior Mediastinal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Qureshi, Beenish; Albany, Costantine] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Qureshi, B (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.	calbany@iupui.edu							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8							e10	10.1056/NEJMicm1314944	http://dx.doi.org/10.1056/NEJMicm1314944			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140976				2022-12-28	WOS:000340509900012
J	Pilgrim, T; Heg, D; Roffi, M; Tuller, D; Muller, O; Vuilliomenet, A; Cook, S; Weilenmann, D; Kaiser, C; Jamshidi, P; Fahrni, T; Moschovitis, A; Noble, S; Eberli, FR; Wenaweser, P; Juni, P; Windecker, S				Pilgrim, Thomas; Heg, Dik; Roffi, Marco; Tuller, David; Muller, Olivier; Vuilliomenet, Andre; Cook, Stephane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Fahrni, Therese; Moschovitis, Aris; Noble, Stephane; Eberli, Franz R.; Wenaweser, Peter; Juni, Peter; Windecker, Stephan			Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial	LANCET			English	Article							BARE-METAL STENTS; ARTERY-DISEASE; CLINICAL-OUTCOMES; POOLED ANALYSIS; FOLLOW-UP; THROMBOSIS; INTERVENTION; LEADERS; SAFETY; METAANALYSIS	Background Refinements in stent design affecting strut thickness, surface polymer, and drug release have improved clinical outcomes of drug-eluting stents. We aimed to compare the safety and efficacy of a novel, ultrathin strut cobalt-chromium stent releasing sirolimus from a biodegradable polymer with a thin strut durable polymer everolimus-eluting stent. Methods We did a randomised, single-blind, non-inferiority trial with minimum exclusion criteria at nine hospitals in Switzerland. We randomly assigned (1:1) patients aged 18 years or older with chronic stable coronary artery disease or acute coronary syndromes undergoing percutaneous coronary intervention to treatment with biodegradable polymer sirolimus-eluting stents or durable polymer everolimus-eluting stents. Randomisation was via a central web-based system and stratified by centre and presence of ST segment elevation myocardial infarction. Patients and outcome assessors were masked to treatment allocation, but treating physicians were not. The primary endpoint, target lesion failure, was a composite of cardiac death, target vessel myocardial infarction, and clinically-indicated target lesion revascularisation at 12 months. A margin of 3.5% was defined for non-inferiority of the biodegradable polymer sirolimus-eluting stent compared with the durable polymer everolimus-eluting stent. Analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT01443104. Findings Between Feb 24, 2012, and May 22, 2013, we randomly assigned 2119 patients with 3139 lesions to treatment with sirolimus-eluting stents (1063 patients, 1594 lesions) or everolimus-eluting stents (1056 patients, 1545 lesions). 407 (19%) patients presented with ST-segment elevation myocardial infarction. Target lesion failure with biodegradable polymer sirolimus-eluting stents (69 cases; 6.5%) was non-inferior to durable polymer everolimus-eluting stents (70 cases; 6.6%) at 12 months (absolute risk difference -0.14%, upper limit of one-sided 95% CI 1.97%, p for non-inferiority <0.0004). No significant differences were noted in rates of definite stent thrombosis (9 [0.9%] vs 4 [0.4%], rate ratio [RR] 2.26, 95% CI 0.70-7.33, p=0.16). In pre-specified stratified analyses of the primary endpoint, biodegradable polymer sirolimus-eluting stents were associated with improved outcome compared with durable polymer everolimus-eluting stents in the subgroup of patients with ST-segment elevation myocardial infarction (7 [3.3%] vs 17 [8.7%], RR 0.38, 95% CI 0.16-0.91, p=0.024, p for interaction=0.014). Interpretation In a patient population with minimum exclusion criteria and high adherence to dual antiplatelet therapy, biodegradable polymer sirolimus-eluting stents were non-inferior to durable polymer everolimus-eluting stents for the combined safety and efficacy outcome target lesion failure at 12 months. The noted benefit in the subgroup of patients with ST-segment elevation myocardial infarction needs further study.	[Pilgrim, Thomas; Fahrni, Therese; Moschovitis, Aris; Wenaweser, Peter; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland; [Roffi, Marco; Noble, Stephane] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland; [Tuller, David; Eberli, Franz R.] Triemli Municipal Hosp, Dept Cardiol, Zurich, Switzerland; [Muller, Olivier] Univ Lausanne Hosp, Dept Cardiol, Lausanne, Switzerland; [Vuilliomenet, Andre] Kantonsspital, Dept Cardiol, Aarau, Switzerland; [Cook, Stephane] Univ Hosp, Dept Cardiol, Fribourg, Switzerland; [Weilenmann, Daniel] Kantonsspital, Dept Cardiol, St Gallen, Switzerland; [Kaiser, Christoph] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Jamshidi, Peiman] Kantonsspital, Dept Cardiol, Luzern, Switzerland; [Heg, Dik; Juni, Peter] Univ Hosp Bern, Inst Social & Prevent Med, CH-3010 Bern, Switzerland; [Heg, Dik; Juni, Peter] Univ Hosp Bern, Clin Trials Unit, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Geneva; Triemli Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Basel; Kantonsspital Aarau AG (KSA); Lucerne Cantonal Hospital; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Windecker, S (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Kaiser, Christoph/AAA-9284-2022; Wenaweser, Peter/AAN-7009-2021; Pilgrim, Thomas/AAS-9120-2021; Juni, Peter/Q-8700-2016	Pilgrim, Thomas/0000-0001-8721-4068; Juni, Peter/0000-0002-5985-0670; Heg, Dik/0000-0002-8766-7945	Clinical Trials Unit; University of Bern; Biotronik, Bulach, Switzerland	Clinical Trials Unit; University of Bern; Biotronik, Bulach, Switzerland	Clinical Trials Unit, University of Bern, and Biotronik, Bulach, Switzerland.	Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dahm JB, 2009, EUROINTERVENTION, V4, P502, DOI 10.4244/EIJV4I4A85; Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; de Belder A, 2014, J AM COLL CARDIOL, V63, P1371, DOI 10.1016/j.jacc.2013.10.053; de Waha A, 2014, EUROINTERVENTION; Hamon M, 2013, EUROINTERVENTION, V8, P1006, DOI 10.4244/EIJV8I9A155; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kastrati A, 2001, CIRCULATION, V103, P2816; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Lansky AJ, 2010, CIRC-CARDIOVASC INTE, V3, P602, DOI 10.1161/CIRCINTERVENTIONS.110.959080; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Natsuaki M, 2014, JAMA-J AM MED ASSOC, V311, P2125, DOI 10.1001/jama.2014.3584; Navarese EP, 2013, BMJ-BRIT MED J, V347, pf6530; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pilgrim T, 2014, AM HEART J, V168, P256, DOI 10.1016/j.ahj.2014.06.004; Prineas R., 1982, MINNESOTA CODE MANUA; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P55, DOI 10.1016/j.jcin.2013.07.012; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Smits PC, 2013, EUROPCR 2014 PAR FRA; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Stefanini GG, 2013, LANCET, V382, P1879, DOI 10.1016/S0140-6736(13)61782-1; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; von Birgelen C, 2014, LANCET, V383, P413, DOI 10.1016/S0140-6736(13)62037-1; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Windecker S, 2013, EUROPCR 2013 PAR FRA; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859	42	199	201	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2111	2122		10.1016/S0140-6736(14)61038-2	http://dx.doi.org/10.1016/S0140-6736(14)61038-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25189359				2022-12-28	WOS:000346354300027
J	van der Wouden, JC; Koning, S				van der Wouden, Johannes C.; Koning, Sander			Treatment of impetigo in resource-limited settings	LANCET			English	Editorial Material							PREVALENCE; BURDEN		[van der Wouden, Johannes C.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, NL-1007 MB Amsterdam, Netherlands; [Koning, Sander] Univ Med Ctr Rotterdam, Dept Gen Practice, Erasmus MC, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC	van der Wouden, JC (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, NL-1007 MB Amsterdam, Netherlands.	j.vanderwouden@vumc.nl	van der Wouden, Johannes C/O-5109-2019	van der Wouden, Johannes C/0000-0001-6639-6050				Bigger JW, 1944, LANCET, V2, P78; Bowen AC, 2014, LANCET, V384, P2132, DOI 10.1016/S0140-6736(14)60841-2; Carapetis JR, 1999, EPIDEMIOL INFECT, V122, P59, DOI 10.1017/S0950268898001952; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Faye O, 2007, INT J DERMATOL, V46, P19, DOI 10.1111/j.1365-4632.2007.03364.x; Fleming DM, 2005, BRIT J GEN PRACT, V55, P589; Harvey F, 1917, LANCET, V2, P582; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Koning S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003261.pub3; MACKENNA RMB, 1945, LANCET, V249, P357; Mohammedamin RS, 2006, BMC DERMATOL, V6, DOI 10.1186/1471-5945-6-4; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467	12	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2090	2091		10.1016/S0140-6736(14)61395-7	http://dx.doi.org/10.1016/S0140-6736(14)61395-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25172375				2022-12-28	WOS:000346354300008
J	Pinsky, PF; Gierada, DS; Hocking, W; Patz, EF; Kramer, BS				Pinsky, Paul F.; Gierada, David S.; Hocking, William; Patz, Edward F., Jr.; Kramer, Barnett S.			National Lung Screening Trial Findings by Age: Medicare-Eligible Versus Under-65 Population	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER MORTALITY; WEDGE RESECTION; LOBECTOMY; SURVIVAL; OUTCOMES; SURGERY	Background: The NLST (National Lung Screening Trial) showed reduced lung cancer mortality in high-risk participants (smoking history of >= 30 pack-years) aged 55 to 74 years who were randomly assigned to screening with low-dose computed tomography (LDCT) versus those assigned to chest radiography. An advisory panel recently expressed reservations about Medicare coverage of LDCT screening because of concerns about performance in the Medicare-aged population, which accounted for only 25% of the NLST participants. Objective: To examine the results of the NLST LDCT group by age (Medicare-eligible vs. <65 years). Design: Secondary analysis of a group from a randomized trial (NCT00047385). Setting: 33 U.S. screening centers. Patients: 19 612 participants aged 55 to 64 years (under-65 cohort) and 7110 participants aged 65 to 74 years (65+ cohort) at randomization. Intervention: 3 annual rounds of LDCT screening. Measurements: Demographics, smoking and medical history, screening examination adherence and results, diagnostic follow-up procedures and complications, lung cancer diagnoses, treatment, survival, and mortality. Results: The aggregate false-positive rate was higher in the 65+ cohort than in the under-65 cohort (27.7% vs. 22.0%; P < 0.001). Invasive diagnostic procedures after false-positive screening results were modestly more frequent in the older cohort (3.3% vs. 2.7%; P = 0.039). Complications from invasive procedures were low in both groups (9.8% in the under-65 cohort vs. 8.5% in the 65+ cohort). Prevalence and positive predictive value (PPV) were higher in the 65+ cohort (PPV, 4.9% vs. 3.0%). Resection rates for screen-detected cancer were similar (75.6% in the under-65 cohort vs. 73.2% in the 65+ cohort). Five-year all-cause survival was lower in the 65+ cohort (55.1% vs. 64.1%; P = 0.018). Limitation: The oldest screened patient was aged 76 years. Conclusion: NLST participants aged 65 years or older had a higher rate of false-positive screening results than those younger than 65 years but a higher cancer prevalence and PPV. Screen-detected cancer was treated similarly in the groups.	[Pinsky, Paul F.; Kramer, Barnett S.] NCI, Bethesda, MD 20892 USA; [Gierada, David S.] Washington Univ, Sch Med, St Louis, MO 63110 USA; Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA; [Patz, Edward F., Jr.] Duke Univ, Sch Med, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Marshfield Clinic; Duke University	Pinsky, PF (corresponding author), NCI, 9609 Med Ctr Dr,Room 5E108, Bethesda, MD 20892 USA.	pp4f@nih.gov		Patz, Edward/0000-0003-3374-1596	National Institutes of Health; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025522, N01CN025476, N01CN025514, N01CN025518, N01CN025524, N01CN025511, N01CN025513, N01CN075022, N01CN025515, N01CN025516, N01CN025512] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [N01CA075022, N01CA025512, UG1CA189828, N01CA025516, N01CA025514, N01CA025515, N01CA025511, U01CA079778, U01CA080098, N01CA025518, N01CA025524, N01CA025513, N01CA025522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Cattaneo SM, 2008, ANN THORAC SURG, V85, P231, DOI 10.1016/j.athoracsur.2007.07.080; Centers for Medicare & Medicaid Services, 2014, MEDCAC M 4 30 2014 L; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Demmy TL, 1999, ANN THORAC SURG, V68, P194, DOI 10.1016/S0003-4975(99)00467-1; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Ellis MC, 2011, ANN THORAC SURG, V92, P1958, DOI 10.1016/j.athoracsur.2011.05.120; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Greenberg AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039403; Grills IS, 2010, J CLIN ONCOL, V28, P928, DOI 10.1200/JCO.2009.25.0928; Kates M, 2011, CHEST, V139, P491, DOI 10.1378/chest.09-2547; Kozower BD, 2010, ANN THORAC SURG, V90, P875, DOI 10.1016/j.athoracsur.2010.03.115; Mery CM, 2005, CHEST, V128, P237, DOI 10.1378/chest.128.1.237; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; National Cancer Institute's, SURV EP END RES SEER; National Center for Health Statistics, 2014, NAT HLTH INT SURV; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Pinsky PF, 2012, J MED SCREEN, V19, P154, DOI 10.1258/jms.2012.012010; Senan S, 2013, LANCET ONCOL, V14, pE270, DOI 10.1016/S1470-2045(12)70592-2; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261	21	62	63	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					627	U120		10.7326/M14-1484	http://dx.doi.org/10.7326/M14-1484			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25199624	Green Accepted			2022-12-28	WOS:000347244100003
J	Barbier, EB				Barbier, Edward B.			A global strategy for protecting vulnerable coastal populations	SCIENCE			English	Editorial Material							ADAPTATION		Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA	University of Wyoming	Barbier, EB (corresponding author), Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA.	ebarbier@uwyo.edu						Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Cheong SM, 2013, NAT CLIM CHANGE, V3, P787, DOI 10.1038/NCLIMATE1854; Climate Funds Update, ADAPTATION; CPRA (Coastal Protection and Restoration Authority of Louisiana), 2012, LOUIS COMPR MAST PLA; Daly M, 2010, J INT DEV, V22, P265, DOI 10.1002/jid.1678; Financial Tracking Service, 2014, GLOB OV 2012 POOL FU; IPCC Working Group II, 2014, CLIM CHANG 2014 IMP; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Moss RH, 2013, SCIENCE, V342, P696, DOI 10.1126/science.1239569; Nicholls R., 2007, RANKING WORLDS CITIE, DOI [https://doi.org/10.1787/011766488208, DOI 10.1787/011766488208]; U.S. Navy Civil Engineer Corps, EUR JOINT ENG TRAIN; World Bank, 2010, EC AD CLIM CHANG SYN	14	56	57	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1250	1251		10.1126/science.1254629	http://dx.doi.org/10.1126/science.1254629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214595				2022-12-28	WOS:000341483800023
J	Watts, G				Watts, Geoff			Profile Niveen Abu-Rmeileh: rising star in the Middle East	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					847	847		10.1016/S0140-6736(14)61477-X	http://dx.doi.org/10.1016/S0140-6736(14)61477-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	25209477				2022-12-28	WOS:000341362200014
J	Gunning, E; Richards, E				Gunning, Elinor; Richards, Emma			Should patients be able to email their general practitioner?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIAN E-MAIL; HEALTH-CARE; COMMUNICATION; CONSULTATIONS		[Gunning, Elinor] UCL Med Sch, Dept Primary Care & Populat Hlth, London, England; [Richards, Emma] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	University of London; University College London; Imperial College London	Gunning, E (corresponding author), UCL Med Sch, Dept Primary Care & Populat Hlth, London, England.	Elinor.Gunning@nhs.net; emmalees@doctors.org.uk						Atherton H, 2013, BRIT J GEN PRACT, V63, pE760, DOI 10.3399/bjgp13X674440; Atherton H, 2013, BRIT J GEN PRACT, V63, P118, DOI 10.3399/bjgp13X664072; Atherton H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007978.pub2; Balint M., 1957, DOCTOR; BMA, 2014, BMA RESP LANC STUD E; Brooks RG, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.1.e2; Byron K, 2008, ACAD MANAGE REV, V33, P309, DOI 10.5465/AMR.2008.31193163; Campbell JL, 2014, LANCET; Car J, 2004, BMJ-BRIT MED J, V329, P439, DOI 10.1136/bmj.329.7463.439; Car J, 2004, BMJ-BRIT MED J, V329, P435, DOI 10.1136/bmj.329.7463.435; Crotty BH, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2943; Department of Health, MAK NHS MOR EFF LESS; GMC, PRESCR GUID REM PRES; GMC, CONF GUID; Hobbs J, 2003, INT J MED INFORM, V70, P1, DOI 10.1016/S1386-5056(03)00007-8; Katz SJ, 2004, AM J MANAG CARE, V10, P593; Katz SJ, 2003, J GEN INTERN MED, V18, P736, DOI 10.1046/j.1525-1497.2003.20756.x; Medial Protection Society, 2012, COMM PAT FAX EM; Montague E., 2013, J PARTICIP MED, P5; NHS England, 2014, GEN MED SERV CONTR P; RCGP, 2014, 2022 GP VIS GEN PRAC; Rosen P, 2007, PEDIATRICS, V120, P701, DOI 10.1542/peds.2007-1094; Singh H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1143; Tiko's GP Group, POLL SHOULD PAT BE A; Virji A, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-18; Ye JL, 2010, PATIENT EDUC COUNS, V80, P266, DOI 10.1016/j.pec.2009.09.038	26	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2014	349								g5338	10.1136/bmj.g5338	http://dx.doi.org/10.1136/bmj.g5338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LO	25183708				2022-12-28	WOS:000341386500001
J	Bordoli, MR; Yum, J; Breitkopf, SB; Thon, JN; Italiano, JE; Xiao, J; Worby, C; Wong, SK; Lin, G; Edenius, M; Keller, TL; Asara, JM; Dixon, JE; Yeo, CY; Whitman, M				Bordoli, Mattia R.; Yum, Jina; Breitkopf, Susanne B.; Thon, Jonathan N.; Italiano, Joseph E., Jr.; Xiao, Junyu; Worby, Carolyn; Wong, Swee-Kee; Lin, Grace; Edenius, Maja; Keller, Tracy L.; Asara, John M.; Dixon, Jack E.; Yeo, Chang-Yeol; Whitman, Malcolm			A Secreted Tyrosine Kinase Acts in the Extracellular Environment	CELL			English	Article							CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; BONE-DEVELOPMENT; BINDING SITE; MOUSE; GENES; MESD; METALLOPROTEINASES; PHOSPHORYLATION; IDENTIFICATION	Although tyrosine phosphorylation of extracellular proteins has been reported to occur extensively in vivo, no secreted protein tyrosine kinase has been identified. As a result, investigation of the potential role of extracellular tyrosine phosphorylation in physiological and pathological tissue regulation has not been possible. Here, we show that VLK, a putative protein kinase previously shown to be essential in embryonic development, is a secreted protein kinase, with preference for tyrosine, that phosphorylates a broad range of secreted and ER-resident substrate proteins. We find that VLK is rapidly and quantitatively secreted from platelets in response to stimuli and can tyrosine phosphorylate coreleased proteins utilizing endogenous as well as exogenous ATP sources. We propose that discovery of VLK activity provides an explanation for the extensive and conserved pattern of extracellular tyrosine phosphophorylation seen in vivo, and extends the importance of regulated tyrosine phosphorylation into the extracellular environment.	[Bordoli, Mattia R.; Yum, Jina; Wong, Swee-Kee; Lin, Grace; Edenius, Maja; Keller, Tracy L.; Yeo, Chang-Yeol; Whitman, Malcolm] Univ Hartford, Sch Dent Med, Dept Dev Biol, Boston, MA 02241 USA; [Breitkopf, Susanne B.; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Breitkopf, Susanne B.; Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Thon, Jonathan N.; Italiano, Joseph E., Jr.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Thon, Jonathan N.; Italiano, Joseph E., Jr.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Italiano, Joseph E., Jr.] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Yum, Jina; Yeo, Chang-Yeol] Ewha Womans Univ, Global Top5 Res Program, Seoul 120750, South Korea; [Yum, Jina; Yeo, Chang-Yeol] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Xiao, Junyu; Worby, Carolyn; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92031 USA	University of Hartford; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Ewha Womans University; Ewha Womans University; University of California System; University of California San Diego	Yeo, CY (corresponding author), Univ Hartford, Sch Dent Med, Dept Dev Biol, Boston, MA 02241 USA.	cyeo@ewha.ac.kr; mwhitman@hms.harvard.edu	Xiao, Junyu/ABE-2192-2020	Xiao, Junyu/0000-0003-1822-1701; Bordoli, Mattia/0000-0001-6917-8753; Yeo, Chang-Yeol/0000-0002-4440-1215; Thon, Jonathan/0000-0002-7969-7001	National Institutes of Health [GM089885, DE024312, HI68130, 1K99HL114719-01A1, 5P30CA006516, 5P01CA120964]; NIH [1S10OD010612, DK 18024, DK 18849]; Korean Government (NRF) [2012R1A5A1048236, 2012R1A2A2A01046485]; Next Generation BioGreen 21 Program [PJ00812701]; Swiss National Science Foundation; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL114719, R01HL068130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018024, R01DK018024, R01DK018849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089885] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Government (NRF)(Korean Government); Next Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Min Yuan for help with mass spectrometry experiments, Peter Hornbeck (Cell Signaling Technologies) for valuable discussions, Ross Okazaki and Rajesh Kulenthirarajan for platelet isolation, and Shin-Ichi Nishikawa (RIKEN) for cDNAs encoding wild-type mouse VLK and VLK KM. This work was supported in part by the National Institutes of Health grants GM089885 and DE024312 (M.W.), HI68130 (J.E.I.), 1K99HL114719-01A1 (J.N.T), 5P30CA006516, 5P01CA120964, NIH shared instrumentation grant 1S10OD010612 (J.M.A.), DK 18024, and DK 18849 (J.E.D.), and grants from the Korean Government to C.Y.Y. (NRF 2012R1A5A1048236 and 2012R1A2A2A01046485, Next Generation BioGreen 21 Program PJ00812701). M.R.B. was supported by a Swiss National Science Foundation fellowship.	Ahn HS, 1997, MOL PHARMACOL, V51, P350, DOI 10.1124/mol.51.2.350; Bai Y, 2012, CANCER RES, V72, P2501, DOI 10.1158/0008-5472.CAN-11-3015; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Barak NN, 2009, J MOL BIOL, V385, P1630, DOI 10.1016/j.jmb.2008.11.052; Barnewitz K, 2004, J BIOL CHEM, V279, P39829, DOI 10.1074/jbc.M406839200; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Braganhol E, 2013, ADV EXP MED BIOL, V986, P81, DOI 10.1007/978-94-007-4719-7_5; Breitkopf S.B., 2012, CURR PROTOC MOL BIOL; BROWN J, 1987, J CELL BIOL, V105, P1571, DOI 10.1083/jcb.105.4.1571; Chen JL, 2011, STRUCTURE, V19, P313, DOI 10.1016/j.str.2011.01.010; Chen JL, 2010, J BIOMOL NMR, V47, P283, DOI 10.1007/s10858-010-9426-8; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Dudkiewicz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066427; FABER HR, 1995, STRUCTURE, V3, P551, DOI 10.1016/S0969-2126(01)00189-7; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Goncalves L, 2011, INT J DEV BIOL, V55, P281, DOI 10.1387/ijdb.103273lg; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hsu YH, 2012, J CLIN ENDOCR METAB, V97, pE1958, DOI 10.1210/jc.2012-1890; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Imuta Y, 2009, DEV DYNAM, V238, P210, DOI 10.1002/dvdy.21822; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kinoshita M, 2009, DEVELOPMENT, V136, P2069, DOI 10.1242/dev.026435; Lu P, 2011, COLD SPRING HARB PER, V3; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Melvin VS, 2013, DEV DYNAM, V242, P817, DOI 10.1002/dvdy.23969; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Probst S, 2013, DIFFERENTIATION, V85, P121, DOI 10.1016/j.diff.2013.03.002; PROCKOP DJ, 1985, J CLIN INVEST, V75, P783, DOI 10.1172/JCI111773; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Raijmakers R, 2010, ANAL CHEM, V82, P824, DOI 10.1021/ac901764g; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Rozenvayn N, 2003, J BIOL CHEM, V278, P8126, DOI 10.1074/jbc.M206493200; Santos-Martinez MJ, 2008, THROMB RES, V121, P535, DOI 10.1016/j.thromres.2007.06.002; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Thon JN, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1838; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Yalak G, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003273; Yokasaki Y, 2000, TRENDS CARDIOVAS MED, V10, P155, DOI 10.1016/S1050-1738(00)00055-4; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	54	87	97	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1033	1044		10.1016/j.cell.2014.06.048	http://dx.doi.org/10.1016/j.cell.2014.06.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171405	Bronze, Green Accepted			2022-12-28	WOS:000340945000010
J	Erzberger, JP; Stengel, F; Pellarin, R; Zhang, SY; Schaefer, T; Aylett, CHS; Cimermancic, P; Boehringer, D; Sali, A; Aebersold, R; Ban, N				Erzberger, Jan P.; Stengel, Florian; Pellarin, Riccardo; Zhang, Suyang; Schaefer, Tanja; Aylett, Christopher H. S.; Cimermancic, Peter; Boehringer, Daniel; Sali, Andrej; Aebersold, Ruedi; Ban, Nenad			Molecular Architecture of the 40S center dot eIF1 center dot eIF3 Translation Initiation Complex	CELL			English	Article							RNA RECOGNITION MOTIF; CROSS-LINKED PEPTIDES; HEPATITIS-C-VIRUS; MESSENGER-RNA; STRUCTURAL INSIGHTS; RIBOSOME; SUBUNIT; BINDING; RECRUITMENT; MECHANISMS	Eukaryotic translation initiation requires the recruitment of the large, multiprotein eIF3 complex to the 40S ribosomal subunit. We present X-ray structures of all major components of the minimal, six-subunit Saccharomyces cerevisiae eIF3 core. These structures, together with electron microscopy reconstructions, cross-linking coupled to mass spectrometry, and integrative structure modeling, allowed us to position and orient all eIF3 components on the 40S center dot eIF1 complex, revealing an extended, modular arrangement of eIF3 subunits. Yeast eIF3 engages 40S in a clamp-like manner, fully encircling 40S to position key initiation factors on opposite ends of the mRNA channel, providing a platform for the recruitment, assembly, and regulation of the translation initiation machinery. The structures of eIF3 components reported here also have implications for understanding the architecture of the mammalian 43S preinitiation complex and the complex of eIF3, 40S, and the hepatitis C internal ribosomal entry site RNA.	[Erzberger, Jan P.; Zhang, Suyang; Schaefer, Tanja; Aylett, Christopher H. S.; Boehringer, Daniel; Ban, Nenad] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland; [Stengel, Florian; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Pellarin, Riccardo; Cimermancic, Peter; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Pellarin, Riccardo; Cimermancic, Peter; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Zurich	Erzberger, JP (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	jan.erzberger@mol.biol.ethz.ch; ban@mol.biol.ethz.ch		Zhang, Suyang/0000-0002-2322-9276; Stengel, Florian/0000-0003-1447-4509	EMBO postdoctoral fellowship; Sir Henry Wellcome Fellowship [095951]; ETH postdoctoral fellowship; HHMI Predoctoral Fellowship; Swiss National Science Foundation (SNSF) [PA00P3_139727, PBZHP3-133388]; NIH [U54 GM103511, R01 GM083960]; ETH Zurich; SystemsX; ERC advanced grant [233226]; SNSF; National Center of Excellence in Research Structural Biology and RNA and Disease programs; ERC grant [250071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960, T32GM067547, U54GM103511, P41GM109824] Funding Source: NIH RePORTER	EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Fellowship; ETH postdoctoral fellowship; HHMI Predoctoral Fellowship(Howard Hughes Medical Institute); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ETH Zurich(ETH Zurich); SystemsX; ERC advanced grant; SNSF(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research Structural Biology and RNA and Disease programs; ERC grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank F. Tritschler, B. Greber, M. Leibundgut, N. Schmitz, S. Klinge, S.J. Kim, B. Webb, D. Russel, M. Bonomi, Y. Spill, and members from the Ban, Sali, and Aebersold labs for helpful discussions and C. Weirich and C. Greenberg for critical reading of the manuscript. We are indebted to P. Tittman at the ETH scientific center for optical and electron microscopy and to the staff at the Swiss Light Source. This work was supported by an EMBO postdoctoral fellowship (to J.P.E.), a Sir Henry Wellcome Fellowship (Grant 095951 to F. S.), an ETH postdoctoral fellowship (to C. S. H. A.), and a HHMI Predoctoral Fellowship (to P. C.). We acknowledge support from Swiss National Science Foundation (SNSF) grants PA00P3_139727 and PBZHP3-133388 (to R. P.), NIH grants U54 GM103511 and R01 GM083960 (to A. S.), funding from ETH Zurich, SystemsX, and ERC advanced grant 233226 (to R. A.), and support from the SNSF, the National Center of Excellence in Research Structural Biology and RNA and Disease programs, and ERC grant 250071 (to N. B.).	Abergel C, 1999, STRUCTURE, V7, P1291, DOI 10.1016/S0969-2126(00)80062-3; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Cerna D, 2005, J MOL BIOL, V351, P923, DOI 10.1016/j.jmb.2005.06.025; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; Ellisdon AM, 2012, NAT STRUCT MOL BIOL, V19, P328, DOI 10.1038/nsmb.2235; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karaskova M, 2012, J BIOL CHEM, V287, P28420, DOI 10.1074/jbc.M112.386656; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Khoshnevis S, 2014, NUCLEIC ACIDS RES, V42, P4123, DOI 10.1093/nar/gkt1369; Khoshnevis S, 2012, RNA, V18, P2306, DOI 10.1261/rna.032532.112; Khoshnevis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012784; Kim JH, 2011, EMBO J, V30, P2454, DOI 10.1038/emboj.2011.146; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Ruggero D, 2013, COLD SPRING HARB PER, V5; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Voigts-Hoffmann F, 2012, CURR OPIN STRUC BIOL, V22, P768, DOI 10.1016/j.sbi.2012.07.010; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	58	155	156	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1123	1135		10.1016/j.cell.2014.07.044	http://dx.doi.org/10.1016/j.cell.2014.07.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171412	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000340945000017
J	Richardson, LP; Ludman, E; McCauley, E; Lindenbaum, J; Larison, C; Zhou, C; Clarke, G; Brent, D; Katon, W				Richardson, Laura P.; Ludman, Evette; McCauley, Elizabeth; Lindenbaum, Jeff; Larison, Cindy; Zhou, Chuan; Clarke, Greg; Brent, David; Katon, Wayne			Collaborative Care for Adolescents With Depression in Primary Care A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICATION ALGORITHM PROJECT; COGNITIVE-BEHAVIORAL THERAPY; DETECTING MAJOR DEPRESSION; CONSENSUS CONFERENCE PANEL; MENTAL-HEALTH; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; COST-EFFECTIVENESS; GLAD-PC; CHILDHOOD	IMPORTANCE Up to 20% of adolescents experience an episode of major depression by age 18 years yet few receive evidence-based treatments for their depression. OBJECTIVE To determine whether a collaborative care intervention for adolescents with depression improves depressive outcomes compared with usual care. DESIGN Randomized trial with blinded outcome assessment conducted between April 2010 and April 2013. SETTING Nine primary care clinics in the Group Health system in Washington State. PARTICIPANTS Adolescents (aged 13-17 years) who screened positive for depression (Patient Health Questionnaire 9-item [PHQ-9] score >= 10) on 2 occasions or who screened positive and met criteria for major depression, spoke English, and had telephone access were recruited. Exclusions included alcohol/drug misuse, suicidal plan or recent attempt, bipolar disorder, developmental delay, and seeing a psychiatrist. INTERVENTIONS Twelve-month collaborative care intervention including an initial in-person engagement session and regular follow-up by master's-level clinicians. Usual care control youth received depression screening results and could access mental health services through Group Health. MAIN OUTCOMES AND MEASURES The primary outcome was change in depressive symptoms on a modified version of the Child Depression Rating Scale-Revised (CDRS-R; score range, 14-94) from baseline to 12 months. Secondary outcomes included change in Columbia Impairment Scale score (CIS), depression response (>= 50% decrease on the CDRS-R), and remission (PHQ-9 score <5). RESULTS Intervention youth (n = 50), compared with those randomized to receive usual care (n = 51), had greater decreases in CDRS-R scores such that by 12 months intervention youth had a mean score of 27.5 (95% CI, 23.8-31.1) compared with 34.6 (95% CI, 30.6-38.6) in control youth (overall intervention effect: F-2,F-747.3 = 7.24, P < .001). Both intervention and control youth experienced improvement on the CIS with no significant differences between groups. At 12 months, intervention youth were more likely than control youth to achieve depression response (67.6% vs 38.6%, OR = 3.3, 95% CI, 1.4-8.2; P = .009) and remission (50.4% vs 20.7%, OR = 3.9, 95% CI, 1.5-10.6; P = .007). CONCLUSIONS AND RELEVANCE Among adolescents with depression seen in primary care, a collaborative care intervention resulted in greater improvement in depressive symptoms at 12 months than usual care. These findings suggest that mental health services for adolescents with depression can be integrated into primary care. Copyright 2014 American Medical Association. All rights reserved.	[Richardson, Laura P.; Zhou, Chuan] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Richardson, Laura P.; McCauley, Elizabeth; Larison, Cindy; Zhou, Chuan] Seattle Childrens Res Inst Ctr Child Hlth Behav &, Seattle, WA 98121 USA; [Ludman, Evette; Lindenbaum, Jeff] Grp Hlth Res Inst, Seattle, WA USA; [McCauley, Elizabeth; Katon, Wayne] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Clarke, Greg] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; [Brent, David] Univ Pittsburgh, Pittsburgh, PA USA; [Brent, David] Western Psychiat Inst & Clin, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Richardson, LP (corresponding author), Seattle Childrens Res Inst Ctr Child Hlth Behav &, 2001 Eighth Ave,Ste 400, Seattle, WA 98121 USA.	laura.richardson@seattlechildrens.org	Zhou, Chuan/AAJ-1935-2020		National Institute of Mental Health [1R01MH085645-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085645] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by the National Institute of Mental Health (1R01MH085645-01A1, PI: Richardson).	[Anonymous], 2009, SCREENING MAJOR DEPR; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Asarnow JR, 2005, JAMA-J AM MED ASSOC, V293, P311, DOI 10.1001/jama.293.3.311; Asarnow JR, 2002, CHILD ADOL PSYCH CL, V11, P477, DOI 10.1016/S1056-4993(02)00006-8; Bardone AM, 1996, DEV PSYCHOPATHOL, V8, P811, DOI 10.1017/S0954579400007446; Bird HR, 1996, INT J METH PSYCH RES, V6, P295, DOI 10.1002/(SICI)1234-988X(199612)6:4<295::AID-MPR173>3.3.CO;2-5; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1575, DOI 10.1097/00004583-199612000-00008; Brown RA, 1996, J AM ACAD CHILD PSY, V35, P1602, DOI 10.1097/00004583-199612000-00011; Cheung AH, 2007, PEDIATRICS, V120, pE1313, DOI 10.1542/peds.2006-1395; Clarke G, 2005, J AM ACAD CHILD PSY, V44, P888, DOI 10.1016/S0890-8567(09)62194-8; Clarke G., 2006, STAND PROJECT INTERV; Costello EJ, 2014, PSYCHIAT SERV, V65, P359, DOI 10.1176/appi.ps.201100518; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Gardner W, 2007, J AM ACAD CHILD PSY, V46, P611, DOI 10.1097/chi.0b013e318032384b; Grote NK, 2007, SOC WORK, V52, P295, DOI 10.1093/sw/52.4.295; Hughes CW, 2007, J AM ACAD CHILD PSY, V46, P667, DOI 10.1097/chi.0b013e31804a859b; Hughes CW, 1999, J AM ACAD CHILD PSY, V38, P1442, DOI 10.1097/00004583-199911000-00020; Katon W, 2012, ARCH GEN PSYCHIAT, V69, P506, DOI 10.1001/archgenpsychiatry.2011.1548; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Knight JR, 2002, ARCH PEDIAT ADOL MED, V156, P607, DOI 10.1001/archpedi.156.6.607; Kovacs M, 1996, J AM ACAD CHILD PSY, V35, P705, DOI 10.1097/00004583-199606000-00010; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lewinsohn PM, 2000, AM J PSYCHIAT, V157, P1584, DOI 10.1176/appi.ajp.157.10.1584; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Mayes TL, 2010, J CHILD ADOL PSYCHOP, V20, P513, DOI 10.1089/cap.2010.0063; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Poznanski E.O., 1996, CHILDRENS DEPRESSION; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Weissman MM, 1999, JAMA-J AM MED ASSOC, V281, P1707, DOI 10.1001/jama.281.18.1707; Zuckerbrot RA, 2007, PEDIATRICS, V120, pE1299, DOI 10.1542/peds.2007-1144	36	172	173	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					809	816		10.1001/jama.2014.9259	http://dx.doi.org/10.1001/jama.2014.9259			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7NX	25157724	Green Accepted			2022-12-28	WOS:000340788500023
J	Jafari, H; Deshpande, JM; Sutter, RW; Bahl, S; Verma, H; Ahmad, M; Kunwar, A; Vishwakarma, R; Agarwal, A; Jain, S; Estivariz, C; Sethi, R; Molodecky, NA; Grassly, NC; Pallansch, MA; Chatterjee, A; Aylward, RB				Jafari, Hamid; Deshpande, Jagadish M.; Sutter, Roland W.; Bahl, Sunil; Verma, Harish; Ahmad, Mohammad; Kunwar, Abhishek; Vishwakarma, Rakesh; Agarwal, Ashutosh; Jain, Shilpi; Estivariz, Concepcion; Sethi, Raman; Molodecky, Natalie A.; Grassly, Nicholas C.; Pallansch, Mark A.; Chatterjee, Arani; Aylward, R. Bruce			Efficacy of inactivated poliovirus vaccine in India	SCIENCE			English	Article							INTESTINAL IMMUNITY; MUCOSAL IMMUNITY; IMMUNOGENICITY; TRIAL; POLIOMYELITIS; STRATEGIES; MONOVALENT; CHILDREN	Inactivated poliovirus vaccine (IPV) is efficacious against paralytic disease, but its effect on mucosal immunity is debated. We assessed the efficacy of IPV in boosting mucosal immunity. Participants received IPV, bivalent 1 and 3 oral poliovirus vaccine (bOPV), or no vaccine. A bOPV challenge was administered 4 weeks later, and excretion was assessed 3, 7, and 14 days later. Nine hundred and fifty-four participants completed the study. Any fecal shedding of poliovirus type 1 was 8.8, 9.1, and 13.5% in the IPV group and 14.4, 24.1, and 52.4% in the control group by 6- to 11-month, 5-year, and 10-year groups, respectively (IPV versus control: Fisher's exact test P < 0.001). IPV reduced excretion for poliovirus types 1 and 3 between 38.9 and 74.2% and 52.8 and 75.7%, respectively. Thus, IPV in OPV-vaccinated individuals boosts intestinal mucosal immunity.	[Jafari, Hamid; Bahl, Sunil; Ahmad, Mohammad; Kunwar, Abhishek; Vishwakarma, Rakesh; Agarwal, Ashutosh; Sethi, Raman] WHO, India Natl Polio Surveillance Project, New Delhi 110029, India; [Deshpande, Jagadish M.] Enterovirus Res Ctr, Haffkine Inst Compound, Bombay, Maharashtra, India; [Sutter, Roland W.; Verma, Harish; Molodecky, Natalie A.; Aylward, R. Bruce] WHO, CH-1211 Geneva, Switzerland; [Jain, Shilpi; Chatterjee, Arani] Panacea Biotec Ltd, New Delhi, India; [Estivariz, Concepcion; Pallansch, Mark A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; World Health Organization; Centers for Disease Control & Prevention - USA; Imperial College London	Sutter, RW (corresponding author), WHO, Ave Appia, CH-1211 Geneva, Switzerland.	sutterr@who.int	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Deshpande, Jagadish/0000-0001-5194-0375	Rotary International Polio Plus Program; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish	Rotary International Polio Plus Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by Rotary International Polio Plus Program (through a grant approved by the Polio Research Committee of the World Health Organization). The study was approved by the Drugs Controller General (India), the Indian Council of Medical Research, and the Ethics Review Committees of the WHO. The trial was registered with the Indian Clinical Trials Registry (www.ctri.nic.in) (registration number CTRI/2011/09/002018). We acknowledge the contributions of Uttar Pradesh State Government health staff, social mobilization network of the United Nations Children's Fund and CORE, and the operations team from WHO India-National Polio Surveillance Project who were instrumental in the setup and implementation of the study. We also acknowledge the extensive work performed by the laboratory staff at ERC Mumbai. Finally, we express our sincere thanks to the Government of India Ministry of Health and Family Welfare and the GPEI partners. The data set is available in the supplementary materials. The findings and conclusions of this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, or other participating organizations.	Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P349; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P153; [Anonymous], 1995, J Infect Dis, V171, P1097; Arie S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6682; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P222; du Chatelet IP, 2003, VACCINE, V21, P1710, DOI 10.1016/S0264-410X(02)00523-6; El-Sayed N, 2008, NEW ENGL J MED, V359, P1655, DOI 10.1056/NEJMoa0800390; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; FRANCIS T, 1955, JAMA-J AM MED ASSOC, V158, P1266, DOI 10.1001/jama.1955.02960140028004; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Grassly NC, 2012, J INFECT DIS, V205, P1554, DOI 10.1093/infdis/jis241; Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330; Greenwood BM, 1997, J INFECT DIS, V175, pS215; Herremans T, 2002, CLIN INFECT DIS, V34, P1067, DOI 10.1086/339489; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; HULL HF, 1994, LANCET, V343, P1331, DOI 10.1016/S0140-6736(94)92472-4; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; MORINIERE BJ, 1993, LANCET, V341, P1545, DOI 10.1016/0140-6736(93)90693-B; Paul J. R., 1978, HIST POLIOMYELITIS; Piirainen L, 1999, VACCINE, V17, P1084, DOI 10.1016/S0264-410X(98)00325-9; Puligedda RD, 2014, ANTIVIR RES, V108, P36, DOI 10.1016/j.antiviral.2014.05.005; Resik S, 2013, NEW ENGL J MED, V368, P416, DOI 10.1056/NEJMoa1202541; ROBERTSON SE, 1988, LANCET, V1, P897; Sutter R. W., 2012, VACCINES, V28, P598; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103; World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P385; World Health Organization, 2013, WHOPOL1302; World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P1; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P381; World Health Organization, 2014, WKLY EPIDEMIOL REC, V89, P73	34	85	86	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					922	925		10.1126/science.1255006	http://dx.doi.org/10.1126/science.1255006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146288				2022-12-28	WOS:000340524700044
J	Hanage, WP				Hanage, William P.			Microbiome science needs a healthy dose of scepticism	NATURE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hanage, WP (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	whanage@hsph.harvard.edu	Hanage, Bill/CAF-1813-2022					Blaser MJ, 2014, MISSING MICROBES OVE; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Shanahan F, 2012, NUTR REV, V70, pS31, DOI 10.1111/j.1753-4887.2012.00502.x; Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856	9	136	139	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					247	248		10.1038/512247a	http://dx.doi.org/10.1038/512247a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3SF	25143098	Bronze			2022-12-28	WOS:000340508200011
J	Watanabe, H; Schmidt, HA; Kuhn, A; Hoger, SK; Kocagoz, Y; Laumann-Lipp, N; Ozbek, S; Holstein, TW				Watanabe, Hiroshi; Schmidt, Heiko A.; Kuhn, Anne; Hoeger, Stefanie K.; Kocagoez, Yigit; Laumann-Lipp, Nico; Oezbek, Suat; Holstein, Thomas W.			Nodal signalling determines biradial asymmetry in Hydra	NATURE			English	Article							MAXIMUM-LIKELIHOOD PHYLOGENIES; CARTESIAN COORDINATE SYSTEM; LEFT-RIGHT AXIS; HEAD ORGANIZER; GENE FAMILY; BODY AXES; EVOLUTION; WNT; EXPRESSION; EMBRYO	In bilaterians, three orthogonal body axes define the animal form, with distinct anterior-posterior, dorsal-ventral and left-right asymmetries. The key signalling factors are Wnt family proteins for the anterior-posterior axis, Bmp family proteins for the dorsal-ventral axis and Nodal for the left-right axis(1). Cnidarians, the sister group to bilaterians, are characterized by one oral-aboral body axis, which exhibits a distinct biradiality of unknown molecular nature. Here we analysed the biradial growth pattern in the radially symmetrical cni-darian polyp Hydra, and we report evidence of Nodal ina pre-bilaterian clade. We identified aNodal-related gene (Ndr) inHydra magnipa-pillata, and this gene is essential for setting up an axial asymmetry along the main body axis. This asymmetry defines a lateral signalling centre, inducing a new body axis of a budding polyp orthogonal to the mother polyp's axis. Ndr is expressed exclusively in the lateral bud anlage and induces Pitx, which encodes an evolutionarily conserved transcription factor that functions downstream of Nodal. Reminiscent of its function in vertebrates(2,3), Nodal acts downstream of beta-Catenin signalling. Our data support an evolutionary scenario in which a 'core-signalling cassette' consisting of b-Catenin, Nodal and Pitx pre-dated the cnidarian-bilaterian split. We presume that this cassette was co-opted for various modes of axial patterning: for example, for lateral branching in cnidarians and left-right patterning in bilaterians.	[Watanabe, Hiroshi; Kuhn, Anne; Hoeger, Stefanie K.; Kocagoez, Yigit; Laumann-Lipp, Nico; Oezbek, Suat; Holstein, Thomas W.] Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies COS, D-69120 Heidelberg, Germany; [Schmidt, Heiko A.] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna CIBIV, Max F Perutz Labs MFPL, A-1030 Vienna, Austria	Ruprecht Karls University Heidelberg; Medical University of Vienna; University of Vienna	Holstein, TW (corresponding author), Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies COS, D-69120 Heidelberg, Germany.	hiroshi.watanabe@cos.uni-heidelberg.de; thomas.holstein@cos.uni-heidelberg.de	Kocagöz, Yigit/ABG-2596-2021; Schmidt, Heiko A/AAC-4650-2022; Watanabe, Hiroshi/GOP-0177-2022; Özbek, Suat/D-3701-2014	Schmidt, Heiko A/0000-0002-2311-8592; Watanabe, Hiroshi/0000-0001-8887-5407; Holstein, Thomas/0000-0003-0480-4674; Ozbek, Suat/0000-0003-2569-3942	TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation; Heidelberg Excellence Cluster Cellular Networks; German science foundation (DFG) [FOR 1036/TP1, SFB 873/A1, FOR 1036/TP2]	TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Heidelberg Excellence Cluster Cellular Networks; German science foundation (DFG)(German Research Foundation (DFG))	We thank R. Steele for providing the transgenic Hydra strains before publication, for setting up the Cladonema pacificum genome Blast server and for permission to provide the URL; R. Yamada, T. Katsuki and R. Greenspan for providing unpublished C. pacificum sequence data; B. Hobmayer for providing a Hydra scheme from an unpublished manuscript; and H. Yuzawa-Watanabe for technical assistance. We thank O. Simakov, H. Meinhardt, I. Somorjai and B. Hobmayer for discussions and comments on the manuscript. This study was supported by the TOYOBO Biotechnology Foundation and the Alexander von Humboldt Foundation (initial fellowships to H. W.), the Heidelberg Excellence Cluster Cellular Networks, and grants from the German science foundation (DFG) to T. W. H. (FOR 1036/TP1 and SFB 873/A1) and S.O. (FOR 1036/TP2).	BAIRD RV, 1967, J EMBRYOL EXP MORPH, V17, P35; Bode Hans, 2008, V469, P69, DOI 10.1007/978-1-60327-469-2_7; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Brusca RC, 2002, INVERTEBRATES; Chea HK, 2005, DEV DYNAM, V234, P269, DOI 10.1002/dvdy.20549; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Glauber KM, 2013, DEVELOPMENT, V140, P4788, DOI 10.1242/dev.094490; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Inui M, 2012, P NATL ACAD SCI USA, V109, P15354, DOI 10.1073/pnas.1203000109; Khalturin K, 2008, PLOS BIOL, V6, P2436, DOI 10.1371/journal.pbio.0060278; Kuhn A., 1914, ERG FORTSCHR ZOOL, P1; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; Nakamura Y, 2011, P NATL ACAD SCI USA, V108, P9137, DOI 10.1073/pnas.1018109108; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Reinhardt B, 2004, DEV BIOL, V267, P43, DOI 10.1016/j.ydbio.2003.10.031; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Srivastava M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-4; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Warner JF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001404; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yu JK, 2002, EVOL DEV, V4, P418, DOI 10.1046/j.1525-142X.2002.02030.x	35	65	67	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					112	+		10.1038/nature13666	http://dx.doi.org/10.1038/nature13666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25156256				2022-12-28	WOS:000344187500040
J	Iijima, N; Iwasaki, A				Iijima, Norifumi; Iwasaki, Akiko			A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; VAGINAL INFECTION; RM CELLS; IMMUNITY; MIGRATION; RESPONSES; SUBSETS; TYPE-2	CD8 tissue-resident memory T (T-RM) cells provide efficient local control of viral infection, but the role of CD4 T-RM is less clear. Here, by using parabiotic mice, we show that a preexisting pool of CD4 T-RM cells in the genital mucosa was required for full protection from a lethal herpes simplex virus 2 (HSV-2) infection. Chemokines secreted by a local network of macrophages maintained vaginal CD4 T-RM in memory lymphocyte clusters (MLCs), independently of circulating memory T cells. CD4 T-RM cells within the MLCs were enriched in clones that expanded in response to HSV-2. Our results highlight the need for vaccine strategies that enable establishment of T-RM cells for protection from a sexually transmitted virus and provide insights as to how such a pool might be established.	[Iwasaki, Akiko] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	Howard Hughes Medical Institute; NIH [AI054359, AI062428]; Kanae Foundation; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062428, R01AI054359, R56AI062428] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kanae Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Howard Hughes Medical Institute (A. I.), and NIH grants to A. I. (AI054359, AI062428). We thank R. Medzhitov for critical reading of the manuscript; M. Sasai, H. Kanda, S. Umlauf, and G. Lee for technical help and useful advice; A. Ayoub, P. Rakic, M. Tsuneki, D. Carvajal, and D. Rimm for technical help with laser capture microdissection; and D. Hamm and E. Lindsley for help with TCR sequencing. Data presented in the paper are tabulated in the main paper and in the supplementary materials. N.I. is a recipient of the study-abroad grant of Kanae Foundation for the promotion of medical science.	Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; COEN DM, 1989, P NATL ACAD SCI USA, V86, P4736, DOI 10.1073/pnas.86.12.4736; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Iwasaki A, 2003, MICROBES INFECT, V5, P1221, DOI 10.1016/j.micinf.2003.09.006; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Parr MB, 2000, IMMUNOLOGY, V101, P126, DOI 10.1046/j.1365-2567.2000.00080.x; PARR MB, 1994, LAB INVEST, V70, P369; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Tang VA, 2010, J REPROD IMMUNOL, V87, P39, DOI 10.1016/j.jri.2010.06.155; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	25	283	290	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					93	98		10.1126/science.1257530	http://dx.doi.org/10.1126/science.1257530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25170048	Green Accepted			2022-12-28	WOS:000342446900058
J	Sood, N; Bendavid, E; Mukherji, A; Wagner, Z; Nagpal, S; Mullen, P				Sood, Neeraj; Bendavid, Eran; Mukherji, Arnab; Wagner, Zachary; Nagpal, Somil; Mullen, Patrick			Government health insurance for people below poverty line in India: quasi-experimental evaluation of insurance and health outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-INCOME COUNTRIES; MORTALITY; COVERAGE; REFORM; IMPACT; CARE	Objectives To evaluate the effects of a government insurance program covering tertiary care for people below the poverty line in Karnataka, India, on out-of-pocket expenditures, hospital use, and mortality. Design Geographic regression discontinuity study. Setting 572 villages in Karnataka, India. Participants 31 476 households (22 796 below poverty line and 8680 above poverty line) in 300 villages where the scheme was implemented and 28 633 households (21 767 below poverty line and 6866 above poverty line) in 272 neighboring matched villages ineligible for the scheme. Intervention A government insurance program (Vajpayee Arogyashree scheme) that provided free tertiary care to households below the poverty line in about half of villages in Karnataka from February 2010 to August 2012. Main outcome measure Out-of-pocket expenditures, hospital use, and mortality. Results Among households below the poverty line, the mortality rate from conditions potentially responsive to services covered by the scheme (mostly cardiac conditions and cancer) was 0.32% in households eligible for the scheme compared with 0.90% among ineligible households just south of the eligibility border (difference of 0.58 percentage points, 95% confidence interval 0.40 to 0.75; P<0.001). We found no difference in mortality rates for households above the poverty line (households above the poverty line were not eligible for the scheme), with a mortality rate from conditions covered by the scheme of 0.56% in eligible villages compared with 0.55% in ineligible villages (difference of 0.01 percentage points, -0.03 to 0.03; P=0.95). Eligible households had significantly reduced out-of-pocket health expenditures for admissions to hospitals with tertiary care facilities likely to be covered by the scheme (64% reduction, 35% to 97%; P<0.001). There was no significant increase in use of covered services, although the point estimate of a 44.2% increase approached significance (-5.1% to 90.5%; P=0.059). Both reductions in out-of-pocket expenditures and potential increases in use might have contributed to the observed reductions in mortality. Conclusions Insuring poor households for efficacious but costly and underused health services significantly improves population health in India.	[Sood, Neeraj] Univ So Calif, Sch Pharm, Dept Pharmaceut Econ & Policy, Los Angeles, CA USA; [Sood, Neeraj] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA; [Sood, Neeraj] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Mukherji, Arnab] Indian Inst Management, Ctr Publ Policy, Bangalore, Karnataka, India; [Wagner, Zachary] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA USA; [Nagpal, Somil; Mullen, Patrick] World Bank, New Delhi, India	University of Southern California; University of Southern California; National Bureau of Economic Research; Stanford University; Stanford University; Stanford University; Indian Institute of Management (IIM System); Indian Institute of Management Bangalore; University of California System; University of California Berkeley; The World Bank	Sood, N (corresponding author), Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA.	nsood@healthpolicy.usc.edu		Sood, Neeraj/0000-0001-9805-213X; Mukherji, Arnab/0000-0003-1208-6852	Health Results Innovation Trust Fund at the World Bank	Health Results Innovation Trust Fund at the World Bank	This project was funded by the Health Results Innovation Trust Fund at the World Bank. The funding agency played no role in the conduct of this research and the decision to submit this manuscript for publication.	[Anonymous], 2011, HIGH LEV EXP GROUP R; Ansah EK, 2009, PLOS MED, V6, P48, DOI 10.1371/journal.pmed.1000007; Bernal MP, 2010, EFECTO SEGURO POPULA; Camacho A, 2013, ECON DEV CULT CHANGE, V61, P633, DOI 10.1086/669263; Dow WH, 2003, SOC SCI MED, V57, P975, DOI 10.1016/S0277-9536(02)00464-1; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; ESCOBAR ML, 2011, IMPACT HLTH INSURANC; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fink G, 2013, J HEALTH ECON, V32, P1043, DOI 10.1016/j.jhealeco.2013.08.003; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Gruber J, 2012, DEMAND REIMBURSEMENT; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Lin WC, 2009, HEALTH ECON, V18, pS83, DOI 10.1002/hec.1500; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Office of the Registrar General and Census Commissioner India, 2011, SUMM REP CAUS DEATH; Palmer N, 2004, LANCET, V364, P1365, DOI 10.1016/S0140-6736(04)17195-X; Powell-Jackson T, 2014, J DEV ECON, V107, P305, DOI 10.1016/j.jdeveco.2013.11.010; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sosa-Rubi SG, 2009, J HEALTH ECON, V28, P20, DOI 10.1016/j.jhealeco.2008.08.002; Sosa-Rubi SG, 2009, B WORLD HEALTH ORGAN, V87, P512, DOI 10.2471/BLT.08.053256; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Wang H, 2009, HEALTH ECON, V18, pS65, DOI 10.1002/hec.1465; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; World Bank, GOV SPONS HLTH INS I; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	27	55	55	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2014	349								g5114	10.1136/bmj.g5114	http://dx.doi.org/10.1136/bmj.g5114			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP9UR	25214509	Green Published, hybrid			2022-12-28	WOS:000342426400001
J	Franco, A; Malhotra, N; Simonovits, G				Franco, Annie; Malhotra, Neil; Simonovits, Gabor			Publication bias in the social sciences: Unlocking the file drawer	SCIENCE			English	Article							OUTCOME REPORTING BIAS; CLINICAL-TRIALS; METAANALYSIS; JOURNALS; ACCEPTANCE; TESTS	The neuromuscular junction (NMJ) is the synapse between a motor neuron and skeletal muscle. Defects in NMJ transmission cause muscle weakness, termed myasthenia. The muscle protein Dok-7 is essential for activation of the receptor kinase MuSK, which governs NMJ formation, and DOK7 mutations underlie familial limb-girdle myasthenia (DOK7 myasthenia), a neuromuscular disease characterized by small NMJs. Here, we show in a mouse model of DOK7 myasthenia that therapeutic administration of an adeno-associated virus (AAV) vector encoding the human DOK7 gene resulted in an enlargement of NMJs and substantial increases in muscle strength and life span. When applied to model mice of another neuromuscular disorder, autosomal dominant Emery-Dreifuss muscular dystrophy, DOK7 gene therapy likewise resulted in enlargement of NMJs as well as positive effects on motor activity and life span. These results suggest that therapies aimed at enlarging the NMJ may be useful for a range of neuromuscular disorders.	[Franco, Annie; Simonovits, Gabor] Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA; [Malhotra, Neil] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University	Malhotra, N (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	neilm@stanford.edu						Ashnfelter O., 1999, LABOUR ECON, V6, P453, DOI DOI 10.1016/S0927-5371(99)00041-X; BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; BERLIN JA, 1989, J AM STAT ASSOC, V84, P381; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; CARD D, 1995, AM ECON REV, V85, P238; Casey K, 2012, Q J ECON, V127, P1755, DOI 10.1093/qje/qje027; Cooper H, 1997, PSYCHOL METHODS, V2, P447, DOI 10.1037/1082-989X.2.4.447; Cooper H, 2009, HDB RES SYNTHESIS ME; COURSOL A, 1986, PROF PSYCHOL-RES PR, V17, P136, DOI 10.1037/0735-7028.17.2.136; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dickersin K., 2006, PUBLICATION BIAS MET; Doucouliagos C, 2005, J ECON SURV, V19, P367, DOI 10.1111/j.0950-0804.2005.00252.x; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; FELSON DT, 1992, J CLIN EPIDEMIOL, V45, P885, DOI 10.1016/0895-4356(92)90072-U; Gerber A, 2008, Q J POLIT SCI, V3, P313, DOI 10.1561/100.00008024; Gerber AS, 2008, SOCIOL METHOD RES, V37, P3, DOI 10.1177/0049124108318973; Glass G. V., 1981, METAANALYSIS SOCIAL; GREENWALD AG, 1975, PSYCHOL BULL, V82, P1, DOI 10.1037/h0076157; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lee KP, 2006, MED J AUSTRALIA, V184, P621, DOI 10.5694/j.1326-5377.2006.tb00418.x; Light R.J., 1984, SUMMING SCI REV RES; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Min, 1993, ONLINE J CURR CLIN T, V1993, P50; Okike K, 2008, J BONE JOINT SURG AM, V90A, P595, DOI 10.2106/JBJS.G.00279; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Timmer Antje, 2002, BMC Med Res Methodol, V2, P7, DOI 10.1186/1471-2288-2-7	38	634	642	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1502	1505		10.1126/science.1255484	http://dx.doi.org/10.1126/science.1255484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0LM	25170047				2022-12-28	WOS:000341752900041
J	Childress, L				Childress, Lilian			Diamond dynamics under control	SCIENCE			English	Editorial Material							COHERENT; SPECTROSCOPY		McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	McGill University	Childress, L (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	lilian.childress@mcgill.ca	Childress, Lilian/H-1359-2012	Childress, Lilian/0000-0002-0507-6392				Bassett LC, 2014, SCIENCE, V345, P1333, DOI 10.1126/science.1255541; Batalov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195506; Campbell WC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.090502; Cundiff ST, 2013, PHYS TODAY, V66, P44, DOI 10.1063/PT.3.2047; Doherty MW, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025019; Huxter VM, 2013, NAT PHYS, V9, P744, DOI [10.1038/NPHYS2753, 10.1038/nphys2753]; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Maze JR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025025; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Yale CG, 2013, P NATL ACAD SCI USA, V110, P7595, DOI 10.1073/pnas.1305920110	13	2	2	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1247	1248		10.1126/science.1257840	http://dx.doi.org/10.1126/science.1257840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25214593				2022-12-28	WOS:000341483800021
J	O'Donoghue, ML; Braunwald, E; White, HD; Steen, DP; Lukas, MA; Tarka, E; Steg, PG; Hochman, JS; Bode, C; Maggioni, AP; Im, K; Shannon, JB; Davies, RY; Murphy, SA; Crugnale, SE; Wiviott, SD; Bonaca, MP; Watson, DF; Weaver, WD; Serruys, PW; Cannon, CP				O'Donoghue, Michelle L.; Braunwald, Eugene; White, Harvey D.; Steen, Dylan P.; Lukas, Mary Ann; Tarka, Elizabeth; Steg, P. Gabriel; Hochman, Judith S.; Bode, Christoph; Maggioni, Aldo P.; Im, KyungAh; Shannon, Jennifer B.; Davies, Richard Y.; Murphy, Sabina A.; Crugnale, Sharon E.; Wiviott, Stephen D.; Bonaca, Marc P.; Watson, David F.; Weaver, W. Douglas; Serruys, Patrick W.; Cannon, Christopher P.		SOLID-TIMI 52 Investigators	Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; PHOSPHOLIPASE A(2); CARDIOVASCULAR OUTCOMES; ISCHEMIC EVENTS; HEART-DISEASE; LIPOPROTEIN; RISK; MACROPHAGES; MORTALITY; CELLS	IMPORTANCE Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) has been hypothesized to be involved in atherogenesis through pathways related to inflammation. Darapladib is an oral, selective inhibitor of the Lp-PLA2 enzyme. OBJECTIVE To evaluate the efficacy and safety of darapladib in patients after an acute coronary syndrome (ACS) event. DESIGN, SETTING, AND PARTICIPANTS SOLID-TIMI 52 was a multinational, double-blind, placebo-controlled trial that randomized 13 026 participants within 30 days of hospitalization with an ACS (non-ST-elevation or ST-elevation myocardial infarction [MI]) at 868 sites in 36 countries. INTERVENTIONS Patients were randomized to either once-daily darapladib (160 mg) or placebo on a background of guideline-recommended therapy. Patients were followed up for a median of 2.5 years between December 7, 2009, and December 6, 2013. MAIN OUTCOMES AND MEASURES The primary end point (major coronary events) was the composite of coronary heart disease (CHD) death, MI, or urgent coronary revascularization for myocardial ischemia. Kaplan-Meier event rates are reported at 3 years. RESULTS During a median duration of 2.5 years, the primary end point occurred in 903 patients in the darapladib group and 910 in the placebo group (16.3% vs 15.6% at 3 years; hazard ratio [HR], 1.00 [95% CI, 0.91-1.09]; P = .93). The composite of cardiovascular death, MI, or stroke occurred in 824 in the darapladib group and 838 in the placebo group (15.0% vs 15.0% at 3 years; HR, 0.99 [95% CI, 0.90-1.09]; P = .78). There were no differences between the treatment groups for additional secondary end points, for individual components of the primary end point, or in all-cause mortality (371 events in the darapladib group and 395 in the placebo group [7.3% vs 7.1% at 3 years; HR, 0.94 [95% CI, 0.82-1.08]; P = .40). Patients were more likely to report an odor-related concern in the darapladib group vs the placebo group (11.5% vs 2.5%) and also more likely to report diarrhea (10.6% vs 5.6%). CONCLUSIONS AND RELEVANCE In patients who experienced an ACS event, direct inhibition of Lp-PLA2 with darapladib added to optimal medical therapy and initiated within 30 days of hospitalization did not reduce the risk of major coronary events.	[O'Donoghue, Michelle L.; Braunwald, Eugene; Steen, Dylan P.; Im, KyungAh; Murphy, Sabina A.; Crugnale, Sharon E.; Wiviott, Stephen D.; Bonaca, Marc P.; Cannon, Christopher P.] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; [White, Harvey D.] Univ Auckland, Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1, New Zealand; [Lukas, Mary Ann] GlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, Philadelphia, PA USA; [Tarka, Elizabeth; Davies, Richard Y.] GlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, King Of Prussia, PA USA; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75877 Paris, France; [Steg, P. Gabriel] Univ Paris Diderot, Paris, France; [Steg, P. Gabriel] NHLI Imperial Coll, ICMS Royal Brompton Hosp, London, England; [Hochman, Judith S.] NYU Langone Med Ctr, Dept Med, New York, NY USA; [Bode, Christoph] Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol 1, D-79106 Freiburg, Germany; [Maggioni, Aldo P.] ANMCO Res Ctr, Florence, Italy; [Shannon, Jennifer B.; Watson, David F.] GlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, Res Triangle Pk, NC USA; [Weaver, W. Douglas] Henry Ford Hosp, Henry Ford Heart & Vasc Inst, Detroit, MI 48202 USA; [Serruys, Patrick W.] Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands; [Serruys, Patrick W.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England	Harvard University; Brigham & Women's Hospital; Auckland City Hospital; University of Auckland; GlaxoSmithKline; GlaxoSmithKline; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; NYU Langone Medical Center; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); GlaxoSmithKline; Henry Ford Health System; Henry Ford Hospital; Erasmus University Rotterdam; Erasmus MC; Imperial College London	O'Donoghue, ML (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, 350 Longwood Ave,First Floor, Boston, MA 02115 USA.	modonoghue@partners.org	BUAKHAMSRI, ADISAI/ABD-3971-2020; De+Servi, Stefano/AAT-2631-2021; Arkhipov, Mikhail V/Q-2316-2015; Libis, Roman/O-9193-2015; Shvarts, Yury Григорьевич/AAB-4929-2022; Spratt, James/AAH-3589-2020; Benedek, Theodora/F-6353-2016; Olavegogeascoechea, Pablo/Q-2834-2018; Wongpraparut, Nattawut/A-8031-2019; Georgescu, Catalina Arsenescu/R-5709-2017; Boldueva, Svetlana/AAH-3862-2019; Zirlik, Andreas/A-6400-2011; Zateyshchikov, Dmitry A/D-6575-2012; Costa, FA/E-9691-2016; Grinshtein, Yury/M-4091-2014; Maggioni, Aldo Pietro/AAL-5334-2020; Ramshev, Konstantin/GYU-1641-2022; Lotufo, Paulo/A-9843-2008; Zateyshchikov, Dmitry/AGN-8590-2022; Zadionchenko, Vladimir/A-7445-2016; Nicolau, Jose C/E-1487-2012; Sinescu, Crina Julieta/AAA-8793-2021; Linhart, Ales/O-2375-2017; Bilonko, Oksana/AAH-3518-2019; STEG, Philippe Gabriel/Z-1567-2019; Colquhoun, David M/F-9078-2013; Urina-Triana, Miguel A/H-2605-2016; Wainstein, Marco Vugman/AAQ-1248-2020; Frey, Norbert/A-9695-2010; Kobayashi, Junjiro/J-8547-2015; Cannon, Christopher P/AAY-7644-2020; Bonaca, Marc/AAJ-2397-2021; Benedek, Imre/E-7052-2017; Wiviott, Stephen/HIK-2534-2022; Malynovsky, Yaroslav/T-1898-2017; Esposito, Giovanni/F-2880-2010; Aleksandr, Legkonogov/P-8914-2015; Smith, Albert Vernon/K-5150-2015; FUENTES JIMENEZ, FRANCISCO/G-4311-2016; Reis, Gilmar/I-4500-2013; Giugliano, Giuseppe/K-1632-2016	BUAKHAMSRI, ADISAI/0000-0002-1026-1349; Arkhipov, Mikhail V/0000-0002-7924-7668; Libis, Roman/0000-0003-0130-990X; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Spratt, James/0000-0001-8719-4538; Benedek, Theodora/0000-0001-8326-1537; Olavegogeascoechea, Pablo/0000-0002-2625-2922; Wongpraparut, Nattawut/0000-0002-1541-3313; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Boldueva, Svetlana/0000-0002-1898-084X; Zirlik, Andreas/0000-0001-6290-3297; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Costa, FA/0000-0003-0562-2514; Grinshtein, Yury/0000-0001-8847-235X; Maggioni, Aldo Pietro/0000-0003-2764-6779; Ramshev, Konstantin/0000-0002-6978-6641; Lotufo, Paulo/0000-0002-4856-8450; Zateyshchikov, Dmitry/0000-0001-7065-2045; Zadionchenko, Vladimir/0000-0003-2377-5266; Nicolau, Jose C/0000-0002-9680-3689; Sinescu, Crina Julieta/0000-0001-5933-8549; Linhart, Ales/0000-0002-3372-7850; Bilonko, Oksana/0000-0002-9452-3296; Urina-Triana, Miguel A/0000-0001-6003-4622; Wainstein, Marco Vugman/0000-0002-7284-1453; Cannon, Christopher P/0000-0003-4596-2791; Bonaca, Marc/0000-0002-9860-3584; Benedek, Imre/0000-0003-0051-4047; Malynovsky, Yaroslav/0000-0002-9118-1104; Esposito, Giovanni/0000-0003-0565-7127; Shalaev, Sergei/0000-0003-2724-4016; Gorog, Diana/0000-0002-9286-1451; Aleksandr, Legkonogov/0000-0002-5551-4872; Bohorquez, Ricardo/0000-0002-9297-1060; Goessling, Wolfram/0000-0001-9972-1569; Koenig, Wolfgang/0000-0002-2064-9603; Meisel, Simcha/0000-0002-2041-2833; Jaramillo, Monica/0000-0003-0100-5682; Smith, Albert Vernon/0000-0003-1942-5845; Reddy, K Srinath/0000-0003-3416-3548; Campo, Gianluca/0000-0002-5150-188X; Yuan, Zuyi/0000-0002-4141-0298; ELBAZ, Meyer/0000-0002-3520-7883; Hochman, Judith/0000-0002-5889-5981; Valgimigli, Marco/0000-0002-4353-7110; Nikonov, Vadim/0000-0002-0078-9991; Rynkiewicz, Andrzej/0000-0002-5284-9511; Pella, Daniel/0000-0001-9999-6271; Wijns, William/0000-0002-7267-4376; Gazmuri, Raul J./0000-0002-3848-7227; Postadzhiyan, Arman/0000-0001-7643-142X; FUENTES JIMENEZ, FRANCISCO/0000-0002-4584-7366; Colivicchi, Furio/0000-0001-7187-2234; Joost, Alexander/0000-0003-2206-7153; STEG, Philippe Gabriel/0000-0001-6896-2941; Katz, Amos/0000-0003-0422-934X; Petrov, Ivo/0000-0002-9989-0730; solinas, emilia/0000-0003-3532-1317; Aylward, Philip/0000-0002-5358-8552; Manzur, Fernando/0000-0001-6679-5609; Reis, Gilmar/0000-0002-4847-1034; Giugliano, Giuseppe/0000-0002-1467-1687	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The SOLID-TIMI 52 trial was funded by GlaxoSmithKline.	Corsetti JP, 2006, CLIN CHEM, V52, P1331, DOI 10.1373/clinchem.2006.066845; Hakkinen T, 1999, ARTERIOSCL THROM VAS, V19, P2909, DOI 10.1161/01.ATV.19.12.2909; Hsieh CC, 2000, ATHEROSCLEROSIS, V151, P481, DOI 10.1016/S0021-9150(00)00453-6; Jang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018208; Johnson JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089034; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P1586, DOI 10.1161/01.ATV.0000222983.73369.c8; Kolodgie FD, 2004, CIRCULATION, V110, P246; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; O'Donoghue M, 2006, CIRCULATION, V113, P1745, DOI 10.1161/CIRCULATIONAHA.105.612630; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Oldgren J, 2007, EUR HEART J, V28, P699, DOI 10.1093/eurheartj/ehl565; Sabatine MS, 2007, ARTERIOSCL THROM VAS, V27, P2463, DOI 10.1161/ATVBAHA.107.151670; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Thygesen K, 2007, EUR HEART J, V28, P2525; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870	20	311	326	0	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1006	1015		10.1001/jama.2014.11061	http://dx.doi.org/10.1001/jama.2014.11061			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25173516	Bronze, Green Published			2022-12-28	WOS:000341385600018
J	Fernandez-Crehuet, P; Ruiz-Villaverde, R				Fernandez-Crehuet, Pablo; Ruiz-Villaverde, Ricardo			PICTURE QUIZ A 45 year old man with an ulcerated nodule on his right leg	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOCAL HEAT THERAPY; CUTANEOUS LEISHMANIASIS; MUCOCUTANEOUS LEISHMANIASIS; MEGLUMINE ANTIMONIATE; PCR ASSAY; DIAGNOSIS; IDENTIFICATION; TRIAL		[Fernandez-Crehuet, Pablo] Alto Guadalquivir Hosp, Dept Dermatol, Jaen 23740, Spain; [Ruiz-Villaverde, Ricardo] Complejo Hosp Jaen, Dept Dermatol, Jaen, Spain	Complejo Hospitalario de Jaen	Fernandez-Crehuet, P (corresponding author), Alto Guadalquivir Hosp, Dept Dermatol, Jaen 23740, Spain.	pablocrehuet@hotmail.com	Villaverde, Ricardo Ruiz/F-5007-2016	Villaverde, Ricardo Ruiz/0000-0002-0381-6174				Aronson NE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000628; Blum J, 2014, J TRAVEL MED, V21, P116, DOI 10.1111/jtm.12089; Chargui N, 2005, T ROY SOC TROP MED H, V99, P762, DOI 10.1016/j.trstmh.2005.06.002; Clem A, 2010, J GLOB INFECT DIS, V2, P124, DOI 10.4103/0974-777X.62863; Faber WR, 2003, J AM ACAD DERMATOL, V49, P70, DOI 10.1067/mjd.2003.492; Silva JSFE, 2013, REV SOC BRAS MED TRO, V46, P669, DOI 10.1590/0037-8682-0104-2013; Foulet F, 2007, J CLIN MICROBIOL, V45, P2110, DOI 10.1128/JCM.02555-06; Garcia-Almagro D, 2005, ACTAS DERMO-SIFILOGR, V96, P1, DOI 10.1016/S0001-7310(05)73027-1; GONZALEZ U, 2008, COCHRANE DB SYST REV, V4; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; Hajjaran H, 2011, J CLIN LAB ANAL, V25, P20, DOI 10.1002/jcla.20377; Lavergne RA, 2013, CLIN MICROBIOL INFEC; Llambrich A, 2009, BRIT J DERMATOL, V160, P756, DOI 10.1111/j.1365-2133.2008.08986.x; Masmoudi A, 2013, J DERMATOL CASE REP, V7, P31, DOI 10.3315/jdcr.2013.1135; Mohebali M, 2007, ACTA TROP, V103, P33, DOI 10.1016/j.actatropica.2007.05.005; Monge-Maillo B, 2013, DRUGS, V73, P1889, DOI 10.1007/s40265-013-0132-1; Sadeghian G, 2007, CLIN EXP DERMATOL, V32, P371, DOI 10.1111/j.1365-2230.2007.02405.x; Shahbazi F, 2008, PARASITOL RES, V103, P1159, DOI 10.1007/s00436-008-1111-4; Singh A, 2013, INDIAN J DERMATOL VE, V79, P360, DOI 10.4103/0378-6323.110795; Rodriguez BS, 2012, REV ESP SALUD PUBLIC, V86, P555, DOI 10.4321/S1135-57272012000600002; World Health Organization, 2010, WHO TECHN REP SER, p[949, 5, 104]	21	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2014	349								g5296	10.1136/bmj.g5296	http://dx.doi.org/10.1136/bmj.g5296			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QJ	25202145				2022-12-28	WOS:000341690700002
J	Alvarez-Buylla, A				Alvarez-Buylla, Arturo			Yoshiki Sasai (1962-2014) Obituary	NATURE			English	Biographical-Item									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu		Alvarez-Buylla, Arturo/0000-0003-4426-8925				SASAI Y, PUBLICATION LIST	1	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					34	34		10.1038/513034a	http://dx.doi.org/10.1038/513034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186892	Bronze			2022-12-28	WOS:000341174800019
J	Heslop, JJ; Gumm, DC				Heslop, Jeffrey J.; Gumm, Darrel C.			Ventricular Fibrillation during Left Ventriculography	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heslop, Jeffrey J.; Gumm, Darrel C.] OSF St Francis Med Ctr, Peoria, IL 61637 USA		Heslop, JJ (corresponding author), OSF St Francis Med Ctr, Peoria, IL 61637 USA.	jeffrey.j.heslop@osfhealthcare.org							0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10							e14	10.1056/NEJMicm1316331	http://dx.doi.org/10.1056/NEJMicm1316331			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184888				2022-12-28	WOS:000341390600002
J	Hausmann, JS				Hausmann, Jonathan S.			One Stroke at a Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hausmann, Jonathan S.] Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA; [Hausmann, Jonathan S.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School	Hausmann, JS (corresponding author), Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA.	jhausman@bidmc.harvard.edu		Hausmann, Jonathan/0000-0003-0786-8788				Morgan JE, 1873, UNIVERSITY OARS BEIN; Rozin P, 1996, CURR DIR PSYCHOL SCI, V5, P18, DOI 10.1111/1467-8721.ep10772690	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					893	894		10.1001/jama.2014.8148	http://dx.doi.org/10.1001/jama.2014.8148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182095				2022-12-28	WOS:000341668600015
J	Johnston, BC; Kanters, S; Bandayrel, K; Wu, P; Naji, F; Siemieniuk, RA; Ball, GDC; Busse, JW; Thorlund, K; Guyatt, G; Jansen, JP; Mills, EJ				Johnston, Bradley C.; Kanters, Steve; Bandayrel, Kristofer; Wu, Ping; Naji, Faysal; Siemieniuk, Reed A.; Ball, Geoff D. C.; Busse, Jason W.; Thorlund, Kristian; Guyatt, Gordon; Jansen, Jeroen P.; Mills, Edward J.			Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-FAT DIET; LOW-CARBOHYDRATE-DIET; RANDOMIZED CONTROLLED-TRIAL; STRUCTURED COMMERCIAL PROGRAM; ENERGY-RESTRICTED DIETS; HIGH-PROTEIN; BODY-COMPOSITION; GLYCEMIC CONTROL; KETOGENIC DIET; CLINICAL-TRIALS	IMPORTANCE Many claims have been made regarding the superiority of one diet or another for inducing weight loss. Which diet is best remains unclear. OBJECTIVE To determine weight loss outcomes for popular diets based on diet class (macronutrient composition) and named diet. DATA SOURCES Search of 6 electronic databases: AMED, CDSR, CENTRAL, CINAHL, EMBASE, and MEDLINE from inception of each database to April 2014. STUDY SELECTION Overweight or obese adults (body mass index >= 25) randomized to a popular self-administered named diet and reporting weight or body mass index data at 3-month follow-up or longer. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted data on populations, interventions, outcomes, risk of bias, and quality of evidence. A Bayesian framework was used to perform a series of random-effects network meta-analyses with meta-regression to estimate the relative effectiveness of diet classes and programs for change in weight and body mass index from baseline. Our analyses adjusted for behavioral support and exercise. MAIN OUTCOMES AND MEASURES Weight loss and body mass index at 6- and 12-month follow-up (+/- 3 months for both periods). RESULTS Among 59 eligible articles reporting 48 unique randomized trials (including 7286 individuals) and compared with no diet, the largest weight loss was associated with low-carbohydrate diets (8.73 kg [95% credible interval {CI}, 7.27 to 10.20 kg] at 6-month follow-up and 7.25 kg [95% CI, 5.33 to 9.25 kg] at 12-month follow-up) and low-fat diets (7.99 kg [95% CI, 6.01 to 9.92 kg] at 6-month follow-up and 7.27 kg [95% CI, 5.26 to 9.34 kg] at 12-month follow-up). Weight loss differences between individual diets were minimal. For example, the Atkins diet resulted in a 1.71 kg greater weight loss than the Zone diet at 6-month follow-up. Between 6-and 12-month follow-up, the influence of behavioral support (3.23 kg [95% CI, 2.23 to 4.23 kg] at 6-month follow-up vs 1.08 kg [95% CI, -1.82 to 3.96 kg] at 12-month follow-up) and exercise (0.64 kg [95% CI, -0.35 to 1.66 kg] vs 2.13 kg [95% CI, 0.43 to 3.85 kg], respectively) on weight loss differed. CONCLUSIONS AND RELEVANCE Significant weight loss was observed with any low-carbohydrate or low-fat diet. Weight loss differences between individual named diets were small. This supports the practice of recommending any diet that a patient will adhere to in order to lose weight.	[Johnston, Bradley C.; Bandayrel, Kristofer] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Johnston, Bradley C.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Johnston, Bradley C.; Busse, Jason W.; Thorlund, Kristian; Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Johnston, Bradley C.; Bandayrel, Kristofer] Univ Toronto, Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON M5G 1X8, Canada; [Kanters, Steve] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Kanters, Steve; Wu, Ping] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Kanters, Steve; Thorlund, Kristian; Jansen, Jeroen P.; Mills, Edward J.] Redwood Outcomes, Vancouver, BC, Canada; [Naji, Faysal] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Siemieniuk, Reed A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ball, Geoff D. C.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Ball, Geoff D. C.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Busse, Jason W.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Thorlund, Kristian; Mills, Edward J.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Jansen, Jeroen P.] Tufts Univ, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of Ottawa; McMaster University; University of Toronto; University of Alberta; University of Alberta; McMaster University; McMaster University; Stanford University; Massachusetts Department of Public Health; Tufts University	Mills, EJ (corresponding author), Stanford Univ, Sch Med, 1265 Welch Rd, Stanford, CA 94305 USA.	millsej@stanford.edu	Busse, Jason/CAH-3696-2022; Ball, Geoff/AAH-4741-2019	Busse, Jason/0000-0002-0178-8712; Jansen, Jeroen Paul/0000-0003-2686-9217	Canadian Institute of Health research via the Public Health Agency of Canada [201104]; Canadian Institute of Health Research	Canadian Institute of Health research via the Public Health Agency of Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute of Health research knowledge synthesis grant 201104 via the Public Health Agency of Canada. Dr Busse holds a Canadian Institute of Health Research new investigator award. Dr Mills holds a Canada Research Chair in global health.	Aldana SG, 2007, AM J HEALTH PROMOT, V21, P510, DOI 10.4278/0890-1171-21.6.510; [Anonymous], 2004, AM J NURS, V104, P94; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Blumenthal JA, 2000, ARCH INTERN MED, V160, P1947, DOI 10.1001/archinte.160.13.1947; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Brehm BJ, 2005, J CLIN ENDOCR METAB, V90, P1475, DOI 10.1210/jc.2004-1540; Brinkworth GD, 2004, DIABETOLOGIA, V47, P1677, DOI 10.1007/s00125-004-1511-7; Brinkworth GD, 2004, INT J OBESITY, V28, P661, DOI 10.1038/sj.ijo.0802617; Brinkworth GD, 2009, ARCH INTERN MED, V169, P1873, DOI 10.1001/archinternmed.2009.329; Brinkworth GD, 2009, OBESITY, V17, P1916, DOI 10.1038/oby.2009.134; Brownell K, 2004, LEARN PROGRAM WEIGHT; Collins CE, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1980; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; Daly ME, 2006, DIABETIC MED, V23, P15, DOI 10.1111/j.1464-5491.2005.01760.x; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023; Davis NJ, 2009, DIABETES CARE, V32, P1147, DOI 10.2337/dc08-2108; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djuric Z, 2002, OBES RES, V10, P657, DOI 10.1038/oby.2002.89; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465; Farnsworth E, 2003, AM J CLIN NUTR, V78, P31, DOI 10.1093/ajcn/78.1.31; Figueroa A, 2013, MENOPAUSE, V20, P967, DOI [10.1097/GME.0b013e3182831ee4, 10.1097/gme.0b013e3182831ee4]; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 2009, POSTGRAD MED, V121, P113, DOI 10.3810/pgm.2009.09.2046; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Galletly C, 2007, APPETITE, V49, P590, DOI 10.1016/j.appet.2007.03.222; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Goodrick GK, 1998, J CONSULT CLIN PSYCH, V66, P363, DOI 10.1037/0022-006X.66.2.363; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Heshka S, 2000, AM J MED, V109, P282, DOI 10.1016/S0002-9343(00)00494-0; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Iqbal N, 2010, OBESITY, V18, P1733, DOI 10.1038/oby.2009.460; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Johnston B, BRANDED DIETS WEIGHT; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lasker DAW, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-30; Layman DK, 2005, J NUTR, V135, P1903, DOI 10.1093/jn/135.8.1903; Layman DK, 2003, J NUTR, V133, P411, DOI 10.1093/jn/133.2.411; Layman DK, 2009, J NUTR, V139, P514, DOI 10.3945/jn.108.099440; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Luscombe ND, 2003, INT J OBESITY, V27, P582, DOI 10.1038/sj.ijo.0802270; Luscombe ND, 2002, DIABETES CARE, V25, P652, DOI 10.2337/diacare.25.4.652; Marketdata Enterprises, 2009, US WEIGHT LOSS DIET; McAlister FA, 1999, JAMA-J AM MED ASSOC, V282, P1371, DOI 10.1001/jama.282.14.1371; McAuley KA, 2005, DIABETOLOGIA, V48, P8, DOI 10.1007/s00125-004-1603-4; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Morgan LM, 2009, PUBLIC HEALTH NUTR, V12, P799, DOI 10.1017/S1368980008003236; Pagoto SL, 2013, JAMA-J AM MED ASSOC, V310, P687, DOI 10.1001/jama.2013.8601; Parker B, 2002, DIABETES CARE, V25, P425, DOI 10.2337/diacare.25.3.425; Pinto AM, 2013, OBESITY, V21, P673, DOI 10.1002/oby.20044; Porrini M, 1997, PHYSIOL BEHAV, V62, P563, DOI 10.1016/S0031-9384(97)00162-5; Qi QB, 2012, AM J CLIN NUTR, V95, P506, DOI 10.3945/ajcn.111.025270; Rippe JM, 1998, OBES RES, V6, P208, DOI 10.1002/j.1550-8528.1998.tb00339.x; Rock CL, 2007, OBESITY, V15, P939, DOI 10.1038/oby.2007.614; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Ruth MR, 2013, METABOLISM, V62, P1779, DOI 10.1016/j.metabol.2013.07.006; Ryan DH, 2010, JAMA-J AM MED ASSOC, V304, P1835, DOI 10.1001/jama.2010.1531; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Swenson BR, 2007, J SURG RES, V142, P308, DOI 10.1016/j.jss.2007.02.052; Tay J, 2008, J AM COLL CARDIOL, V51, P59, DOI 10.1016/j.jacc.2007.08.050; Thomson CA, 2010, NUTR CANCER, V62, P1142, DOI 10.1080/01635581.2010.513803; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; US Department of Agriculture US Department of Health and Human Services, 2011, DIET GUID AM 2010; USPSTF, 2004, AM J NURS, V104, P97; USPSTF, 2004, AM J NURS, V104, P100; Volek JS, 2009, METABOLISM, V58, P1769, DOI 10.1016/j.metabol.2009.06.005; Volek JS, 2009, LIPIDS, V44, P297, DOI 10.1007/s11745-008-3274-2; Wadden TA, 2004, AM J CLIN NUTR, V80, P560; Westman EC, 2006, INT J CARDIOL, V110, P212, DOI 10.1016/j.ijcard.2005.08.034; Westman EC, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-36; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; Womble LG, 2004, OBES RES, V12, P1011, DOI 10.1038/oby.2004.124; Yancy WS, 2009, QUAL LIFE RES, V18, P281, DOI 10.1007/s11136-009-9444-8; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	88	342	348	5	124	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					923	933		10.1001/jama.2014.10397	http://dx.doi.org/10.1001/jama.2014.10397			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9IE	25182101	Bronze			2022-12-28	WOS:000341668600021
J	Kan, HD				Kan, Haidong			Globalisation and environmental health in China	LANCET			English	Editorial Material							AIR-POLLUTION; CLIMATE; ASIA		[Kan, Haidong] Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China; [Kan, Haidong] Fudan Univ, Global Hlth Inst, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Kan, HD (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China.	haidongkan@gmail.com	Kan, Haidong/AGU-0328-2022					Carmichael GR, 2002, ENVIRON SCI TECHNOL, V36, P4707, DOI 10.1021/es011509c; Chen Z, 2013, LANCET, V382, P1959, DOI 10.1016/S0140-6736(13)62064-4; Gustafsson O, 2009, SCIENCE, V323, P495, DOI 10.1126/science.1164857; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin JT, 2014, P NATL ACAD SCI USA, V111, P1736, DOI 10.1073/pnas.1312860111; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Ni HG, 2009, ENVIRON SCI TECHNOL, V43, P3991, DOI 10.1021/es802725m; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Saikawa E, 2009, ATMOS ENVIRON, V43, P2814, DOI 10.1016/j.atmosenv.2009.02.017; Yang G.H., 2014, ATLAS HUAI RIVER BAS; Yang Y., 2014, IS CHINA TRACK COMPL; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1	12	12	12	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					721	723		10.1016/S0140-6736(14)60957-0	http://dx.doi.org/10.1016/S0140-6736(14)60957-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25176534				2022-12-28	WOS:000341361500008
J	Lax, S; Smith, DP; Hampton-Marcell, J; Owens, SM; Handley, KM; Scott, NM; Gibbons, SM; Larsen, P; Shogan, BD; Weiss, S; Metcalf, JL; Ursell, LK; Vazquez-Baeza, Y; Van Treuren, W; Hasan, NA; Gibson, MK; Colwell, R; Dantas, G; Knight, R; Gilbert, JA				Lax, Simon; Smith, Daniel P.; Hampton-Marcell, Jarrad; Owens, Sarah M.; Handley, Kim M.; Scott, Nicole M.; Gibbons, Sean M.; Larsen, Peter; Shogan, Benjamin D.; Weiss, Sophie; Metcalf, Jessica L.; Ursell, Luke K.; Vazquez-Baeza, Yoshiki; Van Treuren, Will; Hasan, Nur A.; Gibson, Molly K.; Colwell, Rita; Dantas, Gautam; Knight, Rob; Gilbert, Jack A.			Longitudinal analysis of microbial interaction between humans and the indoor environment	SCIENCE			English	Article							HUMAN SKIN MICROBIOTA; DIVERSITY; HOUSE; BACTERIA; SURFACES; SPREAD; FUNGI; TIME	The bacteria that colonize humans and our built environments have the potential to influence our health. Microbial communities associated with seven families and their homes over 6 weeks were assessed, including three families that moved their home. Microbial communities differed substantially among homes, and the home microbiome was largely sourced from humans. The microbiota in each home were identifiable by family. Network analysis identified humans as the primary bacterial vector, and a Bayesian method significantly matched individuals to their dwellings. Draft genomes of potential human pathogens observed on a kitchen counter could be matched to the hands of occupants. After a house move, the microbial community in the new house rapidly converged on the microbial community of the occupants' former house, suggesting rapid colonization by the family's microbiota.	[Lax, Simon; Smith, Daniel P.; Hampton-Marcell, Jarrad; Handley, Kim M.; Scott, Nicole M.; Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Lax, Simon; Smith, Daniel P.; Hampton-Marcell, Jarrad; Owens, Sarah M.; Handley, Kim M.; Scott, Nicole M.; Gibbons, Sean M.; Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Smith, Daniel P.] Baylor Coll Med, Dept Mol Virol & Microbiol, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Owens, Sarah M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Gibbons, Sean M.; Gilbert, Jack A.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Larsen, Peter] Argonne Natl Lab, Dept Biosci, Argonne, IL 60439 USA; [Larsen, Peter] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Shogan, Benjamin D.] Univ Chicago Med, Dept Surg, Chicago, IL 60637 USA; [Weiss, Sophie; Metcalf, Jessica L.; Ursell, Luke K.; Vazquez-Baeza, Yoshiki; Van Treuren, Will; Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80304 USA; [Weiss, Sophie] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80304 USA; [Ursell, Luke K.; Vazquez-Baeza, Yoshiki; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80304 USA; [Vazquez-Baeza, Yoshiki] Univ Colorado, Dept Comp Sci, Boulder, CO 80304 USA; [Hasan, Nur A.; Colwell, Rita] CosmosID, College Pk, MD 20742 USA; [Hasan, Nur A.; Colwell, Rita] Univ Maryland, Inst Adv Comp Studies, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Gibson, Molly K.; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Gibson, Molly K.; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gibson, Molly K.; Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Baylor College of Medicine; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland College Park; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gilbert, JA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	gilbertjack@anl.gov	Gilbert, Jack/AAF-3270-2019; Vazquez-Baeza, Yoshiki/HCI-4852-2022; Gibbons, Sean M./ABH-2562-2020; Smith, Daniel/L-6827-2019; hasan, nur a/AAX-3881-2021; Knight, Rob/D-1299-2010	Vazquez-Baeza, Yoshiki/0000-0001-6014-2009; Gibbons, Sean M./0000-0002-8724-7916; Smith, Daniel/0000-0002-2479-2044; hasan, nur a/0000-0003-0175-8879; Colwell, Rita R./0000-0001-5432-1502; Handley, Kim/0000-0003-0531-3009; Knight, Rob/0000-0002-0975-9019; Owens, Sarah/0000-0002-9946-2787; Dantas, Gautam/0000-0003-0455-8370	Alfred P. Sloan Foundation's Microbiology of the Built Environment Program; NIH Director's New Innovator Award [DP2-DK-098089]; U.S. Environmental Protection Agency STAR Fellowship; NSF [DGE-11143954]; U.S. Department of Energy [DE-AC02-06CH11357]; University of Chicago Research Computing Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872, U01HG004866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, DP2DK098089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation's Microbiology of the Built Environment Program; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Environmental Protection Agency STAR Fellowship(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); University of Chicago Research Computing Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Alfred P. Sloan Foundation's Microbiology of the Built Environment Program and a NIH Director's New Innovator Award (DP2-DK-098089) to G. D. S. M. G was supported by a U.S. Environmental Protection Agency STAR Fellowship. M. K. G. is a NSF graduate research fellow (award DGE-11143954). This work was supported in part by the U.S. Department of Energy under contract DE-AC02-06CH11357. We acknowledge the University of Chicago Research Computing Center for support of this work. All sequence data were submitted to the European Bioinformatics Institute's database under accession no. ERP005806.	Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Bright KR, 2010, J SCH NURS, V26, P33, DOI 10.1177/1059840509354383; CUSTOVIC A, 1994, CLIN EXP ALLERGY, V24, P1164, DOI 10.1111/j.1365-2222.1994.tb03323.x; Dawson P, 2007, J APPL MICROBIOL, V102, P945, DOI 10.1111/j.1365-2672.2006.03171.x; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hoppe P, 1998, INT J BIOMETEOROL, V42, P1, DOI 10.1007/s004840050075; Hyvarinen A, 2002, INT BIODETER BIODEGR, V49, P27, DOI 10.1016/S0964-8305(01)00103-2; Jaffal AA, 1997, ENVIRON INT, V23, P529, DOI 10.1016/S0160-4120(97)00055-X; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lignell U, 2008, LETT APPL MICROBIOL, V47, P303, DOI 10.1111/j.1472-765X.2008.02431.x; Moschandreas DJ, 2003, AEROSOL SCI TECH, V37, P899, DOI 10.1080/02786820300935; Nevalainen A, 2005, INDOOR AIR, V15, P58, DOI 10.1111/j.1600-0668.2005.00344.x; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862	19	536	543	12	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1048	1052		10.1126/science.1254529	http://dx.doi.org/10.1126/science.1254529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170151	Green Accepted			2022-12-28	WOS:000340870900039
J	Shulman, Z; Gitlin, AD; Weinstein, JS; Lainez, B; Esplugues, E; Flavell, RA; Craft, JE; Nussenzweig, MC				Shulman, Ziv; Gitlin, Alexander D.; Weinstein, Jason S.; Lainez, Begona; Esplugues, Enric; Flavell, Richard A.; Craft, Joseph E.; Nussenzweig, Michel C.			Dynamic signaling by T follicular helper cells during germinal center B cell selection	SCIENCE			English	Article							IMMUNITY IN-VIVO; DENDRITIC CELLS; AFFINITY MATURATION; REPORTER MOUSE; LYMPH-NODES; ANTIGEN; EXPRESSION; MOTILITY; REVEALS; PROTEIN	T follicular helper (T-FH) cells select high-affinity, antibody-producing B cells for clonal expansion in germinal centers (GCs), but the nature of their interaction is not well defined. Using intravital imaging, we found that selection is mediated by large but transient contacts between T-FH and GC B cells presenting the highest levels of cognate peptide bound to major histocompatibility complex II. These interactions elicited transient and sustained increases in T-FH intracellular free calcium (Ca2+) that were associated with T-FH cell coexpression of the cytokines interleukin-4 and -21. However, increased intracellular Ca2+ did not arrest T-FH cell migration. Instead, T-FH cells remained motile and continually scanned the surface of many GC B cells, forming short-lived contacts that induced selection through further repeated transient elevations in intracellular Ca2+.	[Shulman, Ziv; Gitlin, Alexander D.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Weinstein, Jason S.; Lainez, Begona; Craft, Joseph E.] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT 06520 USA; [Esplugues, Enric; Flavell, Richard A.; Craft, Joseph E.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.; Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Rockefeller University; Yale University; Yale University; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Esplugues, Enric/AAD-4245-2020	Esplugues, Enric/0000-0002-9733-8707; Gitlin, Alexander/0000-0002-9229-0919; Flavell, Richard/0000-0003-4461-0778; Esplugues, Enric/0000-0002-8130-0413	NIH Medical Scientist Training Program [T32GM07739]; Empire State Stem Cell Fund through New York State Department of Health [C023046]; NIH [AI037526-19, AI072529-06, AI100663-02, AR40072-24, AR053495-08]; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072529, R01AI037526, R37AI037526, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040072, R37AR040072, R21AR063942, P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through New York State Department of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Victora for helpful discussions and suggestions, D. Bosque and T. Eisenreich for help with mouse colony management, A. Abadir for protein production, and K. Yao for technical help. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. Z.S. is a Human Frontiers of Science Program fellow (reference LT000340/2011-L). A. D. G. is supported by NIH Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. Support for the Rockefeller University multiphoton microscope was granted by the Empire State Stem Cell Fund through New York State Department of Health contract C023046. This work was supported by NIH grants AI037526-19, AI072529-06, and AI100663-02 to M.C.N. and NIH grants AR40072-24 and AR053495-08 (the content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH) and the Alliance for Lupus Research to J.E.C. M.C.N. and R. A. F. are HHMI investigators.	Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	35	239	243	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1058	1062		10.1126/science.1257861	http://dx.doi.org/10.1126/science.1257861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170154	Green Accepted			2022-12-28	WOS:000340870900042
J	Baleriola, J; Walker, CA; Jean, YY; Crary, JF; Troy, CM; Nagy, PL; Hengst, U				Baleriola, Jimena; Walker, Chandler A.; Jean, Ying Y.; Crary, John F.; Troy, Carol M.; Nagy, Peter L.; Hengst, Ulrich			Axonally Synthesized ATF4 Transmits a Neurodegenerative Signal across Brain Regions	CELL			English	Article							ALZHEIMERS-DISEASE; MESSENGER-RNA; LOCAL TRANSLATION; HIPPOCAMPAL-NEURONS; AXONS; TRAFFICKING; KINASES; STRESS; DEATH; CHOP	In Alzheimer's disease (AD) brain, exposure of axons to A beta causes pathogenic changes that spread retrogradely by unknown mechanisms, affecting the entire neuron. We found that locally applied Ab1-42 initiates axonal synthesis of a defined set of proteins including the transcription factor ATF4. Inhibition of local translation and retrograde transport or knockdown of axonal Atf4 mRNA abolished Ab-induced ATF4 transcriptional activity and cell loss. Ab1-42 injection into the dentate gyrus (DG) of mice caused loss of forebrain neurons whose axons project to the DG. Protein synthesis and Atf4 mRNA were upregulated in these axons, and coinjection of Atf4 siRNA into the DG reduced the effects of Ab1-42 in the forebrain. ATF4 protein and transcripts were found with greater frequency in axons in the brain of AD patients. These results reveal an active role for intraaxonal translation in neurodegeneration and identify ATF4 as a mediator for the spread of AD pathology.	[Baleriola, Jimena; Crary, John F.; Troy, Carol M.; Nagy, Peter L.; Hengst, Ulrich] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Walker, Chandler A.] Columbia Univ Coll Phys & Surg, Integrated Program Cellular,Mol & Biomed Studies, New York, NY 10032 USA; [Jean, Ying Y.; Crary, John F.; Troy, Carol M.; Nagy, Peter L.; Hengst, Ulrich] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Troy, Carol M.] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Hengst, U (corresponding author), Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.	uh2112@cumc.columbia.edu	Hengst, Ulrich/L-1413-2014; Baleriola, Jimena/AAB-2540-2019; Baleriola, Jimena/AAU-9902-2021; Nagy, Peter Lajos/AAT-6055-2020; Troy, Carol/ABC-2771-2020	Hengst, Ulrich/0000-0002-8061-2861; Nagy, Peter Lajos/0000-0002-7461-8415; 	Alzheimer's Association [NIRG-10-171721]; National Institute of Neurological Disorders and Stroke [NS081333]; pilot study awards from the National Institute on Aging-funded Alzheimer's Disease Research Center at Columbia University [AG008702]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); pilot study awards from the National Institute on Aging-funded Alzheimer's Disease Research Center at Columbia University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Alzheimer's Association (NIRG-10-171721; to U. H.), National Institute of Neurological Disorders and Stroke (NS081333; to C. M. T.), and pilot study awards from the National Institute on Aging-funded Alzheimer's Disease Research Center at Columbia University (AG008702; to J. B. and Y. Y. J.) that also supports the New York Brain Bank. We thank S. Cano and staff in the Personalized Genomic Medicine laboratory for their contribution; H. Moore for assistance with stereology; J. P. Vonsattel for access to human samples; and members of the U. H. group for comments and discussions.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Dubacq C, 2009, J NEUROSCI, V29, P10184, DOI 10.1523/JNEUROSCI.2443-09.2009; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Ivins KJ, 1998, NEUROBIOL DIS, V5, P365, DOI 10.1006/nbdi.1998.0228; Ji SJ, 2014, DEV NEUROBIOL, V74, P245, DOI 10.1002/dneu.22112; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kar AN, 2014, DEV NEUROBIOL, V74, P333, DOI 10.1002/dneu.22141; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; KLEIMAN R, 1994, J NEUROSCI, V14, P1130, DOI 10.1523/JNEUROSCI.14-03-01130.1994; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; LERANTH C, 1989, J COMP NEUROL, V289, P304, DOI 10.1002/cne.902890210; Liu Y, 2008, J NEUROSCI, V28, P13805, DOI 10.1523/JNEUROSCI.4218-08.2008; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Miller JA, 2010, SYST BIO, V1, P611, DOI 10.1007/978-1-4419-5797-9_25; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Poon WW, 2013, J BIOL CHEM, V288, P16937, DOI 10.1074/jbc.M113.463711; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Shulman JM, 2014, HUM MOL GENET, V23, P870, DOI 10.1093/hmg/ddt478; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Willis DE, 2011, J NEUROSCI, V31, P14481, DOI 10.1523/JNEUROSCI.2950-11.2011; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	38	204	206	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1159	1172		10.1016/j.cell.2014.07.001	http://dx.doi.org/10.1016/j.cell.2014.07.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171414	Green Accepted, Bronze			2022-12-28	WOS:000340945000020
J	Churazov, E; Sunyaev, R; Isern, J; Knodlseder, J; Jean, P; Lebrun, F; Chugai, N; Grebenev, S; Bravo, E; Sazonov, S; Renaud, M				Churazov, E.; Sunyaev, R.; Isern, J.; Knoedlseder, J.; Jean, P.; Lebrun, F.; Chugai, N.; Grebenev, S.; Bravo, E.; Sazonov, S.; Renaud, M.			Cobalt-56 gamma-ray emission lines from the type Ia supernova 2014J	NATURE			English	Article							POSITRON-ANNIHILATION SPECTRUM; SN 2014J; MODELS; REGION; CONSTRAINTS; PROGENITOR; DISCOVERY; BINARIES; SPI	A type Ia supernova is thought to be a thermonuclear explosion of either a single carbon-oxygen white dwarf or a pair of merging white dwarfs. The explosion fuses a large amount of radioactive Ni-56 (refs 1-3). After the explosion, the decay chain from Ni-56 to Co-56 to Fe-56 generates gamma-ray photons, which are reprocessed in the expanding ejecta and give rise to powerful optical emission. Here we report the detection of Co-56 lines at energies of 847 and 1,238 kiloelectronvolts and a gamma-ray continuum in the 200-400 kiloelectronvolt band from the type Ia supernova 2014J in the nearby galaxy M82. The line fluxes suggest that about 0.6 +/- 0.1 solar masses of radioactive Ni-56 were synthesized during the explosion. The line broadening gives a characteristic mass-weighted ejecta expansion velocity of 10,000 +/- 3,000 kilometres per second. The observed gamma-ray properties are in broad agreement with the canonical model of an explosion of a white dwarf just massive enough to be unstable to gravitational collapse, but do not exclude merger scenarios that fuse comparable amounts of Ni-56.	[Churazov, E.; Sunyaev, R.; Grebenev, S.; Sazonov, S.] Space Res Inst IKI, Profsouznaya 84-32, Moscow 117997, Russia; [Churazov, E.; Sunyaev, R.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Isern, J.] Inst Space Sci ICE CSIC IEEC, Bellaterra 08193, Spain; [Knoedlseder, J.; Jean, P.] Univ Toulouse, UPS OMP, IRAP, Toulouse, France; [Knoedlseder, J.; Jean, P.] CNRS, IRAP, F-31028 Toulouse 4, France; [Lebrun, F.] Univ Paris Diderot, APC, CNRS IN2P3, Observ Paris,Sorbonne Paris Cite, F-75205 Paris 13, France; [Chugai, N.] Russian Acad Sci, Inst Astron, Moscow 119017, Russia; [Bravo, E.] Univ Politecn Cataluna, ETSAV, Sant Cugat Del Valles 08173, Spain; [Sazonov, S.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia; [Renaud, M.] Univ Montpellier 2, LUPM, CNRS IN2P3, CC 72, F-34095 Montpellier 5, France	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Institute of Astronomy of the Russian Academy of Sciences; Russian Academy of Sciences; Universitat Politecnica de Catalunya; Moscow Institute of Physics & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier	Churazov, E (corresponding author), Space Res Inst IKI, Profsouznaya 84-32, Moscow 117997, Russia.	churazov@mpa-garching.mpg.de	Isern, Jordi/B-1844-2015; Grebenev, Sergei/L-4134-2019; Sazonov, Sergey/J-6881-2016; Bravo, Eduardo/P-1500-2017; Churazov, Eugene/A-7783-2013	Isern, Jordi/0000-0002-0819-9574; Grebenev, Sergei/0000-0002-5501-4253; Bravo, Eduardo/0000-0003-0894-6450; Churazov, Eugene/0000-0002-0322-884X; Chugai, Nikolai/0000-0003-2895-6066; Jean, Pierre/0000-0002-1757-9560	ESA; Russian Scientific Foundation [14-22-00271]; MINECO-FEDER; Generalitat de Catalunya; CNES	ESA(European Space Agency); Russian Scientific Foundation(Russian Science Foundation (RSF)); MINECO-FEDER(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CNES(Centre National D'etudes Spatiales)	This work was based on observations with INTEGRAL, an ESA project with instruments and a science data centre funded by ESA member states (especially the principal investigator countries: Denmark, France, Germany, Italy, Switzerland and Spain) and with the participation of Russia and the United States. We are grateful to the ESA INTEGRAL team and E. Kuulkers for their prompt reaction to the SN 2014J event. E.C., R.S. and S.G. wish to thank the Russian INTEGRAL advisory committee for allocating an additional 10<SUP>6</SUP> s of time from a regular programme to SN 2014J observations. R.S., S.G. and S.S. are partly supported by grant no. 14-22-00271 from the Russian Scientific Foundation. J.I. is supported by MINECO-FEDER and Generalitat de Catalunya grants. The SPI project has been completed under the responsibility and leadership of CNES, France. ISGRI has been realized by CEA with the support of CNES. We thank P. Hoflich, K. Nomoto and S. Woosley for making available their supernova explosion models HED6, W7 and DD4.	Amanullah R, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L21; ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Badenes C, 2003, ASTROPHYS J, V593, P358, DOI 10.1086/376448; Churazov E, 2005, MON NOT R ASTRON SOC, V357, P1377, DOI 10.1111/j.1365-2966.2005.08757.x; Churazov E, 2011, MON NOT R ASTRON SOC, V411, P1727, DOI 10.1111/j.1365-2966.2010.17804.x; Churazov E, 1996, ASTROPHYS J, V471, P673, DOI 10.1086/177997; DOTANI T, 1987, NATURE, V330, P230, DOI 10.1038/330230a0; Dwarkadas VV, 1998, ASTROPHYS J, V497, P807, DOI 10.1086/305478; Foley RJ, 2014, MON NOT R ASTRON SOC, V443, P2887, DOI 10.1093/mnras/stu1378; Fossey S., 2014, CBET, V3792; Gilfanov M, 2010, NATURE, V463, P924, DOI 10.1038/nature08685; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; Hoflich P, 1996, ASTROPHYS J, V457, P500, DOI 10.1086/176748; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Isern J, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220303; Karachentsev ID, 2006, ASTROPHYSICS+, V49, P3, DOI 10.1007/s10511-006-0002-6; Kelly PL, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/3; Kuulkers E., 2014, ASTRON TELEGR, V5835; Lebrun F, 2003, ASTRON ASTROPHYS, V411, pL141, DOI 10.1051/0004-6361:20031367; Malone CM, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/11; Margutti R, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/52; MATZ SM, 1988, NATURE, V331, P416, DOI 10.1038/331416a0; Moll R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/105; NADYOZHIN DK, 1994, ASTROPHYS J SUPPL S, V92, P527, DOI 10.1086/192008; Nielsen MTB, 2014, MON NOT R ASTRON SOC, V442, P3400, DOI 10.1093/mnras/stu913; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Perez-Torres M. A., 2014, PREPRINT; Ropke FK, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L19; Sazonov SY, 2014, ASTRON LETT+, V40, P65, DOI 10.1134/S1063773714030062; SUNYAEV R, 1987, NATURE, V330, P227, DOI 10.1038/330227a0; SYUNYAEV RA, 1990, SOV ASTRON LETT+, V16, P171; TEEGARDEN BJ, 1989, NATURE, V339, P122, DOI 10.1038/339122a0; The LS, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/141; Ubertini P, 2003, ASTRON ASTROPHYS, V411, pL131, DOI 10.1051/0004-6361:20031224; Vedrenne G, 2003, ASTRON ASTROPHYS, V411, pL63, DOI 10.1051/0004-6361:20031482; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; Woosley SE, 2007, ASTROPHYS J, V662, P487, DOI 10.1086/513732; Woosley S. E., 1991, SUPERNOVAE, P63; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.aa.24.090186.001225; Zheng W., 2014, ASTRON TELEGR, V5822	42	121	122	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					406	+		10.1038/nature13672	http://dx.doi.org/10.1038/nature13672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164750	Green Submitted			2022-12-28	WOS:000340840600027
J	Jarosz, DF; Brown, JCS; Walker, GA; Datta, MS; Ung, WL; Lancaster, AK; Rotem, A; Chang, A; Newby, GA; Weitz, DA; Bisson, LF; Lindquist, S				Jarosz, Daniel F.; Brown, Jessica C. S.; Walker, Gordon A.; Datta, Manoshi S.; Ung, W. Lloyd; Lancaster, Alex K.; Rotem, Assaf; Chang, Amelia; Newby, Gregory A.; Weitz, David A.; Bisson, Linda F.; Lindquist, Susan			Cross-Kingdom Chemical Communication Drives a Heritable, Mutually Beneficial Prion-Based Transformation of Metabolism	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PRION; GLUCOSAMINE RESISTANCE; ENVIRONMENTAL-STRESS; GENETIC-VARIATION; WILD YEASTS; INHERITANCE; MICROBIOTA; COMMONS; EXPRESSION	In experimental science, organisms are usually studied in isolation, but in the wild, they compete and cooperate in complex communities. We report a system for cross-kingdom communication by which bacteria heritably transform yeast metabolism. An ancient biological circuit blocks yeast from using other carbon sources in the presence of glucose. [GAR(+)], a protein-based epigenetic element, allows yeast to circumvent this "glucose repression'' and use multiple carbon sources in the presence of glucose. Some bacteria secrete a chemical factor that induces [GAR(+)]. [GAR(+)] is advantageous to bacteria because yeast cells make less ethanol and is advantageous to yeast because their growth and long-term viability is improved in complex carbon sources. This cross-kingdom communication is broadly conserved, providing a compelling argument for its adaptive value. By heritably transforming growth and survival strategies in response to the selective pressures of life in a biological community, [GAR(+)] presents a unique example of Lamarckian inheritance.	[Jarosz, Daniel F.; Brown, Jessica C. S.; Lancaster, Alex K.; Chang, Amelia; Newby, Gregory A.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jarosz, Daniel F.] Stanford Univ, Sch Med, Dept Dev Biol, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Brown, Jessica C. S.; Chang, Amelia; Newby, Gregory A.; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Walker, Gordon A.; Bisson, Linda F.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Datta, Manoshi S.] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Ung, W. Lloyd; Rotem, Assaf; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Lancaster, Alex K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Lancaster, Alex K.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Lindquist, Susan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; Massachusetts Institute of Technology (MIT); University of California System; University of California Davis; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute	Bisson, LF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lfbisson@ucdavis.edu; lindquist_admin@wimit.edu	Lancaster, Alexander K/K-2855-2013	Lancaster, Alexander K/0000-0002-0002-9263; Newby, Gregory A./0000-0001-7869-2615; Jarosz, Daniel/0000-0003-3497-5888; Ung, Warren/0000-0003-3352-9974; Brown, Jessica/0000-0002-3255-1486	G. Harold and Leila Y. Mathers Foundation; Howard Hughes Medical Institute (HHMI; HHMI fellow of the Damon Runyon Cancer Research Foundation [DRG-1964-08]; NIH Pathway to independence award [K99 GM098600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM098600, R00GM098600] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; Howard Hughes Medical Institute (HHMI(Howard Hughes Medical Institute); HHMI fellow of the Damon Runyon Cancer Research Foundation; NIH Pathway to independence award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Drs. A. Grossman, D. Newman, L. Joseph, B. Bassler, and G. C. Walker, who generously provided bacterial strains for this study. We also thank A. Regev, C. Kaiser, D. Thompson, B. Bevis, J. Valastyan, M. Taipale, L. Pepper, B. Vincent, K. Erbil, Q. Zhou, S. Peddada, and members of the Lindquist and Bisson laboratories for materials, discussions, and/or critical reading of the manuscript. N. Azubuine and T. Nanchung provided a constant supply of plates and media. This work was funded by grants from the G. Harold and Leila Y. Mathers Foundation and Howard Hughes Medical Institute (HHMI). D. F. J. was supported as an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-1964-08) and by an NIH Pathway to independence award (K99 GM098600). S. L. is an HHMI investigator.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; BALL AJS, 1976, GENETICS, V84, P311; Bisson LF, 2007, ADV FOOD NUTR RES, V53, P65, DOI 10.1016/S1043-4526(07)53003-2; Boulton R. B., 1996, PRINCIPLES PRACTICES, DOI DOI 10.1007/978-1-4615-1781-8; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Karpel JE, 2008, AM J ENOL VITICULT, V59, P265; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; KRAMER RM, 1984, J PERS SOC PSYCHOL, V46, P1044, DOI 10.1037/0022-3514.46.5.1044; KUNZ BA, 1977, MOL GEN GENET, V153, P169, DOI 10.1007/BF00264732; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Stulke J, 2000, ANNU REV MICROBIOL, V54, P849, DOI 10.1146/annurev.micro.54.1.849; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; VALLEJO CG, 1989, YEAST, V5, P307, DOI 10.1002/yea.320050411; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	48	103	105	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1083	1093		10.1016/j.cell.2014.07.025	http://dx.doi.org/10.1016/j.cell.2014.07.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171409	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000340945000014
J	Palm, NW; de Zoete, MR; Cullen, TW; Barry, NA; Stefanowski, J; Hao, LM; Degnan, PH; Hu, JZ; Peter, I; Zhang, W; Ruggiero, E; Cho, JH; Goodman, AL; Flavell, RA				Palm, Noah W.; de Zoete, Marcel R.; Cullen, Thomas W.; Barry, Natasha A.; Stefanowski, Jonathan; Hao, Liming; Degnan, Patrick H.; Hu, Jianzhong; Peter, Inga; Zhang, Wei; Ruggiero, Elizabeth; Cho, Judy H.; Goodman, Andrew L.; Flavell, Richard A.			Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease	CELL			English	Article							FECAL BACTERIA; IGA PRODUCTION; SECRETED IGA; MICROBIOTA; DIVERSITY; MICE; INDUCTION; PATHOGEN; IMMUNITY; CELLS	Specific members of the intestinal microbiota dramatically affect inflammatory bowel disease (IBD) in mice. In humans, however, identifying bacteria that preferentially affect disease susceptibility and severity remains a major challenge. Here, we used flow-cytometry-based bacterial cell sorting and 16S sequencing to characterize taxa-specific coating of the intestinal microbiota with immunoglobulin A (IgA-SEQ) and show that high IgA coating uniquely identifies colitogenic intestinal bacteria in a mouse model of microbiota-driven colitis. We then used IgA-SEQ and extensive anaerobic culturing of fecal bacteria from IBD patients to create personalized disease-associated gut microbiota culture collections with predefined levels of IgA coating. Using these collections, we found that intestinal bacteria selected on the basis of high coating with IgA conferred dramatic susceptibility to colitis in germfree mice. Thus, our studies suggest that IgA coating identifies inflammatory commensals that preferentially drive intestinal disease. Targeted elimination of such bacteria may reduce, reverse, or even prevent disease development.	[Palm, Noah W.; de Zoete, Marcel R.; Stefanowski, Jonathan; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Cullen, Thomas W.; Barry, Natasha A.; Degnan, Patrick H.; Goodman, Andrew L.] Yale Univ, Sch Med, Microbial Divers Inst, New Haven, CT 06510 USA; [Cullen, Thomas W.; Barry, Natasha A.; Degnan, Patrick H.; Goodman, Andrew L.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA; [Hao, Liming] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Hu, Jianzhong; Peter, Inga] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zhang, Wei; Ruggiero, Elizabeth; Cho, Judy H.] Yale Univ, Sch Med, Dept Med & Genet, New Haven, CT 06510 USA; [de Zoete, Marcel R.; Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Icahn School of Medicine at Mount Sinai; Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	richard.flavell@yale.edu	Hu, Jianzhong/P-6305-2014; de Zoete, Marcel/ABA-7918-2021; de Zoete, Marcel R/O-3012-2014; Hu, Jianzhong/ABE-4311-2020	Hu, Jianzhong/0000-0001-8546-5111; Hu, Jianzhong/0000-0001-8546-5111; Palm, Noah/0000-0001-7262-9455; Stefanowski, Jonathan/0000-0002-2529-7838; Flavell, Richard/0000-0003-4461-0778; de Zoete, Marcel/0000-0002-6561-5810	Netherlands Organization of Scientific Research; Cancer Research Institute Irvington Fellowship Program; NIH [T32 AR 7107-37, U01 DK062422, R01 DK092235, GM103574, GM105456]; NIDDK [K01DK094986]; CCFA Career Development Award; New York Crohn's Foundation; SUCCESS; Blavatnik Family Foundation; Department of Defense [W81XWH-11-1-0745]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092235, K01DK094986, U01DK062422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105456, R01GM103574] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Cancer Research Institute Irvington Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CCFA Career Development Award; New York Crohn's Foundation; SUCCESS; Blavatnik Family Foundation; Department of Defense(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank members of the Flavell laboratory and A.M. Rhebergen for useful advice, discussions, and review of the manuscript; T. Taylor for cell sorting expertise; and A. Shade for guidance on 16S sequencing analysis. This work was supported by a Rubicon Fellowship from the Netherlands Organization of Scientific Research (M.R.d.Z.), the Cancer Research Institute Irvington Fellowship Program and NIH T32 AR 7107-37 (N.W.P.), NIDDK grant K01DK094986 and a CCFA Career Development Award (J.H.), the New York Crohn's Foundation (I.P.), NIH grants U01 DK062422, R01 DK092235, and a SUCCESS grant (J.C.), NIH grants GM103574 and GM105456 (A.L.G.), the Blavatnik Family Foundation and the Department of Defense (W81XWH-11-1-0745) (R.A.F.), and the Howard Hughes Medical Institute (R.A.F. and M.R.d.Z.). R.A.F., M.R.d.Z., and N.W.P. have filed a patent application related to this work.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bemark M, 2012, ANN NY ACAD SCI, V1247, P97, DOI 10.1111/j.1749-6632.2011.06378.x; Ben-Amor K, 2005, APPL ENVIRON MICROB, V71, P4679, DOI 10.1128/AEM.71.8.4679-4689.2005; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Canny G, 2006, METH MOL B, V341, P17; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; D'Auria G, 2013, SCI REP-UK, V3, DOI 10.1038/srep03515; Dantas G, 2013, ANNU REV MICROBIOL, V67, P459, DOI 10.1146/annurev-micro-092412-155642; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fujihashi K, 1996, J EXP MED, V183, P1929, DOI 10.1084/jem.183.4.1929; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mathias A, 2011, GUT MICROBES, V2, P287, DOI 10.4161/gmic.2.5.18269; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Slack E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00100; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Strober W, 2013, TRENDS IMMUNOL, V34, P423, DOI 10.1016/j.it.2013.07.001; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tsuruta T, 2009, FEMS IMMUNOL MED MIC, V56, P185, DOI 10.1111/j.1574-695X.2009.00568.x; van der Waaij LA, 2004, EUR J GASTROEN HEPAT, V16, P669, DOI 10.1097/01.meg.0000108346.41221.19; VANDERWAAIJ LA, 1994, CYTOMETRY, V16, P270, DOI 10.1002/cyto.990160312; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	49	718	746	8	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1000	1010		10.1016/j.cell.2014.08.006	http://dx.doi.org/10.1016/j.cell.2014.08.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171403	Green Accepted, Bronze			2022-12-28	WOS:000340945000007
J	Baldwin, MW; Toda, Y; Nakagita, T; O'Connell, MJ; Klasing, KC; Misaka, T; Edwards, SV; Liberles, SD				Baldwin, Maude W.; Toda, Yasuka; Nakagita, Tomoya; O'Connell, Mary J.; Klasing, Kirk C.; Misaka, Takumi; Edwards, Scott V.; Liberles, Stephen D.			Evolution of sweet taste perception in hummingbirds by transformation of the ancestral umami receptor	SCIENCE			English	Article							MAMMALIAN SWEET; MOLECULAR-BASIS; GENES; SENSE	Sensory systems define an animal's capacity for perception and can evolve to promote survival in new environmental niches. We have uncovered a noncanonical mechanism for sweet taste perception that evolved in hummingbirds since their divergence from insectivorous swifts, their closest relatives. We observed the widespread absence in birds of an essential subunit (T1R2) of the only known vertebrate sweet receptor, raising questions about how specialized nectar feeders such as hummingbirds sense sugars. Receptor expression studies revealed that the ancestral umami receptor (the T1R1-T1R3 heterodimer) was repurposed in hummingbirds to function as a carbohydrate receptor. Furthermore, the molecular recognition properties of T1R1-T1R3 guided taste behavior in captive and wild hummingbirds. We propose that changing taste receptor function enabled hummingbirds to perceive and use nectar, facilitating the massive radiation of hummingbird species.	[Baldwin, Maude W.; Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Baldwin, Maude W.; Edwards, Scott V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Toda, Yasuka; Nakagita, Tomoya; Misaka, Takumi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [O'Connell, Mary J.] Dublin City Univ, Sch Biotechnol, Bioinformat & Mol Evolut Grp, Dublin 9, Ireland; [Klasing, Kirk C.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard University; University of Tokyo; Dublin City University; University of California System; University of California Davis; Harvard University; Harvard Medical School	Baldwin, MW (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	maudebaldwin@gmail.com; stephen_liberles@hms.harvard.edu	Edwards, Scott V./D-9071-2018	Edwards, Scott V./0000-0003-2535-6217; O'Connell, Mary/0000-0002-1877-1001; Toda, Yasuka/0000-0001-5912-6730; Liberles, Stephen/0000-0002-2177-9741; Misaka, Takumi/0000-0002-9547-5767	NSF [DDIG 1110487]; Society for Integrative and Comparative Biology; Sigma Xi; Fulbright Commission; Science Foundation Ireland [EOB2673]; NIH [RO1DC013289]; Japan Society for the Promotion of Science [LS037]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013289] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Society for Integrative and Comparative Biology; Sigma Xi; Fulbright Commission; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank those who supported these experiments (see the supplementary materials for the full list). Grants to M. W. B. (NSF grant DDIG 1110487, Society for Integrative and Comparative Biology, and Sigma Xi); M. J. O'C. (Fulbright Commission and Science Foundation Ireland Research Frontiers Program, grant EOB2673); S. D. L. (NIH, grant RO1DC013289); S. V. E. (NSF); and T. M. (Japan Society for the Promotion of Science, grant LS037) are acknowledged. T1R sequences and alignments are available at GenBank and Dryad.	Brown Joseph W., 2009, P454; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Dyke G., 2011, LIVING DINOSAURS EVO; Feng P, 2013, CHINESE SCI BULL, V58, P2198, DOI 10.1007/s11434-013-5811-5; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Glaser D, 2002, PURE APPL CHEM, V74, P1153, DOI 10.1351/pac200274071153; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Ishimaru Y, 2005, MECH DEVELOP, V122, P1310, DOI 10.1016/j.mod.2005.07.005; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Kuang DH, 2006, P NATL ACAD SCI USA, V103, P14050, DOI 10.1073/pnas.0604717103; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; Medina-Tapia N, 2012, COMP BIOCHEM PHYS A, V161, P307, DOI 10.1016/j.cbpa.2011.11.012; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Oike H, 2007, J NEUROSCI, V27, P5584, DOI 10.1523/JNEUROSCI.0651-07.2007; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Toda Y, 2011, J AGR FOOD CHEM, V59, P12131, DOI 10.1021/jf2029835; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao HB, 2010, MOL BIOL EVOL, V27, P2669, DOI 10.1093/molbev/msq153	25	109	113	7	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					929	933		10.1126/science.1255097	http://dx.doi.org/10.1126/science.1255097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146290	Green Published, Green Accepted			2022-12-28	WOS:000340524700046
J	Taha, MK; Deghmane, AE				Taha, Muhamed-Kheir; Deghmane, Ala-Eddine			Meningococcal carriage: the dilemma of 4CMenB vaccine	LANCET			English	Editorial Material							STRAIN COVERAGE; IMPACT		[Taha, Muhamed-Kheir] Inst Pasteur, Unit Invas Bacterial Infect, F-75724 Paris 15, France; Inst Pasteur, Natl Reference Ctr Meningococci, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Taha, MK (corresponding author), Inst Pasteur, Unit Invas Bacterial Infect, F-75724 Paris 15, France.	mktaha@pasteur.fr	Deghmane, Ala-Eddine/CAF-2140-2022					Bambini S, 2009, DRUG DISCOV TODAY, V14, P252, DOI 10.1016/j.drudis.2008.12.007; Delbos V, 2013, VACCINE, V31, P4416, DOI 10.1016/j.vaccine.2013.06.080; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; European Centre for Disease Prevention and Control, 2011, SURV INV BACT DIS EU; French High Council for Public Health, 2013, PLAC BAXS VACC VACC; Hong E, 2013, VACCINE, V31, P1113, DOI 10.1016/j.vaccine.2012.12.022; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Read RC, 2014, LANCET; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wise J, 2014, BMJ-BRIT MED J, V348, pq2327	13	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2088	2090		10.1016/S0140-6736(14)60935-1	http://dx.doi.org/10.1016/S0140-6736(14)60935-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25145776				2022-12-28	WOS:000346354300007
J	Redondo, RL; Kim, J; Arons, AL; Ramirez, S; Liu, X; Tonegawa, S				Redondo, Roger L.; Kim, Joshua; Arons, Autumn L.; Ramirez, Steve; Liu, Xu; Tonegawa, Susumu			Bidirectional switch of the valence associated with a hippocampal contextual memory engram	NATURE			English	Article							BASOLATERAL AMYGDALA; NEURONAL-ACTIVITY; REWARD-SEEKING; BASAL AMYGDALA; FEAR; DISCRIMINATION; STIMULATION; RESPONSES; RATS	The valence of memories is malleable because of their intrinsic reconstructive property(1). This property of memory has been used clinically to treat maladaptive behaviours(2). However, the neuronal mechanisms and brain circuits that enable the switching of the valence of memories remain largely unknown. Here we investigated these mechanisms by applying the recently developed memory engram cell-manipulation technique(3),(4). We labelled with channelrhodopsin-2 (ChR2) a population of cells in either the dorsal dentate gyrus (DG) of the hippocampus or the basolateral complex of the amygdala (BLA) that were specifically activated during contextual fear or reward conditioning. Both groups of fear-conditioned mice displayed aversive light-dependent responses in an optogenetic place avoidance test, whereas both DG- and BLA-labelled mice that underwent reward conditioning exhibited an appetitive response in an optogenetic place preference test. Next, in an attempt to reverse the valence of memory within a subject, mice whose DG or BLA engram had initially been labelled by contextual fear or reward conditioning were subjected to a second conditioning of the opposite valence while their original DG or BLA engram was reactivated by blue light. Subsequent optogenetic place avoidance and preference tests revealed that although the DG-engram group displayed a response indicating a switch of the memory valence, the BLA-engram group did not. This switch was also evident at the cellular level by a change in functional connectivity between DG engram-bearing cells and BLA engram-bearing cells. Thus, we found that in the DG, the neurons carrying the memory engram of a given neutral context have plasticity such that the valence of a conditioned response evoked by their reactivation can be reversed by re-associating this contextual memory engram with a new unconditioned stimulus of an opposite valence. Our present work provides new insight into the functional neural circuits underlying the malleability of emotional memory.	[Redondo, Roger L.; Kim, Joshua; Arons, Autumn L.; Ramirez, Steve; Liu, Xu; Tonegawa, Susumu] MIT, Dept Biol, RIKEN Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Redondo, Roger L.; Kim, Joshua; Arons, Autumn L.; Ramirez, Steve; Liu, Xu; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Redondo, Roger L.; Arons, Autumn L.; Liu, Xu; Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, RIKEN Ctr Neural Circuit Genet, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu			RIKEN Brain Science Institute; Howard Hughes Medical Institute; The JPB Foundation; National Institutes of Health [T32GM007287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078821, P50MH058880] Funding Source: NIH RePORTER	RIKEN Brain Science Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); The JPB Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank X. Zhou, C. Potter, D. Plana, J. Martin, M. Tsitsiklis, H. Sullivan, W. Yu and A. Moffa for help with the experiments; K. L. Mulroy, T. Ryan and D. Roy for comments and discussions on the manuscript, and all the members of the Tonegawa laboratory for their support. This work was supported by the funds from the RIKEN Brain Science Institute, the Howard Hughes Medical Institute and The JPB Foundation to S. T., and the National Institutes of Health Pre-doctoral Training Grant T32GM007287 to J.K.	Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; CALCAGNETTI DJ, 1994, PROG NEURO-PSYCHOPH, V18, P925, DOI 10.1016/0278-5846(94)90108-2; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Kiyokawa Y, 2014, HORM BEHAV, V65, P114, DOI 10.1016/j.yhbeh.2013.12.005; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pavlov I.P., 1927, CONDITIONED REFLEXES; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sangha S, 2013, J NEUROSCI, V33, P3744, DOI 10.1523/JNEUROSCI.3302-12.2013; Schiltz CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-16; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Wheeler AL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002853; Wolpe J., 1958, PSYCHOTHERAPY RECIPR	28	262	271	6	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					426	+		10.1038/nature13725	http://dx.doi.org/10.1038/nature13725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25162525	Green Submitted, Green Accepted			2022-12-28	WOS:000341814900062
J	Wolz, A				Wolz, Anja			Face to Face with Ebola - An Emergency Care Center in Sierra Leone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Sans Frontieres, Brussels, Belgium	Doctors Without Borders	Wolz, A (corresponding author), Med Sans Frontieres, Brussels, Belgium.								0	33	33	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1081	1083		10.1056/NEJMp1410179	http://dx.doi.org/10.1056/NEJMp1410179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9PI	25162580				2022-12-28	WOS:000341687300001
J	Kruis, AL; Boland, MRS; Assendelft, WJJ; Gussekloo, J; Tsiachristas, A; Stijnen, T; Blom, C; Sont, JK; Rutten-van Molken, MPHM; Chavannes, NH				Kruis, Annemarije L.; Boland, Melinde R. S.; Assendelft, Willem J. J.; Gussekloo, Jacobijn; Tsiachristas, Apostolos; Stijnen, Theo; Blom, Coert; Sont, Jacob K.; Rutten-van Molken, Maureen P. H. M.; Chavannes, Niels H.			Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; EXERCISE TOLERANCE; SELF-MANAGEMENT; OLDER-PEOPLE; COPD; REHABILITATION; COMMUNITY; EXACERBATION; HOME; MULTICENTER	Objective To investigate the long term effectiveness of integrated disease management delivered in primary care on quality of life in patients with chronic obstructive pulmonary disease (COPD) compared with usual care. Design 24 month, multicentre, pragmatic cluster randomised controlled trial Setting 40 general practices in the western part of the Netherlands Participants Patients with COPD according to GOLD (Global Initiative for COPD) criteria. Exclusion criteria were terminal illness, cognitive impairment, alcohol or drug misuse, and inability to fill in Dutch questionnaires. Practices were included if they were willing to create a multidisciplinary COPD team. Intervention General practitioners, practice nurses, and specialised physiotherapists in the intervention group received a two day training course on incorporating integrated disease management in practice, including early recognition of exacerbations and self management, smoking cessation, physiotherapeutic reactivation, optimal diagnosis, and drug adherence. Additionally, the course served as a network platform and collaborating healthcare providers designed an individual practice plan to integrate integrated disease management into daily practice. The control group continued usual care (based on international guidelines). Main outcome measures The primary outcome was difference in health status at 12 months, measured by the Clinical COPD Questionnaire (CCQ); quality of life, Medical Research Council dyspnoea, exacerbation related outcomes, self management, physical activity, and level of integrated care (PACIC) were also assessed as secondary outcomes. Results Of a total of 1086 patients from 40 clusters, 20 practices (554 patients) were randomly assigned to the intervention group and 20 clusters (532 patients) to the usual care group. No difference was seen between groups in the CCQ at 12 months (mean difference -0.01, 95% confidence interval -0.10 to 0.08; P=0.8). After 12 months, no differences were seen in secondary outcomes between groups, except for the PACIC domain "follow-up/coordination" (indicating improved integration of care) and proportion of physically active patients. Exacerbation rates as well as number of days in hospital did not differ between groups. After 24 months, no differences were seen in outcomes, except for the PACIC follow-up/coordination domain. Conclusion In this pragmatic study, an integrated disease management approach delivered in primary care showed no additional benefit compared with usual care, except improved level of integrated care and a self reported higher degree of daily activities. The contradictory findings to earlier positive studies could be explained by differences between interventions (provider versus patient targeted), selective reporting of positive trials, or little room for improvement in the already well developed Dutch healthcare system.	[Kruis, Annemarije L.; Assendelft, Willem J. J.; Gussekloo, Jacobijn; Chavannes, Niels H.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 RC Leiden, Netherlands; [Boland, Melinde R. S.; Tsiachristas, Apostolos; Rutten-van Molken, Maureen P. H. M.] Erasmus Univ, Inst Med Technol Assessment, NL-3000 DR Rotterdam, Netherlands; [Assendelft, Willem J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6500 HB Nijmegen, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, NL-2300 RC Leiden, Netherlands; [Blom, Coert] Stichting Zorgdraad Fdn, NL-6862 XN Oosterbeek, Netherlands; [Sont, Jacob K.] Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kruis, AL (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, POB 9600, NL-2300 RC Leiden, Netherlands.	a.l.kruis@lumc.nl	assendelft, willem/AAW-1854-2021; Molken, Maureen PMH Rutten-van/G-8481-2014; Gussekloo, Jacobijn/ABE-3879-2021; Blom, Coert/G-1311-2016; Molken, Maureen Rutten-van/X-8712-2019; Chavannes, Niels/F-1148-2011; Sont, Jacob K/J-8071-2015; Assendelft, W.J.J./H-8008-2014	assendelft, willem/0000-0002-2966-3778; Molken, Maureen PMH Rutten-van/0000-0001-8706-3159; Gussekloo, Jacobijn/0000-0001-7186-8278; Molken, Maureen Rutten-van/0000-0001-8706-3159; Chavannes, Niels/0000-0002-8607-9199; Sont, Jacob K/0000-0002-5840-0651; Assendelft, W.J.J./0000-0002-2966-3778; Tsiachristas, Apostolos/0000-0002-4662-8915	Netherlands Organisation for Health Research and Development (Zon-MW), subprogramme Effects and Costs [171002203]; Stichting Achmea Gezondheidszorg, a Dutch Healthcare insurance company; Zon-MW; Achmea Zorgverzekeringen; Dutch healthcare insurers: "Centraal Ziekenfonds (CZ) Zorgverzekeringen"; "Zorg en Zekerheid"	Netherlands Organisation for Health Research and Development (Zon-MW), subprogramme Effects and Costs; Stichting Achmea Gezondheidszorg, a Dutch Healthcare insurance company; Zon-MW(Netherlands Organization for Health Research and Development); Achmea Zorgverzekeringen; Dutch healthcare insurers: "Centraal Ziekenfonds (CZ) Zorgverzekeringen"; "Zorg en Zekerheid"	This paper presents independent research funded by the Netherlands Organisation for Health Research and Development (Zon-MW), subprogramme Effects and Costs (project number 171002203), and Stichting Achmea Gezondheidszorg, a Dutch Healthcare insurance company. The funding agencies (Zon-MW and Achmea Zorgverzekeringen) had no influence on the design of the study, the analysis, or the writing of the paper. Throughout the RECODE intervention period, physiotherapists in the intervention group received supplementary funding for providing a COPD specific exercise training programme in patients with MRC scores > 2. This fund is provided by two local Dutch healthcare insurers: "Centraal Ziekenfonds (CZ) Zorgverzekeringen" and "Zorg en Zekerheid." All other components of the integrated disease management programme were financially covered by the patients' basic insurance scheme. The views expressed in this presentation are those of the authors and not necessarily those of the sponsors.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bischoff EWMA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7642; Bjoernshave Bodil, 2010, Clin Epidemiol, V2, P73; Boland MRS, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-40; Boxall Anne-Marie, 2005, J Cardiopulm Rehabil, V25, P378, DOI 10.1097/00008483-200511000-00012; Cambach W, 1997, EUR RESPIR J, V10, P104, DOI 10.1183/09031936.97.10010104; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Chavannes Niels H, 2009, Prim Care Respir J, V18, P171, DOI 10.3132/pcrj.2009.00003; Dahlen SE, 2011, NEW ENGL J MED, V364, P1769, DOI 10.1056/NEJMe1100937; Devane D, 2004, J ADV NURS, V47, P297, DOI 10.1111/j.1365-2648.2004.03093.x; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Global Initiative for Chronic Obstructive Lung Disease, 2014, GLOB STRAT DIAGN MAN; Gottlieb V, 2011, COPD, V8, P380, DOI 10.3109/15412555.2011.610393; Gress Stefan, 2009, Qual Prim Care, V17, P75; Jones Paul W, 2005, COPD, V2, P75; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; Kocks JWH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-62; Kruis A L, 2010, Monaldi Arch Chest Dis, V73, P130; Kruis AL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009437.pub2; Kruis AL, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-17; Kruis Annemarije L, 2010, Int J Chron Obstruct Pulmon Dis, V5, P407, DOI 10.2147/COPD.S9654; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; de Oliveira JCM, 2010, MULTIDISCIP RESP MED, V5, P401, DOI 10.1186/2049-6958-5-6-401; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgan MDL, 2011, THORAX, V66, P935, DOI 10.1136/thoraxjnl-2011-200783; Fernandez AM, 2009, J CARDIOPULM REHABIL, V29, P325, DOI 10.1097/HCR.0b013e3181ac7b9d; Pinnock H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6070; Rea H, 2002, RESPIROLOGY, V7, pA6; Roman M, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-21; Schuurmans H, 2005, QUAL LIFE RES, V14, P2215, DOI 10.1007/s11136-005-8166-9; Smeeth L, 2002, CONTROL CLIN TRIALS, V23, P409, DOI 10.1016/S0197-2456(02)00208-8; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Trappenburg JCA, 2011, THORAX, V66, P977, DOI 10.1136/thoraxjnl-2011-200071; Tsiachristas A, 2011, HEALTH POLICY, V101, P122, DOI 10.1016/j.healthpol.2010.10.013; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; van Wetering CR, 2010, THORAX, V65, P7, DOI 10.1136/thx.2009.118620; Vandelanotte C., 2005, J PHYS ACT HEALTH, V2, P63, DOI DOI 10.1123/JPAH.2.1.63; Vogiatzis I, 2011, CHEST, V140, P744, DOI 10.1378/chest.10-3058; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; WIJKSTRA PJ, 1995, THORAX, V50, P824, DOI 10.1136/thx.50.8.824; Zhou YM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6387	43	83	86	0	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2014	349								g5392	10.1136/bmj.g5392	http://dx.doi.org/10.1136/bmj.g5392			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9QO	25209620	Green Published, hybrid			2022-12-28	WOS:000341691200003
J	Jack, A				Jack, Andrew			Which way now for the Cancer Drugs Fund?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, Anal, London, England		Jack, A (corresponding author), Financial Times, Anal, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Chamberlain C, 2014, BR J CANC; Department of Health, PHARM PRIC REG SCHEM; Hawkes N., 2013, BMJ-BRIT MED J, V349, pg5382; Knapton S., 2014, TELEGRAPH; NHS England, 2014, NAT CANC DRUGS FUND	5	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2014	349								g5524	10.1136/bmj.g5524	http://dx.doi.org/10.1136/bmj.g5524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QM	25204283				2022-12-28	WOS:000341691000008
J	de la Mare, W; Gales, N; Mangel, M				de la Mare, William; Gales, Nick; Mangel, Marc			Applying scientific principles in international law on whaling	SCIENCE			English	Editorial Material									[de la Mare, William; Gales, Nick] Australian Antarctic Div, Kingston, Tas 6050, Australia; [Mangel, Marc] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Australian Antarctic Division; University of California System; University of California Santa Cruz	Mangel, M (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	msmangel@ucsc.edu						Childerhouse S, 2006, J CETACEAN RES MAN S, V8, P260; Gales NJ, 2005, NATURE, V435, P883, DOI 10.1038/435883a; Mangel M., 2001, TRENDS ECOL EVOL, V16, P110; Morell V, 2007, SCIENCE, V316, P532, DOI 10.1126/science.316.5824.532; Oreskes N, 2010, MERCHANTS DOUBT; Taubes G., 2007, GOOD CALORIES BAD CA	6	16	16	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1125	1126		10.1126/science.1254616	http://dx.doi.org/10.1126/science.1254616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2TV	25190783				2022-12-28	WOS:000341179800025
J	Crous, CJ				Crous, Casparus J.			Judge research impact on a local scale	NATURE			English	Editorial Material									Univ Pretoria, ZA-0002 Pretoria, South Africa	University of Pretoria	Crous, CJ (corresponding author), Univ Pretoria, ZA-0002 Pretoria, South Africa.	casper.crous@fabi.up.ac.za							0	5	5	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					7	7		10.1038/513007a	http://dx.doi.org/10.1038/513007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2SD	25186869	Bronze			2022-12-28	WOS:000341174800004
J	Hunt, A; Harrington, D; Robinson, S				Hunt, Alesia; Harrington, Dominic; Robinson, Susan			Vitamin B-12 deficiency	BMJ-BRITISH MEDICAL JOURNAL			English	Review							METHYLMALONIC ACID; COBALAMIN; DIAGNOSIS; HOLOTRANSCOBALAMIN; DISORDERS		[Hunt, Alesia; Harrington, Dominic; Robinson, Susan] Guys & St Thomas NHS Fdn Trust, London, England	Guy's & St Thomas' NHS Foundation Trust	Hunt, A (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.	alesiahunt@nhs.net	Gupta, Vivek Kumar/AAB-8940-2022	Gupta, Vivek/0000-0002-0202-7843				Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; British Columbia Medical Association, 2013, COB VIT B12 DEF INV; British Medical Association Royal Pharmaceutical Society of Great Britain, BRIT NATL FORMULARY; Bunn H., 1970, NEW ENGL J MED, V8, P773; Carmel R, 2008, BLOOD, V112, P2214, DOI 10.1182/blood-2008-03-040253; Clarke R, 2007, CLIN CHEM, V53, P963, DOI 10.1373/clinchem.2006.080382; Devalia V, 2014, BRIT J HAEMATOL, V166, P496, DOI 10.1111/bjh.12959; FINCH CA, 1956, BLOOD, V11, P807, DOI 10.1182/blood.V11.9.807.807; Galloway M, 2007, BMJ-BRIT MED J, V335, P884, DOI 10.1136/bmj.39325.689641.471; Gauchan D, 2012, CL LYMPH MYELOM LEUK, V12, P269, DOI 10.1016/j.clml.2012.01.008; Green R., 2013, ENCY HUMAN NUTR, V4, P351; Grober U, 2013, NUTRIENTS, V5, P5031, DOI 10.3390/nu5125031; Harmening D., 2002, CLIN HAEMATOLOGY FUN, P112; HOVDING G, 1968, BRIT MED J, V3, P102, DOI 10.1136/bmj.3.5610.102; JAMES J, 1971, BRIT MED J, V2, P262, DOI 10.1136/bmj.2.5756.262; Kaushansky K, 2010, WILLIAMS HAEMATOLOGY, P538; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; National Institute for Health and Care Excellence, AN B12 FOL CLIN KNOW; Pawlak R, 2013, NUTR REV, V71, P110, DOI 10.1111/nure.12001; Provan D, 2010, OXFORD HDB CLIN HAEM, P46; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; RASMUSSEN K, 1990, CLIN CHEM, V36, P1523; Sobczynska-Malefora A., 2014, ADV HEMATOL; Sobczynska-Malefora A, 2014, CLIN BIOCHEM, V47, P82, DOI 10.1016/j.clinbiochem.2013.08.006; Solomon LR, 2007, BLOOD REV, V21, P113, DOI 10.1016/j.blre.2006.05.001; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Valente E, 2011, CLIN CHEM, V57, P856, DOI 10.1373/clinchem.2010.158154; Vidal-Alaball J, 2005, COCHRANE DB SYST REV, V3; Vogiatzoglou A, 2009, CLIN CHEM, V55, P2198, DOI 10.1373/clinchem.2009.128678	30	171	178	2	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2014	349								g5226	10.1136/bmj.g5226	http://dx.doi.org/10.1136/bmj.g5226			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MK	25189324				2022-12-28	WOS:000341388800001
J	Charles, R; Jackson, R; Dodman, J				Charles, Robert; Jackson, Robert; Dodman, James			A 20 year old man with a high pressure steam burn	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Charles, Robert; Jackson, Robert; Dodman, James] Pinderfields Gen Hosp, Wakefield WF1 4DG, W Yorkshire, England	Pinderfields Hospital	Charles, R (corresponding author), Pinderfields Gen Hosp, Wakefield WF1 4DG, W Yorkshire, England.	robcharles@doctors.org.uk						American College of Surgeons, 2012, ADV TRAUM LIF SUPP S, P230; Bishop S, 2012, BJA EDUC, V12, P118, DOI 10.1093/bjaceaccp/mks001; British Burn Association, 2001, NAT BURN CAR REV 200; Brusselaers N, 2010, CRIT CARE, V14, DOI 10.1186/cc9300; Edgar D, 2004, BMJ-BRIT MED J, V329, P343, DOI 10.1136/bmj.329.7461.343; Endorf FW, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-69; Latenser BA, 2009, CRIT CARE MED, V37, P2819, DOI 10.1097/CCM.0b013e3181b3a08f; Mitchell CJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2856; National Network for Burn Care, 2011, NAT BURN CAR REF GUI; Norman AT., 2004, CONTIN ED ANAESTHESI, V4, P57; Procter Fiona, 2010, Indian J Plast Surg, V43, pS101, DOI 10.4103/0970-0358.70730; Singer A, 2000, EMERG MED PRACT, V2, P1; Spanholtz TA, 2009, DTSCH ARZTEBL INT, V106, P607, DOI 10.3238/arztebl.2009.0607	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2014	349								g5278	10.1136/bmj.g5278	http://dx.doi.org/10.1136/bmj.g5278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LH	25179860				2022-12-28	WOS:000341385800002
J	Girardi, L				Girardi, Leo			One good cosmic measure	SCIENCE			English	Editorial Material							PLEIADES DISTANCE; CONSTRAINTS; GAIA		Osserv Astron Padova, Ist Nazl Astrofis INAF, I-35122 Padua, Italy	Istituto Nazionale Astrofisica (INAF); University of Padua	Girardi, L (corresponding author), Osserv Astron Padova, Ist Nazl Astrofis INAF, I-35122 Padua, Italy.	leo.girardi@oapd.inaf.it	Girardi, Léo/AAC-1787-2022	Girardi, Léo/0000-0002-6301-3269				Lindegren L, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117905; Melis C, 2014, SCIENCE, V345, P1029, DOI 10.1126/science.1256101; Narayanan VK, 1999, ASTROPHYS J, V523, P328, DOI 10.1086/307716; Perryman MAC, 2001, ASTRON ASTROPHYS, V369, P339, DOI 10.1051/0004-6361:20010085; Pinsonneault MH, 1998, ASTROPHYS J, V504, P170, DOI 10.1086/306077; Riess AG, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/161; Stello D, 2001, ASTRON ASTROPHYS, V374, P105, DOI 10.1051/0004-6361:20010665; van Leeuwen F, 2007, ASTROPHYS SPACE SC L, V350, P3; [No title captured]	9	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1001	1002		10.1126/science.1258425	http://dx.doi.org/10.1126/science.1258425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170136				2022-12-28	WOS:000340870900016
J	Jerby-Arnon, L; Pfetzer, N; Waldman, YY; McGarry, L; James, D; Shanks, E; Seashore-Ludlow, B; Weinstock, A; Geiger, T; Clemons, PA; Gottlieb, E; Ruppin, E				Jerby-Arnon, Livnat; Pfetzer, Nadja; Waldman, Yedael Y.; McGarry, Lynn; James, Daniel; Shanks, Emma; Seashore-Ludlow, Brinton; Weinstock, Adam; Geiger, Tamar; Clemons, Paul A.; Gottlieb, Eyal; Ruppin, Eytan			Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality	CELL			English	Article							GENETIC INTERACTIONS; BIOLOGICAL NETWORKS; HIGH-THROUGHPUT; DNA-DAMAGE; REVEALS; CELLS; SCREEN; RNAI; IDENTIFICATION; DEPENDENCIES	Synthetic lethality occurs when the inhibition of two genes is lethal while the inhibition of each single gene is not. It can be harnessed to selectively treat cancer by identifying inactive genes in a given cancer and targeting their synthetic lethal (SL) partners. We present a data-driven computational pipeline for the genome-wide identification of SL interactions in cancer by analyzing large volumes of cancer genomic data. First, we show that the approach successfully captures known SL partners of tumor suppressors and oncogenes. We then validate SL predictions obtained for the tumor suppressor VHL. Next, we construct a genome-wide network of SL interactions in cancer and demonstrate its value in predicting gene essentiality and clinical prognosis. Finally, we identify synthetic lethality arising from gene overactivation and use it to predict drug efficacy. These results form a computational basis for exploiting synthetic lethality to uncover cancer-specific susceptibilities.	[Jerby-Arnon, Livnat; Waldman, Yedael Y.; Weinstock, Adam; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-6997801 Tel Aviv, Israel; [Pfetzer, Nadja; McGarry, Lynn; James, Daniel; Shanks, Emma; Gottlieb, Eyal] Beatson Inst Canc Res, Canc Res UK, Glasgow G61 1BD, Lanark, Scotland; [Seashore-Ludlow, Brinton; Clemons, Paul A.] Broad Inst Harvard & MIT, Ctr Sci Therapeut, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Geiger, Tamar; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel	Tel Aviv University; Beatson Institute; Cancer Research UK; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tel Aviv University; Sackler Faculty of Medicine	Jerby-Arnon, L (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-6997801 Tel Aviv, Israel.	livnatje@post.tau.ac.il; ruppin@post.tau.ac.il	Gottlieb, Eyal/G-6450-2010; Ruppin, Eytan/R-9698-2017; Seashore-Ludlow, Brinton/E-2309-2017	Gottlieb, Eyal/0000-0002-9770-0956; Ruppin, Eytan/0000-0002-7862-3940; Seashore-Ludlow, Brinton/0000-0001-8658-5967; Shanks, Emma/0000-0001-5391-1869; Geiger, Tamar/0000-0002-9526-197X	Edmond J. Safra bioinformatics center; Israeli Center of Research Excellence program (I-CORE, Gene Regulation in Complex Human Disease Center) [41/11]; Dan David foundation; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Eshkol fellowship (the Israeli Ministry of Science and Technology); Israeli Science Foundation (ISF); Israeli Cancer Research Fund (ICRF); I-CORE program; Cancer Research UK [18278] Funding Source: researchfish	Edmond J. Safra bioinformatics center; Israeli Center of Research Excellence program (I-CORE, Gene Regulation in Complex Human Disease Center); Dan David foundation; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Eshkol fellowship (the Israeli Ministry of Science and Technology); Israeli Science Foundation (ISF)(Israel Science Foundation); Israeli Cancer Research Fund (ICRF); I-CORE program; Cancer Research UK(Cancer Research UK)	We thank A. Wagner, D. Horn, D. Steinberg, E. Halperin, I. Meilijson, L. Wolf, M. Kupiec, M. Oberhardt, and R. Sharan for their help and comments. We thank E. MacKenzie for technical support. L.J.A. and A.W. are partially funded by the Edmond J. Safra bioinformatics center and the Israeli Center of Research Excellence program (I-CORE, Gene Regulation in Complex Human Disease Center No 41/11). L.J.A. was also funded by the Dan David foundation and by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. Y.Y.W. was supported in part by Eshkol fellowship (the Israeli Ministry of Science and Technology). E.R.'s research in cancer is supported by grants from the Israeli Science Foundation (ISF) and Israeli Cancer Research Fund (ICRF). E.R. and T.G. are supported by the I-CORE program.	Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhinder B, 2014, COMB CHEM HIGH T SCR, V17, P98, DOI 10.2174/1386207317666140117101852; Bilal E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003047; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chipman KC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-17; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conde-Pueyo N, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-116; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Lord CJ, 2008, DNA REPAIR, V7, P2010, DOI 10.1016/j.dnarep.2008.08.014; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lu XW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3124; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Sajesh Babu V, 2013, Cancers (Basel), V5, P739, DOI 10.3390/cancers5030739; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Szczurek E, 2013, INT J CANCER, V133, P2123, DOI 10.1002/ijc.28235; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Waldman YY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003806; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101	43	163	173	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1199	1209		10.1016/j.cell.2014.07.027	http://dx.doi.org/10.1016/j.cell.2014.07.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171417	Bronze			2022-12-28	WOS:000340945000023
J	Lemos, GB; Borish, V; Cole, GD; Ramelow, S; Lapkiewicz, R; Zeilinger, A				Lemos, Gabriela Barreto; Borish, Victoria; Cole, Garrett D.; Ramelow, Sven; Lapkiewicz, Radek; Zeilinger, Anton			Quantum imaging with undetected photons	NATURE			English	Article							PARAMETRIC DOWN-CONVERSION; INDUCED COHERENCE; INDUCED EMISSION; 2-PARTICLE INTERFEROMETRY; INDISTINGUISHABILITY; INTERFERENCE; OPTICS	Information is central to quantum mechanics. In particular, quantum interference occurs only if there exists no information to distinguish between the superposed states. The mere possibility of obtaining information that could distinguish between overlapping states inhibits quantum interference(1,2). Here we introduce and experimentally demonstrate a quantum imaging concept based on induced coherence without induced emission(3,4). Our experiment uses two separate down-conversion nonlinear crystals (numbered NL1 and NL2), each illuminated by the same pump laser, creating one pair of photons (denoted idler and signal). If the photon pair is created in NL1, one photon (the idler) passes through the object to be imaged and is overlapped with the idler amplitude created in NL2, its source thus being undefined. Interference of the signal amplitudes coming from the two crystals then reveals the image of the object. The photons that pass through the imaged object (idler photons from NL1) are never detected, while we obtain images exclusively with the signal photons (from NL1 and NL2), which do not interact with the object. Our experiment is fundamentally different from previous quantum imaging techniques, such as interaction-free imaging(5) or ghostimaging(6-9), because now the photons used to illuminate the object do not have to be detected at all and no coincidence detection is necessary. This enables the probe wavelength to be chosen in a range for which suitable detectors are not available. To illustrate this, we show images of objects that are either opaque or invisible to the detected photons. Our experiment is a prototype in quantum information-knowledge can be extracted by, and about, a photon that is never detected.	[Lemos, Gabriela Barreto; Borish, Victoria; Ramelow, Sven; Lapkiewicz, Radek; Zeilinger, Anton] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-1090 Vienna, Austria; [Lemos, Gabriela Barreto; Cole, Garrett D.; Zeilinger, Anton] Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol VCQ, A-1090 Vienna, Austria; [Borish, Victoria; Cole, Garrett D.; Ramelow, Sven; Lapkiewicz, Radek; Zeilinger, Anton] Univ Vienna, A-1090 Vienna, Austria	Austrian Academy of Sciences; University of Vienna; University of Vienna	Lemos, GB (corresponding author), Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, Boltzmanngasse 3, A-1090 Vienna, Austria.	gabriela.barreto.lemos@univie.ac.at; anton.zeilinger@univie.ac.at	Ramelow, Sven/H-6798-2012; Zeilinger, Anton/A-1170-2011; Lemos, Gabriela Barreto/AAV-9770-2020; Lapkiewicz, Radek/B-5786-2015; Cole, Garrett D/B-9383-2011	Ramelow, Sven/0000-0002-7801-4440; Lemos, Gabriela Barreto/0000-0003-4901-0309; Cole, Garrett D/0000-0001-7149-3218; Lapkiewicz, Radek/0000-0002-7026-7275	Austrian Academy of Sciences (OAW) through Vienna Center for Science and Technology (VCQ); EU Marie Curie Fellowship [PIOF-GA-2012-329851]; OAW; European Research Council (ERC) [227844, 600645]	Austrian Academy of Sciences (OAW) through Vienna Center for Science and Technology (VCQ); EU Marie Curie Fellowship(European Commission); OAW; European Research Council (ERC)(European Research Council (ERC)European Commission)	We thank M. Home for reading the manuscript, clarifying suggestions and many discussions, P. Enigl for designing the figures for the objects, D. Greenberger and S. von Egan-Krieger for discussions, and C. Schaeff for equipment loans. Microfabrication was carried out at the Center for Micro- and Nanostructures (ZMNS) of the Vienna University of Technology. We acknowledge D. Ristanic for assistance with cryogenic Si etching and M. Schinnerl for contact mask production. G.B.L. was funded by the Austrian Academy of Sciences (OAW) through a fellowship from the Vienna Center for Science and Technology (VCQ). S.R. is funded by an EU Marie Curie Fellowship (PIOF-GA-2012-329851). This project was supported by OAW, the European Research Council (ERC Advanced grant no. 227844 'QIT4QAD', and SIQS grant no. 600645 EU-FP7-ICT), and the Austrian Science Fund (FWF) with SFB F40 (FOQUS) and W1210-2 (CoQus).	Abouraddy AF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.213903; Aspden RS, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/7/073032; Bass M., 1995, HDB OPTICS, VII; ELITZUR AC, 1993, FOUND PHYS, V23, P987, DOI 10.1007/BF00736012; Feynman R., 1964, FEYNMAN LECTURES PHY, V3; Gatti A, 2008, PROG OPTICS, V51, P251, DOI 10.1016/S0079-6638(07)51005-X; GRAYSON TP, 1994, PHYS REV A, V49, P2948, DOI 10.1103/PhysRevA.49.2948; HORNE M, 1990, NATURE, V347, P429, DOI 10.1038/347429a0; Horne M., 1997, EXPT METAPHYSICS, V1, P109; HORNE MA, 1989, PHYS REV LETT, V62, P2209, DOI 10.1103/PhysRevLett.62.2209; Howell JC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.210403; JELLISON GE, 1982, APPL PHYS LETT, V41, P180, DOI 10.1063/1.93454; Khalaidovski A, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/16/165001; KWIAT P, 1995, PHYS REV LETT, V74, P4763, DOI 10.1103/PhysRevLett.74.4763; Malitson I. H., 1965, J OPT SOC AM, V55, P1250; MANDEL L, 1991, OPT LETT, V16, P1882, DOI 10.1364/OL.16.001882; Pittman TB, 1996, PHYS REV A, V53, P2804, DOI 10.1103/PhysRevA.53.2804; RIBEIRO PHS, 1994, PHYS REV A, V49, P4176, DOI 10.1103/PhysRevA.49.4176; Tasca DS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.033801; Walborn SP, 2010, PHYS REP, V495, P87, DOI 10.1016/j.physrep.2010.06.003; WANG LJ, 1991, PHYS REV A, V44, P4614, DOI 10.1103/PhysRevA.44.4614; White AG, 1998, PHYS REV A, V58, P605, DOI 10.1103/PhysRevA.58.605; Wiseman HM, 2000, PHYS LETT A, V270, P245, DOI 10.1016/S0375-9601(00)00314-5; ZOU XY, 1992, PHYS REV LETT, V69, P3041, DOI 10.1103/PhysRevLett.69.3041; ZOU XY, 1991, PHYS REV LETT, V67, P318, DOI 10.1103/PhysRevLett.67.318	25	286	290	27	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					409	U382		10.1038/nature13586	http://dx.doi.org/10.1038/nature13586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164751	Green Submitted			2022-12-28	WOS:000340840600028
J	Sherrard, LJ; Tunney, MM; Elborn, JS				Sherrard, Laura J.; Tunney, Michael M.; Elborn, J. Stuart			Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis	LANCET			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; STREPTOCOCCUS-MILLERI GROUP; STAPHYLOCOCCUS-AUREUS; PULMONARY EXACERBATIONS; ANTIBIOTIC-RESISTANCE; MACROLIDE RESISTANCE; ADULT PATIENTS; STENOTROPHOMONAS-MALTOPHILIA; MOLECULAR CHARACTERIZATION; BACTERIAL COMMUNITIES		[Sherrard, Laura J.; Tunney, Michael M.; Elborn, J. Stuart] Queens Univ Belfast, CF & Airways Microbiol Grp, Belfast BT9 7BL, Antrim, North Ireland; [Sherrard, Laura J.; Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Elborn, J. Stuart] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Queens University Belfast	Elborn, JS (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland.	s.elborn@qub.ac.uk		TUNNEY, MICHAEL/0000-0002-7433-7074; elborn, joseph/0000-0002-2323-442X	Public Health Agency [STL/3713/07, CDV/3650/07] Funding Source: researchfish	Public Health Agency		Aaron SD, 2005, LANCET, V366, P463, DOI 10.1016/S0140-6736(05)67060-2; Abdulhamid I, 2008, PEDIATR PULM, V43, P281, DOI 10.1002/ppul.20771; ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P1666, DOI 10.1128/AAC.34.9.1666; Barto Tara Lynn, 2010, Hosp Pract (1995), V38, P26; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Bode LGM, 2012, J MICROBIOL METH, V89, P129, DOI 10.1016/j.mimet.2012.02.014; Burns JL, 1999, J INFECT DIS, V179, P1190, DOI 10.1086/314727; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; CUR Pharmaceuticals, 2014, CURX PHARM ANN LIC A; Daniels TWV, 2013, J CYST FIBROS, V12, P22, DOI 10.1016/j.jcf.2012.05.008; Daurel C, 2008, J CLIN MICROBIOL, V46, P546, DOI 10.1128/JCM.01925-07; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Doring Gerd, 2004, J Cyst Fibros, V3, P67, DOI 10.1016/j.jcf.2004.03.008; Fancello L, 2011, J ANTIMICROB CHEMOTH, V66, P2448, DOI 10.1093/jac/dkr315; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Fodor Anthony A, 2012, PLoS One, V7, pe45001, DOI 10.1371/journal.pone.0045001; Fothergill JL, 2011, ANTIMICROB AGENTS CH, V55, P426, DOI 10.1128/AAC.01257-10; Foweraker JE, 2005, J ANTIMICROB CHEMOTH, V55, P921, DOI 10.1093/jac/dki146; Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005; Grinwis ME, 2010, ANTIMICROB AGENTS CH, V54, P2823, DOI 10.1128/AAC.01845-09; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hauser PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090934; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; Hurley MN, 2012, J CYST FIBROS, V11, P288, DOI 10.1016/j.jcf.2012.02.006; Hurley MN, 2013, COCHRANE DB SYST REV, V6; Jakobsen TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068484; Jorgensen KM, 2013, ANTIMICROB AGENTS CH, V57, P4215, DOI 10.1128/AAC.00493-13; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kohler T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000883; Lam J, 2013, CLIN MED INSIGHTS-CI, V7, P61, DOI 10.4137/CCRPM.S10592; Lechtzin N, 2006, RESPIRATION, V73, P27, DOI 10.1159/000087686; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; LiPuma JJ, 2001, CHEST, V120, p118S, DOI 10.1378/chest.120.3_suppl.118S; Llanes C, 2013, J ANTIMICROB CHEMOTH, V68, P1763, DOI 10.1093/jac/dkt115; Lopez-Causape C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071001; Macdonald D, 2010, J ANTIMICROB CHEMOTH, V65, P2373, DOI 10.1093/jac/dkq342; Macfarlane M, 2007, J HOSP INFECT, V65, P231, DOI 10.1016/j.jhin.2006.10.011; MacGowan AP, 2001, J ANTIMICROB CHEMOTH, V48, P17, DOI 10.1093/jac/48.suppl_1.17; MacLeod DL, 2009, J ANTIMICROB CHEMOTH, V64, P829, DOI 10.1093/jac/dkp282; Maeda Y, 2011, J ANTIMICROB CHEMOTH, V66, P476, DOI 10.1093/jac/dkq485; Mandsberg LF, 2009, ANTIMICROB AGENTS CH, V53, P2483, DOI 10.1128/AAC.00428-08; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McCaughey G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069763; Merlo CA, 2007, CHEST, V132, P562, DOI 10.1378/chest.06-2888; Milne KEN, 2012, ANTIMICROB AGENTS CH, V56, P4071, DOI 10.1128/AAC.00072-12; Moriarty TF, 2007, PEDIATR PULM, V42, P1008, DOI 10.1002/ppul.20671; Moskowitz SM, 2011, PEDIATR PULM, V46, P184, DOI 10.1002/ppul.21350; Moskowitz SM, 2004, J CLIN MICROBIOL, V42, P1915, DOI 10.1128/JCM.42.5.1915-1922.2004; Moya B, 2012, ANTIMICROB AGENTS CH, V56, P4771, DOI 10.1128/AAC.00680-12; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Nair CG, 2013, LETT APPL MICROBIOL, V56, P149, DOI 10.1111/lam.12032; Nguyen D, 2007, PEDIATR PULM, V42, P533, DOI 10.1002/ppul.20620; NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518; Nick Jerry A, 2014, Ann Am Thorac Soc, V11, P342, DOI 10.1513/AnnalsATS.201310-352OC; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Rao P, 2012, J CYST FIBROS, V11, P349, DOI 10.1016/j.jcf.2012.01.002; Renner S, 2001, THORAX, V56, P48, DOI 10.1136/thorax.56.1.48; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Roberts MC, 2011, J ANTIMICROB CHEMOTH, V66, P100, DOI 10.1093/jac/dkq425; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rolain JM, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-1; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Sass A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-373; Schaible B, 2012, ANTIMICROB AGENTS CH, V56, P2114, DOI 10.1128/AAC.05574-11; Sherrard LJ, 2013, J ANTIMICROB CHEMOTH, V68, P2369, DOI 10.1093/jac/dkt191; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Sibley CD, 2010, J MED MICROBIOL, V59, P534, DOI 10.1099/jmm.0.016592-0; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith AL, 2003, CHEST, V123, P1495, DOI 10.1378/chest.123.5.1495; Smyth AR, 2010, PEDIATR PULM, V45, P356, DOI 10.1002/ppul.21193; Solis A, 2003, PEDIATR PULM, V36, P189, DOI 10.1002/ppul.10231; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Stoesser N, 2013, J ANTIMICROB CHEMOTH, V68, P2234, DOI 10.1093/jac/dkt180; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Tazumi A, 2009, J ANTIMICROB CHEMOTH, V64, P501, DOI 10.1093/jac/dkp213; Tramper-Stranders GA, 2007, PEDIATR INFECT DIS J, V26, P8, DOI 10.1097/01.inf.0000247109.44249.ac; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; UK Cystic Fibrosis Trust, 2013, UK CYST FIBR REG ANN; UK Cystic Fibrosis Trust Antibiotic Working Group, 2009, ANT TREATM CYST FIBR; UK Cystic Fibrosis Trust Microbiology Laboratory Standards Working Group, 2010, LAB STAND PROC MICR; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Wolter DJ, 2013, CLIN INFECT DIS, V57, P384, DOI 10.1093/cid/cit270; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu K, 2013, ANTIMICROB AGENTS CH, V57, P1546, DOI 10.1128/AAC.02215-12; Yang N, 2013, J PHYSIOL-LONDON, V591, P4581, DOI 10.1113/jphysiol.2013.257436; Zemanick ET, 2015, PEDIATR PULM, V50, P42, DOI 10.1002/ppul.23036; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	111	91	91	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					703	713		10.1016/S0140-6736(14)61137-5	http://dx.doi.org/10.1016/S0140-6736(14)61137-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25152272				2022-12-28	WOS:000341359100028
J	Chatterjee, P				Chatterjee, Patralekha			EMERGENCY MEDICINE Urban building collapse: what are the health implications?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com						[Anonymous], 2014, BANGL COLL BUILD OWN; Bera S, 2013, DOWN EARTH      0615; Chidambaram S., 2014, EC POLITICAL WEEKLY; International Society for the Advancement of Spine Surgery, FUT ORTH TRAIN GLOB; National Crime Records Bureau, 2014, ACC DEATHS SUIC IND; Ramakrishnan L, 2014, FINANCIAL EXPRE 0705	6	1	1	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2014	349								g5256	10.1136/bmj.g5256	http://dx.doi.org/10.1136/bmj.g5256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FP	25148858				2022-12-28	WOS:000340839100003
J	Goudsmit, J				Goudsmit, Jaap			Joep Lange (1954-2014) A leader in developing therapy for AIDS is tragically killed	SCIENCE			English	Biographical-Item									Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Goudsmit, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	jaap@jaapgoudsmit.nl						LANGE J, PUBLICATION LIST	1	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					881	881		10.1126/science.1259453	http://dx.doi.org/10.1126/science.1259453			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146275				2022-12-28	WOS:000340524700026
J	Liao, HG; Zherebetskyy, D; Xin, HL; Czarnik, C; Ercius, P; Elmlund, H; Pan, M; Wang, LW; Zheng, HM				Liao, Hong-Gang; Zherebetskyy, Danylo; Xin, Huolin; Czarnik, Cory; Ercius, Peter; Elmlund, Hans; Pan, Ming; Wang, Lin-Wang; Zheng, Haimei			Facet development during platinum nanocube growth	SCIENCE			English	Article							ELECTRON-MICROSCOPY; GOLD NANOPARTICLES; NANOCRYSTALS; LIQUID; SHAPE; CHEMISTRY	An understanding of how facets of a nanocrystal develop is critical for controlling nanocrystal shape and designing novel functional materials. However, the atomic pathways of nanocrystal facet development are mostly unknown because of the lack of direct observation. We report the imaging of platinum nanocube growth in a liquid cell using transmission electron microscopy with high spatial and temporal resolution. The growth rates of all low index facets are similar until the {100} facets stop growth. The continuous growth of the rest facets leads to a nanocube. Our calculation shows that the much lower ligand mobility on the {100} facets is responsible for the arresting of {100} growing facets. These findings shed light on nanocrystal shape-control mechanisms and future design of nanomaterials.	[Liao, Hong-Gang; Zherebetskyy, Danylo; Xin, Huolin; Wang, Lin-Wang; Zheng, Haimei] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Czarnik, Cory; Pan, Ming] Gatan Inc, Pleasanton, CA 94588 USA; [Ercius, Peter] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Elmlund, Hans] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Zheng, Haimei] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; University of California System; University of California Berkeley	Zheng, HM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	hmzheng@lbl.gov	Liao, Hong-Gang/T-2991-2019; wang, lin/HHM-2225-2022; ELMLUND, HANS/AAA-6625-2021; Zherebetskyy, Danylo/B-3404-2015; Ercius, Peter/AAN-2870-2020; wang, lin/GSE-3040-2022; Xin, Huolin L./E-2747-2010; Liao, hong-gang/M-2476-2015; wang, lili/HDL-7210-2022	Liao, Hong-Gang/0000-0003-2622-9842; Ercius, Peter/0000-0002-6762-9976; Xin, Huolin L./0000-0002-6521-868X; Elmlund, Hans/0000-0002-6992-0601; Zheng, Haimei/0000-0003-3813-4170	U.S. Department of Energy (DOE) Office of Basic Energy Sciences [DE-AC02-05CH11231]; DOE Office of Science	U.S. Department of Energy (DOE) Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE))	We thank B. Sadtler for useful comments on the manuscript. Part of the in situ experiments was performed at Gatan, Incorporated using a Tecnai equipped with a K2-IS camera. We also used FEI Titan, Tecnai UT20, JOEL3010, and TEAM0.5 microscopes at the National Center for Electron Microscopy of Lawrence Berkeley National Laboratory, which is supported by the U.S. Department of Energy (DOE) Office of Basic Energy Sciences under contract no. DE-AC02-05CH11231. H. Z. was a residency faculty member of SinBeRise program of BEARS at University of California, Berkeley, during July 2013 to January 2014 and thanks the DOE Office of Science Early Career Research Program for support.	Bealing CR, 2012, ACS NANO, V6, P2118, DOI 10.1021/nn3000466; Borodko Y, 2013, J PHYS CHEM C, V117, P26667, DOI 10.1021/jp409960p; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Evans JE, 2011, NANO LETT, V11, P2809, DOI 10.1021/nl201166k; Gibbs J. W., 1902, COLLECTED WORKS JW G; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Murphy CJ, 2005, J PHYS CHEM B, V109, P13857, DOI 10.1021/jp0516846; Ringe E, 2011, NANO LETT, V11, P3399, DOI 10.1021/nl2018146; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	21	330	339	19	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					916	919		10.1126/science.1253149	http://dx.doi.org/10.1126/science.1253149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146287				2022-12-28	WOS:000340524700042
J	Christner, BC; Priscu, JC; Achberger, AM; Barbante, C; Carter, SP; Christianson, K; Michaud, AB; Mikucki, JA; Mitchell, AC; Skidmore, ML; Vick-Majors, TJ				Christner, Brent C.; Priscu, John C.; Achberger, Amanda M.; Barbante, Carlo; Carter, Sasha P.; Christianson, Knut; Michaud, Alexander B.; Mikucki, Jill A.; Mitchell, Andrew C.; Skidmore, Mark L.; Vick-Majors, Trista J.		WISSARD Sci Team	A microbial ecosystem beneath the West Antarctic ice sheet	NATURE			English	Article							ACTIVE RESERVOIR BENEATH; SUBGLACIAL LAKE WHILLANS; VOSTOK; STREAM; THYMIDINE; BACTERIA; NITRATE; WATERS; SHELF	Liquid water has been known to occur beneath the Antarctic ice sheet for more than 40 years(1), but only recently have these subglacial aqueous environments been recognized as microbial ecosystems that may influence biogeochemical transformations on a global scale(2-4). Here we present the first geomicrobiological description of water and surficial sediments obtained from direct sampling of a subglacial Antarctic lake. Subglacial Lake Whillans (SLW) lies beneath approximately 800m of ice on the lower portion of the Whillans Ice Stream (WIS) in West Antarctica and is part of an extensive and evolving subglacial drainage network(5). The water column of SLW contained metabolically active microorganisms and was derived primarily from glacial ice melt with solute sources from lithogenic weathering and a minor seawater component. Heterotrophic and autotrophic production data together with small subunit ribosomal RNA gene sequencing and biogeochemical data indicate that SLWis a chemosynthetically driven ecosystem inhabited by a diverse assemblage of bacteria and archaea. Our results confirm that aquatic environments beneath the Antarctic ice sheet support viablemicrobial ecosystems, corroborating previous reports suggesting that they contain globally relevant pools of carbon and microbes(2,4) that can mobilize elements from the lithosphere(6) and influence Southern Ocean geochemical and biological systems(7).	[Christner, Brent C.; Achberger, Amanda M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Priscu, John C.; Michaud, Alexander B.; Vick-Majors, Trista J.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Barbante, Carlo] CNR, Inst Dynam Environm Proc, I-30123 Venice, Italy; [Barbante, Carlo] Ca Foscari Univ Venice, Dept Environm Sci Informat & Stat, I-30123 Venice, Italy; [Carter, Sasha P.] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Christianson, Knut] St Olaf Coll, Dept Phys, Northfield, MN 55057 USA; [Mikucki, Jill A.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Mitchell, Andrew C.] Aberystwyth Univ, Dept Geog & Earth Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Skidmore, Mark L.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Louisiana State University System; Louisiana State University; Montana State University System; Montana State University Bozeman; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia; University of California System; University of California San Diego; Scripps Institution of Oceanography; Saint Olaf College; University of Tennessee System; University of Tennessee Knoxville; Aberystwyth University; Montana State University System; Montana State University Bozeman	Christner, BC (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	xner@lsu.edu; jpriscu@montana.edu	Vick-Majors, Trista/AAQ-6258-2020; Skidmore, Mark/I-4317-2018; Michaud, Alexander B/AAC-4890-2020; Horgan, Huw/I-5847-2019; Barbante, Carlo/B-3195-2011; Tulaczyk, Slawek/O-7375-2018	Vick-Majors, Trista/0000-0002-6868-4010; Michaud, Alexander B/0000-0001-5714-8741; Horgan, Huw/0000-0002-4836-0078; Fricker, Helen Amanda/0000-0002-0921-1432; Tulaczyk, Slawek/0000-0002-9711-4332; Achberger, Amanda/0000-0001-5738-2255; Barbante, Carlo/0000-0003-4177-2288	National Science Foundation from the Division of Polar Programs [0838933, 0838896, 0838941, 0839142, 0839059, 0838885, 0838855, 0838763, 0839107, 0838947, 0838854, 0838764, 1142123]; NSF [1023233, 1115245, 1247192]; Italian National Antarctic Program; NSF's IGERT Program [0654336]; Montana Space Grant Consortium; Directorate For Geosciences [0838885, 0839059] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0839107] Funding Source: National Science Foundation	National Science Foundation from the Division of Polar Programs(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Italian National Antarctic Program; NSF's IGERT Program; Montana Space Grant Consortium; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Whillans Ice Stream Subglacial Access Research Drilling (WISSARD) project was funded by National Science Foundation grants (0838933, 0838896, 0838941, 0839142, 0839059, 0838885, 0838855, 0838763, 0839107, 0838947, 0838854, 0838764 and 1142123) from the Division of Polar Programs. Partial support was also provided by funds from NSF award 1023233 (B. C. C.), NSF award 1115245 (J.C.P.), the NSF's Graduate Research Fellowship Program (1247192; A. M. A.), the Italian National Antarctic Program (C. B.), and fellowships from the NSF's IGERT Program (0654336) and the Montana Space Grant Consortium (A. B. M.). Logistics were provided by the 139th Expeditionary Airlift Squadron of the New York Air National Guard, Kenn Borek Air, and by many dedicated individuals working as part of the Antarctic Support Contractor, managed by Lockheed-Martin. The drilling was directed by F. Rack; D. Blythe, J. Burnett, C. Carpenter, D. Duling (chief driller), D. Gibson, J. Lemery, A. Melby and G. Roberts provided drill support at SLW. L. Geng, B. Vandenheuvel, A. Schauer and E. Steig provided assistance with the stable isotopic analyses. We thank J. Dore for assistance with the nutrient analysis.	Alawi M, 2007, ISME J, V1, P256, DOI 10.1038/ismej.2007.34; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; American Public Health Association A., 1995, STANDARD METHODS EXA; AZAM F, 1979, SCIENCE, V203, P451, DOI 10.1126/science.203.4379.451; Bell R. T., 1993, HDB METHODS AQUATIC; Bell RE, 2002, NATURE, V416, P307, DOI 10.1038/416307a; BLANKENSHIP DD, 1993, NATURE, V361, P526, DOI 10.1038/361526a0; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carter SP, 2012, ANN GLACIOL, V53, P267, DOI 10.3189/2012AoG60A119; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; CHINLEO G, 1988, APPL ENVIRON MICROB, V54, P1934, DOI 10.1128/AEM.54.8.1934-1939.1988; Christianson K, 2012, EARTH PLANET SC LETT, V331, P237, DOI 10.1016/j.epsl.2012.03.013; Christner BC, 2006, LIMNOL OCEANOGR, V51, P2485, DOI 10.4319/lo.2006.51.6.2485; Christner Brent C., 2008, P51, DOI 10.1007/978-3-540-74335-4_4; Costa AW, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047539; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fricker HA, 2007, SCIENCE, V315, P1544, DOI 10.1126/science.1136897; Fricker HA, 2009, J GLACIOL, V55, P303, DOI 10.3189/002214309788608813; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Girsch G, 2013, ATMOS CHEM PHYS DISC, V13, P9443, DOI DOI 10.5194/ACPD-13-9443-2013; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Haran J., 2005, MODIS MOSAIC ANTARCT, DOI [10.7265/N5ZK5DM5.[28]A., DOI 10.7265/N5ZK5DM5.[28]A]; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Horgan HJ, 2013, GEOLOGY, V41, P1159, DOI 10.1130/G34654.1; Horgan HJ, 2012, EARTH PLANET SC LETT, V331, P201, DOI 10.1016/j.epsl.2012.02.023; HORRIGAN SG, 1981, LIMNOL OCEANOGR, V26, P378, DOI 10.4319/lo.1981.26.2.0378; Kaiser J, 2007, ANAL CHEM, V79, P599, DOI 10.1021/ac061022s; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; Kepner RL, 1998, LIMNOL OCEANOGR, V43, P1754, DOI 10.4319/lo.1998.43.7.1754; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Montross SN, 2013, GEOLOGY, V41, P215, DOI 10.1130/G33572.1; OSWALD GKA, 1973, NATURE, V245, P251, DOI 10.1038/245251a0; Priscu J. C., 2008, POLAR LAKES RIVERS; Priscu J. C., 2013, LTER LIMNO METHODS M; PRISCU JC, 1990, MAR ECOL PROG SER, V62, P37, DOI 10.3354/meps062037; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Priscu JC, 2013, ANTARCT SCI, V25, P637, DOI 10.1017/S0954102013000035; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; Siegfried MR, 2014, GEOPHYS RES LETT, V41, P891, DOI 10.1002/2013GL058616; Skidmore M, 2010, HYDROL PROCESS, V24, P517, DOI 10.1002/hyp.7580; Takacs CD, 2001, LIMNOL OCEANOGR, V46, P1189, DOI 10.4319/lo.2001.46.5.1189; Vogel SW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022563; Wadham JL, 2012, NATURE, V488, P633, DOI 10.1038/nature11374; Wadham JL, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003688; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wright A, 2012, ANTARCT SCI, V24, P659, DOI 10.1017/S095410201200048X	50	169	174	5	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					310	+		10.1038/nature13667	http://dx.doi.org/10.1038/nature13667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143114	Green Submitted			2022-12-28	WOS:000340508200035
J	Tramer, MR				Tramer, Martin R.			Do we need to know whether nitrous oxide harms patients?	LANCET			English	Editorial Material							ANESTHESIA; HOMOCYSTEINE		Univ Hosp Geneva, Dept Anaesthesiol Clin Pharmacol & Intens Care Me, Div Anaesthesiol, CH-1211 Geneva, Switzerland	University of Geneva	Tramer, MR (corresponding author), Univ Hosp Geneva, Dept Anaesthesiol Clin Pharmacol & Intens Care Me, Div Anaesthesiol, CH-1211 Geneva, Switzerland.	martin.tramer@hcuge.ch						Badner NH, 1998, ANESTH ANALG, V87, P711, DOI 10.1097/00000539-199809000-00041; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DEACON R, 1980, EUR J BIOCHEM, V104, P419, DOI 10.1111/j.1432-1033.1980.tb04443.x; Herff H, 2007, ANAESTHESIA, V62, P1202, DOI 10.1111/j.1365-2044.2007.05193.x; Jevtovic-Todorovic V, 2003, NEUROSCIENCE, V122, P609, DOI 10.1016/j.neuroscience.2003.07.012; Myles PS, 2014, LANCET; Nagele P, 2008, ANESTHESIOLOGY, V109, P36, DOI 10.1097/ALN.0b013e318178820b; Tramer M, 1996, BRIT J ANAESTH, V76, P186, DOI 10.1093/bja/76.2.186; Viterbo JF, 2012, EUR J ANAESTH, V29, P477, DOI 10.1097/EJA.0b013e3283542421; WHO Expert Committee on Selection and Use of Essential Medicines, 2013, WHO MOD LISTS ESS ME	10	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1407	1409		10.1016/S0140-6736(14)61061-8	http://dx.doi.org/10.1016/S0140-6736(14)61061-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25142709				2022-12-28	WOS:000343107000006
J	Bel, EH; Wenzel, SE; Thompson, PJ; Prazma, CM; Keene, ON; Yancey, SW; Ortega, HG; Pavord, ID				Bel, Elisabeth H.; Wenzel, Sally E.; Thompson, Philip J.; Prazma, Charlene M.; Keene, Oliver N.; Yancey, Steven W.; Ortega, Hector G.; Pavord, Ian D.		SIRIUS Investigators	Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; MULTICENTER	BACKGROUND Many patients with severe asthma require regular treatment with oral glucocorticoids despite the use of high-dose inhaled therapy. However, the regular use of systemic glucocorticoids can result in serious and often irreversible adverse effects. Mepolizumab, a humanized monoclonal antibody that binds to and inactivates interleukin-5, has been shown to reduce asthma exacerbations in patients with severe eosinophilic asthma. METHODS In a randomized, double-blind trial involving 135 patients with severe eosinophilic asthma, we compared the glucocorticoid-sparing effect of mepolizumab (at a dose of 100 mg) with that of placebo administered subcutaneously every 4 weeks for 20 weeks. The primary outcome was the degree of reduction in the glucocorticoid dose (90 to 100% reduction, 75 to less than 90% reduction, 50 to less than 75% reduction, more than 0 to less than 50% reduction, or no decrease in oral glucocorticoid dose, a lack of asthma control during weeks 20 to 24, or withdrawal from treatment). Other outcomes included the rate of asthma exacerbations, asthma control, and safety. RESULTS The likelihood of a reduction in the glucocorticoid-dose stratum was 2.39 times greater in the mepolizumab group than in the placebo group (95% confidence interval, 1.25 to 4.56; P = 0.008). The median percentage reduction from baseline in the glucocorticoid dose was 50% in the mepolizumab group, as compared with no reduction in the placebo group (P = 0.007). Despite receiving a reduced glucocorticoid dose, patients in the mepolizumab group, as compared with those in the placebo group, had a relative reduction of 32% in the annualized rate of exacerbations (1.44 vs. 2.12, P = 0.04) and a reduction of 0.52 points with respect to asthma symptoms (P = 0.004), as measured on the Asthma Control Questionnaire 5 (in which the minimal clinically important difference is 0.5 points). The safety profile of mepolizumab was similar to that of placebo. CONCLUSIONS In patients requiring daily oral glucocorticoid therapy to maintain asthma control, mepolizumab had a significant glucocorticoid-sparing effect, reduced exacerbations, and improved control of asthma symptoms.	[Bel, Elisabeth H.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands; [Wenzel, Sally E.] Univ Pittsburgh, Sch Med, Med Ctr, Dept Pulm Allergy & Crit Care Med,Asthma Inst, Pittsburgh, PA USA; [Thompson, Philip J.] Lung Inst Western Australia, Nedlands, WA, Australia; [Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Crawley, Australia; [Prazma, Charlene M.; Yancey, Steven W.; Ortega, Hector G.] GlaxoSmithKline, Resp Therapeut Area, Res Triangle Pk, NC USA; [Keene, Oliver N.] GlaxoSmithKline, Clin Stat, Stockley Pk, England; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford OX1 2JD, England	University of Amsterdam; Academic Medical Center Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Western Australia; University of Western Australia; GlaxoSmithKline; GlaxoSmithKline; University of Oxford	Bel, EH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.h.bel@amc.uva.nl	Magnan, Antoine/D-4100-2015	Mortimer, Kevin/0000-0002-8118-8871; Wenzel, Sally/0000-0002-4242-0164; Pavord, Ian/0000-0002-4288-5973; Keene, Oliver/0000-0003-0016-9773	GlaxoSmithKline; MRC [MR/L002515/1, G0800649] Funding Source: UKRI; Medical Research Council [G0800649, MR/L002515/1] Funding Source: researchfish; National Institute for Health Research [CL-2006-12-004, NF-SI-0510-10157] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by GlaxoSmithKline; SIRIUS ClinicalTrials.gov number, NCT01691508.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Haldar P, 2011, NEW ENGL J MED, V364, P588, DOI DOI 10.1056/NEJMX110005; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hashimoto S, 2011, THORAX, V66, P514, DOI 10.1136/thx.2010.153411; Heaney LG, 2010, THORAX, V65, P787, DOI 10.1136/thx.2010.137414; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; LIEBERMAN P, 1972, J ALLERGY CLIN IMMUN, V49, P329, DOI 10.1016/0091-6749(72)90131-5; Lock SH, 1996, AM J RESP CRIT CARE, V153, P509, DOI 10.1164/ajrccm.153.2.8564089; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Samitas Konstantinos, 2011, Recent Pat Antiinfect Drug Discov, V6, P189; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SHINER RJ, 1990, LANCET, V336, P137, DOI 10.1016/0140-6736(90)91659-X; Walsh GM, 2012, EXPERT OPIN EMERG DR, V17, P37, DOI 10.1517/14728214.2012.657625; WHITEHEAD J, 1994, STAT MED, V13, P871	22	974	1013	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1189	1197		10.1056/NEJMoa1403291	http://dx.doi.org/10.1056/NEJMoa1403291			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4WH	25199060				2022-12-28	WOS:000342079700006
J	Cockcroft, A; Masisi, M; Thabane, L; Andersson, N				Cockcroft, Anne; Masisi, Mokgweetsi; Thabane, Lehana; Andersson, Neil			Legislators learning to interpret evidence for policy	SCIENCE			English	Editorial Material									[Cockcroft, Anne] CIET Trust Botswana, Gaborone, Botswana; [Masisi, Mokgweetsi] Govt Botswana, Gaborone, Botswana; [Thabane, Lehana] McMaster Univ, Hamilton, ON, Canada; [Andersson, Neil] McGill Univ, Montreal, PQ, Canada; [Andersson, Neil] Univ Autonoma Guerrero, Ctr Invest Trop Dis CIET, Acapulco, Mexico	McMaster University; McGill University	Cockcroft, A (corresponding author), CIET Trust Botswana, Gaborone, Botswana.	acockcroft@ciet.org	Andersson, Neil/G-2248-2011					[Anonymous], 2012, REPORT INT FORUM EVI; Cockcroft A, 2014, J PUBLIC HEALTH POL, V35, P475, DOI 10.1057/jphp.2014.30; Court J., 2006, EVID POLICY, V2, P439, DOI DOI 10.1332/174426406778881764; Geneau R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-P94; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Jewell CJ, 2008, MILBANK Q, V86, P177, DOI 10.1111/j.1468-0009.2008.00519.x; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; World Health Organization, 2013, EV INF POL MAK SURE	11	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1244	1245		10.1126/science.1256911	http://dx.doi.org/10.1126/science.1256911			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214591				2022-12-28	WOS:000341483800019
J	Herrick, JB				Herrick, James B.			Peculiar Elongated and Sickle-Shaped Red Blood Corpuscles in a Case of Severe Anemia (Reprinted from Arch Intern Med (Chic)., vol 6, pg 517-521, 1910)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Herrick J.B., 1910, ARCH INTERN MED, V6, P517	1	18	18	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1063	1063		10.1001/jama.2014.11011	http://dx.doi.org/10.1001/jama.2014.11011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203098				2022-12-28	WOS:000341385600035
J	Pashkin, A; Leitenstorfer, A				Pashkin, Alexej; Leitenstorfer, Alfred			Particle physics in a superconductor	SCIENCE			English	Editorial Material							GAUGE-INVARIANCE; TERAHERTZ PULSES; GENERATION		[Pashkin, Alexej; Leitenstorfer, Alfred] Univ Konstanz, Dept Phys, D-78457 Constance, Germany	University of Konstanz	Pashkin, A (corresponding author), Univ Konstanz, Dept Phys, D-78457 Constance, Germany.	alfred.leitenstorfer@uni-konstanz.de	Leitenstorfer, Alfred/B-9561-2015; Pashkin, Alexej/A-4705-2009	Leitenstorfer, Alfred/0000-0002-9847-257X; Pashkin, Alexej/0000-0003-1309-6171				ANDERSON PW, 1958, PHYS REV, V110, P827, DOI 10.1103/PhysRev.110.827; Cho A, 2012, SCIENCE, V337, P141, DOI 10.1126/science.337.6091.141; Hebling J, 2008, J OPT SOC AM B, V25, pB6, DOI 10.1364/JOSAB.25.0000B6; Junginger F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.147403; Leinss S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.246401; Matsunaga R, 2014, SCIENCE, V345, P1145, DOI 10.1126/science.1254697; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Sell A, 2008, OPT LETT, V33, P2767, DOI 10.1364/OL.33.002767; Varma CM, 2002, J LOW TEMP PHYS, V126, P901, DOI 10.1023/A:1013890507658; Zaks B, 2012, NATURE, V483, P580, DOI 10.1038/nature10864	12	10	10	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1121	1122		10.1126/science.1257302	http://dx.doi.org/10.1126/science.1257302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190780	Green Submitted			2022-12-28	WOS:000341179800022
J	Bui, AH; O'Gara, PT; Economy, KE; Miller, AL; Loscalzo, J				Bui, An H.; O'Gara, Patrick T.; Economy, Katherine E.; Miller, Amy Leigh; Loscalzo, Joseph			A Tight Predicament	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALVULAR HEART-DISEASE; PREGNANT-WOMEN; MITRAL-STENOSIS; MANAGEMENT; OUTCOMES		[Bui, An H.; O'Gara, Patrick T.; Miller, Amy Leigh; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Economy, Katherine E.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021					ALKASAB SM, 1990, AM J OBSTET GYNECOL, V163, P37, DOI 10.1016/S0002-9378(11)90661-9; Barbosa P J, 2000, Arq Bras Cardiol, V75, P215; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Campbell LA, 2001, AM J RESP CRIT CARE, V163, P1051, DOI 10.1164/ajrccm.163.5.16353; Carabello BA, 2005, CIRCULATION, V112, P432, DOI 10.1161/CIRCULATIONAHA.104.532498; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Catanzarite V, 2001, OBSTET GYNECOL, V97, P760, DOI 10.1016/S0029-7844(00)01231-X; Cole Daniel E, 2005, Crit Care Med, V33, pS269, DOI 10.1097/01.CCM.0000182478.14181.DA; Fawzy ME, 2001, J HEART VALVE DIS, V10, P153; Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0; Madazli R, 2010, ARCH GYNECOL OBSTET, V281, P29, DOI 10.1007/s00404-009-1050-z; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Reimold SC, 2003, NEW ENGL J MED, V349, P52, DOI 10.1056/NEJMcp021265; Scirica Benjamin M, 2006, Curr Cardiol Rep, V8, P83, DOI 10.1007/s11886-006-0017-y; Siu SC, 2002, CIRCULATION, V105, P2179, DOI 10.1161/01.CIR.0000015699.48605.08	15	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					953	959		10.1056/NEJMcps1304030	http://dx.doi.org/10.1056/NEJMcps1304030			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184868				2022-12-28	WOS:000341390600013
J	Redberg, RF				Redberg, Rita F.			Sham Controls in Medical Device Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA.							Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Gray DT, 2007, JAMA-J AM MED ASSOC, V298, P1760, DOI 10.1001/jama.298.15.1760-b; Meissner K, 2013, JAMA INTERN MED, V173, P1941, DOI 10.1001/jamainternmed.2013.10391	5	45	45	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					892	893		10.1056/NEJMp1406388	http://dx.doi.org/10.1056/NEJMp1406388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5NB	25184861				2022-12-28	WOS:000341390600006
J	Rogers, P; Adlan, T; Page, G				Rogers, Patrick; Adlan, Tarig; Page, George			Non-invasive imaging in pancreatitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMON BILE-DUCT; CT		[Rogers, Patrick; Adlan, Tarig] Peninsula Radiol Acad, Plymouth PL6 5WR, Devon, England; [Page, George] Kings Coll Hosp London, London SE5 9RS, England	University of Plymouth; King's College Hospital NHS Foundation Trust; King's College Hospital	Rogers, P (corresponding author), Peninsula Radiol Acad, Plymouth Int Business Pk, Plymouth PL6 5WR, Devon, England.	rogers@nhs.net						Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bharwani N, 2011, CLIN RADIOL, V66, P164, DOI 10.1016/j.crad.2010.09.003; Hauptfleisch J, 2013, CLIN RADIOL, V68, pE245, DOI 10.1016/j.crad.2012.12.007; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Kondo S, 2005, EUR J RADIOL, V54, P271, DOI 10.1016/j.ejrad.2004.07.007; Morgan DE, 1997, RADIOLOGY, V203, P773, DOI 10.1148/radiology.203.3.9169703; Regan F, 1996, AM J ROENTGENOL, V167, P1441, DOI 10.2214/ajr.167.6.8956574; STOTT MA, 1991, J CLIN ULTRASOUND, V19, P73, DOI 10.1002/jcu.1870190203; Xiao B, 2010, WORLD J RADIOL, V2, P298, DOI 10.4329/wjr.v2.i8.298; Xiao B, 2010, WORLD J GASTROENTERO, V16, P2735, DOI 10.3748/wjg.v16.i22.2735; Yeh BM, 2009, RADIOGRAPHICS, V29, P1669, DOI 10.1148/rg.296095514	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2014	349								g5223	10.1136/bmj.g5223	http://dx.doi.org/10.1136/bmj.g5223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO2RZ	25170163				2022-12-28	WOS:000341174400001
J	McManus, RJ; Mant, J; Haque, MS; Bray, EP; Bryan, S; Greenfield, SM; Jones, MI; Jowett, S; Little, P; Penaloza, C; Schwartz, C; Shackleford, H; Shovelton, C; Varghese, J; Williams, B; Hobbs, FDR				McManus, Richard J.; Mant, Jonathan; Haque, M. Sayeed; Bray, Emma P.; Bryan, Stirling; Greenfield, Sheila M.; Jones, Miren I.; Jowett, Sue; Little, Paul; Penaloza, Cristina; Schwartz, Claire; Shackleford, Helen; Shovelton, Claire; Varghese, Jinu; Williams, Bryan; Hobbs, F. D. Richard			Effect of Self-monitoring and Medication Self-titration on Systolic Blood Pressure in Hypertensive Patients at High Risk of Cardiovascular Disease The TASMIN-SR Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; MANAGEMENT; GUIDELINES	IMPORTANCE Self-monitoring of blood pressure with self-titration of antihypertensives (self-management) results in lower blood pressure in patients with hypertension, but there are no data about patients in high-risk groups. OBJECTIVE To determine the effect of self-monitoring with self-titration of antihypertensive medication compared with usual care on systolic blood pressure among patients with cardiovascular disease, diabetes, or chronic kidney disease. DESIGN, SETTING, AND PATIENTS A primary care, unblinded, randomized clinical trial involving 552 patients who were aged at least 35 years with a history of stroke, coronary heart disease, diabetes, or chronic kidney disease and with baseline blood pressure of at least 130/80 mm Hg being treated at 59 UK primary care practices was conducted between March 2011 and January 2013. INTERVENTIONS Self-monitoring of blood pressure combined with an individualized self-titration algorithm. During the study period, the office visit blood pressure measurement target was 130/80 mm Hg and the home measurement target was 120/75 mm Hg. Control patients received usual care consisting of seeing their health care clinician for routine blood pressure measurement and adjustment of medication if necessary. MAIN OUTCOMES AND MEASURES The primary outcome was the difference in systolic blood pressure between intervention and control groups at the 12-month office visit. RESULTS Primary outcome data were available from 450 patients (81%). The mean baseline blood pressure was 143.1/80.5 mm Hg in the intervention group and 143.6/79.5 mm Hg in the control group. After 12 months, the mean blood pressure had decreased to 128.2/73.8 mm Hg in the intervention group and to 137.8/76.3 mm Hg in the control group, a difference of 9.2 mm Hg (95% CI, 5.7-12.7) in systolic and 3.4 mm Hg (95% CI, 1.8-5.0) in diastolic blood pressure following correction for baseline blood pressure. Multiple imputation for missing values gave similar results: the mean baseline was 143.5/80.2 mm Hg in the intervention group vs 144.2/79.9 mm Hg in the control group, and at 12 months, the mean was 128.6/73.6 mm Hg in the intervention group vs 138.2/76.4 mm Hg in the control group, with a difference of 8.8 mm Hg (95% CI, 4.9-12.7) for systolic and 3.1 mm Hg (95% CI, 0.7-5.5) for diastolic blood pressure between groups. These results were comparable in all subgroups, without excessive adverse events. CONCLUSIONS AND RELEVANCE Among patients with hypertension at high risk of cardiovascular disease, self-monitoring with self-titration of antihypertensive medication compared with usual care resulted in lower systolic blood pressure at 12 months. Copyright 2014 American Medical Association. All rights reserved.	[McManus, Richard J.; Schwartz, Claire; Hobbs, F. D. Richard] Univ Oxford, NIHR Sch Primary Care Res, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Mant, Jonathan] Univ Cambridge, Strangeways Res Lab, Primary Care Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Haque, M. Sayeed; Greenfield, Sheila M.; Jones, Miren I.; Shackleford, Helen; Shovelton, Claire; Varghese, Jinu] Univ Birmingham, NIHR Sch Primary Care Res, Birmingham, W Midlands, England; [Bray, Emma P.] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England; [Bryan, Stirling] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Bryan, Stirling] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Jowett, Sue; Penaloza, Cristina] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham, W Midlands, England; [Little, Paul] Univ Southampton, Sch Med, Southampton, Hants, England; [Williams, Bryan] UCL, Inst Cardiovasc Sci, NIHR Univ Coll London Hosp Biomed Res Ctr, London, England	University of Oxford; University of Cambridge; University of Birmingham; University of Central Lancashire; Vancouver Coastal Health Research Institute; University of British Columbia; University of Birmingham; University of Southampton; University College London Hospitals NHS Foundation Trust; University of London; University College London	McManus, RJ (corresponding author), Univ Oxford, NIHR Sch Primary Care Res, Nuffield Dept Primary Care Hlth Sci, Woodstock Rd, Oxford OX2 6GG, England.	richard.mcmanus@phc.ox.ac.uk	Haque, Mohammad S/B-9160-2018; Varghese, Jajini/GWU-5455-2022; Jowett, Sue/AAO-4198-2021	Jowett, Sue/0000-0001-8936-3745; hobbs, richard/0000-0001-7976-7172; Varghese, Jajini Susan/0000-0001-8189-5608; Haque, (Mohammad) Sayeed/0000-0002-2467-8575; Bray, Emma/0000-0001-9882-3539; Mant, Jonathan/0000-0002-9531-0268; Williams, Bryan/0000-0002-8094-1841; Little, Paul/0000-0003-3664-1873	National Institute for Health Research (NIHR) [RP-PG 0606-1153]; NIHR National School of Primary Care Research [NSPCR16]; NIHR; Medical Research Council [MC_PC_13090] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10273, PB-PG-1207-15042, RP-PG-1209-10051, NIHR-RP-02-12-015, CDF/01/017, RP-PG-0606-1153] Funding Source: researchfish; Chief Scientist Office [HERU1] Funding Source: researchfish; MRC [MC_PC_13090] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR National School of Primary Care Research; NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG 0606-1153), by the NIHR National School of Primary Care Research (NSPCR16), and by an NIHR career development fellowship (Dr McManus). The study sponsor was the University of Birmingham.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Baral-Grant S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/582068; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bosworth HB, 2011, ARCH INTERN MED, V171, P1173, DOI 10.1001/archinternmed.2011.276; Craig R, 2011, HLTH SURV ENGL 2011; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Home P, 2008, BRIT MED J, V336, P1306, DOI 10.1136/bmj.39560.442095.AD; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK, V4th ed; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Logan AG, 2008, J HYPERTENS, V26, P446, DOI 10.1097/HJH.0b013e3282f2fdd4; Mancia G, 2007, BLOOD PRESSURE, V16, P135, DOI 10.1080/08037050701461084; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mattu GS, 2004, BLOOD PRESS MONIT, V9, P47, DOI 10.1097/00126097-200402000-00009; MCCORMICK A, 1995, MORBIDITY STAT GEN P; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; McManus RJ, 2008, FAM PRACT, V25, P56, DOI 10.1093/fampra/cmm065; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; National Institute for Health and Clinical Excellence, 2008, CHRON KIDN DIS EARL; Navar-Boggan AM, 2014, JAMA-J AM MED ASSOC, V311, P1424, DOI 10.1001/jama.2014.2531; O'Brien C, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-21; Ogedegbe Gbenga, 2006, J Clin Hypertens (Greenwich), V8, P174, DOI 10.1111/j.1524-6175.2006.04872.x; Stergiou GS, 2007, BLOOD PRESS MONIT, V12, P185, DOI 10.1097/MBP.0b013e3280b083ce; Uhlig K, 2013, ANN INTERN MED, V159, P185, DOI 10.7326/0003-4819-159-3-201308060-00008; Watson AJ, 2012, AM HEART J, V164, P625, DOI 10.1016/j.ahj.2012.06.013; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; World Health Organization, 2013, DEF DAIL DOS DEF GEN; Zarnke KB, 1997, AM J HYPERTENS, V10, P58, DOI 10.1016/S0895-7061(96)00305-6	34	247	257	4	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					799	808		10.1001/jama.2014.10057	http://dx.doi.org/10.1001/jama.2014.10057			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157723	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000340788500022
J	Galvani, AP; Ndeffo-Mbah, ML; Wenzel, N; Childs, JE				Galvani, Alison P.; Ndeffo-Mbah, Martial L.; Wenzel, Natasha; Childs, James E.			Ebola Vaccination: If Not Now, When?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS CHALLENGE; PROTECTION; VACCINES		Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; Yale Univ, New Haven, CT 06520 USA	Yale University; Yale University	Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling, POB 208034,60 Coll St, New Haven, CT 06520 USA.	alison.galvani@yale.edu		Ndeffo Mbah, Martial/0000-0003-4158-7613	NIGMS NIH HHS [2 U01 GM087719, U01 GM087719, 5 U01 GM105627, U01 GM105627] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blaney JE, 2011, J VIROL, V85, P10605, DOI 10.1128/JVI.00558-11; Bukreyev A, 2006, J VIROL, V80, P2267, DOI 10.1128/JVI.80.5.2267-2279.2006; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Tsuda Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001275; Warfield KL, EBOLA VIRUS LIKE PAR	10	24	25	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					749	U203		10.7326/M14-1904	http://dx.doi.org/10.7326/M14-1904			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25141813	Green Accepted			2022-12-28	WOS:000347245600035
J	Petersen, J; Volz, J; Rauschenbeutel, A				Petersen, Jan; Volz, Juergen; Rauschenbeutel, Arno			Chiral nanophotonic waveguide interface based on spin-orbit interaction of light	SCIENCE			English	Article							NANOFIBERS; MODES	Controlling the flow of light with nanophotonic waveguides has the potential of transforming integrated information processing. Because of the strong transverse confinement of the guided photons, their internal spin and their orbital angular momentum get coupled. Using this spin-orbit interaction of light, we break the mirror symmetry of the scattering of light with a gold nanoparticle on the surface of a nanophotonic waveguide and realize a chiral waveguide coupler in which the handedness of the incident light determines the propagation direction in the waveguide. We control the directionality of the scattering process and can direct up to 94% of the incoupled light into a given direction. Our approach allows for the control and manipulation of light in optical waveguides and new designs of optical sensors.	[Petersen, Jan; Volz, Juergen; Rauschenbeutel, Arno] TU Wien Atominst, Vienna Ctr Quantum Sci & Technol, A-1020 Vienna, Austria	Technische Universitat Wien	Volz, J (corresponding author), TU Wien Atominst, Vienna Ctr Quantum Sci & Technol, Stadionallee 2, A-1020 Vienna, Austria.	jvolz@ati.ac.at; arno.rauschenbeutel@ati.ac.at	Volz, Jürgen/N-6457-2016; Rauschenbeutel, Arno/C-1472-2013	Volz, Jürgen/0000-0002-3174-2141; Rauschenbeutel, Arno/0000-0003-2467-4029	NanoSci-ERA network "NOIs"; European Commission (IP Simulators and Interfaces with Quantum Systems) [600645]; European Commission (Marie Curie Intra-European Fellowship) [300392]	NanoSci-ERA network "NOIs"; European Commission (IP Simulators and Interfaces with Quantum Systems); European Commission (Marie Curie Intra-European Fellowship)(European CommissionEuropean Commission Joint Research Centre)	We gratefully acknowledge financial support by the NanoSci-ERA network "NOIs" and the European Commission (IP Simulators and Interfaces with Quantum Systems, 600645). J.V. acknowledges support by the European Commission (Marie Curie Intra-European Fellowship grant 300392). The scanning electron microscope imaging has been carried out by use of facilities at the University Service Center for Transmission Electron Microscopy, Vienna University of Technology, Austria.	BARBER PW, 1990, LIGHT SCATTERING PAR, V2; Bauer T, 2014, NAT PHOTONICS, V8, P24, DOI [10.1038/nphoton.2013.289, 10.1038/NPHOTON.2013.289]; Benson O, 2011, NATURE, V480, P193, DOI 10.1038/nature10610; Bliokh KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4300; Bliokh KY, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.061801; Bliokh KY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.030404; Bliokh KY, 2008, NAT PHOTONICS, V2, P748, DOI 10.1038/nphoton.2008.229; Brambilla G, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/4/043001; David A., 2012, ANGULAR MOMENTUM LIG; Goban A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033603; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Junge C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213604; Kapitanova PV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4226; Klitzing K. V., 1980, PHYS REV LETT, V45, P494, DOI [10.1103/PhysRevLett.45.494, DOI 10.1103/PHYSREVLETT.45.494]; Korger J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.113902; Le Kien F, 2004, OPT COMMUN, V242, P445, DOI 10.1016/j.optcom.2004.08.044; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Morrissey MJ, 2013, SENSORS-BASEL, V13, P10449, DOI 10.3390/s130810449; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Myroshnychenko V, 2008, CHEM SOC REV, V37, P1792, DOI 10.1039/b711486a; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Tong LM, 2012, OPT COMMUN, V285, P4641, DOI 10.1016/j.optcom.2012.07.068; Vetsch E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203603; Zhao YQ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.073901	27	496	502	21	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					67	71		10.1126/science.1257671	http://dx.doi.org/10.1126/science.1257671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25190718	Green Submitted			2022-12-28	WOS:000342446900051
J	De Bruyne, B; Fearon, WF; Pijls, NHJ; Barbato, E; Tonino, P; Piroth, Z; Jagic, N; Mobius-Winckler, S; Rioufol, G; Witt, N; Kala, P; MacCarthy, P; Engstrom, T; Oldroyd, K; Mavromatis, K; Manoharan, G; Verlee, P; Frobert, O; Curzen, N; Johnson, JB; Limacher, A; Nuesch, E; Juni, P				De Bruyne, Bernard; Fearon, William F.; Pijls, Nico H. J.; Barbato, Emanuele; Tonino, Pim; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Rioufol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engstroem, Thomas; Oldroyd, Keith; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B.; Limacher, Andreas; Nueesch, Eveline; Jueni, Peter		FAME 2 Investigators	Fractional Flow Reserve-Guided PCI for Stable Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPTIMAL MEDICAL THERAPY; MYOCARDIAL-INFARCTION; PRESSURE MEASUREMENTS; FOLLOW-UP; INTERVENTION; REVASCULARIZATION; OUTCOMES; ANGIOGRAPHY; STENOSIS; SEVERITY	BACKGROUND We hypothesized that in patients with stable coronary artery disease and stenosis, percutaneous coronary intervention (PCI) performed on the basis of the fractional flow reserve (FFR) would be superior to medical therapy. METHODS In 1220 patients with stable coronary artery disease, we assessed the FFR in all stenoses that were visible on angiography. Patients who had at least one stenosis with an FFR of 0.80 or less were randomly assigned to undergo FFR-guided PCI plus medical therapy or to receive medical therapy alone. Patients in whom all stenoses had an FFR of more than 0.80 received medical therapy alone and were included in a registry. The primary end point was a composite of death from any cause, nonfatal myocardial infarction, or urgent revascularization within 2 years. RESULTS The rate of the primary end point was significantly lower in the PCI group than in the medical-therapy group (8.1% vs. 19.5%; hazard ratio, 0.39; 95% confidence interval [CI], 0.26 to 0.57; P<0.001). This reduction was driven by a lower rate of urgent revascularization in the PCI group (4.0% vs. 16.3%; hazard ratio, 0.23; 95% CI, 0.14 to 0.38; P<0.001), with no significant between-group differences in the rates of death and myocardial infarction. Urgent revascularizations that were triggered by myocardial infarction or ischemic changes on electrocardiography were less frequent in the PCI group (3.4% vs. 7.0%, P = 0.01). In a landmark analysis, the rate of death or myocardial infarction from 8 days to 2 years was lower in the PCI group than in the medical-therapy group (4.6% vs. 8.0%, P = 0.04). Among registry patients, the rate of the primary end point was 9.0% at 2 years. CONCLUSIONS In patients with stable coronary artery disease, FFR-guided PCI, as compared with medical therapy alone, improved the outcome. Patients without ischemia had a favorable outcome with medical therapy alone.	[De Bruyne, Bernard; Barbato, Emanuele] Onze Lieve Vrouw Hosp, Cardiovasc Ctr Aalst, Aalst, Belgium; [Fearon, William F.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Fearon, William F.] Palo Alto Vet Affairs Hlth Care Syst, Stanford, CA USA; [Pijls, Nico H. J.; Tonino, Pim] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Pijls, Nico H. J.; Tonino, Pim] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Piroth, Zsolt] Hungarian Inst Cardiol, Budapest, Hungary; [Jagic, Nikola] Clin Ctr Kragujevac, Kragujeva, Serbia; [Mobius-Winckler, Sven] Heart Ctr Leipzig, Leipzig, Germany; [Rioufol, Gilles] Cardiovasc Hosp, Lyon, France; [Witt, Nils] Karolinska Inst Sodersjukhuset, Stockholm, Sweden; [Frobert, Ole] Orebro Univ Hosp, Orebro, Sweden; [Kala, Petr] Univ Hosp, Brno, Czech Republic; [MacCarthy, Philip] Kings Coll Hosp London, London SE5 8RX, England; [Oldroyd, Keith] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland; [Manoharan, Ganesh] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland; [Curzen, Nick] Southampton Univ Hosp NHS Trust, Southampton, Hants, England; [Engstroem, Thomas] Univ Copenhagen Hosp, Rigshosp, DK-2100 Copenhagen, Denmark; [Mavromatis, Kreton] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Verlee, Peter] Eastern Maine Med Ctr, Bangor, Gwynedd, Wales; [Johnson, Jane B.] St Jude Med, St Paul, MN USA; [Limacher, Andreas; Nueesch, Eveline; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Limacher, Andreas; Nueesch, Eveline; Jueni, Peter] Univ Bern, Dept Clin Res, Clin Trials Unit Bern, Bern, Switzerland	Cardiovascular Center Aalst; Stanford University; Catharina Hospital; Eindhoven University of Technology; Heart Center Leipzig GMBH; CHU Lyon; Karolinska Institutet; Orebro University; University Hospital Brno; King's College Hospital NHS Foundation Trust; King's College Hospital; Golden Jubilee Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust; Rigshospitalet; University of Copenhagen; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; St. Jude Medical; University of Bern; University of Bern	De Bruyne, B (corresponding author), Cardiovasc Ctr Aalst, Moorselbaan 164, B-9300 Aalst, Belgium.	bernard.de.bruyne@olvz-aalst.be	curzen, nick/AAD-8161-2020; Carmen, Team3/Y-7384-2019; Juni, Peter/Q-8700-2016; Pilgrim, Thomas/AAS-9120-2021	Carmen, Team3/0000-0002-3614-0924; Juni, Peter/0000-0002-5985-0670; Pilgrim, Thomas/0000-0001-8721-4068; Wijns, William/0000-0002-7267-4376; Lab, Carmen/0000-0002-5935-3236; Limacher, Andreas/0000-0002-9094-9476; Frobert, Ole/0000-0002-5846-345X; Barbato, Emanuele/0000-0002-0050-5178	St. Jude Medical	St. Jude Medical(St. Jude Medical)	Funded by St. Jude Medical; FAME 2 ClinicalTrials.gov number, NCT01132495.	Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Damman P, 2012, CIRCULATION, V125, P568, DOI 10.1161/CIRCULATIONAHA.111.061663; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; DEBRUYNE B, 1994, CIRCULATION, V89, P1013, DOI 10.1161/01.CIR.89.3.1013; Di Serafino L, 2013, AM HEART J, V166, P110, DOI 10.1016/j.ahj.2013.04.007; Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500; Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hannan EL, 2012, CIRCULATION, V125, P1870, DOI 10.1161/CIRCULATIONAHA.111.071811; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Li J, 2013, EUR HEART J, V34, P1375, DOI 10.1093/eurheartj/eht005; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Muller O, 2011, JACC-CARDIOVASC INTE, V4, P1175, DOI 10.1016/j.jcin.2011.09.007; Park SJ, 2013, EUR HEART J, V34, P3353, DOI 10.1093/eurheartj/eht404; PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Prasad A, 2009, J AM COLL CARDIOL, V54, P477, DOI 10.1016/j.jacc.2009.03.063; Puymirat E, 2012, CIRC-CARDIOVASC INTE, V5, P62, DOI 10.1161/CIRCINTERVENTIONS.111.966937; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Toth G, 2014, EUR HEART J; Toth G, 2013, CIRCULATION, V128, P1405, DOI 10.1161/CIRCULATIONAHA.113.002740; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; Ziada K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4099	29	701	732	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1208	1217		10.1056/NEJMoa1408758	http://dx.doi.org/10.1056/NEJMoa1408758			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4WH	25176289	Green Published			2022-12-28	WOS:000342079700008
J	Ortega, HG; Liu, MC; Pavord, ID; Brusselle, GG; FitzGerald, JM; Chetta, A; Humbert, M; Katz, LE; Keene, ON; Yancey, SW; Chanez, P				Ortega, Hector G.; Liu, Mark C.; Pavord, Ian D.; Brusselle, Guy G.; FitzGerald, J. Mark; Chetta, Alfredo; Humbert, Marc; Katz, Lynn E.; Keene, Oliver N.; Yancey, Steven W.; Chanez, Pascal		MENSA Investigators	Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXACERBATION RATES; ATOPIC ASTHMATICS; END-POINTS; PHENOTYPES; STATEMENT; TRISTAN; THERAPY; ADULTS	BACKGROUND Some patients with severe asthma have frequent exacerbations associated with persistent eosinophilic inflammation despite continuous treatment with high-dose inhaled glucocorticoids with or without oral glucocorticoids. METHODS In this randomized, double-blind, double-dummy study, we assigned 576 patients with recurrent asthma exacerbations and evidence of eosinophilic inflammation despite high doses of inhaled glucocorticoids to one of three study groups. Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks. The primary outcome was the rate of exacerbations. Other outcomes included the forced expiratory volume in 1 second (FEV1) and scores on the St. George's Respiratory Questionnaire (SGRQ) and the 5-item Asthma Control Questionnaire (ACQ-5). Safety was also assessed. RESULTS The rate of exacerbations was reduced by 47% (95% confidence interval [CI], 29 to 61) among patients receiving intravenous mepolizumab and by 53% (95% CI, 37 to 65) among those receiving subcutaneous mepolizumab, as compared with those receiving placebo (P<0.001 for both comparisons). Exacerbations necessitating an emergency department visit or hospitalization were reduced by 32% in the group receiving intravenous mepolizumab and by 61% in the group receiving subcutaneous mepolizumab. At week 32, the mean increase from baseline in FEV1 was 100 ml greater in patients receiving intravenous mepolizumab than in those receiving placebo (P = 0.02) and 98 ml greater in patients receiving subcutaneous mepolizumab than in those receiving placebo (P = 0.03). The improvement from baseline in the SGRQ score was 6.4 points and 7.0 points greater in the intravenous and subcutaneous mepolizumab groups, respectively, than in the placebo group (minimal clinically important change, 4 points), and the improvement in the ACQ-5 score was 0.42 points and 0.44 points greater in the two mepolizumab groups, respectively, than in the placebo group (minimal clinically important change, 0.5 points) (P < 0.001 for all comparisons). The safety profile of mepolizumab was similar to that of placebo. CONCLUSIONS Mepolizumab administered either intravenously or subcutaneously significantly reduced asthma exacerbations and was associated with improvements in markers of asthma control.	[Ortega, Hector G.; Katz, Lynn E.; Yancey, Steven W.] GlaxoSmithKline, Resp Therapeut Area Unit, Res Triangle Pk, NC USA; [Liu, Mark C.] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford OX1 2JD, England; [Keene, Oliver N.] GlaxoSmithKline, Clin Stat, Stockley Pk, Middx, England; [Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [FitzGerald, J. Mark] Inst Heart & Lung Hlth, Lung Ctr, Vancouver, BC, Canada; [Chetta, Alfredo] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Humbert, Marc] Univ Paris Sud, Hop Bicetre, Serv Pneumol, AP HP,Dept Hosp Univ Thorax Innovat, F-94275 Le Kremlin Bicetre, France; [Humbert, Marc] INSERM, Unite Mixte Rech 999, F-94275 Le Kremlin Bicetre, France; [Chanez, Pascal] Aix Marseille Univ, Unites Mixtes Rech, INSERM, Unite 1067,Ctr Natl Rech Sci 7733, Marseille, France; [Chanez, Pascal] Aix Marseille Univ, Dept Resp Dis, Marseille, France; [Chanez, Pascal] Aix Marseille Univ, Clin Invest Ctr, AP HP, Hop Nord,Hop Marseille, Marseille, France	GlaxoSmithKline; Johns Hopkins University; Johns Hopkins Medicine; University of Oxford; GlaxoSmithKline; Ghent University; Ghent University Hospital; University of Parma; University Hospital of Parma; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ortega, HG (corresponding author), GlaxoSmithKline, 5 Moore Dr,POB 5-3317-3A, Res Triangle Pk, NC 27709 USA.	hector.g.ortega@gsk.com	Humbert, Marc/AAC-8459-2019; Humbert, Marc/ABD-5112-2021; RAMOS-BARBON, DAVID/C-6624-2009	Humbert, Marc/0000-0003-0703-2892; RAMOS-BARBON, DAVID/0000-0002-9615-6557; Brusselle, Guy/0000-0001-7021-8505; Keene, Oliver/0000-0003-0016-9773; chanez, pascal/0000-0003-4059-0917; , Sandhya/0000-0002-3167-1152; Pavord, Ian/0000-0002-4288-5973; Chetta, Alfredo/0000-0002-0416-5334	GlaxoSmithKline; MRC [G0800649] Funding Source: UKRI; Medical Research Council [G0800649] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10157] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by GlaxoSmithKline; MENSA ClinicalTrials.gov number, NCT01691521.	Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; Custovic A, 2013, ALLERGY, V68, P1520, DOI 10.1111/all.12275; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Haldar P, 2014, J ALLERGY CLIN IMMUN, V133, P921, DOI 10.1016/j.jaci.2013.11.026; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; Keene ON, 2007, PHARM STAT, V6, P89, DOI 10.1002/pst.250; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Menzies-Gow A, 2003, J ALLERGY CLIN IMMUN, V111, P714, DOI 10.1067/mai.2003.1382; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Omachi TA, 2008, ANN ALLERG ASTHMA IM, V101, P130, DOI 10.1016/S1081-1206(10)60200-1; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Stone A, 2013, PHARM STAT, V12, P189, DOI 10.1002/pst.1574; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	20	1336	1379	1	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1198	1207		10.1056/NEJMoa1403290	http://dx.doi.org/10.1056/NEJMoa1403290			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP4WH	25199059	Green Published			2022-12-28	WOS:000342079700007
J	Lambert, CH; Mangin, S; Varaprasad, BSDCS; Takahashi, YK; Hehn, M; Cinchetti, M; Malinowski, G; Hono, K; Fainman, Y; Aeschlimann, M; Fullerton, EE				Lambert, C-H; Mangin, S.; Varaprasad, B. S. D. Ch S.; Takahashi, Y. K.; Hehn, M.; Cinchetti, M.; Malinowski, G.; Hono, K.; Fainman, Y.; Aeschlimann, M.; Fullerton, E. E.			All-optical control of ferromagnetic thin films and nanostructures	SCIENCE			English	Article							MAGNETIZATION REVERSAL; ULTRAFAST	The interplay of light and magnetism allowed light to be used as a probe of magnetic materials. Now the focus has shifted to use polarized light to alter or manipulate magnetism. Here, we demonstrate optical control of ferromagnetic materials ranging from magnetic thin films to multilayers and even granular films being explored for ultra-high-density magnetic recording. Our finding shows that optical control of magnetic materials is a much more general phenomenon than previously assumed and may have a major impact on data memory and storage industries through the integration of optical control of ferromagnetic bits.	[Lambert, C-H; Mangin, S.; Fullerton, E. E.] Univ Calif San Diego, Ctr Magnet Recording Res, La Jolla, CA 92093 USA; [Lambert, C-H; Mangin, S.; Hehn, M.; Malinowski, G.] Univ Lorraine, CNRS, UMR 7198, Inst Jean Lamour, F-54506 Vandoeuvre Les Nancy, France; [Varaprasad, B. S. D. Ch S.; Takahashi, Y. K.; Hono, K.] Natl Inst Mat Sci, Magnet Mat Unit, Tsukuba, Ibaraki 3050047, Japan; [Cinchetti, M.; Aeschlimann, M.] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany; [Cinchetti, M.; Aeschlimann, M.] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany; [Fainman, Y.; Fullerton, E. E.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine; National Institute for Materials Science; University of Kaiserslautern; University of Kaiserslautern; University of California System; University of California San Diego	Mangin, S (corresponding author), Univ Calif San Diego, Ctr Magnet Recording Res, La Jolla, CA 92093 USA.	stephane.mangin@univ-lorraine.fr; efullerton@ucsd.edu	Mangin, Stephane/S-9013-2019; Cinchetti, Mirko/F-9769-2010; Aeschlimann, Martin/D-7141-2011; Hono, Kazuhiro/B-9202-2008; HEHN, Michel/N-1038-2015; Fullerton, Eric E/H-8445-2013; Malinowski, Gregory/E-2867-2016; TAKAHASHI, Yukiko K/H-2961-2011	Mangin, Stephane/0000-0001-6046-0437; Cinchetti, Mirko/0000-0003-0735-8921; Aeschlimann, Martin/0000-0003-3413-5029; Hono, Kazuhiro/0000-0001-7367-0193; HEHN, Michel/0000-0002-4240-5925; Fullerton, Eric E/0000-0002-4725-9509; Malinowski, Gregory/0000-0003-1469-7438; TAKAHASHI, Yukiko K/0000-0001-9197-7236	Agence Nationale de la Recherche (ANR) [ANR-10-BLANC-1005]; Office of Naval Research (ONR) Multidisciplinary University Initiative (MURI) program; Advanced Storage Technology Consortium; Partner University Fund " Novel Magnetic Materials for Spin Torque Physics"; European Project [OP2M FP7-IOF-2011-298060]; Region Lorraine	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Office of Naval Research (ONR) Multidisciplinary University Initiative (MURI) program; Advanced Storage Technology Consortium; Partner University Fund " Novel Magnetic Materials for Spin Torque Physics"; European Project; Region Lorraine(Region Grand-Est)	We thank R. Tolley and M. Gottwald for help on sample fabrication and M. Menarini and V. Lomakin for helpful discussions. This work was supported by the Agence Nationale de la Recherche (ANR), ANR-10-BLANC-1005 "Friends," and work at University of California San Diego was supported by the Office of Naval Research (ONR) Multidisciplinary University Initiative (MURI) program and a grant from the Advanced Storage Technology Consortium. It was also supported by the Partner University Fund " Novel Magnetic Materials for Spin Torque Physics" as well as the European Project (OP2M FP7-IOF-2011-298060) and the Region Lorraine. Work at the National Institute for Materials Science was supported by Advanced Storage Technology Consortium. Author contributions include the following: S.M., M.A., M.C., Y.S., and E.E.F. designed and coordinated the project; C.-H. L. grew, characterized, and optimized the thin films samples, while B.S.D.Ch.S.V., Y.K.T., and K.H. developed and grew the FePt-based granular media. C.-H.L., S.M., and Y.K.T. operated the Kerr microscope and the pump laser experiment. S. M. and E. E. F. coordinated work on the paper with contributions from C.-H.L, M.H., M.C., and G.M., with regular discussions with all authors.	Alebrand S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4759109; Alebrand S, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.092401; Back CH, 1999, SCIENCE, V285, P864, DOI 10.1126/science.285.5429.864; Battiato M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.027203; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Graves CE, 2013, NAT MATER, V12, P293, DOI [10.1038/NMAT3597, 10.1038/nmat3597]; Hassdenteufel A, 2013, ADV MATER, V25, P3122, DOI 10.1002/adma.201300176; Hellwig O, 2007, J MAGN MAGN MATER, V319, P13, DOI 10.1016/j.jmmm.2007.04.035; Kirilyuk A, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/2/026501; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Koopmans B, 2010, NAT MATER, V9, P259, DOI [10.1038/NMAT2593, 10.1038/nmat2593]; Kryder MH, 2008, P IEEE, V96, P1810, DOI 10.1109/JPROC.2008.2004315; Malinowski G, 2008, NAT PHYS, V4, P855, DOI 10.1038/nphys1092; Mangin S, 2014, NAT MATER, V13, P287, DOI [10.1038/NMAT3864, 10.1038/nmat3864]; Mariager SO, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.087201; Mentink JH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.057202; Moser A, 2002, J PHYS D APPL PHYS, V35, pR157, DOI 10.1088/0022-3727/35/19/201; Ostler TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1666; Radu I, 2011, NATURE, V472, P205, DOI 10.1038/nature09901; Richter HJ, 2012, J APPL PHYS, V111, DOI 10.1063/1.3681297; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047601; Stanciu CD, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.220402; Stipe BC, 2010, NAT PHOTONICS, V4, P484, DOI 10.1038/nphoton.2010.90; Turgut E, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.039901; Turgut E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.197201; Vahaplar K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.104402; VANDERZIEL JP, 1965, PHYS REV LETT, V15, P190, DOI 10.1103/PhysRevLett.15.190; Varaprasad BSDCS, 2013, IEEE T MAGN, V49, P718, DOI 10.1109/TMAG.2012.2218227; Zhang L, 2011, J APPL PHYS, V109, DOI 10.1063/1.3536794	30	424	429	31	456	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1337	1340		10.1126/science.1253493	http://dx.doi.org/10.1126/science.1253493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25147280	Green Submitted			2022-12-28	WOS:000341483800062
J	Field, JK				Field, John K.			The screening imperative	NATURE			English	Editorial Material									[Field, John K.] Univ Liverpool, Canc Res Ctr, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Field, JK (corresponding author), Univ Liverpool, Canc Res Ctr, Liverpool L69 3BX, Merseyside, England.	J.K.Field@liv.ac.uk	Field, John K./AAD-5674-2020	Field, John K./0000-0003-3951-6365	National Institute for Health Research [09/61/501, 07/82/01, 09/61/01] Funding Source: researchfish; Department of Health [07/82/01, 09/61/01, 09/61/501] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Duffy SW, 2014, BRIT J CANCER, V110, P1834, DOI 10.1038/bjc.2014.63; Field JK, 2013, LANCET ONCOL, V14, pE591, DOI 10.1016/S1470-2045(13)70293-6; Field JK, 2013, LANCET, V382, P732, DOI 10.1016/S0140-6736(13)61614-1; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; McRonald FE, 2014, CANCER PREV RES, V7, P362, DOI 10.1158/1940-6207.CAPR-13-0206; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085	7	17	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S7	S7		10.1038/513S7a	http://dx.doi.org/10.1038/513S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5DP	25208072				2022-12-28	WOS:000341362800004
J	Sacks, CA; Jarcho, JA; Curfman, GD				Sacks, Chana A.; Jarcho, John A.; Curfman, Gregory D.			Paradigm Shifts in Heart-Failure Therapy - A Timeline	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	74	75	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					989	991		10.1056/NEJMp1410241	http://dx.doi.org/10.1056/NEJMp1410241			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25184412				2022-12-28	WOS:000341382800004
J	Nieuwenhuijse, MJ; Nelissen, RGHH; Schoones, JW; Sedrakyan, A				Nieuwenhuijse, Marc J.; Nelissen, R. G. H. H.; Schoones, J. W.; Sedrakyan, A.			Appraisal of evidence base for introduction of new implants in hip and knee replacement: a systematic review of five widely used device technologies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							METAL-ON-METAL; NATIONAL JOINT REGISTRY; IDEAL FRAMEWORK; MEDICAL DEVICES; ARTHROPLASTY; RISK; METAANALYSIS; REVISION; FAILURE	Objective To determine the evidence of effectiveness and safety for introduction of five recent and ostensibly high value implantable devices in major joint replacement to illustrate the need for change and inform guidance on evidence based introduction of new implants into healthcare. Design Systematic review of clinical trials, comparative observational studies, and registries for comparative effectiveness and safety of five implantable device innovations. Data sources PubMed (Medline), Embase, Web of Science, Cochrane, CINAHL, reference lists of articles, annual reports of major registries, summaries of safety and effectiveness for pre-market application and mandated post-market studies at the US Food and Drug Administration. Study selection The five selected innovations comprised three in total hip replacement (ceramic-on-ceramic bearings, modular femoral necks, and uncemented monoblock cups) and two in total knee replacement (high flexion knee replacement and gender specific knee replacement). All clinical studies of primary total hip or knee replacement for symptomatic osteoarthritis in adults that compared at least one of the clinical outcomes of interest (patient centred outcomes or complications, or both) in the new implant group and control implant group were considered. Data searching, abstraction, and analysis were independently performed and confirmed by at least two authors. Quantitative data syntheses were performed when feasible. Results After assessment of 10 557 search hits, 118 studies (94 unique study cohorts) met the inclusion criteria and reported data related to 15 384 implants in 13 164 patients. Comparative evidence per device innovation varied from four low to moderate quality retrospective studies (modular femoral necks) to 56 studies of varying quality including seven high quality (randomised) studies (high flexion knee replacement). None of the five device innovations was found to improve functional or patient reported outcomes. National registries reported two to 12 year follow-up for revision occurrence related to more than 200 000 of these implants. Reported comparative data with well established alternative devices (over 1 200 000 implants) did not show improved device survival. Moreover, we found higher revision occurrence associated with modular femoral necks (hazard ratio 1.9) and ceramic-on-ceramic bearings (hazard ratio 1.0-1.6) in hip replacement and with high flexion knee implants (hazard ratio 1.0-1.8). Conclusion We did not find convincing high quality evidence supporting the use of five substantial, well known, and already implemented device innovations in orthopaedics. Moreover, existing devices may be safer to use in total hip or knee replacement. Improved regulation and professional society oversight are necessary to prevent patients from being further exposed to these and future innovations introduced without proper evidence of improved clinical efficacy and safety.	[Nieuwenhuijse, Marc J.; Sedrakyan, A.] Weill Cornell Med Coll, Patient Ctr Comparat Effectiveness Program, New York, NY 10065 USA; [Nieuwenhuijse, Marc J.; Sedrakyan, A.] Weill Cornell Med Coll, US FDA, Med Device Epidemiol Sci & Infrastructure Ctr, Dept Publ Hlth, New York, NY 10065 USA; [Nieuwenhuijse, Marc J.; Nelissen, R. G. H. H.] Leiden Univ, Med Ctr, Dept Orthopaed, NL-2300 RC Leiden, Netherlands; [Nieuwenhuijse, Marc J.; Sedrakyan, A.] US FDA, Ctr Devices & Radiol Hlth, Off Surveillance & Biometr, Silver Spring, MD 20993 USA; [Schoones, J. W.] Leiden Univ, Walaeus Lib, Med Ctr, NL-2300 RC Leiden, Netherlands	Cornell University; Cornell University; US Food & Drug Administration (FDA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; US Food & Drug Administration (FDA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sedrakyan, A (corresponding author), Weill Cornell Med Coll, Patient Ctr Comparat Effectiveness Program, New York, NY 10065 USA.	ars2013@med.cornell.edu	Schoones, Johannes Wilhelmus/B-2837-2008; Nelissen, Rob/AAD-8134-2020	Schoones, Johannes Wilhelmus/0000-0003-1120-4781; Nelissen, Rob/0000-0003-1228-4162	US FDA Medical Device Epidemiology Network's (MDEpiNet) Science and Infrastructure Center under the International Consortium of Orthopaedic Registries initiative (ICOR); US FDA	US FDA Medical Device Epidemiology Network's (MDEpiNet) Science and Infrastructure Center under the International Consortium of Orthopaedic Registries initiative (ICOR); US FDA(United States Department of Health & Human Services)	MJN received a fellowship from the US FDA Medical Device Epidemiology Network's (MDEpiNet) Science and Infrastructure Center (director AS) under the International Consortium of Orthopaedic Registries initiative (ICOR, www.icor-initiative.org). AS received funding from the US FDA for establishing the MDEpiNet Science and Infrastructure Center and is the principal investigator of ICOR contract. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Bozic KJ, 2012, J ARTHROPLASTY, V27, P37, DOI 10.1016/j.arth.2012.03.031; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ergina PL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3011; Godlee F., 2011, BMJ-BRIT MED J, V342, pd3123, DOI DOI 10.1136/BMJ.D3123; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horton R, 2012, LANCET, V379, P204, DOI 10.1016/S0140-6736(12)60070-1; Howard JL, 2011, J BONE JOINT SURG AM, V93A, P1597, DOI 10.2106/JBJS.J.00195; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; ICOR Collaborators, 2011, J BONE JOINT S A S3E, V93-A, P1; ICOR Collaborators, 2011, J BONE JOINT S A S3E, V93-A, P43; Jameson SS, 2013, BONE JOINT J, V95B, P747, DOI 10.1302/0301-620X.95B6.31378; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malchau H, 2000, SPINE, V25, P285, DOI 10.1097/00007632-200002010-00004; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3012; McCulloch P, 2012, LANCET, V380, P729, DOI 10.1016/S0140-6736(12)61405-6; Meier B., 2011, NY TIMES; MHRA, 2012, MED DEV AL ALL MET O; Namba RS, 2014, BONE JOINT J, V96B, P217, DOI 10.1302/0301-620X.96B2.32625; Namba RS, 2013, J ARTHROPLASTY, V28, P122, DOI 10.1016/j.arth.2013.04.050; Namba Robert S, 2011, J Bone Joint Surg Am, V93 Suppl 3, P48, DOI 10.2106/JBJS.K.00982; Nelissen Rob G H H, 2011, J Bone Joint Surg Am, V93 Suppl 3, P62, DOI 10.2106/JBJS.K.00907; O'Dowd A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e11; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Sedrakyan A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7434; Skinner JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8188; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; US Food and Drug Administration (FDA), NAT MED DEV POSTM SU; Valstar E, 2012, ACTA ORTHOP, V83, P103, DOI 10.3109/17453674.2012.678796; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weiss RJ, 2012, ACTA ORTHOP, V83, P214, DOI 10.3109/17453674.2012.688726	40	50	51	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2014	349								g5133	10.1136/bmj.g5133	http://dx.doi.org/10.1136/bmj.g5133			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QM	25208953	Green Published, hybrid			2022-12-28	WOS:000341691000001
J	Villar, J; Ismail, LC; Victora, CG; Ohuma, EO; Bertino, E; Altman, DG; Lambert, A; Papageorghiou, AT; Carvalho, M; Jaffer, YA; Gravett, MG; Purwar, M; Frederick, IO; Noble, AJ; Pang, RY; Barros, FC; Chumlea, C; Bhutta, ZA; Kennedy, SH				Villar, Jose; Ismail, Leila Cheikh; Victora, Cesar G.; Ohuma, Eric O.; Bertino, Enrico; Altman, Doug G.; Lambert, Ann; Papageorghiou, Aris T.; Carvalho, Maria; Jaffer, Yasmin A.; Gravett, Michael G.; Purwar, Manorama; Frederick, Ihunnaya O.; Noble, Alison J.; Pang, Ruyan; Barros, Fernando C.; Chumlea, Cameron; Bhutta, Zulfiqar A.; Kennedy, Stephen H.		Int Fetal Newborn Growth	International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; CHILD GROWTH; CENTILE CURVES; T-DISTRIBUTION; LMS METHOD; PRETERM; IMPLEMENTATION; CONSTRUCTION; FETAL; SKEWNESS	Background In 2006, WHO published international growth standards for children younger than 5 years, which are now accepted worldwide. In the INTERGROWTH-21st Project, our aim was to complement them by developing international standards for fetuses, newborn infants, and the postnatal growth period of preterm infants. Methods INTERGROWTH-21st is a population-based project that assessed fetal growth and newborn size in eight geographically defined urban populations. These groups were selected because most of the health and nutrition needs of mothers were met, adequate antenatal care was provided, and there were no major environmental constraints on growth. As part of the Newborn Cross-Sectional Study (NCSS), a component of INTERGROWTH-21st Project, we measured weight, length, and head circumference in all newborn infants, in addition to collecting data prospectively for pregnancy and the perinatal period. To construct the newborn standards, we selected all pregnancies in women meeting (in addition to the underlying population characteristics) strict individual eligibility criteria for a population at low risk of impaired fetal growth (labelled the NCSS prescriptive subpopulation). Women had a reliable ultrasound estimate of gestational age using crown-rump length before 14 weeks of gestation or biparietal diameter if antenatal care started between 14 weeks and 24 weeks or less of gestation. Newborn anthropometric measures were obtained within 12 h of birth by identically trained anthropometric teams using the same equipment at all sites. Fractional polynomials assuming a skewed t distribution were used to estimate the fitted centiles. Findings We identified 20 486 (35%) eligible women from the 59 137 pregnant women enrolled in NCSS between May 14, 2009, and Aug 2, 2013. We calculated sex-specific observed and smoothed centiles for weight, length, and head circumference for gestational age at birth. The observed and smoothed centiles were almost identical. We present the 3rd, 10th, 50th, 90th, and 97th centile curves according to gestational age and sex. Interpretation We have developed, for routine clinical practice, international anthropometric standards to assess newborn size that are intended to complement the WHO Child Growth Standards and allow comparisons across multiethnic populations.	[Villar, Jose; Ismail, Leila Cheikh; Ohuma, Eric O.; Lambert, Ann; Papageorghiou, Aris T.; Kennedy, Stephen H.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Green Templeton Coll, Oxford OX3 9DU, England; [Villar, Jose; Ismail, Leila Cheikh; Ohuma, Eric O.; Lambert, Ann; Papageorghiou, Aris T.; Kennedy, Stephen H.] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Green Templeton Coll, Oxford OX3 9DU, England; [Ohuma, Eric O.; Altman, Doug G.] Univ Oxford, Ctr Stat Med, Botnar Res Ctr, Oxford, England; [Noble, Alison J.] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Victora, Cesar G.; Barros, Fernando C.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, Brazil; [Bertino, Enrico] Univ Turin, Dipartimento Sci Pediat & Adolescenza, Cattedra Neonatol, Turin, Italy; [Carvalho, Maria] Aga Khan Univ, Fac Hlth Sci, Nairobi, Kenya; [Jaffer, Yasmin A.] Minist Hlth, Dept Family & Community Hlth, Muscat, Oman; [Gravett, Michael G.] Univ Washington, Sch Med, Seattle, WA USA; [Purwar, Manorama] Ketkar Hosp, Nagpur INTERGROWTH 21st Res Ctr, Nagpur, Maharashtra, India; [Frederick, Ihunnaya O.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA; [Pang, Ruyan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Barros, Fernando C.] Univ Catolica Pelotas, Programa Posgrad Saude Comportamento, Pelotas, Brazil; [Chumlea, Cameron] Wright State Univ, Lifespan Hlth Res Ctr, Boonshoft Sch Med, Dayton, OH 45435 USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Hlth, Toronto, ON M5G 1X8, Canada	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Universidade Federal de Pelotas; University of Turin; Aga Khan University; University of Washington; University of Washington Seattle; Swedish Medical Center; Peking University; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; University System of Ohio; Wright State University Dayton; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Villar, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	jose.villar@obs-gyn.ox.ac.uk	Sanchez Luna, Manuel/H-2165-2014; Victora, Cesar G/D-4476-2013; Matijasevich, Alicia/C-5576-2009; Victora, Cesar Gomes/Y-2455-2019; Domingues, Marlos/A-4758-2009	Sanchez Luna, Manuel/0000-0001-9543-7392; Victora, Cesar G/0000-0002-2465-2180; Matijasevich, Alicia/0000-0003-0060-1589; Victora, Cesar Gomes/0000-0002-2465-2180; BERTINO, Enrico/0000-0002-6369-9352; Barros, Fernando/0000-0001-5973-1746; Sarris, Ippokratis/0000-0002-8912-5920; Napolitano, Raffaele/0000-0001-9434-7678; Giuliani, Francesca/0000-0002-4265-207X; Todros, Tullia/0000-0003-3016-1510; Papageorghiou, Aris T./0000-0001-8143-2232; Noble, Alison/0000-0002-3060-3772; Domingues, Marlos/0000-0002-2503-2944; Cheikh Ismail, Leila/0000-0003-3048-7481; Ioannou, Christos/0000-0002-3147-6613	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertino E, 2007, ARCH DIS CHILD-FETAL, V92, pF7, DOI 10.1136/adc.2006.096214; Bertino E, 2009, ARCH DIS CHILD-FETAL, V94, pF233, DOI 10.1136/adc.2008.152322; Bhutta ZA, 2013, BJOG-INT J OBSTET GY, V120, P56, DOI 10.1111/1471-0528.12312; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; COLE TJ, 1988, J R STAT SOC A STAT, V151, P385, DOI 10.2307/2982992; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; COLE TJ, 1989, ANN HUM BIOL, V16, P407, DOI 10.1080/03014468900000532; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2013, WORLD REV NUTR DIET, V106, P75, DOI 10.1159/000342550; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Eskenazi B, 2013, BJOG-INT J OBSTET GY, V120, P129, DOI 10.1111/1471-0528.12430; Ferdynus C, 2009, PEDIATRICS, V123, P723, DOI 10.1542/peds.2007-2564; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Green P.J., 1993, NONPARAMETRIC REGRES, DOI [10.1201/b15710, DOI 10.1201/B15710]; Hynek M, 2010, EUR J BIOMED INFORM, V6, P51; Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P42, DOI 10.1111/1471-0528.12125; Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P48, DOI 10.1111/1471-0528.12127; Jones MC, 2003, J R STAT SOC B, V65, P159, DOI 10.1111/1467-9868.00378; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kramer MS, 2013, LANCET GLOB HEALTH, V1, pE7, DOI 10.1016/S2214-109X(13)70014-7; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; McDonald Susan J, 2013, Cochrane Database Syst Rev, pCD004074, DOI 10.1002/14651858.CD004074.pub3; Ohuma EO, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/1471-0528.12080; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Royston P, 2000, STAT MED, V19, P2943, DOI 10.1002/1097-0258(20001115)19:21<2943::AID-SIM559>3.0.CO;2-5; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Salomon LJ, 2007, ULTRASOUND OBST GYN, V29, P550, DOI 10.1002/uog.4019; Stasinopoulos D. M., 2007, J STAT SOFTW, V23, P1, DOI [DOI 10.18637/JSS.V023.I07, 10.18637/jss.v023.i07.]; Team RC., 2022, LANG ENV STAT COMP; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; Villar J, 2010, ARCH DIS CHILD, V95, P1034, DOI 10.1136/adc.2009.175067; Villar J, 2014, LANCET DIABETES ENDO; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Villar J, 2012, AM J OBSTET GYNECOL, V206, P119, DOI 10.1016/j.ajog.2011.10.866; WHO, 1995, PHYS STAT US INT ANT, V854, P1; World Health Organization, 2009, DEV MED CHILD NEUROL, V51, P1002; Wright EM, 1997, J R STAT SOC A STAT, V160, P47, DOI 10.1111/1467-985X.00045; Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281	53	1064	1108	7	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					857	868		10.1016/S0140-6736(14)60932-6	http://dx.doi.org/10.1016/S0140-6736(14)60932-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	25209487				2022-12-28	WOS:000341362200028
J	Tam, JCH; Bidgood, SR; McEwan, WA; James, LC				Tam, Jerry C. H.; Bidgood, Susanna R.; McEwan, William A.; James, Leo C.			Intracellular sensing of complement C3 activates cell autonomous immunity	SCIENCE			English	Article							NF-KAPPA-B; ENTERICA SEROVAR TYPHIMURIUM; ANTIVIRAL ACTIVITY; VIRUS; ADENOVIRUS; PROTEIN; INNATE; IDENTIFICATION; INHIBITOR; MAVS	Pathogens traverse multiple barriers during infection, including cell membranes. We found that during this transition, pathogens carried covalently attached complement C3 into the cell, triggering immediate signaling and effector responses. Sensing of C3 in the cytosol activated mitochondrial antiviral signaling (MAVS)-dependent signaling cascades and induced proinflammatory cytokine secretion. C3 also flagged viruses for rapid proteasomal degradation, preventing their replication. This system could detect both viral and bacterial pathogens but was antagonized by enteroviruses, such as rhinovirus and poliovirus, which cleave C3 using their 3C protease. The antiviral rupintrivir inhibited 3C protease and prevented C3 cleavage, rendering enteroviruses susceptible to intracellular complement sensing. Thus, complement C3 allows cells to detect and disable pathogens that have invaded the cytosol.	[Tam, Jerry C. H.; Bidgood, Susanna R.; McEwan, William A.; James, Leo C.] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	James, LC (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	lcj@mrc-lmb.cam.ac.uk	; Tam, Jerry/P-1995-2014	McEwan, William/0000-0002-4408-0407; Bidgood, Susanna/0000-0002-0426-6565; Tam, Jerry/0000-0001-7991-1568	Medical Research Council (UK) [U105181010]; European Research Council [281627IAI]; Frank Edward Elmore Fund of the University of Cambridge School of Clinical Medicine; Medical Research Council [MC_U105181010] Funding Source: researchfish; MRC [MC_U105181010] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Frank Edward Elmore Fund of the University of Cambridge School of Clinical Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank I. Goodfellow for the kind gift of reagents, including the Caco-2 cell line, human Astrovirus-1 infectious clone pAVIC, and PV 3C protease. This work was funded by the Medical Research Council (UK; U105181010), the European Research Council (281627IAI), and the Frank Edward Elmore Fund of the University of Cambridge School of Clinical Medicine (J.C.H.T.). The data are presented in the main manuscript and the supplementary materials.	Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099; Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Bode J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050327; Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Buck C. B., 2007, CURR PROTOC CELL BIO, V26, P261; CAME PE, 1976, J INFECT DIS, V133, pA136, DOI 10.1093/infdis/133.Supplement_2.A136; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Costabile Maurizio, 2010, J Vis Exp, DOI 10.3791/1923; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; Favoreel HW, 2003, J GEN VIROL, V84, P1, DOI 10.1099/vir.0.18709-0; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; FRITZINGER DC, 1994, P NATL ACAD SCI USA, V91, P12775, DOI 10.1073/pnas.91.26.12775; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; GALLAGHER JG, 1972, INFECT IMMUN, V5, P905, DOI 10.1128/IAI.5.6.905-908.1972; Geigenmuller U, 1997, J VIROL, V71, P1713; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Harris CL, 2000, IMMUNOLOGY, V100, P462, DOI 10.1046/j.1365-2567.2000.00066.x; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Hauler F, 2012, P NATL ACAD SCI USA, V109, P19733, DOI 10.1073/pnas.1210659109; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; HOULE JJ, 1984, J IMMUNOL, V133, P1444; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; McEwan WA, 2012, J VIROL, V86, P8482, DOI 10.1128/JVI.00728-12; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Meiffren G, 2010, AUTOPHAGY, V6, P299, DOI 10.4161/auto.6.2.11132; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Patick AK, 1999, ANTIMICROB AGENTS CH, V43, P2444, DOI 10.1128/AAC.43.10.2444; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Schober D, 1998, J VIROL, V72, P1354, DOI 10.1128/JVI.72.2.1354-1364.1998; Seitsonen JJT, 2012, J VIROL, V86, P7207, DOI 10.1128/JVI.06425-11; SETH P, 1994, BIOCHEM BIOPH RES CO, V205, P1318, DOI 10.1006/bbrc.1994.2809; SETH P, 1994, J VIROL, V68, P933, DOI 10.1128/JVI.68.2.933-940.1994; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Vaysburd M, 2013, P NATL ACAD SCI USA, V110, P12397, DOI 10.1073/pnas.1301918110; VOGEL CW, 1984, J IMMUNOL METHODS, V73, P203, DOI 10.1016/0022-1759(84)90045-0; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang YT, 2012, IMMUNOLOGY, V136, P78, DOI 10.1111/j.1365-2567.2012.03561.x; Watkinson RE, 2013, J VIROL, V87, P7309, DOI 10.1128/JVI.00647-13; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Zalman LS, 2000, ANTIMICROB AGENTS CH, V44, P1236, DOI 10.1128/AAC.44.5.1236-1241.2000; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	57	101	103	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1134	+	1256070	10.1126/science.1256070	http://dx.doi.org/10.1126/science.1256070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6ZI	25190799	Green Accepted			2022-12-28	WOS:000349775200001
J	Benboubker, L; Dimopoulos, MA; Dispenzieri, A; Catalano, J; Belch, AR; Cavo, M; Pinto, A; Weisel, K; Ludwig, H; Bahlis, N; Banos, A; Tiab, M; Delforge, M; Cavenagh, J; Geraldes, C; Lee, JJ; Chen, C; Oriol, A; de la Rubia, J; Qiu, LG; White, DJ; Binder, D; Anderson, K; Fermand, JP; Moreau, P; Attal, M; Knight, R; Chen, G; Van Oostendorp, J; Jacques, C; Ervin-Haynes, A; Avet-Loiseau, H; Hulin, C; Facon, T				Benboubker, Lotfi; Dimopoulos, Meletios A.; Dispenzieri, Angela; Catalano, John; Belch, Andrew R.; Cavo, Michele; Pinto, Antonello; Weisel, Katja; Ludwig, Heinz; Bahlis, Nizar; Banos, Anne; Tiab, Mourad; Delforge, Michel; Cavenagh, Jamie; Geraldes, Catarina; Lee, Je-Jung; Chen, Christine; Oriol, Albert; de la Rubia, Javier; Qiu, Lugui; White, Darrell J.; Binder, Daniel; Anderson, Kenneth; Fermand, Jean-Paul; Moreau, Philippe; Attal, Michel; Knight, Robert; Chen, Guang; Van Oostendorp, Jason; Jacques, Christian; Ervin-Haynes, Annette; Avet-Loiseau, Herve; Hulin, Cyrille; Facon, Thierry		FIRST Trial Team	Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREDNISONE PLUS THALIDOMIDE; STEM-CELL TRANSPLANTATION; BORTEZOMIB-MELPHALAN-PREDNISONE; DIAGNOSED MULTIPLE-MYELOMA; QUALITY-OF-LIFE; ELDERLY-PATIENTS; RESPONSE CRITERIA; INITIAL TREATMENT; ORAL MELPHALAN; PHASE-III	BACKGROUND The combination melphalan-prednisone-thalidomide (MPT) is considered a standard therapy for patients with myeloma who are ineligible for stem-cell transplantation. However, emerging data on the use of lenalidomide and low-dose dexamethasone warrant a prospective comparison of the two approaches. METHODS We randomly assigned 1623 patients to lenalidomide and dexamethasone in 28-day cycles until disease progression (535 patients), to the same combination for 72 weeks (18 cycles; 541 patients), or to MPT for 72 weeks (547 patients). The primary end point was progression-free survival with continuous lenalidomide-dexamethasone versus MPT. RESULTS The median progression-free survival was 25.5 months with continuous lenalidomide-dexamethasone, 20.7 months with 18 cycles of lenalidomide-dexamethasone, and 21.2 months with MPT (hazard ratio for the risk of progression or death, 0.72 for continuous lenalidomide-dexamethasone vs. MPT and 0.70 for continuous lenalidomide-dexamethasone vs. 18 cycles of lenalidomide-dexamethasone; P<0.001 for both comparisons). Continuous lenalidomide-dexamethasone was superior to MPT for all secondary efficacy end points, including overall survival (at the interim analysis). Overall survival at 4 years was 59% with continuous lenalidomide-dexamethasone, 56% with 18 cycles of lenalidomide-dexamethasone, and 51% with MPT. Grade 3 or 4 adverse events were somewhat less frequent with continuous lenalidomide-dexamethasone than with MPT (70% vs. 78%). As compared with MPT, continuous lenalidomide-dexamethasone was associated with fewer hematologic and neurologic toxic events, a moderate increase in infections, and fewer second primary hematologic cancers. CONCLUSIONS As compared with MPT, continuous lenalidomide-dexamethasone given until disease progression was associated with a significant improvement in progression-free survival, with an overall survival benefit at the interim analysis, among patients with newly diagnosed multiple myeloma who were ineligible for stem-cell transplantation.	[Benboubker, Lotfi] CHRU, Serv Hematol & Therapie Cellulaire, Hop Bretonneau, Tours, France; [Banos, Anne] Ctr Hosp Cote Basque, Bayonne, France; [Tiab, Mourad] Ctr Hosp Dept Oudairies, La Roche Sur Yon, France; [Fermand, Jean-Paul] Hop St Louis, Paris, France; [Moreau, Philippe] CHU Nantes, Serv Hematol, F-44035 Nantes 01, France; [Attal, Michel; Avet-Loiseau, Herve] CHRU Hop Purpan, Toulouse, France; [Hulin, Cyrille] CHU Nancy Brabois, Vandoeuvre Les Nancy, France; [Facon, Thierry] Ctr Hosp Reg Univ, Serv Malad Sang, Hop Claude Huriez, F-59037 Lille, France; [Dimopoulos, Meletios A.] Univ Athens, Sch Med, Athens, Greece; [Dispenzieri, Angela] Mayo Clin, Ctr Canc, Rochester, MN USA; [Catalano, John] Monash Univ, Frankston Hosp, Frankston, Vic, Australia; [Belch, Andrew R.] Univ Alberta, Edmonton, AB, Canada; [Belch, Andrew R.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Bahlis, Nizar] Univ Calgary, Calgary, AB, Canada; [Chen, Christine] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada; [White, Darrell J.] Dalhousie Univ, Halifax, NS, Canada; [White, Darrell J.] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Cavo, Michele] Univ Bologna, Sch Med, Seragnoli Inst Hematol, Bologna, Italy; [Pinto, Antonello] Ist Ricovero & Cura Carattere Sci, Unita Operat Complessa Ematol Oncol, Ist Nazl Tumori Fdn G Pascale, Naples, Italy; [Weisel, Katja] Univ Tubingen, Tubingen, Germany; [Ludwig, Heinz] Wilhelminenspital Stadt Wien, Dept Internal Med 1, Ctr Oncol & Hematol, Vienna, Austria; [Delforge, Michel] Univ Hosp Leuven, Leuven, Belgium; [Cavenagh, Jamie] Barts Hlth NHS Trust, Dept Haematol, St Bartholomews Hosp, London, England; [Geraldes, Catarina] Coimbra Univ Hosp, Dept Clin Hematol, Coimbra, Portugal; [Lee, Je-Jung] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol & Oncol, Hwasun, Jeollanamdo, South Korea; [Oriol, Albert] Inst Josep Carreras, Dept Clin Hematol, Inst Catal Oncol Hosp Germans Trias & Pujol, Barcelona, Spain; [de la Rubia, Javier] Hosp Univ La Fe, Valencia, Spain; [de la Rubia, Javier] Univ Catolica Valencia San Vicente Martir, Valencia, Spain; [Qiu, Lugui] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Qiu, Lugui] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Qiu, Lugui] Peking Union Med Coll, Tianjin, Peoples R China; [Binder, Daniel] Kantonsspital Winterthur, Winterthur, Switzerland; [Anderson, Kenneth] Dana Farber Canc Inst, Boston, MA 02115 USA; [Knight, Robert; Chen, Guang; Van Oostendorp, Jason; Jacques, Christian; Ervin-Haynes, Annette] Celgene, Summit, NJ USA	CHU Tours; CHD Vendee; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; CHU de Toulouse; CHU de Nancy; Universite de Lille - ISITE; CHU Lille; Athens Medical School; National & Kapodistrian University of Athens; Mayo Clinic; Frankston Hospital; Monash University; University of Alberta; University of Alberta; University of Calgary; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Bologna; IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Eberhard Karls University of Tubingen; Wilhelminenspital; KU Leuven; University Hospital Leuven; Barts Health NHS Trust; University of London; Queen Mary University London; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Chonnam National University; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Hospital Universitari i Politecnic La Fe; Universidad Catolica de Valencia San Vicente Martir; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Dana-Farber Cancer Institute; Bristol-Myers Squibb; Celgene Corporation	Facon, T (corresponding author), Ctr Hosp Reg Univ, Serv Malad Sang, Hop Claude Huriez, F-59037 Lille, France.	thierry.facon@chru-lille.fr	Salles, Gilles/Z-2336-2019; Pisani, Francesco/ABH-8545-2020; Kovacs, Michael/G-3315-2011; Oriol, Albert/K-9923-2017; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Avet-Loiseau, Herve/P-8872-2014; CAVO, MICHELE/AAK-8274-2020; Greil, Richard F/C-7673-2017; Ottmann, Oliver/D-5007-2016	Salles, Gilles/0000-0002-9541-8666; Pisani, Francesco/0000-0002-6853-5605; Oriol, Albert/0000-0001-6804-2221; Avet-Loiseau, Herve/0000-0002-3050-0140; CAVO, MICHELE/0000-0003-4514-3227; Greil, Richard F/0000-0002-4462-3694; Reu, Frederic/0000-0003-1160-8030; Geraldes, Catarina/0000-0001-8627-6187; moreau, philippe/0000-0003-1780-8746; Gonzalez, Marta Sonia/0000-0001-5494-9009; nahi, hareth/0000-0003-4711-5094; Bouscary, Didier/0000-0003-3654-5064; pierre, philippe/0000-0003-0863-8255; Dimopoulos, Meletios/0000-0001-8990-3254; de la Rubia, Javier/0000-0002-8354-768X; Dispenzieri, Angela/0000-0001-8780-9512; Ottmann, Oliver/0000-0001-9559-1330	Intergroupe Francophone du Myelome; Celgene; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Intergroupe Francophone du Myelome; Celgene(Bristol-Myers SquibbCelgene Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Intergroupe Francophone du Myelome and Celgene.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Beksac M, 2011, EUR J HAEMATOL, V86, P16, DOI 10.1111/j.1600-0609.2010.01524.x; Cheung K, 2009, EQ 5D USER GUIDE BAS; Cocks K, 2007, EUR J CANCER, V43, P1670, DOI 10.1016/j.ejca.2007.04.022; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Dimopoulos MA, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.405.405; Dimopoulos MA, 2012, BLOOD, V119, P2764, DOI 10.1182/blood-2011-08-373514; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Durie Brian G M, 2003, Hematol J, V4, P379; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Fayers PM, 2011, BLOOD, V118, P1239, DOI 10.1182/blood-2011-03-341669; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Hulin C, 2009, J CLIN ONCOL, V27, P3664, DOI 10.1200/JCO.2008.21.0948; Kapoor P, 2011, LEUKEMIA, V25, P689, DOI 10.1038/leu.2010.313; Ludwig H, 2014, LEUKEMIA, V28, P981, DOI 10.1038/leu.2013.293; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Moreau P, 2013, ANN ONCOL, V24, P133, DOI 10.1093/annonc/mdt297; National Cancer Institute, 2006, COMM TERM CRIT ADV E; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2008, BLOOD, V112, P3107, DOI 10.1182/blood-2008-04-149427; Palumbo A, 2014, J CLIN ONCOL, V32, P634, DOI 10.1200/JCO.2013.52.0023; Palumbo A, 2014, LANCET ONCOL, V15, P333, DOI 10.1016/S1470-2045(13)70609-0; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; San Miguel JF, 2013, J CLIN ONCOL, V31, P448, DOI 10.1200/JCO.2012.41.6180; Waage A, 2010, BLOOD, V116, P1405, DOI 10.1182/blood-2009-08-237974; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Wijermans P, 2010, J CLIN ONCOL, V28, P3160, DOI 10.1200/JCO.2009.26.1610	38	564	575	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					906	917		10.1056/NEJMoa1402551	http://dx.doi.org/10.1056/NEJMoa1402551			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184863	Green Published			2022-12-28	WOS:000341390600008
J	Lohr, JM				Lohr, J-Matthias			PERSONAL VIEW Pancreatic cancer should be treated as a medical emergency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADENOCARCINOMA; SURGERY		[Lohr, J-Matthias] Karolinska Inst, Stockholm, Sweden; [Lohr, J-Matthias] Karolinska Univ Hosp, Gastroctr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lohr, JM (corresponding author), Karolinska Inst, Stockholm, Sweden.	matthias.lohr@ki.se	Löhr, Matthias/A-3692-2012	Löhr, Matthias/0000-0002-7647-198X				Aveyard E, 2013, WAITING TIMES SUSPEC; Balzano G, 2008, BRIT J SURG, V95, P1387, DOI 10.1002/bjs.6324; Birk D, 1998, J Hepatobiliary Pancreat Surg, V5, P450, DOI 10.1007/s005340050071; Bond-Smith G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2476; Christians KK, 2014, ONCOLOGIST, V19, P266, DOI 10.1634/theoncologist.2013-0273; Hall TC, 2012, ANN ROY COLL SURG, V94, P318, DOI 10.1308/003588412X13171221592410; Lohr M, 2006, NAT CLIN PRACT GASTR, V3, P236, DOI 10.1038/ncpgasthep0469; Luebeck EG, 2010, NATURE, V467, P1053, DOI 10.1038/4671053a; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; McPherson T, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4007; NHS, 2013, CANC WAIT TIM GUID V; Pancreatic Cancer UK, POL BRIEF EV LIF MAT; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; WILLIAMSON RCN, 1988, BRIT MED J, V296, P445, DOI 10.1136/bmj.296.6620.445	14	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2014	349								g5261	10.1136/bmj.g5261	http://dx.doi.org/10.1136/bmj.g5261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MK	25189693				2022-12-28	WOS:000341388800003
J	Smith, JM				Smith, Jeanette M.			Campfire in the Redwoods Edwin Deakin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					872	872		10.1001/jama.2013.279699	http://dx.doi.org/10.1001/jama.2013.279699			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182083				2022-12-28	WOS:000341668600001
J	Chen, LC				Chen, Lincoln C.			China Medical Board: a century of Rockefeller health philanthropy	LANCET			English	Editorial Material									China Med Board, Cambridge, MA 02138 USA		Chen, LC (corresponding author), China Med Board, Cambridge, MA 02138 USA.	lchen@cmbfound.org						Bower J, 1972, W MED CHINESE PALACE; Brown RE, 1979, ROCKEFELLER MED MEN; Bullock Mary Brown, 1980, AM TRANSPLANT ROCKEF; Chain E, 1940, LANCET, V2, P226; Chen C. C., 1989, MED RURAL CHINA PERS; China Medical Board, 2014, CHIN MED BOARD CENT; Downs WG, 1973, ARTHROPOD BORNE VIRU; Ettling J., 1981, GERM LAZINESS ROCKEF; Fisher Donald., 1982, PHILANTHROPY CULTURA, P232; Flexner A., 1910, MEDICAL ED US CANADA; Fosdick RB, 1952, STORY ROCKEFELLER FD; Ryan Jennifer, 2014, PHILANTHROPY HLTH CH; Welch WH., 1916, I HYGIENE BEING REPO	13	0	0	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					717	719		10.1016/S0140-6736(14)60965-X	http://dx.doi.org/10.1016/S0140-6736(14)60965-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25176532				2022-12-28	WOS:000341361500006
J	Antonsen, J; Tilma, J				Antonsen, Jacob; Tilma, Jorgen			Mechanical Small-Bowel Obstruction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Antonsen, Jacob] Herlev Univ Hosp, DK-2730 Herlev, Denmark; [Tilma, Jorgen] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Antonsen, J (corresponding author), Herlev Univ Hosp, DK-2730 Herlev, Denmark.	jacobantonsen@dadlnet.dk							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					E12	E12		10.1056/NEJMicm1312048	http://dx.doi.org/10.1056/NEJMicm1312048			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162906				2022-12-28	WOS:000340819800001
J	Pfeiff, J; Robinson, J; Hagopian, A; Johnson, W; Fort, M; Gimbel-Sherr, K; Rowden, R; Friedman, E; Davis, P; Adedokun, L; Gloyd, S				Pfeiff, James; Robinson, Julia; Hagopian, Amy; Johnson, Wendy; Fort, Meredith; Gimbel-Sherr, Kenneth; Rowden, Rick; Friedman, Eric; Davis, Paul; Adedokun, Lola; Gloyd, Steve			The end of AIDS and the NGO Code of Conduct	LANCET			English	Editorial Material							HEALTH SYSTEMS		[Pfeiff, James; Robinson, Julia; Hagopian, Amy; Gimbel-Sherr, Kenneth; Gloyd, Steve] Hlth Alliance Int, Seattle, WA 98115 USA; [Pfeiff, James; Robinson, Julia; Hagopian, Amy; Johnson, Wendy; Fort, Meredith; Gimbel-Sherr, Kenneth; Gloyd, Steve] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fort, Meredith] Univ Colorado Denver, Dept Family Med, Denver, CO USA; [Rowden, Rick] Jawaharlal Nehru Univ, New Delhi 110067, India; [Friedman, Eric] Georgetown Law, Washington, DC USA; [Davis, Paul] Hlth GAP, Washington, DC USA; [Adedokun, Lola] Doris Duke Charitable Fdn, New York, NY USA	University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Jawaharlal Nehru University, New Delhi	Pfeiff, J (corresponding author), Hlth Alliance Int, Seattle, WA 98115 USA.	juliarob@uw.edu		Fort, Meredith/0000-0003-0589-1044	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI027757] Funding Source: Medline; NICHD NIH HHS [R01 HD074557] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2019, IDF DIABETES ATLAS, V9th; Bajunirwe F, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002875; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Kharas H., 2012, GLOBAL PARTNERSHIP E; Kim JY, 2013, CALIF SER PUB ANTHR, V26, P184; Luboga S, 2013, 141 AM PUBL HLTH ASS; Pfeiffer J, 2008, AM J PUBLIC HEALTH, V98, P2134, DOI 10.2105/AJPH.2007.125989; President's Emergency Plan for AIDS Relief, 2011, FY 2012 COUNTR OP PL; Sherr K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035840; Simonds RJ, 2012, HEALTH AFFAIR, V31, P1397, DOI 10.1377/hlthaff.2012.0193; Stuckler D, 2011, INT J HEALTH SERV, V41, P67, DOI 10.2190/HS.41.1.e; The Paris Declaration on Aid Effectiveness (2005) & the Accra Agenda for Action, 2008, PARIS DECLARATION AI	12	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					639	640		10.1016/S0140-6736(14)61259-9	http://dx.doi.org/10.1016/S0140-6736(14)61259-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5CJ	25152262				2022-12-28	WOS:000341359100006
J	Dixson, DL; Abrego, D; Hay, ME				Dixson, Danielle L.; Abrego, David; Hay, Mark E.			RETRACTED: Chemically mediated behavior of recruiting corals and fishes: A tipping point that may limit reef recovery (Retracted Article)	SCIENCE			English	Article; Retracted Publication							REGION-WIDE DECLINES; MARINE RESERVES; HERBIVOROUS FISHES; PHASE-SHIFTS; RESILIENCE; LARVAE; POPULATIONS; DISPERSAL; DIVERSITY; PREY	Coral reefs are in global decline, converting from dominance by coral to dominance by seaweed. Once seaweeds become abundant, coral recovery is suppressed unless herbivores return to remove seaweeds, and corals then recruit. Variance in the recovery of fishes and corals is not well understood. We show that juveniles of both corals and fishes are repelled by chemical cues from fished, seaweed-dominated reefs but attracted to cues from coral-dominated areas where fishing is prohibited. Chemical cues of specific seaweeds from degraded reefs repulsed recruits, and cues from specific corals that are typical of healthy reefs attracted recruits. Juveniles were present at but behaviorally avoided recruiting to degraded reefs dominated by seaweeds. For recovery, degraded reefs may need to be managed to produce cues that attract, rather than repel, recruiting corals and fishes.	[Dixson, Danielle L.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA; [Abrego, David] Zayed Univ, Dept Nat Sci & Publ Hlth, Abu Dhabi, U Arab Emirates	University System of Georgia; Georgia Institute of Technology; Zayed University	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011; Dixson, Danielle L/B-9253-2018	Hay, Mark E/0000-0002-6130-9349; Dixson, Danielle L/0000-0003-1493-1482	NSF [OCE-0929119]; NIH [U01-TW007401]; Teasley Endowment; FOGARTY INTERNATIONAL CENTER [U19TW007401, U01TW007401] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support was provided by NSF grant OCE-0929119, NIH grant U01-TW007401, and the Teasley Endowment. We thank V. Bonito for assistance and the Fijian government and the Korolevu-i-wai district elders for research permissions. Data are tabulated in the supplementary materials.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Andras TD, 2012, J CHEM ECOL, V38, P1203, DOI 10.1007/s10886-012-0204-9; Arnold SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028681; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Baird AH, 2013, CORAL REEFS, V32, P803, DOI 10.1007/s00338-013-1025-1; BENAYAHU Y, 1981, B MAR SCI, V31, P514; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cesar H., 2003, EC WORLD WIDE CORAL; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Dixson DL, 2012, ANIM BEHAV, V84, P45, DOI 10.1016/j.anbehav.2012.04.001; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gleason DF, 2009, CORAL REEFS, V28, P549, DOI 10.1007/s00338-009-0480-1; Golbuu Y, 2007, MAR BIOL, V152, P639, DOI 10.1007/s00227-007-0717-x; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Kuffner IB, 2004, CORAL REEFS, V23, P455, DOI 10.1007/s00338-004-0416-8; Lecchini D, 2013, MAR ECOL PROG SER, V475, P303, DOI 10.3354/meps10094; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pratchett MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070443; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x	36	183	187	13	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					892	897		10.1126/science.1255057	http://dx.doi.org/10.1126/science.1255057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146281	Green Accepted			2022-12-28	WOS:000340524700036
J	Rempe, G				Rempe, Gerhard			QUANTUM OPTICS A photon steers a photon with an atom	SCIENCE			English	Editorial Material							SWITCH		Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Rempe, G (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	gerhard.rempe@mpq.mpg.de						Gorniaczyk H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053601; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Miller DAB, 2010, NAT PHOTONICS, V4, P3, DOI 10.1038/nphoton.2009.240; Ourjoumtsev A, 2011, NATURE, V474, P623, DOI 10.1038/nature10170; Reiserer A, 2014, NATURE, V508, P237, DOI 10.1038/nature13177; Reiserer A, 2013, SCIENCE, V342, P1349, DOI 10.1126/science.1246164; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Shomroni I, 2014, SCIENCE, V345, P903, DOI 10.1126/science.1254699; Tiarks D, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053602; Tiecke TG, 2014, NATURE, V508, P241, DOI 10.1038/nature13188	11	1	1	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					871	871		10.1126/science.1258142	http://dx.doi.org/10.1126/science.1258142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146268				2022-12-28	WOS:000340524700019
J	Romiguier, J; Gayral, P; Ballenghien, M; Bernard, A; Cahais, V; Chenuil, A; Chiari, Y; Dernat, R; Duret, L; Faivre, N; Loire, E; Lourenco, JM; Nabholz, B; Roux, C; Tsagkogeorga, G; Weber, AAT; Weinert, LA; Belkhir, K; Bierne, N; Glemin, S; Galtier, N				Romiguier, J.; Gayral, P.; Ballenghien, M.; Bernard, A.; Cahais, V.; Chenuil, A.; Chiari, Y.; Dernat, R.; Duret, L.; Faivre, N.; Loire, E.; Lourenco, J. M.; Nabholz, B.; Roux, C.; Tsagkogeorga, G.; Weber, A. A. -T.; Weinert, L. A.; Belkhir, K.; Bierne, N.; Glemin, S.; Galtier, N.			Comparative population genomics in animals uncovers the determinants of genetic diversity	NATURE			English	Article							EVOLUTION	Genetic diversity is the amount of variation observed between DNA sequences from distinct individuals of a given species. This pivotal concept of population genetics has implications for species health, domestication, management and conservation. Levels of genetic diversity seem to vary greatly in natural populations and species, but the determinants of this variation, and particularly the relative influences of species biology and ecology versus population history, are still largely mysterious(1,2). Here we show that the diversity of a species is predictable, and is determined in the first place by its ecological strategy. We investigated the genome-wide diversity of 76 non-model animal species by sequencing the transcriptome of two to ten individuals in each species. The distribution of genetic diversity between species revealed no detectable influence of geographic range or invasive status but was accurately predicted by key species traits related to parental investment: long-lived or low-fecundity species with brooding ability were genetically less diverse than short-lived or highly fecund ones. Our analysis demonstrates the influence of long-term life-history strategies on species response to short-term environmental perturbations, a result with immediate implications for conservation policies.	[Romiguier, J.; Gayral, P.; Ballenghien, M.; Bernard, A.; Cahais, V.; Dernat, R.; Faivre, N.; Loire, E.; Lourenco, J. M.; Nabholz, B.; Roux, C.; Tsagkogeorga, G.; Weinert, L. A.; Belkhir, K.; Bierne, N.; Glemin, S.; Galtier, N.] Univ Montpellier 2, Inst Evolutionary Sci, CNRS, UMR 5554, F-34095 Montpellier, France; [Romiguier, J.; Roux, C.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Gayral, P.] Univ Tours, CNRS, UMR 7261, Inst Rech Biol Insecte, F-37200 Tours, France; [Chenuil, A.; Weber, A. A. -T.] Aix Marseille Univ, Inst Mediterraneen Biodivers & Ecol Marine & Cont, CNRS, IRD,UAPV, F-13007 Marseille, France; [Chiari, Y.] Univ S Alabama, Dept Biol, Mobile, AL 36688 USA; [Duret, L.] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Tsagkogeorga, G.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Weinert, L. A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of South Alabama; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of London; Queen Mary University London; University of Cambridge	Galtier, N (corresponding author), Univ Montpellier 2, Inst Evolutionary Sci, CNRS, UMR 5554, Pl E Bataillon, F-34095 Montpellier, France.	nicolas.galtier@univ-montp2.fr	Chiari, Ylenia/AAW-3108-2020; Nabholz, Benoit/AAE-2864-2021; CHENUIL, Anne/E-3902-2012	Chiari, Ylenia/0000-0003-2338-8602; CHENUIL, Anne/0000-0001-8141-7147; Duret, Laurent/0000-0003-2836-3463; Romiguier, Jonathan/0000-0002-2527-4740; loire, etienne/0000-0002-3465-7727; roux, camille/0000-0001-9497-1446; Weber, Alexandra/0000-0002-7980-388X; Bernard, Aurelien/0000-0003-1864-5395	European Research Council advanced grant [232971]	European Research Council advanced grant(European Research Council (ERC))	We thank the following for providing samples: F. Delsuc, E. Douzery, M. Tilak, G. Dugas, S. Harispe, C. Benoist, D. Bouchon (woodlice), J. Bierne, M. Bierne, B. Houseaux, M. Strand, C. Lemaire, D. Lallias, Service Modele Biologique Station Marine Roscoff (nemertines), X. Turon, S. Lopez-Legentil (Cystodytes), P. Jarne, P. David, R. Dillon, J. Auld, R. Relyea, C. Lively, J. Jokela, V. Poullain, T. Stewart (snails), S. Lapegue, V. Boulo, F. Batista, D. Lallias, L. Fast Jensen, M. Cantou (oysters), J. Do Nascimento, C. Daguin-Thiebaut, M. Cantou (crabs), L. Bonnaud (cuttlefish), D. Aurelle (gorgonians), F. Viard, Y. Pechenik, A. Cahill, R. Colins (slipper limpets), L. Dupont (earthworms), D. Jollivet (trumpet worms), M. A. Felix, I. Nuez (nematodes), N. Rodes, T. Lenormand, E. Flaven (brine shrimps), Rotterdam Zoo, Zurich Zoo, C. Libert, Montpellier Zoo, S. Martin, la Ferme aux Crocodiles, O. Verneau, C. Ayres, M. Carretero, M. Vanberger, K. Pobolsaj, M. Zuffi, C. Palacios, L. du Preez, B. Halpern, Budapest Zoo (turtles), P. Peret, C. Doutrelant, B. Halpern, B. Rosivall (tits), M. de Dinechin, B. Rey (penguins), Z. Melo-Fereira, P. Alves (hares), N. Brand, M. Chapuisat (bees), R. Blatrix, A. Lenoir, I. Nodet, A. Lugagne, S. Blanquart, L. Serres-Giardi, V. Roustang, N. Francois, G. Ballantyne, A. Carbonnel, Y. Samuel, G. James, G. Kalytta, F. Guerrini, S. Stenzel, J. Beekman, X. Cerda, S. Ikoen (ants), I. Hanski, S. Ikonen, J. Kullberg, Z. Kolev (fritillary butterflies), F. Viard, X. Turon, Di Jiang, D. Chourrout, B. Vercaemer, E. Newman-Smith, Ascidian Stock Center, Service Modele Biologique Station Marine Roscoff (ciona), L. Excoffier, G. Heckel (voles), F. Dedeine (termites), C. Atyame, O. Duron, M. Weill (mosquitoes), M. Cantou, H. Violette, F. Batista, J. Hondeville (seahorses), C. Fraisse, G. Pogson, N. Saarman, J. Normand (mussels), E. Poulin, C. Gonzalez-Weivar, and J. P. Feral (sea urchins). This work was supported by European Research Council advanced grant 232971 (PopPhyl).	Banks SC, 2013, TRENDS ECOL EVOL, V28, P670, DOI 10.1016/j.tree.2013.08.005; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Gayral P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003457; Gayral P, 2011, MOL ECOL RESOUR, V11, P650, DOI 10.1111/j.1755-0998.2011.03010.x; Gueguen L, 2013, MOL BIOL EVOL, V30, P1745, DOI 10.1093/molbev/mst097; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; MAC ARTHUR ROBERT H., 1967; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nair P, 2014, P NATL ACAD SCI USA, V111, P569, DOI 10.1073/pnas.1323086111; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Perry GH, 2012, GENOME RES, V22, P602, DOI 10.1101/gr.130468.111; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Tsagkogeorga G, 2012, GENOME BIOL EVOL, V4, P852, DOI 10.1093/gbe/evs054; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950	25	339	341	4	339	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					261	U243		10.1038/nature13685	http://dx.doi.org/10.1038/nature13685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25141177				2022-12-28	WOS:000344631400049
J	Myles, PS; Leslie, K; Chan, MTV; Forbes, A; Peyton, PJ; Paech, MJ; Beattie, WS; Sessler, DI; Devereaux, PJ; Silbert, B; Schricker, T; Wallace, S				Myles, Paul S.; Leslie, Kate; Chan, Matthew T. V.; Forbes, Andrew; Peyton, Philip J.; Paech, Michael J.; Beattie, W. Scott; Sessler, Daniel I.; Devereaux, P. J.; Silbert, Brendan; Schricker, Thomas; Wallace, Sophie		ANZCA Trials Grp ENIGMA-II Investi	The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial	LANCET			English	Article							PERIOPERATIVE CARDIAC EVENTS; FOLIC-ACID SUPPLEMENTATION; SURGICAL-WOUND INFECTION; CARDIOVASCULAR-DISEASE; B-VITAMINS; POSTOPERATIVE NAUSEA; PLASMA HOMOCYSTEINE; SITE INFECTION; MORTALITY; MORBIDITY	Background Nitrous oxide is commonly used in general anaesthesia but concerns exist that it might increase perioperative cardiovascular risk. We aimed to gather evidence to establish whether nitrous oxide affects perioperative cardiovascular risk. Methods We did an international, randomised, assessor-blinded trial in patients aged at least 45 years with known or suspected coronary artery disease having major non-cardiac surgery. Patients were randomly assigned via automated telephone service, stratified by site, to receive a general anaesthetic with or without nitrous oxide. Attending anaesthetists were aware of patients' group assignments, but patients and assessors were not. The primary outcome measure was a composite of death and cardiovascular complications (non-fatal myocardial infarction, stroke, pulmonary embolism, or cardiac arrest) within 30 days of surgery. Our modified intention-to-treat population included all patients randomly assigned to groups and undergoing induction of general anaesthesia for surgery. This trial is registered at ClinicalTrials.gov, number NCT00430989. Findings Of 10 102 eligible patients, we enrolled 7112 patients between May 30, 2008, and Sept 28, 2013. 3543 were assigned to receive nitrous oxide and 3569 were assigned not to receive nitrous oxide. 3483 patients receiving nitrous oxide and 3509 not receiving nitrous oxide were assessed for the primary outcome. The primary outcome occurred in 283 (8%) patients receiving nitrous oxide and in 296 (8%) patients not receiving nitrous oxide (relative risk 0.96, 95% CI 0.83-1.12; p=0.64). Surgical site infection occurred in 321 (9%) patients assigned to nitrous oxide, and in 311 (9%) patients in the no-nitrous oxide group (p=0.61), and severe nausea and vomiting occurred in 506 patients (15%) assigned to nitrous oxide and 378 patients (11%) not assigned to nitrous oxide (p<0.0001). Interpretation Our findings support the safety profile of nitrous oxide use in major non-cardiac surgery. Nitrous oxide did not increase the risk of death and cardiovascular complications or surgical-site infection, the emetogenic effect of nitrous oxide can be controlled with antiemetic prophylaxis, and a desired effect of reduced volatile agent use was shown.	[Myles, Paul S.; Wallace, Sophie] Alfred Hosp, Melbourne, Vic 3004, Australia; [Myles, Paul S.; Leslie, Kate; Forbes, Andrew; Wallace, Sophie] Monash Univ, Melbourne, Vic 3004, Australia; [Leslie, Kate] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Chan, Matthew T. V.] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Peyton, Philip J.] Austin Hosp, Melbourne, Vic 3084, Australia; [Paech, Michael J.] Univ Western Australia, Perth, WA 6009, Australia; [Beattie, W. Scott] Toronto Gen Hosp, Toronto, ON, Canada; [Sessler, Daniel I.] Cleveland Clin, Cleveland, OH 44106 USA; [Devereaux, P. J.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Silbert, Brendan] St Vincents Hosp, Melbourne, Vic, Australia; [Schricker, Thomas] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada	Florey Institute of Neuroscience & Mental Health; Monash University; Royal Melbourne Hospital; Chinese University of Hong Kong; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Western Australia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Cleveland Clinic Foundation; McMaster University; St Vincent's Hospital Melbourne; McGill University; Royal Victoria Hospital	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic 3004, Australia.	p.myles@alfred.org.au	Obal, Detlef/A-6542-2009; Sessler, Daniel/D-3504-2011; Devereaux, PJ/AAF-2862-2019; Sneyd, John/AFV-7887-2022; Sneyd, John Robert/B-2957-2012; Devereaux, PJ/AAY-1757-2021; Sneyd, John/AFV-7886-2022; Myles, Paul/AAU-9524-2020; Chan, Matthew/J-2884-2013; Obal, Detlef/J-1032-2019	Obal, Detlef/0000-0002-1126-2132; Sessler, Daniel/0000-0001-9932-3077; Sneyd, John/0000-0003-3546-9856; Sneyd, John Robert/0000-0003-3546-9856; Sneyd, John/0000-0003-3546-9856; Myles, Paul/0000-0002-3324-5456; Chan, Matthew/0000-0002-3574-7855; Obal, Detlef/0000-0002-1126-2132; Egan, Cameron/0000-0002-8927-7588; Devereaux, PJ/0000-0003-2935-637X; Leslie, Kate/0000-0001-8512-3517; Kunst, Gudrun/0000-0002-9789-1334; PAECH, MICHAEL/0000-0001-9023-6575; Forbes, Andrew/0000-0003-4269-914X; Banner-Goodspeed, Valerie/0000-0002-7644-2521; haller, guy/0000-0001-7367-7029	Australian National Health and Medical Research Council; Australian and New Zealand College of Anaesthetists; Heart and Stroke Foundation of Quebec; Heart and Stroke Foundation of Ontario, Canada; General Research Fund of the Research Grant Council, Hong Kong Special Administrative Region, China	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian and New Zealand College of Anaesthetists; Heart and Stroke Foundation of Quebec; Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario); General Research Fund of the Research Grant Council, Hong Kong Special Administrative Region, China	Funding Australian National Health and Medical Research Council; Australian and New Zealand College of Anaesthetists; Heart and Stroke Foundation of Quebec, Heart and Stroke Foundation of Ontario, Canada; General Research Fund of the Research Grant Council, Hong Kong Special Administrative Region, China.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Badner NH, 2000, ANESTH ANALG, V91, P1073, DOI 10.1097/00000539-200011000-00006; Bistulfi G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-6; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Chan MTV, 2011, PAIN, V152, P2514, DOI 10.1016/j.pain.2011.07.015; Chen Y, 2013, ANESTHESIOLOGY, V118, P1322, DOI 10.1097/ALN.0b013e31829107b8; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; ERMENS AAM, 1991, CLIN PHARMACOL THER, V49, P385, DOI 10.1038/clpt.1991.45; Fleischmann E, 2005, LANCET, V366, P1101, DOI 10.1016/S0140-6736(05)67422-3; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Grocott MPW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004082.pub5; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang T, 2012, CLIN NUTR, V31, P448, DOI 10.1016/j.clnu.2011.01.003; Imberger G, 2014, BRIT J ANAESTH, V112, P410, DOI 10.1093/bja/aet416; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Leonardi S, 2013, EUR HEART J, V34, P894, DOI 10.1093/eurheartj/eht003; Leslie K, 2013, ANESTH ANALG, V116, P1034, DOI 10.1213/ANE.0b013e318270014a; Leslie K, 2011, ANESTH ANALG, V112, P387, DOI 10.1213/ANE.0b013e3181f7e2c4; Lison S, 2011, BLOOD COAGUL FIBRIN, V22, P190, DOI 10.1097/MBC.0b013e328343f7be; Mangano DT, 1995, NEW ENGL J MED, V333, P1750, DOI 10.1056/NEJM199512283332607; Meyhoff CS, 2009, JAMA-J AM MED ASSOC, V302, P1543, DOI 10.1001/jama.2009.1452; Miller ER, 2010, AM J CARDIOL, V106, P517, DOI 10.1016/j.amjcard.2010.03.064; Myles PS, 2008, ANESTHESIOLOGY, V109, P657, DOI 10.1097/ALN.0b013e31818629db; Myles PS, 2007, ANESTHESIOLOGY, V107, P221, DOI 10.1097/01.anes.0000270723.30772.da; Myles PS, 2009, AM HEART J, V157, P488, DOI 10.1016/j.ahj.2008.11.015; Myles PS, 1999, ANESTH ANALG, V88, P83, DOI 10.1097/00000539-199901000-00016; Nagele P, 2013, ANESTHESIOLOGY, V119, P19, DOI 10.1097/ALN.0b013e31829761e3; NUNN JF, 1987, BRIT J ANAESTH, V59, P3, DOI 10.1093/bja/59.1.3; Qadan M, 2009, ARCH SURG-CHICAGO, V144, P359, DOI 10.1001/archsurg.2009.1; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; Turan A, 2013, ANESTH ANALG, V116, P1026, DOI 10.1213/ANE.0b013e31824590a5; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202	36	123	129	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1446	1454		10.1016/S0140-6736(14)60893-X	http://dx.doi.org/10.1016/S0140-6736(14)60893-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25142708				2022-12-28	WOS:000343107000025
J	Sarangapani, KK; Duro, E; Deng, Y; Alves, FD; Ye, QZ; Opoku, KN; Ceto, S; Rappsilber, J; Corbett, KD; Biggins, S; Marston, AL; Asbury, CL				Sarangapani, Krishna K.; Duro, Eris; Deng, Yi; Alves, Flavia de Lima; Ye, Qiaozhen; Opoku, Kwaku N.; Ceto, Steven; Rappsilber, Juri; Corbett, Kevin D.; Biggins, Sue; Marston, Adele L.; Asbury, Charles L.			Sister kinetochores are mechanically fused during meiosis I in yeast	SCIENCE			English	Article							MONOPOLIN COMPLEX; MICROTUBULE ATTACHMENTS; MOLECULAR ARCHITECTURE; CHROMOSOME SEGREGATION; BUDDING YEAST; PROTEIN; DIVISION; ORIENTATION; CHECKPOINT	Production of healthy gametes requires a reductional meiosis I division in which replicated sister chromatids comigrate, rather than separate as in mitosis or meiosis II. Fusion of sister kinetochores during meiosis I may underlie sister chromatid comigration in diverse organisms, but direct evidence for such fusion has been lacking. We used laser trapping and quantitative fluorescence microscopy to study native kinetochore particles isolated from yeast. Meiosis I kinetochores formed stronger attachments and carried more microtubule-binding elements than kinetochores isolated from cells in mitosis or meiosis II. The meiosis I-specific monopolin complex was both necessary and sufficient to drive these modifications. Thus, kinetochore fusion directs sister chromatid comigration, a conserved feature of meiosis that is fundamental to Mendelian inheritance.	[Sarangapani, Krishna K.; Deng, Yi; Opoku, Kwaku N.; Asbury, Charles L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Duro, Eris; Alves, Flavia de Lima; Rappsilber, Juri; Marston, Adele L.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Ye, Qiaozhen; Corbett, Kevin D.] Ludwig Inst Canc Res, San Diego Branch, La Jolla, CA 92093 USA; [Ceto, Steven; Biggins, Sue] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Rappsilber, Juri] Tech Univ Berlin, Dept Biotechnol, Inst Bioanalyt, Berlin, Germany; [Corbett, Kevin D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Biggins, Sue] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Edinburgh; Ludwig Institute for Cancer Research; Fred Hutchinson Cancer Center; Technical University of Berlin; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Asbury, CL (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	adele.marston@ed.ac.uk; casbury@u.washington.edu	Deng, Yi/F-9358-2015; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015	Deng, Yi/0000-0002-6822-6343; Rappsilber, Juri/0000-0001-5999-1310; Corbett, Kevin/0000-0001-5854-2388; Ye, Qiaozhen/0000-0002-3942-4121; Marston, Adele/0000-0002-3596-9407; Biggins, Susan/0000-0002-4499-6319; Ceto, Steven/0000-0002-0101-3685	Wellcome Trust [096078, 090903, 084229, 077707, 092076, 091020]; NIH [RO1GM079373, S10RR026406, R01GM064386, R01GM104141]; Packard Fellowship [2006-30521]; Ludwig Institute for Cancer Research; Sidney Kimmel Foundation; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079373, R01GM104141, R01GM064386] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); Ludwig Institute for Cancer Research; Sidney Kimmel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hoskins, M. Miller, N. Umbreit, and E. Yusko for helpful comments. We thank A. Desai for providing antibodies and A. Hoskins for SNAPf and CLIPf plasmids. The Wellcome Trust supported this work through a Sir Henry Wellcome Fellowship to E. D. (096078), Senior Research Fellowships to A. L. M. (090903) and J.R. (084229), and two Wellcome Trust Centre Core Grants (077707 and 092076) and an instrument grant (091020). The work was also supported by NIH grants to C. L. A. (RO1GM079373 and S10RR026406), S. B. (R01GM064386), and K. D. C. (R01GM104141) and by a Packard Fellowship to C. L. A. (2006-30521). K. D. C. also acknowledges support from the Ludwig Institute for Cancer Research and the Sidney Kimmel Foundation. Additional data described in this work can be found in the supplementary materials. E. D., K. K. S., S. B., A. L. M., and C. L. A. conceived the experiments. E. D. generated new yeast strains and isolated kinetochore particles. K. K. S. performed laser trap experiments. Y.D. performed the fluorescence measurements. F.d.L.A. and J.R. performed proteomics analysis. Q.Y. and K. D. C. purified monopolin. K.N.O. and S. C. optimized fluorescent labeling of kinetochore particles. E. D., K. K. S., A. L. M., and C. L. A. prepared the manuscript.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Corbett KD, 2012, CELL REPORTS, V1, P583, DOI 10.1016/j.celrep.2012.05.012; Corbett KD, 2010, CELL, V142, P556, DOI 10.1016/j.cell.2010.07.017; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Li XX, 2009, NAT CELL BIOL, V11, P1103, DOI 10.1038/ncb1923; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Paliulis LV, 2000, J CELL BIOL, V150, P1223, DOI 10.1083/jcb.150.6.1223; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Sarkar S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003610; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765	23	53	53	7	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					248	251		10.1126/science.1256729	http://dx.doi.org/10.1126/science.1256729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25213378	Green Accepted			2022-12-28	WOS:000342721500051
J	Okun, MS				Okun, Michael S.			Deep-Brain Stimulation - Entering the Era of Human Neural-Network Modulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE		[Okun, Michael S.] Univ Florida, McKnight Brain Inst, Hlth Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL 32611 USA; [Okun, Michael S.] Univ Florida, McKnight Brain Inst, Hlth Ctr Movement Disorders & Neurorestorat, Dept Neurosurg, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Coll Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, McKnight Brain Inst, Hlth Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL 32611 USA.			Okun, Michael/0000-0002-6247-9358				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078	5	64	71	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1369	1373		10.1056/NEJMp1408779	http://dx.doi.org/10.1056/NEJMp1408779			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25197963				2022-12-28	WOS:000342674800003
J	Jasny, B; Roberts, L; Enserink, M; Smith, O				Jasny, Barbara; Roberts, Leslie; Enserink, Martin; Smith, Orla			Global health What works	SCIENCE			English	Editorial Material																			0	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1256	1257		10.1126/science.345.6202.1256	http://dx.doi.org/10.1126/science.345.6202.1256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO6TG	25214599				2022-12-28	WOS:000341483800031
J	Ryan, DP; Hong, TS; Bardeesy, N				Ryan, David P.; Hong, Theodore S.; Bardeesy, Nabeel			Pancreatic Adenocarcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PHASE-III TRIAL; INTRAEPITHELIAL NEOPLASIA; ADJUVANT CHEMOTHERAPY; POOLED ANALYSIS; EGF RECEPTOR; CANCER RISK; GEMCITABINE; KRAS; RESECTION; FAMILIES		[Ryan, David P.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA; [Hong, Theodore S.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ryan, DP (corresponding author), Massachusetts Gen Hosp, Dept Med, 15 Fruit St, Boston, MA 02114 USA.	dpryan@mgh.harvard.edu	Bukki, Johannes/D-4980-2015	Bukki, Johannes/0000-0003-1232-1103	MedImmune; Boehringer Ingelheim; Illumina	MedImmune(AstraZenecaMedimmune); Boehringer Ingelheim(Boehringer Ingelheim); Illumina	Dr. Ryan reports receiving fees for serving on an advisory board from MedImmune, consulting fees from Boehringer Ingelheim and Illumina, and travel support from EMD Serono. No other potential conflict of interest relevant to this article was reported.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; American Joint Committee on Cancer (AJCC), 2010, AJCC CANC STAGING MA, V7th; [Anonymous], 1987, Cancer, V59, P2006; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bosetti C, 2012, ANN ONCOL, V23, P1880, DOI 10.1093/annonc/mdr541; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Canto MI, 2013, GUT, V62, P339, DOI 10.1136/gutjnl-2012-303108; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Chauffert B, 2008, ANN ONCOL, V19, P1592, DOI 10.1093/annonc/mdn281; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; Faris JE, 2013, ONCOLOGIST, V18, P543, DOI 10.1634/theoncologist.2012-0435; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fukutomi A, 2013, J CLIN ONCOL, V31; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Hustinx SR, 2005, MODERN PATHOL, V18, P959, DOI 10.1038/modpathol.3800377; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Iqbal J, 2012, BRIT J CANCER, V107, P2005, DOI 10.1038/bjc.2012.483; Jacobs EJ, 2010, INT J CANCER, V127, P1421, DOI 10.1002/ijc.25148; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI DOI 10.3322/CAAC.20; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Keenan BP, 2014, GASTROENTEROLOGY, V146, P1784, DOI 10.1053/j.gastro.2014.02.055; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Klein AP, 2004, CANCER RES, V64, P2634, DOI 10.1158/0008-5472.CAN-03-3823; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; Lee JJ, 2014, P NATL ACAD SCI USA, V111, pE3091, DOI 10.1073/pnas.1411679111; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Martin RCG, 2009, ARCH SURG-CHICAGO, V144, P154, DOI 10.1001/archsurg.2008.547; Modolell I, 1999, ANN ONCOL, V10, P82, DOI 10.1023/A:1008301206176; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Porta Miquel, 2005, Clin Transl Oncol, V7, P189, DOI 10.1007/BF02712816; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rebours V, 2008, AM J GASTROENTEROL, V103, P111, DOI 10.1111/j.1572-0241.2007.01597.x; Regine WF, 2011, ANN SURG ONCOL, V18, P1319, DOI 10.1245/s10434-011-1630-6; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ruijs MWG, 2010, J MED GENET, V47, P421, DOI 10.1136/jmg.2009.073429; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.3.CO;2-L; Vauthey JN, 2009, ANN SURG ONCOL, V16, P1725, DOI 10.1245/s10434-009-0409-5; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Vonderheide RH, 2013, CURR OPIN IMMUNOL, V25, P200, DOI 10.1016/j.coi.2013.01.006; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	75	1425	1474	9	180	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					1039	1049		10.1056/NEJMra1404198	http://dx.doi.org/10.1056/NEJMra1404198			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25207767				2022-12-28	WOS:000341382800009
J	Kusters, DM; Avis, HJ; de Groot, E; Wijburg, FA; Kastelein, JJP; Wiegman, A; Hutten, BA				Kusters, D. Meeike; Avis, Hans J.; de Groot, Eric; Wijburg, Frits A.; Kastelein, John J. P.; Wiegman, Albert; Hutten, Barbara A.			Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							THICKNESS; EFFICACY; SAFETY		[Kusters, D. Meeike; Avis, Hans J.; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [de Groot, Eric] Univ Amsterdam, Dept Imagelabonline & Imagelabcardiovasc, Amsterdam, Netherlands; [Wijburg, Frits A.; Wiegman, Albert] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hutten, BA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.a.hutten@amc.uva.nl	Kastelein, John/AAF-7950-2020	Wiegman, Albert/0000-0001-6223-5671; Wijburg, Frits/0000-0002-0950-1368				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331; Wiegman A, 2004, LANCET, V363, P369, DOI 10.1016/S0140-6736(04)15467-6	6	117	119	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1055	1057		10.1001/jama.2014.8892	http://dx.doi.org/10.1001/jama.2014.8892			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203086	Bronze			2022-12-28	WOS:000341385600024
J	Takahashi, N; Vereecke, L; Bertrand, MJM; Duprez, L; Berger, SB; Divert, T; Goncalves, A; Sze, M; Gilbert, B; Kourula, S; Goossens, V; Lefebvre, S; Gunther, C; Becker, C; Bertin, J; Gough, PJ; Declercq, W; van Loo, G; Vandenabeele, P				Takahashi, Nozomi; Vereecke, Lars; Bertrand, Mathieu J. M.; Duprez, Linde; Berger, Scott B.; Divert, Tatyana; Goncalves, Amanda; Sze, Mozes; Gilbert, Barbara; Kourula, Stephanie; Goossens, Vera; Lefebvre, Sylvie; Gunther, Claudia; Becker, Christoph; Bertin, John; Gough, Peter J.; Declercq, Wim; van Loo, Geert; Vandenabeele, Peter			RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis	NATURE			English	Article							NECROSIS-FACTOR RECEPTOR-1; CELL-DEATH; KINASE; INFLAMMATION; NECROPTOSIS; UBIQUITINATION; RIPOPTOSOME; CROSSROADS; REGULATOR; LETHALITY	Receptor interacting protein kinase 1 (RIPK1) has an essential role in the signalling triggered by death receptors and pattern recognition receptors(1,2). RIPK1 is believed to function as a node driving NF-kappa B-mediated cell survival and inflammation as well as caspase-8 (CASP8)-dependent apoptotic or RIPK3/MLKL-dependent necroptotic cell death. The physiological relevance of this dual function has remained elusive because of the perinatal death of RIPK1 full knockout mice(3). To circumvent this problem, we generated RIPK1 conditional knockout mice, and show that mice lacking RIPK1 in intestinal epithelial cells (IECs) spontaneously develop severe intestinal inflammation associated with IEC apoptosis leading to early death. This early lethality was rescued by antibiotic treatment, MYD88 deficiency or tumour-necrosis factor (TNF) receptor 1 deficiency, demonstrating the importance of commensal bacteria and TNF in the IEC Ripk1 knockout phenotype. CASP8 deficiency, but not RIPK3 deficiency, rescued the inflammatory phenotype completely, indicating the indispensable role of RIPK1 in suppressing CASP8-dependent apoptosis but not RIPK3-dependent necroptosis in the intestine. RIPK1 kinase-dead knock-in mice did not exhibit any sign of inflammation, suggesting that RIPK1-mediated protection resides in its kinase-independent platform function. Depletion of RIPK1 in intestinal organoid cultures sensitized them to TNF-induced apoptosis, confirming the in vivo observations. Unexpectedly, TNF-mediated NF-kappa B activation remained intact in these organoids. Our results demonstrate that RIPK1 is essential for survival of IECs, ensuring epithelial homeostasis by protecting the epithelium from CASP8-mediated IEC apoptosis independently of its kinase activity and NF-kappa B activation.	[Takahashi, Nozomi; Vereecke, Lars; Bertrand, Mathieu J. M.; Duprez, Linde; Divert, Tatyana; Goncalves, Amanda; Sze, Mozes; Gilbert, Barbara; Kourula, Stephanie; Goossens, Vera; Lefebvre, Sylvie; Declercq, Wim; van Loo, Geert; Vandenabeele, Peter] VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Takahashi, Nozomi; Vereecke, Lars; Bertrand, Mathieu J. M.; Duprez, Linde; Divert, Tatyana; Goncalves, Amanda; Sze, Mozes; Gilbert, Barbara; Kourula, Stephanie; Goossens, Vera; Lefebvre, Sylvie; Declercq, Wim; van Loo, Geert; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Berger, Scott B.; Bertin, John; Gough, Peter J.] GlaxoSmithKline, Immunoinflammat Therapeut Area, Pattern Recognit Receptor Discovery Performance U, Collegeville, PA 19426 USA; [Goncalves, Amanda] VIB Bio Imaging Core Gent, B-9052 Ghent, Belgium; [Gunther, Claudia; Becker, Christoph] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; GlaxoSmithKline; Flanders Institute for Biotechnology (VIB); University of Erlangen Nuremberg; Ghent University	Vandenabeele, P (corresponding author), VIB Inflammat Res Ctr, Technol Pk 927, B-9052 Ghent, Belgium.	Peter.Vandenabeele@irc.vib-ugent.be	Becker, Christoph/L-2996-2016; , van Loo Geert/AAD-1220-2019; Vereecke, Lars/H-6639-2016; Vandenabeele, Peter/AAD-5793-2022; van Loo, Geert/C-1505-2009; Vereecke, Lars/ABH-2926-2020; Vandenabeele, Peter/C-8597-2009; Bertrand, Mathieu J/P-6465-2016; Bertrand, Mathieu JM/AAD-2653-2019; Becker, Christoph/A-6694-2008	, van Loo Geert/0000-0002-8427-4775; Vandenabeele, Peter/0000-0002-6669-8822; Vereecke, Lars/0000-0002-1593-862X; Bertrand, Mathieu J/0000-0001-9000-0626; Bertrand, Mathieu JM/0000-0001-9000-0626; Goncalves, Amanda Maffioletti Mac Cord/0000-0003-2748-3033; Becker, Christoph/0000-0002-1388-1041; Takahashi, Nozomi/0000-0002-3751-4203; Kourula (nee Schulz), Stephanie/0000-0002-7667-7072	Research Foundation Flanders (FWO); VIB; FWO; FWO Odysseus Grant; FWO, Foundation against Cancer; Queen Elisabeth Medical foundation; Belgian (Interuniversity Attraction Poles) [IAP 7/32]; Flemish (Research Foundation Flanders) [FWOG.0875.11, FWOG.0973.11, FWO G.0A45.12N, FWO G.0787.13N, G.0544.11N, G0C3114N]; Flemish (Methusalem grant) [BOF09/01M00709]; Ghent University (MRP); Ghent University (GROUP-ID consortium); Foundation against Cancer [F94, 2010-162]; IZKF of the FAU Erlangen-Nurnberg; DFG [SPP1656, BE3686/2, SFB796]; Methusalem	Research Foundation Flanders (FWO)(FWO); VIB; FWO(FWO); FWO Odysseus Grant(FWO); FWO, Foundation against Cancer; Queen Elisabeth Medical foundation; Belgian (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish (Research Foundation Flanders); Flemish (Methusalem grant); Ghent University (MRP); Ghent University (GROUP-ID consortium); Foundation against Cancer; IZKF of the FAU Erlangen-Nurnberg; DFG(German Research Foundation (DFG)); Methusalem	We thank the Transgenic Mice Core Facility (IRC, VIB-UGent, Ghent) for their assistance. Villin-Cre, villin-Cre-ERT2 and RIPK3 knockout mice were provided by D. Gumucio (University of Michigan), S. Robine (Paris, France) and K. Newton and V. Dixit (Genentech), respectively. We thank A. Bredan for editing the manuscript, and P. De Bleser and M. Vuylsteke for statistical analysis. P. V. is senior full professor at Ghent University and holder of a Methusalem grant. L. V. is holder of a fellowship from Research Foundation Flanders (FWO). W. D. and G. V. L. have research professor positions at Ghent University. M. B. has a tenure track position in the Multidisciplinary Research Program of Ghent University (GROUP-ID). N.T. and V. G. are paid by the Methusalem grant, S. L. by a VIB grant and S. K. by a grant from the FWO. G. V. L. was supported by an FWO Odysseus Grant and by research grants from FWO, Foundation against Cancer and the Queen Elisabeth Medical foundation. Research in P.V.'s group is supported by Belgian grants (Interuniversity Attraction Poles, IAP 7/32), Flemish grants (Research Foundation Flanders, FWOG.0875.11, FWOG.0973.11, FWO G.0A45.12N, FWO G.0787.13N, G.0544.11N, G0C3114N and Methusalem grant BOF09/01M00709), Ghent University grants (MRP, GROUP-ID consortium), grant from the Foundation against Cancer (F94 and 2010-162) and grants from VIB. C. B. and C. G. received funding from the IZKF of the FAU Erlangen-Nurnberg and the DFG within the projects SPP1656, BE3686/2 and SFB796.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kajino-Sakamoto R, 2010, J IMMUNOL, V185, P4729, DOI 10.4049/jimmunol.0903587; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Moujalled DM, 2012, CELL DEATH DIFFER, V19, P808, DOI 10.1038/cdd.2011.151; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	41	233	237	5	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					95	+		10.1038/nature13706	http://dx.doi.org/10.1038/nature13706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186904				2022-12-28	WOS:000341174800037
J	Huang, C; Yu, H; Koplan, JP				Huang, Cheng; Yu, Hai; Koplan, Jeffrey P.			Can China diminish its burden of non-communicable diseases and injuries by promoting health in its policies, practices, and incentives?	LANCET			English	Review							GLOBAL BURDEN; SYSTEM REFORM; TOBACCO CONTROL; AIR-POLLUTION; MENTAL-HEALTH; PUBLIC-HEALTH; RISK-FACTORS; OBESITY; MORTALITY; URBANIZATION	China has rapidly progressed through epidemiological and demographic transitions and is now confronting an increasing burden from non-communicable diseases and injuries. China could take advantage of what has been learnt about prevention and control of non-communicable diseases and injuries, which is well summarised in the WHO best buys (a set of affordable, feasible, and cost-effective intervention strategies in any resource setting), to improve individual and population health. Implementation of these strategies could allow China to exceed the incremental gains in decreasing non-communicable diseases and injury burdens of high-income countries, and greatly shorten the interval needed to achieve decreased morbidity and mortality in its population. With the lessons learnt from other countries and its own programmes and policies, China could provide a health model for the world.	[Huang, Cheng] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC USA; [Yu, Hai] Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30345 USA	George Washington University; Zhejiang University; Emory University	Koplan, JP (corresponding author), Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30345 USA.	jkoplan@emory.edu						Alcorn T, 2011, LANCET, V378, P305, DOI 10.1016/S0140-6736(11)61153-7; [Anonymous], 2010, LANCET, V376, P2, DOI 10.1016/S0140-6736(10)61039-2; [Anonymous], 2013, XINHUA NEWS; Bureau of Disease Control in the Ministry of Health Office of National Patriotic Health Campaign Committee Chinese Center for Disease Control and Prevention, NAT CAMP HLTH LIF AL; Central Committee of the Communist Party of China, 2007, STAT COUNC CENTR COM; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen HH, 2012, SHANGHAI ARCH PSYCHI, V24, P1; Chen J, 2007, CATENA, V69, P1, DOI 10.1016/j.catena.2006.04.019; Chen RenJie, 2010, China Environmental Science, V30, P410; Chen Shulin, 2013, Ment Health Fam Med, V10, P133; Chinese Centre for Disease Control and Prevention, 2012, CHIN NAT PLAN NCD PR; Clean Air Alliance of China (CAAC, 2013, 12 5 YEAR PLAN AIR P; Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166; CY Ji, 2008, CHIN J SCH HLTH, V29, P106; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Emory Global Health Institution, GLOB HLTH I CHIN TOB; Eriksen M, 2012, TOBACCO ATLAS; European Commission, 2007, BEST PRACT ROAD SAF; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Gao X, 2010, HEALTH POLICY, V95, P74, DOI 10.1016/j.healthpol.2009.11.004; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Green L.W., 2005, HLTH PROGRAM PLANNIN, V4th; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Han QD, 2008, LANCET, V372, P1439, DOI 10.1016/S0140-6736(08)61350-1; Heilmann S, 2008, STUD COMP INT DEV, V43, P1, DOI 10.1007/s12116-007-9014-4; Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Hu GQ, 2010, J RURAL HEALTH, V26, P73, DOI 10.1111/j.1748-0361.2009.00255.x; Hu TW, 2010, TOB CONTROL, V19, P58, DOI 10.1136/tc.2009.031799; Huang C, 2013, TOB CONTROL, V22, P27, DOI 10.1136/tobaccocontrol-2012-050884; IHME, 2013, GBD COMP; Institute for Health Metrics and Evaluation, 2013, GBD PROF CHIN; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P1, DOI 10.3967/0895-3988.2013.01.001; Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA530, DOI 10.1289/ehp.0901615; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kjellstrom T, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P817; Kopits E, 2005, ACCIDENT ANAL PREV, V37, P169, DOI 10.1016/j.aap.2004.04.006; Koplan JP, 2010, LANCET, V375, P1330, DOI 10.1016/S0140-6736(10)60398-4; Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x; Li CX, 2012, RARE METALS, V31, P31, DOI 10.1007/s12598-012-0457-z; Li Q, 2011, GLOBAL ADULT TOBACCO; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Li XY, 2008, PSYCHOL MED, V38, P397, DOI 10.1017/S0033291707001407; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu H, 2013, ATMOS CHEM PHYS, V13, P12013, DOI 10.5194/acp-13-12013-2013; Liu J, 2011, WORLD PSYCHIATRY, V10, P210; Lv J, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20004; Martin E, 2013, MEXICO TACKLES OBESI; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayhew DR, 2002, INJ PREV, V8, P3; Mori N, 2012, AM J PUBLIC HEALTH, V102, P2068, DOI 10.2105/AJPH.2012.300913; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Nissinen A, 2001, B WORLD HEALTH ORGAN, V79, P963; Niu Bolin, 2011, Yale Journal of Biology and Medicine, V84, P155; Nordic Expert Group on Mental Health, 2011, STRENGTH MENT HLTH N; Phillips MR, 2013, LANCET, V381, P1964, DOI 10.1016/S0140-6736(13)61177-0; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Prochaska JO., 2016, CHANGING THRIVE USIN, V1st ed.; Pruss-Ustun A., 2006, WORLD HEALTH; Ran M.S., 2005, FAMILY BASED MENTAL; Redmon P, 2013, TOB CONTROL, V22, P4, DOI 10.1136/tobaccocontrol-2012-050924; Remais JV, 2011, ENVIRON HEALTH PERSP, V119, P893, DOI 10.1289/ehp.1003024; Riley NE, 2004, POPUL BULL, V59, P3; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318; The Central People's Government of the People's Republic of China, 2011, CHIN 12 5 YEAR PLAN; The Ministry of Public Security of the People's Republic of China, 2013, NUMB CHIN DRIV NOW E; The Organisation for Economic Co-operation and Development, OECD ENV PERF REV; The Organisation for Economic Co-operation and Development, 2010, OECD ENV PERF REV JA; Tian XY, 2014, J RURAL HEALTH, V30, P101, DOI 10.1111/jrh.12041; Topic Group of Party School of the Central Committee of CPC, 2013, TOB CONTR INT EXP CH; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Wang H, 2013, OBES REV, V14, P134, DOI 10.1111/obr.12106; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wang XP, 2006, ATMOS ENVIRON, V40, P1706, DOI 10.1016/j.atmosenv.2005.10.066; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Waters H R, 2004, Asia Pac J Public Health, V16, P23, DOI 10.1177/101053950401600105; Watts J, 2005, LANCET, V366, P1761, DOI 10.1016/S0140-6736(05)67711-2; WHO, 2013, COMPR MENT HLTH ACT; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, LIF EXP LIF EXP DAT; World Health Organization, TOBACCO ATLAS; World Health Organization, 2004, WORLD REPORT ROAD TR; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization (WHO), 2011, BURD BEST BUYS RED E; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xiang YT, 2012, LANCET, V380, P1715, DOI 10.1016/S0140-6736(11)60893-3; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P422, DOI 10.1016/S0895-3988(11)60002-0; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2014, TOB CONTROL, V23, P167, DOI 10.1136/tobaccocontrol-2012-050691; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang XG, 2010, CHIN PREV MED, V11, P5; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang J, 2014, SUICIDE LIFE-THREAT, V44, P560, DOI 10.1111/sltb.12090; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085319; Zhang Rong, 2009, Journal of Environment and Health, V26, P3; Zhang W, 2006, ACCIDENT ANAL PREV, V38, P22, DOI 10.1016/j.aap.2005.06.015; Zhao W, 2008, OBES REV, V9, P62, DOI 10.1111/j.1467-789X.2007.00440.x; Zhao ZT, 2003, HEALTH PROMOT INT, V18, P247, DOI 10.1093/heapro/dag020; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124; Zhu C, 2012, LANCET, V379, P779, DOI 10.1016/S0140-6736(11)61933-8	109	41	49	2	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					783	792		10.1016/S0140-6736(14)61214-9	http://dx.doi.org/10.1016/S0140-6736(14)61214-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25176549				2022-12-28	WOS:000341361500039
J	Gerstein, MB; Rozowsky, J; Yan, KK; Wang, DF; Cheng, C; Brown, JB; Davis, CA; Hillier, L; Sisu, C; Li, JJ; Pei, BK; Harmanci, AO; Duff, MO; Djebali, S; Alexander, RP; Alver, BH; Auerbach, R; Bell, K; Bickel, PJ; Boeck, ME; Boley, NP; Booth, BW; Cherbas, L; Cherbas, P; Di, C; Dobins, A; Drenkows, J; Ewing, B; Fang, G; Fastucas, M; Feingold, EA; Frankish, A; Gao, GJ; Good, PJ; Guigo, R; Hammonds, A; Harrow, J; Hoskins, RA; Howald, C; Hu, L; Huang, HY; Hubbard, TJP; Huynh, C; Jhas, S; Kasper, D; Kato, M; Kaufman, TC; Kitchen, RR; Ladewig, E; Lagarde, J; Lai, E; Leng, L; Lu, Z; MacCoss, M; May, G; McWhirter, R; Merrihew, G; Miller, DM; Mortazavi, A; Murad, R; Oliver, B; Olson, S; Park, PJ; Pazin, MJ; Perrimon, N; Pervouchine, D; Reinke, V; Reymond, A; Robinson, G; Samsonova, A; Saunders, GI; Schlesingers, F; Sethi, A; Slack, FJ; Spencer, WC; Stoiber, MH; Strasbourger, P; Tanzer, A; Thompson, OA; Wan, KH; Wang, GL; Wang, H; Watkins, KL; Wen, JY; Wen, KJ; Xue, CH; Yang, L; Yip, K; Zaleskis, C; Zhang, Y; Zheng, H; Brenner, SE; Graveley, BR; Ceniker, SE; Gingeras, TR; Waterston, R				Gerstein, Mark B.; Rozowsky, Joel; Yan, Koon-Kiu; Wang, Daifeng; Cheng, Chao; Brown, James B.; Davis, Carrie A.; Hillier, LaDeana; Sisu, Cristina; Li, Jingyi Jessica; Pei, Baikang; Harmanci, Arif O.; Duff, Michael O.; Djebali, Sarah; Alexander, Roger P.; Alver, Burak H.; Auerbach, Raymond; Bell, Kimberly; Bickel, Peter J.; Boeck, Max E.; Boley, Nathan P.; Booth, Benjamin W.; Cherbas, Lucy; Cherbas, Peter; Di, Chao; Dobins, Alex; Drenkows, Jorg; Ewing, Brent; Fang, Gang; Fastucas, Megan; Feingold, Elise A.; Frankish, Adam; Gao, Guanjun; Good, Peter J.; Guigo, Roderic; Hammonds, Ann; Harrow, Jen; Hoskins, Roger A.; Howald, Cedric; Hu, Long; Huang, Haiyan; Hubbard, Tim J. P.; Huynh, Chau; Jhas, Sonali; Kasper, Dionna; Kato, Masaomi; Kaufman, Thomas C.; Kitchen, Robert R.; Ladewig, Erik; Lagarde, Julien; Lai, Eric; Leng, Ling; Lu, Zhi; MacCoss, Michael; May, Gemma; McWhirter, Rebecca; Merrihew, Gennifer; Miller, David M.; Mortazavi, Ali; Murad, Rabi; Oliver, Brian; Olson, Sara; Park, Peter J.; Pazin, Michael J.; Perrimon, Norbert; Pervouchine, Dmitri; Reinke, Valerie; Reymond, Alexandre; Robinson, Garrett; Samsonova, Anastasia; Saunders, Gary I.; Schlesingers, Felix; Sethi, Anurag; Slack, Frank J.; Spencer, William C.; Stoiber, Marcus H.; Strasbourger, Pnina; Tanzer, Andrea; Thompson, Owen A.; Wan, Kenneth H.; Wang, Guilin; Wang, Huaien; Watkins, Kathie L.; Wen, Jiayu; Wen, Kejia; Xue, Chenghai; Yang, Li; Yip, Kevin; Zaleskis, Chris; Zhang, Yan; Zheng, Henry; Brenner, Steven E.; Graveley, Brenton R.; Ceniker, Susan E.; Gingeras, Thomas R.; Waterston, Robert			Comparative analysis of the transcriptome across distant species	NATURE			English	Article							GENE-EXPRESSION; LANDSCAPE; EVOLUTION; TISSUES; GENOME; CELLS	The transcriptome is the readout of the genome. Identifying common features in it across distant species can reveal fundamental principles. To this end, the ENCODE and modENCODE consortia have generated large amounts of matched RNA-sequencing data for human, worm and fly. Uniform processing and comprehensive annotation of these data allow comparison across metazoan phyla, extending beyond earlier within-phylum transcriptome comparisons and revealing ancient, conserved features(1-6). Specifically, we discover co-expression modules shared across animals, many of which are enriched in developmental genes. Moreover, we use expression patterns to align the stages in worm and fly development and find a novel pairing between worm embryo and fly pupae, in addition to the embryo-to-embryo and larvae-to-larvae pairings. Furthermore, we find that the extent of non-canonical, non-coding transcription is similar in each organism, per base pair. Finally, we find in all three organisms that the gene-expression levels, both coding and non-coding, can be quantitatively predicted from chromatin features at the promoter using a 'universal model' based on a single set of organism-independent parameters.	[Gerstein, Mark B.; Rozowsky, Joel; Yan, Koon-Kiu; Wang, Daifeng; Sisu, Cristina; Pei, Baikang; Harmanci, Arif O.; Alexander, Roger P.; Auerbach, Raymond; Fang, Gang; Kitchen, Robert R.; Leng, Ling; Mortazavi, Ali; Sethi, Anurag; Zhang, Yan; Zheng, Henry] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.; Rozowsky, Joel; Yan, Koon-Kiu; Wang, Daifeng; Sisu, Cristina; Pei, Baikang; Harmanci, Arif O.; Alexander, Roger P.; Auerbach, Raymond; Fang, Gang; Kitchen, Robert R.; Leng, Ling; Mortazavi, Ali; Sethi, Anurag; Zhang, Yan; Zheng, Henry] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA; [Cheng, Chao] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH 03755 USA; [Cheng, Chao] Geisel Sch Med Dartmouth, Inst Quantitat Biomed Sci, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Brown, James B.; Boley, Nathan P.; Booth, Benjamin W.; Hammonds, Ann; Hoskins, Roger A.; Stoiber, Marcus H.; Wan, Kenneth H.; Ceniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Brown, James B.; Li, Jingyi Jessica; Bickel, Peter J.; Huang, Haiyan; Robinson, Garrett] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Davis, Carrie A.; Bell, Kimberly; Dobins, Alex; Drenkows, Jorg; Fastucas, Megan; Jhas, Sonali; Schlesingers, Felix; Wang, Huaien; Xue, Chenghai; Zaleskis, Chris; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hillier, LaDeana; Boeck, Max E.; Ewing, Brent; Huynh, Chau; MacCoss, Michael; Merrihew, Gennifer; Strasbourger, Pnina; Thompson, Owen A.; Waterston, Robert] Dept Genome Sci, Seattle, WA 98195 USA; [Hillier, LaDeana; Boeck, Max E.; Ewing, Brent; Huynh, Chau; MacCoss, Michael; Merrihew, Gennifer; Strasbourger, Pnina; Thompson, Owen A.; Waterston, Robert] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Li, Jingyi Jessica] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Li, Jingyi Jessica] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Duff, Michael O.; May, Gemma; Olson, Sara; Yang, Li; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Djebali, Sarah; Guigo, Roderic; Lagarde, Julien; Pervouchine, Dmitri] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Djebali, Sarah; Guigo, Roderic; Lagarde, Julien; Pervouchine, Dmitri] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona 08003, Catalonia, Spain; [Alver, Burak H.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Boley, Nathan P.; Stoiber, Marcus H.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cherbas, Lucy; Cherbas, Peter; Kaufman, Thomas C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Cherbas, Lucy; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Di, Chao; Gao, Guanjun; Hu, Long; Lu, Zhi; Wen, Kejia] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Feingold, Elise A.; Good, Peter J.; Pazin, Michael J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Frankish, Adam; Harrow, Jen; Hubbard, Tim J. P.; Saunders, Gary I.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Howald, Cedric; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Howald, Cedric] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Hubbard, Tim J. P.] Kings Coll London, London WC2R 2LS, England; [Kasper, Dionna; Reinke, Valerie; Wang, Guilin] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Kato, Masaomi; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Ladewig, Erik; Lai, Eric; Wen, Jiayu] Sloan Kettering Inst, New York, NY 10065 USA; [May, Gemma] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [McWhirter, Rebecca; Miller, David M.; Spencer, William C.; Watkins, Kathie L.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Mortazavi, Ali; Murad, Rabi] Univ Calif Irvine, Irvine, CA 92697 USA; [Mortazavi, Ali; Murad, Rabi] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Oliver, Brian] NIDDK, Sect Dev Genom, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Perrimon, Norbert; Samsonova, Anastasia] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert; Samsonova, Anastasia] Harvard Univ, Sch Med, Drosophila RNAi Screening Ctr, Boston, MA 02115 USA; [Perrimon, Norbert; Samsonova, Anastasia] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Saunders, Gary I.] European Bioinformat Inst, Hinxton CB10 1SD, England; [Tanzer, Andrea] Univ Pompeu Fabra, Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Catalonia, Spain; [Tanzer, Andrea] Univ Vienna, Theoret Biochem Grp TBI, Inst Theoret Chem, A-1090 Vienna, Austria; [Yang, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Yip, Kevin] Chinese Univ Hong Kong, Hong Kong Bioinformat Ctr, Shatin, Hong Kong, Peoples R China; [Yip, Kevin] Chinese Univ Hong Kong, CUHK BGI Innovat Inst Trans Omics 5, Shatin, Hong Kong, Peoples R China; [Brenner, Steven E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Yale University; Yale University; Yale University; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cold Spring Harbor Laboratory; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Connecticut; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wellcome Trust Sanger Institute; University of Lausanne; Swiss Institute of Bioinformatics; University of London; King's College London; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Carnegie Mellon University; Vanderbilt University; University of California System; University of California Irvine; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Vienna; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese University of Hong Kong; Chinese University of Hong Kong; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gerstein, MB (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, Bass 432,266 Whitney Ave, New Haven, CT 06520 USA.	cmptxn@gersteinlab.org	Di, Chao/G-1130-2015; hu, long/GQI-0544-2022; Lagarde, Julien/AAI-1686-2020; Tanzer, Andrea/AAY-5431-2021; Hubbard, Tim J.P./AAT-4571-2020; Samsonova, Anastasia/Q-7591-2016; Sisu, Cristina/K-8994-2019; Brown, James/H-2971-2015; Guigo, Roderic/D-1303-2010; Kutalik, Zoltan/HHZ-5697-2022; Djebali, Sarah/O-9817-2014; Brenner, Steven E/A-8729-2008; Graveley, Brenton R/C-3108-2013; Samsonova, Anastasia/AAU-7269-2021; Wang, Daifeng/K-2412-2019; Hubbard, Tim J/C-2567-2008; Wen, Jiayu/R-1673-2017; Tanzer, Andrea/L-3147-2015; Yip, Kevin/AAT-4771-2020; Pervouchine, Dmitri/AAU-5399-2021; Pervouchine, Dmitri/AAE-2178-2020; Pervouchine, Dmitri/H-5252-2015; Li, Jingyi Jessica/I-2779-2019; Alexander, Roger/A-8643-2008	Lagarde, Julien/0000-0002-0290-7445; Tanzer, Andrea/0000-0003-2873-4236; Hubbard, Tim J.P./0000-0002-1767-9318; Samsonova, Anastasia/0000-0002-9353-9173; Sisu, Cristina/0000-0001-9371-0797; Guigo, Roderic/0000-0002-5738-4477; Kutalik, Zoltan/0000-0001-8285-7523; Djebali, Sarah/0000-0002-0599-1267; Brenner, Steven E/0000-0001-7559-6185; Samsonova, Anastasia/0000-0002-9353-9173; Hubbard, Tim J/0000-0002-1767-9318; Wen, Jiayu/0000-0003-1249-6456; Tanzer, Andrea/0000-0003-2873-4236; Yip, Kevin/0000-0001-5516-9944; Pervouchine, Dmitri/0000-0003-0543-9760; Pervouchine, Dmitri/0000-0003-0543-9760; Li, Jingyi Jessica/0000-0002-9288-5648; Alexander, Roger/0000-0002-2967-7395; Park, Peter/0000-0001-9378-960X; Rozowsky, Joel/0000-0002-3565-0762; Hu, Long/0000-0003-2120-3416; Zheng, Henry/0000-0001-6430-4124; Dobin, Alexander/0000-0002-4115-9128; yang, li/0000-0001-8833-7473; Perrimon, Norbert/0000-0001-7542-472X; Saunders, Gary/0000-0002-7468-0008; boeck, Max/0000-0001-9668-407X; Kasper, Dionna/0000-0002-3964-6680; Graveley, Brenton/0000-0001-5777-5892; Bell, Kimberly/0000-0003-2204-8569; Slack, Frank/0000-0001-8263-0409; Pazin, Michael/0000-0002-7561-3640; Gerstein, Mark/0000-0002-9746-3719; Frankish, Adam/0000-0002-4333-628X; Reymond, Alexandre/0000-0003-1030-8327; Alver, Burak/0000-0002-5019-7652	NHGRI; ENCODE; modENCODE project; National Human Genome Research Institute modENCODE Project under Department of Energy [U01 HG004271, U54 HG006944]; Department of Energy [R01 GM076655, DE-AC02-05CH11231, U54 HG007005]; NHGRI [K99 HG006698]; DOE [DE-AC02-05CH11231]; modENCODE DAC sub award [5710003102, 1 U01HG007031-01]; ENCODE DAC [5U01HG004695-04]; NIH [HG007000, HG007355]; Indiana METACyt Initiative of Indiana University - Lilly Endowment, Inc.; National Institutes of Health [U01HG004258, 5U54HG004555]; Wellcome Trust [WT098051]; Spanish Ministry of Education [BIO2011-26205];  [U01-HG004261];  [RC2-HG005639];  [U01 HG 004263]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004271, U41HG007355, U41HG007000, U54HG004555, U01HG007031, K99HG006698, U01HG004263, U01HG004261, RC2HG005639, U54HG007004, U41HG007234, U54HG007005, U54HG006994, U01HG004695, U01HG004258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076655] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ENCODE; modENCODE project; National Human Genome Research Institute modENCODE Project under Department of Energy; Department of Energy(United States Department of Energy (DOE)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); DOE(United States Department of Energy (DOE)); modENCODE DAC sub award; ENCODE DAC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana METACyt Initiative of Indiana University - Lilly Endowment, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Spanish Ministry of Education(Spanish Government); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank the NHGRI and the ENCODE and modENCODE projects for support. In particular, this work was funded by a contract from the National Human Genome Research Institute modENCODE Project, contract U01 HG004271 and U54 HG006944, to S.E.C. (principal investigator) and P.C., T.R.G., R.A.H. and B.R.G. (co-principal investigators) with additional support from R01 GM076655 (S.E.C.) both under Department of Energy contract no. DE-AC02-05CH11231, and U54 HG007005 to B.R.G. J.B.B.'s work was supported by NHGRI K99 HG006698 and DOE DE-AC02-05CH11231. Work in P.J.B.'s group was supported by the modENCODE DAC sub award 5710003102, 1 U01HG007031-01 and the ENCODE DAC 5U01HG004695-04. Work in M.B.G.'s group was supported by NIH grants HG007000 and HG007355. Work in Bloomington was supported in part by the Indiana METACyt Initiative of Indiana University, funded by an award from the Lilly Endowment, Inc. Work in E.C.L.'s group was supported by U01-HG004261 and RC2-HG005639. P.J.P. acknowledges support from the National Institutes of Health (grant no. U01HG004258). We thank the HAVANA team for providing annotation of the human reference genome, whose work is supported by National Institutes of Health (grant no. 5U54HG004555), the Wellcome Trust (grant no. WT098051). R.G. acknowledges support from the Spanish Ministry of Education (grant BIO2011-26205). We also acknowledge use of the Yale University Biomedical High Performance Computing Center. R.W.'s lab was supported by grant no. U01 HG 004263.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Li JJ, 2014, GENOME RES, V24, P1086, DOI 10.1101/gr.170100.113; Lu ZJ, 2011, GENOME RES, V21, P276, DOI 10.1101/gr.110189.110; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; modENCODE Consortium, 2010, SCIENCE, V330, P1798; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Simola DF, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r105; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; Yan KK, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-8-r100	19	183	185	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					445	+		10.1038/nature13424	http://dx.doi.org/10.1038/nature13424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164755	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000340840600037
J	Youk, H; Lim, WA				Youk, Hyun; Lim, Wendell A.			Sending Mixed Messages for Cell Population Control	CELL			English	Editorial Material							T-CELLS; DEATH	Cells often receive signals to proliferate, but how population density is controlled is unclear. Hart et al. now show that a single secreted molecule that instructs both proliferation and death in T cells establishes a bistable response: the population is driven to either extinction or to a homeostatically defined density.	[Youk, Hyun; Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Youk, Hyun; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.	wendell.lim@ucsf.edu	Youk, Hyun/E-2661-2016	Youk, Hyun/0000-0003-1687-5760	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM055040, R01 GM062583, P50 GM081879] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062583, R01GM055040, P50GM081879] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dai ZH, 1999, J IMMUNOL, V163, P3131; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Hart Y, 2014, CELL, V158, P1022, DOI 10.1016/j.cell.2014.07.033; Haskel-Ittah M, 2012, CELL, V150, P1016, DOI 10.1016/j.cell.2012.06.044; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; Quiel J, 2011, P NATL ACAD SCI USA, V108, P3312, DOI 10.1073/pnas.1018525108; Wang RD, 1996, EUR J IMMUNOL, V26, P2263, DOI 10.1002/eji.1830260944; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782	10	11	11	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					973	975		10.1016/j.cell.2014.08.013	http://dx.doi.org/10.1016/j.cell.2014.08.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171399	Bronze, Green Accepted			2022-12-28	WOS:000340945000002
J	Makris, UE; Abrams, RC; Gurland, B; Reid, MC				Makris, Una E.; Abrams, Robert C.; Gurland, Barry; Reid, M. Carrington			Management of Persistent Pain in the Older Patient A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LOW-BACK-PAIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROBLEM-SOLVING THERAPY; CHRONIC NONCANCER PAIN; MUSCULOSKELETAL PAIN; PRIMARY-CARE; KNEE PAIN; PHARMACOLOGICAL MANAGEMENT; SELF-MANAGEMENT; OPIOID USE	IMPORTANCE Persistent pain is highly prevalent, costly, and frequently disabling in later life. OBJECTIVE To describe barriers to the management of persistent pain among older adults, summarize current management approaches, including pharmacologic and nonpharmacologic modalities; present rehabilitative approaches; and highlight aspects of the patient-physician relationship that can help to improve treatment outcomes. This review is relevant for physicians who seek an age-appropriate approach to delivering pain care for the older adult. EVIDENCE ACQUISITION Search of MEDLINE and the Cochrane database from January 1990 through May 2014, using the search terms older adults, senior, ages 65 and above, elderly, and aged along with non-cancer pain, chronic pain, persistent pain, pain management, intractable pain, and refractory pain to identify English-language peer-reviewed systematic reviews, meta-analyses, Cochrane reviews, consensus statements, and guidelines relevant to the management of persistent pain in older adults. FINDINGS Of the 92 identified studies, 35 evaluated pharmacologic interventions, whereas 57 examined nonpharmacologic modalities; the majority (n = 50) focused on older adults with osteoarthritis. This evidence base supports a stepwise approach with acetaminophen as first-line therapy. If treatment goals are not met, a trial of a topical nonsteroidal anti-inflammatory drug, tramadol, or both is recommended. Oral nonsteroidal anti-inflammatory drugs are not recommended for long-term use. Careful surveillance to monitor for toxicity and efficacy is critical, given that advancing age increases risk for adverse effects. A multimodal approach is strongly recommended-emphasizing a combination of both pharmacologic and nonpharmacologic treatments to include physical and occupational rehabilitation, as well as cognitive-behavioral and movement-based interventions. An integrated pain management approach is ideally achieved by cultivating a strong therapeutic alliance between the older patient and the physician. CONCLUSIONS AND RELEVANCE Treatment planning for persistent pain in later life requires a clear understanding of the patient's treatment goals and expectations, comorbidities, and cognitive and functional status, as well as coordinating community resources and family support when available. A combination of pharmacologic, nonpharmacologic, and rehabilitative approaches in addition to a strong therapeutic alliance between the patient and physician is essential in setting, adjusting, and achieving realistic goals of therapy.Copyright 2014 American Medical Association. All rights reserved.	[Makris, Una E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Rheumat Dis, Dallas, TX 75390 USA; [Makris, Una E.] Vet Adm Med Ctr, Dept Med, Div Rheumatol, Dallas, TX 75216 USA; [Abrams, Robert C.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Abrams, Robert C.; Reid, M. Carrington] Weill Cornell Med Coll, Div Geriatr & Palliat Med, New York, NY USA; [Gurland, Barry] Columbia Univ, Stroud Ctr, New York, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cornell University; Cornell University; Columbia University	Reid, MC (corresponding author), Weill Cornell Med Coll, Div Geriatr & Palliat Med, 525 E 68th St,Box 39, New York, NY 10065 USA.	mcr2004@med.cornell.edu		Reid, Cary/0000-0001-8117-662X; Makris, Una/0000-0003-4750-0777	National Institute on Aging [R03AG040653, P30AG022845]; Cornell Translational Research Institute for Pain in Later Life [P30AG022845]; Rheumatology Research Foundation/ASP Junior Career Development Award in Geriatric Medicine; Center for Translational Medicine, National Institutes of Health/National Center for Advancing Translational Sciences [KL2TR001103, UL1TR001105]; Columbia University Stroud Center; Agency for Healthcare Quality and Research [R01HS020648]; Howard and Phyllis Schwartz Philanthropic Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS020648] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105, KL2TR001103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG040653, P30AG022845] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cornell Translational Research Institute for Pain in Later Life; Rheumatology Research Foundation/ASP Junior Career Development Award in Geriatric Medicine; Center for Translational Medicine, National Institutes of Health/National Center for Advancing Translational Sciences; Columbia University Stroud Center; Agency for Healthcare Quality and Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Howard and Phyllis Schwartz Philanthropic Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Makris was supported by a National Institute on Aging GEMSSTAR grant (R03AG040653) and a pilot grant award from the Cornell Translational Research Institute for Pain in Later Life (P30AG022845); she is currently supported by the Rheumatology Research Foundation/ASP Junior Career Development Award in Geriatric Medicine and by Center for Translational Medicine, National Institutes of Health/National Center for Advancing Translational Sciences grants KL2TR001103 and UL1TR001105. Dr Gurland is supported by the Columbia University Stroud Center. Dr Reid is supported by grants from the National Institute on Aging (P30AG022845) and Agency for Healthcare Quality and Research (R01HS020648). Dr Abrams and Dr Reid receive support from the Howard and Phyllis Schwartz Philanthropic Fund.	Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Alexopoulos GS, 2011, ARCH GEN PSYCHIAT, V68, P33, DOI 10.1001/archgenpsychiatry.2010.177; Sansone Randy A, 2009, Psychiatry (Edgmont), V6, P17; Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311; Baer PA, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-44; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beletsky L, 2012, JAMA-J AM MED ASSOC, V308, P1863, DOI 10.1001/jama.2012.14205; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; Bordin E.S., 1979, PSYCHOTHERAPY THEORY, V16, P252, DOI [10.1037/h0085885, DOI 10.1037/H0085885, https://doi.org/10.1037/h0085885]; Boyle J, 2012, DIABETES CARE, V35, P2451, DOI 10.2337/dc12-0656; Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Buchman AS, 2010, ARTHRIT CARE RES, V62, P1287, DOI 10.1002/acr.20200; Buckeridge D, 2010, J AM GERIATR SOC, V58, P1664, DOI 10.1111/j.1532-5415.2010.03015.x; Burch F, 2004, OSTEOARTHR CARTILAGE, V12, P253, DOI 10.1016/j.joca.2003.10.007; Butler SF, 2004, PAIN, V112, P65, DOI 10.1016/j.pain.2004.07.026; Chappell AS, 2009, PAIN, V146, P253, DOI 10.1016/j.pain.2009.06.024; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Dorflinger L, 2013, TRANSL BEHAV MED, V3, P39, DOI 10.1007/s13142-012-0158-z; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Ferreira PH, 2013, PHYS THER, V93, P470, DOI 10.2522/ptj.20120137; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; Fine PG, 2012, PAIN MED, V13, pS57, DOI 10.1111/j.1526-4637.2011.01307.x; Focht BC, 2006, J AGING PHYS ACTIV, V14, P212, DOI 10.1123/japa.14.2.212; Frantsve LME, 2007, PAIN MED, V8, P25, DOI 10.1111/j.1526-4637.2007.00250.x; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Gueldner S H, 2001, J Gerontol Nurs, V27, P35; Hadjistavropoulos T, 2007, CLIN J PAIN, V23, pS1, DOI 10.1097/AJP.0b013e31802be869; Hanlon JT, 2009, PAIN MED, V10, P959, DOI 10.1111/j.1526-4637.2009.00698.x; Hasegawa R, 2010, PHYS OCCUP THER GERI, V28, P44, DOI 10.3109/02703180903381086; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; Hicks TJ, 1999, GERIATR NURS, V20, P144, DOI 10.1016/S0197-4572(99)70006-6; Huusko TM, 2000, BRIT MED J, V321, P1107, DOI 10.1136/bmj.321.7269.1107; Inciardi JA, 2009, PAIN MED, V10, P537, DOI 10.1111/j.1526-4637.2009.00603.x; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; Jena AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1393; Jerant AF, 2005, PATIENT EDUC COUNS, V57, P300, DOI 10.1016/j.pec.2004.08.004; Johnson CM, 2006, GERIATR NURS, V27, P309, DOI 10.1016/j.gerinurse.2006.08.010; Kang JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000035; Karp JF, 2012, PAIN MED, V13, P405, DOI 10.1111/j.1526-4637.2011.01322.x; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Leveille SG, 2002, J GEN INTERN MED, V17, P766, DOI 10.1046/j.1525-1497.2002.20229.x; Leveille SG, 2001, ANN INTERN MED, V135, P1038, DOI 10.7326/0003-4819-135-12-200112180-00007; Leveille SG, 2007, PAIN, V128, P69, DOI 10.1016/j.pain.2006.08.031; Leveille SG, 2009, JAMA-J AM MED ASSOC, V302, P2214, DOI 10.1001/jama.2009.1738; Levy SS, 2012, DISABIL HEALTH J, V5, P305, DOI 10.1016/j.dhjo.2012.07.003; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Lunde LH, 2009, J CLIN PSYCHOL MED S, V16, P254, DOI 10.1007/s10880-009-9162-y; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Maizels M, 2005, AM FAM PHYSICIAN, V71, P483; Makris UE, 2010, J RHEUMATOL, V37, P1236, DOI 10.3899/jrheum.090935; Malonne H, 2005, J CLIN PHARM THER, V30, P113, DOI 10.1111/j.1365-2710.2004.00624.x; Malonne H, 2004, CLIN THER, V26, P1774, DOI 10.1016/j.clinthera.2004.11.005; Manheimer E, 2007, ANN INTERN MED, V146, P868, DOI 10.7326/0003-4819-146-12-200706190-00008; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Morello CM, 1999, ARCH INTERN MED, V159, P1931, DOI 10.1001/archinte.159.16.1931; Morone NE, 2009, PAIN MED, V10, P1395, DOI 10.1111/j.1526-4637.2009.00746.x; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; National Alliance for Model State Drug Laws (NAMSDL), STAT STAT PRESCR DRU; Nicholas MK, 2013, PAIN, V154, P824, DOI 10.1016/j.pain.2013.02.009; Nimrod G, 2010, GERONTOLOGIST, V50, P382, DOI 10.1093/geront/gnp141; Nordin C, 2013, J REHABIL MED, V45, P580, DOI 10.2340/16501977-1136; O'Neil CK, 2012, AM J GERIATR PHARMAC, V10, P331, DOI 10.1016/j.amjopharm.2012.09.004; Olfson M, 2013, J CLIN PSYCHIAT, V74, P932, DOI 10.4088/JCP.13m08349; Papaleontiou M, 2010, J AM GERIATR SOC, V58, P1353, DOI 10.1111/j.1532-5415.2010.02920.x; Park J, 2012, J AM GERIATR SOC, V60, P555, DOI 10.1111/j.1532-5415.2011.03846.x; Park J, 2011, HOLIST NURS PRACT, V25, P316, DOI 10.1097/HNP.0b013e318232c5f9; Patel KV, 2013, PAIN, V154, P2649, DOI 10.1016/j.pain.2013.07.029; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Perlman AI, 2006, ARCH INTERN MED, V166, P2533, DOI 10.1001/archinte.166.22.2533; Reid MC, 2010, PAIN MED, V11, P1063, DOI 10.1111/j.1526-4637.2010.00883.x; Reid MC, 2011, PAIN MED, V12, P1336, DOI 10.1111/j.1526-4637.2011.01211.x; Reid MC, 2005, J GERONTOL A-BIOL, V60, P793, DOI 10.1093/gerona/60.6.793; Reid MC, 2003, J AM GERIATR SOC, V51, P1092, DOI 10.1046/j.1532-5415.2003.51357.x; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Shega JW, PUBLICATION PRACTICE; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Spitz A, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-35; Steultjens EMJ, 2004, AGE AGEING, V33, P453, DOI 10.1093/ageing/afh174; Taylor AL, 2008, JAMA-J AM MED ASSOC, V299, P89, DOI 10.1001/jama.2007.25; Teh CF, 2009, PAIN MED, V10, P521, DOI 10.1111/j.1526-4637.2008.00556.x; Thielke S, 2012, J FAM PRACTICE, V61, P666; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; Tobias KR, 2014, PAIN MANAG NURS, V15, P760, DOI 10.1016/j.pmn.2013.07.013; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Trivedi Madhukar H, 2004, Prim Care Companion J Clin Psychiatry, V6, P12; Underwood M, 2008, BMJ-BRIT MED J, V336, P138, DOI 10.1136/bmj.39399.656331.25; Varrassi G, 2010, CURR MED RES OPIN, V26, P1231, DOI 10.1185/03007991003689175; Walsh NE, 2006, PHYS THER REV, V11, P289, DOI 10.1179/108331906X163432; Whitney SL, 2013, J GERIATR PHYS THER, V36, P3, DOI 10.1519/JPT.0b013e3182550ea5; Whitson HE, 2010, J GERONTOL A-BIOL, V65, P1325, DOI 10.1093/gerona/glq139; Zhang W, 2004, ANN RHEUM DIS, V63, P901, DOI 10.1136/ard.2003.018531	108	166	176	3	62	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					825	836		10.1001/jama.2014.9405	http://dx.doi.org/10.1001/jama.2014.9405			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157726	Green Accepted			2022-12-28	WOS:000340788500025
J	Gill, PG; Purnell, MA; Crumpton, N; Brown, KR; Gostling, NJ; Stampanoni, M; Rayfield, EJ				Gill, Pamela G.; Purnell, Mark A.; Crumpton, Nick; Brown, Kate Robson; Gostling, Neil J.; Stampanoni, M.; Rayfield, Emily J.			Dietary specializations and diversity in feeding ecology of the earliest stem mammals	NATURE			English	Article							MICROWEAR TEXTURE ANALYSIS; FINITE-ELEMENT-ANALYSIS; DENTAL MICROWEAR; BITE FORCE; EVOLUTION; BEHAVIOR; HARDNESS; BATS; DIVERSIFICATION; DISCRIMINATION	The origin and radiation of mammals are key events in the history of life, with fossils placing the origin at 220 million years ago, in the Late Triassic period(1). The earliest mammals, representing the first 50 million years of their evolution and including the most basal taxa, are widely considered to be generalized insectivores(1,2). This implies that the first phase of the mammalian radiation-associated with the appearance in the fossil record of important innovations such as heterodont dentition, diphyodonty and the dentary-squamosal jaw joint(1,3)-was decoupled from ecomorphological diversification(2,4). Finds of exceptionally complete specimens of later Mesozoic mammals have revealed greater ecomorphological diversity than previously suspected, including adaptations for swimming, burrowing, digging and even gliding(2,5,6), but such well-preserved fossils of earlier mammals do not exist(1), and robust analysis of their ecomorphological diversity has previously been lacking. Here we present the results of an integrated analysis, using synchrotron X-ray tomography and analyses of biomechanics, finite element models and tooth microwear textures. We find significant differences in function and dietary ecology between two of the earliest mammalia form taxa, Morganucodon and Kuehneotherium-taxa that are central to the debate on mammalian evolution. Morganucodon possessed comparatively more forceful and robust jaws and consumed 'harder' prey, comparable to extant small bodied mammals that eat considerable amounts of coleopterans. Kuehneotherium ingested a diet comparable to extant mixed feeders and specialists on 'soft' prey such as lepidopterans. Our results reveal previously hidden trophic specialization at the base of the mammalian radiation; hence even the earliest mammalia forms were beginning to diversify-morphologically, functionally and ecologically. In contrast to the prevailing view(2,4), this pattern suggests that lineage splitting during the earliest stages of mammalian evolution was associated with ecomorphological specialization and niche partitioning.	[Gill, Pamela G.; Crumpton, Nick; Gostling, Neil J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Purnell, Mark A.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Brown, Kate Robson] Univ Bristol, Dept Archaeol & Anthropol, Bristol BS8 1UU, Avon, England; [Stampanoni, M.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, M.] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Stampanoni, M.] Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland; [Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1TQ, Avon, England	University of Bristol; University of Leicester; University of Bristol; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bristol	Gill, PG (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	pam.gill@bristol.ac.uk; e.rayfield@bristol.ac.uk	Stampanoni, Marco/GRR-9695-2022; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/J-4099-2013; Purnell, Mark/A-2336-2010; Rayfield, Emily/F-5038-2010	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Purnell, Mark/0000-0002-1777-9220; Rayfield, Emily/0000-0002-2618-750X; Gill, Pamela/0000-0001-5957-3581; Gostling, Neil J./0000-0002-5960-7769	Natural Environment Research Council [NE/E010431/1, NE/K01496X/1]; European Commission [RII3-CT-2004-506008];  [NE/G018189/1]; NERC [NE/E010431/1, NE/G018189/1, NE/K01496X/1] Funding Source: UKRI; Natural Environment Research Council [NE/G018189/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank G. Armstrong, R. Asher, E. Bernard, P. Brewer, J. Bright, I. Corfe, A. Currant, A. Gill, T. Goddard, C. Hintermueller, J. Hooker, G. Jones, S. Lautenschlager, M. Lowe, F. Marone, F. Marx, C. Palmer, M. Pound, M. Ruecklin and J. Sibbick. This work was funded by Natural Environment Research Council grants NE/E010431/1 and NE/K01496X/1 to E. J. R. and P. G. G.; M. A. P. was supported by NE/G018189/1. Use of the Swiss Light Source, Paul Scherrer Institut, was supported by the European Commission 6th Framework Programme (RII3-CT-2004-506008).	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Aguirre LF, 2002, P ROY SOC B-BIOL SCI, V269, P1271, DOI 10.1098/rspb.2002.2011; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; [Anonymous], 2012, 2517822012 ISO; Barlow KE, 1997, J ZOOL, V243, P597, DOI 10.1111/j.1469-7998.1997.tb02804.x; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; Calandra I, 2012, J HUM EVOL, V63, P85, DOI 10.1016/j.jhevol.2012.05.001; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; Cox PG, 2011, J ANAT, V219, P696, DOI 10.1111/j.1469-7580.2011.01436.x; Crompton A.W., 1986, P263; CROMPTON AW, 1967, SCIENCE, V155, P1006, DOI 10.1126/science.155.3765.1006; Cuff AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065295; Currey J. D., 2002, BONES STRUCTURE MECH, P58; Davis JL, 2010, J EXP BIOL, V213, P1844, DOI 10.1242/jeb.041129; Donald B. J. M., 2007, PRACTICAL STRESS ANA; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2006, ZOOLOGY, V109, P66, DOI 10.1016/j.zool.2005.08.004; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Evans AR, 2005, AUST J ZOOL, V53, P9, DOI 10.1071/ZO04018; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P271; Freeman PW, 2007, J ZOOL, V271, P469, DOI 10.1111/j.1469-7998.2006.00231.x; Freeman PW, 2010, J ZOOL, V282, P284, DOI 10.1111/j.1469-7998.2010.00741.x; GARDINER B. G., 1961, PALAEONTOLOGY, V4, P87; Gill P. G, 2004, THESIS U BRISTOL; GILL PG, 1974, ARCH ORAL BIOL, V19, P327, DOI 10.1016/0003-9969(74)90195-2; Grimaldi DA, 2005, EVOLUTION INSECTS, P469; Grossnickle DM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2110; HIIEMAE K, 1971, ZOOL J LINN SOC-LOND, V50, P75, DOI 10.1111/j.1096-3642.1971.tb00752.x; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Kemp T. S., 2005, ORIGIN EVOLUTION MAM; KERMACK DORIS M., 1968, J LINN SOC LONDON ZOOL, V47, P407; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Purnell MA, 2013, J ZOOL, V291, P249, DOI 10.1111/jzo.12068; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; Purnell MA, 2012, J R SOC INTERFACE, V9, P2225, DOI 10.1098/rsif.2012.0140; Rasband W. S., 2012, IMAGE J; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Therrien F, 2005, J ZOOL, V267, P249, DOI 10.1017/S0952836905007430; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; Tseng ZJ, 2010, ZOOL J LINN SOC-LOND, V158, P683, DOI 10.1111/j.1096-3642.2009.00555.x; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880	63	102	105	3	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					303	+		10.1038/nature13622	http://dx.doi.org/10.1038/nature13622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143112	Green Submitted, hybrid			2022-12-28	WOS:000340508200033
J	Jamuar, SS; Lam, ATN; Kircher, M; D'Gama, AM; Wang, J; Barry, BJ; Zhang, XC; Hill, RS; Partlow, JN; Rozzo, A; Servattalab, S; Mehta, BK; Topcu, M; Amrom, D; Andermann, E; Dan, B; Parrini, E; Guerrini, R; Scheffer, IE; Berkovic, SF; Leventer, RJ; Shen, YP; Wu, BL; Barkovich, AJ; Sahin, M; Chang, BS; Bamshad, M; Nickerson, DA; Shendure, J; Poduri, A; Yu, TW; Walsh, CA				Jamuar, Saumya S.; Lam, Anh-Thu N.; Kircher, Martin; D'Gama, Alissa M.; Wang, Jian; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Topcu, Meral; Amrom, Dina; Andermann, Eva; Dan, Bernard; Parrini, Elena; Guerrini, Renzo; Scheffer, Ingrid E.; Berkovic, Samuel F.; Leventer, Richard J.; Shen, Yiping; Wu, Bai Lin; Barkovich, A. James; Sahin, Mustafa; Chang, Bernard S.; Bamshad, Michael; Nickerson, Deborah A.; Shendure, Jay; Poduri, Annapurna; Yu, Timothy W.; Walsh, Christopher A.			Somatic Mutations in Cerebral Cortical Malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE INTELLECTUAL DISABILITY; EXOME; MOSAICISM; DISEASE; DYNC1H1; TUBB2B; AKT3	BACKGROUND Although there is increasing recognition of the role of somatic mutations in genetic disorders, the prevalence of somatic mutations in neurodevelopmental disease and the optimal techniques to detect somatic mosaicism have not been systematically evaluated. METHODS Using a customized panel of known and candidate genes associated with brain malformations, we applied targeted high-coverage sequencing (depth, = 200x) to leukocyte-derived DNA samples from 158 persons with brain malformations, including the double-cortex syndrome (subcortical band heterotopia, 30 persons), polymicrogyria with megalencephaly (20), periventricular nodular heterotopia (61), and pachygyria (47). We validated candidate mutations with the use of Sanger sequencing and, for variants present at unequal read depths, subcloning followed by colony sequencing. RESULTS Validated, causal mutations were found in 27 persons (17%; range, 10 to 30% for each phenotype). Mutations were somatic in 8 of the 27 (30%), predominantly in persons with the double-cortex syndrome (in whom we found mutations in DCX and LIS1), persons with periventricular nodular heterotopia (FLNA), and persons with pachygyria (TUBB2B). Of the somatic mutations we detected, 5 (63%) were undetectable with the use of traditional Sanger sequencing but were validated through subcloning and subsequent sequencing of the subcloned DNA. We found potentially causal mutations in the candidate genes DYNC1H1, KIF5C, and other kinesin genes in persons with pachygyria. CONCLUSIONS Targeted sequencing was found to be useful for detecting somatic mutations in patients with brain malformations. High-coverage sequencing panels provide an important complement to whole-exome and whole-genome sequencing in the evaluation of somatic mutations in neuropsychiatric disease. (Funded by the National Institute of Neurological Disorders and Stroke and others.)	[Jamuar, Saumya S.; Lam, Anh-Thu N.; D'Gama, Alissa M.; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Yu, Timothy W.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet & Gen, Manton Ctr Orphan Dis Res, Howard Hughes Med Inst, Boston, MA USA; [Wang, Jian; Shen, Yiping; Wu, Bai Lin] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Sahin, Mustafa; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Jamuar, Saumya S.; Lam, Anh-Thu N.; D'Gama, Alissa M.; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Yu, Timothy W.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Jamuar, Saumya S.; Lam, Anh-Thu N.; D'Gama, Alissa M.; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Sahin, Mustafa; Poduri, Annapurna; Yu, Timothy W.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Shen, Yiping; Wu, Bai Lin] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chang, Bernard S.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Yu, Timothy W.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Jamuar, Saumya S.] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore; [Kircher, Martin; Bamshad, Michael; Nickerson, Deborah A.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wang, Jian; Shen, Yiping] Shanghai Childrens Med Ctr, Dept Lab Med, Shanghai, Peoples R China; [Topcu, Meral] Hacettepe Univ, Sch Med, Dept Pediat, Div Neurol, TR-06100 Ankara, Turkey; [Amrom, Dina; Andermann, Eva] McGill Univ, Montreal Neurol Hosp & Inst, Neurogenet Unit, Montreal, PQ, Canada; [Andermann, Eva] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Dan, Bernard] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Neurol, Brussels, Belgium; [Parrini, Elena; Guerrini, Renzo] Univ Florence, Childrens Hosp A Meyer, Pediat Neurol Unit & Labs, Florence, Italy; [Scheffer, Ingrid E.; Berkovic, Samuel F.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3010, Australia; [Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Leventer, Richard J.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; [Shen, Yiping; Wu, Bai Lin] Claritas Genom, Cambridge, MA USA; [Walsh, Christopher A.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Walsh, Christopher A.] Harvard, Cambridge, MA USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Barkovich, A. James] USCF, Benioff Childrens Hosp, San Francisco, CA USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; KK Women's & Children's Hospital; University of Washington; University of Washington Seattle; Shanghai Jiao Tong University; Hacettepe University; McGill University; McGill University; Universite Libre de Bruxelles; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco	Walsh, CA (corresponding author), Boston Childrens Hosp, Ctr Life Sci, Div Genet & Gen, 15062-2,3 Blackfan Circle, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Shendure, Jay/AAU-3684-2021; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013; SAHIN, MUSTAFA/I-8653-2019; Kircher, Martin/HDL-9392-2022; Yu, Timothy W./AAF-5738-2019; Kircher, Martin/H-6909-2019; Parrini, Elena/K-5283-2016; Zhang, Xiaochang/G-4857-2014	Scheffer, Ingrid E/0000-0002-2311-2174; SAHIN, MUSTAFA/0000-0001-7044-2953; Yu, Timothy W./0000-0003-2988-7701; Kircher, Martin/0000-0001-9278-5471; Walsh, Christopher/0000-0002-0156-2238; Parrini, Elena/0000-0001-8933-7694; Dan, Bernard/0000-0002-2051-9876; Mehta, Bhaven/0000-0003-1077-7895; Guerrini, Renzo/0000-0002-7272-7079; Shendure, Jay/0000-0002-1516-1865; Berkovic, Samuel/0000-0003-4580-841X; Zhang, Xiaochang/0000-0001-5768-7470	National Institute of Neurological Disorders and Stroke; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079277, R01NS073601, R01NS035129, R37NS035129, K23NS069784] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke and others.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Cushion TD, 2013, BRAIN, V136, P536, DOI 10.1093/brain/aws338; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Huisman SA, 2013, J MED GENET, V50, P339, DOI 10.1136/jmedgenet-2012-101477; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jamuar S, 2012, EUR J MED GENET, V55, P167, DOI 10.1016/j.ejmg.2012.01.019; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Opitz JM, 2011, NEW ENGL J MED, V365, P660, DOI 10.1056/NEJMe1107384; Pagnamenta AT, 2012, J HUM GENET, V57, P70, DOI 10.1038/jhg.2011.128; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rohlin A, 2009, HUM MUTAT, V30, P1012, DOI 10.1002/humu.20980; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	27	215	220	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					733	743		10.1056/NEJMoa1314432	http://dx.doi.org/10.1056/NEJMoa1314432			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140959	Green Accepted			2022-12-28	WOS:000340509900008
J	Teymoortash, A				Teymoortash, Afshin			Intraoral Presentation of Antrochoanal Polyp	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Marburg, Marburg, Germany	Philipps University Marburg	Teymoortash, A (corresponding author), Univ Marburg, Marburg, Germany.	teymoort@med.uni-marburg.de							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					766	766		10.1056/NEJMicm1314825	http://dx.doi.org/10.1056/NEJMicm1314825			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140962				2022-12-28	WOS:000340509900011
J	Nelson, E; van Dokkum, P; Franx, M; Brammer, G; Momcheva, I; Schreiber, NF; da Cunha, E; Tacconi, L; Bezanson, R; Kirkpatrick, A; Leja, J; Rix, HW; Skelton, R; van der Wel, A; Whitaker, K; Wuyts, S				Nelson, Erica; van Dokkum, Pieter; Franx, Marijn; Brammer, Gabriel; Momcheva, Ivelina; Schreiber, Natascha Foerster; da Cunha, Elisabete; Tacconi, Linda; Bezanson, Rachel; Kirkpatrick, Allison; Leja, Joel; Rix, Hans-Walter; Skelton, Rosalind; van der Wel, Arjen; Whitaker, Katherine; Wuyts, Stijn			A massive galaxy in its core formation phase three billion years after the Big Bang	NATURE			English	Article							HUBBLE-SPACE-TELESCOPE; STAR-FORMING GALAXIES; EXTRAGALACTIC LEGACY SURVEY; COMPACT QUIESCENT GALAXIES; HIGH-REDSHIFT; SUBMILLIMETER GALAXIES; VELOCITY DISPERSIONS; METALLICITY RELATION; LARGE-SAMPLE; RED NUGGETS	Most massive galaxies are thought to have formed their dense stellar cores in early cosmic epochs(1-3). Previous studies have found galaxies with high gas velocity dispersions(4) or small apparent sizes(5-7), but so far no objects have been identified with both the stellar structure and the gas dynamics of a forming core. Here we report a candidate core in the process of formation 11 billion years ago, at redshift z = 2.3. This galaxy, GOODS-N-774, has a stellar mass of 100 billion solar masses, a half-light radius of 1.0 kiloparsecs and a star formation rate of 90(-20)(+45) solar masses per year. The star-forming gas has a velocity dispersion of 317 +/- 30 kilometres per second. This is similar to the stellar velocity dispersions of the putative descendants of GOODS-N-774, which are compact quiescent galaxies at z approximate to 2 (refs 8-11) and giant elliptical galaxies in the nearby Universe. Galaxies such as GOODS-N-774 seem to be rare; however, from the star formation rate and size of this galaxy weinfer that many star-forming cores may be heavily obscured, and could be missed in optical and near-infrared surveys.	[Nelson, Erica; van Dokkum, Pieter; Momcheva, Ivelina; Leja, Joel] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Franx, Marijn] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Brammer, Gabriel] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Schreiber, Natascha Foerster; Tacconi, Linda; Wuyts, Stijn] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [da Cunha, Elisabete; Rix, Hans-Walter; van der Wel, Arjen] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Bezanson, Rachel] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Kirkpatrick, Allison] Univ Massachusetts, Dept Astron, Amherst, MA 01002 USA; [Skelton, Rosalind] South African Astron Observ, ZA-7935 Cape Town, South Africa; [Whitaker, Katherine] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA	Yale University; Leiden University; Leiden University - Excl LUMC; Space Telescope Science Institute; Max Planck Society; Max Planck Society; University of Arizona; University of Massachusetts System; University of Massachusetts Amherst; National Research Foundation - South Africa; South African Astronomical Observatory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Nelson, E (corresponding author), Yale Univ, Dept Astron, New Haven, CT 06511 USA.	erica.nelson@yale.edu	Brammer, Gabriel/AAB-4859-2020; da Cunha, Elisabete/AAY-2027-2021; van der Wel, Arjen/G-8365-2011; Skelton, Rosalind/S-1845-2016	Brammer, Gabriel/0000-0003-2680-005X; da Cunha, Elisabete/0000-0001-9759-4797; van der Wel, Arjen/0000-0002-5027-0135; Skelton, Rosalind/0000-0001-7393-3336; Leja, Joel/0000-0001-6755-1315	STScI [GO-1277]	STScI(Space Telescope Science Institute)	Support from STScI grant GO-1277 is acknowledged.	Alexander DM, 2003, ASTRON J, V126, P539, DOI 10.1086/376473; Barro G., 2014, PREPRINT; Barro G., 2013, PREPRINT; Belli S, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/117; Bertin G, 2002, ASTRON ASTROPHYS, V386, P149, DOI 10.1051/0004-6361:20020248; Bezanson R, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/1/L8; Brammer GB, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/13; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cimatti A, 2008, ASTRON ASTROPHYS, V482, P21, DOI 10.1051/0004-6361:20078739; da Cunha E, 2008, MON NOT R ASTRON SOC, V388, P1595, DOI 10.1111/j.1365-2966.2008.13535.x; Daddi E, 2005, ASTROPHYS J, V626, P680, DOI 10.1086/430104; Dekel A, 2014, MON NOT R ASTRON SOC, V438, P1870, DOI 10.1093/mnras/stt2331; Dekel A, 2013, MON NOT R ASTRON SOC, V435, P999, DOI 10.1093/mnras/stt1338; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Erb DK, 2006, ASTROPHYS J, V647, P128, DOI 10.1086/505341; Gilli R, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322892; Grimm HJ, 2003, MON NOT R ASTRON SOC, V339, P793, DOI 10.1046/j.1365-8711.2003.06224.x; Grogin NA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/35; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Kirkpatrick A, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/139; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Kriek M, 2009, ASTROPHYS J, V700, P221, DOI 10.1088/0004-637X/700/1/221; Leja J, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/2/L24; Lutz D, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117107; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Newman AB, 2010, ASTROPHYS J LETT, V717, pL103, DOI 10.1088/2041-8205/717/2/L103; Oser L, 2010, ASTROPHYS J, V725, P2312, DOI 10.1088/0004-637X/725/2/2312; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Skelton R. E., 2014, PREPRINT; Steidel C., 2014, ASTROPHYS J UNPUB; Szomoru D, 2010, ASTROPHYS J LETT, V714, pL244, DOI 10.1088/2041-8205/714/2/L244; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Toft S, 2007, ASTROPHYS J, V671, P285, DOI 10.1086/521810; Toft S, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/68; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Trujillo I, 2006, ASTROPHYS J, V650, P18, DOI 10.1086/506464; van de Sande J, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/85; van der Wel A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/28; van Dokkum P., 2014, ASTROPHYS J UNPUB; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; van Dokkum PG, 2009, NATURE, V460, P717, DOI 10.1038/nature08220; Wang WH, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/155; Whitaker KE, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/86; Williams CC, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/1; Wuyts S, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/96	46	64	64	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					394	+		10.1038/nature13616	http://dx.doi.org/10.1038/nature13616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25162527	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000341814900054
J	Imazio, M; Brucato, A; Ferrazzi, P; Pullara, A; Adler, Y; Barosi, A; Caforio, AL; Cemin, R; Chirillo, F; Comoglio, C; Cugola, D; Cumetti, D; Dyrda, O; Ferrua, S; Finkelstein, Y; Flocco, R; Gandino, A; Hoit, B; Innocente, F; Maestroni, S; Musumeci, F; Oh, J; Pergolini, A; Polizzi, V; Ristic, A; Simon, C; Spodick, DH; Tarzia, V; Trimboli, S; Valenti, A; Belli, R; Gaita, F				Imazio, Massimo; Brucato, Antonio; Ferrazzi, Paolo; Pullara, Alberto; Adler, Yehuda; Barosi, Alberto; Caforio, Alida L.; Cemin, Roberto; Chirillo, Fabio; Comoglio, Chiara; Cugola, Diego; Cumetti, Davide; Dyrda, Oleksandr; Ferrua, Stefania; Finkelstein, Yaron; Flocco, Roberto; Gandino, Anna; Hoit, Brian; Innocente, Francesco; Maestroni, Silvia; Musumeci, Francesco; Oh, Jae; Pergolini, Amedeo; Polizzi, Vincenzo; Ristic, Arsen; Simon, Caterina; Spodick, David H.; Tarzia, Vincenzo; Trimboli, Stefania; Valenti, Anna; Belli, Riccardo; Gaita, Fiorenzo		COPPS-2 Investigators	Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation The COPPS-2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POST-PERICARDIOTOMY SYNDROME; PLACEBO-CONTROLLED TRIAL; CARDIAC-SURGERY; DOUBLE-BLIND; METAANALYSIS; MULTICENTER; GUIDELINES; EFFUSIONS; BYPASS; RISKS	IMPORTANCE Postpericardiotomy syndrome, postoperative atrial fibrillation (AF), and postoperative effusions may be responsible for increased morbidity and health care costs after cardiac surgery. Postoperative use of colchicine prevented these complications in a single trial. OBJECTIVE To determine the efficacy and safety of perioperative use of oral colchicine in reducing postpericardiotomy syndrome, postoperative AF, and postoperative pericardial or pleural effusions. DESIGN, SETTING, AND PARTICIPANTS Investigator-initiated, double-blind, placebo-controlled, randomized clinical trial among 360 consecutive candidates for cardiac surgery enrolled in 11 Italian centers between March 2012 and March 2014. At enrollment, mean age of the trial participants was 67.5 years (SD, 10.6 years), 69% were men, and 36% had planned valvular surgery. Main exclusion criteria were absence of sinus rhythm at enrollment, cardiac transplantation, and contraindications to colchicine. INTERVENTIONS Patients were randomized to receive placebo (n=180) or colchicine (0.5 mg twice daily in patients >= 70 kg or 0.5mg once daily in patients <70 kg; n=180) starting between 48 and 72 hours before surgery and continued for 1 month after surgery. MAIN OUTCOMES AND MEASURES Occurrence of postpericardiotorny syndrome within 3 months; main secondary study end points were postoperative AF and pericardial or pleural effusion. RESULTS The primary end point of postpericardiotomy syndrome occurred in 35 patients (19.4%) assigned to colchicine and in 53 (29.4%) assigned to placebo (absolute difference, 10.0%; 95% CI, 1.1%-18.7%; number needed to treat = 10). There were no significant differences between the colchicine and placebo groups for the secondary end points of postoperative AF (colchicine, 61 patients [33.9%]; placebo, 75 patients [41.7%]; absolute difference, 7.8%; 95% CI, -2.2% to 17.6%) or postoperative pericardial/pleural effusion (colchicine, 103 patients [57.2%]; placebo, 106 patients [58.9%]; absolute difference, 1.7%; 95% CI, -8.5% to 11.7%), although there was a reduction in postoperative AF in the prespecified on-treatment analysis (placebo, 61/148 patients [41.2%]; colchicine, 38/141 patients [27.0%]; absolute difference, 14.2%; 95% CI, 3.3%-24.7%). Adverse events occurred in 21 patients (11.7%) in the placebo group vs 36 (20.0%) in the colchicine group (absolute difference, 8.3%; 95% CI; 0.76%-15.9%; number needed to harm = 12), but discontinuation rates were similar. No serious adverse events were observed. CONCLUSIONS AND RELEVANCE Among patients undergoing cardiac surgery, perioperative use of colchicine compared with placebo reduced the incidence of postpericardiotomy syndrome but not of postoperative AF or postoperative pericardial/pleural effusion. The increased risk of gastrointestinal adverse effects reduced the potential benefits of colchicine in this setting.	[Imazio, Massimo; Belli, Riccardo] Maria Vittoria Hosp, Dept Cardiol, I-10141 Turin, Italy; [Imazio, Massimo; Pullara, Alberto; Gaita, Fiorenzo] Univ Turin, Turin, Italy; [Brucato, Antonio; Ferrazzi, Paolo; Cugola, Diego; Cumetti, Davide; Innocente, Francesco; Maestroni, Silvia; Simon, Caterina; Valenti, Anna] Osped Papa Giovanni XXIII, Bergamo, Italy; [Pullara, Alberto; Gaita, Fiorenzo] AOU Citta Salute & Sci Torino, Turin, Italy; [Adler, Yehuda] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Adler, Yehuda] Sacker Univ, Tel Aviv, Israel; [Barosi, Alberto; Gandino, Anna] Osped Niguarda Ca Granda, Dept Internal Med & Cardiac Surg, Milan, Italy; [Caforio, Alida L.; Tarzia, Vincenzo] Univ Padua, Dept Cardiol Thorac & Vasc Sci, Padua, Italy; [Cemin, Roberto] Osped Reg San Maurizio, Dept Cardiol, Bolzano, Italy; [Chirillo, Fabio] Ca Foncello Hosp, Dept Cardiol & Cardiac Surg, Treviso, Italy; [Comoglio, Chiara; Dyrda, Oleksandr; Trimboli, Stefania] Villa Maria Pia Hosp, Dept Cardiac Surg & Rehabil, Turin, Italy; [Ferrua, Stefania] Osped Infermi, Dept Cardiol, Rivoli, Italy; [Finkelstein, Yaron] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Flocco, Roberto] Osped Mauriziano Umberto 1, Turin, Italy; [Hoit, Brian] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Hoit, Brian] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Musumeci, Francesco; Pergolini, Amedeo; Polizzi, Vincenzo] Osped San Camillo, Dept Cardiac Surg, Rome, Italy; [Oh, Jae] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Ristic, Arsen] Univ Belgrade, Dept Cardiol, Sch Med, Belgrade, Serbia; [Ristic, Arsen] Clin Ctr Serbia, Belgrade, Serbia; [Spodick, David H.] St Vincent Hosp, Worcester, MA 01604 USA	Maria Vittoria Hospital; University of Turin; ASST Papa Giovanni XXIII; A.O.U. Citta della Salute e della Scienza di Torino; Chaim Sheba Medical Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Padua; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Hospital of Rimini; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Mauritian Umberto I Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Azienda Ospedaliera San Camillo-Forlanini; Mayo Clinic; University of Belgrade; Clinical Centre of Serbia	Imazio, M (corresponding author), Maria Vittoria Hosp, Dept Cardiol, Via Cibrario 72, I-10141 Turin, Italy.	massimo_imazio@yahoo.it	Tarzia, Vincenzo/AAC-2097-2019; brucato, antonio/U-6879-2019; Gerosa, Gino/M-8106-2014; Caforio, Alida/AAC-3223-2019	Tarzia, Vincenzo/0000-0003-2360-2031; brucato, antonio/0000-0002-7566-5600; Gerosa, Gino/0000-0002-6261-699X; Gaita, Fiorenzo/0000-0003-3178-6205; Costanzo, Piera/0000-0002-4640-724X; Imazio, Massimo/0000-0002-5722-0245; Caforio, Alida Linda Patrizia/0000-0002-4901-5655; Ristic, Arsen/0000-0002-0713-1180	(ASLTO2) within the Italian National Health Service; Acarpia (Madeira, Portugal); FARGIM (Catania, Italy)	(ASLTO2) within the Italian National Health Service; Acarpia (Madeira, Portugal); FARGIM (Catania, Italy)	The COPPS-2 trial was supported by Azienda Sanitaria 3 of Torino (now ASLTO2) within the Italian National Health Service. Acarpia (Madeira, Portugal) provided the study drug and placebo as an unrestricted institutional grant. FARGIM (Catania, Italy) provided funding to support insurance costs for the trial.	Abdelhadi RH, 2004, AM J CARDIOL, V93, P1176, DOI 10.1016/j.amjcard.2004.01.053; Bunge JJH, 2014, AM HEART J, V168, P126, DOI 10.1016/j.ahj.2014.03.017; Bunge JJ, 2014, AM HEART J, V168, pe1; Burgess DC, 2006, EUR HEART J, V27, P2846, DOI 10.1093/eurheartj/ehl272; Finkelstein Y, 2002, HERZ, V27, P791, DOI 10.1007/s00059-002-2376-5; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Hogue CW, 2005, CHEST, V128, p9S, DOI 10.1378/chest.128.2_suppl.9S; HORNEFFER PJ, 1990, J THORAC CARDIOV SUR, V100, P292; Imazio M, 2014, LANCET, V383, P2232, DOI 10.1016/S0140-6736(13)62709-9; Imazio M, 2013, NEW ENGL J MED, V369, P1522, DOI 10.1056/NEJMoa1208536; Imazio M, 2013, INT J CARDIOL, V168, P648, DOI 10.1016/j.ijcard.2012.09.052; Imazio M, 2013, J CARDIOVASC MED, V14, P351, DOI 10.2459/JCM.0b013e328353807d; Imazio M, 2013, AM HEART J, V166, P13, DOI 10.1016/j.ahj.2013.03.025; Imazio M, 2012, CURR OPIN PULM MED, V18, P366, DOI 10.1097/MCP.0b013e32835311a2; Imazio M, 2011, CIRCULATION, V124, P2290, DOI 10.1161/CIRCULATIONAHA.111.026153; Imazio M, 2011, AM J CARDIOL, V108, P1183, DOI 10.1016/j.amjcard.2011.06.025; Imazio M, 2011, AM HEART J, V162, P527, DOI 10.1016/j.ahj.2011.05.017; Imazio M, 2011, AM J CARDIOL, V108, P575, DOI 10.1016/j.amjcard.2011.03.087; Imazio M, 2010, EUR HEART J, V31, P2749, DOI 10.1093/eurheartj/ehq319; Ishii Y, 2005, CIRCULATION, V111, P2881, DOI 10.1161/CIRCULATIONAHA.104.475194; Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789; Mitchell LB, 2011, CAN J CARDIOL, V27, P91, DOI 10.1016/j.cjca.2010.11.005; Mott AR, 2001, J AM COLL CARDIOL, V37, P1700, DOI 10.1016/S0735-1097(01)01223-2; Van Wagoner DR, 2011, CIRCULATION, V124, P2281, DOI 10.1161/CIRCULATIONAHA.111.057075; Wessman DE, 2006, SOUTH MED J, V99, P309, DOI 10.1097/01.smj.0000203330.15503.0b	25	208	223	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1016	1023		10.1001/jama.2014.11026	http://dx.doi.org/10.1001/jama.2014.11026			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25172965	Green Published, Bronze			2022-12-28	WOS:000341385600019
J	Rogers, A; Karavitaki, N; Wass, JAH				Rogers, Angela; Karavitaki, Niki; Wass, John A. H.			Diagnosis and management of prolactinomas and non-functioning pituitary adenomas	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MULTIPLE ENDOCRINE NEOPLASIA; CLINICAL-PRACTICE GUIDELINE; NATURAL-HISTORY; TYPE-1 MEN1; HYPERPROLACTINEMIA; CABERGOLINE; PREVALENCE; RADIOTHERAPY; MUTATIONS; TUMORS		[Rogers, Angela; Karavitaki, Niki; Wass, John A. H.] Univ Oxford, Dept Endocrinol, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford, England	University of Oxford	Wass, JAH (corresponding author), Univ Oxford, Dept Endocrinol, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford, England.	john.wass@nhs.net	Karavitaki, Niki/AAI-3634-2020	KARAVITAKI, NIKI/0000-0002-4696-0643				Colao A, 2003, EUR J ENDOCRINOL, V148, P325, DOI 10.1530/eje.0.1480325; Colao A, 2009, BEST PRACT RES CL EN, V23, P575, DOI 10.1016/j.beem.2009.05.003; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P4769, DOI 10.1210/jc.2006-1668; Deepak D, 2007, CLIN ENDOCRINOL, V66, P503, DOI 10.1111/j.1365-2265.2007.02759.x; Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x; Freda PU, 2011, J CLIN ENDOCR METAB, V96, P894, DOI 10.1210/jc.2010-1048; Gittoes NJL, 1998, CLIN ENDOCRINOL, V48, P331; Greenman Y, 2009, BEST PRACT RES CL EN, V23, P625, DOI 10.1016/j.beem.2009.05.005; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Karavitaki N, 2007, CLIN ENDOCRINOL, V67, P938, DOI 10.1111/j.1365-2265.2007.02990.x; Karavitaki N, 2006, CLIN ENDOCRINOL, V65, P524, DOI 10.1111/j.1365-2265.2006.02627.x; Losa M, 2002, J CLIN ENDOCR METAB, V87, P3180, DOI 10.1210/jc.87.7.3180; McCutcheon IE, 2013, CURR PROB CANCER, V37, P6, DOI 10.1016/j.currproblcancer.2012.10.001; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Fernandez-Balsells MM, 2011, J CLIN ENDOCR METAB, V96, P905, DOI 10.1210/jc.2010-1054; Molitch ME, 2014, J NEURO-ONCOL, V117, P421, DOI 10.1007/s11060-013-1270-8; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Pereira EA, 2013, BR J NEUROSURG; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Thakker RV, 2014, MOL CELL ENDOCRINOL, V386, P2, DOI 10.1016/j.mce.2013.08.002; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Thakker RV, 1998, J CLIN ENDOCR METAB, V83, P2617, DOI 10.1210/jc.83.8.2617; Verhelst J, 1999, J CLIN ENDOCR METAB, V84, P2518, DOI 10.1210/jc.84.7.2518; WEBSTER J, 1994, NEW ENGL J MED, V331, P904, DOI 10.1056/NEJM199410063311403	26	25	28	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2014	349								g5390	10.1136/bmj.g5390	http://dx.doi.org/10.1136/bmj.g5390			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QO	25208537				2022-12-28	WOS:000341691200002
J	Yawn, BP; Buchanan, GR; Afenyi-Annan, AN; Ballas, SK; Hassell, KL; James, AH; Jordan, L; Lanzkron, SM; Lottenberg, R; Savage, WJ; Tanabe, PJ; Ware, RE; Murad, MH; Goldsmith, JC; Ortiz, E; Fulwood, R; Horton, A; John-Sowah, J				Yawn, Barbara P.; Buchanan, George R.; Afenyi-Annan, Araba N.; Ballas, Samir K.; Hassell, Kathryn L.; James, Andra H.; Jordan, Lanetta; Lanzkron, Sophie M.; Lottenberg, Richard; Savage, William J.; Tanabe, Paula J.; Ware, Russell E.; Murad, M. Hassan; Goldsmith, Jonathan C.; Ortiz, Eduardo; Fulwood, Robinson; Horton, Ann; John-Sowah, Joylene			Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE CHEST SYNDROME; PULMONARY-HYPERTENSION; ADVISORY-COMMITTEE; CONTROLLED-TRIAL; HYDROXYUREA; CHILDREN; ANEMIA; TRANSFUSION; PREVENTION; STROKE	IMPORTANCE Sickle cell disease (SCD) is a life-threatening genetic disorder affecting nearly 100 000 individuals in the United States and is associated with many acute and chronic complications requiring immediate medical attention. Two disease-modifying therapies, hydroxyurea and long-term blood transfusions, are available but underused. OBJECTIVE To support and expand the number of health professionals able and willing to provide care for persons with SCD. EVIDENCE REVIEW Databases of MEDLINE (including in-process and other nonindexed citations), EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHL, TOXLINE, and Scopus were searched using prespecified search terms and keywords to identify randomized clinical trials, nonrandomized intervention studies, and observational studies. Literature searches of English-language publications from 1980 with updates through April 1, 2014, addressed key questions developed by the expert panel members and methodologists. FINDINGS Strong recommendations for preventive services include daily oral prophylactic penicillin up to the age of 5 years, annual transcranial Doppler examinations from the ages of 2 to 16 years in those with sickle cell anemia, and long-term transfusion therapy to prevent stroke in those children with abnormal transcranial Doppler velocity (>= 200 cm/s). Strong recommendations addressing acute complications include rapid initiation of opioids for treatment of severe pain associated with a vasoocclusive crisis, and use of incentive spirometry in patients hospitalized for a vasoocclusive crisis. Strong recommendations for chronic complications include use of analgesics and physical therapy for treatment of avascular necrosis, and use of angiotensin-converting enzyme inhibitor therapy for microalbuminuria in adults with SCD. Strong recommendations for children and adults with proliferative sickle cell retinopathy include referral to expert specialists for consideration of laser photocoagulation and for echocardiography to evaluate signs of pulmonary hypertension. Hydroxyurea therapy is strongly recommended for adults with 3 or more severe vasoocclusive crises during any 12-month period, with SCD pain or chronic anemia interfering with daily activities, or with severe or recurrent episodes of acute chest syndrome. A recommendation of moderate strength suggests offering treatment with hydroxyurea without regard to the presence of symptoms for infants, children, and adolescents. In persons with sickle cell anemia, preoperative transfusion therapy to increase hemoglobin levels to 10 g/dL is strongly recommended with a moderate strength recommendation to maintain sickle hemoglobin levels of less than 30% prior to the next transfusion during long-term transfusion therapy. A strong recommendation to assess iron overload is accompanied by a moderate strength recommendation to begin iron chelation therapy when indicated. CONCLUSIONS AND RELEVANCE Hydroxyurea and transfusion therapy are strongly recommended for many individuals with SCD. Many other recommendations are based on quality of evidence that is less than high due to the paucity of clinical trials regarding screening, management, and monitoring for individuals with SCD.	[Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MN 55904 USA; [Buchanan, George R.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Afenyi-Annan, Araba N.] Univ N Carolina, Chapel Hill, NC USA; [Ballas, Samir K.] Thomas Jefferson Univ, Cardeza Fdn, Philadelphia, PA 19107 USA; [Hassell, Kathryn L.] Univ Colorado, Denver, CO 80202 USA; [James, Andra H.] Univ Virginia, Charlottesville, VA USA; [Jordan, Lanetta] Univ Miami, Miller Sch Med, Fdn Sickle Cell Dis Res, Miami, FL 33136 USA; [Lanzkron, Sophie M.] Johns Hopkins Sch Med, Baltimore, MD USA; [Lottenberg, Richard] Univ Florida, Gainesville, FL USA; [Savage, William J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Savage, William J.] Harvard Univ, Sch Med, Boston, MA USA; [Tanabe, Paula J.] Duke Univ, Sch Nursing, Durham, NC USA; [Tanabe, Paula J.] Duke Univ, Sch Med, Durham, NC USA; [Ware, Russell E.] Cincinnati Childrens Hosp Med, Cincinnati, OH USA; [Murad, M. Hassan] Mayo Clin, Coll Med, Rochester, MN USA; [Goldsmith, Jonathan C.; Ortiz, Eduardo; Fulwood, Robinson; John-Sowah, Joylene] NHLBI, Bethesda, MD 20892 USA; [Horton, Ann] Amer Inst Res, Silver Spring, MD USA	Olmsted Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; Jefferson University; University of Colorado System; University of Colorado Denver; University of Virginia; University of Miami; Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Duke University; Cincinnati Children's Hospital Medical Center; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); American Institutes for Research	Yawn, BP (corresponding author), Olmsted Med Ctr, Dept Res & Educ, 210 Ninth St SE, Rochester, MN 55904 USA.	byawn@olmmed.org	Lanzkron, Sophie/AFU-9516-2022; Al Kindi, Salam/HGD-7360-2022; Lanzkron, Sophie/AAD-7584-2022; Murad, M. Hassan/AAW-4367-2020; kindi, Salam Al/Q-5172-2019	Lanzkron, Sophie/0000-0002-2878-0251; Lanzkron, Sophie/0000-0002-2878-0251; James, Andra/0000-0003-4570-6595; Murad, Mohammad Hassan/0000-0001-5502-5975	National Heart, Lung, and Blood Institute (NHLBI)	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The National Heart, Lung, and Blood Institute (NHLBI) sponsored the development of this guideline to assist health care professionals in the management of common issues of sickle cell disease. The NHLBI established the expert panel and invited the panel members. All members served as volunteers and received no compensation from the NHLBI or any other entity for their participation.	Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Ahmed F, 2011, VACCINE, V29, P9171, DOI 10.1016/j.vaccine.2011.08.005; Alio Amina P, 2005, J Natl Med Assoc, V97, P792; Anderson LM, 2013, J CLIN EPIDEMIOL, V66, P1223, DOI 10.1016/j.jclinepi.2013.06.014; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ataga KI, 2000, AM J HEMATOL, V63, P205, DOI 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.3.CO;2-#; Aygun B, 2002, TRANSFUSION, V42, P37, DOI 10.1046/j.1537-2995.2002.00007.x; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Ballas SK, 2010, AM J HEMATOL, V85, P6, DOI 10.1002/ajh.21550; Ballas SK, 2005, AM J HEMATOL, V79, P17, DOI 10.1002/ajh.20336; Ballas SK, 2004, MICROCIRCULATION, V11, P209, DOI 10.1080/10739680490279410; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Barfield WD, 2010, AM J PREV MED, V38, pS542, DOI 10.1016/j.amepre.2009.12.020; BELLET PS, 1995, NEW ENGL J MED, V333, P699, DOI 10.1056/NEJM199509143331104; Benjamin LJ, 1999, GUIDELINE FOR THE MA; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Booth C, 2010, INT J INFECT DIS, V14, pE2, DOI 10.1016/j.ijid.2009.03.010; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; Brito JP, 2013, J CLIN ENDOCR METAB, V98, P3246, DOI 10.1210/jc.2013-1814; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; CHARACHE S, 1979, ARCH INTERN MED, V139, P67, DOI 10.1001/archinte.139.1.67; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chou ST, 2013, HEMATOL-AM SOC HEMAT, P439, DOI 10.1182/asheducation-2013.1.439; Curtis Kathryn M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Dampier C, 2002, J PAIN, V3, P461, DOI 10.1054/jpai.2002.128064; Danielson CFM, 2002, THER APHER, V6, P24, DOI 10.1046/j.1526-0968.2002.00396.x; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; Elagouz M, 2010, SURV OPHTHALMOL, V55, P359, DOI 10.1016/j.survophthal.2009.11.004; Enninful-Eghan H, 2010, J PEDIATR-US, V157, P479, DOI 10.1016/j.jpeds.2010.03.007; Farrell K, 2010, J NATL MED ASSOC, V102, P1000, DOI 10.1016/S0027-9684(15)30726-4; Flanagan JM, 2010, MUTAT RES-GEN TOX EN, V698, P38, DOI 10.1016/j.mrgentox.2010.03.001; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Hebbel R.P, 1994, SICKLE CELL DIS BASI; Herrick JB., 1910, ARCH INTERN MED, V6, P517, DOI [10.1001/archinte.1910.00050330050003, DOI 10.1001/ARCHINTE.1910.00050330050003]; Howard J, 2013, LANCET, V381, P930, DOI 10.1016/S0140-6736(12)61726-7; Hsieh MM, 2014, JAMA-J AM MED ASSOC, V312, P48, DOI 10.1001/jama.2014.7192; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Jacob E, 2005, J PAIN SYMPTOM MANAG, V29, P392, DOI 10.1016/j.jpainsymman.2004.07.006; Kavanagh PL, 2011, PEDIATRICS, V128, pE1552, DOI 10.1542/peds.2010-3686; King SB, 2004, FREE RADICAL BIO MED, V37, P737, DOI 10.1016/j.freeradbiomed.2004.02.073; Klings ES, 2014, AM J RESP CRIT CARE, V189, P727, DOI 10.1164/rccm.201401-0065ST; Kochanek K. D., 2011, CTR DIS CONTROL PREV, V59, P1; Lanzkron S, 2008, ANN INTERN MED, V148, P939, DOI 10.7326/0003-4819-148-12-200806170-00221; McGann PT, 2011, BRIT J HAEMATOL, V154, P134, DOI 10.1111/j.1365-2141.2011.08698.x; Miller ST, 2001, J PEDIATR-US, V139, P385, DOI 10.1067/mpd.2001.117580; MILNER PF, 1991, NEW ENGL J MED, V325, P1476, DOI 10.1056/NEJM199111213252104; MORIARTY BJ, 1988, EYE, V2, P330, DOI 10.1038/eye.1988.62; Olujohungbe AB, 2011, J ANDROL, V32, P375, DOI 10.2164/jandrol.110.010934; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Paule I, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-30; POWARS DR, 1991, ANN INTERN MED, V115, P614, DOI 10.7326/0003-4819-115-8-614; Segal Jodi B, 2008, Evid Rep Technol Assess (Full Rep), P1; Serjeant DR, 2001, SICKLE CELL DISEASE; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sheth S, 2013, BRIT J HAEMATOL, V162, P455, DOI 10.1111/bjh.12413; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Strouse JJ, 2008, PEDIATRICS, V122, P1332, DOI 10.1542/peds.2008-0441; Talano JAM, 2003, PEDIATRICS, V111, pE661, DOI 10.1542/peds.111.6.e661; US Centers for Disease Control and Prevention, SICKLE CELL DISEASE; Verduzco LA, 2009, BLOOD, V114, P5117, DOI 10.1182/blood-2009-05-220921; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Villers MS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.016; Voskaridou E, 2010, BLOOD, V115, P2354, DOI 10.1182/blood-2009-05-221333; Wang WC, 2013, COCHRANE DB SYST REV, V11; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2004, J PEDIATR-US, V145, P346, DOI 10.1016/j.jpeds.2004.04.058; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475	73	837	846	2	144	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1033	1048		10.1001/jama.2014.10517	http://dx.doi.org/10.1001/jama.2014.10517			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203083				2022-12-28	WOS:000341385600021
J	Zhou, J; Lancaster, L; Donohue, JP; Noller, HF				Zhou, Jie; Lancaster, Laura; Donohue, John Paul; Noller, Harry F.			How the ribosome hands the A-site tRNA to the P site during EF-G-catalyzed translocation	SCIENCE			English	Article							MESSENGER-RNA; MOVEMENT; SUBUNIT; VISUALIZATION; HYDROLYSIS; HEAD; GTP	Coupled translocation of messenger RNA and transfer RNA (tRNA) through the ribosome, a process catalyzed by elongation factor EF-G, is a crucial step in protein synthesis. The crystal structure of a bacterial translocation complex describes the binding states of two tRNAs trapped in mid-translocation. The deacylated P-site tRNA has moved into a partly translocated pe/E chimeric hybrid state. The anticodon stem-loop of the A-site tRNA is captured in transition toward the 30S P site, while its 3' acceptor end contacts both the A and P loops of the 50S subunit, forming an ap/ap chimeric hybrid state. The structure shows how features of ribosomal RNA rearrange to hand off the A-site tRNA to the P site, revealing an active role for ribosomal RNA in the translocation process.	[Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol, RNA, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol, RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu		Zhou, Jie/0000-0001-6521-1384	NIH [GM-17129, GM59140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, R01GM017129, R01GM059140, R37GM017129] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM-17129 and GM59140. We thank the beamline staffs at the Advanced Light Source, Stanford Synchrotron Radiation Laboratory, and Advanced Photon Source for their expert support. Structures have been deposited with Protein Data Bank (PDB) accession numbers 4QS0, 4QS1, 4QS2, and 4QS3.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; Brilot AF, 2013, P NATL ACAD SCI USA, V110, P20994, DOI 10.1073/pnas.1311423110; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Cunha CE, 2013, TRANSLATION, V1, DOI 10.4161/trla.24315; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Holtkamp W, 2014, EMBO J, V33, P1073, DOI 10.1002/embj.201387465; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Khade PK, 2011, NAT STRUCT MOL BIOL, V18, P1300, DOI 10.1038/nsmb.2140; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086	30	117	118	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1188	1191		10.1126/science.1255030	http://dx.doi.org/10.1126/science.1255030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190797	Green Accepted			2022-12-28	WOS:000341179800049
J	Burov, E; Gerya, T				Burov, Evgueni; Gerya, Taras			Asymmetric three-dimensional topography over mantle plumes	NATURE			English	Article							DYNAMIC TOPOGRAPHY; FLOOD BASALTS; CONTINENTAL LITHOSPHERE; SURFACE-TOPOGRAPHY; TEMPERATURE; INSTABILITY; TRANSITION; CONVECTION; RHEOLOGY; AFRICA	The role of mantle-lithosphere interactions in shaping surface topography has long been debated(1-3). In general(3,4), it is supposed that mantle plumes and vertical mantle flows result in axisymmetric, long-wavelength topography, which strongly differs from the generally asymmetric short-wavelength topography created by intraplate tectonic forces. However, identification of mantle-induced topography is difficult(3), especially in the continents(5). It can be argued therefore that complex brittle-ductile rheology and stratification of the continental lithosphere result in short-wavelength modulation and localization of deformation induced by mantle flow(6). This deformation should also be affected by far-field stresses and, hence, interplay with the 'tectonic' topography (for example, in the 'active/passive' rifting scenario(7,8)). Testing these ideas requires fully coupled three-dimensional numerical modelling of mantle-lithosphere interactions, which so far has not been possible owing to the conceptual and technical limitations of earlier approaches. Here we present new, ultra-high-resolution, three-dimensional numerical experiments on topography over mantle plumes, incorporating a weakly pre-stressed (ultra-slow spreading), rheologically realistic lithosphere. The results show complex surface evolution, which is very different from the smooth, radially symmetric patterns usually assumed as the canonical surface signature of mantle upwellings(9). In particular, the topography exhibits strongly asymmetric, small-scale, three-dimensional features, which include narrow and wide rifts, flexural flank uplifts and fault structures. This suggests a dominant role for continental rheological structure and intra-plate stresses in controlling dynamic topography, mantle-lithosphere interactions, and continental break-up processes above mantle plumes.	[Burov, Evgueni] Univ Paris 06, Sorbonne Univ, UMR 7193, Inst Sci Terre Paris ISTeP, F-75005 Paris, France; [Burov, Evgueni] CNRS, UMR 7193, Inst Sci Terre Paris ISTeP, F-75005 Paris, France; [Gerya, Taras] ETH, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Swiss Federal Institutes of Technology Domain; ETH Zurich	Burov, E (corresponding author), Univ Paris 06, Sorbonne Univ, UMR 7193, Inst Sci Terre Paris ISTeP, F-75005 Paris, France.	evgenii.burov@upmc.fr	Gerya, Taras/V-2330-2019	Gerya, Taras/0000-0002-1062-2722	Advanced ERC grant RHEOLITH; INSU-CNRS; UPMC Invited Professor grant; ETH Invited Professor grant	Advanced ERC grant RHEOLITH; INSU-CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC Invited Professor grant; ETH Invited Professor grant	B. Evans and P. Molnar are thanked for discussions. A. B. Watts is thanked for comments on the manuscript and corrections to it. This study was co-funded by an Advanced ERC grant RHEOLITH (E. B.), by INSU-CNRS, by a UPMC Invited Professor grant (T. G.) and by an ETH Invited Professor grant (E. B.). Numerical simulations were performed on the ETH Brutus cluster and on the ERC-funded SGI Ulysse cluster of ISTEP (UPMC). Open source software ParaView (http://www.paraview.org) was used for 3D visualization.	ANDERSON DL, 1994, EARTH PLANET SC LETT, V123, P269, DOI 10.1016/0012-821X(94)90273-9; BOHER M, 1992, J GEOPHYS RES-SOL EA, V97, P345, DOI 10.1029/91JB01640; Buck R., 2007, TREATISE GEOPHYS, V6, P335; Burgmann R., 2008, ANN REV EARTH PLANET, V36, P531; Burov E, 2005, GEOPHYS J INT, V161, P469, DOI 10.1111/j.1365-246X.2005.02588.x; Burov E, 2008, LITHOS, V103, P178, DOI 10.1016/j.lithos.2007.09.014; Burov E, 2007, TECTONOPHYSICS, V434, P15, DOI 10.1016/j.tecto.2007.01.002; Burov EB, 2011, MAR PETROL GEOL, V28, P1402, DOI 10.1016/j.marpetgeo.2011.05.008; Burov E, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041535; CARISTAN Y, 1982, J GEOPHYS RES, V87, P6781, DOI 10.1029/JB087iB08p06781; CARTER NL, 1983, TECTONOPHYSICS, V92, P275, DOI 10.1016/0040-1951(83)90200-7; Collins JA, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003881; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Crameri F, 2012, GEOPHYS J INT, V189, P38, DOI 10.1111/j.1365-246X.2012.05388.x; CUNDALL PA, 1989, ING ARCH, V59, P148, DOI 10.1007/BF00538368; DAVIES GF, 1992, EARTH PLANET SC LETT, V113, P277, DOI 10.1016/0012-821X(92)90225-K; Duretz T, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003567; Durham WB, 2009, PHYS EARTH PLANET IN, V172, P67, DOI 10.1016/j.pepi.2008.07.045; Faccenna C, 2010, NATURE, V465, P602, DOI 10.1038/nature09064; Flament N, 2013, LITHOSPHERE-US, V5, P189, DOI 10.1130/L245.1; Foulger GR, 2000, GEOPHYS J INT, V142, pF1, DOI 10.1046/j.1365-246x.2000.00245.x; Gerya T. V., 2010, INTRO NUMERICAL GEOD, DOI 10.1017/9781316534243; Gerya TV, 2007, PHYS EARTH PLANET IN, V163, P83, DOI 10.1016/j.pepi.2007.04.015; Goes S, 1999, SCIENCE, V286, P1928, DOI 10.1126/science.286.5446.1928; GOETZE C, 1979, GEOPHYS J ROY ASTR S, V59, P463, DOI 10.1111/j.1365-246X.1979.tb02567.x; Guillou-Frottier L, 2007, GLOBAL PLANET CHANGE, V58, P119, DOI 10.1016/j.gloplacha.2006.10.003; HAGER BH, 1985, NATURE, V313, P541, DOI 10.1038/313541a0; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Lin SC, 2005, NATURE, V436, P250, DOI 10.1038/nature03697; Lithgow-Bertelloni C, 1998, NATURE, V395, P269, DOI 10.1038/26212; Lustrino M, 2007, GEOL SOC AM SPEC PAP, V430, P723, DOI 10.1130/2007.2430(33); Molnar P, 2004, GEOPHYS J INT, V158, P1134, DOI 10.1111/j.1365-246X.2004.02312.x; Molnar P, 2013, J GEOPHYS RES-SOL EA, V118, P2544, DOI 10.1002/jgrb.50203; Moreira M, 1996, GEOPHYS RES LETT, V23, P2453, DOI 10.1029/96GL02301; Moucha R, 2011, NAT GEOSCI, V4, P707, DOI [10.1038/ngeo1235, 10.1038/NGEO1235]; Pik R, 2006, CHEM GEOL, V226, P100, DOI 10.1016/j.chemgeo.2005.09.016; Ranalli G., 1995, RHEOLOGY EARTH; Sleep NH, 2002, GEOL SOC SPEC PUBL, V199, P135, DOI 10.1144/GSL.SP.2002.199.01.08; Sleep NH, 1997, J GEOPHYS RES-SOL EA, V102, P10001, DOI 10.1029/97JB00551; Sun DY, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042339; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; Ueda K, 2008, PHYS EARTH PLANET IN, V171, P296, DOI 10.1016/j.pepi.2008.06.032; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; WESSEL P, 1994, J GEOPHYS RES-SOL EA, V99, P2747, DOI 10.1029/93JB02876	45	140	147	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					85	+		10.1038/nature13703	http://dx.doi.org/10.1038/nature13703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186903				2022-12-28	WOS:000341174800035
J	Reames, BN; Finks, JF; Bacal, D; Carlin, AM; Dimick, JB				Reames, Bradley N.; Finks, Jonathan F.; Bacal, Daniel; Carlin, Arthur M.; Dimick, Justin B.			Changes in Bariatric Surgery Procedure Use in Michigan, 2006-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SLEEVE GASTRECTOMY; OBESITY; TRENDS		[Reames, Bradley N.; Dimick, Justin B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Bacal, Daniel] Oakwood Hosp & Med Ctr, Dearborn, MI USA; [Carlin, Arthur M.] Henry Ford Hlth Syst, Detroit, MI USA	University of Michigan System; University of Michigan; Beaumont Health; Henry Ford Health System; Henry Ford Hospital	Reames, BN (corresponding author), Univ Michigan, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	breames@umich.edu		Reames, Bradley N./0000-0001-7575-7196	NATIONAL CANCER INSTITUTE [T32CA009672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK100710] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009672, 5T32CA009672-23] Funding Source: Medline; NIDDK NIH HHS [R21 DK100710] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Carlin AM, 2013, ANN SURG, V257, P791, DOI 10.1097/SLA.0b013e3182879ded; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Lazzati A, 2014, SURG OBES RELAT DIS, V10, P328, DOI 10.1016/j.soard.2013.07.015; Nguyen NT, 2013, J AM COLL SURGEONS, V216, P252, DOI 10.1016/j.jamcollsurg.2012.10.003; Nguyen NT, 2011, J AM COLL SURGEONS, V213, P261, DOI 10.1016/j.jamcollsurg.2011.04.030; Padwal R, 2011, J GEN INTERN MED, V26, P1183, DOI 10.1007/s11606-011-1721-x	6	96	96	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					959	961		10.1001/jama.2014.7651	http://dx.doi.org/10.1001/jama.2014.7651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182106	Green Accepted, Bronze			2022-12-28	WOS:000341668600026
J	Carneiro, M; Rubin, CJ; Di Palma, F; Albert, FW; Alfoldi, J; Barrio, AM; Pielberg, G; Rafati, N; Sayyab, S; Turner-Maier, J; Younis, S; Afonso, S; Aken, B; Alves, JM; Barrell, D; Bolet, G; Boucher, S; Burbano, HA; Campos, R; Chang, JL; Duranthon, V; Fontanesi, L; Garreau, H; Heiman, D; Johnson, J; Mage, RG; Peng, Z; Queney, G; Rogel-Gaillard, C; Ruffier, M; Searle, S; Villafuerte, R; Xiong, AQ; Young, S; Forsberg-Nilsson, K; Good, JM; Lander, ES; Ferrand, N; Lindblad-Toh, K; Andersson, L				Carneiro, Miguel; Rubin, Carl-Johan; Di Palma, Federica; Albert, Frank W.; Alfoeldi, Jessica; Barrio, Alvaro Martinez; Pielberg, Gerli; Rafati, Nima; Sayyab, Shumaila; Turner-Maier, Jason; Younis, Shady; Afonso, Sandra; Aken, Bronwen; Alves, Joel M.; Barrell, Daniel; Bolet, Gerard; Boucher, Samuel; Burbano, Hernan A.; Campos, Rita; Chang, Jean L.; Duranthon, Veronique; Fontanesi, Luca; Garreau, Herve; Heiman, David; Johnson, Jeremy; Mage, Rose G.; Peng, Ze; Queney, Guillaume; Rogel-Gaillard, Claire; Ruffier, Magali; Searle, Steve; Villafuerte, Rafael; Xiong, Anqi; Young, Sarah; Forsberg-Nilsson, Karin; Good, Jeffrey M.; Lander, Eric S.; Ferrand, Nuno; Lindblad-Toh, Kerstin; Andersson, Leif			Rabbit genome analysis reveals a polygenic basis for phenotypic change during domestication	SCIENCE			English	Article							SELECTION; GENETICS; SWEEPS	The genetic changes underlying the initial steps of animal domestication are still poorly understood. We generated a high-quality reference genome for the rabbit and compared it to resequencing data from populations of wild and domestic rabbits. We identified more than 100 selective sweeps specific to domestic rabbits but only a relatively small number of fixed (or nearly fixed) single-nucleotide polymorphisms (SNPs) for derived alleles. SNPs with marked allele frequency differences between wild and domestic rabbits were enriched for conserved noncoding sites. Enrichment analyses suggest that genes affecting brain and neuronal development have often been targeted during domestication. We propose that because of a truly complex genetic background, tame behavior in rabbits and other domestic animals evolved by shifts in allele frequencies at many loci, rather than by critical changes at only a few domestication loci.	[Carneiro, Miguel; Afonso, Sandra; Alves, Joel M.; Campos, Rita; Ferrand, Nuno] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, P-4485661 Vairao, Portugal; [Rubin, Carl-Johan; Barrio, Alvaro Martinez; Pielberg, Gerli; Rafati, Nima; Younis, Shady; Lindblad-Toh, Kerstin; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, Uppsala, Sweden; [Di Palma, Federica; Alfoeldi, Jessica; Turner-Maier, Jason; Chang, Jean L.; Heiman, David; Johnson, Jeremy; Young, Sarah; Lander, Eric S.; Lindblad-Toh, Kerstin] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Di Palma, Federica] Genome Anal Ctr, Norwich, Norfolk, England; [Albert, Frank W.; Burbano, Hernan A.; Good, Jeffrey M.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Sayyab, Shumaila; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Younis, Shady] Ain Shams Univ, Dept Anim Prod, Cairo, Egypt; [Aken, Bronwen; Barrell, Daniel; Ruffier, Magali; Searle, Steve] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Aken, Bronwen; Barrell, Daniel; Ruffier, Magali] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Alves, Joel M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Bolet, Gerard; Garreau, Herve] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Boucher, Samuel] Labovet Conseil, F-85505 Les Herbiers, France; [Duranthon, Veronique] INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France; [Fontanesi, Luca] Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, I-40127 Bologna, Italy; [Mage, Rose G.] NIAID, Lab Immunol, NIH, Bethesda, MD 20892 USA; [Peng, Ze] US Dept Energy Joint Genome Inst, Lawrence Berkeley Natl Lab, Walnut Creek, CA 94598 USA; [Queney, Guillaume] ANTAGENE, Anim Genom Lab, Lyon, France; [Rogel-Gaillard, Claire] INRA, Genet Anim & Biol Integrat UMR1313, F-78350 Jouy En Josas, France; [Villafuerte, Rafael] IESA CSIC Campo Santo Martires 7, Inst Estudios Sociales Avanzados, Cordoba, Spain; [Xiong, Anqi; Forsberg-Nilsson, Karin] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Ferrand, Nuno] Univ Porto, Fac Ciencias, Dept Biol, P-4169007 Oporto, Portugal; [Andersson, Leif] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Universidade do Porto; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; The Genome Analysis Centre (TGAC); Max Planck Society; Swedish University of Agricultural Sciences; Egyptian Knowledge Bank (EKB); Ain Shams University; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Cambridge; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Bologna; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-IESA - Instituto de Estudios Sociales Avanzados; Uppsala University; University of Montana System; University of Montana; Universidade do Porto; Texas A&M University System; Texas A&M University College Station	Lindblad-Toh, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, Uppsala, Sweden.	kersli@broadinstitute.org; leif.andersson@imbim.uu.se	Campos, Rita/AAH-2067-2022; Campos, Rita/T-3575-2017; Villafuerte, Rafael/P-9155-2019; Duranthon, Véronique/D-8855-2019; Campos, Rita/AFL-9850-2022; afonso, sandra/M-5702-2013; QUENEY, Guillaume/C-5723-2009; Ferrand, Nuno/E-6085-2014; Afonso, Sandra/AAV-9350-2021; Forsberg-Nilsson, Karin/D-9604-2019; Fontanesi, Luca/L-1770-2014; Villafuerte, Rafael/L-8715-2013; Rafati, Nima/AAX-8592-2021; Carneiro, Miguel/L-7864-2013; Alves, Joel/L-8007-2013	Campos, Rita/0000-0003-4184-3269; Campos, Rita/0000-0003-4184-3269; Villafuerte, Rafael/0000-0001-7582-4299; Duranthon, Véronique/0000-0001-8120-7481; Campos, Rita/0000-0003-4184-3269; afonso, sandra/0000-0001-7212-991X; QUENEY, Guillaume/0000-0002-6071-5169; Ferrand, Nuno/0000-0002-2408-4195; Afonso, Sandra/0000-0001-7212-991X; Forsberg-Nilsson, Karin/0000-0003-0692-6245; Fontanesi, Luca/0000-0001-7050-3760; Villafuerte, Rafael/0000-0001-7582-4299; Rafati, Nima/0000-0002-3687-9745; Carneiro, Miguel/0000-0001-9882-7775; Younis, Shady/0000-0002-4319-1738; Albert, Frank/0000-0002-1380-8063; Xiong, Anqi/0000-0003-3212-5142; Heiman, David/0000-0001-7895-4259; Barrell, Daniel/0000-0002-0977-0963; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Alves, Joel/0000-0001-6138-9134; Aken, Bronwen/0000-0002-3032-4095; Burbano, Hernan A./0000-0003-3433-719X; Di-Palma, Federica/0000-0002-4394-0102; Ruffier, Magali/0000-0002-8386-1580; Rubin, Carl-Johan/0000-0001-8238-5052	National Human Genome Research Institute [U54 HG003067]; European Research Council; Wellcome Trust [WT095908, WT098051]; NIH, NIAID; European Molecular Biology Laboratory; European Social Fund; Portuguese Ministerio da Ciencia, Tecnologia e Ensino Superior [SFRH/BPD/72343/2010, SFRH/BPD/64365/2009, SFRH/BD/72381/2010]; NSF [OISE-0754461]; FEDER through COMPETE program; Fundacao para a Ciencia e a Tecnologia [PTDC/CVT/122943/2010, PTDC/BIA-EVF/115069/2009, PTDC/BIA-BDE/72304/2006, PTDC/BIA-BDE/72277/2006]; project "Genomics and Evolutionary Biology" - North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under National Strategic Reference Framework; project "Genomics Applied to Genetic Resources" - North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under National Strategic Reference Framework; European Regional Development Fund (COST Action) [TD1101]; Higher Education Commission in Pakistan; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Molecular Biology Laboratory; European Social Fund(European Social Fund (ESF)); Portuguese Ministerio da Ciencia, Tecnologia e Ensino Superior; NSF(National Science Foundation (NSF)); FEDER through COMPETE program; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); project "Genomics and Evolutionary Biology" - North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under National Strategic Reference Framework; project "Genomics Applied to Genetic Resources" - North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under National Strategic Reference Framework; European Regional Development Fund (COST Action); Higher Education Commission in Pakistan(Higher Education Commission of Pakistan); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the National Human Genome Research Institute (U54 HG003067 to E. S. L.), European Research Council project BATESON to L. A., the Wellcome Trust (grants WT095908 and WT098051), the intramural research program of the NIH, NIAID (R. G. M.), the European Molecular Biology Laboratory, Programa Operacional Potencial Humano-Quadro de Referencia Estrategica Nacional funds from the European Social Fund and Portuguese Ministerio da Ciencia, Tecnologia e Ensino Superior [postdoc grants to M. C. (SFRH/BPD/72343/2010) and R. C. (SFRH/BPD/64365/2009) and Ph.D. grant to J.M.A. (SFRH/BD/72381/2010)], a NSF international postdoctoral fellowship to J.M.G. (OISE-0754461), FEDER funds through the COMPETE program and Portuguese national funds through the Fundacao para a Ciencia e a Tecnologia (PTDC/CVT/122943/2010, PTDC/BIA-EVF/115069/2009, PTDC/BIA-BDE/72304/2006, and PTDC/BIA-BDE/72277/2006), the projects "Genomics and Evolutionary Biology" and "Genomics Applied to Genetic Resources" cofinanced by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte) under the National Strategic Reference Framework and the European Regional Development Fund, travel grants to M. C. (COST Action TD1101), and Higher Education Commission in Pakistan (support for Sh.S.). We are grateful to L. Gaffney for assistance with figure preparation, P. C. Alves and S. Mills for providing the snowshoe hare sample, and S. Paabo for hosting M. C., S. A., and R. C. Sequencing was performed by the Broad Institute Genomics Platform. Computer resources were supplied by BITS and UPPNEX at Science for Life Laboratory. The O. cuniculus genome assembly has been deposited in GenBank under the accession number AAGW02000000. The RNA sequencing data have been deposited in GenBank under the bioproject PRJNA78323, the rabbit genome resequencing data under the bioproject PRJNA242290, and the sequence capture data under the bioproject PRJNA221358.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Andersson L, 2013, CURR OPIN GENET DEV, V23, P295, DOI 10.1016/j.gde.2013.02.014; Carneiro M, 2012, MOL BIOL EVOL, V29, P1837, DOI 10.1093/molbev/mss025; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; Clutton-Brock J., 1999, NATURAL HIST DOMESTI; Darwin C., 1859, ORIGINS SPECIES MEAN; Deng H, 2012, NAT REV NEUROL, V8, P203, DOI 10.1038/nrneurol.2012.26; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105	18	246	255	7	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1074	1079		10.1126/science.1253714	http://dx.doi.org/10.1126/science.1253714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170157	Green Accepted, Green Submitted			2022-12-28	WOS:000340870900046
J	Koch, H; Galushko, A; Albertsen, M; Schintlmeister, A; Gruber-Dorninger, C; Lucker, S; Pelletier, E; Le Paslier, D; Spieck, E; Richter, A; Nielsen, PH; Wagner, M; Daims, H				Koch, Hanna; Galushko, Alexander; Albertsen, Mads; Schintlmeister, Arno; Gruber-Dorninger, Christiane; Luecker, Sebastian; Pelletier, Eric; Le Paslier, Denis; Spieck, Eva; Richter, Andreas; Nielsen, Per H.; Wagner, Michael; Daims, Holger			Growth of nitrite-oxidizing bacteria by aerobic hydrogen oxidation	SCIENCE			English	Article							SP-NOV; METABOLISM; PHYSIOLOGY; EVOLUTION	The bacterial oxidation of nitrite to nitrate is a key process of the biogeochemical nitrogen cycle. Nitrite-oxidizing bacteria are considered a highly specialized functional group, which depends on the supply of nitrite from other microorganisms and whose distribution strictly correlates with nitrification in the environment and in wastewater treatment plants. On the basis of genomics, physiological experiments, and single-cell analyses, we show that Nitrospira moscoviensis, which represents a widely distributed lineage of nitrite-oxidizing bacteria, has the genetic inventory to utilize hydrogen (H-2) as an alternative energy source for aerobic respiration and grows on H-2 without nitrite. CO2 fixation occurred with H-2 as the sole electron donor. Our results demonstrate a chemolithoautotrophic lifestyle of nitrite-oxidizing bacteria outside the nitrogen cycle, suggesting greater ecological flexibility than previously assumed.	[Koch, Hanna; Galushko, Alexander; Schintlmeister, Arno; Gruber-Dorninger, Christiane; Luecker, Sebastian; Wagner, Michael; Daims, Holger] Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, A-1090 Vienna, Austria; [Albertsen, Mads; Nielsen, Per H.] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Ctr Microbial Communities, DK-9000 Aalborg, Denmark; [Schintlmeister, Arno] Univ Vienna, Large Instrument Facil Adv Isotope Res, A-1090 Vienna, Austria; [Pelletier, Eric; Le Paslier, Denis] Genoscope, Inst Genom, Direct Sci Vivant, CEA, F-91057 Evry, France; [Pelletier, Eric; Le Paslier, Denis] CNRS, UMR8030, F-91057 Evry, France; [Pelletier, Eric; Le Paslier, Denis] Univ Evry Val dEssonne, F-91057 Evry, France; [Spieck, Eva] Univ Hamburg, Biozentrum Klein Flottbek, D-22609 Hamburg, Germany; [Richter, Andreas] Univ Vienna, Div Terr Ecosyst Res, Dept Microbiol & Ecosyst Sci, A-1090 Vienna, Austria	University of Vienna; Aalborg University; University of Vienna; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Hamburg; University of Vienna	Daims, H (corresponding author), Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, Waehringer Guertel 18, A-1090 Vienna, Austria.	daims@microbial-ecology.net	Lücker, Sebastian/E-6186-2013; Nielsen, Per Halkjær/T-6796-2018; Daims, Holger/I-8410-2012; Richter, Andreas/D-8483-2012; Spieck, Eva/E-7223-2017; Galushko, Alexander/I-4980-2015; Koch, Hanna/ABD-5584-2021; Wagner, Michael/A-7801-2011; Albertsen, Mads/T-7358-2018	Lücker, Sebastian/0000-0003-2935-4454; Nielsen, Per Halkjær/0000-0002-6402-1877; Daims, Holger/0000-0002-4195-0913; Richter, Andreas/0000-0003-3282-4808; Galushko, Alexander/0000-0002-0387-7997; Wagner, Michael/0000-0002-9778-7684; Schintlmeister, Arno/0000-0002-1146-0032; Koch, Hanna/0000-0002-8550-9871; Gruber-Dorninger, Christiane/0000-0003-0407-6013; Albertsen, Mads/0000-0002-6151-190X; Valeeva, Aygul V./0000-0002-9968-9586; Le Paslier, Denis/0000-0003-4335-9956; Pelletier, Eric/0000-0003-4228-1712	Vienna Science and Technology Fund (WWTF) [LS09-40]; Austrian Science Fund (FWF) [P25231-B21, P24101-B22]; Danish Council for Strategic Research (EcoDesign); Deutsche Forschungsgemeinschaft (DFG) [SP667/3-1]; European Research Council [294343]; Austrian Science Fund (FWF) [P 24101] Funding Source: researchfish	Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Danish Council for Strategic Research (EcoDesign); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the anonymous reviewers for their valuable comments and suggestions. The sequences of genes reported in this paper are available at NCBI GenBank under accession nos. KJ920237 to KJ920263. Other supporting data are available in the supplementary materials. This work was supported by the Vienna Science and Technology Fund (WWTF, grant LS09-40), the Austrian Science Fund (FWF, grants P25231-B21 and P24101-B22), the Danish Council for Strategic Research (EcoDesign), the Deutsche Forschungsgemeinschaft (DFG, grant SP667/3-1), and the European Research Council [Advanced Grant Nitrification Reloaded (NITRICARE) 294343].	Arp D. J., 2011, AM SOC MICROBIOLOGY, P95; BOCK E, 1995, ARCH MICROBIOL, V163, P16, DOI 10.1007/BF00262198; BOCK E, 1976, ARCH MICROBIOL, V108, P305, DOI 10.1007/BF00454857; Bock E., 2001, PROKARYOTES HDB BIOL, P457; Daims H, 2001, APPL ENVIRON MICROB, V67, P5273, DOI 10.1128/AEM.67.11.5273-5284.2001; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Greening C, 2014, P NATL ACAD SCI USA, V111, P4257, DOI 10.1073/pnas.1320586111; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Hommes NG, 2003, J BACTERIOL, V185, P6809, DOI 10.1128/JB.185.23.6809-6814.2003; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Lebedeva EV, 2011, FEMS MICROBIOL ECOL, V75, P195, DOI 10.1111/j.1574-6941.2010.01006.x; LOVLEY DR, 1988, GEOCHIM COSMOCHIM AC, V52, P2993, DOI 10.1016/0016-7037(88)90163-9; Lucker S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00027; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Pester M., 2013, ENV MICROBIOL; Schramm A, 2000, ENVIRON MICROBIOL, V2, P680, DOI 10.1046/j.1462-2920.2000.00150.x; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Sorokin DY, 2012, ISME J, V6, P2245, DOI 10.1038/ismej.2012.70; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Ward BB, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P199, DOI 10.1016/B978-0-12-372522-6.00005-0; WATSON SW, 1986, ARCH MICROBIOL, V144, P1, DOI 10.1007/BF00454947	22	93	98	7	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1052	1054		10.1126/science.1256985	http://dx.doi.org/10.1126/science.1256985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170152				2022-12-28	WOS:000340870900040
J	Staniforth, GL; Tuite, MF				Staniforth, Gemma L.; Tuite, Mick F.			Monoculture Breeds Poor Social Skills	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; YEAST	Two studies from Jarosz et al. describe how [GAR(+)], a protein-based epigenetic determinant found mainly in wild yeast strains, can be activated by microbial cross-kingdom communication. With the aid of genetically and ecologically diverse bacteria, yeast can override an ancient regulatory mechanism of glucose repression, promoting both microbial diversity and lifespan extension.	[Staniforth, Gemma L.; Tuite, Mick F.] Univ Kent, Sch Biosci, Kent Fungal Grp, Canterbury CT2 7NJ, Kent, England	University of Kent	Staniforth, GL (corresponding author), Univ Kent, Sch Biosci, Kent Fungal Grp, Canterbury CT2 7NJ, Kent, England.	g.l.staniforth@kent.ac.uk; m.f.tuite@kent.ac.uk	Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X	BBSRC [BB/J000191/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J000191/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexandre H, 2004, INT J FOOD MICROBIOL, V93, P141, DOI 10.1016/j.ijfoodmicro.2003.10.013; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Jarosz DF, 2014, CELL, V158, P1072, DOI 10.1016/j.cell.2014.07.024; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; KUNZ BA, 1977, MOL GEN GENET, V153, P169, DOI 10.1007/BF00264732; Riedlinger J, 2006, APPL ENVIRON MICROB, V72, P3550, DOI 10.1128/AEM.72.5.3550-3557.2006; Smith MG, 2004, MOL CELL BIOL, V24, P3874, DOI 10.1128/MCB.24.9.3874-3884.2004	10	0	0	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					975	977		10.1016/j.cell.2014.08.004	http://dx.doi.org/10.1016/j.cell.2014.08.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171400	Bronze			2022-12-28	WOS:000340945000003
J	Polonsky, TS; Blumenthal, RS; Greenland, P				Polonsky, Tamar S.; Blumenthal, Roger S.; Greenland, Philip			Coronary Artery Calcium Score	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR RISK; HEART-DISEASE		[Polonsky, Tamar S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Blumenthal, Roger S.] Johns Hopkins Univ, Sch Med, Ciccarone Prevent Cardiol Ctr, Baltimore, MD USA; [Greenland, Philip] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	University of Chicago; Johns Hopkins University; Northwestern University	Polonsky, TS (corresponding author), 5841 S Maryland Ave,MC6080, Chicago, IL 60637 USA.	tpolonsky@medicine.bsd.uchicago.edu	Greenland, Philip/ABD-5528-2021; Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168				Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Goff D. C., 2013, CIRCULATION; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Hendrick RE, 2010, RADIOLOGY, V257, P246, DOI 10.1148/radiol.10100570; Horton KM, 2002, CIRCULATION, V106, P532, DOI 10.1161/01.CIR.0000027136.56615.DE; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nasir K, 2004, CIRCULATION, V110, P2150, DOI 10.1161/01.CIR.0000144464.11080.14; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	9	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					837	838		10.1001/jama.2014.1948	http://dx.doi.org/10.1001/jama.2014.1948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157727				2022-12-28	WOS:000340788500026
J	Habre, C; Tramer, MR; Popping, DM; Elia, N				Habre, Celine; Tramer, Martin R.; Poepping, Daniel M.; Elia, Nadia			Ability of a meta-analysis to prevent redundant research: systematic review of studies on pain from propofol injection	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; EQUIPOISE; ETHICS; DATE	Objective To examine whether, according to the conclusions of a 2000 systematic review with meta-analysis on interventions to prevent pain from propofol injection that provided a research agenda to guide further research on the topic, subsequently published trials were more often optimally blinded, reported on children, and used the most efficacious intervention as comparator; and to check whether the number of new trials published each year had decreased and whether the designs of trials that cited the review differed from those that did not. Study design Systematic review comparing old trials (published before, and included in, the review) with new trials (published afterwards). Data sources Medline, Cochrane, Embase, and bibliographies to January 2013. Eligibility criteria for study selection Randomised studies testing any intervention to prevent pain from propofol injection in humans. Results 136 new trials (19 778 patients) were retrieved. Compared with the 56 old trials (6264 patients), the proportion of optimally blinded trials had increased from 10.7% to 38.2% (difference 27.5%, 95% confidence interval 16.0% to 39.0%, P<0.001), and the proportion of trials that used the most efficacious intervention as comparator had increased from 12.5% to 27.9% (difference 15.4%, 4.0% to 26.9%, P=0.022). The proportion of paediatric trials had increased from 5.4% to 12.5%, although this was not significant (difference 7.1%, -1.0% to 15.2%, P=0.141). The number of new trials published each year was significantly higher (median number/year 12 (range 7-20) v 2.5 (0-9), P<0.001) with no obvious decreasing trend. 72.8% (n=99) of the new trials cited the review, with their designs similar to trials not citing the review. Only 36.0% (n=49) of the new trials were considered clinically relevant since they used the most efficacious intervention as comparator or included a paediatric population. Conclusions The impact of the systematic review on the design of subsequent research was low. There was an improvement in the reporting of optimal blinding procedures and a tendency towards an increase in the proportion of paediatric trials. The most efficacious intervention was more often chosen as comparator but remained marginally used, and the number of trials published per year had not decreased. The use of systematic reviews should be encouraged to inform rational, and thus ethical, trial design and improve the relevance of new research.	[Habre, Celine] Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland; [Tramer, Martin R.; Elia, Nadia] Univ Hosp Geneva, Div Anaesthesiol, CH-1211 Geneva 14, Switzerland; [Tramer, Martin R.] Univ Geneva, Fac Med, Geneva, Switzerland; [Poepping, Daniel M.] Univ Hosp Munster, Dept Anaesthesiol & Intens Care, Munster, Germany; [Elia, Nadia] Univ Geneva, Fac Med, Inst Global Hlth, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Munster; University of Geneva	Habre, C (corresponding author), Univ Hosp Geneva, Dept Radiol, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	celine.habre@hcuge.ch	Elia, Nadia/Y-6999-2019	Elia, Nadia/0000-0003-1787-9288				Ashcroft R, 1999, BIOETHICS, V13, P314, DOI 10.1111/1467-8519.00160; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Chalmers I, 2005, LANCET, V365, P469; Clarke M, 2004, PLOS MED, V1, P100, DOI 10.1371/journal.pmed.0010035; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Eger EI, 2004, AM J HEALTH-SYST PH, V61, pS3, DOI 10.1093/ajhp/61.suppl_4.S3; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Garattini S, 2003, BMJ-BRIT MED J, V326, P1199, DOI 10.1136/bmj.326.7400.1199; Gilbert R, 2005, INT J EPIDEMIOL, V34, P874, DOI 10.1093/ije/dyi088; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jalota L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1110; Krishnan V, 2013, AM J ORTHOD DENTOFAC, V144, P577, DOI 10.1016/j.ajodo.2013.05.008; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Mann Howard, 2003, BMC Med Res Methodol, V3, P7, DOI 10.1186/1471-2288-3-7; Peters DH, BMJ, V347, pf6753; Picard P, 2000, ANESTH ANALG, V90, P963; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Tovell A, 1964, MED J AUSTRALIA, V2, P320; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8; Yuan HF, 2013, LANCET, V381, pE4, DOI 10.1016/S0140-6736(13)60174-9	25	33	33	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2014	349								g5219	10.1136/bmj.g5219	http://dx.doi.org/10.1136/bmj.g5219			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO2RX	25161280	Green Published, hybrid			2022-12-28	WOS:000341174200013
J	Jiang, PH; Beauchamp, GK				Jiang, Peihua; Beauchamp, Gary K.			EVOLUTION Sensing nectar's sweetness	SCIENCE			English	Editorial Material									[Jiang, Peihua; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Jiang, PH (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pjiang@monell.org; beauchamp@monell.org						Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Barrett P. H., 1987, CHARLES DARWINS NOTE; Feng P, 2014, GENOME BIOL EVOL, V6, P1254, DOI 10.1093/gbe/evu095; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Zhao HB, 2010, MOL BIOL EVOL, V27, P2642, DOI 10.1093/molbev/msq152	9	2	2	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					878	879		10.1126/science.1259175	http://dx.doi.org/10.1126/science.1259175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146273				2022-12-28	WOS:000340524700024
J	Marshall, S				Marshall, Shawn			CLIMATE CHANGE Glacier retreat crosses a line	SCIENCE			English	Editorial Material							SURFACE MASS-BALANCE; LEVEL		Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada	University of Calgary	Marshall, S (corresponding author), Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada.	shawn.marshall@ucalgary.ca						Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Leclercq PW, 2011, SURV GEOPHYS, V32, P519, DOI 10.1007/s10712-011-9121-7; Marzeion B, 2012, CRYOSPHERE, V6, P1295, DOI 10.5194/tc-6-1295-2012; Marzeion B, 2014, SCIENCE, V345, P919, DOI 10.1126/science.1254702; Mernild SH, 2014, J CLIMATE, V27, P6051, DOI 10.1175/JCLI-D-13-00669.1; Oerlemans J, 2007, CRYOSPHERE, V1, P59, DOI 10.5194/tc-1-59-2007; Radic V, 2011, NAT GEOSCI, V4, P91, DOI [10.1038/ngeo1052, 10.1038/NGEO1052]; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Vaughan D. G., 2013, CLIMATE CHANGE 2013	10	10	12	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					872	872		10.1126/science.1258584	http://dx.doi.org/10.1126/science.1258584			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146269				2022-12-28	WOS:000340524700020
J	Shomroni, I; Rosenblum, S; Lovsky, Y; Bechler, O; Guendelman, G; Dayan, B				Shomroni, Itay; Rosenblum, Serge; Lovsky, Yulia; Bechler, Orel; Guendelman, Gabriel; Dayan, Barak			All-optical routing of single photons by a one-atom switch controlled by a single photon	SCIENCE			English	Article							PHASE-SHIFTS; TRAPPED ATOM; QUANTUM; BLOCKADE; CAVITY	The prospect of quantum networks, in which quantum information is carried by single photons in photonic circuits, has long been the driving force behind the effort to achieve all-optical routing of single photons. We realized a single-photon-activated switch capable of routing a photon from any of its two inputs to any of its two outputs. Our device is based on a single atom coupled to a fiber-coupled, chip-based microresonator. A single reflected control photon toggles the switch from high reflection (R similar to 65%) to high transmission (T similar to 90%), with an average of similar to 1.5 control photons per switching event (similar to 3, including linear losses). No additional control fields are required. The control and target photons are both in-fiber and practically identical, making this scheme compatible with scalable architectures for quantum information processing.	[Shomroni, Itay; Rosenblum, Serge; Lovsky, Yulia; Bechler, Orel; Guendelman, Gabriel; Dayan, Barak] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dayan, B (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	barak.dayan@weizmann.ac.il	Shomroni, Itay/AAD-3789-2019; Shomroni, Itay/AAD-3160-2020; Dayan, Barak/Q-7480-2017	Shomroni, Itay/0000-0002-9947-5502; Dayan, Barak/0000-0001-8592-8550; Guendelman, Gabriel/0000-0003-4877-3953; Rosenblum, Serge/0000-0002-1984-3206	Israeli Science Foundation; Joseph and Celia Reskin Career Development Chair in Physics; Crown Photonics Center	Israeli Science Foundation(Israel Science Foundation); Joseph and Celia Reskin Career Development Chair in Physics; Crown Photonics Center	Support from the Israeli Science Foundation, the Joseph and Celia Reskin Career Development Chair in Physics, and the Crown Photonics Center is acknowledged. This research was made possible in part by the historic generosity of the Harold Perlman family.	Baur S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.073901; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Chen W, 2013, SCIENCE, V341, P768, DOI 10.1126/science.1238169; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Dawes AMC, 2005, SCIENCE, V308, P672, DOI 10.1126/science.1110151; Dayan B, 2008, SCIENCE, V319, P1062, DOI 10.1126/science.1152261; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Gea-Banacloche J, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033832; Haroche S., 2013, EXPLORING QUANTUM AT; Hofmann HF, 2003, J OPT B-QUANTUM S O, V5, P218, DOI 10.1088/1464-4266/5/3/304; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Junge C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213604; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Koshino K, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.010301; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Pinotsi D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093603; Press D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117402; Reiserer A, 2014, NATURE, V508, P237, DOI 10.1038/nature13177; Reiserer A, 2013, SCIENCE, V342, P1349, DOI 10.1126/science.1246164; Rosenblum S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.033854; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Tiecke TG, 2014, NATURE, V508, P241, DOI 10.1038/nature13188; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Volz J., 2014, ARXIV14031860	30	292	296	14	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					903	906		10.1126/science.1254699	http://dx.doi.org/10.1126/science.1254699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146283	Green Submitted			2022-12-28	WOS:000340524700038
J	Zhang, X; Bishof, M; Bromley, SL; Kraus, CV; Safronova, MS; Zoller, P; Rey, AM; Ye, J				Zhang, X.; Bishof, M.; Bromley, S. L.; Kraus, C. V.; Safronova, M. S.; Zoller, P.; Rey, A. M.; Ye, J.			Spectroscopic observation of SU(N)-symmetric interactions in Sr orbital magnetism	SCIENCE			English	Article							OPTICAL LATTICE CLOCK; SPIN	SU(N) symmetry can emerge in a quantum system with N single-particle spin states when spin is decoupled from interparticle interactions. Taking advantage of the high measurement precision offered by an ultrastable laser, we report a spectroscopic observation of SU(N <= 10) symmetry in Sr-87. By encoding the electronic orbital degree of freedom in two clock states while keeping the system open to as many as 10 nuclear spin sublevels, we probed the non-equilibrium two-orbital SU(N) magnetism via Ramsey spectroscopy of atoms confined in an array of two-dimensional optical traps; we studied the spin-orbital quantum dynamics and determined the relevant interaction parameters. This study lays the groundwork for using alkaline-earth atoms as testbeds for important orbital models.	[Zhang, X.; Bishof, M.; Bromley, S. L.; Rey, A. M.; Ye, J.] NIST, JILA, Boulder, CO 80309 USA; [Zhang, X.; Bishof, M.; Bromley, S. L.; Rey, A. M.; Ye, J.] Univ Colorado, Boulder, CO 80309 USA; [Zhang, X.; Bishof, M.; Bromley, S. L.; Rey, A. M.; Ye, J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Kraus, C. V.; Zoller, P.] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria; [Kraus, C. V.; Zoller, P.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Safronova, M. S.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Safronova, M. S.] NIST, Joint Quantum Inst, College Pk, MD 20742 USA; [Safronova, M. S.] Univ Maryland, College Pk, MD 20742 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Austrian Academy of Sciences; University of Innsbruck; University of Delaware; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Rey, AM (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	arey@jilau1.colorado.edu; ye@jila.colorado.edu	Zoller, Peter/O-1639-2014; Ye, Jun/C-3312-2011	Zoller, Peter/0000-0003-4014-1505; Ye, Jun/0000-0003-0076-2112; Bromley, Sarah/0000-0002-8130-6276	National Defense Science and Engineering Graduate Fellowship program; NSF Graduate Research Fellowship program; NISI; NSF [PFC-1125844]; Air Force Office of Scientific Research (MURI); Air Force Office of Scientific Research (single investigator award); Defense Advanced Research Projects Agency (QuASAR); Austrian Science Foundation; SFB FoQus (Foundations and Applications of Quantum Science); European Research Council Synergy Grant (UQUAM); Simulators and Interfaces with Quantum Systems (SIQS) project	National Defense Science and Engineering Graduate Fellowship program; NSF Graduate Research Fellowship program(National Science Foundation (NSF)); NISI; NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Air Force Office of Scientific Research (single investigator award); Defense Advanced Research Projects Agency (QuASAR)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Austrian Science Foundation(Austrian Science Fund (FWF)); SFB FoQus (Foundations and Applications of Quantum Science); European Research Council Synergy Grant (UQUAM)(European Research Council (ERC)); Simulators and Interfaces with Quantum Systems (SIQS) project	We thank P. Julienne, B. Gadway, T. Nicholson, B. Bloom, and A. V. Gorshkov for technical discussions. Supported by the National Defense Science and Engineering Graduate Fellowship program and the NSF Graduate Research Fellowship program (M.B) and by NISI, NSF grant PFC-1125844, Air Force Office of Scientific Research (MURI and single investigator award), Defense Advanced Research Projects Agency (QuASAR), Austrian Science Foundation, SFB FoQus (Foundations and Applications of Quantum Science), European Research Council Synergy Grant (UQUAM), and Simulators and Interfaces with Quantum Systems (SIQS) project. The data described in the paper am archived in a database at JILA.	Banerjee D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.125303; Bishof M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052716; Blatt S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.073202; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; Boyd MM, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022510; Boyd MM, 2006, SCIENCE, V314, P1430, DOI 10.1126/science.1133732; Cazalilla MA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103033; Corboz P, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041013; Daley AJ, 2011, QUANTUM INF PROCESS, V10, P865, DOI 10.1007/s11128-011-0293-3; Daley AJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.170504; de Escobar YNM, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.062708; Foss-Feig M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.051603; Gorshkov AV, 2010, NAT PHYS, V6, P289, DOI 10.1038/NPHYS1535; Gorshkov AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.110503; Hermele M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174441; Hermele M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.135301; Idziaszek Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.113202; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; Koller AP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.123001; Kraft S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.130401; KUGEL KI, 1982, USP FIZ NAUK+, V136, P621, DOI 10.1070/PU1982v025n04ABEH004537; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Martin MJ, 2013, SCIENCE, V341, P632, DOI 10.1126/science.1236929; Pagano G, 2014, NAT PHYS, V10, P198, DOI [10.1038/nphys2878, 10.1038/NPHYS2878]; Reichenbach I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.123001; Stein A, 2010, EUR PHYS J D, V57, P171, DOI 10.1140/epjd/e2010-00058-y; Stellmer S., 2014, DEGENERATE QUANTUM G, V2; Stellmer S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043611; Taie S, 2012, NAT PHYS, V8, P825, DOI [10.1038/NPHYS2430, 10.1038/nphys2430]; Takasu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.040404; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; WEN XG, 1989, PHYS REV B, V39, P11413, DOI 10.1103/PhysRevB.39.11413; Wu CJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.186402; Yamazaki R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.050405; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483	37	247	247	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1467	1473		10.1126/science.1254978	http://dx.doi.org/10.1126/science.1254978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25147278	Green Submitted			2022-12-28	WOS:000341752900033
J	Shen, Y; Ho, LC				Shen, Yue; Ho, Luis C.			The diversity of quasars unified by accretion and orientation	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; BLACK-HOLE MASSES; X-RAY-PROPERTIES; DATA RELEASE; SCALING RELATIONSHIPS; STELLAR OBJECTS; EMISSION-LINES; HOST GALAXIES; RADIO-LOUD; DEPENDENCE	Quasars are rapidly accreting supermassive black holes at the centres of massive galaxies. They display a broad range of properties across all wavelengths, reflecting the diversity in the physical conditions of the regions close to the central engine. These properties, however, are not random, but form well-defined trends. The dominant trend is known as 'Eigenvector l', in which many properties correlate with the strength of optical iron and [O III] emission(1-3). The main physical driver of Eigenvector 1 has long been suspected(4) to be the quasar luminosity normalized by the mass of the hole (the 'Eddington ratio'), which is an important parameter of the black hole accretion process. But a definitive proof has been missing. Here we report an analysis of archival data that reveals that the Eddington ratio indeed drives Eigenvector 1. We also find that orientation plays a significant role in determining the observed kinematics of the gas in the broad-line region, implying a flattened, disk-like geometry for the fast-moving clouds close to the black hole. Our results show that most of the diversity of quasar phenomenology can be unified using two simple quantities: Eddington ratio and orientation.	[Shen, Yue] Carnegie Observ, Pasadena, CA 91101 USA; [Shen, Yue; Ho, Luis C.] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Ho, Luis C.] Peking Univ, Sch Phys, Dept Astron, Beijing 100871, Peoples R China	Carnegie Institution for Science; Peking University; Peking University	Shen, Y (corresponding author), Carnegie Observ, 813 Santa Barbara St, Pasadena, CA 91101 USA.	yshen@obs.carnegiescience.edu		Shen, Yue/0000-0003-1659-7035	NASA through Hubble Fellowship - Space Telescope Science Institute [HST-HF-51314.01]; NASA [NAS 5-26555]; Kavli Foundation, Peking University; Chinese Academy of Science [XDB09030102]	NASA through Hubble Fellowship - Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); Kavli Foundation, Peking University; Chinese Academy of Science(Chinese Academy of Sciences)	Support for the work of Y.S. was provided by NASA through Hubble Fellowship grant number HST-HF-51314.01,awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy for NASA, under contract number NAS 5-26555. L.C.H. acknowledges support from the Kavli Foundation, Peking University, and the Chinese Academy of Science through grant number XDB09030102 (Emergence of Cosmological Structures) from the Strategic Priority Research Program. This work makes extensive use of SDSS-I/II and SDSS-III data (http://www.sdss.org/ and http://www.sdss3.org/).	Ahn CP, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/17; ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; BALDWIN JA, 1977, ASTROPHYS J, V214, P679, DOI 10.1086/155294; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; Bentz MC, 2009, ASTROPHYS J, V697, P160, DOI 10.1088/0004-637X/697/1/160; Boroson TA, 2002, ASTROPHYS J, V565, P78, DOI 10.1086/324486; BOROSON TA, 1992, ASTROPHYS J SUPPL S, V80, P109, DOI 10.1086/191661; DOPITA MA, 1995, ASTROPHYS J, V455, P468, DOI 10.1086/176596; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Laor A, 1997, ASTROPHYS J, V477, P93, DOI 10.1086/303696; Laor A, 2000, ASTROPHYS J, V543, pL111, DOI 10.1086/317280; Marziani P, 2003, ASTROPHYS J SUPPL S, V145, P199, DOI 10.1086/346025; Park D, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/6; Peterson BM, 2004, ASTROPHYS J, V613, P682, DOI 10.1086/423269; Runnoe JC, 2013, MON NOT R ASTRON SOC, V429, P135, DOI 10.1093/mnras/sts322; Schneider DP, 2010, ASTRON J, V139, P2360, DOI 10.1088/0004-6256/139/6/2360; Shen J, 2008, ASTRON J, V135, P928, DOI 10.1088/0004-6256/135/3/928; Shen Y, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/98; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Stern J, 2013, MON NOT R ASTRON SOC, V431, P836, DOI 10.1093/mnras/stt211; Sulentic JW, 2000, ASTROPHYS J, V536, pL5, DOI 10.1086/312717; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; Vestergaard M, 2006, ASTROPHYS J, V641, P689, DOI 10.1086/500572; Wang T, 1996, ASTRON ASTROPHYS, V309, P81; WILLS BJ, 1986, ASTROPHYS J, V302, P56, DOI 10.1086/163973; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Zhang K, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/51	27	230	231	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					210	+		10.1038/nature13712	http://dx.doi.org/10.1038/nature13712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209799	Green Submitted			2022-12-28	WOS:000341362800045
J	Chapman, S				Chapman, Simon			E-cigarettes: the best and the worst case scenarios for public health-an essay by Simon Chapman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING; CONSUMPTION; REDUCTION; NICOTINE; CANCER; COHORT; RISK; MEN		Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					Achey TL, 1978, LORILLARD RES; Agaku IT, 2014, BMJ OPEN, V8; [Anonymous], 2014, WHO C PART WHO FRAM; Australian Institute of Health and Welfare, 2014, NDSHS 2013 DAT REF S; Brown J, 2014, ADDICTION, V109, P1531, DOI 10.1111/add.12623; Cardinale A, 2012, CRIT REV TOXICOL, V42, P68, DOI 10.3109/10408444.2011.623150; Champion D, 2005, J EPIDEMIOL COMMUN H, V59, P679, DOI 10.1136/jech.2005.035915; Etter JF, 2014, ADDICT BEHAV, V39, P491, DOI 10.1016/j.addbeh.2013.10.028; Farsalinos KE, 2014, INT J ENV RES PUB HE, V11, P4356, DOI 10.3390/ijerph110404356; Fuoco FC, 2014, ENVIRON POLLUT, V184, P523, DOI 10.1016/j.envpol.2013.10.010; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Hart C, 2013, AM J EPIDEMIOL, V178, P770, DOI 10.1093/aje/kwt038; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5335; Knight J, 2004, TOB CONTROL, V13, P13, DOI 10.1136/tc.2004.007641; Martinez-Sanchez JM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005894; Pisinger C, 2007, NICOTINE TOB RES, V9, P631, DOI 10.1080/14622200701365327; Schober W, 2014, INT J HYG ENVIR HEAL, V217, P628, DOI 10.1016/j.ijheh.2013.11.003; Song YM, 2008, J CLIN ONCOL, V26, P5101, DOI 10.1200/JCO.2008.17.0498; Straif K, 2014, LANCET ONCOL, V15, P683, DOI 10.1016/S1470-2045(14)70168-8; Tverdal A, 2006, TOB CONTROL, V15, P472, DOI 10.1136/tc.2006.016246; Utah Department of Health, 2013, EL CIG US UT STUD GR	21	43	45	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2014	349								g5512	10.1136/bmj.g5512	http://dx.doi.org/10.1136/bmj.g5512			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9QM	25204397				2022-12-28	WOS:000341691000007
J	Lederle, FA; Powell, JT; Nienaber, CA				Lederle, Frank A.; Powell, Janet T.; Nienaber, Christoph A.			Does intensive medical treatment improve outcomes in aortic dissection?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES; THERAPY		[Lederle, Frank A.] VA Hlth Care Syst 111 O, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [Powell, Janet T.] Univ London Imperial Coll Sci Technol & Med, Vasc Surg Res Grp, London W6 8RP, England; [Nienaber, Christoph A.] Univ Rostock, Heart Ctr Rostock, D-18055 Rostock, Germany	Imperial College London; University of Rostock	Lederle, FA (corresponding author), VA Hlth Care Syst 111 O, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA.	frank.lederle@va.gov	Powell, Janet/AAW-8669-2021	Powell, Janet/0000-0002-3905-1468				AUSTEN WG, 1967, ARCH SURG-CHICAGO, V95, P835; Booher AM, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.01.020; Bouri S, 2014, HEART, V100, P456, DOI 10.1136/heartjnl-2013-304262; Chan KK, 2014, COCHRANE DB SYST REV, V2; Eggebrecht H, 2005, J HUM HYPERTENS, V19, P227, DOI 10.1038/sj.jhh.1001800; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Howard DPJ, 2013, CIRCULATION, V127, P2031, DOI 10.1161/CIRCULATIONAHA.112.000483; Howick J, 2009, J ROY SOC MED, V102, P186, DOI 10.1258/jrsm.2009.090020; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kox M, 2013, JAMA INTERN MED, V173, P1369, DOI 10.1001/jamainternmed.2013.6702; Messerli FH, 2008, J HUM HYPERTENS, V22, P585, DOI 10.1038/jhh.2008.28; MILLS SE, 1979, AM J SURG, V137, P240, DOI 10.1016/0002-9610(79)90154-5; MORAN JF, 1978, SURG FORUM, V29, P231; Pacini D, 2013, INT J CARDIOL, V167, P2806, DOI 10.1016/j.ijcard.2012.07.008; Suzuki T, 2012, AM J CARDIOL, V109, P122, DOI 10.1016/j.amjcard.2011.08.012; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; U.S. Department of Health and Human Services National Institute of Health National Heart Lung and Blood Institute, 2004, 7 US DEP HLTH HUM SE; Wheat M W Jr, 1980, World J Surg, V4, P563; Wheat M W Jr, 1971, Curr Probl Surg, P1; WHEAT MW, 1969, J THORAC CARDIOV SUR, V58, P344, DOI 10.1016/S0022-5223(19)42583-X; Wiysonge CS, 2013, JAMA-J AM MED ASSOC, V310, P1851, DOI 10.1001/jama.2013.277510	21	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2014	349								g5288	10.1136/bmj.g5288	http://dx.doi.org/10.1136/bmj.g5288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QM	25205491				2022-12-28	WOS:000341691000004
J	Janjua, W				Janjua, Wakaas			Project flu buster	LANCET			English	Editorial Material									King Edward Five Ways Sch, Birmingham B32 4BT, W Midlands, England		Janjua, W (corresponding author), King Edward Five Ways Sch, Birmingham B32 4BT, W Midlands, England.	wakaas@hotmail.co.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					839	839		10.1016/S0140-6736(14)61465-3	http://dx.doi.org/10.1016/S0140-6736(14)61465-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	25209475				2022-12-28	WOS:000341362200009
J	Fregnac, Y; Laurent, G				Fregnac, Yves; Laurent, Gilles			Where is the brain in the Human Brain Project?	NATURE			English	Editorial Material									[Fregnac, Yves] CNRS, Unit Neurosci Informat & Complex Gif Sur Yvet, F-75700 Paris, France; [Laurent, Gilles] Max Planck Inst Brain Res, Frankfurt, Germany	Centre National de la Recherche Scientifique (CNRS); Max Planck Society	Fregnac, Y (corresponding author), CNRS, Unit Neurosci Informat & Complex Gif Sur Yvet, F-75700 Paris, France.	fregnac@unic.cnrs-gif.fr; gilles.laurent@brain.mpg.de						Bargmann C., 2014, BRAIN 2025 SCI VISIO; European Commission, 2013, FUT EM TECHN FET FP7; Frackowiak R., 2014, NEW SCI; Fregnac Y., 2013, CELL, V155, P265; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Markram H, 2011, PROCEDIA COMPUT SCI, V7, P39, DOI 10.1016/j.procs.2011.12.015; Poo MM, 2014, NATL SCI REV, V1, P12, DOI 10.1093/nsr/nwt019; Seung S., 2012, CONNECTOME BRAINS WI	9	33	36	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					27	29		10.1038/513027a	http://dx.doi.org/10.1038/513027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186884	Green Published, Bronze			2022-12-28	WOS:000341174800011
J	Melis, C; Reid, MJ; Mioduszewski, AJ; Stauffer, JR; Bower, GC				Melis, Carl; Reid, Mark J.; Mioduszewski, Amy J.; Stauffer, John R.; Bower, Geoffrey C.			A VLBI resolution of the Pleiades distance controversy	SCIENCE			English	Article							ECLIPSING BINARY HD-23642; OPEN CLUSTERS; HIPPARCOS-PARALLAXES; CATALOG; CONSTRAINTS; ASTROMETRY; ACCURACY; ERRORS; STARS	Because of its proximity and its youth, the Pleiades open cluster of stars has been extensively studied and serves as a cornerstone for our understanding of the physical properties of young stars. This role is called into question by the "Pleiades distance controversy," wherein the cluster distance of 120.2 +/- 1.5 parsecs (pc) as measured by the optical space astrometry mission Hipparcos is significantly different from the distance of 133.5 +/- 1.2 pc derived with other techniques. We present an absolute trigonometric parallax distance measurement to the Pleiades cluster that uses very long baseline radio interferometry (VLBI). This distance of 136.2 +/- 1.2 pc is the most accurate and precise yet presented for the cluster and is incompatible with the Hipparcos distance determination. Our results cement existing astrophysical models for Pleiades-age stars.	[Melis, Carl] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Reid, Mark J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Mioduszewski, Amy J.] Natl Radio Astron Observ, Array Operat Ctr, Socorro, NM 87801 USA; [Stauffer, John R.] CALTECH, SSC, Pasadena, CA 91125 USA; [Bower, Geoffrey C.] ASIAA, Hilo, HI 96720 USA	University of California System; University of California San Diego; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Radio Astronomy Observatory (NRAO); California Institute of Technology; Academia Sinica - Taiwan	Melis, C (corresponding author), Univ Calif San Diego, Ctr Astrophys & Space Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cmelis@ucsd.edu	Bower, Geoffrey/ABC-8386-2020	Bower, Geoffrey/0000-0003-4056-9982	U.S. National Science Foundation [AST-1313428, AST-1003318]; Lawrence Livermore National Laboratory; Spitzer Science Center Visiting Graduate Student Program; Academica Sinica Institute for Astronomy and Astrophysics; Direct For Mathematical & Physical Scien [1313428] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Spitzer Science Center Visiting Graduate Student Program; Academica Sinica Institute for Astronomy and Astrophysics; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the National Radio Astronomy Observatory, Green Bank Telescope, Arecibo Observatory, and Effelsberg Telescope staff who coordinated, conducted, and correlated observations for this project. All data presented in this paper are maintained in the National Radio Astronomy Observatory archive. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. This work made use of the Swinburne University of Technology software correlator, developed as part of the Australian Major National Research Facilities Programme and operated under license. C. M. acknowledges financial support from the U.S. National Science Foundation through awards AST-1313428 and AST-1003318, from a Lawrence Livermore National Laboratory minigrant to the University of California-Los Angeles, and from the Spitzer Science Center Visiting Graduate Student Program. G.C.B. acknowledges support from the Academica Sinica Institute for Astronomy and Astrophysics.	An D, 2007, ASTROPHYS J, V655, P233, DOI 10.1086/509653; Gatewood G, 2000, ASTROPHYS J, V533, P938, DOI 10.1086/308679; GIANNUZZI MA, 1995, ASTRON ASTROPHYS, V293, P360; Groenewegen MAT, 2007, ASTRON ASTROPHYS, V463, P579, DOI 10.1051/0004-6361:20066303; Hog E, 2000, ASTRON ASTROPHYS, V355, pL27; JOHNSON HL, 1957, ASTROPHYS J, V126, P121, DOI 10.1086/146377; Loinard L, 2007, ASTROPHYS J, V671, P546, DOI 10.1086/522493; Makarov VV, 2002, ASTRON J, V124, P3299, DOI 10.1086/344683; Munari U, 2004, ASTRON ASTROPHYS, V418, pL31, DOI 10.1051/0004-6361:20040124; Narayanan VK, 1999, ASTROPHYS J, V523, P328, DOI 10.1086/307716; NICOLET B, 1981, ASTRON ASTROPHYS, V104, P185; Pan XP, 2004, NATURE, V427, P326, DOI 10.1038/nature02296; Percival SM, 2005, ASTRON ASTROPHYS, V429, P887, DOI 10.1051/0004-6361:20041694; Perryman MAC, 2001, ASTRON ASTROPHYS, V369, P339, DOI 10.1051/0004-6361:20010085; Pinsonneault MH, 1998, ASTROPHYS J, V504, P170, DOI 10.1086/306077; Reid IN, 1999, ANNU REV ASTRON ASTR, V37, P191, DOI 10.1146/annurev.astro.37.1.191; Reid M. J., 2014, ANN REV ASTRON ASTRO; Roser S., 2013, P IAU S, V289, P66; Soderblom DR, 2005, ASTRON J, V129, P1616, DOI 10.1086/427860; Southworth J, 2005, ASTRON ASTROPHYS, V429, P645, DOI 10.1051/0004-6361:20041867; Stello D, 2001, ASTRON ASTROPHYS, V374, P105, DOI 10.1051/0004-6361:20010665; Trumpler R.J., 1930, LICK OBS B, V420, P154; van Leeuwen F, 1999, ASTRON ASTROPHYS, V341, pL71; van Leeuwen F, 2009, ASTRON ASTROPHYS, V497, P209, DOI 10.1051/0004-6361/200811382; van Leeuwen F., 1983, THESIS LEIDEN U LEID; Zacharias N, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/44; Zwahlen N, 2004, ASTRON ASTROPHYS, V425, pL45, DOI 10.1051/0004-6361:200400062	27	96	96	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1029	1032		10.1126/science.1256101	http://dx.doi.org/10.1126/science.1256101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170147	Green Submitted			2022-12-28	WOS:000340870900033
J	Drosten, C; Meyer, B; Muller, MA; Corman, VM; Al-Masri, M; Hossain, R; Madani, H; Sieberg, A; Bosch, BJ; Lattwein, E; Alhakeem, RF; Assiri, AM; Hajomar, W; Albarrak, AM; Al-Tawfiq, JA; Zumla, AI; Memish, ZA				Drosten, Christian; Meyer, Benjamin; Mueller, Marcel A.; Corman, Victor M.; Al-Masri, Malak; Hossain, Raheela; Madani, Hosam; Sieberg, Andrea; Bosch, Berend Jan; Lattwein, Erik; Alhakeem, Raafat F.; Assiri, Abdullah M.; Hajomar, Waleed; Albarrak, Ali M.; Al-Tawfiq, Jaffar A.; Zumla, Alimuddin I.; Memish, Ziad A.			Transmission of MERS-Coronavirus in Household Contacts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SAUDI-ARABIA; ANTIBODIES; SEROLOGY; WORKERS; CAMELS	BACKGROUND Strategies to contain the Middle East respiratory syndrome coronavirus (MERS-CoV) depend on knowledge of the rate of human-to-human transmission, including subclinical infections. A lack of serologic tools has hindered targeted studies of transmission. METHODS We studied 26 index patients with MERS-CoV infection and their 280 household contacts. The median time from the onset of symptoms in index patients to the latest blood sampling in contact patients was 17.5 days (range, 5 to 216; mean, 34.4). Probable cases of secondary transmission were identified on the basis of reactivity in two reverse-transcriptase polymerase-chain-reaction (RT-PCR) assays with independent RNA extraction from throat swabs or reactivity on enzyme-linked immuno-sorbent assay against MERS-CoV 51 antigen, supported by reactivity on recombinant S-protein immunofluorescence and demonstration of neutralization of more than 50% of the infectious virus seed dose on plaque-reduction neutralization testing. RESULTS Among the 280 household contacts of the 26 index patients, there were 12 probable cases of secondary transmission (4%; 95% confidence interval, 2 to 7). Of these cases, 7 were identified by means of RT-PCR, all in samples obtained within 14 days after the onset of symptoms in index patients, and 5 were identified by means of serologic analysis, all in samples obtained 13 days or more after symptom onset in index patients. Probable cases of secondary transmission occurred in 6 of 26 clusters (23%). Serologic results in contacts who were sampled 13 days or more after exposure were similar to overall study results for combined RT-PCR and serologic testing. CONCLUSIONS The rate of secondary transmission among household contacts of patients with MERS-CoV infection has been approximately 5%. Our data provide insight into the rate of subclinical transmission of MERS-CoV in the home.	[Drosten, Christian; Meyer, Benjamin; Mueller, Marcel A.; Corman, Victor M.; Sieberg, Andrea] Univ Bonn, Inst Virol, Med Ctr, D-53105 Bonn, Germany; [Lattwein, Erik] Euroimmun, Lubeck, Germany; [Al-Masri, Malak; Alhakeem, Raafat F.; Assiri, Abdullah M.; Zumla, Alimuddin I.; Memish, Ziad A.] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia; [Albarrak, Ali M.] Prince Sultan Mil Med City, Riyadh, Saudi Arabia; [Memish, Ziad A.] Alfaisal Univ, Riyadh 11514, Saudi Arabia; [Al-Tawfiq, Jaffar A.] Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; [Hossain, Raheela; Madani, Hosam] Minist Hlth, Reg Lab, Jeddah, Saudi Arabia; [Hajomar, Waleed] Minist Hlth, Reg Lab, Riyadh, Saudi Arabia; [Al-Tawfiq, Jaffar A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Bosch, Berend Jan] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Zumla, Alimuddin I.] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin I.] UCL Hosp, Natl Inst Hlth Res Biomed Res Ctr, London, England	University of Bonn; EUROIMMUN; Ministry of Health - Saudi Arabia; Prince Sultan Military Medical City; John Hopkins Aramco Healthcare; Johns Hopkins University; Johns Hopkins Medicine; Ministry of Health - Saudi Arabia; Ministry of Health - Saudi Arabia; Indiana University System; Indiana University Bloomington; Utrecht University; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Memish, ZA (corresponding author), Alfaisal Univ, POB 54146, Riyadh 11514, Saudi Arabia.	drosten@virology-bonn.de; zmemish@yahoo.com	Bosch, Berend/ABD-8740-2021; Meyer, Bernhard/Q-9413-2016; Memish, Ziad Ahmed/AEJ-9424-2022; ZUMLA, Alimuddin/ABA-8208-2020; Assiri, Abdullah M./GQP-2239-2022; Meyer, Benjamin/F-3285-2018; Müller, Marcel A./O-2425-2019; assiri, abdullah/AAF-5665-2021; Corman, Victor M/K-1319-2019	Memish, Ziad Ahmed/0000-0002-5099-0714; ZUMLA, Alimuddin/0000-0002-5111-5735; Meyer, Benjamin/0000-0003-0601-3550; Müller, Marcel A./0000-0003-2242-5117; assiri, abdullah/0000-0002-5605-2876; Corman, Victor M/0000-0002-3605-0136; Sieberg, Andrea/0000-0003-3716-9996	European Commission EMPERIE program [223498]; ANTIGONE program [278976]; German Center for Infection Research; German Ministry for Research and Education; German Research Council [01KIO701, DR 772/3-1]; University College London (UCL) Hospitals NHS Foundation Trust; National Institute of Health Research, Biomedical Research Centre, UCL Hospitals; European and Developing Countries Clinical Trials Partnership; Seventh Framework Program of the European Commission for Rapid Identification of Respiratory Tract Infections	European Commission EMPERIE program; ANTIGONE program; German Center for Infection Research; German Ministry for Research and Education(Federal Ministry of Education & Research (BMBF)); German Research Council(German Research Foundation (DFG)); University College London (UCL) Hospitals NHS Foundation Trust; National Institute of Health Research, Biomedical Research Centre, UCL Hospitals; European and Developing Countries Clinical Trials Partnership; Seventh Framework Program of the European Commission for Rapid Identification of Respiratory Tract Infections	Dr. Drosten reports receiving grant support from the European Commission EMPERIE program (contract no. 223498) and ANTIGONE program (contract no. 278976) and from the German Center for Infection Research, the German Ministry for Research and Education, and the German Research Council (grants 01KIO701 and DR 772/3-1); and Dr. Zumla, receiving support from the University College London (UCL) Hospitals NHS Foundation Trust, the National Institute of Health Research, Biomedical Research Centre, UCL Hospitals, the European and Developing Countries Clinical Trials Partnership, and the Seventh Framework Program of the European Commission for Rapid Identification of Respiratory Tract Infections. No other potential conflict of interest relevant to this article was reported.	Aburizaiza AS, 2014, J INFECT DIS, V209, P243, DOI 10.1093/infdis/jit589; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Gierer S, 2013, EMERG INFECT DIS, V19, P2034, DOI 10.3201/eid1912.130701; Ho HT, 2006, CHEST, V129, P95, DOI 10.1378/chest.129.1.95; Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402; Meyer B, 2014, VIRUS RES, V194, P175, DOI 10.1016/j.virusres.2014.03.018; Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746; Muller MA, 2012, MBIO, V3; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.14.20441; Reusken CB, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.50.20662; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	21	267	277	2	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					828	835		10.1056/NEJMoa1405858	http://dx.doi.org/10.1056/NEJMoa1405858			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162889	Green Published, Bronze			2022-12-28	WOS:000340819800009
J	Smith, JM				Smith, Jeanette M.			Woman Walking in an Exotic Forest (Femme se promenant dans une forest exotique)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					772	776		10.1001/jama.2013.279685	http://dx.doi.org/10.1001/jama.2013.279685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157706				2022-12-28	WOS:000340788500001
J	Barry, JF; McCarron, DJ; Norrgard, EB; Steinecker, MH; DeMille, D				Barry, J. F.; McCarron, D. J.; Norrgard, E. B.; Steinecker, M. H.; DeMille, D.			Magneto-optical trapping of a diatomic molecule	NATURE			English	Article							ATOMS; BEAM; COLD; GAS	Laser cooling and trapping are central to modern atomic physics. The most used technique in cold-atomphysics is the magneto-optical trap (MOT), which combines laser cooling with a restoring force from radiation pressure. For a variety of atomic species, MOTs can capture and cool large numbers of particles to ultracold temperatures (less than similar to 1 millikelvin); this has enabled advances in areas that range fromoptical clocks to the study of ultracold collisions, while also serving as the ubiquitous starting point for further cooling into the regime of quantum degeneracy. Magneto-optical trapping of molecules could provide a similarly powerful starting point for the study and manipulation of ultracold molecular gases. The additional degrees of freedom associated with the vibration and rotation of molecules, particularly their permanent electric dipole moments, allow a broad array of applications not possible with ultracold atoms(1). Spurred by these ideas, a variety of methods has been developed to create ultracold molecules. Temperatures below 1 microkelvin have been demonstrated for diatomic molecules assembled from pre-cooled alkali atoms(2,3), but for the wider range of species amenable to direct cooling and trapping, only recently have temperatures below 100 millikelvin been achieved(4,5). The complex internal structure of molecules complicates magneto-optical trapping. However, ideas and methods necessary for creating a molecular MOT have been developed(6-11) recently. Here we demonstrate three dimensional magneto-optical trapping of a diatomic molecule, strontium monofluoride (SrF), at a temperature of approximately 2.5 millikelvin, the lowest yet achieved by direct cooling of a molecule. This method is a straightforward extension of atomic techniques and is expected to be viable for a significant number of diatomic species(6,7). With further development, we anticipate that this techniquemay be employed in any number of existing and proposed molecular experiments, in applications ranging from precision measurement(12) to quantum simulation(13) and quantum information(14) to ultracold chemistry(15).	[Barry, J. F.; McCarron, D. J.; Norrgard, E. B.; Steinecker, M. H.; DeMille, D.] Yale Univ, Dept Phys, New Haven, CT 06520 USA	Yale University	McCarron, DJ (corresponding author), Yale Univ, Dept Phys, POB 208120, New Haven, CT 06520 USA.	daniel.mccarron@yale.edu	McCarron, Daniel/M-7341-2016	McCarron, Daniel/0000-0002-8562-3439; Norrgard, Eric/0000-0002-8715-4648	AFOSR (MURI); ARO; ARO (MURI); NSF GRFP	AFOSR (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); ARO; ARO (MURI)(MURI); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank E.R. Edwards for contributions towards the construction of the experiment. We acknowledge funding from AFOSR (MURI), ARO, and ARO (MURI). E.B.N. acknowledges funding from the NSF GRFP.	Barry JF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.103002; Barry JF, 2011, PHYS CHEM CHEM PHYS, V13, P18936, DOI 10.1039/c1cp20335e; Barry J. F., 2013, THESIS YALE U; Berkeland DJ, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033413; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Chieda MA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063401; Chin C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055048; CHU S, 1985, PHYS REV LETT, V55, P48, DOI 10.1103/PhysRevLett.55.48; Danzl JG, 2010, NAT PHYS, V6, P265, DOI 10.1038/NPHYS1533; DeMille D, 2013, MOL PHYS, V111, P1805, DOI 10.1080/00268976.2013.793833; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Di Rosa MD, 2004, EUR PHYS J D, V31, P395, DOI 10.1140/epjd/e2004-00167-2; Fernandes DR, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/63001; Flemming J, 1997, OPT COMMUN, V135, P269, DOI 10.1016/S0030-4018(96)00660-8; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hummon MT, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.143001; Hutzler NR, 2012, CHEM REV, V112, P4803, DOI 10.1021/cr200362u; Kloter B, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.033402; Krems RV, 2008, PHYS CHEM CHEM PHYS, V10, P4079, DOI 10.1039/b802322k; LETT PD, 1988, PHYS REV LETT, V61, P169, DOI 10.1103/PhysRevLett.61.169; LETT PD, 1989, J OPT SOC AM B, V6, P2084, DOI 10.1364/JOSAB.6.002084; Metcalf HJ., 1999, LASER COOLING TRAPPI; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Nasyrov K, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.023412; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; PRENTISS M, 1988, OPT LETT, V13, P452, DOI 10.1364/OL.13.000452; PRENTISS MG, 1991, OPT LETT, V16, P1695, DOI 10.1364/OL.16.001695; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Shuman ES, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.223001; Stuhl BK, 2012, NATURE, V492, P396, DOI 10.1038/nature11718; Stuhl BK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.243002; Tarbutt MR, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/053034; Tiwari VB, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063421; WALLACE CD, 1994, J OPT SOC AM B, V11, P703, DOI 10.1364/JOSAB.11.000703	37	316	318	8	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					286	+		10.1038/nature13634	http://dx.doi.org/10.1038/nature13634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143111	Green Submitted			2022-12-28	WOS:000340508200029
J	DeVincenzo, JP; Whitley, RJ; Mackman, RL; Scaglioni-Weinlich, C; Harrison, L; Farrell, E; McBride, S; Lambkin-Williams, R; Jordan, R; Xin, Y; Ramanathan, S; O'Riordan, T; Lewis, SA; Li, XM; Toback, SL; Lin, SL; Chien, JW				DeVincenzo, John P.; Whitley, Richard J.; Mackman, Richard L.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen; Lambkin-Williams, Robert; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.			Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE SEVERITY; VIRAL LOAD; INFLUENZA-VIRUS; INFECTION; CHILDREN; INFANTS; HOSPITALIZATIONS; OSELTAMIVIR; EFFICACY; SAFETY	BACKGROUND Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality. No accepted antiviral treatment exists. METHODS We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clinical challenge strain of RSV intranasally. Participants were monitored for 12 days. At the time of a positive test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts. Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days. Dose selection for cohorts 5, 6, and 7 occurred after an interim analysis of data for cohorts 1 to 4. The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation. Secondary end points were mucus weight and symptom scores. RESULTS Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was associated with a lower viral load (adjusted mean, 250.7 vs. 757.7 log 10 plaque-forming-unit equivalents [PFUe] x hours per milliliter; P< 0.001), lower total mucus weight (mean, 6.9 g vs. 15.1 g; P = 0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 x hours; P = 0.005). The results were similar in cohorts 5, 6, and 7. Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806. CONCLUSIONS Treatment with GS-5806 reduced the viral load and the severity of clinical disease in a challenge study of healthy adults. (Funded by Gilead Sciences; ClinicalTrials.gov number, NCT01756482.)	[DeVincenzo, John P.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen] Univ Tennessee, Sch Med, Memphis, TN USA; [DeVincenzo, John P.] Childrens Fdn Res Inst, Le Bonheur Childrens Hosp, Memphis, TN 38103 USA; [Whitley, Richard J.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Mackman, Richard L.; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.] Gilead Sci Inc, Foster City, CA 94404 USA; [Lambkin-Williams, Robert] Retroscreen Virol, London, England	University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; Gilead Sciences	DeVincenzo, JP (corresponding author), Childrens Fdn Res Inst, Le Bonheur Childrens Hosp, Rm 400R,50 North Dunlap St, Memphis, TN 38103 USA.	jdevincenzo@uthsc.edu	Lambkin-Williams, Rob/L-2397-2019; Lambkin-Williams, Robert/P-5963-2016	Lambkin-Williams, Rob/0000-0003-2107-0174; Lambkin-Williams, Robert/0000-0003-2107-0174	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Funded by Gilead Sciences; ClinicalTrials.gov number, NCT01756482.	Andabaka T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006602.pub4; [Anonymous], 2011, SIMPL FLU A B RSV AS; Bagga B, 2013, ANTIVIR THER, V18, P785, DOI 10.3851/IMP2629; Beal SL, 2009, NONMEM USERS GUIDE 1; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; DeVincenzo JP, 2004, PEDIATR RES, V56, P914, DOI 10.1203/01.PDR.0000145255.86117.6A; Duncan CB, 2009, J INFECT DIS, V200, P1242, DOI 10.1086/605948; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hayden FG, 2000, ANTIVIR THER, V5, P205; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Lee N, 2013, CLIN INFECT DIS, V57, P1069, DOI 10.1093/cid/cit471; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Romero JR, 2003, PEDIATR INFECT DIS J, V22, pS46, DOI 10.1097/00006454-200302001-00007; Seo S, 2013, BIOL BLOOD MARROW TR, V19, P589, DOI 10.1016/j.bbmt.2012.12.019; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; VENTRE K, 2007, COCHRANE DB SYST REV, V1; Waghmare A, 2013, CLIN INFECT DIS, V57, P1731, DOI 10.1093/cid/cit639; Walsh EE, 2013, J INFECT DIS, V207, P1424, DOI 10.1093/infdis/jit038; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309	38	232	240	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					711	722		10.1056/NEJMoa1401184	http://dx.doi.org/10.1056/NEJMoa1401184			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140957				2022-12-28	WOS:000340509900006
J	Sackton, KL; Dimova, N; Zeng, X; Tian, W; Zhang, MM; Sackton, TB; Meaders, J; Pfaff, KL; Sigoillot, F; Yu, HT; Luo, XL; King, RW				Sackton, Katharine L.; Dimova, Nevena; Zeng, Xing; Tian, Wei; Zhang, Mengmeng; Sackton, Timothy B.; Meaders, Johnathan; Pfaff, Kathleen L.; Sigoillot, Frederic; Yu, Hongtao; Luo, Xuelian; King, Randall W.			Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; DEGRON RECOGNITION; SUBSTRATE-BINDING; DESTRUCTION; DEGRADATION; ACTIVATOR; CDC20; COMPLEX/CYCLOSOME; ENGAGEMENT	Protein machines are multi-subunit protein complexes that orchestrate highly regulated biochemical tasks. An example is the anaphase promoting complex/cyclosome (APC/C), a 13-subunit ubiquitin ligase that initiates the metaphase-anaphase transition and mitotic exit by targeting proteins such as securin and cyclin B1 for ubiquitin-dependent destruction by the proteasome(1,2). Because blocking mitotic exit is an effective approach for inducing tumour cell death(3,4), the APC/Crepresents a potential novel target for cancer therapy. APC/C activation in mitosis requires binding of Cdc20 (ref. 5), which forms a co-receptor with the APC/C to recognize substrates containing a destruction box(D-box)(6-14). Here we demonstrate that we can synergistically inhibit APC/C-dependent proteolysis and mitotic exit by simultaneously disrupting two protein-protein interactions within the APC/C-Cdc20-substrate ternary complex. We identify a small molecule, called apcin (APC inhibitor), which binds to Cdc20 and competitively inhibits the ubiquitylation of D-box-containing substrates. Analysis of the crystal structure of the apcin-Cdc20 complex suggests that apcin occupies the D-box-binding pocket on the side face of the WD40-domain. The ability of apcin to block mitotic exit is synergistically amplified by co-addition of tosyl-L-arginine methyl ester, a small molecule that blocks the APC/C-Cdc20 interaction(15,16). This work suggests that simultaneous disruption of multiple, weak protein-protein interactions is an effective approach for inactivating a protein machine.	[Sackton, Katharine L.; Dimova, Nevena; Zeng, Xing; Zhang, Mengmeng; Meaders, Johnathan; Pfaff, Kathleen L.; Sigoillot, Frederic; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tian, Wei; Yu, Hongtao; Luo, Xuelian] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sackton, Timothy B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Yu, Hongtao] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Howard Hughes Medical Institute	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu		Sackton, Timothy/0000-0003-1673-9216; Sigoillot, Frederic/0000-0002-8695-4838; tian, wei/0000-0003-3207-375X; Yu, Hongtao/0000-0002-8861-049X	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Institutes of Health [GM085004, GM066492]; Lynch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085004, R56GM066492, R01GM066492] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Harper for providing constructs for WD40-containing proteins, T. Gahman for assistance with apcin synthesis and D. Tomchick for assistance with structure refinement. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work was supported by grants from the National Institutes of Health (GM085004 to X. L. and GM066492 to R. W. K.) and by a grant from the Lynch Foundation to R.W.K.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lara-Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049041; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Salic A, 2005, METHOD ENZYMOL, V399, P567, DOI 10.1016/S0076-6879(05)99038-1; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sedgwick GG, 2013, EMBO J, V32, P303, DOI 10.1038/emboj.2012.335; Sigoillot FD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025511; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; van Zon W, 2010, J CELL BIOL, V190, P587, DOI 10.1083/jcb.200912084; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zeng X, 2012, NAT CHEM BIOL, V8, P383, DOI [10.1038/nchembio.801, 10.1038/NCHEMBIO.801]; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	40	171	177	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					646	+		10.1038/nature13660	http://dx.doi.org/10.1038/nature13660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25156254	Green Accepted			2022-12-28	WOS:000343801500053
J	Chen, XP; Cui, ZL; Fan, MS; Vitousek, P; Zhao, M; Ma, WQ; Wang, ZL; Zhang, WJ; Yan, XY; Yang, JC; Deng, XP; Gao, Q; Zhang, Q; Guo, SW; Ren, J; Li, SQ; Ye, YL; Wang, ZH; Huang, JL; Tang, QY; Sun, YX; Peng, XL; Zhang, JW; He, MR; Zhu, YJ; Xue, JQ; Wang, GL; Wu, L; An, N; Wu, LQ; Ma, L; Zhang, WF; Zhang, FS				Chen, Xinping; Cui, Zhenling; Fan, Mingsheng; Vitousek, Peter; Zhao, Ming; Ma, Wenqi; Wang, Zhenlin; Zhang, Weijian; Yan, Xiaoyuan; Yang, Jianchang; Deng, Xiping; Gao, Qiang; Zhang, Qiang; Guo, Shiwei; Ren, Jun; Li, Shiqing; Ye, Youliang; Wang, Zhaohui; Huang, Jianliang; Tang, Qiyuan; Sun, Yixiang; Peng, Xianlong; Zhang, Jiwang; He, Mingrong; Zhu, Yunji; Xue, Jiquan; Wang, Guiliang; Wu, Liang; An, Ning; Wu, Liangquan; Ma, Lin; Zhang, Weifeng; Zhang, Fusuo			Producing more grain with lower environmental costs	NATURE			English	Article							GREENHOUSE-GAS EMISSIONS; YIELD; FERTILIZER; PRODUCTIVITY; MANAGEMENT; EFFICIENCY; NITROGEN; DEMAND; MAIZE; WHEAT	Agriculture faces great challenges to ensure global food security by increasing yields while reducing environmental costs(1,2). Here we address this challenge by conducting a total of 153 site-year field experiments covering the main agro-ecological areas for rice, wheat and maize production in China. A set of integrated soil-crop system management practices based on a modern understanding of crop ecophysiology and soil biogeochemistry increases average yields for rice, wheat and maize from 7.2 million grams per hectare (Mg ha(-1)), 7.2 Mg ha(-1) and 10.5 Mg ha(-1) to 8.5 Mg ha(-1), 8.9 Mg ha(-1) and 14.2 Mg ha(-1), respectively, without any increase in nitrogen fertilizer. Model simulation and life-cycle assessment(3) show that reactive nitrogen losses and greenhouse gas emissions are reduced substantially by integrated soil-crop system management. If farmers in China could achieve average grain yields equivalent to 80% of this treatment by 2030, over the same planting area as in 2012, total production of rice, wheat and maize in China would be more than enough to meet the demand for direct human consumption and a substantially increased demand for animal feed, while decreasing the environmental costs of intensive agriculture.	[Chen, Xinping; Cui, Zhenling; Fan, Mingsheng; Wang, Guiliang; Wu, Liang; An, Ning; Wu, Liangquan; Ma, Lin; Zhang, Weifeng; Zhang, Fusuo] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Vitousek, Peter] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Zhao, Ming; Zhang, Weijian] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Ma, Wenqi] Agr Univ Hebei, Coll Resources & Environm Sci, Baoding 071001, Peoples R China; [Wang, Zhenlin; Zhang, Jiwang; He, Mingrong] Shandong Agr Univ, Coll Agron, Tai An 271000, Shandong, Peoples R China; [Yan, Xiaoyuan] Chinese Acad Sci, Inst Soil Sci, Nanjing 210008, Peoples R China; [Yang, Jianchang] Yangzhou Univ, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Peoples R China; [Deng, Xiping; Li, Shiqing] Northwest Agr & Forestry Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China; [Gao, Qiang] Jilin Agr Univ, Coll Resources & Environm Sci, Changchun 130118, Peoples R China; [Zhang, Qiang] Shanxi Acad Agr Sci, Inst Agr Environm & Resource, Taiyuan 030031, Peoples R China; [Guo, Shiwei] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China; [Ren, Jun] Jilin Acad Agr Sci, Res Ctr Agr Environm & Resources, Changchun 130033, Peoples R China; [Ye, Youliang; Zhu, Yunji] Henan Agr Univ, Coll Resources & Environm Sci, Zhengzhou 450000, Peoples R China; [Wang, Zhaohui; Xue, Jiquan] Northwest Agr & Forestry Univ, Yangling 712100, Peoples R China; [Huang, Jianliang] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Tang, Qiyuan] Hunan Agr Univ, Crop Physiol Ecol & Prod Ctr, Changsha 410128, Hunan, Peoples R China; [Sun, Yixiang] Anhui Acad Agr Sci, Soil & Fertilizer Res Inst, Hefei 230031, Peoples R China; [Peng, Xianlong] Northeast Agr Univ, Coll Resources & Environm Sci, Harbin 150030, Peoples R China	China Agricultural University; Stanford University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hebei Agricultural University; Shandong Agricultural University; Chinese Academy of Sciences; Institute of Soil Science, CAS; Yangzhou University; Northwest A&F University - China; Jilin Agricultural University; Shanxi Agricultural University; Nanjing Agricultural University; Jilin Academy of Agricultural Sciences; Henan Agricultural University; Northwest A&F University - China; Huazhong Agricultural University; Hunan Agricultural University; Anhui Academy of Agricultural Sciences; Northeast Agricultural University - China	Zhang, FS (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	zhangfs@cau.edu.cn	Ma, Wenqi/S-5640-2019; Li, Shiqing/AAG-8907-2019; He, mingrong/AAU-7247-2020; Yan, Xiaoyuan/M-9840-2016; Zhang, Fusuo/AAV-4517-2021	Li, Shiqing/0000-0001-6886-7637; Yan, Xiaoyuan/0000-0001-8645-4836; zhang, fusuo/0000-0001-8971-0129; Cui, Zhenling/0000-0002-5419-3771; deng, xi ping/0000-0003-4577-9217	Chinese National Basic Research Program [2009CB118600]; NSFC [31121062]; Special Fund for Agro-scientific Research in the Public Interest [201103003]	Chinese National Basic Research Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	We thank P. A. Matson, G. P. Robertson, I. Ortiz-Monasterio and G. Maltais-Landry for their comments on an earlier version of the manuscript or assistance during the manuscript revision,and we thank C. L. Kou, D. S. Tan, Z. M. Wang, Z. A. Lin, X. Y. Zhang, J. L. Gao and Y. Zhu for joining field experiments. We also acknowledge all those who provided local assistance ortechnical help to the Integrated Nutrient Management Network in China. This work was financially supported by the Chinese National Basic Research Program (2009CB118600), the Innovative Group Grant from the NSFC (31121062) and the Special Fund for Agro-scientific Research in the Public Interest (201103003).	Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; Audsley E, 1997, MR3CT942028 SILS RES; Braschkat J., 1993, Z PFLANZ BODENKUNDE, V156, P393; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chen X, 2006, NUTR CYCL AGROECOSYS, V74, P91, DOI 10.1007/s10705-005-1701-9; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chien SH, 2009, ADV AGRON, V102, P267, DOI 10.1016/S0065-2113(09)01008-6; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cui ZL, 2013, GLOBAL CHANGE BIOL, V19, P2467, DOI 10.1111/gcb.12213; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Denmead O. T., 1983, Gaseous loss of nitrogen from plant-soil systems, P133; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dobermann A., 2005, AGRON FAC PUBL, V316, P1; Feng JF, 2013, AGR ECOSYST ENVIRON, V164, P220, DOI 10.1016/j.agee.2012.10.009; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Grassini P, 2012, P NATL ACAD SCI USA, V109, P1074, DOI 10.1073/pnas.1116364109; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Holland E. A., 1999, Standard soil methods for long-term ecological research., P185; Hou P, 2012, FIELD CROP RES, V129, P1, DOI 10.1016/j.fcr.2012.01.006; Intergovernmental Panel on Climate Change, 2006, 2006 IPCC GUIDELINES, P111; Lehmann J., 2002, Trees, crops and soil fertility: concepts and research methods, P151, DOI 10.1079/9780851995939.0151; Ma L, 2013, ENVIRON SCI TECHNOL, V47, P7260, DOI 10.1021/es400456u; National Bureau of Statistics of China, 2013, CHIN STAT YB 2013; National Bureau of Statistics of China, 2013, CHIN CIT STAT YB 201; National Bureau of Statistics of China, 2013, NONGK AGR YB; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; SAS Institute, 1998, SAS US GUID STAT; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Van Wart J, 2013, GLOBAL CHANGE BIOL, V19, P3822, DOI 10.1111/gcb.12302; Yue S. C., 2012, AGRON J, V104, P1; Zhang FS, 2013, NATURE, V497, P33, DOI 10.1038/497033a; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; [赵荣芳 Zhao Rongfang], 2009, [土壤学报, Acta Pedologica Sinica], V46, P684; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	38	944	1174	153	2062	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					486	+		10.1038/nature13609	http://dx.doi.org/10.1038/nature13609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25186728				2022-12-28	WOS:000343775900039
J	Boyle, CA; Perrin, JM; Moyer, VA				Boyle, Coleen A.; Perrin, James M.; Moyer, Virginia A.			Use of Clinical Preventive Services in Infants, Children, and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Boyle, Coleen A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Perrin, James M.] MassGen Hosp Children, Div Gen Pediat, Ctr Child & Adolescent Hlth Res & Policy, Boston, MA USA; [Perrin, James M.] Harvard Univ, Sch Med, Boston, MA USA; [Moyer, Virginia A.] Amer Board Pediat Inc, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Boyle, CA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd, Atlanta, GA 30333 USA.			Perrin, James/0000-0002-1810-3708	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, 2014, MMWR MORB MORTAL S2, V63, P1; Cheng TL, 2014, JAMA-J AM MED ASSOC, V311, P1733, DOI 10.1001/jama.2014.930; Council on ChildrenWith Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for ChildrenWith Special Needs Project Advisory Committee, 2006, PEDIATRICS, V118, P405; Maciosek MV, 2010, HEALTH AFFAIR, V29, P1656, DOI 10.1377/hlthaff.2008.0701; Melnyk BM, 2012, PEDIATRICS, V130, pE399, DOI 10.1542/peds.2011-2087; Schroeder L, 2006, PEDIATRICS, V117, P1101, DOI 10.1542/peds.2005-1335; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO	7	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1509	1510		10.1001/jama.2014.12890	http://dx.doi.org/10.1001/jama.2014.12890			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25208100	Green Accepted			2022-12-28	WOS:000342983200010
J	Gao, D; Vela, I; Sboner, A; Iaquinta, PJ; Karthaus, WR; Gopalan, A; Dowling, C; Wanjala, JN; Undvall, EA; Arora, VK; Wongvipat, J; Kossai, M; Ramazanoglu, S; Barboza, LP; Di, W; Cao, Z; Zhang, QF; Sirota, I; Ran, L; MacDonald, TY; Beltran, H; Mosquera, JM; Touijer, KA; Scardino, PT; Laudone, VP; Curtis, KR; Rathkopf, DE; Morris, MJ; Danila, DC; Slovin, SF; Solomon, SB; Eastham, JA; Chi, P; Carver, B; Rubin, MA; Scher, HI; Clevers, H; Sawyers, CL; Chen, Y				Gao, Dong; Vela, Ian; Sboner, Andrea; Iaquinta, Phillip J.; Karthaus, Wouter R.; Gopalan, Anuradha; Dowling, Catherine; Wanjala, Jackline N.; Undvall, Eva A.; Arora, Vivek K.; Wongvipat, John; Kossai, Myriam; Ramazanoglu, Sinan; Barboza, Luendreo P.; Di, Wei; Cao, Zhen; Zhang, Qi Fan; Sirota, Inna; Ran, Leili; MacDonald, Theresa Y.; Beltran, Himisha; Mosquera, Juan-Miguel; Touijer, Karim A.; Scardino, Peter T.; Laudone, Vincent P.; Curtis, Kristen R.; Rathkopf, Dana E.; Morris, Michael J.; Danila, Daniel C.; Slovin, Susan F.; Solomon, Stephen B.; Eastham, James A.; Chi, Ping; Carver, Brett; Rubin, Mark A.; Scher, Howard I.; Clevers, Hans; Sawyers, Charles L.; Chen, Yu			Organoid Cultures Derived from Patients with Advanced Prostate Cancer	CELL			English	Article							IN-VITRO EXPANSION; CELL-LINE; MOLECULAR CHARACTERIZATION; INCREASED SURVIVAL; DRUG-SENSITIVITY; CARCINOMA; IDENTIFICATION; REARRANGEMENT; CASTRATION; MODEL	The lack of in vitro prostate cancer models that recapitulate the diversity of human prostate cancer has hampered progress in understanding disease pathogenesis and therapy response. Using a 3D organoid system, we report success in long-term culture of prostate cancer from biopsy specimens and circulating tumor cells. The first seven fully characterized organoid lines recapitulate the molecular diversity of prostate cancer subtypes, including TMPRSS2-ERG fusion, SPOP mutation, SPINK1 overexpression, and CHD1 loss. Whole-exome sequencing shows a low mutational burden, consistent with genomics studies, but with mutations in FOXA1 and PIK3R1, as well as in DNA repair and chromatin modifier pathways that have been reported in advanced disease. Loss of p53 and RB tumor suppressor pathway function are the most common feature shared across the organoid lines. The methodology described here should enable the generation of a large repertoire of patient-derived prostate cancer lines amenable to genetic and pharmacologic studies.	[Gao, Dong; Vela, Ian; Iaquinta, Phillip J.; Dowling, Catherine; Wanjala, Jackline N.; Arora, Vivek K.; Wongvipat, John; Barboza, Luendreo P.; Di, Wei; Cao, Zhen; Zhang, Qi Fan; Sirota, Inna; Ran, Leili; Chi, Ping; Carver, Brett; Sawyers, Charles L.; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Vela, Ian; Dowling, Catherine; Touijer, Karim A.; Scardino, Peter T.; Laudone, Vincent P.; Eastham, James A.; Carver, Brett] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Sboner, Andrea; Ramazanoglu, Sinan] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA; [Sboner, Andrea; Beltran, Himisha; Rubin, Mark A.] Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA; [Sboner, Andrea; Kossai, Myriam; Ramazanoglu, Sinan; MacDonald, Theresa Y.; Beltran, Himisha; Mosquera, Juan-Miguel; Rathkopf, Dana E.; Morris, Michael J.; Danila, Daniel C.; Slovin, Susan F.; Chi, Ping; Rubin, Mark A.; Scher, Howard I.; Chen, Yu] New York Presbyterian Hosp, New York, NY 10065 USA; [Karthaus, Wouter R.; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Karthaus, Wouter R.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Gopalan, Anuradha] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Undvall, Eva A.] Mem Sloan Kettering Canc Ctr, Lab Med, New York, NY 10065 USA; [Sboner, Andrea; Kossai, Myriam; Ramazanoglu, Sinan; MacDonald, Theresa Y.; Mosquera, Juan-Miguel; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Solomon, Stephen B.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Beltran, Himisha; Rathkopf, Dana E.; Morris, Michael J.; Danila, Daniel C.; Slovin, Susan F.; Chi, Ping; Scher, Howard I.; Chen, Yu] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Arora, Vivek K.; Rathkopf, Dana E.; Morris, Michael J.; Danila, Daniel C.; Slovin, Susan F.; Chi, Ping; Scher, Howard I.; Chen, Yu] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	sawyersc@mskcc.org; cheny1@mskcc.org	Vela, Ian/K-4800-2014; Sawyers, Charles/G-5327-2016; Undvall, Eva/AFR-7042-2022	Undvall, Eva/0000-0002-4705-1812; Karthaus, Wouter R./0000-0002-9234-9044; Rubin, Mark/0000-0002-8321-9950; Gao, Dong/0000-0003-1821-2741; Rathkopf, Dana/0000-0002-4503-7582; Morris, Michael J./0000-0002-9454-0096	Prostate Cancer Foundation (PCF); National Institutes of Health [5K08CA140946, P50CA092629, CA15516901A1, 5R01CA116337]; US Department of Defense [W81XWH-10-1-0197, W81XWH-09-1-0147]; Movember Foundation; Geoffrey Beene Cancer Center; STARR Cancer Consortium [I8-A722]; Stand Up To Cancer - Prostate Cancer Foundation Prostate Dream Team Translational Research Grant [SU2C-AACR-DT0712]; NATIONAL CANCER INSTITUTE [K08CA140946, P30CA008748, R01CA116337, R01CA155169, P50CA092629, K08CA151660, R01CA182503] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	Prostate Cancer Foundation (PCF); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Movember Foundation; Geoffrey Beene Cancer Center; STARR Cancer Consortium; Stand Up To Cancer - Prostate Cancer Foundation Prostate Dream Team Translational Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank the Prostate Cancer Foundation (PCF) for generous financial support as well as Drs.Howard Soule and Jonathon Simons for stimulating discussions. We thank the follow MSKCC core facilities: Genomics Core Laboratory (Daoqi You, Agnes Viales), and Molecular Cytology (Ning Fan and Mesruh Turkekul). We thank the National Institutes of Health (5K08CA140946, Y.C.; P50CA092629 Y.C., H.I.S., B.C., C.L.S.; CA15516901A1, C.L.S.; 5R01CA116337, H.B. and M.A.R.), US Department of Defense (W81XWH-10-1-0197, Y.C.; W81XWH-09-1-0147, H.I.S.), Movember Foundation (Y.C., D.C.D., B.C., S.B.S., C.L.S.), the Geoffrey Beene Cancer Center (Y.C., B.C.) the STARR Cancer Consortium for funding (I8-A722, Y.C., H.B., M.A.R.).Research supported by a Stand Up To Cancer - Prostate Cancer Foundation Prostate Dream Team Translational Research Grant (SU2C-AACR-DT0712).Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. H.C.is an inventor on several parents related to this work.	Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Burkhardt L, 2013, CANCER RES, V73, P2795, DOI 10.1158/0008-5472.CAN-12-1342; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Johnson H, 2013, HUM PATHOL, V44, P2241, DOI 10.1016/j.humpath.2013.05.006; Kaighn M E, 1978, Natl Cancer Inst Monogr, P17; Karthaus W.R., 2014, CELL, V158; Korenchuk S, 2001, IN VIVO, V15, P163; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu W, 2012, ONCOGENE, V31, P3939, DOI 10.1038/onc.2011.554; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Navone NM, 1997, CLIN CANCER RES, V3, P2493; Parwani AV, 2004, AM J SURG PATHOL, V28, P651, DOI 10.1097/00000478-200405000-00014; Rathkopf D, 2013, CANCER J, V19, P43, DOI 10.1097/PPO.0b013e318282635a; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Ryan C.J., 2012, ASCO M, V30; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schelling LA, 2013, HUM PATHOL, V44, P2227, DOI 10.1016/j.humpath.2013.05.005; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016	47	863	899	23	235	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					176	187		10.1016/j.cell.2014.08.016	http://dx.doi.org/10.1016/j.cell.2014.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25201530	Green Accepted, Bronze			2022-12-28	WOS:000343095000018
J	Lagerqvist, B; Frobert, O; Olivecrona, GK; Gudnason, T; Maeng, M; Alstrom, P; Andersson, J; Calais, F; Carlsson, J; Collste, O; Gotberg, M; Hardhammar, P; Ioanes, D; Kallryd, A; Linder, R; Lundin, A; Odenstedt, J; Omerovic, E; Puskar, V; Todt, T; Zelleroth, E; Ostlund, O; James, SK				Lagerqvist, Bo; Frobert, Ole; Olivecrona, Goran K.; Gudnason, Thorarinn; Maeng, Michael; Alstrom, Patrik; Andersson, Jonas; Calais, Fredrik; Carlsson, Jorg; Collste, Olov; Gotberg, Matthias; Hardhammar, Peter; Ioanes, Dan; Kallryd, Anders; Linder, Rickard; Lundin, Anders; Odenstedt, Jacob; Omerovic, Elmir; Puskar, Verner; Todt, Tim; Zelleroth, Eva; Ostlund, Ollie; James, Stefan K.			Outcomes 1 Year after Thrombus Aspiration for Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; DRUG-ELUTING STENTS; ANGIOPLASTY; ABCIXIMAB; THROMBECTOMY; ANGIOGRAPHY	BACKGROUND Routine intracoronary thrombus aspiration before primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) has not been proved to reduce short-term mortality. We evaluated clinical outcomes at 1 year after thrombus aspiration. METHODS We randomly assigned 7244 patients with STEMI to undergo manual thrombus aspiration followed by PCI or to undergo PCI alone, in a registry-based, randomized clinical trial. The primary end point of all-cause mortality at 30 days has been reported previously. Death from any cause at 1 year was a prespecified secondary end point of the trial. RESULTS No patients were lost to follow-up. Death from any cause occurred in 5.3% of the patients (191 of 3621 patients) in the thrombus-aspiration group, as compared with 5.6% (202 of 3623) in the PCI-only group (hazard ratio, 0.94; 95% confidence interval [CI], 0.78 to 1.15; P = 0.57). Rehospitalization for myocardial infarction at 1 year occurred in 2.7% and 2.7% of the patients, respectively (hazard ratio, 0.97; 95% CI, 0.73 to 1.28; P = 0.81), and stent thrombosis in 0.7% and 0.9%, respectively (hazard ratio, 0.84; 95% CI, 0.50 to 1.40; P = 0.51). The composite of death from any cause, rehospitalization for myocardial infarction, or stent thrombosis occurred in 8.0% and 8.5% of the patients, respectively (hazard ratio, 0.94; 95% CI, 0.80 to 1.11; P = 0.48). The results were consistent across all the major subgroups, including grade of thrombus burden and coronary flow before PCI. CONCLUSIONS Routine thrombus aspiration before PCI in patients with STEMI did not reduce the rate of death from any cause or the composite of death from any cause, rehospitalization for myocardial infarction, or stent thrombosis at 1 year.	[Lagerqvist, Bo; Ostlund, Ollie; James, Stefan K.] Uppsala Univ, Dept Med Sci, Cardiol Sect, S-75185 Uppsala, Sweden; [Lagerqvist, Bo; Ostlund, Ollie; James, Stefan K.] Uppsala Univ, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; [Frobert, Ole; Calais, Fredrik] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Olivecrona, Goran K.; Gotberg, Matthias; Kallryd, Anders] Lund Univ, Dept Coronary Heart Dis, Skane Univ Hosp, Clin Sci Sect, Lund, Sweden; [Alstrom, Patrik; Collste, Olov] Karolinska Inst, Dept Cardiol, Sodersjukhuset, Danderyd, Sweden; [Linder, Rickard] Karolinska Inst, Dept Cardiol, Danderyd, Sweden; [Andersson, Jonas] Umea Univ Hosp, Dept Cardiol, S-90185 Umea, Sweden; [Carlsson, Jorg] Kalmar Cty Hosp, Cardiol Sect, Kalmar, Sweden; [Carlsson, Jorg] Linnaeus Univ, Kalmar, Sweden; [Hardhammar, Peter] Halmstad Cty Hosp, Dept Cardiol, Halmstad, Sweden; [Ioanes, Dan; Odenstedt, Jacob; Omerovic, Elmir] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Kallryd, Anders] Skaraborgs Hosp, Dept Cardiol, Skovde, Sweden; [Puskar, Verner] Ryhov Hosp, Dept Radiol, Jonkoping, Sweden; [Todt, Tim] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden; [Zelleroth, Eva] Malarsjukhuset, Dept Radiol, Eskilstuna, Sweden; [Gudnason, Thorarinn] Landspitali Univ Hosp, Dept Cardiol, Reykjavik, Iceland; [Gudnason, Thorarinn] Landspitali Univ Hosp, Cardiovasc Res Ctr, Reykjavik, Iceland; [Maeng, Michael] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark	Uppsala University; Uppsala University; Orebro University; Lund University; Skane University Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Umea University; Linnaeus University; Sahlgrenska University Hospital; Linkoping University; Landspitali National University Hospital; Landspitali National University Hospital; Aarhus University	James, SK (corresponding author), Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden.	stefan.james@ucr.uu.se	James, Stefan K/J-4554-2014; Maeng, Michael/AAY-2135-2021	Maeng, Michael/0000-0002-4310-6433; Frobert, Ole/0000-0002-5846-345X; Ostlund, Ollie/0000-0001-8028-2308; Gotberg, Matthias/0000-0002-0912-7927	Swedish Research Council; Swedish Association of Local Authorities and Regions; Terumo Medical; Medtronic; Vascular Solutions; Swedish Heart-Lung Foundation [20100178, B0010401]; Landspitali University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association of Local Authorities and Regions; Terumo Medical; Medtronic(Medtronic); Vascular Solutions; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Landspitali University Hospital	Supported by unrestricted research grants from the Swedish Research Council, the Swedish Association of Local Authorities and Regions, Terumo Medical, Medtronic, and Vascular Solutions, by grants from the Swedish Heart-Lung Foundation (20100178, to Dr. Frobert; and B0010401, to Dr. James), and by the Landspitali University Hospital Research Fund (to Dr. Gudnason).	Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; Costopoulos C, 2013, INT J CARDIOL, V163, P229, DOI 10.1016/j.ijcard.2011.11.014; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Fernandez-Rodriguez D, 2014, CIRC-CARDIOVASC INTE, V7, P294, DOI 10.1161/CIRCINTERVENTIONS.113.000964; Fokkema ML, 2009, EUR HEART J, V30, P908, DOI 10.1093/eurheartj/ehp033; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Frobert O, 2010, AM HEART J, V160, P1042, DOI 10.1016/j.ahj.2010.08.040; Gibson CM, 2001, CIRCULATION, V103, P2550; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Jolly SS, 2014, AM HEART J, V167, P315, DOI 10.1016/j.ahj.2013.12.002; Kumbhani DJ, 2013, J AM COLL CARDIOL, V62, P1409, DOI 10.1016/j.jacc.2013.04.025; Lagerqvist B, 2009, CIRC-CARDIOVASC INTE, V2, P401, DOI 10.1161/CIRCINTERVENTIONS.108.844985; Sarno G, 2014, J AM COLL CARDIOL, V64, P16, DOI 10.1016/j.jacc.2014.04.022; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; Sianos G, 2010, J INVASIVE CARDIOL, V22, p6B; Steg PG, 2013, HEART, V99, P1156, DOI 10.1136/heartjnl-2013-304498; Stone GW, 2013, CIRC-CARDIOVASC INTE, V6, P527, DOI 10.1161/CIRCINTERVENTIONS.113.000644; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Stone GW, 2002, J AM COLL CARDIOL, V39, P591, DOI 10.1016/S0735-1097(01)01779-X; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8	24	253	274	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1111	1120		10.1056/NEJMoa1405707	http://dx.doi.org/10.1056/NEJMoa1405707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25176395	Green Published			2022-12-28	WOS:000341687300006
J	Takeuchi, T; Morris, RGM				Takeuchi, Tomonori; Morris, Richard G. M.			NEUROSCIENCE Shedding light on a change of mind	NATURE			English	Editorial Material								Sophisticated genetic tools that make brain cells responsive to light have now been used in mice to trigger a memory connected with a particular place, and to switch its association from negative to positive, or vice versa. See Letter p. 426	[Takeuchi, Tomonori; Morris, Richard G. M.] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh	Takeuchi, T (corresponding author), Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland.	tomonori.takeuchi@ed.ac.uk; r.g.m.morris@ed.ac.uk	Morris, Richard G M/C-9982-2013; Takeuchi, Tomonori/P-5988-2016	Takeuchi, Tomonori/0000-0002-9981-4260; MORRIS, Richard G M/0000-0001-8661-1520				ETTLINGER G, 1959, BRAIN, V82, P232, DOI 10.1093/brain/82.2.232; Gaffan D, 2008, CORTEX, V44, P928, DOI 10.1016/j.cortex.2008.03.005; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Saddoris MP, 2009, J NEUROSCI, V29, P15386, DOI 10.1523/JNEUROSCI.3233-09.2009; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036	7	0	0	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					323	324		10.1038/nature13745	http://dx.doi.org/10.1038/nature13745			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25162529				2022-12-28	WOS:000341814900043
J	Kelly, JD				Kelly, J. Daniel			Make diagnostic centres a priority for Ebola crisis	NATURE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kelly, JD (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	dan.kelly@ucsf.edu							0	16	16	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					145	145		10.1038/513145a	http://dx.doi.org/10.1038/513145a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5DP	25209763	Bronze			2022-12-28	WOS:000341362800017
J	Nogrady, B				Nogrady, Bianca			Chemical tricks	NATURE			English	Editorial Material							B7 FAMILY; CANCER; MEMBER											Butts C, 2014, LANCET ONCOL, V15, P59, DOI 10.1016/S1470-2045(13)70510-2; Dong HD, 1999, NAT MED, V5, P1365; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	4	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S10	S11		10.1038/513S10a	http://dx.doi.org/10.1038/513S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208066	Bronze			2022-12-28	WOS:000341362800006
J	Subbaraman, N				Subbaraman, Nidhi			A burning issue	NATURE			English	Editorial Material							LUNG-CANCER; CHINA; RISK											Daiki M., 2010, NAT GENET, V42, P893; Hosgood HD, 2008, BRIT J CANCER, V99, P1934, DOI 10.1038/sj.bjc.6604744; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190	6	10	10	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S16	S17		10.1038/513S16a	http://dx.doi.org/10.1038/513S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208069	Bronze			2022-12-28	WOS:000341362800009
J	Sidebotham, P; Fraser, J; Fleming, P; Ward-Platt, M; Hain, R				Sidebotham, Peter; Fraser, James; Fleming, Peter; Ward-Platt, Martin; Hain, Richard			Child death in high-income countries 2 Patterns of child death in England and Wales	LANCET			English	Article							UNEXPECTED INFANT DEATHS; ACCIDENTAL SUFFOCATION; PALLIATIVE CARE; SUDDEN; MORTALITY; RISK; POPULATION; PREVALENCE; SURVIVAL; TRENDS	In the past century, child mortality has fallen to very low rates in all developed countries. However, rates between and within countries vary widely, and factors can be identified that could be modified to reduce the risk of future deaths. An understanding of the nature and patterns of child death and of the factors contributing to child deaths is essential to drive preventive initiatives. We discuss the epidemiology of child deaths in England and Wales. We use available data, particularly that of death registration and other available datasets, and published literature to emphasise issues relevant to reduction of child deaths in developed countries. We examine the different patterns of mortality at different ages in five broad categories of death: perinatal causes, congenital abnormalities, acquired natural causes, external causes, and unexplained deaths. For each category, we explore what is known about the main causes of death and some of the contributory factors. We then explain how this knowledge might be used to help to drive prevention initiatives.	[Sidebotham, Peter] Univ Warwick, Div Mental Hlth & Well Being, Coventry CV4 7AL, W Midlands, England; [Fraser, James] Bristol Royal Hosp Children, Bristol, Avon, England; [Fleming, Peter] St Michaels Hosp, Sch Social & Community Med, Bristol, Avon, England; [Ward-Platt, Martin] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hain, Richard] Bangor Univ, Welsh Paediat Palliat Med Network, Bangor, Gwynedd, Wales; [Hain, Richard] Univ Glamorgan, Childrens Hosp, Cardiff, S Glam, Wales	University of Warwick; Bristol Royal Hospital For Children; University of Bristol; Newcastle University - UK; Bangor University; University of South Wales	Sidebotham, P (corresponding author), Univ Warwick, Div Mental Hlth & Well Being, Coventry CV4 7AL, W Midlands, England.	p.sidebotham@warwick.ac.uk	Sidebotham, Peter D/E-3011-2010; Fleming, Peter/O-3231-2019	Sidebotham, Peter D/0000-0003-4891-6926; Fleming, Peter/0000-0003-2521-5764	UK Department for Education	UK Department for Education	PS runs Warwick's advanced course in the management of unexpected child death. He has received grant money from the UK Department for Education for research into child death review and the development of training materials on child death review. JF and PF are on the faculty of the Warwick advanced course in the management of unexpected child death. MW-P and RH declare that no competing interests.	ACT (Association for Children with Life-Threatening and Terminal Conditions and Their Families) and the RCPCH (Royal College of Paediatrics and Child Health), 1997, GUID DEV CHILDR PALL; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Bate J, 2009, PEDIATR BLOOD CANCER, V53, P371, DOI 10.1002/pbc.22057; Blair PS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3666; Brandon M., 2010, BUILDING LEARNING SE; Brandon M., 2009, UNDERSTANDING SERIOU; Brook L, 2008, ARCH DIS CHILD, V93, P1067, DOI 10.1136/adc.2007.127332; Brookman F, 2006, J INTERPERS VIOLENCE, V21, P869, DOI 10.1177/0886260506288935; Chambers L., 2018, GUIDE CHILDRENS PALL; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; (CMACE) C. f.M.a.C.E, 2011, PER MORT 2009 UK; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Cote A, 2010, PAEDIATR RESPIR REV, V11, P219, DOI 10.1016/j.prrv.2009.12.002; Crume TL, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e18; Denning GM, 2013, INJURY PREV, V19, P250, DOI 10.1136/injuryprev-2012-040548; Department for Education, 2011, CHILD DEATH REV YEAR; Department for Transport, 2010, REP ROAD CAS GREAT B; Department for Transport, 2010, CHILD CAS REP ROAD A; Department of Transport, 2012, REP ROAD CAS GREAT B; Desapriya E, 2011, INJURY PREV, V17, P4, DOI 10.1136/ip.2010.026914; DiGuiseppi C, 1997, BRIT MED J, V314, P710, DOI 10.1136/bmj.314.7082.710; Dull PM, 2012, VACCINE, V30, pB18, DOI 10.1016/j.vaccine.2012.01.062; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; ECDC, 2011, ANN EP REP 2011 REP; Farnsworth Clyde H, 1994, N Y Times Web, pA6; Fleming P., 2000, SUDDEN UNEXPECTED DE; Fleming PJ, 2004, BMJ-BRIT MED J, V328, P331, DOI 10.1136/bmj.328.7435.331; Fraser J, 2014, LANCET, V384, P894, DOI 10.1016/S0140-6736(13)61089-2; Fraser LK, 2012, PEDIATRICS, V129, pE923, DOI 10.1542/peds.2011-2846; Fujiwara T, 2009, PEDIATRICS, V124, pE210, DOI 10.1542/peds.2008-3675; Griffin B, 2011, INJURY PREV, V17, P10, DOI 10.1136/ip.2010.030304; Guileyardo JM, 1999, AM J FOREN MED PATH, V20, P286, DOI 10.1097/00000433-199909000-00014; Hain RDW, 2005, PALLIATIVE MED, V19, P137, DOI 10.1191/0269216305pm967oa; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Hanna N.J, 2002, NATL SENTINEL CLIN A; Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520; Harvey A, 2009, B WORLD HEALTH ORGAN, V87, P390, DOI 10.2471/BLT.08.059808; Hauck FR, 2003, PEDIATRICS, V111, P1207; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; health W., 2008, STAT INJ DEATHS RIS; Hollowell J, 2011, SEMIN PERINATOL, V35, P240, DOI 10.1053/j.semperi.2011.02.021; Iijima S, 2009, AM J PERINAT, V26, P399, DOI 10.1055/s-0029-1214234; Irving C, 2011, J MATERN-FETAL NEO M, V24, P137, DOI 10.3109/14767051003758879; Kim SY, 2012, J FORENSIC SCI, V57, P364, DOI 10.1111/j.1556-4029.2011.01937.x; Kinney HC, 2007, PEDIATR DEVEL PATHOL, V10, P208, DOI 10.2350/06-08-0144.1; Knowles RL, 2012, ARCH DIS CHILD, V97, P861, DOI 10.1136/archdischild-2012-301662; Krous HF, 2005, PEDIATR DEVEL PATHOL, V8, P307, DOI 10.1007/s10024-005-1155-8; Ladhani S, 2010, PEDIATR INFECT DIS J, V29, P310, DOI 10.1097/INF.0b013e3181d73322; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; Maternal and Child Health Research Consortium, 1997, CONF ENQ STILL BIRTH; Morrison A, 1999, Inj Prev, V5, P171; Munro E., 2020, EFFECTIVE CHILD PROT, V3; National Confidential Enquiry into Patient Outcome and Death, 2007, TRAUM WHO CAR; National Confidential Enquiry into Perioperative Deaths (NCEPOD), 1999, EXTREMES AGE 1999 RE; NCEPOD, 2011, SURG CHILDR AR WE TH; NCEPOD, 2009, DEATHS AC HOSP CAR E; O'Leary M, 2008, SEMIN ONCOL, V35, P484, DOI 10.1053/j.seminoncol.2008.07.008; Office for National Statistics, 2012, CHILD MORT STAT CHIL; Office for National Statistics, 2009, MORT STAT DEATHS REG; Office for National Statistics, 2010, MORT STAT DEATHS REG; Office for National Statistics, 2016, 2011 CENS REL FEM MA; Office for National Statistics, 2018, DEATHS REGISTERED EN; Office for National Statistics, 2011, CHILD MORT STAT CHIL; Office for National Statistics, 2013, CHILD MORT STAT CHIL; Overpeck MD, 2002, PEDIATRICS, V109, P274, DOI 10.1542/peds.109.2.274; Palusci VJ, 2010, CHILD ABUSE NEGLECT, V34, P396, DOI 10.1016/j.chiabu.2009.11.002; Panickar JR, 2005, THORAX, V60, P1035, DOI 10.1136/thx.2005.044750; Papadakis M, 2009, EUROPACE, V11, P1353, DOI 10.1093/europace/eup229; Pearson G., 2008, WHY CHILDREN DIE PIL; Pearson GA, 2011, ARCH DIS CHILD, V96, P927, DOI 10.1136/adc.2009.177071; Petrou S, 2014, LANCET, V384, P831, DOI 10.1016/S0140-6736(14)61372-6; Pritchard C, 2010, BRIT J SOC WORK, V40, P1700, DOI 10.1093/bjsw/bcp089; Pritchard C, 2008, CHILD ABUSE REV, V17, P297, DOI 10.1002/car.1016; Rattihalli R, 2012, ARCH DIS CHILD-FETAL, V97, pF160, DOI 10.1136/archdischild-2011-301096; Royal College of Pathologists Royal College of Paediatrics and Child Health, 2004, SUDD UN DEATH INF MU; Ryan M, FRANCES INGLIS KILLE; Sachedina N, 2010, LANCET, V376, P1846, DOI 10.1016/S0140-6736(10)61195-6; Seaton SE, 2013, ARCH DIS CHILD-FETAL, V98, pF15, DOI 10.1136/fetalneonatal-2011-301572; Sethi Sudhir, 2010, Community Pract, V83, P16; Shapiro-Mendoza CK, 2009, PEDIATRICS, V123, P533, DOI 10.1542/peds.2007-3746; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Sibert J, 2007, UNEXPECTED DEATH CHI, P61; Sidebotham P, 2014, LANCET, V384, P915, DOI 10.1016/S0140-6736(14)60581-X; Sidebotham P, 2012, ARCH DIS CHILD, V97, P193, DOI 10.1136/adc.2010.207647; Sidebotham P, 2011, CHILD ABUSE NEGLECT, V35, P299, DOI 10.1016/j.chiabu.2011.01.005; Sidebotham P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b531; Smith K, 2010, HOMICIDES FIREARM OF, V2; Smith LK, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6654; Sneiderman B, 1997, Health Law J, V5, P1; Stiller C, 2007, CHILDHOOD CANC BRITA; Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397; Taylor LK, 2010, ARCH DIS CHILD, V95, P89, DOI 10.1136/adc.2009.158774; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; The National Confidential Enquiry into Peri-Operative Deaths (NCEPOD), 2003, WHO OP; Trachtenberg FL, 2012, PEDIATRICS, V129, P630, DOI 10.1542/peds.2011-1419; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Verhagen AAE, 2009, ARCH PEDIAT ADOL MED, V163, P895, DOI 10.1001/archpediatrics.2009.166; Verhagen E, 2005, NEW ENGL J MED, V352, P959, DOI 10.1056/NEJMp058026; WILLINGER M, 1991, Pediatric Pathology, V11, P677; Wolfe I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1277; Wood F, 2010, PALLIATIVE MED, V24, P796, DOI 10.1177/0269216310376555	101	43	44	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					904	914		10.1016/S0140-6736(13)61090-9	http://dx.doi.org/10.1016/S0140-6736(13)61090-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	25209490	Green Submitted			2022-12-28	WOS:000341362200033
J	Sedgwick, P				Sedgwick, Philip			What is a factorial study design?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7294; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4176	4	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2014	349								g5455	10.1136/bmj.g5455	http://dx.doi.org/10.1136/bmj.g5455			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MS	25193939				2022-12-28	WOS:000341389600003
J	Findlay, GM; Boyle, EA; Hause, RJ; Klein, JC; Shendure, J				Findlay, Gregory M.; Boyle, Evan A.; Hause, Ronald J.; Klein, Jason C.; Shendure, Jay			Saturation editing of genomic regions by multiplex homology-directed repair	NATURE			English	Article							GENETIC SCREENS	Saturation mutagenesis(1,2)-coupled to an appropriate biological assay-represents a fundamental means of achieving a high-resolution understanding of regulatory(3) and protein-coding(4) nucleic acid sequences of interest. However, mutagenized sequences introduced in trans on episomes or via random or "safe-harbour'' integration fail to capture the native context of the endogenous chromosomal locus(5). This shortcoming markedly limits the interpretability of the resulting measurements of mutational impact. Here, we couple CRISPR/Cas9 RNA-guided cleavage(6) with multiplex homology-directed repair using a complex library of donor templates to demonstrate saturation editing of genomic regions. In exon 18 of BRCA1, we replace a six-base-pair (bp) genomic region with all possible hexamers, or the full exon with all possible single nucleotide variants (SNVs), and measure strong effects on transcript abundance attributable to nonsense-mediated decay and exonic splicing elements. We similarly perform saturation genome editing of a well-conserved coding region of an essential gene, DBR1, and measure relative effects on growth that correlate with functional impact. Measurement of the functional consequences of large numbers of mutations with saturation genome editing will potentially facilitate high-resolution functional dissection of both cis-regulatory elements and trans-acting factors, as well as the interpretation of variants of uncertain significance observed in clinical sequencing.	[Findlay, Gregory M.; Boyle, Evan A.; Hause, Ronald J.; Klein, Jason C.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	gf2@uw.edu; shendure@uw.edu	Findlay, Gregory/AAX-9029-2020; Shendure, Jay/AAU-3684-2021	Findlay, Gregory/0000-0002-7767-8608; Klein, Jason/0000-0001-9566-6347; Boyle, Evan/0000-0003-4494-9771; Shendure, Jay/0000-0002-1516-1865; Hause, Ronald/0000-0002-5229-7366	National Institutes of Health [DP1HG007811]; UW Medical Scientist Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Medical Scientist Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Zhang and his laboratory for the CRISPR/Cas9 backbone constructs used in this study and G. Church and his laboratory for providing reagents used to establish CRISPR/Cas9 editing techniques in our lab. We also thank members of the Shendure laboratory for helpful discussions and D. Prunkard for assistance with FACS. This work was supported by the National Institutes of Health (DP1HG007811 to J.S.) and the UW Medical Scientist Training Program (G. M. F. and J.K.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BOTSTEIN D, 1985, SCIENCE, V229, P1193, DOI 10.1126/science.2994214; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-90	35	198	218	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					120	+		10.1038/nature13695	http://dx.doi.org/10.1038/nature13695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25141179	Green Accepted			2022-12-28	WOS:000341174800042
J	Marin, JR; Shaikh, N; Docimo, SG; Hickey, RW; Hoberman, A				Marin, Jennifer R.; Shaikh, Nader; Docimo, Steven G.; Hickey, Robert W.; Hoberman, Alejandro			Suprapubic Bladder Aspiration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ULTRASOUND; CATHETERIZATION		[Marin, Jennifer R.; Shaikh, Nader; Docimo, Steven G.; Hickey, Robert W.; Hoberman, Alejandro] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Marin, Jennifer R.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marin, JR (corresponding author), Childrens Hosp Pittsburgh, 4401 Penn Ave,AOB,Suite 2400, Pittsburgh, PA 15224 USA.	jennifer.marin@chp.edu		Marin, Jennifer/0000-0003-3090-664X				Chen L, 2005, PEDIATRICS, V115, P108, DOI 10.1542/peds.2004-0738; GOCHMAN RF, 1991, ANN EMERG MED, V20, P631, DOI 10.1016/S0196-0644(05)82381-9; Witt M, 2005, ACAD EMERG MED, V12, P371, DOI 10.1197/j.aem.2004.11.023	3	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10								10.1056/NEJMvcm1209888	http://dx.doi.org/10.1056/NEJMvcm1209888			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184887				2022-12-28	WOS:000341390600001
J	Urnov, FD				Urnov, Fyodor D.			BIOLOGICAL TECHNIQUES Edit the genome to understand it	NATURE			English	Editorial Material									Sangamo BioSci Inc, Richmond, CA 94804 USA	Sangamo Therapeutics, Inc.	Urnov, FD (corresponding author), Sangamo BioSci Inc, Richmond, CA 94804 USA.	furnov@sangamo.com						Braberg H, 2013, CELL, V154, P775, DOI 10.1016/j.cell.2013.07.033; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROBERTSON M, 1980, NATURE, V285, P358, DOI 10.1038/285358a0; Sexton A., 2014, GENES DEV; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	11	4	4	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					40	41		10.1038/nature13659	http://dx.doi.org/10.1038/nature13659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25141180				2022-12-28	WOS:000341174800023
J	Yip, W; Hsiao, W				Yip, Winnie; Hsiao, William			Harnessing the privatisation of China's fragmented health-care delivery	LANCET			English	Review							PRIVATE FOR-PROFIT; QUALITY-OF-CARE; HOSPITAL OWNERSHIP; NONCOMMUNICABLE DISEASES; FINANCIAL INCENTIVES; SYSTEM REFORM; PERFORMANCE; PREVALENCE; MORTALITY; SERVICES	Although China's 2009 health-care reform has made impressive progress in expansion of insurance coverage, much work remains to improve its wasteful health-care delivery. Particularly, the Chinese health-care system faces substantial challenges in its transformation from a profit-driven public hospital-centred system to an integrated primary care-based delivery system that is cost effective and of better quality to respond to the changing population needs. An additional challenge is the government's latest strategy to promote private investment for hospitals. In this Review, we discuss how China's health-care system would perform if hospital privatisation combined with hospital-centred fragmented delivery were to prevail-population health outcomes would suffer; health-care expenditures would escalate, with patients bearing increasing costs; and a two-tiered system would emerge in which access and quality of care are decided by ability to pay. We then propose an alternative pathway that includes the reform of public hospitals to pursue the public interest and be more accountable, with public hospitals as the benchmarks against which private hospitals would have to compete, with performance-based purchasing, and with population-based capitation payment to catalyse coordinated care. Any decision to further expand the for-profit private hospital market should not be made without objective assessment of its effect on China's health-policy goals.	[Yip, Winnie] Univ Oxford, Blavatnik Sch Govt, Oxford OX1 4JJ, England; [Hsiao, William] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health	Yip, W (corresponding author), Univ Oxford, Blavatnik Sch Govt, 10 Merton St, Oxford OX1 4JJ, England.	winnie.yip@bsg.ox.ac.uk						Allen P, 2014, INT J HEALTH PLAN M, V29, P141, DOI 10.1002/hpm.2200; Baker LC, 2010, HEALTH AFFAIR, V29, P2252, DOI 10.1377/hlthaff.2009.1099; Barro JR, 2006, J HEALTH ECON, V25, P702, DOI 10.1016/j.jhealeco.2005.11.001; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Beijing Municipal Health Bureau, 2013, GUID INT CAR NETW; Bevan G, 2011, BMJ, P343; Bloom N, 2010, NATL BUR EC RES B AG, V16032; Bloom N, 2012, ACAD MANAGE PERSPECT, V26, P12, DOI 10.5465/amp.2011.0077; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; BMA, 2013, UND REF NHS TRUSTS F; Central Committee of the Communist Party and State Council. People's Republic of China, 2014, STAND C STAT COUNC C; Chaoyang District Health Bureau, 2013, IMPL PLAN DEV INT CA; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Chumbler NR, 2005, EVAL HEALTH PROF, V28, P464, DOI 10.1177/0163278705281079; Cooper Z., 2010, DOES HOSP COMPETITIO; Curry N, 2010, CLIN SERVICE INTEGRA; Dan SJ, 2011, CHINESE HLTH RESOUR, V14, P325; Department of Health of Hongkong, 2014, HLTH FACTS HONGK; Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399; Devereaux PJ, 2004, CAN MED ASSOC J, V170, P1817, DOI 10.1503/cmaj.1040722; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; Dudley L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub3; Eggleston K, 2008, HEALTH ECON, V17, P1345, DOI 10.1002/hec.1333; Eichler R, 2009, PERFORMANCE BASED IC; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P29, DOI 10.2471/BLT.13.124495; Gohler A, 2006, J CARD FAIL, V12, P554, DOI 10.1016/j.cardfail.2006.03.003; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Goodwin N., 2014, PROVIDING INTEGRATED; Government of Pudong People's Republic of China, 12 5 YEAR PLAN HLTH; Ham C., 2011, INTEGRATED CARE WHAT; Haseltine WA, 2013, AFF EXC SING; He C, 2014, HOSP INVESTMENT SERI; He D, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-39; He GX, 2011, CLIN INFECT DIS, V52, pE153, DOI 10.1093/cid/cir075; Hillman BJ, 2010, NEW ENGL J MED, V363, P4, DOI 10.1056/NEJMp1003173; Hofmarcher MM, 2007, 30 OECD; Hou JL, 2014, LANCET, V384, P819, DOI 10.1016/S0140-6736(14)61307-6; HSIAO WC, 1995, HEALTH AFFAIR, V14, P260, DOI 10.1377/hlthaff.14.2.260; Hsiao WC, 2013, PUBLIC INTERESTS PUB; Huang C, 2014, LANCET, V384, P783, DOI 10.1016/S0140-6736(14)61214-9; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Klein S., 2011, VETERANS HLTH ADM IM; Kong L, 2013, HLTH NEWSPAPER; Korda H, 2011, INQUIRY-J HEALTH CAR, V48, P277, DOI 10.5034/inquiryjrnl_48.04.01; Kruis AL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009437.pub2; Lea L, 2018, WHICH POLICIES INCRE; Li K, DEEPENING HEALTHCARE; Li WP, 2006, JIANGSU SOC SCI, V5, P72; Li YB, 2012, HEALTH AFFAIR, V31, P1075, DOI 10.1377/hlthaff.2010.0965; Liu XZ, 1999, HEALTH POLICY PLANN, V14, P409, DOI 10.1093/heapol/14.4.409; Mahmood W, 2014, NEW MODELS PHOTOVOLT; McCarthy DM, 2009, KAISER PERMANENTE BR; McDonald KM, 2007, CLOSING QUALITY GAP; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Health, 2014, DEV MAN PRIV HOSP; Ministry of Health, 2013, BRIEF PUBL HOSP REF; Ministry of Health National Development and Reform Commission Ministry of Finance, 2014, REG LARG MED EQ ALL; Ministry of Health of Singapore, 2014, SING HLTH FACTS; Ministry of Health of the People's Republic of China, 2009, CHIN HLTH STAT YB; Monitor, 2013, ANN EP ACC 2012 2013; Monitor, 2013, NHS FDN TRUSTS COD G; National Bureau of Statistics of China, 2013, CHIN CIT STAT YB 201; National Development and Reform Commission Ministry of Health Ministry of Finance Ministry of Commerce Ministry of Human Resources and Social Security. People's Republic of China, 2014, FURTH ENC GUID EST M; National Health and Family Planning Commission State Administration of Traditional Chinese Medicine. People's Republic of China, 2014, ACC DEV EST HOSP SOC; Nolte E, 2014, WHAT IS EVIDENCE EC; OECD, 2013, JOINT M CHEM COMM WO; Ofman JJ, 2004, AM J MED, V117, P182, DOI 10.1016/j.amjmed.2004.03.018; Oh EH, 2005, INT J TECHNOL ASSESS, V21, P73, DOI 10.1017/S0266462305050099; Ou Y, 2014, AM J INFECT CONTROL, V42, P516, DOI 10.1016/j.ajic.2014.01.001; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Paris V, 2010, 50 OECD, V50; Peabody J, 2011, HEALTH AFFAIR, V30, P773, DOI 10.1377/hlthaff.2009.0782; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; People's Republic of China, 2014, 12 5 YEAR PLAN NAT E; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Propper C, 2011, OXFORD HDB HLTH EC; Reynolds L, 2011, INT J HEALTH PLAN M, V26, P449, DOI 10.1002/hpm.1112; Ryan AM, 2012, HEALTH AFFAIR, V31, P797, DOI 10.1377/hlthaff.2011.0626; Shanghai Municipal Health Bureau, 2010, GUID INT CAR NETW; Shen X., 2013, CHINA ACAD J ELECT P, V13, P4; Shen YC, 2007, INQUIRY-J HEALTH CAR, V44, P41, DOI 10.5034/inquiryjrnl_44.1.41; Shih A., 2008, ORG US HLTH CARE DEL; Shortell S, 2014, ACCOUNTABLE CARE ORG; Silverman EM, 1999, NEW ENGL J MED, V341, P420, DOI 10.1056/NEJM199908053410606; Singh D, 2006, IMPROVING CARE PEOPL; State Council. People's Republic of China, 2014, PLAN FURTH REF HLTH; State Council. People's Republic of China, 2014, 12 5 YEAR PLAN HLTH; State Council. People's Republic of China, 2012, DEEP MED HLTH SYST N; State Council. People's Republic of China, 2014, DEV PLAN NAT STRAT E; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Tencent Finance, 2014, 5 LIST CO AR WILL IN; The World Bank, 2013, OECD HLTH DAT 2013; Tiemann O, 2012, HEALTH POLICY, V104, P163, DOI 10.1016/j.healthpol.2011.11.010; Wang SY, 2011, HLTH HARMONIOUS LIFE; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; World Health Organization, HLTH GLANC AS PAC 20, DOI [10.1787/9789264183902-en, DOI 10.1787/9789264183902-EN]; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yip W, 2003, INNOVATIONS HLTH SER; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Zhu F, 2013, CHINESE HOSP MANAGE, V33, P10	106	243	260	22	179	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					805	818		10.1016/S0140-6736(14)61120-X	http://dx.doi.org/10.1016/S0140-6736(14)61120-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25176551	Bronze, Green Published			2022-12-28	WOS:000341361500041
J	Brucker, RM; Bordenstein, SR				Brucker, Robert M.; Bordenstein, Seth R.			Response to Comment on "The hologenomic basis of speciation: Gut bacteria cause hybrid lethality in the genus Nasonia"	SCIENCE			English	Editorial Material							MICROBIOTA; EVOLUTION; ANIMALS	Chandler and Turelli postulate that intrinsic hybrid dysfunction underscores hybrid lethality in Nasonia. Although it is a suitable conception for examining hybrid incompatibilities, their account of the evidence is factually inaccurate and leaves out the evolutionary process for why lethality became conditional on nuclear- microbe interactions. Hybrid incompatibilities in the context of phylosymbiosis are resolved by hologenomic principles and exemplify this emerging postmodern synthesis.	[Brucker, Robert M.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Brucker, Robert M.] Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Harvard University; Vanderbilt University	Brucker, RM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.	bruckerm@gmail.com; s.bordenstein@vanderbilt.edu			Direct For Biological Sciences [1046149] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Brucker RM, 2013, ZOOLOGY, V116, P260, DOI 10.1016/j.zool.2013.08.003; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Brucker RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051269; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Burton RS, 2013, ANNU REV ECOL EVOL S, V44, P281, DOI 10.1146/annurev-ecolsys-110512-135758; Chandler JA, 2014, SCIENCE, V345, DOI 10.1126/science.1251997; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Gadau J, 1999, GENETICS, V153, P1731; Hubbell Stephen P., 2001, V32, pi; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Rosenberg E., 2013, HOLOGENOME CONCEPT H; Sanders JG, 2014, MOL ECOL, V23, P1268, DOI 10.1111/mec.12611; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	16	10	10	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200								10.1126/science.1256708	http://dx.doi.org/10.1126/science.1256708			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170145				2022-12-28	WOS:000340870900027
J	Chandler, JA; Turelli, M				Chandler, James Angus; Turelli, Michael			Comment on "The hologenomic basis of speciation: Gut bacteria cause hybrid lethality in the genus Nasonia"	SCIENCE			English	Editorial Material							POSTZYGOTIC ISOLATION	Brucker and Bordenstein (Reports, 9 August 2013, p. 667) claim that adaptive codivergence of gut bacteria with hosts contributes to hybrid lethality. Yet, they provide no evidence for coadaptation of bacteria and Nasonia hosts. Their data on hybrid viability suggest that bacteria contribute to inviability only because intrinsic hybrid dysfunction increases susceptibility to free- living bacteria. Hologenomic speciation remains testable speculation without experimental support.	[Chandler, James Angus] Calif Acad Sci, Dept Microbiol, San Francisco, CA 94118 USA; [Turelli, Michael] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA	California Academy of Sciences; University of California System; University of California Davis	Turelli, M (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA.	mturelli@ucdavis.edu			NIGMS NIH HHS [R01-GM-104325-01, R01 GM104325] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104325] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Ives AR, 2006, AM NAT, V168, pE1, DOI 10.1086/505157; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; ORR HA, 1993, EVOLUTION, V47, P1606, DOI [10.2307/2410171, 10.1111/j.1558-5646.1993.tb02179.x]; Orr HA, 2001, EVOLUTION, V55, P1085; Rafferty NE, 2013, ECOLOGY, V94, P2321, DOI 10.1890/12-1948.1; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; Turelli M, 2014, EVOLUTION, V68, P1176, DOI 10.1111/evo.12330	15	16	16	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200								10.1126/science.1251997	http://dx.doi.org/10.1126/science.1251997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170144	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000340870900026
J	Wang, JX; Rogers, LM; Gross, EZ; Ryals, AJ; Dokucu, ME; Brandstatt, KL; Hermiller, MS; Voss, JL				Wang, Jane X.; Rogers, Lynn M.; Gross, Evan Z.; Ryals, Anthony J.; Dokucu, Mehmet E.; Brandstatt, Kelly L.; Hermiller, Molly S.; Voss, Joel L.			Targeted enhancement of cortical-hippocampal brain networks and associative memory	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; RHESUS-MONKEY; STIMULATION; CONNECTIVITY; SYSTEMS; CORTEX; AREA	The influential notion that the hippocampus supports associative memory by interacting with functionally distinct and distributed brain regions has not been directly tested in humans. We therefore used targeted noninvasive electromagnetic stimulation to modulate human cortical-hippocampal networks and tested effects of this manipulation on memory. Multiple-session stimulation increased functional connectivity among distributed cortical-hippocampal network regions and concomitantly improved associative memory performance. These alterations involved localized long-term plasticity because increases were highly selective to the targeted brain regions, and enhancements of connectivity and associative memory persisted for similar to 24 hours after stimulation. Targeted cortical-hippocampal networks can thus be enhanced noninvasively, demonstrating their role in associative memory.	[Wang, Jane X.; Gross, Evan Z.; Ryals, Anthony J.; Brandstatt, Kelly L.; Hermiller, Molly S.; Voss, Joel L.] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Dept Med Social Sci, Chicago, IL 60611 USA; [Wang, Jane X.; Gross, Evan Z.; Ryals, Anthony J.; Brandstatt, Kelly L.; Hermiller, Molly S.; Voss, Joel L.] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Rogers, Lynn M.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Dokucu, Mehmet E.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Voss, JL (corresponding author), Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Dept Med Social Sci, Chicago, IL 60611 USA.	joel-voss@northwestern.edu		Hermiller, Molly/0000-0001-7234-4695; Voss, Joel/0000-0003-4180-9335; Dokucu, Mehmet/0000-0002-1720-3467	National Institute of Mental Health [P50-MH094263]; National Institute of Neurological Disorders and Stroke [F32-NS083340]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS083340] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was supported by awards P50-MH094263 from the National Institute of Mental Health and F32-NS083340 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Neuroimaging was performed at the Northwestern University Center for Translational Imaging facility supported by the Northwestern University Department of Radiology. All primary behavioral data are archived in paper and electronic format in the Laboratory for Human Neuroscience of the Northwestern University Feinberg School of Medicine. All primary MRI data are archived in the Northwestern University Neuroimaging Data Archive (https://nunda.northwestern.edu).	Aggleton JP, 2012, NEUROSCI BIOBEHAV R, V36, P1579, DOI 10.1016/j.neubiorev.2011.09.005; Alvarez-Salvado E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0152; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Finke C, 2013, J NEUROSCI, V33, P11061, DOI 10.1523/JNEUROSCI.0744-13.2013; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; MESULAM MM, 1977, BRAIN RES, V136, P393, DOI 10.1016/0006-8993(77)90066-X; Mullally SL, 2012, J NEUROSCI, V32, P5646, DOI 10.1523/JNEUROSCI.5522-11.2012; Olsen RK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00146; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Shohamy D, 2013, J EXP PSYCHOL GEN, V142, P1159, DOI 10.1037/a0034461; Staresina BP, 2013, J NEUROSCI, V33, P14184, DOI 10.1523/JNEUROSCI.1987-13.2013; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wassermann EM, 2012, PHARMACOL THERAPEUT, V133, P98, DOI 10.1016/j.pharmthera.2011.09.003; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	25	303	318	11	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1054	1057		10.1126/science.1252900	http://dx.doi.org/10.1126/science.1252900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170153	Green Accepted			2022-12-28	WOS:000340870900041
J	Chowdhury, S; Jarecki, BW; Chanda, B				Chowdhury, Sandipan; Jarecki, Brian W.; Chanda, Baron			A Molecular Framework for Temperature-Dependent Gating of Ion Channels	CELL			English	Article							SHAKER K+-CHANNEL; PROTEIN-FOLDING THERMODYNAMICS; FOCUSED ELECTRIC-FIELD; VOLTAGE-SENSING DOMAIN; MOLAR HEAT-CAPACITY; AMINO-ACID-RESIDUES; TRP CHANNELS; COLD RECEPTOR; POTASSIUM CHANNELS; AQUEOUS-SOLUTION	Perception of heat or cold in higher organisms is mediated by specialized ion channels whose gating is exquisitely sensitive to temperature. The physicochemical underpinnings of this temperature-sensitive gating have proven difficult to parse. Here, we took a bottom-up protein design approach and rationally engineered ion channels to activate in response to thermal stimuli. By varying amino acid polarities at sites undergoing state-dependent changes in solvation, we were able to systematically confer temperature sensitivity to a canonical voltage-gated ion channel. Our results imply that the specific heat capacity change during channel gating is a major determinant of thermosensitive gating. We also show that reduction of gating charges amplifies temperature sensitivity of designer channels, which accounts for low-voltage sensitivity in all known temperature- gated ion channels. These emerging principles suggest a plausible molecular mechanism for temperature-dependent gating that reconcile how ion channels with an overall conserved transmembrane architecture may exhibit a wide range of temperature- sensing phenotypes.	[Chowdhury, Sandipan; Chanda, Baron] Univ Wisconsin, Grad Program Biophys, Madison, WI 53705 USA; [Chowdhury, Sandipan; Jarecki, Brian W.; Chanda, Baron] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chanda, B (corresponding author), Univ Wisconsin, Grad Program Biophys, 1111 Highland Ave, Madison, WI 53705 USA.	chanda@wisc.edu		Chanda, Baron/0000-0003-4954-7034	National Institutes of Health [RO1-NS081293]; Shaw Scientist award; Vilas Research foundation; NIH training grant [5T32HL007936-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shaw Scientist award; Vilas Research foundation; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Q. Cui, M. Jackson, T. Record, C. Czajkwoski, and members of the Chanda laboratory for their comments and discussions; R. R. Trivedi (Khorana fellow) for early help with data collection; and K. M. Schuldt and T. R. Lingle for technical assistance. The project was supported by funds from the National Institutes of Health (RO1-NS081293), Shaw Scientist award, and Vilas Research foundation to B. C. B. W. J was partially supported by NIH training grant (5T32HL007936-09).	Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Chowdhury S, 2013, J GEN PHYSIOL, V141, P11, DOI 10.1085/jgp.201210860; Chowdhury S, 2012, J GEN PHYSIOL, V139, P3, DOI 10.1085/jgp.201110722; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Dib-Hajj SD, 2008, ADV GENET, V63, P85, DOI 10.1016/S0065-2660(08)01004-3; Gagnon DG, 2010, J GEN PHYSIOL, V136, P555, DOI 10.1085/jgp.201010487; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P160, DOI 10.1038/nsmb.2747; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; MAKHATADZE GI, 1994, BIOPHYS CHEM, V51, P291, DOI 10.1016/0301-4622(94)00050-6; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; MAKHATADZE GI, 1990, BIOPHYS CHEM, V38, P33, DOI 10.1016/0301-4622(90)80037-8; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nguyen TP, 2002, J GEN PHYSIOL, V120, P419, DOI 10.1085/jgp.20028636; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Pusch M, 1997, J GEN PHYSIOL, V109, P105, DOI 10.1085/jgp.109.1.105; Rodriguez BM, 1996, NEUROPHARMACOLOGY, V35, P775, DOI 10.1016/0028-3908(96)00111-6; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; SCHELLMAN JA, 1981, BIOPOLYMERS, V20, P1989, DOI 10.1002/bip.1981.360200921; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Xu YP, 2013, NAT STRUCT MOL BIOL, V20, P574, DOI 10.1038/nsmb.2535; Xu YP, 2010, CELL, V142, P580, DOI 10.1016/j.cell.2010.07.013; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	62	71	71	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1148	1158		10.1016/j.cell.2014.07.026	http://dx.doi.org/10.1016/j.cell.2014.07.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25156949	Green Accepted, Bronze			2022-12-28	WOS:000340945000019
J	Tsai, MF; Miller, C				Tsai, Ming-Feng; Miller, Christopher			Building a Temperature-Sensitive Ion Channel	CELL			English	Editorial Material							TRP CHANNELS; ACTIVATION; MUTATIONS; RECEPTOR	The biophysical basis of temperature-sensitive ion channel gating has been a tough nut to crack. Chowdhury, et al. use a protein engineering approach to render a temperature-insensitive voltage-gated channel cold- or heat-responsive to reveal principles for temperature-gating and a plausible model for molecularly enabling this mode of environmental responsiveness.	[Tsai, Ming-Feng; Miller, Christopher] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02453 USA	Brandeis University; Howard Hughes Medical Institute	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02453 USA.	cmiller@brandeis.edu		TSAI, MING-FENG/0000-0003-4277-1885				Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; SCHELLMAN JA, 1981, BIOPOLYMERS, V20, P1989, DOI 10.1002/bip.1981.360200921; Vargas E, 2012, J GEN PHYSIOL, V140, P587, DOI 10.1085/jgp.201210873; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107	9	4	4	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					977	979		10.1016/j.cell.2014.08.008	http://dx.doi.org/10.1016/j.cell.2014.08.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171401	Bronze			2022-12-28	WOS:000340945000004
J	Holmes, D				Holmes, David			Profile Gary Huffnagle: rewriting the rules on the lung microbiome	LANCET			English	Biographical-Item																			0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					653	653		10.1016/S0140-6736(14)61382-9	http://dx.doi.org/10.1016/S0140-6736(14)61382-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25152264				2022-12-28	WOS:000341359100014
J	Read, RC; Baxter, D; Chadwick, DR; Faust, SN; Finn, A; Gordon, SB; Heath, PT; Lewis, DJM; Pollard, AJ; Turner, DPJ; Bazaz, R; Ganguli, A; Havelock, T; Neal, KR; Okike, IO; Morales-Aza, B; Patel, K; Snape, MD; Williams, J; Gilchrist, S; Gray, SJ; Maiden, MCJ; Toneatto, D; Wang, HJ; McCarthy, M; Dull, PM; Borrow, R				Read, Robert C.; Baxter, David; Chadwick, David R.; Faust, Saul N.; Finn, Adam; Gordon, Stephen B.; Heath, Paul T.; Lewis, David J. M.; Pollard, Andrew J.; Turner, David P. J.; Bazaz, Rohit; Ganguli, Amitava; Havelock, Tom; Neal, Keith R.; Okike, Ifeanyichukwu O.; Morales-Aza, Begonia; Patel, Kamlesh; Snape, Matthew D.; Williams, John; Gilchrist, Stefanie; Gray, Steve J.; Maiden, Martin C. J.; Toneatto, Daniela; Wang, Huajun; McCarthy, Maggie; Dull, Peter M.; Borrow, Ray			Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial	LANCET			English	Article							C CONJUGATE VACCINATION; INFLUENZAE TYPE-B; NASOPHARYNGEAL CARRIAGE; NEISSERIA-MENINGITIDIS; HERD-IMMUNITY; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL VACCINE; IMPACT; COMMUNITY; DISEASE	Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates in 18-24-year-olds. Methods In this phase 3, observer-blind, randomised controlled trial, university students aged 18-24 years from ten sites in England were randomly assigned (1:1:1, block size of three) to receive two doses 1 month apart of Japanese Encephalitis vaccine (controls), 4CMenB, or one dose of MenACWY-CRM then placebo. Participants were randomised with a validated computer-generated random allocation list. Participants and outcome-assessors were masked to the treatment group. Meningococci were isolated from oropharyngeal swabs collected before vaccination and at five scheduled intervals over 1 year. Primary outcomes were cross-sectional carriage 1 month after each vaccine course. Secondary outcomes included comparisons of carriage at any timepoint after primary analysis until study termination. Reactogenicity and adverse events were monitored throughout the study. Analysis was done on the modified intention-to- treat population, which included all enrolled participants who received a study vaccination and provided at least one assessable swab after baseline. This trial is registered with ClinicalTrials.gov, registration number NCT01214850. Findings Between Sept 21 and Dec 21, 2010, 2954 participants were randomly assigned (987 assigned to control [984 analysed], 979 assigned to 4CMenB [974 analysed], 988 assigned to MenACWY-CRM [983 analysed]); 33% of the 4CMenB group, 34% of the MenACWY-CRM group, and 31% of the control group were positive for meningococcal carriage at study entry. By 1 month, there was no significant difference in carriage between controls and 4CMenB (odds ratio 1.2, 95% CI 0.8-1.7) or MenACWY-CRM (0.9, [0.6-1.3]) groups. From 3 months after dose two, 4CMenB vaccination resulted in significantly lower carriage of any meningococcal strain (18.2% [95% CI 3.4-30.8] carriage reduction), capsular groups BCWY (26.6% [10.5-39.9] carriage reduction), capsular groups CWY (29.6% [8.1-46.0] carriage reduction), and serogroups CWY (28.5% [2.8-47.5] carriage reduction) compared with control vaccination. Significantly lower carriage rates were also noted in the MenACWY-CRM group compared with controls: 39.0% (95% CI 17.3-55.0) carriage reduction for serogroup Y and 36.2% (15.6-51.7) carriage reduction for serogroup CWY. Study vaccines were generally well tolerated, with increased rates of transient local injection pain and myalgia in the 4CMenB group. No safety concerns were identified. Interpretation Although we detected no significant difference between groups at 1 month after vaccine course, MenACWY-CRM and 4CMenB vaccines reduced meningococcal carriage rates during 12 months after vaccination and therefore might affect transmission when widely implemented.	[Read, Robert C.; Faust, Saul N.; Havelock, Tom] Univ Southampton, Acad Unit Clin Expt Sci, Southampton, Hants, England; [Read, Robert C.; Faust, Saul N.; Havelock, Tom] Univ Southampton, NIHR Southampton Resp Biomed Res Unit, Fac Med, Southampton, Hants, England; [Read, Robert C.; Faust, Saul N.; Havelock, Tom] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Baxter, David; Borrow, Ray] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Chadwick, David R.; Williams, John] James Cook Univ Hosp, Middlesbrough, Middx, England; [Faust, Saul N.; Havelock, Tom] Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Finn, Adam] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Finn, Adam] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Gordon, Stephen B.; Ganguli, Amitava] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Heath, Paul T.; Okike, Ifeanyichukwu O.] Univ London, Div Clin Sci, London, England; [Lewis, David J. M.] Univ Surrey, Surrey Clin Res Ctr, Guildford GU2 5XH, Surrey, England; [Pollard, Andrew J.; Snape, Matthew D.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Pollard, Andrew J.] NIHR Oxford Biomed Ctr, Oxford, England; [Turner, David P. J.] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Bazaz, Rohit] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Patel, Kamlesh] Manchester Royal Infirm, NIHR Wellcome Trust Clin Res Facil, Manchester M13 9WL, Lancs, England; [Gilchrist, Stefanie; Gray, Steve J.; Borrow, Ray] Manchester Royal Infirm, Publ Hlth England, Manchester M13 9WL, Lancs, England; [Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Toneatto, Daniela; Wang, Huajun; McCarthy, Maggie; Dull, Peter M.] Novartis Vaccines & Diagnost, Cambridge, MA USA	University of Southampton; University of Southampton; University of Southampton; University of Manchester; James Cook University Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Bristol; University of Bristol; Liverpool School of Tropical Medicine; University of Liverpool; University of London; University of Surrey; University of Oxford; University of Nottingham; University of Sheffield; University of Manchester; Public Health England; University of Manchester; University of Oxford; Novartis	Read, RC (corresponding author), Univ Southampton, Univ Hosp Southampton NHS Fdn Trust, Mailpoint 814,South Acad Block,Tremona Rd, Southampton SO16 6YD, Hants, England.	R.C.Read@soton.ac.uk	Maiden, Martin C J/C-5055-2014; Maiden, Martin/N-6805-2019; Faust, Saul/J-9779-2014	Maiden, Martin C J/0000-0001-6321-5138; Maiden, Martin/0000-0001-6321-5138; Faust, Saul/0000-0003-3410-7642; Heath, Paul/0000-0002-7540-7433; Bazaz, Rohit/0000-0002-6078-9272; Gordon, Stephen/0000-0001-6576-1116; Turner, David/0000-0001-7432-3505; Snape, Matthew/0000-0003-0531-5426; Finn, Adam/0000-0003-1756-5668; Lewis, David JM/0000-0003-3105-9075; Read, Robert/0000-0002-4297-6728; OKIKE, IFEANYICHUKWU/0000-0002-4001-2642	Novartis Vaccines	Novartis Vaccines	Novartis Vaccines.	Arnold R, 2011, VACCINE, V29, P7100, DOI 10.1016/j.vaccine.2011.06.120; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Cohen R, 2012, BMC INFECT DIS; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Erlich KS, 2012, HUM VACC IMMUNOTHER, V8, P1029, DOI 10.4161/hv.20473; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Holmes JD, 2008, EPIDEMIOL INFECT, V136, P790, DOI 10.1017/S0950268807009211; Hong E, 2013, VACCINE, V31, P1113, DOI 10.1016/j.vaccine.2012.12.022; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Millar EV, 2006, CLIN INFECT DIS, V43, P8, DOI 10.1086/504802; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; Prymula R, 2009, VACCINE, V28, P71, DOI 10.1016/j.vaccine.2009.09.113; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Soriano-Gabarro M, 2011, EXPERT REV ANTI-INFE, V9, P761, DOI [10.1586/ERI.11.89, 10.1586/eri.11.89]; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; TAKALA AK, 1991, J INFECT DIS, V164, P982, DOI 10.1093/infdis/164.5.982; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1	30	202	205	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2123	2131		10.1016/S0140-6736(14)60842-4	http://dx.doi.org/10.1016/S0140-6736(14)60842-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25145775	Green Accepted			2022-12-28	WOS:000346354300028
J	Klompas, M; Diekema, DJ; Fishman, NO; Yokoe, DS				Klompas, Michael; Diekema, Daniel J.; Fishman, Neil O.; Yokoe, Deborah S.			Ebola Fever: Reconciling Planning With Risk in US Hospitals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEMORRHAGIC-FEVER; VIRUS TRANSMISSION; KIKWIT; CONGO; OUTBREAK		Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Iowa, Carver Coll Med, Iowa City, IA USA; Univ Penn Hlth Syst, Philadelphia, PA USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Iowa; University of Pennsylvania	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mklompas@partners.org	Klompas, Michael/Z-2415-2019	Diekema, Daniel/0000-0003-1273-0724				Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Centers for Disease Control and Prevention, 2014, INF PREV CONTR REC H; Centers for Disease Control and Prevention, 2014, OUTBR CHRON EB HEM F; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; Muyembe-Tamfum JJ, 1999, J INFECT DIS, V179, pS259, DOI 10.1086/514302; Richards GA, 2000, CRIT CARE MED, V28, P240, DOI 10.1097/00003246-200001000-00041	8	17	17	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					751	U206		10.7326/M14-1918	http://dx.doi.org/10.7326/M14-1918			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25141883				2022-12-28	WOS:000347245600036
J	Bender, E				Bender, Eric			THE DOMINANT MALIGNANCY	NATURE			English	Editorial Material																			0	79	89	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S2	S3		10.1038/513S2a	http://dx.doi.org/10.1038/513S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208070				2022-12-28	WOS:000341362800002
J	Hay, D; Hill, M; Littlewood, T				Hay, Deborah; Hill, Matilda; Littlewood, Tim			RATIONAL TESTING Neutropenia in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AGRANULOCYTOSIS; PREVALENCE; ANTIBODIES; INFECTION; DISEASES; VALUES		[Hay, Deborah; Littlewood, Tim] Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford, England; [Hill, Matilda] Univ Oxford, Sch Clin Med, Oxford, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford	Littlewood, T (corresponding author), Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford, England.	tim.littlewood@orh.nhs.uk		Hill, Matilda/0000-0002-1566-2512				Abuirmeileh A, 2014, INT J CLIN PHARM-NET, V36, P264, DOI 10.1007/s11096-013-9897-2; Andersohn F, 2007, ANN INTERN MED, V146, P657, DOI 10.7326/0003-4819-146-9-200705010-00009; Andres E, 2008, CURR OPIN HEMATOL, V15, P15, DOI 10.1097/MOH.0b013e3282f15fb9; BAIN B, 1984, J CLIN PATHOL, V37, P188, DOI 10.1136/jcp.37.2.188; Binder A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5060; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Boxer L, 2002, SEMIN HEMATOL, V39, P75, DOI 10.1053/shem.2002.31911; Giannini EG, 2012, LIVER INT, V32, P1113, DOI 10.1111/j.1478-3231.2012.02798.x; Haddy TB, 1999, J LAB CLIN MED, V133, P15, DOI 10.1053/lc.1999.v133.a94931; HADLEY AG, 1987, BRIT J HAEMATOL, V65, P61, DOI 10.1111/j.1365-2141.1987.tb06136.x; Halfdanarson TR, 2008, EUR J HAEMATOL, V80, P523, DOI 10.1111/j.1600-0609.2008.01050.x; LALEZARI P, 1986, J PEDIATR-US, V109, P764, DOI 10.1016/S0022-3476(86)80690-4; Levine AM, 2006, ARCH INTERN MED, V166, P405, DOI 10.1001/.405; Lima SP, 2006, ANN HEMATOL, V85, P705, DOI 10.1007/s00277-006-0150-0; LOUGHRAN TP, 1993, BLOOD, V82, P1; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Martinez-Banos D, 2006, RHEUMATOLOGY, V45, P994, DOI 10.1093/rheumatology/kel016; Moore DAJ, 2000, INT J STD AIDS, V11, P8, DOI 10.1258/0956462001914832; Mutharasan Priscilla, 2012, Endocr Pract, V18, pe69, DOI 10.4158/EP11339.CR; Newburger PE, 2013, SEMIN HEMATOL, V50, P198, DOI 10.1053/j.seminhematol.2013.06.010; NOSSENT JC, 1991, Q J MED, V80, P605; Papadaki HA, 1999, ANN HEMATOL, V78, P293, DOI 10.1007/s002770050518; Parmentier S, 2012, HAEMATOL-HEMATOL J, V97, P723, DOI 10.3324/haematol.2011.056879; Riera NE, 2010, INT J LAB HEMATOL, V32, pE96, DOI 10.1111/j.1751-553X.2009.01173.x; Rolston KVI, 2004, CLIN INFECT DIS, V39, pS44, DOI 10.1086/383053; SCHOOLEY RT, 1984, AM J MED, V76, P85, DOI 10.1016/0002-9343(84)90754-X; van Staa TP, 2003, AM J HEMATOL, V72, P248, DOI 10.1002/ajh.10295	27	4	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2014	349								g5340	10.1136/bmj.g5340	http://dx.doi.org/10.1136/bmj.g5340			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QP	25214496				2022-12-28	WOS:000341691300002
J	Mehta, B; Venkatramani, R				Mehta, Bhakti; Venkatramani, Rajkumar			Langerhans'-Cell Histiocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mehta, Bhakti; Venkatramani, Rajkumar] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Mehta, B (corresponding author), Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.	rvenkatramani@chla.usc.edu							0	5	5	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					1050	1050		10.1056/NEJMicm1312532	http://dx.doi.org/10.1056/NEJMicm1312532			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25207768				2022-12-28	WOS:000341382800010
J	Llor, C; McNulty, CAM; Butler, CC				Llor, Carl; McNulty, Cliodna A. M.; Butler, Christopher C.			Ordering and interpreting ear swabs in otitis externa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MICROBIOLOGY; MANAGEMENT		[Llor, Carl; Butler, Christopher C.] Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales; [McNulty, Cliodna A. M.] Gloucestershire Royal Hosp, Dept Microbiol, Publ Hlth England Primary Care Unit, Gloucester GL1 3NN, England; [Butler, Christopher C.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England	Cardiff University; Gloucestershire Royal Hospital; University of Oxford	Llor, C (corresponding author), Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales.	carlesllor@urv.cat		Llor, Carl/0000-0001-6644-717X; Butler, Christopher/0000-0002-0102-3453				Collier SA, 2013, OTOLARYNG HEAD NECK, V148, P128, DOI 10.1177/0194599812467000; England RJA, 2000, J LARYNGOL OTOL, V114, P24, DOI 10.1258/0022215001903834; Geyer M, 2011, BRIT J BIOMED SCI, V68, P174, DOI 10.1080/09674845.2011.11730346; Guevara N, 2013, EUR ANN OTORHINOLARY, V130, P115, DOI 10.1016/j.anorl.2012.04.011; Health Protection Agency, 2012, B 1 INV EAR SWABS AS; Kaushik V, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004740.pub2; Macfadyen CA, 2005, COCHRANE DB SYST REV; Ninkovic G, 2008, AURIS NASUS LARYNX, V35, P480, DOI 10.1016/j.anl.2007.09.013; Pabla L, 2012, EUR ARCH OTO-RHINO-L, V269, P753, DOI 10.1007/s00405-011-1687-7; Public Health England (HPA), 2013, MAN INF GUID PRIM CA; Roland PS, 2002, LARYNGOSCOPE, V112, P1166, DOI 10.1097/00005537-200207000-00005; Rosenfeld RM, 2014, OTOLARYNG HEAD NECK, V150, P1, DOI 10.1177/0194599813514365; SMITH IM, 1990, CLIN OTOLARYNGOL, V15, P155, DOI 10.1111/j.1365-2273.1990.tb00449.x; Stroman DW, 2001, LARYNGOSCOPE, V111, P2054, DOI 10.1097/00005537-200111000-00035; van Dongen TMA, 2014, NEW ENGL J MED, V370, P723, DOI 10.1056/NEJMoa1301630	15	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2014	349								g5259	10.1136/bmj.g5259	http://dx.doi.org/10.1136/bmj.g5259			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LH	25179670				2022-12-28	WOS:000341385800001
J	Edwards, T; Endo, T; Walton, JH; Sen, S				Edwards, Trenton; Endo, Takatsugu; Walton, Jeffrey H.; Sen, Sabyasachi			Observation of the transition state for pressure-induced BO3 -> BO4 conversion in glass	SCIENCE			English	Article							INDUCED STRUCTURAL-CHANGES; BOROALUMINATE LIQUIDS; BORON COORDINATION; HIGH-RESOLUTION; BOROSILICATE; B-11; BORATE; MECHANISMS	A fundamental mechanistic understanding of the pressure- and/or temperature-induced facile transformation of the coordination environment of boron is important for changing the physical properties of glass. We have used in situ high-pressure (up to 2 gigapascals) boron-11 solid-state nuclear magnetic resonance spectroscopy in combination with ab initio calculations to investigate the nature of the transition state for the pressure-induced BO3 -> BO4 conversion in a borosilicate glass at ambient temperature. The results indicate an anisotropic elastic deformation of the BO3 planar triangle, under isotropic stress, into a trigonal pyramid that likely serves as a precursor for the subsequent formation of a BO4 tetrahedron.	[Edwards, Trenton; Endo, Takatsugu; Sen, Sabyasachi] Univ Calif Davis, Div Mat Sci & Engn, Davis, CA 95616 USA; [Walton, Jeffrey H.] Univ Calif Davis, Nucl Magnet Resonance Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Sen, S (corresponding author), Univ Calif Davis, Div Mat Sci & Engn, Davis, CA 95616 USA.	sbsen@ucdavis.edu	Endo, Takatsugu/I-3916-2013; , Jeff/AAI-3575-2020	, Jeff/0000-0002-2359-955X; Endo, Takatsugu/0000-0002-7272-0715	National Science Foundation [NSF-DMR 1104869]; Japan Society for Promotion of Science	National Science Foundation(National Science Foundation (NSF)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	T. Edwards and S. S. were supported by a grant from the National Science Foundation (NSF-DMR 1104869). T. Endo was supported by a postdoctoral fellowship for research abroad by the Japan Society for Promotion of Science.	Angeli F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054110; [Anonymous], 1998, PHYS CHEM SOLIDS; Du LS, 2004, J NON-CRYST SOLIDS, V337, P196, DOI 10.1016/j.jnoncrysol.2004.03.115; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Guignard M, 2007, CHEM MATER, V19, P286, DOI 10.1021/cm062208a; Kroeker S, 2001, INORG CHEM, V40, P6239, DOI 10.1021/ic010305u; Michel F, 2013, J NON-CRYST SOLIDS, V379, P169, DOI 10.1016/j.jnoncrysol.2013.08.007; Sen S, 1998, J NON-CRYST SOLIDS, V226, P29, DOI 10.1016/S0022-3093(97)00491-2; Sen S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094203; Sen S, 1999, J NON-CRYST SOLIDS, V253, P84, DOI 10.1016/S0022-3093(99)00346-4; Sen S, 2008, MOL SIMULAT, V34, P1115, DOI 10.1080/08927020802258716; STEBBINS JF, 1991, NATURE, V351, P638, DOI 10.1038/351638a0; TURNER GL, 1986, J MAGN RESON, V67, P544, DOI 10.1016/0022-2364(86)90391-4; Uzun SS, 2007, J PHYS CHEM B, V111, P9758, DOI 10.1021/jp072223i; Wolf G. H., 1995, REV MINERALOGY, V32; Wondraczek L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014202	16	36	36	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1027	1029		10.1126/science.1256224	http://dx.doi.org/10.1126/science.1256224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170146				2022-12-28	WOS:000340870900032
J	Petrie, RJ; Koo, H; Yamada, KM				Petrie, Ryan J.; Koo, Hyun; Yamada, Kenneth M.			Generation of compartmentalized pressure by a nuclear piston governs cell motility in a 3D matrix	SCIENCE			English	Article							MIGRATION; NESPRIN-3	Cells use actomyosin contractility to move through three-dimensional (3D) extracellular matrices. Contractility affects the type of protrusions cells use to migrate in 3D, but the mechanisms are unclear. In this work, we found that contractility generated high-pressure lobopodial protrusions in human cells migrating in a 3D matrix. In these cells, the nucleus physically divided the cytoplasm into forward and rear compartments. Actomyosin contractility with the nucleoskeleton-intermediate filament linker protein nesprin-3 pulled the nucleus forward and pressurized the front of the cell. Reducing expression of nesprin-3 decreased and equalized the intracellular pressure. Thus, the nucleus can act as a piston that physically compartmentalizes the cytoplasm and increases the hydrostatic pressure between the nucleus and the leading edge of the cell to drive lamellipodia-independent 3D cell migration.	[Petrie, Ryan J.; Koo, Hyun; Yamada, Kenneth M.] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Koo, Hyun] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Ctr Oral Biol, Rochester, NY 14642 USA; [Koo, Hyun] Univ Penn, Sch Dent Med, Dept Orthodont, Biofilm Res Labs,Levy Ctr Oral Hlth, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Rochester; University of Pennsylvania	Petrie, RJ (corresponding author), Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA.	petrier@mail.nih.gov; kyamada@mail.nih.gov			National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank K. Carver for helping to characterize various primary human cells; D. Starr for providing the nesprin-3 antibody; and M. Hoffman, A. Doyle, W. Daley, and K. Holmberg for critical comments on the manuscript. This work was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH. The data presented in this manuscript are found in the main paper and the supplementary materials and methods.	Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; KELLY SM, 1991, AM J PHYSIOL, V260, pC652, DOI 10.1152/ajpcell.1991.260.3.C652; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Morgan JT, 2011, MOL BIOL CELL, V22, P4324, DOI 10.1091/mbc.E11-04-0287; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wu J, 2014, BIOPHYS J, V106, P7, DOI 10.1016/j.bpj.2013.11.4489	16	218	221	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1062	1065		10.1126/science.1256965	http://dx.doi.org/10.1126/science.1256965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170155	Green Accepted			2022-12-28	WOS:000340870900043
J	Hart, Y; Reich-Zeliger, S; Antebi, YE; Zaretsky, I; Mayo, AE; Alon, U; Friedman, N				Hart, Yuval; Reich-Zeliger, Shlomit; Antebi, Yaron E.; Zaretsky, Irina; Mayo, Avraham E.; Alon, Uri; Friedman, Nir			Paradoxical Signaling by a Secreted Molecule Leads to Homeostasis of Cell Levels	CELL			English	Article							REGULATORY T-CELLS; PRECURSOR FREQUENCY; INTERLEUKIN-2 IL-2; ACTIVATION; DIFFERENTIATION; PROLIFERATION; RESPONSES; EFFECTOR; MODEL; DEATH	A widespread feature of extracellular signaling in cell circuits is paradoxical pleiotropy: the same secreted signaling molecule can induce opposite effects in the responding cells. For example, the cytokine IL-2 can promote proliferation and death of T cells. The role of such paradoxical signaling remains unclear. To address this, we studied CD4(+) T cell expansion in culture. We found that cells with a 30-fold difference in initial concentrations reached a homeostatic concentration nearly independent of initial cell levels. Below an initial threshold, cell density decayed to extinction (OFF-state). We show that these dynamics relate to the paradoxical effect of IL-2, which increases the proliferation rate cooperatively and the death rate linearly. Mathematical modeling explained the observed cell and cytokine dynamics and predicted conditions that shifted cell fate from homeostasis to the OFF-state. We suggest that paradoxical signaling provides cell circuits with specific dynamical features that are robust to environmental perturbations.	[Hart, Yuval; Mayo, Avraham E.; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Reich-Zeliger, Shlomit; Antebi, Yaron E.; Zaretsky, Irina; Friedman, Nir] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Friedman, N (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	nir.friedman@weizmann.ac.il	Hart, Yuval/HGD-6424-2022; mayo, avi/N-3756-2019	mayo, avi/0000-0002-4479-3423; Antebi, Yaron/0000-0002-5771-6814	Israeli Science Foundation; Human Frontier Science Program; European Research Council (ERC) under the European Union's 7th Framework Programme (ERC) [249919]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation	Israeli Science Foundation(Israel Science Foundation); Human Frontier Science Program(Human Frontier Science Program); European Research Council (ERC) under the European Union's 7th Framework Programme (ERC); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This research was supported by grants from the Israeli Science Foundation, The Human Frontier Science Program, and the European Research Council under the European Union's 7th Framework Programme (ERC Grant agreement 249919) (to U.A.). This research was also supported by a grant from the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (to N.F.). U.A. is the incumbent of the Abisch-Frenkel Professorial Chair. N.F. is the incumbent of the Pauline Recanati Career Development Chair of Immunology. Y.H. wishes to thank Naama Barkai for fruitful discussions.	Ashcroft GS, 1999, MICROBES INFECT, V1, P1275, DOI 10.1016/S1286-4579(99)00257-9; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Banks HT, 2011, J IMMUNOL METHODS, V373, P143, DOI 10.1016/j.jim.2011.08.014; Banks HT, 2011, B MATH BIOL, V73, P116, DOI 10.1007/s11538-010-9524-5; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; Dadon D, 2012, DIABETES OBES METAB, V14, P101, DOI 10.1111/j.1463-1326.2012.01646.x; Dai ZH, 1999, J IMMUNOL, V163, P3131; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; FUJII M, 1986, J EXP MED, V163, P550, DOI 10.1084/jem.163.3.550; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Hart Y, 2012, P NATL ACAD SCI USA, V109, P8346, DOI 10.1073/pnas.1117475109; Haskel-Ittah M, 2012, CELL, V150, P1016, DOI 10.1016/j.cell.2012.06.044; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; MolinaParis C, 2011, MATHEMATICAL MODELS AND IMMUNE CELL BIOLOGY, P1; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Quiel J, 2011, P NATL ACAD SCI USA, V108, P3312, DOI 10.1073/pnas.1018525108; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sprinzak D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002069; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tkach KE, 2014, ELIFE, V3, DOI 10.7554/eLife.01944; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Wang RD, 1996, EUR J IMMUNOL, V26, P2263, DOI 10.1002/eji.1830260944; Waysbort N, 2013, J IMMUNOL, V191, P5822, DOI 10.4049/jimmunol.1301575; Whitmire JK, 2008, J IMMUNOL, V180, P6777, DOI 10.4049/jimmunol.180.10.6777; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691; Zaretsky I, 2012, LAB CHIP, V12, P5007, DOI 10.1039/c2lc40808b; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	45	56	57	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1022	1032		10.1016/j.cell.2014.07.033	http://dx.doi.org/10.1016/j.cell.2014.07.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171404	Bronze			2022-12-28	WOS:000340945000009
J	Jarosz, DF; Lancaster, AK; Brown, JCS; Lindquist, S				Jarosz, Daniel F.; Lancaster, Alex K.; Brown, Jessica C. S.; Lindquist, Susan			An Evolutionarily Conserved Prion-like Element Converts Wild Fungi from Metabolic Specialists to Generalists	CELL			English	Article							FLUCTUATING ENVIRONMENTS; SACCHAROMYCES-CEREVISIAE; GLUCOSAMINE RESISTANCE; YEAST GENOME; INHERITANCE; STRESS; DUPLICATION; EPIGENETICS; DIVERSITY; MECHANISM	[GAR(+)] is a protein-based element of inheritance that allows yeast ( Saccharomyces cerevisiae) to circumvent a hallmark of their biology: extreme metabolic specialization for glucose fermentation. When glucose is present, yeast will not use other carbon sources. [GAR(+)] allows cells to circumvent this "glucose repression.'' [GAR(+)] is induced in yeast by a factor secreted by bacteria inhabiting their environment. We report that de novo rates of [GAR(+)] appearance correlate with the yeast's ecological niche. Evolutionarily distant fungi possess similar epigenetic elements that are also induced by bacteria. As expected for a mechanism whose adaptive value originates from the selective pressures of life in biological communities, the ability of bacteria to induce [GAR(+)] and the ability of yeast to respond to bacterial signals have been extinguished repeatedly during the extended monoculture of domestication. Thus, [GAR(+)] is a broadly conserved adaptive strategy that links environmental and social cues to heritable changes in metabolism.	[Jarosz, Daniel F.; Lancaster, Alex K.; Brown, Jessica C. S.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jarosz, Daniel F.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Dept Dev Biol, Stanford, CA 94305 USA; [Lancaster, Alex K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Lancaster, Alex K.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Brown, Jessica C. S.; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Lancaster, Alexander K/K-2855-2013	Lancaster, Alexander K/0000-0002-0002-9263; Jarosz, Daniel/0000-0003-3497-5888; Brown, Jessica/0000-0002-3255-1486	G. Harold and Leila Y. Mathers Foundation; Howard Hughes Medical Institutes (HHMI); HHMI fellow of the Damon Runyon Cancer Research Foundation [DRG-1964-08]; NIH Pathway to Independence Award [K99 GM098600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM098600, K99GM098600] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; Howard Hughes Medical Institutes (HHMI)(Howard Hughes Medical Institute); HHMI fellow of the Damon Runyon Cancer Research Foundation; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jason Gestwicki, Matthew D. Herron, Joanna Masel, Dawn Thompson, Aviv Regev, George Bell, Prathapan Thiru, and Lucy Joseph for materials and discussions. Ndubuisi Azubuine and Tsering Nanchung provided a constant supply of plates and media. We are grateful to Tom DiCesare for assistance with the production of Figure 6. This work was funded by grants from the G. Harold and Leila Y. Mathers Foundation and the Howard Hughes Medical Institutes (HHMI). D.F.J. was supported as an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-1964-08) and by an NIH Pathway to Independence Award (K99 GM098600). S. L. is an HHMI investigator.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BALL AJS, 1976, GENETICS, V84, P311; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bisson LF, 2007, ADV FOOD NUTR RES, V53, P65, DOI 10.1016/S1043-4526(07)53003-2; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Jong IG, 2011, BIOESSAYS, V33, P215, DOI 10.1002/bies.201000127; Diezmann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005317; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Hellborg L, 2009, EUKARYOT CELL, V8, P1739, DOI 10.1128/EC.00115-09; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KUNZ BA, 1977, MOL GEN GENET, V153, P169, DOI 10.1007/BF00264732; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lagaudriere-Gesbert C, 2002, P NATL ACAD SCI USA, V99, P1515, DOI 10.1073/pnas.042688099; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Lancaster AK, 2009, EVOLUTION, V63, P2350, DOI 10.1111/j.1558-5646.2009.00729.x; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Levy SF, 2012, ADV EXP MED BIOL, V751, P431, DOI 10.1007/978-1-4614-3567-9_20; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Palkova Z, 2004, EMBO REP, V5, P470, DOI 10.1038/sj.embor.7400145; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Weber KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013922; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06	43	74	74	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1072	1082		10.1016/j.cell.2014.07.024	http://dx.doi.org/10.1016/j.cell.2014.07.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171408	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000340945000013
J	Marsden, MD; Zack, JA				Marsden, Matthew D.; Zack, Jerome A.			Neutralizing the HIV Reservoir	CELL			English	Editorial Material							CD4(+) T-CELLS; INFECTION; LATENCY	Halper-Stromberg et al. use a humanized mouse model to demonstrate that broadly neutralizing antibodies, when administered with a combination of HIV latency activators, can reduce persistent HIV reservoirs, as measured by plasma virus rebound. Their results support the use of broadly neutralizing antibodies in HIV-reservoir-purging strategies.	[Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA; [Zack, Jerome A.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zack, JA (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA.	jzack@ucla.edu			NIAID NIH HHS [P30 AI028697, R01 AI070010, U19 AI096113] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070010, P30AI028697, U19AI096113] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Choudhary SK, 2012, J VIROL, V86, P114, DOI 10.1128/JVI.05590-11; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Marsden MD, 2013, BIOORG MED CHEM LETT, V23, P4003, DOI 10.1016/j.bmcl.2013.05.032; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	10	9	9	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					971	972		10.1016/j.cell.2014.08.010	http://dx.doi.org/10.1016/j.cell.2014.08.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171398	Green Accepted, Bronze			2022-12-28	WOS:000340945000001
J	Spivak, JL; Considine, M; Williams, DM; Talbot, CC; Rogers, O; Moliterno, AR; Jie, CF; Ochs, MF				Spivak, Jerry L.; Considine, Michael; Williams, Donna M.; Talbot, Conover C., Jr.; Rogers, Ophelia; Moliterno, Alison R.; Jie, Chunfa; Ochs, Michael F.			Two Clinical Phenotypes in Polycythemia Vera	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOPROLIFERATIVE DISORDERS; ALLELE BURDEN; TGF-BETA; PROGENITOR-CELL; PROTEIN TC21; JAK2 V617F; EXPRESSION; GENE; JAK2V617F; MUTATION	BACKGROUND Polycythemia vera is the ultimate phenotypic consequence of the V617F mutation in Janus kinase 2 (encoded by JAK2), but the extent to which this mutation influences the behavior of the involved CD34+ hematopoietic stem cells is unknown. METHODS We analyzed gene expression in CD34+ peripheral-blood cells from 19 patients with polycythemia vera, using oligonucleotide microarray technology after correcting for potential confounding by sex, since the phenotypic features of the disease differ between men and women. RESULTS Men with polycythemia vera had twice as many up-regulated or down-regulated genes as women with polycythemia vera, in a comparison of gene expression in the patients and in healthy persons of the same sex, but there were 102 genes with differential regulation that was concordant in men and women. When these genes were used for class discovery by means of unsupervised hierarchical clustering, the 19 patients could be divided into two groups that did not differ significantly with respect to age, neutrophil JAK2 V617F allele burden, white-cell count, platelet count, or clonal dominance. However, they did differ significantly with respect to disease duration; hemoglobin level; frequency of thromboembolic events, palpable splenomegaly, and splenectomy; chemotherapy exposure; leukemic transformation; and survival. The unsupervised clustering was confirmed by a supervised approach with the use of a top-scoring-pair classifier that segregated the 19 patients into the same two phenotypic groups with 100% accuracy. CONCLUSIONS Removing sex as a potential confounder, we identified an accurate molecular method for classifying patients with polycythemia vera according to disease behavior, independently of their JAK2 V617F allele burden, and identified previously unrecognized molecular pathways in polycythemia vera outside the canonical JAK2 pathway that may be amenable to targeted therapy. (Funded by the Department of Defense and the National Institutes of Health.)	[Spivak, Jerry L.; Williams, Donna M.; Rogers, Ophelia; Moliterno, Alison R.] Johns Hopkins Univ, Sch Med, Div Hematol, Dept Med, Baltimore, MD 21205 USA; [Considine, Michael] Johns Hopkins Univ, Sch Med, Div Biostat & Bioinformat, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Talbot, Conover C., Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Sci, Baltimore, MD 21205 USA; [Jie, Chunfa] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Ochs, Michael F.] Coll New Jersey, Dept Math & Stat, Ewing, NJ USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; College of New Jersey	Spivak, JL (corresponding author), Johns Hopkins Univ, Sch Med, Div Hematol, Traylor 924,720 Rutland Ave, Baltimore, MD 21205 USA.	jIspivak@jhmi.edu			Department of Defense; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082995] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Department of Defense and the National Institutes of Health.	Anand S, 2011, BLOOD, V118, P1610, DOI 10.1182/blood-2011-02-335042; Baricos WH, 1999, J AM SOC NEPHROL, V10, P790; Berkofsky-Fessler W, 2010, CLIN CANCER RES, V16, P4339, DOI 10.1158/1078-0432.CCR-10-1092; Catani L, 2009, LEUKEMIA, V23, P997, DOI 10.1038/leu.2008.357; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Gangat N, 2008, EUR J HAEMATOL, V80, P197, DOI 10.1111/j.1600-0609.2007.01003.x; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Koli K, 2008, BONE, V43, P679, DOI 10.1016/j.bone.2008.06.016; Lamy T, 1997, AM J MED, V102, P14, DOI 10.1016/S0002-9343(96)00351-8; Lee JH, 2009, MOL CANCER RES, V7, P1663, DOI 10.1158/1541-7786.MCR-09-0191; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Moliterno AR, 2008, EXP HEMATOL, V36, P1480, DOI 10.1016/j.exphem.2008.05.006; Moliterno AR, 2006, BLOOD, V108, P3913, DOI 10.1182/blood-2006-03-008805; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Passamonti F, 2010, LEUKEMIA, V24, P1574, DOI 10.1038/leu.2010.148; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ridnour LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044081; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; Rosario M, 2001, MOL CELL BIOL, V21, P3750, DOI 10.1128/MCB.21.11.3750-3762.2001; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Shibata S, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-6; SILVERSTEIN MN, 1974, ARCH INTERN MED, V134, P113, DOI 10.1001/archinte.134.1.113; Slezak S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-39; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Stein Brady L, 2011, Thrombosis, V2011, P874146, DOI 10.1155/2011/874146; Stein BL, 2010, HAEMATOL-HEMATOL J, V95, P1090, DOI 10.3324/haematol.2009.014407; Tripodo C, 2012, BLOOD, V120, P3541, DOI 10.1182/blood-2011-12-398537; VIDEBAEK A, 1950, ACTA MED SCAND, V138, P179; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; WASSERMAN LR, 1971, BRIT J HAEMATOL, V21, P371, DOI 10.1111/j.1365-2141.1971.tb02698.x; Yuwaraj S, 2001, GENOMICS, V71, P330, DOI 10.1006/geno.2000.6444	39	44	45	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					808	817		10.1056/NEJMoa1403141	http://dx.doi.org/10.1056/NEJMoa1403141			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162887	Green Accepted			2022-12-28	WOS:000340819800007
J	Watts, G				Watts, Geoff			Lorna Wing Obituary	LANCET			English	Biographical-Item																			0	0	0	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					658	658		10.1016/S0140-6736(14)61384-2	http://dx.doi.org/10.1016/S0140-6736(14)61384-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25157389	Bronze			2022-12-28	WOS:000341359100016
J	Kotecha, D; Holmes, J; Krum, H; Altman, DG; Manzano, L; Cleland, JGF; Lip, GYH; Coats, AJS; Andersson, B; Kirchhof, P; von Lueder, TG; Wedel, H; Rosano, G; Shibata, MC; Rigby, A; Flather, MD				Kotecha, Dipak; Holmes, Jane; Krum, Henry; Altman, Douglas G.; Manzano, Luis; Cleland, John G. F.; Lip, Gregory Y. H.; Coats, Andrew J. S.; Andersson, Bert; Kirchhof, Paulus; von Lueder, Thomas G.; Wedel, Hans; Rosano, Giuseppe; Shibata, Marcelo C.; Rigby, Alan; Flather, Marcus D.		Beta-Blockers Heart Failure Collab	Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis	LANCET			English	Article							MORTALITY; CARVEDILOL; EPIDEMIOLOGY; RATIONALE; SURVIVAL; TRENDS; TRIAL; RISK; TIME	Background Atrial fibrillation and heart failure often coexist, causing substantial cardiovascular morbidity and mortality. beta blockers are indicated in patients with symptomatic heart failure with reduced ejection fraction; however, the efficacy of these drugs in patients with concomitant atrial fibrillation is uncertain. We therefore meta-analysed individual-patient data to assess the efficacy of beta blockers in patients with heart failure and sinus rhythm compared with atrial fibrillation. Methods We extracted individual-patient data from ten randomised controlled trials of the comparison of beta blockers versus placebo in heart failure. The presence of sinus rhythm or atrial fibrillation was ascertained from the baseline electrocardiograph. The primary outcome was all-cause mortality. Analysis was by intention to treat. Outcome data were meta-analysed with an adjusted Cox proportional hazards regression. The study is registered with Clinicaltrials.gov, number NCT0083244, and PROSPERO, number CRD42014010012. Findings 18 254 patients were assessed, and of these 13 946 (76%) had sinus rhythm and 3066 (17%) had atrial fibrillation at baseline. Crude death rates over a mean follow-up of 1.5 years (SD 1.1) were 16% (2237 of 13 945) in patients with sinus rhythm and 21% (633 of 3064) in patients with atrial fibrillation. beta-blocker therapy led to a significant reduction in all-cause mortality in patients with sinus rhythm (hazard ratio 0.73, 0.67-0.80; p<0.001), but not in patients with atrial fibrillation (0.97, 0.83-1.14; p=0.73), with a significant p value for interaction of baseline rhythm (p=0.002). The lack of efficacy for the primary outcome was noted in all subgroups of atrial fibrillation, including age, sex, left ventricular ejection fraction, New York Heart Association class, heart rate, and baseline medical therapy. Interpretation Based on our findings, beta blockers should not be used preferentially over other rate-control medications and not regarded as standard therapy to improve prognosis in patients with concomitant heart failure and atrial fibrillation.	[Kotecha, Dipak; Lip, Gregory Y. H.; Kirchhof, Paulus] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Kotecha, Dipak] Royal Brompton & Harefield NHS Trust, Clin Trials & Evaluat Unit, London, England; [Kotecha, Dipak; Krum, Henry; von Lueder, Thomas G.] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Holmes, Jane; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Manzano, Luis] Univ Alcala, Hosp Univ Ramon Y Cajal, Dept Internal Med, Madrid, Spain; [Cleland, John G. F.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England; [Cleland, John G. F.] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, London, England; [Cleland, John G. F.] Univ Hull, Hull York Med Sch, Kingston Upon Hull, Yorks, England; [Lip, Gregory Y. H.; Kirchhof, Paulus] Sandwell & West Birmingham NHS Trust, City Hosp, Birmingham, W Midlands, England; [Coats, Andrew J. S.] Monash Univ, Melbourne, Vic 3004, Australia; [Coats, Andrew J. S.] Univ Warwick, Warwick, England; [Andersson, Bert] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Kirchhof, Paulus] Univ Hosp Munster, Dept Cardiovasc Med, Munster, Germany; [von Lueder, Thomas G.] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Rosano, Giuseppe] Inst Ricovero & Cura Carattere Sci San Raffaele P, Dept Med Sci, Rome, Italy; [Shibata, Marcelo C.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Rigby, Alan] Castle Hill Hosp, Acad Cardiol, Kingston Upon Hull, Yorks, England; [Flather, Marcus D.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Birmingham; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Monash University; University of Oxford; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; University of Hull; University of York - UK; University of Birmingham; Monash University; University of Warwick; Sahlgrenska University Hospital; University of Munster; University of Oslo; University of Alberta; University of Hull; University of East Anglia	Kotecha, D (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Sch Med, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	d.kotecha@bham.ac.uk	Cleland, John G./AAZ-4185-2020; Kirchhof, Paulus/AAT-7074-2021; Shibata, Marcelo/AAS-9521-2021; Rigby, Alan/AFM-1194-2022; Rosano, Giuseppe M. C./K-8718-2018; Espinosa, Luis Manzano/AAB-1702-2020; Kotecha, Dipak/Q-2827-2016	Cleland, John G./0000-0002-1471-7016; Kirchhof, Paulus/0000-0002-1881-0197; Rigby, Alan/0000-0001-8331-3907; Rosano, Giuseppe M. C./0000-0003-4023-2263; Espinosa, Luis Manzano/0000-0002-0472-1820; Kotecha, Dipak/0000-0002-2570-9812	Menarini Farmaceutica Internazionale; National Institute for Health Research [NF-SI-0611-10227, CL-2012-09-001] Funding Source: researchfish	Menarini Farmaceutica Internazionale(Menarini Group); National Institute for Health Research(National Institute for Health Research (NIHR))	Menarini Farmaceutica Internazionale (administrative support grant).	Amin AN, 2013, AM J THER, V20, P143, DOI 10.1097/MJT.0b013e3182512c7e; Braunschweig F, 2011, EUROPACE, V13, pII13, DOI 10.1093/europace/eur081; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Clark DM, 1997, J AM COLL CARDIOL, V30, P1039, DOI 10.1016/S0735-1097(97)00254-4; Cleland JGF, 2003, LANCET, V362, P14, DOI 10.1016/S0140-6736(03)13801-9; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hjalmarson A, 1999, LANCET, V353, P2001; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Komajda M, 2009, EUR HEART J, V30, P478, DOI 10.1093/eurheartj/ehn539; Koopman L, 2008, INT J TECHNOL ASSESS, V24, P358, DOI 10.1017/S0266462308080471; Kotecha D, 2014, BETA BLOCKERS HEART; Kotecha D, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-7; Krijthe BP, 2013, EUR HEART J, V34; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Lenzen MJ, 2005, EUR HEART J, V26, P2706, DOI 10.1093/eurheartj/ehi499; Liu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090555; MacMahon S, 1997, LANCET, V349, P375; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Mamas MA, 2009, EUR J HEART FAIL, V11, P676, DOI 10.1093/eurjhf/hfp085; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nasr IA, 2007, EUR HEART J, V28, P457, DOI 10.1093/eurheartj/ehl484; Neilan TG, 2013, J AM COLL CARDIOL, V62, P2205, DOI 10.1016/j.jacc.2013.07.067; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Rienstra M, 2013, JACC-HEART FAIL, V1, P21, DOI 10.1016/j.jchf.2012.09.002; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Smith CT, 2007, CLIN TRIALS, V4, P621, DOI 10.1177/1740774507085276; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776	48	354	378	4	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2235	2243		10.1016/S0140-6736(14)61373-8	http://dx.doi.org/10.1016/S0140-6736(14)61373-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25193873	Green Submitted			2022-12-28	WOS:000346655700026
J	Chera, S; Baronnier, D; Ghila, L; Cigliola, V; Jensen, JN; Gu, GQ; Furuyama, K; Thorel, F; Gribble, FM; Reimann, F; Herrera, PL				Chera, Simona; Baronnier, Delphine; Ghila, Luiza; Cigliola, Valentina; Jensen, Jan N.; Gu, Guoqiang; Furuyama, Kenichiro; Thorel, Fabrizio; Gribble, Fiona M.; Reimann, Frank; Herrera, Pedro L.			Diabetes recovery by age-dependent conversion of pancreatic delta-cells into insulin producers	NATURE			English	Article							ALPHA; GLUCOSE; HUMANS	Total or near-total loss of insulin-producing beta-cells occurs in type 1 diabetes(1,2). Restoration of insulin production in type 1 diabetes is thus a major medical challenge. We previously observed in mice in which beta-cells are completely ablated that the pancreas reconstitutes new insulin-producing cells in the absence of autoimmunity(3). The process involves the contribution of islet non-beta-cells; specifically, glucagon-producing alpha-cells begin producing insulin by a process of reprogramming (transdifferentiation) without proliferation(3). Here we show the influence of age on beta-cell reconstitution from heterologous islet cells after near-total beta-cell loss in mice. We found that senescence does not alter alpha-cell plasticity: alpha-cells can reprogram to produce insulin from puberty through to adulthood, and also in aged individuals, even a long time after beta-cell loss. In contrast, before puberty there is no detectable alpha-cell conversion, although beta-cell reconstitution after injury is more efficient, always leading to diabetes recovery. This process occurs through a newly discovered mechanism: the spontaneous en masse reprogramming of somatostatin-producing delta-cells. The juveniles display somatostatin-to-insulin delta-cell conversion, involving dedifferentiation, proliferation and re-expression of islet developmental regulators. This juvenile adaptability relies, at least in part, upon the combined action of FoxO1 and downstream effectors. Restoration of insulin producing-cells from non-beta-cell origins is thus enabled throughout life via delta- or alpha-cell spontaneous reprogramming. A landscape with multiple intra-islet cell interconversion events is emerging, offering new perspectives for therapy.	[Chera, Simona; Baronnier, Delphine; Ghila, Luiza; Cigliola, Valentina; Furuyama, Kenichiro; Thorel, Fabrizio; Herrera, Pedro L.] Univ Geneva, Fac Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Jensen, Jan N.] Novo Nordisk AS, DK-2820 Gentofte, Denmark; [Gu, Guoqiang] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Gribble, Fiona M.; Reimann, Frank] Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Geneva; Novo Nordisk; Vanderbilt University; University of Cambridge	Herrera, PL (corresponding author), Univ Geneva, Fac Med, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	pedro.herrera@unige.ch	CHERA, Simona/N-3207-2014; GHILA, Luiza/N-1372-2014; Cigliola, Valentina/AAM-9083-2020	CHERA, Simona/0000-0001-6310-3486; GHILA, Luiza/0000-0001-7173-6312; FURUYAMA, Kenichiro/0000-0003-4878-2841; Valentina, Cigliola/0000-0002-1596-7332; Herrera Merino, Pedro Luis/0000-0003-0771-9504; Gribble, Fiona/0000-0002-4232-2898; Reimann, Frank/0000-0001-9399-6377	Wellcome Trust [WT088357/Z/09/Z, WT084210/Z/07/Z]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (Beta Cell Biology Consortium); Juvenile Diabetes Research Foundation; Swiss National Science Foundation [NRP63]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065949, U01DK089566, U01DK072522] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12012/3] Funding Source: researchfish; MRC [MC_UU_12012/3] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (Beta Cell Biology Consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. Belin, P. Vassalli, R. Stein,A. Cookson,A. Ruizi Altaba, M. Gonzalez Gaitan, B. Galliot and I. Rodriguez for comments, support and discussions,and to G. Gallardo, O. Fazio, K. Hammad and B. Polat for technical help. We thank G. Gradwohl for the Ngn3-YFP mice. F.M.G. and F.R. were funded by Wellcome Trust grants WT088357/Z/09/Z and WT084210/Z/07/Z, respectively. This work was funded with grants from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (Beta Cell Biology Consortium), the Juvenile Diabetes Research Foundation and the Swiss National Science Foundation (NRP63) to P.L.H.	Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Atkinson M. A., 2012, COLD SPRING HARB PER; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Desgraz R, 2011, TRENDS ENDOCRIN MET, V22, P34, DOI 10.1016/j.tem.2010.09.004; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Karges B, 2006, DIABETES-METAB RES, V22, P184, DOI 10.1002/dmrr.600; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Morgan TH, 1901, SCIENCE, V14, P235, DOI 10.1126/science.14.346.235; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Tanaka H, 2010, EUR J PHARMACOL, V645, P185, DOI 10.1016/j.ejphar.2010.07.018; Thorel F, 2011, DIABETES, V60, P2872, DOI 10.2337/db11-0876; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yoneda S, 2013, J CLIN ENDOCR METAB, V98, P2053, DOI 10.1210/jc.2012-3832	23	261	272	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					503	+		10.1038/nature13633	http://dx.doi.org/10.1038/nature13633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25141178	Green Accepted, Green Published			2022-12-28	WOS:000343775900043
J	Gustafsson, MV; Aref, T; Kockum, AF; Ekstrom, MK; Johansson, G; Delsing, P				Gustafsson, Martin V.; Aref, Thomas; Kockum, Anton Frisk; Ekstrom, Maria K.; Johansson, Goran; Delsing, Per			Propagating phonons coupled to an artificial atom	SCIENCE			English	Article							CIRCUIT QUANTUM ELECTRODYNAMICS; SUPERCONDUCTING QUBIT; ACOUSTIC-WAVES; RESONATOR; ELECTRONS	Quantum information can be stored in micromechanical resonators, encoded as quanta of vibration known as phonons. The vibrational motion is then restricted to the stationary eigenmodes of the resonator, which thus serves as local storage for phonons. In contrast, we couple propagating phonons to an artificial atom in the quantum regime and reproduce findings from quantum optics, with sound taking over the role of light. Our results highlight the similarities between phonons and photons but also point to new opportunities arising from the characteristic features of quantum mechanical sound. The low propagation speed of phonons should enable new dynamic schemes for processing quantum information, and the short wavelength allows regimes of atomic physics to be explored that cannot be reached in photonic systems.	[Gustafsson, Martin V.; Aref, Thomas; Kockum, Anton Frisk; Ekstrom, Maria K.; Johansson, Goran; Delsing, Per] Chalmers, SE-41296 Gothenburg, Sweden; [Gustafsson, Martin V.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Chalmers University of Technology; Columbia University	Gustafsson, MV (corresponding author), Chalmers, Kemivagen 9, SE-41296 Gothenburg, Sweden.	mg3465@columbia.edu; per.delsing@chalmers.se	Johansson, Göran/Y-3488-2019; Kockum, Anton Frisk/E-8255-2014; Johansson, Göran/B-1144-2008; Delsing, Per/F-7288-2010	Johansson, Göran/0000-0001-5193-5250; Kockum, Anton Frisk/0000-0002-2534-3021; Johansson, Göran/0000-0001-5193-5250; Delsing, Per/0000-0002-1222-3506	Swedish Research Council (VR); Wallenberg Foundation; European Union through the European Research Council; Scalable Superconducting Processors for Entangled Quantum Information Technology project; Wenner-Gren Foundations	Swedish Research Council (VR)(Swedish Research Council); Wallenberg Foundation(European Commission); European Union through the European Research Council; Scalable Superconducting Processors for Entangled Quantum Information Technology project; Wenner-Gren Foundations	We acknowledge financial support from the Swedish Research Council (VR), the Wallenberg Foundation, and the European Union through the European Research Council and the Scalable Superconducting Processors for Entangled Quantum Information Technology project. The samples were made at the Nanofabrication Laboratory at Chalmers. We acknowledge fruitful discussions with P. Leek, R. Manenti, and D. Niesner. M. V. G. acknowledges funding from the Wenner-Gren Foundations and support from X. Zhu and P. Kim during the manuscript preparation.	Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; AUTLER SH, 1955, PHYS REV, V100, P703, DOI 10.1103/PhysRev.100.703; Barnes CHW, 2000, PHYS REV B, V62, P8410, DOI 10.1103/PhysRevB.62.8410; Bristol T. W., 1972, 1972 IEEE ULTR S P, P343, DOI DOI 10.1109/ULT-SYM.1972.196097; Campbell C. K., 1998, SURFACE ACOUSTIC WAV; Carmichael H. J., 1999, STAT METHODS QUANTUM, V1; Casanova J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.263603; Datta S., 1986, SURFACE ACOUSTIC WAV; Eichenfield M, 2009, NATURE, V462, P78, DOI 10.1038/nature08524; Eichler C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220503; ElHabti A, 1996, J ACOUST SOC AM, V100, P272, DOI 10.1121/1.415953; Forn-Diaz P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.237001; Gardiner C. W., 1991, QUANTUM NOISE; Gustafsson MV, 2012, NAT PHYS, V8, P338, DOI [10.1038/nphys2217, 10.1038/NPHYS2217]; Habraken SJM, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115004; Hermelin S, 2011, NATURE, V477, P435, DOI 10.1038/nature10416; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Hoi IC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053601; Hoi IC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.263601; Hoi IC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.073601; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Kockum AF, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.013837; KUBO R, 1957, J PHYS SOC JPN, V12, P570, DOI 10.1143/JPSJ.12.570; LaHaye MD, 2009, NATURE, V459, P960, DOI 10.1038/nature08093; Manenti R., 2014, THESIS U OXFORD UK; McNeil RPG, 2011, NATURE, V477, P439, DOI 10.1038/nature10444; Morgan D, 2010, SURFACE ACOUSTIC WAV; Naber WJM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136807; Niemczyk T, 2010, NAT PHYS, V6, P772, DOI 10.1038/NPHYS1730; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Peropadre B, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035009; Pirkkalainen JM, 2013, NATURE, V494, P211, DOI 10.1038/nature11821; Rau I, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054521; Rayleigh L., 1885, P LONDON MATH SOC S, Vs1-17, P4; Ruskov R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.064308; Shen JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213001; Soykal OO, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.235502; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851	40	268	273	7	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					207	211		10.1126/science.1257219	http://dx.doi.org/10.1126/science.1257219			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25213379	Green Submitted			2022-12-28	WOS:000342721500041
J	Geisbert, TW				Geisbert, Thomas W.			MEDICAL RESEARCH Ebola therapy protects severely ill monkeys	NATURE			English	Editorial Material							NONHUMAN-PRIMATES; POSTEXPOSURE PROTECTION; VIRUS INFECTION		Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA.	twgeisbe@utmb.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC7AI070083] Funding Source: NIH RePORTER; NIAID NIH HHS [UC7 AI094660, UC7 AI070083] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2013, REP FIL MED COUNT WO; Baize S., 2014, N ENGL J MED; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Feldmann H., 2013, FIELDS VIROLOGY, V1, P923; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; Hayden EC, 2014, NATURE; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202	17	10	15	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					41	43		10.1038/nature13746	http://dx.doi.org/10.1038/nature13746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25171470	Green Accepted			2022-12-28	WOS:000342420800029
J	Watson, T				Watson, Traci			Breathing trouble	NATURE			English	Editorial Material							AIR-POLLUTION; LUNG-CANCER; EXPOSURE; MORTALITY											Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Inst Health Metrics & Evaluation, 2010, GLOB BURD DIS CAUS P; Loomis D, 2013, LANCET ONCOL, V14, P1262, DOI 10.1016/S1470-2045(13)70487-X; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Turner MC, 2011, AM J RESP CRIT CARE, V184, P1374, DOI 10.1164/rccm.201106-1011OC	7	16	16	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					S14	S15		10.1038/513S14a	http://dx.doi.org/10.1038/513S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25208068	Bronze			2022-12-28	WOS:000341362800008
J	Richards, T				Richards, Tessa			PATIENT PARTNERSHIP When doctors and patients disagree	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Bloem BR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1838; Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5570; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Richards T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2614; Shrimsley R., 2014, FINANCIAL TIMES; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513	7	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2014	349								g5567	10.1136/bmj.g5567	http://dx.doi.org/10.1136/bmj.g5567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QO	25209622				2022-12-28	WOS:000341691200026
J	de Gage, SB; Moride, Y; Ducruet, T; Kurth, T; Verdoux, H; Tournier, M; Pariente, A; Begaud, B				de Gage, Sophie Billioti; Moride, Yola; Ducruet, Thierry; Kurth, Tobias; Verdoux, Helene; Tournier, Marie; Pariente, Antoine; Begaud, Bernard			Benzodiazepine use and risk of Alzheimer's disease: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; OLDER-ADULTS; DEMENTIA; SLEEP; USAGE; ASSOCIATION; POPULATION; PREVALENCE; DEPRESSION	Objectives To investigate the relation between the risk of Alzheimer's disease and exposure to benzodiazepines started at least five years before, considering both the dose-response relation and prodromes (anxiety, depression, insomnia) possibly linked with treatment. Design Case-control study. Setting The Quebec health insurance program database (RAMQ). Participants 1796 people with a first diagnosis of Alzheimer's disease and followed up for at least six years before were matched with 7184 controls on sex, age group, and duration of follow-up. Both groups were randomly sampled from older people (age >66) living in the community in 2000-09. Main outcome measure The association between Alzheimer's disease and benzodiazepine use started at least five years before diagnosis was assessed by using multivariable conditional logistic regression. Ever exposure to benzodiazepines was first considered and then categorised according to the cumulative dose expressed as prescribed daily doses (1-90, 91-180, >180) and the drug elimination half life. Results Benzodiazepine ever use was associated with an increased risk of Alzheimer's disease (adjusted odds ratio 1.51, 95% confidence interval 1.36 to 1.69; further adjustment on anxiety, depression, and insomnia did not markedly alter this result: 1.43, 1.28 to 1.60). No association was found for a cumulative dose <91 prescribed daily doses. The strength of association increased with exposure density (1.32 (1.01 to 1.74) for 91-180 prescribed daily doses and 1.84 (1.62 to 2.08) for >180 prescribed daily doses) and with the drug half life (1.43 (1.27 to 1.61) for short acting drugs and 1.70 (1.46 to 1.98) for long acting ones). Conclusion Benzodiazepine use is associated with an increased risk of Alzheimer's disease. The stronger association observed for long term exposures reinforces the suspicion of a possible direct association, even if benzodiazepine use might also be an early marker of a condition associated with an increased risk of dementia. Unwarranted long term use of these drugs should be considered as a public health concern.	[de Gage, Sophie Billioti; Verdoux, Helene; Tournier, Marie; Pariente, Antoine; Begaud, Bernard] Univ Bordeaux, INSERM, Pharmacoepidemiol U657, F-33000 Bordeaux, France; [Moride, Yola; Ducruet, Thierry] Univ Montreal, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Moride, Yola] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Kurth, Tobias] INSERM, Res Ctr Epidemiol & Biostat, Team Neuroepidemiol U897, F-33000 Bordeaux, France; [Kurth, Tobias] Univ Bordeaux, Coll Hlth Sci, F-33000 Bordeaux, France; [Verdoux, Helene; Tournier, Marie] Ctr Hosp Charles Perrens, F-33000 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	de Gage, SB (corresponding author), Univ Bordeaux, INSERM, Pharmacoepidemiol U657, F-33000 Bordeaux, France.	sophie.billioti-de-gage@u-bordeaux.fr	Kurth, Tobias/A-9243-2012; Tournier, Marie/T-6493-2019; Verdoux, Helene/T-1996-2019; Pariente, Antoine/S-9231-2019	Kurth, Tobias/0000-0001-7169-2620; Verdoux, Helene/0000-0003-2948-3782; Pariente, Antoine/0000-0002-7873-5483	IRESP (Institut de Recherche en Sante Publique); French Ministry of Health (Direction Generale de la Sante); Funding Agency for Health Research of Quebec (Fonds de la Recherche en Sante du Quebec, FRSQ)	IRESP (Institut de Recherche en Sante Publique); French Ministry of Health (Direction Generale de la Sante); Funding Agency for Health Research of Quebec (Fonds de la Recherche en Sante du Quebec, FRSQ)	This research was conducted by the INSERM (Institut National de la Sante et de la Recherche Medicale) and University of Bordeaux. Additional support was provided by unconditional grants from IRESP (Institut de Recherche en Sante Publique); the French Ministry of Health (Direction Generale de la Sante); and the Funding Agency for Health Research of Quebec (Fonds de la Recherche en Sante du Quebec, FRSQ).	Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Aparasu RR, 2003, J AM GERIATR SOC, V51, P671, DOI 10.1034/j.1600-0579.2003.00212.x; Assem-Hilger E, 2009, INT J GERIATR PSYCH, V24, P563, DOI 10.1002/gps.2155; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beekman ATF, 1998, INT J GERIATR PSYCH, V13, P717, DOI 10.1002/(SICI)1099-1166(1998100)13:10<717::AID-GPS857>3.0.CO;2-M; Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Cheng JS, 2008, INT J GERIATR PSYCH, V23, P618, DOI 10.1002/gps.1950; Curran HV, 2003, PSYCHOL MED, V33, P1223, DOI 10.1017/S0033291703008213; CURRAN HV, 1986, BIOL PSYCHOL, V23, P179, DOI 10.1016/0301-0511(86)90081-5; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; Dell'osso B, 2013, EUR PSYCHIAT, V28, P7, DOI 10.1016/j.eurpsy.2011.11.003; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donoghue J, 2010, INT J PSYCHIAT CLIN, V14, P78, DOI 10.3109/13651500903447810; Dotson VM, 2010, NEUROLOGY, V75, P27, DOI 10.1212/WNL.0b013e3181e62124; Egan M, 2000, J AM GERIATR SOC, V48, P811, DOI 10.1111/j.1532-5415.2000.tb04758.x; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; European Medicines Agency, 2012, SUMM PROD CHAR BENZ; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Fineberg NA, 2013, J PSYCHOPHARMACOL, V27, P761, DOI 10.1177/0269881113495118; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourrier A, 2001, EUR J CLIN PHARMACOL, V57, P419, DOI 10.1007/s002280100326; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; GHONEIM MM, 1990, ANESTHESIOLOGY, V72, P926; Hutchinson MA, 1996, PROG NEUROBIOL, V49, P73, DOI 10.1016/S0301-0082(96)00011-1; Ilomaki J, 2011, ANN PHARMACOTHER, V45, P1240, DOI 10.1345/aph.1Q375; International AsD, 2009, WORLD ALZH REP 2009; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lagnaoui R, 2009, AGE AGEING, V38, P226, DOI 10.1093/ageing/afn277; Lechevallier N, 2003, REV EPIDEMIOL SANTE, V51, P317; Leicht H, 2011, ACTA PSYCHIAT SCAND, V124, P384, DOI 10.1111/j.1600-0447.2011.01741.x; Lemeshow S, 1998, AM J EPIDEMIOL, V148, P298; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Monane M, 1996, CLIN PHARMACOL THER, V59, P83, DOI 10.1016/S0009-9236(96)90027-2; Neutel CI, 2005, INT REV PSYCHIATR, V17, P189, DOI 10.1080/09540260500071863; Ostbye Truls, 2005, Chronic Dis Can, V26, P93; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Pariente A, 2008, DRUG AGING, V25, P61, DOI 10.2165/00002512-200825010-00007; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Poyares D, 2004, J PSYCHIATR RES, V38, P327, DOI 10.1016/j.jpsychires.2003.10.003; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosenberg PB, 2011, INT J GERIATR PSYCH, V26, P364, DOI 10.1002/gps.2535; SHIMOHAMA S, 1988, ANN NEUROL, V23, P404, DOI 10.1002/ana.410230419; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sterniczuk R, 2013, CURR ALZHEIMER RES, V10, P767, DOI 10.2174/15672050113109990134; Swaen G, 2009, J CLIN EPIDEMIOL, V62, P270, DOI 10.1016/j.jclinepi.2008.06.013; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Taragano FE, 2009, J CLIN PSYCHIAT, V70, P584, DOI 10.4088/JCP.08m04181; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Van der Mussele S, 2013, INT J GERIATR PSYCH, V28, P265, DOI 10.1002/gps.3820; Veronese A, 2007, EUR J CLIN PHARMACOL, V63, P867, DOI 10.1007/s00228-007-0341-1; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; WHO, 2003, INTR DRUG UT RES; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210; Zandstra SM, 2004, FAM PRACT, V21, P266, DOI 10.1093/fampra/cmh309	65	320	327	0	70	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2014	349								g5205	10.1136/bmj.g5205	http://dx.doi.org/10.1136/bmj.g5205			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QM	25208536	Green Published, hybrid			2022-12-28	WOS:000341691000003
J	Clemens, TL				Clemens, Thomas L.			Vitamin B-12 Deficiency and Bone Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA; [Clemens, Thomas L.] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA	Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Clemens, TL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.							Cagnacci A, 2008, BONE, V42, P314, DOI 10.1016/j.bone.2007.10.022; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Tucker KL, 2005, J BONE MINER RES, V20, P152, DOI [10.1359/jbmr.2005.20.1.152, 10.1359/JBMR.041018]; Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje	5	11	11	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					963	964		10.1056/NEJMcibr1407247	http://dx.doi.org/10.1056/NEJMcibr1407247			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184870				2022-12-28	WOS:000341390600015
J	Puzziferri, N; Roshek, TB; Mayo, HG; Gallagher, R; Belle, SH; Livingston, EH				Puzziferri, Nancy; Roshek, Thomas B., III; Mayo, Helen G.; Gallagher, Ryan; Belle, Steven H.; Livingston, Edward H.			Long-term Follow-up After Bariatric Surgery A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							Y GASTRIC BYPASS; QUALITY-OF-LIFE; LAPAROSCOPIC-SLEEVE-GASTRECTOMY; VERTICAL BANDED GASTROPLASTY; PROSPECTIVE RANDOMIZED-TRIAL; CARDIOVASCULAR RISK-FACTORS; MORBID-OBESITY; WEIGHT-LOSS; OUTCOMES; EFFICACY	IMPORTANCE Bariatric surgery is an accepted treatment for obesity. Despite extensive literature, few studies report long-term follow-up in cohorts with adequate retention rates. OBJECTIVE To assess the quality of evidence and treatment effectiveness 2 years after bariatric procedures for weight loss, type 2 diabetes, hypertension, and hyperlipidemia in severely obese adults. EVIDENCE REVIEW MEDLINE and Cochrane databases were searched from 1946 through May 15, 2014. Search terms included bariatric surgery, individual bariatric procedures, and obesity. Studies were included if they described outcomes for gastric bypass, gastric band, or sleeve gastrectomy performed on patients with a body mass index of 35 or greater, had more than 2 years of outcome information, and had follow-up measures for at least 80% of the initial cohort. Two investigators reviewed each study and a third resolved study inclusion disagreements. FINDINGS Of 7371 clinical studies reviewed, 29 studies (0.4%, 7971 patients) met inclusion criteria. All gastric bypass studies (6 prospective cohorts, 5 retrospective cohorts) and sleeve gastrectomy studies (2 retrospective cohorts) had 95% confidence intervals for the reported mean, median, or both exceeding 50% excess weight loss. This amount of excess weight loss occurred in 31% of gastric band studies (9 prospective cohorts, 5 retrospective cohorts). The mean sample-size-weighted percentage of excess weight loss for gastric bypass was 65.7% (n = 3544) vs 45.0%(n = 4109) for gastric band. Nine studies measured comorbidity improvement. For type 2 diabetes (glycated hemoglobin <6.5% without medication), sample-size-weighted remission rates were 66.7% for gastric bypass (n = 428) and 28.6% for gastric band (n = 96). For hypertension (blood pressure <140/90 mmHg without medication), remission rates were 38.2% for gastric bypass (n = 808) and 17.4% for gastric band (n = 247). For hyperlipidemia (cholesterol <200 mg/dL, high-density lipoprotein >40 mg/dL, low-density lipoprotein <160 mg/dL, and triglycerides <200 mg/dL), remission rates were 60.4% for gastric bypass (n = 477) and 22.7% for gastric band (n = 97). CONCLUSIONS AND RELEVANCE Very few bariatric surgery studies report long-term results with sufficient patient follow-up to minimize biased results. Gastric bypass has better outcomes than gastric band procedures for long-term weight loss, type 2 diabetes control and remission, hypertension, and hyperlipidemia. Insufficient evidence exists regarding long-term outcomes for gastric sleeve resections.	[Puzziferri, Nancy; Roshek, Thomas B., III; Gallagher, Ryan; Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Puzziferri, Nancy; Livingston, Edward H.] North Texas Vet Adm Healthcare Syst, Dept Surg, Dallas, TX USA; [Mayo, Helen G.] Univ Texas Southwestern Med Ctr Lib, Dallas, TX USA; [Belle, Steven H.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Belle, Steven H.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Livingston, Edward H.] Univ Texas Arlington, Dept Biomed Engn, Arlington, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Arlington	Puzziferri, N (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, MC 9156,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	nancy.puzziferri@utsouthwestern.edu	Mayo, Helen/F-9734-2011	Mayo, Helen/0000-0003-1238-370X	Department of Surgery of the University of Texas Southwestern Medical Center, Dallas; National Institutes of Health National Center for Advancing Translational Sciences (NIH/NCATS) [KL2TR001103]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105, KL2TR001103] Funding Source: NIH RePORTER	Department of Surgery of the University of Texas Southwestern Medical Center, Dallas; National Institutes of Health National Center for Advancing Translational Sciences (NIH/NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Department of Surgery of the University of Texas Southwestern Medical Center, Dallas, provided funding for all aspects of the preparation of this manuscript. A grant from the National Institutes of Health National Center for Advancing Translational Sciences (NIH/NCATS) (KL2TR001103) supported part of the primary author's salary, allowing time to conceive and prepare the manuscript.	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Adams TD, 2010, OBESITY, V18, P121, DOI 10.1038/oby.2009.178; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 2009, J Am Coll Cardiol, V54, pe13, DOI 10.1016/j.jacc.2009.07.010; [Anonymous], BOD MASS IND TABL 1; Basdevant A, 2007, OBES SURG, V17, P39, DOI 10.1007/s11695-007-9004-7; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Caiazzo R, 2010, BRIT J SURG, V97, P884, DOI 10.1002/bjs.6993; CHALMERS TC, 1977, NEW ENGL J MED, V297, P1091, DOI 10.1056/NEJM197711172972004; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Czupryniak L, 2007, OBES SURG, V17, P162, DOI 10.1007/s11695-007-9042-1; Favretti F, 2007, OBES SURG, V17, P168, DOI 10.1007/s11695-007-9043-0; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Graefen M, 2010, EUR UROL, V57, P938, DOI 10.1016/j.eururo.2010.02.004; Gravante G, 2007, ARCH SURG-CHICAGO, V142, P958, DOI 10.1001/archsurg.142.10.958; HALL JC, 1990, ANN SURG, V211, P419, DOI 10.1097/00000658-199004000-00007; Hauser DL, 2010, OBES SURG, V20, P283, DOI 10.1007/s11695-009-0042-1; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Kalfarentzos F, 2006, OBES SURG, V16, P151, DOI 10.1381/096089206775565096; Kehagias I, 2013, SURG OBES RELAT DIS, V9, P363, DOI 10.1016/j.soard.2011.12.011; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Mathus-Vliegen EMH, 2007, BRIT J SURG, V94, P457, DOI 10.1002/bjs.5607; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nguyen NT, 2009, ANN SURG, V250, P631, DOI 10.1097/SLA.0b013e3181b92480; O'Brien PE, 2013, ANN SURG, V257, P87, DOI 10.1097/SLA.0b013e31827b6c02; O'Brien PE, 2005, OBES SURG, V15, P820, DOI 10.1381/0960892054222858; Phillips E, 2009, SURG OBES RELAT DIS, V5, P588, DOI 10.1016/j.soard.2008.12.007; Ponce J, 2005, J AM COLL SURGEONS, V201, P529, DOI 10.1016/j.jamcollsurg.2005.05.001; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Ray JB, 2011, SURG OBES RELAT DIS, V7, P140, DOI 10.1016/j.soard.2010.08.011; Riele WWT, 2010, BRIT J SURG, V97, P1535, DOI 10.1002/bjs.7130; Sekhar N, 2007, SURG ENDOSC, V21, P665, DOI 10.1007/s00464-006-9151-2; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Skroubis G, 2006, OBES SURG, V16, P488, DOI 10.1381/096089206776327251; Sovik TT, 2011, ANN INTERN MED, V155, P281, DOI 10.7326/0003-4819-155-5-201109060-00005; Sultan S, 2010, SURG OBES RELAT DIS, V6, P373, DOI 10.1016/j.soard.2010.02.043; Suter M, 2006, OBES SURG, V16, P829, DOI 10.1381/096089206777822359; Suter M, 2005, ANN SURG, V241, P55, DOI 10.1097/01.sla.0000150071.86934.36; Vagenas K, 2008, WORLD J GASTROENTERO, V14, P6024, DOI 10.3748/wjg.14.6024; van Dielen FMH, 2005, OBES SURG, V15, P1292, DOI 10.1381/096089205774512456; Van Nieuwenhove Y, 2011, OBES SURG, V21, P582, DOI 10.1007/s11695-010-0341-6; Weiner RA, 2007, OBES SURG, V17, P1297, DOI 10.1007/s11695-007-9232-x; Yan E, 2008, AM J SURG, V195, P94, DOI 10.1016/j.amjsurg.2007.01.036	47	502	524	1	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					934	942		10.1001/jama.2014.10706	http://dx.doi.org/10.1001/jama.2014.10706			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25182102	Green Accepted, Bronze			2022-12-28	WOS:000341668600022
J	Hou, JL; Michaud, C; Li, ZH; Dong, Z; Sun, BZ; Zhang, JH; Cao, DP; Wan, XH; Zeng, C; Wei, B; Tao, LJ; Li, XS; Wang, WM; Lu, YQ; Xia, XL; Guo, GF; Zhang, ZY; Cao, YF; Guan, YZ; Meng, QY; Wang, Q; Zhao, YH; Liu, HP; Lin, HQ; Ke, Y; Chen, L				Hou, Jianlin; Michaud, Catherine; Li, Zhihui; Dong, Zhe; Sun, Baozhi; Zhang, Junhua; Cao, Depin; Wan, Xuehong; Zeng, Cheng; Wei, Bo; Tao, Lijian; Li, Xiaosong; Wang, Weimin; Lu, Yingqing; Xia, Xiulong; Guo, Guifang; Zhang, Zhiyong; Cao, Yunfei; Guan, Yuanzhi; Meng, Qingyue; Wang, Qing; Zhao, Yuhong; Liu, Huaping; Lin, Huiqing; Ke, Yang; Chen, Lincoln			Transformation of the education of health professionals in China: progress and challenges	LANCET			English	Review								In this Review we examine the progress and challenges of China's ambitious 1998 reform of the world's largest health professional educational system. The reforms merged training institutions into universities and greatly expanded enrolment of health professionals. Positive achievements include an increase in the number of graduates to address human resources shortages, acceleration of production of diploma nurses to correct skill-mix imbalance, and priority for general practitioner training, especially of rural primary care workers. These developments have been accompanied by concerns: rapid expansion of the number of students without commensurate faculty strengthening, worries about dilution effect on quality, outdated curricular content, and ethical professionalism challenged by narrow technical training and growing admissions of students who did not express medicine as their first career choice. In this Review we underscore the importance of rebalance of the roles of health sciences institutions and government in educational policies and implementation. The imperative for reform is shown by a looming crisis of violence against health workers hypothesised as a result of many factors including deficient educational preparation and harmful profit-driven clinical practices.	[Hou, Jianlin; Dong, Zhe] Peking Univ, Inst Med Educ, Beijing 100191, Peoples R China; [Michaud, Catherine; Li, Zhihui; Chen, Lincoln] China Med Board, Cambridge, MA USA; [Sun, Baozhi] China Med Univ, Ctr Med Educ Res, Shenyang, Peoples R China; [Zhang, Junhua] Minist Hlth, Hlth Human Resources Dev Ctr, Beijing, Peoples R China; [Cao, Depin] Harbin Med Univ, Harbin, Peoples R China; [Wan, Xuehong] Sichuan Univ, West China Sch Med, Chengdu 610064, Peoples R China; [Wan, Xuehong] Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China; [Zeng, Cheng; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Peoples R China; [Zeng, Cheng; Li, Xiaosong] Sichuan Univ, West China Hosp 4, Chengdu 610064, Peoples R China; [Wei, Bo] Guangxi Food & Drug Adm, Nanning, Peoples R China; [Tao, Lijian] Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Wang, Weimin; Ke, Yang] Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Lu, Yingqing; Wang, Qing] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xia, Xiulong] Jiujiang Univ, Med Ctr, Jiujiang, Peoples R China; [Guo, Guifang] Peking Univ, Sch Nursing, Beijing 100191, Peoples R China; [Zhang, Zhiyong; Cao, Yunfei] Guangxi Med Univ, Nanning, Peoples R China; [Guan, Yuanzhi] Peking Union Med Coll, Off Educ Adm, Beijing 100021, Peoples R China; [Meng, Qingyue] Peking Univ, China Ctr Hlth Dev Studies, Beijing 100871, Peoples R China; [Zhao, Yuhong] China Med Univ, Dept Human Resources, Shenyang, Peoples R China; [Liu, Huaping] Peking Union Med Coll, Sch Nursing, Beijing 100021, Peoples R China; [Lin, Huiqing] Minist Educ, Beijing, Peoples R China	Peking University; China Medical University; Harbin Medical University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Peking University; Fudan University; Jiujiang University; Peking University; Guangxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; School of Nursing - PUMC	Ke, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China.	keyang@bjmu.edu.cn	Lin, Huiqing/ABH-5093-2020; Hou, Jianlin/AAF-5901-2020; TAO, Li/HIR-4254-2022	Hou, Jianlin/0000-0003-1989-2056	China Medical Board for this Review	China Medical Board for this Review	Funding was provided by the China Medical Board for this Review.	Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; [Anonymous], 2013, JINGHUA DAILY   1023; Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; Flexner A, 1910, CARNEGIE FDN ADV TEA, V4; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Gao TQ, 1999, MED EDUC, V33, P768, DOI 10.1046/j.1365-2923.1999.00313.x; Hesketh T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5730; Hu H, 2014, XINHUA DAILY TE 0308; Jiang J., 2011, TIME; Jiang P, 2012, PERCEPTION MANAGEMEN; Li H., 2013, REPORT VIOLENCE HOSP; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Lixu Li, 2004, Asia Pacific Education Review, V5, P14; Min W., 2004, ASIAN U HIST PERSPEC, P53; Ministry of Education of the Russian Federation, 2014, NUMB MED SCH; Ministry of Health of the Russian Federation, 2012, NUMB MED SCH GRAD; National Development and Reform Commission of the People's Republic of China National Health and Family Planning Commission of the People's Republic of China Ministry of Education of the People's Republic of China Ministry of Finance of the People's Republic of China Ministry of Human Resources and Social Security of the People's Republic of China, 2010, SUGG IMPL FREE TRAIN; National Development and Reform Commission of the People's Republic of China National Health and Family Planning Commission of the People's Republic of China State Commission Office of Public Sectors Reform Ministry of Education of the People's Republic of China Ministry of Finance of the People's Republic of China Ministry of Human Resources and Social Security of the People's Republic of China, 2010, GEN PRACT CTR PRIM C; National Health and Family Planning Commission of the People's Republic of China, 2012, GOV PRIOR CHIN EXC D; National Health and Family Planning Commission of the People's Republic of China Ministry of Education of the People's Republic of China, 2012, GEN PRACT ASS TRAIN; National Health and Family Planning Commission of the People's Republic of China Ministry of Education of the People's Republic of China, 2012, CRIT STAND TRAIN GEN; National health and Family planning commission of the People's Republic of China Ministry of Public Security of the People's Republic of China, 2013, GUID ENH HOSP SAF; National Health and Family Planning Commission of the People's Republic of China Ministry of Public Security of the People's Republic of China, 2013, GUID ENH HOSP SAF; National Health and Family Planning Commission of the People's Republic of China Ministry of Public Security of the People's Republic of China, 2012, MAIN MED ORD MED I; Schwarz MR, 2004, MED TEACH, V26, P215, DOI 10.1080/01421590310001642939; Xu D, 2010, LANCET, V375, P1502, DOI 10.1016/S0140-6736(10)60241-3; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zeng J, 2013, LANCET, V382, P1878, DOI 10.1016/S0140-6736(13)62624-0; Zhang DQ, 2008, LANCET, V372, P1865, DOI 10.1016/S0140-6736(08)61355-0	30	108	118	6	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					819	827		10.1016/S0140-6736(14)61307-6	http://dx.doi.org/10.1016/S0140-6736(14)61307-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	25176552				2022-12-28	WOS:000341361500042
J	Araya, CL; Kawli, T; Kundaje, A; Jiang, LX; Wu, BJ; Vafeados, D; Terrell, R; Weissdepp, P; Gevirtzman, L; Mace, D; Niu, W; Boyle, AP; Xie, D; Ma, LJ; Murray, JI; Reinke, V; Waterston, RH; Snyder, M				Araya, Carlos L.; Kawli, Trupti; Kundaje, Anshul; Jiang, Lixia; Wu, Beijing; Vafeados, Dionne; Terrell, Robert; Weissdepp, Peter; Gevirtzman, Louis; Mace, Daniel; Niu, Wei; Boyle, Alan P.; Xie, Dan; Ma, Lijia; Murray, John I.; Reinke, Valerie; Waterston, Robert H.; Snyder, Michael			Regulatory analysis of the C. elegans genome with spatiotemporal resolution	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; CELL LINEAGE; CHIP-SEQ; TRANSCRIPTION FACTORS; FACTOR COLOCALIZATION; BINDING; MORPHOGENESIS; SIMILARITY; HOMOLOG	Discovering the structure and dynamics of transcriptional regulatory events in the genome with cellular and temporal resolution is crucial to understanding the regulatory underpinnings of development and disease. We determined the genomic distribution of binding sites for 92 transcription factors and regulatory proteins across multiple stages of Caenorhabditis elegans development by performing 241 ChIP-seq (chromatin immunoprecipitation followed by sequencing) experiments. Integration of regulatory binding and cellular-resolution expression data produced a spatio-temporally resolved metazoan transcription factor binding map. Using this map, we explore developmental regulatory circuits that encode combinatorial logic at the levels of co-binding and co-expression of transcription factors, characterizing the genomic coverage and clustering of regulatory binding, the binding preferences of, and biological processes regulated by, transcription factors, the global transcription factor co-associations and genomic subdomains that suggest shared patterns of regulation, and identifying key transcription factors and transcription factor co-associations for fate specification of individual lineages and cell types.	[Araya, Carlos L.; Kawli, Trupti; Jiang, Lixia; Wu, Beijing; Boyle, Alan P.; Xie, Dan; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Kundaje, Anshul] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Vafeados, Dionne; Terrell, Robert; Weissdepp, Peter; Gevirtzman, Louis; Mace, Daniel; Waterston, Robert H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Niu, Wei; Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Ma, Lijia] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Murray, John I.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Stanford University; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; Yale University; University of Chicago; University of Pennsylvania; Pennsylvania Medicine	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	watersto@u.washington.edu; mpsnyder@stanford.edu	Kundaje, Anshul/Y-2739-2019; Boyle, Alan/I-1848-2014; Kundaje, Anshul/Y-2598-2019	Kundaje, Anshul/0000-0003-3084-2287; Boyle, Alan/0000-0002-2081-1105; Kundaje, Anshul/0000-0003-3084-2287; Araya, Carlos/0000-0002-5512-3062; Snyder, Michael/0000-0003-0784-7987	NHGRI as part of the modENCODE project [U01 HG004267]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004267, K99HG007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072675] Funding Source: NIH RePORTER	NHGRI as part of the modENCODE project; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Euskirchen at the Stanford Center for Genomics and Personalized Medicine for sequencing ChIP libraries and members of the Reinke laboratory for contributing ChIP-seq data. We thank members of the Waterston laboratory, Sarov laboratory and Kim laboratory for tagged constructs and generating C. elegans strains. We thank J. Reuter, D. Phanstiel, H. Tilgner and D. Fowler for critical comments on the manuscript This work is supported by the NHGRI as part of the modENCODE project (U01 HG004267).	Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; BRENNER S, 1974, GENETICS, V77, P71; Brooks DR, 2003, J BIOL CHEM, V278, P52340, DOI 10.1074/jbc.M308858200; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gu WF, 2012, CELL, V151, P1488, DOI 10.1016/j.cell.2012.11.023; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hallam S, 2000, DEVELOPMENT, V127, P4239; Hammar P., 2014, NATURE GENET; Hirose T, 2010, P NATL ACAD SCI USA, V107, P15479, DOI 10.1073/pnas.1010023107; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Hope IA, 2003, GENE, V304, P43, DOI 10.1016/S0378-1119(02)01175-7; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Mace DL, 2013, G3-GENES GENOM GENET, V3, P851, DOI 10.1534/g3.113.005918; Mathies LD, 2003, DEVELOPMENT, V130, P2881, DOI 10.1242/DEV.00483; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Salser SJ, 1996, DEVELOPMENT, V122, P1651; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; Sommermann EM, 2010, DEV BIOL, V347, P154, DOI 10.1016/j.ydbio.2010.08.020; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Van Nostrand EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003325; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	49	75	75	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					400	U363		10.1038/nature13497	http://dx.doi.org/10.1038/nature13497			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164749	Green Accepted, hybrid			2022-12-28	WOS:000340840600026
J	DebRoy, S; Gebbie, M; Ramesh, A; Goodson, JR; Cruz, MR; van Hoof, A; Winkler, WC; Garsin, DA				DebRoy, Sruti; Gebbie, Margo; Ramesh, Arati; Goodson, Jonathan R.; Cruz, Melissa R.; van Hoof, Ambro; Winkler, Wade C.; Garsin, Danielle A.			A riboswitch-containing sRNA controls gene expression by sequestration of a response regulator	SCIENCE			English	Article							ETHANOLAMINE UTILIZATION; ENTEROCOCCUS-FAECALIS; BINDING	The ethanolamine utilization (eut) locus of Enterococcus faecalis, containing at least 19 genes distributed over four polycistronic messenger RNAs, appears to be regulated by a single adenosyl cobalamine (AdoCbl)-responsive riboswitch. We report that the AdoCbl-binding riboswitch is part of a small, trans-acting RNA, EutX, which additionally contains a dual-hairpin substrate for the RNA binding-response regulator, EutV. In the absence of AdoCbl, EutX uses this structure to sequester EutV. EutV is known to regulate the eut messenger RNAs by binding dual-hairpin structures that overlap terminators and thus prevent transcription termination. In the presence of AdoCbl, EutV cannot bind to EutX and, instead, causes transcriptional read through of multiple eut genes. This work introduces riboswitch-mediated control of protein sequestration as a posttranscriptional mechanism to coordinately regulate gene expression.	[DebRoy, Sruti; Cruz, Melissa R.; van Hoof, Ambro; Garsin, Danielle A.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Gebbie, Margo; Goodson, Jonathan R.; Winkler, Wade C.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Ramesh, Arati] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Health Science Center Houston; University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garsin, DA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	wwinkler@umd.edu; danielle.a.garsin@uth.tmc.edu		Ramesh, Arati/0000-0001-8655-0051; van Hoof, Ambro/0000-0002-7800-9764; Gebbie, Margo/0000-0002-2203-344X; Cruz, Melissa/0000-0003-2399-3343	NIH [R01AI076406, R56AI110432, R01GM099790]; NSF [MCB-1051440]; Welch Foundation [AU-1773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110432, R01AI110432, R01AI076406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The data reported are presented in the main paper and the supplementary materials. This work was supported by the NIH grants R01AI076406 (D. A. G.), R56AI110432 (D. A. G. and W. C. W.) and R01GM099790 (A. V. H.), a NSF grant MCB-1051440 (W. C. W.) and a Welch Foundation grant AU-1773 (A. V. H.). For transmission electron microscopy imaging, we thank S. Kolodziej and P. Navarro; J. R. Mellin and P. Cossart are acknowledged for valuable discussions.	Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Baker KA, 2011, J BACTERIOL, V193, P2575, DOI 10.1128/JB.00217-11; Del Papa MF, 2008, J BACTERIOL, V190, P7147, DOI 10.1128/JB.00952-08; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Ramesh A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002666; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; SCARLETT FA, 1976, J GEN MICROBIOL, V95, P173, DOI 10.1099/00221287-95-1-173; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	14	90	94	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					937	940		10.1126/science.1255091	http://dx.doi.org/10.1126/science.1255091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146291	Green Accepted			2022-12-28	WOS:000340524700048
J	Geldner, N				Geldner, Niko			BOTANY Making phloem-a near-death experience	SCIENCE			English	Editorial Material							SIEVE ELEMENT		Univ Lausanne, DBMV, Biophore, UNIL Sorge, CH-1015 Lausanne, Switzerland	University of Lausanne	Geldner, N (corresponding author), Univ Lausanne, DBMV, Biophore, UNIL Sorge, CH-1015 Lausanne, Switzerland.	niko.geldner@unil.ch	Geldner, Niko/Y-2481-2019	Geldner, Niko/0000-0002-2300-9644				Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Burch-Smith TM, 2012, ANNU REV PLANT BIOL, V63, P239, DOI 10.1146/annurev-arplant-042811-105453; Esau K., 1977, ANATOMY OF SEED PLAN; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Furuta KM, 2014, SCIENCE, V345, P933, DOI 10.1126/science.1253736; Ham BK, 2014, J EXP BOT, V65, P1799, DOI 10.1093/jxb/ert417; Rodriguez-Villalon A, 2014, P NATL ACAD SCI USA, V111, P11551, DOI 10.1073/pnas.1407337111; Sjolund RD, 1997, PLANT CELL, V9, P1137, DOI 10.1105/tpc.9.7.1137; Wu H, 2003, ACTA BOT SIN, V45, P322	9	3	3	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					875	876		10.1126/science.1258711	http://dx.doi.org/10.1126/science.1258711			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146271				2022-12-28	WOS:000340524700022
J	Otto, CM; Prendergast, B				Otto, Catherine M.; Prendergast, Bernard			Aortic-Valve Stenosis - From Patients at Risk to Severe Valve Obstruction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VALVULAR HEART-DISEASE; VON-WILLEBRAND-FACTOR; ASYMPTOMATIC PATIENTS; CLINICAL FACTORS; NATURAL-HISTORY; LOW GRADIENT; TRANSCATHETER; REPLACEMENT; MODERATE; OUTCOMES	Valvular aortic stenosis is a progressive disease in which the end stage is characterized by obstruction of left ventricular outflow, resulting in inadequate cardiac output, decreased exercise capacity, heart failure, and death from cardiovascular causes. The prevalence of aortic stenosis is only about 0.2% among adults between the ages of 50 and 59 years but increases to 9.8% in octogenarians, with an overall prevalence of 2.8% in adults older than 75 years of age. Although mortality is not increased when aortic stenosis is asymptomatic, the rate of death is more than 50% at 2 years for patients with symptomatic disease unless aortic-valve replacement is performed promptly. A total of 65,000 aortic-valve replacements were performed in the United States in 2010, primarily for aortic stenosis; 70% of these procedures were performed in patients older than 65 years of age, contributing to the high cost of health care in our aging population.(5) Currently, there are no medical therapies to prevent or slow the progression of the disease. Instead, improving patient outcomes depends on identifying those at risk for valve disease, accurately measuring the severity of stenosis, managing any concurrent disease, and ensuring the appropriate timing and type of aortic-valve replacement.	[Otto, Catherine M.] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Prendergast, Bernard] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England	University of Washington; University of Washington Seattle; University of Oxford	Otto, CM (corresponding author), Univ Washington, Div Cardiol, 1959 NE Pacific St,Box 356422, Seattle, WA 98195 USA.	cmotto@u.washington.edu			Edwards Lifesciences	Edwards Lifesciences	Dr. Prendergast reports receiving lecture fees from Edwards Lifesciences. No other potential conflict of interest relevant to this article was reported.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Bonow R.O., 2013, VALVULAR HEART DIS, P179; Clavel MA, 2010, CIRCULATION, V122, P1928, DOI 10.1161/CIRCULATIONAHA.109.929893; Detaint D, 2014, HEART, V100, P126, DOI 10.1136/heartjnl-2013-304920; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Eleid MF, 2013, HEART, V99, P1668, DOI 10.1136/heartjnl-2013-304606; Eveborn GW, 2013, HEART, V99, P396, DOI 10.1136/heartjnl-2012-302265; Fougeres E, 2012, EUR HEART J, V33, P2426, DOI 10.1093/eurheartj/ehs176; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gotzmann M, 2012, CATHETER CARDIO INTE, V79, P693, DOI 10.1002/ccd.23240; Holme I, 2012, HEART, V98, P377, DOI 10.1136/heartjnl-2011-300475; Huntington K, 1997, J AM COLL CARDIOL, V30, P1809, DOI 10.1016/S0735-1097(97)00372-0; Iung B, 2012, HEART, V98, pIV7, DOI 10.1136/heartjnl-2012-302395; Jander N, 2014, HEART, V100, P28, DOI 10.1136/heartjnl-2013-304443; Kalsch H, 2014, HEART, V100, P930, DOI 10.1136/heartjnl-2013-305205; Katz R, 2006, CIRCULATION, V113, P2113, DOI 10.1161/CIRCULATIONAHA.105.598086; Khawaja MZ, 2013, CATHETER CARDIO INTE, V81, P366, DOI 10.1002/ccd.24534; Kitai T, 2011, HEART, V97, P2029, DOI 10.1136/heartjnl-2011-300137; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Kurtz CE, 2010, MEDICINE, V89, P349, DOI 10.1097/MD.0b013e3181fe5648; Lancellotti P, 2013, J AM COLL CARDIOL, V62, P260, DOI 10.1016/j.jacc.2013.05.011; Lancellotti P, 2012, J AM COLL CARDIOL, V59, P235, DOI 10.1016/j.jacc.2011.08.072; Lindman BR, 2013, CIRC RES, V113, P223, DOI 10.1161/CIRCRESAHA.111.300084; Linefsky JP, 2011, J AM COLL CARDIOL, V58, P291, DOI 10.1016/j.jacc.2010.11.073; Loscalzo J, 2012, NEW ENGL J MED, V367, P1954, DOI 10.1056/NEJMcibr1205363; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Marechaux S, 2010, EUR HEART J, V31, P1390, DOI 10.1093/eurheartj/ehq076; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; Nadir MA, 2011, J AM COLL CARDIOL, V58, P570, DOI 10.1016/j.jacc.2011.01.063; National Center for Health Statistics, 2010, NAT HOSP DISCH SURV; Natorska J, 2011, HEART, V97, P2023, DOI 10.1136/hrt.2010.217273; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Novaro GM, 2007, J AM COLL CARDIOL, V50, P1992, DOI 10.1016/j.jacc.2007.07.064; Olsen MH, 2005, AM J CARDIOL, V95, P132, DOI 10.1016/j.amjcard.2004.08.080; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Owens DS, 2010, AM J CARDIOL, V105, P701, DOI 10.1016/j.amjcard.2009.10.071; Ozkan A, 2013, CIRCULATION, V128, P622, DOI 10.1161/CIRCULATIONAHA.112.001094; Panzer S, 2010, THROMB HAEMOSTASIS, V103, P408, DOI 10.1160/TH09-06-0391; Probst V, 2006, CIRCULATION, V113, P856, DOI 10.1161/CIRCULATIONAHA.105.569467; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rajani R, 2010, HEART, V96, P689, DOI 10.1136/hrt.2009.181644; Reynolds MR, 2012, J AM COLL CARDIOL, V60, P2683, DOI 10.1016/j.jacc.2012.09.018; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; Rosenhek R, 2004, EUR HEART J, V25, P199, DOI 10.1016/j.ehj.2003.12.002; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Rosenhek R, 2012, EUR HEART J, V33, P822, DOI 10.1093/eurheartj/ehr061; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Saito T, 2012, AM J CARDIOL, V110, P93, DOI 10.1016/j.amjcard.2012.02.056; Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Stewart RAH, 2010, EUR HEART J, V31, P2216, DOI 10.1093/eurheartj/ehq159; Stortecky S, 2012, HEART, V98, pIV52, DOI 10.1136/heartjnl-2012-302403; Teo KK, 2011, CAN J CARDIOL, V27, P800, DOI 10.1016/j.cjca.2011.03.012; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Towler DA, 2013, CIRC RES, V113, P198, DOI 10.1161/CIRCRESAHA.113.300155; Tzemos N, 2008, JAMA-J AM MED ASSOC, V300, P1317, DOI 10.1001/jama.300.11.1317; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Vasques F, 2012, AM HEART J, V163, P477, DOI 10.1016/j.ahj.2011.12.005; Walther T, 2012, HEART, V98, pIV23, DOI 10.1136/heartjnl-2012-302399	66	311	327	7	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					744	756		10.1056/NEJMra1313875	http://dx.doi.org/10.1056/NEJMra1313875			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140960				2022-12-28	WOS:000340509900009
J	Tullus, K				Tullus, Kjell			Vesicoureteric reflux in children	LANCET			English	Article							URINARY-TRACT-INFECTION; DOPPLER WAVE-FORM; ANTIBIOTIC-PROPHYLAXIS; URETERAL JET; ENDOSCOPIC TREATMENT; ANTIMICROBIAL PROPHYLAXIS; VOIDING UROSONOGRAPHY; INTERNATIONAL REFLUX; SURGICAL-TREATMENT; CONTRAST AGENTS	Vesicoureteric reflux is defined as the retrograde passage of urine from the bladder into one or both ureters and often up to the kidneys, and mainly affects babies and infants. In severe cases dilatation of the ureter, renal pelvis, and calyces might be seen. Traditionally it was thought that only a low percentage of children have vesicoureteric reflux, but studies have suggested as many as 25-40% are affected. Guidelines recommend that the number of investigations for vesicoureteric reflux in children who have had a febrile urinary tract infection be reduced, but this approach is controversial. The recommendations also suggest that prophylactic antibiotics and surgery should be avoided in children with non-severe vesicoureteric reflux. In this Seminar I present data on the management of children with vesicoureteric reflux and give suggestions on how to navigate this difficult area.	Great Ormond St Hosp Sick Children, Dept Nephrol, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Tullus, K (corresponding author), Great Ormond St Hosp Sick Children, Dept Nephrol, Great Ormond St, London WC1N 3JH, England.	Kjell.tullus@gosh.nhs.uk	Victora, Cesar Gomes/Y-2455-2019; Tullus, Kjell/C-6589-2008	Victora, Cesar Gomes/0000-0002-2465-2180; 				AARONSON IA, 1993, EUR UROL, V23, P394, DOI 10.1159/000474637; [Anonymous], 1991, J R Coll Physicians Lond, V25, P36; [Anonymous], CONTRIB NEPHROL; ARANT BS, 1991, AM J KIDNEY DIS, V17, P491, DOI 10.1016/S0272-6386(12)80490-2; Bader M, 2013, PEDIATR NEPHROL, V28, P2267, DOI 10.1007/s00467-013-2410-2; BAILEY RR, 1992, J UROLOGY, V148, P1709, DOI 10.1016/S0022-5347(17)37010-6; Birmingham Reflux Study Group, BMJ CLIN RES ED, V295, P237; Brandstrom P, 2010, J UROLOGY, V184, P274, DOI 10.1016/j.juro.2010.01.055; Brandstrom P, 2010, J UROLOGY, V184, P286, DOI 10.1016/j.juro.2010.01.061; Brandstrom P, 2010, J UROLOGY, V184, P292, DOI 10.1016/j.juro.2010.01.060; Carpenter MA, 2013, PEDIATRICS, V132, pE34, DOI 10.1542/peds.2012-2301; Coulthard MG, 2007, BRIT MED J, V335, P463, DOI 10.1136/bmj.39325.436667.3A; Craig JC, 1997, ARCH DIS CHILD, V76, P275, DOI 10.1136/adc.76.3.275; Craig JC, 2011, PEDIATRICS, V128, P984, DOI 10.1542/peds.2011-2631; Craig JC, 2009, NEW ENGL J MED, V361, P1748, DOI 10.1056/NEJMoa0902295; Darge K, 2008, PEDIATR RADIOL, V38, P126; Darge K, 2008, PEDIATR RADIOL, V38, P40, DOI 10.1007/s00247-007-0529-7; Darge K, 2008, PEDIATR RADIOL, V38, P54, DOI 10.1007/s00247-007-0528-8; Diamond DA, 2012, NEW ENGL J MED, V366, P1218, DOI 10.1056/NEJMct1108922; DUCKETT JW, 1992, J UROLOGY, V148, P1674, DOI 10.1016/S0022-5347(17)36999-9; Elder JS, 2006, J UROLOGY, V175, P716, DOI 10.1016/S0022-5347(05)00210-7; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; Fettich J, 2003, EUR J NUCL MED MOL I, V30, pBP39, DOI 10.1007/s00259-003-1137-x; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; GORDON I, 1990, PEDIATR NEPHROL, V4, P604, DOI 10.1007/BF00858633; Gordon I, 2001, EUR J NUCL MED, V28, pBP16; Hannula A, 2010, PEDIATR NEPHROL, V25, P1463, DOI 10.1007/s00467-010-1542-x; Hansson S, 2004, J UROLOGY, V172, P1071, DOI 10.1097/01.ju.0000135337.71154.60; Hoberman A, 2014, NEW ENGL J MED, V370, P2367, DOI 10.1056/NEJMoa1401811; Holmdahl G, 2010, J UROLOGY, V184, P280, DOI 10.1016/j.juro.2010.01.059; Ilic T, 2011, MED SCI MONITOR, V17, pCR355; Jodal U, 1987, Infect Dis Clin North Am, V1, P713; KALLENIUS G, 1981, LANCET, V2, P1369; Kenda RB, 2000, PEDIATR NEPHROL, V14, P297, DOI 10.1007/s004670050762; Kljucevsek D, 2009, PEDIATR NEPHROL, V24, P313, DOI 10.1007/s00467-008-1002-z; Koff SA, 1998, J UROLOGY, V160, P1019, DOI 10.1016/S0022-5347(01)62686-7; KOLLERMA.MW, 1967, Z KINDERHEILKD, V100, P185, DOI 10.1007/BF00504296; La Scola C, 2013, PEDIATRICS, V131, pE665, DOI 10.1542/peds.2012-0164; Lackgren G, 1999, ACTA PAEDIATR, V88, P62, DOI 10.1080/080352599750029628; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; Lee HY, 2009, PEDIATR NEPHROL, V24, P2009, DOI 10.1007/s00467-009-1232-8; Lee MD, 2009, J PEDIATR-US, V154, P797, DOI 10.1016/j.jpeds.2008.12.045; Leroy S, 2011, J PEDIATR, V159, pe4; Leroy S, 2011, J PEDIATR-US, V159, P644, DOI 10.1016/j.jpeds.2011.03.008; Leung VYF, 2007, PEDIATR RADIOL, V37, P417, DOI 10.1007/s00247-007-0433-1; Leung VYF, 2002, ULTRASOUND MED BIOL, V28, P865, DOI 10.1016/S0301-5629(02)00537-9; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; Mantadakis E, 2011, PEDIATRICS, V128, pE169, DOI 10.1542/peds.2010-3460; MARTINELL J, 1990, BRIT MED J, V300, P840, DOI 10.1136/bmj.300.6728.840; Montini G, 2008, PEDIATRICS, V122, P1064, DOI 10.1542/peds.2007-3770; Moorthy I, 2005, ARCH DIS CHILD, V90, P733, DOI 10.1136/adc.2004.057604; Mori R, 2007, BRIT MED J, V335, P395, DOI 10.1136/bmj.39286.700891.AD; Mukherjee S, 2009, J PEDIATR SURG, V44, P417, DOI 10.1016/j.jpedsurg.2008.10.102; ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7; Olbing H, 2003, PEDIATR NEPHROL, V18, P1128, DOI 10.1007/s00467-003-1256-4; Silva JMP, 2006, PEDIATR NEPHROL, V21, P981, DOI 10.1007/s00467-006-0151-1; Pennesi M, 2008, PEDIATRICS, V121, pE1489, DOI 10.1542/peds.2007-2652; Phillips D, 1996, EUR J PEDIATR, V155, P684; Quirino IG, 2011, J UROLOGY, V185, P258, DOI 10.1016/j.juro.2010.09.029; ROBERTS JA, 1977, PEDIATRICS, V59, P566; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Round J, 2012, ACTA PAEDIATR, V101, P278, DOI 10.1111/j.1651-2227.2011.02542.x; Roussey-Kesler G, 2008, J UROLOGY, V179, P674, DOI 10.1016/j.juro.2007.09.090; Routh JC, 2010, PEDIATRICS, V125, P1010, DOI 10.1542/peds.2009-2225; Routh JC, 2010, PEDIATRICS, V125, pE446, DOI 10.1542/peds.2009-1237; Sargent MA, 2000, PEDIATR RADIOL, V30, P587, DOI 10.1007/s002470000263; Sillen U, 2010, J UROLOGY, V184, P298, DOI 10.1016/j.juro.2010.03.063; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; Skoog SJ, 2010, J UROLOGY, V184, P1145, DOI 10.1016/j.juro.2010.05.066; Smellie JM, 2001, LANCET, V357, P1329, DOI 10.1016/S0140-6736(00)04520-7; Smellie JM, 1998, PEDIATR NEPHROL, V12, P727, DOI 10.1007/s004670050535; SMELLIE JM, 1992, PEDIATR NEPHROL, V6, P223, DOI 10.1007/BF00878353; Snow BW, 2010, J PEDIATR UROL, V6, P543, DOI 10.1016/j.jpurol.2010.02.211; South M, 2009, ARCH DIS CHILD, V94, P927, DOI 10.1136/adc.2008.149815; Stark H, 1997, PEDIATR NEPHROL, V11, P174, DOI 10.1007/s004670050252; Steyaert H, 2000, BJU INT, V85, P168, DOI 10.1046/j.1464-410x.2000.00451.x; Sung J, 2012, PEDIATR NEPHROL, V27, P551, DOI 10.1007/s00467-011-1933-7; Tekgul S, 2012, EUR UROL, V62, P534, DOI 10.1016/j.eururo.2012.05.059; Toffolo A, 2012, ACTA PAEDIATR, V101, P1018, DOI 10.1111/j.1651-2227.2012.02785.x; Tullus K, 2013, PEDIATR NEPHROL, V28, P1719, DOI 10.1007/s00467-013-2471-2; Venhola M, 2010, ACTA PAEDIATR, V99, P1875, DOI 10.1111/j.1651-2227.2010.01909.x; Wennerstrom M, 2000, ARCH PEDIAT ADOL MED, V154, P339, DOI 10.1001/archpedi.154.4.339; Wennerstrom M, 2000, J HYPERTENS, V18, P485, DOI 10.1097/00004872-200018040-00019; Wennerstrom M, 1998, ARCH PEDIAT ADOL MED, V152, P879; Wennerstrom M, 2000, J PEDIATR-US, V136, P30, DOI 10.1016/S0022-3476(00)90045-3; Wheeler D, 2003, ARCH DIS CHILD, V88, P688, DOI 10.1136/adc.88.8.688; Williams G, 2011, COCHRANE DB SYST REV, V3; Williams G, 2008, J AM SOC NEPHROL, V19, P847, DOI 10.1681/ASN.2007020245; WISWELL TE, 1993, CLIN PEDIATR, V32, P130, DOI 10.1177/000992289303200301	89	34	41	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					371	379		10.1016/S0140-6736(14)60383-4	http://dx.doi.org/10.1016/S0140-6736(14)60383-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25164069				2022-12-28	WOS:000348509000030
J	Keskin, H; Shen, Y; Huang, F; Patel, M; Yang, T; Ashley, K; Mazin, AV; Storici, F				Keskin, Havva; Shen, Ying; Huang, Fei; Patel, Mikir; Yang, Taehwan; Ashley, Katie; Mazin, Alexander V.; Storici, Francesca			Transcript-RNA-templated DNA recombination and repair	NATURE			English	Article							DOUBLE-STRAND BREAK; HOMOLOGOUS RECOMBINATION; TY1 RETROTRANSPOSITION; REVERSE-TRANSCRIPTASE; RECA PROTEIN; YEAST; GENE; REPLICATION; MUTAGENESIS; COMPLEX	Homologous recombination is a molecular process that has multiple important roles in DNA metabolism, both for DNA repair and genetic variation in all forms of life(1). Generally, homologous recombination involves the exchange of genetic information between two identical or nearly identical DNA molecules(1); however, homologous recombination can also occur between RNA molecules, as shown for RNA viruses(2). Previous research showed that synthetic RNA oligonudeotides can act as templates for DNA double-strand break (DSB) repair in yeast and human cells(3,4), and artificial long RNA templates injected in ciliate cells can guide genomic rearrangements(5). Here we report that endogenous transcript RNA mediates homologous recombination with chromosomal DNA in yeast Saccharomyces cerevisiae. We developed a system to detect the events of homologous recombination initiated by transcript RNA following the repair of a chromosomal DSB occurring either in a homologous but remote locus, or in the same transcript-generating locus in reverse-transcription-defective yeast strains. We found that RNA-DNA recombination is blocked by ribonudeases H1 and H2. In the presence of H-type ribonudeases, DSB repair proceeds through a complementary DNA intermediate, whereas in their absence, it proceeds directly through RNA. The proximity of the transcript to its chromosomal DNA partner in the same locus facilitates Rad52-driven homologous recombination during DSB repair. We demonstrate that yeast and human Rad52 proteins efficiently catalyse annealing of RNA to a DSB-like DNA end in vitro. Our results reveal a novel mechanism of homologous recombination and DNA repair in which transcript RNA is used as a template for DSB repair. Thus, considering the abundance of RNA transcripts in cells, RNA may have a marked impact on genomic stability and plasticity.	[Keskin, Havva; Shen, Ying; Yang, Taehwan; Ashley, Katie; Storici, Francesca] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Huang, Fei; Patel, Mikir; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	University System of Georgia; Georgia Institute of Technology; Drexel University	Storici, F (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	storici@gatech.edu		Yang, Taehwan/0000-0002-3320-9500	National Science Foundation [MCB-1021763]; Georgia Research Alliance [R9028]; National Cancer Institute of the National Institutes of Health [CA100839, P30CA056036]; Ministry of Science of Turkey; NATIONAL CANCER INSTITUTE [P30CA056036, R56CA100839, R01CA100839] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1021763] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Georgia Research Alliance; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Science of Turkey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Garfinkel for plasmids pSM50, BDG606, BDG283, BDG102 and BDG598; K. D. Koh for strain KK-72; S. Y. Goo for construction of the YEp195SpGAL-RNH201 and YEp195SpGAL-rnh201(D39A) plasmids; S. Kowalczykowski for providing yeast Rad52 and RPA proteins; M. Fasken and A. Corbett for advice on the work and manuscript; B. Weiss, S. Balachander and C. Meers for critical reading of the manuscript; and all members of the Storici laboratory for assistance and feedback on this research. We acknowledge funding from the National Science Foundation grant number MCB-1021763 (to F.S.), the Georgia Research Alliance grant number R9028 (to F.S.)and the National Cancer Institute of the National Institutes of Health grant numbers CA100839 and P30CA056036 (to A.V.M.), for supporting this work. H.K. was supported by a fellowship from the Ministry of Science of Turkey.	BOEKE JD, 1986, MOL CELL BIOL, V6, P3575, DOI 10.1128/MCB.6.11.3575; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Dakshinamurthy A, 2010, GENETICS, V185, P1193, DOI 10.1534/genetics.110.119115; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; DOMBROSKI BA, 1994, MOL CELL BIOL, V14, P4485, DOI 10.1128/MCB.14.7.4485; Fasken MB, 2011, J BIOL CHEM, V286, P37429, DOI 10.1074/jbc.M111.271494; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Karst SM, 2000, BIOCHEM BIOPH RES CO, V268, P112, DOI 10.1006/bbrc.1999.2048; Kasahara M, 2000, GENE DEV, V14, P360; Keskin H, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-11; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lee BS, 2000, MOL CELL BIOL, V20, P2436, DOI 10.1128/MCB.20.7.2436-2445.2000; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Onozawa M, 2014, P NATL ACAD SCI USA, V111, P7729, DOI 10.1073/pnas.1321889111; Rocha PP, 2013, SCIENCE, V342, P1333, DOI 10.1126/science.1246106; Rossi MJ, 2011, METHODS MOL BIOL, V745, P407, DOI 10.1007/978-1-61779-129-1_23; Ruff P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku101; SHARON G, 1994, MOL CELL BIOL, V14, P6540, DOI 10.1128/MCB.14.10.6540; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Shen Y, 2011, MUTAT RES-FUND MOL M, V717, P91, DOI 10.1016/j.mrfmmm.2011.03.016; Shen Y, 2011, METHODS MOL BIOL, V745, P193, DOI 10.1007/978-1-61779-129-1_12; Sherman F, 1986, LAB COURSE MANUAL ME; Sokal R. R., 1981, BIOMETRY; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Stuckey S, 2011, METHODS MOL BIOL, V745, P173, DOI 10.1007/978-1-61779-129-1_11; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Nguyen TA, 2011, FEBS J, V278, P4927, DOI 10.1111/j.1742-4658.2011.08394.x; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Zaitsev EN, 2000, GENE DEV, V14, P740	44	209	220	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					436	+		10.1038/nature13682	http://dx.doi.org/10.1038/nature13682			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25186730	Green Accepted			2022-12-28	WOS:000345770600051
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE INTERVENTION; RANDOMIZED-TRIAL; BLOOD-PRESSURE; UNITED-STATES; PRIMARY-CARE; REDUCTION; MORTALITY; FITNESS; WEIGHT	Description: Update and refinement of the 2003 U. S. Preventive Services Task Force (USPSTF) recommendation on dietary counseling for adults with risk factors for cardiovascular disease (CVD). Methods: The USPSTF reviewed the evidence on whether primary care-relevant counseling interventions for a healthful diet and physical activity modify self-reported behaviors, intermediate physiologic outcomes, diabetes incidence, and cardiovascular morbidity or mortality in adults with CVD risk factors, as well as the adverse effects of counseling interventions. Population: This recommendation applies to adults aged 18 years or older in primary care settings who are overweight or obese and have known CVD risk factors (hypertension, dyslipidemia, impaired fasting glucose, or the metabolic syndrome). Recommendation: The USPSTF recommends offering or referring adults who are overweight or obese and have additional CVD risk factors to intensive behavioral counseling interventions to promote a healthful diet and physical activity for CVD prevention. (B recommendation)	[LeFevre, Michael L.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		LeFevre, ML (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.							[Anonymous], 2014, SUMM REC CLIN PREV S; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Curry SJ, 2014, ANN INTERN MED, V160, P407, DOI 10.7326/M13-2128; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; Etz RS, 2008, AM J PREV MED, V35, pS390, DOI 10.1016/j.amepre.2008.08.008; Fagerberg B, 1998, AM J HYPERTENS, V11, P14, DOI 10.1016/S0895-7061(97)00363-4; Fiore MC, 2008, TREATING TOBACCO USE; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Ford ES, 2012, PREV MED, V55, P23, DOI 10.1016/j.ypmed.2012.04.016; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lin J.S., 2014, AHRQ PUBLICATION; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; National Center for Health Statistics, 2014, SPEC FEAT PRESCR DRU; National Heart Lung and Blood Institute, 2006, BRIEF YOUR GUID LOW; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; US Department of Agriculture US Department of Health and Human Services, 2020, DIET GUID AM 2020 20; US Preventive Serv Task Force, 2009, ANN INTERN MED, V150, P551, DOI 10.7326/0003-4819-150-8-200904210-00009; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248	21	192	195	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					587	U90		10.7326/M14-1796	http://dx.doi.org/10.7326/M14-1796			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25155419				2022-12-28	WOS:000343906800020
J	Ibrahim, N; Sereno, PC; Dal Sasso, C; Maganuco, S; Fabbri, M; Martill, DM; Zouhri, S; Myhrvold, N; Iurino, DA				Ibrahim, Nizar; Sereno, Paul C.; Dal Sasso, Cristiano; Maganuco, Simone; Fabbri, Matteo; Martill, David M.; Zouhri, Samir; Myhrvold, Nathan; Iurino, Dawid A.			Semiaquatic adaptations in a giant predatory dinosaur	SCIENCE			English	Article							EVOLUTION; SPINOSAURUS; INFORMATION	We describe adaptations for a semiaquatic lifestyle in the dinosaur Spinosaurus aegyptiacus. These adaptations include retraction of the fleshy nostrils to a position near the mid-region of the skull and an elongate neck and trunk that shift the center of body mass anterior to the knee joint. Unlike terrestrial theropods, the pelvic girdle is downsized, the hindlimbs are short, and all of the limb bones are solid without an open medullary cavity, for buoyancy control in water. The short, robust femur with hypertrophied flexor attachment and the low, flat-bottomed pedal claws are consistent with aquatic foot-propelled locomotion. Surface striations and bone microstructure suggest that the dorsal "sail" may have been enveloped in skin that functioned primarily for display on land and in water.	[Ibrahim, Nizar; Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Dal Sasso, Cristiano; Maganuco, Simone] Museo Storia Nat Milano, I-20121 Milan, Italy; [Fabbri, Matteo] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Martill, David M.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England; [Zouhri, Samir] Univ Hassan 2, Fac Sci Ain Chock, Lab Geosci, Casablanca, Morocco; [Myhrvold, Nathan] Intellectual Ventures, Bellevue, WA 98005 USA; [Iurino, Dawid A.] Univ Roma La Sapienza, Dipartimento Sci Terra, I-00185 Rome, Italy	University of Chicago; University of Bristol; University of Portsmouth; Hassan II University of Casablanca; Intellectual Ventures; Sapienza University Rome	Ibrahim, N (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nibrahim@uchicago.edu	IURINO, DAWID ADAM/AAM-7104-2020; Zouhri, Samir/T-7894-2019	IURINO, DAWID ADAM/0000-0002-3702-9726; Zouhri, Samir/0000-0002-3811-9977; Myhrvold, Nathan/0000-0003-3994-5143; Dal Sasso, Cristiano/0000-0001-6791-6601; Martill, David/0000-0002-3208-5702	Island Fund of the New York Community Trust; National Geographic Society [SP-13-12]; NSF [DBI-1062542]; Div Of Biological Infrastructure [1062542] Funding Source: National Science Foundation	Island Fund of the New York Community Trust; National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. Abraczinskas for final drafts of all text figures; M. Auditore for discussions and drawings; T. Keillor, L. Conroy, and E. Fitzgerald for image processing and modeling; R. Masek, T. Keillor, E. Fitzgerald, and F. Bacchia for fossil preparation; C. Straus, N. Gruszauskas, D. Klein, and the University of Chicago Medical Center for computed tomographic scanning; M. Zilioli, F. Marchesini, M. Pacini, E. Lamm, and P. Vignola for preparation of histological samples; A. Di Marzio (Siemens Milano) and P. Biondetti (Fondazione Ospedale Maggiore Istituto di Ricovero e Cura a Carattere Scientifico, Milan) for computed tomography scanning and rendering of MSNM V4047; and the Island Fund of the New York Community Trust and National Geographic Society (grant SP-13-12) for support of this research. N. I. was also supported by NSF grant DBI-1062542. We also thank the embassy of the Kingdom of Morocco in Washington, DC, for their continued interest in this project. Skeletal measurements and geologic data are included in the supplementary materials. The neotype is going to be deposited at the Faculte des Sciences Ain Chock (University of Casablanca), Casablanca, Morocco.	Amson E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0192; Bailey JB, 1997, J PALEONTOL, V71, P1124, DOI 10.1017/S0022336000036076; Bates KT, 2012, PALEOBIOLOGY, V38, P486, DOI 10.1666/10004.1; Brochu C., 2002, J VERTEBRATE PALEO S, V7, P1, DOI DOI 10.1671/0272-4634(2002)022[0001:ARAOPA]2.0.CO;2; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Cladellas M. L. Casanovas, 1993, ESPANA ZUB MONOGR, V5, P135; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Fish FE, 2006, ANNU REV FLUID MECH, V38, P193, DOI 10.1146/annurev.fluid.38.050304.092201; Fish FE, 2004, IEEE J OCEANIC ENG, V29, P605, DOI 10.1109/JOE.2004.833213; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; Lavocat R., 1954, C S G OLOGIQUE INT C, V15, P65; Leitch DB, 2012, J EXP BIOL, V215, P4217, DOI 10.1242/jeb.076836; Madar SI, 1998, ADV VERT PALEOBIOL, P353; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Manegold A, 2006, ACTA ORNITHOL, V41, P79, DOI 10.3161/068.041.0113; McFeeters B, 2013, CAN J EARTH SCI, V50, P636, DOI 10.1139/cjes-2012-0129; Nothdurft W., 2002, LOST DINOSAURS EGYPT; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Smith JB, 2006, J PALEONTOL, V80, P400, DOI 10.1666/0022-3360(2006)080[0400:NIRTHO]2.0.CO;2; STROMER E, 1936, ABH BAYER AKAD WISS, V33, P1; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Stromer E., 1934, ABH BAYER AKAD WISS, V22, P1; Taquet P., 1998, CR HEBD ACAD SCI, V299, P347	29	118	124	5	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1613	1616		10.1126/science.1258750	http://dx.doi.org/10.1126/science.1258750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25213375	Green Submitted			2022-12-28	WOS:000342164500046
J	Feng, Y; Krumholz, MR				Feng, Yi; Krumholz, Mark R.			Early turbulent mixing as the origin of chemical homogeneity in open star clusters	NATURE			English	Article							COMPREHENSIVE ABUNDANCE ANALYSIS; ADAPTIVE MESH REFINEMENT; H II REGIONS; ELEMENTAL ABUNDANCE; MOLECULAR CLOUDS; MOVING GROUP; RED GIANTS; EVOLUTION; FRAGMENTATION; SIGNATURES	The abundances of elements in stars are critical clues to stars' origins. Observed star-to-star variations in logarithmic abundance within an open star cluster-a gravitationally bound ensemble of stars in the Galactic plane-are typically only about 0.01 to 0.05 over many elements(1-9), which is noticeably smaller than the variation of about 0.06 to 0.3 seen in the interstellar medium from which the stars form(10-14). It is unknown why star clusters are so homogenous, and whether homogeneity should also prevail in regions of lower star formation efficiency that do not produce bound clusters. Here we report simulations that trace the mixing of chemical elements as star-forming clouds assemble and collapse. We show that turbulent mixing during cloud assembly naturally produces a stellar abundance scatter at least five times smaller than that in the gas, which is sufficient to explain the observed chemical homogeneity of stars. Moreover, mixing occurs very early, so that regions with star formation efficiencies of about 10 per cent are nearly as well mixed as those with formation efficiencies of about 50 per cent. This implies that even regions that do not form bound clusters are likely to be well mixed, and improves the prospects of using 'chemical tagging' to reconstruct (via their unique chemical signatures, or tags) star clusters whose constituent stars have become unbound from one another and spread across the Galactic disk.	[Feng, Yi; Krumholz, Mark R.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Krumholz, MR (corresponding author), Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA.	mkrumhol@ucsc.edu		Feng, Yi/0000-0002-0475-7479; Krumholz, Mark/0000-0003-3893-854X	NSF [AST-0955300, AST-1405962, AST-1229745]; NASA ATP [NNX13AB84G]; NASA TCAN [NNX14AB52G]; NASA through Space Telescope Science Institute [13256]; NASA [NAS 5-26555]; Direct For Mathematical & Physical Scien [1405962] Funding Source: National Science Foundation; Division Of Astronomical Sciences [0955300, 1229745] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA ATP(National Aeronautics & Space Administration (NASA)); NASA TCAN; NASA through Space Telescope Science Institute(Space Telescope Science Institute); NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded by NSF grants AST-0955300 and AST-1405962, NASA ATP grant NNX13AB84G, NASA TCAN grant NNX14AB52G, and NASA through Hubble Award number 13256 issued by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. The simulations reported in this research were carried out on the UCSC supercomputer Hyades, which is supported by the NSF (award number AST-1229745).	Berg DA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/128; Bland-Hawthorn J, 2010, ASTROPHYS J, V721, P582, DOI 10.1088/0004-637X/721/1/582; Bland-Hawthorn J, 2010, ASTROPHYS J, V713, P166, DOI 10.1088/0004-637X/713/1/166; Bresolin F, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/129; Bubar EJ, 2010, ASTRON J, V140, P293, DOI 10.1088/0004-6256/140/2/293; Carroll- Nellenback J., 2013, ASTROPHYS J UNPUB; de Avillez MA, 2002, ASTROPHYS J, V581, P1047, DOI 10.1086/344256; De Silva GM, 2007, ASTRON J, V133, P1161, DOI 10.1086/511182; De Silva GM, 2007, ASTRON J, V133, P694, DOI 10.1086/510131; De Silva GM, 2013, MON NOT R ASTRON SOC, V431, P1005, DOI 10.1093/mnras/stt153; De Silva GM, 2011, MON NOT R ASTRON SOC, V415, P563, DOI 10.1111/j.1365-2966.2011.18728.x; Freeman K, 2002, ANNU REV ASTRON ASTR, V40, P487, DOI 10.1146/annurev.astro.40.060401.093840; Gilmore G, 2012, MESSENGER, V147, P25; Heitsch F, 2008, ASTROPHYS J, V674, P316, DOI 10.1086/523697; Hockney R. W., 1989, COMPUTER SIMULATION; Klein RI, 1999, J COMPUT APPL MATH, V109, P123, DOI 10.1016/S0377-0427(99)00156-9; Koyama H, 2002, ASTROPHYS J, V564, pL97, DOI 10.1086/338978; Krumholz MR, 2007, ASTROPHYS J, V654, P304, DOI 10.1086/509101; Krumholz MR, 2014, PHYS REP, V539, P49, DOI 10.1016/j.physrep.2014.02.001; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Li Y, 2013, APJ, V766, P17, DOI [10.1088/0004-637X/766/1/17.1302.0094, DOI 10.1088/0004-637X/766/1/17.1302.0094]; Martel H, 2006, ASTROPHYS J SUPPL S, V163, P122, DOI 10.1086/500090; Mitschang AW, 2014, MON NOT R ASTRON SOC, V438, P2753, DOI 10.1093/mnras/stt2320; Mitschang AW, 2013, MON NOT R ASTRON SOC, V428, P2321, DOI 10.1093/mnras/sts194; MURRAY SD, 1990, ASTROPHYS J, V357, P105, DOI 10.1086/168895; Pancino E, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200912965; Portegies Zwart S, 2009, ASTROPHYS J LETT, V696, pL13, DOI 10.1088/0004-637X/696/1/L13; Reddy ABS, 2013, MON NOT R ASTRON SOC, V431, P3338, DOI 10.1093/mnras/stt412; Reddy ABS, 2012, MON NOT R ASTRON SOC, V419, P1350, DOI 10.1111/j.1365-2966.2011.19791.x; Rosolowsky E, 2008, ASTROPHYS J, V675, P1213, DOI 10.1086/527407; Sanders NE, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/133; Tan JC, 2006, ASTROPHYS J, V641, pL121, DOI 10.1086/504150; Ting YS, 2012, MON NOT R ASTRON SOC, V427, P882, DOI 10.1111/j.1365-2966.2012.22028.x; Truelove JK, 1998, ASTROPHYS J, V495, P821, DOI 10.1086/305329; Vazquez-Semadeni E, 2007, ASTROPHYS J, V657, P870, DOI 10.1086/510771; Yang CC, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/48	38	64	64	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					523	+		10.1038/nature13662	http://dx.doi.org/10.1038/nature13662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25174709	Green Submitted			2022-12-28	WOS:000342075800034
J	Karthaus, WR; Iaquinta, PJ; Drost, J; Gracanin, A; Van Boxtel, R; Wongvipat, J; Dowling, CM; Gao, D; Begthel, H; Sachs, N; Vries, RGJ; Cuppen, E; Chen, Y; Sawyers, CL; Clevers, HC				Karthaus, Wouter R.; Iaquinta, Phillip J.; Drost, Jarno; Gracanin, Ana; Van Boxtel, Ruben; Wongvipat, John; Dowling, Catherine M.; Gao, Dong; Begthel, Harry; Sachs, Norman; Vries, Robert G. J.; Cuppen, Edwin; Chen, Yu; Sawyers, Charles L.; Clevers, Hans C.			Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures	CELL			English	Article							UROGENITAL SINUS MESENCHYME; IN-VITRO EXPANSION; STEM-CELLS; MURINE PROSTATE; ANDROGEN RECEPTOR; EPITHELIAL-CELLS; INSTRUCTIVE INDUCTION; KERATIN EXPRESSION; SELF-RENEWAL; CANCER	The prostate gland consists of basal and luminal cells arranged as pseudostratified epithelium. In tissue recombination models, only basal cells reconstitute a complete prostate gland, yet murine lineage-tracing experiments show that luminal cells generate basal cells. It has remained challenging to address the molecular details of these transitions and whether they apply to humans, due to the lack of culture conditions that recapitulate prostate gland architecture. Here, we describe a 3D culture system that supports long-term expansion of primary mouse and human prostate organoids, composed of fully differentiated CK5+ basal and CK8+ luminal cells. Organoids are genetically stable, reconstitute prostate glands in recombination assays, and can be experimentally manipulated. Single human luminal and basal cells give rise to organoids, yet luminal-cell-derived organoids more closely resemble prostate glands. These data support a luminal multilineage progenitor cell model for prostate tissue and establish a robust, scalable system for mechanistic studies.	[Karthaus, Wouter R.; Drost, Jarno; Gracanin, Ana; Van Boxtel, Ruben; Begthel, Harry; Sachs, Norman; Vries, Robert G. J.; Cuppen, Edwin; Clevers, Hans C.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Karthaus, Wouter R.; Drost, Jarno; Gracanin, Ana; Van Boxtel, Ruben; Begthel, Harry; Sachs, Norman; Vries, Robert G. J.; Cuppen, Edwin; Clevers, Hans C.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Iaquinta, Phillip J.; Wongvipat, John; Dowling, Catherine M.; Gao, Dong; Chen, Yu; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Clevers, HC (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Drost, Jarno/J-9758-2012; Drost, Jarno/M-6964-2017; Sawyers, Charles/G-5327-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; Cuppen, Edwin/0000-0002-0400-9542; Sachs, Norman/0000-0002-5467-7151; Gao, Dong/0000-0003-1821-2741; van Boxtel, Ruben/0000-0003-1285-2836; Karthaus, Wouter R./0000-0002-9234-9044	Netherlands Genomics Initiative Zenith grant [935.12.003]; NWO-ZonMw VENI [91614138]; PCF; Sta Op Tegen Kanker International Translational Cancer Research Grant;  [EU/232814-StemCellMark]; NATIONAL CANCER INSTITUTE [R01CA155169, P30CA008748] Funding Source: NIH RePORTER	Netherlands Genomics Initiative Zenith grant; NWO-ZonMw VENI; PCF; Sta Op Tegen Kanker International Translational Cancer Research Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.v.B. and E.C. were supported by the Netherlands Genomics Initiative Zenith grant (935.12.003). J.D. was supported by NWO-ZonMw VENI (91614138). N.S. was supported by EU/232814-StemCellMark. C.L.S. and Y.C. were supported by the PCF. W.R.K. and H.C.C. were supported by a Sta Op Tegen Kanker International Translational Cancer Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. H.C.C. and W.R.K. are inventors of several patents related to organoid culture.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Cook C, 2007, DEV BIOL, V312, P217, DOI 10.1016/j.ydbio.2007.09.038; CUNHA GR, 1973, ANAT REC, V175, P87, DOI 10.1002/ar.1091750108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Gao D., 2014, CELL, V158; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; HAYASHI N, 1993, EPITHELIAL CELL BIOL, V2, P66; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Mehta V, 2011, DEV DYNAM, V240, P2548, DOI 10.1002/dvdy.22741; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Missol-Kolka E, 2011, PROSTATE, V71, P254, DOI 10.1002/pros.21239; Niranjan Birunthi, 2013, Methods Mol Biol, V945, P365, DOI 10.1007/978-1-62703-125-7_22; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Qin J, 2013, NATURE, V493, P236, DOI 10.1038/nature11674; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; TIMMS BG, 1995, MICROSC RES TECHNIQ, V30, P319, DOI 10.1002/jemt.1070300407; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Xue Y, 1998, PROSTATE, V34, P292, DOI 10.1002/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	48	437	460	7	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 25	2014	159	1					163	175		10.1016/j.cell.2014.08.017	http://dx.doi.org/10.1016/j.cell.2014.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QQ	25201529	Green Accepted, Bronze			2022-12-28	WOS:000343095000017
J	Antonarakis, ES; Lu, CX; Wang, H; Luber, B; Nakazawa, M; Roeser, JC; Chen, Y; Mohammad, TA; Chen, YD; Fedor, HL; Lotan, TL; Zheng, QZ; De Marzo, AM; Isaacs, JT; Isaacs, WB; Nadal, R; Paller, CJ; Denmeade, SR; Carducci, MA; Eisenberger, MA; Luo, J				Antonarakis, Emmanuel S.; Lu, Changxue; Wang, Hao; Luber, Brandon; Nakazawa, Mary; Roeser, Jeffrey C.; Chen, Yan; Mohammad, Tabrez A.; Chen, Yidong; Fedor, Helen L.; Lotan, Tamara L.; Zheng, Qizhi; De Marzo, Angelo M.; Isaacs, John T.; Isaacs, William B.; Nadal, Rosa; Paller, Channing J.; Denmeade, Samuel R.; Carducci, Michael A.; Eisenberger, Mario A.; Luo, Jun			AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR SPLICE VARIANTS; ACTIVE ANDROGEN RECEPTOR; INCREASED SURVIVAL; INHIBITOR; ACETATE; CHEMOTHERAPY; TUMORS	BACKGROUND The androgen-receptor isoform encoded by splice variant 7 lacks the ligand-binding domain, which is the target of enzalutamide and abiraterone, but remains constitutively active as a transcription factor. We hypothesized that detection of androgen-receptor splice variant 7 messenger RNA (AR-V7) in circulating tumor cells from men with advanced prostate cancer would be associated with resistance to enzalutamide and abiraterone. METHODS We used a quantitative reverse-transcriptase-polymerase-chain-reaction assay to evaluate AR-V7 in circulating tumor cells from prospectively enrolled patients with metastatic castration-resistant prostate cancer who were initiating treatment with either enzalutamide or abiraterone. We examined associations between AR-V7 status (positive vs. negative) and prostate-specific antigen (PSA) response rates (the primary end point), freedom from PSA progression (PSA progression-free survival), clinical or radiographic progression-free survival, and overall survival. RESULTS A total of 31 enzalutamide-treated patients and 31 abiraterone-treated patients were enrolled, of whom 39% and 19%, respectively, had detectable AR-V7 in circulating tumor cells. Among men receiving enzalutamide, AR-V7-positive patients had lower PSA response rates than AR-V7-negative patients (0% vs. 53%, P = 0.004) and shorter PSA progression-free survival (median, 1.4 months vs. 6.0 months; P<0.001), clinical or radiographic progression-free survival (median, 2.1 months vs. 6.1 months; P<0.001), and overall survival (median, 5.5 months vs. not reached; P = 0.002). Similarly, among men receiving abiraterone, AR-V7-positive patients had lower PSA response rates than AR-V7-negative patients (0% vs. 68%, P = 0.004) and shorter PSA progression-free survival (median, 1.3 months vs. not reached; P<0.001), clinical or radiographic progression-free survival (median, 2.3 months vs. not reached; P<0.001), and overall survival (median, 10.6 months vs. not reached, P = 0.006). The association between AR-V7 detection and therapeutic resistance was maintained after adjustment for expression of full-length androgen receptor messenger RNA. CONCLUSIONS Detection of AR-V7 in circulating tumor cells from patients with castration-resistant prostate cancer may be associated with resistance to enzalutamide and abiraterone. These findings require large-scale prospective validation.	[Antonarakis, Emmanuel S.; Wang, Hao; Luber, Brandon; Isaacs, John T.; Nadal, Rosa; Paller, Channing J.; Denmeade, Samuel R.; Carducci, Michael A.; Eisenberger, Mario A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Fedor, Helen L.; Lotan, Tamara L.; Zheng, Qizhi; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Lu, Changxue; Nakazawa, Mary; Roeser, Jeffrey C.; Chen, Yan; Isaacs, William B.; Luo, Jun] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA; [Mohammad, Tabrez A.; Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Antonarakis, ES (corresponding author), Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Prostate Canc Res Program, 1650 Orleans St,CRB1-1M45, Baltimore, MD 21287 USA.	eantona1@jhmi.edu; jluo1@jhmi.edu	MOHAMMAD, TABREZ/AAN-7495-2020; Antonarakis, Emmanuel S./E-4550-2011; Carducci, Michael/R-8164-2019	Antonarakis, Emmanuel Stylianos/0000-0003-3531-3851; Lotan, Tamara/0000-0002-0494-9067; MOHAMMAD, TABREZ/0000-0002-9553-7841; Nakazawa, Mari/0000-0001-6055-8960	Prostate Cancer Foundation (PCF) Young Investigator Award; PCF Challenge Award; Department of Defense Prostate Cancer Research Program [W81XWH-10-2-0056, W81XWH-10-2-0046, W81XWH-12-1-0605]; Johns Hopkins Prostate Cancer Specialized Program of Research Excellence grant [P50 CA058236]; National Institutes of Health [P30 CA006973]; NATIONAL CANCER INSTITUTE [T32CA009071, P30CA006973, P50CA058236] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER	Prostate Cancer Foundation (PCF) Young Investigator Award; PCF Challenge Award; Department of Defense Prostate Cancer Research Program(United States Department of Defense); Johns Hopkins Prostate Cancer Specialized Program of Research Excellence grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by a Prostate Cancer Foundation (PCF) Young Investigator Award (to Dr. Antonarakis), a PCF Challenge Award, grants from the Department of Defense Prostate Cancer Research Program (W81XWH-10-2-0056 and W81XWH-10-2-0046, to the Prostate Cancer Biorepository Network [PCBN]; and W81XWH-12-1-0605, to Dr. Luo), a Johns Hopkins Prostate Cancer Specialized Program of Research Excellence grant (P50 CA058236), and a grant from the National Institutes of Health (P30 CA006973).	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Efstathiou E, 2014, EUR UROL; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Longo DL, 2010, NEW ENGL J MED, V363, P479, DOI 10.1056/NEJMe1006300; Mitsiades N, 2012, CANCER RES, V72, P6142, DOI 10.1158/0008-5472.CAN-12-1335; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Ravindranathan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2912; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Sadar MD, 2011, CANCER RES, V71, P1208, DOI 10.1158/0008-5472.CAN_10-3398; Sahu B, 2013, CANCER RES, V73, P1570, DOI 10.1158/0008-5472.CAN-12-2350; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	33	1819	1902	6	149	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					1028	1038		10.1056/NEJMoa1315815	http://dx.doi.org/10.1056/NEJMoa1315815			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25184630	Green Accepted, Bronze			2022-12-28	WOS:000341382800008
J	Kopel, E; Kaliner, E; Grotto, I				Kopel, Eran; Kaliner, Ehud; Grotto, Itamar			Lessons from a Public Health Emergency - Importation of Wild Poliovirus to Israel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REINTRODUCTION		[Kopel, Eran; Kaliner, Ehud; Grotto, Itamar] Minist Hlth, Publ Hlth Serv, Jerusalem, Israel; [Grotto, Itamar] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel	Ben Gurion University	Kopel, E (corresponding author), Minist Hlth, Publ Hlth Serv, Jerusalem, Israel.		Grotto, Itamar/F-2028-2012	Grotto, Itamar/0000-0002-3363-3715				Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P165; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Kaliner E, 2014, EUROSURVEILLANCE, V19, P54, DOI 10.2807/1560-7917.ES2014.19.7.20703; Shulman LM, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.7.20709	5	37	37	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					981	983		10.1056/NEJMp1406250	http://dx.doi.org/10.1056/NEJMp1406250			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25207764				2022-12-28	WOS:000341382800001
J	Montalescot, G; van 't Hof, AW; Lapostolle, F; Silvain, J; Lassen, JF; Bolognese, L; Cantor, WJ; Cequier, A; Chettibi, M; Goodman, SG; Hammett, CJ; Huber, K; Janzon, M; Merkely, B; Storey, RF; Zeymer, U; Stibbe, O; Ecollan, P; Heutz, WMJM; Swahn, E; Collet, JP; Willems, FF; Baradat, C; Licour, M; Tsatsaris, A; Vicaut, E; Hamm, CW				Montalescot, Gilles; van 't Hof, Arnoud W.; Lapostolle, Frederic; Silvain, Johanne; Lassen, Jens Flensted; Bolognese, Leonardo; Cantor, Warren J.; Cequier, Angel; Chettibi, Mohamed; Goodman, Shaun G.; Hammett, Christopher J.; Huber, Kurt; Janzon, Magnus; Merkely, Bela; Storey, Robert F.; Zeymer, Uwe; Stibbe, Olivier; Ecollan, Patrick; Heutz, Wim M. J. M.; Swahn, Eva; Collet, Jean-Philippe; Willems, Frank F.; Baradat, Caroline; Licour, Muriel; Tsatsaris, Anne; Vicaut, Eric; Hamm, Christian W.		ATLANTIC Investigators	Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; GLYCOPROTEIN IIB/IIIA INHIBITORS; IIB-IIIA INHIBITORS; PLATELET INHIBITION; PRIMARY ANGIOPLASTY; DOUBLE-BLIND; CLOPIDOGREL; PRASUGREL; MANAGEMENT; INITIATION	BACKGROUND The direct-acting platelet P2Y(12) receptor antagonist ticagrelor can reduce the incidence of major adverse cardiovascular events when administered at hospital admission to patients with ST-segment elevation myocardial infarction (STEMI). Whether prehospital administration of ticagrelor can improve coronary reperfusion and the clinical outcome is unknown. METHODS We conducted an international, multicenter, randomized, double-blind study involving 1862 patients with ongoing STEMI of less than 6 hours' duration, comparing prehospital (in the ambulance) versus in-hospital (in the catheterization laboratory) treatment with ticagrelor. The coprimary end points were the proportion of patients who did not have a 70% or greater resolution of ST-segment elevation before percutaneous coronary intervention (PCI) and the proportion of patients who did not have Thrombolysis in Myocardial Infarction flow grade 3 in the infarct-related artery at initial angiography. Secondary end points included the rates of major adverse cardiovascular events and definite stent thrombosis at 30 days. RESULTS The median time from randomization to angiography was 48 minutes, and the median time difference between the two treatment strategies was 31 minutes. The two coprimary end points did not differ significantly between the prehospital and in-hospital groups. The absence of ST-segment elevation resolution of 70% or greater after PCI (a secondary end point) was reported for 42.5% and 47.5% of the patients, respectively. The rates of major adverse cardiovascular events did not differ significantly between the two study groups. The rates of definite stent thrombosis were lower in the prehospital group than in the in-hospital group (0% vs. 0.8% in the first 24 hours; 0.2% vs. 1.2% at 30 days). Rates of major bleeding events were low and virtually identical in the two groups, regardless of the bleeding definition used. CONCLUSIONS Prehospital administration of ticagrelor in patients with acute STEMI appeared to be safe but did not improve pre-PCI coronary reperfusion.	[Montalescot, Gilles; Silvain, Johanne; Collet, Jean-Philippe] Univ Paris 06, INSERM, Allies Cardiovasc Trials Initiat & Organized Netw, CHU Pitie Salpetriere,AP HP,Inst Cardiol,Unite Mi, Paris, France; [Stibbe, Olivier] Brigade Sapeurs Pompiers Paris, Serv Med Urgence, Paris, France; [Ecollan, Patrick] CHU Pitie Salpetriere, AP HP, Serv Mobile Urgence & Reanimat, F-75013 Paris, France; [Vicaut, Eric] Hop Lariboisiere, ACTION Study Grp, Unite Rech Clin, F-75475 Paris, France; [Lapostolle, Frederic] Hop Avicenne, Serv Aide Med Urgente 93, F-93009 Bobigny, France; [Baradat, Caroline; Licour, Muriel; Tsatsaris, Anne] AstraZeneca, Rueil Malmaison, France; [van 't Hof, Arnoud W.] Isala Clin, Dept Cardiol, Zwolle, Netherlands; [Heutz, Wim M. J. M.] Regionale Ambulance Voorziening, Gelderland Midden, Netherlands; [Willems, Frank F.] Rijnstate Ziekenhuis, Dept Cardiol, Arnhem, Netherlands; [Lassen, Jens Flensted] Aarhus Univ Hosp, Dept Cardiol B, DK-8000 Aarhus, Denmark; [Bolognese, Leonardo] Azienda Osped Arezzo, Cardiovasc & Neurol Dept, Arezzo, Italy; [Cantor, Warren J.] Univ Toronto, Southlake Reg Hlth Ctr, Toronto, ON, Canada; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Canadian Heart Res Ctr, Div Cardiol, Toronto, ON, Canada; [Cequier, Angel] Univ Barcelona, Heart Dis Inst, Hosp Univ Bellvitge, Barcelona, Spain; [Chettibi, Mohamed] Ctr Hosp Univ Franz Fanon, Blida, Algeria; [Hammett, Christopher J.] Royal Brisbane & Womens Hosp, Dept Cardiol, Brisbane, Qld, Australia; [Huber, Kurt] Wilhelminenspital Stadt Wien, Dept Med Cardiol & Intens Care Med 3, Vienna, Austria; [Janzon, Magnus; Swahn, Eva] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Janzon, Magnus; Swahn, Eva] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Storey, Robert F.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Zeymer, Uwe] Klinikum Stadt Ludwigshafen, Ludwigshafen, Germany; [Zeymer, Uwe] Inst Herzinfarktforsch Ludwigshafen, Ludwigshafen, Germany; [Hamm, Christian W.] Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; AstraZeneca; Isala Clinics; Rijnstate Hospital; Aarhus University; Southlake Regional Health Centre; University of Toronto; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Royal Brisbane & Women's Hospital; Wilhelminenspital; Linkoping University; Linkoping University; Semmelweis University; University of Sheffield; Ludwigshafen Hospital; Institute Heart Attack Research; Kerckhoff Clinic	Montalescot, G (corresponding author), CHU Pitie Salpetriere, Allies Cardiovasc Trials Initiat & Organized Netw, Inst Cardiol, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Hamm, Christian W./I-3155-2017; Alber, Hannes F/H-6355-2015; Lassen, Jens Flensted/AAY-2127-2021; Storey, Robert/AAA-6853-2019; Lantelme, Pierre/B-4567-2013; SILVAIN, Johanne/C-7521-2016	Hamm, Christian W./0000-0001-6763-4161; Lassen, Jens Flensted/0000-0001-7972-9192; Storey, Robert/0000-0002-6677-6229; SILVAIN, Johanne/0000-0002-1901-2808; tazarourte, karim/0000-0002-3376-1258; TEIGER, emmanuel/0000-0001-7515-4344; CALABRIA, PAOLO/0000-0002-7601-5722; Rosell-Ortiz, Fernando/0000-0003-0260-9955; Reiffen, Hans-Peter/0000-0002-4462-1496; Sanchez-Brunete, Vicente/0000-0002-8025-0856; Merkely, Bela/0000-0001-6514-0723	AstraZeneca; Bayer; Boehringer Ingelheim; Cardiovascular Research Foundation; Europa Organisation; Gerson Lehrman Group; Iroko Cardio International; Lead-Up; Luminex; McKinsey and Company; Remedica; Servier; TIMI Study Group; WebMD; Wolters Kluwer Health; Bristol-Myers Squibb; Biotronik; Eli Lilly; Medicines Company; Menarini Group; Roche; Sanofi-Aventis; Pfizer; Daiichi-Sankyo; Medtronic; Menarini; Accumetrics; Abbott Laboratories; Nanosphere; Stentys; Correvio; Merck Serono; Regeneron; Novartis; PlaqueTec; Merck Sharp; Dohme; bioM rieux; European Cardiovascular Research Center; Celgene; Fresenius; Fresenius, LFB	AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Cardiovascular Research Foundation; Europa Organisation; Gerson Lehrman Group; Iroko Cardio International; Lead-Up; Luminex; McKinsey and Company; Remedica; Servier(Servier); TIMI Study Group; WebMD; Wolters Kluwer Health; Bristol-Myers Squibb(Bristol-Myers Squibb); Biotronik; Eli Lilly(Eli Lilly); Medicines Company; Menarini Group(Menarini Group); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Medtronic(Medtronic); Menarini(Menarini Group); Accumetrics; Abbott Laboratories(Abbott Laboratories); Nanosphere; Stentys; Correvio; Merck Serono(Merck & Company); Regeneron(Regeneron); Novartis(Novartis); PlaqueTec; Merck Sharp; Dohme; bioM rieux; European Cardiovascular Research Center; Celgene(Bristol-Myers SquibbCelgene Corporation); Fresenius; Fresenius, LFB	Supported by AstraZeneca.; Dr. Montalescot reports receiving consulting fees from Bayer, Boehringer Ingelheim, Cardiovascular Research Foundation, Europa Organisation, the Gerson Lehrman Group, Iroko Cardio International, Lead-Up, Luminex, McKinsey and Company, Remedica, Servier, the TIMI Study Group, WebMD, Wolters Kluwer Health, Bristol-Myers Squibb, AstraZeneca, Biotronik, Eli Lilly, the Medicines Company, Menarini Group, Roche, Sanofi-Aventis, Pfizer, Daiichi-Sankyo, and Medtronic and grant support from Bristol-Myers Squibb, AstraZeneca, Biotronik, Eli Lilly, the Medicines Company, Menarini, Sanofi-Aventis, Pfizer, Roche, Accumetrics, Medtronic, Abbott Laboratories, Daiichi-Sankyo, Nanosphere, and Stentys. Dr. van ' t Hof reports receiving consulting fees from the Medicines Company, Eli Lilly, and Daiichi-Sankyo, lecture fees from the Medicines Company, Eli Lilly, Daiichi-Sankyo, Medtronic, and Correvio, and grant support from the Medicines Company, Eli Lilly, Daiichi-Sankyo, Medtronic, Abbott Laboratories, and Correvio. Dr. Lapostolle reports receiving honoraria from Boehringer Ingelheim, Bayer, the Medicines Company, Correvio, Daiichi-Sankyo, and Eli Lilly and lecture fees and grant support from Merck Serono, Roche, Boehringer Ingelheim, Bayer, the Medicines Company, Correvio, DaiichiSankyo, and Eli Lilly. Dr. Silvain reports receiving consulting fees from AstraZeneca, Daiichi-Sankyo, Eli Lilly, the Medicines Company, Bristol-Myers Squibb, Boehringer Ingelheim, and Iroko Cardio International and lecture fees from AstraZeneca, Daiichi-Sankyo, Eli Lilly, the Medicines Company, Bristol-Myers Squibb, Boehringer Ingelheim, and Iroko Cardio International, Stentys, and Servier. Dr. Lassen, Dr. Cantor, and Dr. Willems report receiving lecture fees from AstraZeneca. Dr. Bolognese reports receiving consulting and lecture fees and fees for board membership from Daiichi-Sankyo, Eli Lilly, Menarini, Abbott Laboratories, AstraZeneca, and Iroko Cardio International. Dr. Cequier reports receiving consulting fees from AstraZeneca, Abbott Laboratories, Medtronic, Boston Scientific, Ferrer, DaiichiSankyo, and Eli Lilly, lecture fees from AstraZeneca, DaiichiSankyo, Eli Lilly, and Servier, and grant support from AstraZeneca, Abbott Laboratories, and Medtronic. Dr. Goodman reports receiving consulting fees, lecture fees, and grant support through his institution from AstraZeneca, Eli Lilly, and Sanofi-Aventis. Dr. Hammett reports receiving consulting fees from AstraZeneca, Eli Lilly, Bayer, Boehringer Ingelheim, Amgen, and the Medicines Company and lecture fees from AstraZeneca, Eli Lilly, Bayer, and Boehringer Ingelheim. Dr. Storey reports receiving honoraria from AstraZeneca, Correvio, Daiichi-Sankyo, Eli Lilly, Merck, Roche, Regeneron, Sanofi-Aventis, the Medicines Company, and Medscape, consulting fees from AstraZeneca, Accumetrics, Novartis, and PlaqueTec, lecture fees from AstraZeneca and Accumetrics, travel support from AstraZeneca, and grant support from AstraZeneca, Accumetrics, Daiichi-Sankyo, Eli Lilly, and Merck. Dr. Zeymer reports receiving honoraria and speaker fees from AstraZeneca, Daiichi-Sankyo, Eli Lilly, Bayer, the Medicines Company, Sanofi-Aventis, Novartis, Boehringer Ingelheim, and Merck Sharp and Dohme and grant support from Daiichi-Sankyo, Eli Lilly, Sanofi-Aventis, and Novartis. Dr. Ecollan reports receiving consulting fees from Abbott Laboratories, Eli Lilly, AstraZeneca, Sanofi-Aventis, and bioM rieux. Dr.; Collet reports receiving consulting fees from Sanofi-Aventis, lecture fees from Daiichi-Sankyo, Bristol-Myers Squibb, and AstraZeneca, and grant support from Bristol-Myers Squibb and Medtronic. Ms. Baradat, Ms. Licour, and Dr. Tsatsaris are employees of AstraZeneca. Dr. Vicaut reports receiving fees for serving on a data and safety monitoring board at the European Cardiovascular Research Center, consulting fees from Abbott Laboratories, Bristol-Myers Squibb, Celgene, Fresenius, LFB, Eli Lilly, Medtronic, Pfizer, and Sanofi-Aventis, lecture fees from Novartis, and grant support from Boehringer Ingelheim and Sanofi-Aventis. Dr. Hamm reports receiving lecture fees from Daiichi-Sankyo, Correvio, and Sanofi-Aventis and grant support from AstraZeneca. No other potential conflict of interest relevant to this article was reported.	Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Anderson JL, 2013, CIRCULATION, V127, pE663, DOI 10.1161/CIR.0b013e31828478ac; Bellemain-Appaix A, 2013, JAMA-J AM MED ASSOC, V309, P1461, DOI 10.1001/jama.2013.2680; Bellemain-Appaix A, 2010, J AM COLL CARDIOL, V56, P1542, DOI 10.1016/j.jacc.2010.07.012; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Cohen MV, 2014, J CARDIOVASC PHARM T, V19, P179, DOI 10.1177/1074248413508465; De Luca G, 2008, HEART, V94, P1548, DOI 10.1136/hrt.2008.141648; De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118; Deeks ED, 2011, DRUGS, V71, P909, DOI 10.2165/11206850-000000000-00000; Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Herrmann HC, 2009, JACC-CARDIOVASC INTE, V2, P917, DOI 10.1016/j.jcin.2009.06.018; Huber K, 2010, EUR HEART J, V31, P1708, DOI 10.1093/eurheartj/ehq143; Lindholm D, 2014, EUR HEART J; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Montalescot G, 2013, AM HEART J, V165, P515, DOI 10.1016/j.ahj.2012.12.015; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Shahzad A, 2014, LANCET; Steg PG, 2013, CIRCULATION, V128, P1055, DOI 10.1161/CIRCULATIONAHA.113.002589; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Storey RF, 2010, J AM COLL CARDIOL, V56, P1456, DOI 10.1016/j.jacc.2010.03.100; ten Berg JM, 2010, J AM COLL CARDIOL, V55, P2446, DOI 10.1016/j.jacc.2009.11.091; Valgimigli M, 2012, JACC-CARDIOVASC INTE, V5, P268, DOI 10.1016/j.jcin.2012.01.006; van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Westerhout CM, 2011, AM HEART J, V161, P283, DOI 10.1016/j.ahj.2010.10.033; Zeymer U, 2012, CLIN RES CARDIOL, V101, P305, DOI 10.1007/s00392-011-0393-1	40	411	418	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					1016	1027		10.1056/NEJMoa1407024	http://dx.doi.org/10.1056/NEJMoa1407024			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25175921	Green Published			2022-12-28	WOS:000341382800007
J	Roberts, KG; Li, Y; Payne-Turner, D; Harvey, RC; Yang, YL; Pei, D; McCastlain, K; Ding, L; Lu, C; Song, G; Ma, J; Becksfort, J; Rusch, M; Chen, SC; Easton, J; Cheng, J; Boggs, K; Santiago-Morales, N; Iacobucci, I; Fulton, RS; Wen, J; Valentine, M; Cheng, C; Paugh, SW; Devidas, M; Chen, IM; Reshmi, S; Smith, A; Hedlund, E; Gupta, P; Nagahawatte, P; Wu, G; Chen, X; Yergeau, D; Vadodaria, B; Mulder, H; Winick, NJ; Larsen, EC; Carroll, WL; Heerema, NA; Carroll, AJ; Grayson, G; Tasian, SK; Moore, AS; Keller, F; Frei-Jones, M; Whitlock, JA; Raetz, EA; White, DL; Hughes, TP; Auvil, JMG; Smith, MA; Marcucci, G; Bloomfield, CD; Mrozek, K; Kohlschmidt, J; Stock, W; Kornblau, SM; Konopleva, M; Paietta, E; Pui, CH; Jeha, S; Relling, MV; Evans, WE; Gerhard, DS; Gastier-Foster, JM; Mardis, E; Wilson, RK; Loh, ML; Downing, JR; Hunger, SP; Willman, CL; Zhang, J; Mullighan, CG				Roberts, K. G.; Li, Y.; Payne-Turner, D.; Harvey, R. C.; Yang, Y-L.; Pei, D.; McCastlain, K.; Ding, L.; Lu, C.; Song, G.; Ma, J.; Becksfort, J.; Rusch, M.; Chen, S-C.; Easton, J.; Cheng, J.; Boggs, K.; Santiago-Morales, N.; Iacobucci, I.; Fulton, R. S.; Wen, J.; Valentine, M.; Cheng, C.; Paugh, S. W.; Devidas, M.; Chen, I-M.; Reshmi, S.; Smith, A.; Hedlund, E.; Gupta, P.; Nagahawatte, P.; Wu, G.; Chen, X.; Yergeau, D.; Vadodaria, B.; Mulder, H.; Winick, N. J.; Larsen, E. C.; Carroll, W. L.; Heerema, N. A.; Carroll, A. J.; Grayson, G.; Tasian, S. K.; Moore, A. S.; Keller, F.; Frei-Jones, M.; Whitlock, J. A.; Raetz, E. A.; White, D. L.; Hughes, T. P.; Auvil, J. M. Guidry; Smith, M. A.; Marcucci, G.; Bloomfield, C. D.; Mrozek, K.; Kohlschmidt, J.; Stock, W.; Kornblau, S. M.; Konopleva, M.; Paietta, E.; Pui, C-H.; Jeha, S.; Relling, M. V.; Evans, W. E.; Gerhard, D. S.; Gastier-Foster, J. M.; Mardis, E.; Wilson, R. K.; Loh, M. L.; Downing, J. R.; Hunger, S. P.; Willman, C. L.; Zhang, J.; Mullighan, C. G.			Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL PRECURSOR; ETV6-NTRK3 FUSION TRANSCRIPTS; PEDIATRIC ACUTE LEUKEMIAS; INHIBITOR THERAPY; GENE FUSION; CRLF2; EXPRESSION; IMATINIB; DELETION; MODELS	BACKGROUND Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is characterized by a gene-expression profile similar to that of BCR-ABL1-positive ALL, alterations of lymphoid transcription factor genes, and a poor outcome. The frequency and spectrum of genetic alterations in Ph-like ALL and its responsiveness to tyrosine kinase inhibition are undefined, especially in adolescents and adults. METHODS We performed genomic profiling of 1725 patients with precursor B-cell ALL and detailed genomic analysis of 154 patients with Ph-like ALL. We examined the functional effects of fusion proteins and the efficacy of tyrosine kinase inhibitors in mouse pre-B cells and xenografts of human Ph-like ALL. RESULTS Ph-like ALL increased in frequency from 10% among children with standard-risk ALL to 27% among young adults with ALL and was associated with a poor outcome. Kinase-activating alterations were identified in 91% of patients with Ph-like ALL; rearrangements involving ABL1, ABL2, CRLF2, CSF1R, EPOR, JAK2, NTRK3, PDGFRB, PTK2B, TSLP, or TYK2 and sequence mutations involving FLT3, IL7R, or SH2B3 were most common. Expression of ABL1, ABL2, CSF1R, JAK2, and PDGFRB fusions resulted in cytokine-independent proliferation and activation of phosphorylated STAT5. Cell lines and human leukemic cells expressing ABL1, ABL2, CSF1R, and PDGFRB fusions were sensitive in vitro to dasatinib, EPOR and JAK2 rearrangements were sensitive to ruxolitinib, and the ETV6-NTRK3 fusion was sensitive to crizotinib. CONCLUSIONS Ph-like ALL was found to be characterized by a range of genomic alterations that activate a limited number of signaling pathways, all of which may be amenable to inhibition with approved tyrosine kinase inhibitors. Trials identifying Ph-like ALL are needed to assess whether adding tyrosine kinase inhibitors to current therapy will improve the survival of patients with this type of leukemia.	[Roberts, K. G.; Payne-Turner, D.; Yang, Y-L.; McCastlain, K.; Song, G.; Ma, J.; Chen, S-C.; Cheng, J.; Santiago-Morales, N.; Iacobucci, I.; Wen, J.; Downing, J. R.; Mullighan, C. G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Li, Y.; Becksfort, J.; Rusch, M.; Hedlund, E.; Gupta, P.; Nagahawatte, P.; Wu, G.; Chen, X.; Zhang, J.] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Pei, D.; Cheng, C.] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Paugh, S. W.; Relling, M. V.; Evans, W. E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Pui, C-H.; Jeha, S.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Li, Y.; Ding, L.; Lu, C.; Rusch, M.; Easton, J.; Cheng, J.; Boggs, K.; Fulton, R. S.; Hedlund, E.; Gupta, P.; Nagahawatte, P.; Wu, G.; Chen, X.; Yergeau, D.; Vadodaria, B.; Mulder, H.; Relling, M. V.; Evans, W. E.; Mardis, E.; Wilson, R. K.; Downing, J. R.; Zhang, J.; Mullighan, C. G.] St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Valentine, M.] St Jude Childrens Res Hosp, Dept Cytogenet Shared Resource, Memphis, TN 38105 USA; [Harvey, R. C.; Chen, I-M.; Willman, C. L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Harvey, R. C.; Chen, I-M.; Willman, C. L.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Ding, L.; Lu, C.; Fulton, R. S.; Mardis, E.; Wilson, R. K.] Washington Univ, Genome Inst, St Louis, MO 63130 USA; [Ding, L.; Lu, C.; Fulton, R. S.; Mardis, E.; Wilson, R. K.] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63130 USA; [Mardis, E.; Wilson, R. K.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63130 USA; [Devidas, M.] Univ Florida, Coll Med, Gainesville, FL USA; [Reshmi, S.; Smith, A.; Gastier-Foster, J. M.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Heerema, N. A.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Marcucci, G.; Bloomfield, C. D.; Mrozek, K.; Kohlschmidt, J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Winick, N. J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Grayson, G.] Scott & White Hosp & Clin, Temple, TX USA; [Grayson, G.] Texas A&M Hlth Sci Ctr, Temple, TX USA; [Frei-Jones, M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Kornblau, S. M.; Konopleva, M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA; [Kornblau, S. M.; Konopleva, M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA; [Larsen, E. C.] Maine Childrens Canc Program, Scarborough, ME USA; [Carroll, W. L.] NYU, Inst Canc, New York, NY USA; [Paietta, E.] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA; [Carroll, A. J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Tasian, S. K.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Moore, A. S.] Univ Queensland, Queensland Childrens Med Res Inst, Herston, Qld, Australia; [Moore, A. S.] Royal Childrens Hosp Brisbane, Herston, Qld, Australia; [White, D. L.; Hughes, T. P.] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia; [Keller, F.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Keller, F.] Emory Univ, Sch Med, Atlanta, GA USA; [Whitlock, J. A.] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Whitlock, J. A.] Univ Toronto, Toronto, ON, Canada; [Raetz, E. A.] Univ Utah, Hunstman Canc Inst, Salt Lake City, UT USA; [Auvil, J. M. Guidry; Gerhard, D. S.] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Smith, M. A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Devidas, M.; Chen, I-M.; Reshmi, S.; Carroll, W. L.; Auvil, J. M. Guidry; Smith, M. A.; Relling, M. V.; Gerhard, D. S.; Gastier-Foster, J. M.; Loh, M. L.; Downing, J. R.; Hunger, S. P.; Willman, C. L.; Zhang, J.; Mullighan, C. G.] NIH, Childrens Oncol Grp TARGET ALL Project, Bethesda, MD 20892 USA; [Kohlschmidt, J.] Mayo Clin, Alliance Clin Trials Oncol Stat, Rochester, MN USA; [Kohlschmidt, J.] Mayo Clin, Ctr Data, Rochester, MN USA; [Stock, W.] Univ Chicago Med, Chicago, IL USA; [Loh, M. L.] Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, San Francisco, CA USA; [Loh, M. L.] Univ Calif San Francisco, Helen Diller Family Canc Ctr, San Francisco, CA 94143 USA; [Hunger, S. P.] Univ Colorado, Sch Med, Aurora, CO USA; [Hunger, S. P.] Childrens Hosp Colorado, Aurora, CO USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of New Mexico; University of New Mexico; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); State University System of Florida; University of Florida; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; New York University; Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Queensland; Royal Children's Hospital Brisbane; South Australian Health & Medical Research Institute (SAHMRI); Children's Healthcare of Atlanta (CHOA); Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Children's Oncology Group (COG); National Institutes of Health (NIH) - USA; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, 262 Danny Thomas Pl,Mail Stop 342, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Evans, William E./C-2069-2012; Mullighan, Charles/H-3253-2011; LI, YONGJIN/E-1688-2011; Relling, Mary/N-5032-2018; Cheng, Cheng/N-8075-2018; McCastlain, Kelly/O-3366-2018; Mardis, Elaine/W-2202-2019; Moore, Andrew S/I-6275-2012; Devidas, Meenakshi/H-1170-2019; Mrózek, Krzysztof/A-3142-2008; Wu, Gang/M-8012-2014; Rusch, Michael/AAG-1998-2019; Wilson, Richard K./AAF-4139-2019; Paugh, Steven/A-7739-2008; Hughes, Tim/AAO-9975-2021; Chen, Xiang/N-2524-2018; Downing, James R./N-8102-2018; Pui, Ching-Hon/N-8076-2018	Evans, William E./0000-0002-9333-5322; Mullighan, Charles/0000-0002-1871-1850; McCastlain, Kelly/0000-0001-7868-3049; Moore, Andrew S/0000-0001-8062-1779; Devidas, Meenakshi/0000-0002-1099-3478; Wu, Gang/0000-0002-1678-5864; Rusch, Michael/0000-0002-5363-1848; Wilson, Richard K./0000-0002-1992-1358; Paugh, Steven/0000-0001-5697-9228; Chen, Xiang/0000-0002-2499-8261; Pui, Ching-Hon/0000-0003-0303-5658; Whitlock, James/0000-0002-7887-0634; Hughes, Timothy/0000-0002-0910-3730; Easton, John/0000-0003-4503-6608; YANG, YUNG-LI/0000-0002-3598-7218; White, Deborah/0000-0003-4844-333X; Tasian, Sarah/0000-0003-1327-1662; Wen, Ji/0000-0002-3327-5591; Loh, Mignon/0000-0003-4099-4700; Smith, Malcolm/0000-0001-9880-9876; Harvey, Richard/0000-0002-4904-9767	American Lebanese Syrian Associated Charities from National Cancer Institute [CA 21765, U01 CA157937-01, F32 CA141762, R37 CA36401, U24-CA114737, U10 CA21115, CA14958, U10 CA101140, CA145707, U10 CA98543, U10 CA98413, U24 CA114766]; Stand Up to Cancer Innovative Research Grant; St. Baldrick's Foundation Scholar Award; St. Baldrick's Consortium Award from the Leukemia and Lymphoma Society Specialized Center of Research; Leukemia and Lymphoma Society Special Fellow Award; Alex's Lemonade Stand Foundation Young Investigator Awards; Alex's Lemonade Stand Foundation Scholar in Developmental Therapeutics Award; National Institute of General Medical Sciences [92666]; NATIONAL CANCER INSTITUTE [T32CA128583, U10CA098543, U24CA114766, U10CA180827, U10CA180861, U10CA014958, U10CA180820, P30CA016672, U10CA021115, U10CA101140, R37CA036401, P30CA021765, U24CA114737, F32CA141762, R25CA023944, RC1CA145707, RC2CA148529, U10CA098413, U01CA157937, U10CA180899, U10CA180886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities from National Cancer Institute; Stand Up to Cancer Innovative Research Grant; St. Baldrick's Foundation Scholar Award; St. Baldrick's Consortium Award from the Leukemia and Lymphoma Society Specialized Center of Research; Leukemia and Lymphoma Society Special Fellow Award(Leukemia and Lymphoma Society); Alex's Lemonade Stand Foundation Young Investigator Awards; Alex's Lemonade Stand Foundation Scholar in Developmental Therapeutics Award; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by funding from the American Lebanese Syrian Associated Charities (to St. Jude Children's Research Hospital), grants from the National Cancer Institute (CA 21765, to St. Jude Children's Research Hospital; U01 CA157937-01, to Drs. Willman and Hunger; F32 CA141762, to Dr. Paugh; R37 CA36401, to Dr. Evans; U24-CA114737, U10 CA21115, and CA14958, to Dr. Paietta; U10 CA101140, to Cancer and Leukemia Group B Leukemia Correlative Science; CA145707, to Drs. Willman and Mullighan; and U10 CA98543, U10 CA98413, and U24 CA114766, to the Children's Oncology Group), a Stand Up to Cancer Innovative Research Grant and a St. Baldrick's Foundation Scholar Award (both to Dr. Mullighan), a St. Baldrick's Consortium Award (to Dr. Hunger), a grant from the Leukemia and Lymphoma Society Specialized Center of Research (to Drs. Carroll, Hunger, and Mullighan), a Leukemia and Lymphoma Society Special Fellow Award (to Dr. Roberts), Alex's Lemonade Stand Foundation Young Investigator Awards (to Drs. Roberts and Tasian), an Alex's Lemonade Stand Foundation Scholar in Developmental Therapeutics Award (to Dr. Tasian), and a grant from the National Institute of General Medical Sciences (92666, to Dr. Relling).	Alessandri AJ, 2001, MED PEDIATR ONCOL, V37, P415, DOI 10.1002/mpo.1222; COX DR, 1972, J R STAT SOC B, V34, P187; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Eguchi M, 2001, MED PEDIATR ONCOL, V37, P417, DOI 10.1002/mpo.1223; Ernst T, 2011, BRIT J HAEMATOL, V153, P43, DOI 10.1111/j.1365-2141.2010.08457.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Harvey RC, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.826.826; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Kiyokawa N, 2013, AM SOC HEM ANN M NEW; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kronnie G Te, 2013, AM SOC HEM ANN M NEW; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lengline E, 2013, HAEMATOLOGICA, V98, pE146, DOI 10.3324/haematol.2013.095372; Loh ML, 2013, BLOOD, V121, P485, DOI 10.1182/blood-2012-04-422691; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Maude SL, 2012, BLOOD, V120, P3510, DOI 10.1182/blood-2012-03-415448; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2013, SEMIN HEMATOL, V50, P314, DOI 10.1053/j.seminhematol.2013.10.001; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Poitras JL, 2008, GENE CHROMOSOME CANC, V47, P884, DOI 10.1002/gcc.20585; R Core Team, 2020, R LANG ENV STAT COMP; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Soler G, 2008, LEUKEMIA, V22, P1278, DOI 10.1038/sj.leu.2405033; Stock W, 2010, HEMATOL-AM SOC HEMAT, P21, DOI 10.1182/asheducation-2010.1.21; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Tasian SK, 2012, BLOOD, V120, P833, DOI 10.1182/blood-2011-12-389932; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; van der Veer A, 2013, BLOOD, V122, P2622, DOI 10.1182/blood-2012-10-462358; Weston BW, 2013, J CLIN ONCOL, V31, pE413, DOI 10.1200/JCO.2012.47.6770; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103	38	844	890	9	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					1005	1015		10.1056/NEJMoa1403088	http://dx.doi.org/10.1056/NEJMoa1403088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25207766	Green Accepted			2022-12-28	WOS:000341382800006
J	Kureshi, F; Jones, PG; Buchanan, DM; Abdallah, MS; Spertus, JA				Kureshi, Faraz; Jones, Philip G.; Buchanan, Donna M.; Abdallah, Mouin S.; Spertus, John A.			Variation in patients' perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OPTIMAL MEDICAL THERAPY; DECISION-MAKING; CARDIAC-CATHETERIZATION; ORGANIZATIONAL CULTURE; INFORMED-CONSENT; HEALTH; BENEFITS; ANGIOPLASTY; QUALITY; ANGINA	Objectives To assess the perceptions of patients with stable coronary artery disease of the urgency and benefits of elective percutaneous coronary intervention and to examine how they vary across centers and by providers. Design Cross sectional study. Setting 10 US academic and community hospitals performing percutaneous coronary interventions between 2009 and 2011. Participants 991 patients with stable coronary artery disease undergoing elective percutaneous coronary intervention. Main outcome measures Patients' perceptions of the urgency and benefits of percutaneous coronary intervention, assessed by interview. Multilevel hierarchical logistic regression models examined the variation in patients' understanding across centers and operators after adjusting for patient characteristics, using median odds ratios. Results The most common reported benefits from percutaneous coronary intervention were to extend life (90%, n=892; site range 80-97%) and to prevent future heart attacks (88%, n=872; site range 79-97%). Although nearly two thirds of patients (n=661) reported improvement of symptoms as a benefit of percutaneous coronary intervention (site range 52-87%), only 1% (n=9) identified this as the only benefit. Substantial variability was noted in the ways informed consent was obtained at each site. After adjusting for patient and operator characteristics, the median odds ratios showed significant variation in patients' perceptions of percutaneous coronary intervention across sites (range 1.4-3.1) but not across operators within a site. Conclusion Patients have a poor understanding of the benefits of elective percutaneous coronary intervention, with significant variation across sites. No sites had a high proportion of patients accurately understanding the benefits. Coupled with the wide variability in the ways in which hospitals obtain informed consent, these findings suggest that hospital level interventions into the structure and processes of obtaining informed consent for percutaneous coronary intervention might improve patient comprehension and understanding.	[Kureshi, Faraz; Jones, Philip G.; Buchanan, Donna M.; Abdallah, Mouin S.; Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Kureshi, Faraz; Buchanan, Donna M.; Abdallah, Mouin S.; Spertus, John A.] Univ Missouri, Kansas City, MO 64110 USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Kureshi, F (corresponding author), St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA.	kureshif@umkc.edu	Spertus, John/ABD-3075-2021; Abdallah, Mouin/AAO-5143-2021		American Heart Association Outcomes Research Center [0875149N]; National Heart Lung and Blood Institute [R01-HL096624]; National Institutes of Health [T32HL110837]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110837, R01HL096624] Funding Source: NIH RePORTER	American Heart Association Outcomes Research Center(American Heart Association); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by an American Heart Association Outcomes Research Center grant (0875149N) and the National Heart Lung and Blood Institute (R01-HL096624). While the grants supported different aims, they employed the same patient population, study design, and data collection, and were combined for the purpose of these analyses. FK received support from National Institutes of Health grant T32HL110837. The funding agencies had no role in data collection, analysis, interpretation or the decision to submit the results.	Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P21, DOI 10.1161/CIRCOUTCOMES.108.791863; Austin PC, 2003, AM HEART J, V145, P27, DOI 10.1067/mhj.2003.23; Bakalar N, 2012, NY TIMES; Beller GA, 2000, J AM COLL CARDIOL, V36, P652, DOI 10.1016/S0735-1097(00)00832-9; Bellot J, 2011, NURS FORUM, V46, P29, DOI 10.1111/j.1744-6198.2010.00207.x; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chandrasekharan DP, 2011, EUR J CARDIO-THORAC, V39, P912, DOI 10.1016/j.ejcts.2010.08.033; CHASSIN MR, 1986, NEW ENGL J MED, V314, P285, DOI 10.1056/NEJM198601303140505; CLEARY PD, 1991, MED CARE, V29, P939, DOI 10.1097/00005650-199110000-00001; Coylewright M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049827; Davies HTO, 2000, QUAL HEALTH CARE, V9, P111, DOI 10.1136/qhc.9.2.111; Deber RB, 1996, ARCH INTERN MED, V156, P1414, DOI 10.1001/archinte.156.13.1414; Feder B.J., 2007, NY TIMES; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Gershon RRM, 2004, J NURS ADMIN, V34, P33, DOI 10.1097/00005110-200401000-00008; Glickman SW, 2007, INT J QUAL HEALTH C, V19, P341, DOI 10.1093/intqhc/mzm047; Head SJ, 2013, EUR HEART J, V34, P2510, DOI 10.1093/eurheartj/eht059; Holmboe ES, 2000, J GEN INTERN MED, V15, P632, DOI 10.1046/j.1525-1497.2000.90823.x; Holmes DR, 2008, JACC-CARDIOVASC INTE, V1, P34, DOI 10.1016/j.jcin.2007.10.001; JENKINS CD, 1994, PSYCHOSOM MED, V56, P203, DOI 10.1097/00006842-199405000-00005; Kee F, 1997, QUAL HEALTH CARE, V6, P131, DOI 10.1136/qshc.6.3.131; Kimble LP, 1998, HEART LUNG, V27, P308, DOI 10.1016/S0147-9563(98)90051-6; Krumholz HM, 2013, JAMA INTERN MED, V173, P1252, DOI 10.1001/jamainternmed.2013.6057; KUHN EM, 1995, HEALTH SERV RES, V30, P425; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lee John H, 2012, Mo Med, V109, P79; Liao L, 1996, J GEN INTERN MED, V11, P373, DOI 10.1007/BF02600051; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; Moulton B, 2010, J LAW MED ETHICS, V38, P85, DOI 10.1111/j.1748-720X.2010.00469.x; Ozkan O, 2008, INT J CARDIOVAS IMAG, V24, P567, DOI 10.1007/s10554-008-9297-1; Pearson P, 2010, J HEALTH SERV RES PO, V15, P4, DOI 10.1258/jhsrp.2009.009052; Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954; Rose G A, 1968, Monogr Ser World Health Organ, V56, P1; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Scott Tim, 2003, J Health Serv Res Policy, V8, P105, DOI 10.1258/135581903321466085; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spertus J, 2011, CIRCULATION, V124, P2368; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Tait AR, 2009, ARCH INTERN MED, V169, P1907, DOI 10.1001/archinternmed.2009.390; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wennberg DE, 2003, HLTH AFF MILLWOOD S; Wennberg John, 2004, HLTH AFF MILLWOOD S, P140, DOI DOI 10.1377/HLTHAFF.VAR.140; Whittle J, 2007, AM HEART J, V154, P662, DOI 10.1016/j.ahj.2007.04.065; Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007; Winstein KJ, 2010, WALL STREET J	48	37	40	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2014	349								g5309	10.1136/bmj.g5309	http://dx.doi.org/10.1136/bmj.g5309			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9QJ	25200209	Green Published, hybrid			2022-12-28	WOS:000341690700003
J	Fraser, J; Sidebotham, P; Frederick, J; Covington, T; Mitchell, EA				Fraser, James; Sidebotham, Peter; Frederick, John; Covington, Teresa; Mitchell, Edwin A.			Child death in high-income countries 1 Learning from child death review in the USA, England, Australia, and New Zealand	LANCET			English	Article							UNEXPECTED INFANT DEATHS; SOCIOECONOMIC INEQUALITIES; MALTREATMENT FATALITIES; SYSTEMATIC ANALYSIS; HEALTH-SERVICES; UNITED-STATES; MORTALITY; SUDDEN; TRENDS; UNDERASCERTAINMENT	Despite pronounced reductions in child mortality in industrialised countries, variations exist within and between countries. Many child deaths are preventable, and much could be done to further reduce mortality. For the family, their community, and professionals caring for them, every child's death is a tragedy. Systematic review of all child deaths is grounded in respect for the rights of children and their families, and aimed towards the prevention of future child deaths. In a Series of three papers, we discuss child death in high-income countries in the context of evolving child death review processes. This paper outlines the background to and development of child death review in the USA, England, Australia, and New Zealand. We consider the purpose, process, and outputs of child death review, and discuss how these factors can contribute to a greater understanding of children's deaths and to knowledge for the prevention of future child deaths.	[Fraser, James] Bristol Royal Hosp Children, Bristol, Avon, England; [Sidebotham, Peter] Univ Warwick, Div Mental Hlth & Well Being, Coventry CV4 7AL, W Midlands, England; [Frederick, John] Monash Univ, Abuse Prevent Res Australia, Melbourne, Vic 3004, Australia; [Covington, Teresa] Michigan Publ Hlth Inst, Natl Ctr Review & Prevent Child Deaths, Okemos, MI USA; [Mitchell, Edwin A.] Univ Auckland, Dept Paediat, Auckland, New Zealand	Bristol Royal Hospital For Children; University of Warwick; Monash University; University of Auckland	Sidebotham, P (corresponding author), Univ Warwick, Div Mental Hlth & Well Being, Coventry CV4 7AL, W Midlands, England.	p.sidebotham@warwick.ac.uk	Sidebotham, Peter D/E-3011-2010; Frederick, John/AAC-5403-2019; Frederick, John/AAC-5416-2019	Sidebotham, Peter D/0000-0003-4891-6926; Frederick, John/0000-0002-3011-9745; Frederick, John/0000-0002-3011-9745	UK Department for Education; Cure Kids	UK Department for Education; Cure Kids	JaF is on the faculty of the Warwick advanced course in the management of unexpected child death. PS runs the Warwick advanced course in the management of unexpected child death. He has received grant money from the UK Department for Education for research into child death review and for the development of training materials on child death review. TC is the Director of the US National Center for the Review and Prevention of Child Deaths. EAM is a member of the National Child and Youth Mortality Review Committee and the Auckland Child and Youth Mortality Review Committee. He leads the New Zealand sudden unexpected death in infancy case-control study. He is supported by Cure Kids. JoF declares no competing interests.	Advisory Board on Child Abuse and Neglect, 1995, NAT SHAM FAT CHILD A; Australian Bureau of Statistics, 2009, 3303 0 CAUS DEATH AU; Australian Bureau of Statistics, 2009, 3302 0 DEATHS AUSTR; Blair PS, 2006, LANCET, V367, P314, DOI 10.1016/S0140-6736(06)67968-3; Brandon M., 2010, BUILDING LEARNING SE; Brandon M, 2008, ANAL CHILD DEATHS SE; Brandon M., 2009, UNDERSTANDING SERIOU; Center for Disease Control and Prevention National Center for Health Statistics, UND CAUS DEATH 2009; Child and Youth Mortality Review Committee, 2011, ROP AR AU MAT HUNG; Child and Youth Mortality Review Committee, 2013, ROP AR AU MAT HUNG T; Child and Youth Mortality Review Committee, 2009, 5 REP MIN HLTH REP M; Child and Youth Mortality Review Committee, 2011, LOW SPEED RUN MORT; Commission for Children and Young People and Child Guardian Queensland, 2009, ANN REP DEATHS CHILD; Commissioner for Children Tasmania, 2006, ADV MIN HLTH HUM SER; Cote A, 2010, PAEDIATR RESPIR REV, V11, P219, DOI 10.1016/j.prrv.2009.12.002; Crume TL, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e18; Department for Education, 2011, CHILD DEATH REV YEAR; Desapriya E, 2011, INJURY PREV, V17, P4, DOI 10.1136/ip.2010.026914; Durfee M, 2002, CHILD ABUSE NEGLECT, V26, P619, DOI 10.1016/S0145-2134(02)00337-X; Durfee M, 2009, PEDIATR CLIN N AM, V56, P379, DOI 10.1016/j.pcl.2009.01.004; DURFEE MJ, 1992, JAMA-J AM MED ASSOC, V267, P3172, DOI 10.1001/jama.267.23.3172; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; EWIGMAN B, 1993, PEDIATRICS, V91, P330; Fleming PJ, 2004, BMJ-BRIT MED J, V328, P331, DOI 10.1136/bmj.328.7435.331; Government HM, 2013, WORKING TOGETHER SAF; Grason H, 1999, Matern Child Health J, V3, P151, DOI 10.1023/A:1022345922254; Griffiths Clare, 2005, Health Stat Q, P6; Health Inequalities Unit, 2007, REV HLTH IN INF MORT; Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463; Hunt R, 2000, J PAEDIATR CHILD H, V36, P498, DOI 10.1046/j.1440-1754.2000.00556.x; Johansson LA, 2006, J CLIN EPIDEMIOL, V59, P125, DOI 10.1016/j.jclinepi.2005.05.006; Lamont A, 2010, CHILD DEATHS ABUSE N; Malloy MH, 2005, PEDIATRICS, V115, P1247, DOI 10.1542/peds.2004-2188; Misra DP, 2004, MATERN CHILD HLTH J, V8, P217, DOI 10.1023/B:MACI.0000047420.41215.f0; MITCHELL EA, 1987, NEW ZEAL MED J, V100, P269; Mitchell EA, 2012, NEW ZEAL MED J, V125, P50; Moore A, 2005, ARCH DIS CHILD, V90, P687, DOI 10.1136/adc.2004.068460; Munro E, 2013, MUNRO REV CHILD PROT; New Zealand Mortality Review Data Group, NZ CHILD YOUTH MORT; Newton R, 2010, U NSW LAW J, V33, P987; Office for National Statistics, 2012, CHILD MORT STAT CHIL; Office for National Statistics, 2018, DEATHS REGISTERED EN; Onwuachi-Saunders C, 1999, Inj Prev, V5, P276; Palusci VJ, 2010, CHILD ABUSE NEGLECT, V34, P324, DOI 10.1016/j.chiabu.2009.09.018; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pearson G., 2008, WHY CHILDREN DIE PIL; Pearson GA, 2011, ARCH DIS CHILD, V96, P922, DOI 10.1136/adc.2009.177089; Pearson GA, 2011, ARCH DIS CHILD, V96, P927, DOI 10.1136/adc.2009.177071; Quan LA, 2011, INJURY PREV, V17, P28, DOI 10.1136/ip.2010.026849; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rangel EL, 2010, J TRAUMA, V69, P20, DOI 10.1097/TA.0b013e3181bbd7c3; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Rimsza ME, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e11; Rose W., 2008, IMPROVING SAFEGUARDI; Royal College of Pathologists Royal College of Paediatrics and Child Health, 2004, SUDD UN DEATH INF MU; Schnitzer PG, 2008, AM J PUBLIC HEALTH, V98, P296, DOI 10.2105/AJPH.2006.087783; Schnitzer PG, 2012, AM J PUBLIC HEALTH, V102, P1204, DOI 10.2105/AJPH.2011.300613; Shapiro-Mendoza CK, 2009, PEDIATRICS, V123, P533, DOI 10.1542/peds.2007-3746; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Sidebotham P, 2008, RESPONDING CHILD DIE; Sidebotham P., 2008, PREVENTING CHILDHOOD; Sidebotham P, 2012, ARCH DIS CHILD, V97, P189, DOI 10.1136/archdischild-2011-300401; Sidebotham P, 2011, INJURY PREV, V17, P55, DOI 10.1136/ip.2010.027169; Sidebotham P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b531; Smith LK, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6654; Smith LK, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4702; UK Office for National Statistics, 2009, MORT STAT DEATHS REG; US Department of Health and Human Services, HLTH PEOPL 2020 INJ; Vincent S, 2014, CHILD ABUSE REV, V23, P116, DOI 10.1002/car.2276; Weber MA, 2008, ARCH DIS CHILD, V93, P1048, DOI 10.1136/adc.2007.136739; Wolfe I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1277; Yasumi K, 2009, J FORENSIC LEG MED, V16, P70, DOI 10.1016/j.jflm.2008.07.007; You D., 2010, LEVELS TRENDS CHILD	73	64	64	2	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					894	903		10.1016/S0140-6736(13)61089-2	http://dx.doi.org/10.1016/S0140-6736(13)61089-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DK	25209489	Green Submitted			2022-12-28	WOS:000341362200032
J	Avorn, J				Avorn, Jerry			Rethinking the Use of Physicians as Hired Expert Lecturers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA; [Avorn, Jerry] Brigham & Womens Hosp, Boston, MA 02120 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	avorn@post.harvard.edu						Agrawal S, 2013, NEW ENGL J MED, V368, P2054, DOI 10.1056/NEJMp1303523; Avorn J, 2004, POWERFUL MED BENEFIT; Kesselheim AS, 2012, NEW ENGL J MED, V367, P1119, DOI 10.1056/NEJMsa1202397; MA Thomson O'Brien, 2000, COCHRANE DB SYST REV; Sagara E., 2014, PROPUBLICA      0311; Thomas Katie, 2013, NY TIMES, pA1; Tobin L., 2014, LONDON EVENING  0407; U.S. Department of Justice, 2012, GLAXOSMITHKLINE PLEA	8	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					363	U173		10.7326/M14-0847	http://dx.doi.org/10.7326/M14-0847			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO7VT	25178570				2022-12-28	WOS:000341561400007
J	Miller, SB; Yildiz, FZ; Lo, JA; Wang, B; D'Souza, VM				Miller, Sarah B.; Yildiz, F. Zehra; Lo, Jennifer A.; Wang, Bo; D'Souza, Victoria M.			A structure-based mechanism for tRNA and retroviral RNA remodelling during primer annealing	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; HIV-1 NUCLEOCAPSID PROTEIN; ACID-CHAPERONE ACTIVITY; NUCLEOTIDE-SEQUENCE; DNA-SYNTHESIS; NMR STRUCTURE; INITIATION; IDENTIFICATION; TRANSITIONS; TRNA(LYS,3)	To prime reverse transcription, retroviruses require annealing of a transfer RNA molecule to the U5 primer binding site (U5-PBS) region of the viral genome(1,2). The residues essential for primer annealing are initially locked in intramolecular interactions(3-5); hence, annealing requires the chaperone activity of the retroviral nucleocapsid (NC) protein to facilitate structural rearrangements(6). Here we show that, unlike classical chaperones, the Moloney murine leukaemia virus NC uses a unique mechanism for remodelling: it specifically targets multiple structured regions in both the U5-PBS and tRNA(Pro) primer that otherwise sequester residues necessary for annealing. This high-specificity and high-affinity binding by NC consequently liberates these sequestered residues-which are exactly complementary-for intermolecular interactions. Furthermore, NC utilizes a step-wise, entropy-driven mechanism to trigger both residue-specific destabilization and residue-specific release. Our structures of NC bound to U5-PBS and tRNAPro reveal the structure-based mechanism for retroviral primer annealing and provide in sights as to how ATP-independent chaperones can target specific RNAs amidst the cellular milieu of non-target RNAs. [GRAPHICS] .	[Miller, Sarah B.; Yildiz, F. Zehra; Lo, Jennifer A.; Wang, Bo; D'Souza, Victoria M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	D'Souza, VM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dsouza@mcb.harvard.edu		/0000-0002-9520-6874	Merck; Damon Runyon Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Merck(Merck & Company); Damon Runyon Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank the laboratory of S. Goff for the pNCS plasmid, C. Salguero for the artistic rendition of the model, as well as M. Summers and R. Gaudet for critical reading of the manuscript and the Merck Research Fellowship and Damon Runyon Cancer Research scholarship for funding.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Auerbach MR, 2003, P NATL ACAD SCI USA, V100, P11678, DOI 10.1073/pnas.2034020100; Beerens N, 2002, RNA, V8, P357, DOI 10.1017/S1355838202028194; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; CORDELL B, 1976, J VIROL, V19, P548, DOI 10.1128/JVI.19.2.548-558.1976; D'Souza V, 2004, J MOL BIOL, V337, P427, DOI 10.1016/j.jmb.2004.01.037; D'Souza V, 2001, J MOL BIOL, V314, P217, DOI 10.1006/jmbi.2001.5139; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; de Smit MH, 2002, NUCLEIC ACIDS RES, V30, P4232, DOI 10.1093/nar/gkf539; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Dey A, 2005, BIOCHEMISTRY-US, V44, P3735, DOI 10.1021/bi047639q; Fedorova O, 2010, J MOL BIOL, V397, P799, DOI 10.1016/j.jmb.2010.02.001; Gonsky J, 2001, J VIROL, V75, P2616, DOI 10.1128/JVI.75.6.2616-2626.2001; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; HARADA F, 1979, J BIOL CHEM, V254, P979; Hargittai MRS, 2001, J MOL BIOL, V312, P985, DOI 10.1006/jmbi.2001.5021; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Lim D, 2002, J VIROL, V76, P8360, DOI 10.1128/JVI.76.16.8360-8373.2002; Liu SX, 2010, NAT STRUCT MOL BIOL, V17, P1453, DOI 10.1038/nsmb.1937; Martin-Tumasz S, 2011, NUCLEIC ACIDS RES, V39, P7837, DOI 10.1093/nar/gkr455; Miller JT, 2004, NUCLEIC ACIDS RES, V32, P4687, DOI 10.1093/nar/gkh813; MOUGEL M, 1993, NUCLEIC ACIDS RES, V21, P4677, DOI 10.1093/nar/21.20.4677; Nonin-Lecomte S, 2006, NUCLEIC ACIDS RES, V34, P1847, DOI 10.1093/nar/gkl111; Onafuwa-Nuga AA, 2005, J VIROL, V79, P13528, DOI 10.1128/JVI.79.21.13528-13537.2005; Paillart JC, 2004, J BIOL CHEM, V279, P48397, DOI 10.1074/jbc.M408294200; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; PRATS AC, 1991, NUCLEIC ACIDS RES, V19, P3533, DOI 10.1093/nar/19.13.3533; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rein A, 2010, RNA BIOL, V7, P700, DOI 10.4161/rna.7.6.13685; Semrad K, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/532908; Spriggs S, 2008, BIOCHEMISTRY-US, V47, P13064, DOI 10.1021/bi8014373; Tamura M, 2002, J MOL BIOL, V320, P455, DOI 10.1016/S0022-2836(02)00515-6; Theimer CA, 2003, RNA, V9, P1446, DOI 10.1261/rna.5152303; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Woodson SA, 2010, RNA BIOL, V7, P677, DOI 10.4161/rna.7.6.13615	38	25	27	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					591	+		10.1038/nature13709	http://dx.doi.org/10.1038/nature13709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25209668	Green Submitted			2022-12-28	WOS:000346247600004
J	Burns, M; Essafi, S; Bame, JR; Bull, SP; Webster, MP; Balieu, S; Dale, JW; Butts, CP; Harvey, JN; Aggarwal, VK				Burns, Matthew; Essafi, Stephanie; Bame, Jessica R.; Bull, Stephanie P.; Webster, Matthew P.; Balieu, Sebastien; Dale, James W.; Butts, Craig P.; Harvey, Jeremy N.; Aggarwal, Varinder K.			Assembly-line synthesis of organic molecules with tailored shapes	NATURE			English	Article							REAGENT-CONTROLLED HOMOLOGATION; BORONIC ESTERS; STEREOCONTROLLED SYNTHESIS; CONFORMATION DESIGN; NATURAL-PRODUCTS; ASYMMETRIC-SYNTHESIS; GRIGNARD-REAGENTS; CHIRAL CARBENOIDS; EFFICIENT; SEQUENCE	Molecular 'assembly lines', in which organic molecules undergo iterative processes such as chain elongation and functional group manipulation, are found in many natural systems, including polyketide biosynthesis. Here we report the creation of such an assembly line using the iterative, reagent-controlled homologation of a boronic ester. This process relies on the reactivity of alpha-lithioethyl tri-isopropylbenzoate, which inserts into carbon-boron bonds with exceptionally high fidelity and stereocontrol; each chain-extension step generates a new boronic ester, which is immediately ready for further homologation. We used this method to generate organic molecules that contain ten contiguous, stereochemically defined methyl groups. Several stereoisomers were synthesized and shown to adopt different shapes-helical or linear-depending on the stereochemistry of the methyl groups. This work should facilitate the rational design of molecules with predictable shapes, which could have an impact in areas of molecular sciences in which bespoke molecules are required.	[Burns, Matthew; Essafi, Stephanie; Bame, Jessica R.; Bull, Stephanie P.; Webster, Matthew P.; Balieu, Sebastien; Butts, Craig P.; Harvey, Jeremy N.; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Dale, James W.] Novartis Horsham Res Ctr, Horsham RH13 5AB, W Sussex, England	University of Bristol; Novartis	Aggarwal, VK (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	craig.butts@bristol.ac.uk; jeremy.harvey@bristol.ac.uk; v.aggarwal@bristol.ac.uk	Harvey, Jeremy N/E-8848-2010; Harvey, Jeremy/AAC-6433-2019; Butts, Craig/B-7576-2008; Aggarwal, Varinder/AAG-8504-2019; Bull, Stephanie/AAG-7028-2020	Harvey, Jeremy N/0000-0002-1728-1596; Harvey, Jeremy/0000-0002-1728-1596; Butts, Craig/0000-0001-6678-8839; Bull, Stephanie/0000-0001-5129-1731; Aggarwal, Varinder/0000-0003-0344-6430	EPSRC [EP/I038071/1, EP/G036764/1]; European Research Council (FP7, ERC grant) [246785]; Novartis; BBSRC [BB/F011539/1] Funding Source: UKRI; EPSRC [EP/K03927X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F011539/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K03927X/1, EP/I038071/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (FP7, ERC grant); Novartis(Novartis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank EPSRC (EP/I038071/1) and the European Research Council (FP7/2007-2013, ERC grant no. 246785) for financial support. M. B. thanks the EPSRC-funded Bristol Chemical Synthesis Centre for Doctoral Training (EP/G036764/1) and Novartis for a PhD studentship. We wish to thank C. Woodall for assistance with X-ray analysis and E. Bozoki for assistance with preparative high-performance liquid chromatography purification.	Adler TB, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3040174; Albert BJ, 2010, ANGEW CHEM INT EDIT, V49, P2747, DOI 10.1002/anie.200907076; Beckmann E, 2004, SYNLETT, P2275, DOI 10.1055/s-2004-832835; Besong G, 2006, ORG BIOMOL CHEM, V4, P2193, DOI 10.1039/b603857c; Blair DJ, 2014, ANGEW CHEM INT EDIT, V53, P5552, DOI 10.1002/anie.201400944; Blakemore PR, 2007, J AM CHEM SOC, V129, P3068, DOI 10.1021/ja068808s; Blakemore PR, 2006, ORG LETT, V8, P773, DOI 10.1021/ol053055k; Boger DL, 1998, J AM CHEM SOC, V120, P9149, DOI 10.1021/ja9816640; Brand GJ, 2009, ORG LETT, V11, P4668, DOI 10.1021/ol901944b; Butts CP, 2011, ORG BIOMOL CHEM, V9, P177, DOI 10.1039/c0ob00479k; Butts CP, 2011, CHEM COMMUN, V47, P1193, DOI 10.1039/c0cc04114a; Chini MG, 2012, J ORG CHEM, V77, P1489, DOI 10.1021/jo2023763; Di Micco S, 2010, EUR J ORG CHEM, V2010, P1411, DOI 10.1002/ejoc.200901255; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dutheuil G, 2009, ANGEW CHEM INT EDIT, V48, P6317, DOI 10.1002/anie.200901194; Emerson CR, 2013, CHEM-EUR J, V19, P16342, DOI 10.1002/chem.201302511; Fletcher CJ, 2013, ANGEW CHEM INT EDIT, V52, P2503, DOI 10.1002/anie.201208403; Han SB, 2010, J AM CHEM SOC, V132, P15559, DOI 10.1021/ja1082798; Hanessian S, 2006, SYNTHESIS-STUTTGART, P1057, DOI 10.1055/s-2006-926376; Hanessian S, 2003, J AM CHEM SOC, V125, P13784, DOI 10.1021/ja030139k; Hoffmann RW, 2000, ANGEW CHEM INT EDIT, V39, P2054, DOI 10.1002/1521-3773(20000616)39:12<2054::AID-ANIE2054>3.3.CO;2-Q; Hoffmann RW, 1998, CHEM-EUR J, V4, P559, DOI 10.1002/(SICI)1521-3765(19980416)4:4<559::AID-CHEM559>3.3.CO;2-K; HOFFMANN RW, 1992, ANGEW CHEM INT EDIT, V31, P1124, DOI 10.1002/anie.199211241; HOPPE D, 1990, ANGEW CHEM INT EDIT, V29, P1422, DOI 10.1002/anie.199014221; Hoppe D., 1997, ANGEW CHEM INT EDIT, V36, P2282, DOI DOI 10.1002/ANIE.199722821; Hunter L, 2009, ANGEW CHEM INT EDIT, V48, P5457, DOI 10.1002/anie.200901956; Larouche-Gauthier R, 2011, CHEM COMMUN, V47, P12592, DOI 10.1039/c1cc14469c; Lee SJ, 2008, J AM CHEM SOC, V130, P466, DOI 10.1021/ja078129x; Lotz B, 1996, POLYMER, V37, P4979, DOI 10.1016/0032-3861(96)00370-9; Matteson DS, 2013, J ORG CHEM, V78, P10009, DOI 10.1021/jo4013942; MATTESON DS, 1980, J AM CHEM SOC, V102, P7590, DOI 10.1021/ja00545a046; Negishi E, 2005, DALTON T, P827, DOI 10.1039/b417134a; Negishi E, 2004, P NATL ACAD SCI USA, V101, P5782, DOI 10.1073/pnas.0307514101; Nilewski C, 2009, J AM CHEM SOC, V131, P15866, DOI 10.1021/ja906461h; Pulis AP, 2012, J AM CHEM SOC, V134, P7570, DOI 10.1021/ja303022d; Rayner PJ, 2013, J AM CHEM SOC, V135, P8071, DOI 10.1021/ja4033956; Robinson A, 2010, ANGEW CHEM INT EDIT, V49, P6673, DOI 10.1002/anie.201003236; SMITH PW, 1988, J AM CHEM SOC, V110, P7917, DOI 10.1021/ja00231a076; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; STILL WC, 1980, J AM CHEM SOC, V102, P1201, DOI 10.1021/ja00523a066; Stymiest JL, 2007, ANGEW CHEM INT EDIT, V46, P7491, DOI 10.1002/anie.200702146; Sun X, 2013, ORG LETT, V15, P4500, DOI 10.1021/ol402049y; ter Horst B, 2007, ORG LETT, V9, P3013, DOI 10.1021/ol071078o; ter Horst B, 2010, CHEM COMMUN, V46, P2535, DOI 10.1039/b926265b; TSUZUKI S, 1991, J AM CHEM SOC, V113, P4665, DOI 10.1021/ja00012a040; VIGNERON JP, 1973, TETRAHEDRON, V29, P1055, DOI 10.1016/0040-4020(73)80060-2; Wang CY, 2009, ANGEW CHEM INT EDIT, V48, P5240, DOI 10.1002/anie.200901680; WANG XH, 1992, J AM CHEM SOC, V114, P4128, DOI 10.1021/ja00037a014; WEI A, 1995, J AM CHEM SOC, V117, P9432, DOI 10.1021/ja00142a008; Woerly EM, 2014, NAT CHEM, V6, P484, DOI 10.1038/NCHEM.1947	50	168	169	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					183	188		10.1038/nature13711	http://dx.doi.org/10.1038/nature13711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209797	Green Accepted			2022-12-28	WOS:000341362800041
J	Carbone, L; Harris, RA; Gnerre, S; Veeramah, KR; Lorente-Galdos, B; Huddleston, J; Meyer, TJ; Herrero, J; Roos, C; Aken, B; Anaclerio, F; Archidiacono, N; Baker, C; Barre, D; Batzer, M; Beal, K; Blancher, A; Bohrson, CL; Brameier, M; Campbell, MS; Capozzi, O; Casola, C; Chiatante, G; Cree, A; Damert, A; de Jong, PJ; Dumas, L; Fernandez-Callejo, M; Flicek, P; Fuchs, NV; Gue, I; Gut, M; Hahn, MW; Hernandez-Rodriguez, J; Hillier, LW; Hubley, R; Ianc, B; Izsvak, Z; Jablonski, NG; Johnstone, LM; Karimpour-Fard, A; Konkel, MK; Kostka, D; Lazar, NH; Lee, SL; Lewis, LR; Liu, Y; Locke, DP; Mallick, S; Mendez, FL; Muffato, M; Nazareth, LV; Nevonen, KA; O'Bleness, M; Ochis, C; Odom, DT; Pollard, KS; Quilez, J; Reich, D; Rocchi, M; Schumann, GG; Searle, S; Sikela, JM; Skollar, G; Smit, A; Sonmez, K; ten Hallers, B; Terhune, E; Thomas, GWC; Ullmer, B; Ventura, M; Walker, JA; Wall, JD; Walter, L; Ward, MC; Wheelan, SJ; Whelan, CW; White, S; Wilhelm, LJ; Woerner, AE; Yandell, M; Zhu, BL; Hammer, MF; Marques-Bonet, T; Eichler, EE; Fulton, L; Fronick, C; Muzny, DM; Warren, WC; Worley, KC; Rogers, J; Wilson, RK; Gibbs, RA				Carbone, Lucia; Harris, R. Alan; Gnerre, Sante; Veeramah, Krishna R.; Lorente-Galdos, Belen; Huddleston, John; Meyer, Thomas J.; Herrero, Javier; Roos, Christian; Aken, Bronwen; Anaclerio, Fabio; Archidiacono, Nicoletta; Baker, Carl; Barre, Daniel; Batzer, Marka.; Beal, Kathryn; Blancher, Antoine; Bohrson, Craig L.; Brameier, Markus; Campbell, Michael S.; Capozzi, Oronzo; Casola, Claudio; Chiatante, Giorgia; Cree, Andrew; Damert, Annette; de Jong, Pieter J.; Dumas, Laura; Fernandez-Callejo, Marcos; Flicek, Paul; Fuchs, Nina V.; Gue, Ivo; Gut, Marta; Hahn, Matthew W.; Hernandez-Rodriguez, Jessica; Hillier, LaDeana W.; Hubley, Robert; Ianc, Bianca; Izsvak, Zsuzsanna; Jablonski, Nina G.; Johnstone, Laurel M.; Karimpour-Fard, Anis; Konkel, Miriam K.; Kostka, Dennis; Lazar, Nathan H.; Lee, Sandra L.; Lewis, Lora R.; Liu, Yue; Locke, Devin P.; Mallick, Swapan; Mendez, Fernando L.; Muffato, Matthieu; Nazareth, Lynne V.; Nevonen, Kimberly A.; O'Bleness, Majesta; Ochis, Cornelia; Odom, Duncan T.; Pollard, Katherine S.; Quilez, Javier; Reich, David; Rocchi, Mariano; Schumann, Gerald G.; Searle, Stephen; Sikela, James M.; Skollar, Gabriella; Smit, Arian; Sonmez, Kemal; ten Hallers, Boudewijn; Terhune, Elizabeth; Thomas, Gregg W. C.; Ullmer, Brygg; Ventura, Mario; Walker, Jerilyn A.; Wall, Jeffrey D.; Walter, Lutz; Ward, Michelle C.; Wheelan, Sarah J.; Whelan, Christopher W.; White, Simon; Wilhelm, Larry J.; Woerner, August E.; Yandell, Mark; Zhu, Baoli; Hammer, Michael F.; Marques-Bonet, Tomas; Eichler, Evan E.; Fulton, Lucinda; Fronick, Catrina; Muzny, Donna M.; Warren, Wesley C.; Worley, Kim C.; Rogers, Jeffrey; Wilson, Richard K.; Gibbs, Richard A.			Gibbon genome and the fast karyotype evolution of small apes	NATURE			English	Article							CHROMOSOME INSTABILITY; GENE; RETROTRANSPOSON; BINDING; MECHANISM; INFERENCE; REGIONS; CTCF; RNA	Gibbons are small arboreal apes that display an accelerated rate of evolutionary chromosomal rearrangement and occupy a key node in the primate phylogeny between Old World monkeys and great apes. Here we present the assembly and analysis of a northern white-checked gibbon (Nomascus leucogenys) genome. We describe the propensity for a gibbon-specific retrotransposon (LAVA) to insert into chromosome segregation genes and alter transcription by providing a premature termination site, suggesting a possible molecular mechanism for the genome plasticity of the gibbon lineage. We further show that the gibbon genera (Nomascus, Hylobates, Hoolock and Symphalangus) experienced a near-instantaneous radiation similar to 5 million years ago, coincident with major geographical changes in southeast Asia that caused cycles of habitat compression and expansion. Finally, we identify signatures of positive selection in genes important for forelimb development (TBX5) and connective tissues (COLIA1) that may have been involved in the adaptation of gibbons to their arboreal habitat.	[Carbone, Lucia; Meyer, Thomas J.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Carbone, Lucia; Nevonen, Kimberly A.; Terhune, Elizabeth; Wilhelm, Larry J.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; [Carbone, Lucia] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Carbone, Lucia; Lazar, Nathan H.; Sonmez, Kemal] Oregon Hlth & Sci Univ, Bioinformat & Computat Biol Div, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gnerre, Sante] Nabsys, Providence, RI 02903 USA; [Veeramah, Krishna R.; Johnstone, Laurel M.; Mendez, Fernando L.; Woerner, August E.; Hammer, Michael F.] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA; [Veeramah, Krishna R.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11790 USA; [Lorente-Galdos, Belen; Fernandez-Callejo, Marcos; Hernandez-Rodriguez, Jessica; Quilez, Javier; Marques-Bonet, Tomas] Univ Pompeu Fabra, Inst Biol Evolut UPF CSIC, IBE, Barcelona 08003, Spain; [Huddleston, John; Baker, Carl; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Huddleston, John; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Herrero, Javier; Aken, Bronwen; Barre, Daniel; Beal, Kathryn; Flicek, Paul; Muffato, Matthieu] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Herrero, Javier] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Roos, Christian; Brameier, Markus; Walter, Lutz] German Primate Ctr, Leibniz Inst Primate Res, Gene Bank Primates, D-37077 Gottingen, Germany; [Aken, Bronwen; Barre, Daniel; Odom, Duncan T.; Searle, Stephen; White, Simon] European Bioinformat Inst, Cambridge CB10 1SD, England; [Anaclerio, Fabio; Archidiacono, Nicoletta; Capozzi, Oronzo; Chiatante, Giorgia; Rocchi, Mariano; Ventura, Mario] Univ Bari, Dept Biol, I-70125 Bari, Italy; [Batzer, Marka.; Konkel, Miriam K.; Walker, Jerilyn A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Blancher, Antoine] Univ Toulouse 3, F-31062 Toulouse, France; [Bohrson, Craig L.; Wheelan, Sarah J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Blostat & Bioinformat, Baltimore, MD 21205 USA; [Campbell, Michael S.; Yandell, Mark] Univ Utah, Salt Lake City, UT 84112 USA; [Casola, Claudio] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA; [Cree, Andrew; Lee, Sandra L.; Lewis, Lora R.; Liu, Yue; Nazareth, Lynne V.; Muzny, Donna M.; Worley, Kim C.; Rogers, Jeffrey; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Damert, Annette; Ianc, Bianca; Ochis, Cornelia] Univ Babes Bolyai, Inst Interdisciplinary Res Bionanosci, Ctr Mol Biol, Cluj Napoca 400084, Romania; [de Jong, Pieter J.; ten Hallers, Boudewijn; Zhu, Baoli] Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; [Dumas, Laura; Karimpour-Fard, Anis; O'Bleness, Majesta; Sikela, James M.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Fuchs, Nina V.; Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Gue, Ivo; Gut, Marta; Marques-Bonet, Tomas] CNAG, Barcelona 08028, Spain; [Hahn, Matthew W.; Thomas, Gregg W. C.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47408 USA; [Hillier, LaDeana W.; Locke, Devin P.; Smit, Arian; Fulton, Lucinda; Fronick, Catrina; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Hubley, Robert] Inst Syst Biol, Seattle, WA 98109 USA; [Jablonski, Nina G.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Kostka, Dennis] Univ Pittsburgh, Sch Med, Dept Dev Biol, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA; [Mallick, Swapan; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Odom, Duncan T.; Ward, Michelle C.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA; [Pollard, Katherine S.; Wall, Jeffrey D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.; Wall, Jeffrey D.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Schumann, Gerald G.] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Skollar, Gabriella] Gibbon Conservat Ctr, Santa Clarita, CA 91350 USA; [Sonmez, Kemal; Whelan, Christopher W.] Oregon Hlth & Sci Univ, Ctr Spoken Language Understanding, Inst Dev & Disabil, Portland, OR 97239 USA; [Ullmer, Brygg] Louisiana State Univ, Sch Elect Engn & Comp Sci, Baton Rouge, LA 70803 USA; [Yandell, Mark] Univ Utah, USTAR Ctr Genet Discovery, Salt Lake City, UT 84112 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Baylor College of Medicine; University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); The Genome Analysis Centre (TGAC); Deutsches Primatenzentrum (DPZ); European Molecular Biology Laboratory (EMBL); Universita degli Studi di Bari Aldo Moro; Louisiana State University System; Louisiana State University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Johns Hopkins University; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station; Baylor College of Medicine; Babes Bolyai University from Cluj; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Colorado System; University of Colorado Anschutz Medical Campus; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Institute for Systems Biology (ISB); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Paul Ehrlich Institute; Oregon Health & Science University; Louisiana State University System; Louisiana State University; Utah System of Higher Education; University of Utah	Carbone, L (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	carbone@ohsu.edu	Wilson, Richard K./AAF-4139-2019; Sonmez, Kemal/ABF-3992-2020; Walter, Lutz/I-2606-2017; Quilez, Javier/J-7107-2015; Harris, R. Alan/AAI-2784-2020; Gut, Ivo/ABF-3188-2020; Herrero, Javier/H-6971-2019; Marques-Bonet, Tomas/ABF-3734-2020; Ventura, Mario/E-6420-2011	Wilson, Richard K./0000-0002-1992-1358; Sonmez, Kemal/0000-0002-2816-6438; Walter, Lutz/0000-0001-9408-3131; Quilez, Javier/0000-0002-0108-2672; Harris, R. Alan/0000-0002-7333-4752; Gut, Ivo/0000-0001-7219-632X; Herrero, Javier/0000-0001-7313-717X; Marques-Bonet, Tomas/0000-0002-5597-3075; Terhune, Elizabeth/0000-0003-0202-6936; Lazar, Nathan/0000-0001-8798-824X; Flicek, Paul/0000-0002-3897-7955; White, Simon/0000-0001-6375-2363; Lorente-Galdos, Belen/0000-0001-5390-2452; Rocchi, Mariano/0000-0002-9451-5616; Fuchs, Nina/0000-0003-4175-0740; Hernandez-Rodriguez, Jessica/0000-0002-0402-286X; archidiacono, nicoletta/0000-0002-1439-9521; Odom, Duncan/0000-0001-6201-5599; Mendez, Fernando/0000-0002-0879-3813; Whelan, Christopher/0000-0001-8446-8468; Ventura, Mario/0000-0001-7762-8777; Muffato, Matthieu/0000-0002-7860-3560; Chiatante, Giorgia/0000-0002-7505-4818; Worley, Kim/0000-0002-0282-1000; CAPOZZI, Oronzo/0000-0002-7443-6777; Hahn, Matthew/0000-0002-5731-8808; Casola, Claudio/0000-0003-4853-1866; Aken, Bronwen/0000-0002-3032-4095; Izsvak, Zsuzsanna/0000-0002-2053-2384; Barrell, Daniel/0000-0002-0977-0963; Locke, Devin/0000-0002-2527-0475; Johnstone, Laurel/0000-0001-7335-3972	National Human Genome Research Institute(NHGRI) [U54 HG003273, U54 HG003079]; National Institutes of Health NIH/NIAAA [P30 M019355]; National Institutes of Health NIH/NCRR [P51 RR000163, R01_HG005226]; NIH [P30CA006973]; National Library of Medicine Biomedical Informatics Research Training Program [R01 GM59290, U41 HG007497-01, R01 MH081203, HG002385]; National Science Foundation (NSF) [CNS-1126739, DBI-0845494]; PRIN; Futuro in ricerca [RBFR103CE3]; ERC Starting Grant [260372]; MICINN (Spain) [BFU2011-28549]; Ministry of National Education; CNCS-UEFISCDI [PN-II-ID-PCE-2012-4-0090]; Deutsche Forschungsgemeinschaft [SCHU1014/8-1]; ERC; EMBO Young Investigator Award; ERC Starting Grant; Commonwealth Scholarship Commission; Wellcome Trust [WT095908, WT098051]; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Cancer Research UK [15603] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U41HG007497, R01HG002385, U54HG003273, R01HG002939, R01HG005226, U41HG007234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P30AA019355] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	National Human Genome Research Institute(NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine Biomedical Informatics Research Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Futuro in ricerca; ERC Starting Grant(European Research Council (ERC)); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of National Education; CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); ERC Starting Grant(European Research Council (ERC)); Commonwealth Scholarship Commission; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The gibbon genome project was funded by the National Human Genome Research Institute(NHGRI) including grants U54 HG003273 (RAG.) and U54 HG003079 (R.K.W.) with further support from National Institutes of Health NIH/NIAAA P30 M019355 and NIH/NCRR P51 RR000163 (L.C.), R01_HG005226 (J.D.W., M.F.H.), NIH P30CA006973 (S.J.W.), a fellowship from the National Library of Medicine Biomedical Informatics Research Training Program (N.H.L.), R01 GM59290 (M.A.B.) and U41 HG007497-01 (M.A.B, M.K.K.), R01 MH081203 (J.M.S.), HG002385 (E.E.E.), National Science Foundation (NSF) CNS-1126739 (B.U., M.A.B., M.K.K.) and DBI-0845494 (M.W.H.), PRIN 2012 (M.R.), Futuro in ricerca 2010 RBFR103CE3 (M.V.), ERC Starting Grant (260372) and MICINN (Spain) BFU2011-28549 (T.M.-B.), grant of the Ministry of National Education, CNCS-UEFISCDI, project number PN-II-ID-PCE-2012-4-0090 (A.D.), grant of the Deutsche Forschungsgemeinschaft SCHU1014/8-1 (G.G.S.), ERC Starting and Advanced Grant and EMBO Young Investigator Award (Z.I., N.V.F.), ERC Starting Grant and EMBO Young Investigator Award (D.T.O.), Commonwealth Scholarship Commission (M.C.W.). E.E.E. is an investigator of the Howard Hughes Medical Institute. We acknowledge the contributions of the staff of the HGSC, including the operations team: H. Dinh, S. Jhangiani V. Korchina, C. Kovar; the library team: K. Blankenburg, L. Pu, S. Vattathil; the assembly team: D. Rio-Deiros, H. Jiang; the submissions team: M. Batterton, D. Kalra, K. Wilczek-Boney, W. Hale, G. Fowler, J. Zhang; the quality control team: P. Aqrawi, S. Gross, V. Joshi, J. Santibanez; and the sequence production team: U. Anosike, C. Babu, D. Bandaranaike, B. Beltran, D. Berhane-Mersha, C. Bickham, T. Bolden, M. Dao, M. Davila, L. Davy-Carroll, S. Denson, P. Fernando, C. Francis, R. Garcia III, B. Hollins, B. Johnson, J. Jones, J. Kalu, N. Khan, B. Leal, F. Legall III, Y. Liu, J. Lopez, R. Mata, M. Obregon, C. Onwere, A. Parra, Y. Perez, A. Perez, C. Pham, J. Quiroz, S. Ruiz, M. Scheel, D. Simmons, I. Sisson, J. Tisius, G. Toledanes, R. Varghese, V. Vee, D. Walker, C. White, A. Williams, R. Wright, T. Attaway, T. Garrett, C. Mercado, N. Ngyen, H. Paul and Z. Trejos. We thank Z. Ivics for providing some of the reagents. We additionally acknowledge the Production Sequencing Group at The Genome Institute. Wellcome Trust (grant numbers WT095908 and WT098051), NHGRI (U41HG007234) and European Molecular Biology Laboratory. For the production of next-generation sequences, we acknowledge the Massively Parallel Sequencing Shared Resources (MPSSR) at OHSU, the National Center of Genomic Analyses (CNAG) (Barcelona, Spain), the University of Arizona Genetics Core (UAGC), and the UCSF sequencing core. We also acknowledge the Louisiana Optical Network Institute (LONI). We thank the Gibbon Conservation Center and the Fort Wayne Children's Zoo for providing the gibbon samples. The MAKER annotation pipeline is supported by NSF IOS-1126998.We thank T. Brown for proofreading and editing the manuscript.	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Browne ML, 2012, AM J MED GENET A, V158A, P2463, DOI 10.1002/ajmg.a.35565; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Carbone L, 2006, PLOS GENET, V2, P2162, DOI 10.1371/journal.pgen.0020223; Carbone L, 2012, GENOME BIOL EVOL, V4, P760, DOI 10.1093/gbe/evs048; Carbone L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000538; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Girirajan S, 2009, GENOME RES, V19, P178, DOI 10.1101/gr.086041.108; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Harvey P.H., 1987, P181; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hessle L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063080; Hirai H, 2007, HUM GENET, V122, P477, DOI 10.1007/s00439-007-0425-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kim SK, 2011, MOL BIOL EVOL, V28, P2211, DOI 10.1093/molbev/msr033; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Maia ARR, 2012, J CELL BIOL, V199, P285, DOI 10.1083/jcb.201203091; Marchani EE, 2009, GENOMICS, V94, P78, DOI 10.1016/j.ygeno.2009.04.002; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Masuda A, 2008, HUM MOL GENET, V17, P4022, DOI 10.1093/hmg/ddn305; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Michilsens F, 2009, J ANAT, V215, P335, DOI 10.1111/j.1469-7580.2009.01109.x; Mittermeier R., 2013, HDB MAMMALS WORLD, V3; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Schwalie PC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r148; Wall JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053682; Wheelan SJ, 2005, GENOME RES, V15, P1073, DOI 10.1101/gr.3688905; Wojtasz L, 2012, GENE DEV, V26, P958, DOI 10.1101/gad.187559.112; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x; Xu JX, 2008, REV PALAEOBOT PALYNO, V148, P36, DOI 10.1016/j.revpalbo.2007.08.004; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	46	196	201	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					195	+		10.1038/nature13679	http://dx.doi.org/10.1038/nature13679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209798	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000341362800043
J	Livneh, U; Zador, A				Livneh, Uri; Zador, Anthony			SENSORY SYSTEMS Sound processing takes motor control	NATURE			English	Editorial Material							AUDITORY-CORTEX		[Livneh, Uri; Zador, Anthony] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Livneh, U (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu						Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	6	0	0	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					180	181		10.1038/nature13658	http://dx.doi.org/10.1038/nature13658			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25162533				2022-12-28	WOS:000341362800039
J	Saugstad, OD				Saugstad, Ola Didrik			New growth charts for newborn babies	LANCET			English	Editorial Material							WEIGHT-LOSS; REFERENCES; HEALTH; BIRTH		Univ Oslo, Dept Paediat Res, Div Women & Child Hlth, Oslo Univ Hosp, N-0027 Oslo, Norway	University of Oslo	Saugstad, OD (corresponding author), Univ Oslo, Dept Paediat Res, Div Women & Child Hlth, Oslo Univ Hosp, N-0027 Oslo, Norway.	odsaugstad@rr-research.no	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254				Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; [Anonymous], 2009, HUMAN ONTOGENETICS, V3, P7, DOI DOI 10.1002/HUON.200900001; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Flaherman VJ, 2010, BREASTFEED MED, V5, P165, DOI 10.1089/bfm.2009.0047; MAISELS MJ, 1983, J PEDIATR-US, V102, P117, DOI 10.1016/S0022-3476(83)80305-9; McDonald Susan J, 2013, Cochrane Database Syst Rev, pCD004074, DOI 10.1002/14651858.CD004074.pub3; Michaelsen KF, 2014, ACTA PAEDIATR, V103, P464, DOI 10.1111/apa.12586; OLSEN SF, 1992, LANCET, V339, P1003, DOI 10.1016/0140-6736(92)90533-9; Tinggaard J, 2014, ACTA PAEDIATR, V103, P214, DOI 10.1111/apa.12468; Vain NE, 2014, LANCET, V384, P235, DOI 10.1016/S0140-6736(14)60197-5; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; World Health Organization,, 2012, GUID BAS NEWB RES	12	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2014	384	9946					833	835		10.1016/S0140-6736(14)61287-3	http://dx.doi.org/10.1016/S0140-6736(14)61287-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DK	25209472				2022-12-28	WOS:000341362200005
J	Buizert, C; Gkinis, V; Severinghaus, JP; He, F; Lecavalier, BS; Kindler, P; Leuenberger, M; Carlson, AE; Vinther, B; Masson-Delmotte, V; White, JWC; Liu, ZY; Otto-Bliesner, B; Brook, EJ				Buizert, Christo; Gkinis, Vasileios; Severinghaus, Jeffrey P.; He, Feng; Lecavalier, Benoit S.; Kindler, Philippe; Leuenberger, Markus; Carlson, Anders E.; Vinther, Bo; Masson-Delmotte, Valerie; White, James W. C.; Liu, Zhengyu; Otto-Bliesner, Bette; Brook, Edward J.			Greenland temperature response to climate forcing during the last deglaciation	SCIENCE			English	Article							TRAPPED AIR; ICE; SEASONALITY; ACCUMULATION; CIRCULATION; TERMINATION; DIFFUSION; RECORD	Greenland ice core water isotopic composition (delta O-18) provides detailed evidence for abrupt climate changes but is by itself insufficient for quantitative reconstruction of past temperatures and their spatial patterns. We investigate Greenland temperature evolution during the last deglaciation using independent reconstructions from three ice cores and simulations with a coupled ocean-atmosphere climate model. Contrary to the traditional delta O-18 interpretation, the Younger Dryas period was 4.5 degrees +/- 2 degrees C warmer than the Oldest Dryas, due to increased carbon dioxide forcing and summer insolation. The magnitude of abrupt temperature changes is larger in central Greenland (9 degrees to 14 degrees C) than in the northwest (5 degrees to 9 degrees C), fingerprinting a North Atlantic origin. Simulated changes in temperature seasonality closely track changes in the Atlantic overturning strength and support the hypothesis that abrupt climate change is mostly a winter phenomenon.	[Buizert, Christo; Carlson, Anders E.; Brook, Edward J.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Gkinis, Vasileios; Vinther, Bo] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-1168 Copenhagen, Denmark; [Gkinis, Vasileios; White, James W. C.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Severinghaus, Jeffrey P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [He, Feng; Liu, Zhengyu] Univ Wisconsin, Nelson Inst Environm Studies, Ctr Climat Res, Madison, WI 53706 USA; [Lecavalier, Benoit S.] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Kindler, Philippe; Leuenberger, Markus] Univ Bern, Inst Phys, Div Climate & Environm Phys, Bern, Switzerland; [Kindler, Philippe; Leuenberger, Markus] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Masson-Delmotte, Valerie] Inst Pierre Simon Laplace UMR CEA CNRS UVSQ 8212, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Liu, Zhengyu] Peking Univ, Lab Climate & Ocean Atmosphere Studies, Beijing 100871, Peoples R China; [Otto-Bliesner, Bette] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA	Oregon State University; University of Copenhagen; Niels Bohr Institute; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Wisconsin System; University of Wisconsin Madison; Memorial University Newfoundland; University of Bern; University of Bern; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Peking University; National Center Atmospheric Research (NCAR) - USA	Buizert, C (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	buizertc@science.oregonstate.edu	Otto-Bliesner, Bette/AAY-7691-2020; Gkinis, Vasileios/E-8185-2011; White, James W.C./A-7845-2009; Masson-Delmotte, Valerie L/G-1995-2011; Brook, Edward/AAB-7807-2021; He, Feng/B-3583-2008; Leuenberger, Markus C/K-9655-2016	Gkinis, Vasileios/0000-0002-5910-1549; White, James W.C./0000-0001-6041-4684; Masson-Delmotte, Valerie L/0000-0001-8296-381X; He, Feng/0000-0002-3355-6406; Leuenberger, Markus C/0000-0003-4299-6793; Buizert, Christo/0000-0002-2227-1747; Vinther, Bo/0000-0002-6078-771X	NSF [08-06377, 0806414]; National Oceanic and Atmospheric Administration Climate and Global Change fellowship program; Agence Nationale de la Recherche through grants ANR VMC NEEM and ANR CEPS GREENLAND; U.S. NSF P2C2 program; Office of Science of the Department of Energy [DE-AC05-OOOR22725]; Belgium (FNRS-CFB); FWO; Canada (NRCan/GSC); China (CAS); Denmark (FIST); France (IPEV); CNRS/INSU; CEA; ANR; Germany (AWI); Iceland (RannIs); Japan (NIPR); Korea (KOPRI); Netherlands (NWO/ALW); Sweden (VR); Switzerland (SNF); United Kingdom (NERC); USA (U.S. NSF, Office of Polar Programs); Office of Polar Programs (OPP) [0806387] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration Climate and Global Change fellowship program; Agence Nationale de la Recherche through grants ANR VMC NEEM and ANR CEPS GREENLAND(French National Research Agency (ANR)); U.S. NSF P2C2 program; Office of Science of the Department of Energy(United States Department of Energy (DOE)); Belgium (FNRS-CFB)(Fonds de la Recherche Scientifique - FNRS); FWO(FWO); Canada (NRCan/GSC)(Natural Resources Canada); China (CAS)(Chinese Academy of Sciences); Denmark (FIST)(Department of Science & Technology (India)); France (IPEV); CNRS/INSU(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); ANR(French National Research Agency (ANR)); Germany (AWI); Iceland (RannIs); Japan (NIPR); Korea (KOPRI); Netherlands (NWO/ALW)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Sweden (VR)(Swedish Research Council); Switzerland (SNF); United Kingdom (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); USA (U.S. NSF, Office of Polar Programs); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We are are indebted in countless ways to our mentor, friend, and colleague Sigfus J. Johnsen (1940-2013). We thank S. Marcott, D. Noone, J. Rosen, P. Langen, I. Seierstad, A. Landais, B. Minster, S. Falourd, and J. Shakun for fruitful discussions or assistance. Constructive comments by two anonymous reviewers helped improve the manuscript. We acknowledge funding through NSF grants 08-06377 (J. P. S.) and 0806414 (E. J. B.), the National Oceanic and Atmospheric Administration Climate and Global Change fellowship program, administered by the University Corporation for Atmospheric Research (C. B.), Agence Nationale de la Recherche through grants ANR VMC NEEM and ANR CEPS GREENLAND (V.M.-D.), and the U.S. NSF P2C2 program (A. E. C., Z.L., F. H., and B.O.-B.). This research used resources of the Oak Ridge Leadership Computing Facility, located in the National Center for Computational Sciences at Oak Ridge National Laboratory, which is supported by the Office of Science of the Department of Energy under contract DE-AC05-OOOR22725. NEEM is directed and organized by the Center of Ice and Climate at the Niels Bohr Institute and U. S. NSF, Office of Polar Programs. It is supported by funding agencies and institutions in Belgium (FNRS-CFB and FWO), Canada (NRCan/GSC), China (CAS), Denmark (FIST), France (IPEV, CNRS/INSU, CEA, and ANR), Germany (AWI), Iceland (RannIs), Japan (NIPR), Korea (KOPRI), The Netherlands (NWO/ALW), Sweden (VR), Switzerland (SNF), United Kingdom (NERC) and the USA (U.S. NSF, Office of Polar Programs). NEEM data and temperature reconstructions are provided as supplementary data files.	Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Boyle EA, 1997, GEOPHYS RES LETT, V24, P273, DOI 10.1029/97GL00081; Broecker WS, 2006, GLOBAL PLANET CHANGE, V54, P211, DOI 10.1016/j.gloplacha.2006.06.019; Carlson AE, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000371; CHARLES CD, 1994, SCIENCE, V263, P508, DOI 10.1126/science.263.5146.508; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Fluckiger J, 2008, CLIM DYNAM, V31, P633, DOI 10.1007/s00382-008-0373-y; Funder S, 2011, DEV QUATER SCI, V15, P699, DOI 10.1016/B978-0-444-53447-7.00050-7; Gkinis V., 2014, EARTH PLANET SCI LET; Goujon C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003319; Grachev AM, 2005, QUATERNARY SCI REV, V24, P513, DOI 10.1016/j.quascirev.2004.10.016; Guillevic M, 2013, CLIM PAST, V9, P1029, DOI 10.5194/cp-9-1029-2013; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Kiehl JT, 2006, J CLIMATE, V19, P2584, DOI 10.1175/JCLI3747.1; Kindler P, 2014, CLIM PAST, V10, P887, DOI 10.5194/cp-10-887-2014; Langen PL, 2009, CLIM DYNAM, V32, P1035, DOI 10.1007/s00382-008-0438-y; Li C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023492; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Liu ZY, 2012, P NATL ACAD SCI USA, V109, P11101, DOI 10.1073/pnas.1202183109; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Menviel L, 2011, QUATERNARY SCI REV, V30, P1155, DOI 10.1016/j.quascirev.2011.02.005; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Severinghaus JP, 2003, GEOCHIM COSMOCHIM AC, V67, P325, DOI 10.1016/S0016-7037(02)00965-1; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Shakun JD, 2010, QUATERNARY SCI REV, V29, P1801, DOI 10.1016/j.quascirev.2010.03.016; Werner M, 2000, GEOPHYS RES LETT, V27, P723, DOI 10.1029/1999GL006075	32	165	169	5	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1177	1180		10.1126/science.1254961	http://dx.doi.org/10.1126/science.1254961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190795	Green Published			2022-12-28	WOS:000341179800046
J	Twoon, M; Ng, NYB; Thomson, SE				Twoon, M.; Ng, N. Y. B.; Thomson, S. E.			10-MINUTE CONSULTATION Breast lumps	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; WOMEN; RISK; AGE		[Twoon, M.; Ng, N. Y. B.] Univ Aberdeen, Aberdeen, Scotland; [Thomson, S. E.] Aberdeen Royal Infirm, Plast & Reconstruct Surg Unit, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Thomson, SE (corresponding author), Univ Aberdeen, Aberdeen, Scotland.	Suzanne.thomson@doctors.org.uk						Bouchardy C, 2007, BRIT J CANCER, V96, P1743, DOI 10.1038/sj.bjc.6603783; Chaturvedi AK, 2009, J CLIN ONCOL, V27, P967, DOI 10.1200/JCO.2008.18.4549; Chuang SC, 2010, BRIT J CANCER, V102, P1190, DOI 10.1038/sj.bjc.6605616; Elebro K, 2014, CANCER CAUSE CONTROL, V25, P945, DOI 10.1007/s10552-014-0394-2; Hussein AA, 2013, J THORAC DIS, V5, pS2; Mark K, 2014, OBSTET GYNECOL, V123, P734, DOI 10.1097/AOG.0000000000000139; McDonald JA, 2013, CURR BREAST CANC REP, V5; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; National Institute for Health and Care Excellence, 2013, BREAST CANC MAN FH C; National Institute for Health and Care Excellence, 2009, REF GUID SUSP CANC	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2014	349								g5275	10.1136/bmj.g5275	http://dx.doi.org/10.1136/bmj.g5275			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5MS	25193977				2022-12-28	WOS:000341389600001
J	Ho, JWK; June, YL; Liu, T; Alver, BH; Lee, S; Ikegami, K; Sohn, KA; Minoda, A; Tolstorukov, MY; Appert, A; Parker, SCJ; Gu, TT; Kundaje, A; Riddle, NC; Bishop, E; Egelhofer, TA; Hu, SS; Alekseyenko, AA; Rechtsteiner, A; Asker, D; Belsky, JA; Bowmanm, SK; Chens, QB; Chen, RAJ; Day, DS; Dong, Y; Dose, AC; Duan, XK; Epstein, CB; Ercan, S; Feingold, EA; Ferrari, F; Garrigues, JM; Gehlenborg, N; Good, PJ; Haseley, P; He, D; Herrmann, M; Hoffman, MM; Jeffers, TE; Kharchenko, PV; Kolasinska-Zwierz, P; Kotwaliwale, CV; Kumar, N; Langley, SA; Larschan, EN; Latorre, I; Libbrecht, MW; Lin, XQ; Park, R; Pazin, MJ; Pham, HN; Plachetka, A; Qin, B; Schwartz, YB; Shoresh, N; Stempor, P; Vielle, A; Wang, CY; Whittle, CM; Xue, HL; Kingstonm, RE; Kim, JH; Bernstein, BE; Dernburg, AF; Pirrotta, V; Kuroda, MI; Noble, WS; Tullius, TD; Kellis, M; MacAlpine, DM; Strome, S; Elgin, SCR; Liu, XS; Lieb, JD; Ahringer, J; Karpen, GH; Park, PJ				Ho, Joshua W. K.; June, Youngsook L.; Liu, Tao; Alver, Burak H.; Lee, Soohyun; Ikegami, Kohta; Sohn, Kyung-Ah; Minoda, Aki; Tolstorukov, Michael Y.; Appert, Alex; Parker, Stephen C. J.; Gu, Tingting; Kundaje, Anshul; Riddle, Nicole C.; Bishop, Eric; Egelhofer, Thea A.; Hu, Sheng'en Shawn; Alekseyenko, Artyom A.; Rechtsteiner, Andreas; Asker, Dalal; Belsky, Jason A.; Bowmanm, Sarah K.; Chens, Q. Brent; Chen, Ron A. -J.; Day, Daniel S.; Dong, Yan; Dose, Andrea C.; Duan, Xikun; Epstein, Charles B.; Ercan, Sevinc; Feingold, Elise A.; Ferrari, Francesco; Garrigues, Jacob M.; Gehlenborg, Nils; Good, Peter J.; Haseley, Psalm; He, Daniel; Herrmann, Moritz; Hoffman, Michael M.; Jeffers, Tess E.; Kharchenko, Peter V.; Kolasinska-Zwierz, Paulina; Kotwaliwale, Chitra V.; Kumar, Nischay; Langley, Sasha A.; Larschan, Erica N.; Latorre, Isabel; Libbrecht, Maxwell W.; Lin, Xueqiu; Park, Richard; Pazin, Michael J.; Pham, Hoang N.; Plachetka, Annette; Qin, Bo; Schwartz, Yuri B.; Shoresh, Noam; Stempor, Przemyslaw; Vielle, Anne; Wang, Chengyang; Whittle, Christina M.; Xue, Huiling; Kingstonm, Robert E.; Kim, Ju Han; Bernstein, Bradley E.; Dernburg, Abby F.; Pirrotta, Vincenzo; Kuroda, Mitzi I.; Noble, William S.; Tullius, Thomas D.; Kellis, Manolis; MacAlpine, David M.; Strome, Susan; Elgin, Sarah C. R.; Liu, Xiaole Shirley; Lieb, Jason D.; Ahringer, Julie; Karpen, Gary H.; Park, Peter J.			Comparative analysis of metazoan chromatin organization	NATURE			English	Article							CENTROMERIC CHROMATIN; DROSOPHILA GENOME; MODENCODE; ELEMENTS; ELEGANS; STATE; TRANSCRIPTION; METHYLATION; DOMAINS; ENCODE	Genome function is dynamically regulated in part by chromatin, which consists of the histones, non-histone proteins and RNA molecules that package DNA. Studies in Caenorhabditis elegans and Drosophila melanogaster have contributed substantially to our understanding of molecular mechanisms of genome function in humans, and have revealed conservation of chromatin components and mechanisms(1-3). Nevertheless, the three organisms have markedly different genome sizes, chromosome architecture and gene organization. On human and fly chromosomes, for example, pericentric heterochromatin flanks single centromeres, whereas worm chromosomes have dispersed heterochromatin-like regions enriched in the distal chromosomal 'arms', and centromeres distributed along their lengths(4,5). To systematically investigate chromatin organization and associated gene regulation across species, we generated and analysed a large collection of genome-wide chromatin data sets from cell lines and developmental stages in worm, fly and human. Here we present over 800 new data sets from our ENCODE and modENCODE consortia, bringing the total to over 1,400. Comparison of combinatorial patterns of histone modifications, nuclear lamina-associated domains, organization of large-scale topological domains, chromatin environment at promoters and enhancers, nucleosome positioning, and DNA replication patterns reveals many conserved features of chromatin organization among the three organisms. We also find notable differences in the composition and locations of repressive chromatin. These data sets and analyses provide a rich resource for comparative and species-specific investigations of chromatin composition, organization and function.	[Ho, Joshua W. K.; June, Youngsook L.; Alver, Burak H.; Lee, Soohyun; Tolstorukov, Michael Y.; Bishop, Eric; Day, Daniel S.; Ferrari, Francesco; Gehlenborg, Nils; Haseley, Psalm; Kharchenko, Peter V.; Park, Richard; Xue, Huiling; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Ho, Joshua W. K.; June, Youngsook L.; Tolstorukov, Michael Y.; Alekseyenko, Artyom A.; Haseley, Psalm; Plachetka, Annette; Xue, Huiling; Kuroda, Mitzi I.; Park, Peter J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Liu, Tao; Liu, Xiaole Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Liu, Tao; Liu, Xiaole Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Liu, Tao; Liu, Xiaole Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Ikegami, Kohta; Chens, Q. Brent; Ercan, Sevinc; Jeffers, Tess E.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Ikegami, Kohta; Chens, Q. Brent; Ercan, Sevinc; Jeffers, Tess E.; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Sohn, Kyung-Ah] Ajou Univ, Dept Informat & Comp Engn, Suwon 443749, South Korea; [Sohn, Kyung-Ah; Kim, Ju Han] Seoul Natl Univ, Coll Med, Syst Biomed Informat Res Ctr, Seoul 110799, South Korea; [Minoda, Aki; Langley, Sasha A.; Pham, Hoang N.; Vielle, Anne; Dernburg, Abby F.; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Genome Dynam, Berkeley, CA 94720 USA; [Minoda, Aki; He, Daniel; Kotwaliwale, Chitra V.; Langley, Sasha A.; Pham, Hoang N.; Whittle, Christina M.; Dernburg, Abby F.; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Tolstorukov, Michael Y.; Bowmanm, Sarah K.; Kingstonm, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Tolstorukov, Michael Y.; Bowmanm, Sarah K.; Kingstonm, Robert E.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Appert, Alex; Chen, Ron A. -J.; Dong, Yan; Herrmann, Moritz; Kolasinska-Zwierz, Paulina; Latorre, Isabel; Stempor, Przemyslaw; Vielle, Anne; Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Appert, Alex; Chen, Ron A. -J.; Dong, Yan; Herrmann, Moritz; Kolasinska-Zwierz, Paulina; Latorre, Isabel; Stempor, Przemyslaw; Vielle, Anne; Ahringer, Julie] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Parker, Stephen C. J.] NIGMS, NIH, Bethesda, MD 20892 USA; [Parker, Stephen C. J.; Feingold, Elise A.; Good, Peter J.; Pazin, Michael J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Gu, Tingting; Riddle, Nicole C.; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kundaje, Anshul; Kumar, Nischay; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Alver, Burak H.; Kundaje, Anshul; Epstein, Charles B.; Gehlenborg, Nils; Kumar, Nischay; Shoresh, Noam; Vielle, Anne; Bernstein, Bradley E.; Kellis, Manolis; Liu, Xiaole Shirley] Broad Inst, Cambridge, MA 02141 USA; [Bishop, Eric; Park, Richard; Tullius, Thomas D.] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Egelhofer, Thea A.; Rechtsteiner, Andreas; Garrigues, Jacob M.; Strome, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Hu, Sheng'en Shawn; Duan, Xikun; Lin, Xueqiu; Qin, Bo; Wang, Chengyang] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Alekseyenko, Artyom A.; Plachetka, Annette; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Asker, Dalal; Schwartz, Yuri B.; Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Asker, Dalal] Univ Alexandria, Fac Agr, Food Sci & Technol Dept, Alexandria 21545, Egypt; [Belsky, Jason A.; MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Day, Daniel S.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Dose, Andrea C.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Ercan, Sevinc] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hoffman, Michael M.] Princess Margaret Canc Ctr, Toronto, ON M6G 1L7, Canada; [Kotwaliwale, Chitra V.; Pham, Hoang N.; Whittle, Christina M.; Bernstein, Bradley E.; Dernburg, Abby F.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Larschan, Erica N.] Brown Univ, Dept Mol Biol Cellular Biol & Biochem, Providence, RI 02912 USA; [Libbrecht, Maxwell W.; Noble, William S.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Schwartz, Yuri B.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Kim, Ju Han] Seoul Natl Univ, Coll Med, Div Biomed Informat, Seoul Natl Univ Biomed Informat, Seoul 110799, South Korea; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Noble, William S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Tullius, Thomas D.] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Ajou University; Seoul National University (SNU); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; University of California System; University of California Santa Cruz; Tongji University; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Egyptian Knowledge Bank (EKB); Alexandria University; Duke University; Harvard University; University of California System; University of California Davis; New York University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Howard Hughes Medical Institute; Brown University; University of Washington; University of Washington Seattle; Umea University; Seoul National University (SNU); Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Boston University; Harvard University; Boston Children's Hospital	MacAlpine, DM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	david.macalpine@duke.edu; sstrome@ucsc.edu; selgin@biology2.wustl.edu; xsliu@jimmy.harvard.edu; jdlieb@uchicago.edu; ja219@cam.ac.uk; ghkarpen@lbl.gov; peter_park@hms.harvard.edu	Parker, Stephen/ABF-1063-2021; Kundaje, Anshul/Y-2598-2019; Minoda, Aki/D-5335-2017; lin, xueqiu/AGI-7531-2022; Kundaje, Anshul/Y-2739-2019; Ho, Joshua W. K./AAK-7759-2020; Ferrari, Francesco/H-5007-2012; Sohn, Kyung-Ah/AAD-8788-2021; Kellis, Manolis/ABE-7385-2020; Hoffman, Michael M./I-1924-2012; Tullius, Thomas D./A-9685-2008; Liu, Tao/AAO-6310-2021; Asker, Dalal/B-5722-2009; Minoda, Aki/Q-4454-2019; Liu, Tao/G-3585-2010	Kundaje, Anshul/0000-0003-3084-2287; Minoda, Aki/0000-0002-2927-5791; Kundaje, Anshul/0000-0003-3084-2287; Ho, Joshua W. K./0000-0003-2331-7011; Ferrari, Francesco/0000-0002-9811-3753; Sohn, Kyung-Ah/0000-0001-8941-1188; Kellis, Manolis/0000-0001-7113-9630; Hoffman, Michael M./0000-0002-4517-1562; Tullius, Thomas D./0000-0003-4425-796X; Liu, Tao/0000-0002-8818-8313; Minoda, Aki/0000-0002-2927-5791; Liu, Tao/0000-0002-8818-8313; Belsky, Jason/0000-0003-2945-6282; Asker, Dalal/0000-0002-2291-7579; Park, Peter/0000-0001-9378-960X; Chen, Q Brent/0000-0002-7534-7725; Pazin, Michael/0000-0002-7561-3640; Lee, Soohyun/0000-0002-3594-6213; Stempor, Przemyslaw/0000-0002-9464-7475; Jeffers, Tess/0000-0003-4908-0796; Riddle, Nicole/0000-0003-1827-9145; Alver, Burak/0000-0002-5019-7652; Epstein, Charles B./0000-0001-8358-8345; Gehlenborg, Nils/0000-0003-0327-8297; Chen, Ron/0000-0001-9186-6747; Lieb, Jason/0000-0001-7601-8061; Ahringer, Julie/0000-0002-7074-4051; Elgin, Sarah C. R./0000-0002-5176-2510; Liu, Tao/0000-0003-0446-9001; Rechtsteiner, Andreas/0000-0001-6031-1087; Latorre, Isabel/0000-0003-0638-1783	NHGRI [U01HG004258, U01 HG004270, U01HG004279, U54HG004570, U01HG004695, K99HG006259]; NHBIB [5RL9EB008539]; NIGMS; NIH [U54CA121852]; NSF [1122374]; National Natural Science Foundation of China [31028011]; MEST Korea [MHW-2013-HI13C2164]; Wellcome Trust [54523];  [NRF-2012-0000994]; Direct For Biological Sciences [0644282] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, U54HG006991, T32HG002295, U01HG004258, U01HG004270, U01HG004279, K99HG006259, R01HG004037, U01HG004695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [RL9EB008539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098461, R37GM048405, T32GM071340] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHBIB; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MEST Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Wellcome Trust(Wellcome Trust); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was mainly funded by NHGRI U01HG004258 (G.H.K., S.C.R.E., M.I.K., P.J.P., V.P.), U01 HG004270 (J.D.L., J.A., A.F.D., X.S.L., S.S.), U01HG004279 (D.M.M.), U54HG004570 (B.E.B.) and U01HG004695 (W.S.N.). It is also supported by NHBIB 5RL9EB008539 (J.W.K.H.), NHGRI K99HG006259 (M.M.H.), NIGMS fellowships (S.C.J.P., E.N.L.), NIH U54CA121852 (T.D.T.), NSF 1122374 (D.S.D.), National Natural Science Foundation of China 31028011 (X.S.L.), MEST Korea MHW-2013-HI13C2164 (J.H.K.), NRF-2012-0000994 (K-AS.), and Wellcome Trust 54523 (J.A.). We thank D. Acevedo and C. Kennedy for technical assistance.	Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	24	236	239	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					449	U507		10.1038/nature13415	http://dx.doi.org/10.1038/nature13415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25164756	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000340840600038
J	Puri, S				Puri, Sunita			Extraordinary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Dept Gen Med Disciplines, Div Palliat Med, Hosp & Clin, Palo Alto, CA 94304 USA	Stanford University	Puri, S (corresponding author), Stanford Univ, Dept Gen Med Disciplines, Div Palliat Med, Hosp & Clin, Palo Alto, CA 94304 USA.	sunita.puri@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					793	794		10.1001/jama.2014.6776	http://dx.doi.org/10.1001/jama.2014.6776			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157720				2022-12-28	WOS:000340788500019
J	Chalhoub, B; Denoeud, F; Liu, SY; Parkin, IAP; Tang, HB; Wang, XY; Chiquet, J; Belcram, H; Tong, CB; Samans, B; Correa, M; Da Silva, C; Just, J; Falentin, C; Koh, CS; Le Clainche, I; Bernard, M; Bento, P; Noel, B; Labadie, K; Alberti, A; Charles, M; Arnaud, D; Guo, H; Daviaud, C; Alamery, S; Jabbari, K; Zhao, MX; Edger, PP; Chelaifa, H; Tack, D; Lassalle, G; Mestiri, I; Schnel, N; Le Paslier, MC; Fan, GY; Renault, V; Bayer, PE; Golicz, AA; Manoli, S; Lee, TH; Thi, VHD; Chalabi, S; Hu, Q; Fan, CC; Tollenaere, R; Lu, YH; Battail, C; Shen, JX; Sidebottom, CHD; Wang, XF; Canaguier, A; Chauveau, A; Berard, A; Deniot, G; Guan, M; Liu, ZS; Sun, FM; Lim, YP; Lyons, E; Town, CD; Bancroft, I; Wang, XW; Meng, JL; Ma, JX; Pires, JC; King, GJ; Brunel, D; Delourme, R; Renard, M; Aury, JM; Adams, KL; Batley, J; Snowdon, RJ; Tost, J; Edwards, D; Zhou, YM; Hua, W; Sharpe, AG; Paterson, AH; Guan, CY; Wincker, P				Chalhoub, Boulos; Denoeud, France; Liu, Shengyi; Parkin, Isobel A. P.; Tang, Haibao; Wang, Xiyin; Chiquet, Julien; Belcram, Harry; Tong, Chaobo; Samans, Birgit; Correa, Margot; Da Silva, Corinne; Just, Jeremy; Falentin, Cyril; Koh, Chu Shin; Le Clainche, Isabelle; Bernard, Maria; Bento, Pascal; Noel, Benjamin; Labadie, Karine; Alberti, Adriana; Charles, Mathieu; Arnaud, Dominique; Guo, Hui; Daviaud, Christian; Alamery, Salman; Jabbari, Kamel; Zhao, Meixia; Edger, Patrick P.; Chelaifa, Houda; Tack, David; Lassalle, Gilles; Mestiri, Imen; Schnel, Nicolas; Le Paslier, Marie-Christine; Fan, Guangyi; Renault, Victor; Bayer, Philippe E.; Golicz, Agnieszka A.; Manoli, Sahana; Lee, Tae-Ho; Vinh Ha Dinh Thi; Chalabi, Smahane; Hu, Qiong; Fan, Chuchuan; Tollenaere, Reece; Lu, Yunhai; Battail, Christophe; Shen, Jinxiong; Sidebottom, Christine H. D.; Wang, Xinfa; Canaguier, Aurelie; Chauveau, Aurelie; Berard, Aurelie; Deniot, Gwenaelle; Guan, Mei; Liu, Zhongsong; Sun, Fengming; Lim, Yong Pyo; Lyons, Eric; Town, Christopher D.; Bancroft, Ian; Wang, Xiaowu; Meng, Jinling; Ma, Jianxin; Pires, J. Chris; King, Graham J.; Brunel, Dominique; Delourme, Regine; Renard, Michel; Aury, Jean-Marc; Adams, Keith L.; Batley, Jacqueline; Snowdon, Rod J.; Tost, Jorg; Edwards, David; Zhou, Yongming; Hua, Wei; Sharpe, Andrew G.; Paterson, Andrew H.; Guan, Chunyun; Wincker, Patrick			Early allopolyploid evolution in the post-Neolithic Brassica napus oilseed genome	SCIENCE			English	Article							GENE; DOMINANCE; COTTON; PLANT	Oilseed rape (Brassica napus L.) was formed similar to 7500 years ago by hybridization between B. rapa and B. oleracea, followed by chromosome doubling, a process known as allopolyploidy. Together with more ancient polyploidizations, this conferred an aggregate 72x genome multiplication since the origin of angiosperms and high gene content. We examined the B. napus genome and the consequences of its recent duplication. The constituent A(n) and C-n subgenomes are engaged in subtle structural, functional, and epigenetic cross-talk, with abundant homeologous exchanges. Incipient gene loss and expression divergence have begun. Selection in B. napus oilseed types has accelerated the loss of glucosinolate genes, while preserving expansion of oil biosynthesis genes. These processes provide insights into allopolyploid evolution and its relationship with crop domestication and improvement.	[Chalhoub, Boulos; Belcram, Harry; Just, Jeremy; Le Clainche, Isabelle; Arnaud, Dominique; Jabbari, Kamel; Chelaifa, Houda; Mestiri, Imen; Vinh Ha Dinh Thi; Chalabi, Smahane; Lu, Yunhai; Canaguier, Aurelie] Univ Evry Val dEssone, Inst Natl Rech Agron INRA, Unite Rech Genom Vegetale, UMR1165, F-91057 Evry, France; [Denoeud, France; Correa, Margot; Da Silva, Corinne; Bernard, Maria; Bento, Pascal; Noel, Benjamin; Labadie, Karine; Alberti, Adriana; Battail, Christophe; Aury, Jean-Marc; Wincker, Patrick] Commissariat Energie Atom CEA, Inst Genom IG, F-91057 Evry, France; [Denoeud, France; Wincker, Patrick] Univ Evry Val dEssone, UMR 8030, F-91057 Evry, France; [Denoeud, France; Wincker, Patrick] Ctr Natl Rech Sci CNRS, UMR 8030, Evry, France; [Liu, Shengyi; Tong, Chaobo; Hu, Qiong; Wang, Xinfa; Hua, Wei] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr Peoples Republ China, Oil Crops Res Inst, Wuhan 430062, Peoples R China; [Parkin, Isobel A. P.] Agr & Agri Food Canada, Saskatoon, SK S7N 0X2, Canada; [Tang, Haibao; Town, Christopher D.] J Craig Venter Inst, Rockville, MD 20850 USA; [Tang, Haibao] Fujian Agr & Forestry Univ, Ctr Genom & Biotechnol, Fuzhou 350002, Fujian Province, Peoples R China; [Wang, Xiyin; Guo, Hui; Lee, Tae-Ho; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wang, Xiyin] Hebei United Univ, Sch Life Sci, Ctr Genom & Computat Biol, Tangshan 063000, Hebei, Peoples R China; [Chiquet, Julien] Univ Evry Val dEssone, Lab Math & Modelisat dEvry, CNRS, USC,INRA,UMR 8071, F-91057 Evry, France; [Samans, Birgit; Snowdon, Rod J.] Univ Giessen, Res Ctr Biosyst Land Use & Nutr, Dept Plant Breeding, D-35392 Giessen, Germany; [Falentin, Cyril; Lassalle, Gilles; Schnel, Nicolas; Deniot, Gwenaelle; Delourme, Regine; Renard, Michel] INRA, Inst Genet Environm & Protect Plantes IGEPP, UMR1349, F-35653 Le Rheu, France; [Koh, Chu Shin; Sidebottom, Christine H. D.; Sharpe, Andrew G.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Charles, Mathieu; Le Paslier, Marie-Christine; Chauveau, Aurelie; Berard, Aurelie; Brunel, Dominique] INRA, Ctr Natl Genotypage, CEA IG, US1279, F-91057 Evry, France; [Daviaud, Christian; Tost, Jorg] CEA IG, Ctr Natl Genotypage, Lab Epigenet & Environm, F-91000 Evry, France; [Alamery, Salman; Bayer, Philippe E.; Golicz, Agnieszka A.; Manoli, Sahana; Tollenaere, Reece; Batley, Jacqueline; Edwards, David] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Jabbari, Kamel] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Zhao, Meixia; Ma, Jianxin] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Edger, Patrick P.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Tack, David; Adams, Keith L.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Fan, Guangyi; Sun, Fengming] Beijing Genome Inst Shenzhen, Shenzhen 518083, Peoples R China; [Renault, Victor] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Fan, Chuchuan; Shen, Jinxiong; Meng, Jinling; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Guan, Mei; Liu, Zhongsong; Guan, Chunyun] Hunan Agr Univ, Coll Agron, Changsha 410128, Hunan, Peoples R China; [Lim, Yong Pyo] Chungnam Natl Univ, Dept Hort, Mol Genet & Genom Lab, Taejon 305764, South Korea; [Lyons, Eric] Univ Arizona, Sch Plant Sci, IPlant Collaborat, Tucson, AZ USA; [Bancroft, Ian] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Pires, J. Chris] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [King, Graham J.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia; [Batley, Jacqueline; Edwards, David] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Agriculture & Agri Food Canada; J. Craig Venter Institute; Fujian Agriculture & Forestry University; University System of Georgia; University of Georgia; North China University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Justus Liebig University Giessen; INRAE; National Research Council Canada; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Queensland; University of Cologne; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Berkeley; University of British Columbia; Beijing Genomics Institute (BGI); Foundation Jean Dausset-CEPH; Huazhong Agricultural University; Hunan Agricultural University; Chungnam National University; University of Arizona; University of York - UK; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Missouri System; University of Missouri Columbia; Southern Cross University; University of Western Australia	Chalhoub, B (corresponding author), Univ Evry Val dEssone, Inst Natl Rech Agron INRA, Unite Rech Genom Vegetale, UMR1165, 2 Rue Gaston Cremieux, F-91057 Evry, France.	chalhoub@evry.inra.fr	Shen, Jinxiong/Z-3988-2019; Wang, Xiaowu/L-2579-2019; Labadie, Karine/AAG-7355-2022; King, Graham J/AAW-3368-2020; Parkin, Isobel/AAD-6625-2020; Chiquet, Julien/M-8347-2019; Attia, KOTB A/U-4076-2017; ZHAO, MEIXIA/N-3124-2015; Bancroft, Ian/AAH-3831-2020; Alberti, Adriana/E-7142-2017; Bayer, Philipp Emanuel/L-4481-2018; Tang, Haibao/A-6715-2011; Tost, Joerg/H-7129-2019; Batley, Jacqueline/A-5723-2008; Edger, Patrick/ABE-6442-2020; Edger, Patrick/AAP-3846-2021; Labadie, Karine/AFL-7408-2022; Shen, Jinxiong/AAT-3318-2021; Alberti, Adriana/AAZ-2013-2021; Pires, J. Chris/O-5122-2014; Aury, Jean-Marc/N-1621-2019; Edwards, David/H-3710-2015; Liu, Shengyi/S-6772-2016	Labadie, Karine/0000-0001-7467-8509; King, Graham J/0000-0002-5975-6051; Chiquet, Julien/0000-0002-3629-3429; Attia, KOTB A/0000-0002-2992-1765; ZHAO, MEIXIA/0000-0001-8812-8217; Alberti, Adriana/0000-0003-3372-9423; Bayer, Philipp Emanuel/0000-0001-8530-3067; Tang, Haibao/0000-0002-3460-8570; Tost, Joerg/0000-0002-2683-0817; Batley, Jacqueline/0000-0002-5391-5824; Labadie, Karine/0000-0001-7467-8509; Alberti, Adriana/0000-0003-3372-9423; Pires, J. Chris/0000-0001-9682-2639; Aury, Jean-Marc/0000-0003-1718-3010; Edwards, David/0000-0001-7599-6760; Bernard, Maria/0000-0001-9005-5563; Mestiri, Imen/0000-0002-7528-2781; Parkin, Isobel/0000-0002-5807-9466; Liu, Shengyi/0000-0002-4955-4763; Golicz, Agnieszka/0000-0002-9711-4826; DINH, Thi Vinh Ha/0000-0002-5420-7352; Fan, Chuchuan/0000-0001-8443-7194; DA SILVA, Corinne/0000-0002-7618-7831; Bancroft, Ian/0000-0001-7707-1171; Denoeud, France/0000-0001-8819-7634; Battail, Christophe/0000-0001-6849-7824; Noel, Benjamin/0000-0002-5830-3253; Koh, ChuShin/0000-0001-7313-2125; Lyons, Eric/0000-0002-3348-8845; Just, Jeremy/0000-0003-0842-9808; FALENTIN, Cyril/0000-0002-9901-3412	French ANR (Agence Nationale de la Recherche) [ANR-09-GENM-021]; Sofi-Proteol for bioinformatic personnnel; National Basic Research Program of China [2011CB109300]; Canadian Canola Genome Sequencing Initiative (Genome Alberta); Canadian Canola Genome Sequencing Initiative; Biotechnology and Biological Sciences Research Council [BB/E017363/1] Funding Source: researchfish; BBSRC [BB/E017363/1] Funding Source: UKRI	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Sofi-Proteol for bioinformatic personnnel; National Basic Research Program of China(National Basic Research Program of China); Canadian Canola Genome Sequencing Initiative (Genome Alberta); Canadian Canola Genome Sequencing Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sequence Read Archive accession numbers of B. napus sequencing data are ERP005275 and PRJEB6069, and those of B. rapa and B. oleracea data are PRJNA248388 and PRJNA158027. The B. napus assembly is available at ENA (European Nucleotide Archive), in the WGS section for contigs (accession numbers CCCW010000001 to CCCW010044187) and the CON section for scaffolds, chromosomes, and annotation (accession numbers LK031787 to LK052685). The B. napus genome is also available at CoGe (https://genomevolution.org/CoGe/) and at (www.genoscope.cns.fr/brassicanapus) the Genoscope Genome Database, with additional tools for comparative genomic analysis. The B. napus segregating populations Darmor-bzh x Yudal and Darmor x Bristol are available at INRA-IGEPP, Rennes, France, under a material transfer agreement. This project was funded by the French ANR (Agence Nationale de la Recherche, www.agence-nationale-recherche.fr) 2009 (ANR-09-GENM-021) to B. C., P. W., D. B., and R. D., with additional funding from Sofi-Proteol for bioinformatic personnnel (J. J.); the National Basic Research Program of China (2011CB109300) for S. L., Y. Z., C. G., and W. H.; and the Canadian Canola Genome Sequencing Initiative (http://aafc-aac.usask.ca/canseq/, Genome Alberta, and industry partners) for I. A. P. P., A. G. S., C. K., and C. S. Research leaders are B. C., S. L., I. A. P. P., X. W., I. B., R. D., J. B., D. E., Y. Z., W. H., A. G. S., A. H. P., C. G., and P. W. Additional acknowledgements and author contributions are included in the supplementary materials.	Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Allender CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-54; Buggs RJA, 2011, CURR BIOL, V21, P551, DOI 10.1016/j.cub.2011.02.016; Darwin C., 1905, VARIATION ANIMALS PL, V2, P398; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; FOISSET N, 1995, THEOR APPL GENET, V91, P756, DOI 10.1007/BF00220955; Garsmeur O, 2014, MOL BIOL EVOL, V31, P448, DOI 10.1093/molbev/mst230; Ilut DC, 2012, AM J BOT, V99, P383, DOI 10.3732/ajb.1100312; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu H. L., 2000, RAPESEED GENETICS BR, P1; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lynch M, 2000, GENETICS, V154, P459; Nagaharu U., 1935, JPN J BOT, V7, P389, DOI DOI 10.1038/35036519; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Prakash S., 1980, Brassica crops and wild allies. [I]., P151; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Sharpe AG, 2003, GENOME, V46, P461, DOI 10.1139/G03-031; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zou XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045751	24	1367	1509	44	568	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					950	953		10.1126/science.1253435	http://dx.doi.org/10.1126/science.1253435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146293				2022-12-28	WOS:000340524700051
J	Althoff, T; Hibbs, RE; Banerjee, S; Gouaux, E				Althoff, Thorsten; Hibbs, Ryan E.; Banerjee, Surajit; Gouaux, Eric			X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors	NATURE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; COUPLING AGONIST BINDING; CRYSTAL-STRUCTURE; M2 DOMAIN; PHARMACOLOGY; ANTAGONISTS; PERMEATION; COMPLEXES	Cys-loop receptors are neurotransmitter-gated ion channels that are essential mediators of fast chemical neurotransmission and are associated with a large number of neurological diseases and disorders, as well as parasitic infections(1-4). Members of this ion channel superfamily mediate excitatory or inhibitory neurotransmission depending on their ligand and ion selectivity. Structural information for Cys-loop receptors comes from several sources including electron microscopic studies of the nicotinic acetylcholine receptor(5), high-resolution X-ray structures of extracellular domains(6) and X-ray structures of bacterial orthologues(7-10). In 2011 our group published structures of the Caenorhabditis elegans glutamate-gated chloride channel (GluCl) in complex with the allosteric partial agonist ivermectin, which provided insights into the structure of a possibly open state of a eukaryotic Cys-loop receptor, the basis for anion selectivity and channel block, and the mechanism by which ivermectin and related molecules stabilize the open state and potentiate neurotransmitter binding(11). However, there remain unanswered questions about the mechanism of channel opening and closing, the location and nature of the shut ion channel gate, the transitions between the closed/resting, open/activated and closed/desensitized states, and the mechanism by which conformational changes are coupled between the extracellular, orthosteric agonist binding domain and the transmembrane, ion channel domain. Here we present two conformationally distinct structures of C. elegans GluCl in the absence of ivermectin. Structural comparisons reveal a quaternary activation mechanism arising from rigid-body movements between the extracellular and transmembrane domains and a mechanism for modulation of the receptor by phospholipids.	[Althoff, Thorsten; Hibbs, Ryan E.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Banerjee, Surajit] Cornell Univ, NE CAT, Argonne, IL 60439 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Cornell University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Althoff, Thorsten/AAT-6968-2021	Gouaux, Eric/0000-0002-8549-2360; Althoff, Thorsten/0000-0001-5688-5328; Banerjee, Surajit/0000-0002-9414-7163	Deutsche Forschungsgemeinschaft [AL 1725-1/1]; NIH National Research Service Award [F32NS061404]; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM100400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061404] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all staff of beamline 24-ID-C at the Advanced Photon Source. We thank L. Vaskalis and H. Owen for help in figure and manuscript preparation, respectively. D. Cawley at the Vaccine and Gene Therapy Institute, OHSU, provided the monoclonal antibody. We appreciate discussions with Gouaux laboratory members. This work was supported by a postdoctoral fellowship (Forschungsstipendium AL 1725-1/1) from the Deutsche Forschungsgemeinschaft to T. A. and an individual NIH National Research Service Award (F32NS061404) to R. E. H; E. G. is supported by the NIH and is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Boatin BA, 2006, ADV PARASIT, V61, P349, DOI 10.1016/S0065-308X(05)61009-3; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Gleitsman KR, 2009, CHEMBIOCHEM, V10, P1385, DOI 10.1002/cbic.200900092; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lee WY, 2008, J GEN PHYSIOL, V132, P265, DOI 10.1085/jgp.200810014; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Velisetty P, 2014, J BIOL CHEM, V289, P3013, DOI 10.1074/jbc.M113.523050; Yoluk O, 2013, BIOPHYS J, V105, P640, DOI 10.1016/j.bpj.2013.06.037	46	192	194	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					333	+		10.1038/nature13669	http://dx.doi.org/10.1038/nature13669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143115	Green Accepted			2022-12-28	WOS:000340508200040
J	Kwiatkowski, DJ; Manning, BD				Kwiatkowski, David J.; Manning, Brendan D.			Molecular Basis of Giant Cells in Tuberous Sclerosis Complex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NOVO PYRIMIDINE SYNTHESIS; MTOR; LYMPHANGIOLEIOMYOMATOSIS; GROWTH; ACTIVATION; TSC2; ANGIOMYOLIPOMA; PROLIFERATION; DOWNSTREAM; EVEROLIMUS		[Kwiatkowski, David J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Kwiatkowski, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956				Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Bourneville D., 1880, ARCH NEUROL-CHICAGO, V1, P81; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Franz DN, 2013, LANCET, V381, P116; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4	20	38	41	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					778	780		10.1056/NEJMcibr1406613	http://dx.doi.org/10.1056/NEJMcibr1406613			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140966				2022-12-28	WOS:000340509900016
J	Mehilli, J; Massberg, S				Mehilli, Julinda; Massberg, Steffen			Revisiting the BIOSCIENCE of drug-eluting stent technology	LANCET			English	Editorial Material							INTRAVASCULAR ULTRASOUND; NON-INFERIORITY; THROMBOSIS; COATINGS		[Mehilli, Julinda] Univ Munich, Munich Univ Clin, D-81377 Munich, Germany; Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Mehilli, J (corresponding author), Univ Munich, Munich Univ Clin, D-81377 Munich, Germany.	julinda.mehilli@med.uni-muenchen.de	Massberg, Steffen/AAN-6054-2021; Mehilli, Julinda/F-2629-2016					Bangalore S, 2013, BMJ-BRIT MED J, V8347, P6625; Barragan P, 2014, EUROINTERVENTION, V9, P1454, DOI 10.4244/EIJV9I12A243; Byrne RA, 2014, LANCET, V383, P386, DOI 10.1016/S0140-6736(13)62240-0; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Cheneau E, 2003, CIRCULATION, V108, P43, DOI 10.1161/01.CIR.0000078636.71728.40; Hamon M, 2013, EUROINTERVENTION, V8, P1006, DOI 10.4244/EIJV8I9A155; Hong YJ, 2013, INT J CARDIOL, V166, P646, DOI 10.1016/j.ijcard.2011.11.092; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Palmerini T, 2013, J AM COLL CARDIOL, V62, P1915, DOI 10.1016/j.jacc.2013.08.725; Pilgrim T, 2014, LANCET; Yamaji K, 2012, CIRC-CARDIOVASC INTE, V5, P47, DOI 10.1161/CIRCINTERVENTIONS.111.964965	11	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2086	2088		10.1016/S0140-6736(14)61415-X	http://dx.doi.org/10.1016/S0140-6736(14)61415-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25189360				2022-12-28	WOS:000346354300006
J	Sanchez, LT				Sanchez, Luis T.			Disruptive Behaviors Among Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sanchez, Luis T.] Massachusetts Med Soc, Phys Hlth Serv, Waltham, MA USA		Sanchez, LT (corresponding author), Phys Hlth Serv Inc, 860 Winter St, Waltham, MA 02451 USA.	ltsanchez@verizon.net						American Medical Association Council on Ethical and Judicial Affairs, 2000, 2A00 AM MED ASS; [Anonymous], 2008, SENTINEL EVENT ALERT, P1; Friedberg MW, 2013, FACTORS AFFECTING PR; Joint Commission Hospital Accreditation Standards, LD030303LD18; Joint Commission on Accreditation of Healthcare Organizations, 2012, JT COMM PERSPECT, V32, P7; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; MacDonald O., 2011, DISRUPTIVE PHYS BEHA; Rosenstein AH, 2008, JT COMM J QUAL PATIE, V34, P464, DOI 10.1016/S1553-7250(08)34058-6	8	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2209	2210		10.1001/jama.2014.10218	http://dx.doi.org/10.1001/jama.2014.10218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25144182				2022-12-28	WOS:000345684800010
J	Schulz, MD; Atay, C; Heringer, J; Romrig, FK; Schwitalla, S; Aydin, B; Ziegler, PK; Varga, J; Reindl, W; Pommerenke, C; Salinas-Riester, G; Bock, A; Alpert, C; Blaut, M; Polson, SC; Brandl, L; Kirchner, T; Greten, FR; Polson, SW; Arkan, MC				Schulz, Manon D.; Atay, Cigdem; Heringer, Jessica; Romrig, Franziska K.; Schwitalla, Sarah; Aydin, Begum; Ziegler, Paul K.; Varga, Julia; Reindl, Wolfgang; Pommerenke, Claudia; Salinas-Riester, Gabriela; Boeck, Andreas; Alpert, Carl; Blaut, Michael; Polson, Sara C.; Brandl, Lydia; Kirchner, Thomas; Greten, Florian R.; Polson, Shawn W.; Arkan, Melek C.			High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity	NATURE			English	Article							MICROBIAL ECOLOGY; GUT; INNATE; INFLAMMATION; METABOLISM; INTERFACE; SEQUENCES; CELLS	Several features common to a Western lifestyle, including obesity and low levels of physical activity, are known risk factors for gastrointestinal cancers(1). There is substantial evidence suggesting that diet markedly affects the composition of the intestinal microbiota(2). Moreover, there is now unequivocal evidence linking dysbiosis to cancer development(3). However, the mechanisms by which high-fat diet (HFD)-mediated changes in the microbial community affect the severity of tumorigenesis in the gut remain to be determined. Here we demonstrate that an HFD promotes tumour progression in the small intestine of genetically susceptible, K-ras(G12Dint), mice independently of obesity. HFD consumption, in conjunction with K-ras mutation, mediated a shift in the composition of the gut microbiota, and this shift was associated with a decrease in Paneth-cell-mediated antimicrobial host defence that compromised dendritic cell recruitment and MHC class II molecule presentation in the gut-associated lymphoid tissues. When butyrate was administered to HFD-fed K-ras(G12Dint) mice, dendritic cell recruitment in the gut-associated lymphoid tissues was normalized, and tumour progression was attenuated. Importantly, deficiency in MYD88, a signalling adaptor for pattern recognition receptors and Toll-like receptors, blocked tumour progression. The transfer of faecal samples from HFD-fed mice with intestinal tumours to healthy adult K-ras(G12Dint) mice was sufficient to transmit disease in the absence of an HFD. Furthermore, treatment with antibiotics completely blocked HFD-induced tumour progression, suggesting that distinct shifts in the microbiota have a pivotal role in aggravating disease. Collectively, these data underscore the importance of the reciprocal interaction between host and environmental factors in selecting a microbiota that favours carcinogenesis, and they suggest that tumorigenesis is transmissible among genetically predisposed individuals.	[Schulz, Manon D.; Atay, Cigdem; Heringer, Jessica; Romrig, Franziska K.; Schwitalla, Sarah; Arkan, Melek C.] Tech Univ Munich, Inst Mol Immunol, Klinikum Rechts Isar, D-81675 Munich, Germany; [Aydin, Begum] Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey; [Ziegler, Paul K.; Varga, Julia; Greten, Florian R.] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany; [Ziegler, Paul K.; Varga, Julia; Kirchner, Thomas; Greten, Florian R.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Ziegler, Paul K.; Varga, Julia; Kirchner, Thomas; Greten, Florian R.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Reindl, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Dept Internal Med 2, D-68167 Mannheim, Germany; [Pommerenke, Claudia; Salinas-Riester, Gabriela] Univ Med Ctr Gottingen, Microarray & Deep Sequencing Core Facil, D-37077 Gottingen, Germany; [Boeck, Andreas] Tech Univ Munich, Inst Math Stat, D-81675 Munich, Germany; [Alpert, Carl; Blaut, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, D-14558 Nuthetal, Germany; [Polson, Sara C.; Polson, Shawn W.] Univ Delaware, Delaware Biotechnol Inst, Ctr Bioinformat & Computat Biol, Newark, DE 19711 USA; [Brandl, Lydia; Kirchner, Thomas] Univ Munich, Inst Pathol, D-80337 Munich, Germany	Technical University of Munich; Bogazici University; Octapharma; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Gottingen; Technical University of Munich; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Delaware; University of Munich	Arkan, MC (corresponding author), Tech Univ Munich, Inst Mol Immunol, Klinikum Rechts Isar, D-81675 Munich, Germany.	canan.arkan@lrz.tum.de	Greten, Florian R/AAF-5196-2020; Sch/AAA-9548-2021; Ziegler, Paul/AAO-4379-2021; Polson, Shawn/B-7696-2011	Greten, Florian R/0000-0002-3928-6080; Ziegler, Paul/0000-0002-7703-7747; Aydin, Begum/0000-0002-7066-5257; Polson, Shawn/0000-0002-3398-6932; Blaut, Michael/0000-0002-6628-2907; Varga, Julia/0000-0002-5171-3671	LOEWE Center for Cell and Gene Therapy Frankfurt (CGT) [III L 4-518/17.004]; Georg-Speyer-Haus; Deutsche Forschungsgemeinschaft (DFG) [Gr1916/5-1]; Deutsche Krebshilfe [108872, 107977]; ERC [ROSCAN-281967]; US National Institutes of Health National Institute of General Medical Sciences [8 P20 GM103446-12]; US National Science Foundation EPSCoR [EPS-081425]; DFG [AR710/2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	LOEWE Center for Cell and Gene Therapy Frankfurt (CGT); Georg-Speyer-Haus; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); ERC(European Research Council (ERC)European Commission); US National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation EPSCoR(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Burmeister and J. Khasawneh for technical assistance and H. Wagner for generously providing Myd88<SUP>-/-</SUP> mice. We are thankful to K. Offe and the PhD program 'Medical Life Sciences and Technology' for providing a fellowship to J.H. for one year. This work was supported in part by the LOEWE Center for Cell and Gene Therapy Frankfurt (CGT, III L 4-518/17.004) and institutional funds from the Georg-Speyer-Haus, as well as grants from the Deutsche Forschungsgemeinschaft (DFG) (Gr1916/5-1), the Deutsche Krebshilfe (108872) and the ERC (ROSCAN-281967) to F.R.G. Computational infrastructure made available to S.W.P. by the University of Delaware Center for Bioinformatics and Computational Biology Core Facility and the Delaware Biotechnology Institute was supported by grants from the US National Institutes of Health National Institute of General Medical Sciences (8 P20 GM103446-12) and the US National Science Foundation EPSCoR (EPS-081425). This work was supported by grants from the Deutsche Krebshilfe (107977) and the DFG (AR710/2-1) to M.C.A.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Meyer S, 2010, MOL HUM REPROD, V16, P846, DOI 10.1093/molehr/gaq060; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Redgwell RJ, 2005, MOL NUTR FOOD RES, V49, P521, DOI 10.1002/mnfr.200500028; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Smyth G.K., 2004, STAT APPL GENET MOL; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	37	272	295	5	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					508	+		10.1038/nature13398	http://dx.doi.org/10.1038/nature13398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25174708	Green Accepted			2022-12-28	WOS:000343775900044
J	Arlet, JB; Ribeil, JA; Guillem, F; Negre, O; Hazoume, A; Marcion, G; Beuzard, Y; Dussiot, M; Moura, IC; Demarest, S; de Beauchene, IC; Belaid-Choucair, Z; Sevin, M; Maciel, TT; Auclair, C; Leboulch, P; Chretien, S; Tchertanov, L; Baudin-Creuza, V; Seigneuric, R; Fontenay, M; Garrido, C; Hermine, O; Courtois, G				Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Negre, Olivier; Hazoume, Adonis; Marcion, Guillaume; Beuzard, Yves; Dussiot, Michael; Moura, Ivan Cruz; Demarest, Samuel; de Beauchene, Isaure Chauvot; Belaid-Choucair, Zakia; Sevin, Margaux; Maciel, Thiago Trovati; Auclair, Christian; Leboulch, Philippe; Chretien, Stany; Tchertanov, Luba; Baudin-Creuza, Veronique; Seigneuric, Renaud; Fontenay, Michaela; Garrido, Carmen; Hermine, Olivier; Courtois, Genevieve			HSP70 sequestration by free alpha-globin promotes ineffective erythropoiesis in beta-thalassaemia	NATURE			English	Article							GAMMA-GLOBIN; ERYTHROID PRECURSORS; GENE-EXPRESSION; PROTEIN; GATA-1; DIFFERENTIATION; HEMOGLOBIN; APOPTOSIS; CLEAVAGE; CELLS	beta-Thalassaemia major (beta-TM) is an inherited haemoglobinopathy caused by a quantitative defect in the synthesis of beta-globin chains of haemoglobin, leading to the accumulationof free alpha-globin chains that form toxic aggregates(1,2). Despite extensive knowledge of the molecular defects causing beta-TM, little is known of the mechanisms responsible for the ineffective erythropoiesis observed in the condition, which is characterized by accelerated erythroid differentiation, maturation arrest and apoptosis at the polychromatophilic stage(3-6). We have previously demonstrated that normal human erythroid maturation requires a transient activation of caspase-3 at the later stages of maturation(7). Although erythroid transcription factor GATA-1, themaster transcriptional factor of erythropoiesis, is a caspase-3 target, it is not cleaved during erythroid differentiation. We have shown that, in human erythroblasts, the chaperone heat shock protein70 (HSP70) is constitutively expressed and, at later stages of maturation, translocates into the nucleus and protects GATA-1 from caspase-3 cleavage(8). The primary role of this ubiquitous chaperone is to participate in the refolding of proteins denatured by cytoplasmic stress, thus preventing their aggregation(9). Here we show in vitro that during the maturation of human beta-TM erythroblasts, HSP70 interacts directly with free alpha-globin chains. As a consequence, HSP70 is sequestrated in the cytoplasm and GATA-1 is no longer protected, resulting in end-stage maturation arrest and apoptosis. Transduction of a nuclear-targeted HSP70 mutant or a caspase-3-uncleavable GATA-1 mutant restores terminal maturation of beta-TM erythroblasts, which may provide a rationale for new targeted therapies of beta-TM.	[Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Dussiot, Michael; Moura, Ivan Cruz; Belaid-Choucair, Zakia; Maciel, Thiago Trovati; Hermine, Olivier; Courtois, Genevieve] Ctr Natl Rech Sci CNRS Equipe Rech Labellisee, UMR 1163, Lab INSERM, 24 Blvd Montparnasse, F-75015 Paris, France; [Arlet, Jean-Benoit] Hop Europeen Georges Pompidou, Sorbonne Paris Cite, Fac Med Paris Descartes, Serv Med Interne, F-75908 Paris, France; [Arlet, Jean-Benoit] Hop Europeen Georges Pompidou, AP HP, F-75908 Paris, France; [Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Dussiot, Michael; Moura, Ivan Cruz; Belaid-Choucair, Zakia; Maciel, Thiago Trovati; Hermine, Olivier; Courtois, Genevieve] Paris Descartes Sorbonne Paris Cite Univ, Hop Necker, AP HP, Imagine Inst, F-75015 Paris, France; [Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Dussiot, Michael; Moura, Ivan Cruz; Belaid-Choucair, Zakia; Maciel, Thiago Trovati; Fontenay, Michaela; Hermine, Olivier; Courtois, Genevieve] Lab Excellence GR Ex, F-75015 Paris, France; [Ribeil, Jean-Antoine] Hop Necker Enfants Malad, Sorbonne Paris Cite, Fac Med Paris Descartes, Dept Biotherapie, F-75015 Paris, France; [Ribeil, Jean-Antoine] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Negre, Olivier; Beuzard, Yves; Leboulch, Philippe; Chretien, Stany] CEA, Inst Emerging Dis & Innovat Therapies iMETI, F-92260 Fontenay Aux Roses, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Garrido, Carmen] INSERM, Equipe Labellisee Ligue Canc, UMR 866, F-21033 Dijon, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Garrido, Carmen] Assoc Rech Canc, F-21033 Dijon, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Garrido, Carmen] Lab Excellence Lipoprot & Sante LipSTIC, F-21033 Dijon, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Seigneuric, Renaud; Garrido, Carmen] Univ Burgundy, Fac Med & Pharm, F-21033 Dijon, France; [Dussiot, Michael; Moura, Ivan Cruz; Maciel, Thiago Trovati] Hop Bichat Claude Bernard, INSERM, UMR 699, F-75018 Paris, France; [Moura, Ivan Cruz; Maciel, Thiago Trovati] Univ Paris 06, F-75013 Paris, France; [Moura, Ivan Cruz; Maciel, Thiago Trovati] Univ Denis Diderot Paris VII, F-75013 Paris, France; [Demarest, Samuel; de Beauchene, Isaure Chauvot; Auclair, Christian; Tchertanov, Luba] Ecole Normale Super, CNRS, UMR 8113, F-94230 Cachan, France; [de Beauchene, Isaure Chauvot; Auclair, Christian; Tchertanov, Luba] LERMIT, Campus Paris Saclay, F-92296 Chatenay Malabry, France; [Leboulch, Philippe] Womens Hosp Med Ctr, Boston, MA 02115 USA; [Leboulch, Philippe] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Baudin-Creuza, Veronique] Univ Paris 11, INSERM, UMR 779, Le Kremlin Bicetre, France; [Fontenay, Michaela] Univ Paris 05, CNRS, INSERM, Inst Cochin,UMR 1016,UMR 8104, F-75014 Paris, France; [Fontenay, Michaela] Hop Cochin, Hop Univ Paris Ctr, AP HP, Serv Hematol Biol, F-75014 Paris, France; [Garrido, Carmen] Ctr Anticanc George Francois Leclerc, F-21079 Dijon, France; [Hermine, Olivier] Fac Med Paris Descartes, Sorbonne Paris Cite, Serv Hematol, F-75015 Paris, France; [Hermine, Olivier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Hermine, O (corresponding author), Ctr Natl Rech Sci CNRS Equipe Rech Labellisee, UMR 1163, Lab INSERM, 24 Blvd Montparnasse, F-75015 Paris, France.	ohermine@gmail.com; genevieve_courtois@yahoo.fr	Garrido, Carolina/GWM-5557-2022; Hermine, Olivier/Q-7072-2018; Chretien, Stany/M-5166-2018; Garrido, carmen/G-1633-2018; Arlet, Jean Benoit/D-3124-2016; Maciel, Thiago/A-4475-2013; Ribeil, Jean-Antoine/AAK-7979-2020; Maciel, Thiago Trovati/AAF-5462-2021; BAUDIN-CREUZA, Véronique/K-7309-2017; Ribeil, Jean-Antoine/F-7896-2017; , Tchertanov/CAF-3310-2022; NEGRE, Olivier/AAA-2027-2022; Cruz Moura, Ivan/A-9510-2013	Garrido, carmen/0000-0003-1368-1493; Maciel, Thiago/0000-0002-9347-981X; Ribeil, Jean-Antoine/0000-0002-4549-4783; Maciel, Thiago Trovati/0000-0002-9347-981X; BAUDIN-CREUZA, Véronique/0000-0003-1032-3236; Ribeil, Jean-Antoine/0000-0002-5733-9123; Marcion, Guillaume/0000-0002-3634-6316; Hermine, Olivier/0000-0003-2574-3874; Fontenay, Michaela/0000-0002-5492-6349; Moura, Ivan/0000-0002-2977-0354; guillem, flavia/0000-0002-9680-311X; Cruz Moura, Ivan/0000-0002-8418-2803	Societe Nationale Francaise de Medecine Interne (SNFMI); Societe Francaise d'Hematologie (SFH); Centre National de la Recherche Scientifique (CNRS); Assistance publique - Hopitaux de Paris (AP-HP) (poste d'accueil APHP-CNRS); Groupe Pasteur Mutualite; Institut FARMAN (ENS de Cachan); ENS de Cachan; Conseil Regional de Bourgogne; l'Institut National du Cancer, INCa; National Research Agency under the 'Investments for the Future' program [ANR-10-IAHU-01]; Ligue nationale contre le cancer; Fondation pour la recherche medicale (FRM); Fondation de France; French National Research Agency [ANR-11-IDEX-0005-02]	Societe Nationale Francaise de Medecine Interne (SNFMI); Societe Francaise d'Hematologie (SFH); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Assistance publique - Hopitaux de Paris (AP-HP) (poste d'accueil APHP-CNRS); Groupe Pasteur Mutualite; Institut FARMAN (ENS de Cachan); ENS de Cachan; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); l'Institut National du Cancer, INCa; National Research Agency under the 'Investments for the Future' program(French National Research Agency (ANR)); Ligue nationale contre le cancer(Ligue nationale contre le cancer); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); French National Research Agency(French National Research Agency (ANR))	J.-B.A. was a recipient of grants from the Societe Nationale Francaise de Medecine Interne (SNFMI), Societe Francaise d'Hematologie (SFH), Centre National de la Recherche Scientifique (CNRS) and Assistance publique - Hopitaux de Paris (AP-HP) (poste d'accueil APHP-CNRS), and from Groupe Pasteur Mutualite. S.D. was a recipient of funding from Institut FARMAN (ENS de Cachan). I.C.B. was a recipient of a PhD scholarship fund from ENS de Cachan. A. H. was a recipient of a post-doctoral grant from the Conseil Regional de Bourgogne and M. S. from l'Institut National du Cancer, INCa. This program has received a state subsidy managed by the National Research Agency under the 'Investments for the Future' program bearing the reference ANR-10-IAHU-01, Ligue nationale contre le cancer, Fondation pour la recherche medicale (FRM) and Fondation de France. The labex GR-Ex is funded by the program 'Investments for the Future' of the French National Research Agency, reference ANR-11-IDEX-0005-02. We would also like to thank N. Goudin and R. Desvaux from the Plateforme d'imagerie cellulaire de l'IFR94, Faculte de Medecine Necker (Paris, France) for experimental help in image acquisition and analysis on confocal microscopy, and the Department of Biotherapy at the Necker Hospital (Paris, France) for providing blood samples. We thank P. England from CNRS 1129, unite de biochimiecellulaire, Institut Pasteur, Paris, for his experimental help. We thank E. Frisan from the Department of Haematology and INSERM U1016, Hopital Cochin, Paris, and A. de Thonel from INSERM U866, Dijon, for the gift of HSP70(S400A) mutant. We thank U. Testa, A. Zeuner and R. de Maria from the Department of Haematology and Oncology, Instituto Superiore di Santia, Rome, Italy, for the gift of cDNAs of GATA-1. We also thank C. Brouzes from the Department of biological haematology for her help for the smears' reading.	Anson ML, 1930, J GEN PHYSIOL, V13, P469, DOI 10.1085/jgp.13.4.469; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Centis F, 2000, BLOOD, V96, P3624; De Franceschi L, 2007, HAEMATOLOGICA, V92, P1319, DOI 10.3324/haematol.11556; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; DOVER GJ, 1987, BLOOD, V69, P1109; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Frisan E, 2012, BLOOD, V119, P1532, DOI 10.1182/blood-2011-03-343475; Gabet AS, 2011, CELL DEATH DIFFER, V18, P678, DOI 10.1038/cdd.2010.140; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Khandros E, 2010, HEMATOL ONCOL CLIN N, V24, P1071, DOI 10.1016/j.hoc.2010.08.013; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Ribeil JA, 2013, SCI WORLD J, DOI 10.1155/2013/394295; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Schallmeiner E, 2007, NAT METHODS, V4, P135, DOI 10.1038/nmeth974; Suragani R., 2014, BLOOD; Yao X, 2009, EXP HEMATOL, V37, P889, DOI 10.1016/j.exphem.2009.05.004; YUAN J, 1993, BLOOD, V82, P374, DOI 10.1182/blood.V82.2.374.bloodjournal822374; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhu JQ, 2011, BLOOD, V117, P3045, DOI 10.1182/blood-2010-07-294751	28	86	88	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					242	+		10.1038/nature13614	http://dx.doi.org/10.1038/nature13614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25156257				2022-12-28	WOS:000342663100045
J	Borsa, AA; Agnew, DC; Cayan, DR				Borsa, Adrian Antal; Agnew, Duncan Carr; Cayan, Daniel R.			Ongoing drought-induced uplift in the western United States	SCIENCE			English	Article							GLOBAL POSITIONING SYSTEM; LAND SUBSIDENCE; WATER STORAGE; DEFORMATION; GPS; SEISMICITY; CALIFORNIA; VALLEY	The western United States has been experiencing severe drought since 2013. The solid earth response to the accompanying loss of surface and near-surface water mass should be a broad region of uplift. We use seasonally adjusted time series from continuously operating global positioning system stations to measure this uplift, which we invert to estimate mass loss. The median uplift is 5 millimeters (mm), with values up to 15 mm in California's mountains. The associated pattern of mass loss, ranging up to 50 centimeters (cm) of water equivalent, is consistent with observed decreases in precipitation and streamflow. We estimate the total deficit to be similar to 240 gigatons, equivalent to a 10-cm layer of water over the entire region, or the annual mass loss from the Greenland Ice Sheet.	[Borsa, Adrian Antal; Agnew, Duncan Carr; Cayan, Daniel R.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Cayan, Daniel R.] US Geol Survey, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of the Interior; United States Geological Survey	Borsa, AA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	aborsa@ucsd.edu	Borsa, Adrian/AAH-2158-2019	Borsa, Adrian/0000-0002-9939-1480	NSF; NASA under NSF [EAR-1261833]; USGS [G13AP00059]; Directorate For Geosciences [1261833] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA under NSF; USGS(United States Geological Survey); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The GPS data we use come primarily from the PBO and are publicly available from UNAVCO through the Geodesy Advancing Geosciences and EarthScope Facility, which is supported by the NSF and NASA under NSF cooperative agreement no. EAR-1261833. Meteorological data are publicly available from the National Climatic Data Center's Global Historical Climatology Network. The software used for load computation (SPOTL) is publicly available, and the processing software may be obtained from us. We acknowledge the efforts of many at UNAVCO to produce the exceptional PBO GPS data set, especially the station installation efforts of C. Walls, K. Austin, and K. Feaux. We thank M. Dettinger for comments. This work was supported by USGS grant no. G13AP00059.	Agnew D.C., 2007, TREATISE GEOPHYS, V3, P163, DOI [10.1016/B978-044452748-6.00056-0, DOI 10.1016/B978-044452748-6.00056-0, 10.1016/B978-044452748-6/00056-0]; Agnew D.C., 2012, SPOTL SOME PROGRAMS; Amos CB, 2014, NATURE, V509, P483, DOI 10.1038/nature13275; Argus DF, 2014, GEOPHYS RES LETT, V41, P1971, DOI 10.1002/2014GL059570; Astiz L, 2000, J GEOPHYS RES-SOL EA, V105, P2937, DOI 10.1029/1999JB900336; Bennett RA, 2008, GEOPHYS J INT, V174, P1052, DOI 10.1111/j.1365-246X.2008.03846.x; Bettinelli P, 2008, EARTH PLANET SC LETT, V266, P332, DOI 10.1016/j.epsl.2007.11.021; Bevis M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023491; Cleveland R.B., 1990, J OFF STAT, V6, P3; Davis JL, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008690; Dzurisin D., 2007, VOLCANO DEFORMATION; Elosegui P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016579; ELOSEGUI P, 1995, J GEOPHYS RES-SOL EA, V100, P9921, DOI 10.1029/95JB00868; FARRELL WE, 1972, REV GEOPHYS SPACE GE, V10, P761, DOI 10.1029/RG010i003p00761; Frappart F, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044010; Galloway DL, 2011, HYDROGEOL J, V19, P1459, DOI 10.1007/s10040-011-0775-5; Grapenthin R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044590; Gutmann ED, 2012, HYDROL PROCESS, V26, P2951, DOI 10.1002/hyp.8329; Hanson RT, 2010, IAHS-AISH P, V339, P467; IKEHARA ME, 1994, HYDROLOG SCI J, V39, P417, DOI 10.1080/02626669409492765; Ji KH, 2013, GEOPHYS RES LETT, V40, P1054, DOI 10.1002/grl.50258; King MA, 2010, SURV GEOPHYS, V31, P465, DOI 10.1007/s10712-010-9100-4; King NE, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004448; Langbein J, 1995, GEOPHYS RES LETT, V22, P3533, DOI 10.1029/95GL03325; Larson KM, 2010, IEEE J-STARS, V3, P91, DOI 10.1109/JSTARS.2009.2033612; Ouellette KJ, 2013, WATER RESOUR RES, V49, P2508, DOI 10.1002/wrcr.20173; Pollitz FF, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004139; Ramillien G, 2008, SURV GEOPHYS, V29, P361, DOI 10.1007/s10712-008-9048-9; Smith-Konter BR, 2011, J GEOPHYS RES-SOL EA, V116, DOI [10.1029/2010JB00S117, 10.1029/2010JB008117]; Steckler MS, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007018; Thomas AC, 2014, GEOPHYS RES LETT, V41, P1537, DOI 10.1002/2014GL059323; Van Camp M, 2014, GEOPHYS J INT, V197, P192, DOI 10.1093/gji/ggt524; Wahr J, 2013, J GEOPHYS RES-SOL EA, V118, P1795, DOI 10.1002/jgrb.50104; Wan W, 2015, GPS SOLUT, V19, P237, DOI 10.1007/s10291-014-0383-7	34	157	160	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1587	1590		10.1126/science.1260279	http://dx.doi.org/10.1126/science.1260279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25147281				2022-12-28	WOS:000342164500038
J	Fiore, AM				Fiore, Arlene M.			ATMOSPHERIC CHEMISTRY No equatorial divide for a cleansing radical	NATURE			English	Editorial Material							INTERCOMPARISON PROJECT ACCMIP; PREINDUSTRIAL; VARIABILITY; HYDROXYL		[Fiore, Arlene M.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Fiore, Arlene M.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University; Columbia University	Fiore, AM (corresponding author), Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA.	amfiore@ldeo.columbia.edu		Fiore, Arlene/0000-0003-0221-2122				Krol M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002423; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; Patra PK, 2014, NATURE, V513, P219, DOI 10.1038/nature13721; Voulgarakis A, 2013, ATMOS CHEM PHYS, V13, P2563, DOI 10.5194/acp-13-2563-2013; Wennberg PO, 2006, NATURE, V442, P145, DOI 10.1038/442145a; Young PJ, 2013, ATMOS CHEM PHYS, V13, P2063, DOI 10.5194/acp-13-2063-2013	8	11	11	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					176	178		10.1038/513176a	http://dx.doi.org/10.1038/513176a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25209794				2022-12-28	WOS:000341362800036
J	Stocker, TF; Plattner, GK				Stocker, Thomas F.; Plattner, Gian-Kasper			Rethink IPCC reports	NATURE			English	Editorial Material									[Stocker, Thomas F.] Univ Bern, CH-3012 Bern, Switzerland; [Plattner, Gian-Kasper] Univ Bern, IPCC Working Grp 1, Tech Support Unit, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Stocker, TF (corresponding author), Univ Bern, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch	Plattner, Gian-Kasper/A-5245-2016	Plattner, Gian-Kasper/0000-0002-3765-0045				[Anonymous], 2013, ANN 1 ATL GLOB REG C; Blunden J, 2014, B AM METEOROL SOC, V95, pS1, DOI 10.1175/2014BAMSStateoftheClimate.1; IPCC, 2012, MAN RISKS EXTR EV DI; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Solomon S, 2008, SCIENCE, V319, P1457, DOI 10.1126/science.1155724; Stocker TF, 2013, NAT GEOSCI, V6, P7, DOI 10.1038/ngeo1678; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1	7	17	19	5	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					163	165		10.1038/513163a	http://dx.doi.org/10.1038/513163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5DP	25209782	Bronze			2022-12-28	WOS:000341362800025
J	Donze, JD; Ridker, PM; Finlayson, SRG; Bates, DW				Donze, Jacques D.; Ridker, Paul M.; Finlayson, Samuel R. G.; Bates, David W.			Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; CRITICALLY-ILL; ATHEROSCLEROSIS; INFECTION; INFLAMMATION; PREVENTION; MECHANISMS; THROMBOEMBOLISM	Objectives To evaluate the impact of preoperative sepsis on risk of postoperative arterial and venous thromboses. Design Prospective cohort study using the National Surgical Quality Improvement Program database of the American College of Surgeons (ACS-NSQIP). Setting Inpatient and outpatient procedures in 374 hospitals of all types across the United States, 2005-12. Participants 2 305 380 adults who underwent surgical procedures. Main outcome measures Arterial thrombosis (myocardial infarction or stroke) and venous thrombosis (deep venous thrombosis or pulmonary embolism) in the 30 days after surgery. Results Among all surgical procedures, patients with preoperative systemic inflammatory response syndrome or any sepsis had three times the odds of having an arterial or venous postoperative thrombosis (odds ratio 3.1, 95% confidence interval 3.0 to 3.1). The adjusted odds ratios were 2.7 (2.5 to 2.8) for arterial thrombosis and 3.3 (3.2 to 3.4) for venous thrombosis. The adjusted odds ratios for thrombosis were 2.5 (2.4 to 2.6) in patients with systemic inflammatory response syndrome, 3.3 (3.1 to 3.4) in patients with sepsis, and 5.7 (5.4 to 6.1) in patients with severe sepsis, compared with patients without any systemic inflammation. In patients with preoperative sepsis, both emergency and elective surgical procedures had a twofold increased odds of thrombosis. Conclusions Preoperative sepsis represents an important independent risk factor for both arterial and venous thromboses. The risk of thrombosis increases with the severity of the inflammatory response and is higher in both emergent and elective surgical procedures. Suspicion of thrombosis should be higher in patients with sepsis who undergo surgery.	[Donze, Jacques D.] Univ Hosp Bern, Div Gen Internal Med, CH-3010 Bern, Switzerland; [Donze, Jacques D.; Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA 02120 USA; [Donze, Jacques D.; Ridker, Paul M.; Bates, David W.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02215 USA; [Finlayson, Samuel R. G.] Univ Utah, Dept Surg, Salt Lake City, UT 84132 USA	University of Bern; University Hospital of Bern; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Utah System of Higher Education; University of Utah	Donze, JD (corresponding author), Univ Spital Bern, Inselspital, Univ Klin Allgemeine Innere Med, CH-3010 Bern, Switzerland.	donze.author@gmail.com	Bates, David/AAE-7283-2019	Venkatasubramanian, Siddharth/0000-0002-5860-0768	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	JD was partly supported by the Swiss National Science Foundation for his time. The Swiss Science National Foundation had no role in the design and conduct of this study, the analysis or interpretation of the data, or the preparation of this manuscript.	Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; ASHTON CM, 1993, ANN INTERN MED, V118, P504, DOI 10.7326/0003-4819-118-7-199304010-00004; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CADE JF, 1982, CRIT CARE MED, V10, P448, DOI 10.1097/00003246-198207000-00006; Caprini JA, 2005, DM-DIS MON, V51, P70, DOI 10.1016/j.disamonth.2005.02.003; CAPRINI JA, 1991, SEMIN THROMB HEMOST, V17, P304; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Fong IW, 2000, CAN MED ASSOC J, V163, P49; Gardlund B, 1996, LANCET, V347, P1357; Ghattas A, 2013, J AM COLL CARDIOL, V62, P1541, DOI 10.1016/j.jacc.2013.07.043; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; GRAHAM JW, 1993, J APPL PSYCHOL, V78, P119, DOI 10.1037/0021-9010.78.1.119; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HIRSCH DR, 1995, JAMA-J AM MED ASSOC, V274, P335, DOI 10.1001/jama.274.4.335; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Levine RL, 2008, THROMB HAEMOSTASIS, V99, P892, DOI 10.1160/TH08-01-0004; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lindsberg PJ, 2003, STROKE, V34, P2518, DOI 10.1161/01.STR.0000089015.51603.CC; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Paganini-Hill A, 2003, STROKE, V34, P452, DOI 10.1161/01.STR.0000053451.28410.98; PINGLETON SK, 1981, CHEST, V79, P647, DOI 10.1378/chest.79.6.647; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rogers SO, 2007, J AM COLL SURGEONS, V204, P1211, DOI 10.1016/j.jamcollsurg.2007.02.072; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAIKKU P, 1992, ANN INTERN MED, V116, P273, DOI 10.7326/0003-4819-116-4-273; Shorr AF, 2009, THROMB HAEMOSTASIS, V101, P139, DOI 10.1160/TH08-07-0468; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Vallance P, 1997, LANCET, V349, P1391, DOI 10.1016/S0140-6736(96)09424-X; VISION Pilot Study Investigators, 2011, Open Med, V5, pe193; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; [No title captured]	37	24	25	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2014	349								g5334	10.1136/bmj.g5334	http://dx.doi.org/10.1136/bmj.g5334			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9QJ	25199629	Green Published, hybrid			2022-12-28	WOS:000341690700004
J	Karhu, K; Auffret, MD; Dungait, JAJ; Hopkins, DW; Prosser, JI; Singh, BK; Subke, JA; Wookey, PA; Agren, GI; Sebastia, MT; Gouriveau, F; Bergkvist, G; Meir, P; Nottingham, AT; Salinas, N; Hartley, IP				Karhu, Kristiina; Auffret, Marc D.; Dungait, Jennifer A. J.; Hopkins, David W.; Prosser, James I.; Singh, Brajesh K.; Subke, Jens-Arne; Wookey, Philip A.; Agren, Goran I.; Sebastia, Maria-Teresa; Gouriveau, Fabrice; Bergkvist, Goran; Meir, Patrick; Nottingham, Andrew T.; Salinas, Norma; Hartley, Iain P.			Temperature sensitivity of soil respiration rates enhanced by microbial community response	NATURE			English	Article							THERMAL-ACCLIMATION; CARBON; ADAPTATION; DECOMPOSITION; FEEDBACKS	Soils store about four times as much carbon as plant biomass(1), and soil microbial respiration releases about 60 petagrams of carbon per year to the atmosphere as carbon dioxide(2). Short-term experiments have shown that soil microbial respiration increases exponentially with temperature(3). This information has been incorporated into soil carbon and Earth-system models, which suggest that warming-induced increases in carbon dioxide release from soils represent an important positive feedback loop that could influence twenty-first-century climate change(4). The magnitude of this feedback remains uncertain, however, not least because the response of soil microbial communities to changing temperatures has the potential to either decrease(5-7) or increase(8,9) warming-induced carbon losses substantially. Here we collect soils from different ecosystems along a climate gradient from the Arctic to the Amazon and investigate how microbial community-level responses control the temperature sensitivity of soil respiration. We find that the microbial community-level response more often enhances than reduces the mid-to long-term (90 days) temperature sensitivity of respiration. Furthermore, the strongest enhancing responses were observed in soils with high carbon-to-nitrogen ratios and in soils from cold climatic regions. After 90 days, microbial community responses increased the temperature sensitivity of respiration in high-latitude soils by a factor of 1.4 compared to the instantaneous temperature response. This suggests that the substantial carbon stores in Arctic and boreal soils could be more vulnerable to climate warming than currently predicted.	[Karhu, Kristiina; Hartley, Iain P.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England; [Auffret, Marc D.; Prosser, James I.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [Dungait, Jennifer A. J.] Rothamsted Res North Wyke, Okehampton EX20 2SB, Devon, England; [Hopkins, David W.] Royal Agr Univ, Sch Agr Food & Environm, Cirencester GL7 6JS, Glos, England; [Singh, Brajesh K.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Subke, Jens-Arne] Univ Stirling, Sch Nat Sci Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Wookey, Philip A.] Heriot Watt Univ, Sch Life Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Agren, Goran I.] Swedish Univ Agr Sci SLU, Dept Ecol, S-75007 Uppsala, Sweden; [Sebastia, Maria-Teresa; Gouriveau, Fabrice] Forest Sci Ctr Catalonia CTFC, Lab Funct Ecol & Global Change, Solsona 25280, Spain; [Sebastia, Maria-Teresa] Univ Lleida, Sch Agrifood & Forestry Sci & Engn, Dept Hort Bot & Landscaping, Lleida 25198, Spain; [Bergkvist, Goran] Swedish Univ Agr Sci SLU, Dept Crop Prod Ecol, S-75007 Uppsala, Sweden; [Meir, Patrick; Nottingham, Andrew T.] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Meir, Patrick] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Salinas, Norma] Pontificia Univ Catolica Peru, Secc Quim, Lima 32, Peru	University of Exeter; University of Aberdeen; Western Sydney University; University of Stirling; Heriot Watt University; Swedish University of Agricultural Sciences; Centre Tecnologic Forestal de Catalunya (CTFC); Universitat de Lleida; Swedish University of Agricultural Sciences; University of Edinburgh; Australian National University; Pontificia Universidad Catolica del Peru	Karhu, K (corresponding author), Univ Helsinki, Dept Forest Sci, FIN-00014 Helsinki, Finland.	kristiina.karhu@helsinki.fi	GOURIVEAU, Fabrice/H-8858-2015; Sebastia, M. Teresa/B-5479-2013; Meir, Patrick/J-8344-2012; Dungait, Jenni/F-1110-2013; Wookey, Philip/AAA-6271-2020; Prosser, Jim/F-5280-2010; Hartley, Iain P/J-7892-2016; Subke, Jens-Arne/M-3049-2013; Singh, Brajesh/R-6321-2019; Dungait, Jennifer/AAV-7301-2021; Karhu, Kristiina/F-8272-2012; Salinas, Norma/K-8960-2015	GOURIVEAU, Fabrice/0000-0001-9733-8558; Sebastia, M. Teresa/0000-0002-9017-3575; Dungait, Jenni/0000-0001-9074-4174; Wookey, Philip/0000-0001-5957-6424; Prosser, Jim/0000-0003-1757-5102; Hartley, Iain P/0000-0002-9183-6617; Subke, Jens-Arne/0000-0001-9244-639X; Singh, Brajesh/0000-0003-4413-4185; Salinas, Norma/0000-0001-9941-2109; Hopkins, David/0000-0003-0953-8643; Bergkvist, Goran/0000-0001-9287-0510; AUFFRET, Marc/0000-0002-2321-8219; Agren, Goran/0000-0003-4582-3986	Natural Environment Research Council (NERC) [NE/H022333/1]; Academy of Finland; ARC [FT110100457, DP130104841]; NERC [NE/G018278/1]; Grain Research and Development Corporation; BBSRC [BBS/E/C/00005214, BBS/E/C/00005196] Funding Source: UKRI; NERC [NE/H022333/1, NE/H023550/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005196, BBS/E/C/00005214] Funding Source: researchfish; Natural Environment Research Council [NE/H022333/1, NE/G018278/1, NE/H023550/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Academy of Finland(Academy of Finland); ARC(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grain Research and Development Corporation(Grains R&D Corp); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the staff of the Forestry Commission at Alice Holt Forest, T. Taylor from RSPB Aylesbeare Common Reserve, J. Harris from Cranfield University, C. Moscatelli and S. Marinari from Tuscia University, J. A. Carreira de la Fuente from the University of Jaen, R. Giesler from Umea University and E. Cosio from The Pontifical Catholic University of Peru for help with site selection and soil sampling. We thank N. England for technical assistance with constructing the incubation system, J. Zaragoza Castells for help with soil sampling, A. Elliot for conducting the particle size analyses, J. Grapes for help with carbon and nitrogen analysis and S. Rouillard, H. Jones and T. Kurten for assistance with graphics. This work was carried out with Natural Environment Research Council (NERC) funding (grant number NE/H022333/1). K. K. was supported by an Academy of Finland post-doctoral research grant while finalizing this manuscript. P. M. was supported by ARC FT110100457 and NERC NE/G018278/1, and B. K. S by the Grain Research and Development Corporation and ARC DP130104841.	Agren GI, 2002, SOIL BIOL BIOCHEM, V34, P129, DOI 10.1016/S0038-0717(01)00156-0; Agren GI, 1996, OIKOS, V76, P522, DOI 10.2307/3546345; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Bradford MA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00333; Bradford MA, 2010, GLOBAL CHANGE BIOL, V16, P1576, DOI 10.1111/j.1365-2486.2009.02040.x; Crowther TW, 2013, ECOL LETT, V16, P469, DOI 10.1111/ele.12069; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Galbraith D, 2010, NEW PHYTOL, V187, P647, DOI 10.1111/j.1469-8137.2010.03350.x; Hartley IP, 2008, ECOL LETT, V11, P1092, DOI 10.1111/j.1461-0248.2008.01223.x; Hartley IP, 2007, GLOBAL CHANGE BIOL, V13, P2654, DOI 10.1111/j.1365-2486.2007.01454.x; Hochachka PW, 2002, BIOCH ADAPTATIONS, P466; HOWARD DM, 1993, SOIL BIOL BIOCHEM, V25, P1537, DOI 10.1016/0038-0717(93)90008-Y; IPCC, 2013, CLIMATE CHANGE 2022; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; Lehmeier CA, 2013, SOIL BIOL BIOCHEM, V57, P374, DOI 10.1016/j.soilbio.2012.10.030; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Loveys BR, 2003, GLOBAL CHANGE BIOL, V9, P895, DOI 10.1046/j.1365-2486.2003.00611.x; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Malcolm GM, 2008, GLOBAL CHANGE BIOL, V14, P1169, DOI 10.1111/j.1365-2486.2008.01555.x; Nie M, 2013, ECOL LETT, V16, P234, DOI 10.1111/ele.12034; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Shao P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034034; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]	30	389	419	70	1199	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					81	+		10.1038/nature13604	http://dx.doi.org/10.1038/nature13604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186902	Green Submitted			2022-12-28	WOS:000341174800034
J	Sharma, P; Ward, A; Gibaud, T; Hagan, MF; Dogic, Z				Sharma, Prerna; Ward, Andrew; Gibaud, T.; Hagan, Michael F.; Dogic, Zvonimir			Hierarchical organization of chiral rafts in colloidal membranes	NATURE			English	Article							LIPID RAFTS; NUCLEATION; MORPHOLOGY; CURVATURE; PARTICLES; CRYSTALS; KINETICS; CLUSTERS; DOMAINS; TENSION	Liquid-liquid phase separation is ubiquitous in suspensions of nanoparticles, proteins and colloids. It has an important role in gel formation, protein crystallization and perhaps even as an organizing principle in cellular biology(1,2). With a fewnotable exceptions(3,4), liquid-liquid phase separation in bulk proceeds through the continuous coalescence of droplets until the system undergoes complete phase separation. But when colloids, nanoparticles or proteins are confined to interfaces, surfaces or membranes, their interactions differ fundamentally from those mediated by isotropic solvents(5,6), and this results in significantly more complex phase behaviour(7-13). Here we show that liquid-liquid phase separation in monolayer membranes composed of two dissimilar chiral colloidal rods gives rise to thermodynamically stable rafts that constantly exchange monomeric rods with the background reservoir to maintain a self-limited size. We visualize and manipulate rafts to quantify their assembly kinetics and to show that membrane distortions arising from the rods' chirality lead to long-range repulsive raft-raft interactions. Rafts assemble into cluster crystals at high densities, but they can also form bonds to yield higher-order structures. Taken together, our observations demonstrate a robust membrane-based pathway for the assembly of mono-disperse membrane clusters that is complementary to existing methods for colloid assembly in bulk suspensions(14-16). They also reveal that chiral inclusions in membranes can acquire long-range repulsive interactions, which might more generally have a role in stabilizing assemblages of finite size(13,17).	[Sharma, Prerna; Ward, Andrew; Hagan, Michael F.; Dogic, Zvonimir] Brandeis Univ, Dept Phys, Waltham, MA 02454 USA; [Gibaud, T.] Univ Lyon 1, CNRS UMR 5672, Ecole Normale Super Lyon, Phys Lab, F-69007 Lyon, France	Brandeis University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dogic, Z (corresponding author), Brandeis Univ, Dept Phys, 415 South St, Waltham, MA 02454 USA.	zdogic@brandeis.edu	Hagan, Michael F/N-2177-2014; Gibaud, Thomas/D-1276-2009; Gibaud, Thomas/O-1910-2019	Hagan, Michael F/0000-0002-9211-2434; Gibaud, Thomas/0000-0003-4826-8025; Gibaud, Thomas/0000-0003-4826-8025; Ward, Andrew/0000-0001-5147-4140	US National Science Foundation [NSF-MRSEC-0820492, NSF-DMR-0955776, NSF-MRI-0923057]; Petroleum Research Fund [ACS-PRF 50558-DNI7]	US National Science Foundation(National Science Foundation (NSF)); Petroleum Research Fund(American Chemical Society)	We acknowledge discussions with R. B. Meyer. This work was supported by the US National Science Foundation (NSF-MRSEC-0820492, NSF-DMR-0955776 and NSF-MRI-0923057) and the Petroleum Research Fund (ACS-PRF 50558-DNI7). We acknowledge use of the Brandeis MRSEC optical microscopy facility.	Barry E, 2010, P NATL ACAD SCI USA, V107, P10348, DOI 10.1073/pnas.1000406107; Barry E, 2009, J PHYS CHEM B, V113, P3910, DOI 10.1021/jp8067377; Barry E, 2009, SOFT MATTER, V5, P2563, DOI 10.1039/b822478a; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; CROCKER JC, 1994, PHYS REV LETT, V73, P352, DOI 10.1103/PhysRevLett.73.352; DAN N, 1994, J PHYS II, V4, P1713, DOI 10.1051/jp2:1994227; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Dogic Z, 2001, PHILOS T R SOC A, V359, P997, DOI 10.1098/rsta.2000.0814; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Gibaud T, 2012, NATURE, V481, P348, DOI 10.1038/nature10769; GOULIAN M, 1993, EUROPHYS LETT, V23, P155, DOI 10.1209/0295-5075/23/2/014; Groenewold J, 2001, J PHYS CHEM B, V105, P11702, DOI 10.1021/jp011646w; Hyman AA, 2012, SCIENCE, V337, P1047, DOI 10.1126/science.1223728; Kaplan CN, 2014, SOFT MATTER, V10, P4700, DOI 10.1039/c4sm00803k; Lau AWC, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48006; Lettinga MP, 2005, EUROPHYS LETT, V71, P692, DOI 10.1209/epl/i2005-10127-x; Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maniatis T, 1989, DECONTAMINATION DILU; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; OLDENBOURG R, 1995, J MICROSC-OXFORD, V180, P140, DOI 10.1111/j.1365-2818.1995.tb03669.x; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Rozovsky S, 2005, J AM CHEM SOC, V127, P36, DOI 10.1021/ja046300o; Sarasij RC, 2007, BIOPHYS J, V92, P3140, DOI 10.1529/biophysj.106.085662; SEUL M, 1995, SCIENCE, V267, P476, DOI 10.1126/science.267.5197.476; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Tombolato F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258302; Ursell TS, 2009, P NATL ACAD SCI USA, V106, P13301, DOI 10.1073/pnas.0903825106; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; WEIS RM, 1984, NATURE, V310, P47, DOI 10.1038/310047a0; Zakhary M. J., 2014, NATURE COMMUN, V5	38	45	45	2	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					77	+		10.1038/nature13694	http://dx.doi.org/10.1038/nature13694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186901	Green Submitted			2022-12-28	WOS:000341174800033
J	Tully, RB; Courtois, H; Hoffman, Y; Pomarede, D				Tully, R. Brent; Courtois, Helene; Hoffman, Yehuda; Pomarede, Daniel			The Laniakea supercluster of galaxies	NATURE			English	Article							WIENER RECONSTRUCTION; IRAS-GALAXIES; DENSITY; SCALE; CALIBRATION; VELOCITY; FIELDS	Galaxies congregate in clusters and along filaments, and are missing from large regions referred to as voids. These structures are seen in maps derived from spectroscopic surveys(1,2) that reveal networks of structure that are interconnected with no clear boundaries. Extended regions with a high concentration of galaxies are called 'superclusters', although this term is not precise. There is, however, another way to analyse the structure. If the distance to each galaxy from Earth is directly measured, then the peculiar velocity can be derived from the subtraction of the mean cosmic expansion, the product of distance times the Hubble constant, from observed velocity. The peculiar velocity is the line-of-sight departure from the cosmic expansion and arises from gravitational perturbations; a map of peculiar velocities can be translated into a map of the distribution of matter(3). Here we report a map of structure made using a catalogue of peculiar velocities. We find locations where peculiar velocity flows diverge, as water does at watershed divides, and we trace the surface of divergent points that surrounds us. Within the volume enclosed by this surface, the motions of galaxies are inward after removal of the mean cosmic expansion and long range flows. We define a supercluster to be the volume within such a surface, and so we are defining the extent of our home supercluster, which we call Laniakea.	[Tully, R. Brent] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Courtois, Helene] Univ Lyon 1, Inst Nucl Phys, CNRS IN2P3, F-69622 Lyon, France; [Hoffman, Yehuda] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Pomarede, Daniel] CEA Saclay, Inst Rech Lois Fondamentales Univers, F-91191 Gif Sur Yvette, France	University of Hawaii System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Hebrew University of Jerusalem; CEA; UDICE-French Research Universities; Universite Paris Saclay	Tully, RB (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	tully@ifa.hawaii.edu	Hoffman, Yehuda/AAO-4882-2021; Courtois, Helene/AGZ-3259-2022; Pomarede, Daniel/AAH-7438-2020	Hoffman, Yehuda/0000-0002-8158-0566; Courtois, Helene/0000-0003-0509-1776; Pomarede, Daniel/0000-0003-2038-0488	US National Science Foundation [AST09-08846]; Space Telescope Science Institute for observing time with Hubble Space Telescope; Jet Propulsion Lab for observations with Spitzer Space Telescope; NASA [NNX12AE70G]; Israel Science Foundation [1013/12]; Lyon Institute of Origins [ANR-10-LABX-66]; CNRS [PICS-06233]	US National Science Foundation(National Science Foundation (NSF)); Space Telescope Science Institute for observing time with Hubble Space Telescope(Space Telescope Science Institute); Jet Propulsion Lab for observations with Spitzer Space Telescope; NASA(National Aeronautics & Space Administration (NASA)); Israel Science Foundation(Israel Science Foundation); Lyon Institute of Origins; CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank our many collaborators in the accumulation of Cosmicflows-2 distances. We thank the CLUES collaboration, and in particular S. Gottlober and J. Sorce in connection with the analysis. T. Jarrett provided an unpublished 2MASS Extended Source Catalog redshift compendium, the only all-sky redshift catalogue extensive enough to match the region of our reconstruction. The narration in the Supplementary Video is by S. Anvar and the original music is played by N.-E. Pomarede. The name 'Laniakea' was suggested by N. Napoleon, Kapiolani Community College, Hawaii. Financial support was provided by US National Science Foundation award AST09-08846, several awards through the Space Telescope Science Institute for observing time with Hubble Space Telescope, an award from the Jet Propulsion Lab for observations with Spitzer Space Telescope, and NASA award NNX12AE70G for analysis of data from the Wide-field Infrared Survey Explorer. We also acknowledge support from the Israel Science Foundation (1013/12) and the Lyon Institute of Origins under grant ANR-10-LABX-66 and the CNRS under PICS-06233.	Courtois HM, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/3/69; Courtois HM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/43; DEKEL A, 1993, ASTROPHYS J, V412, P1, DOI 10.1086/172896; Dekel A, 1999, ASTROPHYS J, V522, P1, DOI 10.1086/307636; DELAPPARENT V, 1986, ASTROPHYS J, V302, pL1, DOI 10.1086/184625; DEVAUCOULEURS G, 1953, ASTRON J, V58, P30, DOI 10.1086/106805; Doumler T, 2013, MON NOT R ASTRON SOC, V430, P902, DOI 10.1093/mnras/sts603; DRESSLER A, 1987, ASTROPHYS J, V313, pL37, DOI 10.1086/184827; Fixsen DJ, 1996, ASTROPHYS J, V473, P576, DOI 10.1086/178173; Freedman WL, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/24; Gott JR, 2005, ASTROPHYS J, V624, P463, DOI 10.1086/428890; HAYNES MP, 1988, PR S PHYS, P31; Hoffman Y., 2001, LARGE SCALE TIDAL VE; Hoffman Y, 2012, MON NOT R ASTRON SOC, V425, P2049, DOI 10.1111/j.1365-2966.2012.21553.x; Jarrett TH, 2000, ASTRON J, V119, P2498, DOI 10.1086/301330; Kitaura FS, 2012, MON NOT R ASTRON SOC, V427, pL35, DOI 10.1111/j.1745-3933.2012.01340.x; Pomarede D, 2008, ASTR SOC P, V385, P327; RAYCHAUDHURY S, 1989, NATURE, V342, P251, DOI 10.1038/342251a0; Riess AG, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/119; Sorce JG, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L12; STRAUSS MA, 1992, ASTROPHYS J, V385, P421, DOI 10.1086/170953; STRAUSS MA, 1995, PHYS REP, V261, P271, DOI 10.1016/0370-1573(95)00013-7; ZAROUBI S, 1995, ASTROPHYS J, V449, P446, DOI 10.1086/176070; Zaroubi S, 1999, ASTROPHYS J, V520, P413, DOI 10.1086/307473	25	167	169	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					71	+		10.1038/nature13674	http://dx.doi.org/10.1038/nature13674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186900	Green Submitted			2022-12-28	WOS:000341174800031
J	Herz, HM; Morgan, M; Gao, X; Jackson, J; Rickels, R; Swanson, SK; Florens, L; Washburn, MP; Eissenberg, JC; Shilatifard, A				Herz, Hans-Martin; Morgan, Marc; Gao, Xin; Jackson, Jessica; Rickels, Ryan; Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.; Eissenberg, Joel C.; Shilatifard, Ali			Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling	SCIENCE			English	Article							PERICENTRIC HETEROCHROMATIN; DROSOPHILA-MELANOGASTER; CHROMOSOMAL-PROTEIN; EPIGENETIC CONTROL; DRIVER MUTATIONS; METHYLATION; HP1; DYNAMICS; PRC2	Histone H3 lysine(27)-to-methionine (H3K27M) gain-of-function mutations occur in highly aggressive pediatric gliomas. We established a Drosophila animal model for the pathogenic histone H3K27M mutation and show that its overexpression resembles polycomb repressive complex 2 (PRC2) loss-of-function phenotypes, causing derepression of PRC2 target genes and developmental perturbations. Similarly, an H3K9M mutant depletes H3K9 methylation levels and suppresses position-effect variegation in various Drosophila tissues. The histone H3K9 demethylase KDM3B/JHDM2 associates with H3K9M-containing nucleosomes, and its misregulation in Drosophila results in changes of H3K9 methylation levels and heterochromatic silencing defects. We have established histone lysine-to-methionine mutants as robust in vivo tools for inhibiting methylation pathways that also function as biochemical reagents for capturing site-specific histone-modifying enzymes, thus providing molecular insight into chromatin signaling pathways.	[Herz, Hans-Martin; Morgan, Marc; Gao, Xin; Rickels, Ryan; Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Jackson, Jessica; Eissenberg, Joel C.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Saint Louis University; University of Kansas; University of Kansas Medical Center	Shilatifard, A (corresponding author), Northwestern Univ, Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60208 USA.	ash@northwestern.edu	Gao, Xin/GPX-0396-2022; Herz, Hans-Martin/N-2594-2018	Herz, Hans-Martin/0000-0003-4780-9176; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585; Gao, Xin/0000-0002-9459-0472	NIH [CA R01CA089455]; NATIONAL CANCER INSTITUTE [R01CA089455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Jenuwein, J. Muller, R. White, and the Bloomington Stock Center for providing antibodies and fly stocks; the Stowers Molecular Biology core for generating histone point mutants; the Stowers Tissue Culture Core for generating histone mutant cell lines; and S. Marshall and W. Hodges for technical assistance. Histone lysine-to-methionine studies in the Shilatifard laboratory were supported in part by NIH grant CA R01CA089455. Data generated for this study are deposited under Gene Expression Omnibus (GEO) accession number GSE59891. Chromatin immunoprecipitation (ChIP)-chip data of H3K27me3 are from GEO accession number GSE42106. Antibodies toward H3K27M were provided by Cell Signaling Technology. A. S. is a paid member of the scientific advisory board of Cell Signaling Technology.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Brauchle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060549; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; EISSENBERG JC, 1992, GENETICS, V131, P345; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; Lu BY, 1998, DEVELOPMENT, V125, P2223; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102	30	126	129	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1065	1070		10.1126/science.1255104	http://dx.doi.org/10.1126/science.1255104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170156	Green Accepted			2022-12-28	WOS:000340870900044
J	Meng, HYA; Su, KYL; Rieke, GH; Stevenson, DJ; Plavchan, P; Rujopakarn, W; Lisse, CM; Poshyachinda, S; Reichart, DE				Meng, Huan Y. A.; Su, Kate Y. L.; Rieke, George H.; Stevenson, David J.; Plavchan, Peter; Rujopakarn, Wiphu; Lisse, Carey M.; Poshyachinda, Saran; Reichart, Daniel E.			Large impacts around a solar-analog star in the era of terrestrial planet formation	SCIENCE			English	Article							DEBRIS; EARTH; MOON; VARIABILITY	The final assembly of terrestrial planets occurs via massive collisions, which can launch copious clouds of dust that are warmed by the star and glow in the infrared. We report the real-time detection of a debris-producing impact in the terrestrial planet zone around a 35-million-year-old solar-analog star. We observed a substantial brightening of the debris disk at a wavelength of 3 to 5 micrometers, followed by a decay over a year, with quasi-periodic modulations of the disk flux. The behavior is consistent with the occurrence of a violent impact that produced vapor out of which a thick cloud of silicate spherules condensed that were then ground into dust by collisions. These results demonstrate how the time domain can become a new dimension for the study of terrestrial planet formation.	[Meng, Huan Y. A.; Rieke, George H.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Meng, Huan Y. A.; Rieke, George H.] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Su, Kate Y. L.; Rieke, George H.; Rujopakarn, Wiphu] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Su, Kate Y. L.; Rieke, George H.; Rujopakarn, Wiphu] Univ Arizona, Dept Astron, Tucson, AZ 85721 USA; [Stevenson, David J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Plavchan, Peter] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Plavchan, Peter] Missouri State Univ, Springfield, MO 65897 USA; [Rujopakarn, Wiphu] Chulalongkorn Univ, Dept Phys, Fac Sci, Bangkok 10330, Thailand; [Rujopakarn, Wiphu] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Lisse, Carey M.] Johns Hopkins Univ, Dept Space, Appl Phys Lab, Laurel, MD 20723 USA; [Poshyachinda, Saran] Minist Sci & Technol, Natl Astron Res Inst Thailand Publ Org, Chiang Mai 50200, Thailand; [Reichart, Daniel E.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); Missouri State University; Chulalongkorn University; University of Tokyo; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Meng, HYA (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 East Univ Blvd, Tucson, AZ 85721 USA.		Rujopakarn, Wiphu/AAV-2176-2021; Lisse, Carey M/B-7772-2016; Meng, Huan/C-4627-2015	Lisse, Carey M/0000-0002-9548-1526; Su, Kate/0000-0002-3532-5580; Meng, Huan/0000-0003-0006-7937; Rujopakarn, Wiphu/0000-0002-0303-499X; Plavchan, Peter/0000-0002-8864-1667	NASA [NNX13AE74G]; NASA through JPL/Caltech; Direct For Mathematical & Physical Scien [1211782] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NASA through JPL/Caltech; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	H.Y.A.M, K.Y.L.S., and G. H. R. thank R. Malhotra and A. Gaspar for valuable discussions. This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory (JPL), California Institute of Technology, under a contract with NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech and by NASA grant NNX13AE74G. All data are publicly available through the NASA/IPAC Infrared Science Archive.	ARTYMOWICZ P, 1988, ASTROPHYS J, V335, pL79, DOI 10.1086/185344; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Elser S, 2011, ICARUS, V214, P357, DOI 10.1016/j.icarus.2011.05.025; Helled R., 2014, PROTOSTARS IN PRESS; Jeffries RD, 2004, MON NOT R ASTRON SOC, V351, P1401, DOI 10.1111/j.1365-2966.2004.07886.x; Jewitt D, 1999, ASTRON J, V117, P1056, DOI 10.1086/300743; Johnson BC, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/45; Johnson BC, 2012, ICARUS, V217, P416, DOI 10.1016/j.icarus.2011.11.020; Kallinger T, 2008, ASTRON ASTROPHYS, V481, P571, DOI 10.1051/0004-6361:20077559; MCDONNELL JAM, 1986, NATURE, V321, P338, DOI 10.1038/321338a0; Meng HYA, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/1/L17; Naylor T, 2002, MON NOT R ASTRON SOC, V335, P291, DOI 10.1046/j.1365-8711.2002.05592.x; Olofsson J, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118735; Osten R, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/2/L44; Perez-Becker D, 2013, MON NOT R ASTRON SOC, V433, P2294, DOI 10.1093/mnras/stt895; Raymond S. N., 2014, PROTOSTARS IN PRESS, VVI; Reegen P, 2007, ASTRON ASTROPHYS, V467, P1353, DOI 10.1051/0004-6361:20066597; Righter K, 2011, P NATL ACAD SCI USA, V108, P19165, DOI 10.1073/pnas.1013480108; Soderblom D. R., 2014, PROTOSTARS IN PRESS; Warren PH, 2008, GEOCHIM COSMOCHIM AC, V72, P3562, DOI 10.1016/j.gca.2008.04.031; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525; Wyatt MC, 2002, MON NOT R ASTRON SOC, V334, P589, DOI 10.1046/j.1365-8711.2002.05533.x; Zuckerman B, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/77	27	50	50	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1032	1035		10.1126/science.1255153	http://dx.doi.org/10.1126/science.1255153			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25170148	Green Accepted, Green Submitted			2022-12-28	WOS:000340870900034
J	Loberg, M; Kalager, M; Holme, O; Hoff, G; Adami, HO; Bretthauer, M				Loberg, Magnus; Kalager, Mette; Holme, Oyvind; Hoff, Geir; Adami, Hans-Olov; Bretthauer, Michael			Long-Term Colorectal-Cancer Mortality after Adenoma Removal	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONOSCOPIC POLYPECTOMY; SURVEILLANCE; RISK; GUIDELINES; NORWAY; COMPLETENESS; PREVENTION; ENDOSCOPY; REGISTRY; SOCIETY	BACKGROUND Although colonoscopic surveillance of patients after removal of adenomas is widely promoted, little is known about colorectal-cancer mortality among these patients. METHODS Using the linkage of the Cancer Registry and the Cause of Death Registry of Norway, we estimated colorectal-cancer mortality among patients who had undergone removal of colorectal adenomas during the period from 1993 through 2007. Patients were followed through 2011. We calculated standardized incidence-based mortality ratios (SMRs) using rates for the Norwegian population at large for comparison. Norwegian guidelines recommended colonoscopy after 10 years for patients with high-risk adenomas (adenomas with high-grade dysplasia, a villous component, or a size mm) and after 5 years for patients with three or more adenomas; no surveillance was recommended for patients with low-risk adenomas. Polyp size and exact number were not available in the registry. We defined high-risk adenomas as multiple adenomas and adenomas with a villous component or high-grade dysplasia. RESULTS We identified 40,826 patients who had had colorectal adenomas removed. During a median follow-up of 7.7 years (maximum, 19.0), 1273 patients were given a diagnosis of colorectal cancer. A total of 398 deaths from colorectal cancer were expected and 383 were observed, for an SMR of 0.96 (95% confidence interval [CI], 0.87 to 1.06) among patients who had had adenomas removed. Colorectal-cancer mortality was increased among patients with high-risk adenomas (expected deaths, 209; observed deaths, 242; SMR, 1.16; 95% CI, 1.02 to 1.31), but it was reduced among patients with low-risk adenomas (expected deaths, 189; observed deaths, 141; SMR, 0.75; 95% CI, 0.63 to 0.88). CONCLUSIONS After a median of 7.7 years of follow-up, colorectal-cancer mortality was lower among patients who had had low-risk adenomas removed and moderately higher among those who had had high-risk adenomas removed, as compared with the general population. (Funded by the Norwegian Cancer Society and others.)	[Loberg, Magnus; Kalager, Mette; Hoff, Geir; Adami, Hans-Olov; Bretthauer, Michael] Univ Oslo, Dept Hlth Management & Hlth Econ, N-0317 Oslo, Norway; [Loberg, Magnus; Bretthauer, Michael] Oslo Univ Hosp, Dept Transplantat Med, Oslo, Norway; [Hoff, Geir] Canc Registry Norway, Oslo, Norway; [Kalager, Mette; Hoff, Geir] Telemark Hosp, Dept Res & Dev, Skien, Norway; [Holme, Oyvind; Bretthauer, Michael] Sorlandet Hosp Kristiansand, Dept Med, Kristiansand, Norway; [Loberg, Magnus; Kalager, Mette; Holme, Oyvind; Adami, Hans-Olov; Bretthauer, Michael] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oslo; University of Oslo; University of Oslo; Telemark Hospital Trust; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet	Loberg, M (corresponding author), Univ Oslo, Dept Hlth Management & Hlth Econ, N-0317 Oslo, Norway.	magnus.loberg@medisin.uio.no	Løberg, Magnus/F-1152-2016	Løberg, Magnus/0000-0003-2231-1304	Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	Funded by the Norwegian Cancer Society and others.	[Anonymous], GASTR QUAL PROGR; Atkin WS, 2012, ENDOSCOPY, V44, pSE151, DOI 10.1055/s-0032-1309821; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Bretthauer M, 2012, NEW ENGL J MED, V366, P759, DOI 10.1056/NEJMe1114639; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Garborg K, 2013, ANN ONCOL, V24, P1963, DOI 10.1093/annonc/mdt157; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hassan C, 2013, ENDOSCOPY, V45, P842, DOI 10.1055/s-0033-1344548; Hoff G, 1996, SCAND J GASTROENTERO, V31, P834, DOI 10.3109/00365529609051989; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Loeve F, 2004, INT J CANCER, V111, P147, DOI 10.1002/ijc.20241; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Soreide K, 2012, COLORECTAL DIS, V14, P320, DOI 10.1111/j.1463-1318.2011.02631.x; Statistics Norway, POP SEX AG; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; World Health Organization, 2000, INT CLASSIFICATION D; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	24	210	213	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					799	807		10.1056/NEJMoa1315870	http://dx.doi.org/10.1056/NEJMoa1315870			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZN	25162886				2022-12-28	WOS:000340819800006
J	Sarewitz, D				Sarewitz, Daniel			Allow use of electronic cigarettes to assess risk	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@asu.edu							0	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					349	349		10.1038/512349a	http://dx.doi.org/10.1038/512349a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8GC	25164716	Bronze			2022-12-28	WOS:000340840600003
J	Bromm, V				Bromm, Volker			ASTRONOMY Imprint of an ancient conflagration	SCIENCE			English	Editorial Material							1ST STARS; SUPERNOVA; UNIVERSE; ENRICHMENT; EXPLOSION; SIGNATURE; GALAXY		Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bromm, V (corresponding author), Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA.	vbromm@astro.as.utexas.edu						Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/11/112901; Cooke J, 2012, NATURE, V491, P228, DOI 10.1038/nature11521; Frebel A, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/74; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Hirano S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/60; Karlsson T, 2013, REV MOD PHYS, V85, P809, DOI 10.1103/RevModPhys.85.809; Keller SC, 2014, NATURE, V506, P463, DOI 10.1038/nature12990; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Whalen DJ, 2013, ASTROPHYS J LETT, V762, DOI 10.1088/2041-8205/762/1/L6	15	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					868	869		10.1126/science.1255524	http://dx.doi.org/10.1126/science.1255524			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146266				2022-12-28	WOS:000340524700017
J	Goldberg, GW; Jiang, WY; Bikard, D; Marraffini, LA				Goldberg, Gregory W.; Jiang, Wenyan; Bikard, David; Marraffini, Luciano A.			Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting	NATURE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIVIRAL DEFENSE; IMMUNITY; RNA; INTERFERENCE; COMPLEX; SYSTEMS; DNA; SEQUENCE; PROTEIN	A fundamental feature of immune systems is the ability to distinguish pathogenic from self and commensal elements, and to attack the former but tolerate the latter(1). Prokaryotic CRISPR-Cas immune systems defend against phage infection byusing Cas nucleases and small RNA guides that specify one or more target sites for cleavage of the viral genome(2,3). Temperate phages include viruses that can integrate into the bacterial chromosome, and they can carry genes that provide a fitness advantage to the lysogenic host(4,5). However, CRISPR-Cas targeting that relies strictly on DNA sequence recognition provides indiscriminate immunity both to lytic and lysogenic infection by temperate phages(6)-compromising the genetic stability of these potentially beneficial elements altogether. Here we show that the Staphylococcus epidermidis CRISPR-Cas system can prevent lytic infection but tolerate lysogenization by temperate phages. Conditional tolerance is achieved through transcription-dependent DNA targeting, and ensures that targeting is resumed upon induction of the prophage lytic cycle. Our results provide evidence for the functional divergence of CRISPR-Cas systems and highlight the importance of targeting mechanism diversity. In addition, they extend the concept of 'tolerance to non-self' to the prokaryotic branch of adaptive immunity.	[Goldberg, Gregory W.; Jiang, Wenyan; Bikard, David; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Rockefeller University	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA.	marraffini@rockefeller.edu	Bikard, David/L-2971-2015; Bikard, David/AAZ-3752-2021	Bikard, David/0000-0002-5729-1211; Bikard, David/0000-0002-5729-1211; Goldberg, Gregory/0000-0002-5022-9976	Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; National Institutes of Health Director's New Innovator Award [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556, T32AI070084] Funding Source: NIH RePORTER	Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge T. Bae for providing strains; B. Levin, J. Modell and P. Samai for discussion of the paper, and A. Hatoum-Aslan, as well the Torres laboratory (New York University), for their optimization of RNA preparation protocols for S. aureus. We also thank J. Chen of the Novick laboratory for advice on the construction of temperate phages with a selectable marker. Finally, we acknowledge The Rockefeller University Genomics Resource Center core facility for performing the next-generation sequencing in this work. L. A. M. is supported by the Searle Scholars Program, the Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award and a National Institutes of Health Director's New Innovator Award (1DP2AI104556-01).	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Barrangou R, 2013, WIRES RNA, V4, P267, DOI 10.1002/wrna.1159; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cumby Nichole, 2012, Bacteriophage, V2, P225; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Helle L, 2011, MICROBIOL-SGM, V157, P3314, DOI 10.1099/mic.0.052548-0; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; HORINOUCHI S, 1982, J BACTERIOL, V150, P804, DOI 10.1128/JB.150.2.804-814.1982; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Moore SD, 2002, J VIROL, V76, P10245, DOI 10.1128/JVI.76.20.10245-10255.2002; Nozawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019543; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	37	176	184	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					633	+		10.1038/nature13637	http://dx.doi.org/10.1038/nature13637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25174707	Green Accepted			2022-12-28	WOS:000343801500050
J	Lin, JS; O'Connor, E; Evans, CV; Senger, CA; Rowland, MG; Groom, HC				Lin, Jennifer S.; O'Connor, Elizabeth; Evans, Corinne V.; Senger, Caitlyn A.; Rowland, Maya G.; Groom, Holly C.			Behavioral Counseling to Promote a Healthy Lifestyle in Persons With Cardiovascular Risk Factors: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; IMPAIRED GLUCOSE-TOLERANCE; IMPROVE PHYSICAL-ACTIVITY; TREATED HYPERTENSIVE MEN; BLOOD-PRESSURE; EDUCATION-PROGRAM; DIETARY PATTERNS; GENERAL-PRACTICE; HEART-DISEASE; WEIGHT-LOSS	Background: Most Americans do not meet diet and physical activity recommendations despite known health benefits. Purpose: To systematically review the benefits and harms of lifestyle counseling interventions in persons with cardiovascular risk factors for the U. S. Preventive Services Task Force. Data Sources: MEDLINE, PsycINFO, the Database of Abstracts of Reviews of Effects, and the Cochrane Central Register of Controlled Trials (January 2001 to October 2013); experts; and existing systematic reviews. Study Selection: Two investigators independently reviewed 7218 abstracts and 553 articles against a set of inclusion and quality criteria. Data Extraction: Data from 74 trials were abstracted by one reviewer and checked by a second. Data Synthesis: At 12 to 24 months, intensive lifestyle counseling in persons selected for risk factors reduced total cholesterol levels by an average of 0.12 mmol/L (95% CI, 0.16 to 0.07 mmol/L) (4.48 mg/dL [CI, 6.36 to 2.59 mg/dL]), low-density lipoprotein cholesterol levels by 0.09 mmol/L (CI, 0.14 to 0.04 mmol/L) (3.43 mg/dL [CI, 5.37 to 1.49 mg/dL]), systolic blood pressure by 2.03 mm Hg (CI, 2.91 to 1.15 mm Hg), diastolic blood pressure by 1.38 mm Hg (CI, 1.92 to 0.83 mm Hg), fasting glucose levels by 0.12 mmol/L (CI, 0.18 to 0.05 mmol/L) (2.08 mg/dL [CI, 3.29 to 0.88 mg/dL]), diabetes incidence by a relative risk of 0.58 (CI, 0.37 to 0.89), and weight outcomes by a standardized mean difference of 0.25 (CI, 0.35 to 0.16). Behavioral changes in dietary intake and physical activity were generally concordant with changes in physiologic outcomes. Limitation: Sparse reporting of patient health outcomes, longerterm follow-up of outcomes, and harms. Conclusion: Intensive diet and physical activity behavioral counseling in persons with risk factors for cardiovascular disease resulted in consistent improvements across various important intermediate health outcomes up to 2 years.	[Lin, Jennifer S.; O'Connor, Elizabeth; Evans, Corinne V.; Senger, Caitlyn A.; Rowland, Maya G.; Groom, Holly C.] Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR USA	Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.			Groom, Holly/0000-0003-2866-9788	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	AGEWALL S, 1994, J INTERN MED, V236, P651, DOI 10.1111/j.1365-2796.1994.tb00858.x; Anderson AL, 2011, J AM DIET ASSOC, V111, P84, DOI 10.1016/j.jada.2010.10.012; ANDERSSEN SA, 1995, NUTR METAB CARDIOVAS, V5, P189; [Anonymous], 2002, Am Fam Physician, V66, P1931; [Anonymous], 2008, US PREV SERV TASK FO; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; APPLEGATE WB, 1992, ARCH INTERN MED, V152, P1162, DOI 10.1001/archinte.152.6.1162; ARROLL B, 1995, NEW ZEAL MED J, V108, P266; Ayala Carma, 2005, J Clin Hypertens (Greenwich), V7, P513, DOI 10.1111/j.1524-6175.2005.04286.x; Babazono A, 2007, DIS MANAG HEALTH OUT, V15, P119, DOI 10.2165/00115677-200715020-00007; Baker MK, 2011, DIABETES RES CLIN PR, V91, P1, DOI 10.1016/j.diabres.2010.06.030; Berg AO, 2003, AM J PREV MED, V24, P93; BLOEMBERG BPM, 1991, AM J EPIDEMIOL, V134, P39, DOI 10.1093/oxfordjournals.aje.a115991; Bo S, 2007, J GEN INTERN MED, V22, P1695, DOI 10.1007/s11606-007-0399-6; Bruckert E, 2008, CARDIOVASC DRUG THER, V22, P495, DOI 10.1007/s10557-008-6137-4; Burke V, 2007, J CLIN EPIDEMIOL, V60, P133, DOI 10.1016/j.jclinepi.2006.05.012; Carroll Margaret D, 2012, NCHS Data Brief, P1; Chowdhury R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6698; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Crowe FL, 2012, EUR J CLIN NUTR, V66, P950, DOI 10.1038/ejcn.2012.51; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eakin E, 2009, AM J PREV MED, V36, P142, DOI 10.1016/j.amepre.2008.09.042; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Edelman D, 2006, J GEN INTERN MED, V21, P728, DOI 10.1111/j.1525-1497.2006.00495.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Fagerberg B, 1998, AM J HYPERTENS, V11, P14, DOI 10.1016/S0895-7061(97)00363-4; Flocke SA, 2005, FAM MED, V37, P415; Ford ES, 2012, PREV MED, V55, P23, DOI 10.1016/j.ypmed.2012.04.016; Fortier MS, 2011, APPL PHYSIOL NUTR ME, V36, P503, DOI [10.1139/H11-040, 10.1139/h11-040]; Gillett M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16330; Hayashi T, 2010, J WOMENS HEALTH, V19, P1129, DOI 10.1089/jwh.2009.1631; Hebert ET, 2012, BRIT J SPORT MED, V46, P625, DOI 10.1136/bjsports-2011-090734; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Hyman DJ, 1998, AM J PREV MED, V15, P139, DOI 10.1016/S0749-3797(98)00038-5; IVES DG, 1993, AM J PREV MED, V9, P274, DOI 10.1016/S0749-3797(18)30703-7; JANUS ED, 2012, TRIALS, V13, pNIL_0001, DOI DOI 10.1186/1745-6215-13-152; JOHNSTON HJ, 1995, MED J AUSTRALIA, V162, P524, DOI 10.5694/j.1326-5377.1995.tb138510.x; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kanaya AM, 2012, AM J PUBLIC HEALTH, V102, P1551, DOI 10.2105/AJPH.2011.300456; Kant AK, 2009, J NUTR, V139, P1374, DOI 10.3945/jn.109.104505; Keyserling TC, 2008, PREV MED, V46, P499, DOI 10.1016/j.ypmed.2008.02.011; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Kulzer B, 2009, DIABETES CARE, V32, P1143, DOI 10.2337/dc08-2141; Lakerveld J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-47; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LeBlanc E, 2011, SCREENING MANAGEMENT; LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006; Lin JS, 2010, ANN INTERN MED, V153, P736, DOI 10.7326/0003-4819-153-11-201012070-00007; Lin JS, 2014, AHRQ PUBLICATION; Lin PH, 2013, J ACAD NUTR DIET, V113, P1465, DOI 10.1016/j.jand.2013.06.343; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mensink M, 2003, DIABETES RES CLIN PR, V61, P49, DOI 10.1016/S0168-8227(03)00067-6; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Migneault JP, 2012, ANN BEHAV MED, V43, P62, DOI 10.1007/s12160-011-9319-4; Moore SM, 2011, PSYCHOL HEALTH, V26, P485, DOI 10.1080/08870440903548749; Moreau KL, 2001, MED SCI SPORT EXER, V33, P1825, DOI 10.1097/00005768-200111000-00005; Morey MC, 2012, J AM GERIATR SOC, V60, P1655, DOI 10.1111/j.1532-5415.2012.04119.x; Moyer VA, 2012, ANN INTERN MED, V157, P367, DOI 10.7326/0003-4819-157-5-201209040-00486; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Murphy SM, 2012, J EPIDEMIOL COMMUN H, V66, P745, DOI 10.1136/jech-2011-200689; National Institute for Health and Care Excellence, 2012, GUID MAN; Nettleton JA, 2009, AM J CLIN NUTR, V90, P647, DOI 10.3945/ajcn.2009.27597; NILSSON PM, 1992, J HYPERTENS, V10, P1071; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Staff UDoA, 2000, NUTR YOUR HLTH DIET; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; US Department of Health and Human Services, HLTH PEOPL 2020 TOP; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248; van Keulen HM, 2011, ANN BEHAV MED, V41, P104, DOI 10.1007/s12160-010-9231-3; Van Roie E, 2010, J AGING PHYS ACTIV, V18, P335, DOI 10.1123/japa.18.3.335; van Sluijs EMF, 2005, AM J PUBLIC HEALTH, V95, P1825, DOI 10.2105/AJPH.2004.044537; Watanabe M, 2003, DIABETES CARE, V26, P3209, DOI 10.2337/diacare.26.12.3209; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yates T, 2009, DIABETES CARE, V32, P1404, DOI 10.2337/dc09-0130; Yoon Sung Sug, 2012, NCHS Data Brief, P1	90	125	127	2	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					568	U73		10.7326/M14-0130	http://dx.doi.org/10.7326/M14-0130			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9PL	25155549				2022-12-28	WOS:000343906800018
J	Kuehn, HS; Ouyang, WM; Lo, B; Deenick, EK; Niemela, JE; Avery, DT; Schickel, JN; Tran, DQ; Stoddard, J; Zhang, Y; Frucht, DM; Dumitriu, B; Scheinberg, P; Folio, LR; Frein, CA; Price, S; Koh, C; Heller, T; Seroogy, CM; Huttenlocher, A; Rao, VK; Su, HC; Kleiner, D; Notarangelo, LD; Rampertaap, Y; Olivier, KN; McElwee, J; Hughes, J; Pittaluga, S; Oliveira, JB; Meffre, E; Fleisher, TA; Holland, SM; Lenardo, MJ; Tangye, SG; Uzel, G				Kuehn, Hye Sun; Ouyang, Weiming; Lo, Bernice; Deenick, Elissa K.; Niemela, Julie E.; Avery, Danielle T.; Schickel, Jean-Nicolas; Tran, Dat Q.; Stoddard, Jennifer; Zhang, Yu; Frucht, David M.; Dumitriu, Bogdan; Scheinberg, Phillip; Folio, Les R.; Frein, Cathleen A.; Price, Susan; Koh, Christopher; Heller, Theo; Seroogy, Christine M.; Huttenlocher, Anna; Rao, V. Koneti; Su, Helen C.; Kleiner, David; Notarangelo, Luigi D.; Rampertaap, Yajesh; Olivier, Kenneth N.; McElwee, Joshua; Hughes, Jason; Pittaluga, Stefania; Oliveira, Joao B.; Meffre, Eric; Fleisher, Thomas A.; Holland, Steven M.; Lenardo, Michael J.; Tangye, Stuart G.; Uzel, Gulbu			Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4	SCIENCE			English	Article							REGULATORY T-CELLS; COMMON VARIABLE IMMUNODEFICIENCY; B-CELLS; METASTATIC MELANOMA; AUTOIMMUNE-DISEASE; TOLERANCE; LYMPHOPROLIFERATION; ACCUMULATION; ACTIVATION; MECHANISMS	Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an inhibitory receptor found on immune cells. The consequences of mutations in CTLA4 in humans are unknown. We identified germline heterozygous mutations in CTLA4 in subjects with severe immune dysregulation from four unrelated families. Whereas Ctla4 heterozygous mice have no obvious phenotype, human CTLA4 haploinsufficiency caused dysregulation of FoxP3(+) regulatory T (T-reg) cells, hyperactivation of effector T cells, and lymphocytic infiltration of target organs. Patients also exhibited progressive loss of circulating B cells, associated with an increase of predominantly autoreactive CD21(lo) B cells and accumulation of B cells in nonlymphoid organs. Inherited human CTLA4 haploinsufficiency demonstrates a critical quantitative role for CTLA-4 in governing T and B lymphocyte homeostasis.	[Kuehn, Hye Sun; Niemela, Julie E.; Stoddard, Jennifer; Fleisher, Thomas A.] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Ouyang, Weiming; Frucht, David M.] US FDA, Lab Cell Biol, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Lo, Bernice; Price, Susan; Rao, V. Koneti; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Immunol Lab, Bethesda, MD 20892 USA; [Lo, Bernice; Zhang, Yu; Price, Susan; Rao, V. Koneti; Su, Helen C.; Holland, Steven M.; Lenardo, Michael J.] NIAID, Clin Genom Program, Bethesda, MD 20892 USA; [Deenick, Elissa K.; Avery, Danielle T.; Tangye, Stuart G.] Garvan Inst Med Res, Immunol & Immunodeficiency Grp, Div Immunol, Sydney, NSW 2010, Australia; [Deenick, Elissa K.; Tangye, Stuart G.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Schickel, Jean-Nicolas; Meffre, Eric] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Tran, Dat Q.] Univ Texas Med Sch, Dept Pediat, Houston, TX 77030 USA; [Zhang, Yu; Su, Helen C.] NIAID, Immunol Dis Unit, Lab Host Defenses, Bethesda, MD 20892 USA; [Dumitriu, Bogdan; Scheinberg, Phillip] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [Folio, Les R.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Frein, Cathleen A.] Frederick Natl Lab Canc Res, Clin Res Directorate, Clin Monitoring Res Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Koh, Christopher; Heller, Theo] NIDDK, Liver Dis Branch, Bethesda, MD 20892 USA; [Seroogy, Christine M.; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Kleiner, David; Pittaluga, Stefania] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Childrens Hosp, Div Immunol, Boston, MA 02117 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Rampertaap, Yajesh; Olivier, Kenneth N.; Holland, Steven M.; Uzel, Gulbu] NIAID, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [McElwee, Joshua; Hughes, Jason] Merck & Co Inc, Merck Res Labs, Boston, MA 02130 USA; [Oliveira, Joao B.] Inst Med Integral Prof Fernando Figueira IMIP, BR-50070 Recife, PE, Brazil	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Garvan Institute of Medical Research; University of New South Wales Sydney; Yale University; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Merck & Company; Instituto de Medicina Integral Professor Fernando Figueira (IMIP)	Fleisher, TA (corresponding author), NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA.	tfleishe@cc.nih.gov; lenardo@nih.gov; guzel@niaid.nih.gov	Kleiner, David E/N-2770-2013; Su, Helen C/H-9541-2015; Notarangelo, Luigi D/F-9718-2016; Tangye, Stuart G/H-4023-2014; Oliveira, Joao Bosco/AAC-9947-2021; Lo, Bernice/H-7538-2017; Scheinberg, Phillip/H-5251-2012; Oliveira, João/GXN-3304-2022; Rao, V. Koneti/AAR-2171-2020; Deenick, Elissa/AAY-8998-2020; Folio, Les R./AAO-5456-2021	Kleiner, David E/0000-0003-3442-4453; Su, Helen C/0000-0002-5582-9110; Notarangelo, Luigi D/0000-0002-8335-0262; Tangye, Stuart G/0000-0002-5360-5180; Oliveira, Joao Bosco/0000-0001-9388-8173; Lo, Bernice/0000-0002-1087-6845; Scheinberg, Phillip/0000-0002-9047-4538; Rao, V. Koneti/0000-0002-7881-6902; Deenick, Elissa/0000-0002-9271-0004; Heller, Theo/0000-0002-2643-6289; Niemela, Julie/0000-0003-4197-3792	Intramural Research Program, NIH Clinical Center; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Cancer Institute [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases [5R01HL113304-01, AI071087, AI095848, AI061093]; National Health and Medical Research Council of Australia; Cancer Council NSW; NATIONAL CANCER INSTITUTE [ZICBC010687] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113304, ZIAHL006201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000732, R21AI095848, P01AI061093, ZIAAI001059, R01AI071087, ZIAAI000769] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304] Funding Source: NIH RePORTER	Intramural Research Program, NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	We thank the referring physicians, as well as the patients and families. The data are tabulated in the main paper and in the supplementary materials. Supported by the Intramural Research Program, NIH Clinical Center (H. S. K., T. A. F., J.S., J.E.N., L. R. F.); the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (B. L., Y.Z., V. K. R., H. C. S., Y.R., K.N.O., S.Pr., S. M. H., M.J.L., G. U.); the National Cancer Institute under contract HHSN261200800001E (C. A. F.); National Institute of Allergy and Infectious Diseases grant 5R01HL113304-01 (D. Q. T.); the National Health and Medical Research Council of Australia (E. K. D., S. G. T.); Cancer Council NSW (S. G. T.); and National Institute of Allergy and Infectious Diseases grants AI071087, AI095848, and AI061093 (E. M.). The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The sequencing data are deposited in dbGaP under accession no. phs000797.v1.p1.	Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021; Bluestone JA, 2010, NAT REV IMMUNOL, V10, P797, DOI 10.1038/nri2869; Callahan MK, 2010, SEMIN ONCOL, V37, P473, DOI 10.1053/j.seminoncol.2010.09.001; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Herrero-Beaumont G, 2012, REUMATOL CLIN, V8, P78, DOI 10.1016/j.reuma.2011.08.002; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Price S, 2014, BLOOD, V123, P1989, DOI 10.1182/blood-2013-10-535393; Quandt D, 2007, J IMMUNOL, V179, P7316, DOI 10.4049/jimmunol.179.11.7316; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	28	553	570	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2014	345	6204					1623	1627		10.1126/science.1255904	http://dx.doi.org/10.1126/science.1255904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP6CG	25213377	Green Accepted			2022-12-28	WOS:000342164500049
J	Sharpe, M; Walker, J; Hansen, CH; Martin, P; Symeonides, S; Gourley, C; Wall, L; Weller, D; Murray, G				Sharpe, Michael; Walker, Jane; Hansen, Christian Holm; Martin, Paul; Symeonides, Stefan; Gourley, Charlie; Wall, Lucy; Weller, David; Murray, Gordon		SMaRT Symptom Management Research	Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial	LANCET			English	Article							QUALITY-OF-LIFE; MANAGEMENT; ASSOCIATION; PREVALENCE; HEALTH; PAIN; OUTPATIENTS; DISABILITY; DISORDERS; DISEASES	Background Medical conditions are often complicated by major depression, with consequent additional impairment of quality of life. We aimed to compare the effectiveness of an integrated treatment programme for major depression in patients with cancer (depression care for people with cancer) with usual care. Methods SMaRT Oncology-2 is a parallel-group, multicentre, randomised controlled effectiveness trial. We enrolled outpatients with major depression from three cancer centres and their associated clinics in Scotland, UK. Participants were randomly assigned in a 1:1 ratio to the depression care for people with cancer intervention or usual care, with stratification (by trial centre) and minimisation (by age, primary cancer, and sex) with allocation concealment. Depression care for people with cancer is a manualised, multicomponent collaborative care treatment that is delivered systematically by a team of cancer nurses and psychiatrists in collaboration with primary care physicians. Usual care is provided by primary care physicians. Outcome data were collected up until 48 weeks. The primary outcome was treatment response (>= 50% reduction in Symptom Checklist Depression Scale [SCL-20] score, range 0-4) at 24 weeks. Trial statisticians and data collection staff were masked to treatment allocation, but participants could not be masked to the allocations. Analyses were by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN40568538. Findings 500 participants were enrolled between May 12, 2008, and May 13, 2011; 253 were randomly allocated to depression care for people with cancer and 247 to usual care. 143 (62%) of 231 participants in the depression care for people with cancer group and 40 (17%) of 231 in the usual care group responded to treatment: absolute difference 45% (95% CI 37-53), adjusted odds ratio 8.5 (95% CI 5.5-13.4), p<0.0001. Compared with patients in the usual care group, participants allocated to the depression care for people with cancer programme also had less depression, anxiety, pain, and fatigue; and better functioning, health, quality of life, and perceived quality of depression care at all timepoints (all p<0.05). During the study, 34 cancer-related deaths occurred (19 in the depression care for people with cancer group, 15 in the usual care group), one patient in the depression care for people with cancer group was admitted to a psychiatric ward, and one patient in this group attempted suicide. None of these events were judged to be related to the trial treatments or procedures. Interpretation Our findings suggest that depression care for people with cancer is an effective treatment for major depression in patients with cancer. It offers a model for the treatment of depression comorbid with other medical conditions.	[Sharpe, Michael; Walker, Jane] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JK, England; [Hansen, Christian Holm] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Martin, Paul] Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland; [Symeonides, Stefan; Gourley, Charlie; Wall, Lucy] Univ Edinburgh, Western Gen Hosp, Canc Res UK Ctr, Edinburgh, Midlothian, Scotland; [Weller, David; Murray, Gordon] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; University of Edinburgh; University of Edinburgh	Sharpe, M (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JK, England.	michael.sharpe@psych.ox.ac.uk		sharpe, michael/0000-0002-6474-9980; Hansen, Christian/0000-0002-5949-0097	Cancer Research UK and Chief Scientist Office of the Scottish Government; MRC [G0800803] Funding Source: UKRI; Medical Research Council [G0800803] Funding Source: researchfish; Chief Scientist Office [SCD/11] Funding Source: researchfish	Cancer Research UK and Chief Scientist Office of the Scottish Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Cancer Research UK and Chief Scientist Office of the Scottish Government.	AARONSON NK, 1994, INT J MENT HEALTH, V23, P75, DOI 10.1080/00207411.1994.11449284; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Brown LF, 2010, PSYCHO-ONCOLOGY, V19, P734, DOI 10.1002/pon.1627; Colleoni M, 2000, LANCET, V356, P1326, DOI 10.1016/S0140-6736(00)02821-X; Department of Health England, 2013, LIV CANC TAK ACT IMP; Derogatis L., 1977, SCL 90 R VERSION MAN; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Ekers D, 2013, J AFFECT DISORDERS, V149, P14, DOI 10.1016/j.jad.2013.02.032; Ell K, 2008, J CLIN ONCOL, V26, P4488, DOI 10.1200/JCO.2008.16.6371; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; Fann JR, 2009, J GEN INTERN MED, V24, P417, DOI 10.1007/s11606-009-0999-4; First MB., 1996, STRUCTURED CLIN INTE; Hopko DR, 2003, CLIN PSYCHOL REV, V23, P699, DOI 10.1016/S0272-7358(03)00070-9; Institute of Medicine, 2006, CANC PATIENT CANC SU; Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, 2008, CANC CARE WHOLE PATI; KATHOL RG, 1990, AM J PSYCHIAT, V147, P1021; Katon W, 2012, AM J PREV MED, V42, P550, DOI 10.1016/j.amepre.2012.01.017; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, JAMA-J AM MED ASSOC, V304, P163, DOI 10.1001/jama.2010.944; Li M, 2012, J CLIN ONCOL, V30, P1187, DOI 10.1200/JCO.2011.39.7372; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mynors-Wallis, 2005, PROBLEM SOLVING TREA; National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H; O'Connor M, 2012, J PAIN SYMPTOM MANAG, V43, P29, DOI 10.1016/j.jpainsymman.2011.03.010; O'Connor M, 2010, GEN HOSP PSYCHIAT, V32, P334, DOI 10.1016/j.genhosppsych.2010.01.001; Sharpe M, 2004, BRIT J CANCER, V90, P314, DOI 10.1038/sj.bjc.6601578; Storey DJ, 2007, ANN ONCOL, V18, P1861, DOI 10.1093/annonc/mdm349; Strong V, 2008, LANCET, V372, P40, DOI 10.1016/S0140-6736(08)60991-5; TAYLOR DJ, 2011, TLS TIMES LIT S 1014, P10; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker J, 2014, PSYCHOL MED, V44, P897, DOI 10.1017/S0033291713001372; Walker J, 2013, ANN ONCOL, V24, P895, DOI 10.1093/annonc/mds575; Walker J, 2014, LANCET ONCOL; Walker J, 2014, LANCET PSYCHIAT; Walker J, 2008, J CLIN ONCOL, V26, P4725, DOI 10.1200/JCO.2007.11.8844; Walker J, 2010, J PSYCHOSOM RES, V68, P313, DOI 10.1016/j.jpsychores.2009.11.002; Walker J, 2009, GEN HOSP PSYCHIAT, V31, P436, DOI 10.1016/j.genhosppsych.2009.05.010; Walker J, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-18; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	42	160	162	1	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1099	1108		10.1016/S0140-6736(14)61231-9	http://dx.doi.org/10.1016/S0140-6736(14)61231-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	25175478				2022-12-28	WOS:000342630600030
J	Jiggins, CD				Jiggins, Chris D.			EVOLUTIONARY BIOLOGY Radiating genomes	NATURE			English	Editorial Material							ADAPTIVE RADIATION; CICHLIDS	Genome sequences and gene-expression data from representatives of five distinct lineages of African cichlid fish reveal signatures of the genomic changes that underlie the astounding cichlid diversity seen today. See Article p. 375	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Jiggins, CD (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	c.jiggins@zoo.cam.ac.uk	Jiggins, Chris/T-4296-2019; Jiggins, Chris D/B-9960-2008	Jiggins, Chris/0000-0002-7809-062X; Jiggins, Chris D/0000-0002-7809-062X				Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044670; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Ohno S., 2014, EVOLUTION GENE DUPLI; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144	9	2	2	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					318	319		10.1038/nature13742	http://dx.doi.org/10.1038/nature13742			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25186726				2022-12-28	WOS:000341814900039
J	Austin, J				Austin, Jim			Reviewing the reviewers	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1206	1206		10.1126/science.345.6201.1206	http://dx.doi.org/10.1126/science.345.6201.1206			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2TV	25190798				2022-12-28	WOS:000341179800051
J	West, JP; Gitler, AD				West, Joseph Paul, III; Gitler, Aaron D.			Clogging information flow in ALS	SCIENCE			English	Editorial Material							HEXANUCLEOTIDE REPEAT; C9ORF72; EXPANSION; GRANULES		[West, Joseph Paul, III; Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [West, Joseph Paul, III] E Carolina Univ, Greenville, NC 27834 USA	Stanford University; University of North Carolina; East Carolina University	West, JP (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	agitler@stanford.edu		Gitler, Aaron/0000-0001-8603-1526				DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041	12	10	10	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1118	1119		10.1126/science.1259461	http://dx.doi.org/10.1126/science.1259461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190778	Green Submitted			2022-12-28	WOS:000341179800020
J	Hutchinson, J				Hutchinson, John			EVOLUTIONARY DEVELOPMENTAL BIOLOGY Dynasty of the plastic fish	NATURE			English	Editorial Material							PHENOTYPIC PLASTICITY; GENETIC ASSIMILATION		Univ London Royal Vet Coll, Struct & Mot Lab, Dept Comparat Biomed Sci, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Hutchinson, J (corresponding author), Univ London Royal Vet Coll, Struct & Mot Lab, Dept Comparat Biomed Sci, Hatfield AL9 7TA, Herts, England.	jhutchinson@rvc.ac.uk	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038	NERC [NE/K004751/1] Funding Source: UKRI; Natural Environment Research Council [NE/K004751/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Cloutier R, 2013, GEOSCI CAN, V40, P149, DOI 10.12789/geocanj.2013.40.008; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; Geoffroy E., 1802, ANN MUS HIST NAT PAR, V1, P57; Le Guyader, 2004, GEOFFROY SAINT HILAI; Near TJ, 2014, EVOLUTION, V68, P1014, DOI 10.1111/evo.12323; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341	10	1	1	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					37	38		10.1038/nature13743	http://dx.doi.org/10.1038/nature13743			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25162531				2022-12-28	WOS:000341174800021
J	Madhi, SA; Cutland, CL; Kuwanda, L; Weinberg, A; Hugo, A; Jones, S; Adrian, PV; van Niekerk, N; Treurnicht, F; Ortiz, JR; Venter, M; Violari, A; Neuzil, KM; Simoes, EAF; Klugman, KP; Nunes, MC				Madhi, Shabir A.; Cutland, Clare L.; Kuwanda, Locadiah; Weinberg, Adriana; Hugo, Andrea; Jones, Stephanie; Adrian, Peter V.; van Niekerk, Nadia; Treurnicht, Florette; Ortiz, Justin R.; Venter, Marietjie; Violari, Avy; Neuzil, Kathleen M.; Simoes, Eric A. F.; Klugman, Keith P.; Nunes, Marta C.		Maternal Flu Trial Matflu Team	Influenza Vaccination of Pregnant Women and Protection of Their Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMAGGLUTINATION-INHIBITING ANTIBODY; HIV-INFECTION; DOUBLE-BLIND; CARDIOPULMONARY HOSPITALIZATIONS; RESPIRATORY ILLNESS; VIRUS INFECTION; ADULTS; INDIVIDUALS; RESPONSES; IMPACT	BACKGROUND There are limited data on the efficacy of vaccination against confirmed influenza in pregnant women with and those without human immunodeficiency virus (HIV) infection and protection of their infants. METHODS We conducted two double-blind, randomized, placebo-controlled trials of trivalent inactivated influenza vaccine (IIV3) in South Africa during 2011 in pregnant women infected with HIV and during 2011 and 2012 in pregnant women who were not infected. The immunogenicity, safety, and efficacy of IIV3 in pregnant women and their infants were evaluated until 24 weeks after birth. Immune responses were measured with a hemagglutination inhibition (HAI) assay, and influenza was diagnosed by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays of respiratory samples. RESULTS The study cohorts included 2116 pregnant women who were not infected with HIV and 194 pregnant women who were infected with HIV. At 1 month after vaccination, seroconversion rates and the proportion of participants with HAI titers of 1: 40 or more were higher among IIV3 recipients than among placebo recipients in both cohorts. Newborns of IIV3 recipients also had higher HAI titers than new-borns of placebo recipients. The attack rate for RT-PCR-confirmed influenza among both HIV-uninfected placebo recipients and their infants was 3.6%. The attack rates among HIV-uninfected IIV3 recipients and their infants were 1.8% and 1.9%, respectively, and the respective vaccine-efficacy rates were 50.4% (95% confidence interval [CI], 14.5 to 71.2) and 48.8% (95% CI, 11.6 to 70.4). Among HIV-infected women, the attack rate for placebo recipients was 17.0% and the rate for IIV3 recipients was 7.0%; the vaccine-efficacy rate for these IIV3 recipients was 57.7% (95% CI, 0.2 to 82.1). CONCLUSIONS Influenza vaccine was immunogenic in HIV-uninfected and HIV-infected pregnant women and provided partial protection against confirmed influenza in both groups of women and in infants who were not exposed to HIV.	[Madhi, Shabir A.; Cutland, Clare L.; Kuwanda, Locadiah; Hugo, Andrea; Jones, Stephanie; Adrian, Peter V.; van Niekerk, Nadia; Klugman, Keith P.; Nunes, Marta C.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.; Cutland, Clare L.; Kuwanda, Locadiah; Hugo, Andrea; Jones, Stephanie; Adrian, Peter V.; van Niekerk, Nadia; Nunes, Marta C.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa; [Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.; Treurnicht, Florette; Venter, Marietjie] Natl Inst Communicable Dis, Ctr Vaccines & Immunol, Natl Hlth Lab Serv, Johannesburg, South Africa; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, ZA-0001 Pretoria, South Africa; [Weinberg, Adriana] Univ Colorado, Sch Med, Aurora, CO USA; [Weinberg, Adriana] Univ Colorado, Childrens Hosp, Aurora, CO USA; [Simoes, Eric A. F.] Univ Colorado, Dept Pediat Med & Pathol, Sch Med, Aurora, CO USA; [Simoes, Eric A. F.] Colorado Sch Publ Hlth, Dept Epidemiol, Ctr Global Hlth, Aurora, CO USA; [Ortiz, Justin R.] Univ Washington, Dept Med, Seattle, WA USA; [Ortiz, Justin R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ortiz, Justin R.; Neuzil, Kathleen M.] PATH, Vaccine Access & Delivery Global Program, Seattle, WA USA; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; Rollins School Public Health; Emory University	Madhi, SA (corresponding author), Chris Hani Baragwanath Hosp, Resp & Meningeal Pathogens Res Unit, Chris Hani Rd, ZA-2013 Bertsham, Gauteng, South Africa.	shabirm@nicd.ac.za; nunesm@rmpru.co.za	Cutland, Clare L./GXE-9967-2022; Venter, Marietjie/P-9604-2016	Cutland, Clare L./0000-0001-8250-8307; Venter, Marietjie/0000-0003-2696-824X; Ortiz, Justin/0000-0002-3138-5965; Nanan, Ralph/0000-0002-1749-6378; Nunes, Marta/0000-0003-3788-878X	Bill and Melinda Gates Foundation [OPP1002747]; National Institutes of Health, National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute [UL1 TR000154]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation in Vaccine-Preventable Diseases; Respiratory and Meningeal Pathogens Research Unit of the Medical Research Council; GlaxoSmithKline; Pfizer; Sanofi Pasteur; Novartis; MedImmune; Merck; Becton Dickinson; Roche; Janssen; Aeras; Gilead; Drugs for Neglected Diseases Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health, National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation in Vaccine-Preventable Diseases; Respiratory and Meningeal Pathogens Research Unit of the Medical Research Council; GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Sanofi Pasteur; Novartis(Novartis); MedImmune(AstraZenecaMedimmune); Merck(Merck & Company); Becton Dickinson; Roche(Roche Holding); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Aeras; Gilead(Gilead Sciences); Drugs for Neglected Diseases Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants from the Bill and Melinda Gates Foundation (OPP1002747), the National Institutes of Health, National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute (UL1 TR000154, for REDCap), the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation in Vaccine-Preventable Diseases, and the Respiratory and Meningeal Pathogens Research Unit of the Medical Research Council.; Dr. Madhi reports receiving lecture fees and fees for serving on advisory boards from GlaxoSmithKline, Pfizer, and Sanofi Pasteur and grant support from Novartis, GlaxoSmithKline, Pfizer, Sanofi Pasteur, and MedImmune; and Dr. Weinberg consulting fees from Merck and grant support from Merck, MedImmune, Becton Dickinson, Roche, and GlaxoSmithKline; and Dr. Violari fees for serving on a data and safety monitoring board from Janssen and grant support from Janssen, Aeras, Gilead, and the Drugs for Neglected Diseases Initiative. No other potential conflict of interest relevant to this article was reported.	Anema A, 2008, HIV MED, V9, P57, DOI 10.1111/j.1468-1293.2008.00515.x; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P201; [Anonymous], 2014, INFL SURV REP S AFR; Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Benne CA, 1998, CLIN DIAGN LAB IMMUN, V5, P114, DOI 10.1128/CDLI.5.1.114-117.1998; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; BLACK SC, 2011, PEDIATR INFECT DIS J, V40, P30; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; Englund JA, 2010, PEDIATR INFECT DIS J, V29, P105, DOI 10.1097/INF.0b013e3181b84c34; France EK, 2006, ARCH PEDIAT ADOL MED, V160, P1277, DOI 10.1001/archpedi.160.12.1277; Fuller JD, 1999, CLIN INFECT DIS, V28, P541, DOI 10.1086/515170; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HULKA JF, 1964, OBSTET GYNECOL, V23, P830; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2003, JAIDS-J ACQ IMM DEF, V34, P430, DOI 10.1097/00126334-200312010-00011; Kroon FP, 2000, VACCINE, V18, P3040, DOI 10.1016/S0264-410X(00)00079-7; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Madhi SA, 2011, CLIN INFECT DIS, V52, P128, DOI 10.1093/cid/ciq004; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; NELSON KE, 1988, ANN INTERN MED, V109, P383, DOI 10.7326/0003-4819-109-5-383; Neuzil KM, 2003, JAIDS-J ACQ IMM DEF, V34, P304, DOI 10.1097/00126334-200311010-00008; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592; STAPRANS SI, 1995, J EXP MED, V182, P1727, DOI 10.1084/jem.182.6.1727; Tasker SA, 1998, VACCINE, V16, P1039, DOI 10.1016/S0264-410X(97)00275-2; Thompson MG, 2014, CLIN INFECT DIS, V58, P449, DOI 10.1093/cid/cit750; VAXIGRIP, 2011, IN INFL VACC SPLIT V; World Health Organization, 2010, REC VIR INFL VACC US; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; 2004, TABLE GRADING SEVERI	39	375	383	4	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					918	931		10.1056/NEJMoa1401480	http://dx.doi.org/10.1056/NEJMoa1401480			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5NB	25184864	Green Published			2022-12-28	WOS:000341390600009
J	Standen, EM; Du, TY; Larsson, HCE				Standen, Emily M.; Du, Trina Y.; Larsson, Hans C. E.			Developmental plasticity and the origin of tetrapods	NATURE			English	Article							PHENOTYPIC PLASTICITY; TERRESTRIAL LOCOMOTION; EVOLUTION; PALEONTOLOGY; FIN	The origin of tetrapods from their fish antecedents, approximately 400 million years ago, was coupled with the origin of terrestrial locomotion and the evolution of supporting limbs. Polypterus is a member of the basal-most group of ray-finned fish (actinopterygians) and has many plesiomorphic morphologies that are comparable to elpistostegid fishes, which are stem tetrapods. Polypterus therefore serves as an extant analogue of stem tetrapods, allowing us to examine how developmental plasticity affects the 'terrestrialization' of fish. We measured the developmental plasticity of anatomical and biomechanical responses in Polypterus reared on land. Here we show the remarkable correspondence between the environmentally induced phenotypes of terrestrialized Polypterus and the ancient anatomical changes in stem tetrapods, and we provide insight into stem tetrapod behavioural evolution. Our results raise the possibility that environmentally induced developmental plasticity facilitated the origin of the terrestrial traits that led to tetrapods.	[Standen, Emily M.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Du, Trina Y.; Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 0C4, Canada	University of Ottawa; McGill University	Standen, EM (corresponding author), Univ Ottawa, Dept Biol, Gendron Hall,30 Marie Curie Private, Ottawa, ON K1N 6N5, Canada.	estanden@uottawa.ca; hans.ce.larsson@mcgill.ca	Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770; Du, Trina/0000-0003-2193-0795	National Sciences and Engineering Research Council of Canada [261796-2011]; Robert G. Goelet Research Award	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Robert G. Goelet Research Award	We thank F. A. Jenkins Jr and C. R. Marshall for encouragement and discussions with E. M. S. during the initial phases of this project. We also thank E. Abouheif for discussions and editing of the manuscript. We thank J. Dawson for the loan of camera equipment, S. Bertram for access to laboratory space while running the experiment and B. Bongfeldt for animal care and preliminary data analysis. We are grateful for the Tomlinson Post-doctoral Fellowship (E. M. S.), for grants from the National Sciences and Engineering Research Council of Canada (PDF to E. M. S., CGS-M to T.Y.D. and Discovery Grant #261796-2011 to H. C. E. L.), for the Robert G. Goelet Research Award (E. M. S.) and to Canada Research Chairs (H.C.E.L.).	Ahlberg PE, 2006, NATURE, V440, P747, DOI 10.1038/440747a; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Bartsch P, 1997, ACTA ZOOL-STOCKHOLM, V78, P309, DOI 10.1111/j.1463-6395.1997.tb01014.x; Batschelet E., 1981, CIRCULAR STAT BIOL; Batschelet E, 1965, STAT METHODS ANAL PR; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Blob RW, 2001, J EXP BIOL, V204, P1099; BRECHBUHLER C, 1995, COMPUT VIS IMAGE UND, V61, P154, DOI 10.1006/cviu.1995.1013; Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Clack J.A., 2012, GAINING GROUND, VSecond; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Coates MI, 2008, ANNU REV ECOL EVOL S, V39, P571, DOI 10.1146/annurev.ecolsys.38.091206.095546; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; GOSLINE WA, 1977, J ZOOL, V183, P329; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Kawano SM, 2013, INTEGR COMP BIOL, V53, P283, DOI 10.1093/icb/ict051; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Paniagua B, 2009, INSIGHT J; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rajakumar R, 2012, SCIENCE, V335, P79, DOI 10.1126/science.1211451; Reinschmidt C., 1997, MATLAB TOOLBOX 3 DIM; Shen L, 2009, EVOLUTION, V63, P1003, DOI 10.1111/j.1558-5646.2008.00557.x; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Styner M., 2006, INSIGHT J; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; TUCKER VA, 1975, AM SCI, V63, P413; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; West-Eberhard Mary Jane, 2003, pi; WINTERBOTTOM R, 1973, P ACAD NAT SCI PHILA, V125, P225; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825; Zar JH., 1999, BIOSTAT ANAL, V663rd	41	129	130	3	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					54	+		10.1038/nature13708	http://dx.doi.org/10.1038/nature13708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25162530				2022-12-28	WOS:000341174800028
J	Wulder, MA; Coops, NC				Wulder, Michael A.; Coops, Nicholas C.			Make Earth observations open access	NATURE			English	Editorial Material							LANDSAT DATA		[Wulder, Michael A.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC, Canada; [Coops, Nicholas C.] Univ British Columbia, Fac Forest Resources Management, Vancouver, BC V5Z 1M9, Canada	Natural Resources Canada; Canadian Forest Service; University of British Columbia	Wulder, MA (corresponding author), Nat Resources Canada, Canadian Forest Serv, Victoria, BC, Canada.	mike.wulder@nrcan-rncan.gc.ca	Wulder, Michael A/J-5597-2016; Coops, Nicholas C/J-1543-2012; Coops, Nicholas/L-3652-2019	Wulder, Michael A/0000-0002-6942-1896; Coops, Nicholas C/0000-0002-0151-9037; Coops, Nicholas/0000-0002-0151-9037				Belward A.S., 2014, ISPRS J PHOTOGRAMM R; Hansen MC, 2012, REMOTE SENS ENVIRON, V122, P66, DOI 10.1016/j.rse.2011.08.024; Milesi C., 2011, EOS T, V92, P109, DOI DOI 10.1029/2011EO130001; Phelps J, 2012, NAT CLIM CHANGE, V2, P497, DOI [10.1038/NCLIMATE1462, 10.1038/nclimate1462]; Roy DP, 2010, REMOTE SENS LETT, V1, P111, DOI 10.1080/01431160903486693; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010	7	145	159	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					30	31		10.1038/513030a	http://dx.doi.org/10.1038/513030a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186885	Bronze			2022-12-28	WOS:000341174800012
J	Lee, M; Kim, B; Kim, VN				Lee, Mihye; Kim, Boseon; Kim, V. Narry			Emerging Roles of RNA Modification: m(6)A and U-Tail	CELL			English	Review							ARABIDOPSIS MESSENGER-RNA; 3' END; MICRORNA BIOGENESIS; POLY(A) POLYMERASE; PRE-MICRORNA; NUCLEAR-RNA; 5' TERMINUS; STEM-LOOP; METHYLATION; URIDYLATION	Although more than 100 types of RNA modification have been described thus far, most of them were thought to be rare in mRNAs and in regulatory noncoding RNAs. Recent developments have unveiled that at least some of the modifications are considerably abundant and widely conserved. This Minireview summarizes the molecular machineries and biological functions of methylation (N6-methyladenosine, m(6)A) and uridylation (U-tail).	[Lee, Mihye; Kim, Boseon; Kim, V. Narry] Inst for Basic Sci Korea, IBS Ctr RNA Res, Seoul 151742, South Korea; [Lee, Mihye; Kim, Boseon; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU)	Kim, VN (corresponding author), Inst for Basic Sci Korea, IBS Ctr RNA Res, Seoul 151742, South Korea.	narrykim@snu.ac.kr		Lee, Mihye/0000-0001-9689-6937	Institute for Basic Science (IBS) from the Ministry of Science, Information, and Communication Technology (ICT) [EM1402]; Future Planning of Korea; BK21 Research Fellowships from the Ministry of Education of Korea	Institute for Basic Science (IBS) from the Ministry of Science, Information, and Communication Technology (ICT); Future Planning of Korea; BK21 Research Fellowships from the Ministry of Education of Korea(Ministry of Education (MOE), Republic of Korea)	The authors are grateful to the members of their laboratory, particularly Jaechul Lim and Minju Ha for helpful discussions and comments. This work was supported by the Research Center Program (EM1402) of the Institute for Basic Science (IBS) from the Ministry of Science, Information, and Communication Technology (ICT) and Future Planning of Korea (M.L., B. K., and V.N.K.) and by BK21 Research Fellowships from the Ministry of Education of Korea (B. K.).	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Bokar J.A., 2005, FINE TUNING RNA FUNC; Bokar JA, 1997, RNA, V3, P1233; CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Faehnle C.R., 2014, NATURE; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Ibrahim F, 2006, SCIENCE, V314, P1893, DOI 10.1126/science.1135268; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Lyons SM, 2014, RNA, V20, P88, DOI 10.1261/rna.042531.113; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Morozov IY, 2012, MOL CELL BIOL, V32, P2585, DOI 10.1128/MCB.00316-12; Morozov IY, 2010, MOL CELL BIOL, V30, P460, DOI 10.1128/MCB.00997-09; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Norbury CJ, 2013, NAT REV MOL CELL BIO, V14, P643, DOI 10.1038/nrm3645; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Sement FM, 2013, NUCLEIC ACIDS RES, V41, P7115, DOI 10.1093/nar/gkt465; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Slevin MK, 2014, MOL CELL, V53, P1020, DOI 10.1016/j.molcel.2014.02.027; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; Su W, 2013, RNA, V19, P1, DOI 10.1261/rna.034470.112; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Ustianenko D, 2013, RNA, V19, P1632, DOI 10.1261/rna.040055.113; Vilfan ID, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-8; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Yeom KH, 2011, EMBO REP, V12, P690, DOI 10.1038/embor.2011.100; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zheng GQ, 2013, RNA BIOL, V10, P915, DOI 10.4161/rna.24711; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	64	188	200	8	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					980	987		10.1016/j.cell.2014.08.005	http://dx.doi.org/10.1016/j.cell.2014.08.005			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25171402	Bronze			2022-12-28	WOS:000340945000005
J	Diacon, AH; Pym, A; Grobusch, MP; de los Rios, JM; Gotuzzo, E; Vasilyeva, I; Leimane, V; Andries, K; Bakare, N; De Marez, T; Haxaire-Theeuwes, M; Lounis, N; Meyvisch, P; De Paepe, E; van Heeswijk, RPG; Dannemann, B				Diacon, Andreas H.; Pym, Alexander; Grobusch, Martin P.; de los Rios, Jorge M.; Gotuzzo, Eduardo; Vasilyeva, Irina; Leimane, Vaira; Andries, Koen; Bakare, Nyasha; De Marez, Tine; Haxaire-Theeuwes, Myriam; Lounis, Nacer; Meyvisch, Paul; De Paepe, Els; van Heeswijk, Rolf P. G.; Dannemann, Brian		TMC207-C208 Study Grp	Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY BACTERICIDAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; DIARYLQUINOLINE TMC207	BACKGROUND Bedaquiline (Sirturo, TMC207), a diarylquinoline that inhibits mycobacterial ATP synthase, has been associated with accelerated sputum-culture conversion in patients with multidrug-resistant tuberculosis, when added to a preferred background regimen for 8 weeks. METHODS In this phase 2b trial, we randomly assigned 160 patients with newly diagnosed, smear-positive, multidrug-resistant tuberculosis to receive either 400 mg of bedaquiline once daily for 2 weeks, followed by 200 mg three times a week for 22 weeks, or placebo, both in combination with a preferred background regimen. The primary efficacy end point was the time to sputum-culture conversion in liquid broth. Patients were followed for 120 weeks from baseline. RESULTS Bedaquiline reduced the median time to culture conversion, as compared with placebo, from 125 days to 83 days (hazard ratio in the bedaquiline group, 2.44; 95% confidence interval, 1.57 to 3.80; P< 0.001 by Cox regression analysis) and increased the rate of culture conversion at 24 weeks (79% vs. 58%, P = 0.008) and at 120 weeks (62% vs. 44%, P = 0.04). On the basis of World Health Organization outcome definitions for multidrug-resistant tuberculosis, cure rates at 120 weeks were 58% in the bedaquiline group and 32% in the placebo group (P = 0.003). The overall incidence of adverse events was similar in the two groups. There were 10 deaths in the bedaquiline group and 2 in the placebo group, with no causal pattern evident. CONCLUSIONS The addition of bedaquiline to a preferred background regimen for 24 weeks resulted in faster culture conversion and significantly more culture conversions at 120 weeks, as compared with placebo. There were more deaths in the bedaquiline group than in the placebo group. (Funded by Janssen Pharmaceuticals; TMC207-C208 ClinicalTrials.gov number, NCT00449644.)	[Diacon, Andreas H.] Univ Stellenbosch, Natl Res Fdn, Ctr Excellence Biomed TB Res, Div Med Physiol, Cape Town, South Africa; [Diacon, Andreas H.] Univ Stellenbosch, Natl Res Fdn, Ctr Excellence Biomed TB Res, Dept Sci & Technol, Cape Town, South Africa; [Diacon, Andreas H.] Univ Stellenbosch, MRC, Ctr TB Res, Fac Med & Hlth Sci, Cape Town, South Africa; [Pym, Alexander] MRC, Durban, South Africa; [Pym, Alexander] Kwazulu Res Inst TB & HIV, Durban, South Africa; [Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Ctr Trop Med & Travel Med,Dept Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [de los Rios, Jorge M.] Hosp Maria Auxiliadora, Serv Neumol, Ctr Excelencia El Control TB Nino Jesus, Lima, Peru; [Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Vasilyeva, Irina] Russian Acad Med Sci, Cent TB Res Inst, Moscow 109801, Russia; [Leimane, Vaira] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia; [Andries, Koen; Bakare, Nyasha; Haxaire-Theeuwes, Myriam; Lounis, Nacer; Meyvisch, Paul; De Paepe, Els; van Heeswijk, Rolf P. G.] Janssen Infect Dis, Beerse, Belgium; [De Marez, Tine; Dannemann, Brian] Janssen Res & Dev, Titusville, NJ 08560 USA	National Research Foundation - South Africa; Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; University of Amsterdam; Academic Medical Center Amsterdam; Universidad Peruana Cayetano Heredia; Russian Academy of Medical Sciences; Riga East University Hospital; Johnson & Johnson; Janssen Pharmaceuticals	Dannemann, B (corresponding author), Janssen Res & Dev, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA.	bdannema@its.jnj.com		Pym, Alexander/0000-0002-6260-8180; Soria, Jaime/0000-0002-5863-0502	Janssen Pharmaceuticals [TMC207-C208]	Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Funded by Janssen Pharmaceuticals; TMC207-C208 ClinicalTrials.gov number, NCT00449644.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bloss E, 2010, INT J TUBERC LUNG D, V14, P275; CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Diacon AH, 2010, EUR J CLIN MICROBIOL, V29, P1561, DOI 10.1007/s10096-010-1043-7; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Fridericia L, 1920, ACTA MED SCAND, V57, P469, DOI DOI 10.1111/J.0954-6820.1920.TB18266.X; Janssen Pharmaceutical, 2012, PRESCR INF SIRT BED; Kent PT., 1985, PUBLIC HLTH MICROBIO; Lounis N, 2006, ANTIMICROB AGENTS CH, V50, P3543, DOI 10.1128/AAC.00766-06; Pym A., 2013, INT J TUBERC LUNG S2, V17, pS236; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Sagwa Evans, 2012, South Med Rev, V5, P6; Tasneen R, 2011, ANTIMICROB AGENTS CH, V55, P5485, DOI 10.1128/AAC.05293-11; Veziris N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017556; World Health Organization, GLOB TUB REP 2013; World Health Organization (WHO), GUID PROGR MAN DRUG; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	19	463	492	5	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					723	732		10.1056/NEJMoa1313865	http://dx.doi.org/10.1056/NEJMoa1313865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140958	Bronze			2022-12-28	WOS:000340509900007
J	Klig, JE; Sharma, A; Skolnik, AB				Klig, Jean E.; Sharma, Amita; Skolnik, Aaron B.			Case 26-2014: A 21-Month-Old Boy with Lethargy, Respiratory Distress, and Abdominal Distention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SALICYLATE		[Klig, Jean E.; Sharma, Amita] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Klig, Jean E.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Klig, Jean E.; Sharma, Amita] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Skolnik, Aaron B.] Banner Good Samaritan Med Ctr, Dept Med Toxicol, Phoenix, AZ USA; [Skolnik, Aaron B.] Univ Arizona, Coll Med, Dept Emergency Med, Phoenix, AZ USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Banner Research; Banner Health; University of Arizona	Klig, JE (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.		Klig, Jean/N-8505-2019	Skolnik, Aaron/0000-0001-7373-5890				Am Acad Clin Toxicology, 1999, J TOXICOL-CLIN TOXIC, V37, P731; American College of Medical Toxicology, 2013, GUID DOC MAN PRIOR S; Avner JR, 2010, TXB PEDIAT EMERGENCY, P153; Bora K, 2010, AM J EMERG MED, V28, P383, DOI 10.1016/j.ajem.2009.12.003; CHAPMAN BJ, 1989, Q J MED, V72, P699; COHEN AS, 1956, NEW ENGL J MED, V254, P457, DOI 10.1056/NEJM195603082541003; Fertel BS, 2009, KIDNEY INT, V75, P1349, DOI 10.1038/ki.2008.443; HILL JB, 1973, NEW ENGL J MED, V288, P1110, DOI 10.1056/NEJM197305242882107; Isaacman DJ, 2012, APLS PEDIAT EMERGENC, P148; JUNG TTK, 1993, OTOLARYNG CLIN N AM, V26, P791; LEVY G, 1978, PEDIATRICS, V62, P867; Ludwig S, 2010, TXB PEDIAT EMERGENCY, P1; Nelson L., 2019, GOLDFRANKS TOXICOLOG, V11th; Proudfoot AT, 2004, J TOXICOL-CLIN TOXIC, V42, P1, DOI 10.1081/CLT-120028740; Shalkham AS, 2006, AM J KIDNEY DIS, V48, P239, DOI 10.1053/j.ajkd.2006.04.080; THISTED B, 1987, ACTA ANAESTH SCAND, V31, P312, DOI 10.1111/j.1399-6576.1987.tb02574.x; THURSTON JH, 1970, J CLIN INVEST, V49, P2139, DOI 10.1172/JCI106431; Zorc JA, 2008, PEDIAT EMERGENCY MED, P115	18	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					767	773		10.1056/NEJMcpc1400834	http://dx.doi.org/10.1056/NEJMcpc1400834			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140963				2022-12-28	WOS:000340509900013
J	Carlile, TM; Rojas-Duran, MF; Zinshteyn, B; Shin, H; Bartoli, KM; Gilbert, WV				Carlile, Thomas M.; Rojas-Duran, Maria F.; Zinshteyn, Boris; Shin, Hakyung; Bartoli, Kristen M.; Gilbert, Wendy V.			Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE DELETION; DETERMINANTS; PSI; IDENTIFICATION; STABILIZATION; SYNTHETASE; SEQUENCES; ALIGNMENT; SYNTHASE	Post-transcriptional modification of RNA nucleosides occurs in all living organisms. Pseudouridine, the most abundant modified nucleoside in non-codingRNAs(1), enhances the function of transfer RNA and ribosomal RNA by stabilizing the RNA structure(2-8). Messenger RNAs were not known to contain pseudouridine, but artificial pseudouridylation dramatically affects mRNA function-it changes the genetic code by facilitating non-canonical base pairing in the ribosome decoding centre(9,10). However, without evidence of naturally occurring mRNA pseudouridylation, its physiological relevance was unclear. Here we present a comprehensive analysis of pseudouridylation in Saccharomyces cerevisiae and human RNAs using Pseudo-seq, a genome-wide, single-nucleotide-resolution method for pseudouridine identification. Pseudo-seq accurately identifies known modification sites aswell as many novel sites in non-coding RNAs, and reveals hundreds of pseudouridylated sites in mRNAs. Genetic analysis allowed us to assign most of the new modification sites to one of seven conserved pseudouridine synthases, Pus1-4, 6, 7 and 9. Notably, the majority of pseudouridines in mRNA are regulated in response to environmental signals, such as nutrient deprivation in yeast and serum starvation in human cells. These results suggest a mechanism for the rapid and regulated rewiring of the genetic code through inducible mRNA modifications. Our findings reveal unanticipated roles for pseudouridylation and provide a resource for identifying the targets of pseudouridine synthases implicated in human disease(11-13).	[Carlile, Thomas M.; Rojas-Duran, Maria F.; Zinshteyn, Boris; Shin, Hakyung; Bartoli, Kristen M.; Gilbert, Wendy V.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gilbert, WV (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	wgilbert@mit.edu		/0000-0003-2807-9657; Carlile, Thomas/0000-0002-7699-9354; Zinshteyn, Boris/0000-0003-0103-3501	American Cancer Society - Robbie Sue Mudd Kidney Cancer Research Scholar Grant [RSG-13-396-01-RMC]; National Institutes of Health [GM094303, GM081399]; American Cancer Society New England Division (Ellison Foundation Postdoctoral Fellowship); American Cancer Society [PF-13-319-01 - RMC]; NIH Pre-Doctoral Training Grant [T32GM007287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM081399, K99GM081399, R01GM094303, T32GM007287, R01GM101316] Funding Source: NIH RePORTER	American Cancer Society - Robbie Sue Mudd Kidney Cancer Research Scholar Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society New England Division (Ellison Foundation Postdoctoral Fellowship); American Cancer Society(American Cancer Society); NIH Pre-Doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Cheeseman, C. Burge, U. RajBhandary, D. Bartel and members of the Gilbert laboratory for comments and discussion. The sequencing was performed at the BioMicro Center under the direction of S. Levine. This work was supported by grants from The American Cancer Society - Robbie Sue Mudd Kidney Cancer Research Scholar Grant (RSG-13-396-01-RMC) and the National Institutes of Health (GM094303, GM081399) to W. V. G. T. M. C. was supported by the American Cancer Society New England Division (Ellison Foundation Postdoctoral Fellowship), and K. M. B. was supported by a Postdoctoral Fellowship (PF-13-319-01 - RMC) from the American Cancer Society. This work was supported in part by the NIH Pre-Doctoral Training Grant T32GM007287.	Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941; Arluison V, 1999, J MOL BIOL, V289, P491, DOI 10.1006/jmbi.1999.2789; ARNEZ JG, 1994, BIOCHEMISTRY-US, V33, P7560, DOI 10.1021/bi00190a008; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Charette M, 2000, IUBMB LIFE, V49, P341; Chen L, 2013, P NATL ACAD SCI USA, V110, pE2741, DOI 10.1073/pnas.1218884110; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Davis DR, 1998, J BIOMOL STRUCT DYN, V15, P1121, DOI 10.1080/07391102.1998.10509006; DAVIS DR, 1991, BIOCHEMISTRY-US, V30, P4223, DOI 10.1021/bi00231a017; DAVIS FF, 1957, J BIOL CHEM, V227, P907; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fernandez IS, 2013, NATURE, V500, P107, DOI 10.1038/nature12302; HALL KB, 1991, BIOCHEMISTRY-US, V30, P1795, DOI 10.1021/bi00221a010; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hudson GA, 2013, RNA, V19, P1474, DOI 10.1261/rna.039610.113; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Sambrook J., 2001, MOL CLONING; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543	44	561	584	14	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					143	+		10.1038/nature13802	http://dx.doi.org/10.1038/nature13802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25192136	Green Accepted, Green Submitted			2022-12-28	WOS:000344187500046
J	Bos, KI; Harkins, KM; Herbig, A; Coscolla, M; Weber, N; Comas, I; Forrest, SA; Bryant, JM; Harris, SR; Schuenemann, VJ; Campbell, TJ; Majander, K; Wilbur, AK; Guichon, RA; Steadman, DLW; Cook, DC; Niemann, S; Behr, MA; Zumarraga, M; Bastida, R; Huson, D; Nieselt, K; Young, D; Parkhill, J; Buikstra, JE; Gagneux, S; Stone, AC; Krause, J				Bos, Kirsten I.; Harkins, Kelly M.; Herbig, Alexander; Coscolla, Mireia; Weber, Nico; Comas, Inaki; Forrest, Stephen A.; Bryant, Josephine M.; Harris, Simon R.; Schuenemann, Verena J.; Campbell, Tessa J.; Majander, Kerttu; Wilbur, Alicia K.; Guichon, Ricardo A.; Steadman, Dawnie L. Wolfe; Cook, Della Collins; Niemann, Stefan; Behr, Marcel A.; Zumarraga, Martin; Bastida, Ricardo; Huson, Daniel; Nieselt, Kay; Young, Douglas; Parkhill, Julian; Buikstra, Jane E.; Gagneux, Sebastien; Stone, Anne C.; Krause, Johannes			Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis	NATURE			English	Article							TRANSMISSION; DISEASE; DNA	Modern strains of Mycobacterium tuberculosis from the Americas are closely related to those from Europe, supporting the assumption that human tuberculosis was introduced post-contact(1). This notion, however, is incompatible with archaeological evidence of pre-contact tuberculosis in the New World(2). Comparative genomics of modern isolates suggests that M. tuberculosis attained its worldwide distribution following human dispersals out of Africa during the Pleistocene epoch(3), although this has yet to be confirmed with ancient calibration points. Here we present three 1,000-year-old mycobacterial genomes from Peruvian human skeletons, revealing that a member of the M. tuberculosis complex caused human disease before contact. The ancient strains are distinct from known human-adapted forms and are most closely related to those adapted to seals and sea lions. Two independent dating approaches suggest a most recent common ancestor for the M. tuberculosis complex less than 6,000 years ago, which supports a Holocene dispersal of the disease. Our results implicate sea mammals as having played a role in transmitting the disease to humans across the ocean.	[Bos, Kirsten I.; Herbig, Alexander; Forrest, Stephen A.; Schuenemann, Verena J.; Majander, Kerttu; Krause, Johannes] Univ Tubingen, Dept Archaeol Sci, D-72070 Tubingen, Germany; [Harkins, Kelly M.; Wilbur, Alicia K.; Buikstra, Jane E.; Stone, Anne C.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Herbig, Alexander; Weber, Nico; Huson, Daniel; Nieselt, Kay] Univ Tubingen, Ctr Bioinformat, D-72076 Tubingen, Germany; [Coscolla, Mireia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland; [Coscolla, Mireia; Gagneux, Sebastien] Univ Basel, CH-4003 Basel, Switzerland; [Comas, Inaki] FISABIO Publ Hlth, Genom & Hlth Unit, Valencia 46020, Spain; [Comas, Inaki] Inst Salud Carlos III, CIBER Ctr Invest Biomed Red Epidemiol & Publ Hlth, Madrid 28029, Spain; [Bryant, Josephine M.; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Campbell, Tessa J.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Guichon, Ricardo A.] UNMDP, FCEyN, Dept Biol, CONICET,Lab Ecologia Evolut Humana FACSO,UNCPBA, RA-7631 Quequen, Argentina; [Steadman, Dawnie L. Wolfe] Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA; [Cook, Della Collins] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Niemann, Stefan] Forschungszentrum Borstel, D-23845 Borstel, Germany; [Niemann, Stefan] Forschungszentrum Borstel, German Ctr Infect Res, D-23845 Borstel, Germany; [Behr, Marcel A.] McGill Univ, McGill Int TB Ctr, Montreal, PQ H3G 1A4, Canada; [Zumarraga, Martin] CICVyA INTA Castelar, Inst Biotechnol, Buenos Aires, DF, Argentina; [Bastida, Ricardo] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Inst Invest Marinas & Costeras CONICET UNMcP, RA-7600 Mar Del Plata, Buenos Aires, Argentina; [Young, Douglas] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England; [Young, Douglas] MRC Natl Inst Med Res, Div Mycobacterial Res, London NW7 1AA, England; [Krause, Johannes] Univ Tubingen, Senckenberg Ctr Human Evolut & Palaeoenvironm, D-72070 Tubingen, Germany; [Krause, Johannes] Max Planck Inst Sci & Hist, D-07745 Jena, Germany	Eberhard Karls University of Tubingen; Arizona State University; Arizona State University-Tempe; Eberhard Karls University of Tubingen; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Wellcome Trust Sanger Institute; University of Cape Town; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Tennessee System; University of Tennessee Knoxville; Indiana University System; Indiana University Bloomington; Forschungszentrum Borstel; Forschungszentrum Borstel; German Center for Infection Research; McGill University; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Mar del Plata; Imperial College London; MRC National Institute for Medical Research; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Bos, KI (corresponding author), Univ Tubingen, Dept Archaeol Sci, Ruemelinstr 23, D-72070 Tubingen, Germany.	kirsten.bos@ifu.uni-tuebingen.de; johannes.krause@uni-tuebingen.de	Comas, Iñaki/F-1185-2011; Gagneux, Sebastien/ABE-7909-2020; Steadman, Dawnie/AAG-4216-2020; Coscolla, Mireia/ABD-7942-2021; Niemann, Stefan/C-9327-2011; Huson, Daniel H./AAC-5494-2019; Parkhill, Julian/G-4703-2011; Krause, Johannes/E-6640-2015; Harris, Simon R/K-1318-2013; Bryant, Josephine/ABC-8288-2021; Comas, Iñaki/AAA-1155-2019; Krause, Johannes/AFP-2642-2022	Comas, Iñaki/0000-0001-5504-9408; Parkhill, Julian/0000-0002-7069-5958; Krause, Johannes/0000-0001-5475-4690; Harris, Simon R/0000-0003-1512-6194; Comas, Iñaki/0000-0001-5504-9408; Krause, Johannes/0000-0001-9144-3920; Bos, Kirsten/0000-0003-2937-3006; Niemann, Stefan/0000-0002-6604-0684; Stone, Anne/0000-0001-8021-8314; Steadman, Dawnie/0000-0003-0812-0739; Gagneux, Sebastien/0000-0001-7783-9048; Harkins, Kelly/0000-0002-0756-4250; Herbig, Alexander/0000-0003-1176-1166; Campbell, Tessa/0000-0001-6215-2681; Coscolla, Mireia/0000-0003-0752-0538	European Research Council starting grant APGREID; National Science Foundation [NSF BCS-1063939, NSF-REU BCS-0612222, NSF BCS-0612222]; Social Sciences and Humanities Research Council of Canada [756-2011-501]; National Science Foundation Graduate Research Fellowship [DGE-1311230]; Jacob K. Javits Fellowship; Ramon y Cajal Spanish [RYC-2012-10627]; Swiss National Science Foundation [PP0033_119205]; National Institutes of Health [AI090928]; European Research Council, Argentina [309540, PICT0575]; Wadsworth Fellowship from the Wenner-Gren Foundation; Wellcome Trust [098051]; Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928] Funding Source: NIH RePORTER; Medical Research Council [974668, MC_U117581288] Funding Source: researchfish; Direct For Social, Behav & Economic Scie [1063939] Funding Source: National Science Foundation; MRC [MC_U117581288] Funding Source: UKRI	European Research Council starting grant APGREID; National Science Foundation(National Science Foundation (NSF)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Jacob K. Javits Fellowship; Ramon y Cajal Spanish; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council, Argentina; Wadsworth Fellowship from the Wenner-Gren Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the following people and institutions for assistance and/or permission for sampling: Museo Contisuyo, Centro Mallqui, S. Guillen, Instituto Nacional de Cultura, Peru, G. Cock, C. Gaither, M. Murphy, M. C. Lozada, S. Burgess, D. Blom, B. Owen,A. Oquiche Hernani, P. Palacios Filinich,S. Williams, B. Vargas, D. Rice, and H. Klaus, S. Pfieffer, the University of Toronto, the Upper Mississippi Valley Archaeological Research Foundation, L. Conrad, Indiana University, G. Milner, the Pennsylvania State University, the American Museum of Natural History, A. Stodder, B. Brier, I. Tattersall, K. Mowbray, the National Museum of Natural History (Smithsonian Institution), B. Billeck, the Smithsonian Institution, N. Tuross, L.-A. Pfister, Rochester Museum & Science Center, L. P. Saunders, C. Grivas, G. Housman, and M. Nieves-Colon. We thank H. Poinar for discussions about capture regions for M. tuberculosis screening. We thank B. Coombes and B. Krause-Kyora for providing modern tuberculosis for bait manufacture. The Huron Wendat Nation is aware of the sampling of Uxbridge bone and is a recipient of information from this study. We acknowledge the following sources of funding: European Research Council starting grant APGREID (to J.K.), the National Science Foundation (to A.C.S. and J.E.B.) for NSF BCS-1063939, NSF-REU BCS-0612222, and NSF BCS-0612222, the George E. Burch Fellow in Theoretic Medicine and Affiliated Sciences at the Smithsonian Institution (2003-2007, to J.E.B.), Social Sciences and Humanities Research Council of Canada postdoctoral fellowship grant 756-2011-501 (to K.I.B.), National Science Foundation Graduate Research Fellowship DGE-1311230 and Jacob K. Javits Fellowship (to K.M.H.), Ramon y Cajal Spanish research grant RYC-2012-10627 (to I.C.), Swiss National Science Foundation PP0033_119205 (to S.G.), National Institutes of Health AI090928 (to S.G.), European Research Council 309540 (to S.G.), PICT0575 Argentina (to R.A.G.), Wadsworth Fellowship from the Wenner-Gren Foundation (to T.J.C.), Wellcome Trust 098051 (to J.P., J.M.B. and S.R.H.), and funding from the Medical Research Council (to J.M.B.).	Anawalt P. R., 1992, LAT AM ANTIQ, V3, P114, DOI DOI 10.2307/971939; ARRIAZA BT, 1995, AM J PHYS ANTHROPOL, V98, P37, DOI 10.1002/ajpa.1330980104; Bastida R, 1999, J WILDLIFE DIS, V35, P796, DOI 10.7589/0090-3558-35.4.796; Bastida R., 2011, REV ARGENT ANTROPOL, V13, P83; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Botella H, 2012, TRENDS MICROBIOL, V20, P106, DOI 10.1016/j.tim.2012.01.005; Bouwman AS, 2012, P NATL ACAD SCI USA, V109, P18511, DOI 10.1073/pnas.1209444109; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295; Cockburn A., 1963, EVOLUTION ERADICATIO; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Coscolla M, 2013, EMERG INFECT DIS, V19, P969, DOI 10.3201/eid1906.121012; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Herring DA, 2007, AM J HUM BIOL, V19, P190, DOI 10.1002/ajhb.20618; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Jurczynski K, 2011, J ZOO WILDLIFE MED, V42, P222, DOI 10.1638/2009-0207.1; PATRUCCO R, 1983, CURR ANTHROPOL, V24, P393, DOI 10.1086/203016; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Roberts C. A., 2003, BIOARCHAEOLOGY TUBER, P187; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Shapiro B, 2006, INT J INFECT DIS, V10, P334, DOI 10.1016/j.ijid.2006.02.006; Wirth T., 2008, PLOS PATHOG, V4	30	299	307	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					494	+		10.1038/nature13591	http://dx.doi.org/10.1038/nature13591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25141181	Green Accepted, Green Published			2022-12-28	WOS:000343775900041
J	Schenkel, JM; Fraser, KA; Beura, LK; Pauken, KE; Vezys, V; Masopust, D				Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Pauken, Kristen E.; Vezys, Vaiva; Masopust, David			Resident memory CD8 T cells trigger protective innate and adaptive immune responses	SCIENCE			English	Article							NATURAL-KILLER-CELLS; VIRUS-INFECTION; RM CELLS; TISSUE; MIGRATION; HERPES	The pathogen recognition theory dictates that, upon viral infection, the innate immune system first detects microbial products and then responds by providing instructions to adaptive CD8 T cells. Here, we show in mice that tissue resident memory CD8 T cells (T-RM cells), non-recirculating cells located at common sites of infection, can achieve near-sterilizing immunity against viral infections by reversing this flow of information. Upon antigen resensitization within the mouse female reproductive mucosae, CD8(+) T-RM cells secrete cytokines that trigger rapid adaptive and innate immune responses, including local humoral responses, maturation of local dendritic cells, and activation of natural killer cells. This provided near-sterilizing immunity against an antigenically unrelated viral infection. Thus, CD8(+) T-RM cells rapidly trigger an antiviral state by amplifying receptor-derived signals from previously encountered pathogens.	[Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Pauken, Kristen E.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Pauken, Kristen E.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Masopust, D (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	Schenkel, Jason/AAV-8184-2020; Vezys, Vaiva/N-3144-2013; Beura, Lalit/W-6281-2019; Pauken, Kristen E./ABA-9363-2020; masopust, david/B-5027-2008	Schenkel, Jason/0000-0003-4641-6872; Vezys, Vaiva/0000-0002-2520-809X	NIH [R01AI084913, T32AI007313, F30DK100159]; NIH Director's New Innovator Award Program [DP2-OD-006467]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI084913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was funded by NIH grant R01AI084913 (D. M.), NIH Director's New Innovator Award Program DP2-OD-006467 (D. M.), and NIH grants T32AI007313 and F30DK100159 (J.M.S.).	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180	22	430	438	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					98	101		10.1126/science.1254536	http://dx.doi.org/10.1126/science.1254536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25170049	Green Accepted			2022-12-28	WOS:000342446900059
J	Qiu, XG; Wong, G; Audet, J; Bello, A; Fernando, L; Alimonti, JB; Fausther-Bovendo, H; Wei, HY; Aviles, J; Hiatt, E; Johnson, A; Morton, J; Swope, K; Bohorov, O; Bohorova, N; Goodman, C; Kim, D; Pauly, MH; Velasco, J; Pettitt, J; Olinger, GG; Whaley, K; Xu, BL; Strong, JE; Zeitlin, L; Kobinger, GP				Qiu, Xiangguo; Wong, Gary; Audet, Jonathan; Bello, Alexander; Fernando, Lisa; Alimonti, Judie B.; Fausther-Bovendo, Hugues; Wei, Haiyan; Aviles, Jenna; Hiatt, Ernie; Johnson, Ashley; Morton, Josh; Swope, Kelsi; Bohorov, Ognian; Bohorova, Natasha; Goodman, Charles; Kim, Do; Pauly, Michael H.; Velasco, Jesus; Pettitt, James; Olinger, Gene G.; Whaley, Kevin; Xu, Bianli; Strong, James E.; Zeitlin, Larry; Kobinger, Gary P.			Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp	NATURE			English	Article							POSTEXPOSURE PROTECTION; MEDIATED PROTECTION; HEMORRHAGIC-FEVER; ANTIBODIES; INFECTION; CHALLENGE	Without an approved vaccine or treatments, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission. These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa. Here we show that a combination of monoclonal antibodies (ZMapp), optimized from two previous antibody cocktails, is able to rescue 100% of rhesus macaques when treatment is initiated up to 5 days post-challenge. High fever, viraemia and abnormalities in blood count and blood chemistry were evident in many animals before ZMapp intervention. Advanced disease, as indicated by elevated liver enzymes, mucosal haemorrhages and generalized petechia could be reversed, leading to full recovery. ELISA and neutralizing antibody assays indicate that ZMapp is cross-reactive with the Guinean variant of Ebola. ZMapp exceeds the efficacy of any other therapeutics described so far, and results warrant further development of this cocktail for clinical use.	[Qiu, Xiangguo; Wong, Gary; Audet, Jonathan; Bello, Alexander; Fernando, Lisa; Alimonti, Judie B.; Fausther-Bovendo, Hugues; Wei, Haiyan; Aviles, Jenna; Strong, James E.; Kobinger, Gary P.] Publ Hlth Agcy Canada, Natl Lab Zoonot Dis & Special Pathogens, Winnipeg, MB R3E 3R2, Canada; [Wong, Gary; Audet, Jonathan; Bello, Alexander; Fausther-Bovendo, Hugues; Strong, James E.; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada; [Wei, Haiyan; Xu, Bianli] Henan Ctr Dis Control & Prevent, Inst Infect Dis, Zhengzhou 450012, Henan, Peoples R China; [Hiatt, Ernie; Johnson, Ashley; Morton, Josh; Swope, Kelsi] Kentucky BioProc, Owensboro, KY 42301 USA; [Bohorov, Ognian; Bohorova, Natasha; Goodman, Charles; Kim, Do; Pauly, Michael H.; Velasco, Jesus; Whaley, Kevin; Zeitlin, Larry] Mapp Biopharmaceut Inc, San Diego, CA 92121 USA; [Pettitt, James; Olinger, Gene G.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Strong, James E.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada; [Kobinger, Gary P.] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0T5, Canada; [Kobinger, Gary P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Manitoba; University of Pennsylvania	Zeitlin, L (corresponding author), Mapp Biopharmaceut Inc, San Diego, CA 92121 USA.	larry.zeitlin@mappbio.com; gary.kobinger@phac-aspc.gc.ca	Audet, Jonathan/AAH-5546-2019; Hiatt, Emmett Ernie/HHN-0699-2022	Audet, Jonathan/0000-0002-0743-7489; Swope, Kelsi/0000-0003-1085-0319; Olinger, Gene/0000-0001-7338-0292; Goodman, Charles/0000-0002-7968-9466	Defense Threat Reduction Agency (DTRA) [HDTRA1-13-C-0018]; National Institutes of Health [U19AI109762]; Public Health Agency of Canada (PHAC); Canadian Safety and Security Program (CSSP); Canadian Institute for Health Research (CIHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109762] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Agency of Canada (PHAC); Canadian Safety and Security Program (CSSP); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank K. Tierney, A. Grolla, S. Jones, J. Dong and D. Kobasa for their technical assistance, V. Klimyuk and Y. Gleba for access to the magnICON expression system, and H. Steinkellner for access to transgenic N. benthamiana. This work was supported by the Defense Threat Reduction Agency (DTRA contract HDTRA1-13-C-0018), the National Institutes of Health (U19AI109762), the Public Health Agency of Canada (PHAC), and a Canadian Safety and Security Program (CSSP) grant to G. P. K. and X. Q. G. W. is the recipient of a Doctoral Research Award from the Canadian Institute for Health Research (CIHR).	Baize S., 2014, N ENGL J MED; Bausch DG, 2008, ANTIVIR RES, V78, P150, DOI 10.1016/j.antiviral.2008.01.152; CDC, CHRON EB HEM FEV OUT; Clark DV, 2012, VIRUSES-BASEL, V4, P1668, DOI 10.3390/v4091668; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Guimard Y, 1999, J INFECT DIS, V179, pS268, DOI 10.1086/514315; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; NC3RS, PRACT BLOOD SAMPL VO; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; ProMEDmail. org, 2014, EB VIR DIS W AFR; Qiu XG, 2013, SCI REP-UK, V3, DOI 10.1038/srep03365; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575; Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reliefweb W., 2014, AFR EB EP LIK LAST M; UPMChealthsecurity. org, 2013, NEXT GEN MON ANT CHA; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202; WHO, EB VIR DIS EVD; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wong G, VACCINE IN PRESS; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108	33	692	761	5	510	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					47	+		10.1038/nature13777	http://dx.doi.org/10.1038/nature13777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25171469	Green Accepted			2022-12-28	WOS:000342420800032
J	Abboud, R; Sham, R				Abboud, Ramzi; Sham, Ronald			Weakness, Fatigue, and an Abnormal White Blood Cell Count	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC LYMPHOCYTIC-LEUKEMIA; DISEASE		[Abboud, Ramzi] Univ Rochester, Rochester, NY USA; [Sham, Ronald] Rochester Gen Hosp, Rochester, NY 14621 USA	University of Rochester; Rochester General Hospital	Sham, R (corresponding author), Rochester Gen Hosp, 1425 Portland Ave,POB 233, Rochester, NY 14621 USA.	ronald.sham@rochestergeneral.org	Abboud, Ramzi/AAW-2283-2020					Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Ghia P, 2012, HEMATOL-AM SOC HEMAT, P97, DOI 10.1182/asheducation-2012.1.97; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Lichtman M.A., 2011, WILLIAMS MANUAL HEMA; Rawstron AC, 2007, LEUKEMIA, V21, P956, DOI 10.1038/sj.leu.2404584	5	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1051	1052		10.1001/jama.2014.2440	http://dx.doi.org/10.1001/jama.2014.2440			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203085				2022-12-28	WOS:000341385600023
J	Raiten, JM				Raiten, Jesse Michael			The Language of Experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Raiten, JM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA.	j.raiten@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					1001	1001		10.1001/jama.2014.7848	http://dx.doi.org/10.1001/jama.2014.7848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25203079				2022-12-28	WOS:000341385600015
J	Yong, SC; Roversi, P; Lillington, J; Rodriguez, F; Krehenbrink, M; Zeldin, OB; Garman, EF; Lea, SM; Berks, BC				Yong, Shee Chien; Roversi, Pietro; Lillington, James; Rodriguez, Fernanda; Krehenbrink, Martin; Zeldin, Oliver B.; Garman, Elspeth F.; Lea, Susan M.; Berks, Ben C.			A complex iron-calcium cofactor catalyzing phosphotransfer chemistry	SCIENCE			English	Article							ALKALINE-PHOSPHATASE; NORTH-ATLANTIC; CYANOBACTERIUM; UTEROFERRIN; LIMITATION; OCEAN	Alkaline phosphatases play a crucial role in phosphate acquisition by microorganisms. To expand our understanding of catalysis by this class of enzymes, we have determined the structure of the widely occurring microbial alkaline phosphatase PhoX. The enzyme contains a complex active-site cofactor comprising two antiferromagnetically coupled ferric iron ions (Fe3+), three calcium ions (Ca2+), and an oxo group bridging three of the metal ions. Notably, the main part of the cofactor resembles synthetic oxide-centered triangular metal complexes. Structures of PhoX-ligand complexes reveal how the active-site metal ions bind substrate and implicate the cofactor oxo group in the catalytic mechanism. The presence of iron in PhoX raises the possibility that iron bioavailability limits microbial phosphate acquisition.	[Yong, Shee Chien; Rodriguez, Fernanda; Krehenbrink, Martin; Zeldin, Oliver B.; Garman, Elspeth F.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Roversi, Pietro; Lillington, James; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Berks, BC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	susan.lea@path.ox.ac.uk; ben.berks@bioch.ox.ac.uk	Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021; Lea, Susan M/B-7678-2009	Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Lea, Susan M/0000-0001-9287-8053; Garman, Elspeth/0000-0001-8329-5665; Berks, Ben/0000-0001-9685-4067	University of Oxford, Pembroke College Oxford, Oxford Martin School Vaccine Design Institute; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [F02150X]; European Molecular Biology Organization; Biotechnology and Biological Sciences Research Council [BB/F02150X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D032210/1, EP/L011972/1, EP/D048559/1] Funding Source: researchfish; BBSRC [BB/F02150X/1] Funding Source: UKRI; EPSRC [EP/L011972/1, EP/D032210/1, EP/D048559/1] Funding Source: UKRI	University of Oxford, Pembroke College Oxford, Oxford Martin School Vaccine Design Institute; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank G. O'Toole for providing P. fluorescens Pf0-1 genomic DNA; J. Marcoux, B. Pilgrim, and A. Parkin for exploratory experiments; and F. Armstrong, T. Browning, J. McGrady, G. Henderson, D. Herschlag, C. Schofield, A. Thomson, C. Timmel, N. Williams, and R. Williams for valuable discussions. This work was funded by the University of Oxford, Pembroke College Oxford, Oxford Martin School Vaccine Design Institute, the Engineering and Physical Sciences Research Council, the Biotechnology and Biological Sciences Research Council (grant F02150X), and the European Molecular Biology Organization. Structure coordinates and x-ray data have been deposited in the Protein Data Bank with accession codes 4a9v, 4amf, 4alf, and 3zwu.	CANNON RD, 1988, PROG INORG CHEM, V36, P195, DOI 10.1002/9780470166376.ch3; GABER BP, 1979, J BIOL CHEM, V254, P8340; Harke MJ, 2012, MICROB ECOL, V63, P188, DOI 10.1007/s00248-011-9894-8; Jakuba RW, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003119; Kamerlin SCL, 2013, Q REV BIOPHYS, V46, P1, DOI 10.1017/S0033583512000157; Kathuria S, 2011, ENVIRON MICROBIOL, V13, P74, DOI 10.1111/j.1462-2920.2010.02310.x; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Monds RD, 2006, APPL ENVIRON MICROB, V72, P1910, DOI 10.1128/AEM.72.3.1910-1924.2006; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Moore CM, 2006, GLOBAL CHANGE BIOL, V12, P626, DOI 10.1111/j.1365-2486.2006.01122.x; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Oganesyan VS, 2000, J CHEM PHYS, V113, P5003, DOI 10.1063/1.1289531; Orchard ED, 2009, ENVIRON MICROBIOL, V11, P2400, DOI 10.1111/j.1462-2920.2009.01968.x; Prodius D, 2006, POLYHEDRON, V25, P2175, DOI 10.1016/j.poly.2006.01.019; ROY NK, 1982, J BACTERIOL, V150, P1033, DOI 10.1128/JB.150.3.1033-1039.1982; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Schenk G, 2005, P NATL ACAD SCI USA, V102, P273, DOI 10.1073/pnas.0407239102; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; WANG DL, 1991, BIOCHEMISTRY-US, V30, P8187, DOI 10.1021/bi00247a014; Williams NH, 1999, J AM CHEM SOC, V121, P3341, DOI 10.1021/ja9827797; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	25	51	54	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1170	1173		10.1126/science.1254237	http://dx.doi.org/10.1126/science.1254237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25190793	Green Accepted			2022-12-28	WOS:000341179800044
J	Tempel, E				Tempel, Elmo			COSMOLOGY Meet the Laniakea supercluster	NATURE			English	Editorial Material							GALAXIES		Tartu Astrophys Observ, Dept Cosmol, EE-61602 Toravere, Estonia		Tempel, E (corresponding author), Tartu Astrophys Observ, Dept Cosmol, EE-61602 Toravere, Estonia.	elmo.tempel@to.ee	Tempel, Elmo/J-8291-2015	Tempel, Elmo/0000-0002-5249-7018				Bond JR, 1996, NATURE, V380, P603, DOI 10.1038/380603a0; JOEVEER M, 1978, MON NOT R ASTRON SOC, V185, P357, DOI 10.1093/mnras/185.2.357; Liivamagi LJ, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201016288; Shaya EJ, 2013, MON NOT R ASTRON SOC, V436, P2096, DOI 10.1093/mnras/stt1714; Sinclair B, 2010, ASTROPHYS J, V718, P1445, DOI 10.1088/0004-637X/718/2/1445; Zaroubi S, 1999, ASTROPHYS J, V520, P413, DOI 10.1086/307473	8	4	4	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					41	42		10.1038/513041a	http://dx.doi.org/10.1038/513041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25186896				2022-12-28	WOS:000341174800024
